Citrus Sinensis ID: 017147
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 376 | 2.2.26 [Sep-21-2011] | |||||||
| Q39011 | 380 | Shaggy-related protein ki | yes | no | 0.997 | 0.986 | 0.930 | 0.0 | |
| Q39010 | 412 | Shaggy-related protein ki | no | no | 0.994 | 0.907 | 0.895 | 0.0 | |
| Q39012 | 407 | Shaggy-related protein ki | no | no | 0.970 | 0.896 | 0.909 | 0.0 | |
| Q8VZD5 | 410 | Shaggy-related protein ki | no | no | 0.968 | 0.887 | 0.824 | 0.0 | |
| P43289 | 409 | Shaggy-related protein ki | no | no | 0.968 | 0.889 | 0.794 | 1e-179 | |
| P43288 | 405 | Shaggy-related protein ki | no | no | 0.976 | 0.906 | 0.795 | 1e-179 | |
| Q40518 | 409 | Shaggy-related protein ki | N/A | no | 0.976 | 0.897 | 0.781 | 1e-177 | |
| P51137 | 411 | Glycogen synthase kinase- | N/A | no | 0.976 | 0.892 | 0.784 | 1e-177 | |
| P51139 | 411 | Glycogen synthase kinase- | N/A | no | 0.976 | 0.892 | 0.780 | 1e-176 | |
| P51138 | 411 | Glycogen synthase kinase- | N/A | no | 0.976 | 0.892 | 0.769 | 1e-175 |
| >sp|Q39011|KSG7_ARATH Shaggy-related protein kinase eta OS=Arabidopsis thaliana GN=ASK7 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 739 bits (1909), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/375 (93%), Positives = 363/375 (96%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EM AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET
Sbjct: 6 EMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 65
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPES+YRV
Sbjct: 66 VAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRV 125
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
LKHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQVKICDF
Sbjct: 126 LKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDF 185
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 186 GSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
AVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID ASRLL
Sbjct: 246 AVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLL 305
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 361
QYSPSLRCTALEACAHPFFDELREPNARLPNGRP PPLFNFKQE++G+SPELVNKLIPDH
Sbjct: 306 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAGSSPELVNKLIPDH 365
Query: 362 VKRQLGLNFLHPAGT 376
+KRQLGL+FL+ +GT
Sbjct: 366 IKRQLGLSFLNQSGT 380
|
Negative regulator in brassinosteroid signal transduction pathway important for plant growth. May be also involved in auxin signaling pathway. Phosphorylates and increases the degradation of BZR1 and BZR2/BES1 by the proteasome. Phosphorylates BHLH150, beet curly top virus C4 and tomato golden mosaic virus AC4 on threonine and serine residues. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q39010|KSG6_ARATH Shaggy-related protein kinase zeta OS=Arabidopsis thaliana GN=ASK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 716 bits (1848), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 335/374 (89%), Positives = 361/374 (96%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EMSAAV++G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+
Sbjct: 38 EMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGES 97
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQDRRYKNRELQLMR+MDHPNV+SLKHCFFSTT+++ELFLNLVMEYVPE++YRV
Sbjct: 98 VAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRV 157
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
LKHY+S+NQRMP+ YVKLYTYQIFRGLAYIHT P VCHRD+KPQNLLVDPLTHQ K+CDF
Sbjct: 158 LKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDF 217
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAK L+ GEANISYICSR+YRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 218 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGEN 277
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
+VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL
Sbjct: 278 SVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 337
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 361
QYSPSLRCTALEACAHPFF+ELREPNARLPNGRPLPPLFNFKQELSGASPEL+N+LIP+H
Sbjct: 338 QYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQELSGASPELINRLIPEH 397
Query: 362 VKRQLGLNFLHPAG 375
V+RQ+ F AG
Sbjct: 398 VRRQMNGGFPFQAG 411
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39012|KSG9_ARATH Shaggy-related protein kinase iota OS=Arabidopsis thaliana GN=ASK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 709 bits (1831), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/365 (90%), Positives = 355/365 (97%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EMSAAV++G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+
Sbjct: 36 EMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGES 95
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQDRRYKNRELQLMR MDHPNVISLKHCFFSTTS++ELFLNLVMEYVPE++YRV
Sbjct: 96 VAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRV 155
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
L+HY+S+NQRMP+ YVKLYTYQIFRGLAYIHTVP VCHRD+KPQNLLVDPLTHQVK+CDF
Sbjct: 156 LRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 215
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAK L+ GE NISYICSR+YRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 216 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGEN 275
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
+VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL
Sbjct: 276 SVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 335
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 361
QYSPSLRCTALEACAHPFF+ELREPNARLPNGRPLPPLFNFKQEL GAS EL+N+LIP+H
Sbjct: 336 QYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQELGGASMELINRLIPEH 395
Query: 362 VKRQL 366
V+RQ+
Sbjct: 396 VRRQM 400
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 644 bits (1661), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 301/365 (82%), Positives = 333/365 (91%), Gaps = 1/365 (0%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EM AAVVDG+ TGHII TTIGGKNG+PKQTISYMAER+VG GSFGIVFQAKCLETGET
Sbjct: 40 EMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGET 99
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQD+RYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE++YRV
Sbjct: 100 VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRV 159
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
KHYS ANQRMP+IYVKLYTYQI R LAYIH VCHRD+KPQNLLV+P THQVK+CDF
Sbjct: 160 SKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDF 219
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAK L+ GE NISYICSR+YRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPLFPGE+
Sbjct: 220 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGES 279
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKR PPEA+DL SRLL
Sbjct: 280 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLL 339
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPD 360
QYSP+LR TA+EA HPFFDELR+PN RLPNGR LPPLFNFK QEL GAS EL++KLIPD
Sbjct: 340 QYSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPD 399
Query: 361 HVKRQ 365
H ++Q
Sbjct: 400 HARKQ 404
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 629 bits (1622), Expect = e-179, Method: Compositional matrix adjust.
Identities = 290/365 (79%), Positives = 331/365 (90%), Gaps = 1/365 (0%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EM A +V+G+ TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLETGET
Sbjct: 39 EMEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGET 98
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQDRRYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE+++RV
Sbjct: 99 VAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRV 158
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
+KHY+ NQRMPL+YVKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+CDF
Sbjct: 159 IKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDF 218
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAK L+ GE NISYICSR+YRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFPGE+
Sbjct: 219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGES 278
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLL
Sbjct: 279 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 338
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPD 360
QYSP+LRC AL++ HPFFDELR+PNARLPNGR LPPLFNFK EL G E+V KL+P+
Sbjct: 339 QYSPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPE 398
Query: 361 HVKRQ 365
H ++Q
Sbjct: 399 HARKQ 403
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 627 bits (1618), Expect = e-179, Method: Compositional matrix adjust.
Identities = 295/371 (79%), Positives = 332/371 (89%), Gaps = 4/371 (1%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EM A VVDG+ TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLETGET
Sbjct: 35 EMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGET 94
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQDRRYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE+++RV
Sbjct: 95 VAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRV 154
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
+KHY+ NQRMPLIYVKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+CDF
Sbjct: 155 IKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDF 214
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAK L+ GE NISYICSR+YRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFPGE+
Sbjct: 215 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGES 274
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLL
Sbjct: 275 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 334
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPD 360
QYSP+LR AL+ HPFFDELR+PNARLPNGR LPPLFNFK EL G E+V KL+P+
Sbjct: 335 QYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVPE 394
Query: 361 HVKRQ---LGL 368
H ++Q LGL
Sbjct: 395 HARKQCPWLGL 405
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 622 bits (1604), Expect = e-177, Method: Compositional matrix adjust.
Identities = 290/371 (78%), Positives = 331/371 (89%), Gaps = 4/371 (1%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
E+ AA+VDG+ TGHII TTIGG++G+PKQTISYMAER+VG GSFG+VFQAKCLETGET
Sbjct: 39 EIEAAIVDGNGTETGHIIVTTIGGRHGQPKQTISYMAERIVGQGSFGVVFQAKCLETGET 98
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQD+RYKNRELQ MR++DHPNV+ LKHCFFSTT K+E++LNLV+EYVPE+++RV
Sbjct: 99 VAIKKVLQDKRYKNRELQTMRLLDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHRV 158
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
+KHY+ NQRMPLI VKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+CDF
Sbjct: 159 IKHYNKLNQRMPLILVKLYTYQIFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKLCDF 218
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAK L+ GE NISYICSR+YRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPLFPGE+
Sbjct: 219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGES 278
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
VDQLVEIIKVLGTPTREEI+CMNPNY +F+FPQIKAHPWHK+FHKRMPPEA+DL SRLL
Sbjct: 279 GVDQLVEIIKVLGTPTREEIKCMNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 338
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPD 360
QYSP+LRCTALEA H FFDELR+PN RLPNGR LPPLFNFK EL G S E + KL+P+
Sbjct: 339 QYSPNLRCTALEAVTHAFFDELRDPNTRLPNGRVLPPLFNFKAHELKGVSAENLLKLVPE 398
Query: 361 HVKRQ---LGL 368
H ++Q LGL
Sbjct: 399 HARKQCPSLGL 409
|
May mediate extracellular signals to regulate transcription in differentiating cells. Nicotiana tabacum (taxid: 4097) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 620 bits (1600), Expect = e-177, Method: Compositional matrix adjust.
Identities = 291/371 (78%), Positives = 328/371 (88%), Gaps = 4/371 (1%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EM A VVDG+ TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLETGET
Sbjct: 41 EMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGET 100
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQD+RYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE+++RV
Sbjct: 101 VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRV 160
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
+KHYS NQRMP+IYVKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+CDF
Sbjct: 161 IKHYSKLNQRMPMIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDF 220
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAK L+ GE NISYICSR+YRAPELIFGATEYTT+ID+WS GCVLAELLLGQPLFPGE
Sbjct: 221 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGER 280
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMP EA+DL SRLL
Sbjct: 281 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDLVSRLL 340
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPD 360
QYSP+LRC AL+ HPFFDELR+PNARLP GR LPPLFNFK EL G E + KL+P+
Sbjct: 341 QYSPNLRCQALDCLTHPFFDELRDPNARLPTGRFLPPLFNFKPHELKGVPVETLMKLVPE 400
Query: 361 HVKRQ---LGL 368
H ++Q LGL
Sbjct: 401 HARKQCPFLGL 411
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 617 bits (1591), Expect = e-176, Method: Compositional matrix adjust.
Identities = 288/369 (78%), Positives = 328/369 (88%), Gaps = 2/369 (0%)
Query: 2 EMSAA-VVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE 60
EM AA +VDG+ TGHII TTIGGKNG+PKQTISYMAERVVG GSFG+VFQAKCLETGE
Sbjct: 39 EMEAATIVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 98
Query: 61 TVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYR 120
TVAIKKVLQD+RYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE++ R
Sbjct: 99 TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSR 158
Query: 121 VLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 180
V++HY+ NQRMP+IYVKLY+YQI R LAYIH VCHRD+KPQNLLV+P THQ+KICD
Sbjct: 159 VIRHYNKMNQRMPMIYVKLYSYQICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICD 218
Query: 181 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 240
FGSAK L+ GE NISYICSR+YRAPELIFGATEYTT+IDIWSAGCVL ELLLGQPLFPGE
Sbjct: 219 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGE 278
Query: 241 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRL
Sbjct: 279 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 338
Query: 301 LQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIP 359
LQYSP+LR TALEA HPF+D++R+PN RLPNGR LPPLFNFK EL G E++ KL+P
Sbjct: 339 LQYSPNLRSTALEALVHPFYDDVRDPNTRLPNGRFLPPLFNFKVNELKGVPAEMLVKLVP 398
Query: 360 DHVKRQLGL 368
H ++Q L
Sbjct: 399 PHARKQCAL 407
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 613 bits (1580), Expect = e-175, Method: Compositional matrix adjust.
Identities = 283/368 (76%), Positives = 323/368 (87%), Gaps = 1/368 (0%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EM A VVDG+ GH+I TTIGGKNG+PKQTISYMAER VG GSFG+VFQAKCLETGET
Sbjct: 40 EMEAHVVDGNSTEAGHVIVTTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGET 99
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQD+RYKNRELQ MR++DHPNV++LKHCFFSTT K+EL+LNLV+E+VPE+++RV
Sbjct: 100 VAIKKVLQDKRYKNRELQTMRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRV 159
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
++HYS NQRMPLIYVKLY+YQI R LAYIH V HRD+KPQNLLV+P THQ+K+CDF
Sbjct: 160 IRHYSKMNQRMPLIYVKLYSYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCDF 219
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAK L+ GE NISYICSR+YRAPELIFGATEYT++IDIWSAGCVL ELLLGQPLFPG +
Sbjct: 220 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQPLFPGAS 279
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+F KRMPPEA+DL SRLL
Sbjct: 280 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDLVSRLL 339
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPD 360
QYSP+LR TALEA HPFFDELR+PN RLPNGR LPPLFNFK EL G E++ KL+P
Sbjct: 340 QYSPNLRSTALEALVHPFFDELRDPNTRLPNGRHLPPLFNFKANELKGVPAEMLVKLVPS 399
Query: 361 HVKRQLGL 368
H ++Q L
Sbjct: 400 HARKQCSL 407
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 376 | ||||||
| 359483773 | 380 | PREDICTED: shaggy-related protein kinase | 0.997 | 0.986 | 0.941 | 0.0 | |
| 224116828 | 380 | predicted protein [Populus trichocarpa] | 0.997 | 0.986 | 0.944 | 0.0 | |
| 255562450 | 380 | Glycogen synthase kinase-3 beta, putativ | 0.997 | 0.986 | 0.938 | 0.0 | |
| 297804284 | 380 | hypothetical protein ARALYDRAFT_914806 [ | 0.997 | 0.986 | 0.933 | 0.0 | |
| 15233984 | 380 | Shaggy-related protein kinase eta [Arabi | 0.997 | 0.986 | 0.930 | 0.0 | |
| 1161512 | 380 | shaggy-like kinase etha [Arabidopsis tha | 0.997 | 0.986 | 0.925 | 0.0 | |
| 312281491 | 380 | unnamed protein product [Thellungiella h | 0.997 | 0.986 | 0.930 | 0.0 | |
| 227204507 | 374 | AT4G18710 [Arabidopsis thaliana] | 0.994 | 1.0 | 0.930 | 0.0 | |
| 224079065 | 380 | predicted protein [Populus trichocarpa] | 0.997 | 0.986 | 0.930 | 0.0 | |
| 18700188 | 380 | AT4g18710/F28A21_120 [Arabidopsis thalia | 0.997 | 0.986 | 0.928 | 0.0 |
| >gi|359483773|ref|XP_003633016.1| PREDICTED: shaggy-related protein kinase eta-like [Vitis vinifera] gi|297740523|emb|CBI30705.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 745 bits (1924), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/375 (94%), Positives = 367/375 (97%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
E+SA VVDG+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET
Sbjct: 6 EISAPVVDGNDPVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 65
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQDRRYKNRELQLMR MDHPNVISLKHCFFSTTS++ELFLNLVMEYVPE+MYRV
Sbjct: 66 VAIKKVLQDRRYKNRELQLMRTMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETMYRV 125
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
LKHYS+A QRMPLIYVKLYTYQIFRGLAYIH+VP VCHRDLKPQNLLVDPLTHQVK+CDF
Sbjct: 126 LKHYSNAKQRMPLIYVKLYTYQIFRGLAYIHSVPGVCHRDLKPQNLLVDPLTHQVKLCDF 185
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAK L+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 186 GSAKVLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
AVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL
Sbjct: 246 AVDQLVEIIKVLGTPTREEIRCMNPSYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 305
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 361
QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIP+H
Sbjct: 306 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPEH 365
Query: 362 VKRQLGLNFLHPAGT 376
V+RQ+GL+F HPAGT
Sbjct: 366 VRRQIGLSFFHPAGT 380
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116828|ref|XP_002317404.1| predicted protein [Populus trichocarpa] gi|222860469|gb|EEE98016.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 744 bits (1921), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/375 (94%), Positives = 362/375 (96%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EM+A V DG+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET
Sbjct: 6 EMNARVADGNDPVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 65
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTT NELFLNLVMEYVPESMYRV
Sbjct: 66 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTDNNELFLNLVMEYVPESMYRV 125
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
LKHYS+A Q MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK+CDF
Sbjct: 126 LKHYSNAKQAMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKLCDF 185
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAK L+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF GEN
Sbjct: 186 GSAKVLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFSGEN 245
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL
Sbjct: 246 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 305
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 361
QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLP LFNFKQEL+GASPELVNKLIPDH
Sbjct: 306 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPALFNFKQELNGASPELVNKLIPDH 365
Query: 362 VKRQLGLNFLHPAGT 376
VKRQ+GLN +H AGT
Sbjct: 366 VKRQMGLNLMHLAGT 380
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255562450|ref|XP_002522231.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] gi|223538484|gb|EEF40089.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 742 bits (1916), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/375 (93%), Positives = 364/375 (97%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EM+A VVD +D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET
Sbjct: 6 EMAARVVDSNDPVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 65
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQD+RYKNRELQLMRVMDHPNVISLKHCFFSTT+ NELFLNLVMEYVPESMYRV
Sbjct: 66 VAIKKVLQDKRYKNRELQLMRVMDHPNVISLKHCFFSTTNNNELFLNLVMEYVPESMYRV 125
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
LKHYS+A Q MPL+YVKLY YQIFRGLAYIHTVP VCHRDLKPQN+LVDPLTHQVK+CDF
Sbjct: 126 LKHYSNAKQTMPLVYVKLYMYQIFRGLAYIHTVPGVCHRDLKPQNILVDPLTHQVKLCDF 185
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAK L+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 186 GSAKVLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL
Sbjct: 246 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 305
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 361
QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQEL+GASPELVNKLIPDH
Sbjct: 306 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELNGASPELVNKLIPDH 365
Query: 362 VKRQLGLNFLHPAGT 376
+KRQ+GLNFLH AGT
Sbjct: 366 MKRQMGLNFLHLAGT 380
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297804284|ref|XP_002870026.1| hypothetical protein ARALYDRAFT_914806 [Arabidopsis lyrata subsp. lyrata] gi|297315862|gb|EFH46285.1| hypothetical protein ARALYDRAFT_914806 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 741 bits (1913), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/375 (93%), Positives = 363/375 (96%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EM AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET
Sbjct: 6 EMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 65
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPES+YRV
Sbjct: 66 VAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRV 125
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
LKHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQVKICDF
Sbjct: 126 LKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDF 185
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 186 GSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
AVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID ASRLL
Sbjct: 246 AVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLL 305
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 361
QYSPSLRCTALEACAHPFFDELREPNARLPNGRP PPLFNFKQE++GASPELVNKLIPDH
Sbjct: 306 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAGASPELVNKLIPDH 365
Query: 362 VKRQLGLNFLHPAGT 376
+KRQLGL+FL+ +GT
Sbjct: 366 IKRQLGLSFLNQSGT 380
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15233984|ref|NP_193606.1| Shaggy-related protein kinase eta [Arabidopsis thaliana] gi|47117893|sp|Q39011.2|KSG7_ARATH RecName: Full=Shaggy-related protein kinase eta; AltName: Full=ASK-eta; AltName: Full=Protein BRASSINOSTEROID INSENSITIVE 2; AltName: Full=Protein ULTRACURVATA 1 gi|4539390|emb|CAB37456.1| shaggy-like protein kinase etha (EC 2.7.1.-) [Arabidopsis thaliana] gi|7268665|emb|CAB78873.1| shaggy-like protein kinase etha (EC 2.7.1.-) [Arabidopsis thaliana] gi|21554512|gb|AAM63594.1| shaggy-like protein kinase etha (EC 2.7.1.-) [Arabidopsis thaliana] gi|25140476|gb|AAN71719.1| glycogen synthase kinase 3 beta protein kinase DWARF12 [Arabidopsis thaliana] gi|109946417|gb|ABG48387.1| At4g18710 [Arabidopsis thaliana] gi|332658679|gb|AEE84079.1| Shaggy-related protein kinase eta [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1909), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/375 (93%), Positives = 363/375 (96%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EM AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET
Sbjct: 6 EMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 65
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPES+YRV
Sbjct: 66 VAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRV 125
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
LKHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQVKICDF
Sbjct: 126 LKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDF 185
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 186 GSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
AVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID ASRLL
Sbjct: 246 AVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLL 305
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 361
QYSPSLRCTALEACAHPFFDELREPNARLPNGRP PPLFNFKQE++G+SPELVNKLIPDH
Sbjct: 306 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAGSSPELVNKLIPDH 365
Query: 362 VKRQLGLNFLHPAGT 376
+KRQLGL+FL+ +GT
Sbjct: 366 IKRQLGLSFLNQSGT 380
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1161512|emb|CAA64409.1| shaggy-like kinase etha [Arabidopsis thaliana] gi|1627516|emb|CAA70144.1| shaggy-like kinase etha [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1909), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/375 (92%), Positives = 365/375 (97%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EM AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET
Sbjct: 6 EMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 65
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTT K+ELFLNLVMEYVPE++YRV
Sbjct: 66 VAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTEKDELFLNLVMEYVPETLYRV 125
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
LKHYSSANQRMPL+YVKLY+YQIFRGLAYIH+ P VCHRDLKPQNLLVDPLTHQVKICDF
Sbjct: 126 LKHYSSANQRMPLVYVKLYSYQIFRGLAYIHSCPGVCHRDLKPQNLLVDPLTHQVKICDF 185
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAKQL+ GE NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 186 GSAKQLVKGEPNISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
AVDQLVEIIKVLGTPTREEIRCMNPNYTDF+FPQIKAHPWHK+FHKRMPPEA+DLASRLL
Sbjct: 246 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFKFPQIKAHPWHKIFHKRMPPEAVDLASRLL 305
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 361
QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQE++G+SPELVNKLIPDH
Sbjct: 306 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQEVAGSSPELVNKLIPDH 365
Query: 362 VKRQLGLNFLHPAGT 376
+KRQLGL+FL+ +GT
Sbjct: 366 IKRQLGLSFLNQSGT 380
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|312281491|dbj|BAJ33611.1| unnamed protein product [Thellungiella halophila] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1905), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/375 (93%), Positives = 362/375 (96%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EM AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET
Sbjct: 6 EMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 65
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPES+YRV
Sbjct: 66 VAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRV 125
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
LKHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQVKICDF
Sbjct: 126 LKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDF 185
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 186 GSAKQLVRGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
AVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID ASRLL
Sbjct: 246 AVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLL 305
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 361
QYSPSLRCTALEACAHPFFDELREPNARLPNGRP PPLFNFKQE++ ASPELVNKLIPDH
Sbjct: 306 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAAASPELVNKLIPDH 365
Query: 362 VKRQLGLNFLHPAGT 376
+KRQLGL+FL+ +GT
Sbjct: 366 IKRQLGLSFLNQSGT 380
|
Source: Thellungiella halophila Species: Eutrema halophilum Genus: Eutrema Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|227204507|dbj|BAH57105.1| AT4G18710 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 737 bits (1902), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/374 (93%), Positives = 362/374 (96%)
Query: 3 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 62
M AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV
Sbjct: 1 MPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
Query: 63 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 122
AIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPES+YRVL
Sbjct: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRVL 120
Query: 123 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182
KHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQVKICDFG
Sbjct: 121 KHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDFG 180
Query: 183 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 242
SAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA
Sbjct: 181 SAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
Query: 243 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 302
VDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID ASRLLQ
Sbjct: 241 VDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLLQ 300
Query: 303 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHV 362
YSPSLRCTALEACAHPFFDELREPNARLPNGRP PPLFNFKQE++G+SPELVNKLIPDH+
Sbjct: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAGSSPELVNKLIPDHI 360
Query: 363 KRQLGLNFLHPAGT 376
KRQLGL+FL+ +GT
Sbjct: 361 KRQLGLSFLNQSGT 374
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224079065|ref|XP_002305736.1| predicted protein [Populus trichocarpa] gi|222848700|gb|EEE86247.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1901), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/375 (93%), Positives = 361/375 (96%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EM+ V DG+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFG+VFQAKCLETGET
Sbjct: 6 EMTTRVADGNDPVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGVVFQAKCLETGET 65
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTT+ NELFLNLVMEYVPESMYRV
Sbjct: 66 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTNNNELFLNLVMEYVPESMYRV 125
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
LKHYS+A Q MPLIYVKLY YQIFRGLAYIH VP VCHRDLKPQNLLVDPLTHQVK+CDF
Sbjct: 126 LKHYSNAKQTMPLIYVKLYMYQIFRGLAYIHAVPGVCHRDLKPQNLLVDPLTHQVKLCDF 185
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAK L+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 186 GSAKVLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
AVDQLV+IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL
Sbjct: 246 AVDQLVDIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 305
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 361
QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLP LFNFKQEL+GASPELVNKLIP+H
Sbjct: 306 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPSLFNFKQELNGASPELVNKLIPEH 365
Query: 362 VKRQLGLNFLHPAGT 376
VKRQ+GLNF+H AGT
Sbjct: 366 VKRQMGLNFMHLAGT 380
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18700188|gb|AAL77705.1| AT4g18710/F28A21_120 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1900), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/375 (92%), Positives = 362/375 (96%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EM AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET
Sbjct: 6 EMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 65
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPES+YRV
Sbjct: 66 VAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRV 125
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
LKHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQVKICDF
Sbjct: 126 LKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDF 185
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 186 GSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
AVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID ASRLL
Sbjct: 246 AVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLL 305
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 361
QYSPSLRCTALEACAHPFFDE REPNARLPNGRP PPLFNFKQE++G+SPELVNKLIPDH
Sbjct: 306 QYSPSLRCTALEACAHPFFDEHREPNARLPNGRPFPPLFNFKQEVAGSSPELVNKLIPDH 365
Query: 362 VKRQLGLNFLHPAGT 376
+KRQLGL+FL+ +GT
Sbjct: 366 IKRQLGLSFLNQSGT 380
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 376 | ||||||
| TAIR|locus:2124082 | 380 | BIN2 "BRASSINOSTEROID-INSENSIT | 0.997 | 0.986 | 0.930 | 8.3e-193 | |
| TAIR|locus:2052861 | 412 | SKdZeta "SHAGGY-related protei | 0.994 | 0.907 | 0.895 | 4.4e-187 | |
| TAIR|locus:2202255 | 407 | GSK1 "GSK3/SHAGGY-like protein | 0.970 | 0.896 | 0.909 | 4.5e-185 | |
| TAIR|locus:2222642 | 410 | SK13 "shaggy-like kinase 13" [ | 0.968 | 0.887 | 0.824 | 6e-167 | |
| TAIR|locus:2074464 | 409 | ATSK12 [Arabidopsis thaliana ( | 0.968 | 0.889 | 0.794 | 3.4e-164 | |
| TAIR|locus:2832141 | 405 | SK 11 "AT5G26751" [Arabidopsis | 0.976 | 0.906 | 0.795 | 5.5e-164 | |
| TAIR|locus:2126993 | 472 | SK32 "shaggy-like protein kina | 0.957 | 0.762 | 0.764 | 1.6e-157 | |
| TAIR|locus:2024341 | 421 | SK41 "shaggy-like protein kina | 0.973 | 0.869 | 0.722 | 2.3e-151 | |
| TAIR|locus:2098896 | 438 | AT3G61160 [Arabidopsis thalian | 0.965 | 0.828 | 0.695 | 2.9e-142 | |
| ZFIN|ZDB-GENE-990714-4 | 421 | gsk3b "glycogen synthase kinas | 0.962 | 0.859 | 0.636 | 2e-127 |
| TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1868 (662.6 bits), Expect = 8.3e-193, P = 8.3e-193
Identities = 349/375 (93%), Positives = 363/375 (96%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EM AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET
Sbjct: 6 EMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 65
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPES+YRV
Sbjct: 66 VAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRV 125
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
LKHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQVKICDF
Sbjct: 126 LKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDF 185
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 186 GSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
AVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID ASRLL
Sbjct: 246 AVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLL 305
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 361
QYSPSLRCTALEACAHPFFDELREPNARLPNGRP PPLFNFKQE++G+SPELVNKLIPDH
Sbjct: 306 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAGSSPELVNKLIPDH 365
Query: 362 VKRQLGLNFLHPAGT 376
+KRQLGL+FL+ +GT
Sbjct: 366 IKRQLGLSFLNQSGT 380
|
|
| TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1814 (643.6 bits), Expect = 4.4e-187, P = 4.4e-187
Identities = 335/374 (89%), Positives = 361/374 (96%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EMSAAV++G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+
Sbjct: 38 EMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGES 97
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQDRRYKNRELQLMR+MDHPNV+SLKHCFFSTT+++ELFLNLVMEYVPE++YRV
Sbjct: 98 VAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRV 157
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
LKHY+S+NQRMP+ YVKLYTYQIFRGLAYIHT P VCHRD+KPQNLLVDPLTHQ K+CDF
Sbjct: 158 LKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDF 217
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAK L+ GEANISYICSR+YRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 218 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGEN 277
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
+VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL
Sbjct: 278 SVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 337
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 361
QYSPSLRCTALEACAHPFF+ELREPNARLPNGRPLPPLFNFKQELSGASPEL+N+LIP+H
Sbjct: 338 QYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQELSGASPELINRLIPEH 397
Query: 362 VKRQLGLNFLHPAG 375
V+RQ+ F AG
Sbjct: 398 VRRQMNGGFPFQAG 411
|
|
| TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1795 (636.9 bits), Expect = 4.5e-185, P = 4.5e-185
Identities = 332/365 (90%), Positives = 355/365 (97%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EMSAAV++G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+
Sbjct: 36 EMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGES 95
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQDRRYKNRELQLMR MDHPNVISLKHCFFSTTS++ELFLNLVMEYVPE++YRV
Sbjct: 96 VAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRV 155
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
L+HY+S+NQRMP+ YVKLYTYQIFRGLAYIHTVP VCHRD+KPQNLLVDPLTHQVK+CDF
Sbjct: 156 LRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 215
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAK L+ GE NISYICSR+YRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN
Sbjct: 216 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGEN 275
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
+VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL
Sbjct: 276 SVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 335
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 361
QYSPSLRCTALEACAHPFF+ELREPNARLPNGRPLPPLFNFKQEL GAS EL+N+LIP+H
Sbjct: 336 QYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQELGGASMELINRLIPEH 395
Query: 362 VKRQL 366
V+RQ+
Sbjct: 396 VRRQM 400
|
|
| TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1624 (576.7 bits), Expect = 6.0e-167, P = 6.0e-167
Identities = 301/365 (82%), Positives = 333/365 (91%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EM AAVVDG+ TGHII TTIGGKNG+PKQTISYMAER+VG GSFGIVFQAKCLETGET
Sbjct: 40 EMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGET 99
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQD+RYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE++YRV
Sbjct: 100 VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRV 159
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
KHYS ANQRMP+IYVKLYTYQI R LAYIH VCHRD+KPQNLLV+P THQVK+CDF
Sbjct: 160 SKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDF 219
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAK L+ GE NISYICSR+YRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPLFPGE+
Sbjct: 220 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGES 279
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKR PPEA+DL SRLL
Sbjct: 280 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLL 339
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPD 360
QYSP+LR TA+EA HPFFDELR+PN RLPNGR LPPLFNFK QEL GAS EL++KLIPD
Sbjct: 340 QYSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPD 399
Query: 361 HVKRQ 365
H ++Q
Sbjct: 400 HARKQ 404
|
|
| TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1598 (567.6 bits), Expect = 3.4e-164, P = 3.4e-164
Identities = 290/365 (79%), Positives = 331/365 (90%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EM A +V+G+ TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLETGET
Sbjct: 39 EMEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGET 98
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQDRRYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE+++RV
Sbjct: 99 VAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRV 158
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
+KHY+ NQRMPL+YVKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+CDF
Sbjct: 159 IKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDF 218
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAK L+ GE NISYICSR+YRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFPGE+
Sbjct: 219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGES 278
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLL
Sbjct: 279 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 338
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPD 360
QYSP+LRC AL++ HPFFDELR+PNARLPNGR LPPLFNFK EL G E+V KL+P+
Sbjct: 339 QYSPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPE 398
Query: 361 HVKRQ 365
H ++Q
Sbjct: 399 HARKQ 403
|
|
| TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1596 (566.9 bits), Expect = 5.5e-164, P = 5.5e-164
Identities = 295/371 (79%), Positives = 332/371 (89%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
EM A VVDG+ TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLETGET
Sbjct: 35 EMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGET 94
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQDRRYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE+++RV
Sbjct: 95 VAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRV 154
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
+KHY+ NQRMPLIYVKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+CDF
Sbjct: 155 IKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDF 214
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAK L+ GE NISYICSR+YRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFPGE+
Sbjct: 215 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGES 274
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLL
Sbjct: 275 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 334
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPD 360
QYSP+LR AL+ HPFFDELR+PNARLPNGR LPPLFNFK EL G E+V KL+P+
Sbjct: 335 QYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVPE 394
Query: 361 HVKRQ---LGL 368
H ++Q LGL
Sbjct: 395 HARKQCPWLGL 405
|
|
| TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1535 (545.4 bits), Expect = 1.6e-157, P = 1.6e-157
Identities = 276/361 (76%), Positives = 321/361 (88%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
+M VV+GS TG +I+TT+GG++G+PKQTISYMA+RVVGTGSFG+VFQAKCLETGE
Sbjct: 104 DMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQ 163
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQD+RYKNRELQ+MR+ DHPNV+ L+H FFSTT K+EL+LNLV+EYVPE++YR
Sbjct: 164 VAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRA 223
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
KHY+ NQ MP+I+V+LYTYQI R L Y+H V VCHRD+KPQNLLV+P THQ+KICDF
Sbjct: 224 SKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDF 283
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAK L+ GE NISYICSR+YRAPELIFGATEYT +ID+WS GCV+AELLLGQPLFPGE+
Sbjct: 284 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGES 343
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
+DQLVEIIK+LGTPTREEIRCMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLL
Sbjct: 344 GIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 403
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPD 360
QYSP+LRCTALEACAHPFFD+LR+PN LPNGR LPPLFNF QEL+GAS EL +LIP
Sbjct: 404 QYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRLIPA 463
Query: 361 H 361
H
Sbjct: 464 H 464
|
|
| TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1477 (525.0 bits), Expect = 2.3e-151, P = 2.3e-151
Identities = 265/367 (72%), Positives = 315/367 (85%)
Query: 7 VVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKK 66
++DG+ GH+I TT+ G+NG+ +QT+SY++E VVGTGSFG+VFQAKC ETGE VAIKK
Sbjct: 54 IIDGAGAEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKK 113
Query: 67 VLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYS 126
VLQD+RYKNRELQ+M+++DHPN ++LKH FFS T E++LNLV+E+VPE++ RV + YS
Sbjct: 114 VLQDKRYKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYS 173
Query: 127 SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186
NQ MPLIYVKLYTYQI R LAYIH +CHRD+KPQNLLV+P THQ+KICDFGSAK
Sbjct: 174 RTNQLMPLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKV 233
Query: 187 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 246
L+ GE N+SYICSR+YRAPELIFGA+EYTT+IDIWS GCV+AELLLGQPLFPGE+ VDQL
Sbjct: 234 LVKGEPNVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 293
Query: 247 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 306
VEIIKVLGTPTREEI+CMNPNYT+F+FPQIK HPWHKVF KR+PPEA+DL R QYSP+
Sbjct: 294 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPN 353
Query: 307 LRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQ 365
LRCTALEAC HP FDELR+PN RLPNGRPLPPLFNFK QELSG PE+VN+L+P+H ++Q
Sbjct: 354 LRCTALEACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVPEHARKQ 413
Query: 366 LGLNFLH 372
LH
Sbjct: 414 NLFMALH 420
|
|
| TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1391 (494.7 bits), Expect = 2.9e-142, P = 2.9e-142
Identities = 253/364 (69%), Positives = 307/364 (84%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
+M ++ G+ +G II+T G N + +TISY AE V+GTGSFG+VFQAKCLET E
Sbjct: 75 DMDCGIIKGNGTESGRIITTKKKGLNDQKDKTISYRAEHVIGTGSFGVVFQAKCLETEEK 134
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRV 121
VAIKKVLQD+RYKNRELQ+MR++DHPNV+ LKH FFSTT K+EL+LNLV+EYVPE++YR
Sbjct: 135 VAIKKVLQDKRYKNRELQIMRMLDHPNVVELKHSFFSTTEKDELYLNLVLEYVPETIYRA 194
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181
+ Y+ NQ MPLIY++LYTYQI R + Y+H V VCHRD+KPQNLLV+ +TH+VKICDF
Sbjct: 195 SRSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCHRDIKPQNLLVNNVTHEVKICDF 254
Query: 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
GSAK LI GE NISYICSR+YRAPELIFGATEYT++ID+WS GCV+AEL LG PLFPGE
Sbjct: 255 GSAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAIDMWSVGCVMAELFLGHPLFPGET 314
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
+VDQLVEIIK+LGTP REEI+ MNP Y DF+FPQIKA PWHK+F +++ PEA+DLASRLL
Sbjct: 315 SVDQLVEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQPWHKIFRRQVSPEAMDLASRLL 374
Query: 302 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPD 360
QYSP+LRCTALEACAHPFFD+LR+P A LPNGR LPPLF+F QEL+GAS EL ++LIP+
Sbjct: 375 QYSPNLRCTALEACAHPFFDDLRDPRASLPNGRALPPLFDFTAQELAGASVELRHRLIPE 434
Query: 361 HVKR 364
H ++
Sbjct: 435 HARK 438
|
|
| ZFIN|ZDB-GENE-990714-4 gsk3b "glycogen synthase kinase 3 beta" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1251 (445.4 bits), Expect = 2.0e-127, P = 2.0e-127
Identities = 236/371 (63%), Positives = 299/371 (80%)
Query: 9 DGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL 68
DGS T +++T G+ + Q +SY +V+G GSFG+V+QAK ++GE VAIKKVL
Sbjct: 33 DGSKVTT--VVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 69 QDRRYKNRELQLMRVMDHPNVISLKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSS 127
QD+R+KNRELQ+MR +DH N++ L++ F+S+ K+E++LNLV++YVPE++YRV +HYS
Sbjct: 89 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGDKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 128 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187
A Q +P++YVKLY YQ+FR LAYIH+ +CHRD+KPQNLL+DP T +K+CDFGSAKQL
Sbjct: 149 AKQTLPMVYVKLYMYQLFRSLAYIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 188 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 247
+ GE N+SYICSR+YRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLV
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 307
EIIKVLGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF R PPEAI L SRLL+Y+P+
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 308 RCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQL 366
R T LEACAH FFDELREPN +LPNGR P LFNF QELS ++P L + LIP H + Q
Sbjct: 328 RLTPLEACAHSFFDELREPNVKLPNGREKPSLFNFTTQELS-SNPTLASILIPAHARNQA 386
Query: 367 GLNF-LHPAGT 376
G + +P+ T
Sbjct: 387 GASTPTNPSAT 397
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P43289 | KSG3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7945 | 0.9680 | 0.8899 | no | no |
| P43288 | KSG1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7951 | 0.9760 | 0.9061 | no | no |
| Q10452 | GSK3_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.5546 | 0.9228 | 0.8966 | yes | no |
| Q39012 | KSG9_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9095 | 0.9707 | 0.8968 | no | no |
| A8X5H5 | GSK3_CAEBR | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6547 | 0.8111 | 0.8495 | N/A | no |
| Q39010 | KSG6_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8957 | 0.9946 | 0.9077 | no | no |
| Q39011 | KSG7_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9306 | 0.9973 | 0.9868 | yes | no |
| Q39019 | KSG10_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7220 | 0.9734 | 0.8693 | no | no |
| P38615 | RIM11_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.5202 | 0.8457 | 0.8594 | yes | no |
| Q9U2Q9 | GSK3_CAEEL | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6547 | 0.8111 | 0.8425 | yes | no |
| Q9FVS6 | KSG4_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7275 | 0.9734 | 0.8714 | no | no |
| Q40518 | MSK1_TOBAC | 2, ., 7, ., 1, 1, ., 1 | 0.7816 | 0.9760 | 0.8973 | N/A | no |
| Q9WV60 | GSK3B_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.6402 | 0.9281 | 0.8309 | yes | no |
| P51136 | GSK3_DICDI | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6142 | 0.8856 | 0.7130 | yes | no |
| P51137 | MSK1_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7843 | 0.9760 | 0.8929 | N/A | no |
| P51138 | MSK2_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7690 | 0.9760 | 0.8929 | N/A | no |
| P51139 | MSK3_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7804 | 0.9760 | 0.8929 | N/A | no |
| O04160 | KSGT_BRANA | 2, ., 7, ., 1, 1, ., 1 | 0.7520 | 0.9627 | 0.7735 | N/A | no |
| P18266 | GSK3B_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.6402 | 0.9281 | 0.8309 | yes | no |
| Q8VZD5 | KSG5_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8246 | 0.9680 | 0.8878 | no | no |
| Q91757 | GSK3B_XENLA | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6320 | 0.9361 | 0.8380 | N/A | no |
| Q5YJC2 | GSK3B_SPECI | 2, ., 7, ., 1, 1, ., 1 | 0.6373 | 0.9281 | 0.8309 | N/A | no |
| P49841 | GSK3B_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.6402 | 0.9281 | 0.8309 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.993 |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 376 | |||
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-137 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-91 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-87 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-85 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-82 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-81 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-78 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-76 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-75 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-74 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-74 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-73 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-71 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-69 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-69 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-68 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-68 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-61 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-61 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-60 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-60 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-60 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-60 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-59 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-59 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-59 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-59 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-58 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-58 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-58 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-58 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-58 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-57 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-57 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-55 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-55 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-54 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-51 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-51 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-50 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-50 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-50 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-50 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-49 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-48 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-48 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-48 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-47 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-46 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-45 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-43 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-41 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-41 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-40 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-39 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-39 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-39 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-38 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-38 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-37 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-36 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-36 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-34 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-34 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-33 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-33 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-32 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-32 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-31 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-29 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-29 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-28 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-27 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-27 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-27 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-26 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-26 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-25 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-24 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-23 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-23 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-23 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-23 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-23 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-23 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-22 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-21 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-21 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-20 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-20 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-20 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-20 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-20 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-19 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-19 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-19 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-18 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-18 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-18 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-17 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-17 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-16 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-16 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-16 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-16 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-15 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-15 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-15 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-05 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.002 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 399 bits (1025), Expect = e-137
Identities = 176/333 (52%), Positives = 242/333 (72%), Gaps = 6/333 (1%)
Query: 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKH 94
SY ++G GSFG+V++A C++T E VAIKKVLQD +YKNREL +M+ ++H N+I LK
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKD 126
Query: 95 CFFSTT-SKNE--LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
+++ KNE +FLN+VME++P+++++ +KHY+ N +PL VKLY+YQ+ R LAYI
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 211
H+ +CHRDLKPQNLL+DP TH +K+CDFGSAK L+AG+ ++SYICSRFYRAPEL+ GA
Sbjct: 187 HS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
T YTT ID+WS GC++AE++LG P+F G+++VDQLV II+VLGTPT ++++ MNPNY D
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 331
+FP +K KVF K P +AI+ S+ L+Y P R +EA A PFFD+LR+P +LP
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLP 365
Query: 332 NG-RPLPPLFNF-KQELSGASPELVNKLIPDHV 362
LP LFNF E+ S K+IP
Sbjct: 366 KYIDKLPDLFNFCDAEIKEMSDACRRKIIPKCT 398
|
Length = 440 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 275 bits (706), Expect = 8e-91
Identities = 114/307 (37%), Positives = 177/307 (57%), Gaps = 24/307 (7%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 89
Y + +G+G++G+V A TG VAIKK+ L D + RE++L+R + H N+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 90 ISLKHCF--FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
I L S N++++ V E + +++V+K Q + +++ + YQI RG
Sbjct: 62 IGLLDILRPPSPEDFNDVYI--VTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRG 115
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYR 203
L Y+H+ V HRDLKP N+LV+ +KICDFG A+ + E Y+ +R+YR
Sbjct: 116 LKYLHSA-NVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
APEL+ ++ YT +IDIWS GC+ AELL +PLFPG + +DQL I++VLGTP+ E+++
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233
Query: 264 M-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
+ + ++ P+ P K+F PEAIDL ++L + P R TA EA AHP+
Sbjct: 234 ITSEKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292
Query: 321 DELREPN 327
+L +P
Sbjct: 293 AQLHDPE 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 265 bits (679), Expect = 2e-87
Identities = 108/292 (36%), Positives = 171/292 (58%), Gaps = 29/292 (9%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHPNVISLK 93
+G G++G+V++A+ +TGE VA+KK+ D + RE+ L++ + HPN++ L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 94 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
++ +L+L V EY + + L + +K YQ+ RGLAY H+
Sbjct: 65 DVI---HTERKLYL--VFEYCDMDLKKYLDKRPGP---LSPNLIKSIMYQLLRGLAYCHS 116
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFG 210
R+ HRDLKPQN+L++ +K+ DFG A+ G +Y + + +YRAPE++ G
Sbjct: 117 H-RILHRDLKPQNILINR-DGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLG 172
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--CMNPNY 268
+ Y+T++DIWS GC+ AE++ G+PLFPG++ +DQL +I ++LGTPT E P+Y
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
FP+ KV R+ PE IDL S++LQY+P+ R +A EA HP+F
Sbjct: 233 KP-TFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 259 bits (665), Expect = 3e-85
Identities = 117/293 (39%), Positives = 164/293 (55%), Gaps = 25/293 (8%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLK 93
+G G+ GIVF+AK ETGETVA+KKV R RE++ ++ HP V+ L
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 94 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
F + LVMEY+P + VL+ + +P VK Y + +G+AY+H
Sbjct: 66 DVFPHGSG-----FVLVMEYMPSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFG 210
+ HRDLKP NLL+ +KI DFG A+ L + E Y + +R+YRAPEL++G
Sbjct: 118 N-GIMHRDLKPANLLISA-DGVLKIADFGLAR-LFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPN 267
A +Y +D+W+ GC+ AELL G PLFPGEN ++QL + + LGTP E + + P+
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PD 233
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
Y FP+ K P ++F PEA+DL LL Y PS R +A EA HP+F
Sbjct: 234 YNKITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 252 bits (645), Expect = 3e-82
Identities = 109/294 (37%), Positives = 165/294 (56%), Gaps = 20/294 (6%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKN---RELQLMRVMDHPNV 89
Y +G G++G+V++A+ TGE VAIKK+ RE++L++ ++HPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
I L F L LV E++ +Y+++K + +P +K Y YQ+ +GLA
Sbjct: 61 IKLLDVFRHKGD-----LYLVFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLA 112
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELI 208
+ H+ + HRDLKP+NLL++ +K+ DFG A+ Y+ +R+YRAPEL+
Sbjct: 113 FCHS-HGILHRDLKPENLLINT-EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN- 267
G Y+T +DIWS GC+ AELL +PLFPG++ +DQL +I + LGTP E
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230
Query: 268 -YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
F FP+ P K+F P+A+DL S++L Y P R TA +A AHP+F
Sbjct: 231 RNYKFSFPKKAGMPLPKLF-PNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 248 bits (636), Expect = 3e-81
Identities = 100/291 (34%), Positives = 145/291 (49%), Gaps = 43/291 (14%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 90
Y +G GSFG V+ A+ +TG+ VAIK + +DR RE+++++ + HPN++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
L F L LVMEY ++ +LK R+ + Y QI L
Sbjct: 61 RLYDVFEDED-----KLYLVMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALE 111
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 209
Y+H+ + HRDLKP+N+L+D VK+ DFG A+QL GE +++ + Y APE++
Sbjct: 112 YLHSK-GIVHRDLKPENILLDE-DGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
G Y ++DIWS G +L ELL G+P FPG++ QL+E+ K +G P
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKPKPPFPP------- 218
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
+ PEA DL +LL P R TA EA HPFF
Sbjct: 219 ---------------PEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 239 bits (613), Expect = 8e-78
Identities = 98/289 (33%), Positives = 142/289 (49%), Gaps = 39/289 (13%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 92
R +G+GSFG V++AK TG+ VA+K + + RE++++R + HPN++ L
Sbjct: 4 LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 93 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
F + L LVMEY L Y S + K QI RGL Y+H
Sbjct: 64 IDAF--EDKDH---LYLVMEYCEGG---DLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGA 211
+ + HRDLKP+N+L+D VKI DFG AK+L+ + +++ + +Y APE++ G
Sbjct: 116 SN-GIIHRDLKPENILLDE-NGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
Y +D+WS G +L ELL G+P F GEN +DQL I ++LG P
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL-------------- 219
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
+ + EA DL + L PS R TA E HP+F
Sbjct: 220 --------EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 236 bits (604), Expect = 5e-76
Identities = 109/296 (36%), Positives = 171/296 (57%), Gaps = 32/296 (10%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQ-LMRVMDHPNVIS 91
+ +G G+FG V+ A+ ETGE VAIKK+ + ++ + RE++ L ++ +HPN++
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
LK F +EL+ V EY+ ++Y+++K + ++ YQI +GLA+I
Sbjct: 63 LKEVF---RENDELYF--VFEYMEGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHI 115
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 211
H HRDLKP+NLLV VKI DFG A+++ + Y+ +R+YRAPE++ +
Sbjct: 116 HKHGFF-HRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE-------IRCM 264
T Y++ +DIW+ GC++AEL +PLFPG + +DQL +I VLGTPT+++ +
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
FRFPQ H++ PEAIDL +L++ P R TA +A HP+F
Sbjct: 234 G-----FRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 235 bits (602), Expect = 1e-75
Identities = 106/299 (35%), Positives = 161/299 (53%), Gaps = 29/299 (9%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDH 86
Y + +G G++ +V++A+ ETG VAIKK+ R + RE++L++ + H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 87 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
PN+I L F K+ +NLV E++ + +V+K + + +K Y R
Sbjct: 62 PNIIGLLDVF---GHKS--NINLVFEFMETDLEKVIK---DKSIVLTPADIKSYMLMTLR 113
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC---SRFYR 203
GL Y+H + HRDLKP NLL+ +K+ DFG A+ G N +R+YR
Sbjct: 114 GLEYLH-SNWILHRDLKPNNLLIAS-DGVLKLADFGLARSF--GSPNRKMTHQVVTRWYR 169
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
APEL+FGA Y +D+WS GC+ AELLL P PG++ +DQL +I + LGTPT E
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229
Query: 264 MN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
+ P+Y +F+ P ++F +A+DL RLL +P+ R TA +A HP+F
Sbjct: 230 VTSLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 232 bits (595), Expect = 1e-74
Identities = 89/293 (30%), Positives = 156/293 (53%), Gaps = 26/293 (8%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 95
+G G++G V++A+ +TGE VA+KK+ + + RE++L++ + HPN++ LK
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
S K +++ V EY+ + +L + +K Y Q+ GL Y+H+
Sbjct: 67 VTSKG-KGSIYM--VFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSN- 119
Query: 156 RVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFG 210
+ HRD+K N+L++ + +K+ DFG A+ + Y + + +YR PEL+ G
Sbjct: 120 GILHRDIKGSNILIN---NDGVLKLADFGLARP-YTKRNSADYTNRVITLWYRPPELLLG 175
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPN 267
AT Y +D+WS GC+LAEL LG+P+F G ++QL +I ++ G+PT E + + P
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PW 234
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
+ + + + + F + P A+DL +LL P R +A +A H +F
Sbjct: 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 9e-74
Identities = 102/291 (35%), Positives = 164/291 (56%), Gaps = 21/291 (7%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH 94
VVG G++G+V + + TGE VAIKK + ++ RE++++R + H N+++LK
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 95 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 154
F K L+L V EYV ++ +L+ +P V+ Y +Q+ + +AY H+
Sbjct: 68 AF---RRKGRLYL--VFEYVERTLLELLEASPGG---LPPDAVRSYIWQLLQAIAYCHSH 119
Query: 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYRAPELIFGAT 212
+ HRD+KP+N+LV + +K+CDFG A+ L A A+ Y+ +R+YRAPEL+ G T
Sbjct: 120 -NIIHRDIKPENILVSE-SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG--TPTREEIRCMNPNYTD 270
Y +D+W+ GC++AELL G+PLFPG++ +DQL I K LG P+ +E+ NP +
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237
Query: 271 FRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
FP+ + + ++ A+D L+ P R T E HP+F
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 4e-73
Identities = 110/305 (36%), Positives = 165/305 (54%), Gaps = 26/305 (8%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHP 87
Y VG+G++G V A +TG VAIKK+ + R Y REL+L++ MDH
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74
Query: 88 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
NVI L F +S + + LV + + ++K Q++ +++ YQI R
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILR 129
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 206
GL YIH+ + HRDLKP N+ V+ ++KI DFG A+ + Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPE 185
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
++ Y ++DIWS GC++AELL G+ LFPG + +DQL I+ ++GTP E ++ ++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245
Query: 267 ----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
NY PQ+ + +VF P AIDL ++L P R TA EA AHP+ E
Sbjct: 246 ESARNYIQ-SLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303
Query: 323 LREPN 327
+P
Sbjct: 304 YHDPE 308
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 226 bits (578), Expect = 2e-71
Identities = 114/332 (34%), Positives = 178/332 (53%), Gaps = 36/332 (10%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 88
Y +G G++G+V A TG VAIKK+ R RE++++R H N
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL--REIKILRRFKHEN 64
Query: 89 VISLKHCFFSTT--SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
+I + + S N++++ V E + +Y+++K +N +++ + YQI R
Sbjct: 65 IIGILDIIRPPSFESFNDVYI--VQELMETDLYKLIKTQHLSND-----HIQYFLYQILR 117
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFY 202
GL YIH+ V HRDLKP NLL++ +KICDFG A+ + Y+ +R+Y
Sbjct: 118 GLKYIHSA-NVLHRDLKPSNLLLNT-NCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
RAPE++ + YT +IDIWS GC+LAE+L +PLFPG++ + QL I+ VLGTP++E++
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235
Query: 263 CM-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
C+ + ++ P PW+K+F P+A+DL ++L ++P R T EA AHP+
Sbjct: 236 CIISLRARNYIKSLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294
Query: 320 ----FDELREPNARLPNGRPLPPLFNFKQELS 347
D EP A P P F +L
Sbjct: 295 LEQYHDPSDEPVAE----EPFPFDFELFDDLP 322
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 220 bits (562), Expect = 4e-69
Identities = 118/333 (35%), Positives = 186/333 (55%), Gaps = 21/333 (6%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 89
Y+ + +G G++GIV AK ET E VAIKK+ D + RE++L+R +DH NV
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
I++K + + +V E + ++++++ ++Q + + + + YQ+ RGL
Sbjct: 67 IAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIR----SSQTLSDDHCQYFLYQLLRGLK 122
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPELI 208
YIH+ V HRDLKP NLL++ +KICDFG A+ G+ Y+ +R+YRAPEL+
Sbjct: 123 YIHSA-NVLHRDLKPSNLLLNA-NCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELL 180
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-NPN 267
+EYTT+ID+WS GC+ AELL +PLFPG++ V QL I ++LG+P+ E++ + N
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240
Query: 268 YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
+ P + ++F P AIDL ++L + PS R T EA AHP+ L +
Sbjct: 241 ARRYIRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299
Query: 326 PNARLPNGRPLPPLFNFKQELSGASPELVNKLI 358
P+ P F+F E + E + +LI
Sbjct: 300 PSDEPVCQTP----FSFDFEEDALTEEDIKELI 328
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 220 bits (562), Expect = 4e-69
Identities = 105/309 (33%), Positives = 173/309 (55%), Gaps = 31/309 (10%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QD--RRYKNRELQLMRVM-DH 86
Y + +G G++GIV++A T E VA+KK+ D R + RE+ ++ + DH
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF--REIMFLQELGDH 66
Query: 87 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
PN++ L + ++N+ + LV EY+ ++ V++ AN ++ + YQ+ +
Sbjct: 67 PNIVKLLNVI---KAENDKDIYLVFEYMETDLHAVIR----ANILED-VHKRYIMYQLLK 118
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS------YICSR 200
L YIH+ V HRDLKP N+L++ VK+ DFG A+ L E N Y+ +R
Sbjct: 119 ALKYIHS-GNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 201 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260
+YRAPE++ G+T YT +D+WS GC+L E+LLG+PLFPG + ++QL +II+V+G P+ E+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236
Query: 261 IRCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
I + + P P ++ + +A+DL +LL ++P+ R TA EA H
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH 295
Query: 318 PFFDELREP 326
P+ + P
Sbjct: 296 PYVAQFHNP 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 218 bits (558), Expect = 2e-68
Identities = 118/344 (34%), Positives = 180/344 (52%), Gaps = 32/344 (9%)
Query: 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKK------VLQDRRYKNRELQLMRVMDHPN 88
Y +G+G++G+V A +G+ VAIKK V + REL+++R H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 89 VISLKHCFFSTTSKNELFLN--LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
+I+++ F + +VM+ M L H ++Q + +++ + YQ+ R
Sbjct: 66 IIAIRDIL---RPPGADFKDVYVVMDL----MESDLHHIIHSDQPLTEEHIRYFLYQLLR 118
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-----ISYICSRF 201
GL YIH+ V HRDLKP NLLV+ ++I DFG A+ L + Y+ +R+
Sbjct: 119 GLKYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
YRAPEL+ EYTT+ID+WS GC+ AE+L + LFPG+N V QL I+ VLG+P+ E +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236
Query: 262 RCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
+ Y P+ + PW K+F K PEA+DL S++LQ+ P R T +A H
Sbjct: 237 NRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQH 294
Query: 318 PFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 361
PF + +P+ + PP F+F E S E + + I
Sbjct: 295 PFLAQYHDPD----DEPTCPPPFDFDFEAIELSREQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 8e-68
Identities = 103/291 (35%), Positives = 164/291 (56%), Gaps = 26/291 (8%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 95
+G G++G+V++A+ TGE VA+KK+ + + RE+ L++ ++HPN++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVKLYTYQIFRGLAYIHT 153
S E L LV E++ LK Y SS + +K Y YQ+ +G+AY H+
Sbjct: 67 VHS-----ENKLYLVFEFLDLD----LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGAT 212
RV HRDLKPQNLL+D +K+ DFG A+ + + + +YRAPE++ G+
Sbjct: 118 -HRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSR 175
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 269
+Y+T +DIWS GC+ AE++ +PLFPG++ +DQL I + LGTP + + + P+Y
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PDYK 234
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
FP+ KV + + +DL S++L Y P+ R +A A HP+F
Sbjct: 235 P-TFPKWARQDLSKVV-PNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 4e-61
Identities = 121/326 (37%), Positives = 181/326 (55%), Gaps = 27/326 (8%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 89
Y + V+G GS+G+V A TGE VAIKK+ + D RE++L+R++ HP++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
+ +KH + + + +V E + +++V+K AN + + + + YQ+ R L
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK----ANDDLTPEHHQFFLYQLLRALK 117
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----ISYICSRFYRAP 205
YIHT V HRDLKP+N+L + ++KICDFG A+ Y+ +R+YRAP
Sbjct: 118 YIHTA-NVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 206 ELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-R 262
EL G+ ++YT +IDIWS GC+ AE+L G+PLFPG+N V QL I +LGTP+ E I R
Sbjct: 176 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMP---PEAIDLASRLLQYSPSLRCTALEACAHPF 319
N + K P F ++ P P A+ L RLL + P R TA EA A P+
Sbjct: 235 VRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292
Query: 320 FDELREPNARLPNGRPLPPL-FNFKQ 344
F L + R P+ +P+ L F F++
Sbjct: 293 FKGLAKVE-REPSAQPITKLEFEFER 317
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 6e-61
Identities = 109/290 (37%), Positives = 171/290 (58%), Gaps = 21/290 (7%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKH 94
+VG GS+G+V + K ETG+ VAIKK L+ ++ RE+++++ + H N+++L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 95 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 154
F K L+L V E+V ++ L+ Y + + V+ Y +QI RG+ + H+
Sbjct: 68 VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHS- 118
Query: 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATE 213
+ HRD+KP+N+LV + VK+CDFG A+ L A GE Y+ +R+YRAPEL+ G T+
Sbjct: 119 HNIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--PTREEIRCMNPNYTDF 271
Y ++DIW+ GC++ E+L G+PLFPG++ +DQL IIK LG P +EI NP +
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 272 RFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
R P++K P K F K + +DLA + L+ P R ++ + H FF
Sbjct: 238 RLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 196 bits (499), Expect = 3e-60
Identities = 109/303 (35%), Positives = 169/303 (55%), Gaps = 29/303 (9%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 89
Y +G G++G+V++A+ T ET+A+KK+ ++ + RE+ L++ M H N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSA-----NQRMPLIYVKLYTYQI 144
+ L+ S E L LV EY+ + KH S+ N R+ +K Y YQI
Sbjct: 64 VRLQDVVHS-----EKRLYLVFEYLDLDLK---KHMDSSPDFAKNPRL----IKTYLYQI 111
Query: 145 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYR 203
RG+AY H+ RV HRDLKPQNLL+D T+ +K+ DFG A+ I + + +YR
Sbjct: 112 LRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
APE++ G+ Y+T +DIWS GC+ AE++ +PLFPG++ +D+L +I ++LGTP E
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230
Query: 264 MN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
+ P+Y FP+ V + P +DL S++L+ PS R TA A H +F
Sbjct: 231 VTSLPDYKS-AFPKWPPKDLATVV-PTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
Query: 322 ELR 324
+L
Sbjct: 289 DLG 291
|
Length = 294 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 3e-60
Identities = 97/289 (33%), Positives = 152/289 (52%), Gaps = 25/289 (8%)
Query: 43 GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVM-DHPNVISLKH 94
G G+F V +A+ +TG+ AIK + + +K+ RE+Q +R + HPN++ L
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKK--HFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 95 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL--IYVKLYTYQIFRGLAYIH 152
F + L LV E + ++Y ++K ++ PL VK Y YQ+ + L ++H
Sbjct: 66 VLFDRKTGR---LALVFELMDMNLYELIK-----GRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 212
+ HRD+KP+N+L+ +K+ DFGS + + + YI +R+YRAPE +
Sbjct: 118 R-NGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-NYTDF 271
Y +DIW+ GCV E+L PLFPG N +DQ+ +I VLGTP E ++ + ++
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
FP K K+ E +DL +LL Y P R TA +A HP+F
Sbjct: 235 NFPSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 196 bits (499), Expect = 6e-60
Identities = 115/306 (37%), Positives = 168/306 (54%), Gaps = 29/306 (9%)
Query: 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRVM 84
T Y+ + VG G+FG+V A+ TG+ VAIKK VL R Y REL+L++ +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY--RELKLLKHL 66
Query: 85 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 144
H N+ISL F S + V E + ++R+L Q +++ + YQI
Sbjct: 67 RHENIISLSDIFISPLED----IYFVTELLGTDLHRLLTSRPLEKQ-----FIQYFLYQI 117
Query: 145 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 204
RGL Y+H+ V HRDLKP N+L++ +KICDFG A+ I Y+ +R+YRA
Sbjct: 118 LRGLKYVHSAG-VVHRDLKPSNILINE-NCDLKICDFGLAR--IQDPQMTGYVSTRYYRA 173
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
PE++ +Y +DIWSAGC+ AE+L G+PLFPG++ V+Q I +LGTP + I +
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233
Query: 265 NPNYTDFRF----PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
T RF P+ + P+ + F K P AIDL ++L + P R +A EA AHP+
Sbjct: 234 CSENT-LRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291
Query: 321 DELREP 326
+P
Sbjct: 292 APYHDP 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 6e-60
Identities = 99/303 (32%), Positives = 153/303 (50%), Gaps = 46/303 (15%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMD---HPN 88
+G G++G V++A+ L TG VA+KKV R RE+ L++ ++ HPN
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
++ L + EL L LV E+V + + L +P +K Q+ RG+
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG--LPPETIKDLMRQLLRGV 120
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 208
++H+ R+ HRDLKPQN+LV QVKI DFG A+ A S + + +YRAPE++
Sbjct: 121 DFLHS-HRIVHRDLKPQNILVTS-DGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
++ Y T +D+WS GC+ AEL +PLF G + DQL +I V+G P+ EE
Sbjct: 179 LQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE-------- 229
Query: 269 TDFRFPQIKAHPWHKVFHKR-----------MPPEAIDLASRLLQYSPSLRCTALEACAH 317
+P+ + P F + E +DL ++L ++P R +A EA H
Sbjct: 230 ----WPRNVSLPRSS-FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284
Query: 318 PFF 320
P+F
Sbjct: 285 PYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 2e-59
Identities = 108/290 (37%), Positives = 166/290 (57%), Gaps = 24/290 (8%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLKHCF 96
+G G++ V++ + TGE VA+K++ D RE+ LM+ + H N++ L H
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66
Query: 97 FSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQR-MPLIYVKLYTYQIFRGLAYIHT 153
T +K L LV EY M + LK Y + + + VK +TYQ+ +G+A+ H
Sbjct: 67 IHTENK----LMLVFEY----MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGAT 212
RV HRDLKPQNLL++ ++K+ DFG A+ I + + + +YRAP+++ G+
Sbjct: 119 -NRVLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTD 270
Y+TSIDIWS GC++AE++ G+PLFPG N DQL++I +++GTPT ++ P Y
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236
Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
FP+ ++F P IDL RLLQ +P LR +A +A HP+F
Sbjct: 237 -TFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 3e-59
Identities = 111/317 (35%), Positives = 159/317 (50%), Gaps = 46/317 (14%)
Query: 42 VGTGSFGIVFQAKCLE--TGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 92
+G G++G V++AK G+ AIKK D+ RE+ L+R + H NV+SL
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 93 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRM-PLIYVKLYTYQIFRGLAYI 151
F K+ + L+ +Y +++++K + A + P VK +QI G+ Y+
Sbjct: 68 VEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124
Query: 152 HTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSA-------KQLIAGEANISYICSRF 201
H+ V HRDLKP N+LV P VKI D G A K L + + I +
Sbjct: 125 HS-NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI---W 180
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKV 252
YRAPEL+ GA YT +IDIW+ GC+ AELL +P+F G A DQL I +V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240
Query: 253 LGTPTREE---IRCMNPNY----TDFRFPQIKAHPWHKVFHKRMP--PEAIDLASRLLQY 303
LGTPT ++ I+ M P Y DF+ ++ K K + DL +LL+Y
Sbjct: 241 LGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299
Query: 304 SPSLRCTALEACAHPFF 320
P+ R TA EA HP+F
Sbjct: 300 DPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 193 bits (491), Expect = 5e-59
Identities = 100/293 (34%), Positives = 158/293 (53%), Gaps = 19/293 (6%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 95
+G G++G V++A+ TG+ VA+KK + + RE+ L++++ I
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 96 FFSTTSKN-ELFLNLVMEYVPESMYRVL-KHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
KN + L LV EY+ + + + + + +P +K + YQ+ +G+A+ H
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGAT 212
V HRDLKPQNLLVD +KI D G + I ++ I + +YRAPE++ G+T
Sbjct: 129 HG-VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST 187
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
Y+T +DIWS GC+ AE+ QPLFPG++ + QL+ I K+LGTPT + P + R
Sbjct: 188 HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSKLR 243
Query: 273 ----FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
FPQ K + + PE +DL ++L+Y P+ R +A A HP+FD
Sbjct: 244 DWHEFPQWKPQDLSRAV-PDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 9e-59
Identities = 107/298 (35%), Positives = 174/298 (58%), Gaps = 40/298 (13%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 95
+G G++G+V++A+ TGE VA+KK+ D + RE+ L++ ++HPN++ L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVKLYTYQIFRGLAYIHT 153
+ +N+L+L V E+ +++ LK + +S +PL +K Y +Q+ +GLA+ H+
Sbjct: 68 IHT---ENKLYL--VFEF----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFG 210
RV HRDLKPQNLL++ +K+ DFG A+ G +Y + + +YRAPE++ G
Sbjct: 119 -HRVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 174
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT- 269
Y+T++DIWS GC+ AE++ + LFPG++ +DQL I + LGTP + P T
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV----VWPGVTS 230
Query: 270 --DFR--FPQIKAHPWHKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFF 320
D++ FP+ + KV +PP + DL S++L Y P+ R +A A AHPFF
Sbjct: 231 LPDYKPSFPKWARQDFSKV----VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 1e-58
Identities = 100/294 (34%), Positives = 165/294 (56%), Gaps = 34/294 (11%)
Query: 45 GSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHCFFS 98
G++G+V++A+ +TGE VA+KK+ ++ + RE+ ++ + HPN++++K
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75
Query: 99 TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 158
+ +++++ VMEYV + +++ Q VK Q+ G+A++H +
Sbjct: 76 SNL-DKIYM--VMEYVEHDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHD-NWIL 128
Query: 159 HRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFGATE 213
HRDLK NLL L + +KICDFG A++ G Y + + +YRAPEL+ GA E
Sbjct: 129 HRDLKTSNLL---LNNRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKE 183
Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273
Y+T+ID+WS GC+ AELL +PLFPG++ +DQL +I K+LGTPT + P +++
Sbjct: 184 YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW----PGFSELPG 239
Query: 274 PQIKAHPWH------KVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
+ K + K F + DL +RLL Y P+ R +A +A HP+F
Sbjct: 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 2e-58
Identities = 110/306 (35%), Positives = 166/306 (54%), Gaps = 31/306 (10%)
Query: 42 VGTGSFGIVFQAKCLET--GETVAIKKV--------LQDRRYKNRELQLMR-VMDHPNVI 90
+G G++GIV A+ ET ETVAIKK+ L R REL+L+R H N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL--RELKLLRHFRGHKNIT 65
Query: 91 SLKHCFFSTTSK-NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
L NEL+L E + ++++++ + Q + + + + YQI GL
Sbjct: 66 CLYDMDIVFPGNFNELYL--YEELMEADLHQIIR----SGQPLTDAHFQSFIYQILCGLK 119
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-----YICSRFYRA 204
YIH+ V HRDLKP NLLV+ ++KICDFG A+ + Y+ +R+YRA
Sbjct: 120 YIHSA-NVLHRDLKPGNLLVN-ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RC 263
PE++ YT +ID+WS GC+LAELL +P+F G++ VDQL +I++VLGTP E + R
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237
Query: 264 MNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
+P ++ P I P+ +F P A+DL +LL + P+ R + EA HP+
Sbjct: 238 GSPKAQNYIRSLPNIPKKPFESIFPN-ANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296
Query: 322 ELREPN 327
+P+
Sbjct: 297 IWHDPD 302
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 192 bits (488), Expect = 3e-58
Identities = 110/305 (36%), Positives = 165/305 (54%), Gaps = 27/305 (8%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRVMDHP 87
Y + + VG+G++G V A TGE VAIKK + R Y REL L++ M H
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY--RELTLLKHMQHE 74
Query: 88 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
NVI L F S S +E LVM Y+ + +++ H S ++ V+ YQ+
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK------VQYLVYQMLC 128
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 206
GL YIH+ + HRDLKP NL V+ ++KI DFG A+ A Y+ +R+YRAPE
Sbjct: 129 GLKYIHSAG-IIHRDLKPGNLAVNE-DCELKILDFGLARH--ADAEMTGYVVTRWYRAPE 184
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 265
+I Y ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P E ++ +
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244
Query: 266 ---PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
+Y P+ + +F + P+A+DL ++L+ R TA EA HP+FD
Sbjct: 245 KAAKSYIK-SLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302
Query: 323 LREPN 327
R+ +
Sbjct: 303 FRDAD 307
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 4e-58
Identities = 101/297 (34%), Positives = 159/297 (53%), Gaps = 22/297 (7%)
Query: 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRR----YKNRELQLMRVMDHPNV 89
+Y +G GS+ V++ + TG+ VA+K++ L+ RE L++ + H N+
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 148
++L + + L LV EY + LK Y + + V+L+ +Q+ RGL
Sbjct: 66 VTLHDIIHTKKT-----LTLVFEY----LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPEL 207
AY H RV HRDLKPQNLL+ ++K+ DFG A+ + + + + + + +YR P++
Sbjct: 117 AYCHQ-RRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDV 174
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIR--CM 264
+ G+TEY+TS+D+W GC+ E+ G+PLFPG + DQL +I +VLGTPT E
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234
Query: 265 NPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
NP + + FP P + P +LA + LQY P R +A EA HP+F
Sbjct: 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 5e-58
Identities = 108/299 (36%), Positives = 164/299 (54%), Gaps = 26/299 (8%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHPNVISLK 93
VG+G++G V A TG VAIKK+ R Y REL+L++ M H NVI L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMKHENVIGLL 80
Query: 94 HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
F S + LVM ++ + +++KH + R ++ YQ+ +GL YIH
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR-----IQFLVYQMLKGLKYIH 135
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 212
+ HRDLKP NL V+ ++KI DFG A+Q Y+ +R+YRAPE+I
Sbjct: 136 AAG-IIHRDLKPGNLAVNE-DCELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWM 191
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 268
YT ++DIWS GC++AE+L G+PLF G + +DQL+EI+KV GTP++E ++ + NY
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNY 251
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327
+ P+ + + + P A+++ ++L R TA EA AHP+F+E +P
Sbjct: 252 VK-KLPRFRKKDFRSLL-PNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 2e-57
Identities = 105/290 (36%), Positives = 161/290 (55%), Gaps = 24/290 (8%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 95
+G G++G VF+AK ET E VA+K+V D + RE+ L++ + H N++ L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
S + L LV EY + + K++ S N + VK + +Q+ +GLA+ H+
Sbjct: 68 LHS-----DKKLTLVFEYCDQDLK---KYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS-H 118
Query: 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 214
V HRDLKPQNLL++ ++K+ DFG A+ I + + + +YR P+++FGA Y
Sbjct: 119 NVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 177
Query: 215 TTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDF 271
+TSID+WSAGC+ AEL G+PLFPG + DQL I ++LGTPT E ++ P+Y +
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237
Query: 272 -RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
+P + V ++ DL LL +P R +A EA HP+F
Sbjct: 238 PMYPATTS--LVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 4e-57
Identities = 109/304 (35%), Positives = 157/304 (51%), Gaps = 46/304 (15%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 95
+G G++GIV++A+ +GE VA+KKV D RE+ L+ + HPN++ LK
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
+ +FL VMEY + + +L + + VK Q+ RGL Y+H
Sbjct: 75 VVGK-HLDSIFL--VMEYCEQDLASLLDNMPTP---FSESQVKCLMLQLLRGLQYLHE-N 127
Query: 156 RVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYIC--------SRFYRAP 205
+ HRDLK NLL LT + +KI DFG A+ + +YRAP
Sbjct: 128 FIIHRDLKVSNLL---LTDKGCLKIADFGLAR-------TYGLPAKPMTPKVVTLWYRAP 177
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI---- 261
EL+ G T YTT+ID+W+ GC+LAELL +PL PG++ ++QL II++LGTP E I
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN-ESIWPGF 236
Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMP--PEA-IDLASRLLQYSPSLRCTALEACAHP 318
+ P F P+ P++ + HK P EA + L + LL Y P R TA EA
Sbjct: 237 SDL-PLVGKFTLPK---QPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291
Query: 319 FFDE 322
+F E
Sbjct: 292 YFKE 295
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 5e-55
Identities = 91/310 (29%), Positives = 161/310 (51%), Gaps = 38/310 (12%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL--QDRRYKN--RELQLMRVMDHPNVIS 91
YM R +G GS G+VF A + + VA+KK++ + K+ RE++++R +DH N++
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 92 LKHCFFSTTSKNELFLN---------LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 142
+ + S + +V EY+ + VL+ + + +L+ Y
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMY 121
Query: 143 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI----C 198
Q+ RGL YIH+ V HRDLKP N+ ++ +KI DFG A+ + ++ Y+
Sbjct: 122 QLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 199 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL---VEIIKVLGT 255
+++YR+P L+ YT +ID+W+AGC+ AE+L G+PLF G + ++Q+ +E + V+
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240
Query: 256 PTREEIRCMNPNYTDFRFPQIKAHPW--HKVFHKRMP---PEAIDLASRLLQYSPSLRCT 310
R E+ + P++ ++ + +P PEA+D ++L ++P R T
Sbjct: 241 EDRNELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293
Query: 311 ALEACAHPFF 320
A EA HP+
Sbjct: 294 AEEALMHPYM 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 7e-55
Identities = 100/295 (33%), Positives = 165/295 (55%), Gaps = 33/295 (11%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMDHPNVIS 91
+G G++G+V++ + +TG+ VA+KK+ R ++ RE+ L++ + HPN++
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGL 148
L+ ++ L+L + E++ SM LK Y Q M VK Y YQI +G+
Sbjct: 64 LQDVLMQ---ESRLYL--IFEFL--SMD--LKKYLDSLPKGQYMDAELVKSYLYQILQGI 114
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPEL 207
+ H+ RV HRDLKPQNLL+D +K+ DFG A+ I + + +YRAPE+
Sbjct: 115 LFCHS-RRVLHRDLKPQNLLIDN-KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEV 172
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN-- 265
+ G+ Y+T +DIWS G + AE+ +PLF G++ +DQL I ++LGTPT + +
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
P+Y + FP+ K + K + + +DL ++L Y P+ R +A +A HP+F
Sbjct: 233 PDYKN-TFPKWKK-GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 3e-54
Identities = 95/291 (32%), Positives = 157/291 (53%), Gaps = 25/291 (8%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHC 95
+G GS+G+VF+ + ETG+ VAIKK ++ ++ RE+++++ + HPN+++L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
F + + L+LV EY ++ L+ + +P +K +Q + + + H
Sbjct: 69 F-----RRKRKLHLVFEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHK-H 119
Query: 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELIFGATEY 214
HRD+KP+N+L+ Q+K+CDFG A+ L + + Y+ +R+YRAPEL+ G T+Y
Sbjct: 120 NCIHRDVKPENILITK-QGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG--TPTREEIRCMNPNYTDFR 272
+D+W+ GCV AELL GQPL+PG++ VDQL I K LG P ++I N + F+
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN-QF--FK 235
Query: 273 FPQIKAHPWHKVFHKRMP---PEAIDLASRLLQYSPSLRCTALEACAHPFF 320
I + + P A+ LQ P+ R + E HP+F
Sbjct: 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 4e-53
Identities = 90/291 (30%), Positives = 134/291 (46%), Gaps = 46/291 (15%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRVMDHPNVISLK 93
++G GSFG V+ A +TGE +A+K V L + RE++++ + HPN++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62
Query: 94 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
+ S + + LN+ +EYV S L ++P ++ YT QI GLAY+H
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGS----LSSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFYRAPELIF 209
+ + HRD+K N+LVD VK+ DFG AK+L GE S + ++ APE+I
Sbjct: 119 S-NGIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
G EY + DIWS GC + E+ G+P + + I G P
Sbjct: 177 G-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP------------- 222
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
P+I H + EA D + L+ P R TA E HPF
Sbjct: 223 ----PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 2e-51
Identities = 70/247 (28%), Positives = 120/247 (48%), Gaps = 40/247 (16%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLKHCF 96
+G G FG V+ A+ +TG+ VAIK + ++ RE+++++ ++HPN++ L F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 97 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
++E L LVMEY S+ +LK ++ + QI GL Y+H+
Sbjct: 61 -----EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSNG 112
Query: 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGATEY 214
+ HRDLKP+N+L+D +VK+ DFG +K L + ++ + I + Y APE++ G Y
Sbjct: 113 -IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD-FRF 273
+ DIWS G +L EL +L ++I+ + + +
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208
Query: 274 PQIKAHP 280
+I H
Sbjct: 209 KEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 173 bits (439), Expect = 5e-51
Identities = 104/315 (33%), Positives = 150/315 (47%), Gaps = 51/315 (16%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKV---------LQDRRYKN---------RELQLMRV 83
+G G++G V +A TG+ VAIKKV +DR+ REL++M
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 84 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 143
+ H N++ L + F+NLVM+ M LK R+ VK Q
Sbjct: 77 IKHENIMGLVDVYVE-----GDFINLVMDI----MASDLKKVVDRKIRLTESQVKCILLQ 127
Query: 144 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-----LIAGEANISYIC 198
I GL +H HRDL P N+ ++ KI DFG A++ + +
Sbjct: 128 ILNGLNVLHKW-YFMHRDLSPANIFINS-KGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 199 SR----------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 248
R +YRAPEL+ GA +Y ++D+WS GC+ AELL G+PLFPGEN +DQL
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245
Query: 249 IIKVLGTPTRE---EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 305
I ++LGTP + + + + P YT+F + K K +AIDL LL+ +P
Sbjct: 246 IFELLGTPNEDNWPQAKKL-PLYTEFTPRKPKD---LKTIFPNASDDAIDLLQSLLKLNP 301
Query: 306 SLRCTALEACAHPFF 320
R +A EA H +F
Sbjct: 302 LERISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 172 bits (436), Expect = 2e-50
Identities = 106/304 (34%), Positives = 165/304 (54%), Gaps = 24/304 (7%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 89
Y VG+G++G V A + VA+KK+ L R REL+L++ M H NV
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 90 ISLKHCFFSTTSK---NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
I L F TS NE++L V + + ++K Q++ +V+ YQ+ R
Sbjct: 77 IGLLDVFTPATSIENFNEVYL--VTNLMGADLNNIVKC-----QKLSDEHVQFLIYQLLR 129
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 206
GL YIH+ + HRDLKP N+ V+ +++I DFG A+Q A + Y+ +R+YRAPE
Sbjct: 130 GLKYIHSAG-IIHRDLKPSNVAVNE-DCELRILDFGLARQ--ADDEMTGYVATRWYRAPE 185
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
++ Y ++DIWS GC++AELL G+ LFPG + +DQL I++V+GTP+ E ++ ++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245
Query: 267 NYTDFRF---PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
+ P + K+F + P AIDL ++L R +A EA AHP+F +
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304
Query: 324 REPN 327
+P
Sbjct: 305 HDPE 308
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 172 bits (436), Expect = 3e-50
Identities = 93/342 (27%), Positives = 141/342 (41%), Gaps = 46/342 (13%)
Query: 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHP 87
SY R +G GSFG V+ A+ + VA+K + + RE+Q++ ++HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
I + FF ++E L LVMEYV L + QI
Sbjct: 58 PNIVKLYDFF----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSA 113
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-------SYICSR 200
L Y+H+ + HRD+KP+N+L+D VK+ DFG AK L + + + +
Sbjct: 114 LEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 201 FYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGT 255
Y APE++ G + ++S DIWS G L ELL G P F GE A Q ++II L T
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232
Query: 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315
P A P + + A DL +LL P R ++
Sbjct: 233 P-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
Query: 316 AHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKL 357
+H L+ + L + + L + L++ L
Sbjct: 274 SHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSL 315
|
Length = 384 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 169 bits (428), Expect = 6e-50
Identities = 106/294 (36%), Positives = 164/294 (55%), Gaps = 28/294 (9%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH 94
VVG G++G+V + + ET E VAIKK + REL+++R + N++ LK
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 95 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 154
F + +L+L V EYV ++M +L+ + +P V+ Y YQ+ + + + H
Sbjct: 68 AF---RRRGKLYL--VFEYVEKNMLELLEEMPNG---VPPEKVRSYIYQLIKAIHWCHK- 118
Query: 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANIS-YICSRFYRAPELIFGAT 212
+ HRD+KP+NLL+ +K+CDFG A+ L G AN + Y+ +R+YR+PEL+ GA
Sbjct: 119 NDIVHRDIKPENLLISH-NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM--NPNYTD 270
Y ++D+WS GC+L EL GQPLFPGE+ +DQL I KVLG E+++ NP +
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236
Query: 271 FRFPQIKAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
RFP + HP + +R + +DL LL+ +P+ R + HP F
Sbjct: 237 LRFPAV-NHP--QSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 8e-50
Identities = 95/311 (30%), Positives = 151/311 (48%), Gaps = 49/311 (15%)
Query: 43 GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMDHPNVISL 92
G G+FG V++A+ ++TG VA+KK+L N RE+++++ + HPNV+ L
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILM----HNEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 93 KHCFF-----STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
S + +++ V Y+ + +L S I K Y Q+ G
Sbjct: 73 IDMAVERPDKSKRKRGSVYM--VTPYMDHDLSGLL-ENPSVKLTESQI--KCYMLQLLEG 127
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK---------QLIAGEANISY-- 196
+ Y+H + HRD+K N+L+D +KI DFG A+ + G Y
Sbjct: 128 INYLHE-NHILHRDIKAANILIDN-QGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185
Query: 197 -ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
+ +R+YR PEL+ G YTT++DIW GCV AE+ +P+ G++ +DQL I K+ GT
Sbjct: 186 LVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245
Query: 256 PTREEIRCMNPNYTDF-RFPQIKAHPWH-----KVFHKRMPPEAIDLASRLLQYSPSLRC 309
PT E P + + + + + F ++ PE +DL S+LL P R
Sbjct: 246 PTEETW----PGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRL 300
Query: 310 TALEACAHPFF 320
TA +A HP+F
Sbjct: 301 TASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 6e-49
Identities = 98/307 (31%), Positives = 166/307 (54%), Gaps = 21/307 (6%)
Query: 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 89
+Y+ +G G++ V++ + T VA+K++ + RE+ L++ + H N+
Sbjct: 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 148
++L + S L LV EY+ + LK Y + + VKL+ +Q+ RGL
Sbjct: 67 VTLHDIIHTEKS-----LTLVFEYLDKD----LKQYLDDCGNSINMHNVKLFLFQLLRGL 117
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPEL 207
Y H +V HRDLKPQNLL++ ++K+ DFG A+ + I + + + + +YR P++
Sbjct: 118 NYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDI 175
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM--N 265
+ G+T+Y+T ID+W GC+ E+ G+PLFPG +QL I ++LGTPT E + N
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
+ + +P+ +A H R+ + +L S+LLQ+ R +A EA HP+F L E
Sbjct: 236 EEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294
Query: 326 PNARLPN 332
+LP+
Sbjct: 295 RIHKLPD 301
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-48
Identities = 106/326 (32%), Positives = 170/326 (52%), Gaps = 43/326 (13%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 87
Y + +G+G+ GIV A TG+ VAIKK+ R ++N REL LM++++H
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKL--SRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 88 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
N+I L + F S E + LVME + ++ +V+ ++RM + YQ+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-QMDLDHERMSYL-----LYQMLC 129
Query: 147 GLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 205
G+ ++H+ + HRDLKP N++V T +KI DFG A+ Y+ +R+YRAP
Sbjct: 130 GIKHLHSAG-IIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAP 186
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
E+I G Y ++DIWS GC++ E++ G LFPG + +DQ +II+ LGTP+ E + +
Sbjct: 187 EVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245
Query: 266 P---NYTDFRFPQIKAHPWHKVF------------HKRMPPEAIDLASRLLQYSPSLRCT 310
P NY + R P+ + + ++F +K +A DL S++L P R +
Sbjct: 246 PTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS 304
Query: 311 ALEACAHPF----FDELREPNARLPN 332
+A HP+ +D E A P
Sbjct: 305 VDDALQHPYINVWYDP-SEVEAPPPA 329
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 1e-48
Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 93
VG+G++G V A +TG VA+KK+ + R Y REL+L++ M H NVI L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 82
Query: 94 HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
F S E + LV + + ++K Q++ +V+ YQI RGL YIH
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 137
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 212
+ + HRDLKP NL V+ ++KI DFG A+ + Y+ +R+YRAPE++
Sbjct: 138 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 193
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 268
Y ++DIWS GC++AELL G+ LFPG + +DQL I++++GTP E ++ ++ NY
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 253
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327
Q+ + VF P A+DL ++L R TA +A AH +F + +P+
Sbjct: 254 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 4e-48
Identities = 101/307 (32%), Positives = 155/307 (50%), Gaps = 37/307 (12%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKK---VLQD-----RRYKNRELQLMRVMDHPNVI 90
+R +G G+FG+V+ G+ VA+KK V Q+ R + REL+++ H NV+
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF--RELKMLCFFKHDNVL 62
Query: 91 S--------LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 142
S F E+++ V E M L + Q + +VK++ Y
Sbjct: 63 SALDILQPPHIDPF------EEIYV------VTELMQSDLHKIIVSPQPLSSDHVKVFLY 110
Query: 143 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI--SYICSR 200
QI RGL Y+H+ + HRD+KP NLLV+ +KICDFG A+ E+ + ++
Sbjct: 111 QILRGLKYLHSA-GILHRDIKPGNLLVNS-NCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 201 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260
+YRAPE++ G+ YT+++DIWS GC+ AELL + LF ++ + QL I +LGTP+ E
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228
Query: 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAH 317
+R P V + EA+ L R+L + P R +A +A AH
Sbjct: 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288
Query: 318 PFFDELR 324
P+ DE R
Sbjct: 289 PYLDEGR 295
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 5e-47
Identities = 98/296 (33%), Positives = 158/296 (53%), Gaps = 20/296 (6%)
Query: 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNV 89
SY+ +G GS+ V++ G+ VA+K + RE L++ + H N+
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI 65
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
+ L + + L V EY+ + + + + + V+L+ +Q+ RGLA
Sbjct: 66 VLLHDIIHTKET-----LTFVFEYMHTDLAQYMIQHPGG---LHPYNVRLFMFQLLRGLA 117
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPELI 208
YIH + HRDLKPQNLL+ L ++K+ DFG A+ + I + S + + +YR P+++
Sbjct: 118 YIHG-QHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVL 175
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIRCMN-- 265
GAT+Y++++DIW AGC+ E+L GQP FPG + +QL +I VLG PT + ++
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235
Query: 266 PNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
PNY F K V+ + PP+A DLAS++L P R +A +A HP+F
Sbjct: 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-46
Identities = 100/299 (33%), Positives = 164/299 (54%), Gaps = 23/299 (7%)
Query: 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 89
+Y+ +G G++ VF+ + T VA+K++ + RE+ L++ + H N+
Sbjct: 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 148
++L + S L LV EY+ + LK Y M + VK++ YQI RGL
Sbjct: 67 VTLHDIVHTDKS-----LTLVFEYLDKD----LKQYMDDCGNIMSMHNVKIFLYQILRGL 117
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPEL 207
AY H +V HRDLKPQNLL++ ++K+ DFG A+ + + + + + + +YR P++
Sbjct: 118 AYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
+ G++EY+T ID+W GC+ E+ G+PLFPG D+L I ++LGTPT E ++ N
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235
Query: 268 --YTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
+ ++ FP+ K P + H R+ E I+L ++ LQY R +A EA H +F L
Sbjct: 236 DEFKNYNFPKYKPQPL--INHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-45
Identities = 98/296 (33%), Positives = 161/296 (54%), Gaps = 23/296 (7%)
Query: 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 89
+Y+ +G G++ VF+ + T VA+K++ + RE+ L++ + H N+
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 148
++L H T E L LV EY+ LK Y + M + VK++ +Q+ RGL
Sbjct: 66 VTL-HDIIHT----ERCLTLVFEYLDSD----LKQYLDNCGNLMSMHNVKIFMFQLLRGL 116
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPEL 207
+Y H ++ HRDLKPQNLL++ ++K+ DFG A+ + + + + + + +YR P++
Sbjct: 117 SYCHK-RKILHRDLKPQNLLINE-KGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 174
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--CMN 265
+ G+TEY+T ID+W GC+L E+ G+P+FPG ++L I ++LGTPT E N
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234
Query: 266 PNYTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
+ + FPQ +A P + H R+ + IDL S LL Y R +A A H +F
Sbjct: 235 EEFRSYLFPQYRAQPL--INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 8e-45
Identities = 83/287 (28%), Positives = 131/287 (45%), Gaps = 46/287 (16%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRVMDHPNVISLKHC 95
+G G FG V++A+ TG+ VAIK + L+ + K E+Q+++ HPN++
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 96 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 154
+ K+EL++ VME+ S+ +LK NQ + + ++ +GL Y+H+
Sbjct: 66 YLK---KDELWI--VMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 155 PRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 212
+ HRD+K N+L LT +VK+ DFG + QL +A + + + ++ APE+I G
Sbjct: 118 -GIIHRDIKAANIL---LTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-K 172
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
Y DIWS G EL G+P + + L +I G P R
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPG-------------LR 218
Query: 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
P W F D + LQ +P R TA + HPF
Sbjct: 219 NP----EKWSDEFK--------DFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 3e-43
Identities = 91/292 (31%), Positives = 138/292 (47%), Gaps = 55/292 (18%)
Query: 42 VGTGSFGIVFQAKCLETGETVAI----KKVLQDRR---YKNRELQLMRVMDHPNVISLKH 94
+G GSFG V + +TG+ A+ KK + R+ + E ++ ++HP ++ L H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-H 59
Query: 95 CFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
F T K L LV+EY P E L + S R + Y +I L Y+H
Sbjct: 60 YAFQTEEK----LYLVLEYAPGGE-----LFSHLSKEGRFSEERARFYAAEIVLALEYLH 110
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGA 211
++ + +RDLKP+N+L+D H +K+ DFG AK+L + + + C + Y APE++ G
Sbjct: 111 SL-GIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
Y ++D WS G +L E+L G+P F E+ ++ E I
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL----------------KDPL 210
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC---AHPFF 320
RFP + + PEA DL S LLQ P+ R + A AHPFF
Sbjct: 211 RFP------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-41
Identities = 89/303 (29%), Positives = 150/303 (49%), Gaps = 39/303 (12%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH 94
+G G++G V++A+ +TGE VA+KKV D + RE++++R ++H N+++LK
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 95 CFFSTTS-----KNELFLNLVMEYVPESMYRVLK----HYSSANQRMPLIYVKLYTYQIF 145
K++ LV EY+ + +L+ H+S + +K + Q+
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-------IKSFMKQLL 126
Query: 146 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYR 203
GL Y H HRD+K N+L++ Q+K+ DFG A+ + E+ + + + +YR
Sbjct: 127 EGLNYCHK-KNFLHRDIKCSNILLNN-KGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
PEL+ G Y +ID+WS GC+L EL +P+F + QL I ++ G+P
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA---- 240
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKR-------MPPEAIDLASRLLQYSPSLRCTALEACA 316
+ P+ + P K + +R +P A+DL +L PS RCTA EA
Sbjct: 241 VWPDVI--KLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298
Query: 317 HPF 319
P+
Sbjct: 299 SPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-41
Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 44/293 (15%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 89
Y + +G GSFG V+ + G+ +K++ ++R E+++++ ++HPN+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
I F L +VMEY + + +K + P + + Q+ L
Sbjct: 62 IKYYESFEEKGK-----LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-AGEANISYICSRFYRAPEL 207
Y+H+ ++ HRD+KPQN+ + VK+ DFG +K L + + + + +Y +PEL
Sbjct: 117 KYLHS-RKILHRDIKPQNIFLTS-NGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
Y DIWS GCVL EL + F GEN + +L K+L + + +
Sbjct: 175 CQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELAL--KIL----KGQYPPIPSQ 226
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
Y E +L S LLQ P R + + PF
Sbjct: 227 Y---------------------SSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-40
Identities = 87/300 (29%), Positives = 145/300 (48%), Gaps = 30/300 (10%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH- 94
+G G+FG VF+A+ +T + VA+KKVL + + RE+++++++ H NV++L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 95 CFFSTT--SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
C T ++ + LV E+ + +L S+ N + L +K + GL YIH
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEHDLAGLL---SNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK---QLIAGEAN--ISYICSRFYRAPEL 207
++ HRD+K N+L+ +K+ DFG A+ + N + + + +YR PEL
Sbjct: 137 R-NKILHRDMKAANILITK-DGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPEL 194
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
+ G +Y ID+W AGC++AE+ P+ G QL I ++ G+ T E + P
Sbjct: 195 LLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE----VWPG 250
Query: 268 ------YTDFRFPQ-IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
+ PQ K ++ P A+DL +LL P+ R A A H FF
Sbjct: 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 1e-39
Identities = 87/292 (29%), Positives = 141/292 (48%), Gaps = 24/292 (8%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVM---DHPN 88
+G G++G V++A+ +G VA+K V R + RE+ L++ + DHPN
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
++ L ++ + E + LV E+V + + L +P +K Q RGL
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG--LPAETIKDLMRQFLRGL 121
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 208
++H + HRDLKP+N+LV QVK+ DFG A+ A + + +YRAPE++
Sbjct: 122 DFLHA-NCIVHRDLKPENILVTS-GGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
+T Y T +D+WS GC+ AE+ +PLF G + DQL +I ++G P ++ +
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVTL 237
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
F P V + L +L ++P R +A A HPFF
Sbjct: 238 PRGAFSPRGPRPVQSVV-PEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-39
Identities = 97/302 (32%), Positives = 157/302 (51%), Gaps = 26/302 (8%)
Query: 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRR----YKNRELQLMRVMDHPNV 89
SY +G GS+ V++ K G+ VA+K + LQ+ RE L++ + H N+
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
+ L + + L LV EYV + + + + + VKL+ +Q+ RGL+
Sbjct: 66 VLLHDIIHTKET-----LTLVFEYVHTDLCQYMDKHPGG---LHPENVKLFLFQLLRGLS 117
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPELI 208
YIH + HRDLKPQNLL+ T ++K+ DFG A+ + + + + + +YR P+++
Sbjct: 118 YIHQ-RYILHRDLKPQNLLISD-TGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMN-- 265
G+TEY+T +D+W GC+ E++ G FPG + DQL I VLGTP + ++
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235
Query: 266 PNYTDFRFPQIKA----HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
P++ RF W+K+ + A DLAS+LLQ P R +A A +H +F
Sbjct: 236 PHFKPERFTLYSPKNLRQAWNKLSYVN---HAEDLASKLLQCFPKNRLSAQAALSHEYFS 292
Query: 322 EL 323
+L
Sbjct: 293 DL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 9e-39
Identities = 101/314 (32%), Positives = 163/314 (51%), Gaps = 35/314 (11%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 87
Y + +G+G+ GIV A G VA+KK+ R ++N REL L++ ++H
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL--SRPFQNQTHAKRAYRELVLLKCVNHK 80
Query: 88 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
N+ISL + F S E + LVME + ++ +V+ H ++RM + YQ+
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLC 134
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 206
G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +R+YRAPE
Sbjct: 135 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 192
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
+I G Y ++DIWS GC++ EL+ G +F G + +DQ ++I+ LGTP+ E + + P
Sbjct: 193 VILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251
Query: 267 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 312
NY + R PQ + ++F + P +A DL S++L P R +
Sbjct: 252 TVRNYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVD 310
Query: 313 EACAHPFFDELREP 326
EA HP+ +P
Sbjct: 311 EALRHPYITVWYDP 324
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-38
Identities = 88/290 (30%), Positives = 137/290 (47%), Gaps = 48/290 (16%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---------NRELQLMRVMDHPNVI 90
++G+GSFG V++ L+ G+ A+K+V + +E+ L+ + HPN++
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
+ T + E L + +E VP S+ ++LK Y S P ++LYT QI GL
Sbjct: 66 Q-----YLGTEREEDNLYIFLELVPGGSLAKLLKKYGS----FPEPVIRLYTRQILLGLE 116
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 209
Y+H HRD+K N+LVD VK+ DFG AKQ++ S+ S ++ APE+I
Sbjct: 117 YLHD-RNTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
Y + DIWS GC + E+ G+P + + ++ + + K+ + I
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPI-------- 223
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
P H + EA D + LQ PSLR TA E HPF
Sbjct: 224 ----------PDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 5e-38
Identities = 88/320 (27%), Positives = 133/320 (41%), Gaps = 77/320 (24%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRE-LQLMRVMDH 86
+ +++G GSF V AK ET + AI K+L R+ Y E L R+ H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAI-KILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 87 PNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIF 145
P +I L + F ++E L V+EY P + + ++ Y S +++ + Y +I
Sbjct: 62 PGIIKLYYTF-----QDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRFYAAEIL 112
Query: 146 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICSRF 201
L Y+H+ + HRDLKP+N+L+D H +KI DFG+AK L
Sbjct: 113 LALEYLHSK-GIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 202 -----------------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 244
Y +PEL+ S D+W+ GC++ ++L G+P F G N
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229
Query: 245 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 304
+I+K ++ FP PP+A DL +LL
Sbjct: 230 TFQKILK-----------------LEYSFPPN------------FPPDAKDLIEKLLVLD 260
Query: 305 PSLRCTALEAC----AHPFF 320
P R E AHPFF
Sbjct: 261 PQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 5e-37
Identities = 101/314 (32%), Positives = 165/314 (52%), Gaps = 35/314 (11%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 87
Y + +G+G+ GIV A VAIKK+ R ++N REL LM+ ++H
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 88 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
N+ISL + F S E + LVME + ++ +V++ ++RM + YQ+
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLC 130
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 206
G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +R+YRAPE
Sbjct: 131 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+ LGTP E ++ + P
Sbjct: 189 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 267 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 312
NY + R P+ + K+F + P +A DL S++L P+ R +
Sbjct: 248 TVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
Query: 313 EACAHPFFDELREP 326
EA HP+ + +P
Sbjct: 307 EALQHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 1e-36
Identities = 101/326 (30%), Positives = 167/326 (51%), Gaps = 41/326 (12%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 87
Y + +G+G+ GIV A VAIKK+ R ++N REL LM+ ++H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 88 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
N+I L + F S E + +VME + ++ +V++ ++RM + YQ+
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLC 137
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 206
G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +R+YRAPE
Sbjct: 138 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
+I G Y ++DIWS GC++ E++ G LFPG + +DQ ++I+ LGTP E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 267 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 312
Y + R P+ + + K+F + P +A DL S++L S R +
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 313 EACAHPFFD------ELREPNARLPN 332
EA HP+ + E P ++P+
Sbjct: 314 EALQHPYINVWYDPSEAEAPPPKIPD 339
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 86/292 (29%), Positives = 129/292 (44%), Gaps = 54/292 (18%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHC 95
V+G GS G+V++ + TG+ A+KK+ D + R EL+ +R + P V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 96 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 154
F+ +++V+EY+ S+ +LK ++P + QI +GL Y+HT
Sbjct: 68 FYKEGE-----ISIVLEYMDGGSLADLLK----KVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAPELIF 209
+ HRD+KP NLL++ +VKI DFG +K L N C+ F Y +PE I
Sbjct: 119 RHIIHRDIKPSNLLIN-SKGEVKIADFGISKVL----ENTLDQCNTFVGTVTYMSPERIQ 173
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVD-QLVEIIKVLGTPTREEIRCMNPN 267
G + Y+ + DIWS G L E LG+ P P +L++ I C P
Sbjct: 174 GES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CDGPP 220
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
+ PE D S LQ P R +A E HPF
Sbjct: 221 P----SLP----------AEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 2e-36
Identities = 98/294 (33%), Positives = 157/294 (53%), Gaps = 27/294 (9%)
Query: 42 VGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN------RELQLMRVMD---HPNVIS 91
+G G++G VF+A+ L+ G VA+K+V + RE+ ++R ++ HPNV+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 92 L-KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
L C S T + E L LV E+V + + L +P +K +Q+ RGL +
Sbjct: 69 LFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 210
+H+ RV HRDLKPQN+LV + Q+K+ DFG A+ A S + + +YRAPE++
Sbjct: 126 LHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 183
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270
++ Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V+G P E+ P D
Sbjct: 184 SS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR--D 236
Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLL----QYSPSLRCTALEACAHPFF 320
P+ H ++ + +L LL ++P+ R +A A +HP+F
Sbjct: 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 3e-34
Identities = 79/288 (27%), Positives = 139/288 (48%), Gaps = 48/288 (16%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRVMDHPNVISLKH 94
++G G+FG+V++ LETG+ VAIK++ L+ + + +E+ L++ + HPN++
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 95 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
+ L +++EY S+ +++K + + + V +Y YQ+ +GLAY+H
Sbjct: 67 SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHE 117
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFGAT 212
V HRD+K N+L VK+ DFG A +L + S + + ++ APE+I +
Sbjct: 118 -QGVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S 174
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
+T+ DIWS GC + ELL G P + N + L I++ + +
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-------------DDHP---P 218
Query: 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
P + + PE D + Q P+LR TA + HP+
Sbjct: 219 LP------------EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 5e-34
Identities = 79/292 (27%), Positives = 135/292 (46%), Gaps = 50/292 (17%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRVMDHPNVISLKHC 95
+G G+FG V+ A L+TGE +A+K++ +QD K E++++ ++ HPN++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64
Query: 96 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 154
+ + ++ + MEY ++ +L+H + + +++YT Q+ GLAY+H+
Sbjct: 65 YGVEVHREKV--YIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHS- 117
Query: 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-----IAGEANISYICSRFYRAPELIF 209
+ HRD+KP N+ +D +K+ DFG A +L GE S + Y APE+I
Sbjct: 118 HGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 210 GAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
G + + DIWS GCV+ E+ G+ + + Q++ + P
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP---------- 226
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
P ++ PE D R L+ P R TA E HPF
Sbjct: 227 -----IPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-34
Identities = 107/316 (33%), Positives = 157/316 (49%), Gaps = 44/316 (13%)
Query: 42 VGTGSFGIVFQAKCLETGET--VAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFF 97
VG G++G V++AK + + A+K++ RE+ L+R + HPNVISL+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 98 STTSKNELFLNLVMEYVPESMYRVLKHY--SSANQR---MPLIYVKLYTYQIFRGLAYIH 152
S + + L+ +Y ++ ++K + S AN++ +P VK YQI G+ Y+H
Sbjct: 69 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 153 TVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQL---IAGEANISYICSRF-YRAP 205
V HRDLKP N+LV P +VKI D G A+ + A++ + F YRAP
Sbjct: 126 A-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVLGTP 256
EL+ GA YT +IDIW+ GC+ AELL +P+F DQL I V+G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244
Query: 257 TR---EEIRCMNPNYT---DFR------FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 304
E+I+ M + T DFR IK HKV + +A L +LL
Sbjct: 245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV---KPDSKAFHLLQKLLTMD 301
Query: 305 PSLRCTALEACAHPFF 320
P R T+ +A P+F
Sbjct: 302 PIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 1e-33
Identities = 105/314 (33%), Positives = 158/314 (50%), Gaps = 40/314 (12%)
Query: 42 VGTGSFGIVFQAKCLETGET--VAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFF 97
VG G++G V++AK + + A+K++ RE+ L+R + HPNVI+L+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 98 STTSKNELFLNLVMEYVPESMYRVLKHY--SSANQR---MPLIYVKLYTYQIFRGLAYIH 152
S + + + L+ +Y ++ ++K + S AN++ +P VK YQI G+ Y+H
Sbjct: 69 SHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 153 TVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQL---IAGEANISYICSRF-YRAP 205
V HRDLKP N+LV P +VKI D G A+ + A++ + F YRAP
Sbjct: 126 A-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVLGTP 256
EL+ GA YT +IDIW+ GC+ AELL +P+F DQL I V+G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244
Query: 257 TR---EEIRCMNPNY----TDFRFPQIKAHPWHKVFHK-RMPPEA--IDLASRLLQYSPS 306
E+IR M P Y DFR K K ++ P++ L +LL P+
Sbjct: 245 ADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPT 303
Query: 307 LRCTALEACAHPFF 320
R T+ +A P+F
Sbjct: 304 KRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 90/296 (30%), Positives = 133/296 (44%), Gaps = 59/296 (19%)
Query: 45 GSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR------ELQLMRVMDHPNVISLKHCFF 97
G++G VF AK TG+ AIK + D KN+ E ++ P V+ L ++
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60
Query: 98 STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 156
S K L+L VMEY+P + +L++ S ++ + ++Y +I L Y+H+
Sbjct: 61 SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHSN-G 113
Query: 157 VCHRDLKPQNLLVDPLTHQVKICDFGSAK----QLIAGEANISYICSRF-----YRAPEL 207
+ HRDLKP N+L+D H +K+ DFG +K + + R Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
I G ++ ++D WS GC+L E L+G P F GE EEI N
Sbjct: 173 ILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETP----------------EEI-FQNIL 214
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL---EACAHPFF 320
+P+ + EAIDL S+LL P R A E HPFF
Sbjct: 215 NGKIEWPEDV----------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 5e-32
Identities = 74/292 (25%), Positives = 130/292 (44%), Gaps = 49/292 (16%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKH 94
+G G+ G+V + TG+ +A+K + + ++ REL ++ + P ++
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 95 CFFSTTSKNELFLNLVMEYV-PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
F++ ++ + MEY+ S+ ++LK R+P + + +GL Y+H
Sbjct: 67 AFYN---NGDISI--CMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHE 118
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 213
++ HRD+KP N+LV+ Q+K+CDFG + QL+ A +++ + Y APE I G +
Sbjct: 119 KHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-ND 175
Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENA-----VDQLVEIIKVLGTPTREEIRCMNPNY 268
Y+ DIWS G L EL G+ +P EN + L I+ P
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP-- 221
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
P++ + + P+ D + L P R + E HPF
Sbjct: 222 -----PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 6e-32
Identities = 82/297 (27%), Positives = 139/297 (46%), Gaps = 51/297 (17%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMDHPNV 89
+ +GTG+F +QA+ ++TG +A+K+V R + +E++LM ++HP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
I +T + NL +E++ S+ +L Y + + + + YT Q+ RGL
Sbjct: 66 I---RMLGATCEDSHF--NLFVEWMAGGSVSHLLSKYGAFKEA---VIIN-YTEQLLRGL 116
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-----AGEANISYICSRFYR 203
+Y+H ++ HRD+K NLL+D +++I DFG+A +L AGE + + +
Sbjct: 117 SYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
APE++ G +Y S D+WS GCV+ E+ +P + E + L I K I
Sbjct: 176 APEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---------IAS 225
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
P I H + P D+ R L+ P R + E HP F
Sbjct: 226 ATTA------PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 75/284 (26%), Positives = 126/284 (44%), Gaps = 41/284 (14%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCFFS 98
+G GS+G V++A ETG+ VAIK V + + +E+ +++ D P ++ +F
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF- 68
Query: 99 TTSKNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 157
+L+ +VMEY S+ ++K N+ + + YQ +GL Y+H+ +
Sbjct: 69 --KNTDLW--IVMEYCGAGSVSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLHSN-KK 120
Query: 158 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFGATEYTT 216
HRD+K N+L++ Q K+ DFG + QL A + I + F+ APE+I Y
Sbjct: 121 IHRDIKAGNILLNE-EGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNN 178
Query: 217 SIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQI 276
DIWS G E+ G+P + + + + I P P
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-------------KP-------PPT 218
Query: 277 KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
+ P ++ PE D + L P R +A++ HPF
Sbjct: 219 LSDP------EKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 34/231 (14%)
Query: 39 ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 89
+ +G G+FG V++ VA+K + +D + RE ++MR +DHPN+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVKLYTYQIFRG 147
+ L T + L +VMEY+P L Y + + + L + + QI RG
Sbjct: 64 VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF----YR 203
+ Y+ + HRDL +N LV VKI DFG ++ L + Y + R
Sbjct: 116 MEYLESK-NFIHRDLAARNCLVGE-NLVVKISDFGLSRDL----YDDDYYKVKGGKLPIR 169
Query: 204 --APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 251
APE + ++T+ D+WS G +L E+ LG+ +PG + +++E +K
Sbjct: 170 WMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVLEYLK 218
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 85/296 (28%), Positives = 139/296 (46%), Gaps = 60/296 (20%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRVMDHPNVISL 92
+ +GTGSFG V + +G+ A+K K+++ ++ + E ++++ + HP +++L
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 93 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
F +++ L LVMEYVP E L + + R P + Y Q+ L Y
Sbjct: 67 YGSF-----QDDSNLYLVMEYVPGGE-----LFSHLRKSGRFPEPVARFYAAQVVLALEY 116
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 209
+H++ V +RDLKP+NLL+D + +KI DFG AK++ + +C + Y APE+I
Sbjct: 117 LHSLDIV-YRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIIL 171
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
Y ++D W+ G ++ E+L G P F +N Q+ E K+L
Sbjct: 172 S-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYE--KILE--------------G 213
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFF 320
RFP P+A DL LLQ + R L+ HP+F
Sbjct: 214 KVRFP------------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 7e-30
Identities = 81/300 (27%), Positives = 129/300 (43%), Gaps = 61/300 (20%)
Query: 39 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 89
+ +G G+FG V++ K + VA+K + +D + RE ++MR +DHPNV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 148
+ L T + L+ +VMEY+ L Y N+ ++ L + + QI RG+
Sbjct: 64 VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR--APE 206
Y+ + + HRDL +N LV VKI DFG ++ L + R APE
Sbjct: 116 EYLESKNFI-HRDLAARNCLVGE-NLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE 173
Query: 207 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
+ ++T+ D+WS G +L E+ LG+ +PG + ++++E +K
Sbjct: 174 SLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLEYLK-------------- 217
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
+R PQ PPE DL + P R T F EL E
Sbjct: 218 ---NGYRLPQP----------PNCPPELYDLMLQCWAEDPEDRPT---------FSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 52/290 (17%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVL---QDRRYKNRELQLMRVMDHPNVISLKHCFF 97
+G G+ G V++A TG+ VAIKK+ Q++ E+ +M+ HPN++ +
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 98 STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMP---LIYVKLYTYQIFRGLAYIHT 153
+EL++ VMEY+ S+ ++ RM + YV ++ +GL Y+H+
Sbjct: 86 V---GDELWV--VMEYMDGGSLTDIITQNFV---RMNEPQIAYVCR---EVLQGLEYLHS 134
Query: 154 VPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFG 210
+ HRD+K N+L L+ VK+ DFG A QL ++ S + + ++ APE+I
Sbjct: 135 QNVI-HRDIKSDNIL---LSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR 190
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270
+Y +DIWS G + E+ G+P + E + L I G P +
Sbjct: 191 -KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIPPLKN---------- 238
Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
W F D ++ L P R +A E HPF
Sbjct: 239 -------PEKWSPEF--------KDFLNKCLVKDPEKRPSAEELLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-29
Identities = 82/303 (27%), Positives = 139/303 (45%), Gaps = 53/303 (17%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------------ELQLM 81
++ ++G G++G V+ A + TGE +A+K+V R E++ +
Sbjct: 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 82 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLY 140
+ +DH N++ E +L++ +EYVP S+ L+ Y +++ V+ +
Sbjct: 63 KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFF 113
Query: 141 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ---LIAGEANISYI 197
T Q+ GLAY+H+ + HRDLK NLLVD KI DFG +K+ + + N+S
Sbjct: 114 TEQVLEGLAYLHS-KGILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 198 CSRFYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
S F+ APE+I ++ Y+ +DIWS GCV+ E+ G+ + E A+ + ++
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL------- 224
Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
+ A P + P A+D + +P R TA E
Sbjct: 225 ----------------GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
Query: 317 HPF 319
HPF
Sbjct: 269 HPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-29
Identities = 87/291 (29%), Positives = 132/291 (45%), Gaps = 58/291 (19%)
Query: 45 GSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQ---LMRVMDHPNVISLKHCF 96
G+FG V+ AK TG+ AIK ++ + N + + +M + P V L +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63
Query: 97 FSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
+S SK+ L+L VMEY+ S+ + L +P + K Y ++ G+ +H
Sbjct: 64 YSFQSKDYLYL--VMEYLNGGDCASLIKTLGG-------LPEDWAKQYIAEVVLGVEDLH 114
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 212
+ HRD+KP+NLL+D H +K+ DFG ++ G N ++ + Y APE I G
Sbjct: 115 Q-RGIIHRDIKPENLLIDQTGH-LKLTDFGLSR---NGLENKKFVGTPDYLAPETILGVG 169
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
+ D WS GCV+ E L G P F E D + + I R +N
Sbjct: 170 D-DKMSDWWSLGCVIFEFLFGYPPFHAE-TPDAVFDNI---------LSRRIN------- 211
Query: 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFF 320
W + + PEA+DL +RLL P+ R A E +HPFF
Sbjct: 212 --------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-29
Identities = 90/308 (29%), Positives = 143/308 (46%), Gaps = 67/308 (21%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL--------QDRRYK-----NRELQLMR 82
++ ++G+GSFG V+ +GE +A+K+V +DR+ RE+ L++
Sbjct: 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 83 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYT 141
+ H N++ S + LN+ +EYVP S+ +L +Y + + + V+ +
Sbjct: 62 ELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112
Query: 142 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI------- 194
QI +GL Y+H + HRD+K N+LVD +KI DFG +K+L EAN
Sbjct: 113 RQILKGLNYLHN-RGIIHRDIKGANILVDN-KGGIKISDFGISKKL---EANSLSTKTNG 167
Query: 195 ---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251
S S F+ APE++ T YT DIWS GC++ E+L G+ FP QL I K
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFPD---CTQLQAIFK 223
Query: 252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
+ + P+I ++ + EAID + + + R TA
Sbjct: 224 IGENAS----------------PEIPSN---------ISSEAIDFLEKTFEIDHNKRPTA 258
Query: 312 LEACAHPF 319
E HPF
Sbjct: 259 AELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-28
Identities = 67/240 (27%), Positives = 108/240 (45%), Gaps = 22/240 (9%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLM---RVMDHPNVISL 92
++G G++G V++ K + TG VA+K + D + RE+ L+ R PN+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 93 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
+ L ++MEY R L ++ Y+ + ++ L YIH
Sbjct: 68 YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFGA 211
V V HRD+K N+LV T VK+CDFG A L + +++ + ++ APE+I
Sbjct: 119 KVG-VIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
Y T DIWS G + E+ G P + +A ++ I K P R E + +F
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK--SKPPRLEDNGYSKLLREF 234
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-28
Identities = 85/289 (29%), Positives = 130/289 (44%), Gaps = 41/289 (14%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 94
VG G +G VF AK +TGE VA+K++ L + R+ E ++ ++ L +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 95 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 154
F L+L MEYVP +R L + + + + Y ++F + +H +
Sbjct: 69 AF---QDDEYLYL--AMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFEAVDALHEL 120
Query: 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 214
HRDLKP+N L+D H +K+ DFG +K ++ AN S + S Y APE++ G Y
Sbjct: 121 G-YIHRDLKPENFLIDASGH-IKLTDFGLSKGIVT-YAN-SVVGSPDYMAPEVLRG-KGY 175
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 274
++D WS GC+L E L G P F G + + T R P Y D RF
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR-------PVYDDPRF- 227
Query: 275 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
+ EA DL ++L+ + + HPFF E+
Sbjct: 228 -------------NLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 17/216 (7%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNR---ELQLMRVMDHPN 88
+ E+ +G G F +V++A CL G VA+KKV + D + + E+ L++ +DHPN
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
VI F NE LN+V+E + R++KH+ + +P + Y Q+
Sbjct: 64 VIKYLASFI---ENNE--LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPE 206
L ++H+ R+ HRD+KP N+ + T VK+ D G + + A S + + +Y +PE
Sbjct: 119 LEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 242
I Y DIWS GC+L E+ Q F G+
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 22/225 (9%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISLKH 94
+G GSFG V + + G+ + K++ ++++ E+ ++R + HPN++
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 95 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
+++ L +VMEY + ++++ + + ++ Q+ L H
Sbjct: 67 RIIDRSNQT---LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 154 V----PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAPE 206
V HRDLKP N+ +D + VK+ DFG AK L G + +Y+ + +Y +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDA-NNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251
+ + Y DIWS GC++ EL P F N QL IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQ-LQLASKIK 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 87/311 (27%), Positives = 139/311 (44%), Gaps = 53/311 (17%)
Query: 27 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQ 79
+P++ + + E +G GSFG V+ A+ + T E VAIKK+ + N +E++
Sbjct: 10 KDDPEKLFTDLRE--IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 80 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 139
++ + HPN I K C+ + LVMEY S +L+ + Q + + +
Sbjct: 68 FLQQLRHPNTIEYKGCYLREHTA-----WLVMEYCLGSASDILEVHKKPLQEVEIAAI-- 120
Query: 140 YTYQIFRGLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYIC 198
+ +GLAY+H+ R+ HRD+K N LL +P VK+ DFGSA + AN S++
Sbjct: 121 -CHGALQGLAYLHSHERI-HRDIKAGNILLTEP--GTVKLADFGSAS--LVSPAN-SFVG 173
Query: 199 SRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
+ ++ APE+I E Y +D+WS G EL +P NA+ L I +
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----- 228
Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
N + P + ++ W F +D LQ P R ++ E
Sbjct: 229 --------NDS------PTLSSNDWSDYFRN-----FVDSC---LQKIPQDRPSSEELLK 266
Query: 317 HPFFDELREPN 327
H F R P
Sbjct: 267 HRFVLRERPPT 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 85/319 (26%), Positives = 132/319 (41%), Gaps = 77/319 (24%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----VM---DHPNVISLK 93
V+G G+FG V+ + +TG+ A+K + + K ++ +R ++ D P ++ L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66
Query: 94 HCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
+ F ++E L LVMEY+P + +L P + Y ++ L +H
Sbjct: 67 YYSF----QDEEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVH 118
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF----------- 201
+ + HRD+KP N+L+D H +K+ DFG K++ + Y+
Sbjct: 119 KLGFI-HRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 202 -------------------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 242
Y APE++ G T Y D WS G +L E+L G P F +
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT- 234
Query: 243 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 302
L E T +I +N RFP + PEAIDL RLL
Sbjct: 235 ---LQE--------TYNKI--INWK-ESLRFPP----------DPPVSPEAIDLICRLLC 270
Query: 303 YSPSLR-CTALEACAHPFF 320
P R + E +HPFF
Sbjct: 271 -DPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 76/295 (25%), Positives = 134/295 (45%), Gaps = 53/295 (17%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDHPNVI 90
+++G G+FG V+ ++TG +A+K+V D E+QL++ + H ++
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
C +++ L++ MEY+P S+ LK Y + + + + YT QI G+
Sbjct: 68 QYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVE 118
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICSRFYRAP 205
Y+H+ + HRD+K N+L D VK+ DFG++K+L +G S + ++ +P
Sbjct: 119 YLHS-NMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
E+I G Y D+WS GC + E+L +P + + + I K+ PT
Sbjct: 177 EVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN------- 225
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
PQ+ +H + P+A + R + R +A E H F
Sbjct: 226 --------PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 77/294 (26%), Positives = 123/294 (41%), Gaps = 52/294 (17%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRVMDHPNVISLKH 94
+G G FG V K T A+K V + + + E +++ +HP ++ L +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59
Query: 95 CFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
F K++ ++ ++MEY E L + Y + Y+H
Sbjct: 60 RTF----KDKKYIYMLMEYCLGGE-----LWTILRDRGLFDEYTARFYIACVVLAFEYLH 110
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 212
+ +RDLKP+NLL+D VK+ DFG AK+L +G+ ++ + Y APE+I
Sbjct: 111 NR-GIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG 168
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
Y S+D WS G +L ELL G+P F GE+ D + +I N
Sbjct: 169 -YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IYNDILKGNGKLE--- 214
Query: 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFFD 321
FP + A DL +LL+ +P R L+ H +F+
Sbjct: 215 FPNY------------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 7e-26
Identities = 88/302 (29%), Positives = 130/302 (43%), Gaps = 62/302 (20%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQDRRY-----KNRELQLMRVMDHPNV 89
+V+G GSFG V A+ T E A+K +LQD + R L L HP +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG--KHPFL 58
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
L H F T K+ LF VMEYV + M+ + + + R + Y +I G
Sbjct: 59 TQL-HSCFQT--KDRLFF--VMEYVNGGDLMFHIQR-----SGRFDEPRARFYAAEIVLG 108
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 206
L ++H + +RDLK N+L+D H +KI DFG K+ I G S C + Y APE
Sbjct: 109 LQFLHE-RGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPE 166
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
++ Y ++D W+ G +L E+L GQ F G++ D+L + I
Sbjct: 167 ILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-DELFQSIL--------------- 209
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFFD 321
+ R+P + + EA + L +P R L HPFF
Sbjct: 210 -EDEVRYP------------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256
Query: 322 EL 323
E+
Sbjct: 257 EI 258
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-26
Identities = 78/293 (26%), Positives = 128/293 (43%), Gaps = 46/293 (15%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLKHC 95
V+G G+ +V+ A CL E VAIK++ ++ + +E+Q M +HPNV+ +
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66
Query: 96 FFSTTSKNELFLNLVMEYVPE-SMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
F +EL+ LVM Y+ S+ ++K Y +I L ++ +GL Y+H+
Sbjct: 67 SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120
Query: 154 VPRVCHRDLKPQNLLVDPLTH-QVKICDFGSAKQLIAG-----EANISYICSRFYRAPEL 207
++ HRD+K N+L+ VKI DFG + L G + +++ + + APE+
Sbjct: 121 NGQI-HRDIKAGNILLG--EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
+ Y DIWS G EL G + + L+ ++ N
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ-------------ND- 223
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
P ++ +K + K + S LQ PS R TA E H FF
Sbjct: 224 -----PPSLETGADYKKYSKSFR----KMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 40 RVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 90
+ +G G+FG V++ GE VA+K + + + E +M+ + HPN++
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLA 149
L T L+ +V EY+P L + +++ L + QI +G+
Sbjct: 65 RLLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE 206
Y+ + V HRDL +N LV VKI DFG ++ + + + + APE
Sbjct: 117 YLESKNFV-HRDLAARNCLVT-ENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE 174
Query: 207 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
+ ++T+ D+WS G +L E+ LG+ +PG
Sbjct: 175 SLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPG 207
|
Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-25
Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 18/217 (8%)
Query: 43 GTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR-----ELQLMRVMDHPNVISLKHCF 96
G GS+G V++ K L + A+K+V L K R E++++ ++HPN+IS K F
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68
Query: 97 FSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
L +VMEY P + + + + +P + Q+ RGL +H
Sbjct: 69 LDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ- 122
Query: 156 RVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 214
++ HRDLK N LLV VKI D G +K L A + I + Y APE ++ Y
Sbjct: 123 KILHRDLKSANILLVAN--DLVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGRPY 178
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251
+ DIWS GC+L E+ P F + D ++ +
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 97/335 (28%), Positives = 148/335 (44%), Gaps = 64/335 (19%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM----DHPNVIS 91
+V+G GSFG V A+ T E AIK + +D ++ +++ RV+ +HP
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHP---F 57
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
L H F + +K LF VMEY+ L + ++ R + Y +I GL ++
Sbjct: 58 LTHLFCTFQTKEHLFF--VMEYLNGGD---LMFHIQSSGRFDEARARFYAAEIICGLQFL 112
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 210
H + +RDLK N+L+D H +KI DFG K+ + GE S C + Y APE++ G
Sbjct: 113 HK-KGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270
+Y S+D WS G +L E+L+GQ F GE+ D+L + I +
Sbjct: 171 -QKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSI-------LNDR--------- 212
Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-TALEACAHPFFDELREPNAR 329
P F + + EA D S+L + P+ R + HPFF R +
Sbjct: 213 ---------PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF---RGIDWE 257
Query: 330 LPNGRPLPPLF-----------NFKQELSGASPEL 353
R +PP F NF +E + L
Sbjct: 258 RLEKREIPPPFKPKVKSPSDASNFDREFTNEKVRL 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 7e-24
Identities = 84/297 (28%), Positives = 131/297 (44%), Gaps = 37/297 (12%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 96
+G G+ G V + K + TG +A K V R+ RELQ+M P ++S F
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 97 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
NE + + ME++ S+ R+ K +P+ + + GL Y++ V
Sbjct: 73 L-----NENNICMCMEFMDCGSLDRIYKKGGP----IPVEILGKIAVAVVEGLTYLYNVH 123
Query: 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 215
R+ HRD+KP N+LV+ Q+K+CDFG + +LI A+ +++ + Y +PE I G +YT
Sbjct: 124 RIMHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG-KYT 180
Query: 216 TSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 274
D+WS G + EL LG+ P D + + +L
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-----------------LQ 223
Query: 275 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-HPFFDELREPNARL 330
QI P ++ P + D L P+ R T + CA PF LR N L
Sbjct: 224 QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDL 280
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 8e-24
Identities = 86/294 (29%), Positives = 138/294 (46%), Gaps = 58/294 (19%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVISLKHCFF 97
+G+G++G V++A+ + TGE VAIK + D +E+ +++ HPN++ F
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV---AYFG 67
Query: 98 STTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
S +++L+ +VMEY + +Y+V + S Q + YV + +GLAY+H
Sbjct: 68 SYLRRDKLW--IVMEYCGGGSLQDIYQVTRGPLSELQ---IAYV---CRETLKGLAYLHE 119
Query: 154 VPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFG 210
++ HRD+K N+L LT VK+ DFG + QL A A S+I + ++ APE+
Sbjct: 120 TGKI-HRDIKGANIL---LTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA-- 173
Query: 211 ATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
A E Y DIW+ G EL QP P + + ++ L ++
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQP--PMFD-----LHPMRALFLISKS------- 219
Query: 267 NYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
+F P++K W VFH D + L P R TA + HPF
Sbjct: 220 ---NFPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 9e-24
Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 89
Y RVVG G+FGIV + + V IK++ +R E Q+++++ HPN+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
I F + L +VMEY P ++ ++ N + + + QI L
Sbjct: 62 IEYYENFLEDKA-----LMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILHFFVQILLAL 114
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 208
++HT + HRDLK QN+L+D VKI DFG +K L + + + + Y +PEL
Sbjct: 115 HHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
G Y DIW+ GCVL EL + F N
Sbjct: 174 EG-KPYNQKSDIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 1e-23
Identities = 74/294 (25%), Positives = 116/294 (39%), Gaps = 53/294 (18%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 90
+ +G GSFG V++A T + VAIK + + +E+Q + P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
F + L ++MEY S +LK ++ Y+ ++ GL
Sbjct: 63 KYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLE 112
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAP 205
Y+H HRD+K N+L+ VK+ DFG + QL + +S ++ + F+ AP
Sbjct: 113 YLHE-EGKIHRDIKAANILLSE-EGDVKLADFGVSGQL---TSTMSKRNTFVGTPFWMAP 167
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
E+I + Y DIWS G EL G+P + + L I K N
Sbjct: 168 EVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK------------NN 214
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
P P ++ + + K F D S L P R +A E H F
Sbjct: 215 P-------PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 1e-23
Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 50/230 (21%)
Query: 40 RVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVIS 91
+ +G G+FG V++ K VA+K + +D + R E ++M+ + HPNV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY---------SSANQRMPLIYVKLYTY 142
L T + L+ LV+EY+ L Y S + L + +
Sbjct: 61 LLGV---CTEEEPLY--LVLEYME---GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 143 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 202
QI +G+ Y+ + + HRDL +N LV VKI DFG ++ + + +Y
Sbjct: 113 QIAKGMEYLASK-KFVHRDLAARNCLVGE-DLVVKISDFGLSRDVYDDD---------YY 161
Query: 203 R------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
R APE + +T+ D+WS G +L E+ LG +PG
Sbjct: 162 RKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 83/299 (27%), Positives = 138/299 (46%), Gaps = 35/299 (11%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHC 95
+G G+ G+V + +G +A K + + R REL+++ + P ++
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67
Query: 96 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 154
F+S E+ ++ ME++ S+ +VLK R+P + + + RGL Y+
Sbjct: 68 FYS---DGEI--SICMEHMDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREK 118
Query: 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 214
++ HRD+KP N+LV+ ++K+CDFG + QLI AN S++ +R Y +PE + G T Y
Sbjct: 119 HKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THY 175
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-----TREEIRCMNPNYT 269
T DIWS G L E+ +G+ P +A E+ + G P +E R ++ +
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPVSEGEAKESHRPVSGHPP 231
Query: 270 DFRFPQ--------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
D P I P K+ E D + L+ +P R E HPF
Sbjct: 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-23
Identities = 75/218 (34%), Positives = 109/218 (50%), Gaps = 37/218 (16%)
Query: 39 ERVV-GTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK---NRELQLMRVMDHPNVISLK 93
ERVV G G++GIV+ A+ L T +AIK++ +D RY + E+ L + H N++
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ-- 69
Query: 94 HCFFSTTSKNELFLNLVMEYVP--------ESMYRVLKHYSSANQRMPLIYVKLYTYQIF 145
+ + S+N F + ME VP S + LK + YT QI
Sbjct: 70 --YLGSDSENGFFK-IFMEQVPGGSLSALLRSKWGPLKDNEQT--------IIFYTKQIL 118
Query: 146 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---- 201
GL Y+H ++ HRD+K N+LV+ + VKI DFG++K+L A I+ F
Sbjct: 119 EGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL----AGINPCTETFTGTL 173
Query: 202 -YRAPELI-FGATEYTTSIDIWSAGCVLAELLLGQPLF 237
Y APE+I G Y DIWS GC + E+ G+P F
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 2e-23
Identities = 93/336 (27%), Positives = 146/336 (43%), Gaps = 66/336 (19%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM----DHPNVIS 91
+++G GSFG VF A+ T + AIK + +D + +++ RV+ +HP
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP---F 57
Query: 92 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
L H + + +K LF VMEY+ + M+ + + + L Y +I GL
Sbjct: 58 LTHLYCTFQTKENLFF--VMEYLNGGDLMFHI-----QSCHKFDLPRATFYAAEIICGLQ 110
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 208
++H+ + +RDLK N+L+D H +KI DFG K+ + G+A C + Y APE++
Sbjct: 111 FLHS-KGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL 168
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
G +Y TS+D WS G +L E+L+GQ F G + + + IR NP Y
Sbjct: 169 LG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSIRMDNPCY 215
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREPN 327
+ + EA D+ +L P R + HPFF E+
Sbjct: 216 PRW-----------------LTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW-- 256
Query: 328 ARLPNGRPLPPL----------FNFKQELSGASPEL 353
+ L PP NF +E P L
Sbjct: 257 SALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRL 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 2e-23
Identities = 97/337 (28%), Positives = 153/337 (45%), Gaps = 68/337 (20%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM----DHPNVIS 91
+V+G GSFG V A+ GE A+K + +D + +++ RV+ ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 92 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
L +C F T K LF VME++ + M+ + R L Y +I GL
Sbjct: 61 L-YCTFQT--KEHLFF--VMEFLNGGDLMFHI-----QDKGRFDLYRATFYAAEIVCGLQ 110
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 208
++H+ + +RDLK N+++D H +KI DFG K+ + G+ S C + Y APE++
Sbjct: 111 FLHS-KGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL 168
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
G +YT S+D WS G +L E+L+GQ F G++ D+L E I+V TP
Sbjct: 169 QG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV-DTP------------ 213
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREPN 327
+P+ W + E+ D+ +L + P+ R + HPFF + N
Sbjct: 214 ---HYPR-----W-------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI---N 255
Query: 328 ARLPNGRPLPPLF-----------NFKQELSGASPEL 353
R L P F NF +E P L
Sbjct: 256 WTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRL 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-23
Identities = 72/290 (24%), Positives = 128/290 (44%), Gaps = 46/290 (15%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 92
RV+G G+FG V + +T + A+K K ++ +N E ++++ ++HP +++L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 93 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
+ F ++E + LV++ + L+++ S + VK + +I L Y+H
Sbjct: 66 WYSF-----QDEENMYLVVDLLLGGD---LRYHLSQKVKFSEEQVKFWICEIVLALEYLH 117
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 212
+ + HRD+KP N+L+D H V I DF A ++ S + Y APE++
Sbjct: 118 S-KGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG 175
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
Y+ ++D WS G E L G+ + G + R++IR
Sbjct: 176 -YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQIRAK-------- 213
Query: 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEACAHPFF 320
Q A + EAID ++LL+ P R + HP+F
Sbjct: 214 --QETADVLYPATW---STEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-23
Identities = 74/301 (24%), Positives = 129/301 (42%), Gaps = 47/301 (15%)
Query: 43 GTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRVMDHPNVISLK--HCFF 97
G G++G+V + + + TG +A+K++ + + K +L+ +D IS++ C +
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK----RLLMDLD----ISMRSVDCPY 61
Query: 98 STTSKNELFLN----LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
+ T LF + ME + S+ + K +P + I + L Y+H+
Sbjct: 62 TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 213
V HRD+KP N+L++ QVK+CDFG + L+ A + Y APE I
Sbjct: 122 KLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELN 180
Query: 214 ---YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270
Y D+WS G + EL G+ FP ++ ++ +V+ P+
Sbjct: 181 QKGYDVKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVEEPS------------- 225
Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 330
PQ+ A ++ PE D ++ L+ + R E HPFF+ N +
Sbjct: 226 ---PQLPA--------EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDV 274
Query: 331 P 331
Sbjct: 275 A 275
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 3e-23
Identities = 70/244 (28%), Positives = 113/244 (46%), Gaps = 45/244 (18%)
Query: 40 RVVGTGSFGIVFQAKCLE-----TGETVAIKK-----VLQDRRYKNRELQLMRVMDHPNV 89
+ +G G FG V + TGE VA+K Q R RE++++R +DH N+
Sbjct: 10 KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 148
+ K ++ L L+MEY+P L+ Y ++ ++ L + L++ QI +G+
Sbjct: 69 VKYKGVCEKPGGRS---LRLIMEYLP---SGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------F 201
Y+ + R HRDL +N+LV+ VKI DFG AK L + Y + F
Sbjct: 123 DYLGSQ-RYIHRDLAARNILVES-EDLVKISDFGLAKVLPEDK---DYYYVKEPGESPIF 177
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELL---------LGQPL-----FPGENAVDQLV 247
+ APE + + + S D+WS G L EL + L G+ V +L+
Sbjct: 178 WYAPECLRTSKFSSAS-DVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236
Query: 248 EIIK 251
E++K
Sbjct: 237 ELLK 240
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 6e-23
Identities = 99/326 (30%), Positives = 145/326 (44%), Gaps = 61/326 (18%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 92
R +G GSFG V+ A+ + T E VAIKK+ + N +E++ ++ + HPN I
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 93 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
K C+ E LVMEY S +L+ + Q + + + T+ +GLAY+H
Sbjct: 91 KGCYL-----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLH 142
Query: 153 TVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 211
+ + HRD+K N LL +P QVK+ DFGSA IA AN S++ + ++ APE+I
Sbjct: 143 S-HNMIHRDIKAGNILLTEP--GQVKLADFGSAS--IASPAN-SFVGTPYWMAPEVILAM 196
Query: 212 TE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
E Y +D+WS G EL +P NA+ L I + N +
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------NES-- 241
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 329
P ++++ W F + LQ P R T+ E H F LRE
Sbjct: 242 ----PTLQSNEWSDYFR--------NFVDSCLQKIPQDRPTSEELLKHMFV--LRE---- 283
Query: 330 LPNGRPLPPLFNFKQELSGASPELVN 355
RP L + Q A EL N
Sbjct: 284 ----RPETVLIDLIQRTKDAVRELDN 305
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 9e-23
Identities = 90/324 (27%), Positives = 137/324 (42%), Gaps = 61/324 (18%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISLKH 94
+G GSFG V+ A T E VA+KK+ + N +E++ ++ + HPN I K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 95 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 154
C+ + LVMEY S +L+ + Q + + + T+ +GLAY+H+
Sbjct: 89 CYLKEHTA-----WLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLHSH 140
Query: 155 PRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 213
+ HRD+K N LL +P QVK+ DFGSA + AN S++ + ++ APE+I E
Sbjct: 141 NMI-HRDIKAGNILLTEP--GQVKLADFGSAS--KSSPAN-SFVGTPYWMAPEVILAMDE 194
Query: 214 --YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
Y +D+WS G EL +P NA+ L I + N +
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------NDS---- 237
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 331
P ++++ W F LQ P R + E H F +
Sbjct: 238 --PTLQSNEWTDSFRG--------FVDYCLQKIPQERPASAELLRHDF----------VR 277
Query: 332 NGRPLPPLFNFKQELSGASPELVN 355
RP L + Q A EL N
Sbjct: 278 RDRPARVLIDLIQRTKDAVRELDN 301
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 3e-22
Identities = 75/299 (25%), Positives = 128/299 (42%), Gaps = 48/299 (16%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKN--RELQLMRVMDHPNVISLKHCF 96
+G G++G V++ TG T+A+K++ L + ++ EL ++ P ++ F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 97 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 156
F + + + MEY+ L A + +P ++ TY + +GL ++
Sbjct: 69 FIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 157 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI-----FGA 211
+ HRD+KP N+LV+ QVK+CDFG + L+A A + C Y APE I
Sbjct: 124 IIHRDVKPTNVLVNG-NGQVKLCDFGVSGNLVASLAKTNIGCQS-YMAPERIKSGGPNQN 181
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKVLGTPTREEIRCMNPNY 268
YT D+WS G + E+ LG+ +P E N QL I+ G P + Y
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----LPSGY 234
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327
+ +A D ++ L P+ R T + HP+ + + +
Sbjct: 235 S---------------------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 3e-22
Identities = 72/220 (32%), Positives = 109/220 (49%), Gaps = 24/220 (10%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 92
R +G GSFG V+ A+ + E VAIKK+ + N +E++ ++ + HPN I
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 93 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
+ C+ E LVMEY S +L+ + Q + + V T+ +GLAY+H
Sbjct: 81 RGCYL-----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLH 132
Query: 153 TVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 211
+ + HRD+K N LL +P VK+ DFGSA I AN ++ + ++ APE+I
Sbjct: 133 S-HNMIHRDVKAGNILLSEP--GLVKLGDFGSAS--IMAPAN-XFVGTPYWMAPEVILAM 186
Query: 212 TE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 249
E Y +D+WS G EL +P NA+ L I
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 8e-22
Identities = 84/300 (28%), Positives = 138/300 (46%), Gaps = 53/300 (17%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRVMDHPNVISLKHC 95
+G GS GIV A TG VA+KK+ D R + R E+ +MR HPN++ +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81
Query: 96 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 154
+ S +EL++ VME++ ++ ++ H RM + + + L+++H
Sbjct: 82 YSSYLVGDELWV--VMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA- 133
Query: 155 PRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGA 211
V HRD+K ++L LT +VK+ DFG Q+ S + + ++ APE+I
Sbjct: 134 QGVIHRDIKSDSIL---LTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SR 189
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
Y T +DIWS G ++ E++ G+P + E + + + IR P
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------KRIRDNLP----- 232
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 331
P++K HKV P R+L P+ R TA E HPF + P++ +P
Sbjct: 233 --PKLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 93/343 (27%), Positives = 144/343 (41%), Gaps = 66/343 (19%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHPNVI 90
+V+G GSFG V AK G+ A+ KVLQ + ++ Q L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
L H F T K L V++YV E + + + + P + Y +I L
Sbjct: 60 GL-HYSFQTADK----LYFVLDYVNGGELFFHLQRE-----RSFPEPRARFYAAEIASAL 109
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 207
Y+H++ + +RDLKP+N+L+D H V + DFG K+ I S C + Y APE+
Sbjct: 110 GYLHSL-NIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV 167
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
+ Y ++D W G VL E+L G P F + ++ + +L P R + PN
Sbjct: 168 LR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYD--NILNKPLR-----LKPN 218
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDEL 323
+ A L LLQ + R A LE H FF +
Sbjct: 219 IS---------------------VSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257
Query: 324 REPNARLPNGRPLPPLFNFK----QELSGASPELVNKLIPDHV 362
N + + P FN +L PE + +P+ V
Sbjct: 258 ---NWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPNSV 297
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-21
Identities = 85/312 (27%), Positives = 130/312 (41%), Gaps = 52/312 (16%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVISLK 93
+G G FG V + TG+ A KK L +R K R E +++ + ++SL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 94 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAYIH 152
+ F + L LVM + + H + + P Y QI GL ++H
Sbjct: 60 YAFETKDD-----LCLVMTLMNGGDLKY--HIYNVGEPGFPEARAIFYAAQIICGLEHLH 112
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 212
R+ +RDLKP+N+L+D + V+I D G A +L G+ + Y APE++ G
Sbjct: 113 QR-RIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE- 169
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
Y S+D ++ GC L E++ G+ F Q E ++ +EE++
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRR-------- 209
Query: 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 327
+ + PEA DL LLQ P R +A E HP F +L
Sbjct: 210 ---TLEMA--VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR- 263
Query: 328 ARLPNGRPLPPL 339
RL G PP
Sbjct: 264 -RLEAGMLEPPF 274
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-21
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 20/219 (9%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKV-LQ--DRRYKN---RELQLMRVMDHPNVISLKHC 95
+G GSFG+VF+ A+K++ L +RR + E +++ +D +I
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 96 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 154
F LN+VMEY ++++LK + +P V + QI GLA++H+
Sbjct: 68 FLDKGK-----LNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHS- 119
Query: 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGAT 212
++ HRD+K NL +D VKI D G AK L AN + + + +Y +PEL
Sbjct: 120 KKILHRDIKSLNLFLDA-YDNVKIGDLGVAKLLSDNTNFAN-TIVGTPYYLSPELC-EDK 176
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251
Y D+W+ G VL E G+ F N +++II+
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-21
Identities = 58/213 (27%), Positives = 106/213 (49%), Gaps = 31/213 (14%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYK--NRELQLMRVMDHPNVI 90
V+G G++G V+ G+ +A+K+V D + Y+ E+ L++ + H N++
Sbjct: 7 VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
+ T ++ +++ ME+VP S+ +L + +P YT QI G+A
Sbjct: 66 Q-----YLGTCLDDNTISIFMEFVPGGSISSILNRFGP----LPEPVFCKYTKQILDGVA 116
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI-------CSRFY 202
Y+H V HRD+K N+++ P +K+ DFG A++L + ++ + ++
Sbjct: 117 YLHN-NCVVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 235
APE+I + Y DIWS GC + E+ G+P
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 3e-21
Identities = 73/279 (26%), Positives = 125/279 (44%), Gaps = 42/279 (15%)
Query: 43 GTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFF 97
G G+ G V + + TG A+K + D ++ REL++ + P ++ F
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69
Query: 98 STTSKNELFLNLVMEYVP----ESMY-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
+S + + + MEY +S+Y +V K ++ L + + +GL+Y+H
Sbjct: 70 DESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-VLGKI---AESVLKGLSYLH 122
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 212
+ ++ HRD+KP N+L+ QVK+CDFG + +L+ A ++ + FY APE I G
Sbjct: 123 S-RKIIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSLAG-TFTGTSFYMAPERIQGKP 179
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVD----QLVEIIKVLGTPT----------- 257
Y+ + D+WS G L E+ + FP E +L+ I + P
Sbjct: 180 -YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW 238
Query: 258 REEIR-----CMNPNYTDFRFP-QIKAHPWHKVFHKRMP 290
EE + C+ + T P + HPW K K+
Sbjct: 239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 5e-21
Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 24/209 (11%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 94
VGTG+FG V + + A+K + L+ ++ + E ++++ + HP +I L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67
Query: 95 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
T ++ FL ++MEYVP ++ L++ + L Y +I L Y+H+
Sbjct: 68 ----WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL----FYASEIVCALEYLHS 119
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGAT 212
+ +RDLKP+N+L+D H +K+ DFG AK+L +C + Y APE+I +
Sbjct: 120 K-EIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRD---RTWTLCGTPEYLAPEVI-QSK 173
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
+ ++D W+ G ++ E+L+G P F +N
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-20
Identities = 65/236 (27%), Positives = 116/236 (49%), Gaps = 27/236 (11%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRVMDHPNVI 90
+++G G+FG V+ +TG +A+K+V D E+QL++ + H ++
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
C + L++ ME++P S+ LK Y + + + + YT QI G++
Sbjct: 68 QYYGCLRDPMERT---LSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICSRFYRAP 205
Y+H+ + HRD+K N+L D VK+ DFG++K+L ++G S + ++ +P
Sbjct: 121 YLHS-NMIVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
E+I G Y DIWS GC + E+L +P + + + I K+ PT +
Sbjct: 179 EVISGEG-YGRKADIWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPTNPVL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-20
Identities = 99/345 (28%), Positives = 145/345 (42%), Gaps = 78/345 (22%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQD-----RRYKNRELQLMRVMDHPNV 89
+V+G GSFG V A+ T E AIK +LQD + R L L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA--KHPFL 58
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
+L HC F T K+ LF VMEYV + M+++ + R + Y ++
Sbjct: 59 TAL-HCCFQT--KDRLFF--VMEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLA 108
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 206
L ++H V +RDLK N+L+D H K+ DFG K+ I + C + Y APE
Sbjct: 109 LMFLHR-HGVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE 166
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
I EY S+D W+ G ++ E++ GQP F +N D L E I
Sbjct: 167 -ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESIL--------------- 209
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC-----AHPF 319
+ D +P W + EA+ + + +P+ R C A + HPF
Sbjct: 210 -HDDVLYPV-----W-------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256
Query: 320 FDELREPNARLPNGRPLPPLF-----------NFKQELSGASPEL 353
F +E + L R + P F NF Q+ + P L
Sbjct: 257 F---KEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQDFTKEEPVL 298
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-20
Identities = 82/295 (27%), Positives = 123/295 (41%), Gaps = 52/295 (17%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----RRYKNRELQLMRVMDHPNV 89
Y+ RV+G G+FG + E V K+V L RR E+ ++ ++ HPN+
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
I+ + F + L + MEY ++Y + Q V Y +QI +
Sbjct: 62 IAYYNHFMDDNT-----LLIEMEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAV 114
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYIC--SRFYRA 204
+YIH + HRD+K N+ LT +K+ DFG +K L E +++ + +Y +
Sbjct: 115 SYIHKA-GILHRDIKTLNIF---LTKAGLIKLGDFGISKIL-GSEYSMAETVVGTPYYMS 169
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
PEL G +Y DIW+ GCVL ELL + F N ++ +V+I +
Sbjct: 170 PELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI--------------V 214
Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
NYT E I L LLQ P R TA E P
Sbjct: 215 QGNYTPVVSVYSS--------------ELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-20
Identities = 70/215 (32%), Positives = 110/215 (51%), Gaps = 17/215 (7%)
Query: 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRVMDHP 87
++ E+ +G G F V++A CL G VA+KKV L D + + +E+ L++ ++HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
NVI F NE LN+V+E + R++KH+ + +P V Y Q+
Sbjct: 63 NVIKYYASFI---EDNE--LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAP 205
L ++H+ RV HRD+KP N+ + T VK+ D G + + A S + + +Y +P
Sbjct: 118 ALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 240
E I Y DIWS GC+L E+ Q F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-20
Identities = 86/312 (27%), Positives = 135/312 (43%), Gaps = 50/312 (16%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 91
RV+G G FG V + TG+ A KK L+ +R K R E Q++ ++ V+S
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
L + + +K+ L L L + + + + Y+ N Y +I GL +
Sbjct: 65 LAYAY---ETKDALCLVLTLMNGGDLKFHI---YNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 211
H R+ +RDLKP+N+L+D H ++I D G A ++ GE + + Y APE++
Sbjct: 119 HR-ERIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV-KN 175
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
YT S D W GC++ E++ G+ F E +K REE+
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK------REEVE--------- 214
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--C---TALEACAHPFFDELREP 326
++K + + ++ A + +LL P R C A E AHPFF
Sbjct: 215 --RRVKEDQ--EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF- 269
Query: 327 NARLPNGRPLPP 338
RL G PP
Sbjct: 270 -KRLEAGMLEPP 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 7e-20
Identities = 83/311 (26%), Positives = 135/311 (43%), Gaps = 65/311 (20%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR------ELQLMRVMDHPNVISL 92
+++ G++G V+ + ET + A+KK+ Q+ +N+ E ++ ++P V+S+
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 93 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
C F T L +VMEYV +LK+ + +P+ ++Y + L Y+
Sbjct: 67 -FCSFETKR----HLCMVMEYVEGGDCATLLKNIGA----LPVDMARMYFAETVLALEYL 117
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG------EANISYICSRF---- 201
H V HRDLKP NLL+ + H +K+ DFG +K + E +I F
Sbjct: 118 HNYGIV-HRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 202 ------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
Y APE+I Y +D W+ G +L E L+G F G+ + ++I
Sbjct: 176 VCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS---- 230
Query: 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TAL 312
++I P + +P +A DL SRLL+ +P R A
Sbjct: 231 ---DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLERLGTGGAF 268
Query: 313 EACAHPFFDEL 323
E H FF L
Sbjct: 269 EVKQHRFFLGL 279
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 7e-20
Identities = 84/302 (27%), Positives = 138/302 (45%), Gaps = 53/302 (17%)
Query: 40 RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRR---YKNRELQ-LMRVMDHP 87
RV+GTG++G VF + + + G+ A+K ++Q + + E Q L V P
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
+++L H F T +K L+L+++YV + + H + V++Y +I
Sbjct: 66 FLVTL-HYAFQTDTK----LHLILDYV--NGGELFTHLYQ-REHFTESEVRVYIAEIVLA 117
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-ICSRF-YRAP 205
L ++H + + +RD+K +N+L+D H V + DFG +K+ +A E +Y C Y AP
Sbjct: 118 LDHLHQL-GIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 206 ELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
E+I G + + ++D WS G + ELL G F + + EI + R +
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR----------RIL 225
Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFD 321
K+ P F K M EA D +LL+ P R A E HPFF
Sbjct: 226 ------------KSKP---PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
Query: 322 EL 323
+
Sbjct: 271 GI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 8e-20
Identities = 68/242 (28%), Positives = 120/242 (49%), Gaps = 27/242 (11%)
Query: 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRVM 84
I++ +++G G+FG V+ ++TG +A K+V D E+QL++ +
Sbjct: 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 85 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQ 143
H ++ C + E L + MEY+P S+ LK Y + + + + YT Q
Sbjct: 62 QHERIVQYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQ 114
Query: 144 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICS 199
I G++Y+H+ + HRD+K N+L D VK+ DFG++K+L ++G S +
Sbjct: 115 ILEGMSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 200 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
++ +PE+I G Y D+WS GC + E+L +P + A + I K+ PT
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAAIFKIATQPTNP 228
Query: 260 EI 261
++
Sbjct: 229 QL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 8e-20
Identities = 67/213 (31%), Positives = 114/213 (53%), Gaps = 27/213 (12%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYKNR-ELQLMRVM-DHPNVISLKHCF 96
V+G G++G V++A+ +TG+ VAIK +++D + + E ++R +HPN+ + F
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 97 F---STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
+ ++L+ LVME S+ ++K +R+ ++ + RGLAY+H
Sbjct: 73 IKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 153 TVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISYICSRFYRAPELI 208
+V HRD+K QN+L LT +VK+ DFG + QL + G N ++I + ++ APE+I
Sbjct: 131 E-NKVIHRDIKGQNIL---LTKNAEVKLVDFGVSAQLDSTLGRRN-TFIGTPYWMAPEVI 185
Query: 209 FGATE------YTTSIDIWSAGCVLAELLLGQP 235
A + Y D+WS G EL G+P
Sbjct: 186 --ACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 9e-20
Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 38/210 (18%)
Query: 42 VGTGSFGIVFQAKCL------ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVIS 91
+G G+FG V C TGE VA+KK+ R RE+++++ + H N++
Sbjct: 12 LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLAY 150
K +S +N L LVMEY+P Y L+ Y ++ R+ + LY QI +G+ Y
Sbjct: 70 YKGVCYSAGRRN---LRLVMEYLP---YGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----------AGEANISYICSR 200
+ R HRDL +N+LV+ VKI DFG K L GE+ I
Sbjct: 124 L-GSKRYVHRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI------ 175
Query: 201 FYRAPELIFGATEYTTSIDIWSAGCVLAEL 230
F+ APE + ++++ + D+WS G VL EL
Sbjct: 176 FWYAPESL-TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 85/284 (29%), Positives = 130/284 (45%), Gaps = 47/284 (16%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHPNVI 90
+V+G GSFG V AK G+ A+K VLQ + NR+ Q L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVK-VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
L H F TT K L V+++V E + + + S R + Y +I L
Sbjct: 60 GL-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERSFPEPR-----ARFYAAEIASAL 109
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 207
Y+H++ + +RDLKP+N+L+D H V + DFG K+ IA + C + Y APE+
Sbjct: 110 GYLHSI-NIVYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV 167
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII-KVL----GTPTR---- 258
I Y ++D W G VL E+L G P F + + I+ K L G
Sbjct: 168 I-RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSI 226
Query: 259 -----EEIRCMNPNYTDFRFPQIKAHP------WHKVFHKRMPP 291
E+ R + F +I+ HP W + K++PP
Sbjct: 227 LEELLEKDRQRRLGAKE-DFLEIQEHPFFESLSWTDLEQKKIPP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 94/320 (29%), Positives = 137/320 (42%), Gaps = 58/320 (18%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVISLK 93
+G GSFG V Q + +T A+K + + E+ L +V + P ++ LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLK 59
Query: 94 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
FS S +L+L L E L H+ R L + YT ++ L +H
Sbjct: 60 ---FSFQSPEKLYLVLAFINGGE-----LFHHLQREGRFDLSRARFYTAELLCALENLHK 111
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGAT 212
V +RDLKP+N+L+D H + +CDFG K + + + C + Y APEL+ G
Sbjct: 112 F-NVIYRDLKPENILLDYQGH-IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG 169
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
YT ++D W+ G +L E+L G P F EN V+++ K+L P R
Sbjct: 170 -YTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEP--------------LR 211
Query: 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELREPNAR 329
FP +A DL LL P+ R A E HPFF +L +
Sbjct: 212 FPD------------GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW--KK 257
Query: 330 LPNGRPLPPLFNFKQELSGA 349
L PP FK +S A
Sbjct: 258 LLMKGIQPP---FKPAVSSA 274
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 68/221 (30%), Positives = 116/221 (52%), Gaps = 22/221 (9%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 96
+G G+ G+V + + +G +A K + + R RELQ++ + P ++ F
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 97 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
+S +++ ME++ S+ +VLK +R+P + + + RGLAY+
Sbjct: 73 YSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 215
++ HRD+KP N+LV+ ++K+CDFG + QLI AN S++ +R Y +PE + G T Y+
Sbjct: 124 QIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 180
Query: 216 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
DIWS G L EL +G+ P +A E+ + G P
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPIPPPDA----KELEAIFGRP 217
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-19
Identities = 65/215 (30%), Positives = 110/215 (51%), Gaps = 17/215 (7%)
Query: 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRVMDHP 87
++ E+ +G G F V++A CL + VA+KKV + D + + +E+ L++ ++HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
NVI F NE LN+V+E + +++K++ + +P V Y Q+
Sbjct: 63 NVIKYLDSFI---EDNE--LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAP 205
+ ++H+ RV HRD+KP N+ + T VK+ D G + + A S + + +Y +P
Sbjct: 118 AVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 240
E I Y DIWS GC+L E+ Q F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 92/339 (27%), Positives = 146/339 (43%), Gaps = 69/339 (20%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-LM---RV------MDHPNVI 90
V+G G FG V A+ +TGE AIK + + E++ LM R+ HP ++
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
+L CF T + F VMEY + M + S + Y + GL
Sbjct: 66 NLFACF--QTEDHVCF---VMEYAAGGDLMMHIHTDVFSEPR------AVFYAACVVLGL 114
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 207
Y+H ++ +RDLK NLL+D VKI DFG K+ + S C + + APE+
Sbjct: 115 QYLHE-NKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV 172
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
+ T YT ++D W G ++ E+L+G+ FPG++ + I+ +E+R
Sbjct: 173 LTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-------DEVR----- 219
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFF-- 320
+P + EAI + RLL+ +P R + E A PFF
Sbjct: 220 -----------YPRF------LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262
Query: 321 ---DEL---REPNARLPNGRPLPPLFNFKQELSGASPEL 353
D+L + +P + + NF +E + +P L
Sbjct: 263 INWDDLLARKIKPPFVPTIKGPEDVSNFDEEFTSEAPVL 301
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 6e-19
Identities = 64/236 (27%), Positives = 118/236 (50%), Gaps = 27/236 (11%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRVMDHPNVI 90
+++G G+FG V+ +TG +A+K+V D + E+QL++ + H ++
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
C K L++ +EY+P S+ LK Y + + + + YT QI +G++
Sbjct: 68 QYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVS 120
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICSRFYRAP 205
Y+H+ + HRD+K N+L D VK+ DFG++K++ ++G S + ++ +P
Sbjct: 121 YLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
E+I G Y D+WS C + E+L +P + A + I K+ PT+ +
Sbjct: 179 EVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKIATQPTKPML 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 7e-19
Identities = 98/345 (28%), Positives = 146/345 (42%), Gaps = 70/345 (20%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQD-----RRYKNRELQLMRVMDHPNV 89
RV+G GSFG V A+ E+G A+K +LQD + R L L R +HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFL 58
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
L CF + + LF VME+V + M+ + K ++R + Y +I
Sbjct: 59 TQLYCCFQTP---DRLF--FVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEITSA 108
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 206
L ++H + +RDLK N+L+D H K+ DFG K+ I S C + Y APE
Sbjct: 109 LMFLHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE 166
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
I Y S+D W+ G +L E+L G F EN D L E I +E+
Sbjct: 167 -ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV----- 213
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEA----CAHPFF 320
V+ + +A+D+ + +P++R L HPFF
Sbjct: 214 -----------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256
Query: 321 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 365
EL + N R + P F + + S E V+ PD +K
Sbjct: 257 KEL---DWEKLNRRQIEPPFRPRIK----SREDVSNFDPDFIKED 294
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 8e-19
Identities = 70/221 (31%), Positives = 108/221 (48%), Gaps = 28/221 (12%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISLK 93
+ +G GSFG ++ AK E IK++ ++++ +E+ L+ M HPN+++
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64
Query: 94 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYS---SANQRMPLIYVKLYTYQIFRGL 148
F S LF+ VMEY + M R+ + S +Q + + QI GL
Sbjct: 65 --FASFQENGRLFI--VMEYCDGGDLMKRINRQRGVLFSEDQ------ILSWFVQISLGL 114
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPE 206
+IH ++ HRD+K QN+ + K+ DFG A+QL ++Y C + +Y +PE
Sbjct: 115 KHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE 172
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 247
I Y DIWS GCVL EL + F G N + QLV
Sbjct: 173 -ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG-NNLHQLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 82/299 (27%), Positives = 133/299 (44%), Gaps = 63/299 (21%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD----------RRYKNRELQLMRVMDHPNV 89
+++G G+FG V + TG+ A+K + ++ ++R LQ R HP +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR---HPFL 57
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
+LK+ F + L VMEY E + + + + R + Y +I
Sbjct: 58 TALKYSFQTHD-----RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 206
L Y+H+ V +RDLK +NL++D H +KI DFG K+ I+ A + C + Y APE
Sbjct: 108 LGYLHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
+ +Y ++D W G V+ E++ G+ F ++ ++L E+I + EEI
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEI----- 212
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 320
RFP + + PEA L + LL+ P R A E H FF
Sbjct: 213 -----RFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 96
+G G+ G+VF+ +G +A K + + R RELQ++ + P ++ F
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 97 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
+S +++ ME++ S+ +VLK R+P + + + +GL Y+
Sbjct: 73 YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 123
Query: 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 215
++ HRD+KP N+LV+ ++K+CDFG + QLI AN S++ +R Y +PE + G T Y+
Sbjct: 124 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 180
Query: 216 TSIDIWSAGCVLAELLLGQPLFPGENA 242
DIWS G L E+ +G+ P +A
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPIPPPDA 207
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 4e-18
Identities = 72/220 (32%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM---DHPNVISLK 93
V+G GSFG V A+ T E AIK + +D ++ +++ RV+ P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 94 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
H F T + L VMEYV + MY + + + P + Y +I GL ++
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYHIQQ---VGKFKEP--HAVFYAAEIAIGLFFL 117
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 210
H+ + +RDLK N+++D H +KI DFG K+ I G C + Y APE+I
Sbjct: 118 HS-KGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-A 174
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
Y S+D W+ G +L E+L GQP F GE+ D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 8e-18
Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 31/209 (14%)
Query: 40 RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 90
RV+G G FG V + TGE VA+K + ++ +N E+ +++ + H N++
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYR--VLKHYSSANQRMPLIYVKLYTYQIFRGL 148
K C + + L L+MEYVP R + KH + Q + L+ QI G+
Sbjct: 70 KYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------LFAQQICEGM 120
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR------FY 202
AY+H+ HRDL +N+L+D VKI DFG AK + G Y F+
Sbjct: 121 AYLHS-QHYIHRDLAARNVLLDN-DRLVKIGDFGLAKAVPEGH--EYYRVREDGDSPVFW 176
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL 231
A E + S D+WS G L ELL
Sbjct: 177 YAVECLKENKFSYAS-DVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 92/345 (26%), Positives = 150/345 (43%), Gaps = 74/345 (21%)
Query: 40 RVVGTGSFGIVF--------------QAKCLETGETVAIKKVLQDRRYKNRELQLMRVMD 85
+V+GTG++G VF K L+ V K ++ R + L+ +R
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR--Q 63
Query: 86 HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVL---KHYSSANQRMPLIYVKLYT 141
P +++L H F T +K L+L+++YV M+ L ++S V+ Y+
Sbjct: 64 SPFLVTL-HYAFQTEAK----LHLILDYVSGGEMFTHLYQRDNFSEDE-------VRFYS 111
Query: 142 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-ICSR 200
+I L ++H + + +RD+K +N+L+D H V + DFG +K+ ++ E +Y C
Sbjct: 112 GEIILALEHLHKLG-IVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGT 169
Query: 201 F-YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
Y APE+I G + ++D WS G ++ ELL G F E + E+ +R
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRR 222
Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--- 316
++C P F + PEA DL +LL+ P R A A
Sbjct: 223 ILKCDPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEI 264
Query: 317 --HPFFDEL-------REPNARL-PNGRPLPPLFNFKQELSGASP 351
HPFF L R+ N P+ R + NF +E + P
Sbjct: 265 KEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEP 309
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 16/226 (7%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-MDHPNVISLKHCFFSTT 100
+G G+FG V + +G +A+K++ R E + R+ MD V+ C +
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI----RSTVDEKEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 101 SKNELFLN----LVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
LF + ME + S+ + K+ Y +P + + L Y+
Sbjct: 68 FYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127
Query: 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI--FGATE 213
++ HRD+KP N+L+D +K+CDFG + QL+ A R Y APE I
Sbjct: 128 KIIHRDVKPSNILLD-RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDG 186
Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTR 258
Y D+WS G L E+ G+ +P N+V DQL +++K G P
Sbjct: 187 YDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 84/297 (28%), Positives = 130/297 (43%), Gaps = 66/297 (22%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYK-----NRELQLMRVMDHPNVISLK 93
+GTGSFG V AK TGE AI K L+ R + K +E ++ + HP ++++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAI-KCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM 84
Query: 94 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
F +N ++ ++E+V + H A R P K Y ++ Y+H+
Sbjct: 85 CSF---QDENRVY--FLLEFVVGG--ELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHS 136
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 213
+ +RDLKP+NLL+D H VK+ DFG AK++ + + + Y APE+I +
Sbjct: 137 K-DIIYRDLKPENLLLDNKGH-VKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVI-QSKG 191
Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR--EEI---RCMNPNY 268
+ ++D W+ G +L E + G P F + TP R E+I R PN+
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPFFDD--------------TPFRIYEKILAGRLKFPNW 237
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFF 320
D R A DL LLQ + R L+ HP+F
Sbjct: 238 FDGR--------------------ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274
|
Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 69/223 (30%), Positives = 111/223 (49%), Gaps = 29/223 (13%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRVMDHPNVISLK 93
V+G GSFG V A+ T E AIK + +D ++ +++ ++ + D P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 94 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLI---YVKLYTYQIFRGL 148
H F T + L VMEYV + MY + Q++ Y +I GL
Sbjct: 67 HSCFQTVDR----LYFVMEYVNGGDLMYHI--------QQVGKFKEPQAVFYAAEISVGL 114
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-LIAGEANISYICSRFYRAPEL 207
++H + +RDLK N+++D H +KI DFG K+ ++ G ++ + Y APE+
Sbjct: 115 FFLHR-RGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEI 172
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
I Y S+D W+ G +L E+L GQP F GE+ D+L + I
Sbjct: 173 I-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 3e-17
Identities = 71/250 (28%), Positives = 127/250 (50%), Gaps = 22/250 (8%)
Query: 28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRV 83
G+PK+ Y +G G+ G VF A + TG+ VAIK++ LQ + K E+ +M+
Sbjct: 15 GDPKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 84 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 142
+ +PN+++ F +ELF+ VMEY+ S+ V+ ++ +
Sbjct: 73 LKNPNIVNFLDSFLV---GDELFV--VMEYLAGGSLTDVVTETCMDEAQIAAV-----CR 122
Query: 143 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRF 201
+ + L ++H +V HRD+K N+L+ + VK+ DFG Q+ ++ S + + +
Sbjct: 123 ECLQALEFLHA-NQVIHRDIKSDNVLLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
+ APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 181 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNP 238
Query: 262 RCMNPNYTDF 271
++P + DF
Sbjct: 239 EKLSPIFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-17
Identities = 73/294 (24%), Positives = 132/294 (44%), Gaps = 43/294 (14%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHC 95
++G G+ G V++A L T +A+K + D ++ EL+++ D P +I
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
FF E +++ E++ V + ++P + + +GL Y+ ++
Sbjct: 68 FFV-----ENRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL- 114
Query: 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 215
++ HRD+KP N+LV+ QVK+CDFG + QL+ A +Y+ + Y APE I G +Y
Sbjct: 115 KILHRDVKPSNMLVNT-RGQVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-EQYG 171
Query: 216 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPNYTDFRFP 274
D+WS G EL LG+ +P +I K G+ ++ +C+ D P
Sbjct: 172 IHSDVWSLGISFMELALGRFPYP---------QIQKNQGSLMPLQLLQCI----VDEDPP 218
Query: 275 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
+ + + F + ++ ++ P R HPF + + NA
Sbjct: 219 VLPVGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 4e-17
Identities = 69/250 (27%), Positives = 126/250 (50%), Gaps = 22/250 (8%)
Query: 28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRV 83
G+PK+ Y +G G+ G V+ A + TG+ VAIK++ LQ + K E+ +MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 84 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 142
HPN+++ + +EL++ VMEY+ S+ V+ ++ +
Sbjct: 73 NKHPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CR 122
Query: 143 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRF 201
+ + L ++H+ +V HRD+K N+L+ + VK+ DFG Q+ ++ S + + +
Sbjct: 123 ECLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
+ APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 181 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNP 238
Query: 262 RCMNPNYTDF 271
++ + DF
Sbjct: 239 EKLSAIFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 87/356 (24%), Positives = 133/356 (37%), Gaps = 103/356 (28%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRVMDHPNVISL 92
+V+G G+FG V + +TG A+KK+ + + K + E ++ D+P V+ L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 93 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK--LYTYQIFRGLA 149
+ F ++E +L L+MEY+P M +L + + Y+ + L
Sbjct: 67 YYSF-----QDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG 121
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--------------IAGEANIS 195
YIH RD+KP NLL+D H +K+ DFG L +
Sbjct: 122 YIH-------RDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 196 YICSRF-------------------------YRAPELIFGATEYTTSIDIWSAGCVLAEL 230
+I Y APE +F T Y D WS G ++ E+
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEM 232
Query: 231 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 290
L+G P F +N + +I +N T +FP +
Sbjct: 233 LVGYPPFCSDNPQETYRKI--------------INWKET-LQFPD----------EVPLS 267
Query: 291 PEAIDLASRLLQYSPSLRC---TALEACAHPFF-----DELREPNARLPNGRPLPP 338
PEA DL RL R E +HPFF + +RE A P+ P
Sbjct: 268 PEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRERPA------PIIP 316
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 6e-17
Identities = 86/313 (27%), Positives = 134/313 (42%), Gaps = 50/313 (15%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 91
RV+G G FG V + TG+ A KK L+ +R K R E Q++ ++ V+S
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
L + + +K+ L L L + + + + Y Y +I GL +
Sbjct: 65 LAYAY---ETKDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 211
H R+ +RDLKP+N+L+D H ++I D G A + G+ + + Y APE++
Sbjct: 119 HQ-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KN 175
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
YT S D W+ GC+L E++ GQ F Q + IK REE+ +
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERL------- 216
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326
+K + + ++ P+A L LL P R A E HP F ++
Sbjct: 217 ----VKEVQ--EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN-- 268
Query: 327 NARLPNGRPLPPL 339
RL G PP
Sbjct: 269 FKRLEAGMLEPPF 281
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 9e-17
Identities = 83/299 (27%), Positives = 129/299 (43%), Gaps = 59/299 (19%)
Query: 40 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQ---------DRRYKNRELQLMRVMDHP 87
+V+G G +G VFQ + + +TG+ A+K VL+ D + E ++ + HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
++ L F T K L L++EY+ + H M Y +I
Sbjct: 61 FIVDL-IYAFQTGGK----LYLILEYLSGG--ELFMHLEREGIFMEDT-ACFYLSEISLA 112
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPE 206
L ++H + +RDLKP+N+L+D H VK+ DFG K+ I C Y APE
Sbjct: 113 LEHLHQQG-IIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPE 170
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
I + + ++D WS G ++ ++L G P F EN + +I+K + P
Sbjct: 171 -ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------KLNLP 220
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 320
Y + PEA DL +LL+ +PS R A E +HPFF
Sbjct: 221 PY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 76/299 (25%), Positives = 125/299 (41%), Gaps = 64/299 (21%)
Query: 43 GTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKHC 95
G G+FG V++A+ ETG A K + L+D E+ ++ HPN++ L
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70
Query: 96 FFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLI--YVKLYTYQIFRGLA 149
+F E L +++E+ +S+ L+ L ++ Q+ L
Sbjct: 71 YF-----YENKLWILIEFCDGGALDSIMLELER--------GLTEPQIRYVCRQMLEALN 117
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYICSRFYRAPELI 208
++H+ +V HRDLK N+L+ L VK+ DFG SAK + ++I + ++ APE++
Sbjct: 118 FLHS-HKVIHRDLKAGNILL-TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVV 175
Query: 209 ----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
F Y DIWS G L EL +P P + ++ + ++K+L +
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLLKILKSEP------- 225
Query: 265 NPNYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
P + W F+ D L P R TA E HPF +
Sbjct: 226 ---------PTLDQPSKWSSSFN--------DFLKSCLVKDPDDRPTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-16
Identities = 61/255 (23%), Positives = 120/255 (47%), Gaps = 38/255 (14%)
Query: 42 VGTGSFGIVFQAKCLETGET-VAIKKVL-------QDRRYKNR-------ELQLMR-VMD 85
+G+G+FG V++ + G+ +A+K++ +D+R +++ E+ +++ +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 86 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS---ANQRMPLIYVKLYTY 142
HPN++ ++ T +N+ L +VM+ + + +H++S QR +
Sbjct: 68 HPNIVR----YYKTFLENDR-LYIVMDLIEGAPLG--EHFNSLKEKKQRFTEERIWNIFV 120
Query: 143 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 202
Q+ L Y+H R+ HRDL P N+++ +V I DFG AKQ S + + Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGE-DDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI- 261
PE++ Y D+W+ GC+L ++ QP F N + +I++ + P E +
Sbjct: 180 SCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238
Query: 262 ---------RCMNPN 267
C+ P+
Sbjct: 239 SEDVTDVITSCLTPD 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 78/296 (26%), Positives = 131/296 (44%), Gaps = 45/296 (15%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVMDHPNVISLKHCF 96
+G GS GIV A+ +G VA+K ++ R+ + REL +MR H NV+ + +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM---Y 84
Query: 97 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 156
S EL++ +ME++ + + N+ + + + L Y+H+
Sbjct: 85 KSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQ----IATVCESVLQALCYLHS-QG 137
Query: 157 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYT 215
V HRD+K ++L+ L +VK+ DFG Q+ S + + ++ APE+I T Y
Sbjct: 138 VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRTPYG 195
Query: 216 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 275
T +DIWS G ++ E++ G+P + ++ V + + R+ P
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS-------------PP 234
Query: 276 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 331
K HK+ P D R+L P R TA E HPF + P +P
Sbjct: 235 PKLKNAHKI-----SPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-16
Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 35/211 (16%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 90
Y RVVG GSFG + + + + A+K++ + +E L+ M HPN++
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT--------Y 142
+ K F + + L +VMEY Q++ L KL+
Sbjct: 62 AFKESF-----EADGHLYIVMEYCDGG---------DLMQKIKLQRGKLFPEDTILQWFV 107
Query: 143 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA-GEANISYICS 199
Q+ G+ +IH RV HRD+K +N+ LT +VK+ DFGSA+ L + G +Y+ +
Sbjct: 108 QMCLGVQHIHE-KRVLHRDIKSKNIF---LTQNGKVKLGDFGSARLLTSPGAYACTYVGT 163
Query: 200 RFYRAPELIFGATEYTTSIDIWSAGCVLAEL 230
+Y PE I+ Y DIWS GC+L EL
Sbjct: 164 PYYVPPE-IWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 3e-16
Identities = 64/217 (29%), Positives = 95/217 (43%), Gaps = 45/217 (20%)
Query: 42 VGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLK 93
+G G+FG V + L VA+K + Q+ RE +M +DHP ++ L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61
Query: 94 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
K E + LVME P + + LK + +P+ +K +Q+ G+AY+
Sbjct: 62 ----IGVCKGEPLM-LVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLE 112
Query: 153 TVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-------- 203
+ HRDL +N LLV+ HQ KI DFG ++ L AG S +YR
Sbjct: 113 SK-HFVHRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWP 161
Query: 204 ----APELIFGATEYTTSIDIWSAGCVLAELL-LGQP 235
APE I +++ D+WS G L E G
Sbjct: 162 LKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 80/285 (28%), Positives = 136/285 (47%), Gaps = 47/285 (16%)
Query: 40 RVVGTGSFGIVFQAKCL---ETGETVAIK-------KVLQDRRYKNRELQLMRVMDHPNV 89
+V+G GSFG VF + + + G+ A+K KV +DR E ++ ++HP +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFI 60
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
+ L H F T K L L+++++ + R+ K + VK Y ++
Sbjct: 61 VKL-HYAFQTEGK----LYLILDFLRGGDLFTRLSKEVMFTEED-----VKFYLAELALA 110
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPE 206
L ++H++ + +RDLKP+N+L+D H +K+ DFG +K+ I E C Y APE
Sbjct: 111 LDHLHSLG-IIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 168
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTP------TRE 259
++ +T S D WS G ++ E+L G F G++ + + I+K LG P +
Sbjct: 169 VV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQS 227
Query: 260 EIRCM---NPNYTDFRFPQ----IKAHP------WHKVFHKRMPP 291
+R + NP P IK HP W+K++ + + P
Sbjct: 228 LLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-16
Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 47/288 (16%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVISLKHCFF 97
+G+G++G V++A+ + TGE AIK + +D +E+ +M+ H N+++ F
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73
Query: 98 STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 157
S +++L++ ME+ + + H + + YV T Q GL Y+H+ ++
Sbjct: 74 SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHSKGKM 128
Query: 158 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFGATE--- 213
HRD+K N+L+ H VK+ DFG + Q+ A A S+I + ++ APE+ A E
Sbjct: 129 -HRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184
Query: 214 -YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
Y DIW+ G EL QP + + L + K ++F+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK-----------------SNFQ 227
Query: 273 FPQIKAH-PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
P++K W FH L +P R TA + HPF
Sbjct: 228 PPKLKDKMKWSNSFHH--------FVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 5e-16
Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 91
+V+G GSFG V A+ + A+K + + K +E + L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 92 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
L H F T K L V++Y+ E Y + + R + Y +I L
Sbjct: 61 L-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALG 110
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 208
Y+H++ + +RDLKP+N+L+D H V + DFG K+ I S C + Y APE++
Sbjct: 111 YLHSL-NIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL 168
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
Y ++D W G VL E+L G P F N + I+
Sbjct: 169 H-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 5e-16
Identities = 87/313 (27%), Positives = 136/313 (43%), Gaps = 50/313 (15%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 91
RV+G G FG V + TG+ A K+ L+ +R K R E Q++ ++ V++
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
L + + +K+ L L L + + + + Y+ N Y +I GL +
Sbjct: 65 LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 211
H +RDLKP+N+L+D H ++I D G A ++ GE+ + + Y APE++
Sbjct: 119 HR-ENTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NN 175
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
YT S D W GC++ E++ GQ F G E +K REE+ D
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRK------EKVK------REEV--------DR 215
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CT---ALEACAHPFFDELREP 326
R + + +V+ + EA + LL P R C A E HPFF +
Sbjct: 216 RVLETE-----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN-- 268
Query: 327 NARLPNGRPLPPL 339
RL G PP
Sbjct: 269 FKRLEAGMLDPPF 281
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 84/299 (28%), Positives = 128/299 (42%), Gaps = 62/299 (20%)
Query: 40 RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDRRYKNRELQLMRVMDHPNV 89
+++G G+FG V K TG E + K + +NR LQ R HP +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
+LK+ F + L VMEY E + + + + R + Y +I
Sbjct: 58 TALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 206
L Y+H+ V +RDLK +NL++D H +KI DFG K+ I A + C + Y APE
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
+ +Y ++D W G V+ E++ G+ F ++ ++L E+I + EEIR
Sbjct: 167 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 214
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 320
F + + PEA L S LL+ P R A E H FF
Sbjct: 215 ------------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 87/352 (24%), Positives = 146/352 (41%), Gaps = 100/352 (28%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-------MDHPNVISL 92
+V+G G+FG V + +TG+ A+K +L+ +K +L ++ D P V+SL
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 93 KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
+ F ++ +L L+ME++P + +L Y + ++ + + Y + + +
Sbjct: 67 YYSF-----QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECVLAIEAV 117
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFG------------SAKQLIAGEANISYICS 199
H + + HRD+KP N+L+D H +K+ DFG ++L+ G++N + I +
Sbjct: 118 HKLGFI-HRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175
Query: 200 RF------------------------------------YRAPELIFGATEYTTSIDIWSA 223
R Y APE IF Y D WS
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSL 234
Query: 224 GCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHK 283
G ++ E L+G P F EN+ + +II RE + FP H
Sbjct: 235 GAIMFECLIGWPPFCSENSHETYRKIINW-----RETL----------YFPD-DIH---- 274
Query: 284 VFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFF-----DELREPNA 328
+ EA DL RL+ + + R A E +HPFF D +R+ A
Sbjct: 275 -----LSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRA 321
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 7e-16
Identities = 85/311 (27%), Positives = 144/311 (46%), Gaps = 49/311 (15%)
Query: 28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMR 82
G+P++ + + +G GS GIV A TG+ VA+KK + R+ + REL +MR
Sbjct: 18 GDPREYLDSFIK--IGEGSTGIVCIATEKHTGKQVAVKK-MDLRKQQRRELLFNEVVIMR 74
Query: 83 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 142
H NV+ + + S +EL++ VME++ + ++ N+ +
Sbjct: 75 DYHHENVVDM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATVCL 125
Query: 143 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSR 200
+ R L+Y+H V HRD+K ++L+ ++K+ DFG Q ++ E S + +
Sbjct: 126 SVLRALSYLHN-QGVIHRDIKSDSILLTS-DGRIKLSDFGFCAQ-VSKEVPKRKSLVGTP 182
Query: 201 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260
++ APE+I Y T +DIWS G ++ E++ G+P + E P +
Sbjct: 183 YWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE---------------PPLQA 226
Query: 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
+R + N P++K HKV + +DL +L PS R TA E HPF
Sbjct: 227 MRRIRDNLP----PRVKDS--HKV--SSVLRGFLDL---MLVREPSQRATAQELLQHPFL 275
Query: 321 DELREPNARLP 331
P+ +P
Sbjct: 276 KLAGPPSCIVP 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 7e-16
Identities = 80/286 (27%), Positives = 126/286 (44%), Gaps = 51/286 (17%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHPNVI 90
+V+G GSFG V AK G A+K VLQ + ++ Q L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
L H F T K L V++YV E + + + R + Y ++ +
Sbjct: 60 GL-HYSFQTAEK----LYFVLDYVNGGELFFHLQRERCFLEPR-----ARFYAAEVASAI 109
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 207
Y+H++ + +RDLKP+N+L+D H V + DFG K+ + E S C + Y APE
Sbjct: 110 GYLHSL-NIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE- 166
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII----------------K 251
+ Y ++D W G VL E+L G P F + V Q+ + I
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKPLQLPGGKTVAACD 225
Query: 252 VLGTPTREEIRCMNPNYTDFRFPQIKAH------PWHKVFHKRMPP 291
+L ++ R DF +IK H W ++HKR+ P
Sbjct: 226 LLVGLLHKDQRRRLGAKADFL--EIKNHVFFSPINWDDLYHKRITP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 7e-16
Identities = 67/253 (26%), Positives = 119/253 (47%), Gaps = 29/253 (11%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHCF 96
+G G+FG V++AK ETG +A KV++ + + E++++ +HP ++ L F
Sbjct: 20 LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 97 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 156
+ L +++E+ P + P I ++ Q+ L Y+H++ +
Sbjct: 79 YWDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQI--QVICRQMLEALQYLHSM-K 130
Query: 157 VCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYICSRFYRAPELIFGAT--- 212
+ HRDLK N+L+ L +K+ DFG SAK + + S+I + ++ APE++ T
Sbjct: 131 IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 213 -EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIRCMNPN 267
Y DIWS G L E+ +P N + L++I K L P++ +
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK-----WSME 244
Query: 268 YTDFRFPQIKAHP 280
+ DF + HP
Sbjct: 245 FRDFLKTALDKHP 257
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 7e-16
Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 18/206 (8%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-----RVMDHPN---VIS 91
RV+G G FG V + TG+ A KK L+ +R K R+ + M R+++ N V+S
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
L + + +K+ L L L + + + + Y+ N Y ++ GL +
Sbjct: 65 LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 211
R+ +RDLKP+N+L+D H ++I D G A Q+ GE + + Y APE+I
Sbjct: 119 QR-ERIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-NN 175
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLF 237
+YT S D W GC++ E++ GQ F
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 9e-16
Identities = 76/304 (25%), Positives = 139/304 (45%), Gaps = 55/304 (18%)
Query: 40 RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRRYKNRELQLMRVMDH----P 87
+V+GTG++G VF + + ++G+ A+K ++Q + +V++H P
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
+++L H F T +K L+L+++Y+ + H S +R V++Y+ +I
Sbjct: 66 FLVTL-HYAFQTDTK----LHLILDYINGG--ELFTHLSQ-RERFKEQEVQIYSGEIVLA 117
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-ICSRF-YRAP 205
L ++H + + +RD+K +N+L+D H V + DFG +K+ E +Y C Y AP
Sbjct: 118 LEHLHKLG-IIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 206 ELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
+++ G + ++D WS G ++ ELL G F + + EI + +
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI----------- 224
Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPF 319
+K+ P + + M A D+ RLL P R A E HPF
Sbjct: 225 -----------LKSEP---PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270
Query: 320 FDEL 323
F ++
Sbjct: 271 FQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 68/295 (23%), Positives = 129/295 (43%), Gaps = 48/295 (16%)
Query: 36 YMAERVVGTGSFGIVF--QAKCLETGETVAIKKVL-------QDRRYKNRELQLMRVMDH 86
Y+ ++ +G GSFG V+ + K E + + K + + N+E QL+ +DH
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 87 PNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIF 145
P ++ F ++ + + F ++ EY + L+ + + V + Q+
Sbjct: 62 PAIVK----FHASFLERDAFC-IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116
Query: 146 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRA 204
G+ Y+H R+ HRDLK +N+ + + +KI DFG ++ L+ + ++ + +Y +
Sbjct: 117 LGVHYMH-QRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
PE + Y + DIWS GC+L E+ F G+N L +++++ PT
Sbjct: 174 PEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPT------- 222
Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
P+ + + + +L PSLR +A E +PF
Sbjct: 223 -PSLPE-----------------TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 85/313 (27%), Positives = 142/313 (45%), Gaps = 53/313 (16%)
Query: 28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMR 82
G+P+ + + +G GS GIV A +G+ VA+KK + R+ + REL +MR
Sbjct: 16 GDPRTYLDNFIK--IGEGSTGIVCIATVKSSGKLVAVKK-MDLRKQQRRELLFNEVVIMR 72
Query: 83 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 142
H NV+ + + S +EL++ VME++ + ++ N+ +
Sbjct: 73 DYQHENVVEM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCL 123
Query: 143 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEA--NISYIC 198
+ + L+ +H V HRD+K ++L LTH +VK+ DFG Q ++ E S +
Sbjct: 124 AVLKALSVLHA-QGVIHRDIKSDSIL---LTHDGRVKLSDFGFCAQ-VSKEVPRRKSLVG 178
Query: 199 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258
+ ++ APELI Y +DIWS G ++ E++ G+P + E P
Sbjct: 179 TPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPL 222
Query: 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
+ ++ + N P++K HKV P RLL P+ R TA E HP
Sbjct: 223 KAMKMIRDNLP----PKLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHP 271
Query: 319 FFDELREPNARLP 331
F + P+ +P
Sbjct: 272 FLAKAGPPSCIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 92/341 (26%), Positives = 148/341 (43%), Gaps = 56/341 (16%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLM---RVMDHPNVISLKH 94
++G G+FG V +A + E A+K V +Y E+Q M R D + L
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195
Query: 95 C--FFSTTSKNELFLNLVM-EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
+F + + + +VM +Y P + ++KH +++ + I +Q L Y
Sbjct: 196 IQRYFQNETGH---MCIVMPKYGPCLLDWIMKHGPFSHRHLAQI-----IFQTGVALDYF 247
Query: 152 HTVPRVCHRDLKPQNLL-------VDPLTHQ--------VKICDFGSAKQLIAGEANISY 196
HT + H DLKP+N+L VDP+T++ V+ICD G + +
Sbjct: 248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCD--ERHSRTAI 305
Query: 197 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT- 255
+ +R YR+PE++ G + S D+WS GC++ EL G+ L+ + ++ L + K LG
Sbjct: 306 VSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364
Query: 256 PTREEIRCMNPN----YTDFRFPQIKAHPWH--KVFHKRMPPEAI------DLASRLLQY 303
P+ RC Y + P H ++ R E I DL LL Y
Sbjct: 365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424
Query: 304 SPSLRCTALEACAHP----FFDELRE-PNARLPNGRP-LPP 338
R A + HP ++ E R+ PN P+ R L P
Sbjct: 425 DRQKRLNARQMTTHPYVLKYYPECRQHPNY--PDNRSMLRP 463
|
Length = 467 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 77/315 (24%), Positives = 133/315 (42%), Gaps = 59/315 (18%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLK 93
+VG G FG V + TG+ A+K + + + E ++ + + P + L+
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 94 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
+ F K+ L+L VMEY P + + + ++ ++ M + Y ++ + +
Sbjct: 68 YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY--ICSRFYRAPELI- 208
H + V HRD+KP+N+L+D H +K+ DFGSA +L A + S + + Y APE++
Sbjct: 119 HQMGYV-HRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 209 ----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
G Y D WS G + E++ G+ F + I+
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM-------------- 222
Query: 265 NPNYTDF-RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
N+ F +FP+ ++ + +DL LL R C HPFF ++
Sbjct: 223 --NFQRFLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269
Query: 324 REPNARLPNGRPLPP 338
N R LPP
Sbjct: 270 DWNNIR----NSLPP 280
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE----------LQLMRVMDHPNVIS 91
+G G+FG V+Q + +T A+K + + +E L + + P ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 92 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
LK FS + ++L+L V +Y+ E + + K + R K Y ++ L
Sbjct: 61 LK---FSFQTDSDLYL--VTDYMSGGELFWHLQKEGRFSEDR-----AKFYIAELVLALE 110
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 208
++H + +RDLKP+N+L+D H + +CDFG +K + + C + Y APE++
Sbjct: 111 HLHKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
YT +D WS G ++ E+ G F E+
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 81/309 (26%), Positives = 144/309 (46%), Gaps = 48/309 (15%)
Query: 28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRV 83
G+PK+ Y +G G+ G V+ A + TG+ VAIK++ LQ + K E+ +MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 84 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 142
+PN+++ + +EL++ VMEY+ S+ V+ ++ +
Sbjct: 73 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CR 122
Query: 143 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRF 201
+ + L ++H+ +V HRD+K N+L+ + VK+ DFG Q+ ++ S + + +
Sbjct: 123 ECLQALDFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
+ APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 181 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQ-- 236
Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
NP +R+ D +R L+ R +A E HPF
Sbjct: 237 ---NP--------------------ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL- 272
Query: 322 ELREPNARL 330
+L +P + L
Sbjct: 273 KLAKPLSSL 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 26/224 (11%)
Query: 40 RVVGTGSFGIVFQAKCLETGET----VAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 90
+V+G+G+FG V++ + GE VAIK + ++ K E +M +DHP+V+
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
L S+ + L+ + +P + +L + + + Y+ + QI +G++Y
Sbjct: 73 RLLGICLSSQ------VQLITQLMP--LGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPEL 207
+ R+ HRDL +N+LV H VKI DFG AK L E + + A E
Sbjct: 125 LEEK-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 208 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 248
I YT D+WS G + EL+ G + G AV+ L+E
Sbjct: 183 IL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 85/350 (24%), Positives = 146/350 (41%), Gaps = 80/350 (22%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV--------MDHPNVIS 91
RV+G GS+ V + +T A+K + ++ + ++ ++ +HP ++
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 92 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
L CF T S+ LF V+E+V + M+ + + +++P + + Y+ +I L
Sbjct: 61 LHSCF-QTESR--LFF--VIEFVSGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 110
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 208
++H + +RDLK N+L+D H +K+ D+G K+ I S C + Y APE++
Sbjct: 111 FLHE-RGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII--KVLGTPTR 258
G +Y S+D W+ G ++ E++ G+ F P +N D L ++I K + P
Sbjct: 169 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP-- 225
Query: 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-- 316
R +KA K F + P E L C
Sbjct: 226 -------------RSLSVKASSVLKGFLNKDPKE-------------RLGCHPQTGFRDI 259
Query: 317 --HPFFD----ELREPNARLPNGRPLPP-------LFNFKQELSGASPEL 353
HPFF +L E LP P P L NF + + +L
Sbjct: 260 KSHPFFRNIDWDLLEQKQVLP---PYKPNIESDRDLDNFDPQFTDEPVQL 306
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 67/250 (26%), Positives = 126/250 (50%), Gaps = 22/250 (8%)
Query: 28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRV 83
G+PK+ Y +G G+ G V+ A + TG+ VAI+++ LQ + K E+ +MR
Sbjct: 16 GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 84 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 142
+PN+++ + +EL++ VMEY+ S+ V+ ++ +
Sbjct: 74 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CR 123
Query: 143 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRF 201
+ + L ++H+ +V HRD+K N+L+ + VK+ DFG Q+ ++ S + + +
Sbjct: 124 ECLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
+ APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 182 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 239
Query: 262 RCMNPNYTDF 271
++ + DF
Sbjct: 240 EKLSAIFRDF 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKH------- 94
+G+G+ G V++ + +TG +A+K++ RR N+E + R++ +V+ H
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKE-ENKRILMDLDVVLKSHDCPYIVK 78
Query: 95 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP-LIYVKLYTYQIFRGLAYIHT 153
C+ + +++F+ ME + + ++LK +P I K+ T I + L Y+
Sbjct: 79 CYGYFITDSDVFI--CMELMSTCLDKLLKR---IQGPIPEDILGKM-TVAIVKALHYLKE 132
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFGAT 212
V HRD+KP N+L+D + VK+CDFG + +L+ +A S C+ Y APE I
Sbjct: 133 KHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA-YMAPERIDPPD 190
Query: 213 ---EYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
+Y D+WS G L EL GQ FP +N
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQ--FPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 60/228 (26%), Positives = 111/228 (48%), Gaps = 28/228 (12%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV--------MDHPNVIS 91
RV+G GS+ V + +T A+K V ++ + ++ ++ +HP ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
L CF + E L V+EYV L + +++P + + Y+ +I L Y+
Sbjct: 61 LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 112
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-LIAGEANISYICSRFYRAPELIFG 210
H + +RDLK N+L+D H +K+ D+G K+ L G+ ++ + Y APE++ G
Sbjct: 113 HE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 250
+Y S+D W+ G ++ E++ G+ F P +N D L ++I
Sbjct: 171 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 7e-15
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 21/203 (10%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVISLKHCFF 97
VG+G++G V++A+ L TGE A+K + D +E+ +++ H N+++ F
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73
Query: 98 STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 157
S S+ +L+ + MEY + + H + + + YV T Q GLAY+H+ ++
Sbjct: 74 SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLAYLHSKGKM 128
Query: 158 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFGATE--- 213
HRD+K N+L+ VK+ DFG A ++ A A S+I + ++ APE+ A E
Sbjct: 129 -HRDIKGANILLTD-NGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNG 184
Query: 214 -YTTSIDIWSAGCVLAELLLGQP 235
Y DIW+ G EL QP
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 7e-15
Identities = 71/288 (24%), Positives = 124/288 (43%), Gaps = 46/288 (15%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRVMDHPNV 89
++G G FG V+ + +TG+ A+K L +R K ++ L L+ D P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
+ + + F T K L+L+ + Y + +H + M + Y +I GL
Sbjct: 60 VCMSYAF-HTPDKLSFILDLMNG--GDLHYHLSQHGVFSEAEM-----RFYAAEIILGLE 111
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 209
++H V +RDLKP N+L+D H V+I D G A + + S + + Y APE++
Sbjct: 112 HMH-NRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPG-----ENAVDQLVEIIKV------------ 252
Y +S D +S GC+L +LL G F ++ +D++ + V
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228
Query: 253 -----LGTPTREEIRCMNPNYTDFR-FPQIKAHPWHKVFHKRMPPEAI 294
L + C+ + + P ++ W VF ++ PP I
Sbjct: 229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLI 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 67/220 (30%), Positives = 108/220 (49%), Gaps = 23/220 (10%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRVMDHPNVISLK 93
V+G GSFG V A+ T E AIK + +D ++ +++ ++ + P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 94 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
H F T + L VMEYV + MY++ + R + Y +I GL ++
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFL 117
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 210
H+ + +RDLK N+++D H +KI DFG K+ + C + Y APE+I
Sbjct: 118 HS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-A 174
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
Y S+D W+ G +L E+L GQ F GE+ D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 70/295 (23%), Positives = 130/295 (44%), Gaps = 30/295 (10%)
Query: 45 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104
GS G VF A + V +K + + E L++ ++HP+VI +K S
Sbjct: 77 GSEGRVFVATKPGQPDPVVLK--IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITC- 133
Query: 105 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 164
+V+ + +Y L + ++ +P+ + QI GL Y+H R+ HRD+K
Sbjct: 134 ----MVLPHYSSDLYTYL---TKRSRPLPIDQALIIEKQILEGLRYLHAQ-RIIHRDVKT 185
Query: 165 QNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAG 224
+N+ ++ + QV I D G+A+ + A + + APE + +Y + DIWSAG
Sbjct: 186 ENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNSKADIWSAG 243
Query: 225 CVLAELLL----------GQPLFPGENAVDQLVEIIKVLGT-----PTREEIRCMNPNYT 269
VL E+L P ++ L++II L P R + +
Sbjct: 244 IVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR-LVRGFI 302
Query: 270 DFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
++ + + + + F + +P + L ++L + ++R +A E +P F +L
Sbjct: 303 EYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 64/236 (27%), Positives = 118/236 (50%), Gaps = 32/236 (13%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDH--------PNVIS 91
RV+G GS+ V + + + A+K V ++ + + ++ ++ H P ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 92 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
L CF TTS+ L LV+EYV + M+ + + +++P + + Y +I L
Sbjct: 61 LHSCF-QTTSR----LFLVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYAAEICIALN 110
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELI 208
++H + +RDLK N+L+D H +K+ D+G K+ + G+ ++ + Y APE++
Sbjct: 111 FLHE-RGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL 168
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLF------PGENAVDQLVEIIKVLGTPTR 258
G EY S+D W+ G ++ E++ G+ F P N D L ++I L P R
Sbjct: 169 RGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIR 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 26/220 (11%)
Query: 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDH 86
P++++ ER +G G FG V+ T + VA+K + +E Q+M+ + H
Sbjct: 4 PRESLKL--ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH 60
Query: 87 PNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMP-LIYVKLYTYQI 144
++ L ++ S+ E +V EY+ + S+ LK R+P L+ + QI
Sbjct: 61 DKLVQL----YAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM---AAQI 112
Query: 145 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF--- 201
G+AY+ + HRDL +N+LV KI DFG A+ LI + + ++F
Sbjct: 113 AEGMAYLESR-NYIHRDLAARNILVGE-NLVCKIADFGLAR-LIEDDEYTAREGAKFPIK 169
Query: 202 YRAPELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
+ APE +G +T D+WS G +L E++ G+ +PG
Sbjct: 170 WTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 57/296 (19%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRVMDHPNVISL 92
+++G G+FG V + TG A+K + ++ E+ ++++ HP + +L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 93 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
K+ F T + L VMEY E + + + +R + Y +I L Y
Sbjct: 61 KYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 110
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 209
+H+ V +RD+K +NL++D H +KI DFG K+ I+ A + C + Y APE +
Sbjct: 111 LHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VL 167
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
+Y ++D W G V+ E++ G+ F ++ ++L E+I + EEIR
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 213
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 320
F + + PEA L + LL+ P R A E H FF
Sbjct: 214 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 3e-14
Identities = 67/252 (26%), Positives = 113/252 (44%), Gaps = 45/252 (17%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNR--ELQLMRVMDHPNV 89
Y + +G G FG VF K T E K + L++R E+ +MR + H N+
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74
Query: 90 ISLKHCFFSTTSKNELFLNLVMEY-----VPESMYRVLKHYSSANQRMPLIYVKLYTYQI 144
+ F + ++ L ++ME+ + ++ + K + + + T Q+
Sbjct: 75 VRYIDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEHA----IVDITRQL 127
Query: 145 FRGLAYIHTVP------RVCHRDLKPQNLL-------VDPLTHQV---------KICDFG 182
LAY H + RV HRDLKPQN+ + +T Q KI DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 183 SAKQLIAGEANISYIC--SRFYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPG 239
+K + G ++++ C + +Y +PEL+ T+ Y D+W+ GC++ EL G+ F
Sbjct: 188 LSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
Query: 240 ENAVDQLVEIIK 251
N QL+ +K
Sbjct: 246 ANNFSQLISELK 257
|
Length = 1021 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVISLK 93
+G G FG V + TG+ A KK L +R K + E +++ ++ P +++L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 94 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
+ F S T L LVM + + Y + Y+ + + + V Y+ QI G+ ++
Sbjct: 60 YAFESKTH-----LCLVMSLMNGGDLKYHI---YNVGERGLEMERVIHYSAQITCGILHL 111
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 211
H++ + +RD+KP+N+L+D ++ D G A +L G+ + Y APE I
Sbjct: 112 HSM-DIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-ILKE 168
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLF 237
Y+ +D ++ GC + E++ G+ F
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 4e-14
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 40 RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 90
R +G G FG V + + TGE VA+K + + + +E++++R + H N++
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 149
K T + L+ME++P LK Y N+ ++ L Y QI +G+
Sbjct: 70 KYKGI---CTEDGGNGIKLIMEFLPSGS---LKEYLPRNKNKINLKQQLKYAVQICKGMD 123
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------FY 202
Y+ + V HRDL +N+LV+ HQVKI DFG K + E + Y + F+
Sbjct: 124 YLGSRQYV-HRDLAARNVLVES-EHQVKIGDFGLTKAI---ETDKEYYTVKDDLDSPVFW 178
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL 231
APE + + Y S D+WS G L ELL
Sbjct: 179 YAPECLIQSKFYIAS-DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-14
Identities = 85/317 (26%), Positives = 126/317 (39%), Gaps = 58/317 (18%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVISLK 93
+G G FG V + TG+ A KK+ + R K + + L +V H I
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV--HSRFIVSL 58
Query: 94 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
F T K +L L + + + Y + + N P YT QI GL ++H
Sbjct: 59 AYAFQT--KTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRACFYTAQIISGLEHLHQ 115
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFGAT 212
R+ +RDLKP+N+L+D + V+I D G A +L G++ Y + + APEL+ G
Sbjct: 116 -RRIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-E 172
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLF--PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270
EY S+D ++ G L E++ + F GE KV ++ I + Y D
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPFRARGE----------KVENKELKQRILNDSVTYPD 222
Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-------CTALEACAHPFFDEL 323
+ P + LL P R C L HP F +L
Sbjct: 223 -----------------KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLR--THPLFRDL 263
Query: 324 REPNARLPNGRPLPPLF 340
N R LPP F
Sbjct: 264 ---NWRQLEAGMLPPPF 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-14
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPN 88
+Y RVVG GS+G V + G+ IKK+ ++R+ +E QL+ + HPN
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
+++ + + + L +VM + +Y LK + +P V + QI
Sbjct: 61 IVAYRESW----EGEDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMA 114
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPE 206
L Y+H + HRDLK QN+ + T+ +K+ D G A+ L + + I + +Y +PE
Sbjct: 115 LQYLHE-KHILHRDLKTQNVFLTR-TNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE 172
Query: 207 LIFGATEYTTSIDIWSAGCVLAEL 230
L F Y D+W+ GC + E+
Sbjct: 173 L-FSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 7e-14
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 15/207 (7%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK-NRELQLMRVMDHPNVISLKHCF 96
VVG G++G V++ + ++TG+ AIK V +D + E+ +++ H I+ +
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 97 FSTTSK--NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 154
F S ++ L LVME+ L + N + ++ +I RGLA++H
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICREILRGLAHLH-A 139
Query: 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--IAGEANISYICSRFYRAPELIF--- 209
+V HRD+K QN+L+ +VK+ DFG + QL G N ++I + ++ APE+I
Sbjct: 140 HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDE 197
Query: 210 -GATEYTTSIDIWSAGCVLAELLLGQP 235
Y DIWS G E+ G P
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 7e-14
Identities = 66/249 (26%), Positives = 115/249 (46%), Gaps = 39/249 (15%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHCF 96
+G G+FG V++A+ ETG +A KV+ + + E+ ++ DHPN++ L F
Sbjct: 13 LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 97 FSTTSKNELFLNLVMEY-----VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
+ +N L+ +++E+ V M + + + +++ Q L Y+
Sbjct: 72 Y---YENNLW--ILIEFCAGGAVDAVMLELERPLTEPQ-------IRVVCKQTLEALNYL 119
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYICSRFYRAPELIFG 210
H ++ HRDLK N+L L +K+ DFG SAK + S+I + ++ APE++
Sbjct: 120 HE-NKIIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 211 ATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIR 262
T Y D+WS G L E+ +P N + L++I K L P+R
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSR---- 233
Query: 263 CMNPNYTDF 271
+ + DF
Sbjct: 234 -WSSEFKDF 241
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 8e-14
Identities = 61/221 (27%), Positives = 112/221 (50%), Gaps = 24/221 (10%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRVMDHPNVISL 92
+++G G+FG V + +G+ A+K + ++ E+ ++++ HP + SL
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 93 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
K+ F +K+ L VMEYV E + + + + R + Y +I L Y
Sbjct: 61 KYSF---QTKDRLCF--VMEYVNGGELFFHLSRERVFSEDR-----TRFYGAEIVSALDY 110
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 209
+H+ ++ +RDLK +NL++D H +KI DFG K+ I A + C + Y APE +
Sbjct: 111 LHS-GKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VL 167
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
+Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 61/229 (26%), Positives = 107/229 (46%), Gaps = 28/229 (12%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 89
Y+ + +G GSFG K E G+ IK++ ++R +E+ ++ M HPN+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIY----VKLYTYQIF 145
+ + F + L +VM+Y Y N + +++ + + QI
Sbjct: 62 VQYQESFEENGN-----LYIVMDYCEGG-----DLYKKINAQRGVLFPEDQILDWFVQIC 111
Query: 146 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAG-EANISYICSRFY 202
L ++H ++ HRD+K QN+ LT +K+ DFG A+ L + E + I + +Y
Sbjct: 112 LALKHVHD-RKILHRDIKSQNIF---LTKDGTIKLGDFGIARVLNSTVELARTCIGTPYY 167
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251
+PE I Y DIW+ GCVL E+ + F N + +++II+
Sbjct: 168 LSPE-ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 29/219 (13%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVMDHPN---VISL 92
+V+G G+FG V + + + A+K + + K + +M H N ++ L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108
Query: 93 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
H F +++ +L +VMEY+P L +N +P + + YT ++ L IH
Sbjct: 109 -HYAF----QDDKYLYMVMEYMPGGDLVNL----MSNYDIPEKWARFYTAEVVLALDAIH 159
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAPEL 207
++ + HRD+KP N+L+D H +K+ DFG+ ++ +AN C Y +PE+
Sbjct: 160 SMGFI-HRDVKPDNMLLDKSGH-LKLADFGTCMKM---DANGMVRCDTAVGTPDYISPEV 214
Query: 208 IF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 243
+ G Y D WS G L E+L+G F ++ V
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRVMDHPNV 89
++G G FG V+ + +TG+ A+K L +R K ++ L L+ D P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
+ + + F T K L+L+ + Y + +H + + M + Y +I GL
Sbjct: 60 VCMTYAF-HTPDKLCFILDLMNG--GDLHYHLSQHGVFSEKEM-----RFYATEIILGLE 111
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 209
++H V +RDLKP N+L+D H V+I D G A + + S + + Y APE++
Sbjct: 112 HMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 245
T Y +S D +S GC+L +LL G F D+
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 60/229 (26%), Positives = 112/229 (48%), Gaps = 27/229 (11%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRVMDHPN 88
Y +V+G G+FG V + T + A+K + + D + E +M + P
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
V+ L + F +++ +L +VMEY+P + ++ +Y +P + + YT ++
Sbjct: 105 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLA 154
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRA 204
L IH++ + HRD+KP N+L+D H +K+ DFG+ ++ E + + + + Y +
Sbjct: 155 LDAIHSMGFI-HRDVKPDNMLLDKSGH-LKLADFGTCMKM-NKEGMVRCDTAVGTPDYIS 211
Query: 205 PELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
PE++ G Y D WS G L E+L+G F ++ V +I+
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 61/230 (26%), Positives = 112/230 (48%), Gaps = 29/230 (12%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRVMDHPN 88
Y +V+G G+FG V + + + A+K + + D + E +M + P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
V+ L C F +++ +L +VMEY+P + ++ +Y +P + K YT ++
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVLA 154
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYR 203
L IH++ + HRD+KP N+L+D H +K+ DFG+ ++ E + + + + Y
Sbjct: 155 LDAIHSMGLI-HRDVKPDNMLLDKHGH-LKLADFGTCMKM--DETGMVRCDTAVGTPDYI 210
Query: 204 APELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
+PE++ G Y D WS G L E+L+G F ++ V +I+
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 7e-13
Identities = 67/248 (27%), Positives = 114/248 (45%), Gaps = 57/248 (22%)
Query: 42 VGTGSFGIVFQAKCLETGE-----TVAIKKVLQDRRYKN-----RELQLMRVM-DHPNVI 90
+G G+FG V +A+ + TVA+K + D K+ E+++M+++ H N+I
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 91 SLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLIYV 137
+L T + L++ V+EY P Y + + +
Sbjct: 80 NLLGV---CTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 138 KLYTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 196
+ YQ+ RG+ ++ + + C HRDL +N+LV H +KI DFG A+ +I +
Sbjct: 135 VSFAYQVARGMEFLAS--KKCIHRDLAARNVLVTE-DHVMKIADFGLAR-------DIHH 184
Query: 197 ICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAV 243
I +YR APE +F YT D+WS G +L E+ LG +PG V
Sbjct: 185 I--DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PV 240
Query: 244 DQLVEIIK 251
++L +++K
Sbjct: 241 EELFKLLK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 40 RVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDRRYKNR-------ELQLMRVMDHPNVIS 91
R +GTGSFG V A E VAIK+ + + K + E +++ ++HP ++
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
L F K+E +L LV+E+V + + N+R P Y QI Y+
Sbjct: 96 LYGSF-----KDESYLYLVLEFVIGGEFFT---FLRRNKRFPNDVGCFYAAQIVLIFEYL 147
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 210
++ + +RDLKP+NLL+D +K+ DFG AK + + +C + Y APE++
Sbjct: 148 QSL-NIVYRDLKPENLLLDK-DGFIKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLN 202
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLF 237
+ + D W+ G + E+L+G P F
Sbjct: 203 VG-HGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQDRRYKNRELQLMRVMDHPNVISLKH 94
+G G+FG V++ L+ VA+K +R +E ++++ DHPN++ L
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL-- 57
Query: 95 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 154
K +++ VME VP L R+ + + + G+ Y+ +
Sbjct: 58 -IGVCVQKQPIYI--VMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES- 111
Query: 155 PRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-------APE 206
+ C HRDL +N LV + +KI DFG +++ E Y S + APE
Sbjct: 112 -KNCIHRDLAARNCLVG-ENNVLKISDFGMSRE----EEGGIYTVSDGLKQIPIKWTAPE 165
Query: 207 -LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
L +G YT+ D+WS G +L E LG +PG
Sbjct: 166 ALNYG--RYTSESDVWSYGILLWETFSLGDTPYPG 198
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 79/324 (24%), Positives = 130/324 (40%), Gaps = 79/324 (24%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNR---ELQLMRVMDHPNVISL 92
+++G G G VF + TG+ A+K K + R R E +++ +DHP + +L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 93 KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
F + T +L LVM+Y P ++R+L+ + + + Y ++ L Y+
Sbjct: 67 YASFQTET-----YLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL------------------------ 187
H + V +RDLKP+N+L+ H + + DF +KQ
Sbjct: 120 HLLGIV-YRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 188 ------IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
+ S++ + Y APE+I G + +++D W+ G +L E+L G F G N
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 301
+ I+K + FP + A DL +LL
Sbjct: 237 RDETFSNILK-----------------KEVTFPG----------SPPVSSSARDLIRKLL 269
Query: 302 QYSPSLRC----TALEACAHPFFD 321
PS R A E HPFF
Sbjct: 270 VKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 74/284 (26%), Positives = 116/284 (40%), Gaps = 46/284 (16%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRVMDHPNVISLKHCF 96
+G GSFG VF+ T + VAIK + L++ + +E+ ++ D P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 97 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 156
T L ++MEY+ L ++ +K +I +GL Y+H+ +
Sbjct: 72 LKGTK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLK----EILKGLDYLHSEKK 122
Query: 157 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYT 215
+ HRD+K N+L+ VK+ DFG A QL + +++ + F+ APE+I + Y
Sbjct: 123 I-HRDIKAANVLLSE-QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYD 179
Query: 216 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 275
+ DIWS G EL G+P P + M+P F P+
Sbjct: 180 SKADIWSLGITAIELAKGEP--PNSD----------------------MHPMRVLFLIPK 215
Query: 276 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
F K + L PS R TA E H F
Sbjct: 216 NNPPTLTGEFSKPFK----EFIDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 31/225 (13%)
Query: 42 VGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLK 93
+G GSFG+V + + +G VA+K + D+ +E +M +DH N+I L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 94 HCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
+ +V E P S+ L+ A + + Y QI G+ Y+
Sbjct: 63 GVVLTHPLM------MVTELAPLGSLLDRLR--KDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-------AP 205
+ R HRDL +N+L+ +VKI DFG + L E + Y+ + AP
Sbjct: 115 S-KRFIHRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YV-MEEHLKVPFAWCAP 169
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 249
E + T ++ + D+W G L E+ G+ + G + L +I
Sbjct: 170 ESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 65/326 (19%), Positives = 107/326 (32%), Gaps = 52/326 (15%)
Query: 40 RVVGTGSFG--IVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRVMDHPNVIS 91
++G IV AK T VA+KK+ D K E+ R + HPN++
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPESMYRVL--KHYSSANQRMPLIYVKLYTYQIFRGLA 149
F +EL++ V + L H+ +P + + + L
Sbjct: 64 YVTSF---IVDSELYV--VSPLMAYGSCEDLLKTHFPEG---LPELAIAFILKDVLNALD 115
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELI 208
YIH+ + HR +K ++L+ +V + + +I G+ L
Sbjct: 116 YIHSKGFI-HRSVKASHILLSG-DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 209 FGATE--------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP---- 256
+ + E Y DI+S G EL G F A L+E KV GT
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLL 231
Query: 257 ----------TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 306
+ + R N + + + LQ P
Sbjct: 232 DKSTYPLYEDSMSQSRSSNEHPN-------NRDSVDHPYTRTFSEHFHQFVELCLQRDPE 284
Query: 307 LRCTALEACAHPFFDELREPNARLPN 332
R +A + H FF + + N L +
Sbjct: 285 SRPSASQLLNHSFFKQCKRRNTSLLD 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 5e-12
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 24/203 (11%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRVMDHPNVISLKHCF 96
+G GSFG VF+ T + VAIK + L++ + +E+ ++ D P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 97 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY--QIFRGLAYIHT 153
T L ++MEY+ S +L + PL ++ T +I +GL Y+H+
Sbjct: 72 LKDTK-----LWIIMEYLGGGSALDLL-------EPGPLDETQIATILREILKGLDYLHS 119
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELIFGAT 212
++ HRD+K N+L+ +VK+ DFG A QL + + ++ + F+ APE+I +
Sbjct: 120 EKKI-HRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQS 176
Query: 213 EYTTSIDIWSAGCVLAELLLGQP 235
Y + DIWS G EL G+P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-12
Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 28/205 (13%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRVMDHPNVISLKHCF 96
+G GSFG V++ T E VAIK + L++ + +E+ ++ D P + +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 97 FSTTSKNELFLNLVMEYV-PESMYRVLKHYSSANQRMPL--IYVKLYTYQIFRGLAYIHT 153
T L ++MEY+ S +LK PL Y+ +I +GL Y+H+
Sbjct: 72 LKGTK-----LWIIMEYLGGGSALDLLK-------PGPLEETYIATILREILKGLDYLHS 119
Query: 154 VPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFG 210
R HRD+K N+L L+ Q VK+ DFG A QL + +++ + F+ APE+I
Sbjct: 120 -ERKIHRDIKAANVL---LSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-K 174
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQP 235
+ Y DIWS G EL G+P
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 6e-12
Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 30/218 (13%)
Query: 40 RVVGTGSFGIVFQAKCLETGET-----VAIKKVLQDRRYKNR-----ELQLMRVM-DHPN 88
+ +G G+FG V +A ++ VA+K + R EL++M + +H N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFR 146
+++L + T + + + EY Y L ++ + L L ++YQ+ +
Sbjct: 101 IVNL---LGACTIGGPILV--ITEYC---CYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 147 GLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---Y 202
G+A++ + + C HRDL +N+L+ VKICDFG A+ ++ + +R +
Sbjct: 153 GMAFLAS--KNCIHRDLAARNVLLTH-GKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
APE IF YT D+WS G +L E+ LG +PG
Sbjct: 210 MAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 20/220 (9%)
Query: 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVM 84
P + ++ +G G++G VF+ + G A+K +L + E++ L +
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALS 72
Query: 85 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQ 143
DHPNV+ ++ KN L LV+E S+ ++K + +RM + ++
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 144 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAG--EANISYICS 199
GL ++H V + HRD+K N+L LT + VK+ DFG + QL + N S + +
Sbjct: 133 ALMGLQHLH-VNKTIHRDVKGNNIL---LTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGT 187
Query: 200 RFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQP 235
F+ APE+I + Y D+WS G EL G P
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 40 RVVGTGSFGIVFQAK-CLETGE--TVAIKKVLQDRRYKNREL-----QLMRVMDHPNVIS 91
R +G G FG V+Q E VA+K RE +MR DHP+++
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLAY 150
L ++N ++ +VME P L+ Y N+ + L + LY+YQ+ LAY
Sbjct: 72 L----IGVITENPVW--IVMELAP---LGELRSYLQVNKYSLDLASLILYSYQLSTALAY 122
Query: 151 IHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRA 204
+ + R HRD+ +N+LV P VK+ DFG ++ L E Y S+ + A
Sbjct: 123 LESK-RFVHRDIAARNVLVSSP--DCVKLGDFGLSRYL---EDESYYKASKGKLPIKWMA 176
Query: 205 PELIFGATEYTTSIDIWSAG-CVLAELLLG-QPLFPGEN 241
PE I +T++ D+W G C+ L+LG +P +N
Sbjct: 177 PESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK-NRELQLMRVMDHPNVISLKHCFF 97
+VG G++G V++ + ++TG+ AIK V D + +E+ +++ H I+ + F
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 98 STTSKNELFLN----LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
KN ++ LVME+ L + N + ++ +I RGL+++H
Sbjct: 73 --IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLSHLHQ 129
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--IAGEANISYICSRFYRAPELIF-- 209
+V HRD+K QN+L+ +VK+ DFG + QL G N ++I + ++ APE+I
Sbjct: 130 -HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACD 186
Query: 210 --GATEYTTSIDIWSAGCVLAELLLGQP 235
Y D+WS G E+ G P
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 20/222 (9%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVMDHPNVISLKHCF 96
+G G++G V++ + G A+K +L + E++ L + +HPNV+ F
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 97 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
+ L LV+E S+ ++K QR+ + Y GL ++H
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-N 147
Query: 156 RVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGA 211
R+ HRD+K N+L LT + VK+ DFG + QL + N S + + F+ APE+I
Sbjct: 148 RIIHRDVKGNNIL---LTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMAPEVIACE 203
Query: 212 TEYTTS----IDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 249
+Y S D+WS G EL G P + V L +I
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 67/234 (28%), Positives = 106/234 (45%), Gaps = 33/234 (14%)
Query: 20 STTIGGKNGEPKQTISYMA-ERV--VGTGSFGIVFQAKCLETGETVAIKKVLQD-----R 71
S++ P S ERV +G+G+ G V++ TG A+K + + R
Sbjct: 57 SSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR 116
Query: 72 RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQR 131
R RE++++R ++HPNV+ H F + ++ L + E + + + + R
Sbjct: 117 RQICREIEILRDVNHPNVVKC-HDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR 175
Query: 132 MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--IA 189
QI G+AY+H + HRD+KP NLL++ VKI DFG ++ L
Sbjct: 176 -----------QILSGIAYLHR-RHIVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTM 222
Query: 190 GEANISYICSRFYRAPELI-----FGATEYTTSIDIWSAGCVLAELLLGQPLFP 238
N S + + Y +PE I GA + DIWS G + E LG+ FP
Sbjct: 223 DPCN-SSVGTIAYMSPERINTDLNHGAYDGYAG-DIWSLGVSILEFYLGR--FP 272
|
Length = 353 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NREL----QLMRVMDHPNVI 90
+V+G+G+FG V++ + GE V I +++ R N+E+ +M +D+P+V
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 91 SLKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 148
L C ST + L+ + +P + L Y ++ + Y+ + QI +G+
Sbjct: 73 RLLGICLTST-------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 205
Y+ R+ HRDL +N+LV H VKI DFG AK L A E + + A
Sbjct: 123 NYLEE-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
E I YT D+WS G + EL+
Sbjct: 181 ESILHRI-YTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 32/200 (16%)
Query: 45 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104
G+ G F +T E V IK R E ++R ++HP++I LK F T +K
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF--TYNK-- 156
Query: 105 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 164
F L++ +Y Y +A + + + + + R + Y+H R+ HRD+K
Sbjct: 157 -FTCLILPRYKTDLY----CYLAAKRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKA 210
Query: 165 QNLLVDPLTHQVKIC--DFGSAKQLIAGEANISYICSRFY--------RAPELIFGATEY 214
+N+ ++ H +C DFG+A + AN ++Y APEL+ Y
Sbjct: 211 ENIFIN---HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPY 260
Query: 215 TTSIDIWSAGCVLAELLLGQ 234
++DIWSAG VL E+
Sbjct: 261 GPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 18/222 (8%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFST 99
+V+G G+FG V K T A+K + + K E R + NV+ C + T
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWIT 64
Query: 100 T----SKNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 154
T ++E +L LVM+Y V + +L + R+P + Y ++ + IH +
Sbjct: 65 TLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQL 121
Query: 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSA-KQLIAGEANISY-ICSRFYRAPELIF--- 209
HRD+KP N+L+D H +++ DFGS K G S + + Y +PE++
Sbjct: 122 -HYVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 210 -GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
G +Y D WS G + E+L G+ F E+ V+ +I+
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 28/221 (12%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----VM---DHPNVISL 92
+V+G G+FG V K TG+ A+K + + K E R V+ D + +L
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 93 KHCFFSTTSKNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
+ F ++E L LVM+Y V + +L S R+P + Y ++ + +
Sbjct: 67 HYAF-----QDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG---EANIS-----YICSRFYR 203
H + V HRD+KP N+L+D H +++ DFGS +L+A ++N++ YI +
Sbjct: 119 HQLGYV-HRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 244
A E G Y D WS G + E+L G+ F E+ V+
Sbjct: 177 AME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 61/238 (25%), Positives = 108/238 (45%), Gaps = 49/238 (20%)
Query: 40 RVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQ-----DRRYKNRELQLMRVMDHPNV 89
+ +G G FG V +A TVA+K + + + R E L++ ++HP+V
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL---------- 139
I L + S++ L L++EY + Y L+ + ++++ Y+
Sbjct: 66 IKL----YGACSQDGPLL-LIVEY---AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117
Query: 140 --------------YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185
+ +QI RG+ Y+ + V HRDL +N+LV ++KI DFG ++
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYLAEMKLV-HRDLAARNVLVAE-GRKMKISDFGLSR 175
Query: 186 QLIAGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
+ ++ + R + A E +F YTT D+WS G +L E++ LG +PG
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 18/166 (10%)
Query: 140 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 198
Y++Q+ +G+ ++ + R C HRDL +N+L+ + VKICDFG A+ + +
Sbjct: 184 YSFQVAKGMEFLAS--RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGD 240
Query: 199 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 254
+R + APE IF YT D+WS G +L E+ LG +PG V+I +
Sbjct: 241 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFC 292
Query: 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
+E R P+YT Q WH +R P +L L
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR--PTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 33/226 (14%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR----ELQLMRVMDHPNVISLKH 94
ER +G+G FG V++ VAIK + D K + E+Q ++ + H ++ISL
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL-- 67
Query: 95 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMP-LIYVKLYTYQIFRGLAYIH 152
F+ S E ++ E + + S+ L+ + LI + Q+ G+AY+
Sbjct: 68 --FAVCSVGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASLIDM---ACQVAEGMAYLE 121
Query: 153 TVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQL-----IAGEANISYICSRFYRAPE 206
HRDL +N+LV + L K+ DFG A+ + ++ + I Y + APE
Sbjct: 122 E-QNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPYK----WTAPE 174
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN---AVDQLVE 248
++T D+WS G +L E+ GQ +PG N DQ+
Sbjct: 175 AA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 5e-11
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ------LMRVMDHPNVI 90
+V+G+G+FG V++ + GETV I K+L + ++ +M MDHP+++
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
L S T + LV + +P H N L+ + QI +G+ Y
Sbjct: 73 RLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN--WCVQIAKGMMY 124
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPEL 207
+ R+ HRDL +N+LV H VKI DFG A+ L E + + + A E
Sbjct: 125 LEE-RRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 208 IFGATEYTTSIDIWSAGCVLAELLL--GQP 235
I ++T D+WS G + EL+ G+P
Sbjct: 183 IH-YRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 17/169 (10%)
Query: 140 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 198
Y++Q+ RG+ ++ + R C HRDL +N+L+ + VKICDFG A+ + +
Sbjct: 179 YSFQVARGMEFLAS--RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGS 235
Query: 199 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 254
+R + APE IF YTT D+WS G +L E+ LG +PG V+I +
Sbjct: 236 ARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQINEEFC 287
Query: 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP-PEAIDLASRLLQ 302
++ R P +I W +R +++ LLQ
Sbjct: 288 QRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 7e-11
Identities = 69/267 (25%), Positives = 101/267 (37%), Gaps = 63/267 (23%)
Query: 30 PKQTISYMAERVVGTGSFGIVFQAKC--LETGET---VAIKKVLQD------RRYKNREL 78
+ TI R +G G+FG VF +C LE VA+ K L++ R+ RE
Sbjct: 3 QRDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREA 59
Query: 79 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPES-----------MYRVLKHYSS 127
+L+ H N++ +V EY+ LK S
Sbjct: 60 ELLTNFQHENIVKFYGVCTEGDP-----PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114
Query: 128 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQ 186
+ L + QI G+ Y+ HRDL +N LV L VKI DFG ++
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYL-ASQHFVHRDLATRNCLVGYDLV--VKIGDFGMSRD 171
Query: 187 LIAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELLL-- 232
+ Y +YR PE I +TT D+WS G VL E+
Sbjct: 172 V--------YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYG 221
Query: 233 GQPLFPGENAVDQLVEIIK---VLGTP 256
QP + N ++++E I +L P
Sbjct: 222 KQPWYGLSN--EEVIECITQGRLLQRP 246
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 8e-11
Identities = 72/270 (26%), Positives = 112/270 (41%), Gaps = 65/270 (24%)
Query: 29 EPKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIK--------KVLQDRRYKN 75
P + ++ E +G G+FG V++ + + +VAIK KV Q+ R
Sbjct: 2 IPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR--- 56
Query: 76 RELQLMRVMDHPNVISL--------KHC-FFSTTSKNELFLNLVMEYVPESMYRVLKHYS 126
+E +LM + HPN++ L C F + +L LV P S V
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRN-SPHS--DVGAESG 113
Query: 127 SANQRMPLIYVKLY--TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184
+ L QI G+ Y+ + HRDL +N LV VKI DFG +
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVGE-GLTVKISDFGLS 171
Query: 185 KQLIAGEANISYICSRFYR------------APELI-FGATEYTTSIDIWSAGCVLAELL 231
+ + + + +YR PE I +G ++TT DIWS G VL E+
Sbjct: 172 RDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIF 220
Query: 232 -LG-QPLFPGENAVDQLVEIIK---VLGTP 256
G QP + N +++E+I+ +L P
Sbjct: 221 SYGLQPYYGFSN--QEVIEMIRSRQLLPCP 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 9e-11
Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 35/220 (15%)
Query: 79 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYV 137
QLM+ D+PN I L ++S T+ L +M+Y+ + ++ +LK ++ V
Sbjct: 63 QLMK--DNPNFIKL---YYSVTTLKGHVL--IMDYIKDGDLFDLLKK----EGKLSEAEV 111
Query: 138 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 197
K Q+ L +H + H D+K +N+L D ++ +CD+G K I G Y
Sbjct: 112 KKIIRQLVEALNDLH-KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIG-TPSCYD 167
Query: 198 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI-------- 249
+ Y +PE I G Y S D W+ G + ELL G+ P + D+ +++
Sbjct: 168 GTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGK--HPFKEDEDEELDLESLLKRQQ 224
Query: 250 -----IKVLGTPTREEIRCM---NPNYTDFRFPQIKAHPW 281
IK + + ++ M N NY + +I HP+
Sbjct: 225 KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264
|
Length = 267 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 9e-11
Identities = 66/235 (28%), Positives = 101/235 (42%), Gaps = 55/235 (23%)
Query: 39 ERVVGTGSFGIVFQ--AKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRVMDHPN 88
R +G GSFG+V++ AK + GE VAIK V +++R E +M+ + +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY--------SSANQRMPLIYVKLY 140
V+ L S + L +VME + + LK Y + P K
Sbjct: 71 VVRL----LGVVSTGQPTL-VVMELMAKGD---LKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 141 TY--QIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYI 197
+I G+AY+ + HRDL +N +V + LT VKI DFG + +I
Sbjct: 123 QMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDLT--VKIGDFGMTR-------DIYE- 171
Query: 198 CSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
+ +YR APE + +TT D+WS G VL E+ L + + G
Sbjct: 172 -TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQG 224
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 77/281 (27%), Positives = 125/281 (44%), Gaps = 54/281 (19%)
Query: 42 VGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRRYKN-----RELQLMRVM-DHPN 88
+G G FG V A+ L + TVA+K + D K+ E+++M+++ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL--------KHYSSANQRMP---LIYV 137
+I+L + T L++ ++EY + R YS R+P + +
Sbjct: 83 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 138 KLY--TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 195
L TYQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ + NI
Sbjct: 138 DLVSCTYQVARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDV----NNID 191
Query: 196 YICSRF-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 247
Y + APE +F YT D+WS G ++ E+ LG +PG V++L
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF 249
Query: 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 288
+++K G + C N Y R WH + R
Sbjct: 250 KLLKE-GHRMDKPANCTNELYMMMR------DCWHAIPSHR 283
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 48/148 (32%), Positives = 71/148 (47%), Gaps = 16/148 (10%)
Query: 140 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 198
Y++Q+ RG+ ++ + R C HRDL +N+L+ + VKICDFG A+ + +
Sbjct: 178 YSFQVARGMEFLAS--RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGD 234
Query: 199 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 254
+R + APE IF YTT D+WS G +L E+ LG +PG V+I +
Sbjct: 235 ARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQIDEEFC 286
Query: 255 TPTREEIRCMNPNYTDFRFPQIKAHPWH 282
+E R P Y I WH
Sbjct: 287 RRLKEGTRMRAPEYATPEIYSIMLDCWH 314
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 72/278 (25%), Positives = 113/278 (40%), Gaps = 46/278 (16%)
Query: 57 ETGETVAIKKVLQD-----RRYK--NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109
TG VAIK + D + RE L + HPN+++L + L
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVAL----LDSGEAPPGLLFA 56
Query: 110 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 169
V EYVP R L+ +A+ +P Q+ LA H + HRDLKPQN++V
Sbjct: 57 VFEYVPG---RTLREVLAADGALPAGETGRLMLQVLDALACAHN-QGIVHRDLKPQNIMV 112
Query: 170 DP--LTHQVKICDFGSAKQLI-AGEANIS-------YICSRFYRAPELIFGATEYTTSID 219
+ K+ DFG L +A+++ + + Y APE + G T + D
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-TPNSD 171
Query: 220 IWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ-IKA 278
+++ G + E L GQ + G + + EI+ + ++P D P I
Sbjct: 172 LYAWGLIFLECLTGQRVVQGAS----VAEILY----------QQLSPV--DVSLPPWIAG 215
Query: 279 HPWHKVFHKRM---PPEAIDLASRLLQYSPSLRCTALE 313
HP +V K + P + A L + +L AL
Sbjct: 216 HPLGQVLRKALNKDPRQRAASAPALAERFRALELCALV 253
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 4e-10
Identities = 66/282 (23%), Positives = 111/282 (39%), Gaps = 58/282 (20%)
Query: 40 RVVGTGSFGIVFQAKCLE-----TGET-VAIKK-----VLQDRRYKNRELQLMRVMDHPN 88
+G+G+FG V++ + +G VA+K Q+++ +E LM +HPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK---LYTYQI 144
++ L ++ME + + L+ PL+ +K +
Sbjct: 61 IVKLLGVCLLNEP-----QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115
Query: 145 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ----VKICDFGSAKQLIAGEANISYICSR 200
+G Y+ + HRDL +N LV + VKI DFG A+ + S
Sbjct: 116 AKGCVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK---------SD 165
Query: 201 FYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQL 246
+YR APE L+ G +TT D+WS G ++ E+L LGQ +P N + L
Sbjct: 166 YYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223
Query: 247 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 288
+ R P + Q+ + W + +R
Sbjct: 224 QHV--------TAGGRLQKPENCPDKIYQLMTNCWAQDPSER 257
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 62/228 (27%), Positives = 92/228 (40%), Gaps = 32/228 (14%)
Query: 30 PKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQ 79
P+ I Y R +G G+FG VFQA+ E VA+K + + RE
Sbjct: 3 PRNNIEY--VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 80 LMRVMDHPNVISL--------KHC----FFSTTSKNELFLNLVMEYVPESMYRVLKHYSS 127
LM DHPN++ L C + + NE + +
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 128 ANQRMPLIYVKLY--TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185
+PL + Q+ G+AY+ V HRDL +N LV VKI DFG ++
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGE-NMVVKIADFGLSR 178
Query: 186 QLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 230
+ + + A+ + + PE IF YTT D+W+ G VL E+
Sbjct: 179 NIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 67/219 (30%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 36 YMAERVVGTGSFGIVFQA-KCLETGETVAIKKV-LQDRR---YKNRELQLMRVMDHPNVI 90
Y+ +VG F A + + E V K V L D R Y EL + DH ++
Sbjct: 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128
Query: 91 SLKHCFFSTTSKNELFLNLVMEY-----VPESMYRVLKHYSSANQRMPL--IYVKLYTYQ 143
KH F S ++L L +MEY + + + + LK + +P V L YQ
Sbjct: 129 --KH-FDDFKSDDKLLL--IMEYGSGGDLNKQIKQRLK------EHLPFQEYEVGLLFYQ 177
Query: 144 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICSR 200
I L +H+ ++ HRDLK N+ + P T +K+ DFG +KQ ++ + S+ +
Sbjct: 178 IVLALDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTP 235
Query: 201 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 239
+Y APEL + Y+ D+WS G +L ELL F G
Sbjct: 236 YYLAPEL-WERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 66/246 (26%), Positives = 119/246 (48%), Gaps = 38/246 (15%)
Query: 30 PKQTISYMAERVVGTGSFGIVFQA----------KCLETGETVAIKKVLQDRRYKNRELQ 79
P+++I + + +G G FG V+ K L+ G T++++ L+ E
Sbjct: 4 PRESIKLV--KKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLE-------EAN 53
Query: 80 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK 138
LM+ + H ++ L ++ +K E + ++ EY+ + S+ LK S ++ L +
Sbjct: 54 LMKTLQHDKLVRL----YAVVTKEEP-IYIITEYMAKGSLLDFLK--SDEGGKVLLPKLI 106
Query: 139 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 198
++ QI G+AYI + HRDL+ N+LV KI DFG A+ +I +
Sbjct: 107 DFSAQIAEGMAYIERKNYI-HRDLRAANVLVSESL-MCKIADFGLAR-VIEDNEYTAREG 163
Query: 199 SRF---YRAPELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVL 253
++F + APE I FG+ +T D+WS G +L E++ G+ +PG + D + + +
Sbjct: 164 AKFPIKWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY 221
Query: 254 GTPTRE 259
P E
Sbjct: 222 RMPRME 227
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 28/209 (13%)
Query: 41 VVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVI 90
+G G FG VF AK E GET+ + K LQ + +N REL + R + H NV+
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLIYVKLYT--YQI 144
L + E +++EY + R K + PL + QI
Sbjct: 72 RL----LGLCREAEPHY-MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 145 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRF 201
G+ ++ R HRDL +N LV +VK+ +K + E + I R
Sbjct: 127 ALGMDHLSNA-RFVHRDLAARNCLVSS-QREVKVSLLSLSKDVYNSEYYKLRNALIPLR- 183
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAEL 230
+ APE + +++T D+WS G ++ E+
Sbjct: 184 WLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRY--KNREL----QLMRVMDHPNVI 90
+V+G+G+FG V++ + GE V I KVL++ N+E+ +M + P V
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 91 SLKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 148
L C ST + LV + +P Y L Y N+ R+ + + QI +G+
Sbjct: 73 RLLGICLTST-------VQLVTQLMP---YGCLLDYVRENKDRIGSQDLLNWCVQIAKGM 122
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 205
+Y+ V R+ HRDL +N+LV H VKI DFG A+ L E + + A
Sbjct: 123 SYLEEV-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
E I +T D+WS G + EL+
Sbjct: 181 ESIL-HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 72/284 (25%), Positives = 125/284 (44%), Gaps = 47/284 (16%)
Query: 40 RVVGTGSFGIVFQAKCLETGET---VAIKKV-----LQDRRYKNRELQLMRVMDHPNVIS 91
RV+G G FG V+ +++ A+K + L++ +E +M+ HPNV+S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP----LIYVKLYTYQIFRG 147
L + LV+ +P + L+++ + P LI L Q+ +G
Sbjct: 61 LLGICLPSEG-----SPLVV--LPYMKHGDLRNFIRSETHNPTVKDLIGFGL---QVAKG 110
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL 207
+ Y+ + + HRDL +N ++D + VK+ DFG A+ + E Y + +L
Sbjct: 111 MEYLAS-KKFVHRDLAARNCMLDE-SFTVKVADFGLARDIYDKE----YYSVHNHTGAKL 164
Query: 208 --IFGATE------YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 258
+ A E +TT D+WS G +L EL+ G P +P ++ D V +++ G
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLL 222
Query: 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 302
+ C +P Y ++ WH R P +L SR+ Q
Sbjct: 223 QPEYCPDPLY------EVMLSCWHPKPEMR--PTFSELVSRIEQ 258
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 9e-10
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 24/225 (10%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 91
+V+G G+FG V K L+ + V K+L R E ++ D+ + +
Sbjct: 7 KVIGRGAFGEVAVVK-LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITT 65
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
L + F +N L+L VM+Y +L S R+P + Y ++ + +
Sbjct: 66 LHYAF---QDENNLYL--VMDYYVGG--DLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIF 209
H + V HRD+KP N+L+D + +++ DFGS +L+ S + + Y +PE++
Sbjct: 119 HQLHYV-HRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 210 ----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
G +Y D WS G + E+L G+ F E+ V+ +I+
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 31/209 (14%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 90
E+V+G G FG V + + G+ VAIK + + R E +M DHPN+I
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
L+ +K+ + ++ EY+ S+ + L+ + V + I G+
Sbjct: 69 RLE----GVVTKSRPVM-IITEYMENGSLDKFLRENDG--KFTVGQLVGM-LRGIASGMK 120
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQV-KICDFGSAKQLIAGEANISY------ICSRFY 202
Y+ + V HRDL +N+LV+ ++ V K+ DFG +++L ++ +Y I R +
Sbjct: 121 YLSEMNYV-HRDLAARNILVN--SNLVCKVSDFGLSRRL--EDSEATYTTKGGKIPIR-W 174
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL 231
APE I ++T++ D+WS G V+ E++
Sbjct: 175 TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 42/107 (39%), Positives = 58/107 (54%), Gaps = 13/107 (12%)
Query: 140 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYI 197
+TYQ+ RG+ ++ + HRDL +N+L L VKICDFG A+ I ++N
Sbjct: 242 FTYQVARGMEFLAS-KNCVHRDLAARNVL---LAQGKIVKICDFGLARD-IMHDSNYVSK 296
Query: 198 CSRF----YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
S F + APE IF YTT D+WS G +L E+ LG +PG
Sbjct: 297 GSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 82/315 (26%), Positives = 136/315 (43%), Gaps = 70/315 (22%)
Query: 42 VGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRRYKN-----RELQLMRVMD-HPN 88
+G G FG V +A+ + TVA+K + + K+ E++LM+++ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL--------KHYSSANQRMP---LIYV 137
+I+L T + L++ ++EY + R Y+ ++P L +
Sbjct: 80 IINL---LGVCTQEGPLYV--IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134
Query: 138 KLYT--YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 195
L + YQ+ RG+ Y+ + R HRDL +N+LV + +KI DFG A+ G +I
Sbjct: 135 DLVSCAYQVARGMEYLES-RRCIHRDLAARNVLVTE-DNVMKIADFGLAR----GVHDID 188
Query: 196 YICSRF-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 247
Y + APE +F YT D+WS G ++ E+ LG +PG V++L
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELF 246
Query: 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR----------------MPP 291
+++ RE R P+ + WH V +R +
Sbjct: 247 KLL-------REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299
Query: 292 EAIDLASRLLQYSPS 306
E +DL+ QYSPS
Sbjct: 300 EYLDLSMPFEQYSPS 314
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 16/219 (7%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 89
Y RV+G+G+ G V AK + GE A+K V D+ E+ + D ++
Sbjct: 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93
Query: 90 ISLKHCFFSTTSKNE---LFLNLVMEYVPESMYRV-LKHYSSANQRMPLIYVKLYTYQIF 145
+ F +N L + LV++Y R +K + N+ L Q+
Sbjct: 94 VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153
Query: 146 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFY 202
+ ++H+ + HRD+K N+L+ VK+ DFG +K ++ + ++ + +Y
Sbjct: 154 LAVHHVHS-KHMIHRDIKSANILLCS-NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241
APE I+ Y+ D++S G +L ELL + F GEN
Sbjct: 212 VAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 58/217 (26%), Positives = 106/217 (48%), Gaps = 37/217 (17%)
Query: 39 ERVVGTGSFGIVFQA----------KCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPN 88
E+ +G G FG V+ A K ++ G +++++ L E +M+ + H
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLA-------EANVMKTLQHDK 62
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
++ L + +K +++ + E++ + S+ LK S + PL + ++ QI G
Sbjct: 63 LVKLH----AVVTKEPIYI--ITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEG 114
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRA 204
+A+I + HRDL+ N+LV KI DFG A+ +I + ++F + A
Sbjct: 115 MAFIEQRNYI-HRDLRAANILVSASL-VCKIADFGLAR-VIEDNEYTAREGAKFPIKWTA 171
Query: 205 PELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
PE I FG+ +T D+WS G +L E++ G+ +PG
Sbjct: 172 PEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 84/316 (26%), Positives = 134/316 (42%), Gaps = 71/316 (22%)
Query: 42 VGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRRYKN-----RELQLMRVM-DHPN 88
+G G FG V A+ + + TVA+K + D K+ E+++M+++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL--------KHYSSANQRMP---LIYV 137
+I+L + T L++ ++EY + R YS ++P L +
Sbjct: 80 IINL---LGACTQDGPLYV--LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 138 KLYT--YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 195
L + YQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ + NI
Sbjct: 135 DLVSCAYQVARGMEYLAS-QKCIHRDLAARNVLVTE-DNVMKIADFGLARDV----HNID 188
Query: 196 Y----ICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 247
Y R + APE +F YT D+WS G +L E+ LG +PG V++L
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELF 246
Query: 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR-----------------MP 290
+++K E R P I WH V +R
Sbjct: 247 KLLK-------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299
Query: 291 PEAIDLASRLLQYSPS 306
E +DL+ QYSP
Sbjct: 300 DEYLDLSVPFEQYSPG 315
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 61/240 (25%), Positives = 102/240 (42%), Gaps = 36/240 (15%)
Query: 45 GSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS 101
GS G VF C + G+ I K + + RE+ +++ + H +I+L H +
Sbjct: 103 GSEGEVFV--CTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY----- 155
Query: 102 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 161
+ + + +VM ++ Y + +PL ++ LAY+H + HRD
Sbjct: 156 RWKSTVCMVMPKYKCDLFT----YVDRSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRD 210
Query: 162 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAPELIFGATEYTT 216
+K +N+ +D + V + DFG+A +L + C + +PEL+ Y
Sbjct: 211 VKTENIFLDEPENAV-LGDFGAACKL--DAHPDTPQCYGWSGTLETNSPELL-ALDPYCA 266
Query: 217 SIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 275
DIWSAG VL E+ + LF + K + R IRCM + FPQ
Sbjct: 267 KTDIWSAGLVLFEMSVKNVTLFGKQV---------KSSSSQLRSIIRCMQVH--PLEFPQ 315
|
Length = 392 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVM---DHPNVISLKHC 95
++G G+FG VF+ L+ VA+K +D + K + L R++ DHPN++ L
Sbjct: 2 LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
T + ++ +VME VP + L + + + G+AY+ +
Sbjct: 58 IGVCTQRQPIY--IVMELVPGGDF--LSFLRKKKDELKTKQLVKFALDAAAGMAYLES-K 112
Query: 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFYRAPE-LIFGA 211
HRDL +N LV + +KI DFG ++Q I + + I + + APE L +G
Sbjct: 113 NCIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGIYSSSGLKQIPIK-WTAPEALNYG- 169
Query: 212 TEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
Y++ D+WS G +L E LG +PG
Sbjct: 170 -RYSSESDVWSYGILLWETFSLGVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 8e-09
Identities = 47/151 (31%), Positives = 70/151 (46%), Gaps = 24/151 (15%)
Query: 140 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYI 197
++YQ+ +G++++ HRDL +N+L LTH KICDFG A+ I ++N Y+
Sbjct: 219 FSYQVAKGMSFL-ASKNCIHRDLAARNIL---LTHGRITKICDFGLARD-IRNDSN--YV 271
Query: 198 CSRFYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEII 250
R APE IF YT D+WS G +L E+ LG +PG + ++I
Sbjct: 272 VKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI 330
Query: 251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPW 281
K E R ++P I W
Sbjct: 331 K-------EGYRMLSPECAPSEMYDIMKSCW 354
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-09
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 26/208 (12%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 90
E V+G G FG V + + G+ VAIK + + RR E +M DHPN+I
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 91 SLKHCFFSTTSKNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
L+ T S+ + + ME +S R + + +I + I G+
Sbjct: 69 HLEGVV--TKSRPVMIITEFMENGALDSFLRQ------NDGQFTVIQLVGMLRGIAAGMK 120
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR------FYR 203
Y+ + V HRDL +N+LV+ K+ DFG ++ L ++ +Y S +
Sbjct: 121 YLSEMNYV-HRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELL 231
APE I ++T++ D+WS G V+ E++
Sbjct: 179 APEAI-AYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 51/197 (25%), Positives = 80/197 (40%), Gaps = 26/197 (13%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLMRVMDHPNVISLKHCFFS 98
+G G FG V G+ VA+K + D E +M + HPN++ L
Sbjct: 14 IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQL--LGVV 69
Query: 99 TTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 156
L +V EY+ + L Y S + L + + G+ Y+
Sbjct: 70 LQGNP---LYIVTEYMAKG---SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE-KN 122
Query: 157 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATE 213
HRDL +N+LV K+ DFG AK EA+ + + APE + +
Sbjct: 123 FVHRDLAARNVLVSE-DLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL-REKK 175
Query: 214 YTTSIDIWSAGCVLAEL 230
++T D+WS G +L E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 40 RVVGTGSFGIVFQAKCLETGET-VAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 95
R +G G FG V++ L T VA+K + E Q+M+ + HP +I L
Sbjct: 12 RKLGAGQFGEVWEG--LWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL--- 66
Query: 96 FFSTTSKNE--LFLNLVMEYVPESMYRVLKHYSSANQRMP-LIYVKLYTYQIFRGLAYIH 152
++ + E + +M+Y S+ L+ + ++P LI + Q+ G+AY+
Sbjct: 67 -YAVCTLEEPIYIVTELMKY--GSLLEYLQGGAGRALKLPQLIDM---AAQVASGMAYLE 120
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIF 209
+ HRDL +N+LV + K+ DFG A+ + + ++F + APE
Sbjct: 121 AQNYI-HRDLAARNVLVGE-NNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAAL 177
Query: 210 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
++ D+WS G +L E++ G+ +PG
Sbjct: 178 -YNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 25/219 (11%)
Query: 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDH 86
P++T+ + +G G FG V+ VAIK + Q E LM+ + H
Sbjct: 4 PRETLKL--VKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60
Query: 87 PNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIF 145
P ++ L ++ ++ +++ + EY+ S+ LK + ++ + + QI
Sbjct: 61 PRLVRL----YAVVTQEPIYI--ITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIA 112
Query: 146 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---Y 202
G+A+I + HRDL+ N+LV KI DFG A+ LI + ++F +
Sbjct: 113 EGMAFIERKNYI-HRDLRAANILVSETLC-CKIADFGLAR-LIEDNEYTAREGAKFPIKW 169
Query: 203 RAPELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
APE I +G +T D+WS G +L E++ G+ +PG
Sbjct: 170 TAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 36/108 (33%), Positives = 58/108 (53%), Gaps = 15/108 (13%)
Query: 140 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 198
++ Q+ +G+ ++ + + C HRD+ +N+L+ KICDFG A+ I ++N Y+
Sbjct: 217 FSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDG-RVAKICDFGLARD-IMNDSN--YVV 270
Query: 199 SRFYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
R APE IF YT D+WS G +L E+ LG+ +PG
Sbjct: 271 KGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 50/206 (24%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFFS 98
+G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL----LG 69
Query: 99 TTSKNELFLNLVMEYVPESMYRVLKHYSSAN-QRMPLIYVKLYTYQIFRGLAYIHTVPRV 157
++ F ++ E++ +L + N Q + + + QI + Y+ +
Sbjct: 70 VCTREPPFY-IITEFMTYG--NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 126
Query: 158 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEY 214
HRDL +N LV H VK+ DFG ++ L+ G+ ++ ++F + APE + ++
Sbjct: 127 -HRDLAARNCLVGE-NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESL-AYNKF 182
Query: 215 TTSIDIWSAGCVLAEL-LLGQPLFPG 239
+ D+W+ G +L E+ G +PG
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 53/225 (23%), Positives = 100/225 (44%), Gaps = 29/225 (12%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ-------LMRVMDHPNV 89
+++G G FG V + + L + +K K ++ + E++ M+ DHPNV
Sbjct: 5 KILGEGEFGSVMEGQ-LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 90 ISLKHCFFSTTSKNELFLNLV----MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 145
+ L F +S ++ +V M++ + + +++PL + + I
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 146 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 205
G+ Y+ HRDL +N ++ V + DFG +K++ +G+ Y R + P
Sbjct: 124 LGMEYLSN-RNFIHRDLAARNCMLRE-DMTVCVADFGLSKKIYSGD---YYRQGRIAKMP 178
Query: 206 ELIFGATE------YTTSIDIWSAGCVLAELL-LGQPLFPG-ENA 242
+ + A E YT+ D+W+ G + E+ GQ +PG EN
Sbjct: 179 -VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH 222
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 27/226 (11%)
Query: 35 SYMAERVVGTGSFGIVFQAKCLETGET-VAIKKVLQDRRYKN---RELQLMRVMDHPNVI 90
S + +G G FG V+ G T VA+K + E Q+M+ + H ++
Sbjct: 7 SLQLIKKLGNGQFGEVWMG--TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLV 64
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
L ++ S+ +++ V EY+ + S+ LK ++P + V + Q+ G+A
Sbjct: 65 QL----YAVVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAA-QVAAGMA 116
Query: 150 YIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 205
YI + + HRDL+ N+LV D L KI DFG A+ LI + ++F + AP
Sbjct: 117 YIERMNYI-HRDLRSANILVGDGLV--CKIADFGLAR-LIEDNEYTARQGAKFPIKWTAP 172
Query: 206 EL-IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 249
E ++G +T D+WS G +L EL+ G+ +PG N + L ++
Sbjct: 173 EAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 52/243 (21%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----VMDHPNVISLKHC 95
+V+G G+FG V + +TG A+K + + + ++ +R ++ + + +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 96 FFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
F+S K L+L +ME++P + M ++K + + + Y + + IH
Sbjct: 67 FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEE-----TQFYIAETVLAIDSIHQ 119
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFG------------------------------- 182
+ + HRD+KP NLL+D H VK+ DFG
Sbjct: 120 LGFI-HRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 183 SAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 237
S ++ + N S + + Y APE +F T Y D WS G ++ E+L+G P F
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 238 PGE 240
E
Sbjct: 237 CSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 61/246 (24%), Positives = 104/246 (42%), Gaps = 58/246 (23%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-------MDHPNVISL 92
+V+G G+FG V + +TG A+K + + + ++ +R D V+ +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 93 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
F+S K L+L +ME++P + M ++K + + + + Y + +
Sbjct: 67 ---FYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA-----TQFYIAETVLAIDA 116
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG---------------------------- 182
IH + + HRD+KP NLL+D H VK+ DFG
Sbjct: 117 IHQLGFI-HRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 183 ---SAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 234
S ++ + N S + + Y APE +F T Y D WS G ++ E+L+G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 235 PLFPGE 240
P F E
Sbjct: 234 PPFCSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 52/169 (30%), Positives = 76/169 (44%), Gaps = 18/169 (10%)
Query: 129 NQRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186
N+ L Y+ L ++YQ+ G+ ++ + V HRDL +N+L+ VKICDFG A+
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLASKNCV-HRDLAARNVLICE-GKLVKICDFGLARD 288
Query: 187 LIAGEANISYICSRF----YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGEN 241
++ IS S F + APE IF YTT D+WS G +L E+ LG +P
Sbjct: 289 IMRDSNYISK-GSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELP 346
Query: 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 290
+Q IK R P + +I W + F R
Sbjct: 347 MNEQFYNAIK-------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPD 388
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 66/255 (25%), Positives = 106/255 (41%), Gaps = 54/255 (21%)
Query: 39 ERVVGTGSFGIVFQAKCLETGET-----VAIKKV----LQDRRYKNRELQLMRVMDHPNV 89
+R +G G+FG VF A+C T VA+K + L R+ RE +L+ + H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLIY 136
+ F+ + + +V EY+ P++M V A + L
Sbjct: 70 VK----FYGVCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 137 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 196
+ QI G+ Y+ + V HRDL +N LV VKI DFG ++ + +
Sbjct: 125 MLHIASQIASGMVYLASQHFV-HRDLATRNCLVGA-NLLVKIGDFGMSRDVYS------- 175
Query: 197 ICSRFYRA------------PELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFP-GEN 241
+ +YR PE I ++TT D+WS G +L E+ QP F
Sbjct: 176 --TDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232
Query: 242 AVDQLVEIIKVLGTP 256
V + + +VL P
Sbjct: 233 EVIECITQGRVLERP 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 7e-08
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 90
E+V+G G FG V + G+ VAIK + + RR E +M DHPN+I
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
L+ T SK + +V EY+ S+ L+ + + +I + I G+
Sbjct: 69 HLEGVV--TKSKPVM---IVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMK 120
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-----FYRA 204
Y+ + V HRDL +N+LV+ K+ DFG ++ ++ + +Y + A
Sbjct: 121 YLSDMGYV-HRDLAARNILVNS-NLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWTA 177
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELL 231
PE I ++T++ D+WS G V+ E++
Sbjct: 178 PEAI-AYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 7e-08
Identities = 84/331 (25%), Positives = 134/331 (40%), Gaps = 85/331 (25%)
Query: 30 PKQTISYMAERVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNR-----ELQ 79
++ I+ + E +G GSFG+V++ A+ + GE VA+K V + + R E
Sbjct: 4 SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 80 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLI 135
+M+ +V+ L SK + L +VME + +S R L+ + N P
Sbjct: 62 VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116
Query: 136 YVK---LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 192
++ +I G+AY++ + HRDL +N +V VKI DFG + + +
Sbjct: 117 TLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAH-DFTVKIGDFGMTRDIYETD- 173
Query: 193 NISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAEL--LLGQPLFP 238
+YR APE + +TTS D+WS G VL E+ L QP
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQG 224
Query: 239 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 298
N +Q+++ + M+ Y D P P DL
Sbjct: 225 LSN--EQVLKFV-------------MDGGYLD--------QP------DNCPERVTDLMR 255
Query: 299 RLLQYSPSLRCTALEACA------HPFFDEL 323
Q++P +R T LE HP F E+
Sbjct: 256 MCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 9e-08
Identities = 67/281 (23%), Positives = 118/281 (41%), Gaps = 36/281 (12%)
Query: 40 RVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVI 90
R++G G FG V +A+ + + VA+K + D + RE M+ DHPNVI
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 91 SLKHCFFSTTSKNELFLNLV----MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
L + +K L + +V M++ + ++ +PL + + I
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YR 203
G+ Y+ + HRDL +N +++ V + DFG +K++ +G+ S+ +
Sbjct: 125 GMEYLSS-KNFIHRDLAARNCMLNE-NMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG-ENAVDQLVEIIKVL--GTPTRE 259
A E + YTT D+W+ G + E++ GQ + G EN+ EI L G ++
Sbjct: 183 ALESL-ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----EIYNYLIKGNRLKQ 236
Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
C+ Y ++ W R P L +L
Sbjct: 237 PPDCLEDVY------ELMCQCWSPEPKCR--PSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 9e-08
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 95
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 11 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 66
Query: 96 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 154
++ S+ +++ V EY+ + S+ LK R+P + QI G+AY+ +
Sbjct: 67 -YAVVSEEPIYI--VTEYMSKGSLLDFLKGEMGKYLRLPQLVD--MAAQIASGMAYVERM 121
Query: 155 PRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE-LIF 209
V HRDL+ N+LV + L K+ DFG A+ LI + ++F + APE ++
Sbjct: 122 NYV-HRDLRAANILVGENLV--CKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 210 GATEYTTSIDIWSAGCVLAELLL-GQPLFPG 239
G +T D+WS G +L EL G+ +PG
Sbjct: 178 G--RFTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 50/223 (22%)
Query: 42 VGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISL 92
+G G+FG VF A+C E + + K L++ R+ RE +L+ V+ H +++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71
Query: 93 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK------HYSSANQRMPLIYVKL-----Y 140
F+ ++ L +V EY+ + R L+ + + + + L
Sbjct: 72 ---FYGVCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 141 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 200
QI G+ Y+ ++ V HRDL +N LV VKI DFG ++ + + +
Sbjct: 128 ASQIASGMVYLASLHFV-HRDLATRNCLVGQ-GLVVKIGDFGMSRDIYSTD--------- 176
Query: 201 FYRA------------PELIFGATEYTTSIDIWSAGCVLAELL 231
+YR PE I ++TT DIWS G VL E+
Sbjct: 177 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 63/268 (23%), Positives = 116/268 (43%), Gaps = 35/268 (13%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVISLKHCFF 97
+G+G FG+V+ LE + VAIK + + + + E Q+M + HP ++ L
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQLYGVCT 69
Query: 98 STTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 156
+ + LV E++ + L+ + L+ + L + G+AY+ +
Sbjct: 70 ERSP-----ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL---DVCEGMAYLES-SN 120
Query: 157 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATE 213
V HRDL +N LV VK+ DFG + + + S ++F + +PE +F ++
Sbjct: 121 VIHRDLAARNCLVGE-NQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPE-VFSFSK 177
Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273
Y++ D+WS G ++ E + + P EN + E+++ + R P
Sbjct: 178 YSSKSDVWSFGVLMWE-VFSEGKTPYENRSNS--EVVETINA----GFRLYKPRLASQSV 230
Query: 274 PQIKAHPWHKVFHKRMPPEAIDLASRLL 301
++ H W + PE S LL
Sbjct: 231 YELMQHCW------KERPEDRPSFSLLL 252
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 31/215 (14%)
Query: 39 ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RVMDHPNVI 90
+ V+G G+FG V +A+ + G AIK++ + D R EL+++ ++ HPN+I
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPES-------MYRVLK---HYSSANQRMPLIYVK-- 138
+L ++ +L L +EY P RVL+ ++ AN + +
Sbjct: 72 NLL-----GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 139 -LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISY 196
+ + RG+ Y+ + + HRDL +N+LV + KI DFG S Q + + +
Sbjct: 127 LHFAADVARGMDYL-SQKQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGR 184
Query: 197 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
+ R+ L + YTT+ D+WS G +L E++
Sbjct: 185 LPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 65/225 (28%)
Query: 116 ESMYRVLKH--------YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL 167
+S++ VL+H + S +P VK + ++ L +H VC RDL P N+
Sbjct: 58 DSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVC-RDLNPNNI 116
Query: 168 LVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAG 224
L+D H +++ F ++ GEA Y APE + G +E T + D WS G
Sbjct: 117 LLDDRGH-IQLTYFSRWSEVEDSCDGEA-----VENMYCAPE-VGGISEETEACDWWSLG 169
Query: 225 CVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN----YTDFRFPQIKAHP 280
+L ELL G+ L + C +P+ +T P+
Sbjct: 170 AILFELLTGKTL------------------------VEC-HPSGINTHTTLNIPEW---- 200
Query: 281 WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-----AHPFF 320
+ EA L +LLQ++P+ R A A +HPFF
Sbjct: 201 --------VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 70/277 (25%), Positives = 119/277 (42%), Gaps = 46/277 (16%)
Query: 42 VGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRRYKN-----RELQLMRVM-DHPN 88
+G G FG V A+ + + VA+K + D K+ E+++M+++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLI 135
+I+L + T L++ ++EY P M +++
Sbjct: 86 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 136 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 195
+ YQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ + +
Sbjct: 141 DLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHHIDYYKK 198
Query: 196 YICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 251
R + APE +F YT D+WS G +L E+ LG +PG V++L +++K
Sbjct: 199 TTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLK 256
Query: 252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 288
G + C N Y R WH V +R
Sbjct: 257 E-GHRMDKPSNCTNELYMMMR------DCWHAVPSQR 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 43/199 (21%), Positives = 77/199 (38%), Gaps = 60/199 (30%)
Query: 63 AIKKVLQDRRYKNRELQLMRVMDHPNVISL-------KHCFFSTTSKNELFLNLVMEYVP 115
A +D +E++++ + PN+ L ++MEY+
Sbjct: 58 ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLC------------MIMEYME 102
Query: 116 E-------SMYRVLKHYSSANQRMP----LIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 164
+ + N + L+Y+ QI G+ Y+ ++ V HRDL
Sbjct: 103 NGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMAT---QIASGMRYLESLNFV-HRDLAT 158
Query: 165 QNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY----RAP--------ELIFGAT 212
+N LV + +KI DFG ++ L + + +Y RAP E +
Sbjct: 159 RNCLVGKN-YTIKIADFGMSRNLYSSD---------YYRVQGRAPLPIRWMAWESVLL-G 207
Query: 213 EYTTSIDIWSAGCVLAELL 231
++TT D+W+ G L E+L
Sbjct: 208 KFTTKSDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 62/263 (23%), Positives = 99/263 (37%), Gaps = 58/263 (22%)
Query: 76 RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV-----MEYVPESMYRVLKHYSSANQ 130
E M+ DHPNV+ L T ++E + + V M++ + + Q
Sbjct: 49 SEAVCMKEFDHPNVMRLIGVCLQTV-ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ 107
Query: 131 RMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190
+P + + I G+ Y+ + HRDL +N +++ V + DFG +K++ G
Sbjct: 108 YLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNE-NMNVCVADFGLSKKIYNG 165
Query: 191 EANISYICSRFYRAPELIFGATE------YTTSIDIWSAGCVLAELLL-GQPLFPG-ENA 242
+ Y R + P + + A E YTT D+WS G + E+ GQ +PG EN+
Sbjct: 166 D---YYRQGRIAKMP-VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS 221
Query: 243 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 302
EI L R + PP+ +D
Sbjct: 222 -----EIYDYLRQGNR----------------------------LKQPPDCLDGL----- 243
Query: 303 YSPSLRCTALEACAHPFFDELRE 325
YS C L P F+ LR
Sbjct: 244 YSLMSSCWLLNPKDRPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 5e-07
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 32/206 (15%)
Query: 42 VGTGSFGIVFQA--KCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLK 93
+G+G+FG V + K + VAIK VL++ K+ RE ++M +D+P ++ +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 94 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
+ L LVME K S + + V +Q+ G+ Y+
Sbjct: 62 GVCEAEA------LMLVMEMASGGPLN--KFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113
Query: 154 VPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-------YRAP 205
V HRDL +N LLV+ H KI DFG +K L A + SY +R + AP
Sbjct: 114 KNFV-HRDLAARNVLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYAP 167
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
E I ++++ D+WS G + E
Sbjct: 168 ECI-NFRKFSSRSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 37/211 (17%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNR------ELQLMRVMDHPNVI 90
+++G+G FG V + + G+++ I K +QDR + + M +DH ++
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 91 SLKH-CFFSTTSKNELFLNLVMEYVPES--MYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
L C ++ L LV + P + V +H S + + L + QI +G
Sbjct: 73 RLLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLN----WCVQIAKG 121
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA-------KQLIAGEANISYICSR 200
+ Y+ R+ HR+L +N+L+ V+I DFG A K+ E +
Sbjct: 122 MYYLEE-HRMVHRNLAARNILLKS-DSIVQIADFGVADLLYPDDKKYFYSEHKTPI---K 176
Query: 201 FYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
+ ++FG YT D+WS G + E++
Sbjct: 177 WMALESILFG--RYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 57/225 (25%), Positives = 81/225 (36%), Gaps = 79/225 (35%)
Query: 143 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF- 201
QI L +H+ V HRD+KPQN++ + KI D G+A L G I+YI F
Sbjct: 263 QILFALDGLHSTGIV-HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318
Query: 202 ----YRAPELIFGATEYTTS---------------------------IDIWSAGCVLAEL 230
Y APE +Y S DI+SAG L
Sbjct: 319 LDPRYAAPE------QYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG-----L 367
Query: 231 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 290
+ Q FP + L++ R+ R D+ W K+ R
Sbjct: 368 IFLQMAFPNLRSDSNLIQF-------NRQLKRN------DYDLVA-----WRKLVEPRAS 409
Query: 291 P------EAIDLASR--------LLQYSPSLRCTALEACAHPFFD 321
P E +DL ++++ R +A A AHP+FD
Sbjct: 410 PDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454
|
Length = 566 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 24/205 (11%)
Query: 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVI 90
+++M E +G+G FG+V K VAIK + + + E ++M + HP ++
Sbjct: 6 LTFMKE--LGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLV 62
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYR-VLKHYSSANQRMPLIYVKLYTYQ-IFRGL 148
L + T + L++ V E M L +Y Q + L Q + G+
Sbjct: 63 QL---YGVCTQQKPLYI------VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGM 113
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 205
Y+ + HRDL +N LV T VK+ DFG + ++ E S ++F + P
Sbjct: 114 EYLERNSFI-HRDLAARNCLVSS-TGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPP 170
Query: 206 ELIFGATEYTTSIDIWSAGCVLAEL 230
E +F ++Y++ D+WS G ++ E+
Sbjct: 171 E-VFNFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 33 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMR 82
T+ +M E +G FG V++ E + VAIK L+D+ R + + +MR
Sbjct: 6 TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK-TLKDKAEGPLREEFKHEAMMR 62
Query: 83 V-MDHPNVISL---------KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRM 132
+ HPN++ L FS S ++L LVM + + +
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGE 191
P +V + T QI G+ ++ + V H+DL +N+LV D L VKI D G +++ A +
Sbjct: 123 PADFVHIVT-QIAAGMEFLSS-HHVVHKDLATRNVLVFDKLN--VKISDLGLFREVYAAD 178
Query: 192 ----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
S + R+ +++G +++ DIWS G VL E+
Sbjct: 179 YYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 54/232 (23%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRV---MDHPNVISL 92
R++G G G V+ A VA+KK+ +D K R L+ ++ + HP ++ +
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 93 KHCFFSTTSKNELFLNLVMEYVP--------------ESMYRVLKHYSSANQRMPLIYVK 138
+S S + + M Y+ ES+ + L +S + I+ K
Sbjct: 68 ----YSICSDGDP-VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS-IFHK 121
Query: 139 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-------QLIAGE 191
I + Y+H+ V HRDLKP N+L+ L +V I D+G+A L+ +
Sbjct: 122 -----ICATIEYVHS-KGVLHRDLKPDNILLG-LFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 192 ANISYICSRF------------YRAPELIFGATEYTTSIDIWSAGCVLAELL 231
+ IC Y APE + G + S DI++ G +L ++L
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 47/195 (24%), Positives = 93/195 (47%), Gaps = 18/195 (9%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFFS 98
+GTG FG+V K VAIK + + ++ E ++M + H ++ L +
Sbjct: 12 LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67
Query: 99 TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 158
T + +++ V EY+ +L + +R + + G+AY+ + +
Sbjct: 68 CTKQRPIYI--VTEYMSNGC--LLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES-KQFI 122
Query: 159 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEYT 215
HRDL +N LVD VK+ DFG ++ ++ E S + S+F + PE + ++++
Sbjct: 123 HRDLAARNCLVDD-QGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPE-VLLYSKFS 179
Query: 216 TSIDIWSAGCVLAEL 230
+ D+W+ G ++ E+
Sbjct: 180 SKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 25/205 (12%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCFFS 98
++G G FG V Q + TG+ VA+K + D + E +M + H N++ L
Sbjct: 13 IIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRL----LG 66
Query: 99 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 157
N L++ VME + + ++ L+ + + +I + ++ + G+ Y+ + ++
Sbjct: 67 VILHNGLYI--VMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLES-KKL 121
Query: 158 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEY 214
HRDL +N+LV K+ DFG A+ G N S+ + APE + ++
Sbjct: 122 VHRDLAARNILVSE-DGVAKVSDFGLARVGSMGVDN-----SKLPVKWTAPEAL-KHKKF 174
Query: 215 TTSIDIWSAGCVLAELL-LGQPLFP 238
++ D+WS G +L E+ G+ +P
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 19/161 (11%)
Query: 45 GSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQLMRVMDHPNVISLK------HCFF 97
G+FG V+ + + A+K V + D KN Q V + ++L H ++
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQ---VQAERDALALSKSPFIVHLYY 71
Query: 98 STTSKNELFLNLVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 156
S S N ++L VMEY+ + L H Y ++ M + Y+ ++ L Y+H
Sbjct: 72 SLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHR-HG 124
Query: 157 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 197
+ HRDLKP N+L+ H +K+ DFG +K + E N+ I
Sbjct: 125 IIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFFS 98
+G G FG V+ T + VAIK + +E Q+M+ + H ++ L ++
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68
Query: 99 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 157
S+ +++ V E++ + S+ LK ++P + V + QI G+AYI + +
Sbjct: 69 VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAA-QIADGMAYIERMNYI 124
Query: 158 CHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPEL-IFGAT 212
HRDL+ N+LV D L KI DFG A+ LI + ++F + APE ++G
Sbjct: 125 -HRDLRAANILVGDNLV--CKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG-- 178
Query: 213 EYTTSIDIWSAGCVLAELLL-GQPLFPG 239
+T D+WS G +L EL+ G+ +PG
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 39/219 (17%)
Query: 41 VVGTGSFGIVFQAKCLETG----ETVAIKKVLQ-----DRRYKNRELQLMRVMDHPNVIS 91
++ G+FG +F ++ E V +K V +E L+ + H N++
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY------SSAN--QRMPLIYVKLYTYQ 143
+ H + P + LK + AN Q + + Q
Sbjct: 73 ILHVCIEDGEPPFVLY-------PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 144 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC----- 198
I G++Y+H V H+D+ +N ++D QVKI D ++ L + Y C
Sbjct: 126 IACGMSYLHKR-GVIHKDIAARNCVIDE-ELQVKITDNALSRDLFPMD----YHCLGDNE 179
Query: 199 SRFYR--APELIFGATEYTTSIDIWSAGCVLAELL-LGQ 234
+R + A E + EY+++ D+WS G +L EL+ LGQ
Sbjct: 180 NRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 90
++V+G G FG VF+ G VAIK + K R E +M H N+I
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
L+ T K + + ME ++ + L+ + L+ + I G+ Y
Sbjct: 70 RLEGVV--TKFKPAMIITEYME--NGALDKYLRDHDGEFSSYQLVGM---LRGIAAGMKY 122
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-----FYRAP 205
+ + V HRDL +N+LV+ + K+ DFG ++ ++ + +Y S + AP
Sbjct: 123 LSDMNYV-HRDLAARNILVNS-NLECKVSDFGLSR-VLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL 231
E I ++T++ D+WS G V+ E++
Sbjct: 180 EAI-AYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 63/236 (26%), Positives = 114/236 (48%), Gaps = 35/236 (14%)
Query: 42 VGTGSFGIVFQA--KCLETGETVAIKKVLQ----DRRYKN---RELQLMRVMDHPNVISL 92
+G+G+FG V + K ++ +TVA+K +L+ D K+ RE +M+ +D+P ++ +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 93 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
+ E ++ LVME + L + N+ + + +Q+ G+ Y+
Sbjct: 62 -----IGICEAESWM-LVMEL---AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-------YRAP 205
V HRDL +N+L+ H KI DFG +K L A E +Y ++ + AP
Sbjct: 113 ETNFV-HRDLAARNVLL-VTQHYAKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAP 167
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGE--NAVDQLVEIIKVLGTPTR 258
E + ++++ D+WS G ++ E GQ + G N V Q++E + + P R
Sbjct: 168 ECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQR 222
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 7e-06
Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 55/254 (21%)
Query: 39 ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNV 89
+R +G G+FG VF A+C E + + K L+D R+ +RE +L+ + H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY-------SSANQRMPLIYVKLY- 140
+ F+ + + + +V EY+ + + L+ + + N+ L ++
Sbjct: 70 VK----FYGVCVEGDPLI-MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 141 -TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 199
QI G+ Y+ + HRDL +N LV VKI DFG ++ + + +
Sbjct: 125 IAQQIAAGMVYLAS-QHFVHRDLATRNCLVGE-NLLVKIGDFGMSRDVYSTD-------- 174
Query: 200 RFYRA------------PELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQ 245
+YR PE I ++TT D+WS G VL E+ QP + N ++
Sbjct: 175 -YYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NE 230
Query: 246 LVEII---KVLGTP 256
++E I +VL P
Sbjct: 231 VIECITQGRVLQRP 244
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 7e-06
Identities = 70/341 (20%), Positives = 123/341 (36%), Gaps = 103/341 (30%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRVMDHPNVISL 92
+ +G G+FG V + ++T A+K + + D +N+ E ++ D+ V+ L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 93 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
++S K+ L+ VM+Y+P + M +++ + Y ++ +
Sbjct: 67 ---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIES 116
Query: 151 IHTVPRVCHRDLK--------------------------------------------PQN 166
+H + + HRD+K P
Sbjct: 117 VHKMGFI-HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 167 LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCV 226
+ ++K + +Q A+ S + + Y APE++ T YT D WS G +
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAH-SLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVI 233
Query: 227 LAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH 286
L E+L+GQP F + TP +++ +N W H
Sbjct: 234 LYEMLVGQPPFLAD--------------TPAETQLKVIN---------------WETTLH 264
Query: 287 ----KRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFF 320
++ EA DL RL R A E AHPFF
Sbjct: 265 IPSQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 39/124 (31%), Positives = 57/124 (45%), Gaps = 28/124 (22%)
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
Y APE++ YT D WS G +L E+L+GQP F + TPT ++
Sbjct: 214 YIAPEVLL-RKGYTQLCDWWSVGVILFEMLVGQPPF--------------LAPTPTETQL 258
Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPF 319
+ +N T PQ+K + PEA+DL ++L + R A + AHPF
Sbjct: 259 KVINWENTLHIPPQVK-----------LSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307
Query: 320 FDEL 323
F E+
Sbjct: 308 FSEV 311
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 21/152 (13%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 91
+ +G G+FG V A ++T A+K L+ + NR E ++ D+ V+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
L ++S K+ L+ VM+Y+P M +L + + Y+ T I
Sbjct: 66 L---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAI----ES 116
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182
+H + + HRD+KP N+L+D L +K+ DFG
Sbjct: 117 VHKMGFI-HRDIKPDNILID-LDGHIKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 35/217 (16%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQ-----DRRYKNRELQLM-RVMDHPNVI 90
E V+G G+FG V +A + G AIK + + D R EL+++ ++ HPN+I
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPES-------MYRVLKHYSSANQRMPLIYVKLYTYQ 143
+L +N +L + +EY P RVL+ A + L + Q
Sbjct: 67 NL-----LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLE-TDPAFAKEHGTASTLTSQQ 120
Query: 144 IFR-------GLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFG-SAKQLIAGEANI 194
+ + G+ Y+ + + HRDL +N+LV + L KI DFG S + + + +
Sbjct: 121 LLQFASDVATGMQYL-SEKQFIHRDLAARNVLVGENLA--SKIADFGLSRGEEVYVKKTM 177
Query: 195 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
+ R+ L + YTT D+WS G +L E++
Sbjct: 178 GRLPVRWMAIESLNYSV--YTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 39/214 (18%)
Query: 42 VGTGSFGIVFQAKCLETGETVA--IKKVLQDRRYKNRELQLM------RVMDHPNVIS-L 92
+G G FG V + G + A + K L+ + +L + R ++HPNV+ L
Sbjct: 3 IGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 93 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRM------PLIYVKLYTYQIFR 146
C S LV+E+ P LK+Y +N+ M + ++ ++
Sbjct: 62 GQCIESIP------YLLVLEFCP---LGDLKNYLRSNRGMVAQMAQKDVLQRM-ACEVAS 111
Query: 147 GLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---Y 202
GL ++H + H DL +N L L+ VKI D+G A + + I+ C +
Sbjct: 112 GLLWLHQADFI-HSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRW 168
Query: 203 RAPEL--IFGA----TEYTTSIDIWSAGCVLAEL 230
APEL I G + T +IWS G + EL
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 48/191 (25%), Positives = 87/191 (45%), Gaps = 33/191 (17%)
Query: 62 VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 116
VA+K + D R E+++M + +PN+I L S L ++ EY+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP-----LCMITEYMEN 101
Query: 117 -------SMYRVLKHYSSANQ-----RMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 164
S + ++ AN L+Y+ + QI G+ Y+ ++ V HRDL
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAV---QIASGMKYLASLNFV-HRDLAT 157
Query: 165 QNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDI 220
+N LV + +KI DFG ++ L +G+ + + R+ ++ G ++TT+ D+
Sbjct: 158 RNCLVGN-HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDV 214
Query: 221 WSAGCVLAELL 231
W+ G L E+
Sbjct: 215 WAFGVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 46/204 (22%), Positives = 89/204 (43%), Gaps = 36/204 (17%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFFS 98
+G+G FG+V K + VAIK + + ++ E ++M + HPN++ L +
Sbjct: 12 LGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL----YG 66
Query: 99 TTSKNELFLNLVMEYVPESMYRVLKHYSSAN--QRMPLIYVKLYTY----QIFRGLAYIH 152
+K + +V EY + + N + + + + Y+
Sbjct: 67 VCTKQRP-IFIVTEY--------MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS---RF---YRAPE 206
+ HRDL +N LV + VK+ DFG A+ ++ + Y S +F + PE
Sbjct: 118 S-NGFIHRDLAARNCLVGE-DNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPE 171
Query: 207 LIFGATEYTTSIDIWSAGCVLAEL 230
+F + +++ D+WS G ++ E+
Sbjct: 172 -VFDYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 54/197 (27%), Positives = 81/197 (41%), Gaps = 45/197 (22%)
Query: 77 ELQLMRVMDHPNVISL--KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL 134
E +L+R + HP V++L T LV+ +Y L + + + L
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTC-------LVLPKYRSDLYTYL---GARLRPLGL 259
Query: 135 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC--DFGSA-------- 184
V Q+ + YIH + HRD+K +N+LV+ IC DFG+A
Sbjct: 260 AQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNG---PEDICLGDFGAACFARGSWS 315
Query: 185 ---KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL------LLGQP 235
IAG + + APE++ G YT S+DIWSAG V+ E L
Sbjct: 316 TPFHYGIAGTVDTN--------APEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSAS 366
Query: 236 LFPGENAVD-QLVEIIK 251
D Q++ II+
Sbjct: 367 RGDERRPYDAQILRIIR 383
|
Length = 461 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 37/123 (30%), Positives = 56/123 (45%), Gaps = 31/123 (25%)
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK---VLGTPTR 258
Y APE++ T YT D WS G +L E+L+GQP F + ++ +++I L P +
Sbjct: 214 YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQ 272
Query: 259 EEIRCMNPNYTDF-----RFP----------QIKAHPWHKVFHKRMPPEAIDLASRLLQY 303
+ ++P +D R P +IKAHP+ K ID +S L Q
Sbjct: 273 AK---LSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFK---------TIDFSSDLRQQ 320
Query: 304 SPS 306
S
Sbjct: 321 SAP 323
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 26/200 (13%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVM---DHPNVISLKHCF 96
+G G+FG VF + VA+K + K + LQ R++ HPN++ L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 59
Query: 97 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP-LIYVKLYTYQIFRGLAYIHTVP 155
T K ++ +VME V + ++ LI + G+ Y+ +
Sbjct: 60 GVCTQKQPIY--IVMELVQGGDFLTFLRTEGPRLKVKELIQM---VENAAAGMEYLES-- 112
Query: 156 RVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQ----LIAGEANISYICSRFYRAPE-LIF 209
+ C HRDL +N LV + +KI DFG +++ + A + I + + APE L +
Sbjct: 113 KHCIHRDLAARNCLVTE-KNVLKISDFGMSREEEDGVYASTGGMKQIPVK-WTAPEALNY 170
Query: 210 GATEYTTSIDIWSAGCVLAE 229
G Y++ D+WS G +L E
Sbjct: 171 G--RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 23/153 (15%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRVMDHPNVISL 92
+ +G G+FG V A+ ++T A+K + + D +N+ E ++ D+ V+ L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 93 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
++S K+ L+ VM+Y+P M +L RM + L + I +
Sbjct: 67 ---YYSFQDKDNLYF--VMDYIPGGDMMSLLI-------RMGIFPEDLARFYIAELTCAV 114
Query: 152 HTVPRV--CHRDLKPQNLLVDPLTHQVKICDFG 182
+V ++ HRD+KP N+L+D H +K+ DFG
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 39/121 (32%), Positives = 59/121 (48%), Gaps = 29/121 (23%)
Query: 143 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 202
QI G+ Y+ ++ V HRDL +N LV +KI DFG ++ L AG+ +Y
Sbjct: 146 QIASGMKYLSSLNFV-HRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194
Query: 203 R------------APELIFGATEYTTSIDIWSAGCVLAELLL---GQPLFPGENAVDQLV 247
R A E I ++TT+ D+W+ G L E+L+ QP GE +Q++
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPY--GELTDEQVI 251
Query: 248 E 248
E
Sbjct: 252 E 252
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 41 VVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RVMDHPNVISL 92
V+G G+FG V +A+ + G AIK++ + D R EL+++ ++ HPN+I+L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 93 KHCFFSTTSKNELFLNLVMEYVPES-------MYRVLKHYSSANQRMPLIYVKLYTYQIF 145
++ +L L +EY P RVL+ A L + Q+
Sbjct: 62 L-----GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE-TDPAFAIANSTASTLSSQQLL 115
Query: 146 R-------GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYI 197
G+ Y+ + + HRDL +N+LV + KI DFG S Q + + + +
Sbjct: 116 HFAADVARGMDYL-SQKQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGRL 173
Query: 198 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
R+ L + YTT+ D+WS G +L E++
Sbjct: 174 PVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 45/222 (20%), Positives = 90/222 (40%), Gaps = 35/222 (15%)
Query: 27 NGEPKQTIS---YMAERVVGTGSFGIVFQAKCLE---------------TGETVAIKKVL 68
G P I+ + ++++G G FG V++ +C ET+ ++ ++
Sbjct: 2 EGIPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLV 61
Query: 69 QDRRY-KNRELQLMRV--MDHPNVISLKHCFFSTTSKNELFLNLVM-EYVPESMYRVLKH 124
+ Y ++ + +DH + C + + ++ ++ E + E+ + K
Sbjct: 62 YNNIYDIDKIALWKNIHNIDHLGIPKYYGC--GSFKRCRMYYRFILLEKLVENTKEIFKR 119
Query: 125 YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184
N+ LI K + L YIH + H D+KP+N++VD ++ I D+G A
Sbjct: 120 IKCKNK--KLI--KNIMKDMLTTLEYIHEHG-ISHGDIKPENIMVDG-NNRGYIIDYGIA 173
Query: 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCV 226
I +I Y + + + T Y +D + CV
Sbjct: 174 SHFIIHGKHIEY-----SKEQKDLHRGTLYYAGLDAHNGACV 210
|
Length = 294 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 23/54 (42%), Positives = 33/54 (61%), Gaps = 2/54 (3%)
Query: 137 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190
+K Q+ GL +H + + HRD+KP+NLLV + QVKI DFG+A + G
Sbjct: 311 IKGVMRQVLTGLRKLHRIG-IVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTG 362
|
Length = 507 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 62/311 (19%), Positives = 122/311 (39%), Gaps = 49/311 (15%)
Query: 58 TGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 111
TGE V ++++ + + EL + ++ +HPN++ + F + NEL++
Sbjct: 24 TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA---DNELWVVTSF 80
Query: 112 EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 171
+ + H+ + + Y+ + + L YIH + V HR +K ++L+
Sbjct: 81 MAYGSAKDLICTHFMDGMSELAIAYILQ---GVLKALDYIHHMGYV-HRSVKASHILIS- 135
Query: 172 LTHQVKICDFGSAKQLI--AGEANISYICSRF------YRAPELIFGATE-YTTSIDIWS 222
+ +V + S +I + + ++ + +PE++ + Y DI+S
Sbjct: 136 VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 195
Query: 223 AGCVLAELLLGQPLFPGENAVDQLVEIIK-----VLGTPT--REEIR------------C 263
G EL G F A L+E + +L T T EE+
Sbjct: 196 VGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLG 255
Query: 264 MNPNYTDFRF--PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
+ + R + +HP+++ F P + LQ +P R +A H FF
Sbjct: 256 ESTTVSTPRPSNGESSSHPYNRTF----SPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311
Query: 322 EL-REPNARLP 331
++ R + LP
Sbjct: 312 QIKRRASEALP 322
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 32/219 (14%)
Query: 40 RVVGTGSFGIVFQ--AKCL---ETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 89
R +G GSFG+V++ AK + E VAIK V + + R E +M+ + +V
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRM---PLIYVKLYTY 142
+ L S+ + L ++ME + +S R L+ N L +
Sbjct: 72 VRL----LGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG 126
Query: 143 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYIC 198
+I G+AY++ + HRDL +N +V VKI DFG + + + +
Sbjct: 127 EIADGMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 199 SRFYRAPELIFGATEYTTSIDIWSAGCVLAEL--LLGQP 235
R+ L G +TT D+WS G VL E+ L QP
Sbjct: 185 VRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 143 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYIC 198
QI G+ Y+ ++ V HRDL +N LV + +KI DFG ++ L +G+ + +
Sbjct: 138 QIASGMKYLSSLNFV-HRDLATRNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLP 195
Query: 199 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 231
R+ ++ G ++TT+ D+W+ G L E+L
Sbjct: 196 IRWMSWESILLG--KFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 376 | |||
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.47 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.42 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.37 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.33 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.3 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.17 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.03 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.0 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.98 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.74 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.68 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.63 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.62 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.57 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.52 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.48 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.47 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.29 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.29 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.17 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.05 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.91 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.83 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.81 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.76 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.73 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.67 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.64 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.61 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.54 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.48 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.42 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.22 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.18 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.18 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.14 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.13 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.94 | |
| PLN02236 | 344 | choline kinase | 96.89 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.85 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.82 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.81 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.77 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.34 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.32 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.28 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.19 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.6 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.17 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.01 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.85 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.85 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 94.46 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.25 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 92.47 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 92.38 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 92.22 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 92.21 |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-74 Score=500.50 Aligned_cols=361 Identities=70% Similarity=1.175 Sum_probs=344.1
Q ss_pred ccCcEEEeccCCCCCCCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeec
Q 017147 14 VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLK 93 (376)
Q Consensus 14 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (376)
..+.+......+....+...-.|.-.+++|+|+||.||.|....+++.||||++.++.+...+|+.+|+.++|||||++.
T Consensus 4 ~~~~~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~ 83 (364)
T KOG0658|consen 4 ESGHVIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLL 83 (364)
T ss_pred cceeEEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEE
Confidence 35667778888888888899999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCC
Q 017147 94 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 173 (376)
Q Consensus 94 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~ 173 (376)
.+|......+..++.+||||++.+|.+.++++...+..++...++-|.+||++||.|||+ .||+||||||+|+|+|.++
T Consensus 84 ~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~t 162 (364)
T KOG0658|consen 84 YFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDT 162 (364)
T ss_pred EEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCC
Confidence 998776655567888999999999999999988889999999999999999999999999 7999999999999999988
Q ss_pred CcEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 017147 174 HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 253 (376)
Q Consensus 174 ~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 253 (376)
+.+||||||.|+....++...++.+|++|+|||+++|...|+.+.||||.||++.||+.|++.|+|.+..+++..|++.+
T Consensus 163 g~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~l 242 (364)
T KOG0658|consen 163 GVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVL 242 (364)
T ss_pred CeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCC
Q 017147 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNG 333 (376)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~ 333 (376)
|+|+.+.+.+++++|.+..+|.+...+|.+.+...+++++.||+.++|.++|.+|+++.|+|.||||+.+++++...+++
T Consensus 243 G~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g 322 (364)
T KOG0658|consen 243 GTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNG 322 (364)
T ss_pred CCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhhccCCHHHHhhhcHHHHHhhcCCCCCCCCC
Q 017147 334 RPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAG 375 (376)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (376)
.++|+++++.....+..++..+.++|.+.....+....++++
T Consensus 323 ~~lp~lf~f~~~e~~~~~~~~~~l~p~~~~~~~~~~~~~~~~ 364 (364)
T KOG0658|consen 323 RPLPPLFNFKRAELGISPELVNVLIPEHLREQEKDKILCESA 364 (364)
T ss_pred CcCCCccCchHHHhccchHHHHhhccHhhhhhccccccccCC
Confidence 999999999999999999999999999999999888777653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-62 Score=415.80 Aligned_cols=280 Identities=35% Similarity=0.676 Sum_probs=248.8
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
+.|+.+..+|+|+||.||+|+++.||+.||||++..+.. ...+|+++|++++|+|+|.++++| .....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 579999999999999999999999999999999965433 335899999999999999999999 445559
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
++|+|||+.++++.+.. ....++++.++.|++|++.|+.|+|+ ++++||||||+|||++. ++.+||||||+|+..
T Consensus 77 hLVFE~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~-~gvvKLCDFGFAR~L 151 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQ-NGVVKLCDFGFARTL 151 (396)
T ss_pred EEEeeecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEec-CCcEEeccchhhHhh
Confidence 99999999988888875 45678999999999999999999999 89999999999999997 889999999999987
Q ss_pred c-cCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH--Hhhc
Q 017147 188 I-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE--IRCM 264 (376)
Q Consensus 188 ~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~ 264 (376)
. .++..+.++.|+||+|||++.|...|+.++||||+||++.||++|.+.|+|..+.+++..|.+.+|.-.+.. +-..
T Consensus 152 ~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 152 SAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred cCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence 7 555566788999999999999988899999999999999999999999999999999999999999876654 4456
Q ss_pred CcCCCCCCCCCCCC-CChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 265 NPNYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 265 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
++-|....+|.... ++++..++. ++.-+.||+.+||..||++|++.+|+|+||||.++.
T Consensus 232 N~~F~Gv~lP~~~~~epLe~k~p~-~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~ 291 (396)
T KOG0593|consen 232 NPFFHGVRLPEPEHPEPLERKYPK-ISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI 291 (396)
T ss_pred CCceeeeecCCCCCccchhhhccc-chHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence 77788888888754 466666664 788999999999999999999999999999997654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-63 Score=442.35 Aligned_cols=284 Identities=37% Similarity=0.657 Sum_probs=256.8
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCC-CCceeeeceeeeecCCCCc
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 104 (376)
...++|.+++.||.|+||.||+|+.+.+++.||||++.+.- -...||+..|++|+ ||||+++.+++.+...
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~--- 83 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR--- 83 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc---
Confidence 34679999999999999999999999999999999886542 22348999999999 9999999999954432
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 105 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 105 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
.+|+|||||+.+|+++++. .+..|++..++.|++||+.||+|+|+ +|+.|||+||+|||+.. ...|||+|||+|
T Consensus 84 -~L~fVfE~Md~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~-~~~iKiaDFGLA 157 (538)
T KOG0661|consen 84 -ILYFVFEFMDCNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISG-NDVIKIADFGLA 157 (538)
T ss_pred -eEeeeHHhhhhhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecc-cceeEecccccc
Confidence 5999999999999999986 36889999999999999999999999 89999999999999996 678999999999
Q ss_pred ccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
+........+.++.|+||+|||+++....|+.+.|+||+|||++|+.+-++.|+|.++.+++.+|++.+|+|..+.|..-
T Consensus 158 Rev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 158 REVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred cccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 99998888999999999999999998889999999999999999999999999999999999999999999998776541
Q ss_pred --CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 265 --NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 265 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
.....++.+|.....++...++. .++++.+||.+||+|||.+||||+|+|+||||+.-.
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 22344678899888899988887 899999999999999999999999999999998643
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-61 Score=422.06 Aligned_cols=317 Identities=39% Similarity=0.681 Sum_probs=269.3
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeec------cccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.+|...+.||.|+||.|+.|.++.+|+.||||++.. +.+...+|+++|+.++|+||+.+.+++.......-.-+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 467778999999999999999999999999999863 23444589999999999999999999976444445558
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
|+|+|+|+.+|..+++ .+..+++..++.+++|++.||+|+|+ .+++||||||+|+|++. +..+||+|||+|+..
T Consensus 102 YiV~elMetDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~-~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 102 YLVFELMETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNA-DCDLKICDFGLARYL 175 (359)
T ss_pred EEehhHHhhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeecc-CCCEEeccccceeec
Confidence 9999999988888886 44559999999999999999999999 79999999999999997 788999999999977
Q ss_pred cc---CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 188 IA---GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 188 ~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
.. ....+.++.|+||+|||++.....|+.+.||||+|||+.||++|++.|+|.+..+++..|++.+|+|+.+.+...
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 54 334467888999999999988889999999999999999999999999999999999999999999999988776
Q ss_pred CcC-CCCC--CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCC
Q 017147 265 NPN-YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFN 341 (376)
Q Consensus 265 ~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~ 341 (376)
... ..++ .+|..+..+|...|+ ++++.++||+.+||..||.+|+|++|+|.|||++.+.++...+... +.+.
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~----~~~~ 330 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQ----PIFD 330 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCC----CCCc
Confidence 522 1122 578888899999998 6899999999999999999999999999999999998876553222 1111
Q ss_pred chhhhccCCHHHHhhhcHHHHH
Q 017147 342 FKQELSGASPELVNKLIPDHVK 363 (376)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~ 363 (376)
. .+.. .+.+.+++++.+++.
T Consensus 331 ~-~~~~-~~~~~~r~~i~~e~~ 350 (359)
T KOG0660|consen 331 S-FEHE-LTEEELRELIYKEIL 350 (359)
T ss_pred c-cccc-ccHHHHHHHHHHHHH
Confidence 1 2233 677888888777754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-60 Score=396.00 Aligned_cols=277 Identities=39% Similarity=0.721 Sum_probs=243.7
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.+|...+.||+|.||.||+|.+..+|+.||||++.... ....+|++.|+.++|+||+.++++|-+.. .+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~-----~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS-----NL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC-----ce
Confidence 47999999999999999999999999999999996432 23358999999999999999999994443 38
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
.||+||++.+|...++. ....++...++.|+.+++.||+|||+ +.|+||||||.|+|+++ ++.+||+|||+|+.+
T Consensus 77 ~lVfEfm~tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~-~g~lKiADFGLAr~f 151 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISS-DGQLKIADFGLARFF 151 (318)
T ss_pred EEEEEeccccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcC-CCcEEeecccchhcc
Confidence 89999999999998875 56789999999999999999999999 89999999999999997 888999999999987
Q ss_pred ccCCCce-eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 017147 188 IAGEANI-SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 265 (376)
Q Consensus 188 ~~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 265 (376)
....... ..+.|+||+|||+++|...|+..+|+||.|||+.||+.|.+.|+|.++.+++..|.+.+|+|..+.|..+.
T Consensus 152 ~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 152 GSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred CCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence 6555443 34789999999999999999999999999999999999999999999999999999999999999998775
Q ss_pred -cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 266 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 266 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
++|..+ ...+..+....|+. .+.++.||+.+||.+||.+|+|+.|+|+||||++.
T Consensus 232 lpdY~~~--~~~P~~~~~~lf~a-as~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 232 LPDYVKI--QQFPKPPLNNLFPA-ASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred cccHHHH--hcCCCCcccccccc-ccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 344433 34444555555554 68889999999999999999999999999999973
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-60 Score=421.59 Aligned_cols=257 Identities=31% Similarity=0.495 Sum_probs=213.9
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 101 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (376)
.+.|.+.+.||+|+||.|.+|..+.|++.||||++.+.. ....+|+++|+.|+|||||++++.|
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f----- 245 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF----- 245 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee-----
Confidence 367999999999999999999999999999999996532 1235899999999999999999999
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC--CCcEEE
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKI 178 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~--~~~vkl 178 (376)
+...+.|+||||++| .|.+.+- .++.+.+...+.+++|++.|+.|||+ .||+||||||+|||++.+ +..+||
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred ecCCceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEEe
Confidence 444448999999996 5555443 56788999999999999999999999 799999999999999752 357999
Q ss_pred EeecccccCccCCCceeeeeccccCchhhhhCC--CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCC
Q 017147 179 CDFGSAKQLIAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLGT 255 (376)
Q Consensus 179 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~ 255 (376)
+|||+|+.........+.+|||.|.|||++.+. ..+..++|+||+||+||.+++|.+||.+..... ...+|.+.
T Consensus 321 tDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G--- 397 (475)
T KOG0615|consen 321 TDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG--- 397 (475)
T ss_pred cccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC---
Confidence 999999988877778899999999999999553 234568999999999999999999998765444 34444331
Q ss_pred CCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
.|. +....+..+|+++++||.+||..||++|||++|+|+||||+...
T Consensus 398 --------------~y~--------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 398 --------------RYA--------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred --------------ccc--------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 111 12223345899999999999999999999999999999999753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-58 Score=428.34 Aligned_cols=253 Identities=33% Similarity=0.559 Sum_probs=224.0
Q ss_pred CCCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecC
Q 017147 28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTT 100 (376)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (376)
.++.. .+|...+.||+|||++||.+++..+|+.||+|++.+. +....+|+++.+.|+|||||+++++|
T Consensus 13 ~D~~~-~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F---- 87 (592)
T KOG0575|consen 13 EDPRS-KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF---- 87 (592)
T ss_pred ecCCc-ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe----
Confidence 33444 6899999999999999999999999999999999763 33445899999999999999999999
Q ss_pred CCCceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEE
Q 017147 101 SKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 179 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~ 179 (376)
++..++|||.|+|. ++|.++++ ..+.++|.++++++.||+.||.|||+ ++|+|||||..|+++++ +..|||+
T Consensus 88 -EDs~nVYivLELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~-~~~VKIg 160 (592)
T KOG0575|consen 88 -EDSNNVYIVLELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNE-NMNVKIG 160 (592)
T ss_pred -ecCCceEEEEEecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecC-cCcEEec
Confidence 66666999999999 57666665 45789999999999999999999999 79999999999999996 7789999
Q ss_pred eecccccCccC-CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 180 DFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 180 Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
|||+|...... +...+.+|||.|.|||++... ..+..+||||+||++|.||+|+|||...+..+.+..|..
T Consensus 161 DFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~------- 232 (592)
T KOG0575|consen 161 DFGLATQLEYDGERKKTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL------- 232 (592)
T ss_pred ccceeeeecCcccccceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh-------
Confidence 99999887644 677889999999999999754 489999999999999999999999999999999988876
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
.+|.+| ..+|.+++|||.+||+.||.+|||++++|.|+||+.
T Consensus 233 ----------~~Y~~P------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 233 ----------NEYSMP------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred ----------cCcccc------------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 244443 458999999999999999999999999999999954
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-59 Score=400.98 Aligned_cols=289 Identities=32% Similarity=0.571 Sum_probs=253.0
Q ss_pred CCCCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecC
Q 017147 27 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTT 100 (376)
Q Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (376)
.+..+-.+.|+.+..|++|+||.||+|+++.|++.||+|++.-+.. ...+||.+|.+.+|||||.+.++.....
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 3444567899999999999999999999999999999999965432 1258999999999999999999986554
Q ss_pred CCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEe
Q 017147 101 SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 180 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~D 180 (376)
... +|+|||||+.+|..++.. -..+|+..+++.++.|++.|++|||. +.|+||||||+|+|++. .+.+||+|
T Consensus 149 ~d~---iy~VMe~~EhDLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~-~G~lKiaD 220 (419)
T KOG0663|consen 149 MDK---IYIVMEYVEHDLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSH-KGILKIAD 220 (419)
T ss_pred cce---eeeeHHHHHhhHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeecc-CCcEEecc
Confidence 333 889999999988888864 34789999999999999999999999 79999999999999995 78899999
Q ss_pred ecccccCccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 181 FGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 181 fg~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
||+|+.+..... .+..+.|.||+|||++++...|++++|+||+|||+.||+++.+.|+|..+.+++.+|.+.+|.|+..
T Consensus 221 FGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~ 300 (419)
T KOG0663|consen 221 FGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA 300 (419)
T ss_pred cchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence 999998765533 4556779999999999999999999999999999999999999999999999999999999999998
Q ss_pred HHhhcC--cCCCCCCCCCCCCCChhhhcccC-CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 260 EIRCMN--PNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 260 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.|.... +.+..+.++..+-.+++..|... +++...+|++++|.+||.+|+||+|+|+|+||.+.
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 887543 33345667777777777777765 78999999999999999999999999999999884
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-58 Score=416.41 Aligned_cols=284 Identities=36% Similarity=0.593 Sum_probs=241.4
Q ss_pred CcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
|...+.|+.++.||+|+||.||+|++..+|+.||+|++..+. ....+||.+|++|+||||+++.+..... .
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~ 189 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---L 189 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---C
Confidence 445678999999999999999999999999999999997543 3346999999999999999999988655 2
Q ss_pred ceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 104 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 104 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
...+|+|+|||+.+|..++.. ..-.|++.+++.|+.||+.||+|+|+ +||+|||||.+|||||. ++.+||+|||+
T Consensus 190 ~~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn-~G~LKiaDFGL 264 (560)
T KOG0600|consen 190 SGSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDN-NGVLKIADFGL 264 (560)
T ss_pred CceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcC-CCCEEeccccc
Confidence 334899999999988877753 55689999999999999999999999 89999999999999996 88999999999
Q ss_pred cccCccCC--CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 184 AKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 184 a~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
|+.+.... ..+..+.|.||+|||+++|...|+.++|+||.||||.||++|++.|+|.++.+++..|.+.+|.|....|
T Consensus 265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence 99765544 3567788999999999999999999999999999999999999999999999999999999999999887
Q ss_pred hhcCcCC-CCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 262 RCMNPNY-TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 262 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
....-.+ ..+.-..--...+.+. ...+++.+.+|+.+||+.||.+|.||.++|+|+||..
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred ccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 7322111 1111111112334444 3458999999999999999999999999999999943
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-57 Score=432.01 Aligned_cols=329 Identities=53% Similarity=0.986 Sum_probs=283.3
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecC---CCCceEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTT---SKNELFLNL 109 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~~~~~l 109 (376)
..+|++++.||+|+||+||+|.+..+++.||||++..+.....+|+.+++.++|+||++++++++... .....++++
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 35799999999999999999999999999999999877777778999999999999999988875432 233457889
Q ss_pred EeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 110 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 110 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
||||+++++...+..+......+++..++.++.||+.||.|||+ +||+||||||+|||++.+++.+||+|||+|+....
T Consensus 145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~ 223 (440)
T PTZ00036 145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA 223 (440)
T ss_pred EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence 99999999888887666667889999999999999999999999 79999999999999997566799999999987665
Q ss_pred CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 190 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 190 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
........||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+..+++.+|.|..+.+....+++.
T Consensus 224 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 303 (440)
T PTZ00036 224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA 303 (440)
T ss_pred CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhh
Confidence 55555678899999999987766789999999999999999999999999999999999999999999999988888898
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCC-CCCCCCCCCchh-hhc
Q 017147 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN-GRPLPPLFNFKQ-ELS 347 (376)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~ 347 (376)
++.++......+...++...++++++||.+||++||.+|||+.|+|+||||+.+++.....+. ...+|.++++.. +..
T Consensus 304 ~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (440)
T PTZ00036 304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIK 383 (440)
T ss_pred cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCCHHHHh
Confidence 888888888888888888899999999999999999999999999999999998776544332 245666677664 444
Q ss_pred cCCHHHHhhhcHHHH
Q 017147 348 GASPELVNKLIPDHV 362 (376)
Q Consensus 348 ~~~~~~~~~~~~~~~ 362 (376)
+..++....+.+...
T Consensus 384 ~~~~~~~~~~~~~~~ 398 (440)
T PTZ00036 384 EMSDACRRKIIPKCT 398 (440)
T ss_pred hCCHHHHHHHhhHHH
Confidence 666666666655544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-58 Score=402.12 Aligned_cols=259 Identities=31% Similarity=0.502 Sum_probs=223.0
Q ss_pred CcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
....++|+++++||+|+||+||+++.+.+++.||+|++.+.. .....|..+|..++||+||+++..|.
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ----- 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ----- 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc-----
Confidence 345679999999999999999999999999999999986542 33457999999999999999999984
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
+...+|+|+||+.| .|...|+ ..+.|++..++.|+++|+.||.|||+ +||+||||||+|||+|. .+.++|+||
T Consensus 96 t~~kLylVld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~-~GHi~LtDF 169 (357)
T KOG0598|consen 96 TEEKLYLVLDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDE-QGHIKLTDF 169 (357)
T ss_pred cCCeEEEEEeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecC-CCcEEEecc
Confidence 44449999999997 5555554 56889999999999999999999999 79999999999999997 778999999
Q ss_pred cccccCc-cCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 182 GSAKQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 182 g~a~~~~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
|+|+... .+....+.+||+.|||||++.+. .|+.++|+||||+++|+|++|.+||.+.+......+|.+.-.
T Consensus 170 gL~k~~~~~~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~------ 242 (357)
T KOG0598|consen 170 GLCKEDLKDGDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL------ 242 (357)
T ss_pred ccchhcccCCCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC------
Confidence 9998544 34555677999999999999876 599999999999999999999999999999888888876310
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC----CHHHHhcCCCcccccCCCC
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC----TALEACAHPFFDELREPNA 328 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~----t~~e~l~hp~~~~~~~~~~ 328 (376)
...+..++++++|||+++|++||++|+ ++.++-+||||..++|...
T Consensus 243 ----------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l 292 (357)
T KOG0598|consen 243 ----------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKL 292 (357)
T ss_pred ----------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHH
Confidence 011223799999999999999999996 6889999999999988754
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-57 Score=412.05 Aligned_cols=258 Identities=33% Similarity=0.566 Sum_probs=226.5
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-------ccchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 102 (376)
+...+|.+++.||+|+|++|++|.++.+++.||||++.+. ..+..+|..+|..| .||.|++++..|.+...
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s- 148 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES- 148 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc-
Confidence 3457899999999999999999999999999999988653 34456799999999 89999999999855444
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
+|+|+||++ |.|++++.. -+.|.+..+++|+.||+.||+|||+ +|||||||||+|||+|. ++.+||+||
T Consensus 149 ----LYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~-dmhikITDF 218 (604)
T KOG0592|consen 149 ----LYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDK-DGHIKITDF 218 (604)
T ss_pred ----eEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcC-CCcEEEeec
Confidence 999999999 688888874 4889999999999999999999999 79999999999999997 788999999
Q ss_pred cccccCccCCC--------------ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHH
Q 017147 182 GSAKQLIAGEA--------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 247 (376)
Q Consensus 182 g~a~~~~~~~~--------------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 247 (376)
|.|+.+..... ..+.+||..|++||++.. ...++.+|+|+||||+|+|+.|.+||.+.++.-.++
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq 297 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ 297 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence 99986643211 146899999999999954 458999999999999999999999999999999999
Q ss_pred HHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCC
Q 017147 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327 (376)
Q Consensus 248 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 327 (376)
+|++. +|. |+..+++.++|||+++|..||.+|+|++++.+||||.++.|.+
T Consensus 298 kI~~l-----------------~y~------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 298 KIQAL-----------------DYE------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred HHHHh-----------------ccc------------CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 99984 333 3456899999999999999999999999999999999999887
Q ss_pred CC
Q 017147 328 AR 329 (376)
Q Consensus 328 ~~ 329 (376)
.+
T Consensus 349 lw 350 (604)
T KOG0592|consen 349 LW 350 (604)
T ss_pred hh
Confidence 44
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-56 Score=379.99 Aligned_cols=265 Identities=28% Similarity=0.495 Sum_probs=229.3
Q ss_pred EeccCCCCCCCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeee
Q 017147 20 STTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISL 92 (376)
Q Consensus 20 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~ 92 (376)
...+....+.|....+|++++.||.|+||+|.+++++.+|..||+|++.+.. ....+|..+|+.+.||+++++
T Consensus 30 ~~~~~~~~~~~~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l 109 (355)
T KOG0616|consen 30 PKKWANTPQNPYSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKL 109 (355)
T ss_pred hhhhcCCCCCCcchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEE
Confidence 3444555555667789999999999999999999999999999999986543 333479999999999999999
Q ss_pred ceeeeecCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC
Q 017147 93 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 171 (376)
Q Consensus 93 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~ 171 (376)
+..+ .+..++|+||||++| .|...++ ..++|++..+++|+.||+.||+|||+ .+|++|||||+|||+|.
T Consensus 110 ~~t~-----~d~~~lymvmeyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~ 179 (355)
T KOG0616|consen 110 YGTF-----KDNSNLYMVMEYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQ 179 (355)
T ss_pred EEee-----ccCCeEEEEEeccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeecc
Confidence 9888 555559999999997 4555554 56899999999999999999999999 79999999999999997
Q ss_pred CCCcEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017147 172 LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251 (376)
Q Consensus 172 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 251 (376)
+|.+||+|||+|+..... ..+.+|||.|+|||++... .|+.++|+|||||++|||+.|.+||.+.+...++.+|++
T Consensus 180 -~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~ 255 (355)
T KOG0616|consen 180 -NGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE 255 (355)
T ss_pred -CCcEEEEeccceEEecCc--EEEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh
Confidence 778999999999976443 6788999999999999654 599999999999999999999999999999999999987
Q ss_pred HhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCC
Q 017147 252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326 (376)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 326 (376)
. ++.+| ..++++++|||+++|+.|-++|. ...++.+||||+.+.|.
T Consensus 256 ~-----------------~v~fP------------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 256 G-----------------KVKFP------------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred C-----------------cccCC------------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence 3 33443 45899999999999999999995 46799999999998776
Q ss_pred C
Q 017147 327 N 327 (376)
Q Consensus 327 ~ 327 (376)
.
T Consensus 307 ~ 307 (355)
T KOG0616|consen 307 A 307 (355)
T ss_pred H
Confidence 4
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-56 Score=389.07 Aligned_cols=255 Identities=31% Similarity=0.567 Sum_probs=214.2
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
.+.+.++.||+|..|+||+|+|+.|++.+|+|++... .+...+|+++++..+||+||.++++|+.... .++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~is 154 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EIS 154 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEE
Confidence 3788899999999999999999999999999999432 3444689999999999999999999976552 388
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
|+||||+| +|..+++ ..++++|.....++.++++||.|||..++|+||||||+|||+++ .+.|||||||.++..
T Consensus 155 I~mEYMDgGSLd~~~k----~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs-kGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILK----RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS-KGEVKICDFGVSGIL 229 (364)
T ss_pred eehhhcCCCCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc-CCCEEeccccccHHh
Confidence 99999996 6666655 33789999999999999999999994379999999999999997 889999999999877
Q ss_pred ccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHHhCCCCHHHHh
Q 017147 188 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-----NAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 188 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
... ...+.+||..|||||.+.+. .|+.++||||||+.++|+.+|+.||... +..+.+..|+. +.|+.
T Consensus 230 vnS-~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~--~ppP~---- 301 (364)
T KOG0581|consen 230 VNS-IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD--EPPPR---- 301 (364)
T ss_pred hhh-hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc--CCCCC----
Confidence 655 56789999999999999765 5999999999999999999999999874 33344444433 12211
Q ss_pred hcCcCCCCCCCCCCCCCChhhhccc-CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCC
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 327 (376)
++. .+|+++++||.+||++||.+|+|+.|+++|||+++....+
T Consensus 302 ----------------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~ 345 (364)
T KOG0581|consen 302 ----------------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN 345 (364)
T ss_pred ----------------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence 122 2799999999999999999999999999999999865443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-56 Score=402.68 Aligned_cols=264 Identities=31% Similarity=0.494 Sum_probs=222.1
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccc-------hHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-------~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
...++|++++.||+|+||.||+|+.+.||..||+|++.++... ...|..+|....+++||+++..| ++
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD 212 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QD 212 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cC
Confidence 3567999999999999999999999999999999999876433 34688899999999999999999 55
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
..++||||||++| ++..+|. ..+.|++.++++|+.+++.|++.||+ .|++||||||+|+|||. .|.+||+|||
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~-~GHiKLSDFG 286 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDA-KGHIKLSDFG 286 (550)
T ss_pred CCeeEEEEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecC-CCCEeecccc
Confidence 5569999999996 5555554 56889999999999999999999999 79999999999999997 7789999999
Q ss_pred ccccCcc------------------------CC------------------------CceeeeeccccCchhhhhCCCCC
Q 017147 183 SAKQLIA------------------------GE------------------------ANISYICSRFYRAPELIFGATEY 214 (376)
Q Consensus 183 ~a~~~~~------------------------~~------------------------~~~~~~~t~~y~aPE~l~~~~~~ 214 (376)
+|..... .. ...+.+|||.|+|||++++.+ |
T Consensus 287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y 365 (550)
T KOG0605|consen 287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-Y 365 (550)
T ss_pred ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-C
Confidence 9842210 00 012468999999999998866 9
Q ss_pred CchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHH
Q 017147 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAI 294 (376)
Q Consensus 215 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (376)
+..+|+||||||+||||.|.+||.+.+..+...+|+..... +.+|. ...++++++
T Consensus 366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------l~fP~----------~~~~s~eA~ 420 (550)
T KOG0605|consen 366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------LKFPE----------EVDLSDEAK 420 (550)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------ccCCC----------cCcccHHHH
Confidence 99999999999999999999999999999999999874210 11111 124689999
Q ss_pred HHHHhhcCcCCCCCCC---HHHHhcCCCcccccCCCCCCCC
Q 017147 295 DLASRLLQYSPSLRCT---ALEACAHPFFDELREPNARLPN 332 (376)
Q Consensus 295 ~li~~~L~~dp~~R~t---~~e~l~hp~~~~~~~~~~~~~~ 332 (376)
|||.+||+ ||++|+. ++|+.+||||+.+.|.......
T Consensus 421 DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~ 460 (550)
T KOG0605|consen 421 DLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMP 460 (550)
T ss_pred HHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCC
Confidence 99999999 9999995 8999999999999988665433
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-54 Score=380.04 Aligned_cols=292 Identities=34% Similarity=0.684 Sum_probs=246.2
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc------chHHHHHHHHhCCCCc-eeeeceeeeecCC-CCc
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPN-VISLKHCFFSTTS-KNE 104 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~-~~~ 104 (376)
...|..++.||+|+||+||+|+.+.+|+.||+|++.-+.. ...+|+.+|+.++|+| |+.+++++..... ...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 5578889999999999999999999999999999965433 2368999999999999 9999999865442 234
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 105 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 105 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..+++|+||+.-+|...+.........++...++.++.||+.||+|||+ ++|+||||||+|||+++ ++.+||+|||+|
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~-~G~lKlaDFGlA 167 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISS-SGVLKLADFGLA 167 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECC-CCcEeeeccchH
Confidence 4688999999998888887544332467778999999999999999999 89999999999999997 889999999999
Q ss_pred ccCc-cCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 185 KQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 185 ~~~~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
+... ........++|.+|+|||++++...|+...||||+|||++||+++++.|++..+.+++..|.+.+|+|..+.|+.
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 8655 334456678899999999999998899999999999999999999999999999999999999999999988876
Q ss_pred cC--cCCCCCCCCCCC-CCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCC
Q 017147 264 MN--PNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328 (376)
Q Consensus 264 ~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~ 328 (376)
.. +.|.. .++... ...+....+. .+++..|++.+||+++|.+|.|+..+|.||||..+.....
T Consensus 248 v~~~~~~k~-~f~~~~~~~~l~~~~~~-~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~ 313 (323)
T KOG0594|consen 248 VSSLPDYKA-PFPKWPGPKDLSSILPK-LDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSS 313 (323)
T ss_pred ccccccccc-cCcCCCCccchHHhccc-cCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchh
Confidence 43 33332 344444 3444444443 4689999999999999999999999999999998755433
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-53 Score=397.56 Aligned_cols=279 Identities=35% Similarity=0.616 Sum_probs=230.0
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccch---HHHHHHHHhCC-C-----CceeeeceeeeecCCCCce
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRVMD-H-----PNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~e~~~l~~l~-h-----~~iv~~~~~~~~~~~~~~~ 105 (376)
+|.+.+.||+|+||+|.+|.+..|++.||||+++...... ..|+.+|..|+ | -|+|+++++|+....
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H---- 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH---- 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc----
Confidence 8999999999999999999999999999999998776554 36889999886 3 489999999955444
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC-CCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~-~~~~vkl~Dfg~a 184 (376)
+|||+|.+.-+|+++++.. ....++...++.++.||+.||.+||+ .||||+|||||||||.. ....|||+|||.|
T Consensus 263 -lciVfELL~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 263 -LCIVFELLSTNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred -eeeeehhhhhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999999999999999864 34559999999999999999999999 79999999999999853 3458999999999
Q ss_pred ccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
..... ...+++.++.|+|||+++|.+ |+.+.||||||||++||++|.+.|+|.++.+++..|++.+|.|+...+...
T Consensus 339 c~~~q--~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 339 CFESQ--RVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cccCC--cceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 75433 334899999999999999865 999999999999999999999999999999999999999999998877643
Q ss_pred CcCCCCCCC----CC--------------------------C----CCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC
Q 017147 265 NPNYTDFRF----PQ--------------------------I----KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310 (376)
Q Consensus 265 ~~~~~~~~~----~~--------------------------~----~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 310 (376)
......+.- +. . ....+.......-...+.|||.+||.+||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 221111100 00 0 1112222222223346799999999999999999
Q ss_pred HHHHhcCCCccccc
Q 017147 311 ALEACAHPFFDELR 324 (376)
Q Consensus 311 ~~e~l~hp~~~~~~ 324 (376)
+.++|+||||....
T Consensus 496 p~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 496 PAQALNHPFLTGTS 509 (586)
T ss_pred HHHHhcCccccccc
Confidence 99999999998643
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-54 Score=398.21 Aligned_cols=254 Identities=34% Similarity=0.549 Sum_probs=224.9
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
.+-|++++.||.|+.|.|.+|++..||+..|||++.+. ...+++|+-+|+.+.|||++.+++++ ++..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCc
Confidence 34599999999999999999999999999999999776 45667999999999999999999999 6666
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
.+|+|.||++| .|.+.+. ..+++++.++++++.||+.|+.|+|. .+|+||||||+|+|+|. .++|||+|||+|
T Consensus 86 ~lylvlEyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~-~~nIKIADFGMA 159 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDV-KNNIKIADFGMA 159 (786)
T ss_pred eEEEEEEecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhc-ccCEeeecccee
Confidence 69999999995 5555554 56889999999999999999999999 69999999999999997 555999999999
Q ss_pred ccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
.....+.-..+.+|+|.|.|||++.|..+.+.++||||+|||||.||+|+.||.+.+-...+.++.+
T Consensus 160 sLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~------------- 226 (786)
T KOG0588|consen 160 SLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR------------- 226 (786)
T ss_pred ecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc-------------
Confidence 9877777788899999999999999988779999999999999999999999998887777766655
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
+.|.+| ..+|++++|||++||.+||++|+|.+|+++|||+......
T Consensus 227 ----G~f~MP------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 227 ----GVFEMP------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred ----CcccCC------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 233333 4589999999999999999999999999999999886543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-54 Score=400.51 Aligned_cols=257 Identities=31% Similarity=0.527 Sum_probs=220.8
Q ss_pred CcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccch-------HHHHHHHHhC-CCCceeeeceeeeecCC
Q 017147 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVM-DHPNVISLKHCFFSTTS 101 (376)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-------~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 101 (376)
+...++|.++++||+|.||+|++|..+.+++.||||++.++.... ..|..++... +||.+++++.+|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f----- 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF----- 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----
Confidence 344579999999999999999999999999999999997764333 3566777666 499999999999
Q ss_pred CCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 102 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
+....+|+||||+.|+. +.. ......|++..++.|+++|+.||+|||+ +||+|||||.+|||+|. .|.+||+||
T Consensus 439 QT~~~l~fvmey~~Ggd---m~~-~~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~-eGh~kiADF 512 (694)
T KOG0694|consen 439 QTKEHLFFVMEYVAGGD---LMH-HIHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDT-EGHVKIADF 512 (694)
T ss_pred ccCCeEEEEEEecCCCc---EEE-EEecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcc-cCcEEeccc
Confidence 55555999999999874 222 1245789999999999999999999999 89999999999999998 677999999
Q ss_pred cccccCc-cCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 182 GSAKQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 182 g~a~~~~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
|+++... .+....+.+|||.|+|||++.+. .|+.++|+|||||+|||||.|..||++.++.+.+..|+.
T Consensus 513 GlcKe~m~~g~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~--------- 582 (694)
T KOG0694|consen 513 GLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN--------- 582 (694)
T ss_pred ccccccCCCCCccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc---------
Confidence 9998765 45566788999999999999665 599999999999999999999999999999999988876
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCcccccCCC
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPN 327 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~~ 327 (376)
.+..+| ..+|.++.++++++|.+||++|+. ++++..||||+.+.|..
T Consensus 583 --------d~~~yP------------~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~ 634 (694)
T KOG0694|consen 583 --------DEVRYP------------RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD 634 (694)
T ss_pred --------CCCCCC------------CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHH
Confidence 233333 348999999999999999999996 57999999999998764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-53 Score=375.58 Aligned_cols=255 Identities=30% Similarity=0.532 Sum_probs=218.7
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
...++|.+.+.||+|+||+||+|+++.++..||||.+.+.. .....|+.+|+.++|||||.++++. +..
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~ 81 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDD 81 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecC
Confidence 45678999999999999999999999999999999997653 2235799999999999999999998 444
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC--C---CcEEE
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--T---HQVKI 178 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~--~---~~vkl 178 (376)
.++|+|||||+| +|...++ ..+.+++..++.++.||+.||++||+ ++|+||||||+|||++.. + ..+||
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKI 156 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKI 156 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEe
Confidence 569999999995 7666665 45689999999999999999999999 899999999999999852 1 46999
Q ss_pred EeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 179 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 179 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
+|||+|+....+....+.+|+|.|||||++.. ..|+.|+|+||+|+|+|+|++|++||...+..+.+..+.+.-.
T Consensus 157 ADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~---- 231 (429)
T KOG0595|consen 157 ADFGFARFLQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE---- 231 (429)
T ss_pred cccchhhhCCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc----
Confidence 99999999888777788999999999999965 4599999999999999999999999999998888775544211
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
....++..++....+|+..+|+.+|.+|.+..+-+.||++..
T Consensus 232 ----------------------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 232 ----------------------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred ----------------------ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 111122346778889999999999999999999999999865
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=388.55 Aligned_cols=253 Identities=33% Similarity=0.511 Sum_probs=217.8
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc---------ccchHHHHHHHHhCC-CCceeeeceeeeecC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMD-HPNVISLKHCFFSTT 100 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---------~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 100 (376)
...+.|.+++.||+|+||+|++|.+..++..||+|++.+. .....+|+.+++.+. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456899999999999999999999999999999976543 123347999999999 999999999994433
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEE
Q 017147 101 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 179 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~ 179 (376)
.+|+|||||.| .|++.+. ..+++.+..++.++.|++.|++|||+ +||+||||||+|||++.+.+.+||+
T Consensus 94 -----~~~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~~~Kl~ 163 (370)
T KOG0583|consen 94 -----KIYIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEGNLKLS 163 (370)
T ss_pred -----eEEEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCCCEEEe
Confidence 39999999996 7766665 36889999999999999999999999 7999999999999999743889999
Q ss_pred eecccccC-ccCCCceeeeeccccCchhhhhCCC-CCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017147 180 DFGSAKQL-IAGEANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257 (376)
Q Consensus 180 Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 257 (376)
|||++... .......+.+||+.|+|||++.+.. .-+.++||||+||+||.|++|+.||...+....+..|.+
T Consensus 164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~------ 237 (370)
T KOG0583|consen 164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK------ 237 (370)
T ss_pred ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc------
Confidence 99999977 4556677899999999999997765 446999999999999999999999999887777776554
Q ss_pred HHHHhhcCcCCCCCCCCCCCCCChhhhcccCC-ChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRM-PPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
..+.+| ..+ |+++++|+++||..||.+|+|+.+++.||||+.
T Consensus 238 -----------~~~~~p------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 -----------GEFKIP------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -----------CCccCC------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 223333 336 999999999999999999999999999999996
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=359.01 Aligned_cols=256 Identities=30% Similarity=0.467 Sum_probs=219.6
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeec------cccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
...+.|++.++||+|+|+.||++.+..+|+.+|+|++.. +....++|+.+-+.|+||||+++.+.+ ...
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~ 82 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEE 82 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----ccc
Confidence 456789999999999999999999999999999997742 234456899999999999999999887 667
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC--CCcEEEEee
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDF 181 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~--~~~vkl~Df 181 (376)
.+.|+|+|++.| .|-..+-. ...+++..+..++.||+.||.|+|. +||+|||+||+|+++-+. +.-+||+||
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~F 157 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADF 157 (355)
T ss_pred ceeEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeeccc
Confidence 779999999997 44444432 2567899999999999999999999 899999999999999542 346999999
Q ss_pred cccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 182 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
|+|.....+......+|||.|||||++... .|+.++|||+.|||||.|+.|.+||.+.+....++.|++.
T Consensus 158 GvAi~l~~g~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g--------- 227 (355)
T KOG0033|consen 158 GLAIEVNDGEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG--------- 227 (355)
T ss_pred ceEEEeCCccccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc---------
Confidence 999988877767788999999999999765 4999999999999999999999999999999999888872
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
++.++. ..+.++++++++||++||..||.+|+|+.|+|+|||+.+
T Consensus 228 --------~yd~~~--------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 228 --------AYDYPS--------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred --------ccCCCC--------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 233321 123458999999999999999999999999999999975
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-54 Score=364.01 Aligned_cols=256 Identities=28% Similarity=0.482 Sum_probs=214.1
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeec------cccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
...|++++.||+|+||+||+|.+..+|..+|.|.+.- .+.....|+.+|++|+|||||++++.-+. ++...
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchh
Confidence 3479999999999999999999999999999998852 23444589999999999999999873222 33334
Q ss_pred EEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhc--C-CCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 107 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT--V-PRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 107 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~-~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
++||||||. |+|...+++++.....+++..+|.++.|++.||..+|+ - .-|+||||||.||+++. ++.+||+|||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~-~gvvKLGDfG 173 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTA-NGVVKLGDFG 173 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcC-CCceeeccch
Confidence 889999999 69999999999999999999999999999999999998 2 13899999999999996 8899999999
Q ss_pred ccccCccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 183 SAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 183 ~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
+++....... ..+.+|||+||+||.+.+. .|+.+|||||+||++|||+.-++||.+.+..+.-.+|.++--.|.+
T Consensus 174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p--- 249 (375)
T KOG0591|consen 174 LGRFLSSKTTFAHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP--- 249 (375)
T ss_pred hHhHhcchhHHHHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc---
Confidence 9998765543 4578999999999999765 5999999999999999999999999999777766666653111111
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
....|.++..||.-|+..||+.||+. +|++.++..
T Consensus 250 ------------------------~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~ 284 (375)
T KOG0591|consen 250 ------------------------DEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQS 284 (375)
T ss_pred ------------------------HHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence 02358899999999999999999986 566655543
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=369.41 Aligned_cols=275 Identities=26% Similarity=0.434 Sum_probs=227.0
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
-..+|++++.||.|.-|+||+|+.+.++..+|+|++.+... ..+.|.+||..++||.++.+|..| +.+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~ 149 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETD 149 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----ecc
Confidence 34689999999999999999999999999999999976532 234689999999999999999999 777
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 105 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 105 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
.+.|++||||+|+-+..+++ ...++.|++..+++|+.+++.||+|||. -|||+|||||+||||.+ +|.|-|+||.++
T Consensus 150 ~~~cl~meyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvre-dGHIMLsDFDLS 226 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVRE-DGHIMLSDFDLS 226 (459)
T ss_pred ceeEEEEecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEec-CCcEEeeecccc
Confidence 78999999999744444433 3467889999999999999999999999 59999999999999996 777999999997
Q ss_pred ccCc----------------------------------c-C----------------------CCceeeeeccccCchhh
Q 017147 185 KQLI----------------------------------A-G----------------------EANISYICSRFYRAPEL 207 (376)
Q Consensus 185 ~~~~----------------------------------~-~----------------------~~~~~~~~t~~y~aPE~ 207 (376)
.... . . ....+.+||-+|+|||+
T Consensus 227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv 306 (459)
T KOG0610|consen 227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV 306 (459)
T ss_pred ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence 3210 0 0 01124678999999999
Q ss_pred hhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhccc
Q 017147 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK 287 (376)
Q Consensus 208 l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (376)
+.|.+ .+.++|+|+|||++|||+.|..||.|.+..+++.+|+.. +..||.. .
T Consensus 307 I~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-----------------~l~Fp~~----------~ 358 (459)
T KOG0610|consen 307 IRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-----------------PLKFPEE----------P 358 (459)
T ss_pred eecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-----------------CCcCCCC----------C
Confidence 98766 799999999999999999999999999999999888752 2233321 1
Q ss_pred CCChhHHHHHHhhcCcCCCCCCC----HHHHhcCCCcccccCCCCCCCCCCCCCCCCCc
Q 017147 288 RMPPEAIDLASRLLQYSPSLRCT----ALEACAHPFFDELREPNARLPNGRPLPPLFNF 342 (376)
Q Consensus 288 ~~~~~~~~li~~~L~~dp~~R~t----~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 342 (376)
.++..++|||+++|.+||++|+. |.|+.+||||+.++|...+....+.+|...+.
T Consensus 359 ~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~ 417 (459)
T KOG0610|consen 359 EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDG 417 (459)
T ss_pred cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCcccc
Confidence 36889999999999999999998 99999999999999986654444444544443
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-51 Score=370.71 Aligned_cols=277 Identities=33% Similarity=0.648 Sum_probs=231.1
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.++|++.+.||.|+||+||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH-----TERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc-----CCCeE
Confidence 567999999999999999999999999999999885322 23457999999999999999999883 33458
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
++||||++++|.+.+.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++..
T Consensus 79 ~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~DfG~~~~~ 153 (288)
T cd07871 79 TLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINE-KGELKLADFGLARAK 153 (288)
T ss_pred EEEEeCCCcCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEECcCcceeec
Confidence 89999999988777653 34467899999999999999999999 79999999999999996 778999999998754
Q ss_pred ccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 017147 188 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 265 (376)
Q Consensus 188 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 265 (376)
.... ......+++.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+.+.++.+..+.+....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 3222 22345678999999998766668999999999999999999999999999999999999999999888776543
Q ss_pred -cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 266 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 266 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
..+..+.++.....++... ...++++++|||++||++||.+|||++|+++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINH-APRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred chhhhccccCccCCCchHHh-CCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 2344444555444444433 23578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-51 Score=367.78 Aligned_cols=265 Identities=28% Similarity=0.432 Sum_probs=217.9
Q ss_pred cCCCCCCCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------------------cchHHHHHHHHhC
Q 017147 23 IGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------------RYKNRELQLMRVM 84 (376)
Q Consensus 23 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------------~~~~~e~~~l~~l 84 (376)
........+..++|++.+.||+|.||+|.+|++..+++.||||++.+.. ....+|+.+|+++
T Consensus 86 ~~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl 165 (576)
T KOG0585|consen 86 RYDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL 165 (576)
T ss_pred eecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc
Confidence 4445555667789999999999999999999999999999999996532 1235899999999
Q ss_pred CCCceeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCC-cCHHHHHHHHHHHHHHHHHhhcCCCeeecCCC
Q 017147 85 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 163 (376)
Q Consensus 85 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~-l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlk 163 (376)
.|+|||+++++.-+.. ...+|+|+|||..+ .+. +...... +++.+++.|+.+++.||+|||. +||+|||||
T Consensus 166 ~H~nVV~LiEvLDDP~---s~~~YlVley~s~G---~v~-w~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIK 237 (576)
T KOG0585|consen 166 HHPNVVKLIEVLDDPE---SDKLYLVLEYCSKG---EVK-WCPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIK 237 (576)
T ss_pred CCcCeeEEEEeecCcc---cCceEEEEEeccCC---ccc-cCCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccc
Confidence 9999999999984433 34489999999954 121 2223444 9999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEEeecccccCccCC------CceeeeeccccCchhhhhC---CCCCCchhhhHhHHHHHHHHHhCC
Q 017147 164 PQNLLVDPLTHQVKICDFGSAKQLIAGE------ANISYICSRFYRAPELIFG---ATEYTTSIDIWSAGCVLAELLLGQ 234 (376)
Q Consensus 164 p~Nill~~~~~~vkl~Dfg~a~~~~~~~------~~~~~~~t~~y~aPE~l~~---~~~~~~~~DiwslG~il~~ll~g~ 234 (376)
|+|+|+++ ++.|||+|||.+.....+. .....+|||.|+|||.+.+ ....+.+.||||+||+||.|+.|+
T Consensus 238 PsNLLl~~-~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~ 316 (576)
T KOG0585|consen 238 PSNLLLSS-DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ 316 (576)
T ss_pred hhheEEcC-CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence 99999997 6889999999997653221 1234789999999999866 233578999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 017147 235 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314 (376)
Q Consensus 235 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 314 (376)
.||-+....+...+|++. ...+|.. ..+.++++|||.+||++||++|+++.++
T Consensus 317 ~PF~~~~~~~l~~KIvn~-----------------pL~fP~~----------pe~~e~~kDli~~lL~KdP~~Ri~l~~i 369 (576)
T KOG0585|consen 317 LPFFDDFELELFDKIVND-----------------PLEFPEN----------PEINEDLKDLIKRLLEKDPEQRITLPDI 369 (576)
T ss_pred CCcccchHHHHHHHHhcC-----------------cccCCCc----------ccccHHHHHHHHHHhhcChhheeehhhh
Confidence 999999999999888762 2223321 1368899999999999999999999999
Q ss_pred hcCCCcccc
Q 017147 315 CAHPFFDEL 323 (376)
Q Consensus 315 l~hp~~~~~ 323 (376)
..|||...-
T Consensus 370 k~Hpwvt~~ 378 (576)
T KOG0585|consen 370 KLHPWVTRD 378 (576)
T ss_pred eecceeccC
Confidence 999999753
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-51 Score=364.75 Aligned_cols=258 Identities=32% Similarity=0.520 Sum_probs=209.3
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
..+|..++.||+|+||+||++.+..+|..+|+|.+... .....+|+.+|+.++|||||+.++....... ..++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeE
Confidence 45799999999999999999999999999999998765 3445799999999999999999886422221 4688
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+.|||+++ +|.+.+.. .++.+++..++.+..||+.||+|||+ +||+||||||+|||++..++.+||+|||+++..
T Consensus 93 i~mEy~~~GsL~~~~~~---~g~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKR---YGGKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeeeccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 99999995 77766653 22279999999999999999999999 899999999999999964578999999999866
Q ss_pred cc----CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHh
Q 017147 188 IA----GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 188 ~~----~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
.. ........||+.|||||++........++||||+||++.||+||.+||... ...+.+..+...-
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--------- 239 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--------- 239 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC---------
Confidence 53 223446789999999999975322345999999999999999999999873 3333333322210
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
. ...++..+|+++++||.+||.+||++||||+++|+|||.+...
T Consensus 240 ---------~---------~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 240 ---------S---------LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred ---------C---------CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 0 1124556899999999999999999999999999999998743
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-51 Score=322.49 Aligned_cols=278 Identities=35% Similarity=0.645 Sum_probs=237.4
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
.|.-.+.||+|.||+||+|+++.+++.||+|.+.-+. ....+|+.+|+.++|.|||+++++. ..+..+-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence 5777889999999999999999999999999986442 2345899999999999999999987 3333478
Q ss_pred EEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 109 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 109 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
+|+|||..+|...+. .-++.+..+.++.++.|++.||.++|+ +++.|||+||.|+|++. ++.+|++|||+++.+.
T Consensus 78 lvfe~cdqdlkkyfd---slng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~-ngelkladfglarafg 152 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINR-NGELKLADFGLARAFG 152 (292)
T ss_pred EeHHHhhHHHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEecc-CCcEEecccchhhhcC
Confidence 999999988766665 357889999999999999999999999 79999999999999997 8899999999998664
Q ss_pred cCCCc-eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 189 AGEAN-ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 189 ~~~~~-~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
-.-.. ...+.|.||++|.++.|..-|++..|+||.|||+.|+.. |++.|++.+..+++..|...+|.|..+.|..+..
T Consensus 153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 33322 234669999999999998889999999999999999996 9999999999999999999999999999987764
Q ss_pred CCCCCCCCCCCC-CChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 267 NYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 267 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
-.....+|.+.. -.|.+..+ +++...+||++++|.-+|.+|++++++++||||.+.
T Consensus 233 lpdyk~yp~ypattswsqivp-~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVP-KLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CCCCcccCCccccchHHHHhh-hhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 322234454443 35666554 478899999999999999999999999999999874
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-50 Score=365.23 Aligned_cols=282 Identities=33% Similarity=0.576 Sum_probs=220.7
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.++|++.+.||+|+||+||+|.++.+++.||+|++.... ....+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-----KETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec-----CCeE
Confidence 468999999999999999999999999999999885432 234579999999999999999998843 3458
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
|+||||+.+++.+.+.. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus 79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 79 TLVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISD-TGELKLADFGLARAK 153 (303)
T ss_pred EEEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECCCCcceec
Confidence 99999999988777653 34568999999999999999999999 79999999999999996 778999999998754
Q ss_pred ccC-CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 188 IAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 188 ~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
... .......+|+.|+|||++.+...++.++|+||+||++|+|++|..||.+.. ..+.+..+....+.+....+....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 322 222345678999999998766668999999999999999999999998754 445666777777777655443221
Q ss_pred c--CCCCCCCCCCCCCChhhhccc-CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 266 P--NYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 266 ~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
. .+....+.......+...+.. ..+.++.+||++||++||.+|||+.|+++||||+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 1 111111111111222222211 2467899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=376.55 Aligned_cols=249 Identities=30% Similarity=0.563 Sum_probs=217.1
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccc------hHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
++|.+.+.||+|+||+||+++.+.+.+.||||.+.+..+. ..+|+++++.++||||+.+++.| +....+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 5799999999999999999999999999999998765433 35899999999999999999999 666669
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
++|+|||.|+|..++. ..+.++|+.++.+.++++.||.|||+ ++|.|||+||.|||++. ++.+|+||||+|+.+
T Consensus 77 ~vVte~a~g~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~-~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEK-GGTLKLCDFGLARAM 150 (808)
T ss_pred EEEehhhhhhHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecC-CCceeechhhhhhhc
Confidence 9999999998888876 57889999999999999999999999 79999999999999996 888999999999987
Q ss_pred ccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
..+.. ..+.-|||.|||||++.+ ..|+..+|+||+|||+|||++|++||...........|..- |
T Consensus 151 ~~~t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---~---------- 216 (808)
T KOG0597|consen 151 STNTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---P---------- 216 (808)
T ss_pred ccCceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC---C----------
Confidence 66554 345678999999999975 56999999999999999999999999887766655555441 1
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.. .+..+|..++.|+..+|.+||.+|+|+.+++.|||++.-
T Consensus 217 ----v~------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 217 ----VK------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred ----CC------------CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 11 122579999999999999999999999999999999863
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=368.60 Aligned_cols=318 Identities=37% Similarity=0.644 Sum_probs=239.8
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+|++.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||+++++++..........+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 599999999999999999999999999999988532 12245799999999999999999988655444445688
Q ss_pred EEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 109 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 109 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
+|||||+++|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 81 lv~e~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELMESDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANA-DCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCCCCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCcEEEccCccccccc
Confidence 999999988877765 34568999999999999999999999 79999999999999996 7889999999997543
Q ss_pred cCCC----ceeeeeccccCchhhhhCC-CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 189 AGEA----NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 189 ~~~~----~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
.... .....+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....|.+....+..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2221 1235689999999998542 4588999999999999999999999999988888888888888887765543
Q ss_pred cCcCCC-CC--CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCC
Q 017147 264 MNPNYT-DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLF 340 (376)
Q Consensus 264 ~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~ 340 (376)
....-. .+ ........++...++ .+++++.+||.+||+.||++|||++++++||||+.+...... +...+.+. .
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~-~~~~~~~~-~ 311 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFP-NADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVERE-PSAQPITK-L 311 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcC-CCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccc-cccCcccc-c
Confidence 221100 00 000111112222222 368899999999999999999999999999999987654322 22222222 2
Q ss_pred CchhhhccCCHHHHhhhcHHH
Q 017147 341 NFKQELSGASPELVNKLIPDH 361 (376)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~ 361 (376)
.+..+....+.+.+.....++
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~ 332 (338)
T cd07859 312 EFEFERRRLTKEDVRELIYRE 332 (338)
T ss_pred cccHHHHhcCHHHHHHHHHHH
Confidence 333334455556665554444
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-51 Score=372.67 Aligned_cols=251 Identities=29% Similarity=0.495 Sum_probs=216.4
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
...|.....||+|+.|.||.|....+++.||||.+... +.....|+.+|+..+|+|||.+++.|...+. +|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-----LW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-----LW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce-----eE
Confidence 35799999999999999999999999999999998643 3344589999999999999999999866543 99
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||++| +|.+++. ...++|.++..++.+++.||+|||. +||+|||||.+|||++. ++.+||+|||+|..+
T Consensus 347 VVMEym~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~-~g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTM-DGSVKLTDFGFCAQI 419 (550)
T ss_pred EEEeecCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEecc-CCcEEEeeeeeeecc
Confidence 99999996 6555554 3569999999999999999999999 89999999999999997 778999999999877
Q ss_pred ccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
.... ...+-+|||+|||||++. ...|+.++||||||+++.||+-|.+||-..+....+..|.. -|+|...
T Consensus 420 ~~~~~KR~TmVGTPYWMAPEVvt-rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk------- 490 (550)
T KOG0578|consen 420 SEEQSKRSTMVGTPYWMAPEVVT-RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLK------- 490 (550)
T ss_pred ccccCccccccCCCCccchhhhh-hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcC-------
Confidence 6655 456789999999999995 45699999999999999999999999998888777766654 2333321
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
.+..+|++++|||.+||+.|+.+|++|.|+|+||||+.
T Consensus 491 ------------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 491 ------------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred ------------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 23458999999999999999999999999999999954
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=346.63 Aligned_cols=258 Identities=31% Similarity=0.517 Sum_probs=221.1
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------------ccchHHHHHHHHhC-CCCceeeeceeeeec
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------------RRYKNRELQLMRVM-DHPNVISLKHCFFST 99 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------------~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 99 (376)
...|.-.+.||.|..++|.++.++.++..+|+|++... .....+|+.+|+++ .||+|+++.++|
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--- 92 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--- 92 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec---
Confidence 45788899999999999999999999999999988421 11224699999987 699999999999
Q ss_pred CCCCceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEE
Q 017147 100 TSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 178 (376)
Q Consensus 100 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl 178 (376)
+.+.++++|+|.|+ |.|.+.+. ..-.+++...+.++.|++.|++|||. ++|+||||||+|||++. +.++||
T Consensus 93 --es~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILldd-n~~i~i 164 (411)
T KOG0599|consen 93 --ESDAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDD-NMNIKI 164 (411)
T ss_pred --cCcchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeecc-ccceEE
Confidence 77778999999999 66666664 56789999999999999999999999 89999999999999995 889999
Q ss_pred EeecccccCccCCCceeeeeccccCchhhhh-----CCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 017147 179 CDFGSAKQLIAGEANISYICSRFYRAPELIF-----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 253 (376)
Q Consensus 179 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 253 (376)
+|||++.....++.....+|||.|.|||.+. +.+.|+..+|+|++|||+|.|+.|.+||......-.+..|++.
T Consensus 165 sDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG- 243 (411)
T KOG0599|consen 165 SDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG- 243 (411)
T ss_pred eccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc-
Confidence 9999999998888888899999999999984 3456899999999999999999999999988877778777762
Q ss_pred CCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
.|.| ...-+.++|.+.+|||.+||+.||++|+|+.|+|.||||..+-..
T Consensus 244 ----------------kyqF--------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 244 ----------------KYQF--------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred ----------------cccc--------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 2221 111224579999999999999999999999999999999765433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=354.88 Aligned_cols=279 Identities=25% Similarity=0.422 Sum_probs=227.4
Q ss_pred eccCCCCCCCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeecee
Q 017147 21 TTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHC 95 (376)
Q Consensus 21 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (376)
.....+...|...+.|++..+||.|..++||+|+++.+++.||||++.-+ -....+|+..|+.++||||++++.+
T Consensus 13 ~~~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~s 92 (516)
T KOG0582|consen 13 SASSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCS 92 (516)
T ss_pred ccccccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEE
Confidence 33445566677788999999999999999999999999999999998533 2455789999999999999999999
Q ss_pred eeecCCCCceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC
Q 017147 96 FFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 174 (376)
Q Consensus 96 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~ 174 (376)
|..... +|+||+||. |+++++++.+-.. .+.|..+..++.+++.||.|||+ +|.+|||||+.||||++ +|
T Consensus 93 Fvv~~~-----LWvVmpfMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~-dG 163 (516)
T KOG0582|consen 93 FVVDSE-----LWVVMPFMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDS-DG 163 (516)
T ss_pred EEecce-----eEEeehhhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcC-CC
Confidence 966555 999999999 6899998876443 49999999999999999999999 79999999999999997 88
Q ss_pred cEEEEeecccccCccCC-Cc----eeeeeccccCchhhh-hCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 017147 175 QVKICDFGSAKQLIAGE-AN----ISYICSRFYRAPELI-FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 248 (376)
Q Consensus 175 ~vkl~Dfg~a~~~~~~~-~~----~~~~~t~~y~aPE~l-~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 248 (376)
.|||+|||.+....... .. .+.+||++|||||++ .....|+.|+||||||++..||.+|+.||........+-.
T Consensus 164 ~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~ 243 (516)
T KOG0582|consen 164 TVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL 243 (516)
T ss_pred cEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH
Confidence 99999999876554332 21 345889999999995 4445699999999999999999999999999888776643
Q ss_pred HHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCC
Q 017147 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327 (376)
Q Consensus 249 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 327 (376)
- ..+.|+...... +...-.+.++..++.+|..||.+||++|||++++|+|+||+..+...
T Consensus 244 t--Lqn~pp~~~t~~-----------------~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~ 303 (516)
T KOG0582|consen 244 T--LQNDPPTLLTSG-----------------LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE 303 (516)
T ss_pred H--hcCCCCCccccc-----------------CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence 3 334443211100 00001123577999999999999999999999999999999876543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-49 Score=356.49 Aligned_cols=276 Identities=37% Similarity=0.705 Sum_probs=222.7
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
++|++.+.||+|+||+||+|.++.+++.||+|++.... ....+|+.+++.++|+||+++++++ .....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence 36999999999999999999999999999999886432 2335799999999999999999888 334458
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
|+||||++++++..+.. ....+++..++.++.|++.||.|||+ .|++||||||+||+++. ++.+||+|||++...
T Consensus 76 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~ 150 (287)
T cd07848 76 YLVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISH-NDVLKLCDFGFARNL 150 (287)
T ss_pred EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEEeeccCcccc
Confidence 99999999877666542 34578999999999999999999999 79999999999999996 778999999999765
Q ss_pred ccCC--CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc-
Q 017147 188 IAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM- 264 (376)
Q Consensus 188 ~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~- 264 (376)
.... ......+|+.|+|||++.+. .++.++|+||+||++|+|++|++||.+.+..+.+..+.+..+..+...+...
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 151 SEGSNANYTEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred cccccccccccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 4322 12245689999999999664 4899999999999999999999999998888888888887777766554432
Q ss_pred -CcCCCCCCCCCCC-CCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 265 -NPNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 265 -~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
++.+....++... ...+.......+|.++.+||++||++||++|||++++|+||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 1222222222211 1223334445578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=365.75 Aligned_cols=258 Identities=30% Similarity=0.509 Sum_probs=220.8
Q ss_pred CcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-------chHHHHHHHHhCC-CCceeeeceeeeecCC
Q 017147 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMD-HPNVISLKHCFFSTTS 101 (376)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 101 (376)
......|++.+.||+|.||.||+|.++.+|+.+|+|.+.+... ...+|+.+|+.+. |||||.+.++|
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~----- 105 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF----- 105 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----
Confidence 3455689999999999999999999999999999999976433 5578999999998 99999999999
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCC---CcEE
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT---HQVK 177 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~---~~vk 177 (376)
+....+++|||+|.| .|.+.+... .+++..+..++.|++.|++|||+ .|++||||||+|+|+.... +.+|
T Consensus 106 e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik 179 (382)
T KOG0032|consen 106 EDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIK 179 (382)
T ss_pred EcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEE
Confidence 444459999999995 666666543 39999999999999999999999 7999999999999997532 3799
Q ss_pred EEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017147 178 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257 (376)
Q Consensus 178 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 257 (376)
++|||++............+||++|+|||++.. ..|+..+|+||+||++|.|++|.+||.+.+......++...
T Consensus 180 ~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~----- 253 (382)
T KOG0032|consen 180 LIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG----- 253 (382)
T ss_pred EeeCCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC-----
Confidence 999999998877666778899999999999954 45999999999999999999999999999988888766652
Q ss_pred HHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
++. +....+..++..+++||++||..||.+|+|+.++|+|||++...
T Consensus 254 ------------~~~--------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 254 ------------DFD--------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred ------------CCC--------CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 111 11222345799999999999999999999999999999998753
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-49 Score=367.90 Aligned_cols=288 Identities=32% Similarity=0.556 Sum_probs=228.5
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 104 (376)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++|+||+++++++..... ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999999999999999986421 233479999999999999999988743322 233
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 105 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 105 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..+|+||||+++++...+. ..+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECC-CCcEEEEeCCCc
Confidence 4578999999998777664 347888999999999999999999 79999999999999996 778999999999
Q ss_pred ccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
+............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+++.++.+..+.+...
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 865444434456789999999999664 5899999999999999999999999999999999999999898877654433
Q ss_pred CcC----------CCCCCCCCC---CCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCC
Q 017147 265 NPN----------YTDFRFPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328 (376)
Q Consensus 265 ~~~----------~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~ 328 (376)
.+. +..+.+... ...++........+..+++||.+||+.||.+|||+.++|+||||..+..+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~ 329 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSE 329 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCccc
Confidence 221 111111100 0011111222234678999999999999999999999999999987655543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-49 Score=359.36 Aligned_cols=283 Identities=33% Similarity=0.650 Sum_probs=231.5
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
..++|++.+.||+|+||+||+|.++.+++.||+|.+.... ....+|+.+++.++|+||+++++++.. ...
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 78 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-----DKS 78 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-----CCe
Confidence 3468999999999999999999999999999999886332 234579999999999999999998843 334
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
.|+||||+++++.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus 79 ~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~ 153 (309)
T cd07872 79 LTLVFEYLDKDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARA 153 (309)
T ss_pred EEEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECcccccee
Confidence 889999999987776653 34568899999999999999999999 79999999999999996 77899999999875
Q ss_pred CccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 187 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 187 ~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
...... .....+|+.|+|||.+.+...++.++||||+||++|+|++|++||.+.+..+.+..+.+.++.+....+....
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 154 KSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred cCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 432222 2234678999999998766668999999999999999999999999999999999999999998887765433
Q ss_pred c--CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 266 P--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 266 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
. .+.++.++......+.... ..+++++++||.+||+.||.+|||+.|+++||||+.+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHA-PRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred chhhhhhhhcCccCCCchhhhc-cCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 2 2223334443333333322 347899999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=355.05 Aligned_cols=279 Identities=34% Similarity=0.592 Sum_probs=221.0
Q ss_pred eeeeeeeeecCCCeeEEEEEEcC-CCcEEEEEEeeccc------cchHHHHHHHHhC---CCCceeeeceeeeecCCCCc
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR------RYKNRELQLMRVM---DHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~------~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~ 104 (376)
+|++.+.||+|+||+||+|.+.. +++.||+|.+.... ....+|+.+++.+ +||||+++++++........
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 69999999999999999999865 46889999885322 1234577776665 69999999998754433444
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 105 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 105 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..+++||||++++|.+.+... ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~-~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcC-CCCEEEccccce
Confidence 568899999999888777532 23458999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
.............+|+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+.+..+.+..+.+....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 765544444456789999999998654 5899999999999999999999999999999999999988887776554321
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
.. .....+......++.... ..+++.+++|+.+||+.||++|||+.++|+||||
T Consensus 237 ~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 VA-LPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hc-ccchhccCCCCCCHHHHc-cCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 10 111112222222333332 3578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-49 Score=366.56 Aligned_cols=286 Identities=32% Similarity=0.555 Sum_probs=224.9
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 104 (376)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.++||||+++++++..... ...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999999999999999998542 2233479999999999999999998754332 122
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 105 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 105 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..+|+||||+++++...+. ..+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~-~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEecCCCc
Confidence 3478999999998776653 347888999999999999999999 79999999999999996 788999999999
Q ss_pred ccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
.............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+..+.....
T Consensus 171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 171 RTACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred cccccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 765444444456789999999999654 5899999999999999999999999999988889889988888876544322
Q ss_pred C----------cCCCCCCCCCCC-C--CChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 265 N----------PNYTDFRFPQIK-A--HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 265 ~----------~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
. +.+..+.+...- . .+.........++++++||.+||+.||++|||+.|+|+||||..+..+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP 324 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence 1 111111110000 0 000011122357789999999999999999999999999999875544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=367.32 Aligned_cols=284 Identities=32% Similarity=0.552 Sum_probs=225.5
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+|++.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++|+||+++++++...........|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999999999999988542 12345799999999999999999988544322223588
Q ss_pred EEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 109 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 109 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
+||||+.+++...+. ....+++..++.++.||+.||.|||+ +|++||||||+|||++. ++.+||+|||++....
T Consensus 81 lv~e~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~-~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQSDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNS-NCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccccCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECC-CCCEEeccccceeecc
Confidence 999999988777664 35679999999999999999999999 79999999999999996 7889999999997543
Q ss_pred cCC--CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 189 AGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 189 ~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
... ......+|+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+.+..+.+.+|.+..+.+.....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 222 122346788999999997766689999999999999999999999999999999999999999988765543221
Q ss_pred CCCCCCCCCCC-CCChhh--hcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 267 NYTDFRFPQIK-AHPWHK--VFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 267 ~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
........... ...+.. .+....++++.+||.+||++||.+|||+.|+++||||+..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 11000000000 001111 12334688999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=350.91 Aligned_cols=279 Identities=31% Similarity=0.551 Sum_probs=221.8
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhC---CCCceeeeceeeeecCCCCce
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVM---DHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~ 105 (376)
+|++.+.||+|+||+||+|.++.+++.||+|.+.... ....+|+.+++.+ +|+||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5899999999999999999999999999999886421 1234677776655 799999999988655444456
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.++++|||+.+++...+... ....+++..++.++.|++.||.|||+ .|++||||||+||+++. ++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~-~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTS-GGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccccCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECccCccc
Confidence 68899999999887777532 23458999999999999999999999 79999999999999996 7789999999998
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
............+|+.|+|||++.+. .++.++||||+||++|+|++|++||.+....+.+.++....+.+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred cccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 66544444456778999999999654 48999999999999999999999999998888888888888877665543211
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
. .....+......++... ...++..+.+||.+||++||++|||+.+++.||||
T Consensus 236 ~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 236 T-LPRGAFSPRGPRPVQSV-VPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred c-ccccccCCCCCCchHHh-CcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 00111111112222222 23478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=342.69 Aligned_cols=285 Identities=37% Similarity=0.619 Sum_probs=228.3
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCC----cEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
...|+..+.||+|+||.||+|..+.++ +.||||++.... ...-+|+.+++.++|+|++.+..+|+..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~--- 99 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH--- 99 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc---
Confidence 458999999999999999999766554 369999986542 2334899999999999999999999653
Q ss_pred CceEEEEEeecccchHHHHHHhhhh-cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC---CCcEEE
Q 017147 103 NELFLNLVMEYVPESMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL---THQVKI 178 (376)
Q Consensus 103 ~~~~~~lv~e~~~~~l~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~---~~~vkl 178 (376)
+..+++++||.+.+|+.+++..+. ....++...++.++.||+.|+.|||+ +-|+||||||.|||+..+ .+.|||
T Consensus 100 -d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 100 -DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred -CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccCeeEe
Confidence 445999999999999999975443 34568999999999999999999999 899999999999999752 378999
Q ss_pred EeecccccCccCCC----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCC---------hHHH
Q 017147 179 CDFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---------AVDQ 245 (376)
Q Consensus 179 ~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~ 245 (376)
+|||+++.+...-. ....+.|.||+|||+++|...|+.+.|+|++|||+.||++-.+.|.+.. ..++
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 99999987654322 2345679999999999999999999999999999999999999997644 3478
Q ss_pred HHHHHHHhCCCCHHHHhhcCcCCCCC-----CCC--CCCCCChhhhcc--cCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 246 LVEIIKVLGTPTREEIRCMNPNYTDF-----RFP--QIKAHPWHKVFH--KRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 246 ~~~i~~~~~~~~~~~~~~~~~~~~~~-----~~~--~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
+..|.+.+|.|+...|+.+.. +.++ .++ ......+...+. +.-++.+.+|+.+||++||.+|+|++++|+
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk-~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKK-MPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHcCCCccccchhhhh-CcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 999999999999988775431 1111 111 111111222222 223566999999999999999999999999
Q ss_pred CCCcccc
Q 017147 317 HPFFDEL 323 (376)
Q Consensus 317 hp~~~~~ 323 (376)
|+||..-
T Consensus 337 h~yF~~d 343 (438)
T KOG0666|consen 337 HPYFTED 343 (438)
T ss_pred ccccccC
Confidence 9999874
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=361.47 Aligned_cols=286 Identities=33% Similarity=0.567 Sum_probs=227.5
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 104 (376)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++..... ...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999999999999999886421 223478999999999999999998754332 223
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 105 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 105 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
...|+||||+++++...+. ..+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~-~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECC-CCCEEEeeCccc
Confidence 3578999999998776664 347888999999999999999999 79999999999999996 778999999999
Q ss_pred ccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
+............+|+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+.+..+++.++.+..+.+...
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 167 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred ccCCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 865444444456789999999999654 4899999999999999999999999999998999999988888876655433
Q ss_pred CcC----------CCCCCCCCCCC---CChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 265 NPN----------YTDFRFPQIKA---HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 265 ~~~----------~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
.+. +....++.... .+.........+.++++||.+||+.||++|||+.|+|+||||....++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~ 320 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence 221 11111111100 111122223356789999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=328.13 Aligned_cols=252 Identities=29% Similarity=0.480 Sum_probs=219.6
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
-.++|++++.||+|-||.||+|+.+.++-.||+|++.++. ....+|+++...|+||||+++++.|.+..
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~---- 95 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK---- 95 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc----
Confidence 4578999999999999999999999999999999987653 34458999999999999999999995544
Q ss_pred eEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
.+|+++||.. |.++..|.. ....++++..++.|+.|++.|+.|+|. ++++||||||+|+|++. .+.+||+|||.
T Consensus 96 -riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~-~~~lkiAdfGw 170 (281)
T KOG0580|consen 96 -RIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGS-AGELKIADFGW 170 (281)
T ss_pred -eeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCC-CCCeeccCCCc
Confidence 4999999998 577777753 245679999999999999999999999 89999999999999997 78899999999
Q ss_pred cccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 184 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 184 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
+-... .....+.+||..|.+||...+. .++..+|+|++|++.||++.|.+||......+.+.+|.+.
T Consensus 171 sV~~p-~~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~----------- 237 (281)
T KOG0580|consen 171 SVHAP-SNKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV----------- 237 (281)
T ss_pred eeecC-CCCceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-----------
Confidence 87554 4445678899999999999665 4899999999999999999999999999988888888763
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
++. ++..++.++.|||.+||.++|.+|++..|++.|||+...
T Consensus 238 ------~~~------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 238 ------DLK------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred ------ccc------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 222 334689999999999999999999999999999999753
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=350.40 Aligned_cols=284 Identities=32% Similarity=0.628 Sum_probs=230.4
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++. ....
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~ 78 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKS 78 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCe
Confidence 4568999999999999999999999999999999885332 23457999999999999999999884 3345
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
.|+||||++++|...+.. ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++..
T Consensus 79 ~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~ 153 (301)
T cd07873 79 LTLVFEYLDKDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARA 153 (301)
T ss_pred EEEEEeccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECC-CCcEEECcCcchhc
Confidence 889999999988777653 34568899999999999999999999 79999999999999996 77899999999875
Q ss_pred CccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 187 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 187 ~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
...... .....+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....+....
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 154 KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred cCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 432221 2234568899999998766668899999999999999999999999999888888888888888776665432
Q ss_pred --cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 266 --PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 266 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
..+....++........ .....+++++++||.+||+.||.+|||++|+++||||+.+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~ 295 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLH-NHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER 295 (301)
T ss_pred ccccccccccCccccccHH-hhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence 12222333333222222 2334578999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=353.81 Aligned_cols=250 Identities=27% Similarity=0.425 Sum_probs=208.9
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence 36999999999999999999999999999999985422 2345799999999999999998877 33445
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+|+||||+++ +|.+.+. ....+++..++.++.|++.||+|||+ +|++||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~-~~~~kl~Dfg~~~ 149 (291)
T cd05612 76 LYMLMEYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDK-EGHIKLTDFGFAK 149 (291)
T ss_pred EEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEEEecCcch
Confidence 8999999985 6666664 34678999999999999999999999 79999999999999996 7789999999997
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
..... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 150 ~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~------------- 213 (291)
T cd05612 150 KLRDR--TWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG------------- 213 (291)
T ss_pred hccCC--cccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence 65332 2345689999999998654 4899999999999999999999999988876666555431
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCcccccCC
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 326 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 326 (376)
.. .++..+++.+++||++||+.||.+|++ ++++++||||+.+.+.
T Consensus 214 ----~~------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 214 ----KL------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred ----Cc------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 00 122346889999999999999999995 9999999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=338.71 Aligned_cols=262 Identities=29% Similarity=0.469 Sum_probs=211.3
Q ss_pred ccceeeee-eeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHh-CCCCceeeeceeeeecCCCCceEEEE
Q 017147 32 QTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-MDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 32 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
.+++|++. ++||-|-.|+|..|.++.|++.+|+|++. +....++|+++.-. -.|+|||+++++|... ..+..++.+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rkcLLi 136 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-DSPKARREVELHWMASGHPHIVSIIDVYENS-YQGRKCLLI 136 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-cCHHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCceeeEe
Confidence 56778775 47999999999999999999999999775 45555678876543 3799999999998433 255677889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC--CCcEEEEeeccccc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGSAKQ 186 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~--~~~vkl~Dfg~a~~ 186 (376)
|||.++| .|.+-++. .....|+|.++..|+.||..|+.|||+ .+|+||||||+|+|.... +..+||+|||+|+.
T Consensus 137 VmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 137 VMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEecccccccc
Confidence 9999996 55555543 245669999999999999999999999 599999999999999642 45799999999997
Q ss_pred CccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCHHHHh
Q 017147 187 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD----QLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~ 262 (376)
........+.+.||+|.|||++ +...|+..+|+||+|||+|.|++|.+||.+..... .-.+|..
T Consensus 214 t~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~----------- 281 (400)
T KOG0604|consen 214 TQEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT----------- 281 (400)
T ss_pred cCCCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc-----------
Confidence 7666667778889999999998 66679999999999999999999999998766422 1222221
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
..|.||. +.| ..+|++++|+|++||..+|++|+|++++++|||+....
T Consensus 282 ------gqy~FP~---pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 282 ------GQYEFPE---PEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred ------cCccCCC---hhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 2233332 223 23799999999999999999999999999999998754
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=358.37 Aligned_cols=252 Identities=28% Similarity=0.438 Sum_probs=209.5
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
...+|++.+.||+|+||+||+|.++.+++.||+|++.+.. ....+|+.+++.++||||+++++++.. .
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~ 90 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-----E 90 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-----C
Confidence 4568999999999999999999999999999999986432 224579999999999999999998843 3
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
..+|+||||+.+ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kl~Dfg~ 164 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDN-KGHVKVTDFGF 164 (329)
T ss_pred CEEEEEEcCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECC-CCCEEEeeccC
Confidence 458999999986 6666654 34678999999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 184 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 184 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
+...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~----------- 230 (329)
T PTZ00263 165 AKKVPDR--TFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG----------- 230 (329)
T ss_pred ceEcCCC--cceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----------
Confidence 9765332 2346789999999999654 4789999999999999999999999888766655544331
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCcccccCC
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 326 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 326 (376)
... ++..++..+++||.+||+.||.+|++ ++++++||||++..+.
T Consensus 231 ------~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 231 ------RLK------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred ------CcC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 001 12236889999999999999999997 7999999999886544
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-49 Score=354.87 Aligned_cols=259 Identities=27% Similarity=0.424 Sum_probs=230.6
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
+..+-|.+.+.||+|-|+.|.+|++.-||+.||+|++.+.. .....|+.+|+..+|||||++|++. ...
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQ 89 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQ 89 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----ccc
Confidence 34457999999999999999999999999999999997643 2335899999999999999999998 344
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
..+|+|.|+-++ +|.+.+.. ....+.++.++.|++||+.|+.|+|+ -.+|||||||+|+.+-+.-+-|||.|||+
T Consensus 90 TKlyLiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFGF 165 (864)
T KOG4717|consen 90 TKLYLILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFGF 165 (864)
T ss_pred ceEEEEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeeccc
Confidence 449999999985 88888763 45679999999999999999999999 59999999999999877678999999999
Q ss_pred cccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 184 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 184 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
+..+..+....+.+|+..|-|||+++|..+..+++||||||||||.|++|++||...+..+.+..|+.+.
T Consensus 166 SNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK---------- 235 (864)
T KOG4717|consen 166 SNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK---------- 235 (864)
T ss_pred cccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc----------
Confidence 9999999989999999999999999998877899999999999999999999999999999999998852
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCC
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 327 (376)
|. .+..+|.+++|||..||..||.+|.|.+++.+|+|++.+....
T Consensus 236 -------Yt------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 236 -------YT------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred -------cc------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 22 2345899999999999999999999999999999999876554
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=340.64 Aligned_cols=256 Identities=29% Similarity=0.458 Sum_probs=218.9
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchH-------HHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-------~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
-.++|..+++||+|.||+|-+|+.+.+++.||||++.++....+ .|-.+|+..+||.+..+...| +..
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~ 240 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQ 240 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccC
Confidence 45789999999999999999999999999999999877644433 466789999999999998888 444
Q ss_pred eEEEEEeecccch-HHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
..+|+||||.+|+ |.-.|. ....|++..+++|-.+|+.||.|||+ ++|++||||.+|+|+|. ++.|||+|||+
T Consensus 241 drlCFVMeyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDk-DGHIKitDFGL 314 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDK-DGHIKITDFGL 314 (516)
T ss_pred ceEEEEEEEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheecc-CCceEeeeccc
Confidence 4599999999974 333332 45779999999999999999999999 89999999999999997 77799999999
Q ss_pred cccCc-cCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 184 AKQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 184 a~~~~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
|+.-. .+....+.+|||.|.|||++. ...|+.++|+|.+||++|||++|+.||...+....+..|+..
T Consensus 315 CKE~I~~g~t~kTFCGTPEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e---------- 383 (516)
T KOG0690|consen 315 CKEEIKYGDTTKTFCGTPEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME---------- 383 (516)
T ss_pred chhcccccceeccccCChhhcCchhhc-cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh----------
Confidence 98643 344566889999999999995 456999999999999999999999999999888777766652
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCcccccCCCC
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPNA 328 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~~~ 328 (376)
++. |+..++++++.|+..+|.+||.+|+. +.|+.+|+||..+.|...
T Consensus 384 -------d~k------------FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~ 435 (516)
T KOG0690|consen 384 -------DLK------------FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEAT 435 (516)
T ss_pred -------hcc------------CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHH
Confidence 233 44568999999999999999999984 789999999999988754
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=357.15 Aligned_cols=246 Identities=28% Similarity=0.450 Sum_probs=202.4
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 112 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 112 (376)
+.||+|+||+||+|.++.+++.||+|++.+.. ....+|+.+++.++||||+++++++. ....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ-----THDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----cCCEEEEEEe
Confidence 46999999999999999999999999986432 12346899999999999999998873 3445899999
Q ss_pred cccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC-
Q 017147 113 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG- 190 (376)
Q Consensus 113 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~- 190 (376)
|+++ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.....
T Consensus 76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~-~~~~kl~DfG~a~~~~~~~ 149 (323)
T cd05571 76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDK-DGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECC-CCCEEEeeCCCCcccccCC
Confidence 9986 5555554 35678999999999999999999999 79999999999999996 778999999998753222
Q ss_pred CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 017147 191 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270 (376)
Q Consensus 191 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 270 (376)
.......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+... .
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-----------------~ 211 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E 211 (323)
T ss_pred CcccceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence 223456789999999998654 5899999999999999999999999887766555444321 1
Q ss_pred CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCC
Q 017147 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326 (376)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 326 (376)
.. ++..+++++.+||++||+.||++|| ++.++++||||+.+.+.
T Consensus 212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~ 260 (323)
T cd05571 212 IR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ 260 (323)
T ss_pred CC------------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 11 2335789999999999999999999 89999999999987544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=357.46 Aligned_cols=285 Identities=36% Similarity=0.632 Sum_probs=228.0
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 105 (376)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++..... ....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 468999999999999999999999999999999886432 223479999999999999999988753321 2223
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.+|+++++++++|...+. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 94 ~~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~-~~~~kl~Dfg~~~ 166 (343)
T cd07878 94 EVYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNE-DCELRILDFGLAR 166 (343)
T ss_pred cEEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECC-CCCEEEcCCccce
Confidence 478999999888776654 3569999999999999999999999 79999999999999996 7789999999997
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+..+.+....
T Consensus 167 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 167 QADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred ecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 6533 23356789999999999765568999999999999999999999999999888888888888887766554332
Q ss_pred cCCCC---CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCC
Q 017147 266 PNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327 (376)
Q Consensus 266 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 327 (376)
..... -.++......+...+ ...++.+.+||.+||..||.+|||+.|+++||||.....+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~ 308 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE 308 (343)
T ss_pred hhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence 21110 011222222233322 23678899999999999999999999999999999875543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=347.98 Aligned_cols=257 Identities=26% Similarity=0.392 Sum_probs=206.5
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.|+..+.||+|+||+||+|.+..+++.||+|.+.+.. ....+|+.+++.++|++|+++.+++. ....+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~-----~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc-----cCCeE
Confidence 3788999999999999999999999999999886432 12346999999999999999988873 33458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
++||||+++ +|...+.. .....+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.++|+|||++..
T Consensus 76 ~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~-~~~~kl~Dfg~~~~ 151 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDD-RGHIRISDLGLAVQ 151 (285)
T ss_pred EEEEEecCCCcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECC-CCCEEEeeCCCcEE
Confidence 999999986 55544432 123468999999999999999999999 79999999999999996 77899999999986
Q ss_pred CccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 187 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
...........||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+...+...
T Consensus 152 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 220 (285)
T cd05631 152 IPEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED---------- 220 (285)
T ss_pred cCCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc----------
Confidence 5444434456789999999999654 58999999999999999999999998766543332222211100
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCcccccCC
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 326 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 326 (376)
...++..+++++.+||++||+.||.+|++ ++++++||||+.+.+.
T Consensus 221 ---------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05631 221 ---------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK 270 (285)
T ss_pred ---------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence 01123457899999999999999999997 8999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=360.85 Aligned_cols=276 Identities=23% Similarity=0.349 Sum_probs=212.9
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 112 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 112 (376)
..+|++.+.||+|+||.||+|.+..+++.||+|... .....+|+.+++.++||||++++++|.. ....++|+|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--RGGTATEAHILRAINHPSIIQLKGTFTY-----NKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--hhhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCeeEEEEe
Confidence 357999999999999999999999999999999754 3345689999999999999999998843 334889999
Q ss_pred cccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC--
Q 017147 113 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-- 190 (376)
Q Consensus 113 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-- 190 (376)
++.++|...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. .+.+||+|||++......
T Consensus 164 ~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~-~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 164 RYKTDLYCYLA----AKRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINH-PGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred cCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcC-CCCEEEEeCCcccccccccc
Confidence 99988777664 34568899999999999999999999 79999999999999996 778999999998643222
Q ss_pred CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHHhCCCCHHHHhh
Q 017147 191 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-------NAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 191 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
.......||+.|+|||++.+. .++.++||||+||++|+|++|..||... +....+..+.+..|.++.+....
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 222345789999999998654 5899999999999999999999877543 23456777777777654321100
Q ss_pred c----CcCC----CCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 264 M----NPNY----TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 264 ~----~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
. ...+ ............|.... .++.++.+||.+||++||.+|||+.|+|+||||+.+.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLY--ELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHh--hhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 0 0000 00000000111222221 2577899999999999999999999999999998753
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=349.32 Aligned_cols=278 Identities=33% Similarity=0.567 Sum_probs=210.6
Q ss_pred eeeeecCCCeeEEEEEEc--CCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017147 39 ERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 114 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 114 (376)
.+.||+|+||+||+|.++ .+++.||+|.+.... ....+|+.+++.++||||+++++++.... ...+|++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCC---CcEEEEEEecc
Confidence 457999999999999976 467899999886542 23468999999999999999998875432 33588999999
Q ss_pred cchHHHHHHhhhh-----cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEc---CCCCcEEEEeeccccc
Q 017147 115 PESMYRVLKHYSS-----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD---PLTHQVKICDFGSAKQ 186 (376)
Q Consensus 115 ~~~l~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~---~~~~~vkl~Dfg~a~~ 186 (376)
++++...+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++ ..++.+||+|||+++.
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 9988877753211 22358999999999999999999999 7999999999999994 2356899999999976
Q ss_pred CccCC----CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHh
Q 017147 187 LIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVL 253 (376)
Q Consensus 187 ~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~~i~~~~ 253 (376)
..... ......+|+.|+|||++.+...++.++||||+||++|+|++|++||.+... .+.+..+.+.+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 54322 123457799999999997766689999999999999999999999975442 35677788888
Q ss_pred CCCCHHHHhhcCcCCC------CC---CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 254 GTPTREEIRCMNPNYT------DF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 254 ~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
|.+....+........ ++ .........+........+.++.|||++||++||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 8877766543321100 00 0000000001111112346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=358.46 Aligned_cols=256 Identities=26% Similarity=0.397 Sum_probs=206.3
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
++|++.+.||+|+||+||+|.++.+++.||+|++.+.. ....+|+.++..++|+||+++++.+. +...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~-----~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ-----DKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCCe
Confidence 37999999999999999999999999999999986532 23356899999999999999999883 3445
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+|+|||||+| +|.+.+. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 76 ~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~-~~~vkL~DFGla~ 149 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDS-KGHVKLSDFGLCT 149 (363)
T ss_pred EEEEEcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECC-CCCEEEeeccCcc
Confidence 8999999986 6666654 34679999999999999999999999 79999999999999996 7789999999987
Q ss_pred cCccCC------------------------------------CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHH
Q 017147 186 QLIAGE------------------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAE 229 (376)
Q Consensus 186 ~~~~~~------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ 229 (376)
...... .....+||+.|+|||++.+. .++.++|||||||++|+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~e 228 (363)
T cd05628 150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYE 228 (363)
T ss_pred cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHH
Confidence 532110 01235789999999999654 58999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCC--
Q 017147 230 LLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL-- 307 (376)
Q Consensus 230 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~-- 307 (376)
|++|+.||.+.+..+....+...... ..+|. ...+++++++||.+|+. +|.+
T Consensus 229 ll~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~~li~~l~~-~~~~r~ 282 (363)
T cd05628 229 MLIGYPPFCSETPQETYKKVMNWKET---------------LIFPP----------EVPISEKAKDLILRFCC-EWEHRI 282 (363)
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCcCc---------------ccCCC----------cCCCCHHHHHHHHHHcC-ChhhcC
Confidence 99999999988877777666542111 01111 01268899999999876 4554
Q ss_pred -CCCHHHHhcCCCcccccCCC
Q 017147 308 -RCTALEACAHPFFDELREPN 327 (376)
Q Consensus 308 -R~t~~e~l~hp~~~~~~~~~ 327 (376)
||+++|+++||||+++.+..
T Consensus 283 ~r~~~~ei~~hp~f~~~~~~~ 303 (363)
T cd05628 283 GAPGVEEIKTNPFFEGVDWEH 303 (363)
T ss_pred CCCCHHHHhCCCCCCCCCHHH
Confidence 57999999999999876553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=344.75 Aligned_cols=249 Identities=28% Similarity=0.477 Sum_probs=219.7
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
...+|++.+.||+|.||+|-+|.....|+.||||.+.++. ..+++|+++|..|+||||+.++++| ++.
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENk 125 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENK 125 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCC
Confidence 4468999999999999999999999999999999886643 3446899999999999999999999 555
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
..+.|||||..+ .|++.+. ..+.+++.+++.++.||+.|+.|+|+ ++++|||||.+|||+|. ++++||+|||+
T Consensus 126 dKIvivMEYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~-N~NiKIADFGL 199 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQ-NNNIKIADFGL 199 (668)
T ss_pred ceEEEEEEecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecC-CCCeeeeccch
Confidence 558899999985 7777765 56889999999999999999999999 89999999999999996 78899999999
Q ss_pred cccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 184 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 184 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
+..+.......+++|+|-|.+||++.|.++-++.+|-|||||+||.|+.|..||.|.+....+.+|.+.
T Consensus 200 SNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G----------- 268 (668)
T KOG0611|consen 200 SNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG----------- 268 (668)
T ss_pred hhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc-----------
Confidence 998888888889999999999999988776789999999999999999999999999988887777652
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 321 (376)
.|.-| .-+.++.-||+.||-.||++|.|++++-+|=|.+
T Consensus 269 ------aYrEP-------------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 269 ------AYREP-------------ETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ------cccCC-------------CCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 11111 1367889999999999999999999999997764
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=353.60 Aligned_cols=253 Identities=28% Similarity=0.425 Sum_probs=208.9
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCC-cEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
...++|++.+.||+|+||.||+|.+..++ ..||+|.+.+.. ....+|+.+++.++||||+++++++..
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~---- 102 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD---- 102 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe----
Confidence 34568999999999999999999876655 689999886432 223469999999999999999998843
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
...+|+||||+.+ +|.+.+. ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 103 -~~~~~lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~-~~~ikL~DF 175 (340)
T PTZ00426 103 -ESYLYLVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDK-DGFIKMTDF 175 (340)
T ss_pred -CCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECC-CCCEEEecC
Confidence 3458999999985 6666654 34678999999999999999999999 79999999999999996 788999999
Q ss_pred cccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 182 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
|++..... ......||+.|+|||++.+. .++.++|+||+||++|+|++|.+||.+.+.......+.+..
T Consensus 176 G~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~-------- 244 (340)
T PTZ00426 176 GFAKVVDT--RTYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI-------- 244 (340)
T ss_pred CCCeecCC--CcceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC--------
Confidence 99976532 23456789999999999654 47899999999999999999999999887766555554310
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCC
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 326 (376)
.. ++..+++.+.++|++||+.||.+|+ |++++++||||+++.+.
T Consensus 245 ---------~~------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 245 ---------IY------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred ---------CC------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 01 2234688999999999999999996 89999999999987644
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=341.08 Aligned_cols=276 Identities=36% Similarity=0.578 Sum_probs=218.9
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++++.+ ...+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-----DKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-----CCceE
Confidence 5899999999999999999999999999999885431 234579999999999999999998843 33489
Q ss_pred EEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 109 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 109 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
+++||+++++.+.+.. ....+++..++.++.||+.||.|||+ .|++||||||+||+++. ++.++|+|||++....
T Consensus 76 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~-~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 76 LVFEYCDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINK-NGELKLADFGLARAFG 150 (284)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcC-CCcEEECccchhhccC
Confidence 9999999987776653 34679999999999999999999999 79999999999999996 7789999999987543
Q ss_pred cCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 189 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 189 ~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
.... .....+++.|+|||.+.+...++.++|+||+||++|+|++|..| |.+.+..+.+..+.+..+.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 3222 22345688999999987766679999999999999999998766 566777778888888888777665543321
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
.-....++..............+++++.+||.+||+.||.+|||++++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 111111122211111122234578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=357.60 Aligned_cols=255 Identities=30% Similarity=0.480 Sum_probs=206.8
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
++|++.+.||+|+||+||+|++..+++.||||++.... ....+|+.+++.++|+||+++++++. ...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ-----DENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCe
Confidence 36999999999999999999999999999999986432 22347999999999999999999884 3445
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+|+||||+.+ +|.+.+. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.++|+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~~~ 149 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDA-KGHIKLSDFGLCT 149 (364)
T ss_pred EEEEECCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEeecccce
Confidence 8999999985 6666554 34579999999999999999999999 79999999999999996 7789999999986
Q ss_pred cCccCC---------------------------------------CceeeeeccccCchhhhhCCCCCCchhhhHhHHHH
Q 017147 186 QLIAGE---------------------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCV 226 (376)
Q Consensus 186 ~~~~~~---------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~i 226 (376)
...... ...+.+||+.|+|||++.+. .++.++|||||||+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~i 228 (364)
T cd05599 150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVI 228 (364)
T ss_pred eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhH
Confidence 532211 01124689999999998654 58999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCC
Q 017147 227 LAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 306 (376)
Q Consensus 227 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 306 (376)
+|+|++|.+||.+.+..+....+.+... ...++. ...+++++++||.+||. +|.
T Consensus 229 l~el~~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~s~~~~~li~~ll~-~p~ 282 (364)
T cd05599 229 MYEMLVGYPPFCSDNPQETYRKIINWKE---------------TLQFPD----------EVPLSPEAKDLIKRLCC-EAE 282 (364)
T ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCC---------------ccCCCC----------CCCCCHHHHHHHHHHcc-CHh
Confidence 9999999999998887766655543110 001111 11368999999999997 999
Q ss_pred CCCC---HHHHhcCCCcccccCC
Q 017147 307 LRCT---ALEACAHPFFDELREP 326 (376)
Q Consensus 307 ~R~t---~~e~l~hp~~~~~~~~ 326 (376)
+|++ +.++++||||+...+.
T Consensus 283 ~R~~~~~~~~ll~h~~~~~~~~~ 305 (364)
T cd05599 283 RRLGNNGVNEIKSHPFFKGVDWE 305 (364)
T ss_pred hcCCCCCHHHHhcCCCcCCCCHH
Confidence 9998 9999999999987654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=358.17 Aligned_cols=255 Identities=28% Similarity=0.449 Sum_probs=202.8
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.|++++.||+|+||+||+|.+..+++.||+|++.+.. ....+|+.+++.++|+||+++++++.+ ...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-----~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-----KDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-----CCEE
Confidence 5899999999999999999999999999999986532 223579999999999999999998843 3458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|+||||++| +|.+.+. ....+++..++.++.||+.||+|||+ .||+||||||+|||++. ++.+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~-~~~~kL~DFGl~~~ 150 (381)
T cd05626 77 YFVMDYIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDL-DGHIKLTDFGLCTG 150 (381)
T ss_pred EEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECC-CCCEEEeeCcCCcc
Confidence 999999985 6666654 34578999999999999999999999 79999999999999996 77899999999753
Q ss_pred CccCC------------------------------------------------CceeeeeccccCchhhhhCCCCCCchh
Q 017147 187 LIAGE------------------------------------------------ANISYICSRFYRAPELIFGATEYTTSI 218 (376)
Q Consensus 187 ~~~~~------------------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~ 218 (376)
..... ...+.+||+.|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~ 229 (381)
T cd05626 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLC 229 (381)
T ss_pred cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCcc
Confidence 21000 01234689999999998654 489999
Q ss_pred hhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHH
Q 017147 219 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 298 (376)
Q Consensus 219 DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 298 (376)
|||||||++|+|++|..||...+..+....+...... ..++ ....+++++++||.
T Consensus 230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~----------~~~~~s~~~~dli~ 284 (381)
T cd05626 230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT---------------LHIP----------PQVKLSPEAVDLIT 284 (381)
T ss_pred ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc---------------cCCC----------CCCCCCHHHHHHHH
Confidence 9999999999999999999987766655544431110 0011 01236899999999
Q ss_pred hhcCc--CCCCCCCHHHHhcCCCcccccCC
Q 017147 299 RLLQY--SPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 299 ~~L~~--dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
+||.. +|..|++++++++||||+.+.+.
T Consensus 285 ~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 285 KLCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred HHccCcccccCCCCHHHHhcCcccCCCChh
Confidence 97655 44459999999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=363.97 Aligned_cols=282 Identities=24% Similarity=0.374 Sum_probs=212.2
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCC------ceeeeceeeeecCCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHP------NVISLKHCFFSTTSKN 103 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~ 103 (376)
.++|++.+.||+|+||+||+|.+..+++.||||++.... .....|+.+++.++|. +++++++++.. .
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~----~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----E 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----C
Confidence 368999999999999999999999999999999986432 2234577777777554 47777776632 2
Q ss_pred ceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC---------
Q 017147 104 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--------- 174 (376)
Q Consensus 104 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~--------- 174 (376)
...+|+|||+++++|.+.+.. ...+++..++.++.||+.||+|||+..||+||||||+|||++..+.
T Consensus 204 ~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 204 TGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 335889999998888877753 4579999999999999999999997139999999999999985322
Q ss_pred ------cEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 017147 175 ------QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 248 (376)
Q Consensus 175 ------~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 248 (376)
.+||+|||.+... .......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..
T Consensus 280 ~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred cCCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 4999999988542 2223456789999999999765 489999999999999999999999999998898988
Q ss_pred HHHHhCCCCHHHHhhcCcC-----CCCC--CCCCCCCCChhhhc-----c-cCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017147 249 IIKVLGTPTREEIRCMNPN-----YTDF--RFPQIKAHPWHKVF-----H-KRMPPEAIDLASRLLQYSPSLRCTALEAC 315 (376)
Q Consensus 249 i~~~~~~~~~~~~~~~~~~-----~~~~--~~~~~~~~~~~~~~-----~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l 315 (376)
+.+.+|.++.......... +... ..+......+.... . ...++.+.|||.+||++||.+|||++|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 8888887765433211000 0000 00000000000000 0 01246788999999999999999999999
Q ss_pred cCCCcccccC
Q 017147 316 AHPFFDELRE 325 (376)
Q Consensus 316 ~hp~~~~~~~ 325 (376)
+||||.....
T Consensus 437 ~Hp~~~~~~~ 446 (467)
T PTZ00284 437 THPYVLKYYP 446 (467)
T ss_pred cCccccccCC
Confidence 9999987543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=380.97 Aligned_cols=278 Identities=27% Similarity=0.437 Sum_probs=229.0
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
.++|.++++||+|+||.|.+++++.+++.||+|++.+- ...+..|..+|-.-+.+-|+.++..| +++.
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCcc
Confidence 46899999999999999999999999999999998652 34456888999888999999998888 6667
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
++|+||||++| +|+.++.. ..++++.++++|+.+|+.||.-||++ |+|||||||+|||+|. .|.|||+|||.|
T Consensus 149 ~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~m-gyVHRDiKPDNvLld~-~GHikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSM-GYVHRDIKPDNVLLDK-SGHIKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhc-cceeccCCcceeEecc-cCcEeeccchhH
Confidence 79999999996 77777764 34899999999999999999999995 9999999999999997 778999999999
Q ss_pred ccCccCCC--ceeeeeccccCchhhhhC----CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 185 KQLIAGEA--NISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 185 ~~~~~~~~--~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
-.+..... ....+|||.|+|||++.. .+.|+..+|+||+||++|||+.|..||....-.+++.+|+...
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk----- 297 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK----- 297 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh-----
Confidence 77654432 346789999999999843 2468999999999999999999999999999999999998731
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC---HHHHhcCCCcccccCCCCCCCCCCC
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREPNARLPNGRP 335 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~hp~~~~~~~~~~~~~~~~~ 335 (376)
..+.||.. ..+|+++++||+++++ +|+.|+. ++++.+||||.++.|...+-...+.
T Consensus 298 ----------~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~ 356 (1317)
T KOG0612|consen 298 ----------ESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPV 356 (1317)
T ss_pred ----------hhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCC
Confidence 11223310 2389999999999999 7999998 9999999999999986554333333
Q ss_pred CCCCCCchhhhcc
Q 017147 336 LPPLFNFKQELSG 348 (376)
Q Consensus 336 ~~~~~~~~~~~~~ 348 (376)
. |-++++.+.++
T Consensus 357 v-Pevssd~DTsn 368 (1317)
T KOG0612|consen 357 V-PEVSSDDDTSN 368 (1317)
T ss_pred C-CcCCCCCcccc
Confidence 3 33344444433
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=357.47 Aligned_cols=254 Identities=28% Similarity=0.452 Sum_probs=204.3
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
+|++++.||+|+||+||+|++..+++.||+|++.+.. ....+|+.+++.++|+||+++++++.+ ...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-----~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-----KDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-----CCEE
Confidence 5899999999999999999999999999999986532 234579999999999999999999843 3358
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|+|||||++ +|.+.+. ....+++..++.++.||+.||+|||+ .||+||||||+|||++. ++.+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~-~g~~kL~DFGla~~ 150 (382)
T cd05625 77 YFVMDYIPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDR-DGHIKLTDFGLCTG 150 (382)
T ss_pred EEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEEeECCCCcc
Confidence 999999986 6666654 33568999999999999999999999 79999999999999996 77899999999753
Q ss_pred CccC------------------------------------------------CCceeeeeccccCchhhhhCCCCCCchh
Q 017147 187 LIAG------------------------------------------------EANISYICSRFYRAPELIFGATEYTTSI 218 (376)
Q Consensus 187 ~~~~------------------------------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~ 218 (376)
.... ....+.+||+.|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~ 229 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLC 229 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCee
Confidence 2100 001134689999999999654 589999
Q ss_pred hhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHH
Q 017147 219 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 298 (376)
Q Consensus 219 DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 298 (376)
||||+||++|+|++|++||.+.+..+....+...... ..+| ....+++++.++|.
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p----------~~~~~s~~~~~li~ 284 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS---------------LHIP----------PQAKLSPEASDLII 284 (382)
T ss_pred eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC---------------cCCC----------CcccCCHHHHHHHH
Confidence 9999999999999999999988776655554431110 0011 01247899999999
Q ss_pred hhcCcCCCCCCC---HHHHhcCCCcccccCC
Q 017147 299 RLLQYSPSLRCT---ALEACAHPFFDELREP 326 (376)
Q Consensus 299 ~~L~~dp~~R~t---~~e~l~hp~~~~~~~~ 326 (376)
+|+ .||.+|++ ++++++||||+.+.+.
T Consensus 285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 285 KLC-RGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred HHc-cCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 986 59999997 9999999999887544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=358.30 Aligned_cols=254 Identities=28% Similarity=0.461 Sum_probs=203.9
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
++|++++.||+|+||+||+|.+..+++.||||++.+.. ....+|+.+++.++||||+++++++. +..+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ-----DAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCe
Confidence 36999999999999999999999999999999986532 22356999999999999999999883 3445
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+|+||||++| +|.+.+. ....+++..++.++.|++.||+|||+ .||+||||||+|||++. ++.+||+|||+++
T Consensus 76 ~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~-~~~~kl~DfGla~ 149 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDR-GGHIKLSDFGLST 149 (377)
T ss_pred eEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECC-CCCEEEeeccccc
Confidence 8999999985 6666654 34678999999999999999999999 79999999999999996 7789999999986
Q ss_pred cCccCC------------------------------------------------CceeeeeccccCchhhhhCCCCCCch
Q 017147 186 QLIAGE------------------------------------------------ANISYICSRFYRAPELIFGATEYTTS 217 (376)
Q Consensus 186 ~~~~~~------------------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~ 217 (376)
...... .....+||+.|+|||++.+. .++.+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~ 228 (377)
T cd05629 150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQE 228 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCc
Confidence 321100 00124689999999998654 58999
Q ss_pred hhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHH
Q 017147 218 IDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLA 297 (376)
Q Consensus 218 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 297 (376)
+|||||||++|+|++|.+||.+.+..+.+..+..... ...+|. ...++.++.+||
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~dli 283 (377)
T cd05629 229 CDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE---------------TLYFPD----------DIHLSVEAEDLI 283 (377)
T ss_pred eeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC---------------ccCCCC----------CCCCCHHHHHHH
Confidence 9999999999999999999998887666665543110 011111 113688999999
Q ss_pred HhhcCcCCCCC---CCHHHHhcCCCcccccC
Q 017147 298 SRLLQYSPSLR---CTALEACAHPFFDELRE 325 (376)
Q Consensus 298 ~~~L~~dp~~R---~t~~e~l~hp~~~~~~~ 325 (376)
.+||. +|.+| +|+.++++||||+.+.+
T Consensus 284 ~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 284 RRLIT-NAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred HHHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 99998 77765 59999999999997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=351.11 Aligned_cols=258 Identities=29% Similarity=0.453 Sum_probs=210.4
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
++|++.+.||+|+||.||+|.+..+++.||+|++.+.. ....+|+.++..++||||+++++++. ....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ-----DDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE-----cCCE
Confidence 36999999999999999999999999999999986432 22347899999999999999998883 3445
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.|+||||++| +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kL~Dfg~a~ 149 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDA-SGHIKLTDFGLSK 149 (333)
T ss_pred EEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCCEEEEeCcCCc
Confidence 8999999985 6666664 34678999999999999999999999 79999999999999996 7789999999997
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 150 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-------- 218 (333)
T cd05600 150 GIVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ-------- 218 (333)
T ss_pred cccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc--------
Confidence 5533 23456789999999999665 589999999999999999999999998887776665543211000
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
.+.... ....+++++.+||.+||..+|.+|+++.++++||||+.+.+.
T Consensus 219 -------~~~~~~------~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~ 266 (333)
T cd05600 219 -------RPVYDD------PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWN 266 (333)
T ss_pred -------CCCCCc------cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence 000000 002368999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=346.79 Aligned_cols=319 Identities=35% Similarity=0.636 Sum_probs=245.8
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
..+|.+.+.||+|+||+||+|.+..+++.||||.+... .....+|+.+++.++|+||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 34799999999999999999999999999999987542 122346999999999999999999875544333345
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
+|+++||+.++|.+.+. ....+++..+..++.|++.||.|||+ ++++||||||+||+++. ++.+||+|||++..
T Consensus 84 ~~lv~e~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~-~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMDTDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNA-NCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCCCCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEECcCccccc
Confidence 88999999988777664 34679999999999999999999999 79999999999999996 67899999999976
Q ss_pred CccC-CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 187 LIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 187 ~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.... .......++..|+|||.+.....++.++|+|||||++|+|++|++||.+.+....+..+....+.+..+.+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 5433 222345678899999998654558899999999999999999999999988888888888888887766553221
Q ss_pred c-CCCCC--CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCc
Q 017147 266 P-NYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF 342 (376)
Q Consensus 266 ~-~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 342 (376)
. ....+ ..+......+.. ....+++++.+||++||+.||++|||+.++++||||+.++....... .+..+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~----~~~~~~~ 312 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPV----CQTPFSF 312 (337)
T ss_pred chhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCcc----CCCccch
Confidence 1 11100 011111111222 22357899999999999999999999999999999999876654322 2234455
Q ss_pred hhhhccCCHHHHhhhcHHHH
Q 017147 343 KQELSGASPELVNKLIPDHV 362 (376)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~ 362 (376)
+-+..+.+.+.+++++-.+.
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~ 332 (337)
T cd07858 313 DFEEDALTEEDIKELIYNEM 332 (337)
T ss_pred hhhhhhcCHHHHHHHHHHHH
Confidence 55555577777777765543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=352.27 Aligned_cols=256 Identities=31% Similarity=0.513 Sum_probs=210.1
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
++|++.+.||+|+||+||+|.+..+++.||||++.+.. ....+|+.++..++|+||+++++++. ...+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ-----DEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee-----cCCe
Confidence 36999999999999999999999999999999986432 23457899999999999999998873 3445
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~-~~~~kL~Dfg~~~ 149 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDA-DGHIKLADFGLCK 149 (350)
T ss_pred EEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEeecCCCCc
Confidence 8999999985 66666653 3679999999999999999999999 79999999999999996 7789999999997
Q ss_pred cCccCC------------------------------CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCC
Q 017147 186 QLIAGE------------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 235 (376)
Q Consensus 186 ~~~~~~------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~ 235 (376)
...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCC
Confidence 654332 22345689999999999665 58999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-HHHH
Q 017147 236 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEA 314 (376)
Q Consensus 236 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-~~e~ 314 (376)
||.+.+.......+...... ..+|. ...+++++.+||.+||. ||.+|++ ++++
T Consensus 229 Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~l 282 (350)
T cd05573 229 PFYSDTLQETYNKIINWKES---------------LRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEI 282 (350)
T ss_pred CCCCCCHHHHHHHHhccCCc---------------ccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHH
Confidence 99988876666555441110 01111 11268999999999998 9999999 9999
Q ss_pred hcCCCcccccCCC
Q 017147 315 CAHPFFDELREPN 327 (376)
Q Consensus 315 l~hp~~~~~~~~~ 327 (376)
++||||+.+.+..
T Consensus 283 l~hp~~~~~~~~~ 295 (350)
T cd05573 283 KSHPFFKGIDWEN 295 (350)
T ss_pred hcCCCcCCCCHHH
Confidence 9999999876543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=356.99 Aligned_cols=253 Identities=27% Similarity=0.428 Sum_probs=203.5
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
+|++++.||+|+||+||+|++..+++.||+|++.+. .....+|+.+++.++|+||+++++.+. ....+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCEE
Confidence 699999999999999999999999999999998542 223457999999999999999998883 34458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|+|||||++ +|.+.+. ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|..
T Consensus 77 ~lv~E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~-~~~ikL~DFG~a~~ 150 (376)
T cd05598 77 YFVMDYIPGGDMMSLLI----RLGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDR-DGHIKLTDFGLCTG 150 (376)
T ss_pred EEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECC-CCCEEEEeCCCCcc
Confidence 999999985 6666664 34568999999999999999999999 79999999999999996 77899999999743
Q ss_pred CccC--------------------------------------------CCceeeeeccccCchhhhhCCCCCCchhhhHh
Q 017147 187 LIAG--------------------------------------------EANISYICSRFYRAPELIFGATEYTTSIDIWS 222 (376)
Q Consensus 187 ~~~~--------------------------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~Diws 222 (376)
.... ......+||+.|+|||++.+. .++.++||||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS 229 (376)
T cd05598 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWS 229 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeee
Confidence 2100 001134689999999999654 5899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcC
Q 017147 223 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 302 (376)
Q Consensus 223 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 302 (376)
|||++|+|++|+.||.+.+..+....+...... ..++ ....+++++.+||.+|+
T Consensus 230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~----------~~~~~s~~~~~li~~l~- 283 (376)
T cd05598 230 VGVILYEMLVGQPPFLADTPAETQLKVINWETT---------------LHIP----------SQAKLSREASDLILRLC- 283 (376)
T ss_pred ccceeeehhhCCCCCCCCCHHHHHHHHhccCcc---------------ccCC----------CCCCCCHHHHHHHHHHh-
Confidence 999999999999999988776655544321100 0000 11247899999999987
Q ss_pred cCCCCCC---CHHHHhcCCCcccccC
Q 017147 303 YSPSLRC---TALEACAHPFFDELRE 325 (376)
Q Consensus 303 ~dp~~R~---t~~e~l~hp~~~~~~~ 325 (376)
.+|.+|+ |+.++++||||+.+..
T Consensus 284 ~~p~~R~~~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 284 CGAEDRLGKNGADEIKAHPFFKGIDF 309 (376)
T ss_pred cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence 4999999 9999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=346.09 Aligned_cols=243 Identities=30% Similarity=0.513 Sum_probs=199.4
Q ss_pred eecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017147 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 114 (376)
Q Consensus 42 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 114 (376)
||+|+||+||+|.+..+++.||+|++.+.. ....+|+.+++.++||||+++++++. .....|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCC
Confidence 699999999999999999999999986431 22346899999999999999988873 334589999999
Q ss_pred cc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC-CC
Q 017147 115 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EA 192 (376)
Q Consensus 115 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~ 192 (376)
++ +|.+.+. ....+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+++..... ..
T Consensus 76 ~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~ 149 (312)
T cd05585 76 NGGELFHHLQ----REGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDY-QGHIALCDFGLCKLNMKDDDK 149 (312)
T ss_pred CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECC-CCcEEEEECcccccCccCCCc
Confidence 86 6656554 34678999999999999999999999 79999999999999996 778999999998754322 22
Q ss_pred ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCC
Q 017147 193 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272 (376)
Q Consensus 193 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 272 (376)
.....||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+... ..
T Consensus 150 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-----------------~~- 210 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-----------------PL- 210 (312)
T ss_pred cccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-----------------CC-
Confidence 3345789999999999654 5899999999999999999999999988766655544321 00
Q ss_pred CCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC---CHHHHhcCCCcccccC
Q 017147 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELRE 325 (376)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---t~~e~l~hp~~~~~~~ 325 (376)
.++..+++++.+||.+||+.||.+|+ ++.++++||||....+
T Consensus 211 -----------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~ 255 (312)
T cd05585 211 -----------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW 255 (312)
T ss_pred -----------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence 12234789999999999999999997 5899999999998643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=346.42 Aligned_cols=246 Identities=29% Similarity=0.491 Sum_probs=200.1
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.||+|+||+||+|+++.+++.||+|++.++. .....|..++..+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-----~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-----PDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-----CCEEEEEE
Confidence 46999999999999999999999999986532 1223577777765 69999999998843 34489999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||+++ +|...+. ....+++..++.++.|++.||.|||+ +|++||||||+|||++. ++.+||+|||++......
T Consensus 76 Ey~~~g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~-~~~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 76 EFVNGGDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDH-EGHCKLADFGMCKEGIFN 149 (320)
T ss_pred cCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECC-CCcEEEeeCCCCeecCcC
Confidence 99986 5555443 34679999999999999999999999 79999999999999996 778999999998754322
Q ss_pred -CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 191 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 191 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
.......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+.+..+.+.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~----------------- 211 (320)
T cd05590 150 GKTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND----------------- 211 (320)
T ss_pred CCcccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-----------------
Confidence 22334568999999999865 45899999999999999999999999988877666555431
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH------HHHhcCCCcccccCC
Q 017147 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELREP 326 (376)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~------~e~l~hp~~~~~~~~ 326 (376)
... ++..++.++.+||++||+.||.+|+++ +++++||||+.+.+.
T Consensus 212 ~~~------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~ 262 (320)
T cd05590 212 EVV------------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWE 262 (320)
T ss_pred CCC------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence 001 122368899999999999999999998 899999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=342.89 Aligned_cols=286 Identities=36% Similarity=0.697 Sum_probs=226.8
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++...........
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 458999999999999999999999999999999885321 123469999999999999999987754443444568
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
|+++||+.+++.+.+. ...+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++...
T Consensus 84 ~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~-~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-NCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECC-CCCEEECcccceeec
Confidence 8999999998776664 3569999999999999999999999 79999999999999996 778999999998754
Q ss_pred ccCCC----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 188 IAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 188 ~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
..... .....+|+.|+|||.+.+...++.++||||+||++|+|++|++||.+.+.......+...++.+..+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 33221 12346788999999986655689999999999999999999999999888888888888888877765543
Q ss_pred cCcCCC-CC--CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 264 MNPNYT-DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 264 ~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
...... .+ ..+.....++.... ..+++++.+||.+||+.||++|||+.++++||||+.+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHh-cccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 221100 00 11111122222222 2368899999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=351.79 Aligned_cols=257 Identities=25% Similarity=0.433 Sum_probs=209.1
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
..++|++.+.||+|+||+||+|++..+++.||+|++.+.. ....+|+.+++.++||||+++++++ ...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 4568999999999999999999999999999999986421 2234789999999999999999887 344
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
.++|+||||++| +|.+.+.. ..+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~-~~~~kL~DfG~ 188 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADFGT 188 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcC-CCCEEEEeccc
Confidence 458999999985 66666542 458899999999999999999999 79999999999999996 78899999999
Q ss_pred cccCccCC--CceeeeeccccCchhhhhCC---CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 184 AKQLIAGE--ANISYICSRFYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 184 a~~~~~~~--~~~~~~~t~~y~aPE~l~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
+....... ......||+.|+|||++.+. ..++.++|+|||||++|+|++|.+||.+.+....+.++.....
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---- 264 (370)
T cd05596 189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN---- 264 (370)
T ss_pred eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC----
Confidence 97654322 12345689999999998643 2378899999999999999999999998887766666544111
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCcccccC
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELRE 325 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~e~l~hp~~~~~~~ 325 (376)
...++. ...+|.++++||++||+.+|.+ |+|++++++||||++..+
T Consensus 265 -----------~~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 265 -----------SLTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred -----------cCCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 011111 1136899999999999999988 999999999999987544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=349.83 Aligned_cols=257 Identities=26% Similarity=0.433 Sum_probs=207.7
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
..++|++.+.||+|+||.||+|.++.+++.||+|++.+. .....+|+.+++.++||||+++++++. ..
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-----~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ-----DD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cC
Confidence 346899999999999999999999999999999998642 123457999999999999999999883 34
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
.++|+||||+++ +|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~-~~~~kL~DFG~ 188 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDK-HGHLKLADFGT 188 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECC-CCCEEEEeccc
Confidence 458999999985 67666642 358899999999999999999999 79999999999999996 78899999999
Q ss_pred cccCccCCC--ceeeeeccccCchhhhhCCC---CCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 184 AKQLIAGEA--NISYICSRFYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 184 a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
+........ ..+..||+.|+|||++.+.. .++.++|+||+||++|+|++|..||.+.+.......+......
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~--- 265 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS--- 265 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc---
Confidence 976533221 23557899999999986532 3788999999999999999999999988877666665542110
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCcccccC
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELRE 325 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~e~l~hp~~~~~~~ 325 (376)
..+|. ...++..++++|.+||..++.+ |+|+.++++||||+...+
T Consensus 266 ------------~~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 266 ------------LNFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred ------------cCCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 01110 1136889999999999866544 889999999999987544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=336.71 Aligned_cols=276 Identities=34% Similarity=0.662 Sum_probs=217.4
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+|++.+.||+|++|.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++.+.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-----ESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEE
Confidence 4899999999999999999999999999999885321 234579999999999999999998843 33489
Q ss_pred EEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 109 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 109 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
+||||+++++.+.+... ..+..+++..++.++.|++.||.|||+ +|++||||+|+||+++. ++.++|+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 76 LIFEFLSMDLKKYLDSL-PKGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDN-KGVIKLADFGLARAFG 152 (285)
T ss_pred EEEecCCCCHHHHHhcC-CCCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcC-CCcEEECcccceeecC
Confidence 99999998877776532 224678999999999999999999999 79999999999999996 7889999999987543
Q ss_pred cCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017147 189 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267 (376)
Q Consensus 189 ~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 267 (376)
.... .....+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+....+....+....+.+....+.....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 231 (285)
T cd07861 153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS- 231 (285)
T ss_pred CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh-
Confidence 2221 22345688899999987666678999999999999999999999999888887777777777665544432110
Q ss_pred CCCC--CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 268 YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 268 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
..++ .++......... ....+++++.+||++||+.||++|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hHHHHhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0000 111111111111 223478999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=347.96 Aligned_cols=258 Identities=26% Similarity=0.445 Sum_probs=209.5
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
++|.+.+.||+|+||+||+|.++.+++.||+|++.+.. ....+|+.+++.++|+||+++++++. ....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~-----~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ-----DKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCe
Confidence 36999999999999999999999999999999986532 23457899999999999999988873 3345
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.|+||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ .||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~-~~~~kL~Dfg~a~ 150 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDR-TGHIKLADFGSAA 150 (330)
T ss_pred EEEEECCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECC-CCCEEeccCCCCe
Confidence 8999999975 67666653 23579999999999999999999999 79999999999999996 7889999999997
Q ss_pred cCccCCCc--eeeeeccccCchhhhhC-----CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 186 QLIAGEAN--ISYICSRFYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 186 ~~~~~~~~--~~~~~t~~y~aPE~l~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
........ ....+|+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~---- 226 (330)
T cd05601 151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR---- 226 (330)
T ss_pred ECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC----
Confidence 65433322 23467999999999853 34578899999999999999999999998877766665544210
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCC
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 327 (376)
...++. ...+++++.+||.+||+ ||.+|||++++++||||+.+.+..
T Consensus 227 -----------~~~~~~----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~ 273 (330)
T cd05601 227 -----------FLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNN 273 (330)
T ss_pred -----------ccCCCC----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHH
Confidence 001111 12368899999999998 999999999999999999876543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=348.05 Aligned_cols=246 Identities=28% Similarity=0.440 Sum_probs=200.4
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 112 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 112 (376)
+.||+|+||.||+|.+..+++.||+|++.+.. ....+|+.+++.++||||+++.+++. ....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ-----TKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCEEEEEEe
Confidence 46899999999999999999999999986532 22346889999999999999988873 3345899999
Q ss_pred cccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC-
Q 017147 113 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG- 190 (376)
Q Consensus 113 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~- 190 (376)
|+++ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.....
T Consensus 76 y~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~-~~~~kL~DfG~~~~~~~~~ 149 (328)
T cd05593 76 YVNGGELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDK-DGHIKITDFGLCKEGITDA 149 (328)
T ss_pred CCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECC-CCcEEEecCcCCccCCCcc
Confidence 9986 5544443 34678999999999999999999999 79999999999999996 778999999998753322
Q ss_pred CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 017147 191 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270 (376)
Q Consensus 191 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 270 (376)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+... .
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-----------------~ 211 (328)
T cd05593 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------D 211 (328)
T ss_pred cccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-----------------C
Confidence 222345689999999998654 5899999999999999999999999887765544433220 1
Q ss_pred CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCC
Q 017147 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326 (376)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 326 (376)
. .++..+++++.+||++||+.||.+|+ ++.++++||||....+.
T Consensus 212 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 260 (328)
T cd05593 212 I------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ 260 (328)
T ss_pred c------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 1 12335789999999999999999997 89999999999886543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=346.90 Aligned_cols=246 Identities=28% Similarity=0.449 Sum_probs=201.4
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 112 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 112 (376)
+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.. ...+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCEEEEEEe
Confidence 46999999999999999999999999986532 122468999999999999999988843 345899999
Q ss_pred cccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC-
Q 017147 113 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG- 190 (376)
Q Consensus 113 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~- 190 (376)
|+++ +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus 76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~~~~~~~~~ 149 (323)
T cd05595 76 YANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcC-CCCEEecccHHhccccCCC
Confidence 9986 5544443 34578999999999999999999999 79999999999999996 778999999998753222
Q ss_pred CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 017147 191 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270 (376)
Q Consensus 191 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 270 (376)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+... .
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-----------------~ 211 (323)
T cd05595 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------------E 211 (323)
T ss_pred CccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence 222345689999999998654 5899999999999999999999999887766555544321 1
Q ss_pred CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCC
Q 017147 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326 (376)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 326 (376)
.. ++..+++++.+||.+||+.||.+|+ ++.++++||||....+.
T Consensus 212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~ 260 (323)
T cd05595 212 IR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 260 (323)
T ss_pred CC------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 11 2235789999999999999999998 89999999999986544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=348.43 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=222.4
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
.++|.+++.+|+|+||.+++++++..+..|++|++.-. +.....|+.+++++.|||||.+.+.|. ++..+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~ 78 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQL 78 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCce
Confidence 46899999999999999999999999999999998533 234468999999999999999999984 33345
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+||||+||+| ++.+.+.... +..|+++.++.++.|++.|+.|||+ ++|+|||||+.||+++. +..|||+|||+|+
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk-~~~VkLgDfGlaK 154 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTK-DKKVKLGDFGLAK 154 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccc-cCceeecchhhhh
Confidence 9999999996 6777776533 5789999999999999999999999 89999999999999997 5668999999999
Q ss_pred cCccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 186 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 186 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
...... ...+.+|||.|++||++.+ .+|+.++|||||||++|||++-+++|.+.+......+|.+....|..
T Consensus 155 ~l~~~~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp------ 227 (426)
T KOG0589|consen 155 ILNPEDSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP------ 227 (426)
T ss_pred hcCCchhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC------
Confidence 887776 5678899999999999965 45999999999999999999999999999999999999886544432
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
...+.+++.+|..||..+|..||++.++|.+|.+...
T Consensus 228 ----------------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 228 ----------------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred ----------------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 2358899999999999999999999999999998754
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=347.85 Aligned_cols=251 Identities=28% Similarity=0.458 Sum_probs=210.2
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
...|+..+.||+|+||.||+|.+..+++.||||++.-+. ...++|+.+|..++++||.++++.|+.... +
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----L 86 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----L 86 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----H
Confidence 346888899999999999999999999999999986443 334589999999999999999999976665 8
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
+++||||.| ++.++++ .+..+.+..+..++.+++.|+.|||+ ++.+|||||+.|||+.. .+.+||+|||.+..
T Consensus 87 wiiMey~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~-~g~vkl~DfgVa~q 160 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSE-SGDVKLADFGVAGQ 160 (467)
T ss_pred HHHHHHhcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEec-cCcEEEEecceeee
Confidence 999999996 6666664 45556889999999999999999999 79999999999999997 58899999999876
Q ss_pred CccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 187 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 187 ~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
..... ...+.+|||.|||||++.+ ..|+.++||||||++.+||++|.+|+....+...+..|-+
T Consensus 161 l~~~~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk-------------- 225 (467)
T KOG0201|consen 161 LTNTVKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK-------------- 225 (467)
T ss_pred eechhhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC--------------
Confidence 54433 2368899999999999974 4599999999999999999999999988776443332222
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
...+. +...+|+.+++||..||.+||+.||||.++|+|+|++..
T Consensus 226 ----------~~PP~----L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 226 ----------SAPPR----LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred ----------CCCCc----cccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 11111 112468899999999999999999999999999999763
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=335.07 Aligned_cols=286 Identities=34% Similarity=0.592 Sum_probs=223.8
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCC-CCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 106 (376)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.+. |+||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36999999999999999999999999999999875432 23457999999995 699999998886555444556
Q ss_pred EEEEeecccchHHHHHHhhhhc-CCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSSA-NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.|+||||+++++.+.+...... ...+++..++.++.||+.||.|||+ +|++||||+|+||+++.+++.+||+|||++.
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8899999999888877543322 4568999999999999999999999 7999999999999999657789999999987
Q ss_pred cCccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 186 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 186 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
...... ......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+..+.+.++.+....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 543221 1223356888999999876566799999999999999999999999999888888888887777765544322
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 321 (376)
........++......... ....+++++.+||.+||..||.+|||+.+++.||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcccchhHHH-hccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 1111111112111111111 1234789999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=343.70 Aligned_cols=251 Identities=29% Similarity=0.451 Sum_probs=203.9
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCC-ceeeeceeeeecCCCCceE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHP-NVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~ 106 (376)
+|++.+.||+|+||.||+|.+..+++.||+|++.++. .....|+.++..++|+ +|+.+++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----MDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-----CCE
Confidence 4899999999999999999999999999999986532 2234678888888765 57778777733 334
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+|+||||+++ +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~-~~~~kL~Dfg~~~ 149 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDA-EGHIKIADFGMCK 149 (324)
T ss_pred EEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcC-CCCEEEeecCcce
Confidence 8999999985 6655554 34578999999999999999999999 79999999999999996 7789999999986
Q ss_pred cCcc-CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 186 QLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 186 ~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
.... ........||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+.+..+.+..
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~----------- 217 (324)
T cd05587 150 ENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN----------- 217 (324)
T ss_pred ecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 4322 2223456789999999999654 48999999999999999999999999888776665554310
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCcccccCC
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREP 326 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e~l~hp~~~~~~~~ 326 (376)
. .++..+++++.+||.+||..||.+|+++ +++++||||+.+.+.
T Consensus 218 ------~------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~ 266 (324)
T cd05587 218 ------V------------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE 266 (324)
T ss_pred ------C------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 0 1223478999999999999999999986 899999999987553
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=344.17 Aligned_cols=286 Identities=33% Similarity=0.581 Sum_probs=225.3
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 104 (376)
...+|++.+.||+|+||.||+|.+..+++.||+|.+.+.. ....+|+.+++.++|+||+++++++..... .+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3468999999999999999999999999999999885421 223469999999999999999998753322 223
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 105 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 105 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
...|+||||+.+++.+.+.. .+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~-~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEccCccc
Confidence 35789999999988777642 28889999999999999999999 79999999999999997 778999999999
Q ss_pred ccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
.............+++.|+|||.+.+. .++.++|+||+||++|+|++|+.||.+.+..+....+.+.++.|..+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 166 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred eeCCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 865444333445678899999999664 5899999999999999999999999999988889999998998877554433
Q ss_pred CcCCCCCC--CCCCCCCChhhhc------------ccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 265 NPNYTDFR--FPQIKAHPWHKVF------------HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 265 ~~~~~~~~--~~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
......+. .+.....++...+ ....++.+++||.+||+.||++|||+.|+|.||||+.+-.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 22111110 0111111111111 12346679999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=340.12 Aligned_cols=263 Identities=28% Similarity=0.398 Sum_probs=216.6
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
.-.+.|+.-++||+||||.||-+..+.||+.||+|++.+.+. ....|..+|..++.+.||.+-..|...
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk---- 257 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK---- 257 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC----
Confidence 334578889999999999999999999999999998865432 224688999999999999998888443
Q ss_pred ceEEEEEeecccch-HHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
..+|+|+..|+|+ |.-.| +...+..|++..+++|+.+|+.||++||+ .+||+|||||+|||+|. .+.|+|+|+|
T Consensus 258 -d~LClVLtlMNGGDLkfHi--yn~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd-~GhvRISDLG 332 (591)
T KOG0986|consen 258 -DALCLVLTLMNGGDLKFHI--YNHGNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDD-HGHVRISDLG 332 (591)
T ss_pred -CceEEEEEeecCCceeEEe--eccCCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeecc-CCCeEeeccc
Confidence 3499999999975 22222 22234579999999999999999999999 89999999999999996 7889999999
Q ss_pred ccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 183 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 183 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
+|..+..+......+||..|||||++.+.. |+...|+|||||++|+|+.|+.||..........++-+..-.
T Consensus 333 LAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~------- 404 (591)
T KOG0986|consen 333 LAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE------- 404 (591)
T ss_pred eEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc-------
Confidence 999998888888889999999999997655 999999999999999999999999876544333333221110
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCcccccCCCC
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPNA 328 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~~~ 328 (376)
-...++.++|+++++|++.+|++||.+|+. ++++.+||||++++|+..
T Consensus 405 ------------------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rl 457 (591)
T KOG0986|consen 405 ------------------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRL 457 (591)
T ss_pred ------------------chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHH
Confidence 112244568999999999999999999985 679999999999988743
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=344.10 Aligned_cols=249 Identities=29% Similarity=0.478 Sum_probs=201.8
Q ss_pred eeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHH---HHhCCCCceeeeceeeeecCCCCce
Q 017147 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQL---MRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~---l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
|++.+.||+|+||.||+|.+..+++.||||++.+.. ....+|+.+ ++.++||||+++++++. ...
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence 788999999999999999999999999999986432 122345444 45678999999999884 334
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..|+||||+++ +|...+. ...+++..++.++.||+.||.|||+ .|++||||||+||+++. ++.+||+|||++
T Consensus 76 ~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~-~~~~kL~Dfg~~ 148 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDT-EGFVKIADFGLC 148 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECC-CCcEEeCcccCC
Confidence 58999999997 4444332 3579999999999999999999999 79999999999999996 778999999998
Q ss_pred ccCccC-CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 185 KQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 185 ~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
...... .......||+.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+.+..+....
T Consensus 149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~---------- 217 (324)
T cd05589 149 KEGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE---------- 217 (324)
T ss_pred ccCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 753322 223346789999999998654 58999999999999999999999999888776665554310
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCC
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 326 (376)
. .++..++.++.+||.+||+.||.+|| ++.++++||||+++.+.
T Consensus 218 -------~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~ 266 (324)
T cd05589 218 -------V------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD 266 (324)
T ss_pred -------C------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence 0 12234789999999999999999999 69999999999987544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=335.11 Aligned_cols=283 Identities=35% Similarity=0.565 Sum_probs=225.2
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++.... ..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CC
Confidence 4568999999999999999999999999999999885332 12347999999999999999999875432 23
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.+++||||+.++|.+.+.. ....+++..+..++.|++.||.|||+ .|++||||||+||+++. ++.+||+|||++.
T Consensus 82 ~~~lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~kL~dfg~~~ 156 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTD-KGCLKIADFGLAR 156 (309)
T ss_pred eEEEEEecCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECccceee
Confidence 4789999999888777753 23568999999999999999999999 79999999999999996 7789999999997
Q ss_pred cCccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 186 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 186 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
...... ......+++.|+|||.+.+...++.++|+||+||++|+|++|++||.+.+..+.+..+.+.++.+....+...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 654332 2223345788999999876666899999999999999999999999999999999999998888776554332
Q ss_pred Cc--CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 265 NP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 265 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.. ....+..+......+...+ ..+++.+.+||.+||++||++|||++++++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKF-PWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred hcccccccccccCCCCCchHHhc-cccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 11 1111122211111222221 2258899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=338.07 Aligned_cols=278 Identities=32% Similarity=0.566 Sum_probs=207.6
Q ss_pred eeeeecCCCeeEEEEEEcC--CCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017147 39 ERVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 114 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 114 (376)
...||+|+||+||+|.++. ++..||+|.+.... ....+|+.+++.++||||+++++++.... ...+|+||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHS---DRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccC---CCeEEEEEeee
Confidence 3579999999999999654 56889999886543 23458999999999999999999875432 33478999999
Q ss_pred cchHHHHHHhhh-----hcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEc---CCCCcEEEEeeccccc
Q 017147 115 PESMYRVLKHYS-----SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD---PLTHQVKICDFGSAKQ 186 (376)
Q Consensus 115 ~~~l~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~---~~~~~vkl~Dfg~a~~ 186 (376)
++++...+.... .....+++..++.++.||+.||.|||+ .||+||||||+|||+. ..++.+||+|||+++.
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 998888775321 122358899999999999999999999 7999999999999994 2356899999999976
Q ss_pred CccCCC----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHh
Q 017147 187 LIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVL 253 (376)
Q Consensus 187 ~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~~i~~~~ 253 (376)
...... .....+|+.|+|||++.+...++.++||||+||++|+|++|.+||..... ...+..+...+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 543321 23456799999999997766689999999999999999999999975432 34566677777
Q ss_pred CCCCHHHHhhcCc--CCCCCC----CCCCCCCC---hhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 254 GTPTREEIRCMNP--NYTDFR----FPQIKAHP---WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 254 ~~~~~~~~~~~~~--~~~~~~----~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
+.+....+..... .+.... ........ .........+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 7766655543211 111000 00000000 0111112346679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=348.45 Aligned_cols=256 Identities=26% Similarity=0.409 Sum_probs=206.3
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
++|++.+.||+|+||+||+|.++.+++.||+|++.... .....|+.++..++|++|+++++.+. ....
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-----~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ-----DKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 36999999999999999999999999999999986421 23346899999999999999998883 3445
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+|+||||++| +|.+.+. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~-~~~vkL~DfG~~~ 149 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDA-KGHVKLSDFGLCT 149 (360)
T ss_pred EEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECC-CCCEEEeeccCCc
Confidence 8999999986 6666654 34678999999999999999999999 79999999999999996 7889999999986
Q ss_pred cCccCC------------------------------------CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHH
Q 017147 186 QLIAGE------------------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAE 229 (376)
Q Consensus 186 ~~~~~~------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ 229 (376)
...... ...+.+||+.|+|||++.+. .++.++|||||||++|+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilye 228 (360)
T cd05627 150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYE 228 (360)
T ss_pred ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeee
Confidence 432110 01234689999999999654 58999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC
Q 017147 230 LLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 309 (376)
Q Consensus 230 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 309 (376)
|++|.+||.+.+..+....+..... ...+|. ...+++++++||.+|+. ||.+|+
T Consensus 229 l~tG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~~li~~l~~-~p~~R~ 282 (360)
T cd05627 229 MLIGYPPFCSETPQETYRKVMNWKE---------------TLVFPP----------EVPISEKAKDLILRFCT-DSENRI 282 (360)
T ss_pred cccCCCCCCCCCHHHHHHHHHcCCC---------------ceecCC----------CCCCCHHHHHHHHHhcc-ChhhcC
Confidence 9999999998887776665543110 001110 01268899999999875 999998
Q ss_pred ---CHHHHhcCCCcccccCCC
Q 017147 310 ---TALEACAHPFFDELREPN 327 (376)
Q Consensus 310 ---t~~e~l~hp~~~~~~~~~ 327 (376)
+++++++||||+++.+..
T Consensus 283 ~~~~~~ei~~hp~f~~~~~~~ 303 (360)
T cd05627 283 GSNGVEEIKSHPFFEGVDWGH 303 (360)
T ss_pred CCCCHHHHhcCCCCCCCCHHH
Confidence 489999999999986653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=341.52 Aligned_cols=245 Identities=29% Similarity=0.492 Sum_probs=199.6
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.||+|+||+||+|.+..+++.||+|++.++. .....|..++..+ +||||+++++++. ....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence 46999999999999999999999999987532 2224677788777 6999999999883 334589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||+++ +|...+. ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++......
T Consensus 76 e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~ 149 (318)
T cd05570 76 EYVNGGDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDS-EGHIKIADFGMCKEGILG 149 (318)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECC-CCcEEecccCCCeecCcC
Confidence 99986 5554443 34579999999999999999999999 79999999999999996 778999999998653222
Q ss_pred -CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 191 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 191 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
.......+|+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.......+...
T Consensus 150 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~----------------- 211 (318)
T cd05570 150 GVTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED----------------- 211 (318)
T ss_pred CCcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 223345689999999999654 5899999999999999999999999887766555444321
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCcccccC
Q 017147 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELRE 325 (376)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e~l~hp~~~~~~~ 325 (376)
.. .++..++.++.+||++||..||.+|||+ .++++||||+.+.+
T Consensus 212 ~~------------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 212 EV------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred CC------------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 00 1223478999999999999999999999 99999999988754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=344.86 Aligned_cols=256 Identities=29% Similarity=0.462 Sum_probs=201.1
Q ss_pred eeeeeeeeecCCCeeEEEEEEc---CCCcEEEEEEeeccc--------cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 017147 35 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 102 (376)
+|++.+.||+|+||+||+|++. .+++.||+|++.+.. .....|+.+++.+ +|++|+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 4899999999999999999864 478999999986431 1234688999999 489999998887 3
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
....+|+||||+.+ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~-~~~~kl~Df 149 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDS-EGHVVLTDF 149 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECC-CCCEEEeeC
Confidence 34458899999986 6666554 34678999999999999999999999 79999999999999996 778999999
Q ss_pred cccccCccCCC--ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 182 GSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 182 g~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
|+++....... .....||+.|+|||++.+...++.++|||||||++|+|++|..||...........+.+...
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~----- 224 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL----- 224 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh-----
Confidence 99976433322 23457899999999997655578999999999999999999999975432211111111100
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCC
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 326 (376)
.. ...++..+++.+.+||.+||+.||++|+ +++++++||||+...+.
T Consensus 225 ---~~-----------------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 276 (332)
T cd05614 225 ---KC-----------------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE 276 (332)
T ss_pred ---cC-----------------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 00 0112234789999999999999999999 88999999999986543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=342.89 Aligned_cols=246 Identities=29% Similarity=0.473 Sum_probs=200.5
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.||+|+||.||+|++..+++.||+|++.++. .....|..++..+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-----~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-----KDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCeEEEEE
Confidence 36999999999999999999999999986532 1223577777765 79999999998843 34489999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||+++ +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus 76 E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~-~~~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 76 EYVNGGDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDA-EGHCKLADFGMCKEGILN 149 (321)
T ss_pred eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEeecccceecccC
Confidence 99986 5555553 34678999999999999999999999 79999999999999996 778999999998754322
Q ss_pred -CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 191 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 191 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
.......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+.+..+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~----------------- 211 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD----------------- 211 (321)
T ss_pred CccccccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 22334568999999999865 45899999999999999999999999998877766655431
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-------CHHHHhcCCCcccccCC
Q 017147 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-------TALEACAHPFFDELREP 326 (376)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-------t~~e~l~hp~~~~~~~~ 326 (376)
+.. ++..++.++.+||.+||+.||++|+ +++++++||||..+.+.
T Consensus 212 ~~~------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 212 DVL------------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred CCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 011 1223688999999999999999999 89999999999886544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=345.15 Aligned_cols=247 Identities=29% Similarity=0.441 Sum_probs=199.8
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 112 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 112 (376)
+.||+|+||+||+|.+..+++.||+|++.+.. .....|+.+++.++||||+++.+++. ....+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~-----~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----THDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----cCCEEEEEEe
Confidence 46999999999999999999999999986532 12246888999999999999988873 3345899999
Q ss_pred cccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC-
Q 017147 113 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG- 190 (376)
Q Consensus 113 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~- 190 (376)
|+++ +|...+. ....+++..++.++.||+.||.|||+.+||+||||||+|||++. ++.+||+|||+++.....
T Consensus 76 ~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~-~~~~kL~Dfg~~~~~~~~~ 150 (325)
T cd05594 76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK-DGHIKITDFGLCKEGIKDG 150 (325)
T ss_pred CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECC-CCCEEEecCCCCeecCCCC
Confidence 9986 5544443 34678999999999999999999996249999999999999996 778999999998753322
Q ss_pred CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 017147 191 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270 (376)
Q Consensus 191 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 270 (376)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-----------------~ 212 (325)
T cd05594 151 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E 212 (325)
T ss_pred cccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence 223345689999999998654 5899999999999999999999999887765554443321 1
Q ss_pred CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCC
Q 017147 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326 (376)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 326 (376)
.. ++..+++++.+||.+||+.||++|+ ++.++++||||..+.+.
T Consensus 213 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 213 IR------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred CC------------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 11 2234789999999999999999997 89999999999986544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-46 Score=334.65 Aligned_cols=252 Identities=27% Similarity=0.392 Sum_probs=199.6
Q ss_pred eecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017147 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 114 (376)
Q Consensus 42 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 114 (376)
||+|+||+||++.++.+++.||+|++.+.. .....|+.+++.++|+||+++.+++. ....+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ-----TKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc-----CCCeEEEEEeCC
Confidence 699999999999999999999999986432 12246899999999999999988873 334588999999
Q ss_pred cc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCC-
Q 017147 115 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA- 192 (376)
Q Consensus 115 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~- 192 (376)
++ +|...+.........+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.++|+|||++........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~~~~~~~~~ 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDN-DGNVRISDLGLAVELKDGQSK 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCccceecCCCCcc
Confidence 86 5655554333445679999999999999999999999 79999999999999996 77899999999876543322
Q ss_pred ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCC
Q 017147 193 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272 (376)
Q Consensus 193 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 272 (376)
.....+|+.|+|||++.+. .++.++|+||+||++|+|++|+.||...+.......+.......
T Consensus 154 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------- 216 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND---------------- 216 (280)
T ss_pred ccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc----------------
Confidence 2345678999999999654 58899999999999999999999998755332222222110000
Q ss_pred CCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCC
Q 017147 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326 (376)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 326 (376)
...++..+++++.+++.+||+.||++|+ |++++++||||+.+.+.
T Consensus 217 ---------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 217 ---------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred ---------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 0012234789999999999999999999 88999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=345.75 Aligned_cols=278 Identities=25% Similarity=0.399 Sum_probs=207.3
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 112 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 112 (376)
..+|++.+.||+|+||.||+|.+..+++.||+|+.... ....|+.+++.++|+||+++++++... ...|+|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e 137 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLVSG-----AITCMVLP 137 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEEeC-----CeeEEEEE
Confidence 34799999999999999999999999999999975433 335799999999999999999988543 34889999
Q ss_pred cccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCC
Q 017147 113 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 192 (376)
Q Consensus 113 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~ 192 (376)
++.+++...+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++. .+.+||+|||++........
T Consensus 138 ~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 138 HYSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFIND-VDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred ccCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEecCccccccccCcc
Confidence 999988877753 44678999999999999999999999 79999999999999996 77899999999975444444
Q ss_pred ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhC-CCCCCCCCh---------HHHHHHHHHHhCCCCHHHHh
Q 017147 193 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENA---------VDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 193 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~ 262 (376)
.....||+.|+|||++.+. .++.++|||||||++|+|+++ .++|..... ...+..++..++..+.....
T Consensus 213 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred cccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 4456789999999998654 489999999999999999985 455544221 22344444444433221110
Q ss_pred hcC----cCCCCCC-CCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 263 CMN----PNYTDFR-FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 263 ~~~----~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
... ..+.++. ........+...-...++.++.+||.+||+.||.+|||+.|+|+||||+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 000 0000000 000000011111122467889999999999999999999999999999864
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=341.40 Aligned_cols=251 Identities=29% Similarity=0.426 Sum_probs=203.9
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-------chHHHHHHHHhC-CCCceeeeceeeeecCCCCceE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
+|++.+.||+|+||+||+|++..+++.||+|++.+... ....|..++..+ .|++|+++++++. ....
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ-----TMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe-----cCCE
Confidence 48899999999999999999999999999999865321 123466677666 5788888888873 3345
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+|+||||+++ +|...+. ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 76 ~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~-~~~~kL~DfG~~~ 149 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDS-EGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECC-CCcEEEccCCCce
Confidence 8999999985 6655554 34678999999999999999999999 79999999999999996 7789999999987
Q ss_pred cCcc-CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 186 QLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 186 ~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
.... ........||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+....+....
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~----------- 217 (323)
T cd05616 150 ENMWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN----------- 217 (323)
T ss_pred ecCCCCCccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 5432 2223345689999999999654 58999999999999999999999999988777666655410
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCcccccCC
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 326 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 326 (376)
.. ++..++.++.+|+.+||+.||++|++ ..++++||||+.+.+.
T Consensus 218 ------~~------------~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~ 266 (323)
T cd05616 218 ------VA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 266 (323)
T ss_pred ------CC------------CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 11 22347899999999999999999998 4899999999987644
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=329.98 Aligned_cols=281 Identities=28% Similarity=0.513 Sum_probs=220.8
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc---ccchHHHHHHHHhCCC--C----ceeeeceeeeecCCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRVMDH--P----NVISLKHCFFSTTSKN 103 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~e~~~l~~l~h--~----~iv~~~~~~~~~~~~~ 103 (376)
..+|.+++.+|+|.||+|-.+.+..++..||||++..- +....-|+++|.++.+ | -+|.+.++| +.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence 56899999999999999999999999999999988543 3344568999999842 1 356666666 55
Q ss_pred ceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC-----------
Q 017147 104 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL----------- 172 (376)
Q Consensus 104 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~----------- 172 (376)
.+..|||+|.++-++.+.+.. +.-.+++...++.+.+|++.++++||+ .+++|-||||+|||+.+.
T Consensus 163 rghiCivfellG~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred cCceEEEEeccChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCc
Confidence 666999999999899988874 244568999999999999999999999 699999999999998421
Q ss_pred --------CCcEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHH
Q 017147 173 --------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 244 (376)
Q Consensus 173 --------~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 244 (376)
+..|+++|||.|+.. .+...+.+.|+.|+|||++++-+ ++.++||||+||||+|+.+|...|+..+..+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred cceeccCCCcceEEEecCCccee--ccCcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 235999999999754 33346778899999999998865 9999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCHHHHhhc-CcC--------CCCCCCCC------CCCCChhhhccc--CCChhHHHHHHhhcCcCCCC
Q 017147 245 QLVEIIKVLGTPTREEIRCM-NPN--------YTDFRFPQ------IKAHPWHKVFHK--RMPPEAIDLASRLLQYSPSL 307 (376)
Q Consensus 245 ~~~~i~~~~~~~~~~~~~~~-~~~--------~~~~~~~~------~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~ 307 (376)
.+..+.+++|+.+...+... ... |.+..... ....++...... ....++.|||++||.+||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 99999999998777665544 111 11111000 011122222211 11236899999999999999
Q ss_pred CCCHHHHhcCCCccccc
Q 017147 308 RCTALEACAHPFFDELR 324 (376)
Q Consensus 308 R~t~~e~l~hp~~~~~~ 324 (376)
|+|+.|+|.||||+.+.
T Consensus 397 RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 397 RITLREALSHPFFARLT 413 (415)
T ss_pred cccHHHHhcCHHhhcCC
Confidence 99999999999998753
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=333.47 Aligned_cols=257 Identities=27% Similarity=0.406 Sum_probs=207.0
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.|++.+.||+|+||+||++.+..+++.||+|++..+. ....+|+.+++.++|+||+++++.+. ....+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec-----CCCeE
Confidence 4889999999999999999999999999999886432 22346999999999999999988873 33458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|+||||+.+ +|...+.. .....+++..+..++.|++.||.|||+ .|++||||||+||+++. ++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~~l~Dfg~~~~ 151 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDD-YGHIRISDLGLAVE 151 (285)
T ss_pred EEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECC-CCCEEEeeCCCcee
Confidence 999999985 55555532 223568999999999999999999999 79999999999999996 67899999999976
Q ss_pred CccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 187 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
...........+++.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.......+...+...
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 220 (285)
T cd05605 152 IPEGETIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED---------- 220 (285)
T ss_pred cCCCCccccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc----------
Confidence 5444433445788999999998654 58899999999999999999999998876554443333321100
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCC
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 326 (376)
...++..++..+.+||.+||..||.+|| +++++++||||....+.
T Consensus 221 ---------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 221 ---------------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred ---------------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 0012234788999999999999999999 89999999999886544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=330.57 Aligned_cols=276 Identities=42% Similarity=0.751 Sum_probs=226.6
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+|++.+.||+|++|.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++.. ....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence 5899999999999999999999999999999986433 234579999999999999999998843 34589
Q ss_pred EEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 109 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 109 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
+|+||+.++|.+.+.. ....+++..++.++.|++.||.|||+ .|++|+||||+||+++. ++.++|+|||++....
T Consensus 76 ~v~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~-~~~~~l~dfg~~~~~~ 150 (286)
T cd07832 76 LVMEYMPSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISA-DGVLKIADFGLARLFS 150 (286)
T ss_pred EEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcC-CCcEEEeeeeeccccc
Confidence 9999997788777753 23668999999999999999999999 79999999999999997 7789999999987654
Q ss_pred cCCC--ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 017147 189 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 265 (376)
Q Consensus 189 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 265 (376)
.... .....++..|+|||.+.+...++.++||||+||++|+|++|.+||.+.+....+..+...++.+....+....
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 4321 2345678899999998666667899999999999999999999999988888888888888888776655432
Q ss_pred -cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 017147 266 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321 (376)
Q Consensus 266 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 321 (376)
..+....++.....++...+ ...+.++.+||++||..||++|||++++++||||.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIF-PDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cchhhcccCCCCCcchHHHhC-CCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 12333334433333444333 34678999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=337.86 Aligned_cols=246 Identities=30% Similarity=0.524 Sum_probs=198.0
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHh-CCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRV-MDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.||+|+||+||+|.+..+++.||+|++.... .....|..++.. ++||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-----KENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-----CCEEEEEE
Confidence 46999999999999999999999999986532 122356667765 589999999998843 33489999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||+++ +|...+. ....+++..+..++.|++.||.|||+ +|++||||||+|||++. ++.+||+|||++......
T Consensus 76 ey~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~-~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 76 EYLNGGDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDT-DGHIKIADFGMCKENMLG 149 (316)
T ss_pred eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECC-CCCEEEccCCcceECCCC
Confidence 99985 6666554 34578999999999999999999999 79999999999999996 778999999998753222
Q ss_pred -CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 191 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 191 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
.......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+..+....+... .+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~------------- 213 (316)
T cd05619 150 DAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NP------------- 213 (316)
T ss_pred CCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC-------------
Confidence 223456789999999998654 5899999999999999999999999988766555443221 00
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHH-HHhcCCCcccccCC
Q 017147 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREP 326 (376)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~-e~l~hp~~~~~~~~ 326 (376)
.++..++.++.+||.+||+.||++|+++. ++++||||+.+.+.
T Consensus 214 --------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 214 --------------CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred --------------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence 01223688999999999999999999996 99999999987644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=343.37 Aligned_cols=246 Identities=29% Similarity=0.474 Sum_probs=197.8
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-------chHHHH-HHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNREL-QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.||+|+||+||+|.+..+++.||+|++.+... ....|. .+++.++||||+++++.+.. ...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-----~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----ADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-----CCEEEEEE
Confidence 469999999999999999999999999864321 111233 35678999999999988843 33488999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||+.+ +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus 76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~-~~~~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 76 DYVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDS-QGHVVLTDFGLCKEGIEH 149 (323)
T ss_pred cCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECC-CCcEEEeccCCCcccccC
Confidence 99986 5555554 35678999999999999999999999 79999999999999996 778999999998754322
Q ss_pred -CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 191 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 191 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+... +
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~------------- 212 (323)
T cd05575 150 SKTTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK---P------------- 212 (323)
T ss_pred CCccccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC---C-------------
Confidence 223345689999999998654 5899999999999999999999999988776665554431 0
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCcccccCC
Q 017147 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREP 326 (376)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~e~l~hp~~~~~~~~ 326 (376)
. .+...+++.+.+||++||+.||.+||++ .++++||||..+.+.
T Consensus 213 -~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~ 260 (323)
T cd05575 213 -L------------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWD 260 (323)
T ss_pred -C------------CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 0 0122468899999999999999999997 699999999887653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=339.48 Aligned_cols=246 Identities=29% Similarity=0.493 Sum_probs=197.5
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHh-CCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRV-MDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.||+|+||.||+|+++.+++.||+|++.+.. .....|..++.. ++|+||+++++++. ...++|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ-----TKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE-----eCCEEEEEE
Confidence 46999999999999999999999999986532 123356666664 48999999998883 344589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc-
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 189 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~- 189 (376)
||+.+ +|...+. ....+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++....
T Consensus 76 E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05620 76 EFLNGGDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDR-DGHIKIADFGMCKENVFG 149 (316)
T ss_pred CCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEeCccCCCeecccC
Confidence 99986 6555553 34678999999999999999999999 79999999999999996 77899999999874322
Q ss_pred CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 190 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 190 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
........||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+... .+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~------------- 213 (316)
T cd05620 150 DNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TP------------- 213 (316)
T ss_pred CCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC-------------
Confidence 2223346689999999999654 5899999999999999999999999888766555443321 00
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH-HHHhcCCCcccccCC
Q 017147 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-LEACAHPFFDELREP 326 (376)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-~e~l~hp~~~~~~~~ 326 (376)
.++..++.++++||++||..||++|+++ +++++||||+.+.+.
T Consensus 214 --------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~ 257 (316)
T cd05620 214 --------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWT 257 (316)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHH
Confidence 0122368899999999999999999997 589999999887543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=343.89 Aligned_cols=257 Identities=26% Similarity=0.428 Sum_probs=206.6
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
..++|++.+.||+|+||.||+|.++.+++.||+|++.+.. ....+|+.+++.++||||+++++++. ..
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-----~~ 115 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-----DD 115 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----cC
Confidence 4578999999999999999999999999999999986421 22347899999999999999998883 34
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
.++|+||||+++ +|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~-~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECC-CCCEEEEeCCc
Confidence 458999999985 66666542 458899999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccCCC--ceeeeeccccCchhhhhCCC---CCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 184 AKQLIAGEA--NISYICSRFYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 184 a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
+........ .....||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--- 265 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS--- 265 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc---
Confidence 976543322 23457899999999986432 3788999999999999999999999988877666665542110
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCcccccC
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELRE 325 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~e~l~hp~~~~~~~ 325 (376)
..++. ...++..+++||.+||..++.+ |++++++++||||++..+
T Consensus 266 ------------~~~~~----------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 266 ------------LTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred ------------ccCCC----------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 01111 1247899999999999844443 789999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=338.67 Aligned_cols=260 Identities=27% Similarity=0.414 Sum_probs=206.4
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
++|++.+.||+|+||+||++++..+++.||+|++.+.. ....+|+.++..++|+||+++++++. ...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ-----DENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe-----cCCe
Confidence 47999999999999999999999999999999986421 22357888999999999999999883 3445
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+|+||||+.| +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~ 150 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDK-NGHIRLADFGSCL 150 (331)
T ss_pred EEEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECC-CCCEEEEECCcee
Confidence 8999999975 66666643 34578999999999999999999999 79999999999999986 7789999999987
Q ss_pred cCccCCCc--eeeeeccccCchhhhhC----CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 186 QLIAGEAN--ISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 186 ~~~~~~~~--~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
........ ....||+.|+|||++.+ ...++.++||||+||++|+|++|+.||.+.+..+....+......
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~---- 226 (331)
T cd05597 151 RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH---- 226 (331)
T ss_pred ecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc----
Confidence 55433221 23468999999999853 234788999999999999999999999988776666555431100
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCcccccCCC
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPN 327 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~e~l~hp~~~~~~~~~ 327 (376)
+.++. ....+++.+++||++||+.++.+ |+++.++++||||..+.+..
T Consensus 227 -----------~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~ 276 (331)
T cd05597 227 -----------FQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN 276 (331)
T ss_pred -----------ccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHH
Confidence 00110 01236899999999999765554 78999999999998876543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=338.07 Aligned_cols=310 Identities=35% Similarity=0.662 Sum_probs=238.4
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
..+|++.+.||+|++|.||+|.++.+++.||+|++.... ....+|+.+++.++|+||+++++++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 368999999999999999999999999999999886432 22346899999999999999998774433 33456
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
+|+||||+.+++...+. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++..
T Consensus 83 ~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~dfg~~~~ 156 (334)
T cd07855 83 VYVVMDLMESDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNE-DCELRIGDFGMARG 156 (334)
T ss_pred EEEEEehhhhhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEeccccccee
Confidence 88999999987766654 34569999999999999999999999 79999999999999996 78899999999875
Q ss_pred CccCCC-----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 187 LIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 187 ~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
...... .....++..|+|||.+.+...++.++|+||+||++|+|++|++||.+.+....+..+....|.++...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 433221 123467889999999866556899999999999999999999999999988888888888898877655
Q ss_pred hhcCcCCCC---CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCC
Q 017147 262 RCMNPNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPP 338 (376)
Q Consensus 262 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~ 338 (376)
......... -.++.....+|...+ ...++++.++|.+||+.||++|||+.+++.||||+....+.... .-.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~----~~~~ 311 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIF-PKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEP----TCPP 311 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHc-ccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccc----cCCC
Confidence 432211100 012222223333322 34689999999999999999999999999999999876554322 1223
Q ss_pred CCCchhhhccCCHHHH
Q 017147 339 LFNFKQELSGASPELV 354 (376)
Q Consensus 339 ~~~~~~~~~~~~~~~~ 354 (376)
..+++.+....+.+.+
T Consensus 312 ~~~~~~~~~~~~~~~~ 327 (334)
T cd07855 312 PFDFDFEAIELSREQL 327 (334)
T ss_pred CCCCChhhhhcChhhH
Confidence 4455544444444433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=337.81 Aligned_cols=275 Identities=27% Similarity=0.442 Sum_probs=205.6
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.++|++.+.||+|+||.||+|.+..++..+|+|.+.... ....+|+++++.++|+||+++++++... ..+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEE
Confidence 468999999999999999999999999999999886432 2345799999999999999999988443 348
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
++||||+++ +|.+.+. ....+++..+..++.|++.||.|||+..+|+||||||+|||++. ++.+||+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 153 (331)
T cd06649 79 SICMEHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS-RGEIKLCDFGVSGQ 153 (331)
T ss_pred EEEeecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcC-CCcEEEccCccccc
Confidence 899999996 6666654 34568999999999999999999998236999999999999996 77899999999875
Q ss_pred CccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh---
Q 017147 187 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC--- 263 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~--- 263 (376)
.... ......+|+.|+|||++.+. .++.++|+|||||++|+|++|+.||...+..+... .++.+.......
T Consensus 154 ~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~ 227 (331)
T cd06649 154 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA----IFGRPVVDGEEGEPH 227 (331)
T ss_pred cccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HhcccccccccCCcc
Confidence 5332 23345689999999999654 58999999999999999999999998776544322 222211100000
Q ss_pred -cCcCCC---C----CCCCCCCC------------CChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 264 -MNPNYT---D----FRFPQIKA------------HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 264 -~~~~~~---~----~~~~~~~~------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
..+... . ........ ..........+++++++||.+||++||++|||+.++++||||+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 000000 0 00000000 000000012367899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=327.27 Aligned_cols=276 Identities=33% Similarity=0.641 Sum_probs=215.6
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
++|++.+.||+|++|.||+|.++.+++.||+|++.... ....+|+.+++.++|+|++++++.+.. ...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-----KRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-----CCEE
Confidence 47999999999999999999999999999999885432 223579999999999999999998843 3348
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
++||||++++++..+. .....+++..++.++.|++.||.|||+ .|++||||||+||+++. ++.++|+|||++...
T Consensus 76 ~~v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~ 150 (286)
T cd07847 76 HLVFEYCDHTVLNELE---KNPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITK-QGQIKLCDFGFARIL 150 (286)
T ss_pred EEEEeccCccHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcC-CCcEEECccccceec
Confidence 8999999987655543 234568999999999999999999999 79999999999999996 678999999999865
Q ss_pred ccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
.... ......++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+..+.+..+............
T Consensus 151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 151 TGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred CCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc
Confidence 4433 223345688899999987656688999999999999999999999999888777777776665544332221111
Q ss_pred --CCCCCCCCCCC-CCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 267 --NYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 267 --~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
.+.....+... ..++... ...++..+.+||.+||+.||++|||+.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESK-FPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccccccCCCcccccCHHHH-hccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 01111111111 1112222 23478999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=328.69 Aligned_cols=277 Identities=35% Similarity=0.665 Sum_probs=218.1
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.++|++.+.||+|++|.||+|.++.+++.||+|.+.... ....+|+.+++.++|+||+++++++. ...+.
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH-----TKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe-----cCCeE
Confidence 468999999999999999999999999999999885432 22357999999999999999999883 33458
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
|+||||+.++|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++...
T Consensus 79 ~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~ 153 (291)
T cd07844 79 TLVFEYLDTDLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISE-RGELKLADFGLARAK 153 (291)
T ss_pred EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcC-CCCEEECcccccccc
Confidence 99999999988776653 23468999999999999999999999 79999999999999996 778999999998654
Q ss_pred ccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 188 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 188 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.... ......++..|+|||.+.+...++.++||||+||++|+|++|+.||.+.. ..+.+..+.+.++.+..+.+....
T Consensus 154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence 2221 11223457889999998765668899999999999999999999998766 566677777777877766554332
Q ss_pred cC--CCCCCCCCCCCCChhhhcccCCC--hhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 266 PN--YTDFRFPQIKAHPWHKVFHKRMP--PEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 266 ~~--~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
.. +....++.....+....+. .++ .++.+++.+||+.||++|||+.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAP-RLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hccccccccccccCChhHHHhCc-CCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 21 2222222222222222222 244 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=328.00 Aligned_cols=275 Identities=35% Similarity=0.635 Sum_probs=219.2
Q ss_pred eeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-----chHHHHHHHHhCC-CCceeeeceeeeecCCCCceEEEE
Q 017147 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
|++.+.||+|+||.||+|.+..+++.||+|++.+... ...+|+.++..+. |+|++++++++.+.. ...+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK---TGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC---CCcEEE
Confidence 7789999999999999999999999999998865321 1236888888885 999999999885431 134889
Q ss_pred EeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 110 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 110 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
||||+++++.+.+.. ....+++..++.++.|++.||+|||+ +|++||||+|+||+++. +.+||+|||++.....
T Consensus 78 v~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 78 VFELMDMNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD--DILKLADFGSCRGIYS 151 (282)
T ss_pred EEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC--CCeEEEeccccccccc
Confidence 999999988877753 23568999999999999999999999 79999999999999996 7899999999986654
Q ss_pred CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC-C
Q 017147 190 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN-Y 268 (376)
Q Consensus 190 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~ 268 (376)
........+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+..+.+.++.+........... .
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 444444567889999998765555789999999999999999999999999988888888888887776543322111 1
Q ss_pred CCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
.++.++.......... ...++.++.+||.+||.+||++|||++++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGLRKL-LPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccCcccccccHHHH-cccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1222332222222221 23468999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=309.98 Aligned_cols=283 Identities=31% Similarity=0.593 Sum_probs=238.2
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-ccchHHHHHHHHhCC-CCceeeeceeeeecCCCCceEEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
.++|++.+.+|+|-|+.||.+.+..+++.++||++..- .+.+.+|+.+|+.|. ||||+++.++..+..+.. ..+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt---paLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT---PSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC---chhH
Confidence 56899999999999999999999999999999988653 345679999999997 999999999986655443 6699
Q ss_pred eecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 111 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 111 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
+||++..-...+- ..++...++.++.|++.||.|+|+ .||+|||+||.|+++|.....++|+|+|+|.....+
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 9999974333332 467888899999999999999999 699999999999999987889999999999998888
Q ss_pred CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHh-----hc
Q 017147 191 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIR-----CM 264 (376)
Q Consensus 191 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~-----~~ 264 (376)
......+.+++|..||++..-+.|+.+-|+|||||++..|+..+.| |.|.+..+++.+|.+.+|+......- .+
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 8777888899999999998777899999999999999999997766 57899999999999999986554321 13
Q ss_pred CcCCCCCCCCCCCCCChhhhcccC----CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
++.|.++ +......+|...++.. +++++.||+.++|.+|.++|+||.|++.||||..++..
T Consensus 267 dp~~~~i-~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~ 331 (338)
T KOG0668|consen 267 DPQFEDI-LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA 331 (338)
T ss_pred ChhHhhH-hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence 4444432 2334566777766542 57999999999999999999999999999999887654
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=340.49 Aligned_cols=247 Identities=25% Similarity=0.467 Sum_probs=195.4
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.||+|+||.||+|.+..+++.||+|++.+.. .....|..++..+ +||||+++++++. ....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~-----~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ-----TESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE-----cCCEEEEEE
Confidence 46999999999999999999999999986532 1234688888888 7999999999883 334589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc-c
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-A 189 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~-~ 189 (376)
||+++ +|...+. ....+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.+||+|||+++... .
T Consensus 76 e~~~~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~-~~~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 76 EFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDA-EGHIKLTDYGMCKEGIRP 149 (329)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEECcCccccccccC
Confidence 99986 5555443 34679999999999999999999999 79999999999999996 7789999999987432 2
Q ss_pred CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCCHHHH
Q 017147 190 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--------VDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 190 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~ 261 (376)
........||+.|+|||++.+. .++.++|+||+||++|+|++|+.||..... .+.+.+.+..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------- 219 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE--------- 219 (329)
T ss_pred CCccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------
Confidence 2333456789999999999654 589999999999999999999999963221 1111111110
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC------HHHHhcCCCcccccCC
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELREP 326 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t------~~e~l~hp~~~~~~~~ 326 (376)
... .++..++.++.+||++||+.||.+|+| ++++++||||..+.+.
T Consensus 220 -------~~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~ 271 (329)
T cd05588 220 -------KQI------------RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD 271 (329)
T ss_pred -------CCC------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 000 122347889999999999999999997 7899999999886553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=339.55 Aligned_cols=246 Identities=29% Similarity=0.492 Sum_probs=199.9
Q ss_pred eeeeecCCCeeEEEEEEc---CCCcEEEEEEeeccc--------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 39 ERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
++.||+|+||.||+|++. .+++.||+|++.+.. .....|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-----GGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-----CCeE
Confidence 367999999999999864 478899999886431 123479999999999999999988843 3358
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|+||||+++ +|.+.+. ..+.+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+++.
T Consensus 76 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 149 (323)
T cd05584 76 YLILEYLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDA-QGHVKLTDFGLCKE 149 (323)
T ss_pred EEEEeCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEeeCcCCee
Confidence 999999996 6555554 34678899999999999999999999 79999999999999996 77899999999875
Q ss_pred CccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 187 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 187 ~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~------------- 215 (323)
T cd05584 150 SIHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG------------- 215 (323)
T ss_pred cccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence 43222 23345689999999998654 4789999999999999999999999988776655554431
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccC
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 325 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~ 325 (376)
... ++..+++++.+||.+||+.||++|+ +++++++||||+...+
T Consensus 216 ----~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 216 ----KLN------------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred ----CCC------------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 001 1234688999999999999999999 8999999999987643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=319.04 Aligned_cols=285 Identities=30% Similarity=0.528 Sum_probs=232.2
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC---CC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS---KN 103 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~ 103 (376)
...|+....||+|.||.||+|+++.+++.||+|++.-+. ....+|+++|..|+|+|++.+++++-.... ..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 347888999999999999999999999999999764321 223589999999999999999988743332 34
Q ss_pred ceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 104 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 104 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
...+|+||.+|+.+|..++.. ...+++...+..++.++++||.|+|+ ..|+|||+||.|+|++. ++.+||+|||+
T Consensus 96 r~t~ylVf~~cehDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~-dgilklADFGl 170 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITK-DGILKLADFGL 170 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcC-CceEEeecccc
Confidence 556899999999988888763 44679999999999999999999999 79999999999999996 78999999999
Q ss_pred cccCccCCC-----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 184 AKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 184 a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
++.+..... .+..+.|.+|++||.++|...|+++.|+|+.|||+.+|++|.+.|.++++..++..|...+|....
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 976543322 234566999999999999999999999999999999999999999999999999999999999998
Q ss_pred HHHhhcCc--CCCCCCCCCCCCCChhhh---cc-cCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 259 EEIRCMNP--NYTDFRFPQIKAHPWHKV---FH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 259 ~~~~~~~~--~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
+.|+.+.. -|..+..+.+....++.. .. -.-++++.||+.+||..||.+|++++++++|.||..
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 88876542 122222222222221111 11 012568999999999999999999999999999975
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=330.16 Aligned_cols=280 Identities=35% Similarity=0.617 Sum_probs=225.2
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
.++|++.+.||.|+||.||+|.+..+++.+|+|.+..... ...+|+.+++.++||||+++.+++.... ...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCc
Confidence 4579999999999999999999999999999998864321 2247999999999999999999875432 235
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
.|+||||++++|.+.+.. ....+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.++|+|||++..
T Consensus 81 ~~lv~e~~~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~-~~~~~l~d~g~~~~ 155 (293)
T cd07843 81 IYMVMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNN-RGILKICDFGLARE 155 (293)
T ss_pred EEEEehhcCcCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECC-CCcEEEeecCceee
Confidence 889999999888777653 23468999999999999999999999 79999999999999996 78899999999876
Q ss_pred CccC-CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 187 LIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 187 ~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.... .......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+....+.+..+....+.+....+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 156 YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred ccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 5443 222345568889999998765557899999999999999999999999999888888888888888776665332
Q ss_pred c--CCCCCCCCCCCCCChhhhcccC-CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 266 P--NYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 266 ~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
. ..............+...++.. +++.+.+||++||+.||++|||+.|+++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 1 1111111122222334444444 68899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=342.51 Aligned_cols=246 Identities=30% Similarity=0.479 Sum_probs=196.8
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-------chHHHH-HHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNREL-QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.||+|+||+||+|.+..+++.||+|++.+... ....|. .+++.++||||+++++.+. ....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----cCCEEEEEE
Confidence 469999999999999999999999999864321 112333 3567899999999998873 334589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||+.+ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~-~~~~kL~DfG~~~~~~~~ 149 (325)
T cd05604 76 DFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDS-QGHVVLTDFGLCKEGIAQ 149 (325)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEEeecCCcccCCCC
Confidence 99986 5544443 45679999999999999999999999 79999999999999996 778999999998753222
Q ss_pred -CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 191 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 191 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~----------------- 211 (325)
T cd05604 150 SDTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK----------------- 211 (325)
T ss_pred CCCcccccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 223455789999999998654 4889999999999999999999999988776665554431
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCcccccCC
Q 017147 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREP 326 (376)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~e~l~hp~~~~~~~~ 326 (376)
.. .+....+..+.++|++||+.||.+||++ .++++||||+...+.
T Consensus 212 ~~------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~ 260 (325)
T cd05604 212 PL------------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWT 260 (325)
T ss_pred Cc------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHH
Confidence 00 0112368899999999999999999976 599999999986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=329.17 Aligned_cols=279 Identities=36% Similarity=0.643 Sum_probs=220.8
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccc---------hHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---------KNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---------~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ...|+++++.++|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence 488999999999999999999999999999998654322 2468999999999999999998843 34
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
..++||||+.++|.+.+.. ....+++..+..++.||+.||.|||+ +|++|+||+|+||+++. ++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~-~~~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFMETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIAS-DGVLKLADFGLAR 150 (298)
T ss_pred EEEEEEcccCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcC-CCCEEEccceeee
Confidence 5889999997787777753 12368999999999999999999999 79999999999999996 7889999999997
Q ss_pred cCccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 186 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 186 ~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
....... .....+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+..+...++.+....+...
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence 6544322 223455788999999866566889999999999999999999999998888888888877777766554322
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
...-...........+... .....+..+.+||.+||++||++|||+.+++.||||++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQ-IFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred ccccccccccccCCcchhh-hcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 1110111111111112222 2234688999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=336.67 Aligned_cols=245 Identities=31% Similarity=0.504 Sum_probs=196.6
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-------chHHHHHHHHh-CCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRV-MDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.||+|+||+||+|.+..+++.||+|++..+.. ....|..++.. .+||||+++++++. ....+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ-----TKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence 469999999999999999999999998865321 12245555554 48999999998873 334589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||++| +|...+. ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus 76 e~~~gg~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~-~~~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 76 EYLNGGDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDK-DGHIKIADFGMCKENMNG 149 (316)
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECC-CCCEEEccCcCCeECCCC
Confidence 99986 5555553 34679999999999999999999999 79999999999999996 778999999999754332
Q ss_pred C-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 191 E-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 191 ~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
. ......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+.+..+... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~-------------- 212 (316)
T cd05592 150 EGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--R-------------- 212 (316)
T ss_pred CCccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C--------------
Confidence 2 23345789999999999654 4899999999999999999999999988876665544321 0
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH-HHHhcCCCcccccC
Q 017147 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-LEACAHPFFDELRE 325 (376)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-~e~l~hp~~~~~~~ 325 (376)
..++..++.++.+||.+||+.||++|+++ .++++||||+.+.+
T Consensus 213 -------------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 213 -------------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred -------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence 01223468899999999999999999986 58899999988654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=328.00 Aligned_cols=281 Identities=36% Similarity=0.660 Sum_probs=221.1
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
++|++.+.||+|++|.||+|.+..+++.||+|.+.... ....+|+++++.++|+||+++++++.. ....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-----EKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-----CCeE
Confidence 57999999999999999999999999999999885431 234579999999999999999998843 3458
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
|+||||+++++.+.+... ....+++..++.++.||+.||+|||+ +|++|+||+|+||+++..+..+||+|||++...
T Consensus 77 ~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred EEEEecccccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 999999998877766431 23346888899999999999999999 799999999999999865678999999999754
Q ss_pred ccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 017147 188 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 265 (376)
Q Consensus 188 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 265 (376)
..... .....+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+.++....+.+..+.+....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 32221 2234568899999998765568899999999999999999999999988888888888887777655543211
Q ss_pred -cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 266 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 266 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
+.+. ..++....... ......+++++.++|.+||+.||++||++.++++||||.++.
T Consensus 234 ~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 234 LPDYK-SAFPKWPPKDL-ATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred chhhh-hhcccCCCCCH-HHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 0110 01111111111 112234788999999999999999999999999999999864
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=336.94 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=207.0
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
++|++.+.||+|+||+||+++++.+++.||+|++.+.. ....+|+.++..++|++|+++++++. +...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ-----DENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cCCE
Confidence 37999999999999999999999999999999986421 12356888999999999999998883 3345
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+|+||||+.+ +|.+.+.. ....+++..++.++.||+.||+|||+ .||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~-~~~~kL~DfG~a~ 150 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDM-NGHIRLADFGSCL 150 (332)
T ss_pred EEEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECC-CCCEEEeecchhe
Confidence 8999999985 77666653 24578999999999999999999999 79999999999999996 7789999999987
Q ss_pred cCccCCC--ceeeeeccccCchhhhhC----CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 186 QLIAGEA--NISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 186 ~~~~~~~--~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
....... .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~----- 225 (332)
T cd05623 151 KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE----- 225 (332)
T ss_pred ecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc-----
Confidence 5433222 123568999999999852 34578999999999999999999999998887776665543110
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCcccccCCC
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPN 327 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~e~l~hp~~~~~~~~~ 327 (376)
...++. ....+++++++||++||+.++.+ |++++++++||||.++.+..
T Consensus 226 ----------~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~ 276 (332)
T cd05623 226 ----------RFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDN 276 (332)
T ss_pred ----------cccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHH
Confidence 011111 11247899999999999776555 68999999999999876543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=350.43 Aligned_cols=261 Identities=25% Similarity=0.367 Sum_probs=213.2
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC---C
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS---K 102 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~ 102 (376)
...+|++.+.||+|+||+||+|++..+++.||||++.... ....+|+.++..++|+|++++++.+..... .
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3469999999999999999999999999999999986432 233578899999999999998877643321 2
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
....+++||||+++ +|.+.+.........+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~-~~~vkL~DF 187 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCS-NGLVKLGDF 187 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeC-CCCEEEEec
Confidence 23357899999984 7888776655556789999999999999999999999 79999999999999996 778999999
Q ss_pred cccccCccC---CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 182 GSAKQLIAG---EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 182 g~a~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
|+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~---- 262 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY---- 262 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC----
Confidence 998764332 122346789999999999654 489999999999999999999999998876665554433100
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
..++..+++++.+|+.+||+.||.+||++.++++|||++..
T Consensus 263 ------------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 263 ------------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred ------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 01223478999999999999999999999999999998764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=333.82 Aligned_cols=245 Identities=31% Similarity=0.464 Sum_probs=199.6
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcE-EEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGET-VAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
....+.+.||+|+||+||++..+ |.. ||+|++.... ....+|+.+|.+++|||||++++++..... .
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~ 114 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----S 114 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----c
Confidence 45566777999999999999885 445 9999986532 356689999999999999999999854331 4
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCC-eeecCCCCCcEEEcCCCC-cEEEEeecc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-VCHRDLKPQNLLVDPLTH-QVKICDFGS 183 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~-i~H~dlkp~Nill~~~~~-~vkl~Dfg~ 183 (376)
++|||||+++ +|.+++... ....++...+..++.||+.|++|||+ ++ |+||||||+|||++. .. .+||+|||+
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~-~~~~~KI~DFGl 190 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDL-KGKTLKIADFGL 190 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcC-CCCEEEECCCcc
Confidence 8899999995 666666532 46789999999999999999999999 79 999999999999997 54 899999999
Q ss_pred cccCccC-CCceeeeeccccCchhhhhC-CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 184 AKQLIAG-EANISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 184 a~~~~~~-~~~~~~~~t~~y~aPE~l~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
++..... .......||+.|||||++.+ ...|+.++||||||+++|||+||..||.+.........+.....+|.
T Consensus 191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~---- 266 (362)
T KOG0192|consen 191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP---- 266 (362)
T ss_pred ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC----
Confidence 9866543 33334788999999999974 35699999999999999999999999999888555554443222221
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 315 (376)
++...++.+..|+.+||..||.+||+..+++
T Consensus 267 -----------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~ 297 (362)
T KOG0192|consen 267 -----------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIV 297 (362)
T ss_pred -----------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence 2234788999999999999999999998875
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=335.54 Aligned_cols=251 Identities=29% Similarity=0.455 Sum_probs=202.6
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCC-CceeeeceeeeecCCCCceE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDH-PNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~ 106 (376)
+|+..+.||+|+||+||+|+++.+++.||+|++.++. .....|..++..+.| ++|+++.+++.. ...
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-----VDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-----CCE
Confidence 4788899999999999999999999999999986532 123357778877764 667778777733 334
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+|+||||+++ +|...+. ....+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~-~~~ikL~Dfg~~~ 149 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDS-EGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEecccccc
Confidence 8999999985 6555553 44679999999999999999999999 79999999999999996 7789999999987
Q ss_pred cCccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 186 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 186 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
...... ......||+.|+|||++.+. .++.++|+||+||++|+|++|.+||.+.+.......+...
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~------------ 216 (323)
T cd05615 150 EHMVDGVTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH------------ 216 (323)
T ss_pred ccCCCCccccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence 543222 23345689999999998654 4899999999999999999999999988877666655541
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCcccccCC
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 326 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 326 (376)
... ++..++.++.+++.+||+.||.+|++ ..++++||||+.+.+.
T Consensus 217 -----~~~------------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~ 266 (323)
T cd05615 217 -----NVS------------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD 266 (323)
T ss_pred -----CCC------------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence 011 12347889999999999999999997 5799999999987643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=344.55 Aligned_cols=277 Identities=23% Similarity=0.340 Sum_probs=211.2
Q ss_pred ceeeeeeeeecCCCeeEEEEEEc--CCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
.+|++++.||+|+||.||+|... .+++.||+|.+... ....+|+.+++.++|+||+++++++. ....+|++|
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~~~lv~ 165 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAYR-----WKSTVCMVM 165 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeEe-----eCCEEEEEe
Confidence 47999999999999999999754 35678999987654 34468999999999999999998883 334588999
Q ss_pred ecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCC
Q 017147 112 EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 191 (376)
Q Consensus 112 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 191 (376)
|++.+++...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.++|+|||++.......
T Consensus 166 e~~~~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~-~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYKCDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDE-PENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcC-CCCEEEccCccccccCccc
Confidence 999998877763 35679999999999999999999999 79999999999999996 7789999999987554332
Q ss_pred C---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 192 A---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 192 ~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
. .....||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.. ....+..+.+.++..+.+......
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred ccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 2 2345789999999998654 48999999999999999999999997654 345666677766644322111000
Q ss_pred ----cCCCCCCCCCCCCCChhhhc-ccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 266 ----PNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 266 ----~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
..+..+.............+ ...++.++.+||++||.+||++|||+.++|+||||...
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 00001111000000111111 12457789999999999999999999999999999864
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=341.93 Aligned_cols=244 Identities=27% Similarity=0.491 Sum_probs=195.5
Q ss_pred eecCCCeeEEEEEEcCCCcEEEEEEeeccccc-------hHHHHHHHHhC---CCCceeeeceeeeecCCCCceEEEEEe
Q 017147 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQLMRVM---DHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 42 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-------~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
||+|+||+||+|++..+++.||+|++.+.... ...|..++... +||||+++++++.. ...+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-----~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-----DSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-----CCeEEEEE
Confidence 69999999999999999999999998643211 12355555554 69999999988833 34489999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||+.+ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus 76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~-~~~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 76 DYMSGGELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDA-TGHIALCDFGLSKANLTD 149 (330)
T ss_pred cCCCCChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEecCCcCcCCCCC
Confidence 99985 6655554 35679999999999999999999999 79999999999999996 778999999998754332
Q ss_pred -CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 191 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 191 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
.......||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~----------------- 212 (330)
T cd05586 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG----------------- 212 (330)
T ss_pred CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 22335678999999999876556899999999999999999999999888766555444321
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC----CHHHHhcCCCccccc
Q 017147 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC----TALEACAHPFFDELR 324 (376)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~----t~~e~l~hp~~~~~~ 324 (376)
...++ ...+++++.+||++||+.||.+|| ++.++++||||....
T Consensus 213 ~~~~~-----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 213 KVRFP-----------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CCCCC-----------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 11111 113688999999999999999998 799999999998764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=318.93 Aligned_cols=319 Identities=31% Similarity=0.539 Sum_probs=249.0
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeec------cccchHHHHHHHHhCCCCceeeeceeeeecCCC-Cce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~~~ 105 (376)
..+|.-++.+|.|+- .|..|.+.-.++.||+|++.. ..+...+|..++..++|+||++++.+|...... .-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 458999999999998 788899999999999998843 234556899999999999999999998544332 223
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
..|+|||++..+|-..+. -.+..+.+.++++|+++|++|||+ .||+||||||+||++.. +..+||.|||+|+
T Consensus 95 e~y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~-~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNS-DCTLKILDFGLAR 166 (369)
T ss_pred hHHHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecc-hhheeeccchhhc
Confidence 378999999998877765 346677899999999999999999 79999999999999996 7889999999998
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.....-..+.++.|++|+|||++.+.+ |...+||||+|||+.||++|...|+|.+..++..++.+.+|.|.......+.
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred ccCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 655444566788999999999998876 9999999999999999999999999999999999999999999998777654
Q ss_pred cCCCCC--CCCCCCCCChhhhcccC-----------CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCC
Q 017147 266 PNYTDF--RFPQIKAHPWHKVFHKR-----------MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN 332 (376)
Q Consensus 266 ~~~~~~--~~~~~~~~~~~~~~~~~-----------~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~ 332 (376)
+....+ ..|+...-.+.+.|++. -+..++|++.+||..||++|.+++++|+||||+-+-..+. ..
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~e--v~ 323 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDE--VE 323 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccccc--cc
Confidence 322211 22333333334443321 1346899999999999999999999999999994322221 11
Q ss_pred CCCCCCCCCchhhhccCCHHHHhhhcHHHHHh
Q 017147 333 GRPLPPLFNFKQELSGASPELVNKLIPDHVKR 364 (376)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (376)
.+ .|+...-..+....+++..+..+-+++.+
T Consensus 324 ap-~pe~~d~~~d~~~~t~~e~ke~If~ev~~ 354 (369)
T KOG0665|consen 324 AP-PPEIYDKQLDEREHTIEEWKELIFKEVQR 354 (369)
T ss_pred CC-CCchhhhhcccccCCHHHHHHHHHHHHHh
Confidence 12 22222223345556677777777666654
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=344.47 Aligned_cols=275 Identities=24% Similarity=0.346 Sum_probs=206.8
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 112 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 112 (376)
...|.+.+.||+|+||.||+|.+..+++.||||... .....+|+.+++.++|+||+++++++... ...++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--~~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--YASSVHEARLLRRLSHPAVLALLDVRVVG-----GLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--ccCHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEEEEEEE
Confidence 457999999999999999999999999999999643 23346899999999999999999987433 34889999
Q ss_pred cccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCC
Q 017147 113 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 192 (376)
Q Consensus 113 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~ 192 (376)
++.++|...+.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+++.......
T Consensus 241 ~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~-~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 241 KYRSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNG-PEDICLGDFGAACFARGSWS 315 (461)
T ss_pred ccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECC-CCCEEEcccCCceecccccc
Confidence 999888877753 33469999999999999999999999 79999999999999996 67899999999975433221
Q ss_pred ---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCC-CC------hHHHHHHHHHHhCCCCHHH--
Q 017147 193 ---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-EN------AVDQLVEIIKVLGTPTREE-- 260 (376)
Q Consensus 193 ---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~------~~~~~~~i~~~~~~~~~~~-- 260 (376)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..|+.. .. ....+.++++..+....+.
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred cccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 2235689999999999664 489999999999999999998755432 21 1234555554433221110
Q ss_pred ------HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 261 ------IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 261 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
.............+......|.... .++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYY--KLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhc--cccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0000000000111222223343322 36789999999999999999999999999999974
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=330.91 Aligned_cols=282 Identities=38% Similarity=0.641 Sum_probs=215.9
Q ss_pred eeeeeeeeecCCCeeEEEEEEcC--CCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
+|++.+.||+|++|.||+|.+.. +++.||+|.+.... ....+|+.+++.++||||+++++.+... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 48899999999999999999988 89999999987632 2335799999999999999999988543 224
Q ss_pred EEEEEeecccchHHHHHHhhhhcC-CCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC---CCCcEEEEee
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSAN-QRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP---LTHQVKICDF 181 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~---~~~~vkl~Df 181 (376)
.+|+||||+++++...+....... ..+++..++.++.|++.||.|||+ .+++||||||+||+++. ..+.+||+||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 588999999988887775443333 378999999999999999999999 79999999999999984 2567999999
Q ss_pred cccccCccCCC----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChH---------HHHHH
Q 017147 182 GSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---------DQLVE 248 (376)
Q Consensus 182 g~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~ 248 (376)
|++........ .....+++.|+|||++.+...++.++|+|||||++|+|++|++||.+.... ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99876533222 223466889999999877666899999999999999999999999865533 35566
Q ss_pred HHHHhCCCCHHHHhhcC--cCCCC----CCCCCCCCCChhhhccc--CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 249 IIKVLGTPTREEIRCMN--PNYTD----FRFPQIKAHPWHKVFHK--RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 249 i~~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
+...++.+....+.... +.+.. ..............+.. ..+.++.++|.+||+.||++|||+.|+++||||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 66767766655443211 11111 00001110111111122 567899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=325.30 Aligned_cols=252 Identities=35% Similarity=0.578 Sum_probs=205.0
Q ss_pred eeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccch------HHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK------NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~------~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
|++++.||+|+||+||+|.+..+++.||+|.+....... .+|+.+++.++|+||+++++++.. ....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 899999999999999999999999999999997653222 248899999999999999999855 334889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC-
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL- 187 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~- 187 (376)
|||++.+ +|.+.+. ....+++..+..++.|++.||.+||+ +|++|+||||+||+++. ++.++|+|||.+...
T Consensus 76 v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~~-~~~~~l~Dfg~~~~~~ 149 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLDE-NGEVKLIDFGSSVKLS 149 (260)
T ss_dssp EEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEEST-TSEEEESSGTTTEEST
T ss_pred ccccccccccccccc----cccccccccccccccccccccccccc-ccccccccccccccccc-cccccccccccccccc
Confidence 9999997 7777776 34678999999999999999999999 79999999999999995 788999999999753
Q ss_pred ccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017147 188 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267 (376)
Q Consensus 188 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 267 (376)
..........+++.|+|||++.....++.++|+||+|+++|+|++|..||......+....+.+...........
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 224 (260)
T PF00069_consen 150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ----- 224 (260)
T ss_dssp STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-----
Confidence 222333456678999999998634568999999999999999999999999885555544444432222111100
Q ss_pred CCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
.....++.+.++|.+||+.||++|||+.++++||||
T Consensus 225 -----------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 225 -----------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -----------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -----------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 000123799999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=337.20 Aligned_cols=246 Identities=26% Similarity=0.479 Sum_probs=193.1
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.||+|+||+||+|.+..+++.||+|++.+.. .....|+.++..+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-----CCEEEEEE
Confidence 46999999999999999999999999986532 1234677777666 89999999998843 33489999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc-
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 189 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~- 189 (376)
||+++ +|...+. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||+++....
T Consensus 76 E~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~-~~~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 76 EYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRP 149 (329)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECC-CCCEEEeeCCccccccCC
Confidence 99996 5544443 34679999999999999999999999 79999999999999996 77899999999875322
Q ss_pred CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCCHHHH
Q 017147 190 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--------VDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 190 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~ 261 (376)
........||+.|+|||++.+. .++.++|+|||||++|+|++|..||..... .+.+.+.+..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--------- 219 (329)
T cd05618 150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--------- 219 (329)
T ss_pred CCccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---------
Confidence 2223346789999999999654 589999999999999999999999953211 1111111110
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC------HHHHhcCCCcccccC
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELRE 325 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t------~~e~l~hp~~~~~~~ 325 (376)
... .++..++..+.+||.+||+.||.+|+| ++++++||||+.+.+
T Consensus 220 -------~~~------------~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 220 -------KQI------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred -------CCC------------CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 000 123457889999999999999999998 579999999988754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=338.83 Aligned_cols=246 Identities=28% Similarity=0.467 Sum_probs=200.9
Q ss_pred eeeecCCCeeEEEEEEc---CCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 40 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
+.||+|+||.||++++. .+++.||+|++.+.. .....|+.+++.++||||+++++++. ....+|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEEE
Confidence 57999999999999863 578999999986532 22346899999999999999998884 33458899
Q ss_pred eecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 111 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 111 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
|||+.+ +|.+.+. ....+++..++.++.||+.||.|||+ .||+||||||+||+++. ++.+||+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 77 LDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDE-EGHIKLTDFGLSKESID 150 (318)
T ss_pred EcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECC-CCcEEEeeccCCcccCC
Confidence 999985 6655553 34678999999999999999999999 79999999999999996 77899999999876543
Q ss_pred C-CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 017147 190 G-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268 (376)
Q Consensus 190 ~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 268 (376)
. .......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+.+.
T Consensus 151 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~---------------- 213 (318)
T cd05582 151 HEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA---------------- 213 (318)
T ss_pred CCCceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC----------------
Confidence 3 223345789999999998654 4789999999999999999999999988776666555431
Q ss_pred CCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCcccccCC
Q 017147 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 326 (376)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 326 (376)
... ++..+++++.+||++||+.||++||| +.++++||||+.+.+.
T Consensus 214 -~~~------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~ 263 (318)
T cd05582 214 -KLG------------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN 263 (318)
T ss_pred -CCC------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence 001 12346889999999999999999999 7789999999886543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=326.84 Aligned_cols=275 Identities=36% Similarity=0.681 Sum_probs=218.6
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+|+..+.||.|++|.||+|.+..+++.||||++..+. ....+|+++++.++|+||+++++++. +....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence 4889999999999999999999999999999885432 23457999999999999999999873 334488
Q ss_pred EEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 109 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 109 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
+||||+.+++...+.. .....+++..++.++.|++.||+|||+ .|++|+||+|+||+++. ++.+||+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~-~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 76 LVFEFLHQDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAFG 151 (284)
T ss_pred EEeeccccCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEeeccchhhcc
Confidence 9999999887776643 234568999999999999999999999 79999999999999996 7789999999987543
Q ss_pred cCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc-
Q 017147 189 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP- 266 (376)
Q Consensus 189 ~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 266 (376)
.... .....+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+..+.+.++.+..+.+....+.....
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 3222 22334578899999886655578899999999999999999999999888888888888888776544332110
Q ss_pred -CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 267 -NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 267 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
.+. ..++......+... ...++++++++|.+||+.||++|||+.++++||||
T Consensus 232 ~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 PDYK-PSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHH-hhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 000 01222222222222 23478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=326.76 Aligned_cols=257 Identities=27% Similarity=0.417 Sum_probs=203.1
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.|++.+.||+|+||.||++.+..+++.||+|.+.... .....|+.+++.++|++++.+.+.+. .....
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEE
Confidence 3788899999999999999999999999999886432 12346899999999999999988873 33458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|+||||+.+ +|...+.. .....+++..+..++.|++.||.|||+ .|++||||||+||+++. ++.++|+|||++..
T Consensus 76 ~lv~e~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~-~~~~~l~Dfg~~~~ 151 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDD-HGHIRISDLGLAVH 151 (285)
T ss_pred EEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECC-CCCEEEeeccceee
Confidence 999999985 66655542 223468999999999999999999999 79999999999999996 77899999999876
Q ss_pred CccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 187 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
...........+++.|+|||++.+. .++.++|+||+||++|+|++|..||..................
T Consensus 152 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~----------- 219 (285)
T cd05630 152 VPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----------- 219 (285)
T ss_pred cCCCccccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-----------
Confidence 5443333445789999999999654 4899999999999999999999999875432111111110000
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCcccccCC
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 326 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 326 (376)
....++..+++++.+|+.+||+.||++||| ++|+++||||+.+.+.
T Consensus 220 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05630 220 --------------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK 270 (285)
T ss_pred --------------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence 001123347889999999999999999999 9999999999886544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=350.54 Aligned_cols=255 Identities=27% Similarity=0.357 Sum_probs=210.0
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCC-CcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
...|.+.+.||+|++|.||+|.+..+ ++.||+|.+..+. ....+|+.+++.++||||+++++.+... ..+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~ 140 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD-----DKL 140 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-----CEE
Confidence 44699999999999999999998877 7889999764332 2345799999999999999999988433 348
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|+||||+++ +|.+.+.........+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+++.
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~-~~~~kL~DFgla~~ 218 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQ 218 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECC-CCcEEEEeCcCcee
Confidence 999999985 7777776555556679999999999999999999999 79999999999999996 77899999999986
Q ss_pred CccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 187 LIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 187 ~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-------- 289 (478)
T PTZ00267 219 YSDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-------- 289 (478)
T ss_pred cCCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------
Confidence 543321 334568999999999865 45899999999999999999999999888776666555431000
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.++..++.++.+||.+||..||++|||+.+++.|||++.+
T Consensus 290 --------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 290 --------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred --------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 0123468899999999999999999999999999999754
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=334.79 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=206.3
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
++|++.+.||+|+||+||++++..+++.||+|.+.+.. ....+|+.++..++|++|+++++++ ....+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 47999999999999999999999999999999886421 1234688899999999999999888 33445
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.|+||||+.| +|...+.. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~-~~~~kl~DfG~a~ 150 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDM-NGHIRLADFGSCL 150 (331)
T ss_pred EEEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcC-CCCEEEEecccee
Confidence 8999999985 66666643 24578999999999999999999999 79999999999999996 7789999999997
Q ss_pred cCccCCCc--eeeeeccccCchhhhhCC----CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 186 QLIAGEAN--ISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 186 ~~~~~~~~--~~~~~t~~y~aPE~l~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
........ ....||+.|+|||++.+. ..++.++|+||+||++|+|++|+.||.+.+..+.+..+......
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~---- 226 (331)
T cd05624 151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER---- 226 (331)
T ss_pred eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc----
Confidence 65433222 234689999999998542 34788999999999999999999999988776666555431100
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCcccccCCC
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPN 327 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~e~l~hp~~~~~~~~~ 327 (376)
..++. ....+++++++||.+||+.++.+ |++++++++||||+.+.+..
T Consensus 227 -----------~~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~ 276 (331)
T cd05624 227 -----------FQFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN 276 (331)
T ss_pred -----------ccCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHH
Confidence 01110 01236899999999999976655 46899999999999876543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=360.62 Aligned_cols=266 Identities=27% Similarity=0.419 Sum_probs=212.9
Q ss_pred CcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
+....+|++++.||.|+||+||+|.++.++..+|+|.+... ......|+.+++.++||||++++++|....
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~--- 85 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA--- 85 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC---
Confidence 34567899999999999999999999999999999988542 123457999999999999999999886432
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcC------CCeeecCCCCCcEEEcCC----
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV------PRVCHRDLKPQNLLVDPL---- 172 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------~~i~H~dlkp~Nill~~~---- 172 (376)
...+||||||+++ +|...+.........+++..++.|+.||+.||.|||+. ++|+||||||+||||+..
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 2358899999985 88888876555557899999999999999999999982 139999999999999631
Q ss_pred ------------CCcEEEEeecccccCccCCCceeeeeccccCchhhhhCC-CCCCchhhhHhHHHHHHHHHhCCCCCCC
Q 017147 173 ------------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPG 239 (376)
Q Consensus 173 ------------~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~ 239 (376)
...+||+|||++.............+|+.|+|||++.+. ..++.++||||||||+|+|++|..||..
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 234899999999866444444456789999999998643 3478999999999999999999999987
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 017147 240 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319 (376)
Q Consensus 240 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 319 (376)
.+....+...+... +. ++ ....+.++.+||.+||..+|.+|||+.|+|.|||
T Consensus 246 ~~~~~qli~~lk~~--p~---------------lp-----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 246 ANNFSQLISELKRG--PD---------------LP-----------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQI 297 (1021)
T ss_pred CCcHHHHHHHHhcC--CC---------------CC-----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence 66555444333210 00 00 0125789999999999999999999999999999
Q ss_pred cccccCC
Q 017147 320 FDELREP 326 (376)
Q Consensus 320 ~~~~~~~ 326 (376)
|+.+..+
T Consensus 298 ik~i~~p 304 (1021)
T PTZ00266 298 IKNVGPP 304 (1021)
T ss_pred HhhcCCC
Confidence 9876543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=331.95 Aligned_cols=315 Identities=35% Similarity=0.621 Sum_probs=240.6
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 105 (376)
.++|++.+.||+|++|.||+|.+..+++.||+|++.... ....+|+.+++.++|+|++++.+++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 457999999999999999999999999999999875421 223469999999999999999887743322 2233
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
..|+|+||++++|.+.+.. ..+++..++.++.|++.||.|||+ .|++||||+|+||+++. ++.++|+|||++.
T Consensus 94 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~-~~~~kL~dfg~~~ 166 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNE-DCELKILDFGLAR 166 (343)
T ss_pred cEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEccccccc
Confidence 4789999998888777652 569999999999999999999999 79999999999999996 7889999999997
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
..... .....++..|+|||.+.+...++.++|+||+||++|+|++|+.||.+.+..+.+..+.+..+.+....+....
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 65332 3345678899999998665567899999999999999999999999998888888888888877765544332
Q ss_pred cCCC-CC--CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCc
Q 017147 266 PNYT-DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF 342 (376)
Q Consensus 266 ~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 342 (376)
.... .+ ..+......+...+. .+++.+.+||++||+.||++|||+.++++||||+....+.. .+.++.++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~-----~~~~~~~~~ 318 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFS-GANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED-----EPVAPPYDQ 318 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhc-cCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcc-----cccccccCc
Confidence 1100 00 111112222333222 36899999999999999999999999999999998754432 223344444
Q ss_pred hhhhccCCHHHHhhhcHHHH
Q 017147 343 KQELSGASPELVNKLIPDHV 362 (376)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~ 362 (376)
.-+.......+.+.++-.++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~ 338 (343)
T cd07851 319 SFESRDLTVDEWKELVYKEI 338 (343)
T ss_pred chhhhhcCHHHHHHHhHHHH
Confidence 44445566666666665544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=325.30 Aligned_cols=251 Identities=24% Similarity=0.404 Sum_probs=196.6
Q ss_pred eecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017147 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 114 (376)
Q Consensus 42 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 114 (376)
||+|+||.||++.++.+++.||+|.+..+. .....|+++++.++||||+++.+.+ .....+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 699999999999999999999999885422 1224589999999999999998887 3344589999999
Q ss_pred cc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCCc
Q 017147 115 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 193 (376)
Q Consensus 115 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~ 193 (376)
+| +|...+.. .....+++..+..++.|++.||+|||+ .|++||||||+||+++. ++.++|+|||++.........
T Consensus 76 ~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~-~~~~~l~Dfg~~~~~~~~~~~ 151 (277)
T cd05607 76 NGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDD-QGNCRLSDLGLAVELKDGKTI 151 (277)
T ss_pred CCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcC-CCCEEEeeceeeeecCCCcee
Confidence 86 56555532 223458889999999999999999999 79999999999999996 778999999998766544433
Q ss_pred eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCC
Q 017147 194 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273 (376)
Q Consensus 194 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 273 (376)
....+++.|+|||++.+.. ++.++|+||+||++|+|++|..||.+.........+.+..-. .....
T Consensus 152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~ 217 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-------------DEVKF 217 (277)
T ss_pred eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-------------ccccc
Confidence 4456789999999986654 899999999999999999999999765432222222111000 00000
Q ss_pred CCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCcccccCC
Q 017147 274 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREP 326 (376)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~e~l~hp~~~~~~~~ 326 (376)
....+++++.+||++||++||.+||++ ++++.||||+.+.++
T Consensus 218 -----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~ 263 (277)
T cd05607 218 -----------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFP 263 (277)
T ss_pred -----------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHH
Confidence 012468899999999999999999999 778899999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=332.89 Aligned_cols=288 Identities=38% Similarity=0.699 Sum_probs=232.0
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+|++.+.||.|++|.||+|.+..+++.||||++.... ....+|+.+++.++|+||+++.+++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5899999999999999999999899999999886532 2345799999999999999999988655423334588
Q ss_pred EEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 109 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 109 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
++|||+++++.+.+. ....+++..++.++.|++.||++||+ +|++||||||+||+++. ++.++|+|||++....
T Consensus 81 lv~e~~~~~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~-~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELMETDLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNS-NCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchhhhHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEcccCceEeec
Confidence 999999987776664 34589999999999999999999999 79999999999999997 6889999999998665
Q ss_pred cCC----CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 189 AGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 189 ~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
... ......+++.|+|||.+.+...++.++|+||+||++|+|++|++||.+.+..+.+..+....+.+..+.+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 443 1334567889999999976646899999999999999999999999999999999999999888887665421
Q ss_pred Cc-CCCCC--CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCC
Q 017147 265 NP-NYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 329 (376)
Q Consensus 265 ~~-~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~ 329 (376)
.. ...++ ..+.....++...+ ..+++++.+||++||++||.+|||+++++.||||++++.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~ 301 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE 301 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhc-ccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence 11 11111 01111222333332 3378999999999999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=326.28 Aligned_cols=284 Identities=29% Similarity=0.516 Sum_probs=218.2
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC---C
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS---K 102 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~ 102 (376)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++..... .
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4568999999999999999999999999999999885432 122469999999999999999998754332 2
Q ss_pred CceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 103 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 103 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
.....++||||+.+++...+.. ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg 164 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITK-DGILKLADFG 164 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECC-CCcEEECcCC
Confidence 2345789999999987777653 33468999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCCCc-----eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017147 183 SAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257 (376)
Q Consensus 183 ~a~~~~~~~~~-----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 257 (376)
++......... ....++..|+|||.+.+...++.++|+||+|+++|+|++|++||.+.+....+..+.+..|..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99755332211 2345678899999987665578999999999999999999999999888877777777777655
Q ss_pred HHHHhhcC--cCCCCCCCCCCCCCChhhhc-ccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 258 REEIRCMN--PNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 258 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
.+.+.... ..+....++........... ....+..+.+||.+||..||.+|||++++++||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 54332211 00111112211111111111 11236788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=332.25 Aligned_cols=286 Identities=30% Similarity=0.532 Sum_probs=216.8
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCC------
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK------ 102 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~------ 102 (376)
..+|.+.+.||.|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++......
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 358999999999999999999999999999999885432 2345799999999999999998876443211
Q ss_pred ---CceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEE
Q 017147 103 ---NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 179 (376)
Q Consensus 103 ---~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~ 179 (376)
.....|+||||+++++.+.+. ...+++..++.++.||+.||.|||+ .|++||||||+||+++.++..++|+
T Consensus 84 ~~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 84 SLTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEEC
Confidence 123578999999987766653 2468999999999999999999999 7999999999999998667789999
Q ss_pred eecccccCccCCC----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017147 180 DFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255 (376)
Q Consensus 180 Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 255 (376)
|||.+........ .....++..|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+..+....+.+....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999875432211 122356888999998866556889999999999999999999999988877777766665444
Q ss_pred CCHHHHhhcCcCCCCCCC--CCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 256 PTREEIRCMNPNYTDFRF--PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
+................. ......+... +...++.++++||.+||+.||.+|||+.++++||||+.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~ 308 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRD-LLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC 308 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHH-HccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccC
Confidence 333222111100000000 0001111222 22347889999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=336.34 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=198.0
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
....+|+.++.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++|+||+++++++ ....
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~ 145 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNG 145 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCC
Confidence 34568999999999999999999999999999999985432 2345799999999999999999988 3344
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.+|+||||+.++.+. ......+..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 146 ~~~lv~e~~~~~~L~-------~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~~~~kL~DfG~~~ 216 (353)
T PLN00034 146 EIQVLLEFMDGGSLE-------GTHIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINS-AKNVKIADFGVSR 216 (353)
T ss_pred eEEEEEecCCCCccc-------ccccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcC-CCCEEEcccccce
Confidence 588999999975321 12345677888999999999999999 79999999999999996 7789999999997
Q ss_pred cCccCC-CceeeeeccccCchhhhhC----CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 186 QLIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 186 ~~~~~~-~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
...... ......||..|+|||.+.. ....+.++|||||||++|+|++|+.||......+....+.......
T Consensus 217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~---- 292 (353)
T PLN00034 217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ---- 292 (353)
T ss_pred ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC----
Confidence 654322 2234578999999998732 1224568999999999999999999997433222111111110000
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
.......++.++++||.+||+.||++|||+.|+++||||....
T Consensus 293 ---------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 293 ---------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred ---------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 0001234688999999999999999999999999999998753
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=321.89 Aligned_cols=278 Identities=35% Similarity=0.620 Sum_probs=213.2
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
..+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++.+++. .....
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~~ 78 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL 78 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCeE
Confidence 468999999999999999999999999999999885432 13357999999999999999999874 33358
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
|+||||+.+++...+.. ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||+++..
T Consensus 79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISY-LGELKLADFGLARAK 153 (291)
T ss_pred EEEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcC-CCcEEEecccccccc
Confidence 89999999887766542 33567888899999999999999999 79999999999999996 778999999998754
Q ss_pred ccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 188 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 188 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.... ......+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+.+ ..+.+.++....+.|.........
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 3221 12234568899999998665557889999999999999999999997654 445666676777766655433221
Q ss_pred --cCCCCCCCCCCCCCChhhhccc-CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 266 --PNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 266 --~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
+.+....++............. ..+.++.+++.+||..||++|||+.|++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 1222211111111111111110 136789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=329.44 Aligned_cols=292 Identities=36% Similarity=0.637 Sum_probs=227.4
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCC--CcEEEEEEeeccc------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCce
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLET--GETVAIKKVLQDR------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~aiK~~~~~~------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 105 (376)
+|++.+.||+|+||.||++.+..+ +..||+|++.... ....+|+.+++.+ +|+||+++++...... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 489999999999999999999888 8999999886421 2234689999988 5999999988654322 2233
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.+|++++|++++|.+.+. ....+++..++.++.||+.||+|||+ +|++||||||+||+++. ++.+||+|||++.
T Consensus 80 ~~~~~~e~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~-~~~~kl~Dfg~a~ 153 (332)
T cd07857 80 ELYLYEELMEADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNA-DCELKICDFGLAR 153 (332)
T ss_pred cEEEEEecccCCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcC-CCCEEeCcCCCce
Confidence 478999999988777764 35678999999999999999999999 79999999999999996 7789999999997
Q ss_pred cCccCCC-----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 186 QLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 186 ~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
....... .....+|+.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+....+..++..+|.+..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 5433221 12346788999999986655689999999999999999999999999998899999999999888765
Q ss_pred HhhcCcCCC-CC--CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCCC
Q 017147 261 IRCMNPNYT-DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGR 334 (376)
Q Consensus 261 ~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~ 334 (376)
+........ .+ .........+.... ...+..+.+|+.+||+.||.+|||+.+++.||||+.++++........
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~ 309 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIF-PNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQK 309 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhC-CCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccc
Confidence 543321100 00 11111112222222 235889999999999999999999999999999999877644433333
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=334.99 Aligned_cols=246 Identities=27% Similarity=0.446 Sum_probs=197.4
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-------chH-HHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKN-RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~-~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.||+|+||+||+|++..+++.||+|++.+... ... ++..+++.++|+||+++++++.. ...+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-----~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----ADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-----CCeEEEEE
Confidence 469999999999999999999999999864321 111 23345678899999999988833 34489999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||+++ +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~-~~~~kl~DfG~a~~~~~~ 149 (325)
T cd05602 76 DYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDS-QGHIVLTDFGLCKENIEH 149 (325)
T ss_pred eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEEccCCCCcccccC
Confidence 99996 5555554 34678899999999999999999999 79999999999999996 778999999998754322
Q ss_pred -CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 191 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 191 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
.......||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+.+..+... +
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~------------- 212 (325)
T cd05602 150 NGTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---P------------- 212 (325)
T ss_pred CCCcccccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC---C-------------
Confidence 223345789999999999654 5899999999999999999999999988877666555431 0
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHH----HHhcCCCcccccCC
Q 017147 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL----EACAHPFFDELREP 326 (376)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~----e~l~hp~~~~~~~~ 326 (376)
. .+...++..+.++|.+||+.||.+|+++. ++++|+||..+.+.
T Consensus 213 -~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~ 260 (325)
T cd05602 213 -L------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWD 260 (325)
T ss_pred -c------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHH
Confidence 0 01234789999999999999999999875 89999999876543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=321.89 Aligned_cols=276 Identities=35% Similarity=0.660 Sum_probs=221.6
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
+|++.+.||.|++|.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++.+... ...++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEEE
Confidence 4899999999999999999999999999999886432 2334799999999999999999988543 33889
Q ss_pred EeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 110 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 110 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
||||+++++.+.+.... ....+++..+..++.|++.||.|||+ .|++||||+|+||++++ ++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~-~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 76 VFEYMDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINK-RGELKLADFGLARAFGI 152 (284)
T ss_pred EEecCCccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECC-CCcEEEeecchhhhhcC
Confidence 99999998877775422 23568999999999999999999999 79999999999999996 77899999999875433
Q ss_pred CCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 017147 190 GEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268 (376)
Q Consensus 190 ~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 268 (376)
... .....+++.|+|||.+.+...++.++|+||+||++|+|++|+.||.+.+..+....+.+..+.|....+.... ..
T Consensus 153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 231 (284)
T cd07836 153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QL 231 (284)
T ss_pred CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cC
Confidence 221 2234568889999998766667899999999999999999999999998888888888888877776654332 11
Q ss_pred CC--CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 269 TD--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 269 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
.. ..++......... +...++..++++|.+||+.||.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQ-LFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred chhcccccCCChHHHHH-HhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 11 1222222222222 223468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=324.77 Aligned_cols=258 Identities=29% Similarity=0.467 Sum_probs=216.0
Q ss_pred CCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccch-------HHHHHHHHhC-CCCceeeeceeeeecC
Q 017147 29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVM-DHPNVISLKHCFFSTT 100 (376)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-------~~e~~~l~~l-~h~~iv~~~~~~~~~~ 100 (376)
......+|..+.+||+|+||+|.+|..+.+.+.||||++.++.... ..|..+|... +.|.++++..+|..-+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 3445568999999999999999999999999999999987764332 2466666555 4678888888884444
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEE
Q 017147 101 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 179 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~ 179 (376)
. +|+||||+.| +|.-.++ .-+.+.+..+.+|+.+|+-||-+||+ +||++||||.+||+++. .+.|||+
T Consensus 424 R-----LyFVMEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~-eGHiKi~ 492 (683)
T KOG0696|consen 424 R-----LYFVMEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDS-EGHIKIA 492 (683)
T ss_pred h-----eeeEEEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEecc-CCceEee
Confidence 3 9999999997 4444443 45789999999999999999999999 89999999999999997 6779999
Q ss_pred eecccccCcc-CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 180 DFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 180 Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
|||+++.-.- +....+.+|||.|+|||++.-+ +|+.++|+||+||+||||+.|++||.+.++.+.++.|++.
T Consensus 493 DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~Yq-PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh------ 565 (683)
T KOG0696|consen 493 DFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH------ 565 (683)
T ss_pred ecccccccccCCcceeeecCCCcccccceEEec-ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc------
Confidence 9999985433 3445678999999999999654 5999999999999999999999999999999999998872
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCcccccCCC
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREPN 327 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e~l~hp~~~~~~~~~ 327 (376)
+.. +++.+|.++.+++..+|.+.|.+|+.+ .++..||||+.+.|..
T Consensus 566 -----------nvs------------yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek 616 (683)
T KOG0696|consen 566 -----------NVS------------YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK 616 (683)
T ss_pred -----------cCc------------CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence 222 345689999999999999999999864 5899999999987763
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=314.24 Aligned_cols=258 Identities=26% Similarity=0.439 Sum_probs=203.9
Q ss_pred ceeeee-eeeecCCCeeEEEEEEcCCCcEEEEEEeecc----ccchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEE
Q 017147 34 ISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 34 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
+-|.+. +.||+|+|+.|-.|....++..||+|++.+. +....+|++++... .|+||++++++| +++...
T Consensus 77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~F 151 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRF 151 (463)
T ss_pred HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceE
Confidence 445553 5799999999999999999999999999765 34455899999887 599999999999 555559
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC--cEEEEeeccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSA 184 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~--~vkl~Dfg~a 184 (376)
|+|||-+.| .++..+. ....|++.++.++..+|+.||+|||. +||+||||||+|||...-+. -||||||.+.
T Consensus 152 YLVfEKm~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred EEEEecccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeeccccc
Confidence 999999986 6666665 45679999999999999999999999 89999999999999864222 3899999997
Q ss_pred ccCccC--------CCceeeeeccccCchhhhh----CCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChH---------
Q 017147 185 KQLIAG--------EANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV--------- 243 (376)
Q Consensus 185 ~~~~~~--------~~~~~~~~t~~y~aPE~l~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------- 243 (376)
...... ....+.+|+..|||||++. ....|+.++|.||||||+|.||+|.+||.|.-..
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~ 306 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV 306 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc
Confidence 644222 2234667888899999962 2456899999999999999999999999764321
Q ss_pred ------HHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 244 ------DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 244 ------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
..+..|.+ ..|.||. ..| ..+|.+++|||+.+|..|+.+|.++.++++|
T Consensus 307 Cr~CQ~~LFesIQE-----------------GkYeFPd---kdW-----ahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 307 CRVCQNKLFESIQE-----------------GKYEFPD---KDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred cHHHHHHHHHHHhc-----------------cCCcCCh---hhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 11222221 2233332 222 3479999999999999999999999999999
Q ss_pred CCcccccCC
Q 017147 318 PFFDELREP 326 (376)
Q Consensus 318 p~~~~~~~~ 326 (376)
||++.+...
T Consensus 362 Pw~~~~~~e 370 (463)
T KOG0607|consen 362 PWVQRCAPE 370 (463)
T ss_pred ccccccchh
Confidence 999987543
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=332.86 Aligned_cols=247 Identities=25% Similarity=0.445 Sum_probs=195.3
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.||+|+||+||+|++..+++.||+|++.+.. ....+|+.++..+ +|++|+.+++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-----TSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-----CCEEEEEE
Confidence 46999999999999999999999999997532 1234678888777 69999999998833 33489999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc-
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 189 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~- 189 (376)
||+++ +|...+. ....+++..++.++.||+.||+|||+ +|++||||||+|||++. ++.+||+|||+++....
T Consensus 76 e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~-~~~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 76 EYVNGGDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDA-DGHIKLTDYGMCKEGLGP 149 (327)
T ss_pred eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeC-CCCEEEeccccceeccCC
Confidence 99986 5555443 34579999999999999999999999 79999999999999996 77899999999875322
Q ss_pred CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHHHhh
Q 017147 190 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 190 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
........||+.|+|||++.+. .++.++|+|||||++|+|++|..||.... ..+.+.+.... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~-------- 218 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--K-------- 218 (327)
T ss_pred CCceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--C--------
Confidence 2233456789999999999654 58999999999999999999999996422 11222221110 0
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC------HHHHhcCCCcccccCC
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELREP 326 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t------~~e~l~hp~~~~~~~~ 326 (376)
.. .++..++..+.++|.+||+.||.+|++ .+++++||||+.+.+.
T Consensus 219 ------~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 219 ------PI------------RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269 (327)
T ss_pred ------CC------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence 00 123347889999999999999999998 4699999999987654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=333.47 Aligned_cols=246 Identities=28% Similarity=0.443 Sum_probs=195.7
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-------chHHH-HHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRE-LQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e-~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.||+|+||+||+|++..+++.||+|++.+... ....| ..+++.++|+||+++++.+. .....|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~-----~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ-----TAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCEEEEEE
Confidence 469999999999999999999999999864321 11223 34678899999999998873 333589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||+++ +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 76 DYVNGGELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDS-QGHVVLTDFGLCKEGVEP 149 (321)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEccCCCCccCCCC
Confidence 99986 5544443 34678999999999999999999999 79999999999999996 778999999998753222
Q ss_pred -CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 191 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 191 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
.......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+... +
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~------------- 212 (321)
T cd05603 150 EETTSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P------------- 212 (321)
T ss_pred CCccccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C-------------
Confidence 223345689999999998654 5899999999999999999999999988766555444321 0
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCcccccCC
Q 017147 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREP 326 (376)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~e~l~hp~~~~~~~~ 326 (376)
. .++...+.++.++|.+||+.||.+|+++ .++++||||..+.+.
T Consensus 213 -~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~ 260 (321)
T cd05603 213 -L------------QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWD 260 (321)
T ss_pred -C------------CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence 0 1123467899999999999999999975 599999999876543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=324.50 Aligned_cols=282 Identities=32% Similarity=0.591 Sum_probs=220.2
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC---CC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS---KN 103 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~ 103 (376)
.++|++.+.||+|+||.||+|.++.+++.+|+|++.... ....+|+++++.++|+||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 679999999999999999999999999999999885321 234579999999999999999987754332 23
Q ss_pred ceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 104 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 104 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
...+++|+||+.+++...+.. ....+++..++.++.|++.||.|||+ .|++|+||||+||++++ ++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDN-QGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECcCcc
Confidence 446789999999887666643 34579999999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccCCC------------ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017147 184 AKQLIAGEA------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251 (376)
Q Consensus 184 a~~~~~~~~------------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 251 (376)
+........ .....+++.|+|||.+.+...++.++||||+||++|+|++|++||.+.+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 875432221 12235688899999987655688999999999999999999999999998888888888
Q ss_pred HhCCCCHHHHhhcC--cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 252 VLGTPTREEIRCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 252 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
..+.+....+.... +...+..........+...+ ..+++.+.+||.+||+.||.+|||+.++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 77766654433211 11111000000111122222 2356889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=344.20 Aligned_cols=256 Identities=23% Similarity=0.376 Sum_probs=213.8
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccc----hHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY----KNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
.+.|.++..||.|+||+||+|.++.++-..|.|++...... ..-|++||..++||+||++++.||.... ++
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lw 105 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LW 105 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eE
Confidence 46799999999999999999999999888889987533221 2358999999999999999999977665 89
Q ss_pred EEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 109 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 109 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
|+.|||+|+-.+.+.. .-+..+++.+++.+++|++.||.|||+ ++|+|||||..|||+.. +|.|+|+|||.+....
T Consensus 106 iliEFC~GGAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~Tl-dGdirLADFGVSAKn~ 181 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTL-DGDIRLADFGVSAKNK 181 (1187)
T ss_pred EEEeecCCchHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEe-cCcEeeecccccccch
Confidence 9999999865554432 356789999999999999999999999 79999999999999997 7789999999975432
Q ss_pred -cCCCceeeeeccccCchhhhh----CCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 189 -AGEANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 189 -~~~~~~~~~~t~~y~aPE~l~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
......+++|||+|||||++. ...+|++++||||||++|.+|..+.+|-...+....+.+|.+.-. |+.
T Consensus 182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSeP-PTL----- 255 (1187)
T KOG0579|consen 182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-PTL----- 255 (1187)
T ss_pred hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCC-Ccc-----
Confidence 223345789999999999973 356799999999999999999999999999999988888876311 110
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.-+...+..+.||+.+||.+||..||++.++|+||||+++
T Consensus 256 --------------------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 256 --------------------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred --------------------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 0112246788999999999999999999999999999875
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=328.78 Aligned_cols=279 Identities=36% Similarity=0.575 Sum_probs=220.0
Q ss_pred ccceeee-eeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc------------------chHHHHHHHHhCCCCceeee
Q 017147 32 QTISYMA-ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------YKNRELQLMRVMDHPNVISL 92 (376)
Q Consensus 32 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------------------~~~~e~~~l~~l~h~~iv~~ 92 (376)
..++|.. .+.||.|+||+||+|.+..+++.||+|++..... ...+|+++++.++|+||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 3457765 5779999999999999999999999998854321 23479999999999999999
Q ss_pred ceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC
Q 017147 93 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL 172 (376)
Q Consensus 93 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~ 172 (376)
++++.. ..+.|+||||+.+++.+.+. ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.
T Consensus 86 ~~~~~~-----~~~~~lv~e~~~~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~- 154 (335)
T PTZ00024 86 VDVYVE-----GDFINLVMDIMASDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINS- 154 (335)
T ss_pred eEEEec-----CCcEEEEEeccccCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECC-
Confidence 998843 33588999999998877765 34568999999999999999999999 79999999999999996
Q ss_pred CCcEEEEeecccccCccC---------------CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCC
Q 017147 173 THQVKICDFGSAKQLIAG---------------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 237 (376)
Q Consensus 173 ~~~vkl~Dfg~a~~~~~~---------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf 237 (376)
++.++|+|||.+...... .......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~ 234 (335)
T PTZ00024 155 KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234 (335)
T ss_pred CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 778999999998754311 11112345778999999876656799999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhcCc--CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017147 238 PGENAVDQLVEIIKVLGTPTREEIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315 (376)
Q Consensus 238 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 315 (376)
.+.+..+.+..+...++.+....+..... .+.. +.......+... ....+.++.++|.+||+.||++|||+++++
T Consensus 235 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 235 PGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTE--FTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred CCCCHHHHHHHHHHHhCCCchhhCcchhhcccccc--cCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 99999998988988888777654432210 1111 111111112221 234688999999999999999999999999
Q ss_pred cCCCccccc
Q 017147 316 AHPFFDELR 324 (376)
Q Consensus 316 ~hp~~~~~~ 324 (376)
.||||+...
T Consensus 312 ~~~~~~~~~ 320 (335)
T PTZ00024 312 KHEYFKSDP 320 (335)
T ss_pred cCcccCCCC
Confidence 999998753
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=326.38 Aligned_cols=282 Identities=37% Similarity=0.637 Sum_probs=222.2
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 106 (376)
.+|.+.+.||+|+||.||+|.+..+++.||+|++.+.. ....+|+.+++.++|+||+++++++..... .....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 57999999999999999999999999999999885421 123579999999999999999998754322 12234
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
+|+|+||+..++.... ...+++..+..++.|++.||.|||+ .|++||||||+||+++. ++.+||+|||+++.
T Consensus 95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~-~~~~kL~dfg~~~~ 166 (342)
T cd07879 95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNE-DCELKILDFGLARH 166 (342)
T ss_pred EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCCCCcC
Confidence 6899999987654433 2468999999999999999999999 79999999999999996 78899999999875
Q ss_pred CccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 187 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
... ......+++.|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+....+..+....+.+..........
T Consensus 167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 422 223456788999999986655588999999999999999999999999888888888888877776655443321
Q ss_pred CC-CC--CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 267 NY-TD--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 267 ~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
.. .. ...+......+...++ ..+.++.+||.+||+.||.+||++++++.||||+.+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFP-KASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhc-CCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 10 00 0112222222332222 368899999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=320.93 Aligned_cols=277 Identities=35% Similarity=0.666 Sum_probs=214.3
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+.. ....+|+++++.++|+||+++++++ ......
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 36999999999999999999999899999999875432 2235799999999999999999988 334458
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
|+|+||++++++..+. .....+++..+..++.|++.||.|||+ .|++|+||+|+||++++ ++.++|+|||++...
T Consensus 76 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~-~~~~~l~dfg~~~~~ 150 (286)
T cd07846 76 YLVFEFVDHTVLDDLE---KYPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQ-SGVVKLCDFGFARTL 150 (286)
T ss_pred EEEEecCCccHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCcEEEEeeeeeeec
Confidence 9999999986554443 234558999999999999999999999 79999999999999996 778999999998765
Q ss_pred ccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 017147 188 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 265 (376)
Q Consensus 188 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 265 (376)
..... .....++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+....+....+....+......-....
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 151 AAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred cCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhcc
Confidence 33322 2335678899999998765567889999999999999999999999888777777777766654332211111
Q ss_pred -cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 266 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 266 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
+.......+......-.......++..+.+|+.+||..||++||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0011111222111111111223578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=319.44 Aligned_cols=277 Identities=35% Similarity=0.678 Sum_probs=221.4
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
++|++.+.||+|++|.||+|.+..+++.||+|++... .....+|+.+++.++|+||+++++++.. ....
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence 3699999999999999999999999999999987532 1234579999999999999999999854 3348
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+++|||++++++..+.. ....+++..+..++.|++.|+.|||+ +|++|+||+|+||+++. ++.+||+|||++...
T Consensus 76 ~iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~-~~~~kl~d~g~~~~~ 150 (288)
T cd07833 76 YLVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSE-SGVLKLCDFGFARAL 150 (288)
T ss_pred EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEEeeeccccc
Confidence 89999999876665542 34568999999999999999999999 79999999999999996 788999999998765
Q ss_pred ccCC--CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 188 IAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 188 ~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.... ......++..|+|||++.+...++.++|+||+|+++|+|++|++||.+.+..+.+..+...++...........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 151 RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred CCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 5443 23345678899999999766468999999999999999999999999888888787777777665554333221
Q ss_pred --cCCCCCCCCCC-CCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 266 --PNYTDFRFPQI-KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 266 --~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
+.+....++.. ....+...++..++.++.+||++||..||++|||++++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 11111112211 11223334455568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=331.28 Aligned_cols=252 Identities=26% Similarity=0.422 Sum_probs=195.6
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCC-CCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 106 (376)
..|++++.||+||.++||+|.. .+.+.||+|++.... .....|+.+|.+|+ |.+|++++++- -.+.+
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~~ 434 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDGY 434 (677)
T ss_pred chhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCce
Confidence 4699999999999999999984 455678877664321 23358999999995 89999999865 34667
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
+|+||||-+-+|...|+.+ ...++...+++|+.|++.|+.++|. +||||.||||.|+|+- .|.+||+|||+|..
T Consensus 435 lYmvmE~Gd~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLlV--kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 435 LYMVMECGDIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLLV--KGRLKLIDFGIANA 508 (677)
T ss_pred EEEEeecccccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEEE--eeeEEeeeechhcc
Confidence 9999999998998888753 2334445899999999999999999 7999999999999997 57899999999987
Q ss_pred CccCCC---ceeeeeccccCchhhhhCCC----------CCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 017147 187 LIAGEA---NISYICSRFYRAPELIFGAT----------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 253 (376)
Q Consensus 187 ~~~~~~---~~~~~~t~~y~aPE~l~~~~----------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 253 (376)
+..... ..+.+||+.||+||.+.... +.+.++||||||||||+|+.|++||.... ..+.++.. +
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~a-I 585 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHA-I 585 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHh-h
Confidence 655433 34678999999999984321 14679999999999999999999996543 12222222 1
Q ss_pred CCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
..|. ..+.||.+. -..+++++++.||.+||.+|||+.++|+|||++-
T Consensus 586 ~~P~-----------~~Iefp~~~-----------~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 586 TDPN-----------HEIEFPDIP-----------ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred cCCC-----------ccccccCCC-----------CchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 1121 223344321 1224999999999999999999999999999976
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=321.49 Aligned_cols=257 Identities=27% Similarity=0.409 Sum_probs=206.5
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.|+..+.||+|+||+||+|.+..+++.||+|.+.... ....+|+.+++.++|+|++.+.+.+. .....
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-----cCCEE
Confidence 3788899999999999999999999999999885432 12346999999999999999988873 33458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|++|||+.+ +|...+.. .....+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~-~~~~kl~Dfg~~~~ 151 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDD-YGHIRISDLGLAVK 151 (285)
T ss_pred EEEEEeccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECC-CCCEEEecCCccee
Confidence 999999996 55544432 223469999999999999999999999 79999999999999996 67899999999876
Q ss_pred CccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 187 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
...........++..|+|||.+.+. .++.++|+||+||++|+|++|..||.+.........+........
T Consensus 152 ~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~--------- 221 (285)
T cd05632 152 IPEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE--------- 221 (285)
T ss_pred cCCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc---------
Confidence 5443333455789999999999654 589999999999999999999999988766544444333211110
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCcccccCC
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 326 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 326 (376)
..+...+++++.+|+.+||+.||++||| +.++++||||+.....
T Consensus 222 ----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 222 ----------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred ----------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 0122346889999999999999999999 8899999999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=330.03 Aligned_cols=278 Identities=26% Similarity=0.427 Sum_probs=203.3
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.++|++.+.||+|+||.||++.+..++..+|+|.+.... ....+|+++++.++|+||+++++++... ..+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----CEE
Confidence 468999999999999999999999999999999876432 2345799999999999999999988543 348
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|+||||+.+ +|.+.+. ....+++..+..++.|++.||.|||+..+++||||||+|||++. ++.+||+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~-~~~~kL~Dfg~~~~ 153 (333)
T cd06650 79 SICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQ 153 (333)
T ss_pred EEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcC-CCCEEEeeCCcchh
Confidence 999999985 7766664 34568899999999999999999997247999999999999996 67899999999875
Q ss_pred CccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH--hCCCCHHHHhhc
Q 017147 187 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV--LGTPTREEIRCM 264 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~ 264 (376)
.... ......+|+.|+|||++.+. .++.++|+|||||++|+|++|+.||......+.. .+... .+.+........
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 154 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPR 230 (333)
T ss_pred hhhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCcc
Confidence 4322 22345678999999999654 4899999999999999999999999876543322 11110 000000000000
Q ss_pred Cc-------CCCCCCCCCC---------CCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 265 NP-------NYTDFRFPQI---------KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 265 ~~-------~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.. .+..-..+.. ....-.......++.++++||.+||++||++|||+.|++.||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 00 0000000000 00000000011357889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=320.10 Aligned_cols=274 Identities=39% Similarity=0.732 Sum_probs=222.9
Q ss_pred eeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
|++.+.||+|++|.||+|.+..+++.+++|.+..... ...+|+.+++.++|+||+++++.+... ...++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEE
Confidence 6778899999999999999999999999998864432 245789999999999999999987443 34889
Q ss_pred EeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 110 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 110 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
|+||+++++.+.+.. ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~df~~~~~~~~ 150 (283)
T cd05118 76 VFEFMDTDLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINT-EGVLKLADFGLARSFGS 150 (283)
T ss_pred EEeccCCCHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECC-CCcEEEeeeeeeEecCC
Confidence 999999988777653 23678999999999999999999999 79999999999999996 77899999999876544
Q ss_pred CC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc--
Q 017147 190 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-- 266 (376)
Q Consensus 190 ~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-- 266 (376)
.. ......++..|+|||.+.+...++.++|+||+|+++|+|++|+.||.+.+..+.+..+.+.++.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence 33 222345678899999987664689999999999999999999999999998888888888888877665554433
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
......++......... ....++.++.+||.+||+.||.+||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPLPK-LFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCHHH-hhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 22223333332222222 223478999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=334.25 Aligned_cols=253 Identities=30% Similarity=0.551 Sum_probs=211.9
Q ss_pred eeee--eeeeecCCCeeEEEEEEcCCCcEEEEEEeec------cccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 35 SYMA--ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 35 ~y~~--~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
-|++ .++||+|.||+||-++++.+|+.||||++.+ .+...+.|+.||+.+.||.||.+--.| +....
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~er 637 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPER 637 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCce
Confidence 3554 3689999999999999999999999999854 344556899999999999999997777 33334
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCC--CcEEEEeeccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFGSA 184 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~--~~vkl~Dfg~a 184 (376)
+++|||-+.|++++.+.. ...+++++...++++.||+.||+|||- ++|+|+||||+|||+.+.+ ..+||||||+|
T Consensus 638 vFVVMEKl~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfA 714 (888)
T KOG4236|consen 638 VFVVMEKLHGDMLEMILS--SEKGRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFA 714 (888)
T ss_pred EEEEehhhcchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeeccccce
Confidence 889999999998887753 467899999999999999999999999 7999999999999997533 37999999999
Q ss_pred ccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
+.+....-..+.+|||.|.|||+++..+ |+..-|+||.|||+|.-+.|..||....+. -.+|.+
T Consensus 715 RiIgEksFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQN------------- 778 (888)
T KOG4236|consen 715 RIIGEKSFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQN------------- 778 (888)
T ss_pred eecchhhhhhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccch--hHHhhc-------------
Confidence 9988877778899999999999997654 999999999999999999999999654322 222221
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
..+.+| ..+|.+ ++++++|||+.+|+..-.+|.|+++.|.|||+++.
T Consensus 779 ----AaFMyP---p~PW~e-----is~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 779 ----AAFMYP---PNPWSE-----ISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred ----cccccC---CCchhh-----cCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 112222 344544 79999999999999999999999999999999864
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=329.62 Aligned_cols=292 Identities=34% Similarity=0.663 Sum_probs=228.8
Q ss_pred CcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------ccchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 017147 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 102 (376)
+...++|++.+.||+|+||.||+|.+..+++.+|+|++.+. .....+|+.+++.+ +|+||+++++++...
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~--- 79 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE--- 79 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---
Confidence 34567899999999999999999999989999999988542 12234699999999 999999999877332
Q ss_pred CceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 103 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 103 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
+....|+||||++++|...+.. ..+.+..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 80 ~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~-~~~~kl~d~g 152 (337)
T cd07852 80 NDKDIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNS-DCRVKLADFG 152 (337)
T ss_pred CCceEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEEeecc
Confidence 2334789999999887766642 267888899999999999999999 79999999999999996 7889999999
Q ss_pred ccccCccCC------CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017147 183 SAKQLIAGE------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256 (376)
Q Consensus 183 ~a~~~~~~~------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 256 (376)
++....... ......+|+.|+|||.+.+...++.++|+||+||++|+|++|+.||.+....+....+....+.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07852 153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232 (337)
T ss_pred chhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 987553322 12235678899999988665667899999999999999999999999988888888888888877
Q ss_pred CHHHHhhcCcCCCCCCC---CCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCC
Q 017147 257 TREEIRCMNPNYTDFRF---PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN 332 (376)
Q Consensus 257 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~ 332 (376)
....+..+........+ +..........++ .++.++.+||.+||+.||++|||+.++++||||+.+..+......
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~ 310 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLP-KASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVL 310 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhcc-CCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCC
Confidence 76554433221111111 1111112222222 378999999999999999999999999999999998666544333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=319.01 Aligned_cols=274 Identities=35% Similarity=0.667 Sum_probs=217.2
Q ss_pred eeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
|++.+.||.|++|.||+|.+..+|..||+|++..+. ....+|+++++.++|+|++++++.+. .....|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence 678899999999999999999999999999886432 23457999999999999999999874 3345899
Q ss_pred EeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 110 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 110 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
+|||+++++.+.+... ....+++..+..++.|++.||+|||+ ++++||||+|+||+++. ++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 76 VFEFLDLDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGV 151 (283)
T ss_pred EEeccCcCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcC-CCcEEEeecccccccCC
Confidence 9999988877776532 12468999999999999999999999 79999999999999997 78899999999875432
Q ss_pred CCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc--
Q 017147 190 GEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-- 266 (376)
Q Consensus 190 ~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-- 266 (376)
... .....+++.|+|||++.+...++.++|+||+||++|+|++|.+||.+.+..+.+..+.+..+.+....+.....
T Consensus 152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 221 22335578899999886655578999999999999999999999999888888888888877777655432211
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
++. ..++......... ....++..+.++|.+||+.||.+|||+.+++.||||
T Consensus 232 ~~~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYK-PTFPKWARQDLSK-VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhh-hhcccccccchhh-hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 110 0111111111111 234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=299.74 Aligned_cols=257 Identities=26% Similarity=0.373 Sum_probs=205.9
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
.+|++.+.||+|||+.||++++..++..||+|++.... ....+|++..+.++|||+++++++............||
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 48999999999999999999999999999999986443 34468999999999999999998887666667778999
Q ss_pred Eeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCC--eeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 110 VMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 110 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
+++|.. |+|++.+......+..+++.++..|+.+++.||++||+ .. ++||||||.|||+.. .+.++|.|||.+..
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~-~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSD-SGLPVLMDLGSATQ 178 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecC-CCceEEEeccCccc
Confidence 999998 68999998887788899999999999999999999999 67 999999999999996 78899999999875
Q ss_pred CccCC----------CceeeeeccccCchhhhhC--CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017147 187 LIAGE----------ANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254 (376)
Q Consensus 187 ~~~~~----------~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 254 (376)
..-.- ......+|..|+|||++.- ....+.++|||||||+||+|+.|..||...- + .|
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~-~G 248 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------Q-QG 248 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------h-cC
Confidence 42211 1123467899999999732 2336889999999999999999999995311 1 11
Q ss_pred CCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.... +.-.-..+.+|. ....|+.+.+||+.||+.||.+||++.+++++
T Consensus 249 gSla-----LAv~n~q~s~P~----------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 249 GSLA-----LAVQNAQISIPN----------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CeEE-----EeeeccccccCC----------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1000 000001122222 12368999999999999999999999999864
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=319.74 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=202.9
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-----chHHHHH-HHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQ-LMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
++|++.+.||+|+||.||+|.+..+++.||||.+..... ....|+. .++.++|+||+++++.+... ...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-----~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE-----GDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC-----CcE
Confidence 369999999999999999999999999999998865421 1223444 46777999999999988433 338
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCC-CeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|++|||++++|.+.+.........+++..++.++.|++.||.|||+ + +++||||||+||+++. ++.+||+|||++..
T Consensus 76 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~-~~~~kl~dfg~~~~ 153 (283)
T cd06617 76 WICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINR-NGQVKLCDFGISGY 153 (283)
T ss_pred EEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECC-CCCEEEeecccccc
Confidence 8999999998888887655555779999999999999999999998 6 9999999999999996 77899999999976
Q ss_pred CccCCCceeeeeccccCchhhhhCC---CCCCchhhhHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHh
Q 017147 187 LIAGEANISYICSRFYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~ 262 (376)
...........++..|+|||.+.+. ..++.++|+||+||++|+|++|+.||.... ..+.+..+... .+.
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~----- 226 (283)
T cd06617 154 LVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE--PSP----- 226 (283)
T ss_pred cccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc--CCC-----
Confidence 5433333335678889999988542 336889999999999999999999996532 22333222210 000
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
.+ ....+|.++.+||.+||..+|.+|||++++++||||....
T Consensus 227 ---------~~-----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 227 ---------QL-----------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred ---------CC-----------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 00 0123688999999999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=322.88 Aligned_cols=260 Identities=29% Similarity=0.497 Sum_probs=210.2
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
++|++.+.||+|++|.||+|.+..+++.||+|.+..... ....|+++++.++|+||+++++.+ .....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence 369999999999999999999999999999999865422 234789999999999999999887 33445
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.|+||||+.+ +|.+.+.. .....+++..++.++.|++.||.|||+ .|++|+||||+||+++. ++.++|+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~ 151 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHE-SGHIMLSDFDLSK 151 (316)
T ss_pred EEEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcC-CCCEEEeecchhh
Confidence 8999999986 77666542 234678999999999999999999999 79999999999999996 7789999999986
Q ss_pred cCccCCC------------------------------ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCC
Q 017147 186 QLIAGEA------------------------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 235 (376)
Q Consensus 186 ~~~~~~~------------------------------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~ 235 (376)
....... .....||..|+|||++.+. .++.++|||||||++|+|++|..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~ 230 (316)
T cd05574 152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTT 230 (316)
T ss_pred cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCC
Confidence 5422211 1123578889999999654 47899999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC----H
Q 017147 236 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT----A 311 (376)
Q Consensus 236 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~ 311 (376)
||.+.+....+..+... ...++. ...++.++.++|.+||+.||++||| +
T Consensus 231 pf~~~~~~~~~~~~~~~-----------------~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~ 283 (316)
T cd05574 231 PFKGSNRDETFSNILKK-----------------EVTFPG----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGA 283 (316)
T ss_pred CCCCCchHHHHHHHhcC-----------------CccCCC----------ccccCHHHHHHHHHHccCCHhHCCCchhhH
Confidence 99888776665544321 000110 0126889999999999999999999 9
Q ss_pred HHHhcCCCcccccCCCCCC
Q 017147 312 LEACAHPFFDELREPNARL 330 (376)
Q Consensus 312 ~e~l~hp~~~~~~~~~~~~ 330 (376)
+++++||||+...++....
T Consensus 284 ~~ll~~~~~~~~~~~~~~~ 302 (316)
T cd05574 284 AEIKQHPFFRGVNWALIRH 302 (316)
T ss_pred HHHHcCchhhcCChhhccc
Confidence 9999999999987776554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=315.71 Aligned_cols=248 Identities=28% Similarity=0.491 Sum_probs=201.0
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
+.|.+.+.||+|++|.||.|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++. ..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cC
Confidence 46999999999999999999999999999999875431 23356899999999999999999883 33
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
...++|+||+++ +|.+.+. ....+++..+..++.|++.||.|||+ .|++||||+|+||+++. ++.++|+|||+
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~-~~~~~l~dfg~ 150 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLK----AYGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGA 150 (263)
T ss_pred CeEEEEEEECCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeeccc
Confidence 358999999986 6655554 34568899999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccCCCc----eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 184 AKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 184 a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
+......... ....++..|+|||.+.+.. ++.++|+||+||++|+|++|+.||...+.......+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------ 223 (263)
T cd06625 151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP------ 223 (263)
T ss_pred ceeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC------
Confidence 8754322111 2345678899999996644 8899999999999999999999998766554443332210
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
....++..++..+.++|.+||..+|.+|||+.++++||||
T Consensus 224 ---------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 224 ---------------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ---------------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0111234578899999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=318.70 Aligned_cols=262 Identities=24% Similarity=0.365 Sum_probs=208.1
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
..++|.+.+.||+|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.+ +|+|++++++++...........
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 3568999999999999999999999999999999886432 2334688889888 89999999998865443334568
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|+||||+++ +|.+.+.........+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++..
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~-~~~~kl~dfg~~~~ 177 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTT-EGGVKLVDFGVSAQ 177 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcC-CCCEEEeecccchh
Confidence 899999986 7767665544456678999999999999999999999 79999999999999996 67899999999876
Q ss_pred CccCCC-ceeeeeccccCchhhhhCCC----CCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 187 LIAGEA-NISYICSRFYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 187 ~~~~~~-~~~~~~t~~y~aPE~l~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
...... .....++..|+|||.+.... .++.++|+||+||++|+|++|++||...+....+..+.+.. +.
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~--~~---- 251 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP--PP---- 251 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC--CC----
Confidence 543221 22346788899999985432 25789999999999999999999998876655544332210 00
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 321 (376)
....+...+..+.+||.+||+.||++||++.++++||||+
T Consensus 252 --------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 252 --------------------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred --------------------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 0001123567899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=318.90 Aligned_cols=277 Identities=31% Similarity=0.605 Sum_probs=218.5
Q ss_pred eeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
|++.+.||+|++|.||+|.+..+++.+|+|.+.... ....+|+.+++.++|+|++++++++.... ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 788999999999999999999999999999997542 22347999999999999999999884431 245889
Q ss_pred EeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 110 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 110 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
|+||+++++.+.+.. ....+++..++.++.|++.||+|||+ .|++|+||+|+||+++. ++.++|+|||++.....
T Consensus 78 v~e~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~-~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 78 VFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINN-DGVLKLADFGLARPYTK 152 (287)
T ss_pred EeccccccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcC-CCCEEEccccceeeccC
Confidence 999999887776653 23578999999999999999999999 79999999999999996 78899999999976544
Q ss_pred CCC--ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017147 190 GEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267 (376)
Q Consensus 190 ~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 267 (376)
... .....++..|+|||.+.+...++.++||||||+++|+|++|+.||...+....+..+.+..+.+....+......
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 331 223456788999998766556889999999999999999999999999988888888887777765544322110
Q ss_pred --CCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 268 --YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 268 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
.................+...+++.+.+++++||+.||.+||++.++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00000000011112222333348899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=334.92 Aligned_cols=249 Identities=30% Similarity=0.466 Sum_probs=213.3
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.|.-++.||.|+||.||.|++..+.+.||||++.-+. ..+.+|+..|+.++|||++.+.++|+.... .
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-----a 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-----A 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-----H
Confidence 5888899999999999999999999999999996432 223479999999999999999999965554 8
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
|+|||||-|+-.+++.. ...++.+.++..|..+.+.||.|||+ .+.+|||||..|||++. .+.|||+|||.|...
T Consensus 102 WLVMEYClGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse-~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 102 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSE-PGLVKLADFGSASIM 176 (948)
T ss_pred HHHHHHHhccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecC-CCeeeeccccchhhc
Confidence 89999999977777764 34679999999999999999999999 79999999999999995 889999999999765
Q ss_pred ccCCCceeeeeccccCchhhhh--CCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 188 IAGEANISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 188 ~~~~~~~~~~~t~~y~aPE~l~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
. ...+++|||+|||||+++ ..+.|+-++||||||++..+|.-.++|....+....+.-|.+. ..
T Consensus 177 ~---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-es---------- 242 (948)
T KOG0577|consen 177 A---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ES---------- 242 (948)
T ss_pred C---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-CC----------
Confidence 3 345789999999999984 3466999999999999999999999999999999888887762 11
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
|.+.... -|..+..|+..||++-|.+|||.+++|.|+|+..-
T Consensus 243 --------PtLqs~e--------WS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 243 --------PTLQSNE--------WSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred --------CCCCCch--------hHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 1122222 36788999999999999999999999999998753
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=332.83 Aligned_cols=260 Identities=29% Similarity=0.432 Sum_probs=221.4
Q ss_pred CCCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 017147 28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 101 (376)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (376)
...+....|.+.+.||+|.|++|.+|++..++..||||.+.+.. ....+|+++|+.++|||||+++.+.....
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~- 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA- 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc-
Confidence 56677889999999999999999999999999999999986643 22458999999999999999999984443
Q ss_pred CCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 102 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
.+|+||||+.++ .+..|...++++.+..++.++.|++.|++|||+ ++|+|||||++||||+. +.++||+||
T Consensus 129 ----~lylV~eya~~g---e~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~-~mnikIaDf 199 (596)
T KOG0586|consen 129 ----TLYLVMEYASGG---ELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDE-NMNIKIADF 199 (596)
T ss_pred ----eeEEEEEeccCc---hhHHHHHhcccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhccccc-ccceeeecc
Confidence 499999999963 333444567889999999999999999999999 89999999999999996 777999999
Q ss_pred cccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 182 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
|++..+..+....+++|++.|.|||++.+..+.++++|+||+|+++|.|+.|..||.+.+-.+.-...+.
T Consensus 200 gfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~---------- 269 (596)
T KOG0586|consen 200 GFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR---------- 269 (596)
T ss_pred ccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee----------
Confidence 9999988888888999999999999998888778999999999999999999999998764432222111
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
..+.+ +--++.++.++|+++|..+|.+|++.+++..|.|.......
T Consensus 270 -------gk~rI------------p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 270 -------GKYRI------------PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred -------eeecc------------cceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 11111 12378999999999999999999999999999999876655
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=324.55 Aligned_cols=285 Identities=35% Similarity=0.600 Sum_probs=223.2
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 105 (376)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++..... ....
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 468999999999999999999999999999999886432 223469999999999999999988753321 2223
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
..|++++++++++.+.+. ...+++..++.++.|++.||.|||+ .|++||||||+||+++. ++.+||+|||++.
T Consensus 96 ~~~lv~~~~~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kl~dfg~~~ 168 (345)
T cd07877 96 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLAR 168 (345)
T ss_pred cEEEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcC-CCCEEEecccccc
Confidence 478999999888766654 2468999999999999999999999 79999999999999996 7789999999987
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.... ......+++.|+|||.+.+...++.++|+||+||++|+|++|++||...+....+..+.+..+.+.........
T Consensus 169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 169 HTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred cccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 5422 23345678899999998665568899999999999999999999999888888888888877777665544332
Q ss_pred cCCCCC---CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCC
Q 017147 266 PNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327 (376)
Q Consensus 266 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 327 (376)
...... ..+......+.... ...++++++||.+||+.||.+|+|+.++++||||+....+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~ 310 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhc-CCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence 110000 01111111222111 13688999999999999999999999999999999865543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=317.91 Aligned_cols=261 Identities=25% Similarity=0.369 Sum_probs=206.9
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....|+.+++.+ +|+||+++++++...........
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 4668999999999999999999999999999999875432 2345788999998 69999999998865544455668
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
++||||+++ +|.+.+.........+++..++.++.|++.||.|||+ .+++||||||+||+++. ++.++|+|||++..
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~-~~~~kl~dfg~~~~ 173 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTT-EGGVKLVDFGVSAQ 173 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECC-CCCEEEccCCceee
Confidence 999999985 6766666544455678999999999999999999999 79999999999999996 67799999999876
Q ss_pred CccCC-CceeeeeccccCchhhhhC----CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 187 LIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 187 ~~~~~-~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
..... ......+++.|+|||++.. ...++.++|+||+||++|+|++|..||........+..+... .+.
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~~---- 247 (286)
T cd06638 174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PPP---- 247 (286)
T ss_pred cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CCC----
Confidence 54322 2234467899999998743 234788999999999999999999999876554433222110 000
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
....+...+..+.+||.+||+.||++|||+.++++||||
T Consensus 248 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 248 --------------------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred --------------------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 000112357789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=324.24 Aligned_cols=285 Identities=36% Similarity=0.657 Sum_probs=221.8
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCC-Cce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~~~ 105 (376)
.++|++.+.||+|+||.||+|.+..++..||+|++.... ....+|+.+++.++|+||+++++++...... ...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 457999999999999999999999999999999885421 1234799999999999999999987543221 123
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.+++||||+++++...+. ...+++..++.++.|++.||.|||+ .||+||||||+||+++. ++.++|+|||++.
T Consensus 94 ~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~-~~~~kl~dfg~~~ 166 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLAR 166 (343)
T ss_pred eEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeeccccc
Confidence 468999999777766653 3568999999999999999999999 79999999999999996 7789999999997
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
..... .....+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+....+..+++..+.+..+......
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 167 QTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred ccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 54322 2334668899999998664558899999999999999999999999988888888887776665544333221
Q ss_pred cCCC-CC--CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCC
Q 017147 266 PNYT-DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327 (376)
Q Consensus 266 ~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 327 (376)
.... .+ ..+......+. .+...+++.+.++|.+||+.||++|||+.+++.||||+..+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~ 308 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308 (343)
T ss_pred chhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcc
Confidence 1100 00 01111111111 12345788999999999999999999999999999999886543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=318.57 Aligned_cols=250 Identities=30% Similarity=0.511 Sum_probs=206.8
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
++|++.+.||+|++|.||++.+..+++.||+|++.+.. ....+|+++++.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-----DSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCe
Confidence 36999999999999999999999999999999886432 223478999999999999999998843 344
Q ss_pred EEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+|+||||++ ++|.+.+. ....+++..+..++.|++.||.|||+ +|++|+||+|.||+++. ++.+||+|||++.
T Consensus 76 ~~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~-~~~~kl~dfg~~~ 149 (290)
T cd05580 76 LYLVMEYVPGGELFSHLR----KSGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDS-DGYIKITDFGFAK 149 (290)
T ss_pred EEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECC-CCCEEEeeCCCcc
Confidence 889999996 57766664 34678999999999999999999999 79999999999999996 7789999999997
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
..... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+.. +.
T Consensus 150 ~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~---------- 214 (290)
T cd05580 150 RVKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--GK---------- 214 (290)
T ss_pred ccCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CC----------
Confidence 65443 3344678899999998654 478999999999999999999999988775544444332 00
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCC
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 326 (376)
..++..++..+.++|.+||+.||.+|+ +++++++||||+.+.+.
T Consensus 215 -----------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 215 -----------------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred -----------------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 012234688999999999999999999 89999999999887644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=316.35 Aligned_cols=275 Identities=40% Similarity=0.704 Sum_probs=221.8
Q ss_pred eeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-----chHHHHHHHHhCC-CCceeeeceeeeecCCCCceEEEE
Q 017147 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
|++.+.||+|++|+||+|....+++.|+||.+..... ...+|+..++.++ |+|++++++++.. ....|+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence 6788999999999999999988999999998864322 2346888999999 9999999998844 334889
Q ss_pred EeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 110 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 110 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
||||+++++.+.+... ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~-~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYMEGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSG-PEVVKIADFGLAREIRS 151 (283)
T ss_pred EEecCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcC-CCCEEEeecccceeccC
Confidence 9999988888777532 13578999999999999999999999 79999999999999996 78899999999986655
Q ss_pred CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc--C
Q 017147 190 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP--N 267 (376)
Q Consensus 190 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~ 267 (376)
........++..|+|||.+.+...++.++|+||+|+++++|++|++||.+....+.+.++...++.+....+..... .
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 44444566788999999886656688999999999999999999999999998889999988888877655432211 1
Q ss_pred CCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
..++.++..........++. .+.++.+||++||+.||++|||+.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPN-ASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHccc-CCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 11222222222222232333 37899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=319.65 Aligned_cols=254 Identities=28% Similarity=0.431 Sum_probs=210.6
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
.+-|.++..||+|+||.||+|.++.+|..+|||++.-+ -+.+.+|+.++++.+.+++|++|+.|+-..+ ++||
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIV 106 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIV 106 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEee
Confidence 45689999999999999999999999999999998654 4455689999999999999999999876555 9999
Q ss_pred eeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 111 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 111 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
||||+ |+..++++. .+.++++.++..++..-+.||+|||.+ .-+|||||..|||++. .+..||+|||.|....+
T Consensus 107 MEYCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLNT-~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLNT-DGIAKLADFGVAGQLTD 181 (502)
T ss_pred hhhcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEcc-cchhhhhhccccchhhh
Confidence 99999 677777764 567899999999999999999999995 7789999999999997 67899999999976543
Q ss_pred CC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 017147 190 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268 (376)
Q Consensus 190 ~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 268 (376)
.- ...+.+|||.|||||++..- .|+.++||||||+...||.-|++||.+-.....+..|
T Consensus 182 TMAKRNTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI------------------- 241 (502)
T KOG0574|consen 182 TMAKRNTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI------------------- 241 (502)
T ss_pred hHHhhCccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-------------------
Confidence 32 34567899999999999654 4999999999999999999999999876654333211
Q ss_pred CCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
|..+...|. .++.-|.++.|||++||.+.|++|.|+.++++|||+++.
T Consensus 242 -----PT~PPPTF~--KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 242 -----PTKPPPTFK--KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred -----cCCCCCCCC--ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 111111111 112247789999999999999999999999999999863
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=313.87 Aligned_cols=263 Identities=29% Similarity=0.428 Sum_probs=208.9
Q ss_pred CcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhC-CCCceeeeceeeeecCC-CCc
Q 017147 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTS-KNE 104 (376)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-~~~ 104 (376)
|+..++|++.+.||+|++|.||+|.++.+++.+++|++.... ....+|+.+++.+ +|+||+++++.+..... ...
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 345679999999999999999999999999999999886543 3345799999998 79999999998865443 345
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
..+|+||||+++ +|.+.+......+..+++..++.++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~-~~~~~l~d~~~ 159 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTK-NAEVKLVDFGV 159 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEcc-CCeEEECCCcc
Confidence 568899999996 6666665443345789999999999999999999999 79999999999999996 67899999999
Q ss_pred cccCccCC-CceeeeeccccCchhhhhCC----CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 184 AKQLIAGE-ANISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 184 a~~~~~~~-~~~~~~~t~~y~aPE~l~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
+....... ......+++.|+|||++... ..++.++||||+||++|+|++|.+||........+.++.+.. .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~- 235 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---P- 235 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---C-
Confidence 87543322 22345678899999987432 346788999999999999999999998766555444433210 0
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
+.. ......+.++++||.+||..||++|||+.++++|||+
T Consensus 236 ---------------~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 236 ---------------PTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ---------------CCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 000 0012257899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=316.32 Aligned_cols=283 Identities=29% Similarity=0.518 Sum_probs=220.2
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC----
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS---- 101 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---- 101 (376)
..++|++.+.||+|+||.||+|.++.+++.||+|.+.... ....+|+.+++.++|||++++++++.....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4568999999999999999999999999999999886432 123479999999999999999988754331
Q ss_pred -CCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEe
Q 017147 102 -KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 180 (376)
Q Consensus 102 -~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~D 180 (376)
.+...+|+|+||+++++...+.. ....+++..++.++.|++.||.|||+ .||+|+||+|+||+++. ++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~-~~~~kl~d 159 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNN-KGQIKLAD 159 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCcEEeCc
Confidence 12336889999999987766653 24568999999999999999999999 79999999999999996 77899999
Q ss_pred ecccccCccCCC--ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 181 FGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 181 fg~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
||++........ .....++..|+|||.+.+...++.++||||+||++|+|++|++||...+..+.+..+.+..+.+..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 999876543321 122345778999998866555789999999999999999999999988888888888887777765
Q ss_pred HHHhhcCc--CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 259 EEIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 259 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
..+..... .+............+... ...++..+.++|.+||+.||++|||+.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 54432211 111100001011111122 22468999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=314.29 Aligned_cols=274 Identities=38% Similarity=0.702 Sum_probs=225.1
Q ss_pred eeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
|++.+.||+|++|.||+|++..+++.||+|.+.... .....|+.+++.++|+|++++++++... ...++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence 677889999999999999999999999999886532 1234689999999999999999988433 45889
Q ss_pred EeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 110 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 110 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
|+||++++|.+.+.. ....+++..+..++.|++.||.+||+ +|++||||+|+||+++. ++.++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~-~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 76 VFEYCDMDLKKYLDK---RPGPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINR-DGVLKLADFGLARAFGI 150 (282)
T ss_pred EecCcCcCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcC-CCCEEEecCCcccccCC
Confidence 999999988887764 22578999999999999999999999 79999999999999996 78899999999876543
Q ss_pred CC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC-
Q 017147 190 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN- 267 (376)
Q Consensus 190 ~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~- 267 (376)
.. .......+..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+..+.+..+.+....+......
T Consensus 151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 32 2223445778999999876546899999999999999999999999999999999999998888887766544322
Q ss_pred CCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
+.+..++..........++. ++..+.++|++||..||++||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPR-LDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccccCccchHHhccc-ccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 22334444444444444433 58899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=342.06 Aligned_cols=248 Identities=26% Similarity=0.434 Sum_probs=198.7
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc----ccchHHHHHHHHhCC-CCceeeece-eeeecCCCC-ceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMD-HPNVISLKH-CFFSTTSKN-ELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~-h~~iv~~~~-~~~~~~~~~-~~~ 106 (376)
.+++|.+.|.+|||+.||+|.+...+..||+|++... -....+|+++|+.|+ |+|||.+++ ........+ ..-
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3799999999999999999999988899999987533 233468999999997 999999999 433333333 345
Q ss_pred EEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCC--eeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 107 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 107 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
+.|+||||. |+|.+++..+.. ..|++.++.+|++|+++|+.+||. .. |+|||||-|||||+. ++..||||||.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~-~g~~KLCDFGS 192 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSA-DGNYKLCDFGS 192 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcC-CCCEEeCcccc
Confidence 779999999 699999986554 349999999999999999999999 46 999999999999996 77899999999
Q ss_pred cccCccCCC----------ceeeeeccccCchhhh--hCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017147 184 AKQLIAGEA----------NISYICSRFYRAPELI--FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251 (376)
Q Consensus 184 a~~~~~~~~----------~~~~~~t~~y~aPE~l--~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 251 (376)
|........ ......|+.|+|||.+ ..+...+.|+|||+|||+||.|+....||.......++.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIln---- 268 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILN---- 268 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEe----
Confidence 864332221 1123558999999997 233457999999999999999999999998764332221
Q ss_pred HhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..|.+|.. .+.+..+++||+.||+.||.+||++-|++.
T Consensus 269 -----------------g~Y~~P~~----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 269 -----------------GNYSFPPF----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred -----------------ccccCCCC----------ccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 23344431 236889999999999999999999998874
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=316.63 Aligned_cols=257 Identities=25% Similarity=0.410 Sum_probs=203.7
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
+.|++++.||.|+||.||+|++..+++.+++|.+..... ...+|+.+++.++|+||+++++.+... ..+|+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-----GKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-----CeEEE
Confidence 579999999999999999999999999999999864432 234689999999999999999988433 34899
Q ss_pred Eeecccch-HHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
||||++++ +...+.. ....+++..+..++.|++.|+.|||+ .|++||||||+||+++. ++.++|+|||++....
T Consensus 87 v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 87 MIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTL-DGDIKLADFGVSAKNV 161 (292)
T ss_pred EEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcC-CCCEEEccCccceecc
Confidence 99999975 4333332 34568999999999999999999999 79999999999999986 7789999999986533
Q ss_pred cC-CCceeeeeccccCchhhhhC----CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 189 AG-EANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 189 ~~-~~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
.. .......+++.|+|||.+.+ ...++.++|+|||||++|+|++|.+||...+......++.+.. ++
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~------ 233 (292)
T cd06644 162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PP------ 233 (292)
T ss_pred ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC--Cc------
Confidence 22 12234567889999999842 2346789999999999999999999998776554443332210 00
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
. ...+..++.++.++|.+||..||++||+++++++||||..+...
T Consensus 234 ------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 278 (292)
T cd06644 234 ------T------------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278 (292)
T ss_pred ------c------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 0 00122467899999999999999999999999999999887543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=329.33 Aligned_cols=256 Identities=24% Similarity=0.410 Sum_probs=224.6
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
.+..++..||-||||.|=++.-......+|+|++.+. ......|..+|...+.+.||++|..| .+..+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchh
Confidence 4677888999999999999887665556999987653 23345788999999999999999988 77778
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+|++||-|-| .++..++ ..+.|.+..+++|+.++++|++|||+ +||++|||||+|++++. ++-+||.|||+|+
T Consensus 495 vYmLmEaClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~-~Gy~KLVDFGFAK 568 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDN-RGYLKLVDFGFAK 568 (732)
T ss_pred hhhhHHhhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeecc-CCceEEeehhhHH
Confidence 9999999975 7777776 46789999999999999999999999 89999999999999996 7789999999999
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
....+....+.+|||+|+|||+++..+ .+.++|.||||+++|||++|.+||.+.++...++.|++.+..
T Consensus 569 ki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~---------- 637 (732)
T KOG0614|consen 569 KIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK---------- 637 (732)
T ss_pred HhccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh----------
Confidence 999999999999999999999998765 789999999999999999999999999999999999885321
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCcccccCCCC
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPNA 328 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~~~ 328 (376)
+ .|+..++..+.+||+++...+|.+|+. +.++-+|-||.+..|..-
T Consensus 638 -----i------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwegl 688 (732)
T KOG0614|consen 638 -----I------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGL 688 (732)
T ss_pred -----h------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhh
Confidence 1 134568999999999999999999996 789999999999887643
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=313.17 Aligned_cols=257 Identities=25% Similarity=0.403 Sum_probs=202.7
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhC-CCCceeeeceeeeecCCC-CceEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK-NELFL 107 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~-~~~~~ 107 (376)
.+.|++.+.||+|+||.||+|.+..+++.||+|.+.... .....|+.+++.+ +|+||+++.+.+...... ....+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 457999999999999999999999999999999986442 2345788888888 699999999988654322 23468
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|++|||+++ +|.+.+.. .....+++..+..++.|++.|+.|||+ ++|+|+||+|+||+++. ++.++|+|||++..
T Consensus 85 ~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~-~~~~~l~Dfg~~~~ 160 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECC-CCCEEEccCCCcee
Confidence 899999985 66666653 123568999999999999999999999 79999999999999996 77899999999875
Q ss_pred CccCC-CceeeeeccccCchhhhhC----CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 187 LIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 187 ~~~~~-~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
..... ......+++.|+|||++.+ ...++.++|+||+||++|+|++|..||...........+... +
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~----- 232 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P----- 232 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C-----
Confidence 43221 2234567889999999853 234788999999999999999999999766544333222110 0
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
........++.++.+|+.+||..||.+|||+.+++.||||
T Consensus 233 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 -------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -------------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0000112367899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=307.27 Aligned_cols=249 Identities=27% Similarity=0.448 Sum_probs=201.5
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+|++.+.||.|++|.||++.+..+++.||+|++..+. ....+|+.+++.++|+|++++.+.+. ....++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 4899999999999999999999999999999985432 23456889999999999999987662 1233588
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
++|||+++ ++.+.+.. .....+++..++.++.|++.|+.+||+ .|++||||+|+||+++. ++.++|+|||++...
T Consensus 77 lv~e~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~-~~~~~l~df~~~~~~ 152 (257)
T cd08223 77 IVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTR-TNIIKVGDLGIARVL 152 (257)
T ss_pred EEecccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEec-CCcEEEecccceEEe
Confidence 99999985 66666653 134568999999999999999999999 79999999999999996 778999999998765
Q ss_pred ccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
..... .....+++.|+|||++.+. .++.++|+||+||++|+|++|+.||.+.+.......+.....
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~------------ 219 (257)
T cd08223 153 ENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL------------ 219 (257)
T ss_pred cccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC------------
Confidence 33222 2334578899999998654 478999999999999999999999988776554444333100
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
+ ..+..+++++.+|+.+||+.||++|||+.++++||||
T Consensus 220 -------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 -------P---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -------C---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0122368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=321.71 Aligned_cols=276 Identities=21% Similarity=0.327 Sum_probs=198.0
Q ss_pred eeeeeecC--CCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 38 AERVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 38 ~~~~lg~G--~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
++++||+| +|++||++.++.+++.||+|.+..+. ....+|+.+++.++||||+++++++... ...|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence 46789999 78899999999999999999986432 2345799999999999999999988443 34889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
||||+++ ++.+.+... ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.++++||+.+....
T Consensus 77 v~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~-~~~~~l~~~~~~~~~~ 152 (327)
T cd08227 77 VTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISV-DGKVYLSGLRSNLSMI 152 (327)
T ss_pred EEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEec-CCcEEEcccchhhccc
Confidence 9999985 666666432 23458999999999999999999999 79999999999999996 6789999998654322
Q ss_pred cCCC--------ceeeeeccccCchhhhhCC-CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC--
Q 017147 189 AGEA--------NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-- 257 (376)
Q Consensus 189 ~~~~--------~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-- 257 (376)
.... .....++..|+|||++.+. ..++.++||||+||++|+|++|..||.............. +..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~ 230 (327)
T cd08227 153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCL 230 (327)
T ss_pred cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCcccc
Confidence 1111 1123456779999998653 3588999999999999999999999987654443333221 1110
Q ss_pred -------HHHHhhc------CcCCCCCCC----CCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 258 -------REEIRCM------NPNYTDFRF----PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 258 -------~~~~~~~------~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
.+..... ...+.+... ...........+...+++.+.+||++||++||++|||++++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f 310 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 310 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhh
Confidence 0000000 000000000 00000000111223467899999999999999999999999999999
Q ss_pred cccc
Q 017147 321 DELR 324 (376)
Q Consensus 321 ~~~~ 324 (376)
+.+.
T Consensus 311 ~~~~ 314 (327)
T cd08227 311 KQIK 314 (327)
T ss_pred hhcc
Confidence 8764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=318.13 Aligned_cols=282 Identities=38% Similarity=0.718 Sum_probs=222.6
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
..++|++.+.||.|+||.||+|.+..+++.||+|++.+. ......|+.+++.++||||+++.+++.... .
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~ 83 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL----E 83 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC----C
Confidence 346899999999999999999999999999999987532 223457999999999999999999874322 2
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
..|+++||+++++...+. ...+++..+..++.|++.||.|||+ .|++||||+|+||+++. ++.++|+|||.+.
T Consensus 84 ~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~-~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINE-NCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECC-CCCEEeCcccccc
Confidence 378999999888776664 3468888899999999999999999 79999999999999996 7789999999987
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.... ......+++.|+|||.+.+...++.++|+||+||++|+|++|++||.+.........+.+.++.++.+......
T Consensus 157 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 157 IQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred ccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 5422 22345668889999988654568999999999999999999999999988888888888888887766544221
Q ss_pred cC-CCCC--CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCC
Q 017147 266 PN-YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327 (376)
Q Consensus 266 ~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 327 (376)
.. ..++ ..+.....+....+ ..+++.+.++|++||+.+|++|||+++++.||||...+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~ 298 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT 298 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHc-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence 10 0000 01111111222222 34688999999999999999999999999999998876553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=323.66 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=191.6
Q ss_pred cceeeeeeeeecCCCeeEEEEEEc-----CCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 101 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 101 (376)
.++|++.+.||+|+||.||+|.+. .+++.||+|++.... ....+|+.++..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC--
Confidence 358999999999999999999753 345789999886432 2345799999999 899999999877432
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhh-----------------------------------------------------
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSS----------------------------------------------------- 127 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~----------------------------------------------------- 127 (376)
...++++|||+++ +|.+.+.....
T Consensus 84 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 84 --NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 2247899999985 77777653211
Q ss_pred -----cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCC---ceeeeec
Q 017147 128 -----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICS 199 (376)
Q Consensus 128 -----~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t 199 (376)
....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++....... .....++
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcC-CCcEEEeecccccccccCcchhcccCCCCC
Confidence 02347888899999999999999999 79999999999999996 77899999999975433221 1123346
Q ss_pred cccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCC
Q 017147 200 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKA 278 (376)
Q Consensus 200 ~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (376)
+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+...+.. +. ..
T Consensus 240 ~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~--------------~~------- 296 (338)
T cd05102 240 LKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GT--------------RM------- 296 (338)
T ss_pred ccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CC--------------CC-------
Confidence 789999998654 48999999999999999997 99999886544433332221 00 00
Q ss_pred CChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 279 HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 279 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..+..+++++.+|+.+||+.||.+|||+.++++
T Consensus 297 -----~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 297 -----RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 012346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=310.59 Aligned_cols=278 Identities=36% Similarity=0.625 Sum_probs=215.8
Q ss_pred eeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhC---CCCceeeeceeeeecCCCCceE
Q 017147 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVM---DHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
|++.+.||+|+||.||+|+++.+++.||+|.+.... ....+|+.+++.+ +|+|++++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 688999999999999999999889999999886321 1233577776655 5999999999987655444556
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
++++|||+++++.+.+... ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++. ++.++|+|||++..
T Consensus 81 ~~l~~e~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~-~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTS-DGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcccCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEcc-CCCEEEeccCccee
Confidence 8899999998877766532 22368999999999999999999999 79999999999999997 68899999999977
Q ss_pred CccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 187 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
...........++..|+|||.+.+. .++.++|+||+||++|+|++|++||.+....+.+..+....+.+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV- 234 (287)
T ss_pred ccCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc-
Confidence 6544443445578889999999664 48899999999999999999999999998888888887766655443322110
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
......++......+.. ....+++.+.++|.+||+.||++||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKS-FVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhh-hhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00000111111122211 122467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=331.93 Aligned_cols=248 Identities=29% Similarity=0.519 Sum_probs=204.4
Q ss_pred eeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecccc
Q 017147 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 116 (376)
Q Consensus 41 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~ 116 (376)
+||+|.||+||-|+++.|...+|||.+.... +-..+|+.+.+.|+|.|||++.+++ ..++++-|.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence 6999999999999999999999999986432 3346899999999999999999987 556678899999996
Q ss_pred -hHHHHHHhhhhcCCCc--CHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCC-
Q 017147 117 -SMYRVLKHYSSANQRM--PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA- 192 (376)
Q Consensus 117 -~l~~~l~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~- 192 (376)
+|.++++. .=+++ .+..+.+|..||++||+|||. +.|||||||-+|+|++..+|.+||+|||.++....-..
T Consensus 657 GSLSsLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 657 GSLSSLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CcHHHHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 66666653 23455 788899999999999999999 79999999999999998899999999999987655444
Q ss_pred ceeeeeccccCchhhhh-CCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCC
Q 017147 193 NISYICSRFYRAPELIF-GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271 (376)
Q Consensus 193 ~~~~~~t~~y~aPE~l~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 271 (376)
..++.||..|||||++. |.+.|+.++|||||||++.||.||++||......... +.+. |
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFkV-G----------------- 792 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFKV-G----------------- 792 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhhh-c-----------------
Confidence 34678999999999994 4456999999999999999999999999765543221 1110 0
Q ss_pred CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.+ .-+..++..+|++++.||.+|+..||.+||+|.++|..||++.-
T Consensus 793 my------KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 793 MY------KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ce------ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 00 01223455689999999999999999999999999999999864
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=313.47 Aligned_cols=250 Identities=27% Similarity=0.412 Sum_probs=204.4
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
++|++.+.||.|++|.||+|.+..+++.||+|.+..+. ....+|+.+++.++|+|++++.+.+... ...|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeEE
Confidence 36899999999999999999999999999999886432 2335799999999999999999987433 4589
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+|+||+++ +|.+.+.. ..+++..++.++.|++.|+.|||+ .+++|+||+|+||+++. ++.++|+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~ 148 (274)
T cd06609 76 IIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSE-EGDVKLADFGVSGQL 148 (274)
T ss_pred EEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEcccccceee
Confidence 99999986 66666542 378999999999999999999999 79999999999999997 778999999999766
Q ss_pred ccC-CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
... .......+++.|+|||.+.+.. ++.++|+||+||++|+|++|..||...+.......+.....
T Consensus 149 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~------------ 215 (274)
T cd06609 149 TSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP------------ 215 (274)
T ss_pred cccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC------------
Confidence 443 2233456788899999996544 89999999999999999999999987665444433322100
Q ss_pred CCCCCCCCCCCCCChhhhcccC-CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
...... +++++.+++.+||..||++|||++++++||||++..
T Consensus 216 ----------------~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 216 ----------------PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred ----------------CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 001111 678999999999999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=316.92 Aligned_cols=252 Identities=25% Similarity=0.459 Sum_probs=197.5
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
+|++.+.||+|+||.||+|.+..+++.||+|.+..+. ....+|+.+++.++||||+++++.+... ...++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEEE
Confidence 6889999999999999999999999999999886542 2234799999999999999999988543 34789
Q ss_pred EeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 110 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 110 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
||||++++.+... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++. ++.++|+|||++.....
T Consensus 77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~-~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNT-RGQVKLCDFGVSTQLVN 147 (279)
T ss_pred EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECC-CCCEEEeeCCcceeccc
Confidence 9999997544322 347888899999999999999999 79999999999999997 77899999999975533
Q ss_pred CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHhhcCc
Q 017147 190 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ---LVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 190 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~ 266 (376)
. ......+|..|+|||.+.+. .++.++|+||+||++|+|++|..||........ .....+......
T Consensus 148 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------- 216 (279)
T cd06619 148 S-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--------- 216 (279)
T ss_pred c-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC---------
Confidence 2 23345788999999998654 489999999999999999999999965332110 011111110000
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
. + .......++++.+|+.+||+.||.+||+++++++||||.....
T Consensus 217 -~-----~--------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~ 261 (279)
T cd06619 217 -P-----P--------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND 261 (279)
T ss_pred -C-----C--------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence 0 0 0011235789999999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=328.39 Aligned_cols=246 Identities=30% Similarity=0.461 Sum_probs=202.6
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHH-hCCCCceeeeceeeeecCCCCceEEEE
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-VMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
...+.|.+...+|.|+|+.|-.+.+..+++.+++|++.+......+|+.++. .-+||||+++.+++ .+....|+
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~ 393 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYL 393 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeee
Confidence 4567899999999999999999999999999999999887666777885544 44799999999998 55666999
Q ss_pred Eeecccch-HHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
|||.+.|. +++-+. ....+. ..+..|++||+.|+.|||+ +|++||||||+|||++.+.+.++|+|||.++...
T Consensus 394 v~e~l~g~ell~ri~----~~~~~~-~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 394 VMELLDGGELLRRIR----SKPEFC-SEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred eehhccccHHHHHHH----hcchhH-HHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999974 333332 223333 7788899999999999999 8999999999999995347789999999998654
Q ss_pred cCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 017147 189 AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268 (376)
Q Consensus 189 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 268 (376)
.. ..+.+-|..|.|||++. ...|+.++||||||++||+||+|+.||...... .++...++.+.
T Consensus 468 ~~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~----------- 530 (612)
T KOG0603|consen 468 RS--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPK----------- 530 (612)
T ss_pred hh--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCc-----------
Confidence 44 33445688899999996 456999999999999999999999999876655 33444444332
Q ss_pred CCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
+...+|.+++|||++||+.||.+|+++.+++.||||
T Consensus 531 ----------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 531 ----------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ----------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 123589999999999999999999999999999999
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=314.22 Aligned_cols=255 Identities=25% Similarity=0.400 Sum_probs=204.6
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
.++|++.+.||.|+||.||++.+..+++.+|+|.+..... ...+|+.+++.++|+||+++++.+.. ....|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-----ENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-----CCeEE
Confidence 4679999999999999999999988999999998854322 23478999999999999999998843 33589
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus 79 lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~-~~~~~l~d~g~~~~~ 153 (280)
T cd06611 79 ILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTL-DGDVKLADFGVSAKN 153 (280)
T ss_pred EEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECC-CCCEEEccCccchhh
Confidence 99999997 55555542 34569999999999999999999999 79999999999999996 788999999988654
Q ss_pred ccCC-CceeeeeccccCchhhhhC----CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 188 IAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 188 ~~~~-~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
.... ......+++.|+|||.+.. ...++.++|+||+||++|+|++|++||.+.+....+..+... .++
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~----- 226 (280)
T cd06611 154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EPP----- 226 (280)
T ss_pred cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CCC-----
Confidence 3322 2234567889999999842 234678999999999999999999999887665544433221 000
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.. ..+..++.++.++|.+||..||.+||++.++++||||.+.
T Consensus 227 ------------~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 227 ------------TL-------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ------------Cc-------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 00 0112367899999999999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=314.17 Aligned_cols=253 Identities=26% Similarity=0.424 Sum_probs=203.8
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
...+|++.+.||+|++|.||++.+..+++.||+|.+..+. ....+|+.+++.++|+|++++++.+... ...
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-----~~~ 92 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DEL 92 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-----CEE
Confidence 3468999999999999999999999999999999886433 2345789999999999999999988543 348
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|+||||+++ +|.+.+. ...+++..+..++.|++.||.|||+ .|++||||||+||+++. ++.++|+|||++..
T Consensus 93 ~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~-~~~~kl~dfg~~~~ 165 (296)
T cd06654 93 WVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQ 165 (296)
T ss_pred EEeecccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcC-CCCEEECccccchh
Confidence 899999986 6666553 2457889999999999999999999 79999999999999986 77899999999875
Q ss_pred CccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 187 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 187 ~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
...... .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|+.||...+....+..+... +.+.
T Consensus 166 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~-------- 235 (296)
T cd06654 166 ITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE-------- 235 (296)
T ss_pred ccccccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC--------
Confidence 433222 223467889999999865 44789999999999999999999999877654443322210 0000
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
...+..++..+.+||.+||..||++|||+.++++||||...
T Consensus 236 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 236 -----------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred -----------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 00123467899999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=315.19 Aligned_cols=260 Identities=26% Similarity=0.442 Sum_probs=203.6
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
++|++++.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++.+.. ....|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeEE
Confidence 36899999999999999999999999999999885431 233479999999999999999998743 34588
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||+++ +|...+.. ......+++..+..++.|++.||.|||+..|++|+||||+||+++. ++.++|+|||++...
T Consensus 76 lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~ 153 (286)
T cd06622 76 MCMEYMDAGSLDKLYAG-GVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG-NGQVKLCDFGVSGNL 153 (286)
T ss_pred EEEeecCCCCHHHHHHh-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC-CCCEEEeecCCcccc
Confidence 99999997 55555432 1123478999999999999999999996249999999999999997 778999999998754
Q ss_pred ccCCCceeeeeccccCchhhhhCCC-----CCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 188 IAGEANISYICSRFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 188 ~~~~~~~~~~~t~~y~aPE~l~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
... ......+++.|+|||.+.+.. .++.++|+||+||++|+|++|..||...........+........
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----- 227 (286)
T cd06622 154 VAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP----- 227 (286)
T ss_pred cCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC-----
Confidence 322 223345778899999985432 257899999999999999999999977654443333322211110
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
..++..+++++.+||.+||+.+|++||+++++++||||...+..
T Consensus 228 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 228 --------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred --------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 01122368899999999999999999999999999999886543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=306.63 Aligned_cols=291 Identities=32% Similarity=0.565 Sum_probs=234.1
Q ss_pred CCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
.|.+.-+.+-.+.||-|+||.||.+.+..+|+.||+|++..- .+...+|+++|..++|.|++...++.....-.
T Consensus 48 ~Pqqq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d 127 (449)
T KOG0664|consen 48 PPQQQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS 127 (449)
T ss_pred CccccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence 344455677778899999999999999999999999998642 33445899999999999999998876433322
Q ss_pred CceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 103 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 103 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
--..+|+++|++..+|..++- ....++.+.++-+++||++||+|||+ .+|.||||||.|+|+++ +..+||||||
T Consensus 128 fFqEiYV~TELmQSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNS-NCvLKICDFG 201 (449)
T KOG0664|consen 128 FFQELYVLTELMQSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNS-NCILKICDFG 201 (449)
T ss_pred HHHHHHHHHHHHHhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEecc-CceEEecccc
Confidence 222266888888876665553 56789999999999999999999999 79999999999999997 8899999999
Q ss_pred ccccCccCCC--ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 183 SAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 183 ~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
+++.....+. .+..+.|.+|+|||+++|.+.|+.+.||||.|||+.||+..+..|...+..+++..|.+.+|+|+.+.
T Consensus 202 LARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~Ea 281 (449)
T KOG0664|consen 202 LARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEA 281 (449)
T ss_pred cccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHH
Confidence 9986544433 23356689999999999999999999999999999999999999999999999999999999999998
Q ss_pred HhhcCcCCCCCCCCCCCC-CChhhhcc----cCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 261 IRCMNPNYTDFRFPQIKA-HPWHKVFH----KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
++...+......+..-.. ..+...+. ..-..+..+++.+||..||.+|++.++++.|++....|-
T Consensus 282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred HHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence 886665544332222111 11222111 123457899999999999999999999999999977653
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=306.75 Aligned_cols=249 Identities=31% Similarity=0.456 Sum_probs=204.9
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+|++.+.||+|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.++|+|++++++.+. .....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence 5899999999999999999999999999999886432 23457899999999999999998873 334588
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||+++ +|.+.+... ....+++..+..++.|++.|++|||+ +|++|+||+|+||+++.++..+||+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred EEEecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 99999986 777776532 23458999999999999999999999 799999999999999875667899999999876
Q ss_pred ccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017147 188 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267 (376)
Q Consensus 188 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 267 (376)
..........+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||.+.+.......+.....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~------------- 218 (256)
T cd08220 153 SSKSKAYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF------------- 218 (256)
T ss_pred CCCccccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-------------
Confidence 554444455678899999998654 478999999999999999999999988776655544432100
Q ss_pred CCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
..++..++.++.+++.+||..||++|||+.++++||||
T Consensus 219 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 219 ---------------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ---------------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 00123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=314.26 Aligned_cols=253 Identities=28% Similarity=0.467 Sum_probs=204.7
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
..+|++.+.||.|++|.||++.+..+++.||+|.+.... ....+|+.+++.++|+|++++++.+.. ...+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 92 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-----GDELF 92 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-----CceEE
Confidence 457999999999999999999999999999999886432 233468999999999999999998843 33488
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+|+||+.+ +|...+. ...+++..+..++.|++.|+.|||+ .|++||||+|+||+++. ++.++|+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~-~~~~kl~dfg~~~~~ 165 (296)
T cd06655 93 VVMEYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGM-DGSVKLTDFGFCAQI 165 (296)
T ss_pred EEEEecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccCccchhc
Confidence 99999986 5554443 2468999999999999999999999 79999999999999996 778999999998755
Q ss_pred ccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
..... .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+... +.+.
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~--------- 234 (296)
T cd06655 166 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE--------- 234 (296)
T ss_pred ccccccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc---------
Confidence 43322 223457888999999855 44789999999999999999999999887765554433221 1100
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
...+..+++.+.+||++||..||++|||+.+++.||||+..+
T Consensus 235 ----------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 235 ----------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred ----------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 001234688999999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=306.80 Aligned_cols=252 Identities=25% Similarity=0.433 Sum_probs=205.9
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+|++.+.||.|+||.||+|.+..+++.+|+|.+.... .....|+.+++.++|+||+++++.+... .....|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 4899999999999999999999999999999885432 2234689999999999999998876432 234478
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhh-----cCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH-----TVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-----~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
++|||+++ +|.+.+.........+++..++.++.||+.||.||| + .+++|+||+|+||+++. ++.+||+|||
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~-~~~~kl~d~g 155 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDA-NNNVKLGDFG 155 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEec-CCCEEEeccc
Confidence 99999985 777777665555678999999999999999999999 8 79999999999999996 7889999999
Q ss_pred ccccCccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 183 SAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 183 ~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
++........ .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------- 225 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG--------- 225 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC---------
Confidence 9986654433 3345678999999998654 4889999999999999999999999887754433332221
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
.. ..++...+..+.+++.+||+.+|++|||+.++++|||+
T Consensus 226 ----------~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 226 ----------KF---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ----------CC---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 00 01223468899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=308.51 Aligned_cols=256 Identities=29% Similarity=0.430 Sum_probs=203.9
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
++|++.+.||.|+||+||+|.+..++..+|+|++..+. ....+|+.+++.++|+|++++++.+.. ....|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEEE
Confidence 47999999999999999999999899999999886432 234579999999999999999988743 33488
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+++|++++ ++.+.+... .....+++..++.++.|++.||.+||+ .|++||||+|+||++++ ++.++|+|||++...
T Consensus 76 iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~-~~~~~l~df~~~~~~ 152 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSS-YPRGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGE-DGSVKIADFGVSASL 152 (267)
T ss_pred EEEeccCCCcHHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcC-CCCEEEcccchHHHh
Confidence 99999986 666665431 123568999999999999999999999 79999999999999996 678999999998765
Q ss_pred ccCCCc-----eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 188 IAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 188 ~~~~~~-----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
...... ....++..|+|||.+.....++.++|+|||||++|+|++|+.||...+....+.++... .+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~----- 225 (267)
T cd06610 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--DPP----- 225 (267)
T ss_pred ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC--CCC-----
Confidence 443222 23467889999999866545899999999999999999999999877665544443321 000
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
. ++. ......+++.+.+++.+||..||++|||+.+++.||||
T Consensus 226 -------~--~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 226 -------S--LET-------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred -------C--cCC-------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0 000 00012468899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=316.38 Aligned_cols=264 Identities=23% Similarity=0.361 Sum_probs=203.2
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCC-CCceeeeceeeeecCCCCceEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
++|...+.||+|+||.||++.+..+++.+|+|.+.... ....+|+.++.++. |+||+++++++.... ..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~-----~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG-----DC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC-----cE
Confidence 36777889999999999999999999999999886432 22346888888886 999999999875432 37
Q ss_pred EEEeecccchHHHHHHh-hhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
+++|||+.+++..+... .......+++..+..++.|++.||+|||+..+++||||||+||+++. ++.++|+|||++..
T Consensus 79 ~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~ 157 (288)
T cd06616 79 WICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR-NGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEcc-CCcEEEeecchhHH
Confidence 79999998766554432 12234679999999999999999999997249999999999999996 67899999999976
Q ss_pred CccCCCceeeeeccccCchhhhhCC--CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 187 LIAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
...........+++.|+|||++.+. ..++.++|+||+||++|+|++|+.||..... ....+.+......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~------- 228 (288)
T cd06616 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDP------- 228 (288)
T ss_pred hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCC-------
Confidence 5444333445678899999998655 3588999999999999999999999976542 2222222111000
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
+. ........++.++.+||.+||+.||++|||+++++.||||+.....
T Consensus 229 ---------~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 229 ---------PI-----LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEER 276 (288)
T ss_pred ---------Cc-----CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhc
Confidence 00 0011113478899999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=309.37 Aligned_cols=246 Identities=32% Similarity=0.534 Sum_probs=198.5
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 101 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (376)
+|.+...||.|++|.||+|.+..+++.+|+|.+.... ....+|+.+++.++|+||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence 4888999999999999999999899999999885421 123478999999999999999998743
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEe
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 180 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~D 180 (376)
..+.+++|||+++ +|.+.+. ....+++..+..++.|++.||+|||+ +|++||||+|+||++++ ++.++|+|
T Consensus 78 --~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~-~~~~~l~d 149 (267)
T cd06628 78 --ADHLNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDN-KGGIKISD 149 (267)
T ss_pred --CCccEEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcC-CCCEEecc
Confidence 3348899999986 6666664 34568899999999999999999999 79999999999999996 77899999
Q ss_pred ecccccCccCCC-------ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 017147 181 FGSAKQLIAGEA-------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 253 (376)
Q Consensus 181 fg~a~~~~~~~~-------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 253 (376)
||.++....... .....++..|+|||.+.+. .++.++|+||+||++|+|++|+.||.+.+....+..+....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 228 (267)
T cd06628 150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA 228 (267)
T ss_pred cCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC
Confidence 999876542211 1123467889999998654 47889999999999999999999998776544443322210
Q ss_pred CCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
...++..++..+.++|++||+.||.+||++.++++||||
T Consensus 229 ----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 229 ----------------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ----------------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 001223468899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=309.52 Aligned_cols=252 Identities=29% Similarity=0.527 Sum_probs=199.6
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
+|+..+.||+|++|.||++.+..+++.+|+|++.... ....+|+.+++.++|+||+++++++. ..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-----ED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-----cC
Confidence 4888999999999999999999999999999886432 23457999999999999999999883 33
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
..+++|+||+.+ +|.+.+. ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++..++|+|||.
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~ 150 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGA 150 (268)
T ss_pred CeEEEEEeccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence 448899999996 6666554 34578999999999999999999999 79999999999999987556799999999
Q ss_pred cccCccCCC-----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 184 AKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 184 a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
+........ .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+.......+.+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-- 227 (268)
T cd06630 151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT-- 227 (268)
T ss_pred ccccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC--
Confidence 876543211 123456888999999865 457899999999999999999999997654333222222210000
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 321 (376)
....++..+++++.+++.+||..||++|||+.++++||||+
T Consensus 228 ----------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 228 ----------------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ----------------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 00112234688999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=311.20 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=202.2
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
+-|++.+.||+|+||.||++.+..++..+++|.+.... ....+|+.+++.++|+|++++++.+... ...|+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~~ 79 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWI 79 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CEEEE
Confidence 34789999999999999999999999999999885432 2234689999999999999999988433 34889
Q ss_pred Eeecccch-HHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
|+||++++ +...+.. ....+++..+..++.|++.||.|||+ .|++||||||+||+++. ++.+||+|||++....
T Consensus 80 v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~-~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 80 LIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNT 154 (282)
T ss_pred EEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcc-CCCEEEcccccccccc
Confidence 99999974 4343332 34578999999999999999999999 79999999999999996 7789999999986543
Q ss_pred cCC-CceeeeeccccCchhhhhC----CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 189 AGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 189 ~~~-~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
... ......+++.|+|||++.. ...++.++|+||+||++|+|++|.+||...+..+....+.......
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------- 227 (282)
T cd06643 155 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT------- 227 (282)
T ss_pred ccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-------
Confidence 221 1233467889999999742 2346789999999999999999999998877665555543311000
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
...+..++.++.+||.+||+.||.+|||++++++||||+..
T Consensus 228 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 228 -------------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred -------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 00122368899999999999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=310.67 Aligned_cols=257 Identities=27% Similarity=0.412 Sum_probs=202.6
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhC-CCCceeeeceeeeecCC-CCceEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTS-KNELFL 107 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~~ 107 (376)
.+.|++.+.||.|+||.||+|.+..+++.+|+|.+.... .....|+.+++.+ +|+||+++++.+..... ....++
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 468999999999999999999999999999999886543 2345688888888 69999999998854322 234568
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|++|||+++ +|.+.+... ....+++..++.++.|++.|+.|||+ +|++|+||+|+||+++. ++.++|+|||++..
T Consensus 95 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~-~~~~~l~dfg~~~~ 170 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCcchhh
Confidence 899999986 676666532 23568899999999999999999999 79999999999999996 77899999999875
Q ss_pred CccC-CCceeeeeccccCchhhhhC----CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 187 LIAG-EANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 187 ~~~~-~~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
.... .......+++.|+|||.+.. ...++.++|+|||||++|+|++|..||...........+... ..
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~---- 243 (282)
T cd06636 171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PP---- 243 (282)
T ss_pred hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CC----
Confidence 4322 12234567889999999752 234788999999999999999999999776554433322210 00
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
.......++.++.+||++||..||.+|||+.++++||||
T Consensus 244 --------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 --------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred --------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 000112368899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=313.80 Aligned_cols=255 Identities=27% Similarity=0.438 Sum_probs=203.6
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
....+|++.+.||+|+||.||++.+..+++.||+|.+.... ....+|+.+++.++|+||+++++.+.. ...
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 90 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDE 90 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCE
Confidence 34478999999999999999999999999999999886432 233568899999999999999998843 335
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.|+||||+++ +|.+.+. ...+++..+..++.|++.||.|||+ .|++||||||+||+++. ++.++|+|||++.
T Consensus 91 ~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~-~~~~~l~Dfg~~~ 163 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCA 163 (297)
T ss_pred EEEeecccCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEECcCccce
Confidence 8899999986 5555553 2457889999999999999999999 79999999999999996 7789999999987
Q ss_pred cCccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 186 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 186 ~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
....... .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+....+..+.. .+.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~------- 234 (297)
T cd06656 164 QITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE------- 234 (297)
T ss_pred EccCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC-------
Confidence 5433322 223467889999999865 4578999999999999999999999987654333221111 01000
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
...+..++..+.+|+.+||..||++||++.++++||||+..+
T Consensus 235 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 235 ------------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred ------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 001234678899999999999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=307.92 Aligned_cols=249 Identities=29% Similarity=0.497 Sum_probs=196.7
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
+|++.+.||+|+||.||+|.+..++..||+|++.... ....+|+.+++.++|+||+++++++... ...
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 79 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AEK 79 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CCC
Confidence 6899999999999999999999999999999875321 2245799999999999999999877432 223
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
.+++++||+++ +|.+.+. ....+++..++.++.|++.||+|||+ .+++||||+|+||+++. ++.++|+|||++
T Consensus 80 ~~~l~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~-~~~~~l~dfg~~ 153 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGAS 153 (266)
T ss_pred EEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEccCCCc
Confidence 57899999985 6666664 33568899999999999999999999 79999999999999996 778999999998
Q ss_pred ccCccCC----CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 185 KQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 185 ~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
....... ......++..|+|||.+.+. .++.++|+||+||++|+|++|+.||...+.......+... +.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~~--- 226 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---PT--- 226 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---CC---
Confidence 7543211 11224467889999998654 4889999999999999999999999876554433332211 00
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 321 (376)
...++..+++.+.+++ +||..+|++|||++|+++||||+
T Consensus 227 ---------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 ---------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ---------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0112234678899999 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=295.63 Aligned_cols=260 Identities=25% Similarity=0.398 Sum_probs=210.2
Q ss_pred CCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccch-----HHHHHH-HHhCCCCceeeeceeeeecCCC
Q 017147 29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQL-MRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~e~~~-l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
.+...++.+.+..||.|+.|+|+++..+.+|...|+|.+.+..... ...+.+ ++.-..|+||+.+++|....+
T Consensus 87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d- 165 (391)
T KOG0983|consen 87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD- 165 (391)
T ss_pred cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch-
Confidence 3344567788889999999999999999999999999996542221 122332 233358999999999976655
Q ss_pred CceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 103 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 103 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
++|.||.|..-+..+++. -.++++|..+-.+...++.||.||...+||+|||+||+|||+|. .++|||||||
T Consensus 166 ----V~IcMelMs~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe-~GniKlCDFG 237 (391)
T KOG0983|consen 166 ----VFICMELMSTCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RGNIKLCDFG 237 (391)
T ss_pred ----HHHHHHHHHHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEcc-CCCEEeeccc
Confidence 779999998655555543 34679999999999999999999997689999999999999996 8899999999
Q ss_pred ccccCccCCCceeeeeccccCchhhhhC--CCCCCchhhhHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHH
Q 017147 183 SAKQLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 183 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~ 259 (376)
++....+........|-+.|||||.+.- ...|+.++||||||+.++||.||+.||.+.+ +.+.+.++.+... |..
T Consensus 238 IsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~L- 315 (391)
T KOG0983|consen 238 ISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PLL- 315 (391)
T ss_pred ccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CCC-
Confidence 9998888888888889999999999832 3568999999999999999999999999854 5566766665211 110
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
+ ....+|+++++|+..||.+|+.+||.-.++|+|||+...
T Consensus 316 --------------~----------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 316 --------------P----------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred --------------C----------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 0 012379999999999999999999999999999999865
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=305.35 Aligned_cols=248 Identities=33% Similarity=0.533 Sum_probs=201.2
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
+|+..+.||+|++|+||+|.+..+++.|++|.+.... ....+|+.+++.++|+||+++++.+. ...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence 4788899999999999999998899999999885432 23457999999999999999998773 334
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
.+|+++||+++ +|.+.+. ....+++..++.++.|++.||.|||+ .|++|+||+|+||+++. ++.+||+|||.+
T Consensus 76 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~-~~~~kl~d~~~~ 149 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDT-NGVVKLADFGMA 149 (258)
T ss_pred eEEEEEEecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccCccc
Confidence 48899999986 6666554 34568899999999999999999999 79999999999999996 778999999998
Q ss_pred ccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
.............+++.|+|||.+.....++.++|+||+||++|+|++|+.||......+....+......
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------- 220 (258)
T cd06632 150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL--------- 220 (258)
T ss_pred eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC---------
Confidence 76544433345567889999999854434789999999999999999999999876644444333221000
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
..++..+++++.+|+.+||+.+|++|||+.+++.|||+
T Consensus 221 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 221 ------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 01223468899999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=303.79 Aligned_cols=248 Identities=27% Similarity=0.405 Sum_probs=202.1
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+|.+.+.||+|++|.||+|.+..+++.|++|.+... .....+|+.+++.++|+|++++++.+.. ....|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-----KGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-----CCEEE
Confidence 488899999999999999999999999999988532 2233468899999999999999988743 34588
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||+++ +|.+.+... ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus 76 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~-~~~~~l~df~~~~~~ 151 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDA-YDNVKIGDLGVAKLL 151 (256)
T ss_pred EEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeC-CCCEEEcccccceec
Confidence 99999985 776666532 24678999999999999999999999 79999999999999996 678999999998765
Q ss_pred ccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
..... .....+++.|+|||++.+. .++.++|+|||||++|+|++|+.||...+.......+.+...
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 218 (256)
T cd08529 152 SDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF------------ 218 (256)
T ss_pred cCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 43322 2234678899999998654 478999999999999999999999988776555444332100
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
+ .++..++.++.+++.+||+.+|++||++.++++|||+
T Consensus 219 -------~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 219 -------P---------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -------C---------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 0 0112368899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=315.76 Aligned_cols=278 Identities=26% Similarity=0.402 Sum_probs=202.4
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
++|++.+.||+|+||.||++.+..++..+|+|.+.... ....+|+++++.++||||+++++++.. ...+|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEEE
Confidence 36999999999999999999999999999999875431 224579999999999999999998843 33589
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||+++ +|.+.+. ....+++..+..++.|++.||.|||+..+++||||||+||+++. ++.+||+|||++...
T Consensus 76 lv~ey~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~ 150 (308)
T cd06615 76 ICMEHMDGGSLDQVLK----KAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQL 150 (308)
T ss_pred EEeeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEec-CCcEEEccCCCcccc
Confidence 99999986 6666654 33678999999999999999999997248999999999999996 778999999998754
Q ss_pred ccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017147 188 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267 (376)
Q Consensus 188 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 267 (376)
.... .....+++.|+|||.+.+. .++.++|+||+||++|+|++|+.||...+.... ..+..................
T Consensus 151 ~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 151 IDSM-ANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred cccc-cccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCccccc
Confidence 3322 2345678899999998654 488999999999999999999999987653332 222211100000000000000
Q ss_pred CCCCCCCC----------CCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 268 YTDFRFPQ----------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 268 ~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
......+. .........-...++.++.+|+.+||..||++|||+.++++||||.+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 00000000 0000000000112678899999999999999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=307.08 Aligned_cols=247 Identities=28% Similarity=0.469 Sum_probs=197.0
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
+|++.+.||.|+||.||+|.+ .+++.+|+|.+.... ....+|+.+++.++|+||+++.+++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-----D 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-----C
Confidence 488999999999999999986 578899999875321 224579999999999999999998833 3
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
...++++||+++ +|.+.+. ....+++..+..++.|++.||+|||+ .|++|+||+|+||++++ ++.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~ 148 (265)
T cd06631 75 NTISIFMEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMP-NGIIKLIDFGC 148 (265)
T ss_pred CeEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECC-CCeEEeccchh
Confidence 458999999986 6655554 33568999999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccC-------CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017147 184 AKQLIAG-------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256 (376)
Q Consensus 184 a~~~~~~-------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 256 (376)
+...... .......++..|+|||.+.+. .++.++|+||+||++|+|++|..||...+.......+....+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 226 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL- 226 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-
Confidence 8754211 111234578889999998654 4789999999999999999999999876654443333221110
Q ss_pred CHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
...++..++.++.++|++||..+|.+|||+.++++||||
T Consensus 227 -------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 227 -------------------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred -------------------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 001223468899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=309.16 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=199.2
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++.+... ..+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-----~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-----DKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----CEEE
Confidence 458999999999999999999999999999999886432 2235789999999999999999988433 3488
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
++|||+++ +|.+.+. ..+.+++..++.++.|++.|+.|||+ .|++|+||||+||+++. ++.++|+|||++...
T Consensus 83 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~-~~~~~l~dfg~~~~~ 156 (267)
T cd06645 83 ICMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTD-NGHVKLADFGVSAQI 156 (267)
T ss_pred EEEeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECcceeeeEc
Confidence 99999986 6666554 34578999999999999999999999 79999999999999996 778999999998654
Q ss_pred ccCC-CceeeeeccccCchhhhh--CCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 188 IAGE-ANISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 188 ~~~~-~~~~~~~t~~y~aPE~l~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
.... ......+++.|+|||.+. ....++.++|+||+||++|+|++|..||........+......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~------------ 224 (267)
T cd06645 157 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS------------ 224 (267)
T ss_pred cCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc------------
Confidence 3222 123456789999999874 2334788999999999999999999999766544333222110
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 319 (376)
....+. +. ....++..+.++|.+||+.||++|||++++++|||
T Consensus 225 -----~~~~~~-----~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 225 -----NFQPPK-----LK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -----CCCCCc-----cc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 000000 00 01135788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=305.40 Aligned_cols=250 Identities=29% Similarity=0.464 Sum_probs=202.0
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
++|++.+.||+|+||.||+|.+..+++.+++|.+.... ....+|+.+++.++|+||+++++.+... ..+|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKN-----TDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CcEEEEE
Confidence 57999999999999999999999889999999886543 3456899999999999999999988443 4488999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||+++ +|.+.+.. ....+++..+..++.|++.|+.|||+ .+++|+||+|+||+++. ++.++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~-~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 78 EYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNE-EGQAKLADFGVSGQLTDT 152 (256)
T ss_pred ecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECC-CCcEEEcccccchhcccC
Confidence 99996 66665542 34678999999999999999999999 79999999999999996 778999999998865443
Q ss_pred C-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 191 E-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 191 ~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
. ......++..|+|||.+.+. .++.++||||+||++|+|++|+.||...+.......+...
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~----------------- 214 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK----------------- 214 (256)
T ss_pred ccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC-----------------
Confidence 3 22334568889999998654 5889999999999999999999999876554332221110
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
..+ ....+..++.++.++|.+||+.||++|||+.+++.||||
T Consensus 215 --~~~-------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 215 --PPP-------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred --CCC-------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 000 000122367899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=309.40 Aligned_cols=252 Identities=26% Similarity=0.394 Sum_probs=198.1
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
..+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++.+... ..+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-----~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-----EKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-----CEEE
Confidence 457999999999999999999999999999999886432 2345799999999999999999888433 3488
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||+++ +|.+.+. ....+++..+..++.|++.||.|||+ .||+||||+|+||+++. ++.++|+|||++...
T Consensus 83 iv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~-~~~~~l~dfg~~~~~ 156 (267)
T cd06646 83 ICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTD-NGDVKLADFGVAAKI 156 (267)
T ss_pred EEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCCEEECcCccceee
Confidence 99999996 6655554 34578999999999999999999999 79999999999999986 678999999999765
Q ss_pred ccCC-CceeeeeccccCchhhhhC--CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 188 IAGE-ANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 188 ~~~~-~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
.... ......+++.|+|||.+.+ ...++.++|+||+||++|+|++|..||...+..+....+...
T Consensus 157 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~------------ 224 (267)
T cd06646 157 TATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS------------ 224 (267)
T ss_pred cccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC------------
Confidence 3322 2234567889999998742 334678999999999999999999999765433222111110
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 319 (376)
.+..+. +. ....++..+.+||++||+.||++|||++++++|+|
T Consensus 225 -----~~~~~~-----~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 225 -----NFQPPK-----LK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred -----CCCCCC-----Cc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 000000 00 01236789999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=337.35 Aligned_cols=283 Identities=19% Similarity=0.287 Sum_probs=197.9
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCc-EEEEE------------------Eeecc---ccchHHHHHHHHhCCCCcee
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGE-TVAIK------------------KVLQD---RRYKNRELQLMRVMDHPNVI 90 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~aiK------------------~~~~~---~~~~~~e~~~l~~l~h~~iv 90 (376)
..+|++++.||+|+||+||+|..+.... ..+.| .+... .....+|+.+++.++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999987653322 12211 11111 12235799999999999999
Q ss_pred eeceeeeecCCCCceEEEEEeecccchHHHHHHhhh-hcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEE
Q 017147 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYS-SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 169 (376)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill 169 (376)
++++++... ...|+|++++.+++.+.+.... ..........++.++.||+.||+|||+ +||+||||||+|||+
T Consensus 227 ~l~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl 300 (501)
T PHA03210 227 KIEEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFL 300 (501)
T ss_pred cEeEEEEEC-----CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence 999988443 3488999999988777664321 112334567788999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeecccccCccCCC--ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCC-CCCC--CChHH
Q 017147 170 DPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP-LFPG--ENAVD 244 (376)
Q Consensus 170 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~-pf~~--~~~~~ 244 (376)
+. ++.+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|.. ||.+ .....
T Consensus 301 ~~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 301 NC-DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred CC-CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 96 77899999999986544322 2345789999999999664 48999999999999999999875 4433 23445
Q ss_pred HHHHHHHHhCCCCHHHHhhcC--cCCC-CCCCCCCCCCChhhhc-ccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 245 QLVEIIKVLGTPTREEIRCMN--PNYT-DFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 245 ~~~~i~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
.+.+++..++....+...... .++. ...+.... ..+...+ ...++.++.++|.+||++||.+|||+.|+|+||||
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAG-HSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCc-cchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 566666555433221100000 0000 00000000 0111111 12367889999999999999999999999999999
Q ss_pred cccc
Q 017147 321 DELR 324 (376)
Q Consensus 321 ~~~~ 324 (376)
....
T Consensus 458 ~~~~ 461 (501)
T PHA03210 458 SAEE 461 (501)
T ss_pred hcCC
Confidence 8753
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=305.18 Aligned_cols=245 Identities=29% Similarity=0.485 Sum_probs=198.8
Q ss_pred eecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017147 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 114 (376)
Q Consensus 42 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 114 (376)
||.|++|.||+|.+..+++.||+|++.+.. ....+|+.+++.++|+||+++++.+.+. ..+|+++||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-----KYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-----CccEEEEecC
Confidence 689999999999999999999999986432 2345789999999999999999987433 3488999999
Q ss_pred cc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCCc
Q 017147 115 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 193 (376)
Q Consensus 115 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~ 193 (376)
++ +|.+.+.. ...+++..+..++.|++.||+|||+ +|++|+||+|+||+++. ++.++|+|||++.........
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~-~~~~~l~df~~~~~~~~~~~~ 149 (262)
T cd05572 76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDS-NGYVKLVDFGFAKKLKSGQKT 149 (262)
T ss_pred CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcC-CCCEEEeeCCcccccCccccc
Confidence 85 66666642 3568999999999999999999999 79999999999999996 778999999999876554333
Q ss_pred eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHhhcCcCCCCC
Q 017147 194 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--AVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271 (376)
Q Consensus 194 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 271 (376)
....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.... ..+....+.....
T Consensus 150 ~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 211 (262)
T cd05572 150 WTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG----------------- 211 (262)
T ss_pred ccccCCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC-----------------
Confidence 44567889999999855 448899999999999999999999998766 3333333321000
Q ss_pred CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCcccccC
Q 017147 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELRE 325 (376)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~ 325 (376)
...++...++++.++|.+||+.||++|++ +.|+++||||++..+
T Consensus 212 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 212 ----------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred ----------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 00122335789999999999999999999 999999999998755
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=306.64 Aligned_cols=246 Identities=27% Similarity=0.442 Sum_probs=201.2
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
+|++.+.||.|+||.||+|.+..+++.||+|.+.+.. ....+|+.+++.++||||+++++.+ .+....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 4899999999999999999999999999999886432 2335789999999999999999887 344458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|+|+||+.| +|...+. ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+..
T Consensus 76 ~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~-~~~~~l~d~~~~~~ 149 (258)
T cd05578 76 YLVVDLLLGGDLRYHLS----QKVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDE-QGHVHITDFNIATK 149 (258)
T ss_pred EEEEeCCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcC-CCCEEEeecccccc
Confidence 999999986 6655554 23578999999999999999999999 79999999999999996 77899999999876
Q ss_pred CccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHhhc
Q 017147 187 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
...........++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+. .+.+......
T Consensus 150 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 216 (258)
T cd05578 150 VTPDTLTTSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------------ 216 (258)
T ss_pred cCCCccccccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------------
Confidence 6544334455678889999998654 489999999999999999999999987764 2222211110
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH--HHHhcCCCc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA--LEACAHPFF 320 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~--~e~l~hp~~ 320 (376)
....++..++.++.++|.+||..||.+|+++ .|+++||||
T Consensus 217 ----------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 217 ----------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ----------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 0111223468899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=318.14 Aligned_cols=241 Identities=27% Similarity=0.374 Sum_probs=200.0
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc---ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
.+.+++.||+|-||.||.+.... ...||+|.+... .....+|+.+|+.|+|++||++++++.... -+||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIVt 280 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIVT 280 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEEE
Confidence 56778899999999999999753 347999988643 234458999999999999999999984433 389999
Q ss_pred eccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||+. |+|++.|+. ..+..+...+...++.||++|++||++ +++|||||...||||+. +..+||+|||+|+...++
T Consensus 281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~-~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDE-DLVVKISDFGLARLIGDD 356 (468)
T ss_pred EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeecc-CceEEEcccccccccCCC
Confidence 9998 789988875 456778999999999999999999999 79999999999999996 788999999999944333
Q ss_pred CCceeeee---ccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 191 EANISYIC---SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 191 ~~~~~~~~---t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
.. ....+ ..-|.|||.+.. ..++.+||||||||+||||+| |+.||++.+..+.+..+.+....|-
T Consensus 357 ~Y-~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~--------- 425 (468)
T KOG0197|consen 357 EY-TASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR--------- 425 (468)
T ss_pred ce-eecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---------
Confidence 22 22222 334999999954 459999999999999999999 9999999999999888876432222
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 315 (376)
+..+|+++-+++..||..+|++|||.+.+.
T Consensus 426 -------------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 426 -------------------PEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred -------------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 345899999999999999999999998654
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=304.76 Aligned_cols=246 Identities=32% Similarity=0.510 Sum_probs=193.7
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-------chHHHHH-HHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQ-LMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.||.|+||.||+|.+..+++.||+|.+.+... ....|.. +....+|+|++++++++. ....+|+|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence 568999999999999999999999998864321 1122333 344558999999999883 334589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||+++ +|...+. ....+++..+..++.|++.||.|||+ .|++||||+|+||+++. ++.++|+|||++.....
T Consensus 77 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~- 149 (260)
T cd05611 77 EYLNGGDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQ-TGHLKLTDFGLSRNGLE- 149 (260)
T ss_pred eccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCcEEEeecccceeccc-
Confidence 99986 6666554 34568999999999999999999999 79999999999999996 77899999999875432
Q ss_pred CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 017147 191 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270 (376)
Q Consensus 191 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 270 (376)
.....+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+.......+.....
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 210 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI---------------- 210 (260)
T ss_pred --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc----------------
Confidence 22345788899999986654 79999999999999999999999988776655544332100
Q ss_pred CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC---HHHHhcCCCcccccC
Q 017147 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELRE 325 (376)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~hp~~~~~~~ 325 (376)
.+.......+++++.++|.+||+.||++||| ++|+++||||++++|
T Consensus 211 ---------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 211 ---------NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred ---------CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 0111112246899999999999999999995 579999999998765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=306.26 Aligned_cols=262 Identities=26% Similarity=0.447 Sum_probs=202.5
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
++|+..+.||.|++|.||+|.+..+++.+|+|.+.... ....+|+++++.++|+||+++++++.... ...+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES---SSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC---CCeEE
Confidence 46899999999999999999999999999999886432 23457999999999999999998874432 23478
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||+++ +|.+.+.........+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~-~~~~~l~dfg~~~~~ 155 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTR-KGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEec-CCeEEEeeccccccc
Confidence 99999985 7766665544456678999999999999999999999 79999999999999996 778999999998754
Q ss_pred ccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCCHHHHh
Q 017147 188 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-----VDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 188 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~ 262 (376)
..... ....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||..... .+....+.. ... ..
T Consensus 156 ~~~~~-~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~-~~-- 227 (287)
T cd06621 156 VNSLA-GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---MPN-PE-- 227 (287)
T ss_pred ccccc-ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---CCc-hh--
Confidence 33221 23456788999999855 4589999999999999999999999976522 121111111 000 00
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
++.. .......++.+.+||.+||..||++|||+.|++.||||++..
T Consensus 228 ----------~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 228 ----------LKDE------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred ----------hccC------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 0000 000012467899999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=308.67 Aligned_cols=250 Identities=29% Similarity=0.422 Sum_probs=197.3
Q ss_pred eecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017147 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 114 (376)
Q Consensus 42 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 114 (376)
||+|+||+||+|.+..+++.||+|.+.... .....|+++++.++|||++++++++. .....|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE-----TKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe-----cCCeEEEEEecC
Confidence 689999999999999999999999885421 12246899999999999999988873 334589999999
Q ss_pred cc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCCc
Q 017147 115 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 193 (376)
Q Consensus 115 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~ 193 (376)
++ +|.+.+... ....+++..+..++.|++.||.|||+ +|++||||+|+||+++. ++.++|+|||.+.........
T Consensus 76 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~-~~~~~l~dfg~~~~~~~~~~~ 151 (277)
T cd05577 76 NGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDD-HGNVRISDLGLAVELKGGKKI 151 (277)
T ss_pred CCCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEccCcchhhhccCCcc
Confidence 95 666665432 22468999999999999999999999 79999999999999996 778999999998765443333
Q ss_pred eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCC
Q 017147 194 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273 (376)
Q Consensus 194 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 273 (376)
....++..|+|||.+.+.. ++.++|+||+||++|+|++|+.||...........+.+...
T Consensus 152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------- 211 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL------------------- 211 (277)
T ss_pred ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-------------------
Confidence 3456678899999986654 88999999999999999999999977654221111111000
Q ss_pred CCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCC
Q 017147 274 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326 (376)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 326 (376)
.....++..+++.+.++|.+||+.||.+|| ++.++++||||..+.+.
T Consensus 212 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 212 ------EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred ------cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence 000112234688999999999999999999 89999999999987664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=303.48 Aligned_cols=253 Identities=28% Similarity=0.421 Sum_probs=201.7
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
.++|++.+.||.|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.++||||+++++.+... ..+|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR-----DKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC-----CEEE
Confidence 357999999999999999999999999999999886542 3346799999999999999999887433 3489
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
++|||+++ ++.+.+.. ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 77 l~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~ 151 (262)
T cd06613 77 IVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTE-DGDVKLADFGVSAQL 151 (262)
T ss_pred EEEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECC-CCCEEECccccchhh
Confidence 99999996 55554432 23678999999999999999999999 79999999999999996 778999999998765
Q ss_pred ccCC-CceeeeeccccCchhhhhCC--CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 188 IAGE-ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 188 ~~~~-~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
.... ......++..|+|||.+.+. ..++.++|+||+||++|+|++|.+||...+.......+....-.+.
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~------- 224 (262)
T cd06613 152 TATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP------- 224 (262)
T ss_pred hhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc-------
Confidence 4322 22344678889999998543 2578899999999999999999999988776555443332100000
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 319 (376)
. .......+.++.+|+++||..||.+|||+.+++.|||
T Consensus 225 ----------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 225 ----------K-------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ----------c-------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0 0011235778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=301.78 Aligned_cols=248 Identities=31% Similarity=0.480 Sum_probs=204.2
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+|++.+.||.|+||.||.+++..+++.+++|.+.... ....+|+.+++.++|+||+++++++.. ....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence 5999999999999999999999999999999875432 234579999999999999999999843 34588
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
++|||+++ +|.+.+... ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.+||+|||++...
T Consensus 76 ~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~-~~~~kl~d~~~~~~~ 151 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTK-AGLIKLGDFGISKIL 151 (256)
T ss_pred EEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeC-CCCEEECcCcceEEc
Confidence 99999985 777766532 24568999999999999999999999 79999999999999996 778999999998765
Q ss_pred ccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
.... ......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||...+..+....+... ...
T Consensus 152 ~~~~~~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~--------- 219 (256)
T cd08221 152 GSEYSMAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT--------- 219 (256)
T ss_pred ccccccccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC---------
Confidence 4333 22345678999999998654 4788999999999999999999999887766666555431 100
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
. ....++.++.++|.+||..||.+||++.++++|||+
T Consensus 220 ---~--------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 220 ---P--------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ---C--------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0 012368899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=302.66 Aligned_cols=248 Identities=25% Similarity=0.430 Sum_probs=202.5
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+|++.+.||+|+||.||++.+..+++.||+|.+.... ....+|+.+++.++|+||+++.+.+ ......|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 5899999999999999999999999999999885321 2345789999999999999999887 3344589
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+|+||+.+ +|.+.+.. .....+++..+..++.|++.|+.|||+ +|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~-~~~~~l~d~~~~~~~ 151 (256)
T cd08218 76 IVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTIKLGDFGIARVL 151 (256)
T ss_pred EEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEEeeccceeec
Confidence 99999985 77666643 123457899999999999999999999 79999999999999996 778999999998755
Q ss_pred ccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
..... .....+++.|+|||++.+. .++.++|+||+||++|+|++|..||...+..+....+.... ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~--~~--------- 219 (256)
T cd08218 152 NSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS--YP--------- 219 (256)
T ss_pred CcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC--CC---------
Confidence 43322 1234568889999998654 47889999999999999999999998877666555443311 00
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
..+..++.++.++|.+||+.+|++||++.++++||||
T Consensus 220 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 220 -----------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -----------------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 0123468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=323.52 Aligned_cols=256 Identities=27% Similarity=0.437 Sum_probs=206.6
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.|..++.||-|+||.|.+|....|...||+|.+.+.. ...+.|..||..-..+-||+++..|.+.+ .+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd-----nL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-----NL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC-----ce
Confidence 5889999999999999999999999999999886542 33457889999999999999999995444 49
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|+||+|++| ++..+|. .-+-|.|+.+++|+.++.+|+++.|.+ |++||||||+|||||. ++.|||+|||+|..
T Consensus 705 YFVMdYIPGGDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkm-GFIHRDiKPDNILIDr-dGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDR-DGHIKLTDFGLCTG 778 (1034)
T ss_pred EEEEeccCCccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhc-cceecccCccceEEcc-CCceeeeecccccc
Confidence 999999996 6666654 357899999999999999999999995 9999999999999997 67799999999853
Q ss_pred Cc--------cC------------------C-----------------CceeeeeccccCchhhhhCCCCCCchhhhHhH
Q 017147 187 LI--------AG------------------E-----------------ANISYICSRFYRAPELIFGATEYTTSIDIWSA 223 (376)
Q Consensus 187 ~~--------~~------------------~-----------------~~~~~~~t~~y~aPE~l~~~~~~~~~~Diwsl 223 (376)
+. .. . .....+||+.|+|||++... .|+..+|+||.
T Consensus 779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdwws~ 857 (1034)
T KOG0608|consen 779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDWWSV 857 (1034)
T ss_pred ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-CccccchhhHh
Confidence 21 00 0 01245789999999999654 49999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCc
Q 017147 224 GCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 303 (376)
Q Consensus 224 G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 303 (376)
|||||+|+.|++||......+...+++++. ++ ++.....++|.++.+||.++.+
T Consensus 858 gvil~em~~g~~pf~~~tp~~tq~kv~nw~-------------~~------------l~~~~~~~ls~e~~~li~kLc~- 911 (1034)
T KOG0608|consen 858 GVILYEMLVGQPPFLADTPGETQYKVINWR-------------NF------------LHIPYQGNLSKEALDLIQKLCC- 911 (1034)
T ss_pred hHHHHHHhhCCCCccCCCCCcceeeeeehh-------------hc------------cccccccccCHHHHHHHHHHhc-
Confidence 999999999999998877665544443310 00 1112234689999999999877
Q ss_pred CCCCCCC---HHHHhcCCCcccccCCCC
Q 017147 304 SPSLRCT---ALEACAHPFFDELREPNA 328 (376)
Q Consensus 304 dp~~R~t---~~e~l~hp~~~~~~~~~~ 328 (376)
+++.|+. ++|+..||||+.+.+...
T Consensus 912 sad~RLGkng~d~vKaHpfFkgIDfssl 939 (1034)
T KOG0608|consen 912 SADSRLGKNGADQVKAHPFFKGIDFSSL 939 (1034)
T ss_pred ChhhhhcccchhhhhcCccccccchHhh
Confidence 7889985 678999999998876653
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=311.64 Aligned_cols=255 Identities=27% Similarity=0.412 Sum_probs=202.9
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
.+.|.....||+|+||.||++.+..++..||||.+.... ....+|+.+++.++|+||+++++.+.. ....|
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~ 95 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-----GDELW 95 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-----CCeEE
Confidence 345666788999999999999999999999999885432 234578999999999999999988743 33489
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||+++ ++.+.+. ...+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.++|+|||++...
T Consensus 96 lv~e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~-~~~~kL~dfg~~~~~ 168 (292)
T cd06658 96 VVMEFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTS-DGRIKLSDFGFCAQV 168 (292)
T ss_pred EEEeCCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcC-CCCEEEccCcchhhc
Confidence 99999987 4444432 2468899999999999999999999 79999999999999996 678999999998654
Q ss_pred ccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
.... ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||...+....+..+........
T Consensus 169 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 238 (292)
T cd06658 169 SKEVPKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV--------- 238 (292)
T ss_pred ccccccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc---------
Confidence 3222 2234567899999999854 4488999999999999999999999988776555443332111000
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
+ ....++..+.+++.+||..||++|||++++++||||+....+
T Consensus 239 -------~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 239 -------K----------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred -------c----------cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 0 011367899999999999999999999999999999986544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=316.51 Aligned_cols=282 Identities=31% Similarity=0.518 Sum_probs=227.6
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc---chHHHHHHHHhCC------CCceeeeceeeeecCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMD------HPNVISLKHCFFSTTSK 102 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~ 102 (376)
...+|.+....|+|-|++|..|.+..-|+.||||++..... ...+|+++|+.|+ --|+++++..|.
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~----- 504 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK----- 504 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh-----
Confidence 45689999999999999999999999999999999987643 3458999999995 357888888884
Q ss_pred CceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 103 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 103 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
...++|+|+|-+.-+|.++|+.+.. +-.|....++.|+.|++.||+.|.. .||+|.||||+|||+++....+||||||
T Consensus 505 hknHLClVFE~LslNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 505 HKNHLCLVFEPLSLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred hcceeEEEehhhhchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCc
Confidence 4445999999999999999987643 4568889999999999999999999 6999999999999999878899999999
Q ss_pred ccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 183 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 183 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
.|.....++ .+.+..+..|+|||+++|-+ |+...|+||.||.||||.||+..|+|.+.-+++...+.+-|..+...+.
T Consensus 583 SA~~~~ene-itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR 660 (752)
T KOG0670|consen 583 SASFASENE-ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR 660 (752)
T ss_pred ccccccccc-ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence 998665444 34567788999999998865 9999999999999999999999999999999999999999988876654
Q ss_pred h-------cCcC--CCCCCC------------CCC-CCCChhhhccc--CCC-------hhHHHHHHhhcCcCCCCCCCH
Q 017147 263 C-------MNPN--YTDFRF------------PQI-KAHPWHKVFHK--RMP-------PEAIDLASRLLQYSPSLRCTA 311 (376)
Q Consensus 263 ~-------~~~~--~~~~~~------------~~~-~~~~~~~~~~~--~~~-------~~~~~li~~~L~~dp~~R~t~ 311 (376)
. ++.+ |..... ... +...+...+.. .++ ..+++||.+||..||++|+|+
T Consensus 661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~ 740 (752)
T KOG0670|consen 661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV 740 (752)
T ss_pred hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence 2 1111 111100 000 00111111111 122 368899999999999999999
Q ss_pred HHHhcCCCccc
Q 017147 312 LEACAHPFFDE 322 (376)
Q Consensus 312 ~e~l~hp~~~~ 322 (376)
.++|.||||+.
T Consensus 741 nqAL~HpFi~~ 751 (752)
T KOG0670|consen 741 NQALKHPFITE 751 (752)
T ss_pred HHHhcCCcccC
Confidence 99999999974
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=307.70 Aligned_cols=249 Identities=27% Similarity=0.389 Sum_probs=190.4
Q ss_pred eeecCCCeeEEEEEEcCCCcEEEEEEeecccc-------chHHHHHHH---HhCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLM---RVMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 41 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
.||+|+||.||++.+..+++.+|+|.+.+... ...+|..++ ....|++|+.+.+.+.. ....++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence 48999999999999999999999998864321 112333333 33479999999888743 2348899
Q ss_pred eecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 111 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 111 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
|||+++ +|...+. ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||++.....
T Consensus 76 ~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~-~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 76 LDLMNGGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDLGLACDFSK 149 (279)
T ss_pred EecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECC-CCCEEEccCCcceeccc
Confidence 999996 5555443 34679999999999999999999999 79999999999999996 77899999999865433
Q ss_pred CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 190 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 190 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
.. .....+++.|+|||.+.+...++.++|+||+||++|+|++|..||......... .+.+... .
T Consensus 150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~------------~-- 213 (279)
T cd05633 150 KK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL------------T-- 213 (279)
T ss_pred cC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh------------c--
Confidence 22 223467899999999865455789999999999999999999999764322111 1111000 0
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCCC
Q 017147 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 327 (376)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~~ 327 (376)
....++..++.++.++|++||..||++|+ |+.++++||||+.+++..
T Consensus 214 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~ 265 (279)
T cd05633 214 -----------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ 265 (279)
T ss_pred -----------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence 00112334788999999999999999999 699999999999976554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=321.12 Aligned_cols=238 Identities=28% Similarity=0.448 Sum_probs=202.6
Q ss_pred eeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeeccc-
Q 017147 37 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP- 115 (376)
Q Consensus 37 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~- 115 (376)
.-++.||.|+.|.||+++. .++.||||++. ...+.+|+-|++|+|+||+.+.+++ ....++|||||||.
T Consensus 127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~---elkETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVR---ELKETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhhhccCcccceeeeec--cCceehhHHHh---hhhhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeecccc
Confidence 3467799999999999986 57899999874 4445689999999999999999999 44556999999999
Q ss_pred chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCCcee
Q 017147 116 ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 195 (376)
Q Consensus 116 ~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~ 195 (376)
|-|.++|+ ....++......+..+|+.|+.|||. +.|+|||||.-||||.. +..|||+|||.++.........+
T Consensus 197 GqL~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~-~d~VKIsDFGTS~e~~~~STkMS 270 (904)
T KOG4721|consen 197 GQLYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISY-DDVVKISDFGTSKELSDKSTKMS 270 (904)
T ss_pred ccHHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeec-cceEEeccccchHhhhhhhhhhh
Confidence 68888886 56789999999999999999999999 79999999999999996 67899999999998777766778
Q ss_pred eeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCC
Q 017147 196 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 275 (376)
Q Consensus 196 ~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (376)
++||..|||||++.+. +.+.++|||||||+|||||||..||.+.+...++. |.
T Consensus 271 FaGTVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw------GV-------------------- 323 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW------GV-------------------- 323 (904)
T ss_pred hhhhHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccchheeEE------ec--------------------
Confidence 9999999999999765 58999999999999999999999998876554331 11
Q ss_pred CCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 017147 276 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318 (376)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 318 (376)
....++-..+..+++.++=||++||+-.|..||+..++|.|=
T Consensus 324 -GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 324 -GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred -cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 112233344566888999999999999999999999999884
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=303.34 Aligned_cols=252 Identities=32% Similarity=0.538 Sum_probs=198.2
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc--------------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------RYKNRELQLMRVMDHPNVISLKHCFFSTT 100 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (376)
+|.+.+.||.|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.++|+|++++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 6899999999999999999999999999999874311 123468999999999999999988733
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEE
Q 017147 101 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 179 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~ 179 (376)
....++||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ ++++||||+|+||+++. ++.++|+
T Consensus 80 ---~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~-~~~~~l~ 150 (272)
T cd06629 80 ---EEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDA-DGICKIS 150 (272)
T ss_pred ---CCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcC-CCeEEEe
Confidence 3348899999985 66666543 3678999999999999999999999 79999999999999996 7889999
Q ss_pred eecccccCccCC---CceeeeeccccCchhhhhCCC-CCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017147 180 DFGSAKQLIAGE---ANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255 (376)
Q Consensus 180 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 255 (376)
|||++....... ......++..|+|||.+.+.. .++.++|+||+|+++|+|++|..||...+......++.....
T Consensus 151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~- 229 (272)
T cd06629 151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS- 229 (272)
T ss_pred eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcccc-
Confidence 999987543221 122345678899999986543 478999999999999999999999976655443332211000
Q ss_pred CCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
...+.......++..+.++|.+||..||++|||++++++||||
T Consensus 230 ----------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 230 ----------------------APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ----------------------CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0001111223468899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=302.73 Aligned_cols=250 Identities=29% Similarity=0.491 Sum_probs=197.6
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
.+|++.+.||+|+||.||.+.+..+++.||+|.+..+. ....+|+.+++.+.|+||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence 46999999999999999999999999999999875321 1234699999999999999998876332 12
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
..++++|||+++ +|.+.+. ....+++..+..++.|++.||+|||+ ++++|+||+|+||+++. ++.++|+|||+
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~Dfg~ 152 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDS-VGNVKLGDFGA 152 (265)
T ss_pred ceEEEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecC-CCCEEECcCcc
Confidence 357899999985 6666554 33568889999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccCC----CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 184 AKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 184 a~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
+....... ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+.......+.. .+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~-- 226 (265)
T cd06652 153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT-- 226 (265)
T ss_pred ccccccccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC--
Confidence 87543211 12234578889999998654 488999999999999999999999987655444333221 110
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 321 (376)
....+..++..+.++|++||. +|.+||+++++++|||+.
T Consensus 227 ----------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 227 ----------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ----------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 011223467889999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=308.93 Aligned_cols=254 Identities=29% Similarity=0.461 Sum_probs=202.2
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
+|++.+.||+|+||.||++.+..+++.||+|.+.... ....+|+.+++.++|+||+++++.+. ....+
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~ 76 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-----TKRHL 76 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-----cCCEE
Confidence 6999999999999999999999999999999886532 12347899999999999999998873 33458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|+||||++| +|.+.+. ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||+++.
T Consensus 77 ~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~-~~~~~l~dfg~~~~ 150 (305)
T cd05609 77 CMVMEYVEGGDCATLLK----NIGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITS-MGHIKLTDFGLSKI 150 (305)
T ss_pred EEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECC-CCCEEEeeCCCccc
Confidence 999999986 6666664 34568999999999999999999999 79999999999999996 78899999999863
Q ss_pred CccCC----------------CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017147 187 LIAGE----------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250 (376)
Q Consensus 187 ~~~~~----------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 250 (376)
..... ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+.+..+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~ 229 (305)
T cd05609 151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229 (305)
T ss_pred cCcCccccccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 21100 01123467789999998654 58999999999999999999999998877665555443
Q ss_pred HHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC---HHHHhcCCCcccccCC
Q 017147 251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREP 326 (376)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~hp~~~~~~~~ 326 (376)
.... ..+. ....++.++.++|.+||+.||++||+ +.++++||||....+.
T Consensus 230 ~~~~-----------------~~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~ 282 (305)
T cd05609 230 SDDI-----------------EWPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN 282 (305)
T ss_pred hccc-----------------CCCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence 3100 0000 00136889999999999999999998 7899999999775443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=310.09 Aligned_cols=250 Identities=29% Similarity=0.446 Sum_probs=202.8
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
..|.+.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++.+++.... .
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-----~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-----T 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-----e
Confidence 46999999999999999999999999999999885321 22347899999999999999999885433 3
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
.|+|+||+.|++.+.+.. ....+++..+..++.|++.||.|||+ .|++||||+|+||+++. ++.++|+|||++..
T Consensus 90 ~~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~-~~~~kL~dfg~~~~ 164 (307)
T cd06607 90 AWLVMEYCLGSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTE-PGTVKLADFGSASL 164 (307)
T ss_pred EEEEHHhhCCCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECC-CCCEEEeecCccee
Confidence 889999999987776643 23568999999999999999999999 79999999999999996 77899999999875
Q ss_pred CccCCCceeeeeccccCchhhhhC--CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 187 LIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
.... ....+++.|+|||++.+ ...++.++||||+|+++|+|++|.+||.+.+.......+... ..+
T Consensus 165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~-------- 232 (307)
T cd06607 165 VSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSP-------- 232 (307)
T ss_pred cCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-CCC--------
Confidence 4322 23467888999998742 345788999999999999999999999887765544333210 000
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.. .....+..+.++|.+||+.||++||++.+++.||||..-
T Consensus 233 ----------~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 233 ----------TL--------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred ----------CC--------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 00 011257789999999999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=303.09 Aligned_cols=248 Identities=26% Similarity=0.368 Sum_probs=191.7
Q ss_pred ceeeeeeee--ecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEEE
Q 017147 34 ISYMAERVV--GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 34 ~~y~~~~~l--g~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
+.|++.+.+ |+|+||.||++.++.+++.+|+|.+...... ..|+.....+ +|+|++++++.+... ..+|+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~e~~~~~~~~~h~~iv~~~~~~~~~-----~~~~iv 87 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-AIEPMVHQLMKDNPNFIKLYYSVTTL-----KGHVLI 87 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-hhhHHHHHHhhcCCCEEEEEEEEecC-----CeeEEE
Confidence 456676666 9999999999999999999999988654322 1233333322 799999999988443 358999
Q ss_pred eecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 111 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 111 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
|||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ .|++||||+|+||+++.+++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 88 MDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 999985 77776652 3489999999999999999999999 79999999999999997444899999999875532
Q ss_pred CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcCcCC
Q 017147 190 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGTPTREEIRCMNPNY 268 (376)
Q Consensus 190 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~ 268 (376)
. ....++..|+|||++.+. .++.++|+||+||++|+|++|..||........ ...+......
T Consensus 163 ~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 225 (267)
T PHA03390 163 P---SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK------------- 225 (267)
T ss_pred C---ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc-------------
Confidence 2 234578899999999654 488999999999999999999999986543321 1111111000
Q ss_pred CCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-HHHHhcCCCccc
Q 017147 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEACAHPFFDE 322 (376)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-~~e~l~hp~~~~ 322 (376)
.......+++.+.+||.+||+.||.+|++ ++++|+||||++
T Consensus 226 -------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 226 -------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred -------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 00112247899999999999999999996 599999999974
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=305.35 Aligned_cols=249 Identities=28% Similarity=0.401 Sum_probs=191.9
Q ss_pred eeecCCCeeEEEEEEcCCCcEEEEEEeeccccc-------hHHH---HHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRE---LQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 41 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-------~~~e---~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
.||+|+||.||+|.+..+++.||+|.+.+.... ...| ..+++...|++|+.+.+.+. ....+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----TPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCEEEEE
Confidence 489999999999999999999999988653211 1223 33455568999999988873 33458899
Q ss_pred eecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 111 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 111 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
|||+.| +|...+. ....+++..++.++.|++.|+.|||+ .+++||||||+||+++. ++.++|+|||++.....
T Consensus 76 ~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~-~~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 76 LDLMNGGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDLGLACDFSK 149 (278)
T ss_pred EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECC-CCCEEEccCcCccccCc
Confidence 999986 5544443 34679999999999999999999999 79999999999999996 77899999999875433
Q ss_pred CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 190 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 190 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
.. .....++..|+|||.+.+...++.++|+||+||++|+|++|..||.+........ +.+.... .
T Consensus 150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~-------------~ 214 (278)
T cd05606 150 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT-------------M 214 (278)
T ss_pred cC-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhhc-------------c
Confidence 22 2345688999999998655458899999999999999999999998763221111 0000000 0
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCCC
Q 017147 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 327 (376)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~~ 327 (376)
...++..++.++.+++.+||..||.+|+ ++.++++||||+...+..
T Consensus 215 ------------~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~ 265 (278)
T cd05606 215 ------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM 265 (278)
T ss_pred ------------CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence 0112234689999999999999999999 999999999999876553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=299.41 Aligned_cols=249 Identities=28% Similarity=0.440 Sum_probs=200.7
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+|++.+.||+|+||.||++.+..++..+|+|.+... .....+|+.+++.++|+||+++++.+. .....|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ-----ENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec-----cCCeEE
Confidence 589999999999999999999999999999988543 223457999999999999999998873 334589
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+|+||+++ +|.+.+.. .....+++..+..++.|++.||.|||+ .+++|+||+|+||++++++..++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 76 IVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred EEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 99999985 66666643 123457899999999999999999999 799999999999999975566899999998765
Q ss_pred ccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
..... .....+++.|+|||.+.+. .++.++|+||+||++|+|++|..||...+..+....+....
T Consensus 153 ~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 218 (257)
T cd08225 153 NDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY------------- 218 (257)
T ss_pred cCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-------------
Confidence 43322 1234578889999988554 48899999999999999999999998776555444332210
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
. ......++.++.++|.+||..+|++|||+.++++||||
T Consensus 219 ------~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 219 ------F---------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ------C---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 0 00112367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=304.38 Aligned_cols=249 Identities=27% Similarity=0.408 Sum_probs=201.3
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
..|+..+.||.|+||.||.|.+..++..||+|.+.... ....+|+.+++.++|+||+++++++.. ....|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----GTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCEEE
Confidence 46888999999999999999999999999999886432 233578999999999999999998843 34589
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||+++ +|.+.+. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++. ++.++|+|||++...
T Consensus 79 lv~e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~-~~~~~l~dfg~~~~~ 151 (277)
T cd06640 79 IIMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSE-QGDVKLADFGVAGQL 151 (277)
T ss_pred EEEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcC-CCCEEEcccccceec
Confidence 99999986 6666554 2468899999999999999999999 79999999999999996 778999999999765
Q ss_pred ccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
..... .....++..|+|||.+.+. .++.++|+|||||++|+|++|.+||...+.......+... .
T Consensus 152 ~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-~------------ 217 (277)
T cd06640 152 TDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN-N------------ 217 (277)
T ss_pred cCCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC-C------------
Confidence 43332 2234568889999998654 4789999999999999999999999876654433222110 0
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
...+...++..+.+++.+||+.+|++||++.++++||||...
T Consensus 218 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 218 ---------------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ---------------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 001122357889999999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=301.46 Aligned_cols=306 Identities=28% Similarity=0.429 Sum_probs=231.1
Q ss_pred CCCCccCcEEEeccCCCCCCCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccch---HHHHHHHHhCC-
Q 017147 10 GSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRVMD- 85 (376)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~e~~~l~~l~- 85 (376)
..+|..|-+.+..++.. -...+|.+.+.||-|-|++||+|.+..+.+.||+|++.....+. ..||++|++++
T Consensus 58 ~~dY~kGGYHpV~IGD~----F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~ 133 (590)
T KOG1290|consen 58 PEDYRKGGYHPVRIGDV----FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVRE 133 (590)
T ss_pred hhhhhcCCCceeecccc----ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHh
Confidence 44566777766665543 34469999999999999999999999999999999887654443 47999999873
Q ss_pred -------CCceeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCee
Q 017147 86 -------HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 158 (376)
Q Consensus 86 -------h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~ 158 (376)
..+||++++.|-... .+...+|+|+|+++.+|+.++... ....++...++.|+.||+.||.|||.-.||+
T Consensus 134 ~Dp~~~~~~~VV~LlD~FkhsG-pNG~HVCMVfEvLGdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ecgII 210 (590)
T KOG1290|consen 134 GDPNDPGKKCVVQLLDHFKHSG-PNGQHVCMVFEVLGDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHRECGII 210 (590)
T ss_pred cCCCCCCCceeeeeeccceecC-CCCcEEEEEehhhhhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhcCcc
Confidence 357999999985544 566779999999999999999754 4456889999999999999999999857999
Q ss_pred ecCCCCCcEEEcC-------------------------------------------------------------------
Q 017147 159 HRDLKPQNLLVDP------------------------------------------------------------------- 171 (376)
Q Consensus 159 H~dlkp~Nill~~------------------------------------------------------------------- 171 (376)
|-||||+|||+..
T Consensus 211 HTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~ 290 (590)
T KOG1290|consen 211 HTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAG 290 (590)
T ss_pred ccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcc
Confidence 9999999999810
Q ss_pred -----------------------------------------------C--------------------------------
Q 017147 172 -----------------------------------------------L-------------------------------- 172 (376)
Q Consensus 172 -----------------------------------------------~-------------------------------- 172 (376)
.
T Consensus 291 ~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s 370 (590)
T KOG1290|consen 291 LEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSS 370 (590)
T ss_pred cccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCC
Confidence 0
Q ss_pred -------------------CCcEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhC
Q 017147 173 -------------------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 233 (376)
Q Consensus 173 -------------------~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g 233 (376)
+-++||+|||-|.... ...+.-+.|+.|+|||++.|.. |+..+||||++|+++||+||
T Consensus 371 ~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTG 447 (590)
T KOG1290|consen 371 PGTIASNPLVNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATG 447 (590)
T ss_pred ccccccccccCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcC
Confidence 0025566666554321 1122346688999999999875 99999999999999999999
Q ss_pred CCCCCC------CChHHHHHHHHHHhCCCCHHHHhh--cCcCCC----C-CCCCCCCCCChhhhccc------CCChhHH
Q 017147 234 QPLFPG------ENAVDQLVEIIKVLGTPTREEIRC--MNPNYT----D-FRFPQIKAHPWHKVFHK------RMPPEAI 294 (376)
Q Consensus 234 ~~pf~~------~~~~~~~~~i~~~~~~~~~~~~~~--~~~~~~----~-~~~~~~~~~~~~~~~~~------~~~~~~~ 294 (376)
..+|.. ...++.+..|++.+|..++..... ...+|- + ..+..++..++...+.+ .-..++.
T Consensus 448 DyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fs 527 (590)
T KOG1290|consen 448 DYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFS 527 (590)
T ss_pred ceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHH
Confidence 998853 235678999999999888765431 111111 1 12223333333333222 2235788
Q ss_pred HHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 295 DLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 295 ~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
|||.-||+++|++|+||.++|+|||+..+-.
T Consensus 528 dFL~PmLef~PeKR~tA~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 528 DFLSPMLEFDPEKRPTAAQCLKHPWLNPVAG 558 (590)
T ss_pred HHHHHHHhcCccccccHHHHhcCccccCCCC
Confidence 9999999999999999999999999997643
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=303.15 Aligned_cols=240 Identities=17% Similarity=0.196 Sum_probs=192.1
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 112 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 112 (376)
..||+|++|.||++.. +|+.||+|.+.... ....+|+.+|+.++||||+++++++.+.. ....++++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5689999999999987 78999999886532 22348999999999999999999885522 22345889999
Q ss_pred cccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCC
Q 017147 113 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 191 (376)
Q Consensus 113 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 191 (376)
|+++ +|.+.+. ....+++.....++.|++.|+.|||+..+++||||||+||+++. ++.+||+|||+++.....
T Consensus 103 y~~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~-~~~~kl~dfg~~~~~~~~- 176 (283)
T PHA02988 103 YCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE-NYKLKIICHGLEKILSSP- 176 (283)
T ss_pred eCCCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECC-CCcEEEcccchHhhhccc-
Confidence 9996 5666664 34578889999999999999999997238999999999999996 788999999998754332
Q ss_pred CceeeeeccccCchhhhhCC-CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 017147 192 ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270 (376)
Q Consensus 192 ~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 270 (376)
.....+++.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+.+....+
T Consensus 177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 241 (283)
T PHA02988 177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL-------------- 241 (283)
T ss_pred -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC--------------
Confidence 2345678899999998542 458999999999999999999999999887766655544321110
Q ss_pred CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
. ++...++++.+|+.+||+.||++|||++++++
T Consensus 242 -~------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 242 -K------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -C------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0 12236889999999999999999999999974
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=315.99 Aligned_cols=249 Identities=22% Similarity=0.358 Sum_probs=191.6
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCC-----cEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 101 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 101 (376)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+.... ....+|+.+++.+ +|+||+++++.+...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~-- 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG-- 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--
Confidence 457999999999999999999865443 579999886432 2235799999999 899999999987433
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhh-----------------------------------------------------
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSS----------------------------------------------------- 127 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~----------------------------------------------------- 127 (376)
..+|+|||||.+ +|.+.+.....
T Consensus 115 ---~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 115 ---GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred ---CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 348899999984 77776643210
Q ss_pred -------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCCce
Q 017147 128 -------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI 194 (376)
Q Consensus 128 -------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~ 194 (376)
...++++..++.++.||+.||.|||+ +|++||||||+|||++. ++.+||+|||+++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~-~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTD-GRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeC-CCeEEEeeceeeeeccCCccee
Confidence 12357888999999999999999999 79999999999999996 7889999999997653332211
Q ss_pred ---eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 017147 195 ---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270 (376)
Q Consensus 195 ---~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 270 (376)
...+++.|+|||++.+. .++.++||||+||++|+|++ |..||........+..+......
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~--------------- 333 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ--------------- 333 (374)
T ss_pred eccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC---------------
Confidence 12235679999998654 58999999999999999997 99999876554443333321000
Q ss_pred CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
...+..+++++.+++.+||+.||.+|||+.++++
T Consensus 334 ------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 334 ------------MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ------------ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0011235889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=299.28 Aligned_cols=247 Identities=29% Similarity=0.482 Sum_probs=192.2
Q ss_pred eeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017147 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 114 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 114 (376)
...||+|+||.||++.+..++..||+|.+.... ....+|+.+++.++|+||+++++++.. ....++++||+
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~ 87 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-----NGFFKIFMEQV 87 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-----CCEEEEEEecC
Confidence 357999999999999999999999999886432 234579999999999999999988733 34588999999
Q ss_pred cc-hHHHHHHhhhhcCCCc--CHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCC
Q 017147 115 PE-SMYRVLKHYSSANQRM--PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 191 (376)
Q Consensus 115 ~~-~l~~~l~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 191 (376)
++ +|.+.+.. ....+ ++..+..++.|++.||.|||+ +||+||||||+||+++.+.+.++|+|||.+.......
T Consensus 88 ~~~~L~~~l~~---~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 88 PGGSLSALLRS---KWGPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred CCCCHHHHHHH---hcccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 85 67666653 12334 788888999999999999999 7999999999999998656789999999987543322
Q ss_pred C-ceeeeeccccCchhhhhCC-CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 192 A-NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 192 ~-~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
. .....+++.|+|||.+.+. ..++.++|+||+|+++|+|++|..||.................
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------- 228 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK--------------- 228 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc---------------
Confidence 2 2234568899999998543 3478999999999999999999999976443221111000000
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
....++..+++++.+|+.+||+.+|++|||+.+++.||||
T Consensus 229 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 229 -----------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -----------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 0011233478899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=302.45 Aligned_cols=252 Identities=29% Similarity=0.525 Sum_probs=200.1
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
++|++.+.||+|++|.||+|.++.+++.+|+|.+.... ....+|+++++.++|+||+++++.+... ..++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEEE
Confidence 36888999999999999999999999999999886542 2235789999999999999999888443 4589
Q ss_pred EEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+++||++ ++|.+.+.. ....+++..+..++.|++.|+.|||+..|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~-~~~~~l~d~g~~~~~ 151 (265)
T cd06605 76 ICMEYMDGGSLDKILKE---VQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS-RGQIKLCDFGVSGQL 151 (265)
T ss_pred EEEEecCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC-CCCEEEeecccchhh
Confidence 9999999 477666653 22678999999999999999999999239999999999999997 778999999998755
Q ss_pred ccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCCHHHHh
Q 017147 188 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-----AVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 188 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~ 262 (376)
...... ...++..|+|||.+.+. .++.++|+||+||++|+|++|..||...+ ..+....+.. .+.
T Consensus 152 ~~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~----- 221 (265)
T cd06605 152 VNSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPP----- 221 (265)
T ss_pred HHHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCC-----
Confidence 332222 26678889999998654 58999999999999999999999997652 1122211111 000
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
+.. ....++.++.++|.+||..||++|||+.+++.||||+..
T Consensus 222 -----------~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 222 -----------PRL--------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred -----------CCC--------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 000 001168899999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=297.74 Aligned_cols=250 Identities=29% Similarity=0.467 Sum_probs=205.5
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+|.+.+.||.|+||.||++.+..+++.|++|++.... ....+|+++++.++|+|++++.+.+... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence 5899999999999999999999999999999986432 2345789999999999999999988443 4588
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+|+||+++ +|.+.+.........+++..+..++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~-~~~~~l~d~~~~~~~ 153 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTS-NGLVKLGDFGISKVL 153 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcC-CCcEEECCccceeec
Confidence 99999986 7777776544345789999999999999999999999 79999999999999996 788999999998765
Q ss_pred ccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
.... ......+++.|+|||.+.+. .++.++|+||+|+++++|++|..||...+..+....+.....
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 220 (258)
T cd08215 154 SSTVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY------------ 220 (258)
T ss_pred ccCcceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC------------
Confidence 4432 22345678899999998654 488999999999999999999999987765544443332100
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
+ .++..++..+.+++.+||..+|++|||+.++|+||||
T Consensus 221 -------~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 221 -------P---------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -------C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 0 0122468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=306.96 Aligned_cols=250 Identities=28% Similarity=0.412 Sum_probs=200.3
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+.|+..+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++.. ....|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 78 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-----GTKLW 78 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-----CCceE
Confidence 45888899999999999999999999999999876432 234579999999999999999998843 34488
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||+++ ++.+.+. ...+++..++.++.|++.|+.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus 79 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~-~~~~~l~dfg~~~~~ 151 (277)
T cd06642 79 IIMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSE-QGDVKLADFGVAGQL 151 (277)
T ss_pred EEEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeC-CCCEEEccccccccc
Confidence 99999996 5555543 3568899999999999999999999 79999999999999996 778999999998765
Q ss_pred ccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
..... .....++..|+|||.+.+. .++.++|+||+||++|+|++|..||...........+...
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-------------- 216 (277)
T cd06642 152 TDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN-------------- 216 (277)
T ss_pred cCcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--------------
Confidence 43322 1234568889999998654 5889999999999999999999999765544333221110
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
....+...++.++.++|.+||..+|++|||+.++++||||....
T Consensus 217 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 217 --------------SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred --------------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 00011224678899999999999999999999999999998754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=297.79 Aligned_cols=245 Identities=27% Similarity=0.448 Sum_probs=198.2
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
+|++.+.||.|+||.||++.+..+++.||+|.+.... .....|+.+++.++|+||+++.+.+. ....+|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE-----ADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEEE
Confidence 5899999999999999999999999999999875322 23346889999999999999999883 3345899
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
+|||+++ ++.+.+.. .....+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||.+....
T Consensus 76 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 76 VMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQ-NGKVKLGDFGSARLLT 151 (255)
T ss_pred EEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECC-CCcEEEcccCcceeec
Confidence 9999985 66666543 234568999999999999999999999 79999999999999996 7789999999987554
Q ss_pred cCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017147 189 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267 (376)
Q Consensus 189 ~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 267 (376)
.... .....+++.|+|||++.+. .++.++|+||+|+++|+|++|..||...+.......+.....
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------- 217 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY------------- 217 (255)
T ss_pred ccccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC-------------
Confidence 3222 2345678889999998654 488999999999999999999999988776555544432100
Q ss_pred CCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
..++..++..+.+||.+||+.||++|||+.++++-
T Consensus 218 ---------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 ---------------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---------------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00123367889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=304.70 Aligned_cols=253 Identities=27% Similarity=0.448 Sum_probs=201.8
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
.++|.+.+.||+|+||.||++.+..++..||+|.+.... ....+|+.+++.++|||++++++.+.... ..|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD-----ELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC-----cEE
Confidence 468999999999999999999998899999999885332 22356889999999999999999884433 388
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+|+||+++ +|.+.+. ...+++..+..++.|++.|+.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~-~~~~kL~dfg~~~~~ 165 (293)
T cd06647 93 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQI 165 (293)
T ss_pred EEEecCCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcC-CCCEEEccCcceecc
Confidence 99999986 6655553 2457888999999999999999999 79999999999999996 778999999988654
Q ss_pred ccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
..... .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||...+..+.+..+.. .+.+.
T Consensus 166 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~--------- 234 (293)
T cd06647 166 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE--------- 234 (293)
T ss_pred cccccccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCC---------
Confidence 43322 223457888999999855 4578999999999999999999999987665443322111 00000
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
...+..++..+.++|++||..+|++||++.+++.||||+..+
T Consensus 235 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 235 ----------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred ----------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 001223678899999999999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=305.76 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=201.0
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
..|.....||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|||++++++.+... ...|+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~i 95 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-----EELWV 95 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeC-----CeEEE
Confidence 34556668999999999999999999999999885322 2344789999999999999999987433 34889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
++||+++ +|...+. ...+++..++.++.|++.||.|||+ +|++||||+|+||+++. ++.++|+|||++....
T Consensus 96 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~-~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 96 LMEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTL-DGRVKLSDFGFCAQIS 168 (297)
T ss_pred EEecCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEcc-CCcEEEeechhHhhcc
Confidence 9999996 5544432 2568999999999999999999999 79999999999999996 7789999999987543
Q ss_pred cCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017147 189 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267 (376)
Q Consensus 189 ~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 267 (376)
... ......+++.|+|||.+.+. .++.++|+||+||++|+|++|+.||...+..+.+..+... +..
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~--------- 235 (297)
T cd06659 169 KDVPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPP--------- 235 (297)
T ss_pred cccccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CCC---------
Confidence 322 22345678999999998654 4899999999999999999999999877665544433210 000
Q ss_pred CCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
. ......++..+.++|++||+.+|++||++.++++||||.+...
T Consensus 236 ------------~--~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 236 ------------K--LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred ------------C--ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 0 0011236789999999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=304.93 Aligned_cols=254 Identities=20% Similarity=0.272 Sum_probs=191.6
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcC----------------CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceee
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLE----------------TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVIS 91 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~ 91 (376)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+.++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3579999999999999999998532 34579999886532 23457999999999999999
Q ss_pred eceeeeecCCCCceEEEEEeecccc-hHHHHHHhhh---------------hcCCCcCHHHHHHHHHHHHHHHHHhhcCC
Q 017147 92 LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS---------------SANQRMPLIYVKLYTYQIFRGLAYIHTVP 155 (376)
Q Consensus 92 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~ 155 (376)
+++++.... ..++||||+.+ +|.+.+.... .....+++..+..++.||+.||.|||+ .
T Consensus 84 ~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~ 157 (304)
T cd05096 84 LLGVCVDED-----PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-L 157 (304)
T ss_pred EEEEEecCC-----ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-C
Confidence 999885433 38899999985 7777664321 112346788899999999999999999 7
Q ss_pred CeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh
Q 017147 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 232 (376)
Q Consensus 156 ~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~ 232 (376)
||+||||||+|||++. ++.+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|++
T Consensus 158 ~ivH~dlkp~Nill~~-~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 158 NFVHRDLATRNCLVGE-NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred CccccCcchhheEEcC-CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHH
Confidence 9999999999999996 77899999999976533321 1122346789999998654 48999999999999999986
Q ss_pred --CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC
Q 017147 233 --GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310 (376)
Q Consensus 233 --g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 310 (376)
+..||.+.+..+.+..+.......... .....+..++..+.+|+.+||+.||.+|||
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs 294 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFRDQGRQ---------------------VYLFRPPPCPQGLYELMLQCWSRDCRERPS 294 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhhhcccc---------------------ccccCCCCCCHHHHHHHHHHccCCchhCcC
Confidence 668888776665554433321100000 000012246789999999999999999999
Q ss_pred HHHHh
Q 017147 311 ALEAC 315 (376)
Q Consensus 311 ~~e~l 315 (376)
+.++.
T Consensus 295 ~~~i~ 299 (304)
T cd05096 295 FSDIH 299 (304)
T ss_pred HHHHH
Confidence 99984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=296.55 Aligned_cols=250 Identities=32% Similarity=0.510 Sum_probs=203.9
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
+|++.+.||.|++|.||+|.+..+++.|++|++.... ....+|+..+..++|+|++++++.+... ...++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeEEE
Confidence 6899999999999999999999999999999886543 3345789999999999999999988433 45899
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhc-CCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT-VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
||||+++ +|.+.+.. ...+++..+..++.|++.|+.|||+ . |++|+||+|+||+++. ++.++|+|||.+...
T Consensus 77 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~-~~~~~l~df~~~~~~ 150 (264)
T cd06623 77 VLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINS-KGEVKIADFGISKVL 150 (264)
T ss_pred EEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECC-CCCEEEccCccceec
Confidence 9999994 77666653 3678999999999999999999998 6 9999999999999996 788999999998866
Q ss_pred ccCCCce-eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCHHHHhh
Q 017147 188 IAGEANI-SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 188 ~~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
....... ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+ ..+....+.. ...
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~------ 220 (264)
T cd06623 151 ENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPP------ 220 (264)
T ss_pred ccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCC------
Confidence 4443332 45678899999998554 58899999999999999999999998774 2222222221 000
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccC-CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
...... ++..+.++|.+||..+|++|||+.++++||||+..+
T Consensus 221 -------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 221 -------------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred -------------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 001122 688999999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=303.87 Aligned_cols=250 Identities=29% Similarity=0.448 Sum_probs=202.7
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
+.|...+.||+|+||+||+|.+..+++.|++|++.... ....+|+.+++.++|+|++++++++.+. ..
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 95 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-----HT 95 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CE
Confidence 35777888999999999999999999999999886421 1234789999999999999999988443 34
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
.|+||||+.+++.+.+.. ....+++..+..++.|++.|+.|||+ +|++|+||+|+||+++. ++.+||+|||++..
T Consensus 96 ~~lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~-~~~~kL~dfg~~~~ 170 (313)
T cd06633 96 AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTE-PGQVKLADFGSASK 170 (313)
T ss_pred EEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECC-CCCEEEeecCCCcc
Confidence 889999999987777653 34568999999999999999999999 79999999999999996 67899999999864
Q ss_pred CccCCCceeeeeccccCchhhhhC--CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 187 LIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
... .....++..|+|||.+.. ...++.++|+||+||++|+|++|.+||...+.......+... ..+
T Consensus 171 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~~~-------- 238 (313)
T cd06633 171 SSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSP-------- 238 (313)
T ss_pred cCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCC--------
Confidence 322 224567889999999742 344788999999999999999999999887766555544321 000
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
. ......+..+++|+.+||+.+|.+||++.++++||||+..
T Consensus 239 ----------~--------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 239 ----------T--------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred ----------C--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 0 0112356789999999999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=311.32 Aligned_cols=278 Identities=20% Similarity=0.304 Sum_probs=196.9
Q ss_pred eeeecC--CCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G--~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
..||+| +||+||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++.. ....|+|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-----GSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-----CCceEEEE
Confidence 356666 99999999999999999999886432 233578888999999999999999843 33488999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||+.+ ++.+.+... ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++++||+.+......
T Consensus 79 e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~-~~~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 79 PFMAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISG-DGLVSLSGLSHLYSLVRN 154 (328)
T ss_pred ecccCCCHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeC-CCcEEEechHHHhhhhcc
Confidence 99995 776666543 23458999999999999999999999 79999999999999996 678999999865432211
Q ss_pred CCc--------eeeeeccccCchhhhhCC-CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH--
Q 017147 191 EAN--------ISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE-- 259 (376)
Q Consensus 191 ~~~--------~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-- 259 (376)
... ....++..|+|||++.+. ..++.++|+||+||++|+|++|..||.+.................+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence 110 011235569999998653 347899999999999999999999998877655444333211100000
Q ss_pred -------HHhhcCcCCC----CCCCC-----CCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 260 -------EIRCMNPNYT----DFRFP-----QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 260 -------~~~~~~~~~~----~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.+......+. +.... ......+.......++..+.+||++||+.||++|||+.++++||||+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 0000000000 00000 0000111112223467889999999999999999999999999999987
Q ss_pred cCC
Q 017147 324 REP 326 (376)
Q Consensus 324 ~~~ 326 (376)
...
T Consensus 315 ~~~ 317 (328)
T cd08226 315 KEQ 317 (328)
T ss_pred HHh
Confidence 654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=298.74 Aligned_cols=252 Identities=28% Similarity=0.450 Sum_probs=201.8
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
.|...+.||+|++|.||++.+..+++.+++|++.... ....+|+.+++.++|+|++++++.+... ...|++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-----~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-----DELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-----CeEEEE
Confidence 5666678999999999999999999999999875322 2245789999999999999999987433 348899
Q ss_pred eecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 111 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 111 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
+||+.+ +|.+.+.. ..+++..+..++.|++.||+|||+ +|++||||+|+||+++. ++.++|+|||.+.....
T Consensus 95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTS-DGRVKLSDFGFCAQVSK 167 (285)
T ss_pred EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcC-CCcEEEcccccchhhcc
Confidence 999986 66655542 568999999999999999999999 79999999999999996 78899999998865433
Q ss_pred CCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 017147 190 GEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268 (376)
Q Consensus 190 ~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 268 (376)
... .....+++.|+|||.+.+. .++.++|+||+||++|+|++|..||...+.......+.... .+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~----------- 234 (285)
T cd06648 168 EVPRRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PPK----------- 234 (285)
T ss_pred CCcccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CCC-----------
Confidence 221 2234678899999998654 48899999999999999999999998877655554433210 000
Q ss_pred CCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
......++..+.+|+++||+.||++|||+.++++||||+..+.
T Consensus 235 --------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 235 --------------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred --------------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 0001236789999999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.86 Aligned_cols=250 Identities=27% Similarity=0.464 Sum_probs=199.5
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCC---CCceeeeceeeeecCCCCceE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMD---HPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~ 106 (376)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++ |+|++++++++.. ...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CCE
Confidence 4888999999999999999999999999999875431 23457888988886 9999999998743 334
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.|+||||+++ +|.+.+. ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~ 149 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMK-----AGPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTN-TGNVKLCDFGVAA 149 (277)
T ss_pred EEEEEecCCCCcHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcC-CCCEEEccCCcee
Confidence 8899999986 6655543 2378999999999999999999999 79999999999999996 7889999999987
Q ss_pred cCccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 186 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 186 ~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
....... .....++..|+|||.+.+...++.++|+||+||++|+|++|..||.+.+.......+...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------ 217 (277)
T cd06917 150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------ 217 (277)
T ss_pred ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC------------
Confidence 6544332 233467888999999865555789999999999999999999999876543322211110
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
..+.. .....+.++.+++.+||+.||++||++.+++.||||++.
T Consensus 218 -------~~~~~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 218 -------KPPRL--------EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred -------CCCCC--------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 00000 011257899999999999999999999999999999774
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=296.38 Aligned_cols=250 Identities=29% Similarity=0.523 Sum_probs=197.2
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+|.+.+.||+|+||.||++.+..+++.||+|.+..... ...+|+.+++.++|+||+++++.+. ....++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV-----HREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe-----cCCEEE
Confidence 58999999999999999999998999999999865433 3357999999999999999998763 334488
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+|+||+.+ +|.+.+. ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.+||+|||++...
T Consensus 76 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~-~~~~kl~d~g~~~~~ 149 (264)
T cd06626 76 IFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDH-NGVIKLGDFGCAVKL 149 (264)
T ss_pred EEEecCCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccccccccc
Confidence 99999985 6665554 34568899999999999999999999 79999999999999997 788999999998765
Q ss_pred ccCCCce-----eeeeccccCchhhhhCCC--CCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 188 IAGEANI-----SYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 188 ~~~~~~~-----~~~~t~~y~aPE~l~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
....... ...+++.|+|||.+.+.. .++.++|+||+|+++|+|++|+.||...+........... +...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~--- 225 (264)
T cd06626 150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP--- 225 (264)
T ss_pred CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC---
Confidence 4332211 235678899999985432 3788999999999999999999999765432222211111 1000
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
.+|. ...+++.+.+||.+||+.||.+|||+.+++.|||+
T Consensus 226 -----------~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 226 -----------PIPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -----------CCCc----------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0110 11358899999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=298.26 Aligned_cols=244 Identities=19% Similarity=0.220 Sum_probs=191.2
Q ss_pred ceeeeeeeeecCCCeeEEEEEEc---CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
.+|++.+.||+|+||.||+|.++ ..+..||+|.+.... ....+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-----GN 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----CC
Confidence 47999999999999999999865 346789999886432 233479999999999999999998743 23
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..++||||+++ +|.+.+.. ....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.++++|||.+
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~-~~~~~l~dfg~~ 154 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNS-DLVCKISGFRRL 154 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcC-CCcEEECCCccc
Confidence 48899999996 55545542 23578999999999999999999999 79999999999999996 778999999987
Q ss_pred ccCccCCCce--eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 185 KQLIAGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 185 ~~~~~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
.......... ...++..|+|||.+.+ ..++.++||||+||++|++++ |..||.+.+..+.+..+.+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------ 227 (266)
T cd05064 155 QEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL------ 227 (266)
T ss_pred ccccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC------
Confidence 6432221111 1223567999999865 458999999999999999775 99999888766655544321100
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..+..++..+.+++.+||+.+|.+|||++++++
T Consensus 228 ----------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 228 ----------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 012346889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=302.66 Aligned_cols=256 Identities=29% Similarity=0.467 Sum_probs=199.0
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.++|++.+.||+|+||+||++.+..+++.||+|++.... ....+|+++++.++|+||+++++.+... ..+
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NNI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CEE
Confidence 357999999999999999999999999999999876432 2335799999999999999999988433 458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
++||||+++ +|...+. ..+.+++..+..++.|++.||.|||+..+++||||+|+||+++. ++.++|+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~-~~~~~l~d~gl~~~ 153 (284)
T cd06620 79 CMCMEFMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS-RGQIKLCDFGVSGE 153 (284)
T ss_pred EEEEecCCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECC-CCcEEEccCCcccc
Confidence 999999996 5554443 34578999999999999999999996248999999999999996 77899999999865
Q ss_pred CccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHH-------HHHHHHHhCCCCHH
Q 017147 187 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-------LVEIIKVLGTPTRE 259 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~i~~~~~~~~~~ 259 (376)
..... .....++..|+|||++.+. .++.++|+||+||++|+|++|..||......+. +.......-
T Consensus 154 ~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 226 (284)
T cd06620 154 LINSI-ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV----- 226 (284)
T ss_pred hhhhc-cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-----
Confidence 42222 2245678899999998654 588999999999999999999999986554211 111111000
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.. . .+. .....++.++.+|+.+||+.||++|||++|+++||||..-
T Consensus 227 --~~---~-----~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 227 --QE---P-----PPR--------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred --hc---c-----CCC--------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00 0 000 0001257889999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=324.07 Aligned_cols=282 Identities=20% Similarity=0.254 Sum_probs=184.8
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCC----CcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCC-CCceE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLET----GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELF 106 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 106 (376)
..++|++.+.||+|+||.||+|.+..+ +..||+|++...........+.++...+.++..+...+..... .....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence 457899999999999999999999988 8999999875432211111122223333344444333322211 33445
Q ss_pred EEEEeecccc-hHHHHHHhhhh----------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEE
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSS----------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 169 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~----------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill 169 (376)
+++|+||+++ +|.+.+..... .........+..++.||+.||.|||+ +||+||||||+|||+
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~NILl 288 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQNIIF 288 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHHHEEE
Confidence 8899999985 66666643110 01112244567899999999999999 799999999999999
Q ss_pred cCCCCcEEEEeecccccCccCC--CceeeeeccccCchhhhhCCC---------------------CCCchhhhHhHHHH
Q 017147 170 DPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGAT---------------------EYTTSIDIWSAGCV 226 (376)
Q Consensus 170 ~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~l~~~~---------------------~~~~~~DiwslG~i 226 (376)
+.+++.+||+|||+|+...... ......+|+.|+|||.+.... .++.++||||+||+
T Consensus 289 ~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGvi 368 (566)
T PLN03225 289 SEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 368 (566)
T ss_pred eCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHH
Confidence 8656789999999997543322 223567899999999763221 23456799999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhh--hcccCCChhHHHHHHhhcCcC
Q 017147 227 LAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHK--VFHKRMPPEAIDLASRLLQYS 304 (376)
Q Consensus 227 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~d 304 (376)
+|+|+++..++ .+....+..++...+... ..+....... ....... ......+..+.|||.+||++|
T Consensus 369 L~el~~~~~~~--~~~~~~~~~~l~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 369 FLQMAFPNLRS--DSNLIQFNRQLKRNDYDL-VAWRKLVEPR--------ASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred HHHHHhCcCCC--chHHHHHHHHHHhcCCcH-HHHHHhhccc--------cchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 99999866553 333444444444333322 1121110000 0000000 001112456779999999999
Q ss_pred CCCCCCHHHHhcCCCcccccC
Q 017147 305 PSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 305 p~~R~t~~e~l~hp~~~~~~~ 325 (376)
|.+|||+.++|+||||+....
T Consensus 438 P~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 438 GRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred cccCCCHHHHhCCcCcCCCCc
Confidence 999999999999999987544
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=294.01 Aligned_cols=249 Identities=28% Similarity=0.448 Sum_probs=203.6
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+|++.+.||+|+||.||++.+..+++.+|+|.+.... ....+|+.+++.++|+||+++.+++... ...|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence 5899999999999999999999999999999886432 1234688999999999999999888433 4588
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+|+||+++ +|.+.+.........+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.+||+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~-~~~~kl~d~g~~~~~ 153 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVA-NDLVKIGDLGISKVL 153 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEec-CCcEEEeeccchhhh
Confidence 99999985 7777776544445678999999999999999999999 79999999999999996 778999999999765
Q ss_pred ccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017147 188 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267 (376)
Q Consensus 188 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 267 (376)
... ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+..+....+....
T Consensus 154 ~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 217 (256)
T cd08530 154 KKN-MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK-------------- 217 (256)
T ss_pred ccC-CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------------
Confidence 444 3334567889999999865 457889999999999999999999998877654443332210
Q ss_pred CCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
++. .....+.++++++.+||+.+|++|||+.++++||++
T Consensus 218 -----~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 218 -----YPP---------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred -----CCC---------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 000 112367899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=297.92 Aligned_cols=245 Identities=33% Similarity=0.547 Sum_probs=197.3
Q ss_pred eecCCCeeEEEEEEcCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017147 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 114 (376)
Q Consensus 42 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 114 (376)
||.|+||.||++++..+++.+++|.+..+.. ...+|+.+++.++|+||+++++.+ ......|+++||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 6899999999999999999999998865432 345788999999999999998877 3344588999999
Q ss_pred cc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCC--
Q 017147 115 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-- 191 (376)
Q Consensus 115 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-- 191 (376)
.+ +|.+.+.. ...+++..+..++.|++.||.|||+ .|++|+||+|+||++++ ++.++|+|||++.......
T Consensus 76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDS-NGHLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcC-CCCEEEEecccchhcccCccc
Confidence 85 76666653 3478999999999999999999999 79999999999999997 7789999999987543331
Q ss_pred -------CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 192 -------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 192 -------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||......+....+... .
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~--------- 217 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--K--------- 217 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C---------
Confidence 112345678899999986544 789999999999999999999999887766555444320 0
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH---HHHhcCCCcccccC
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFFDELRE 325 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~---~e~l~hp~~~~~~~ 325 (376)
...+. ...++..+.+|+.+||+.+|.+|||+ .++++||||+++.|
T Consensus 218 ------~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 218 ------IEWPE----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred ------cCCCc----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 00110 01148899999999999999999999 99999999998753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=295.18 Aligned_cols=249 Identities=28% Similarity=0.494 Sum_probs=198.7
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++.+.+.. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence 36999999999999999999999999999999874321 13346999999999999999998774322 2
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
..+++++||+++ +|.+.+. ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||+
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~ 152 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGA 152 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEECcccc
Confidence 347799999986 6665554 33568899999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccC----CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 184 AKQLIAG----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 184 a~~~~~~----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
++..... .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||..........++.. .+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~-- 226 (264)
T cd06653 153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT-- 226 (264)
T ss_pred ccccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCC--
Confidence 9754321 111234578889999998654 478999999999999999999999987765544433321 111
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
...++..+++.+.++|.+||. +|..|||+.++++|||.
T Consensus 227 ----------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 227 ----------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ----------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 112334578999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=312.72 Aligned_cols=250 Identities=23% Similarity=0.351 Sum_probs=191.7
Q ss_pred cceeeeeeeeecCCCeeEEEEEE-----cCCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 101 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 101 (376)
.++|++.+.||+|+||+||+|.+ ..++..||+|++.... ....+|+.+++.+ +||||+++++.+...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-- 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG-- 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence 34799999999999999999974 3456789999885432 2234799999999 899999999988433
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhh-----------------------------------------------------
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSS----------------------------------------------------- 127 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~----------------------------------------------------- 127 (376)
...++|||||++ +|.+.+.....
T Consensus 112 ---~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 112 ---GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ---CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 348899999985 77777653210
Q ss_pred ------------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 128 ------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 128 ------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
....+++..+..++.||+.||.|||+ +|++||||||+|||++. +..+||+|||+++....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~-~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTH-GRITKICDFGLARDIRN 266 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEEC-CCcEEEecCccceeccC
Confidence 12357888899999999999999999 79999999999999996 77899999999976543
Q ss_pred CCCce---eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 190 GEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 190 ~~~~~---~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
..... ...++..|+|||++.+. .++.++|||||||++|+|++ |..||.+......+.+.+.....
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~---------- 335 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR---------- 335 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc----------
Confidence 32211 12235679999999654 58999999999999999998 89999876654444333321000
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
...+...+.++.+|+.+||+.||++|||+.++++.
T Consensus 336 -----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 336 -----------------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred -----------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 00112357899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=298.36 Aligned_cols=249 Identities=27% Similarity=0.419 Sum_probs=200.3
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+-|++.+.||+|+||.||++.+..+++.+|+|.+.... ....+|+.+++.++|+||+++++.+.. ..+.|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 78 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLW 78 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-----CCeEE
Confidence 34888999999999999999999999999999875332 234578999999999999999998843 33488
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||+++ ++.+.+. ...+++..+..++.|++.|+.+||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus 79 lv~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~-~~~~~l~dfg~~~~~ 151 (277)
T cd06641 79 IIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSE-HGEVKLADFGVAGQL 151 (277)
T ss_pred EEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECC-CCCEEEeecccceec
Confidence 99999986 5555553 2468899999999999999999999 79999999999999996 778999999998755
Q ss_pred ccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
..... .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...........+... ..
T Consensus 152 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~----------- 218 (277)
T cd06641 152 TDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-NP----------- 218 (277)
T ss_pred ccchhhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-CC-----------
Confidence 43321 223456888999999854 45788999999999999999999999876654444332110 00
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
..+...++.++.+++.+||..+|.+||++.++++||||...
T Consensus 219 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 219 ----------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ----------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 01123468899999999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=300.96 Aligned_cols=249 Identities=23% Similarity=0.318 Sum_probs=196.7
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCC-----cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
..+|++.+.||+|+||.||+|.+...+ ..||+|.+.... ....+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---- 79 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK---- 79 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC----
Confidence 357999999999999999999976555 679999886432 223579999999999999999998743
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhh------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEE
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 169 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill 169 (376)
....|++|||+++ +|.+.+..... ....+++..+..++.|++.||.|||+ +|++||||||+||++
T Consensus 80 -~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~ 157 (283)
T cd05048 80 -EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLV 157 (283)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEE
Confidence 2348899999985 77777653211 11468889999999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHH
Q 017147 170 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 245 (376)
Q Consensus 170 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 245 (376)
+. ++.++|+|||++........ .....+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+.
T Consensus 158 ~~-~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 158 GE-GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred cC-CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 96 77899999999875433221 2234557889999998654 58999999999999999998 9999998777665
Q ss_pred HHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 246 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 246 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
...+.+.... ..+..+++++.+|+.+||+.||.+||++.+++++
T Consensus 236 ~~~i~~~~~~----------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIRSRQLL----------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHcCCcC----------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5444321000 0123478999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=295.56 Aligned_cols=249 Identities=27% Similarity=0.428 Sum_probs=196.4
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
++|++.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++.+... ..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----Ce
Confidence 47999999999999999999999999999999875321 1234699999999999999999988543 34
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.++++||+++ +|...+.........+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~-~~~~~l~d~g~~~ 154 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcC-CCCEEECccccce
Confidence 8899999995 7766666544455668999999999999999999999 79999999999999996 7789999999987
Q ss_pred cCccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhh
Q 017147 186 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 186 ~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 263 (376)
....... .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...... ..+...+...+.++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 227 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP------ 227 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC------
Confidence 6543322 1234577889999998654 4789999999999999999999999654321 12222222111111
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
......+..+.+++.+||+.+|++|||+.++++
T Consensus 228 --------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 228 --------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred --------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 011235788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=302.65 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=198.8
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-----chHHHHHHHHhC-CCCceeeeceeeeecCCCCce
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 105 (376)
..++|++.+.||+|++|.||+|.+..+++.||+|.+..... ...+|+.++... .|+||+++++++.. ..
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~ 87 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----DS 87 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-----CC
Confidence 44689999999999999999999998899999999864321 123455555555 59999999998843 33
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
..|++|||+++.+..++.. ....+++..+..++.|++.|+.|||+..|++||||+|+||+++. ++.+||+|||++.
T Consensus 88 ~~~~v~e~~~~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~-~~~~kL~dfg~~~ 163 (296)
T cd06618 88 DVFICMELMSTCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDA-SGNVKLCDFGISG 163 (296)
T ss_pred eEEEEeeccCcCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcC-CCCEEECccccch
Confidence 4899999998876666543 23578999999999999999999996249999999999999996 7889999999987
Q ss_pred cCccCCCceeeeeccccCchhhhhCC---CCCCchhhhHhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHH
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~ 261 (376)
............++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||..... .+.+..+... ..
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~---- 236 (296)
T cd06618 164 RLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE---EP---- 236 (296)
T ss_pred hccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC---CC----
Confidence 65443333334567889999998543 2378899999999999999999999976432 2223222211 00
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
. ..+ ....++.++.+|+.+||..||.+|||+++++.||||+..+
T Consensus 237 -------~--~~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 237 -------P--SLP----------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred -------C--CCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 0 000 0113678999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=298.43 Aligned_cols=256 Identities=25% Similarity=0.338 Sum_probs=197.7
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcC-----CCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
.++|++.+.||+|+||.||+|.++. .+..||+|.+..... ...+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG--- 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC---
Confidence 4689999999999999999997652 345799998754322 234688899999999999999887433
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhhc------CCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCc
Q 017147 103 NELFLNLVMEYVP-ESMYRVLKHYSSA------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 175 (376)
Q Consensus 103 ~~~~~~lv~e~~~-~~l~~~l~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~ 175 (376)
...|+||||++ |+|.+.+...... ...++...+..++.|++.||.|||+ +|++||||||+||+++. ++.
T Consensus 82 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~-~~~ 157 (288)
T cd05061 82 --QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAH-DFT 157 (288)
T ss_pred --CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcC-CCc
Confidence 34789999998 5777777543211 2335667888999999999999999 79999999999999996 788
Q ss_pred EEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017147 176 VKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 251 (376)
Q Consensus 176 vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 251 (376)
++|+|||+++....... .....++..|+|||.+.+. .++.++|+||+||++|+|++ |..||.+.+..+....+..
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999999875433221 1112345679999998654 48999999999999999998 7899988776654443322
Q ss_pred HhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc------CCCccccc
Q 017147 252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA------HPFFDELR 324 (376)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~------hp~~~~~~ 324 (376)
. +.+ .++...++.+.+++.+||+.||++|||+.++++ ||||+.+.
T Consensus 237 ~-~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 237 G-GYL---------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred C-CCC---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 1 000 011235789999999999999999999999986 99998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=299.14 Aligned_cols=246 Identities=33% Similarity=0.589 Sum_probs=201.2
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCC-CCceeeeceeeeecCCCCce
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 105 (376)
++|.+.+.||+|+||.||+|.+..+++.||+|++.++. ....+|+.+++.++ |+||+++++++. +..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ-----DEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc-----CCc
Confidence 36999999999999999999999999999999886421 23356889999998 999999998873 344
Q ss_pred EEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..++|||++. ++|.+.+.. ...+++..++.++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~-~~~~~l~df~~~ 149 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDK-DMHIKITDFGTA 149 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEecCCccc
Confidence 5889999995 577776653 3479999999999999999999999 79999999999999996 778999999998
Q ss_pred ccCccCCC---------------------ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChH
Q 017147 185 KQLIAGEA---------------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 243 (376)
Q Consensus 185 ~~~~~~~~---------------------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 243 (376)
........ .....++..|+|||.+.+ ..++.++|+||||++++++++|+.||...+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (280)
T cd05581 150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY 228 (280)
T ss_pred cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 75433221 122356788999999855 44889999999999999999999999987755
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCC
Q 017147 244 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPF 319 (376)
Q Consensus 244 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~e~l~hp~ 319 (376)
..+..+... .+ .++..+++.+.+||.+||+.||++|||+ +++++|||
T Consensus 229 ~~~~~~~~~-----------------~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~ 279 (280)
T cd05581 229 LTFQKILKL-----------------EY------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279 (280)
T ss_pred HHHHHHHhc-----------------CC------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence 554443321 01 1223468899999999999999999999 99999999
Q ss_pred c
Q 017147 320 F 320 (376)
Q Consensus 320 ~ 320 (376)
|
T Consensus 280 ~ 280 (280)
T cd05581 280 F 280 (280)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=294.68 Aligned_cols=245 Identities=22% Similarity=0.346 Sum_probs=195.5
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
.+|++.+.||+|+||.||+|.++.+++.+|+|.+..+.. ...+|+.+++.++|+||+++++++.. ...++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcC-----CCCcEEE
Confidence 469999999999999999999999999999998865432 24579999999999999999988733 3347899
Q ss_pred eecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 111 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 111 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
|||+++ +|.+.+.. .....+++..+..++.|++.||.|||+ +|++||||||+||++++ ++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 81 TEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEeCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcC-CCcEEeCCCcccccccc
Confidence 999985 67666643 123468899999999999999999999 79999999999999986 78899999999876543
Q ss_pred CCCce--eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 190 GEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 190 ~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
..... ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~------------- 222 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY------------- 222 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-------------
Confidence 22111 12235679999988654 58899999999999999998 999998877655544432210
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
....+..++.++.++|.+||+.||++|||+.++++
T Consensus 223 ---------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 223 ---------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ---------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00122347899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=290.29 Aligned_cols=248 Identities=30% Similarity=0.496 Sum_probs=201.3
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
.|++.+.||+|++|.||++.+..+++.+++|++.... ....+|+.+++.++|++++++.+.+... ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEE
Confidence 4889999999999999999999899999999986554 3456799999999999999999988443 348899
Q ss_pred eecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 111 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 111 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
+||+++ +|.+.+.. ....+++..+..++.|++.||.+||+ .|++||||+|+||+++. ++.++|+|||.+.....
T Consensus 76 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~ 150 (253)
T cd05122 76 MEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTS-DGEVKLIDFGLSAQLSD 150 (253)
T ss_pred EecCCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEcc-CCeEEEeeccccccccc
Confidence 999995 66666543 22578999999999999999999999 79999999999999996 78899999999976654
Q ss_pred CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 190 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 190 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
........++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+.......+... ..+.
T Consensus 151 ~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~------------ 216 (253)
T cd05122 151 TKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPG------------ 216 (253)
T ss_pred cccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCCC------------
Confidence 43234556788899999986544 789999999999999999999999877554444332220 0000
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 017147 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319 (376)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 319 (376)
.+ ....++..+.++|.+||+.||++|||+.++++|||
T Consensus 217 ---~~----------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 217 ---LR----------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ---cC----------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00 00113788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=301.60 Aligned_cols=249 Identities=30% Similarity=0.434 Sum_probs=202.9
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.|...+.||+|+||.||++++..++..+|+|++.... ....+|+.+++.++|+|++++++++.... ..
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-----TA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-----eE
Confidence 4889999999999999999999999999999886432 12346899999999999999999884433 38
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
++||||+.|++.+.+.. ....+++..+..++.|++.|+.|||+ +|++||||+|+||+++. ++.++|+|||++...
T Consensus 101 ~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~-~~~~kl~dfg~~~~~ 175 (317)
T cd06635 101 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTE-PGQVKLADFGSASIA 175 (317)
T ss_pred EEEEeCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECC-CCCEEEecCCCcccc
Confidence 89999999987776643 34568999999999999999999999 79999999999999986 678999999998654
Q ss_pred ccCCCceeeeeccccCchhhhhC--CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 188 IAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 188 ~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.. .....+++.|+|||.+.. ...++.++|+||+||++|+|++|..||...+....+..+......+.
T Consensus 176 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 244 (317)
T cd06635 176 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL-------- 244 (317)
T ss_pred CC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--------
Confidence 32 223467888999999742 34478899999999999999999999988776665555443211000
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.....++.+.+|+.+||+.+|.+||++.++++|||+...
T Consensus 245 -------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 245 -------------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred -------------------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 012357789999999999999999999999999999653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=296.47 Aligned_cols=249 Identities=25% Similarity=0.464 Sum_probs=197.9
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc---------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
+|.+.+.||+|+||.||++.+..++..+++|.+... ......|+.+++.++||||+++++.+.+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD----- 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC-----
Confidence 589999999999999999999888777777765321 112346888999999999999998874333
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..++|+||+++ ++...+.........+++..++.++.|++.||.|||+ .|++|+||+|+||+++. +.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~~--~~~~l~d~g~~ 152 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLKN--NLLKIGDFGVS 152 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEeec--CCEeecccCce
Confidence 38899999985 7766676555556789999999999999999999999 79999999999999974 56999999998
Q ss_pred ccCccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 185 KQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 185 ~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
........ .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.........+... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~------- 222 (260)
T cd08222 153 RLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PT------- 222 (260)
T ss_pred eecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CC-------
Confidence 76543322 223456888999999854 44788999999999999999999999876654444333220 00
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
..++..++.++.++|.+||..||++||++.++++||||
T Consensus 223 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 223 -------------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -------------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 00123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=303.51 Aligned_cols=250 Identities=23% Similarity=0.314 Sum_probs=192.4
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcE--EEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 103 (376)
...+|++.+.||+|+||.||+|.++.++.. +|+|.+.... ....+|+.++..+ +|+||+++++++. .
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-----~ 79 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----H 79 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-----C
Confidence 346899999999999999999998877764 5777664321 2334699999999 8999999999873 3
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhh------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEc
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 170 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~ 170 (376)
..++|+||||+++ +|.+.+..... ....+++..++.++.|++.||+|||+ +|++||||||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~ 158 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG 158 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEec
Confidence 3458999999984 77777653221 12368899999999999999999999 7999999999999999
Q ss_pred CCCCcEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017147 171 PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 249 (376)
Q Consensus 171 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i 249 (376)
. ++.+||+|||++..............+..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 159 ~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 159 E-NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred C-CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 6 778999999998643221111122235679999988554 48899999999999999998 99999877665544332
Q ss_pred HHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.... ....+..+++++.+|+.+||+.+|++||++++++++
T Consensus 237 ~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 237 PQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred hcCC----------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1100 000112367899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=327.90 Aligned_cols=142 Identities=24% Similarity=0.374 Sum_probs=122.7
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
.++|.+.+.||+|+||+||+|.+..+++.||||++.... .....|+.++..++|+||++++.++.. ..
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-----AN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-----CC
Confidence 568999999999999999999999999999999986532 344578899999999999999887733 33
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
++|+||||+.| +|..++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~~-~g~vkL~DFGls 151 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISN-EGHIKLTDFGLS 151 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEcC-CCCEEEEeCCCC
Confidence 58999999975 67666642 3568899999999999999999999 79999999999999996 678999999987
Q ss_pred c
Q 017147 185 K 185 (376)
Q Consensus 185 ~ 185 (376)
+
T Consensus 152 ~ 152 (669)
T cd05610 152 K 152 (669)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=302.46 Aligned_cols=251 Identities=28% Similarity=0.426 Sum_probs=202.6
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
...|...+.||+|+||.||+|+++.+++.+|+|.+.... ....+|+.+++.++|+|++++.+++... .
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 88 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----H 88 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----C
Confidence 346888999999999999999999999999999885321 1234689999999999999999988543 3
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
..++||||+.+++...+.. ....+++..+..++.|++.|+.|||+ ++++||||+|+||+++. ++.++|+|||++.
T Consensus 89 ~~~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~ 163 (308)
T cd06634 89 TAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSAS 163 (308)
T ss_pred eeEEEEEccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECC-CCcEEECCcccce
Confidence 4889999999887766643 34568999999999999999999999 79999999999999996 7789999999987
Q ss_pred cCccCCCceeeeeccccCchhhhhC--CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 186 QLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
..... ....+++.|+|||.+.+ ...++.++|||||||++|+|++|..||...+..+....+.+.. .+.
T Consensus 164 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~------ 233 (308)
T cd06634 164 IMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPA------ 233 (308)
T ss_pred eecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC-CCC------
Confidence 54322 23467888999999853 2347889999999999999999999998766555444333210 000
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
......+..+.+||.+||+.+|.+||+++++++|||+...
T Consensus 234 --------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 234 --------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred --------------------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0012367889999999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=342.48 Aligned_cols=257 Identities=27% Similarity=0.458 Sum_probs=208.0
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
++..+|.....||.|.||.||.|.+..+|+..|+|.+.-. .....+|..++..++|||+|+++++=.+.+.
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek--- 1308 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK--- 1308 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH---
Confidence 4566899999999999999999999999999999977421 2334589999999999999999988755544
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
++|.||||.| +|.+++. .+....+...+.|..|++.|+.|||+ +|||||||||.||+++. ++.+|++|||.
T Consensus 1309 --v~IFMEyC~~GsLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~-~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1309 --VYIFMEYCEGGSLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDF-NGLIKYGDFGS 1380 (1509)
T ss_pred --HHHHHHHhccCcHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeec-CCcEEeecccc
Confidence 7899999996 5555554 34557788888999999999999999 79999999999999996 78999999999
Q ss_pred cccCccCC-----CceeeeeccccCchhhhhCCC--CCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017147 184 AKQLIAGE-----ANISYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256 (376)
Q Consensus 184 a~~~~~~~-----~~~~~~~t~~y~aPE~l~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 256 (376)
|..+.... ......||+.|||||++.+.. ....+.|||||||++.||+||+.||...+..-++---+..-.+
T Consensus 1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~- 1459 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK- 1459 (1509)
T ss_pred eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC-
Confidence 98765442 234678999999999996542 3467899999999999999999999876644322111111111
Q ss_pred CHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
..++.++|++.+|||.+||..||++|.++.|+|.|-|-+.-++
T Consensus 1460 --------------------------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1460 --------------------------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred --------------------------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccc
Confidence 1244568999999999999999999999999999999876543
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=299.20 Aligned_cols=256 Identities=26% Similarity=0.462 Sum_probs=199.9
Q ss_pred eeeeeeeeecCCCeeEEEEEEc---CCCcEEEEEEeeccc--------cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 017147 35 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 102 (376)
.|++.+.||.|+||.||+|.+. .+|+.||+|.+.... ....+|+.+++.+ +|+||+.+++++ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 4889999999999999999875 478999999886421 2235689999999 589999998887 3
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
....+|+||||+++ +|.+.+. ....+++..+..++.|++.||.|||+ .|++||||+|+||+++. ++.+||+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~df 149 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLTDF 149 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECC-CCCEEEeeC
Confidence 34458899999996 6666554 34568899999999999999999999 79999999999999996 778999999
Q ss_pred cccccCccCCC--ceeeeeccccCchhhhhCC-CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 182 GSAKQLIAGEA--NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 182 g~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
|++........ .....++..|+|||.+.+. ..++.++|+||+|+++|+|++|..||...+.......+.+.....
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-- 227 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-- 227 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--
Confidence 99876543221 2245678899999998543 246789999999999999999999997543322222222211000
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCC
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 326 (376)
...++..+++.+.+++++||+.||++|+ ++++++.||||+.+++.
T Consensus 228 -----------------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 277 (290)
T cd05613 228 -----------------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWD 277 (290)
T ss_pred -----------------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHH
Confidence 0011234688999999999999999997 89999999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=290.33 Aligned_cols=246 Identities=33% Similarity=0.576 Sum_probs=201.8
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+|++.+.||+|++|.||++.+..+++.||+|.+..... ...+|+++++.++|+|++++.+++.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEE
Confidence 58899999999999999999999999999999865532 24579999999999999999988743 34588
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
++|||+++ +|.+.+. ....+++..++.++.|++.||.+||+ .|++||||+|+||+++. ++.++|+|||.+...
T Consensus 76 ~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~ 149 (254)
T cd06627 76 IILEYAENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTK-DGVVKLADFGVATKL 149 (254)
T ss_pred EEEecCCCCcHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECC-CCCEEEeccccceec
Confidence 99999986 6665554 33678999999999999999999999 79999999999999996 788999999999765
Q ss_pred ccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
..... .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+.......+...
T Consensus 150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 214 (254)
T cd06627 150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD-------------- 214 (254)
T ss_pred CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--------------
Confidence 44332 23346688899999986544 789999999999999999999999876654444332210
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
. ...++..++..+.+++.+||..+|++|||+.++++||||
T Consensus 215 ~--------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 215 D--------------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred C--------------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0 011233478899999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=303.40 Aligned_cols=269 Identities=22% Similarity=0.297 Sum_probs=191.4
Q ss_pred CCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecccc-hH
Q 017147 46 SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SM 118 (376)
Q Consensus 46 ~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l 118 (376)
++|.||++++..+++.||+|++.... ....+|+.+++.++|+||+++++++... ...|++|||+++ ++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-----SELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-----CeEEEEEeccCCCCH
Confidence 44667777777799999999986441 2345799999999999999999988433 348899999995 66
Q ss_pred HHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCC------
Q 017147 119 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA------ 192 (376)
Q Consensus 119 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~------ 192 (376)
.+.+... ....+++..+..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||.+........
T Consensus 87 ~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~-~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 87 EDLLKTH--FPEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSG-DGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEec-CCceEEecCccceeeccccccccccc
Confidence 6666532 23468899999999999999999999 79999999999999996 77899999998864432211
Q ss_pred --ceeeeeccccCchhhhhCC-CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH----HHhhcC
Q 017147 193 --NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE----EIRCMN 265 (376)
Q Consensus 193 --~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----~~~~~~ 265 (376)
.....++..|+|||++.+. ..++.++|+||+||++|+|++|..||........+..... +..... ......
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCccccccCchhhhc
Confidence 1223456789999998653 3478999999999999999999999987665443322221 111100 000000
Q ss_pred cCCCC----CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 266 PNYTD----FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 266 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
..... ...+ .............++.++.+|+.+||++||++|||++++|+||||+.++..
T Consensus 241 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~ 304 (314)
T cd08216 241 DSMSQSRSSNEHP-NNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRR 304 (314)
T ss_pred CCcCccccccccc-chhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhccc
Confidence 00000 0000 001111122223356789999999999999999999999999999987633
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=306.55 Aligned_cols=250 Identities=26% Similarity=0.376 Sum_probs=191.8
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcC-----CCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 102 (376)
++|++.+.||+|+||.||+|.+.. +++.||+|++.... ....+|+.+++.+ +|+||+++++++...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~--- 83 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP--- 83 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC---
Confidence 489999999999999999997543 45789999886432 1234689999999 799999999877432
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhh------------------------------------------------------
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSS------------------------------------------------------ 127 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~------------------------------------------------------ 127 (376)
...++++|||+++ +|.+.+.....
T Consensus 84 -~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 84 -GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred -CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 2347899999995 67666643211
Q ss_pred ---cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCC---ceeeeeccc
Q 017147 128 ---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRF 201 (376)
Q Consensus 128 ---~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~ 201 (376)
....+++..+..++.||+.||+|||+ +||+||||||+||+++. ++.++|+|||++........ .....++..
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~-~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeC-CCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 12368899999999999999999999 79999999999999996 77899999999976533221 112344667
Q ss_pred cCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCC
Q 017147 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHP 280 (376)
Q Consensus 202 y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (376)
|+|||++.+. .++.++||||+||++|+|++ |..||.+....+.+...+.....
T Consensus 241 y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------------------- 294 (337)
T cd05054 241 WMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR------------------------- 294 (337)
T ss_pred ccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC-------------------------
Confidence 9999998664 48999999999999999998 99999875544433332221000
Q ss_pred hhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 281 WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 281 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
...+...++++.+++.+||+.+|++||++.++++|
T Consensus 295 --~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 295 --MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred --CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00122357899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=298.43 Aligned_cols=248 Identities=24% Similarity=0.350 Sum_probs=195.8
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcC-----CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
..+|.+.+.||+|+||.||+|.+.. +++.||+|.+.... ....+|+++++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG--- 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC---
Confidence 3579999999999999999998753 36789999886532 2345799999999999999999988543
Q ss_pred CceEEEEEeecccc-hHHHHHHhhh----------hcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYS----------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 171 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~----------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~ 171 (376)
...++||||+++ +|.+.+.... .....+++..+..++.|++.|+.|||+ +|++||||||+||+++.
T Consensus 81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~~ 157 (280)
T cd05049 81 --DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVGY 157 (280)
T ss_pred --CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEcC
Confidence 348899999985 7776665421 123457889999999999999999999 79999999999999996
Q ss_pred CCCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 017147 172 LTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 247 (376)
Q Consensus 172 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 247 (376)
++.+||+|||++........ .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 158 -~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 158 -DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred -CCeEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 78899999999875432221 1233456789999998654 48999999999999999998 999998877665554
Q ss_pred HHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 248 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+... .. ...+..++..+.+++++||+.||++|||+.|+++
T Consensus 236 ~~~~~--~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 236 CITQG--RL--------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHcC--Cc--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 43321 00 0012246889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=327.37 Aligned_cols=250 Identities=23% Similarity=0.304 Sum_probs=192.0
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
++|++.+.||+|+||.||+|.+..+++.||+|++..+. ....+|+.+++.++||||+++++++.. ...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-----~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-----GDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-----CCE
Confidence 58999999999999999999999999999999986431 223479999999999999999988743 334
Q ss_pred EEEEeecccc-hHHHHHHhhhh-------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEE
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSS-------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 178 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl 178 (376)
.|++|||++| +|.+.+..... ....++...+..++.||+.||+|||+ +||+||||||+||+++. ++.++|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~-dg~vKL 154 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGL-FGEVVI 154 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcC-CCCEEE
Confidence 8899999986 77776653211 12345667788999999999999999 79999999999999996 778999
Q ss_pred EeecccccCccCC-------------------CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCC
Q 017147 179 CDFGSAKQLIAGE-------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 239 (376)
Q Consensus 179 ~Dfg~a~~~~~~~-------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 239 (376)
+|||++....... ......||+.|+|||.+.+. .++.++||||+||++|+|++|..||..
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9999997552110 01124689999999998654 489999999999999999999999987
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 240 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 240 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.+....... .....|.. ..-...+++.+.+++.+||+.||++|++..+.+.+
T Consensus 234 ~~~~ki~~~--~~i~~P~~------------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 234 KKGRKISYR--DVILSPIE------------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred cchhhhhhh--hhccChhh------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 554332211 10000000 00012468899999999999999999987665543
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=295.34 Aligned_cols=249 Identities=23% Similarity=0.296 Sum_probs=192.2
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcC-----CCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+|+.+++.++|+||+++++++.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~----- 79 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS----- 79 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc-----
Confidence 4579999999999999999998652 356799998754321 2347899999999999999998873
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhc------CCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCc
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSSA------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 175 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~ 175 (376)
.....++||||+++ +|.+.+...... ...++...+..++.|++.||.|||+ +|++||||||+||++++ ++.
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~-~~~ 157 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE-DFT 157 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcC-CCC
Confidence 33348899999985 777666532211 1245778889999999999999999 79999999999999996 778
Q ss_pred EEEEeecccccCccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017147 176 VKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 251 (376)
Q Consensus 176 vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 251 (376)
++|+|||+++........ ....+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+.+..+..
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999998754322211 122346779999998654 48999999999999999999 7899988776655544332
Q ss_pred HhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.. .+ .++..++..+.+++.+||+.||++|||+.+++++
T Consensus 237 ~~-~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 237 GG-LL---------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CC-cC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 10 00 0123467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=299.45 Aligned_cols=251 Identities=27% Similarity=0.422 Sum_probs=198.9
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
.|.....||+|+||.||++.+..+++.||+|++.... ....+|+.+++.++|+|++++++.+... ...+++
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv 95 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWVV 95 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-----CEEEEE
Confidence 3444567999999999999999999999999875322 2234689999999999999999988433 348899
Q ss_pred eecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 111 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 111 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
|||+++ +|.+.+. ...+++..++.++.|++.|++|||+ .|++|+||+|+||+++. ++.++|+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~-~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 96 MEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVSK 168 (292)
T ss_pred EecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEcccccceeccc
Confidence 999987 4444432 3468899999999999999999999 79999999999999996 67899999999865433
Q ss_pred CC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 017147 190 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268 (376)
Q Consensus 190 ~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 268 (376)
.. ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+..+....+..... .
T Consensus 169 ~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~--~----------- 234 (292)
T cd06657 169 EVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP--P----------- 234 (292)
T ss_pred ccccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC--c-----------
Confidence 22 1233567889999998854 4578999999999999999999999988766554443322110 0
Q ss_pred CCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
.+ .....++..+.+++.+||..||.+||++.++++||||....
T Consensus 235 ---~~----------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 235 ---KL----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ---cc----------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 00 00123688999999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=297.53 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=193.7
Q ss_pred ceeeeeeeeecCCCeeEEEEEEc-----CCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
.+|.+.+.||+|+||+||++.+. .++..+|+|.+.... ....+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----G 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----C
Confidence 47999999999999999999863 345679999886432 234579999999999999999998743 3
Q ss_pred eEEEEEeecccc-hHHHHHHhhh---------hcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYS---------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 174 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~ 174 (376)
..+++||||+++ +|.+.+.... .....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~-~~ 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGE-NL 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEcc-CC
Confidence 348899999984 7777665321 122358999999999999999999999 79999999999999996 77
Q ss_pred cEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 017147 175 QVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 250 (376)
Q Consensus 175 ~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 250 (376)
.++|+|||++........ .....+++.|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+..+.+..+.
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 899999999975533221 112334667999999865 458999999999999999998 999998877666554443
Q ss_pred HHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
+.. .. ..+..++.++.+|+.+||+.||.+|||+.++++
T Consensus 237 ~~~--~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 237 QGR--VL--------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCC--cC--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 310 00 011236789999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=289.44 Aligned_cols=250 Identities=33% Similarity=0.524 Sum_probs=200.7
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+|++.+.||+|++|.||+|.+..+++.+++|++.... ....+|+.+++.++|+||+++++.+.... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 4888999999999999999999999999999886543 23457999999999999999998874331 24588
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+++||+++ +|.+.+.. ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 78 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~ 151 (260)
T cd06606 78 IFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDS-DGVVKLADFGCAKRL 151 (260)
T ss_pred EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcC-CCCEEEcccccEEec
Confidence 99999965 66666543 3388999999999999999999999 79999999999999997 788999999999866
Q ss_pred ccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 188 IAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 188 ~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
..... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.. ...+.+...
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~---------- 218 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYKIGS---------- 218 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHhccc----------
Confidence 55443 3345678889999998554 4899999999999999999999999876621 111111100
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
......++..++..+.+||.+||+.||++||++.+++.||||
T Consensus 219 --------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 219 --------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred --------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 000111233468899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=293.36 Aligned_cols=251 Identities=22% Similarity=0.284 Sum_probs=193.7
Q ss_pred eeeeeeeecCCCeeEEEEEEcCC---CcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 017147 36 YMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 105 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 105 (376)
|.+.+.||+|+||.||+|....+ +..||+|.+..+.. ...+|+.+++.++|+||+++++.+..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56789999999999999987654 47899998864321 23478999999999999999987754332 3344
Q ss_pred EEEEEeecccc-hHHHHHHhhh--hcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYS--SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
..++++||+.+ +|...+.... .....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLRE-DMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECC-CCeEEECCcc
Confidence 57899999985 6666664322 123468999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 183 SAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 183 ~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
+++........ ....++..|+|||.+.+ ..++.++||||+||++|+|++ |.+||.+.+..+.+..+.... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~-- 233 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN--R-- 233 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--C--
Confidence 99765433221 11223567999999854 458999999999999999999 999998877655544332210 0
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
...+..++.++.+++.+||+.||++|||+.+++++
T Consensus 234 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 234 ------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00123468899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=299.12 Aligned_cols=248 Identities=23% Similarity=0.299 Sum_probs=191.6
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCc--EEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCCCCce
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 105 (376)
++|++.+.||+|+||.||+|....++. .+++|.+.... ....+|+.++.++ +||||+++++++.. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-----RG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-----CC
Confidence 479999999999999999999877765 46888775321 2345689999888 79999999988733 33
Q ss_pred EEEEEeeccc-chHHHHHHhhhh------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC
Q 017147 106 FLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL 172 (376)
Q Consensus 106 ~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~ 172 (376)
.+|+++||++ ++|.+.+..... ....+++..++.++.|++.||+|||+ +|++||||||+|||++.
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~- 154 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGE- 154 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECC-
Confidence 4889999998 477777753211 12358899999999999999999999 79999999999999996
Q ss_pred CCcEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017147 173 THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 251 (376)
Q Consensus 173 ~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 251 (376)
++.+||+|||++..............+..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~ 233 (297)
T cd05089 155 NLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233 (297)
T ss_pred CCeEEECCcCCCccccceeccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence 778999999998643221111112224569999998654 48999999999999999997 9999988876665544332
Q ss_pred HhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
... ...+..++..+.+|+.+||+.||.+|||++++++.
T Consensus 234 ~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 234 GYR----------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 100 00123468899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=290.30 Aligned_cols=243 Identities=21% Similarity=0.298 Sum_probs=192.3
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
.+|++.+.||+|+||.||++..+ .+..+|+|.+.... ....+|+.+++.++||||+++++++.. ....++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-----QKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEcc-----CCCEEEE
Confidence 46899999999999999999865 45679999876432 234579999999999999999988733 3348899
Q ss_pred eecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 111 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 111 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
|||+++ +|.+.+.. ....+++..+..++.|++.||+|||+ +|++||||+|+||+++. ++.+||+|||.++....
T Consensus 78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 78 TEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSS-TGVVKVSDFGMTRYVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcC-CCeEEECCCCCccccCC
Confidence 999985 66666542 23468899999999999999999999 79999999999999996 77899999999875533
Q ss_pred CCCce--eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 190 GEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 190 ~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
..... ...++..|+|||.+.+. .++.++|+||+|+++|+|++ |+.||...+..+.+..+.+....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~----------- 220 (256)
T cd05114 153 DEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL----------- 220 (256)
T ss_pred CceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-----------
Confidence 22211 12335579999998654 58899999999999999999 99999888776666555431100
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..+...+.++.+++.+||+.||++|||++++++
T Consensus 221 -----------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 221 -----------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred -----------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011224778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=289.90 Aligned_cols=248 Identities=30% Similarity=0.491 Sum_probs=196.5
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
++|++.+.||+|+||.||+|.+..+++.||+|.+... .....+|+++++.++|++++++++.+... ..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----Ce
Confidence 5799999999999999999999999999999987531 22345799999999999999999988433 34
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.++||||+++ +|...+.........+++..+..++.|++.||.|||+ .|++||||+|+||+++. ++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~-~~~~~l~d~~~~~ 154 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECC-CCcEEEeccceee
Confidence 8899999985 7777776554455678999999999999999999999 79999999999999996 7789999999987
Q ss_pred cCccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHh
Q 017147 186 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 186 ~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~ 262 (376)
....... .....+++.|+|||.+.+. .++.++|+||+||++|+|++|..||..... .+....+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 223 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC---------- 223 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC----------
Confidence 5433322 2345678889999998654 488999999999999999999999965431 1111111110
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.++. .....++..+.++|.+||..+|++|||+.++++
T Consensus 224 ---------~~~~--------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 224 ---------DYPP--------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ---------CCCC--------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0000 001136789999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=301.01 Aligned_cols=245 Identities=25% Similarity=0.373 Sum_probs=191.0
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcE----EEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGET----VAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
..+|++.+.||+|+||+||+|.+..+++. ||+|.+.... ....+|+.+++.++|+||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~---- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC----
Confidence 34799999999999999999998766654 8999885432 2344688999999999999999887432
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
..++++||+. |+|.+.+.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 82 --~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~-~~~~kl~DfG 154 (316)
T cd05108 82 --TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKT-PQHVKITDFG 154 (316)
T ss_pred --CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecC-CCcEEEcccc
Confidence 1568999998 477776653 33468888999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCCCcee---eeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 183 SAKQLIAGEANIS---YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 183 ~a~~~~~~~~~~~---~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
+++.......... ..++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+.. .+......
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~--- 229 (316)
T cd05108 155 LAKLLGADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGER--- 229 (316)
T ss_pred ccccccCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCC---
Confidence 9986644332221 2235679999998654 58999999999999999997 99999876654432 22221000
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.+ .+...+.++.+++.+||..||++|||+.+++.+
T Consensus 230 --------------~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 230 --------------LP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred --------------CC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 012357789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=292.96 Aligned_cols=249 Identities=20% Similarity=0.275 Sum_probs=193.9
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcC-----CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
++|.+.+.||+|++|.||+|.+.. ++..||+|.+.... ....+|+.+++.++|+||+++++++....
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 82 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL--- 82 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC---
Confidence 579999999999999999999987 77889999875432 22356889999999999999999874433
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhh---cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCC--CcEE
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVK 177 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~--~~vk 177 (376)
..++||||+.| +|.+.+..... ....+++..+..++.||+.||+|||+ ++++||||||+||+++..+ ..+|
T Consensus 83 --~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 --PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred --CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcceE
Confidence 37899999975 77777754321 12358899999999999999999999 7999999999999998532 3699
Q ss_pred EEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 017147 178 ICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVL 253 (376)
Q Consensus 178 l~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 253 (376)
|+|||+++....... ......+..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~- 237 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG- 237 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-
Confidence 999999976532211 1112224579999999654 48999999999999999997 99999887765544332221
Q ss_pred CCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.. ..++..++..+.+++.+||+.||++|||+.++++|
T Consensus 238 ~~---------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 238 GR---------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred Cc---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 00123468899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=290.90 Aligned_cols=238 Identities=22% Similarity=0.319 Sum_probs=185.6
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 114 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 114 (376)
+.||+|+||.||+|.++.+++.+|+|.+.... ....+|+++++.++|+||+++++++... ...|+||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CCeEEEEeec
Confidence 36899999999999999999999999875432 2345799999999999999999988433 3488999999
Q ss_pred cc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCCc
Q 017147 115 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 193 (376)
Q Consensus 115 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~ 193 (376)
.+ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++.........
T Consensus 76 ~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 76 QGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTE-KNVLKISDFGMSREEEDGVYA 150 (252)
T ss_pred cCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcC-CCcEEECccccCccccccccc
Confidence 86 66655542 34568899999999999999999999 79999999999999996 778999999998754322111
Q ss_pred e---eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 194 I---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 194 ~---~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
. ....+..|+|||.+.+. .++.++|+|||||++|+|++ |..||...........+.....
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~--------------- 214 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR--------------- 214 (252)
T ss_pred ccCCCCCCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---------------
Confidence 0 11123569999998554 48999999999999999998 9999977665443332222100
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..++...+..+.+|+.+||+.||++|||+.++++
T Consensus 215 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 215 -------------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112346889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=291.22 Aligned_cols=245 Identities=25% Similarity=0.342 Sum_probs=193.6
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
.++|++.+.||+|+||.||+|.+. ++..||+|.+.... ....+|+.+++.++|+||+++++.+.. ....++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK-----EEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----CCCcEE
Confidence 458999999999999999999864 56779999876432 234579999999999999999888733 334789
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
+|||+++ +|.+.+.. .....+++..+..++.|++.||+|||+ .+++||||||+||+++. ++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 79 ITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSE-SLMCKIADFGLARVIE 154 (261)
T ss_pred EEecCCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecC-CCcEEECCCccceecC
Confidence 9999975 77776653 234568888999999999999999999 79999999999999996 7889999999997654
Q ss_pred cCCCc--eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 189 AGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 189 ~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
..... ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+.+....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---------- 223 (261)
T cd05072 155 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM---------- 223 (261)
T ss_pred CCceeccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 32211 122345679999998654 47889999999999999998 99999887766555444321100
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
+ ....++.++.+++.+||..+|++|||++++.+
T Consensus 224 --------~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 224 --------P----------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred --------C----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 11236889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=290.34 Aligned_cols=245 Identities=20% Similarity=0.280 Sum_probs=192.7
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
..+|++.+.||+|+||+||++.+.. +..+|+|.+.... ....+|+.+++.++||||+++++++... ...++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 76 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RPIYI 76 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CCcEE
Confidence 3579999999999999999998653 4569999876433 2345799999999999999999987332 33789
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
+|||+.+ +|.+.+.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||.++...
T Consensus 77 v~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~-~~~~kl~d~g~~~~~~ 151 (256)
T cd05113 77 VTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDD-QGCVKVSDFGLSRYVL 151 (256)
T ss_pred EEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcC-CCCEEECCCccceecC
Confidence 9999985 66666543 23468999999999999999999999 79999999999999996 7789999999987554
Q ss_pred cCCCce--eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 189 AGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 189 ~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
...... ...++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+....+.+....
T Consensus 152 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 220 (256)
T cd05113 152 DDEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL---------- 220 (256)
T ss_pred CCceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC----------
Confidence 332111 12335679999998654 48899999999999999998 99999887766555444331110
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 221 ------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 ------------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0112357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=286.83 Aligned_cols=255 Identities=25% Similarity=0.445 Sum_probs=204.7
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-------ccchHHHHHHHHhC-CCCceeeeceeeeecCCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 103 (376)
...+|.++++||+|+|++|.+++.++|.+.||+|++.+. -...+.|..+..+- +||.+|-+..+| +.
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-----qt 322 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-----QT 322 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----cc
Confidence 346899999999999999999999999999999988643 23344566666544 799999999888 44
Q ss_pred ceEEEEEeecccch-HHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
+..+++|.||++|+ |.-.++ ....++++.+++|..+|+.||.|||+ +||++||||.+|+|+|. .+.+||+|+|
T Consensus 323 esrlffvieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvllda-eghikltdyg 396 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLDA-EGHIKLTDYG 396 (593)
T ss_pred cceEEEEEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEcc-CCceeecccc
Confidence 44589999999974 332332 45679999999999999999999999 89999999999999997 6779999999
Q ss_pred ccccC-ccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCC-------CChHHHHHHH-HHHh
Q 017147 183 SAKQL-IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-------ENAVDQLVEI-IKVL 253 (376)
Q Consensus 183 ~a~~~-~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-------~~~~~~~~~i-~~~~ 253 (376)
.++.- ..+....+.+|||.|.|||++++. .|+..+|+|+|||+++||+.|+.||.- .+.++-+.++ ++.
T Consensus 397 mcke~l~~gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek- 474 (593)
T KOG0695|consen 397 MCKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK- 474 (593)
T ss_pred hhhcCCCCCcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh-
Confidence 99854 344556678999999999999875 499999999999999999999999952 2223333332 221
Q ss_pred CCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC------HHHHhcCCCcccccCCC
Q 017147 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELREPN 327 (376)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t------~~e~l~hp~~~~~~~~~ 327 (376)
.+. ++..+|-.+..+++..|++||.+|+. ..++..||||+.+.|..
T Consensus 475 ----------------qir------------iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~ 526 (593)
T KOG0695|consen 475 ----------------QIR------------IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDL 526 (593)
T ss_pred ----------------ccc------------ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHH
Confidence 111 23346778889999999999999985 57999999999987764
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=294.49 Aligned_cols=256 Identities=29% Similarity=0.460 Sum_probs=206.6
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
..+.|++...||+|++|.||++.+..++..+++|++.... ....+|+++++.++|+|++++++.+... ...|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-----DELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEEE
Confidence 3457999999999999999999999899999999987543 2345799999999999999999988544 3488
Q ss_pred EEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+++||++ ++|.+.+... ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~ 166 (286)
T cd06614 92 VVMEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSK-DGSVKLADFGFAAQL 166 (286)
T ss_pred EEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcC-CCCEEECccchhhhh
Confidence 9999999 5777777642 1478999999999999999999999 79999999999999996 778999999998654
Q ss_pred ccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
..... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+... +.+.
T Consensus 167 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~--------- 235 (286)
T cd06614 167 TKEKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP--------- 235 (286)
T ss_pred ccchhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC---------
Confidence 33221 1234567889999998654 4899999999999999999999999877665544433321 0000
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
......++..+.+||.+||+.+|.+|||+.+++.||||+...
T Consensus 236 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 236 ----------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred ----------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 000122678999999999999999999999999999999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=292.99 Aligned_cols=248 Identities=25% Similarity=0.329 Sum_probs=194.5
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCC-----CcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
.++|++.+.||+|+||.||++.++.. +..||+|.+..... ...+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--- 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG--- 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC---
Confidence 45899999999999999999998644 37899998864422 234789999999999999999988433
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhh------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCc
Q 017147 103 NELFLNLVMEYVP-ESMYRVLKHYSS------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 175 (376)
Q Consensus 103 ~~~~~~lv~e~~~-~~l~~~l~~~~~------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~ 175 (376)
...|+||||++ ++|...+..... ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.
T Consensus 82 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~-~~~ 157 (277)
T cd05032 82 --QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAE-DLT 157 (277)
T ss_pred --CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcC-CCC
Confidence 44889999998 577777754321 12347888999999999999999999 79999999999999996 788
Q ss_pred EEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017147 176 VKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 251 (376)
Q Consensus 176 vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 251 (376)
+||+|||+++....... .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 99999999875433221 1223456789999998654 48999999999999999998 9999988776555443331
Q ss_pred HhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
+.. ..++...+.++.+++.+||+.+|++|||+.++++
T Consensus 237 --~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 237 --GGH--------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred --CCC--------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 0012235889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=292.85 Aligned_cols=248 Identities=29% Similarity=0.457 Sum_probs=195.3
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
++|++.+.||+|++|.||+|.+..+++.+|+|.+.... ....+|+.+++.++|+||+++++.+... ..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----NE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-----Ce
Confidence 47899999999999999999999999999999875321 2334689999999999999999988443 34
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.+++|||+++ +|.+.+.........+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~ 154 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEECcchhhh
Confidence 8899999986 7777776544455678999999999999999999999 79999999999999996 7789999999987
Q ss_pred cCccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHh
Q 017147 186 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV--DQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 186 ~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~ 262 (376)
....... .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.... .....+.. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~-------- 224 (267)
T cd08229 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CD-------- 224 (267)
T ss_pred ccccCCcccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc-CC--------
Confidence 5533322 2234678899999998654 4789999999999999999999999765422 11111111 00
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+. .....+++.+.+++.+||..||++|||+.++++
T Consensus 225 ----------~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 225 ----------YPP--------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ----------CCC--------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 000 011236889999999999999999999997753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=309.95 Aligned_cols=251 Identities=28% Similarity=0.437 Sum_probs=202.4
Q ss_pred eeeeeeecCCCeeEEEEEEcCCCcEEEEEEee-----cc---ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 37 MAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QD---RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 37 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~-----~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+...+||+|+|-+||+|.|..+|..||.-.+. ++ ......|+.+|+.|+|+||++++.++.+... ..+.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence 34567999999999999999999999854332 22 2455689999999999999999999876554 4577
Q ss_pred EEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcC-CCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+|+|++..+ .|+.|....+......++.|+.||+.||.|||+. .-|+|||||-+||+|+...|.|||+|+|+|...
T Consensus 120 ~iTEL~TSG---tLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 120 FITELFTSG---TLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeecccCC---cHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 999999843 2344455678889999999999999999999983 359999999999999988899999999999865
Q ss_pred ccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017147 188 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267 (376)
Q Consensus 188 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 267 (376)
...- ....+|||.|||||... ..|+..+||||||+-+.||+|+..||.......++.+-+.. |..+..
T Consensus 197 r~s~-aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S-GiKP~s-------- 264 (632)
T KOG0584|consen 197 RKSH-AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS-GIKPAA-------- 264 (632)
T ss_pred hccc-cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc-CCCHHH--------
Confidence 4433 34589999999999985 46999999999999999999999999887666555443321 222111
Q ss_pred CCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
|.+--.+++++||.+||.. .++|+|+.|+|.||||+.-
T Consensus 265 -----------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 265 -----------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred -----------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 1111368999999999999 9999999999999999863
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=289.17 Aligned_cols=242 Identities=27% Similarity=0.396 Sum_probs=195.4
Q ss_pred eeeecCCCeeEEEEEEcCC---CcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.||+|+||.||+|.+... +..||+|.+.... ....+|+.+++.++|+|++++++++.. ...++++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence 4689999999999999866 8899999886543 234579999999999999999988843 44488999
Q ss_pred eccc-chHHHHHHhhhhc-----CCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 112 EYVP-ESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 112 e~~~-~~l~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
||++ ++|.+.+...... ...+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+.
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~-~~~~~l~dfg~~~ 153 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGE-DLVVKISDFGLSR 153 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECC-CCcEEEccccccc
Confidence 9996 5777777643211 4779999999999999999999999 79999999999999997 6889999999998
Q ss_pred cCccCC---CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 186 QLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 186 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
...... ......+++.|+|||.+.+. .++.++|+||+||++|+|++ |..||......+....+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------- 224 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY-------- 224 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence 665432 12334567889999998654 58999999999999999999 699998887665554443210
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
....+..++.++.+++.+||+.||++|||+.++++|
T Consensus 225 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 --------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred --------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 001123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=287.94 Aligned_cols=238 Identities=34% Similarity=0.581 Sum_probs=194.8
Q ss_pred eecCCCeeEEEEEEcCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017147 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 114 (376)
Q Consensus 42 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 114 (376)
||+|+||.||++.+..+++.+|+|.+.+... ....|+.+++.++|+||+++++.+ ......|++|||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 6899999999999998899999998865322 345789999999999999999887 4445589999999
Q ss_pred c-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC-CC
Q 017147 115 P-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EA 192 (376)
Q Consensus 115 ~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~ 192 (376)
+ ++|.+.+.. ...+++..+..++.|++.|+.|||+ .+++|+||+|+||+++. ++.++|+|||.+...... ..
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~-~~~~~l~d~~~~~~~~~~~~~ 149 (250)
T cd05123 76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDA-DGHIKLTDFGLAKELSSEGSR 149 (250)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcC-CCcEEEeecCcceecccCCCc
Confidence 5 577666653 3468999999999999999999999 79999999999999996 778999999998765443 22
Q ss_pred ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCC
Q 017147 193 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272 (376)
Q Consensus 193 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 272 (376)
.....++..|+|||.+.+. ..+.++|+||||+++|+|++|..||...+.......+.. + ..
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~---------------~~- 210 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--D---------------PL- 210 (250)
T ss_pred ccCCcCCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--C---------------CC-
Confidence 3345668889999998654 478899999999999999999999987765444333322 0 00
Q ss_pred CCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH---HHHhcCCCc
Q 017147 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFF 320 (376)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~---~e~l~hp~~ 320 (376)
.++..++..+.++|++||..||++|||+ .++++||||
T Consensus 211 -----------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 211 -----------RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred -----------CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 1223458899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=305.14 Aligned_cols=249 Identities=25% Similarity=0.381 Sum_probs=190.9
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCC-----CcEEEEEEeeccc-----cchHHHHHHHHhCC-CCceeeeceeeeecCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRVMD-HPNVISLKHCFFSTTS 101 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~-----~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 101 (376)
.++|++++.||+|+||.||+|.+... +..||+|++.... ....+|+.+++.+. ||||+++++++..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~--- 112 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK--- 112 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc---
Confidence 46899999999999999999987533 3469999886432 22347999999996 9999999998843
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhh-----------------------------------------------------
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSS----------------------------------------------------- 127 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~----------------------------------------------------- 127 (376)
....|+|||||++ +|.+.+.....
T Consensus 113 --~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 113 --SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred --CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 3348999999984 77766643211
Q ss_pred ---------------------------------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEE
Q 017147 128 ---------------------------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 168 (376)
Q Consensus 128 ---------------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nil 168 (376)
....+++..+..++.|++.||+|||+ .+++||||||+|||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Nil 269 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhEE
Confidence 11347888889999999999999999 79999999999999
Q ss_pred EcCCCCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHH
Q 017147 169 VDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD 244 (376)
Q Consensus 169 l~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 244 (376)
++. ++.+||+|||+++....... .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.......
T Consensus 270 l~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 270 LAQ-GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EeC-CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 996 77899999999876533222 1223456789999998654 48999999999999999997 999998765444
Q ss_pred HHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 245 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 245 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+...+.... . ...+..++.++.+++.+||+.||++|||+.++.+
T Consensus 348 ~~~~~~~~~~-----------------~----------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 348 TFYNKIKSGY-----------------R----------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHhcCC-----------------C----------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 3333222100 0 0012346889999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=296.21 Aligned_cols=249 Identities=22% Similarity=0.276 Sum_probs=194.3
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCC-----CcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
..+|++.+.||+|+||.||+|.+..+ ++.||+|++..... ...+|+.++..++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-- 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ-- 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC--
Confidence 34688999999999999999987543 57899999864432 2357888999999999999999874333
Q ss_pred CceEEEEEeecccc-hHHHHHHhhh------------hcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEE
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 169 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill 169 (376)
..++++||+.+ +|...+.... .....+++..+..++.|++.||.|||+ +|++||||||+||++
T Consensus 82 ---~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~ 157 (283)
T cd05091 82 ---PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLV 157 (283)
T ss_pred ---ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEe
Confidence 37899999985 6666653211 112457888899999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeecccccCccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHH
Q 017147 170 DPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 245 (376)
Q Consensus 170 ~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 245 (376)
+. ++.+||+|||+++........ ....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+.
T Consensus 158 ~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 158 FD-KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred cC-CCceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 96 678999999998755332211 123346789999998654 48999999999999999998 8999988877666
Q ss_pred HHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 246 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 246 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
+..+.+.... .++..++..+.+|+.+||+.+|.+||++.++++.
T Consensus 236 ~~~i~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 236 IEMIRNRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 5554431110 1123478899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=288.82 Aligned_cols=244 Identities=19% Similarity=0.279 Sum_probs=192.2
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
.+|++.+.||+|+||.||++.+. ++..+|+|.+.+... ...+|+++++.++|+||+++++.+. ...+.|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCceEEE
Confidence 46899999999999999999875 567899998865322 3457999999999999999988773 33348899
Q ss_pred eecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 111 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 111 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
|||+++ +|.+.+.. ....+++..+..++.|++.|+.|||+ +|++||||||+||+++. ++.+||+|||+++....
T Consensus 78 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 78 TEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGE-DNVVKVSDFGLARYVLD 152 (256)
T ss_pred EecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECC-CCcEEECCcccceeccc
Confidence 999985 66666643 23468999999999999999999999 79999999999999996 77899999999875533
Q ss_pred CCCce--eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 190 GEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 190 ~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
..... ...++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+....+.....
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------ 219 (256)
T cd05059 153 DQYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR------------ 219 (256)
T ss_pred ccccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc------------
Confidence 22111 11223469999998654 48899999999999999999 8999988776655444332110
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
...+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 220 ----------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 220 ----------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 00112368899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=290.54 Aligned_cols=251 Identities=21% Similarity=0.265 Sum_probs=190.7
Q ss_pred eeeeeeeecCCCeeEEEEEEcCCCc--EEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCC-CCceE
Q 017147 36 YMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELF 106 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~--~~aiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 106 (376)
+.+.+.||+|+||.||+|.+..++. .+|+|.+... .....+|+.+++.++|+||+++++.++.... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567889999999999999877765 6899987543 1223468899999999999999987643321 12234
Q ss_pred EEEEeecccc-hHHHHHHhhh--hcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYS--SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
.+++|||+.+ +|.+.+.... .....+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNE-NMNVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcC-CCCEEECCCCc
Confidence 6799999984 6666553211 123458899999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 184 AKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 184 a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
++....... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+....+....+.+.-.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----- 232 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR----- 232 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 986543321 112234667999999855 458999999999999999999 8999988766554443322100
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
...+..++..+.++|.+||+.||++|||+++++++
T Consensus 233 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 -----------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00122467889999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=292.49 Aligned_cols=249 Identities=21% Similarity=0.312 Sum_probs=193.2
Q ss_pred cceeeeeeeeecCCCeeEEEEEEc----CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
..+|++.+.||+|+||+||+|... .+++.+|+|.+.... ....+|+.+++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 80 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ--- 80 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC---
Confidence 357999999999999999999853 456789999886422 23457999999999999999999874333
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhh-------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEE
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSS-------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 169 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~-------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill 169 (376)
..|++|||+++ +|.+.+..... ....+++..+..++.|++.||.|||+ +|++||||||+||++
T Consensus 81 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili 157 (283)
T cd05090 81 --PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILI 157 (283)
T ss_pred --ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEE
Confidence 38899999985 77666642110 12347888899999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHH
Q 017147 170 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 245 (376)
Q Consensus 170 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 245 (376)
+. ++.+||+|||+++....... .....++..|+|||.+.+. .++.++|+|||||++|+|++ |.+||.+.+..+.
T Consensus 158 ~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 158 GE-QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred cC-CCcEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 96 77899999999976533221 1223346679999998654 48999999999999999998 9999988765544
Q ss_pred HHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 246 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 246 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
...+.... .+ ..+..+++.+.+++.+||+.||.+||++.+++++
T Consensus 236 ~~~~~~~~-~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRKRQ-LL---------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHcCC-cC---------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 43332210 00 0123468899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=289.03 Aligned_cols=245 Identities=24% Similarity=0.314 Sum_probs=192.7
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCC---CcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
++|++.+.||+|+||+||+|.+..+ ...||+|.+..... ...+|+.+++.++|+||+++++.+.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-----SR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-----CC
Confidence 5799999999999999999998654 45799998754321 23468999999999999999998733 33
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..+++|||+++ +|.+.+.. ....+++..+..++.|++.|+.|||+ +||+||||||+||+++. ++.++|+|||++
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~-~~~~~l~dfg~~ 153 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNS-NLVCKVSDFGLS 153 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCCEEECccchh
Confidence 48899999986 66666643 33478999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCccCCCce-e--eeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 185 KQLIAGEANI-S--YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 185 ~~~~~~~~~~-~--~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
.......... . ..++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+.+....+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---- 228 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP---- 228 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC----
Confidence 8764222211 1 223567999999855 458999999999999999998 999998776655544443211000
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.+...++.+.+|+.+||+.+|++||++.+++++
T Consensus 229 ------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 229 ------------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 112368899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=293.99 Aligned_cols=249 Identities=25% Similarity=0.368 Sum_probs=194.3
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCC-----CcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 101 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 101 (376)
.++|++.+.||+|+||.||++.++.. ...+|+|.+.... ....+|+.+++.+ +|+||+++++++..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--- 87 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ--- 87 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC---
Confidence 35799999999999999999987643 3789999886432 1234789999999 79999999998733
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhh------------hcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEE
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 168 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nil 168 (376)
...++++|||+.+ +|...+.... .....+++..+..++.|++.||.|||+ +||+||||||+||+
T Consensus 88 --~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~Nil 164 (293)
T cd05053 88 --EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARNVL 164 (293)
T ss_pred --CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceeeEE
Confidence 3348899999985 7777765321 234568999999999999999999999 79999999999999
Q ss_pred EcCCCCcEEEEeecccccCccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHH
Q 017147 169 VDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD 244 (376)
Q Consensus 169 l~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 244 (376)
++. ++.+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+
T Consensus 165 ~~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 165 VTE-DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EcC-CCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 996 788999999999865433211 11223567999999855 458999999999999999997 999998877655
Q ss_pred HHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 245 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 245 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
....+..... ...+...+.++.+|+.+||..||++|||+.+++++
T Consensus 243 ~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 243 LFKLLKEGYR----------------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 5443322100 00122367899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=287.98 Aligned_cols=244 Identities=24% Similarity=0.308 Sum_probs=192.6
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
++|++.+.||+|++|.||+|.+. +++.||+|.+.... ....+|+.+++.++|+||+++++++... ...|++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv 79 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-----EPIYIV 79 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecC-----CCeeee
Confidence 47999999999999999999864 45789999886543 2345799999999999999999877332 337899
Q ss_pred eeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 111 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 111 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
|||++ ++|.+.+... ....+++..+..++.|++.||.+||+ +|++||||||+||+++. ++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 80 TELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGE-NNICKVADFGLARVIKE 155 (261)
T ss_pred eecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcC-CCCEEECCcceEEEccC
Confidence 99996 5777776532 23568999999999999999999999 79999999999999996 77899999999976542
Q ss_pred CCCce--eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 190 GEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 190 ~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
..... ....+..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||.+.+....+..+.+....
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------- 223 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM----------- 223 (261)
T ss_pred CcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 22111 1112346999998865 458999999999999999999 99999887766555544321100
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..+...+..+.+++.+||+.||.+||++.++++
T Consensus 224 -----------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 224 -----------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred -----------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 011236789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=287.67 Aligned_cols=243 Identities=26% Similarity=0.318 Sum_probs=190.7
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
++|++.+.||+|+||.||+|.+..+ ..||+|++..... ...+|+.+++.++|+||+++++.+. . ...|+|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~lv 78 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIYIV 78 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-----C-CCcEEE
Confidence 4799999999999999999988655 4699998865332 3457999999999999999987652 1 126799
Q ss_pred eecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 111 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 111 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
|||+++ +|.+.+... ....+++..+..++.|++.||.|||+ ++++||||||+||+++. ++.++|+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~-~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 79 TEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLIED 154 (262)
T ss_pred EEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcC-CCcEEeccCCceeeccc
Confidence 999985 777766531 23457889999999999999999999 79999999999999996 77899999999975533
Q ss_pred CCCc--eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 190 GEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 190 ~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
.... ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+....+....+......
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~----------- 222 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----------- 222 (262)
T ss_pred cccccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC-----------
Confidence 3221 123345679999988544 48999999999999999999 89999887766554443221000
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.....++..+.+++.+||+.||++|||+.++++
T Consensus 223 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 223 -----------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -----------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 011236889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=290.88 Aligned_cols=245 Identities=24% Similarity=0.315 Sum_probs=196.9
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
..+|++.+.||.|+||.||+|.+.. ++.+|+|.+..... ....|+.+++.++|+||+++++.+... ...+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 78 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG-----EPVY 78 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC-----CCeE
Confidence 3579999999999999999999877 88999998865433 345789999999999999998887433 3488
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||+++ +|.+.+... ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.+||+|||.+...
T Consensus 79 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~-~~~~kl~d~g~~~~~ 154 (261)
T cd05148 79 IITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGE-DLVCKVADFGLARLI 154 (261)
T ss_pred EEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcC-CceEEEccccchhhc
Confidence 99999985 777777532 34568999999999999999999999 79999999999999996 778999999999755
Q ss_pred ccCCCc-eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 188 IAGEAN-ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 188 ~~~~~~-~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
...... ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.+.+..+.+..+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 223 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM---------- 223 (261)
T ss_pred CCccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC----------
Confidence 332211 12234567999999855 458899999999999999998 89999888766666554431110
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..+..+++.+.+++.+||+.||++|||+.++++
T Consensus 224 ------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 ------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 012246889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=285.26 Aligned_cols=243 Identities=22% Similarity=0.316 Sum_probs=191.7
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc--chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
..+|++.+.||+|+||.||++.. .+..+|+|.+..+.. ...+|+.+++.++|+|++++++++... ....|++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~lv 78 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIV 78 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCceEEE
Confidence 35799999999999999999976 477899998865432 345799999999999999999876432 2237899
Q ss_pred eecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 111 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 111 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
|||+++ +|.+.+... ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 79 TEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASS 154 (256)
T ss_pred EECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcC-CCcEEecCCccceeccc
Confidence 999985 777766531 23358899999999999999999999 79999999999999996 78899999999875433
Q ss_pred CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 017147 190 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268 (376)
Q Consensus 190 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 268 (376)
.. ....++..|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+....+.+..
T Consensus 155 ~~--~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--------------- 216 (256)
T cd05082 155 TQ--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------------- 216 (256)
T ss_pred cC--CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---------------
Confidence 22 223345679999998654 48899999999999999997 999998776555443332210
Q ss_pred CCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.......+++.+.+++.+||+.||++|||+.++++
T Consensus 217 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 217 -------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred -------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=292.05 Aligned_cols=247 Identities=24% Similarity=0.343 Sum_probs=192.9
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcC-----CCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
.+|.+.+.||+|+||.||+|++.. ++..+++|.+.... ....+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD-----G 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-----C
Confidence 469999999999999999998643 45668999875442 334579999999999999999998743 3
Q ss_pred eEEEEEeecccc-hHHHHHHhhh------------hcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 171 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~ 171 (376)
...++||||+++ +|.+.+.... .....+++..++.++.||+.||+|||+ +|++||||||+||+++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVGA 158 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEcc
Confidence 348899999985 7777765321 122458899999999999999999999 89999999999999996
Q ss_pred CCCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 017147 172 LTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 247 (376)
Q Consensus 172 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 247 (376)
++.++|+|||++........ .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+...
T Consensus 159 -~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 159 -NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred -CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 77899999999975433221 1233457789999998654 48899999999999999998 999998777655443
Q ss_pred HHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 248 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+... .. + ......+..+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~~--~~-----------------~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 237 CITQG--RV-----------------L---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHhCC--CC-----------------C---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 32210 00 0 011235789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=290.19 Aligned_cols=244 Identities=23% Similarity=0.316 Sum_probs=190.1
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCc----EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
..+|++.+.||+|+||+||+|.+..++. .||+|.+.... ....+|+.+++.++|+||+++++.+...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS---- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC----
Confidence 4579999999999999999999877766 48999875432 2334688899999999999998877421
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
..++++||++ |++.+.+.. ....+++..+..++.|++.||.|||+ +|++||||||+|||++. ++.+||+|||
T Consensus 82 --~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~-~~~~kL~dfG 154 (279)
T cd05109 82 --TVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKS-PNHVKITDFG 154 (279)
T ss_pred --CcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcC-CCcEEECCCC
Confidence 1568999998 577766653 34568999999999999999999999 79999999999999986 6779999999
Q ss_pred ccccCccCCCce---eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 183 SAKQLIAGEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 183 ~a~~~~~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
+++......... ...+++.|+|||.+.+. .++.++|||||||++|+|++ |..||........... ......++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~- 231 (279)
T cd05109 155 LARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL-LEKGERLP- 231 (279)
T ss_pred ceeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHCCCcCC-
Confidence 998654332221 12335679999998654 48999999999999999998 9999987665443332 22111000
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+...+.++.+++.+||+.||++||++.++++
T Consensus 232 --------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 232 --------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred --------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11235789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=286.00 Aligned_cols=244 Identities=25% Similarity=0.336 Sum_probs=192.8
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
.++|++.+.||+|+||.||+|... +++.||+|.+..... ...+|+.+++.++|+||+++++++. . ...++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~-----~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-Q-----EPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-c-----CCcEE
Confidence 357999999999999999999854 678899998865432 3457999999999999999987652 1 12789
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
+|||+.+ +|.+.+.. .....+++..+..++.|++.||+|||+ .|++||||||+||+++. ++.++|+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 78 ITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSE-TLCCKIADFGLARLIE 153 (260)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcC-CCCEEEccCcceeecC
Confidence 9999985 77666643 234568999999999999999999999 79999999999999996 7789999999997654
Q ss_pred cCCCc--eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 189 AGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 189 ~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
..... ....++..|+|||.+.+. .++.++|+||||+++|+|++ |++||.+.+..+....+......+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 223 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP--------- 223 (260)
T ss_pred CCCcccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC---------
Confidence 22211 122345679999998544 47899999999999999999 999998877655544433211100
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+...+.++.+++.+||+.+|++|||++++++
T Consensus 224 -------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 224 -------------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 12236789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=293.66 Aligned_cols=249 Identities=23% Similarity=0.348 Sum_probs=191.7
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcC-------CCcEEEEEEeecccc-----chHHHHHHHHhC-CCCceeeeceeeeec
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFST 99 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 99 (376)
.++|.+.+.||+|+||.||+|.+.. +...+|+|.+..+.. ...+|+.+++.+ +|+||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 4689999999999999999998653 235799998865321 234688999999 79999999998733
Q ss_pred CCCCceEEEEEeecccc-hHHHHHHhhhh------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCc
Q 017147 100 TSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 166 (376)
Q Consensus 100 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~N 166 (376)
....|+||||+++ +|.+.+..... ....+++..+..++.|++.||+|||+ +|++||||||+|
T Consensus 96 ----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~N 170 (307)
T cd05098 96 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN 170 (307)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHh
Confidence 3348899999985 77777754321 12358889999999999999999999 799999999999
Q ss_pred EEEcCCCCcEEEEeecccccCccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCh
Q 017147 167 LLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 242 (376)
Q Consensus 167 ill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 242 (376)
|+++. ++.+||+|||.+......... ....+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+.
T Consensus 171 ill~~-~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 171 VLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred eEEcC-CCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 99996 678999999998755332211 111234679999998654 48999999999999999998 8999987665
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 243 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 243 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.+....+... . ....+..++.++.+|+.+||..+|++|||+.+++++
T Consensus 249 ~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 249 EELFKLLKEG-H---------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHcC-C---------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 4443332210 0 001123468899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=298.51 Aligned_cols=267 Identities=24% Similarity=0.396 Sum_probs=207.6
Q ss_pred CCCCCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-----------chHHHHHHHHhCCCCceeeece
Q 017147 26 KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----------YKNRELQLMRVMDHPNVISLKH 94 (376)
Q Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----------~~~~e~~~l~~l~h~~iv~~~~ 94 (376)
....|...++|-++.+||+|||+.||+|.+...++.||+|+-.-... ..-+|..|.+.|.||.||++|+
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 34566777899999999999999999999999999999997632221 1226899999999999999999
Q ss_pred eeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcC-CCeeecCCCCCcEEEcCC-
Q 017147 95 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-PRVCHRDLKPQNLLVDPL- 172 (376)
Q Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~i~H~dlkp~Nill~~~- 172 (376)
+|.-.. ..+|-|+|||+|+-++ .|...+..+++.+++.|+.||+.||.||... .-|+|-||||.|||+...
T Consensus 535 yfslDt----dsFCTVLEYceGNDLD---FYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt 607 (775)
T KOG1151|consen 535 YFSLDT----DSFCTVLEYCEGNDLD---FYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT 607 (775)
T ss_pred eeeecc----ccceeeeeecCCCchh---HHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc
Confidence 884222 2288999999985333 2334677899999999999999999999973 479999999999999642
Q ss_pred -CCcEEEEeecccccCccCCCc--------eeeeeccccCchhhhh-C--CCCCCchhhhHhHHHHHHHHHhCCCCCCCC
Q 017147 173 -THQVKICDFGSAKQLIAGEAN--------ISYICSRFYRAPELIF-G--ATEYTTSIDIWSAGCVLAELLLGQPLFPGE 240 (376)
Q Consensus 173 -~~~vkl~Dfg~a~~~~~~~~~--------~~~~~t~~y~aPE~l~-~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 240 (376)
.+.|||+|||+++.+.+.... ....||.||++||.+. + -++.+.++||||+|||+|..+.|+.||...
T Consensus 608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 367999999999987654322 2357899999999863 2 345789999999999999999999999776
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 241 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 241 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
.....+.+--.++ +..+..||.. ..++.++++||++||++.-++|..+.++-.||||
T Consensus 688 qsQQdILqeNTIl-------------kAtEVqFP~K----------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyl 744 (775)
T KOG1151|consen 688 QSQQDILQENTIL-------------KATEVQFPPK----------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYL 744 (775)
T ss_pred hhHHHHHhhhchh-------------cceeccCCCC----------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccc
Confidence 5443322211111 1122333321 2379999999999999999999999999999999
Q ss_pred cc
Q 017147 321 DE 322 (376)
Q Consensus 321 ~~ 322 (376)
.-
T Consensus 745 lP 746 (775)
T KOG1151|consen 745 LP 746 (775)
T ss_pred cc
Confidence 64
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=286.53 Aligned_cols=243 Identities=25% Similarity=0.324 Sum_probs=191.5
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+.... ....+|+.+++.++|+|++++++.+. . ...|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~-----~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-E-----EPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-C-----CCcEE
Confidence 357999999999999999999865 56779999886532 23458999999999999999987652 1 12679
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
+|||+++ +|.+.+.. .....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~-~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 78 VTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGD-GLVCKIADFGLARLIE 153 (260)
T ss_pred EEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeC-CceEEeCCceeeeecc
Confidence 9999985 77666643 123568999999999999999999999 79999999999999996 7789999999997653
Q ss_pred cCCCc--eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 189 AGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 189 ~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
..... ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |.+||.+.+..+....+......
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 222 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM---------- 222 (260)
T ss_pred CcccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 32211 11233557999999854 458899999999999999999 99999887766655544321000
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 315 (376)
..+...+..+.+|+.+||..||++|||+.++.
T Consensus 223 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 223 ------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred ------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 01234688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=283.54 Aligned_cols=242 Identities=25% Similarity=0.376 Sum_probs=193.0
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
..+|++.+.||.|+||.||+|.. .++.||+|.+..... ...+|+.+++.++|+||+++++.+... ...|+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG-----NPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCC-----CCeEE
Confidence 34799999999999999999986 478999999876544 345799999999999999999987542 33889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
||||+++ +|.+.+... ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||.++...
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~-~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 78 VTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSE-DLVAKVSDFGLAKEAS 153 (256)
T ss_pred EEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeC-CCCEEEcccccccccc
Confidence 9999995 777766532 22368999999999999999999999 79999999999999996 7789999999997653
Q ss_pred cCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017147 189 AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267 (376)
Q Consensus 189 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 267 (376)
.... ....+..|+|||.+.+. .++.++|+||+|+++|+|++ |..||...+..+....+.+.
T Consensus 154 ~~~~--~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--------------- 215 (256)
T cd05039 154 QGQD--SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG--------------- 215 (256)
T ss_pred cccc--cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC---------------
Confidence 2221 22335579999998644 58899999999999999997 99999877655443332210
Q ss_pred CCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
+ ....+..+++.+.++|.+||..+|++|||+.+++.
T Consensus 216 ~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 216 Y-------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred C-------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0 00112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=291.68 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=196.3
Q ss_pred eeeeeeeeecCCCeeEEEEEEc---CCCcEEEEEEeeccc--------cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 017147 35 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 102 (376)
+|++.+.||+|++|.||++.+. .+++.||+|.+.+.. .....|+.++..+ +|+||+++.+.+ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 4889999999999999999864 467889999886421 2234689999999 599999998887 3
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
....+|+||||+.+ +|.+.+. ....+++..++.++.|++.||.|||+ .|++||||+|+||+++. ++.++|+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~-~~~~~l~df 149 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDS-EGHVVLTDF 149 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEEEC
Confidence 33458899999986 6655553 34568999999999999999999999 79999999999999996 678999999
Q ss_pred cccccCccCCC--ceeeeeccccCchhhhhCCC-CCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 182 GSAKQLIAGEA--NISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 182 g~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
|++........ .....++..|+|||.+.+.. ..+.++|+||+|+++|+|++|..||...+.......+.+..-.
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--- 226 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--- 226 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc---
Confidence 99876543322 12345788999999985432 3678999999999999999999999754332222222111000
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC---HHHHhcCCCcccccCC
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREP 326 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~hp~~~~~~~~ 326 (376)
. ....+..++..+.++|.+||+.||++||| +.++|+||||+.+.+.
T Consensus 227 ----------~------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 227 ----------S------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred ----------c------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 0 00112336789999999999999999998 5678999999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=289.32 Aligned_cols=258 Identities=28% Similarity=0.364 Sum_probs=188.1
Q ss_pred cee-eeeeeeecCCCeeEEEEE----EcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 34 ISY-MAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 34 ~~y-~~~~~lg~G~~g~Vy~~~----~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
++| ++.+.||+|+||+||++. ...++..||+|.+.... ....+|+.+++.++||||+++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---G 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---C
Confidence 355 999999999999998865 33567899999886432 2335799999999999999998876432 2
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
...++++|||+++ +|.+.+.. ..+++..++.++.|++.||.|||+ +|++||||||+||++++ ++.++|+|||
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg 152 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDN-DRLVKIGDFG 152 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcC-CCcEEEeecc
Confidence 3347899999996 66555532 458999999999999999999999 79999999999999996 6789999999
Q ss_pred ccccCccCCCc----eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCC
Q 017147 183 SAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTPT 257 (376)
Q Consensus 183 ~a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~ 257 (376)
++......... ....++..|+|||.+.+. .++.++|||||||++|+|++|..||...... +...... .+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~ 229 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMT 229 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccc
Confidence 99765432211 112345669999998654 5889999999999999999999998654321 1111110 00000
Q ss_pred HHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
...+.. ..........+..++.++.+++.+||+.||++|||++++++
T Consensus 230 ~~~~~~------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 230 VVRLIE------------LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhhh------------hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000000 00000111123456889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=292.54 Aligned_cols=255 Identities=20% Similarity=0.242 Sum_probs=194.4
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCC----------------cEEEEEEeeccc-----cchHHHHHHHHhCCCCceee
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETG----------------ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVIS 91 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----------------~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~ 91 (376)
..+|++++.||+|+||.||+|.+..++ ..||+|.+..+. ....+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357999999999999999999876543 458999886542 23346999999999999999
Q ss_pred eceeeeecCCCCceEEEEEeecccc-hHHHHHHhhhh-------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCC
Q 017147 92 LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS-------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 163 (376)
Q Consensus 92 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlk 163 (376)
+++++... ...+++|||+.+ +|...+..... ....+++..++.++.|++.||.|||+ +|++|||||
T Consensus 84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlk 157 (296)
T cd05051 84 LLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLA 157 (296)
T ss_pred EEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccc
Confidence 99887433 348899999985 77777654321 12368999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh--CCCCCC
Q 017147 164 PQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFP 238 (376)
Q Consensus 164 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~--g~~pf~ 238 (376)
|+||+++. ++.++|+|||+++....... .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.
T Consensus 158 p~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 158 TRNCLVGK-NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred hhceeecC-CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 99999996 68899999999875433321 1223446789999998654 48999999999999999998 778998
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 239 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 239 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..+..+.+............ ......+..++.++.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 236 HLTDQQVIENAGHFFRDDGR---------------------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CcChHHHHHHHHhccccccc---------------------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 77665555444332111000 0000012236789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=291.11 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=192.7
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEc-----CCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTT 100 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 100 (376)
..++|.+.+.||+|+||.||++.+. .++..+|+|.+.... ....+|+.+++.+ +|+||+++++.+...
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 111 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG- 111 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-
Confidence 3468999999999999999999753 345689999886432 2245799999999 799999999987433
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEE
Q 017147 101 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 179 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~ 179 (376)
...|++|||+.+ +|.+.+... ....+++..+..++.|++.||.|||+ ++++|+||||+||+++. ++.++|+
T Consensus 112 ----~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~~l~ 183 (302)
T cd05055 112 ----GPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTH-GKIVKIC 183 (302)
T ss_pred ----CceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcC-CCeEEEC
Confidence 348899999984 776666431 22348999999999999999999999 79999999999999986 7789999
Q ss_pred eecccccCccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 017147 180 DFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT 255 (376)
Q Consensus 180 Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 255 (376)
|||+++........ ....+++.|+|||.+.+. .++.++||||+||++|+|++ |..||.+....+.+...... +.
T Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~-~~ 261 (302)
T cd05055 184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE-GY 261 (302)
T ss_pred CCcccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc-CC
Confidence 99999755333211 122346789999998654 48999999999999999998 99999887665544443321 00
Q ss_pred CCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
....+...++++.+|+.+||..+|++|||+.++++
T Consensus 262 --------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 262 --------------------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred --------------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00011235789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=288.14 Aligned_cols=254 Identities=17% Similarity=0.203 Sum_probs=184.2
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCC---CcEEEEEEeeccccchH---------------HHHHHHHhCCCCceeeecee
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRRYKN---------------RELQLMRVMDHPNVISLKHC 95 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~~~~~---------------~e~~~l~~l~h~~iv~~~~~ 95 (376)
.+|++.+.||+|+||+||+|.+..+ +..+|+|+......... .+...+..+.|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4799999999999999999998877 66778876432222111 12234456689999999886
Q ss_pred eeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCc
Q 017147 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 175 (376)
Q Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~ 175 (376)
..... ....+.+++++++..++...+.. ....++..++.++.|++.||.|||+ ++++||||||+|||++. ++.
T Consensus 92 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~-~~~ 164 (294)
T PHA02882 92 GSFKR-CRMYYRFILLEKLVENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDG-NNR 164 (294)
T ss_pred eeEec-CCceEEEEEEehhccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCc
Confidence 54332 22345678899887776665542 2345778889999999999999999 79999999999999996 678
Q ss_pred EEEEeecccccCccCC--------CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHH
Q 017147 176 VKICDFGSAKQLIAGE--------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 247 (376)
Q Consensus 176 vkl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 247 (376)
++|+|||+|+...... ......||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999997653221 11234689999999998654 58999999999999999999999998774322222
Q ss_pred HHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 248 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
...+. +.+...... . ......+..+.+++..|++.+|++||+.+++++
T Consensus 244 ~~~~~------~~~~~~~~~--~-------------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 244 HAAKC------DFIKRLHEG--K-------------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHhHH------HHHHHhhhh--h-------------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 21110 000000000 0 001235788999999999999999999999864
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=290.15 Aligned_cols=246 Identities=24% Similarity=0.362 Sum_probs=189.2
Q ss_pred eeeeeeeeecCCCeeEEEEEEcC-----CCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
+|++.+.||+|+||.||+|.+.. ....+|+|.+..... ...+|+.+++.++||||+++++.+.. .
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-----D 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----C
Confidence 47889999999999999998753 235688888764322 24479999999999999999988733 3
Q ss_pred eEEEEEeecccc-hHHHHHHhhh--------------------hcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCC
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYS--------------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 163 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~--------------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlk 163 (376)
...++++||+.+ +|.+.+.... .....+++..+..++.|++.||+|||+ +|++|||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dik 154 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLA 154 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhh
Confidence 337899999994 6766664321 112357889999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCC
Q 017147 164 PQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG 239 (376)
Q Consensus 164 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~ 239 (376)
|+||+++. ++.+||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+
T Consensus 155 p~nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 155 ARNVLVAE-GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hheEEEcC-CCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999996 77899999999875433221 1122345679999998554 48999999999999999998 9999988
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 240 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 240 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
....+....+.+.. ....+..++.++.+|+.+||+.||.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 233 IAPERLFNLLKTGY----------------------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCHHHHHHHHhCCC----------------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 76554443222100 00112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=284.62 Aligned_cols=264 Identities=24% Similarity=0.345 Sum_probs=206.5
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-----chHHHHH-HHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQ-LMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
++.+-+..||.|+||+|++..++.+|+..|+|.+..... ....|.+ +++.-+.||||++++..+.... .
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----c 138 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----C 138 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----e
Confidence 455566789999999999999999999999999864322 2223444 4455579999999998865544 8
Q ss_pred EEEeecccchHHHHHH-hhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPESMYRVLK-HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~-~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
||.||+|+-++..+-+ .+......++|..+-.|....+.||.||.....|+|||+||+|||++. .+.|||||||++..
T Consensus 139 WiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr-~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 139 WICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDR-HGDVKLCDFGICGQ 217 (361)
T ss_pred eeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEec-CCCEeeecccchHh
Confidence 8999999977655543 344556789999999999999999999997569999999999999997 78899999999987
Q ss_pred CccCCCceeeeeccccCchhhhhCCCC-CCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCHHHHhhc
Q 017147 187 LIAGEANISYICSRFYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTPTREEIRCM 264 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 264 (376)
....-..+.-.|-..|||||.+..... |+.+||+||||++|||+.||..||.+.+. .+.++... .|.|+.-...
T Consensus 218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~~-- 293 (361)
T KOG1006|consen 218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLFD-- 293 (361)
T ss_pred HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecCc--
Confidence 665555556677888999999965444 89999999999999999999999988764 33333332 2333211100
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
.. --..+..+..||..||.+|-+.||...+++++||++.....
T Consensus 294 ---~~----------------~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~ 336 (361)
T KOG1006|consen 294 ---KE----------------CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE 336 (361)
T ss_pred ---cc----------------ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence 00 01268899999999999999999999999999999876443
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=286.50 Aligned_cols=244 Identities=25% Similarity=0.320 Sum_probs=191.5
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCc---EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
.+|++.+.||+|+||.||+|.++.++. .+|+|.+.... ....+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----SK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----CC
Confidence 579999999999999999999875543 79999875432 234578999999999999999988732 33
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..|+||||+++ +|.+.+.. ....+++..+..++.|++.||.|||+ .|++||||||+||+++. ++.++|+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~-~~~~~l~dfg~~ 153 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNS-NLVCKVSDFGLS 153 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECC-CCeEEeCCCCcc
Confidence 48899999985 66666542 33568999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCccCCCcee----eeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 185 KQLIAGEANIS----YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 185 ~~~~~~~~~~~----~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
........... ..++..|+|||.+.+. .++.++|+|||||++|++++ |..||.+....+....+.+....+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~--- 229 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP--- 229 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCC---
Confidence 76543322111 1124579999998654 48999999999999999886 999998877655544443211100
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+..+++.+.+++.+||+.+|.+||++.++++
T Consensus 230 -------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 230 -------------------------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -------------------------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 11236889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=291.14 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=192.4
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcC-------CCcEEEEEEeecccc-----chHHHHHHHHhC-CCCceeeeceeeee
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFS 98 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~~iv~~~~~~~~ 98 (376)
..++|.+.+.||+|+||.||+|.+.. ....+|+|.+..... ....|+.+++.+ +|+||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 34689999999999999999998642 345799998764321 234789999999 69999999998743
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHHhhhh------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCC
Q 017147 99 TTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 165 (376)
Q Consensus 99 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~ 165 (376)
...+|++|||+++ +|.+.+..... ....+++..+..++.|++.||.|||+ +|++||||||+
T Consensus 90 -----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~ 163 (314)
T cd05099 90 -----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAAR 163 (314)
T ss_pred -----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeeccccce
Confidence 3348899999985 77777754321 22458889999999999999999999 79999999999
Q ss_pred cEEEcCCCCcEEEEeecccccCccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCC
Q 017147 166 NLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 241 (376)
Q Consensus 166 Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 241 (376)
||+++. ++.+||+|||+++........ ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+..
T Consensus 164 Nill~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 164 NVLVTE-DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred eEEEcC-CCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999996 778999999999755332211 11123457999999865 458999999999999999999 899998877
Q ss_pred hHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 242 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..+....+..... ..++..++.++.+++.+||..||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 242 VEELFKLLREGHR----------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 6555544332100 0012346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=288.90 Aligned_cols=247 Identities=25% Similarity=0.359 Sum_probs=192.1
Q ss_pred ceeeeeeeeecCCCeeEEEEEEc-----CCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
.+|++.+.||+|+||.||+|... .++..+|+|.+.... ....+|+++++.++|+||+++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG----- 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC-----
Confidence 47889999999999999999753 346689999875432 2345799999999999999998877433
Q ss_pred eEEEEEeecccc-hHHHHHHhhhh-----------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSS-----------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL 172 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~ 172 (376)
...+++|||+++ +|.+.+..... ....+++..+..++.|++.|++|||+ +|++||||||+||+++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~- 157 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVGQ- 157 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEcC-
Confidence 337899999985 77776653211 11358889999999999999999999 79999999999999996
Q ss_pred CCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 017147 173 THQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 248 (376)
Q Consensus 173 ~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 248 (376)
++.+||+|||++........ .....+++.|+|||.+.+. .++.++|||||||++|+|++ |.+||......+....
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 77899999999875433221 1123346789999998654 48999999999999999998 9999987776655544
Q ss_pred HHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 249 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
+..... . ..+..+++.+.+||.+||+.||.+||++.++++
T Consensus 237 ~~~~~~--~--------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGRE--L--------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCcc--C--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 432100 0 011246889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=285.28 Aligned_cols=244 Identities=22% Similarity=0.308 Sum_probs=191.5
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCc---EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
.+|+..+.||+|+||.||+|.+..++. .+|+|.+.... .....|+.+++.++|+|++++.+++... .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF-----K 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-----C
Confidence 478999999999999999999876654 79999875432 2234689999999999999999888433 3
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..|+||||+++ +|...+.. ....+++..+..++.|++.|++|||+ .|++||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~dfg~~ 154 (268)
T cd05063 80 PAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNS-NLECKVSDFGLS 154 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcC-CCcEEECCCccc
Confidence 48899999996 55555542 34578999999999999999999999 79999999999999996 778999999998
Q ss_pred ccCccCCCce-e---eeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 185 KQLIAGEANI-S---YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 185 ~~~~~~~~~~-~---~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
.......... . ...++.|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+....+......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~--- 230 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP--- 230 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC---
Confidence 7554322211 1 1123469999998654 47999999999999999997 999998877665555443311111
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
....++.++.+++.+||+.||++||++.++++
T Consensus 231 -------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 -------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01236789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=282.46 Aligned_cols=244 Identities=25% Similarity=0.312 Sum_probs=191.6
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
.++|++.+.||+|++|.||+|.+..+ ..+|+|.+..... ...+|+.+++.++|+|++++++++. . ...++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~ 77 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-----E-EPIYI 77 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-----C-CCcEE
Confidence 35799999999999999999987654 4699998765432 3357999999999999999987652 1 12679
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
+|||+.+ +|.+.+... ....+++..+..++.|++.||.|||+ .|++|+||||+||++++ ++.++|+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~-~~~~~l~dfg~~~~~~ 153 (260)
T cd05069 78 VTEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGD-NLVCKIADFGLARLIE 153 (260)
T ss_pred EEEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcC-CCeEEECCCccceEcc
Confidence 9999985 777777532 23457889999999999999999999 79999999999999996 7789999999997553
Q ss_pred cCCCc--eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 189 AGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 189 ~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
..... ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+....+....+......
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---------- 222 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM---------- 222 (260)
T ss_pred CCcccccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 32211 122345679999988654 48999999999999999999 99999887766555443321000
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..+...+..+.+++.+||..||.+||+++++++
T Consensus 223 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 223 ------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 012246889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=308.05 Aligned_cols=263 Identities=28% Similarity=0.439 Sum_probs=216.8
Q ss_pred CcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhC-CCCceeeeceeeeecCCCCce
Q 017147 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 105 (376)
|-..+.|++.++||.|.+|+||+++++.+++..|+|+...+. ..++.|.++|+.. .|||++.++++|+-.......
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 344668999999999999999999999999999999886543 3345677888877 599999999999766556666
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
.+|||||||+| +..++++... +.++.|+.+.+|++.++.|+.+||. +.++|||||-.|||++. ++.|||+|||.+
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~-e~~VKLvDFGvS 170 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTE-NAEVKLVDFGVS 170 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEec-cCcEEEeeeeee
Confidence 79999999995 7777777654 7889999999999999999999999 79999999999999997 778999999998
Q ss_pred ccCccC-CCceeeeeccccCchhhhhCC----CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 185 KQLIAG-EANISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 185 ~~~~~~-~~~~~~~~t~~y~aPE~l~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
...... ....+.+|||+|||||++... ..|+..+|+||||++..||.-|.+|+.+......+..|-+ .|++
T Consensus 171 aQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPPP- 246 (953)
T KOG0587|consen 171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPP- 246 (953)
T ss_pred eeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCCc-
Confidence 765433 334578999999999999543 2367899999999999999999999998887766654432 1111
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
.+. -+++-+.++.|||..||.+|-.+||+..++|.|||++.
T Consensus 247 ---------------kLk-------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 247 ---------------KLK-------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred ---------------ccc-------chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 000 11234778999999999999999999999999999974
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=285.51 Aligned_cols=228 Identities=25% Similarity=0.343 Sum_probs=179.9
Q ss_pred CCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecccc-hHHHHHH
Q 017147 45 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK 123 (376)
Q Consensus 45 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~ 123 (376)
|.+|+||+|.+..+++.||+|.+...... .+|...+....||||+++++++.. ....|++|||+++ +|.+.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~-~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEY-SRERLTIIPHCVPNMVCLHKYIVS-----EDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhh-hhHHHHHHhcCCCceeehhhheec-----CCeEEEEEecCCCCCHHHHHH
Confidence 88999999999999999999999765433 345555556679999999998743 3348899999995 6766664
Q ss_pred hhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCCceeeeeccccC
Q 017147 124 HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 203 (376)
Q Consensus 124 ~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~ 203 (376)
. ...+++..+..++.|++.||.|||+ .|++||||||+||+++. ++.++++|||.+...... .....++..|+
T Consensus 78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 78 K----FLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDD-RGHIQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred H----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcC-CCCEEEecccchhccccc--cccCCcCcccc
Confidence 3 3458999999999999999999999 79999999999999996 677999999987654332 22334567799
Q ss_pred chhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhh
Q 017147 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHK 283 (376)
Q Consensus 204 aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (376)
|||.+.+ ..++.++|+||+||++|+|++|..||....... . .....
T Consensus 150 aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~---------------~~~~~------------ 195 (237)
T cd05576 150 APEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSGI------N---------------THTTL------------ 195 (237)
T ss_pred CCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------c---------------ccccc------------
Confidence 9998854 447899999999999999999998875322100 0 00000
Q ss_pred hcccCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCc
Q 017147 284 VFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFF 320 (376)
Q Consensus 284 ~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e~l~hp~~ 320 (376)
.++..+++.+.+||.+||+.||++|+|+ +++++||||
T Consensus 196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 1223468899999999999999999985 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=290.49 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=194.3
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEc-------CCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeee
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFF 97 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~ 97 (376)
...++|.+.+.||+|+||.||+|.+. .++..+|+|.+.... ....+|+.+++.+ +|+||+++++.+.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34568999999999999999999753 234579999875432 2345799999999 8999999999874
Q ss_pred ecCCCCceEEEEEeecccc-hHHHHHHhhhh------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCC
Q 017147 98 STTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 164 (376)
Q Consensus 98 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp 164 (376)
. ....|++|||+++ +|.+.+..... ....++...+..++.|++.||.|||+ +|++||||||
T Consensus 92 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp 165 (304)
T cd05101 92 Q-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAA 165 (304)
T ss_pred c-----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeeccccc
Confidence 3 3348899999985 77777754221 12357888899999999999999999 7999999999
Q ss_pred CcEEEcCCCCcEEEEeecccccCccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCC
Q 017147 165 QNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGE 240 (376)
Q Consensus 165 ~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~ 240 (376)
+||+++. ++.+||+|||+++........ ....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.
T Consensus 166 ~Nili~~-~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 166 RNVLVTE-NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred ceEEEcC-CCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999996 778999999999765332211 122345679999998654 48999999999999999998 88999887
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 241 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 241 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
+..+....+..... ...+..++..+.+|+.+||..+|.+|||+.++++.
T Consensus 244 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 244 PVEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CHHHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 76655544322100 00123468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=284.00 Aligned_cols=244 Identities=27% Similarity=0.352 Sum_probs=194.1
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
.++|++.+.||+|+||.||+|.+. +++.+|+|.+..+. ....+|+.+++.++|+||+++++++.. ....++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-----EEPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeec-----CCceEE
Confidence 468999999999999999999975 55789999886542 234579999999999999999988732 234889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
+|||+++ +|.+.+.. .....+++..+..++.|++.|+.|||+ +|++|+||+|+||+++. ++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~-~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 79 VTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGE-NLVCKIADFGLARLIE 154 (261)
T ss_pred EEeccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcC-CCCEEECccccceecc
Confidence 9999985 77666653 123568999999999999999999999 79999999999999996 7889999999987654
Q ss_pred cCCC--ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 189 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 189 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.... ......+..|+|||.+.+. .++.++|+||+||++|+|++ |+.||.+.+....+..+......+
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~--------- 224 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP--------- 224 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence 3211 1122235679999998654 48899999999999999998 999998877666665543311100
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 315 (376)
.+...+.++.+++.+||+.+|++||++++++
T Consensus 225 -------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 255 (261)
T cd05034 225 -------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQ 255 (261)
T ss_pred -------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 1123578999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=290.95 Aligned_cols=254 Identities=22% Similarity=0.272 Sum_probs=190.8
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCC--------------cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeece
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETG--------------ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKH 94 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~--------------~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~ 94 (376)
.+|++.+.||+|+||.||+|.+..++ ..||+|.+.... ....+|+++++.++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 58999999999999999999875432 358999886542 12346999999999999999999
Q ss_pred eeeecCCCCceEEEEEeecccc-hHHHHHHhhhh--------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCC
Q 017147 95 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS--------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 165 (376)
Q Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~ 165 (376)
++... ...++||||+.+ +|.+.+..... ....+++..+..++.|++.||.|||+ +|++||||||+
T Consensus 85 ~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~ 158 (295)
T cd05097 85 VCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLATR 158 (295)
T ss_pred EEcCC-----CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccChh
Confidence 88433 348899999985 67666643210 11246888899999999999999999 79999999999
Q ss_pred cEEEcCCCCcEEEEeecccccCccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh--CCCCCCCC
Q 017147 166 NLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGE 240 (376)
Q Consensus 166 Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~ 240 (376)
||+++. ++.+||+|||++......... ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...
T Consensus 159 Nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 159 NCLVGN-HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hEEEcC-CCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 999996 778999999998754332211 112335679999998654 48999999999999999998 67889887
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 241 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 241 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
+..+.+..+.+........ .+ ...+...++.+.+|+.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~-------~~--------------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 237 SDEQVIENTGEFFRNQGRQ-------IY--------------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ChHHHHHHHHHhhhhcccc-------cc--------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 7665554443311100000 00 0011235789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=286.42 Aligned_cols=242 Identities=26% Similarity=0.386 Sum_probs=187.8
Q ss_pred eeeeeeecCCCeeEEEEEEc----CCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 37 MAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 37 ~~~~~lg~G~~g~Vy~~~~~----~~~~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.+.+.||.|+||.||+|... ..+..|+||.+... .....+|++.++.++||||+++++++..... .
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-----~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-----L 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-----E
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-----c
Confidence 46789999999999999987 44678999998542 2334579999999999999999999863332 7
Q ss_pred EEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
++|+||++ |+|.+.+... ....+++..+..++.|++.||.|||+ ++++|++|+++||+++. ++.+||+|||++..
T Consensus 77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~-~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDS-NGQVKLSDFGLSRP 152 (259)
T ss_dssp EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEET-TTEEEEESTTTGEE
T ss_pred ccccccccccccccccccc--cccccccccccccccccccccccccc-ccccccccccccccccc-cccccccccccccc
Confidence 89999998 5888888642 34678999999999999999999999 79999999999999996 78999999999976
Q ss_pred CccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 187 LIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 187 ~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
....... ........|+|||.+.+.. ++.++||||||+++|||++ |..||...+..+....+.+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-------- 223 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-------- 223 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------
T ss_pred ccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc--------
Confidence 6322211 2234567799999986654 8999999999999999999 7899998877776665533110
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..++..++..+.++|.+||+.||.+|||+.++++
T Consensus 224 --------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 --------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp --------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred --------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1122347889999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=286.27 Aligned_cols=241 Identities=24% Similarity=0.344 Sum_probs=184.2
Q ss_pred eeeecCCCeeEEEEEEcCCCc--EEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~--~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.||+|+||.||+|.+..++. .+++|.+.... ....+|+.++..+ +||||+++++++.. ..+.|++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEEE
Confidence 358999999999999988776 46888775321 2334699999999 79999999998833 33488999
Q ss_pred eccc-chHHHHHHhhhh------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEE
Q 017147 112 EYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 178 (376)
Q Consensus 112 e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl 178 (376)
||++ ++|.+.+..... ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~-~~~~kl 153 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE-NYVAKI 153 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcC-CCeEEE
Confidence 9998 477777754221 12357899999999999999999999 79999999999999996 778999
Q ss_pred EeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 017147 179 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 257 (376)
Q Consensus 179 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 257 (376)
+|||++..............+..|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+....
T Consensus 154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---- 228 (270)
T cd05047 154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---- 228 (270)
T ss_pred CCCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC----
Confidence 99999863322111112223556999999854 458999999999999999997 999998776555443332100
Q ss_pred HHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.. ..+..++.++.+|+.+||..||.+|||+++++.
T Consensus 229 --------------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 229 --------------RL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred --------------CC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 00 011236789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=283.94 Aligned_cols=234 Identities=26% Similarity=0.330 Sum_probs=183.4
Q ss_pred eeecCCCeeEEEEEE--cCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 017147 41 VVGTGSFGIVFQAKC--LETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 112 (376)
Q Consensus 41 ~lg~G~~g~Vy~~~~--~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 112 (376)
.||+|+||.||+|.. ..++..+|+|++.... ....+|+.+++.++|+||+++++.+. .. ..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~-~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-----AE-SWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CC-CcEEEEe
Confidence 589999999999964 4567899999875432 22347889999999999999988752 11 2679999
Q ss_pred cccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCC
Q 017147 113 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 191 (376)
Q Consensus 113 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 191 (376)
|+++ +|.+.+. ....+++..+..++.|++.||+|||+ +|++||||||.||+++. ++.+||+|||++.......
T Consensus 76 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~-~~~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 76 LAELGPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVT-QHYAKISDFGLSKALGADE 149 (257)
T ss_pred cCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcC-CCeEEECCCccccccCCCC
Confidence 9995 5666654 34568999999999999999999999 79999999999999996 7789999999997654332
Q ss_pred Cc----eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 192 AN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 192 ~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
.. ....+++.|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.+...
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~------------ 216 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER------------ 216 (257)
T ss_pred CeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC------------
Confidence 21 11223468999998854 458899999999999999998 9999988776655444332100
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 315 (376)
...+..+++++.+||.+||+.||++||+++++.
T Consensus 217 ----------------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~ 249 (257)
T cd05116 217 ----------------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVE 249 (257)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHH
Confidence 001234789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=285.28 Aligned_cols=244 Identities=24% Similarity=0.347 Sum_probs=191.2
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCc---EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
..|++.+.||+|+||.||+|.++.+++ .||+|.+.... .....|+.+++.++||||+++.+++. ...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC-----CCC
Confidence 469999999999999999999887665 59999876431 23346999999999999999998873 333
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..++||||+++ +|.+.+.. ..+.+++..++.++.|++.||.|||+ +|++|+||||+||+++. +..+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~-~~~~kl~dfg~~ 153 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNS-NLVCKVSDFGLS 153 (269)
T ss_pred ceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcC-CCcEEECCCccc
Confidence 48899999986 56555542 34568999999999999999999999 79999999999999996 778999999998
Q ss_pred ccCccCCCceee---e---eccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 017147 185 KQLIAGEANISY---I---CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 257 (376)
Q Consensus 185 ~~~~~~~~~~~~---~---~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 257 (376)
............ . .+..|+|||.+.+ ..++.++||||+||++|+|++ |..||...+..+....+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~--- 229 (269)
T cd05065 154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR--- 229 (269)
T ss_pred cccccCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc---
Confidence 755332221111 1 1346999999855 458999999999999999886 9999988776655544432110
Q ss_pred HHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+ .+..++..+.+++.+||+.+|++||++.+++.
T Consensus 230 ---------------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 230 ---------------LP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ---------------CC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 11236788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=319.99 Aligned_cols=256 Identities=31% Similarity=0.459 Sum_probs=192.1
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeec---------
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFST--------- 99 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------- 99 (376)
.+|+.++.||+||||.||+|+++-+|+.||||+++-. .....+|+.+|.+|+|||||+++..+...
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 4788899999999999999999999999999999644 23345899999999999999986432100
Q ss_pred ---------------------------------------------C---------------------------------C
Q 017147 100 ---------------------------------------------T---------------------------------S 101 (376)
Q Consensus 100 ---------------------------------------------~---------------------------------~ 101 (376)
. +
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence 0 0
Q ss_pred -------------------CCc--------eEEEEEeecccchHHHHHHhhhhcCCCc-CHHHHHHHHHHHHHHHHHhhc
Q 017147 102 -------------------KNE--------LFLNLVMEYVPESMYRVLKHYSSANQRM-PLIYVKLYTYQIFRGLAYIHT 153 (376)
Q Consensus 102 -------------------~~~--------~~~~lv~e~~~~~l~~~l~~~~~~~~~l-~~~~~~~i~~qi~~al~~LH~ 153 (376)
... .++||=||||+..++..+.. .+... ....+|+++.||++||.|+|+
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~---~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIR---RNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHH---hcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 001 57899999999876666543 22222 477899999999999999999
Q ss_pred CCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc------------------cC-CCceeeeeccccCchhhhhCCC--
Q 017147 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI------------------AG-EANISYICSRFYRAPELIFGAT-- 212 (376)
Q Consensus 154 ~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~------------------~~-~~~~~~~~t~~y~aPE~l~~~~-- 212 (376)
.||+||||||.||++++ .+.|||+|||+|+... .+ ...++.+||.-|+|||++.+..
T Consensus 716 -~giIHRDLKP~NIFLd~-~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 716 -QGIIHRDLKPRNIFLDS-RNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred -CceeeccCCcceeEEcC-CCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 69999999999999996 7789999999997511 01 1345678999999999996655
Q ss_pred CCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChh
Q 017147 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPE 292 (376)
Q Consensus 213 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (376)
.|+.|+|+||||||++||+ .||... ++... ++..+..+. +|.- .-|...--+.
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~---yPF~Ts--MERa~-iL~~LR~g~---------------iP~~------~~f~~~~~~~ 846 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEML---YPFGTS--MERAS-ILTNLRKGS---------------IPEP------ADFFDPEHPE 846 (1351)
T ss_pred cccchhhhHHHHHHHHHHh---ccCCch--HHHHH-HHHhcccCC---------------CCCC------cccccccchH
Confidence 6999999999999999998 456432 23222 222222111 1110 1111122346
Q ss_pred HHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 017147 293 AIDLASRLLQYSPSLRCTALEACAHPFFD 321 (376)
Q Consensus 293 ~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 321 (376)
-..+|++||+.||++||||.|+|++.||-
T Consensus 847 e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 847 EASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 67899999999999999999999999996
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=296.42 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=189.1
Q ss_pred ceeeeeeeeecCCCeeEEEEEE-----cCCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 017147 34 ISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 102 (376)
++|++.+.||+|+||+||+|.+ ..+++.||||.+..+. ....+|+.++..+ +|+||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 83 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--- 83 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC---
Confidence 4799999999999999999984 3467889999886432 2234799999999 689999999876432
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhh------------------------------------------------------
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSS------------------------------------------------------ 127 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~------------------------------------------------------ 127 (376)
...++++||||++ +|.+.+.....
T Consensus 84 -~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 84 -GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred -CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 2247899999985 77666643210
Q ss_pred ---------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCC---cee
Q 017147 128 ---------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NIS 195 (376)
Q Consensus 128 ---------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~ 195 (376)
....+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++........ ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcC-CCcEEEEecccccccccCcchhhcCC
Confidence 01246788889999999999999999 79999999999999996 77899999999876432221 111
Q ss_pred eeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCC
Q 017147 196 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 274 (376)
Q Consensus 196 ~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (376)
..+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+......+......... ..
T Consensus 241 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~-- 302 (343)
T cd05103 241 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR---------------MR-- 302 (343)
T ss_pred CCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC---------------CC--
Confidence 2335679999998654 48999999999999999997 99999876543333222211000 00
Q ss_pred CCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 275 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.+...++++.+++.+||+.||++|||+.++++|
T Consensus 303 ----------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 303 ----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112257789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=303.76 Aligned_cols=245 Identities=22% Similarity=0.310 Sum_probs=192.0
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
+...+...||+|.||+||++++.. .||||++.-+ .+..+.|+.+++.-+|.||+-+.+++. ... +
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~-----~p~-~ 462 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM-----NPP-L 462 (678)
T ss_pred HHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc-----CCc-e
Confidence 456788899999999999999865 5999998543 234568999999999999999988873 222 3
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
.||+.+|+| +|+..+.. ....|.....+.|+.|+++|+.|||. ++|+|||||..||++.+ +++|||+|||++..
T Consensus 463 AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~-~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHE-DLKVKIGDFGLATV 537 (678)
T ss_pred eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEcc-CCcEEEecccceee
Confidence 799999998 77777764 34678999999999999999999999 89999999999999996 68999999999863
Q ss_pred Cc---cCCCceeeeeccccCchhhhhC--CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 187 LI---AGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 187 ~~---~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
-. .........+...|||||+++. ..+|+..+|||||||++|||++|..||...+...++..+-+..+.|...
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s-- 615 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS-- 615 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch--
Confidence 21 1222233455677999999953 3458999999999999999999999999655544443332221122111
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
....+.+.++++|+..||.+++++||+..++|.
T Consensus 616 ----------------------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 616 ----------------------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ----------------------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 112346779999999999999999999988875
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=283.69 Aligned_cols=249 Identities=23% Similarity=0.397 Sum_probs=195.7
Q ss_pred eeeeeeeeecCCCeeEEEEEEcC-CCcEEEEEEeeccc--------------cchHHHHHHHH-hCCCCceeeeceeeee
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR--------------RYKNRELQLMR-VMDHPNVISLKHCFFS 98 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~--------------~~~~~e~~~l~-~l~h~~iv~~~~~~~~ 98 (376)
.|++.+.||+|+||.||++.+.. +++.+|+|.+.... .....|+.++. .++|+||+++++.+.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 48889999999999999999887 67899999874221 11235666665 479999999999883
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEE
Q 017147 99 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 177 (376)
Q Consensus 99 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vk 177 (376)
.....+++|||+++ +|.+.+.........+++..++.++.|++.||.|||+..|++|+||+|+||+++. ++.++
T Consensus 80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~-~~~~~ 154 (269)
T cd08528 80 ----ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE-DDKVT 154 (269)
T ss_pred ----cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECC-CCcEE
Confidence 33458999999985 7777665544556779999999999999999999995258999999999999996 77899
Q ss_pred EEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017147 178 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257 (376)
Q Consensus 178 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 257 (376)
|+|||.+.............++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...+.......+......+.
T Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd08528 155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL 233 (269)
T ss_pred EecccceeecccccccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC
Confidence 9999999765544433455678889999999654 489999999999999999999999987765554443332111100
Q ss_pred HHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.....++.+.++|.+||+.||++||++.|+..+
T Consensus 234 ---------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 ---------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ---------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 012357899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=281.27 Aligned_cols=236 Identities=24% Similarity=0.292 Sum_probs=183.0
Q ss_pred eeecCCCeeEEEEEEc--CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeec
Q 017147 41 VVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY 113 (376)
Q Consensus 41 ~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 113 (376)
.||+|+||.||+|.+. .++..||+|++.... ....+|+.+++.++|+||+++++++. . ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-----~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-----A-EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-----C-CCeEEEEEe
Confidence 3899999999999765 345679999885442 22357899999999999999998762 1 137899999
Q ss_pred ccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCC
Q 017147 114 VPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 192 (376)
Q Consensus 114 ~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~ 192 (376)
+++ +|.+.+.. ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++........
T Consensus 76 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 76 ASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVN-QHYAKISDFGLSKALGADDS 150 (257)
T ss_pred CCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcC-CCcEEeccCCccccccCCcc
Confidence 985 66655542 34578999999999999999999999 79999999999999996 77899999999875433221
Q ss_pred ce----eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017147 193 NI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267 (376)
Q Consensus 193 ~~----~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 267 (376)
.. ...+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+....+....+.+.. +
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~----------- 216 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK--R----------- 216 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC--C-----------
Confidence 11 11224679999998654 48899999999999999996 999998877665544332210 0
Q ss_pred CCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..++...++++.++|.+||..||++||++.++.+
T Consensus 217 ---------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 ---------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112346889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=285.68 Aligned_cols=249 Identities=20% Similarity=0.270 Sum_probs=193.3
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcC----CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLE----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
.++|++.+.||+|+||.||+|.+.. ++..|++|.+.... ....+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---- 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED---- 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence 4589999999999999999999876 35789999876432 2234789999999999999999876432
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhhc----CCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEE
Q 017147 104 ELFLNLVMEYVP-ESMYRVLKHYSSA----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 178 (376)
Q Consensus 104 ~~~~~lv~e~~~-~~l~~~l~~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl 178 (376)
....+++++|++ ++|...+...... ...+++..+..++.|++.||+|||+ ++++||||||+||+++. ++.+||
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~-~~~~kl 158 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDE-ELQVKI 158 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcC-CCcEEE
Confidence 223779999998 5777766543222 1568999999999999999999999 79999999999999986 688999
Q ss_pred EeecccccCccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 017147 179 CDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 254 (376)
Q Consensus 179 ~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 254 (376)
+|||+++........ ....++..|+|||.+.+. .++.++|||||||++|++++ |+.||...+..+....+....
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~- 236 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY- 236 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-
Confidence 999999765333211 112345679999998654 48999999999999999998 999998876655433322210
Q ss_pred CCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.. .....+++++.+++.+||..||++|||+.++++
T Consensus 237 -----------------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 237 -----------------RL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -----------------CC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 011235789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=280.98 Aligned_cols=242 Identities=28% Similarity=0.399 Sum_probs=192.5
Q ss_pred eeeeeeecCCCeeEEEEEEcCCC----cEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 37 MAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 37 ~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
++.+.||.|+||.||++.+..++ ..+|+|.+..... ....|+.+++.++|+||+++++.+... ...
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Cee
Confidence 56788999999999999998766 8999999865432 345799999999999999999988443 348
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|++|||+++ +|.+.+.... ...+++..+..++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||++..
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~-~~~~~l~dfg~~~~ 152 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGE-NLVVKISDFGLSRD 152 (258)
T ss_pred EEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEcc-CCeEEEcccCCcee
Confidence 899999985 7766665311 1228999999999999999999999 79999999999999996 77899999999976
Q ss_pred CccCCCce--eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 187 LIAGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 187 ~~~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
........ ...+++.|+|||.+.+ ..++.++|+||+||++|+|++ |.+||...+..+....+.+....
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------- 223 (258)
T smart00219 153 LYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL-------- 223 (258)
T ss_pred cccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--------
Confidence 54432211 1235678999999844 458999999999999999998 89999887666555544331100
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..+...+.++.+++.+||+.||++|||+.++++
T Consensus 224 --------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 224 --------------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred --------------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 011236889999999999999999999999975
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=280.97 Aligned_cols=236 Identities=28% Similarity=0.377 Sum_probs=184.6
Q ss_pred eeeecCCCeeEEEEEEcCCC---cEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.||+|+||.||+|....++ ..+|+|.+..+.. ...+|+.+++.+.|+||+++++++. .. ..++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~-~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-----GE-PLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----CC-ceEEEE
Confidence 46999999999999876555 7899998865443 3357899999999999999988652 11 268999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||+++ +|.+.+. ....+++..+..++.|++.||+|||. ++++|+||||+||+++. ++.+||+|||+++.....
T Consensus 75 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~-~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 75 ELAPLGPLLKYLK----KRREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVN-RHQAKISDFGMSRALGAG 148 (257)
T ss_pred EeCCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcC-CCcEEeccccccceeecC
Confidence 99985 6776665 33478999999999999999999999 79999999999999996 778999999998765333
Q ss_pred CCce----eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 191 EANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 191 ~~~~----~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.... ...++..|+|||.+.+. .++.++|+|||||++|+|++ |.+||...+..+....+.... +
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~--~--------- 216 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE--R--------- 216 (257)
T ss_pred CcccccccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--c---------
Confidence 2211 11123569999998554 48999999999999999998 999998877654443332210 0
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
...+..++..+.++|.+||+.||++|||+.++++
T Consensus 217 -----------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 -----------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred -----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0012346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=288.17 Aligned_cols=248 Identities=26% Similarity=0.322 Sum_probs=192.8
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcC-----CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
.++|++.+.||+|+||.||+|.+.. ++..+|+|.+.... ....+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~---- 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV---- 79 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC----
Confidence 3579999999999999999998753 67889999886432 234579999999999999999988743
Q ss_pred CceEEEEEeecccc-hHHHHHHhhh------------------hcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCC
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYS------------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 163 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~------------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlk 163 (376)
....+++|||+++ +|.+.+.... .....+++..+..++.|++.||.|||+ +|++|||||
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~ 157 (288)
T cd05050 80 -GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLA 157 (288)
T ss_pred -CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeeccccc
Confidence 2347899999985 7777775321 112347888899999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCC
Q 017147 164 PQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG 239 (376)
Q Consensus 164 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~ 239 (376)
|+||+++. ++.++|+|||++........ ......+..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+
T Consensus 158 p~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 158 TRNCLVGE-NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred HhheEecC-CCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999986 77899999999875432221 1122345679999998654 48999999999999999997 8899988
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 240 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 240 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+..+....+..... ...+..++.++.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 236 MAHEEVIYYVRDGNV----------------------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCHHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 776655543332100 0012236789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=293.11 Aligned_cols=248 Identities=24% Similarity=0.350 Sum_probs=192.0
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCC-------CcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecC
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTT 100 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 100 (376)
.+|++++.||+|+||.||+|.+... +..+|+|.+.... ....+|+.+++.+ +|+||+++++.+..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc--
Confidence 4799999999999999999986532 2368999876432 2345789999999 79999999998743
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhh------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcE
Q 017147 101 SKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL 167 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Ni 167 (376)
....++++||+++ +|.+.+..... ....++...+..++.|++.||.|||+ +|++||||||+||
T Consensus 90 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~Ni 165 (334)
T cd05100 90 ---DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAARNV 165 (334)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceE
Confidence 3348899999985 77777654221 22357788889999999999999999 7999999999999
Q ss_pred EEcCCCCcEEEEeecccccCccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChH
Q 017147 168 LVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAV 243 (376)
Q Consensus 168 ll~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 243 (376)
+++. ++.+||+|||+++........ ....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..
T Consensus 166 ll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 166 LVTE-DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred EEcC-CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9996 678999999998755332211 112234579999998654 48899999999999999998 89999887766
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 244 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 244 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
+....+..... ...+..++.++.+|+.+||+.+|.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 244 ELFKLLKEGHR----------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 65544332100 00122467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=285.70 Aligned_cols=243 Identities=21% Similarity=0.306 Sum_probs=186.8
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCc----EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
++|++.+.||+|+||+||+|.+..+++ .+++|.+.... .....|+.++..++||||+++++++.. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-----~ 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-----A 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-----C
Confidence 579999999999999999999887776 47777764322 122356667889999999999987621 1
Q ss_pred eEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
..++++||++ |+|.+.+.. ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||+
T Consensus 82 -~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~-~~~~kl~Dfg~ 155 (279)
T cd05111 82 -SLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKS-DSIVQIADFGV 155 (279)
T ss_pred -ccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcC-CCcEEEcCCcc
Confidence 2568899998 577777653 34568999999999999999999999 79999999999999996 78899999999
Q ss_pred cccCccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 184 AKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 184 a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
++........ ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+........ +......+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~-- 231 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD-LLEKGERLA-- 231 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcCC--
Confidence 9765433221 123346679999998654 48999999999999999998 999998876544322 222100000
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+...+.++.+++.+||..||++|||+.++++
T Consensus 232 -------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 232 -------------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01124678899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=280.39 Aligned_cols=244 Identities=20% Similarity=0.310 Sum_probs=191.6
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
.+|++.+.||+|+||.||++.+. ++..+|+|.+.... ....+|+.+++.++|+|++++++++.. ....+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE-----RSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEcc-----CCceEEE
Confidence 47999999999999999999875 46789999886432 234579999999999999999988733 3348899
Q ss_pred eecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 111 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 111 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
|||+.+ +|.+.+.. ....+++..++.++.|++.|+++||+ ++++|+||||+||+++. ++.++|+|||.+.....
T Consensus 78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 78 FEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGE-NQVVKVSDFGMTRFVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcC-CCeEEECCCcceeeccc
Confidence 999986 55555532 23568899999999999999999999 79999999999999996 77899999999875433
Q ss_pred CCCc--eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 190 GEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 190 ~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
.... ....++..|+|||.+.+. .++.++|+||+||++|+|++ |..||......+.+..+.+...
T Consensus 153 ~~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------ 219 (256)
T cd05112 153 DQYTSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR------------ 219 (256)
T ss_pred CcccccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC------------
Confidence 2211 122345679999998654 48899999999999999998 9999987776555544322100
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
...+...+..+.+|+.+||+.+|++|||+.+++++
T Consensus 220 ----------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 220 ----------------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 00112257899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=286.32 Aligned_cols=236 Identities=18% Similarity=0.224 Sum_probs=180.7
Q ss_pred eeeecCCCeeEEEEEEcCCCc-------EEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 40 RVVGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~-------~~aiK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+.||+|+||.||+|.++.++. .+|+|.+..... ...+|+.+++.++|||++++++.+.... ..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-----~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-----ESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-----CcE
Confidence 368999999999999865543 488887754322 2356888999999999999999885433 278
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC-------cEEEEe
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-------QVKICD 180 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~-------~vkl~D 180 (376)
+||||+++ +|...+.. ....+++..+..++.||+.||+|||+ +||+||||||+||+++.++. .++++|
T Consensus 76 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 76 MVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred EEEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEecc
Confidence 99999986 56666542 23468899999999999999999999 79999999999999986433 279999
Q ss_pred ecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 181 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 181 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
||++...... ....+++.|+|||++.+...++.++|+||+||++|+|++| .+||...+..........
T Consensus 152 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~-------- 220 (258)
T cd05078 152 PGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED-------- 220 (258)
T ss_pred cccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc--------
Confidence 9998654322 2345678899999997655578999999999999999998 567766554433221110
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.. .++...+.++.+||.+||+.||++|||++++++.
T Consensus 221 ----------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 221 ----------RH------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ----------cc------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 00 0122346789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=284.93 Aligned_cols=261 Identities=28% Similarity=0.373 Sum_probs=188.9
Q ss_pred cceeeeeeeeecCCCeeEEEEE----EcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 33 TISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
..+|++.+.||+|+||.||.+. +..+++.||+|.+.... ....+|+.+++.++|+||+++.+++.... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC---C
Confidence 3479999999999999999997 34578899999986432 23457999999999999999988764432 2
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
..+++||||+++ +|.+.+.. ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~-~~~~~l~dfg~ 154 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVES-ENRVKIGDFGL 154 (284)
T ss_pred CceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECC-CCeEEECCCcc
Confidence 347899999984 77766642 23468899999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccCCCce----eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCCCH
Q 017147 184 AKQLIAGEANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL-GTPTR 258 (376)
Q Consensus 184 a~~~~~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~ 258 (376)
+.......... ...++..|+|||.+.+. .++.++|+|||||++|+|++|..|+...... ....+.... +....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIV 232 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccch
Confidence 98654332211 11223459999998654 4899999999999999999988776543211 110000000 00000
Q ss_pred HHH-hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 259 EEI-RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 259 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..+ ...... ........++.++.+|+.+||+.+|++|||+.++++
T Consensus 233 ~~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 233 YHLIELLKNN-------------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHHHHhcC-------------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000 000000 000112346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=283.45 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=193.0
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCC-----CcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
.+|++.+.||.|+||.||+|+++.+ .+.+++|.+..... ...+|+.+++.++|+||+++++.+. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR-----E 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC-----C
Confidence 5799999999999999999997643 46799998854332 2457999999999999999998773 3
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhhc-----CCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEE
Q 017147 104 ELFLNLVMEYVP-ESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 177 (376)
Q Consensus 104 ~~~~~lv~e~~~-~~l~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vk 177 (376)
....|+||||++ ++|.+.+...... ...+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~-~~~~~ 157 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSS-QREVK 157 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeC-CCcEE
Confidence 344889999998 4777776543211 1268999999999999999999999 79999999999999996 77899
Q ss_pred EEeecccccCccCC--CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 017147 178 ICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 254 (376)
Q Consensus 178 l~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 254 (376)
++|||++....... ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||........+..+...
T Consensus 158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~-- 234 (275)
T cd05046 158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG-- 234 (275)
T ss_pred EcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--
Confidence 99999986443221 12233556779999998654 47899999999999999998 88999776654444332210
Q ss_pred CCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.. .......++..+.+++.+||+.||++|||+.+++.+
T Consensus 235 ---------------~~----------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 235 ---------------KL----------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred ---------------Cc----------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 00 001123468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=297.02 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=193.4
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEc-----CCCcEEEEEEeecccc-----chHHHHHHHHhCC-CCceeeeceeeeecC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR-----YKNRELQLMRVMD-HPNVISLKHCFFSTT 100 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 100 (376)
..++|.+.+.||+|+||.||+|.+. .+++.||+|++..... ...+|+.++..+. ||||+++++++...
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~- 113 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG- 113 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC-
Confidence 3457899999999999999999864 3457899999965421 2347999999997 99999999988433
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhh----------------------------------------------------
Q 017147 101 SKNELFLNLVMEYVPE-SMYRVLKHYSS---------------------------------------------------- 127 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~---------------------------------------------------- 127 (376)
...++|||||.+ +|.+.+.....
T Consensus 114 ----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 114 ----GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred ----CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 348899999994 77777753210
Q ss_pred ------------------------------------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCC
Q 017147 128 ------------------------------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 165 (376)
Q Consensus 128 ------------------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~ 165 (376)
....+++..+..++.|++.||+|||+ ++++||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp~ 268 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAAR 268 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCcc
Confidence 11246777888999999999999999 79999999999
Q ss_pred cEEEcCCCCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCC
Q 017147 166 NLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 241 (376)
Q Consensus 166 Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 241 (376)
|||++. ++.+||+|||+++....... .....+++.|+|||.+.+. .++.++|+||+||++|+|++ |..||....
T Consensus 269 NiLl~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 269 NVLICE-GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred eEEEeC-CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999996 77899999999975432221 1233557789999998654 48899999999999999998 899998766
Q ss_pred hHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 242 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
..+.+...+.. +. ....+..++.++.+|+.+||..+|.+||++.++++.
T Consensus 347 ~~~~~~~~~~~-~~--------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 347 MNEQFYNAIKR-GY--------------------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred chHHHHHHHHc-CC--------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 55544333321 00 001123468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=280.23 Aligned_cols=239 Identities=26% Similarity=0.355 Sum_probs=188.8
Q ss_pred eeeecCCCeeEEEEEEcC-CC--cEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTGSFGIVFQAKCLE-TG--ETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~-~~--~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.||+|++|.||+|.+.. ++ ..+|||.+..+.. ...+|+.+++.++|+||+++++.+.. ...+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 368999999999999865 33 3699998876543 34579999999999999999988743 3488999
Q ss_pred eccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||++ ++|.+.+..... ..+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.+||+|||++......
T Consensus 75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~-~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLAS-DDKVKIGDFGLMRALPQN 150 (257)
T ss_pred EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEec-CCEEEecccccccccccc
Confidence 9997 577777654221 568999999999999999999999 79999999999999997 678999999999765442
Q ss_pred CCc----eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 191 EAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 191 ~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
... ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----------- 218 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE----------- 218 (257)
T ss_pred ccceecccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------
Confidence 211 123456779999998554 48999999999999999998 9999988777665554433100
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.. ..+...+..+.+++.+||+.+|++|||+.++++
T Consensus 219 ----~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 219 ----RL------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ----cC------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 00 011236789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=283.46 Aligned_cols=244 Identities=26% Similarity=0.350 Sum_probs=192.3
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCc----EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
..+|++.+.||+|+||+||+|.++.++. .+|+|...... ....+|+.+++.++|+||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS----- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 3579999999999999999999876665 58999876543 233478999999999999999998753
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
...++||||+++ +|.+.+.. ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~-~~~~kL~dfg 154 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKT-PQHVKITDFG 154 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcC-CCeEEECCCc
Confidence 237899999985 77666643 34468999999999999999999999 79999999999999986 7789999999
Q ss_pred ccccCccCCCceee---eeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 183 SAKQLIAGEANISY---ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 183 ~a~~~~~~~~~~~~---~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
.++........... .++..|+|||.+.. ..++.++|+||+||++|++++ |..||.+.+..+....+.+... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~-- 230 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-L-- 230 (279)
T ss_pred ccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-C--
Confidence 99765433222111 12457999998854 458899999999999999998 9999988776655444332100 0
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..+...+.++.+++.+||..||.+|||+.++++
T Consensus 231 -------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 231 -------------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 011235778999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=282.68 Aligned_cols=237 Identities=16% Similarity=0.182 Sum_probs=176.9
Q ss_pred eeeecCCCeeEEEEEEcC------------CCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 40 RVVGTGSFGIVFQAKCLE------------TGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~------------~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
+.||+|+||.||+++... ....+++|.+..... ...+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~--- 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV--- 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 368999999999998432 223588887754322 2346788999999999999999874333
Q ss_pred ceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC------cEE
Q 017147 104 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH------QVK 177 (376)
Q Consensus 104 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~------~vk 177 (376)
..+++|||++++.++.+.. .....+++..+..++.||+.||+|||+ +|++||||||+|||++.++. .++
T Consensus 78 --~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 78 --ENIMVEEFVEFGPLDLFMH--RKSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred --CCEEEEecccCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEecCCccCCCCceeE
Confidence 3779999999643333321 234568999999999999999999999 79999999999999975221 389
Q ss_pred EEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCC
Q 017147 178 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTP 256 (376)
Q Consensus 178 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~ 256 (376)
++|||++...... ....++..|+|||.+.....++.++|||||||++|+|+ .|..||......+... ....
T Consensus 153 l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~---- 224 (262)
T cd05077 153 LSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEG---- 224 (262)
T ss_pred eCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhc----
Confidence 9999998654322 23456788999999865566899999999999999998 5888987655333211 1110
Q ss_pred CHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.+ . .....++++.+||.+||+.||.+||+..+++++
T Consensus 225 ----------~~---~------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 225 ----------QC---M------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ----------Cc---c------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 00 0 001135789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=286.20 Aligned_cols=254 Identities=21% Similarity=0.285 Sum_probs=189.4
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcC----------------CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeee
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLE----------------TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISL 92 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~ 92 (376)
++|++.+.||+|+||.||+|.+.. ++..+|+|.+.... ....+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 469999999999999999986432 34579999886432 234579999999999999999
Q ss_pred ceeeeecCCCCceEEEEEeecccc-hHHHHHHhhhhc-------CCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCC
Q 017147 93 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSA-------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 164 (376)
Q Consensus 93 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp 164 (376)
++++.... ..+++|||+.+ +|.+.+...... ...+++..+..++.|++.||+|||+ .|++||||||
T Consensus 85 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp 158 (296)
T cd05095 85 LAVCITSD-----PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLAT 158 (296)
T ss_pred EEEEecCC-----ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCh
Confidence 99874433 38899999985 777776542211 1347788899999999999999999 7999999999
Q ss_pred CcEEEcCCCCcEEEEeecccccCccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh--CCCCCCC
Q 017147 165 QNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPG 239 (376)
Q Consensus 165 ~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~ 239 (376)
+||+++. ++.++|+|||++......... .....++.|+|||...+. .++.++|+|||||++|+|++ |..||..
T Consensus 159 ~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 159 RNCLVGK-NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred heEEEcC-CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 9999996 778999999998755332211 112235679999987654 48999999999999999998 7789987
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 240 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 240 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+..+............ ......+ .+..+++.+.+|+.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~-----------~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 237 LSDEQVIENTGEFFRDQ-----------GRQVYLP----------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cChHHHHHHHHHHHhhc-----------cccccCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 66555443322211000 0000000 11236789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=278.12 Aligned_cols=237 Identities=25% Similarity=0.376 Sum_probs=184.6
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 114 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 114 (376)
+.||+|+||.||++.. .++..+|+|.+.... ....+|+.+++.++|+||+++++.+... ...++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEECC
Confidence 3689999999999985 468899999875432 1244799999999999999999987433 3488999999
Q ss_pred cc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCCc
Q 017147 115 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 193 (376)
Q Consensus 115 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~ 193 (376)
++ +|.+.+.. ....+++..+..++.|++.||.|||+ +|++||||+|+||+++. ++.+||+|||++.........
T Consensus 75 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~-~~~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 75 PGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcC-CCeEEECCCccceeccccccc
Confidence 85 66555542 23467899999999999999999999 79999999999999996 778999999998654322211
Q ss_pred e--eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 017147 194 I--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270 (376)
Q Consensus 194 ~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 270 (376)
. ...++..|+|||.+.+ ..++.++|+||+|+++|++++ |..||.+.........+....
T Consensus 150 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~----------------- 211 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY----------------- 211 (250)
T ss_pred cCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence 1 1223566999999854 458899999999999999998 999998876655444332210
Q ss_pred CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
...++..++..+.+++.+||+.+|++|||+.++++
T Consensus 212 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 212 -----------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -----------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 00112346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=277.92 Aligned_cols=237 Identities=25% Similarity=0.366 Sum_probs=185.6
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 114 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 114 (376)
+.||.|+||.||+|.+.. ++.||+|.+.... .....|+++++.++|+||+++++.+... ...++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-----QPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----CCeEEEEEcC
Confidence 368999999999999877 9999999876432 2345799999999999999999887433 3488999999
Q ss_pred cc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCCc
Q 017147 115 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 193 (376)
Q Consensus 115 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~ 193 (376)
.+ +|.+.+.. ....+++..+..++.|++.||.|||+ ++++||||+|+||+++. ++.++|+|||++.........
T Consensus 75 ~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~-~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 75 PGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGE-NNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcC-CCcEEEeeccccccccCCcce
Confidence 75 66665542 34468889999999999999999999 79999999999999996 778999999998754322111
Q ss_pred ---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 194 ---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 194 ---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
.....+..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.........+....+
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~--------------- 213 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR--------------- 213 (251)
T ss_pred eccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC---------------
Confidence 112224569999998654 58999999999999999999 8999988765544433322100
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
...+..++.++.+++.+||+.+|.+|||+.++++
T Consensus 214 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 214 -------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0012346889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=281.60 Aligned_cols=243 Identities=28% Similarity=0.380 Sum_probs=190.7
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCC---CcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
.+|.+.+.||+|+||.||+|.+... ...+|+|...... ....+|+.+++.++|+||+++++++.. .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~- 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-----N- 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----C-
Confidence 4699999999999999999987644 3568999875432 234579999999999999999987632 1
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..|+||||+++ +|.+.+.. ....+++..+..++.|++.||+|||+ .|++||||||+||+++. ++.++|+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~-~~~~~l~d~g~~ 154 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSS-PDCVKLGDFGLS 154 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEec-CCCeEEccCcee
Confidence 25799999985 67766653 23468999999999999999999999 79999999999999996 778999999998
Q ss_pred ccCccCCCce--eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 185 KQLIAGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 185 ~~~~~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
.......... ...++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~------ 227 (270)
T cd05056 155 RYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL------ 227 (270)
T ss_pred eecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC------
Confidence 7654332211 1223457999998854 458999999999999999996 99999888766555443321000
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..+..++..+.+++.+||..+|++|||+.+++.
T Consensus 228 ----------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 228 ----------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 012346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=305.66 Aligned_cols=206 Identities=27% Similarity=0.406 Sum_probs=171.8
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecC-CCCceEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTT-SKNELFL 107 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 107 (376)
.-|...+.||+||||.||+++++.+|+.||||.+.+. +..--+|+++|++++|+|||+++++=-... ..-....
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 4588899999999999999999999999999998653 222347999999999999999987642211 0002225
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC---CCcEEEEeecc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL---THQVKICDFGS 183 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~---~~~vkl~Dfg~ 183 (376)
.+|||||.| +|...+.. ..+...+++.++..++.++..|+.|||+ +||+||||||.||++-.. ...-||+|||.
T Consensus 93 vlvmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred eEEEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 599999995 77666653 3455679999999999999999999999 899999999999998531 23579999999
Q ss_pred cccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCC
Q 017147 184 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 241 (376)
Q Consensus 184 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 241 (376)
|+...++....+.+||+.|.+||+...+..|+..+|.||+||++|+.+||..||....
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 9999998888999999999999999755679999999999999999999999996543
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=280.66 Aligned_cols=246 Identities=21% Similarity=0.296 Sum_probs=182.3
Q ss_pred eeeecCCCeeEEEEEEcC--CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 017147 40 RVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 112 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 112 (376)
+.||+|+||.||+|.... ....+|+|.+.... ....+|+.+++.++|+||+++++.+... ..+|+|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-----~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-----IPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CceEEEEE
Confidence 358999999999996432 34578888765332 1234688999999999999999987433 34889999
Q ss_pred cccc-hHHHHHHhhhh-cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 113 YVPE-SMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 113 ~~~~-~l~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
|+++ +|.+.+..... .....++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTA-DLSVKIGDYGLALEQYPE 153 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecC-CCcEEEeccccccccccc
Confidence 9985 77777754322 12335678888999999999999999 79999999999999996 778999999998654322
Q ss_pred CC---ceeeeeccccCchhhhhC------CCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 191 EA---NISYICSRFYRAPELIFG------ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 191 ~~---~~~~~~t~~y~aPE~l~~------~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
.. .....+++.|+|||++.. ...++.++||||+||++|+|++ |..||......+.+..........
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---- 229 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK---- 229 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc----
Confidence 21 112334667999999743 2346789999999999999999 889998877666555544321110
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+ .......++..+.+++..|+ .||++|||++++++
T Consensus 230 ------------~~-------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 230 ------------LP-------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ------------CC-------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 00 01122346888999999998 59999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=278.49 Aligned_cols=243 Identities=25% Similarity=0.347 Sum_probs=190.8
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
.++|++.+.||+|+||.||++.+. .+..+|+|.+.... ....+|+.+++.++|+||+++++.+.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEE
Confidence 458999999999999999999854 55679999886543 234579999999999999999887743 23789
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
+|||+++ +|.+.+... ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.+||+|||.+....
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 78 ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSA-SLVCKIADFGLARVIE 153 (260)
T ss_pred EEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcC-CCcEEECCCcceeecc
Confidence 9999984 777776532 34567888899999999999999999 79999999999999996 7889999999987543
Q ss_pred cCCCc--eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 189 AGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 189 ~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
..... ....++..|+|||.+.+ ..++.++|+|||||++|++++ |..||.+.+..+....+.....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~----------- 221 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR----------- 221 (260)
T ss_pred CCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-----------
Confidence 32211 12234567999999865 458899999999999999998 9999988766554443322100
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 315 (376)
. ......+.++.+++.+||..||++||++.+++
T Consensus 222 -------~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 254 (260)
T cd05073 222 -------M----------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQ 254 (260)
T ss_pred -------C----------CCcccCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 0 01123688999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=282.77 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=187.4
Q ss_pred eeeeeeeeecCCCeeEEEEEE----cCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 35 SYMAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
.|++++.||+|+||.||+|+. +.++..||+|.+.... ....+|+.+++.++|+|++++.+++... +..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence 578999999999999999974 4578899999885332 2345799999999999999998877432 123
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..++||||++| +|.+.+.. ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++|+|||++
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~-~~~~~l~dfg~~ 156 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVES-EHQVKIGDFGLT 156 (284)
T ss_pred ceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcC-CCCEEECCCccc
Confidence 47899999985 66665542 23468999999999999999999999 89999999999999996 778999999999
Q ss_pred ccCccCCCc----eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH-
Q 017147 185 KQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE- 259 (376)
Q Consensus 185 ~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~- 259 (376)
......... ....++..|+|||.+.+. .++.++|+|||||++|+|+++..|+..... .. .+..+....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~---~~~~~~~~~~~ 230 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT--LF---LKMIGPTHGQM 230 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc--hh---hhhcccccccc
Confidence 765433221 123346679999998654 488999999999999999998776533211 01 1111110000
Q ss_pred ----HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 260 ----EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 260 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
........ .....+..++..+.+|+.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 231 TVTRLVRVLEEG-------------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred cHHHHHHHHHcC-------------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00000000 0001123478899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=282.01 Aligned_cols=235 Identities=19% Similarity=0.239 Sum_probs=177.6
Q ss_pred eeecCCCeeEEEEEEcCC------------------------CcEEEEEEeecccc----chHHHHHHHHhCCCCceeee
Q 017147 41 VVGTGSFGIVFQAKCLET------------------------GETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISL 92 (376)
Q Consensus 41 ~lg~G~~g~Vy~~~~~~~------------------------~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~iv~~ 92 (376)
.||+|+||.||++....+ ...+++|.+..... ...+|+.+++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 589999999999874321 23588888754322 23467889999999999999
Q ss_pred ceeeeecCCCCceEEEEEeecccch-HHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC
Q 017147 93 KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 171 (376)
Q Consensus 93 ~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~ 171 (376)
++++.... ..++||||++++ |...+. .....+++..+..++.|++.||+|||+ +||+||||||+||+++.
T Consensus 82 ~~~~~~~~-----~~~lv~ey~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~ 152 (274)
T cd05076 82 HGVCVRGS-----ENIMVEEFVEHGPLDVCLR---KEKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLAR 152 (274)
T ss_pred EEEEEeCC-----ceEEEEecCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEec
Confidence 99885433 378999999964 444443 234578999999999999999999999 79999999999999974
Q ss_pred C------CCcEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHH-hCCCCCCCCChHH
Q 017147 172 L------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 244 (376)
Q Consensus 172 ~------~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~ 244 (376)
. ...+|++|||++...... ....++..|+|||.+.+...++.++|+|||||++|+|+ +|..||.+....+
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 2 124899999987643222 22356778999999866556899999999999999995 6999998765443
Q ss_pred HHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 245 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 245 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
........ .. ++...++++.++|.+||+.+|++|||+.+++++
T Consensus 230 ~~~~~~~~------------------~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 230 KERFYEKK------------------HR------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHHhc------------------cC------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 32211110 00 111245789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=290.06 Aligned_cols=262 Identities=26% Similarity=0.353 Sum_probs=190.8
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.+++|.-...||+|+||.||++... ++..||||++.... .....|+.++..++|||+|++++++.+... ..
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~ 147 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HR 147 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eE
Confidence 3467888889999999999999854 55899999886533 346789999999999999999999854432 37
Q ss_pred EEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCC--CeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 108 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP--RVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 108 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
+||+||++ |+|.+.+...... .++|.....|+.+++.||+|||... .|+||||||+|||+|+ +...||+|||+|
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~-~~~aKlsDFGLa 224 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE-DFNAKLSDFGLA 224 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC-CCCEEccCccCc
Confidence 79999999 6887777642211 8899999999999999999999832 3999999999999996 889999999999
Q ss_pred ccCcc-CCCceee-eeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCC--hHHHHHHHH-HHhCCCCHH
Q 017147 185 KQLIA-GEANISY-ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--AVDQLVEII-KVLGTPTRE 259 (376)
Q Consensus 185 ~~~~~-~~~~~~~-~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~-~~~~~~~~~ 259 (376)
+.... .....+. .||..|+|||.+.. ...+.++|||||||++.||++|+.+..... ....+.... ..+...
T Consensus 225 ~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~--- 300 (361)
T KOG1187|consen 225 KLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG--- 300 (361)
T ss_pred ccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc---
Confidence 75544 3322233 78999999999854 458999999999999999999998886543 111122211 111111
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 315 (376)
...++.=|.+....... ...-..+..+..+|++.+|.+||+..|++
T Consensus 301 -------~~~eiiD~~l~~~~~~~---~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv 346 (361)
T KOG1187|consen 301 -------KLREIVDPRLKEGEYPD---EKEVKKLAELALRCLRPDPKERPTMSQVV 346 (361)
T ss_pred -------chhheeCCCccCCCCCh---HHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence 11111111111000000 00112366788999999999999999874
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=279.01 Aligned_cols=246 Identities=20% Similarity=0.228 Sum_probs=181.4
Q ss_pred eeeecCCCeeEEEEEEc--CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 017147 40 RVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 112 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 112 (376)
+.||+|+||.||+|... .++..+|+|.+.... ....+|+.+++.++||||+++++.+.. ....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEEE
Confidence 36899999999999754 355789999886432 234569999999999999999988733 334789999
Q ss_pred cccc-hHHHHHHhhhh-cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 113 YVPE-SMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 113 ~~~~-~l~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
|+++ +|.+.+..... .....++..+..++.|++.|+.|||+ +|++|+||||+||+++. ++.+||+|||++......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~-~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTA-DLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcC-CCcEEECCccccccccCc
Confidence 9984 77667654322 22345677788899999999999999 79999999999999996 778999999998654322
Q ss_pred CC---ceeeeeccccCchhhhhCCC------CCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 191 EA---NISYICSRFYRAPELIFGAT------EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 191 ~~---~~~~~~t~~y~aPE~l~~~~------~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
.. .....+++.|+|||++.+.. .++.++|+||+||++|+|++ |..||......+...........
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----- 228 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL----- 228 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC-----
Confidence 21 11234567899999985321 35789999999999999996 99999877665544332221000
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.++ ...+....++.+.+++.+|+ .+|++|||+++++.
T Consensus 229 -----------~~~-------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 -----------KLP-------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred -----------CCC-------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 000 00111235778999999998 68999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=278.53 Aligned_cols=240 Identities=23% Similarity=0.357 Sum_probs=189.7
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
.+|++.+.||+|+||.||++.. +++.||+|.+..+. ....+|+.+++.++|+|++++.+.+... ..+++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN------GLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------CcEEEE
Confidence 5799999999999999999864 78889999886432 2345799999999999999998876321 167999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||+.+ +|.+.+... ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++......
T Consensus 78 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~-~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 78 ELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSE-DGVAKVSDFGLARVGSMG 153 (254)
T ss_pred ECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcC-CCcEEECCCccceecccc
Confidence 99985 777777532 23458899999999999999999999 79999999999999996 778999999998754322
Q ss_pred CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 191 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 191 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
. .....+..|+|||.+.+. .++.++|+|||||++|+|++ |++||...+..+....+.+...
T Consensus 154 ~--~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------------- 215 (254)
T cd05083 154 V--DNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR--------------- 215 (254)
T ss_pred C--CCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC---------------
Confidence 1 122335679999988544 58899999999999999997 9999988776554433322100
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
. .....++..+.+++.+||+.+|++||++++++.
T Consensus 216 ---~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 216 ---M----------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ---C----------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 011246889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=281.48 Aligned_cols=241 Identities=24% Similarity=0.349 Sum_probs=185.8
Q ss_pred eeeecCCCeeEEEEEEcCCC------cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 40 RVVGTGSFGIVFQAKCLETG------ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
+.||+|+||.||++++.... +.+|+|.+.+.. ....+|+.+++.++||||+++++++... ...+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-----EPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-----CCeE
Confidence 36899999999999976544 689999875432 2335789999999999999999887433 3488
Q ss_pred EEeecccc-hHHHHHHhhhh---cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC-----cEEEE
Q 017147 109 LVMEYVPE-SMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-----QVKIC 179 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~-----~vkl~ 179 (376)
+||||+++ +|.+.+..... ....+++..+..++.|++.||.|||+ ++++|+||+|+||+++. +. .++|+
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~~~~~~l~ 153 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSE-KGYDADRVVKIG 153 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEec-CCCCCCcceEEC
Confidence 99999984 77777754222 22457889999999999999999999 79999999999999986 44 79999
Q ss_pred eecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 017147 180 DFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT 255 (376)
Q Consensus 180 Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 255 (376)
|||++........ .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+... ..
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~ 231 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GR 231 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-Cc
Confidence 9999875433221 1123446789999998654 58999999999999999998 99999877765544333210 00
Q ss_pred CCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
...+..++..+.++|.+||+.+|.+||+++++++
T Consensus 232 ---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 ---------------------------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ---------------------------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0012346889999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=285.01 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=189.4
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCc----EEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
..+|+..+.||+|+||.||+|.+..++. .+|+|.+..... ...+|+.+++.++|+||+++++.+...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence 3578999999999999999999887776 468887764422 234788999999999999999877422
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
..++++||++ |++.+.+.. ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||
T Consensus 82 --~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~-~~~~kL~Dfg 154 (303)
T cd05110 82 --TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKS-PNHVKITDFG 154 (303)
T ss_pred --CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecC-CCceEEcccc
Confidence 1458999998 467666642 33468899999999999999999999 79999999999999986 6789999999
Q ss_pred ccccCccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 183 SAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 183 ~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
+++........ ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+.. .+......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~-- 230 (303)
T cd05110 155 LARLLEGDEKEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-DLLEKGERL-- 230 (303)
T ss_pred ccccccCcccccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHCCCCC--
Confidence 99865433221 123346789999998654 48999999999999999997 99999876544332 222211000
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
+ .+...+..+.+++.+||..||++||++.++++.
T Consensus 231 ---------------~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 231 ---------------P----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ---------------C----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 012257789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=307.10 Aligned_cols=244 Identities=25% Similarity=0.357 Sum_probs=201.4
Q ss_pred eeeeeeeeecCCCeeEEEEEEcC-----CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
+-+..+.||+|+||+||+|+... ....||||.+++.. ..+++|++++..++|||||++++++...+-
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P--- 563 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP--- 563 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe---
Confidence 45667889999999999998653 34679999886543 345799999999999999999999954443
Q ss_pred eEEEEEeeccc-chHHHHHHhhhhc----------CCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCC
Q 017147 105 LFLNLVMEYVP-ESMYRVLKHYSSA----------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 173 (376)
Q Consensus 105 ~~~~lv~e~~~-~~l~~~l~~~~~~----------~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~ 173 (376)
+|+|+|||. |+|.++|+..... ..+++..+...|+.||+.|++||-+ +.+|||||-..|+||.+ +
T Consensus 564 --~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVge-~ 639 (774)
T KOG1026|consen 564 --LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVGE-N 639 (774)
T ss_pred --eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceecc-c
Confidence 899999999 7998888653211 2238889999999999999999999 79999999999999996 8
Q ss_pred CcEEEEeecccccCccCCCcee---eeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017147 174 HQVKICDFGSAKQLIAGEANIS---YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 249 (376)
Q Consensus 174 ~~vkl~Dfg~a~~~~~~~~~~~---~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i 249 (376)
..|||+|||+++.....+.... ..-...|||||.|+.. +++++|||||+||+|||+++ |..||.+...++.+..|
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 8999999999997765543221 2235579999999764 59999999999999999998 99999999999888877
Q ss_pred HHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 017147 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314 (376)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 314 (376)
.+..- + .-+++.|.++.+|+..||+.+|.+||+..|+
T Consensus 719 ~~g~l------L----------------------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 719 RAGQL------L----------------------SCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HcCCc------c----------------------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 65210 0 1234689999999999999999999999887
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=277.22 Aligned_cols=239 Identities=24% Similarity=0.388 Sum_probs=180.0
Q ss_pred eeeecCCCeeEEEEEEcC---CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.||+|+||.||+|.+.. .+..+|||.+.... ....+|+.+++.++||||+++++.+... +...+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence 368999999999998653 34579999874321 2334688899999999999998865422 22367999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||+.+ +|.+.+.. ....+++..+..++.|++.||.|||+ .+++||||||+|||++. ++.+||+|||+++.....
T Consensus 77 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~-~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 77 PYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDE-SFTVKVADFGLARDIYDK 151 (262)
T ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcC-CCcEEECCccccccccCC
Confidence 99985 76666642 23446777788899999999999999 79999999999999996 778999999998754322
Q ss_pred CC-----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 191 EA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 191 ~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
.. .....++..|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+... .+
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~-------- 220 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RR-------- 220 (262)
T ss_pred cceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CC--------
Confidence 11 1122346679999998654 58999999999999999999 57788776655444332210 00
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
. ..+..++..+.+++.+||..+|++||++.++++
T Consensus 221 ------~------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 221 ------L------------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred ------C------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 011235788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=277.97 Aligned_cols=250 Identities=22% Similarity=0.322 Sum_probs=189.5
Q ss_pred eeeeeeeecCCCeeEEEEEEc---CCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCC-ce
Q 017147 36 YMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKN-EL 105 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~-~~ 105 (376)
|.+.+.||+|+||.||+|... .+++.+|||.+..+.. ...+|+.+++.++||||+++++++......+ ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677889999999999999865 3578999998865321 2347899999999999999999775443222 22
Q ss_pred EEEEEeecccc-hHHHHHHhhh--hcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYS--SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
..++++||+.+ ++...+.... .....++...+..++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~-~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNE-NMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcC-CCCEEECccc
Confidence 35788999984 5555543211 122357889999999999999999999 79999999999999986 7789999999
Q ss_pred ccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 183 SAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 183 ~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
+++....... .....+++.|++||.+.+. .++.++|||||||++|+|++ |++||.+.+..+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----- 232 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN----- 232 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence 9876533221 1122345679999998654 47899999999999999999 899998877655444333210
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
... .....+..+.+++.+||+.+|++|||+.+++.
T Consensus 233 -----------~~~------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 233 -----------RLK------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred -----------cCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 01235789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=275.59 Aligned_cols=234 Identities=18% Similarity=0.212 Sum_probs=179.3
Q ss_pred eeeecCCCeeEEEEEEcCCC----------cEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 40 RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~----------~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
+.||+|+||.||++.+..++ ..+++|.+.... ....+|+.+++.++|+||+++++.+.. . .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-----~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-D-----E 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-C-----C
Confidence 36899999999999998776 358888765433 344578999999999999999988754 2 2
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC------cEEEE
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH------QVKIC 179 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~------~vkl~ 179 (376)
.++||||+++ +|.+.+.. ....+++..+..++.||+.||+|||+ +|++||||||+||+++.++. .+||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHR---EKNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred cEEEEEcCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEecCccccCCceeEEeC
Confidence 6799999996 55555543 22368899999999999999999999 79999999999999986331 69999
Q ss_pred eecccccCccCCCceeeeeccccCchhhhhCC-CCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 017147 180 DFGSAKQLIAGEANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 257 (376)
Q Consensus 180 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 257 (376)
|||++..... .....++..|+|||++.+. ..++.++|+||+||++|+|++ |..||...+..+....... .
T Consensus 151 Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~----~- 222 (259)
T cd05037 151 DPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD----Q- 222 (259)
T ss_pred CCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc----C-
Confidence 9999876533 2234556789999998654 358999999999999999999 6888876653322211110 0
Q ss_pred HHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.. .+......+.++|.+||..+|++|||+.++++
T Consensus 223 -----------~~--------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 223 -----------HR--------------LPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -----------CC--------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 00112368899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=274.89 Aligned_cols=245 Identities=20% Similarity=0.252 Sum_probs=181.0
Q ss_pred eeecCCCeeEEEEEEcCC--CcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeec
Q 017147 41 VVGTGSFGIVFQAKCLET--GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY 113 (376)
Q Consensus 41 ~lg~G~~g~Vy~~~~~~~--~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 113 (376)
.||+|+||+||++..... ...+++|.+.... ....+|+.+++.++||||+++++.+.. ....|+||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEEec
Confidence 589999999999975433 3456677665332 234478888999999999999998843 3348899999
Q ss_pred ccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCC-
Q 017147 114 VPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE- 191 (376)
Q Consensus 114 ~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~- 191 (376)
+++ +|.+.+.........+++..++.++.||+.||+|||+ ++++||||||+|||++. ++.++|+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~-~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTS-DLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcC-CccEEecccccccccCcchh
Confidence 995 7777775432233456777888999999999999999 79999999999999996 7789999999986432211
Q ss_pred --CceeeeeccccCchhhhhCC------CCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 192 --ANISYICSRFYRAPELIFGA------TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 192 --~~~~~~~t~~y~aPE~l~~~------~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
......++..|+|||++... ..++.++|||||||++|+|++ |..||...+..+.+..+.+.....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~------ 228 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK------ 228 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc------
Confidence 11234567889999987421 235778999999999999997 678998777766665544321100
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+...+...+++.+.+++..|| .+|++||+++++++
T Consensus 229 -----------------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 229 -----------------LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred -----------------cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0011112236788999999999 68999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=288.94 Aligned_cols=245 Identities=26% Similarity=0.367 Sum_probs=193.2
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCc---E-EEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGE---T-VAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~-~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
++-.+.+.||+|+||.||++..+..+. . ||+|....+. ...-.|+++|+.++|||||+++++.....-
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P- 235 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP- 235 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc-
Confidence 345566899999999999998775432 3 8999876422 222379999999999999999998855443
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
+++|||+|.| +|.+.|+. ....++..+...++++.+.||+|||+ ++++||||-..|+|++. +..+||+||
T Consensus 236 ----l~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~-~~~vKISDF 306 (474)
T KOG0194|consen 236 ----LMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSK-KGVVKISDF 306 (474)
T ss_pred ----cEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecC-CCeEEeCcc
Confidence 8899999996 77777764 33469999999999999999999999 79999999999999996 677899999
Q ss_pred cccccCccCCCce-eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 182 GSAKQLIAGEANI-SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 182 g~a~~~~~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
|+++......... ..--...|+|||.+... .|+.++||||+||++||+++ |..||.+....+....+...
T Consensus 307 GLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~------- 378 (474)
T KOG0194|consen 307 GLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN------- 378 (474)
T ss_pred ccccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc-------
Confidence 9987543111111 11124569999999654 69999999999999999998 88999999998888777441
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+. -.++...+.++..++.+|+..||++|+|..++.+
T Consensus 379 ----------~~r----------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 379 ----------GYR----------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ----------Ccc----------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 111 1122346788999999999999999999988763
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=278.51 Aligned_cols=283 Identities=29% Similarity=0.499 Sum_probs=214.1
Q ss_pred CCcccceeeeeeeeecCCCeeEEEEEEcC---CCcEEEEEEeec--cccchHHHHHHHHhCC-CCceeeeceeeeecCCC
Q 017147 29 EPKQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQ--DRRYKNRELQLMRVMD-HPNVISLKHCFFSTTSK 102 (376)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~--~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 102 (376)
.|.....|.++..||+|.|++||++.+.. ..+.||+|.+.. .......|+++|..+. +.||+++.+++ .
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----r 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----R 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----c
Confidence 34556789999999999999999999887 788999998853 3455678999999884 88999999888 4
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
.+..+.+|+||++. ...++.. .++..+++.|++.++.||.++|+ +||+||||||+|+|.+...+.-.|+||
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred cCCeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEec
Confidence 44458899999995 4333332 36678899999999999999999 799999999999999988888999999
Q ss_pred cccccC-----------------cc--C--------------------------CCceeeeeccccCchhhhhCCCCCCc
Q 017147 182 GSAKQL-----------------IA--G--------------------------EANISYICSRFYRAPELIFGATEYTT 216 (376)
Q Consensus 182 g~a~~~-----------------~~--~--------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~ 216 (376)
|+|... .. + .......||++|+|||++...+.-++
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 998511 00 0 00113578999999999988877899
Q ss_pred hhhhHhHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHhhcCc------------------CCCCCCCCCC-
Q 017147 217 SIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEIIKVLGTPTREEIRCMNP------------------NYTDFRFPQI- 276 (376)
Q Consensus 217 ~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~- 276 (376)
++||||.|||+..+++++.|| ...+..+.+.+|...+|...-.....+.. +|.......+
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 999999999999999999886 45666777777777776543322211111 1111100000
Q ss_pred CCC---ChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 277 KAH---PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 277 ~~~---~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
+.. .+.....+..+..+.||+.+||+.||.+|+|++++|.||||....
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 000 122333344567899999999999999999999999999998654
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=302.91 Aligned_cols=247 Identities=22% Similarity=0.363 Sum_probs=199.7
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCC-----cEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
..-+..+.||+|+||.||.+...... ..||+|.+.+... ...+|..+|+.++|||||+++++.++...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~-- 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP-- 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC--
Confidence 35777889999999999999876433 3499999865432 33479999999999999999999977443
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhh---cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEE
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 179 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~ 179 (376)
.+|++|||.| +|+..|+..+. ....++......++.||++|++||++ +++|||||...|+||+. ...|||+
T Consensus 770 ---~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~~-~r~VKIa 844 (1025)
T KOG1095|consen 770 ---PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLDE-RRVVKIA 844 (1025)
T ss_pred ---cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeecc-cCcEEEc
Confidence 7899999995 88888875321 15568999999999999999999999 79999999999999997 6889999
Q ss_pred eecccccCccCCCceee---eeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 017147 180 DFGSAKQLIAGEANISY---ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT 255 (376)
Q Consensus 180 Dfg~a~~~~~~~~~~~~---~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 255 (376)
|||+|+.....+..... .-...|||||.+.. ..++.++|||||||++||+++ |..||++.+..+.+....+.-..
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL 923 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL 923 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc
Confidence 99999955444322111 11245999999965 569999999999999999998 99999999988887765552110
Q ss_pred CCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
. .+..++..+.+++.+||+.+|++||+...+++
T Consensus 924 ----------------~------------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 ----------------D------------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ----------------C------------CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 0 12347889999999999999999999998886
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=273.29 Aligned_cols=259 Identities=27% Similarity=0.381 Sum_probs=189.1
Q ss_pred ceeeeeeeeecCCCeeEEEEEEc----CCCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
.+|++.+.||+|+||.||+|... .+++.+|+|.+..... ...+|+++++.++|+||+++++++... ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP---GG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC---CC
Confidence 46888999999999999999864 3478999998865433 345799999999999999998876432 23
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
.+.+++|||+++ +|.+.+.. ....+++..+..++.|++.||+|||+ +|++|+||||+||+++. ++.++|+|||.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~ 155 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVES-EDLVKISDFGL 155 (284)
T ss_pred CceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcC-CCCEEEccccc
Confidence 348899999985 77766653 23358999999999999999999999 79999999999999996 68899999999
Q ss_pred cccCccCCCce----eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCH
Q 017147 184 AKQLIAGEANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTPTR 258 (376)
Q Consensus 184 a~~~~~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~ 258 (376)
+.......... ...++..|+|||.+.+. .++.++|+|||||++|+|++|..||......... +... .+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~ 232 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR--MIGIAQGQMIV 232 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhcc--ccccccccccH
Confidence 98664332211 12334569999998554 5889999999999999999999998654321100 0000 000000
Q ss_pred HHHh-hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 259 EEIR-CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 259 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..+. ..... . .. ..+..++.++.+|+.+||+.+|++|||+.++++
T Consensus 233 ~~~~~~~~~~-~--~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 233 TRLLELLKEG-E--RL----------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHHHHcC-C--cC----------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000 00000 0 00 011235788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=288.12 Aligned_cols=273 Identities=23% Similarity=0.292 Sum_probs=181.6
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEc----------------CCCcEEEEEEeeccccc------------------hHHH
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCL----------------ETGETVAIKKVLQDRRY------------------KNRE 77 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~----------------~~~~~~aiK~~~~~~~~------------------~~~e 77 (376)
..++|++.+.||+|+||+||++... ..++.||||++..+... ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4568999999999999999999752 24567999998543211 1236
Q ss_pred HHHHHhCCCCce-----eeeceeeeecCC---CCceEEEEEeecccc-hHHHHHHhhhh--------------------c
Q 017147 78 LQLMRVMDHPNV-----ISLKHCFFSTTS---KNELFLNLVMEYVPE-SMYRVLKHYSS--------------------A 128 (376)
Q Consensus 78 ~~~l~~l~h~~i-----v~~~~~~~~~~~---~~~~~~~lv~e~~~~-~l~~~l~~~~~--------------------~ 128 (376)
+.++..++|.++ +++++++..... ......++||||+++ +|.+.+..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 666777776654 455554432111 112347899999995 77666642110 1
Q ss_pred CCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCCcee--eeeccccCchh
Q 017147 129 NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS--YICSRFYRAPE 206 (376)
Q Consensus 129 ~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~~t~~y~aPE 206 (376)
...+++..++.++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||++........... ..+|+.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTV-DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECC-CCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 1234667888999999999999999 79999999999999996 67899999999975433322222 23378999999
Q ss_pred hhhCCCC-------------------C--CchhhhHhHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 207 LIFGATE-------------------Y--TTSIDIWSAGCVLAELLLGQP-LFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 207 ~l~~~~~-------------------~--~~~~DiwslG~il~~ll~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
.+..... + ..+.|+||+||++|+|++|.. ||.+........... . .....|...
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~---~-~~~~~~r~~ 456 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQY---D-NDLNRWRMY 456 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhc---c-chHHHHHhh
Confidence 9743211 1 124799999999999999875 775432211110000 0 000111110
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCC---CCCCCHHHHhcCCCccc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP---SLRCTALEACAHPFFDE 322 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp---~~R~t~~e~l~hp~~~~ 322 (376)
....+........++.++||+.+||..+| .+|+|++|+|+||||..
T Consensus 457 ------------~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 457 ------------KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred ------------cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 00111111234478999999999999876 68999999999999953
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=293.25 Aligned_cols=250 Identities=31% Similarity=0.467 Sum_probs=191.2
Q ss_pred eeeeeeeecCCCee-EEEEEEcCCCcEEEEEEeeccc-cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEEEee
Q 017147 36 YMAERVVGTGSFGI-VFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVME 112 (376)
Q Consensus 36 y~~~~~lg~G~~g~-Vy~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e 112 (376)
|.-.+++|.|+.|+ ||++.. .++.||+|.+.... ....+|+..|+.- .|||||+++..= .+..+.||..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEeh
Confidence 55566799999987 598886 78899999887654 4678999999887 599999986543 66778999999
Q ss_pred cccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC----CCCcEEEEeecccccCc
Q 017147 113 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP----LTHQVKICDFGSAKQLI 188 (376)
Q Consensus 113 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~----~~~~vkl~Dfg~a~~~~ 188 (376)
.|..+|.+++...............+.++.|++.||++||+ .+|+||||||.||||+. ...+++|+|||+|+...
T Consensus 584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 99999999987521111112225567889999999999999 69999999999999975 23579999999999876
Q ss_pred cCCCc----eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 189 AGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 189 ~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
.+... .+..||-.|+|||++.+.. -+.++||||+||++|+.++| ..||...-.. -..|+.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~------------ 727 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILT------------ 727 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhc------------
Confidence 65433 3457799999999997655 57799999999999999995 8999754322 122222
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
..+.+-.+. .....++.|||.+||++||..||+|.++|.||||-.
T Consensus 728 -----~~~~L~~L~---------~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 728 -----GNYTLVHLE---------PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred -----Cccceeeec---------cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 011111100 001228999999999999999999999999999954
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=258.59 Aligned_cols=238 Identities=38% Similarity=0.639 Sum_probs=190.2
Q ss_pred CCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecccc-hHH
Q 017147 46 SFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMY 119 (376)
Q Consensus 46 ~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 119 (376)
+||.||+|.+..+++.+|+|++.... ....+|+..++.++|+|++++.+.+... ...++++||+++ +|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCHH
Confidence 58999999999899999999986542 3456899999999999999999887433 348899999997 777
Q ss_pred HHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCCceeeeec
Q 017147 120 RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 199 (376)
Q Consensus 120 ~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t 199 (376)
+.+.. ...++...+..++.+++.++.+||+ .+++|+||+|.||+++. ++.++|+|||.+.............++
T Consensus 76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~ 149 (244)
T smart00220 76 DLLKK----RGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDE-DGHVKLADFGLARQLDPGGLLTTFVGT 149 (244)
T ss_pred HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECC-CCcEEEccccceeeeccccccccccCC
Confidence 76653 2338899999999999999999999 79999999999999996 678999999999876554444456678
Q ss_pred cccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCC
Q 017147 200 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAH 279 (376)
Q Consensus 200 ~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (376)
..|+|||.+.+ ..++.++|+||+|+++++|++|..||..........+.........
T Consensus 150 ~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---------------------- 206 (244)
T smart00220 150 PEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF---------------------- 206 (244)
T ss_pred cCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC----------------------
Confidence 88999999864 4478899999999999999999999987443333332222100000
Q ss_pred ChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 280 PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 280 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
......++.++.+++.+||..+|++||++.++++||||
T Consensus 207 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 207 ---PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ---ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 00001157899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=277.08 Aligned_cols=241 Identities=30% Similarity=0.444 Sum_probs=192.8
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCC----CcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLET----GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
+..+..+.||.|.||.||.+....- .-.||||....+. ..+..|..+|+.++||||+++++++....
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P---- 464 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP---- 464 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc----
Confidence 3455667899999999999986422 3458999886532 33447899999999999999999983221
Q ss_pred eEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
.+||||+++ |.|.+.++. ....++......|++||+.||.|||+ ...|||||-..|||+.+ ...|||+|||+
T Consensus 465 --~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVsS-p~CVKLaDFGL 537 (974)
T KOG4257|consen 465 --MWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVSS-PQCVKLADFGL 537 (974)
T ss_pred --eeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeecC-cceeeecccch
Confidence 789999999 677777764 45678888899999999999999999 79999999999999997 66799999999
Q ss_pred cccCccCCCceeeee--ccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 184 AKQLIAGEANISYIC--SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 184 a~~~~~~~~~~~~~~--t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
++...+........+ ..-|||||.+. -+.++.+||||-|||.+||++. |..||.+....+.+..+.+.-+.|
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP---- 612 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP---- 612 (974)
T ss_pred hhhccccchhhccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC----
Confidence 998766554333333 34599999984 4458999999999999999987 999999987777665554422111
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 314 (376)
.+.++++.+-.|+.+||++||.+||+..++
T Consensus 613 ------------------------~P~nCPp~LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 613 ------------------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred ------------------------CCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence 245689999999999999999999987654
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=272.98 Aligned_cols=241 Identities=23% Similarity=0.377 Sum_probs=198.9
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccc---hHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---KNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.++...||.|.||.||.+.+++-.-.||+|.+..+... ...|+.+|+.++|||+|++.+++....- +|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP-----FYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP-----FYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC-----eEEEE
Confidence 466778899999999999999999999999999876543 3479999999999999999999954433 88999
Q ss_pred eccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
|||. |+|++.|+.. ....++.....+++.||..|++||.. ++++||||-..|+|+.+ ++.||++|||+++.+...
T Consensus 343 EfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgE-nhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred ecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccc-cceEEeeccchhhhhcCC
Confidence 9998 8999999753 33457777888999999999999999 89999999999999996 889999999999977543
Q ss_pred CCceeeee---ccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 191 EANISYIC---SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 191 ~~~~~~~~---t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
. .....| ..-|.|||.+.-+ .++.++|||+|||+|||+.| |-.||++-+....+..+.+.
T Consensus 419 T-YTAHAGAKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-------------- 482 (1157)
T KOG4278|consen 419 T-YTAHAGAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-------------- 482 (1157)
T ss_pred c-eecccCccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc--------------
Confidence 3 222233 4459999998543 48999999999999999998 99999999877666554432
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 314 (376)
|.+. -++.+++..-+|++.||+|.|.+||+..|+
T Consensus 483 ----yRM~----------~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 483 ----YRMD----------GPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred ----cccc----------CCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 2211 134689999999999999999999998765
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=284.07 Aligned_cols=244 Identities=26% Similarity=0.365 Sum_probs=205.7
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCC---cEEEEEEeec-----cccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQ-----DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
.-.+.++||.|.||.|+++..+..+ ..||||.++. .+.....|+.||-+++||||+++.++... ..-
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk-----s~P 704 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK-----SKP 704 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec-----Cce
Confidence 5678899999999999999988666 4599999853 34445579999999999999999999832 233
Q ss_pred EEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+.||+|||+ |+|..+|+. ..+.|+..++.-+++.|+.|++||-++ |+|||||...|||+++ +-..|++|||+++
T Consensus 705 vMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm-~YVHRDLAARNILVNs-nLvCKVsDFGLSR 779 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDM-NYVHRDLAARNILVNS-NLVCKVSDFGLSR 779 (996)
T ss_pred eEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhc-Cchhhhhhhhheeecc-ceEEEecccccee
Confidence 789999998 678777774 557799999999999999999999995 9999999999999997 8899999999999
Q ss_pred cCccCC-Cceeeee---ccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 186 QLIAGE-ANISYIC---SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 186 ~~~~~~-~~~~~~~---t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
...+.. ...+..| ...|.|||.+. -++++.+|||||+|++|||.++ |..||-+...++.+..|.+..+.|++
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP-- 856 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP-- 856 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC--
Confidence 764443 2233333 35699999995 4569999999999999999886 99999999999999999886655543
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
-+++..+-.|+..||++|-.+||...|++++
T Consensus 857 --------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 857 --------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred --------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 3478999999999999999999999988753
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=275.46 Aligned_cols=248 Identities=24% Similarity=0.348 Sum_probs=202.4
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCC-C--cEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLET-G--ETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~-~--~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
+...+.++||+|.||.|+++.+... | ..||||.+..+.. .+.+|+.+|..|+|+|++++|+++.+..
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp----- 184 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP----- 184 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch-----
Confidence 4667788999999999999988643 3 4589999876543 3458999999999999999999986522
Q ss_pred EEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..+|||+++ |+|++-|+. .....|.....+.|+.||+.|+.||.+ ++.|||||-..|+|+-+ ...|||+|||+.
T Consensus 185 -~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllas-prtVKI~DFGLm 259 (1039)
T KOG0199|consen 185 -AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLAS-PRTVKICDFGLM 259 (1039)
T ss_pred -hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecc-cceeeeecccce
Confidence 559999999 688887765 345678899999999999999999999 89999999999999987 678999999999
Q ss_pred ccCccCCCceeeee----ccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 185 KQLIAGEANISYIC----SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 185 ~~~~~~~~~~~~~~----t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
+....++....... ...|+|||.+.. ..++.++|+|++||++|||++ |..||.|.....++..|-+.-.
T Consensus 260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er----- 333 (1039)
T KOG0199|consen 260 RALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER----- 333 (1039)
T ss_pred eccCCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc-----
Confidence 98766665443222 335999999954 569999999999999999998 8999999998888876653110
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
++ -++.+++++-+++..||..+|.+|||...+...-+.
T Consensus 334 -------------Lp----------RPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 334 -------------LP----------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred -------------CC----------CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 00 124589999999999999999999999888654443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=238.75 Aligned_cols=213 Identities=23% Similarity=0.417 Sum_probs=173.7
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHH-HhCCCCceeeeceeeeecCCCCceE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLM-RVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
.+....+..||+|++|.|=+.++..+|...|+|.+.... .....|+++. +...+|++|.+++.++...+
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd----- 119 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD----- 119 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc-----
Confidence 455666788999999999999999999999999885321 1222445443 34468999999998866655
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
++|.||.|..++..+-++-...++.++|..+-+++..++.||.|||+.-.++|||+||+|||++. .+.+|+||||.+..
T Consensus 120 vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~-~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 120 VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINY-DGQVKICDFGISGY 198 (282)
T ss_pred EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEcc-CCcEEEccccccee
Confidence 89999999998888777777788999999999999999999999998558999999999999996 78899999999986
Q ss_pred CccCCCceeeeeccccCchhhhhC---CCCCCchhhhHhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHH
Q 017147 187 LIAGEANISYICSRFYRAPELIFG---ATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIK 251 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~ 251 (376)
..+.-..+...|-..|+|||.+.. ...|+.++||||||+.+.||.+++.||... ++.+++.++.+
T Consensus 199 L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 199 LVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred ehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 655544444566677999999833 335899999999999999999999999764 45566666554
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=267.30 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=198.1
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
....+++.||+|-||.|.+|+- ..+..||+|++..+ +....+|+++|.+|+||||+.+++++...+. +|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-----ic 611 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-----LC 611 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----hH
Confidence 3678899999999999999984 45689999998654 2445689999999999999999999965544 89
Q ss_pred EEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+|+||++ |+|...+..... ..+.-.....++.||+.|++||.+ -++|||||.+.|+|++. .+.+||+|||.++..
T Consensus 612 mI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~-e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDG-EFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecC-cccEEecCccccccc
Confidence 9999998 677777754211 223455567799999999999999 59999999999999996 788999999999977
Q ss_pred ccCCCce---eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 188 IAGEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 188 ~~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
..++... ..+-...|||||.+.. ++++.++|+|++|+++||+++ ...||......+...+....+..+.+..+.
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL 766 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence 6655432 2233567999999865 459999999999999999875 789998888777776665554433322111
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 315 (376)
.-+.-++..+.+++.+||..|-.+|||.+++-
T Consensus 767 ---------------------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 767 ---------------------SRPPACPQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred ---------------------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 11234688899999999999999999999984
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=300.53 Aligned_cols=253 Identities=22% Similarity=0.319 Sum_probs=182.5
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeec
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY 113 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 113 (376)
..|.....||+|+||.||+|.++.++..||+|++.........|++.++.++|||||++++++.... ..|+||||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~-----~~~lv~Ey 764 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEK-----GAYLIHEY 764 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCC-----CCEEEEeC
Confidence 3466677899999999999999999999999998766555567899999999999999999985433 37899999
Q ss_pred ccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhh---cCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 114 VPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH---TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 114 ~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
+++ +|.+.++ .+++..+..++.|++.|++||| + .+|+||||||+||+++. +...++. ||.......
T Consensus 765 ~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~~-~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 765 IEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIIDG-KDEPHLR-LSLPGLLCT 834 (968)
T ss_pred CCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEECC-CCceEEE-ecccccccc
Confidence 985 6666663 3788899999999999999999 6 69999999999999996 5556664 665543221
Q ss_pred CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcCcCC
Q 017147 190 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMNPNY 268 (376)
Q Consensus 190 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~ 268 (376)
.....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ...+....+..-... .. ..+
T Consensus 835 ---~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~----~~~ 904 (968)
T PLN00113 835 ---DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC--HL----DMW 904 (968)
T ss_pred ---CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc--ch----hhe
Confidence 123467899999999865 4589999999999999999999999853221 111111111100000 00 000
Q ss_pred CCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.+ +..... .........++.+++.+||+.||++|||+.|+++.
T Consensus 905 ~~---~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 905 ID---PSIRGD---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred eC---ccccCC---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00 000000 00001112367889999999999999999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=265.38 Aligned_cols=201 Identities=26% Similarity=0.413 Sum_probs=174.7
Q ss_pred CCCCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccch------------HHHHHHHHhCC---CCceee
Q 017147 27 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK------------NRELQLMRVMD---HPNVIS 91 (376)
Q Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~------------~~e~~~l~~l~---h~~iv~ 91 (376)
.+.+.+..+|..++.+|.|+||+|++|.++.+...|+||.+.+.+... -.|+.||..++ |+||++
T Consensus 554 e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlK 633 (772)
T KOG1152|consen 554 EKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILK 633 (772)
T ss_pred eeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhh
Confidence 344556678999999999999999999999999999999887654332 25999999998 999999
Q ss_pred eceeeeecCCCCceEEEEEeecccc--hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEE
Q 017147 92 LKHCFFSTTSKNELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 169 (376)
Q Consensus 92 ~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill 169 (376)
++++| +++.++||+||--+. +|.+++. ....++|.++..|+.|++.|+++||+ .||+|||||-+|+.+
T Consensus 634 lLdfF-----Eddd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenviv 703 (772)
T KOG1152|consen 634 LLDFF-----EDDDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIV 703 (772)
T ss_pred hhhee-----ecCCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEE
Confidence 99999 777889999998874 5555554 67889999999999999999999999 699999999999999
Q ss_pred cCCCCcEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCC
Q 017147 170 DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 239 (376)
Q Consensus 170 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 239 (376)
++ ++.+||+|||.|.... .......+||..|.|||++.|..+.+.+.|||++|++||.++....||..
T Consensus 704 d~-~g~~klidfgsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 704 DS-NGFVKLIDFGSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ec-CCeEEEeeccchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 97 7789999999997544 34456789999999999998877779999999999999999999999863
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=270.27 Aligned_cols=257 Identities=26% Similarity=0.388 Sum_probs=207.7
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeec----cccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
-.++|+.+..+|+|+||.||+|+++.+++..|+|++.- +-...+.|+-+++..+|+||+.+++.+...+. +
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk-----l 87 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-----L 87 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC-----c
Confidence 35689999999999999999999999999999998864 34556789999999999999999999966555 8
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
++.||||+|+.++.+- ...+.+++.++.+..++.+.+++|||+ .|-+|||||-.|||++. .+.+|++|||.+..+
T Consensus 88 wicMEycgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd-~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTD-EGDVKLADFGVSAQI 162 (829)
T ss_pred EEEEEecCCCccccee---eecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecc-cCceeecccCchhhh
Confidence 9999999975333333 256889999999999999999999999 69999999999999996 788999999998765
Q ss_pred ccC-CCceeeeeccccCchhhh--hCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 188 IAG-EANISYICSRFYRAPELI--FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 188 ~~~-~~~~~~~~t~~y~aPE~l--~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
... ....+..|||+|||||+- .....|...+|+|++|+...|+---++|-........+..+-+..-.|
T Consensus 163 tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qp-------- 234 (829)
T KOG0576|consen 163 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQP-------- 234 (829)
T ss_pred hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCC--------
Confidence 433 234578999999999985 233458999999999999999988888876666665554443321111
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
|.++. ..+-++.+-+|++.+|.++|.+|||++.+|.|||...
T Consensus 235 ---------p~lkD-------k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 235 ---------PTLKD-------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred ---------CcccC-------CccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 11111 1123677889999999999999999999999999853
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-33 Score=233.44 Aligned_cols=259 Identities=22% Similarity=0.309 Sum_probs=187.2
Q ss_pred CcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc---chHHHHHHHHhC-CCCceeeeceeeeecCCCCce
Q 017147 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 105 (376)
....+.|.+.+.||+|-||++.+|+++.++..+++|.++.... ...+|...--.| -|.||+.-+++-+... .
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~----d 95 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS----D 95 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcC----c
Confidence 3455789999999999999999999999999999999875433 233555443334 4899999888765433 3
Q ss_pred EEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEE-cCCCCcEEEEeecc
Q 017147 106 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGS 183 (376)
Q Consensus 106 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill-~~~~~~vkl~Dfg~ 183 (376)
++.+++||++ |+|.+-+. ...+.|...+.++.|++.|+.|||+ +++||||||.+|||+ +++..+|||||||.
T Consensus 96 ~YvF~qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred eEEEeeccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeeccc
Confidence 6889999999 56655443 3568899999999999999999999 899999999999997 44456899999999
Q ss_pred cccCccCCCceeeeeccccCchhhhhCC----CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCH
Q 017147 184 AKQLIAGEANISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLGTPTR 258 (376)
Q Consensus 184 a~~~~~~~~~~~~~~t~~y~aPE~l~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~ 258 (376)
.+....--.. .-.+..|.+||++... -...+.+|+|.||+++|.++||.+||+.....+ -+.+.++.++.-..
T Consensus 170 t~k~g~tV~~--~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 170 TRKVGTTVKY--LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP 247 (378)
T ss_pred ccccCceehh--hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc
Confidence 8754221111 1124558999987432 224678999999999999999999997433222 22233332221110
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCC---CCHHHHhcCCCccc
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR---CTALEACAHPFFDE 322 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---~t~~e~l~hp~~~~ 322 (376)
..| ..| ..+++.+..+.++-|..+|++| -++......-|...
T Consensus 248 -------------~~P--------~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 248 -------------ALP--------KKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred -------------cCc--------hhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 001 111 2378999999999999999999 45555566666643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=257.43 Aligned_cols=244 Identities=26% Similarity=0.399 Sum_probs=188.3
Q ss_pred eeeeeeeecCCCeeEEEEEEcC-------CCcEEEEEEeeccc-----cchHHHHHHHHhCC-CCceeeeceeeeecCCC
Q 017147 36 YMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDR-----RYKNRELQLMRVMD-HPNVISLKHCFFSTTSK 102 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 102 (376)
..+.+.||+|+||+|+++.-.. ....||+|.+.... .....|+++|+.+. |+||+.+.+++..
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~---- 373 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ---- 373 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence 3566689999999999987431 14569999886432 33457999999885 9999999998844
Q ss_pred CceEEEEEeeccc-chHHHHHHhhh---h-------cC--CCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEE
Q 017147 103 NELFLNLVMEYVP-ESMYRVLKHYS---S-------AN--QRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 169 (376)
Q Consensus 103 ~~~~~~lv~e~~~-~~l~~~l~~~~---~-------~~--~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill 169 (376)
...+++|+||+. |+|+..++..+ . .. ..++......+..||+.|++||++ ..++||||-..|||+
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARNVLI 451 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhhEEe
Confidence 334889999999 78888887644 0 11 238999999999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeecccccCccCCCcee--eee--ccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCC-hH
Q 017147 170 DPLTHQVKICDFGSAKQLIAGEANIS--YIC--SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN-AV 243 (376)
Q Consensus 170 ~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~~--t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~-~~ 243 (376)
.. +..+||+|||+|+.......... ..+ ...|||||.+.. ..|+.++||||+||+|||+++ |..||++.. ..
T Consensus 452 ~~-~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~ 529 (609)
T KOG0200|consen 452 TK-NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE 529 (609)
T ss_pred cC-CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence 96 78899999999986544333221 111 223999999966 669999999999999999998 999999855 33
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017147 244 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315 (376)
Q Consensus 244 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 315 (376)
+.+. .++. |.. -..+..+++++-++++.||+.+|++||+..++.
T Consensus 530 ~l~~-~l~~-G~r--------------------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~ 573 (609)
T KOG0200|consen 530 ELLE-FLKE-GNR--------------------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECV 573 (609)
T ss_pred HHHH-HHhc-CCC--------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 3332 2221 100 011335789999999999999999999998876
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=240.12 Aligned_cols=263 Identities=25% Similarity=0.293 Sum_probs=183.0
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-cchHHHHHHHH--hCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMR--VMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~--~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
....+.+.||+|.||.||+|.. +++.||||+++... .....|.+|.+ .++|+||++++..--... ....-++||
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLV 286 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLV 286 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEE
Confidence 3567788999999999999986 56999999997543 33445555554 568999999876543222 124458899
Q ss_pred eeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcC--------CCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 111 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--------PRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 111 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--------~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
++|.+ |+|.+.|+. ..+++....+++.-+++||+|||+- ..|+|||||..||||.+ +....|+||
T Consensus 287 t~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~-DlTccIaDF 360 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN-DLTCCIADF 360 (534)
T ss_pred eeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc-CCcEEeecc
Confidence 99998 798888864 6789999999999999999999971 36999999999999996 889999999
Q ss_pred cccccCccCCC---ceeeeeccccCchhhhhCCCCCC-----chhhhHhHHHHHHHHHhCCCCCC-CCChHHHHHHHHHH
Q 017147 182 GSAKQLIAGEA---NISYICSRFYRAPELIFGATEYT-----TSIDIWSAGCVLAELLLGQPLFP-GENAVDQLVEIIKV 252 (376)
Q Consensus 182 g~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~-----~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~ 252 (376)
|+|..+..... ....+||..|||||++.+.-+.. .+.||||+|.+||||++.-.-+. +....-++---.+.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 99987654432 33578999999999998765554 46899999999999998653332 11111000000011
Q ss_pred hCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccC-CChhHHHHHHhhcCcCCCCCCCHH
Q 017147 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTAL 312 (376)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~t~~ 312 (376)
-..|+.+.+...- ..+..++.|....... --..+.+.+.-||..||+-|+|+.
T Consensus 441 G~hPt~e~mq~~V-------V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 441 GNHPTLEEMQELV-------VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred cCCCCHHHHHHHH-------HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 1123333222110 0000011111111111 235688999999999999999985
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=250.92 Aligned_cols=242 Identities=27% Similarity=0.366 Sum_probs=192.3
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCc----EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
..+..++||+|+||+||++.....++ +||||++.... ....+|+-+|..++|||++++++++....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~----- 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST----- 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----
Confidence 45566789999999999999876654 58899885432 33457889999999999999999884332
Q ss_pred EEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
+-||++|++ |.|++.++. ....+.......|.+||+.|+.|||. ++++||||-..|+||.+ ...+||.|||++
T Consensus 772 -~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVks-P~hvkitdfgla 845 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKS-PNHVKITDFGLA 845 (1177)
T ss_pred -HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecC-CCeEEEEecchh
Confidence 559999999 688888765 55678889999999999999999999 79999999999999997 667999999999
Q ss_pred ccCccCCCceeeee---ccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 185 KQLIAGEANISYIC---SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 185 ~~~~~~~~~~~~~~---t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
+............+ .+-|||-|.+.. +.|+.++||||+||.+||++| |..|+.+....++-..+.+. .
T Consensus 846 ~ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g----e--- 917 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG----E--- 917 (1177)
T ss_pred hccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc----c---
Confidence 97766555443333 455899998864 569999999999999999998 99999988766544333221 1
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.... +...+.++--++.+||..|+..||++.++..
T Consensus 918 ---------RLsq------------PpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 918 ---------RLSQ------------PPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ---------cCCC------------CCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 0111 2236788899999999999999999987753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=216.65 Aligned_cols=208 Identities=36% Similarity=0.583 Sum_probs=173.7
Q ss_pred eecCCCeeEEEEEEcCCCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeeccc-
Q 017147 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP- 115 (376)
Q Consensus 42 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~- 115 (376)
||+|++|.||++.+..+++.+++|++..... ...+|+..++.++|++++++++.+... ...++++|+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCCC
Confidence 6899999999999988899999999876543 467899999999999999999887433 44889999999
Q ss_pred chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCC-Cce
Q 017147 116 ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANI 194 (376)
Q Consensus 116 ~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~ 194 (376)
++|.+.+... ...++...++.++.+++.++.+||+ .|++|+||+|.||+++..++.++|+|||.+....... ...
T Consensus 76 ~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (215)
T cd00180 76 GSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK 151 (215)
T ss_pred CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhh
Confidence 5777666531 1468899999999999999999999 7999999999999999535679999999997654332 122
Q ss_pred eeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCC
Q 017147 195 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 274 (376)
Q Consensus 195 ~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (376)
...+...|++||.+.....++.++|+|++|+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 345677899999985543578999999999999999
Q ss_pred CCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 017147 275 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318 (376)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 318 (376)
..+.+++.+||+.||++||++.++++|+
T Consensus 188 ----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1456899999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=270.08 Aligned_cols=207 Identities=17% Similarity=0.179 Sum_probs=144.6
Q ss_pred hCCC-CceeeeceeeeecC--CCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeee
Q 017147 83 VMDH-PNVISLKHCFFSTT--SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 159 (376)
Q Consensus 83 ~l~h-~~iv~~~~~~~~~~--~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H 159 (376)
.++| +||+++++.|-... ......++.++|+++++|.+.+.. ....+++..+..++.||+.||.|||+ +||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHS-QGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence 3444 46777766652111 111234668899999998888753 34569999999999999999999999 79999
Q ss_pred cCCCCCcEEEcC------------------CCCcEEEEeecccccCccCC-----------------CceeeeeccccCc
Q 017147 160 RDLKPQNLLVDP------------------LTHQVKICDFGSAKQLIAGE-----------------ANISYICSRFYRA 204 (376)
Q Consensus 160 ~dlkp~Nill~~------------------~~~~vkl~Dfg~a~~~~~~~-----------------~~~~~~~t~~y~a 204 (376)
|||||+||||+. .+..+|++|||+++...... ......+|++|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999963 13346666666665321100 0112357889999
Q ss_pred hhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhh
Q 017147 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV 284 (376)
Q Consensus 205 PE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (376)
||++.+. .++.++|||||||+||||++|.+|+.... .....+.... .++.
T Consensus 184 PE~~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~~-------------------------- 233 (793)
T PLN00181 184 PEEDNGS-SSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPPQ-------------------------- 233 (793)
T ss_pred hhhhccC-CCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cChh--------------------------
Confidence 9998765 48999999999999999999998875322 1111111110 0000
Q ss_pred cccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 285 FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 285 ~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
.. ...+...+++.+||..||.+|||+.|+++||||...+
T Consensus 234 ~~-~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~ 272 (793)
T PLN00181 234 IL-LNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR 272 (793)
T ss_pred hh-hcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence 00 0134567899999999999999999999999998753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-29 Score=215.43 Aligned_cols=197 Identities=34% Similarity=0.583 Sum_probs=163.9
Q ss_pred eeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
|.+.+.||.|++|.||++.+..+++.+|+|.+... .....+|++.++.++|+|++++++.+... ...+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEEE
Confidence 67788999999999999999988999999998654 33445799999999999999998877433 348899
Q ss_pred eecccc-hHHHHHHhhhhcCCC-cCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 111 MEYVPE-SMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 111 ~e~~~~-~l~~~l~~~~~~~~~-l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
+|++++ +|.+.+.. ... +++..+..++.+++.++.+||+ .+++|+||+|.||+++. ++.++|+|||.+....
T Consensus 76 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~-~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 76 MEYCEGGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGM-DGLVKLADFGLARFIH 149 (225)
T ss_pred EeccCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeeCceeeEec
Confidence 999997 77766653 223 7889999999999999999999 79999999999999996 6889999999988665
Q ss_pred cCC--CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCC-CChH
Q 017147 189 AGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAV 243 (376)
Q Consensus 189 ~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~ 243 (376)
... ......++..|++||.+.+...++.++|+|++|+++++|++|+.||.+ .+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~ 207 (225)
T smart00221 150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT 207 (225)
T ss_pred CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence 443 234456778899999874444578899999999999999999999977 4443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=222.69 Aligned_cols=190 Identities=26% Similarity=0.369 Sum_probs=150.5
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-cchHHHHHHHH--hCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMR--VMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~--~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
.+.++.+.||+|.||.||++.. -|+.||||++.... ..-.+|.++.+ .|+|+||+.++..-.... ..-..++||
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQLwLv 287 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQLWLV 287 (513)
T ss_pred heeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEEEEe
Confidence 4789999999999999999988 57899999996533 33335555554 579999999887543222 334458999
Q ss_pred eeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcC-------CCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 111 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-------PRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 111 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-------~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
++|.+ |+|.+.|.. ..++.+...+++..++.||++||.- ..|+|||||..||||.+ ++..-|+|+|
T Consensus 288 TdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk-n~~C~IADLG 361 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLG 361 (513)
T ss_pred eecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc-CCcEEEeece
Confidence 99999 799998863 6788889999999999999999961 35999999999999996 8889999999
Q ss_pred ccccCccCC-----CceeeeeccccCchhhhhCCCCC-----CchhhhHhHHHHHHHHHh
Q 017147 183 SAKQLIAGE-----ANISYICSRFYRAPELIFGATEY-----TTSIDIWSAGCVLAELLL 232 (376)
Q Consensus 183 ~a~~~~~~~-----~~~~~~~t~~y~aPE~l~~~~~~-----~~~~DiwslG~il~~ll~ 232 (376)
+|-...... .....+||..|||||++...-.. -..+||||||.++||++.
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 996543331 23467899999999999543221 246899999999999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=207.92 Aligned_cols=167 Identities=20% Similarity=0.173 Sum_probs=124.4
Q ss_pred chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCCcee
Q 017147 116 ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 195 (376)
Q Consensus 116 ~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~ 195 (376)
|+|.+.+.. .+..+++..++.++.|++.||.|||+ ++ ||+|||++. ++.+|+ ||++.......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~-~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTW-DGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcC-ccceee--ccceEeecccc----
Confidence 456666653 24569999999999999999999999 67 999999996 777888 99987553322
Q ss_pred eeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhcCcCCCCCCCC
Q 017147 196 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLGTPTREEIRCMNPNYTDFRFP 274 (376)
Q Consensus 196 ~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (376)
..+|+.|+|||++.+. .++.++||||+||++|+|++|+.||....... .+..+.........
T Consensus 64 ~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------------- 126 (176)
T smart00750 64 SRVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP---------------- 126 (176)
T ss_pred CCCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc----------------
Confidence 2678999999999664 58999999999999999999999997654332 22222221110000
Q ss_pred CCCCCChhhhcccCCCh--hHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 275 QIKAHPWHKVFHKRMPP--EAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 275 ~~~~~~~~~~~~~~~~~--~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
. .......++. ++.++|.+||..||.+|||+.+++.|+|+..
T Consensus 127 ~------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 127 R------DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred c------ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 0 0000011233 6999999999999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-29 Score=244.22 Aligned_cols=259 Identities=25% Similarity=0.376 Sum_probs=191.2
Q ss_pred ee-eeeeeeecCCCeeEEEEEEcCCCcEEEEEEeec----cccc------hHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 35 SY-MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRY------KNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 35 ~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~----~~~~------~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
.| .....+|.|++|.|+.+......+.++.|.+.. .... ...|..+-..+.|+|++.....++....
T Consensus 318 ~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-- 395 (601)
T KOG0590|consen 318 KYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-- 395 (601)
T ss_pred ccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc--
Confidence 34 456789999999999998887777777775531 1110 2245566677899999887766643332
Q ss_pred ceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 104 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 104 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
.+-+||||+++|...+. ....++...+..++.|++.|++|||+ .|+.|||+||+|+++.. ++.+||+|||.
T Consensus 396 ---~~~~mE~~~~Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~-~g~lki~Dfg~ 466 (601)
T KOG0590|consen 396 ---ILQSMEYCPYDLFSLVM----SNGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTE-NGILKIIDFGA 466 (601)
T ss_pred ---chhhhhcccHHHHHHHh----cccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEec-CCceEEeecCc
Confidence 33349999997777765 33578999999999999999999999 69999999999999997 77999999999
Q ss_pred cccCccCCC-----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 184 AKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 184 a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
+........ ....+|+..|+|||++.+........||||.|+++..|++|+.||.-....+....-.
T Consensus 467 ~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-------- 538 (601)
T KOG0590|consen 467 ASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-------- 538 (601)
T ss_pred ceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh--------
Confidence 875533322 3456788999999999777655678999999999999999999997654332221000
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
++... .....-...+...++.+.+.+|.+||+.||.+|+|++++++.+||+.+.
T Consensus 539 --------~~~~~----~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 539 --------NYSDQ----RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred --------ccccc----cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 00000 0000001112234788999999999999999999999999999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=211.67 Aligned_cols=246 Identities=18% Similarity=0.241 Sum_probs=190.5
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCC-----cEEEEEEeeccccch-----HHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~-----~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
.+++....+-+|.||.||.+..+... +.+.+|.+.+..... ..|..++..+.|||++.+.++... +
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie----~ 359 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE----D 359 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee----c
Confidence 47888888999999999999766432 345566665444333 257777888899999999888753 2
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhh----cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEE
Q 017147 104 ELFLNLVMEYVP-ESMYRVLKHYSS----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 178 (376)
Q Consensus 104 ~~~~~lv~e~~~-~~l~~~l~~~~~----~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl 178 (376)
..+.++++.+.+ |+|..++...+. ....++-.+...++.|++.|++|||+ +|++|.||-..|.++++ .-++||
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd-~LqVkl 437 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDD-QLQVKL 437 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehh-heeEEe
Confidence 233668888888 677777763321 12346778888999999999999999 89999999999999995 789999
Q ss_pred EeecccccCccCCCceeeee-----ccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 017147 179 CDFGSAKQLIAGEANISYIC-----SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKV 252 (376)
Q Consensus 179 ~Dfg~a~~~~~~~~~~~~~~-----t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 252 (376)
+|=.+++.....+.. ..| ..-||+||.+.. ..|+.++|+|||||++|||+| |+.|+..-++.+....+.+.
T Consensus 438 tDsaLSRDLFP~DYh--cLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG 514 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYH--CLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG 514 (563)
T ss_pred ccchhccccCccccc--ccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence 999999866544321 222 335999999965 459999999999999999998 99999999988877666542
Q ss_pred hCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+ +. -+-+++.++..++--||+.+|++||+.+|+..
T Consensus 515 yR------------------la----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 YR------------------LA----------QPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ce------------------ec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 11 10 12258999999999999999999999998863
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-28 Score=225.55 Aligned_cols=235 Identities=26% Similarity=0.417 Sum_probs=188.3
Q ss_pred eeecCCCeeEEEEEEc---CCCcEEEEEEeecc------ccchHHHHHHHHhCC-CCceeeeceeeeecCCCCceEEEEE
Q 017147 41 VVGTGSFGIVFQAKCL---ETGETVAIKKVLQD------RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 41 ~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
.+|+|+||.|+++... ..+..||+|+..+. ......|..++...+ ||.++++...|.. +..++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-----~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-----DGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-----ccchhHh
Confidence 3799999999987632 35677999977542 223345777888887 9999999888843 3348899
Q ss_pred eecccch-HHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 111 MEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 111 ~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
.++..|+ +..- ......+.+...+.+...++.|++++|+ .+|+|||+|++||+++. .|.+++.|||+++....
T Consensus 76 ld~~rgg~lft~----l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~-~Ghi~~tdfglske~v~ 149 (612)
T KOG0603|consen 76 LDFLRGGDLFTR----LSKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLL-EGHIKLTDFGLSKEAVK 149 (612)
T ss_pred hhhcccchhhhc----cccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecc-cCccccCCchhhhHhHh
Confidence 9999974 3222 2345678888999999999999999999 69999999999999997 77799999999987655
Q ss_pred CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCHHHHhhcCcCC
Q 017147 190 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTPTREEIRCMNPNY 268 (376)
Q Consensus 190 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~ 268 (376)
.... +||..|||||++. ....++|+||+|+++++|++|..||.+ +....|.+. ++
T Consensus 150 ~~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~-------------- 205 (612)
T KOG0603|consen 150 EKIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELE-------------- 205 (612)
T ss_pred hhhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccC--------------
Confidence 4433 8899999999995 367899999999999999999999988 555555542 11
Q ss_pred CCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCcccccCC
Q 017147 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 326 (376)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 326 (376)
++..++..++++++.++..+|..|.. +.++++|+||+.+.|.
T Consensus 206 ----------------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 206 ----------------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred ----------------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 22347889999999999999999986 4799999999998876
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-25 Score=201.77 Aligned_cols=251 Identities=19% Similarity=0.190 Sum_probs=187.1
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCC-cEEEEEEeeccc----cchHHHHHHHHhCCC----CceeeeceeeeecCCCCce
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR----RYKNRELQLMRVMDH----PNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~aiK~~~~~~----~~~~~e~~~l~~l~h----~~iv~~~~~~~~~~~~~~~ 105 (376)
+|.+.+.||+|+||.||.|.+..++ ..+|+|...... .....|..++..+.. +++..+++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 8999999999999999999988775 678999775432 145678999988873 57777766542 3455
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCC----CcEEEEee
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT----HQVKICDF 181 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~----~~vkl~Df 181 (376)
+.|+||+.++.+|.++..... ...++...+..++.|++.||++||+ .|++||||||+|+++.... ..+.|.||
T Consensus 95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 688999999999988776433 5789999999999999999999999 7999999999999997533 56999999
Q ss_pred cccc--cCccCC--------C-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017147 182 GSAK--QLIAGE--------A-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250 (376)
Q Consensus 182 g~a~--~~~~~~--------~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 250 (376)
|+++ ...... . .....||..|.++.+..+. ..+.+.|+||++.++.+++.|..||.+........+..
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 9998 321111 1 1234589999999988654 47999999999999999999999997765433333222
Q ss_pred HHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
+...... ... +....+.++.++...+-..+...+|....+...
T Consensus 251 ~~~~~~~---------------~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 251 KDPRKLL---------------TDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHhhhhc---------------ccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 2100000 000 111235677777777777888999987766543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=225.32 Aligned_cols=227 Identities=27% Similarity=0.477 Sum_probs=170.6
Q ss_pred CcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
.+...+|..++.|..|+||.||+++|+.+.+.+|+ ++.++....+. ++.....|. .
T Consensus 79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~lilRn---ilt~a~npf--------------------v 134 (1205)
T KOG0606|consen 79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLILRN---ILTFAGNPF--------------------V 134 (1205)
T ss_pred CCCccccceeEeeccCCCCceeeeeccccccchhh-cccccchhhhc---cccccCCcc--------------------e
Confidence 35567899999999999999999999999999999 46555433322 222222222 2
Q ss_pred EeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 110 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 110 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
| |+....++ .-+.++.. ++.|++|||+ .||+|||+||+|+++.. -+.+|+.|||+++...-
T Consensus 135 v-----gDc~tllk----~~g~lPvd--------mvla~Eylh~-ygivhrdlkpdnllIT~-mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 135 V-----GDCATLLK----NIGPLPVD--------MVLAVEYLHS-YGIVHRDLKPDNLLITS-MGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred e-----chhhhhcc----cCCCCcch--------hhHHhHhhcc-CCeecCCCCCCcceeee-cccccccchhhhhhhhh
Confidence 2 33223333 22344433 3789999999 79999999999999997 67899999999864311
Q ss_pred CC----------------CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 017147 190 GE----------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 253 (376)
Q Consensus 190 ~~----------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 253 (376)
.. .....+|||+|+|||++... .|++.+|||++|+|+|+.+.|..||.+.+.++.+...+...
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~ 274 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 274 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence 10 01235789999999999654 49999999999999999999999999999999888777621
Q ss_pred CCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC---CHHHHhcCCCcccccCC
Q 017147 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELREP 326 (376)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---t~~e~l~hp~~~~~~~~ 326 (376)
+.++ +. ...++++++++|.++|..+|..|. .+-++.+|+||+.+.|.
T Consensus 275 -----------------i~wp--------E~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 275 -----------------IEWP--------EE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred -----------------cccc--------cc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 1111 11 234689999999999999999997 46688999999998776
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-26 Score=207.55 Aligned_cols=159 Identities=20% Similarity=0.286 Sum_probs=121.0
Q ss_pred CCcccceeeeeeeeecCCCeeEEEEEEcC-CCcEEEEEEeecc---------ccchHHHHHHHHhCCCCceee-eceeee
Q 017147 29 EPKQTISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQD---------RRYKNRELQLMRVMDHPNVIS-LKHCFF 97 (376)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~---------~~~~~~e~~~l~~l~h~~iv~-~~~~~~ 97 (376)
.+...++|++.+.||+|+||+||+|.++. +++.+|||++... .....+|+++|+.++|+|++. +++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 45667889999999999999999999876 6778899986422 223568999999999999985 332
Q ss_pred ecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCC-CCCcEEEcCCCCcE
Q 017147 98 STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL-KPQNLLVDPLTHQV 176 (376)
Q Consensus 98 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dl-kp~Nill~~~~~~v 176 (376)
.. ..|+||||++|..+..+. .. . ...++.|++.||.|||+ +||+|||| ||+|||++. ++.+
T Consensus 90 -~~-----~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~-~~~i 151 (365)
T PRK09188 90 -TG-----KDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGP-DGEA 151 (365)
T ss_pred -cC-----CcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcC-CCCE
Confidence 11 268999999975333221 11 1 14678899999999999 79999999 999999985 6789
Q ss_pred EEEeecccccCccCCCc---------eeeeeccccCchhhh
Q 017147 177 KICDFGSAKQLIAGEAN---------ISYICSRFYRAPELI 208 (376)
Q Consensus 177 kl~Dfg~a~~~~~~~~~---------~~~~~t~~y~aPE~l 208 (376)
||+|||+|+........ ....+++.|.|||.+
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~ 192 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDAL 192 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccC
Confidence 99999999865433211 234557778999987
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-25 Score=183.15 Aligned_cols=207 Identities=23% Similarity=0.325 Sum_probs=163.8
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc--chHHHHHHHHhCCC-CceeeeceeeeecCCCCceEE
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRVMDH-PNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.+.+.|.+++.||+|+||.+|++....+|+.||||.-....+ ....|..+.+.|++ ..|..+..+. .+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccc
Confidence 345689999999999999999999999999999998765543 34578888888875 4555555444 333446
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC--CCCcEEEEeecccc
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGSAK 185 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~--~~~~vkl~Dfg~a~ 185 (376)
.+||++++.+|.+++.- -...|+...+.-++-|++.-++|+|. ++++||||||+|+|..- ....+.|+|||+|+
T Consensus 87 vlVMdLLGPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 87 VLVMDLLGPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeeeeccCccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchh
Confidence 69999999998888753 23568888999999999999999999 89999999999999753 23579999999998
Q ss_pred cCccCC--------CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHH
Q 017147 186 QLIAGE--------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 247 (376)
Q Consensus 186 ~~~~~~--------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 247 (376)
...+.. ......||..|.+--...+.. -+...|+-|+|.+|.++.-|..||++.......+
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q 231 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ 231 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHH
Confidence 765432 234567888898877665433 5788999999999999999999999866544433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-24 Score=193.87 Aligned_cols=259 Identities=33% Similarity=0.472 Sum_probs=193.6
Q ss_pred eeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCC-ceeeeceeeeecCCCCceEE
Q 017147 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHP-NVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~~ 107 (376)
|.+.+.||.|+||.||.+.+. ..+++|.+.... ....+|+.++..+.|+ +++++.+.+... ...
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-----GSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-----CEE
Confidence 788999999999999999986 788999885432 2345788899999988 799999888322 227
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
+++++++.+ .+.+.+...... ..+....+..++.|++.+++|+|+ .+++|||+||+||+++.....++++|||.+..
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~ 151 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKL 151 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence 899999996 444333321000 378999999999999999999999 79999999999999997333799999999875
Q ss_pred CccCC-------CceeeeeccccCchhhhhCC--CCCCchhhhHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhC
Q 017147 187 LIAGE-------ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLG 254 (376)
Q Consensus 187 ~~~~~-------~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~ 254 (376)
..... ......+|..|++||.+.+. ..++...|+||+|++++++++|..||..... ............
T Consensus 152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 231 (384)
T COG0515 152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231 (384)
T ss_pred cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence 44332 23567889999999999663 4688999999999999999999999887764 333333333222
Q ss_pred CC-CHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 255 TP-TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 255 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
.+ .... .. ..........+.+++.+++..+|..|.+..+...++|.....
T Consensus 232 ~~~~~~~------------~~--------~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 232 TPSLASP------------LS--------PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred Ccccccc------------cC--------ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 21 0000 00 000011235789999999999999999999999887776543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-23 Score=181.00 Aligned_cols=212 Identities=21% Similarity=0.302 Sum_probs=168.1
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc--ccchHHHHHHHHhCC-CCceeeeceeeeecCCCCceEE
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.+...|++++.||+|+||..+.+++.-+++.||||.-+.. ......|....+.|. .++|...+.+- ....+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchh
Confidence 4445899999999999999999999999999999966433 334567888888775 57777664322 333345
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC----CCCcEEEEeecc
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP----LTHQVKICDFGS 183 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~----~~~~vkl~Dfg~ 183 (376)
.+|+|+++.+|.+++.- -+.+|+...+.-++.|++.-++|+|+ +++|+|||||+|+||.. +...|.++|||+
T Consensus 100 iLVidLLGPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 100 ILVIDLLGPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhhhhhCcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 59999999999888763 35679999999999999999999999 89999999999999952 235799999999
Q ss_pred cccCccCCC--------ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHH
Q 017147 184 AKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKV 252 (376)
Q Consensus 184 a~~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~ 252 (376)
|+...+... ..+..||..||+--..+|.. -+.+.|+-|||-++.+.|-|..||.|.. ..+.+++|-+.
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 987654432 34567899999977766654 6889999999999999999999998743 44455555443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-24 Score=186.73 Aligned_cols=238 Identities=24% Similarity=0.297 Sum_probs=145.6
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchH-------HHHHHHHhCC----------CCceeeeceee
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMD----------HPNVISLKHCF 96 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-------~e~~~l~~l~----------h~~iv~~~~~~ 96 (376)
......+.||.|+++.||.+.+..||+.+|+|++........ +|.-....+. |-.++...+..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 367889999999999999999999999999998854332221 2221111111 11222222222
Q ss_pred ee--------cC-CCCce---EEEEEeecccchHHHHHHhhhhcCC---CcCHHHHHHHHHHHHHHHHHhhcCCCeeecC
Q 017147 97 FS--------TT-SKNEL---FLNLVMEYVPESMYRVLKHYSSANQ---RMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 161 (376)
Q Consensus 97 ~~--------~~-~~~~~---~~~lv~e~~~~~l~~~l~~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~~~i~H~d 161 (376)
.. .. ..... ..+++|+-+.++|..++........ .+.......+..|++..+++||+ .|++|+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgd 170 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGD 170 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEecc
Confidence 11 11 01111 2468899888888777653222222 23333344566899999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEEeecccccCccCCCceeeeeccccCchhhhhCC-------CCCCchhhhHhHHHHHHHHHhCC
Q 017147 162 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA-------TEYTTSIDIWSAGCVLAELLLGQ 234 (376)
Q Consensus 162 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~-------~~~~~~~DiwslG~il~~ll~g~ 234 (376)
|+|+|++++. ++.+.|+||+.......... ....+..|.+||..... ..++.+.|.|+||+++|.|.+|.
T Consensus 171 i~~~nfll~~-~G~v~Lg~F~~~~r~g~~~~--~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 171 IKPENFLLDQ-DGGVFLGDFSSLVRAGTRYR--CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp -SGGGEEE-T-TS-EEE--GGGEEETTEEEE--GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred cceeeEEEcC-CCCEEEcChHHHeecCceee--ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 9999999997 78899999998764432211 12335679999987332 23688999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCC
Q 017147 235 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 308 (376)
Q Consensus 235 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 308 (376)
.||......... ++ .|..- . ++++..++||++||++||.+|
T Consensus 248 lPf~~~~~~~~~-----------------------~~--------~f~~C-~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADP-----------------------EW--------DFSRC-R-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTS-----------------------GG--------GGTTS-S----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccc-----------------------cc--------cchhc-C-CcCHHHHHHHHHHccCCcccC
Confidence 999765422100 00 11111 1 479999999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.1e-24 Score=207.53 Aligned_cols=241 Identities=28% Similarity=0.417 Sum_probs=172.3
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc--------chHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
.|...+.||++.|=+|.+|++.+ | .|+||++-+... ...+|++ ...+++||.+.+..+. ..+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence 68889999999999999998754 3 499998855431 1123454 5667999999986654 44445
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
.|+|-+|...+|++-+. ...-+...+.+.|+.||+.||..+|. .||+|||||.+|||+++ -+-+.|+||..-+.
T Consensus 96 AylvRqyvkhnLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTS-WNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITS-WNWLYLTDFASFKP 169 (1431)
T ss_pred HHHHHHHHhhhhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEee-echhhhhcccccCC
Confidence 77999999988888775 33446777888999999999999999 79999999999999997 56699999987764
Q ss_pred CccC---CCceeee-e----ccccCchhhhhCCC----------CCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 017147 187 LIAG---EANISYI-C----SRFYRAPELIFGAT----------EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 247 (376)
Q Consensus 187 ~~~~---~~~~~~~-~----t~~y~aPE~l~~~~----------~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 247 (376)
..-. ....++. . -.+|.|||.+.... ..+++.||||+||+++||++ |++||.-. ++-
T Consensus 170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~ 245 (1431)
T KOG1240|consen 170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLL 245 (1431)
T ss_pred ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHH
Confidence 3222 2222222 1 23599999874311 14678999999999999998 89999521 111
Q ss_pred HHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 248 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
..... +....+. ...+--+..++.||..|++.||++|++|++.|+-
T Consensus 246 aYr~~-~~~~~e~-----------------------~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 246 AYRSG-NADDPEQ-----------------------LLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hHhcc-CccCHHH-----------------------HHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11110 0000000 0001124578999999999999999999999974
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.9e-23 Score=181.32 Aligned_cols=199 Identities=22% Similarity=0.321 Sum_probs=142.6
Q ss_pred CCCceeeeceeeeecCC----------------------CCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHH
Q 017147 85 DHPNVISLKHCFFSTTS----------------------KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 142 (376)
Q Consensus 85 ~h~~iv~~~~~~~~~~~----------------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ 142 (376)
+|||||.+...|.+... .....+|+||.-...+|.+++- ....+....+-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~-----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLW-----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHh-----cCCCchHHHHHHHH
Confidence 59999999887744221 2245689999999988877774 24566677788999
Q ss_pred HHHHHHHHhhcCCCeeecCCCCCcEEEcCCC---CcEEEEeecccccCccC-------CCceeeeeccccCchhhhhCCC
Q 017147 143 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT---HQVKICDFGSAKQLIAG-------EANISYICSRFYRAPELIFGAT 212 (376)
Q Consensus 143 qi~~al~~LH~~~~i~H~dlkp~Nill~~~~---~~vkl~Dfg~a~~~~~~-------~~~~~~~~t~~y~aPE~l~~~~ 212 (376)
|+++|+.|||+ +||.|||+|.+|||+.-++ ..+.|+|||+|-..... ......-|.-.-||||+....+
T Consensus 349 QlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 349 QLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999999 7999999999999984322 36889999998432211 1122334566789999974322
Q ss_pred CC-----CchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhccc
Q 017147 213 EY-----TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK 287 (376)
Q Consensus 213 ~~-----~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (376)
.. -.++|.|+.|.+.||++....||.+..+.-.- ..+|.+-.+|. .++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~------------------~r~Yqe~qLPa---------lp~ 480 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD------------------TRTYQESQLPA---------LPS 480 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheec------------------hhhhhhhhCCC---------Ccc
Confidence 21 24789999999999999999999874432110 01122222222 345
Q ss_pred CCChhHHHHHHhhcCcCCCCCCCHH---HHhc
Q 017147 288 RMPPEAIDLASRLLQYSPSLRCTAL---EACA 316 (376)
Q Consensus 288 ~~~~~~~~li~~~L~~dp~~R~t~~---e~l~ 316 (376)
.+++.+++++..+|+.||++|+++. .+|+
T Consensus 481 ~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 481 RVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred cCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 6899999999999999999999853 5554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.9e-23 Score=172.43 Aligned_cols=135 Identities=19% Similarity=0.246 Sum_probs=103.0
Q ss_pred eeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc------------------------------chHHHHHHHHhCCCCc
Q 017147 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------------------YKNRELQLMRVMDHPN 88 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------------------------------~~~~e~~~l~~l~h~~ 88 (376)
...||+|++|.||+|.+. +|+.||+|++..+.. ....|+..+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999986 899999999864321 1124889999998877
Q ss_pred eeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHh-hcCCCeeecCCCCCcE
Q 017147 89 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI-HTVPRVCHRDLKPQNL 167 (376)
Q Consensus 89 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~i~H~dlkp~Ni 167 (376)
+....... ... .+|||||++|+.+.... .....++...+..++.|++.+|.++ |+ .||+||||||+||
T Consensus 81 v~~p~~~~--~~~-----~~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NI 149 (190)
T cd05147 81 IPCPEPIL--LKS-----HVLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNL 149 (190)
T ss_pred CCCCcEEE--ecC-----CEEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHE
Confidence 64432221 111 36999999975322111 1235788999999999999999999 68 7999999999999
Q ss_pred EEcCCCCcEEEEeecccccC
Q 017147 168 LVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 168 ll~~~~~~vkl~Dfg~a~~~ 187 (376)
|++. +.++|+|||+|...
T Consensus 150 li~~--~~v~LiDFG~a~~~ 167 (190)
T cd05147 150 LYHD--GKLYIIDVSQSVEH 167 (190)
T ss_pred EEEC--CcEEEEEccccccC
Confidence 9983 57999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=172.85 Aligned_cols=171 Identities=13% Similarity=0.105 Sum_probs=125.3
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc----ccc---------hHHHHHHHHhCCCCceeeeceeeee
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRY---------KNRELQLMRVMDHPNVISLKHCFFS 98 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~---------~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (376)
..++|++.+.||.|+||.||++.. ++..+|+|.+... ... .++|+..+.++.|++|..+.+.+..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 456899999999999999999765 4678999998532 111 3578889999999999999887654
Q ss_pred cCCC---CceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC
Q 017147 99 TTSK---NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 174 (376)
Q Consensus 99 ~~~~---~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~ 174 (376)
.... .....+++|||++| +|.+.. .+++ ....+++.++..+|+ .|++|||++|+||++++ ++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~-~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQ-HGMVSGDPHKGNFIVSK-NG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHH-cCCccCCCChHHEEEeC-CC
Confidence 3211 12347899999998 443321 1233 245699999999999 79999999999999996 55
Q ss_pred cEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHH
Q 017147 175 QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 231 (376)
Q Consensus 175 ~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll 231 (376)
++|+|||.+........ -+.+.-...|+.++|+||||+++..+.
T Consensus 173 -i~liDfg~~~~~~e~~a------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKA------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhh------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99999998865422211 111222334678999999999887654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=161.45 Aligned_cols=182 Identities=16% Similarity=0.106 Sum_probs=132.3
Q ss_pred eeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc--------chHHHHHHHHhCCC-CceeeeceeeeecCCCCceEE
Q 017147 37 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDH-PNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 37 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.+...|++|+||+||++.. .+..++.+.+..+.. ...+|+++|+.|.| ++++++++.. . .
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~----~-----~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD----G-----R 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc----C-----E
Confidence 3567899999999998765 678888777754432 34689999999954 7788886631 1 6
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCC-CCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL-KPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dl-kp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|++|||+.|..+.... . .. ...++.|++.+|+++|+ +||+|||| ||+|||++. ++.++|+|||+|..
T Consensus 74 ~lvmeyI~G~~L~~~~----~-----~~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~-~g~i~LIDFG~A~~ 141 (218)
T PRK12274 74 HLDRSYLAGAAMYQRP----P-----RG-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQE-DGSPAVIDFQLAVR 141 (218)
T ss_pred EEEEeeecCccHHhhh----h-----hh-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcC-CCCEEEEECCCcee
Confidence 7999999985332110 0 01 13467899999999999 79999999 799999986 67899999999985
Q ss_pred CccCCCce--------------eeeeccccCchhhhhCCCCCC-chhhhHhHHHHHHHHHhCCCCCCCCC
Q 017147 187 LIAGEANI--------------SYICSRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGEN 241 (376)
Q Consensus 187 ~~~~~~~~--------------~~~~t~~y~aPE~l~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~ 241 (376)
........ -.-.++.|++|+...-....+ ...++++.|+-+|.++|+..++-+.+
T Consensus 142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 44332110 012377788888653222233 56789999999999999998876544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=7e-21 Score=161.65 Aligned_cols=135 Identities=19% Similarity=0.208 Sum_probs=104.1
Q ss_pred eeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc------------------------------chHHHHHHHHhCCCCc
Q 017147 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------------------YKNRELQLMRVMDHPN 88 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------------------------------~~~~e~~~l~~l~h~~ 88 (376)
.+.||+|++|+||+|.+. +|+.||||++..+.. ....|...+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 899999999865321 1136788888998888
Q ss_pred eeeeceeeeecCCCCceEEEEEeecccch-HHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcE
Q 017147 89 VISLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL 167 (376)
Q Consensus 89 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Ni 167 (376)
+.....+.. . . .|+||||++|. +..... ....++...+..++.|++.++.+||+..||+||||||+||
T Consensus 81 i~~p~~~~~--~-~----~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NI 149 (190)
T cd05145 81 VPVPEPILL--K-K----NVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNI 149 (190)
T ss_pred CCCceEEEe--c-C----CEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhE
Confidence 754433321 1 1 36999999975 222211 2346788889999999999999999823999999999999
Q ss_pred EEcCCCCcEEEEeecccccC
Q 017147 168 LVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 168 ll~~~~~~vkl~Dfg~a~~~ 187 (376)
+++ ++.++|+|||++...
T Consensus 150 ll~--~~~~~liDFG~a~~~ 167 (190)
T cd05145 150 LYH--DGKPYIIDVSQAVEL 167 (190)
T ss_pred EEE--CCCEEEEEcccceec
Confidence 998 567999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.7e-20 Score=185.11 Aligned_cols=194 Identities=22% Similarity=0.379 Sum_probs=147.1
Q ss_pred CcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccch-HHHHHHHHhCC---CCceeeeceeeeecCCCCce
Q 017147 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLMRVMD---HPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~ 105 (376)
+.-.+.|.|.+.||+|+||+||.|.+.. |+.||+|+-....... .--.+++.+|+ -+.|..+..++...+.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~---- 768 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA---- 768 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc----
Confidence 3344689999999999999999999876 9999999765443221 11223344444 2334444443332222
Q ss_pred EEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEc------CCCCcEEE
Q 017147 106 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD------PLTHQVKI 178 (376)
Q Consensus 106 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~------~~~~~vkl 178 (376)
-++|+||.+ |+|++++. ..+.+++..+..+++|++.-++.||. .+|||+||||+|+||. .+...++|
T Consensus 769 -S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 -SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred -ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccceEE
Confidence 459999999 78888775 66789999999999999999999999 6999999999999993 22346999
Q ss_pred EeecccccCc---cCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCC
Q 017147 179 CDFGSAKQLI---AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 235 (376)
Q Consensus 179 ~Dfg~a~~~~---~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~ 235 (376)
+|||.+-.+. ++.......+|-.+-++|...|. .+++..|.|+++.+++-||.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHHH
Confidence 9999986543 23333455668889999998664 59999999999999999999983
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-19 Score=153.14 Aligned_cols=135 Identities=18% Similarity=0.255 Sum_probs=101.5
Q ss_pred eeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc----ccchHHHHHHHHhC-----CCCceeeeceeeeecCCCCceE-
Q 017147 37 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVM-----DHPNVISLKHCFFSTTSKNELF- 106 (376)
Q Consensus 37 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~- 106 (376)
.-.+.||+|+||.||. +..++.. +||++... .....+|+.+++.+ .||||+++++++.+... ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g--~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG--TGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC--CeEE
Confidence 3356799999999995 6667666 69987643 33456899999999 57999999998855432 233
Q ss_pred EEEEeeccc---chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHH-HHhhcCCCeeecCCCCCcEEEcCC---CCcEEEE
Q 017147 107 LNLVMEYVP---ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL-AYIHTVPRVCHRDLKPQNLLVDPL---THQVKIC 179 (376)
Q Consensus 107 ~~lv~e~~~---~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al-~~LH~~~~i~H~dlkp~Nill~~~---~~~vkl~ 179 (376)
+.+|+||++ ++|.+.+.. ..+++. ..++.|++.++ +|||+ ++|+||||||+|||++.. +..++|+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 347899955 577777753 245555 35678888888 99999 799999999999999742 3479999
Q ss_pred eeccc
Q 017147 180 DFGSA 184 (376)
Q Consensus 180 Dfg~a 184 (376)
||+.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=157.61 Aligned_cols=139 Identities=16% Similarity=0.136 Sum_probs=104.7
Q ss_pred eeeeeeeeecCCCeeEEEEE-EcCCCcEEEEEEeecccc----------------------------chHHHHHHHHhCC
Q 017147 35 SYMAERVVGTGSFGIVFQAK-CLETGETVAIKKVLQDRR----------------------------YKNRELQLMRVMD 85 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~~~aiK~~~~~~~----------------------------~~~~e~~~l~~l~ 85 (376)
.|.+.+.||+|++|.||+|. +..+|+.||+|++..... ....|+.++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 777999999998864310 1246888998887
Q ss_pred CCceeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCC-eeecCCCC
Q 017147 86 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-VCHRDLKP 164 (376)
Q Consensus 86 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~-i~H~dlkp 164 (376)
+.. +.+..++.. .. .++||||++|..+.... .....+....+..++.|++.++.+||+ .| ++||||||
T Consensus 109 ~~~-i~~p~~~~~-~~-----~~lV~E~~~g~~L~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dikp 177 (237)
T smart00090 109 EAG-VPVPKPIAW-RR-----NVLVMEFIGGDGLPAPR---LKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLSE 177 (237)
T ss_pred hcC-CCCCeeeEe-cC-----ceEEEEEecCCcccccc---cccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCCh
Confidence 532 222222211 11 46999999984322211 123445666778999999999999999 79 99999999
Q ss_pred CcEEEcCCCCcEEEEeeccccc
Q 017147 165 QNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 165 ~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
+||+++ ++.++|+|||.+..
T Consensus 178 ~NIli~--~~~i~LiDFg~a~~ 197 (237)
T smart00090 178 YNILVH--DGKVVIIDVSQSVE 197 (237)
T ss_pred hhEEEE--CCCEEEEEChhhhc
Confidence 999998 56799999999863
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-20 Score=172.46 Aligned_cols=179 Identities=28% Similarity=0.431 Sum_probs=131.2
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
..++||.|++|.. +|.+.+. ........+......++.|+..|++| +|.+|+|+||.||+... +..+||.|||
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~-rr~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~-d~q~kIgDFg 401 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLR-RRRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSD-DDQLKIGDFG 401 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhh-CCCcccccchhHHHHHHHhhccchhh----ccchhhhcccccccccc-chhhhhhhhh
Confidence 4468999999995 5544443 23345566778889999999999999 38999999999999985 6689999999
Q ss_pred ccccCccCC-------CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 017147 183 SAKQLIAGE-------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 254 (376)
Q Consensus 183 ~a~~~~~~~-------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 254 (376)
+........ ..+..+||.+||+||.+.+. .|+.++||||||+||+|++. =...|..... +..+
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~f~T~~er~~t---~~d~----- 472 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQFSTQFERIAT---LTDI----- 472 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHHhccHHHHHHh---hhhh-----
Confidence 987665554 45567899999999999775 49999999999999999997 2233322111 1111
Q ss_pred CCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
....|...+..+ .+.-.+|+.+||...|.+||++.+.--|+|.
T Consensus 473 ----------------------r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 473 ----------------------RDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred ----------------------hcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 011111111111 2355689999999999999988888777775
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.1e-19 Score=148.72 Aligned_cols=239 Identities=18% Similarity=0.242 Sum_probs=171.5
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeec------cccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.+..+...|.+...|..|+++...+ .++.|++.- -.+...+|.-.|+.+.||||+.+++.+-.. ..+
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnl 262 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNL 262 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCc
Confidence 3455667788999999999988554 445554421 134455788889999999999999988333 337
Q ss_pred EEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeec-CCCCCcEEEcCCCCcEEE--Eeecc
Q 017147 108 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR-DLKPQNLLVDPLTHQVKI--CDFGS 183 (376)
Q Consensus 108 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~-dlkp~Nill~~~~~~vkl--~Dfg~ 183 (376)
.++..|++ |+|+.++... .+-.....++.+++.+++.|+.|||+...++-| -|....+++|+ +...+| +|--+
T Consensus 263 v~isq~mp~gslynvlhe~--t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmide-dltarismad~kf 339 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDE-DLTARISMADTKF 339 (448)
T ss_pred eEeeeeccchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecc-hhhhheeccccee
Confidence 79999999 7888888642 233466778999999999999999996455543 57788889985 544443 34333
Q ss_pred cccCccCCCceeeeeccccCchhhhhCCCC--CCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 184 AKQLIAGEANISYICSRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 184 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
+.. .......|.|++||.+...+. .-.++|+|||++++|||.|...||......+.--+|.-
T Consensus 340 sfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial---------- 403 (448)
T KOG0195|consen 340 SFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL---------- 403 (448)
T ss_pred eee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh----------
Confidence 221 112344788999999954332 23579999999999999999999998877654332221
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 315 (376)
+-++..++..++.....|+.-|++.||.+||..+.++
T Consensus 404 -----------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 404 -----------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred -----------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 1122334556889999999999999999999877654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.8e-20 Score=180.44 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=190.8
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCC-CcEEEEEEeecc---cc---chHHHHHHHHhCC-CCceeeeceeeeecCCCCc
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQD---RR---YKNRELQLMRVMD-HPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~aiK~~~~~---~~---~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 104 (376)
...|.+.+.||+|+|+.|-++....+ ...+|.|.+... .. ....|..+-+.+. |+|++++++.. .+.
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCC
Confidence 34689999999999999988876443 345666655332 11 1224666666776 99999998876 444
Q ss_pred eEEEEEeecccch-HHHHHHhhhhcCC-CcCHHHHHHHHHHHHHHHHHhh-cCCCeeecCCCCCcEEEcCCCC-cEEEEe
Q 017147 105 LFLNLVMEYVPES-MYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLAYIH-TVPRVCHRDLKPQNLLVDPLTH-QVKICD 180 (376)
Q Consensus 105 ~~~~lv~e~~~~~-l~~~l~~~~~~~~-~l~~~~~~~i~~qi~~al~~LH-~~~~i~H~dlkp~Nill~~~~~-~vkl~D 180 (376)
.+.+++++|..|+ +.+.+. .... ..+...+..++.|+..++.|+| . .++.|+|+||+|.+++. ++ .+++.|
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~---~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~-s~~~l~~~d 168 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKIS---HPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDE-SGSALKIAD 168 (601)
T ss_pred cccccccCcccccccccccc---cCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhcc-CCCcccCCC
Confidence 4588999998763 333221 2222 5677788999999999999999 8 79999999999999996 56 899999
Q ss_pred ecccccCcc-CCC---ceeeee-ccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017147 181 FGSAKQLIA-GEA---NISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255 (376)
Q Consensus 181 fg~a~~~~~-~~~---~~~~~~-t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 255 (376)
||+|..... ... ....+| ++.|.|||...+........|+||+|+++..+++|..|+......+...
T Consensus 169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-------- 240 (601)
T KOG0590|consen 169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-------- 240 (601)
T ss_pred chhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc--------
Confidence 999987655 222 234577 9999999998765556889999999999999999999987654332110
Q ss_pred CCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
. .+... ...+....+..++....+++.++|..+|..|.+.+++-.+||+..
T Consensus 241 -------------~--~~~~~-~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 241 -------------S--SWKSN-KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -------------e--eeccc-ccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0 00000 011222334567899999999999999999999999999999988
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.1e-18 Score=160.66 Aligned_cols=203 Identities=27% Similarity=0.419 Sum_probs=147.6
Q ss_pred HHhCCCCceeeeceeeeecCCCCceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCe-e
Q 017147 81 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV-C 158 (376)
Q Consensus 81 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i-~ 158 (376)
|+.+.|.|+.++++..++... .++|.+||. |+|.+.+.. ....++......++.+|+.|+.|||+ ..| .
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~-----~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~-s~i~~ 71 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPE-----MIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHN-SPIGY 71 (484)
T ss_pred CcccchhhhhhheeeEecCCc-----eEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhc-Cccee
Confidence 467899999999999876633 889999999 688888764 45667888888999999999999998 455 9
Q ss_pred ecCCCCCcEEEcCCCCcEEEEeecccccCccC---CCceeeeeccccCchhhhhCCC--C----CCchhhhHhHHHHHHH
Q 017147 159 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG---EANISYICSRFYRAPELIFGAT--E----YTTSIDIWSAGCVLAE 229 (376)
Q Consensus 159 H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~l~~~~--~----~~~~~DiwslG~il~~ 229 (376)
|+.++..|.++|. ...+||+|||+....... .......-..-|.|||.+.+.. . .+.+.|+||+|++++|
T Consensus 72 hg~l~s~nClvd~-~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 72 HGALKSSNCLVDS-RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred eeeeccccceeee-eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 9999999999996 889999999998755321 1111111234499999996531 1 3678999999999999
Q ss_pred HHhCCCCCCCCChH----HHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCC
Q 017147 230 LLLGQPLFPGENAV----DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 305 (376)
Q Consensus 230 ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 305 (376)
+++...||...... +.+..+.+....+.+..+.. . ..+.+++..++.+||..+|
T Consensus 151 i~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~---------------------~-~e~~~~l~~l~~~cw~e~P 208 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIEL---------------------L-NELPPELLLLVARCWEEIP 208 (484)
T ss_pred HHhccCccccccccCChHHHHHHHHhcCCCCcCcchhh---------------------h-hhcchHHHHHHHHhcccCh
Confidence 99999999763322 22222222011111111100 0 0245689999999999999
Q ss_pred CCCCCHHHHh
Q 017147 306 SLRCTALEAC 315 (376)
Q Consensus 306 ~~R~t~~e~l 315 (376)
.+||+++++-
T Consensus 209 ~~rPs~~~i~ 218 (484)
T KOG1023|consen 209 EKRPSIEQIR 218 (484)
T ss_pred hhCccHHHHH
Confidence 9999998874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.7e-17 Score=141.39 Aligned_cols=129 Identities=20% Similarity=0.322 Sum_probs=100.7
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
+.||+|++|.||+|.. .+..+++|+..... ....+|+.++..+.|+++.....++..... .
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-----~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN-----F 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC-----C
Confidence 5789999999999987 67789999764321 123468889999999888766555433322 6
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
+++|||++| +|.+.+.. . .. ....++.+++.+|.+||+ .|++|||++|.||+++ ++.++|+|||.+..
T Consensus 75 ~lv~e~~~G~~L~~~~~~----~---~~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINS----N---GM-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEEeCCcCHHHHHHh----c---cH-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 799999987 66555532 1 11 677899999999999999 7999999999999998 56799999999874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-17 Score=141.26 Aligned_cols=132 Identities=19% Similarity=0.160 Sum_probs=99.2
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc--------------------------cchHHHHHHHHhCCCCc
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------------------RYKNRELQLMRVMDHPN 88 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------------------~~~~~e~~~l~~l~h~~ 88 (376)
.|.+.+.||+|+||.||++... +++.+|||++..+. .....|..++..+.+++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4888999999999999999864 89999999865422 01346788888887764
Q ss_pred e--eeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCc
Q 017147 89 V--ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 166 (376)
Q Consensus 89 i--v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~N 166 (376)
+ ...++ .. ..++||||++|..+..+.. ......++.+++.++.++|+ .|++||||+|+|
T Consensus 95 i~v~~~~~----~~-----~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~N 155 (198)
T cd05144 95 FPVPKPID----WN-----RHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYK-HGIIHGDLSEFN 155 (198)
T ss_pred CCCCceee----cC-----CceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHH-CCCCcCCCCccc
Confidence 3 32221 11 1579999999843322211 02356788899999999999 799999999999
Q ss_pred EEEcCCCCcEEEEeecccccC
Q 017147 167 LLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 167 ill~~~~~~vkl~Dfg~a~~~ 187 (376)
|+++. ++.++|+|||.+...
T Consensus 156 ill~~-~~~~~liDfg~~~~~ 175 (198)
T cd05144 156 ILVDD-DEKIYIIDWPQMVST 175 (198)
T ss_pred EEEcC-CCcEEEEECCccccC
Confidence 99996 788999999999644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=136.98 Aligned_cols=125 Identities=20% Similarity=0.317 Sum_probs=93.6
Q ss_pred eeecCCCeeEEEEEEcCCCcEEEEEEeeccc------------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 41 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
.||+|++|.||++.. ++..+++|...... ....+|+++++.+.|+++....-.+..... .+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-----~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN-----KT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC-----CE
Confidence 489999999999984 67889999864321 122468999999988765544333322221 56
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
+||||++| ++.+.+.. ... .++.|++.+|.+||+ .|++|+|++|.||+++ ++.++++|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~--~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEE----GND-------ELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR--DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhh----cHH-------HHHHHHHHHHHHHHH-CCeecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence 99999987 55444431 110 678899999999999 7999999999999998 56799999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.1e-16 Score=153.94 Aligned_cols=132 Identities=19% Similarity=0.262 Sum_probs=99.1
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEee-cc-----------ccchHHHHHHHHhCCCCceeeeceeeeecC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-QD-----------RRYKNRELQLMRVMDHPNVISLKHCFFSTT 100 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~-~~-----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (376)
...|...+.||+|+||+||++..... .+++|+.. +. .....+|+++++.++|++++..........
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 34567788999999999999886433 34444321 11 122357999999999999887655443322
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEE
Q 017147 101 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 179 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~ 179 (376)
. .++||||++| +|.+.+. ....++.|++.+|.+||+ .|++||||||+|||++ ++.++|+
T Consensus 410 ~-----~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl~--~~~~~li 469 (535)
T PRK09605 410 E-----KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIVR--DDRLYLI 469 (535)
T ss_pred C-----CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEEE--CCcEEEE
Confidence 2 5699999987 5554443 246788999999999999 7999999999999994 5679999
Q ss_pred eeccccc
Q 017147 180 DFGSAKQ 186 (376)
Q Consensus 180 Dfg~a~~ 186 (376)
|||+++.
T Consensus 470 DFGla~~ 476 (535)
T PRK09605 470 DFGLGKY 476 (535)
T ss_pred eCccccc
Confidence 9999974
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.7e-15 Score=128.42 Aligned_cols=131 Identities=24% Similarity=0.200 Sum_probs=90.1
Q ss_pred eeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccch----------------------------HHHHHHHHhCCCCc--
Q 017147 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK----------------------------NRELQLMRVMDHPN-- 88 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~----------------------------~~e~~~l~~l~h~~-- 88 (376)
.+.||+|+||+||+|.+. +++.||||++....... ..|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999976 89999999876432111 13344444443322
Q ss_pred eeeeceeeeecCCCCceEEEEEeecccchH-H-HHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCc
Q 017147 89 VISLKHCFFSTTSKNELFLNLVMEYVPESM-Y-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 166 (376)
Q Consensus 89 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l-~-~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~N 166 (376)
+.+.+.. . ..++||||++++. . ..+.... .. ..++.++.+++.++.++|...|++|+||||+|
T Consensus 81 ~~~~~~~----~-----~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N 145 (187)
T cd05119 81 VPKPIDL----N-----RHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYN 145 (187)
T ss_pred CCceEec----C-----CCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence 2222111 1 1579999999721 1 1122110 11 56788999999999999983499999999999
Q ss_pred EEEcCCCCcEEEEeecccccC
Q 017147 167 LLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 167 ill~~~~~~vkl~Dfg~a~~~ 187 (376)
|+++ ++.++|+|||.+...
T Consensus 146 ili~--~~~~~liDfg~a~~~ 164 (187)
T cd05119 146 ILVD--DGKVYIIDVPQAVEI 164 (187)
T ss_pred EEEE--CCcEEEEECcccccc
Confidence 9998 567999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=9.7e-15 Score=128.07 Aligned_cols=133 Identities=18% Similarity=0.228 Sum_probs=95.4
Q ss_pred eeee-cCCCeeEEEEEEcCCCcEEEEEEeecc-----------------ccchHHHHHHHHhCCCCce--eeeceeeeec
Q 017147 40 RVVG-TGSFGIVFQAKCLETGETVAIKKVLQD-----------------RRYKNRELQLMRVMDHPNV--ISLKHCFFST 99 (376)
Q Consensus 40 ~~lg-~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----------------~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~ 99 (376)
..|| .|+.|+||.+.. .+..+++|.+... .....+|+.++..+.|+++ +..+......
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 788889998876 4778999877421 1123469999999998875 4454443221
Q ss_pred CCCCceEEEEEeecccc--hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEE
Q 017147 100 TSKNELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 177 (376)
Q Consensus 100 ~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vk 177 (376)
. ......++|||+++| +|.+.+.. ..+++.. +.|++.+|.+||+ +||+||||||.|||++. ++.++
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~~----~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~-~~~v~ 182 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQE-----APLSEEQ----WQAIGQLIARFHD-AGVYHADLNAHNILLDP-DGKFW 182 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHHH----HHHHHHHHHHHHH-CCCCCCCCCchhEEEcC-CCCEE
Confidence 1 111123599999996 55555432 3455543 5689999999999 79999999999999986 56899
Q ss_pred EEeeccccc
Q 017147 178 ICDFGSAKQ 186 (376)
Q Consensus 178 l~Dfg~a~~ 186 (376)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.1e-16 Score=154.84 Aligned_cols=261 Identities=24% Similarity=0.292 Sum_probs=189.1
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
-.+.+.+.+-+-+|+++.++.+.-..++-..++|...... .....+-.++..-.+|.++.....+. -.
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~-----~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP-----CR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC-----CC
Confidence 4467888889999999999999877777666666543222 22223333333334566655433321 11
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
.-.+++++|.++ ++...++ ..+..+.+.++.++..+..++++||+ ..+.|+|++|.|++... .+..++.|||.
T Consensus 877 sP~~L~~~~~~~~~~~Skl~----~~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~-~gh~~l~~~~t 950 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLH----NSGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAY-DGHRPLTDFGT 950 (1205)
T ss_pred CCcchhhHHhccCCchhhhh----cCCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhcc-cCCcccCcccc
Confidence 227799999985 5555554 34567778889999999999999999 67999999999999986 67799999984
Q ss_pred cccCccC--------------------------------CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHH
Q 017147 184 AKQLIAG--------------------------------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 231 (376)
Q Consensus 184 a~~~~~~--------------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll 231 (376)
....... .......+|+.|.+||.+.+.. ....+|+|+.|+.+++.+
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhh
Confidence 3211000 0122346789999999997765 688999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH
Q 017147 232 LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311 (376)
Q Consensus 232 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~ 311 (376)
+|.+||.....+..+..|.+.. ...+. -+...+.++++++.++|..+|.+|..+
T Consensus 1030 ~g~pp~na~tpq~~f~ni~~~~-----------------~~~p~---------g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNRD-----------------IPWPE---------GPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred cCCCCCCCcchhhhhhccccCC-----------------CCCCC---------CccccChhhhhhhhhhhccCchhccCc
Confidence 9999999998888776665421 11111 112368899999999999999999988
Q ss_pred H---HHhcCCCcccccCCCCCC
Q 017147 312 L---EACAHPFFDELREPNARL 330 (376)
Q Consensus 312 ~---e~l~hp~~~~~~~~~~~~ 330 (376)
. ++-.||||+.+.|.....
T Consensus 1084 ~~~~e~k~~~~~~~~~~~~l~~ 1105 (1205)
T KOG0606|consen 1084 KGAAEVKGHPFFQDVDWENLAL 1105 (1205)
T ss_pred ccccccccCCccCCCCcccccc
Confidence 7 999999999988776543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.9e-15 Score=139.35 Aligned_cols=251 Identities=25% Similarity=0.288 Sum_probs=186.8
Q ss_pred ccceeeeeeeeec--CCCeeEEEEEE--cCCCcEEEEEEee------ccccchHHHHHHHHhC-CCCceeeeceeeeecC
Q 017147 32 QTISYMAERVVGT--GSFGIVFQAKC--LETGETVAIKKVL------QDRRYKNRELQLMRVM-DHPNVISLKHCFFSTT 100 (376)
Q Consensus 32 ~~~~y~~~~~lg~--G~~g~Vy~~~~--~~~~~~~aiK~~~------~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 100 (376)
....+.+.+.+|. |.+|.||.+.+ ..++..+|+|+-. .+.....+|+.-.+.+ .|++.++.+..+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~---- 187 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW---- 187 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc----
Confidence 4457788889999 99999999999 8899999999732 2233444666665555 488888866666
Q ss_pred CCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHH----HHHHhhcCCCeeecCCCCCcEEEcCCCCcE
Q 017147 101 SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR----GLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 176 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~----al~~LH~~~~i~H~dlkp~Nill~~~~~~v 176 (376)
++....|+-+|+|+.++..... .....++...++.++.+... ||..+|+ .+++|-|+||.||+..++....
T Consensus 188 -e~~~~lfiqtE~~~~sl~~~~~---~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 188 -EGSGILFIQTELCGESLQSYCH---TPCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred -ccCCcceeeeccccchhHHhhh---cccccCCchhhhhHHhhhhhcccccccccCC-Ccccccccchhheeccccccee
Confidence 5555588999999976655543 23445888889999999999 9999999 8999999999999998743789
Q ss_pred EEEeecccccCccCCCcee------eeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCC--ChHHHHHH
Q 017147 177 KICDFGSAKQLIAGEANIS------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE--NAVDQLVE 248 (376)
Q Consensus 177 kl~Dfg~a~~~~~~~~~~~------~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~ 248 (376)
+++|||+...+..+..... ..+..-|++||++.+ -++..+|++++|.++.+-.+|..++... +...++..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 9999999987766543221 134556999999854 4799999999999999999887555332 21111110
Q ss_pred HHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 249 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.| ....+-...+.++...+..|+..+|-.|++++.+++|+++...
T Consensus 341 ------------------~~------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 341 ------------------GY------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred ------------------cc------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 00 1111222346677779999999999999999999999998753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.5e-14 Score=117.74 Aligned_cols=131 Identities=21% Similarity=0.238 Sum_probs=101.1
Q ss_pred eeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc--chHHHHHHHHhCCC--CceeeeceeeeecCCCCceEEEEEeec
Q 017147 38 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRVMDH--PNVISLKHCFFSTTSKNELFLNLVMEY 113 (376)
Q Consensus 38 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~lv~e~ 113 (376)
+++.||+|.++.||++... +..+++|....... ....|+..++.+++ .++++++..+.. ....+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-----~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGES-----DGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CCccEEEEEe
Confidence 4578999999999999974 37899998866543 56689999999976 477777665522 2347899999
Q ss_pred ccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcC--CCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 114 VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 114 ~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
+.|.....+ +......++.+++.++..||.. .+++|+|++|.||++++ .+.++++|||.+..
T Consensus 75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~-~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD-GKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC-CcEEEEEecccccC
Confidence 987422111 4455567788999999999983 26999999999999996 67899999999863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.7e-14 Score=121.51 Aligned_cols=211 Identities=18% Similarity=0.198 Sum_probs=144.9
Q ss_pred HHHHhCCCCceeeeceeeeecCCCCceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcC-CC
Q 017147 79 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-PR 156 (376)
Q Consensus 79 ~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~ 156 (376)
.-|-.+-|.|||+++.++.+...++.....++.||+. |++...|+.-......+....-.+|+.||+.||.|||+. .-
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3455667999999988876665555666778999998 688888887777778888888899999999999999984 35
Q ss_pred eeecCCCCCcEEEcCCCCcEEEEeecccccCcc-----CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHH
Q 017147 157 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-----GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 231 (376)
Q Consensus 157 i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-----~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll 231 (376)
|+|+++....|++.. ++-||+.--.-...... ........+-++|.+||.=. ....+.++|||++|.-..+|.
T Consensus 199 iihgnlTc~tifiq~-ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQH-NGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred cccCCcchhheeecC-CceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc-ccccccchhhhhhhHHHHHHH
Confidence 899999999999996 67677642211110000 00111233457799999642 234678999999999999998
Q ss_pred hCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC
Q 017147 232 LGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310 (376)
Q Consensus 232 ~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 310 (376)
.|..- -.+......-..+.+. +..--...-++++++||+-.|..||+
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~--------------------------------i~~len~lqr~~i~kcl~~eP~~rp~ 324 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANV--------------------------------IIGLENGLQRGSITKCLEGEPNGRPD 324 (458)
T ss_pred HheeccCCCcceeehhhhhhhh--------------------------------eeeccCccccCcCcccccCCCCCCcc
Confidence 87632 2222211111111110 00001123357899999999999999
Q ss_pred HHHHhcCCCcccc
Q 017147 311 ALEACAHPFFDEL 323 (376)
Q Consensus 311 ~~e~l~hp~~~~~ 323 (376)
+.+++.||..-++
T Consensus 325 ar~llfHpllfeV 337 (458)
T KOG1266|consen 325 ARLLLFHPLLFEV 337 (458)
T ss_pred hhhhhcCceeeec
Confidence 9999999997554
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.3e-12 Score=122.79 Aligned_cols=164 Identities=23% Similarity=0.309 Sum_probs=121.1
Q ss_pred EEEcCCCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhc
Q 017147 53 AKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSA 128 (376)
Q Consensus 53 ~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~ 128 (376)
+..+.++.+|.+........ ...+-++-|+.++||+|+++++.+ +....+|||+|-+.. |...++.
T Consensus 31 ~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylvTErV~P-l~~~lk~---- 100 (690)
T KOG1243|consen 31 GTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLVTERVRP-LETVLKE---- 100 (690)
T ss_pred cceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEEeecccc-HHHHHHH----
Confidence 45567788888887754333 245678889999999999999887 444469999999874 2234432
Q ss_pred CCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCC-ceeeeeccccCchhh
Q 017147 129 NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPEL 207 (376)
Q Consensus 129 ~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~ 207 (376)
++...+...+.||+.||.|||.-.+++|++|....|+|+. .+..||++|.++........ .....---.|..|+.
T Consensus 101 ---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~-~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 101 ---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNE-SGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEE 176 (690)
T ss_pred ---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcC-CCcEEEeeeEEEeccccCCcccccchhhhcccChhh
Confidence 3367788889999999999984379999999999999997 88899999999865433332 111111223677776
Q ss_pred hhCCCCCCchhhhHhHHHHHHHHHhC
Q 017147 208 IFGATEYTTSIDIWSAGCVLAELLLG 233 (376)
Q Consensus 208 l~~~~~~~~~~DiwslG~il~~ll~g 233 (376)
+.. -.-..|.|.|||++++++.|
T Consensus 177 ~~~---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDP---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCc---cccchhhhhHHHHHHHHhCc
Confidence 522 12467999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.7e-13 Score=130.68 Aligned_cols=141 Identities=18% Similarity=0.244 Sum_probs=90.1
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccc--------------------------------------hH
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY--------------------------------------KN 75 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--------------------------------------~~ 75 (376)
..|.. +.||+|++|+||+|..+.+|+.||||+....... ..
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 7899999999999999888999999988643100 01
Q ss_pred ------HHHHHHHhC----CCCceeeeceeeeecCCCCceEEEEEeecccc-hHHHHHHhhhhcC---CCcCHHHHHHHH
Q 017147 76 ------RELQLMRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSAN---QRMPLIYVKLYT 141 (376)
Q Consensus 76 ------~e~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~---~~l~~~~~~~i~ 141 (376)
+|+..+.++ .+...+.+-.++.+.+. ..++||||+.| .+.+ +......+ ..+.+..+..++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st----~~VLvmE~i~G~~l~d-~~~l~~~g~d~~~la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCS----ETVMVMERMYGIPVSD-VAALRAAGTDMKLLAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCC----CceEEEeeecCccHHh-HHHHHhcCCCHHHHHHHHHHHHH
Confidence 122222222 23333333333322211 15599999998 4433 21111111 135555666666
Q ss_pred HHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC----cEEEEeecccccCcc
Q 017147 142 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH----QVKICDFGSAKQLIA 189 (376)
Q Consensus 142 ~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~----~vkl~Dfg~a~~~~~ 189 (376)
.|++ . .|++|+|++|.||+++. ++ .++++|||++.....
T Consensus 274 ~Qif-------~-~GffHaDpHPGNIlv~~-~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQVF-------R-DGFFHADMHPGNIFVSY-DPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHH-------h-CCeeeCCCChHHeEEec-CCCCCCeEEEEecceEEECCH
Confidence 6665 4 69999999999999986 44 899999999976543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.2e-12 Score=108.43 Aligned_cols=132 Identities=20% Similarity=0.234 Sum_probs=92.6
Q ss_pred eeeeecCCCeeEEEEEEcC------CCcEEEEEEeec--------------ccc------------c----hHHHHHHHH
Q 017147 39 ERVVGTGSFGIVFQAKCLE------TGETVAIKKVLQ--------------DRR------------Y----KNRELQLMR 82 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~--------------~~~------------~----~~~e~~~l~ 82 (376)
...||.|--+.||.|.... .+..+|||+... +.+ . .++|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998643 357899997731 100 0 126888888
Q ss_pred hCCCC--ceeeeceeeeecCCCCceEEEEEeecccch-HH-HHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHh-hcCCCe
Q 017147 83 VMDHP--NVISLKHCFFSTTSKNELFLNLVMEYVPES-MY-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI-HTVPRV 157 (376)
Q Consensus 83 ~l~h~--~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~-~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~i 157 (376)
++... ++..++.+ .. -+|||||++++ +. ..++ ...++...+..+..+++.++..| |+ .|+
T Consensus 82 rl~~~Gv~vP~pi~~----~~-----~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~-~gl 146 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KK-----HVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKE-CNL 146 (197)
T ss_pred HHHHcCCCCCeEEEe----cC-----CEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHh-CCe
Confidence 87543 34444432 11 45999999863 11 1222 22355566777889999999998 88 799
Q ss_pred eecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 158 CHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 158 ~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+|+||++.||+++ ++.+.|+|||.+-..
T Consensus 147 VHGDLs~~NIL~~--~~~v~iIDF~qav~~ 174 (197)
T cd05146 147 VHADLSEYNMLWH--DGKVWFIDVSQSVEP 174 (197)
T ss_pred ecCCCCHHHEEEE--CCcEEEEECCCceeC
Confidence 9999999999997 356999999988543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.4e-12 Score=120.85 Aligned_cols=137 Identities=20% Similarity=0.252 Sum_probs=86.7
Q ss_pred eeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-ch-------------------------------------------
Q 017147 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YK------------------------------------------- 74 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~------------------------------------------- 74 (376)
.+.||.|++|+||+|.. .+|+.||||+...... ..
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 35799999999999985 4789999998754310 01
Q ss_pred HHHHHHHHhC----CCCceeeeceeeeecCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHH-HH
Q 017147 75 NRELQLMRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR-GL 148 (376)
Q Consensus 75 ~~e~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~-al 148 (376)
.+|...+..+ ++.+-+.+-.++..... ..++||||++| ++.+.... .. .... ...++.+++. .+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~-~~--~~~~---~~~ia~~~~~~~l 270 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAAL-DE--AGLD---RKALAENLARSFL 270 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHH-Hh--cCCC---HHHHHHHHHHHHH
Confidence 1233333332 23333333333322221 15699999997 44433321 11 1112 2234445554 46
Q ss_pred HHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 149 ~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
..+|. .|++|+|++|.||+++. ++.++++|||++....
T Consensus 271 ~ql~~-~g~~H~D~hPgNilv~~-~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 271 NQVLR-DGFFHADLHPGNIFVLK-DGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHh-CCceeCCCCcccEEECC-CCcEEEEeCCCeeECC
Confidence 78899 79999999999999986 6789999999997553
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.1e-12 Score=125.38 Aligned_cols=154 Identities=19% Similarity=0.326 Sum_probs=113.0
Q ss_pred HHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCC--------ceee--eeccccCchhhhhCCCC
Q 017147 144 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--------NISY--ICSRFYRAPELIFGATE 213 (376)
Q Consensus 144 i~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--------~~~~--~~t~~y~aPE~l~~~~~ 213 (376)
+..|+.|+|...++||++|.|++|.++. ++.+||+.|+++........ .... .-...|.|||.+.+ ..
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na-~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNA-NGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred ccchhhhhccCcceeecccchhheeecc-CcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 3489999998679999999999999996 78899999999865433111 1111 12456999999966 45
Q ss_pred CCchhhhHhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChh
Q 017147 214 YTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPE 292 (376)
Q Consensus 214 ~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (376)
.+.++|++|+||.+|.+. .|+..+...+.......-....+. -...+..+++++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~-------------------------~~~~~s~~~p~e 240 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA-------------------------GAFGYSNNLPSE 240 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc-------------------------ccccccccCcHH
Confidence 789999999999999999 577777655433222111111000 011122568999
Q ss_pred HHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 293 AIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 293 ~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
+++=+.++|..++..||++.+++..|||.+..
T Consensus 241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred HHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence 99999999999999999999999999998754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=6.6e-12 Score=104.48 Aligned_cols=124 Identities=15% Similarity=0.167 Sum_probs=88.6
Q ss_pred eeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCcee-eeceeeeecCCCCceEEEEEeecc
Q 017147 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVI-SLKHCFFSTTSKNELFLNLVMEYV 114 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~ 114 (376)
.+.|+.|.++.||++.. .+..|++|...... .....|+.+++.+.+.+++ +++... . .. .++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~---~~--~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--P---ET--GVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--C---CC--CeEEEEec
Confidence 45688999999999986 47889999875543 3356899999988655543 333221 1 11 35899999
Q ss_pred cchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCe-----eecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 115 PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV-----CHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 115 ~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i-----~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+|...... . .....++.+++.+|..||+ .++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 74 ~G~~l~~~--------~---~~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~ 135 (170)
T cd05151 74 EGSELLTE--------D---FSDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAG 135 (170)
T ss_pred CCCccccc--------c---ccCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE--CCeEEEEeccccc
Confidence 98421110 0 1113456789999999999 574 9999999999998 4569999999985
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.8e-10 Score=106.98 Aligned_cols=213 Identities=19% Similarity=0.247 Sum_probs=152.1
Q ss_pred eeEEEEEEcCCCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecccc--hHHHH
Q 017147 48 GIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE--SMYRV 121 (376)
Q Consensus 48 g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~ 121 (376)
.+.|+|....+|..|++|.+.-++. ....-+++++++.|.|+|.+.++|. +...++..+++|++|.++ +|.+.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~-t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFL-TYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhh-hhccCcceEEEEEecCCCCchHHHH
Confidence 5779999999999999999943332 2235688999999999999999986 333556668999999994 66665
Q ss_pred HHhh-----------hhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 122 LKHY-----------SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 122 l~~~-----------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
.... ...+...++..+|.|+.|+..||.++|+ .|+.-+-|.|.+||++. +.+|+|+..|........
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G-~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTG-KMRIRISGCGIMDVLQED 446 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeC-cceEEEecccceeeecCC
Confidence 4221 2234557899999999999999999999 79999999999999995 558999888876544322
Q ss_pred CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCC-CCCCChHHH-HHHHHHHhCCCCHHHHhhcCcCC
Q 017147 191 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQ-LVEIIKVLGTPTREEIRCMNPNY 268 (376)
Q Consensus 191 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~ 268 (376)
. . |.+. -..+-|.=.||.++..|.||..- +........ +..|.
T Consensus 447 ~-----------~--~~le----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~------------------ 491 (655)
T KOG3741|consen 447 P-----------T--EPLE----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT------------------ 491 (655)
T ss_pred C-----------C--cchh----HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh------------------
Confidence 2 0 1121 13456999999999999999643 111111111 22111
Q ss_pred CCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
...|.+++++|.-+...++.+ -++.+++.|
T Consensus 492 ------------------~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 492 ------------------TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ------------------hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 125777888888777777775 566666643
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.3e-10 Score=94.25 Aligned_cols=140 Identities=17% Similarity=0.226 Sum_probs=96.1
Q ss_pred eeeeeecCCCeeEEEEEEcCCCcEEEEEEee-cc-----------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 38 AERVVGTGSFGIVFQAKCLETGETVAIKKVL-QD-----------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 38 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~-~~-----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
.+..+-+|+-++|+++.. .|+.+.||.-. +. +.....|+.+|.++.--.|.-..-+|.+...
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~---- 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG---- 84 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC----
Confidence 566789999999999876 78888888542 21 2233468888877653333322222333333
Q ss_pred EEEEEeecccc--hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcE--EEEee
Q 017147 106 FLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV--KICDF 181 (376)
Q Consensus 106 ~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~v--kl~Df 181 (376)
-+|+|||++| ++.+.+.... ...........++..|-..+.-||. ++|+|+||..+||++.+++..+ .++||
T Consensus 85 -~~i~ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdf 160 (229)
T KOG3087|consen 85 -GQIYMEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDF 160 (229)
T ss_pred -CeEEEEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEee
Confidence 4499999998 5555554321 1222233336788888899999999 8999999999999998766654 89999
Q ss_pred cccccC
Q 017147 182 GSAKQL 187 (376)
Q Consensus 182 g~a~~~ 187 (376)
|++...
T Consensus 161 gls~~s 166 (229)
T KOG3087|consen 161 GLSSVS 166 (229)
T ss_pred cchhcc
Confidence 998643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.4e-12 Score=120.43 Aligned_cols=248 Identities=19% Similarity=0.197 Sum_probs=171.6
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEc-CCCcEEEEEEeeccccch------HHHHHHHHhC-CCCceeeeceeeeecCCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDRRYK------NRELQLMRVM-DHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~------~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 103 (376)
...+|..+..||.|.|+.|+.+..+ .++..|++|.+.+..... -.|+.+...+ .|.+++.....+.....
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-- 340 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-- 340 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc--
Confidence 3467889999999999999988755 678899999876543332 2355554444 48888888777744333
Q ss_pred ceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 104 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 104 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
.|+=-|||.+...++-. .....+.+...+.+..|++.|+.++|+ ..++|+|++|+||++..+++..++.|||+
T Consensus 341 ---~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 341 ---GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred ---ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhcccccc
Confidence 56888999864333322 123456778889999999999999999 69999999999999986447889999999
Q ss_pred cccCccCCCceeeeeccccC-chhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 184 AKQLIAGEANISYICSRFYR-APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 184 a~~~~~~~~~~~~~~t~~y~-aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
.....-. .......-.+. .+|++.....+..+.|++|||.-+.+.++|...-...... ..|.. |
T Consensus 414 ~t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~--~-------- 478 (524)
T KOG0601|consen 414 WTRLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRS--G-------- 478 (524)
T ss_pred cccccee--cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeec--c--------
Confidence 8642111 11112222333 3566656666889999999999999999987543222111 00100 0
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
..+. ....+.++..+.+.+...|+..|+.+.++..|+=|..
T Consensus 479 ---------~~p~----------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 479 ---------DTPN----------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ---------cccC----------CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 0000 0112367888999999999999999999988876654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.2e-10 Score=92.32 Aligned_cols=126 Identities=17% Similarity=0.283 Sum_probs=83.8
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEee-cc-----------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVL-QD-----------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~-~~-----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
..+++|+-+.+|.+.. -|..+.+|.-. +. .....+|+.++..+.--.|....=..++... .
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~-----~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN-----G 74 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----C
Confidence 3578999999999865 34456666432 21 1222468888887754333222212222222 4
Q ss_pred EEEeecccchHHH-HHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPESMYR-VLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~~l~~-~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
.|+|||++|.++. .+.. . ...++..+-..+.-||. .||+|+||.++||++.. +.+.++|||++..
T Consensus 75 ~I~me~I~G~~lkd~l~~----~-------~~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~~--~~i~~IDfGLg~~ 140 (204)
T COG3642 75 LIVMEYIEGELLKDALEE----A-------RPDLLREVGRLVGKLHK-AGIVHGDLTTSNIILSG--GRIYFIDFGLGEF 140 (204)
T ss_pred EEEEEEeCChhHHHHHHh----c-------chHHHHHHHHHHHHHHh-cCeecCCCccceEEEeC--CcEEEEECCcccc
Confidence 4999999996544 4432 1 13456677777888999 79999999999999984 4599999999974
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.8e-09 Score=90.54 Aligned_cols=121 Identities=26% Similarity=0.298 Sum_probs=75.6
Q ss_pred eEEEEEEcCCCcEEEEEEeecc--------------c----------------cchHHHHHHHHhCCCCc--eeeeceee
Q 017147 49 IVFQAKCLETGETVAIKKVLQD--------------R----------------RYKNRELQLMRVMDHPN--VISLKHCF 96 (376)
Q Consensus 49 ~Vy~~~~~~~~~~~aiK~~~~~--------------~----------------~~~~~e~~~l~~l~h~~--iv~~~~~~ 96 (376)
.||.|.. .++..+|+|..... . ....+|...|..+..-+ +.+++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888885 56789999977321 0 11136999999997653 45544322
Q ss_pred eecCCCCceEEEEEeeccc--chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHH-hhcCCCeeecCCCCCcEEEcCCC
Q 017147 97 FSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY-IHTVPRVCHRDLKPQNLLVDPLT 173 (376)
Q Consensus 97 ~~~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~-LH~~~~i~H~dlkp~Nill~~~~ 173 (376)
. -+|||||++ |.....+.. ..++......++.+++..+.. +|. .|++|+||.+.||+++. +
T Consensus 80 -----~----~~ivME~I~~~G~~~~~l~~-----~~~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~-~ 143 (188)
T PF01163_consen 80 -----R----NVIVMEYIGEDGVPLPRLKD-----VDLSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDD-G 143 (188)
T ss_dssp -----T----TEEEEE--EETTEEGGCHHH-----CGGGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEET-T
T ss_pred -----C----CEEEEEecCCCccchhhHHh-----ccccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeec-c
Confidence 1 349999999 632233332 112233456677788885555 579 79999999999999995 4
Q ss_pred CcEEEEeecccccC
Q 017147 174 HQVKICDFGSAKQL 187 (376)
Q Consensus 174 ~~vkl~Dfg~a~~~ 187 (376)
.+.|+|||.+...
T Consensus 144 -~~~iIDf~qav~~ 156 (188)
T PF01163_consen 144 -KVYIIDFGQAVDS 156 (188)
T ss_dssp -CEEE--GTTEEET
T ss_pred -eEEEEecCcceec
Confidence 7999999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.2e-08 Score=90.69 Aligned_cols=133 Identities=11% Similarity=0.107 Sum_probs=88.5
Q ss_pred eeEEEEEEcCCCcEEEEEEeeccc---------------cchHHHHHHHHhCCCCceeeeceeeee--cCCCCceEEEEE
Q 017147 48 GIVFQAKCLETGETVAIKKVLQDR---------------RYKNRELQLMRVMDHPNVISLKHCFFS--TTSKNELFLNLV 110 (376)
Q Consensus 48 g~Vy~~~~~~~~~~~aiK~~~~~~---------------~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~~~~~lv 110 (376)
..|+++.. .|+.|.||...... ....+|...+..+...+|....-+.+. ........-++|
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 34555443 56677788553211 124578888877754444443222221 111112235699
Q ss_pred eecccc--hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC------CCCcEEEEeec
Q 017147 111 MEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP------LTHQVKICDFG 182 (376)
Q Consensus 111 ~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~------~~~~vkl~Dfg 182 (376)
||++++ ++.+.+..+. ....+......++.+++..+.-||. .||+|+|+++.|||++. +...+.|+||+
T Consensus 114 te~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 114 TEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHA-AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred EeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHH-CcCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 999997 5666664332 2345667778899999999999999 79999999999999974 24679999999
Q ss_pred ccc
Q 017147 183 SAK 185 (376)
Q Consensus 183 ~a~ 185 (376)
.+.
T Consensus 191 r~~ 193 (268)
T PRK15123 191 RAQ 193 (268)
T ss_pred ccc
Confidence 885
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=8.5e-09 Score=93.79 Aligned_cols=197 Identities=14% Similarity=0.160 Sum_probs=129.6
Q ss_pred eeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccc-hHHHHHHHH-hCCCCceee----eceeeeecCCCCceEEEEE
Q 017147 37 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-KNRELQLMR-VMDHPNVIS----LKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 37 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~e~~~l~-~l~h~~iv~----~~~~~~~~~~~~~~~~~lv 110 (376)
...+.||+|+-+.+|-.-.. .-.+.|+....... ....+..|- .-.||-+.. .....+. . ......-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G-~-~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHG-G-RRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchh---hchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhC-C-CccceeEEe
Confidence 34567999999999865432 23455666543222 112222222 223442221 1111111 1 122226688
Q ss_pred eecccc--hHHHHHH--hhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 111 MEYVPE--SMYRVLK--HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 111 ~e~~~~--~l~~~l~--~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|+.+.| ....+.. ..+.......+..+.+....++.|..-||. +|.+-+|+.++|+|++. +..|.|.|-..-..
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd-~~~V~LVdsDsfqi 166 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSD-DSKVVLVDSDSFQI 166 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeec-CceEEEEcccceee
Confidence 888886 3333322 222334557888999999999999999999 79999999999999995 78899998665554
Q ss_pred CccCCCceeeeeccccCchhhhh----CCCCCCchhhhHhHHHHHHHHHhC-CCCCCCC
Q 017147 187 LIAGEANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLG-QPLFPGE 240 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~----~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~ 240 (376)
...+......+|.+.|.+||.-. -...-+..+|.|.||+++++++.| +.||.|-
T Consensus 167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 44555556678899999999742 112346789999999999999986 9999764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.98 E-value=7.3e-09 Score=89.93 Aligned_cols=138 Identities=18% Similarity=0.197 Sum_probs=89.7
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCc--eeeeceeeeecCCCCceEEEEEee
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPN--VISLKHCFFSTTSKNELFLNLVME 112 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e 112 (376)
+.|+.|..+.||++... +|+.+++|..... ......|..+++.+.+.+ +.+++...... ......++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEEE
Confidence 56899999999999863 3688999987543 234568999999987643 34444433111 11123579999
Q ss_pred cccch-HHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 017147 113 YVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV------------------------------------- 154 (376)
Q Consensus 113 ~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------------------------------------- 154 (376)
|++|. +...+. ...+++.....++.+++.+|..||+.
T Consensus 81 ~i~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 81 RVDGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EeCCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 99874 211110 02344444455555555555555531
Q ss_pred ------------------CCeeecCCCCCcEEEcCC-CCcEEEEeecccc
Q 017147 155 ------------------PRVCHRDLKPQNLLVDPL-THQVKICDFGSAK 185 (376)
Q Consensus 155 ------------------~~i~H~dlkp~Nill~~~-~~~vkl~Dfg~a~ 185 (376)
..++|+|+.|.||+++.+ ++.+.|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 357999999999999863 3458899999885
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1e-07 Score=82.58 Aligned_cols=131 Identities=21% Similarity=0.174 Sum_probs=91.6
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeec--------------------------cccchHHHHHHHHhCCCC-
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------------------------DRRYKNRELQLMRVMDHP- 87 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~--------------------------~~~~~~~e~~~l~~l~h~- 87 (376)
-+.++..||-|--+.||.|.+. .|.++|+|.-.- .+...++|.++|..|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3667789999999999999954 789999994321 012224789999998755
Q ss_pred -ceeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCc
Q 017147 88 -NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 166 (376)
Q Consensus 88 -~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~N 166 (376)
.+.+.++. ..-.+|||+++|-.+.-+ ++..+....++..|+.-+.-+-. .|++|+|+++-|
T Consensus 171 ~~VP~P~~~---------nRHaVvMe~ieG~eL~~~--------r~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefN 232 (304)
T COG0478 171 VKVPKPIAW---------NRHAVVMEYIEGVELYRL--------RLDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFN 232 (304)
T ss_pred CCCCCcccc---------ccceeeeehcccceeecc--------cCcccCHHHHHHHHHHHHHHHHH-cCccccCCchhe
Confidence 45554332 115599999998421111 11334455556666666655556 699999999999
Q ss_pred EEEcCCCCcEEEEeecccc
Q 017147 167 LLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 167 ill~~~~~~vkl~Dfg~a~ 185 (376)
|++++ ++.+.++||--+.
T Consensus 233 IlV~~-dg~~~vIDwPQ~v 250 (304)
T COG0478 233 ILVTE-DGDIVVIDWPQAV 250 (304)
T ss_pred EEEec-CCCEEEEeCcccc
Confidence 99997 6779999997764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.68 E-value=2e-07 Score=80.00 Aligned_cols=108 Identities=18% Similarity=0.243 Sum_probs=75.6
Q ss_pred chHHHHHHHHhCCCCceeee--ceeeeecCCCCceEEEEEeecccc--hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHH
Q 017147 73 YKNRELQLMRVMDHPNVISL--KHCFFSTTSKNELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148 (376)
Q Consensus 73 ~~~~e~~~l~~l~h~~iv~~--~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al 148 (376)
...+|...+..|....|... +.+....... ....++|+|++++ +|.+.+... ...+......++.+++..+
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~-~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGG-GYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLI 131 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC-ceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHH
Confidence 34578877777754444332 2222222211 2346799999987 566665431 2256667788999999999
Q ss_pred HHhhcCCCeeecCCCCCcEEEcCCC--CcEEEEeeccccc
Q 017147 149 AYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFGSAKQ 186 (376)
Q Consensus 149 ~~LH~~~~i~H~dlkp~Nill~~~~--~~vkl~Dfg~a~~ 186 (376)
.-||. .||+|+|+++.|||++.++ ..+.++||+-++.
T Consensus 132 ~~lH~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHD-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHH-CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 7999999999999999633 2799999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.63 E-value=8.4e-07 Score=75.31 Aligned_cols=137 Identities=15% Similarity=0.179 Sum_probs=84.7
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchH-------------HHHHHHHhCCCCceeeece---e
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------------RELQLMRVMDHPNVISLKH---C 95 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-------------~e~~~l~~l~h~~iv~~~~---~ 95 (376)
...+|.+.+++-......|.+..- +|+.+.+|.........+ +++..+..+....+..+.+ +
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 345788889988887777776654 678999997754322221 2333333333222222222 1
Q ss_pred eeecCCCCceEEEEEeecccch-HHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC
Q 017147 96 FFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 174 (376)
Q Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~ 174 (376)
..-....-....+++|||++|- +.+.. .+++. +.-.+..++.-||+ .|++|+|..|.|++++. +
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e~----~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~~--~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIE--------DIDED----LAEKIVEAIKQLHK-HGFYHGDPHPGNFLVSN--N 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccch--------hcCHH----HHHHHHHHHHHHHH-cCCccCCCCcCcEEEEC--C
Confidence 1111112223356899999983 22221 12222 33467778999999 79999999999999984 4
Q ss_pred cEEEEeecccc
Q 017147 175 QVKICDFGSAK 185 (376)
Q Consensus 175 ~vkl~Dfg~a~ 185 (376)
.++++||+..+
T Consensus 172 ~i~iID~~~k~ 182 (229)
T PF06176_consen 172 GIRIIDTQGKR 182 (229)
T ss_pred cEEEEECcccc
Confidence 49999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.62 E-value=1e-06 Score=74.57 Aligned_cols=139 Identities=14% Similarity=0.107 Sum_probs=94.2
Q ss_pred ecCCCeeEEEEEEcCCCcEEEEEEeec----------cccchHHHHHHHHhCCCCceeeeceeeee-cCCCCceEEEEEe
Q 017147 43 GTGSFGIVFQAKCLETGETVAIKKVLQ----------DRRYKNRELQLMRVMDHPNVISLKHCFFS-TTSKNELFLNLVM 111 (376)
Q Consensus 43 g~G~~g~Vy~~~~~~~~~~~aiK~~~~----------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~~~~~~lv~ 111 (376)
|+||.+-|+.... .|+.|-+|.-.. .+....+|...+..|...++.-..-++.. ........-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5588888888765 344688886531 23344689988888864444322222221 1112234466999
Q ss_pred ecccc--hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCC-CcEEEEeeccccc
Q 017147 112 EYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT-HQVKICDFGSAKQ 186 (376)
Q Consensus 112 e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~-~~vkl~Dfg~a~~ 186 (376)
|-++| +|.+.+... .-.+.+......++.+++.++.-||+ .|+.|+|+-+.||+++..+ ..++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98884 666665431 12345667778899999999999999 7999999999999998422 2499999988764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.7e-07 Score=90.26 Aligned_cols=135 Identities=22% Similarity=0.333 Sum_probs=81.0
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeeccccch--------------------------------------------H
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK--------------------------------------------N 75 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--------------------------------------------~ 75 (376)
..|+.++-|+||.|+-+ +|+.||||+...+-... .
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56899999999999954 59999999874321100 0
Q ss_pred HHHHHHHhC----CCCceeeeceeeeecCCCCceEEEEEeecccc-hHHHHHHhhhhcC---CCcCHHHHHHHHHHHHHH
Q 017147 76 RELQLMRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSAN---QRMPLIYVKLYTYQIFRG 147 (376)
Q Consensus 76 ~e~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~---~~l~~~~~~~i~~qi~~a 147 (376)
+|..-+..+ +...-+.+=.++.+.... -.++|||+.| .+.+.... ...+ ..+...-+..++.|++.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l-~~~g~d~k~ia~~~~~~f~~q~~~- 283 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTR----RVLTMEWIDGIKISDIAAL-KSAGIDRKELAELLVRAFLRQLLR- 283 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCC----cEEEEEeeCCEecccHHHH-HhcCCCHHHHHHHHHHHHHHHHHh-
Confidence 233333333 222223333344222211 3499999998 44443221 1111 12223333333333333
Q ss_pred HHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 148 l~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
.|++|+|..|.||+++. ++++.+.|||+......
T Consensus 284 -------dgffHaDpHpGNi~v~~-~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 -------DGFFHADPHPGNILVRS-DGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -------cCccccCCCccceEEec-CCcEEEEcCcceecCCH
Confidence 59999999999999997 68899999999876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.6e-08 Score=96.40 Aligned_cols=246 Identities=20% Similarity=0.188 Sum_probs=162.3
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHhCCCCc-eeeeceeeeecCCCCceEEEEEe
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPN-VISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
..-|....-+++|+++++++.+...+.... .+.+... ....-++++|.+.+||| .+..++ +.+.+.+..+++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~-----d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLE-----DYDGEDYLWIPM 313 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccc-----cCCcccccchhh
Confidence 345667777899999999998776554444 5555433 44456899999999999 333332 225566788999
Q ss_pred ecccch--HHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 112 EYVPES--MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 112 e~~~~~--l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
+++.++ ..... ......+...+...+...-+.++++||+ ..=+|+| ||+..+ ...+..||+.......
T Consensus 314 ~i~s~~rs~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~-~~~~~~d----~~l~s~--~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 314 RICSTGRSSALEM---TVSEIALEQYQFAYPLRKETRPLAELHS-SYKVHRD----NILGSE--EEVKLLDFAVPPQLTR 383 (829)
T ss_pred hhhcCCccccccC---ChhhHhhhhhhhhhhhhhhccccccccc-ccccCcc----cccccc--cccccccccCCcccCc
Confidence 999854 11110 0111223344455566667788999998 4557888 888874 5689999999876655
Q ss_pred CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 190 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 190 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
.....+..+|+.++|||+...+ .+....|.|++|+-..+|.-|-+|-...-. .+. ..|..+
T Consensus 384 ~~~~~t~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~----~~g~~p------------ 444 (829)
T KOG0576|consen 384 TMKPRTAIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLP----MIGNGP------------ 444 (829)
T ss_pred ccccccCCCCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCCCCCCcc--ccC----CCCCCC------------
Confidence 5555677889999999998554 488899999999887788777777544110 000 000000
Q ss_pred CCCCCCCCC-CChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 270 DFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 270 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.-+.+.. ..|...++. ++...|+..-|..|+....++-|-+|+..
T Consensus 445 --~s~~L~~~~aw~~~~~~-------~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 445 --NSPMLTDKSAWSPVFHR-------DFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred --CccccchhhhcCccccc-------CCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 0011111 222222222 57788999999999999999999998764
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.3e-06 Score=75.03 Aligned_cols=132 Identities=19% Similarity=0.187 Sum_probs=87.0
Q ss_pred eeecCCCeeEEEEEEcCCCcEEEEEEeecccc----------------------------chHHHHHHHHhCCCC--cee
Q 017147 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----------------------------YKNRELQLMRVMDHP--NVI 90 (376)
Q Consensus 41 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----------------------------~~~~e~~~l~~l~h~--~iv 90 (376)
.|.+|--+.||+|.. .++..+|+|++..... ...+|..-|+++... .+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 677788889999984 5688999998843211 112577777766432 333
Q ss_pred eeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEc
Q 017147 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 170 (376)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~ 170 (376)
+.+.+. . -.|||||++... ...-.-..-.+..+++..+..+++..+.-|-.-.++||+||+.-|||+.
T Consensus 134 ~Pi~~~-----~----nVLvMEfIg~~g---~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~ 201 (268)
T COG1718 134 EPIAFR-----N----NVLVMEFIGDDG---LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH 201 (268)
T ss_pred Cceeec-----C----CeEEEEeccCCC---CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence 333322 1 339999998530 1000011223344467778888888887766525999999999999998
Q ss_pred CCCCcEEEEeecccccC
Q 017147 171 PLTHQVKICDFGSAKQL 187 (376)
Q Consensus 171 ~~~~~vkl~Dfg~a~~~ 187 (376)
++.+.|+|||-|...
T Consensus 202 --~~~p~iID~~QaV~~ 216 (268)
T COG1718 202 --DGEPYIIDVSQAVTI 216 (268)
T ss_pred --CCeEEEEECcccccc
Confidence 567999999988643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.47 E-value=4.3e-07 Score=92.43 Aligned_cols=203 Identities=23% Similarity=0.327 Sum_probs=133.9
Q ss_pred HHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhc
Q 017147 75 NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 153 (376)
Q Consensus 75 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~ 153 (376)
+.|...+..+.|+|++.++.+-+.....+ ....+..++|.. ++...+. .-...+...++.+..+++.|+.++|+
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHH
Confidence 45777888899999999876554332222 122344567764 4444443 44678889999999999999999999
Q ss_pred CCCeeecCCCCC---cEEEcCCCCcEEEE--eecccccCccCCCceeeeeccccCchhhhhCCC-CCCchhhhHhHHHHH
Q 017147 154 VPRVCHRDLKPQ---NLLVDPLTHQVKIC--DFGSAKQLIAGEANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVL 227 (376)
Q Consensus 154 ~~~i~H~dlkp~---Nill~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwslG~il 227 (376)
....|.-+..+ +--.+. .+.+.++ ||+.++.............+.-+.+||...... ..+...|+|++|...
T Consensus 305 -~~l~~v~L~~s~~~~~~~~~-e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 305 -LSLEHVVLSASSSKESTVDG-EGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred -hccceeEEecccccccccCc-cceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 55555544444 222232 3345555 888887766666555666677788998874322 122346999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCC
Q 017147 228 AELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 307 (376)
Q Consensus 228 ~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 307 (376)
..+..|..+-..... ....+ ......+..+++.+|+.-++++
T Consensus 383 ~~~~~~~~i~~~~~~---~~~~l-----------------------------------~~~~~~~~~d~~~~~~~~~~~~ 424 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAV---PVSLL-----------------------------------DVLSTSELLDALPKCLDEDSEE 424 (1351)
T ss_pred hhhhhcCcccccccc---hhhhh-----------------------------------ccccchhhhhhhhhhcchhhhh
Confidence 999887754321110 00000 0001126788999999999999
Q ss_pred CCCHHHHhcCCCccc
Q 017147 308 RCTALEACAHPFFDE 322 (376)
Q Consensus 308 R~t~~e~l~hp~~~~ 322 (376)
|+++.+++.|||.+-
T Consensus 425 Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 425 RLSALELLTHPFLRF 439 (1351)
T ss_pred ccchhhhhhchhccc
Confidence 999999999999865
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=3.8e-06 Score=80.83 Aligned_cols=137 Identities=18% Similarity=0.239 Sum_probs=80.1
Q ss_pred eeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccch-----------------------------------------HHH
Q 017147 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----------------------------------------NRE 77 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----------------------------------------~~e 77 (376)
-+.||..+.|+|++|+-+ +|+.||||+-..+-+.. ..|
T Consensus 166 ~~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 357999999999999965 49999999764321111 012
Q ss_pred HH----HHHhCCCCc---eeeeceeeeecCCCCceEEEEEeecccc---hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHH
Q 017147 78 LQ----LMRVMDHPN---VISLKHCFFSTTSKNELFLNLVMEYVPE---SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147 (376)
Q Consensus 78 ~~----~l~~l~h~~---iv~~~~~~~~~~~~~~~~~~lv~e~~~~---~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~a 147 (376)
++ +.+.+.|-+ -|.+=.++.+... .-.++||||+| +-.+.+.. ..++...+...+.+...
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i~~~l~~~~~- 314 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAIDK-----RGISPHDILNKLVEAYL- 314 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHHHH-----cCCCHHHHHHHHHHHHH-
Confidence 22 222333444 1222233322211 14499999997 22223322 33444433332222211
Q ss_pred HHHhhcCCCeeecCCCCCcEEEcC---CCCcEEEEeecccccCc
Q 017147 148 LAYIHTVPRVCHRDLKPQNLLVDP---LTHQVKICDFGSAKQLI 188 (376)
Q Consensus 148 l~~LH~~~~i~H~dlkp~Nill~~---~~~~vkl~Dfg~a~~~~ 188 (376)
+-+=. .|++|+|-.|.||++++ .++.+.+.|||+.....
T Consensus 315 -~qIf~-~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 315 -EQIFK-TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred -HHHHh-cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 12223 59999999999999984 36789999999987553
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.29 E-value=5.6e-06 Score=72.30 Aligned_cols=74 Identities=20% Similarity=0.210 Sum_probs=49.0
Q ss_pred eeeeecCCCeeEEEEEEcCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCc--eeeeceeeeecCCCCceEEEEEeecc
Q 017147 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPN--VISLKHCFFSTTSKNELFLNLVMEYV 114 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e~~ 114 (376)
++.|+.|..+.||++.... ..+++|..... .....+|..+++.+.... +.+++... .........+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~--~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFD--TSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEE--EETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeec--ccccccccceEEEEEe
Confidence 4678999999999998644 59999987654 344557888888775433 34444322 1112233478999999
Q ss_pred cc
Q 017147 115 PE 116 (376)
Q Consensus 115 ~~ 116 (376)
+|
T Consensus 78 ~g 79 (239)
T PF01636_consen 78 PG 79 (239)
T ss_dssp SS
T ss_pred cc
Confidence 87
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.8e-05 Score=67.65 Aligned_cols=69 Identities=14% Similarity=0.077 Sum_probs=44.4
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCce--eeeceeeeecCCCCceEEEEEeeccc
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNV--ISLKHCFFSTTSKNELFLNLVMEYVP 115 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~ 115 (376)
..||+|..+.||+. .+..+++|...... ....+|.++++.+..-.+ .+.+++. +......+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence 46899999999974 24567889775422 335689998888764333 3333332 11222568999999
Q ss_pred ch
Q 017147 116 ES 117 (376)
Q Consensus 116 ~~ 117 (376)
|.
T Consensus 78 G~ 79 (226)
T TIGR02172 78 GK 79 (226)
T ss_pred Cc
Confidence 83
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.05 E-value=2.4e-05 Score=63.75 Aligned_cols=126 Identities=21% Similarity=0.315 Sum_probs=84.0
Q ss_pred eeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeec
Q 017147 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY 113 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 113 (376)
-.+.+.|++|.+|.||++.. .|..+|+|+-..+. .....|+++|..++..++-.=+- +++. .++.|||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy-~yg~-------~~i~me~ 93 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVY-FYGE-------DFIRMEY 93 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEE-Eech-------hhhhhhh
Confidence 45677899999999999987 56689999775543 44568999999887655543211 1111 2367999
Q ss_pred ccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCC--CcEEEcCCCCcEEEEeecccc
Q 017147 114 VPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP--QNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 114 ~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp--~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+.| .|.+.... .. +.-+..++++---|-. .||-|+.|.- .||++. +..+.|+||..|+
T Consensus 94 i~G~~L~~~~~~-------~~----rk~l~~vlE~a~~LD~-~GI~H~El~~~~k~vlv~--~~~~~iIDFd~At 154 (201)
T COG2112 94 IDGRPLGKLEIG-------GD----RKHLLRVLEKAYKLDR-LGIEHGELSRPWKNVLVN--DRDVYIIDFDSAT 154 (201)
T ss_pred hcCcchhhhhhc-------cc----HHHHHHHHHHHHHHHH-hccchhhhcCCceeEEec--CCcEEEEEccchh
Confidence 998 44333210 01 2223355666555666 5999999875 366665 3479999999987
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00019 Score=74.44 Aligned_cols=77 Identities=18% Similarity=0.195 Sum_probs=50.1
Q ss_pred eeeeecCCCeeEEEEEEcCCC--cEEEEEEeecc-----ccchHHHHHHHHhCC-CCce--eeeceeeeecCCCCceEEE
Q 017147 39 ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQD-----RRYKNRELQLMRVMD-HPNV--ISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~--~~~aiK~~~~~-----~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~~~~~~~~~~ 108 (376)
++.++.|.++.+|++.....+ ..+++|+.... .....+|+.+++.+. |.++ .+++..+.+. ......|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCce
Confidence 566899999999998764332 46788876432 234568999999996 6654 4444433221 1122367
Q ss_pred EEeecccch
Q 017147 109 LVMEYVPES 117 (376)
Q Consensus 109 lv~e~~~~~ 117 (376)
+||||++|.
T Consensus 121 lVME~v~G~ 129 (822)
T PLN02876 121 YIMEYLEGR 129 (822)
T ss_pred EEEEecCCc
Confidence 999999874
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.0001 Score=67.02 Aligned_cols=136 Identities=19% Similarity=0.244 Sum_probs=92.5
Q ss_pred eeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------c------------------------cchHHHHHHHHhCCC
Q 017147 37 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------R------------------------RYKNRELQLMRVMDH 86 (376)
Q Consensus 37 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~------------------------~~~~~e~~~l~~l~h 86 (376)
.+...|..|--+.||.|. ..+|..+|||++..+ + .+.++|+.-|+++..
T Consensus 147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 345567888889999998 567888999987421 1 111357777777765
Q ss_pred CceeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCc
Q 017147 87 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 166 (376)
Q Consensus 87 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~N 166 (376)
..|.-.--+.+-. -.|||+|+++.-+ ..-.-....++...+..+-.|++.-+.-|-+..++||.||+--|
T Consensus 226 aGIP~PePIlLk~-------hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN 295 (520)
T KOG2270|consen 226 AGIPCPEPILLKN-------HVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN 295 (520)
T ss_pred cCCCCCCceeeec-------ceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence 5544332222111 3499999984211 11111345677778888888888888777654799999999999
Q ss_pred EEEcCCCCcEEEEeecccc
Q 017147 167 LLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 167 ill~~~~~~vkl~Dfg~a~ 185 (376)
+|+. ++.+.|+|.+-+-
T Consensus 296 ~Lyh--dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 296 LLYH--DGKLYIIDVSQSV 312 (520)
T ss_pred heEE--CCEEEEEEccccc
Confidence 9997 5779999988764
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00039 Score=58.89 Aligned_cols=127 Identities=19% Similarity=0.303 Sum_probs=81.9
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc--------------------cchHHHHHHHHhCC------CCceeeec
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------------RYKNRELQLMRVMD------HPNVISLK 93 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------------~~~~~e~~~l~~l~------h~~iv~~~ 93 (376)
..||+|+.-.||.- ..+....||+..... ....+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46899999998863 355667888876554 33346776666665 78888888
Q ss_pred eeeeecCCCCceEEEEEeeccc---chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEc
Q 017147 94 HCFFSTTSKNELFLNLVMEYVP---ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 170 (376)
Q Consensus 94 ~~~~~~~~~~~~~~~lv~e~~~---~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~ 170 (376)
+...+... .-+|+|.+. |+....+..+.. .+.++. .+.. .+-.-.+||-. ++|+.+|++|.||++.
T Consensus 84 G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~~~---~L~~f~~~l~~-~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLG-----LGLVVELIRDADGNISPTLEDYLK-EGGLTE-ELRQ---ALDEFKRYLLD-HHIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCc-----eEEEEEEEECCCCCcCccHHHHHH-cCCccH-HHHH---HHHHHHHHHHH-cCCeecCCCcccEEEE
Confidence 88744443 567888774 333334443332 244555 3333 33334467777 7999999999999996
Q ss_pred CCC--C-cEEEEe
Q 017147 171 PLT--H-QVKICD 180 (376)
Q Consensus 171 ~~~--~-~vkl~D 180 (376)
..+ . .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 422 2 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00039 Score=58.56 Aligned_cols=126 Identities=22% Similarity=0.323 Sum_probs=83.9
Q ss_pred ceeeeeeeeecCCC-eeEEEEEEcCCCcEEEEEEeec----c----------cc-----------chHHHHH---HHHhC
Q 017147 34 ISYMAERVVGTGSF-GIVFQAKCLETGETVAIKKVLQ----D----------RR-----------YKNRELQ---LMRVM 84 (376)
Q Consensus 34 ~~y~~~~~lg~G~~-g~Vy~~~~~~~~~~~aiK~~~~----~----------~~-----------~~~~e~~---~l~~l 84 (376)
.+++.++.||.|.- |.||+++. .|+.||+|.+.. . .. -...|-. .|+.+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 58999999999999 99999986 678999998421 0 00 0123444 34444
Q ss_pred CCCce--eeeceeeeecC-C------------CCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHH
Q 017147 85 DHPNV--ISLKHCFFSTT-S------------KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149 (376)
Q Consensus 85 ~h~~i--v~~~~~~~~~~-~------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~ 149 (376)
.+.++ |+.++.+.-.. . .......||.||+...- .+.... +.+|+.-+.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl~ 178 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDLK 178 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHHH
Confidence 56666 77776653221 0 11223457888776531 222333 347778888
Q ss_pred HhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 150 ~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
.+|. .||+-+|+++.|.. + -+|+|||.+
T Consensus 179 ~~~k-~gI~~~Dv~~~ny~----~--G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHK-LGIVPRDVKPRNYR----G--GKLVDFSSS 206 (207)
T ss_pred HHHH-CCeeeccCcccccc----C--CEEEecccC
Confidence 9999 69999999999975 2 379999865
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00047 Score=60.79 Aligned_cols=69 Identities=16% Similarity=0.066 Sum_probs=41.8
Q ss_pred eecCCC-eeEEEEEEcCCCcEEEEEEeecc-ccchHHHHHHHHhCCC-CceeeeceeeeecCCCCceEEEEEeecccch
Q 017147 42 VGTGSF-GIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMDH-PNVISLKHCFFSTTSKNELFLNLVMEYVPES 117 (376)
Q Consensus 42 lg~G~~-g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~ 117 (376)
|..|.. +.||++.. .+..+.+|..... .....+|+.+++.+.. -.+.+++..... ....++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSD-----DGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEec-----CCccEEEEEeeCCc
Confidence 445555 78899864 3467888876543 1235678988888753 223344443311 12356899999873
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0012 Score=57.76 Aligned_cols=69 Identities=17% Similarity=0.314 Sum_probs=43.7
Q ss_pred eeeeecCCCeeEEEEEEcC-CCcEEEEEEeeccc---cchHHHHHHHHhCCCCcee-eeceeeeecCCCCceEEEEEeec
Q 017147 39 ERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVI-SLKHCFFSTTSKNELFLNLVMEY 113 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~ 113 (376)
++.|..|-...+|++.... .++.|++|+..... ....+|+.+++.+...+++ +++... .+ .++|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEEEEe
Confidence 4567788889999987543 35789999765432 1224788888888644443 222211 11 279999
Q ss_pred ccc
Q 017147 114 VPE 116 (376)
Q Consensus 114 ~~~ 116 (376)
++|
T Consensus 74 i~G 76 (235)
T cd05157 74 IPG 76 (235)
T ss_pred eCC
Confidence 886
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00059 Score=59.81 Aligned_cols=30 Identities=40% Similarity=0.579 Sum_probs=24.8
Q ss_pred CCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 155 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.+++|+|+.|.||+++. +...-|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~-~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQD-GRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEEC-CCEEEEEeCcccC
Confidence 46899999999999984 4445699999875
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00022 Score=67.47 Aligned_cols=170 Identities=21% Similarity=0.245 Sum_probs=108.6
Q ss_pred HHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCC
Q 017147 76 RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155 (376)
Q Consensus 76 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ 155 (376)
-...+++.+.|+|.....++--. ......+|+|+++-++.+.+.... +... +++ . +
T Consensus 31 gr~~~lktl~~~~l~~yl~~~r~----~~~r~IVV~e~~~~Sled~~~~~~-----l~~~-------s~~-------~-~ 86 (725)
T KOG1093|consen 31 GRFQYLKSLQHDNLCQYLDFSRG----KHERVIVVMEHYTMSLEDILKTGN-----LKDE-------SLL-------A-H 86 (725)
T ss_pred hhhHHHHhhcCccceeeEeeecC----ccceEEEEehhhccchHHHHHhcc-----cchh-------hhc-------c-c
Confidence 45678899999999988765421 122277999999999888876321 1100 111 1 2
Q ss_pred CeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCC
Q 017147 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 235 (376)
Q Consensus 156 ~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~ 235 (376)
|+.| .|+ ++.+| .++. . | |- ...+++||||+|.++.++..|..
T Consensus 87 ~~~~-----~~~--------~~~td-~~~t----~-----------~--~~------~~~pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 87 GVLH-----LNI--------IYITD-HFLT----K-----------Y--PS------PIGPKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred ccce-----ehh--------hhccc-cccc----c-----------C--CC------CCCcchhhhhHHHHHHHHHHhhH
Confidence 3333 122 33333 1110 0 1 11 11249999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017147 236 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315 (376)
Q Consensus 236 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 315 (376)
.+......+.+..+.+..-.+.....-. ..+ .+...++....++..+|+-..|..||...++.
T Consensus 130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a----------------~e~-~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 130 LEAELTESEYLEILLKYYTDDQELLSTA----------------MEH-LIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HHHHHHHHHHHHHHHHhccCchhHHHHH----------------HHH-HHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 9988888777776666433322211110 001 12223677888999999999999999999999
Q ss_pred cCCCcccc
Q 017147 316 AHPFFDEL 323 (376)
Q Consensus 316 ~hp~~~~~ 323 (376)
+|+-|..+
T Consensus 193 k~~i~~ev 200 (725)
T KOG1093|consen 193 KRCSFTEV 200 (725)
T ss_pred cCccHHHH
Confidence 99999876
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.54 E-value=3.5e-05 Score=80.98 Aligned_cols=213 Identities=16% Similarity=0.028 Sum_probs=134.3
Q ss_pred HHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCC
Q 017147 77 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155 (376)
Q Consensus 77 e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ 155 (376)
|.+.++...|+++.....-..+.. ....|.+++|+. |.+...+..-......+....+.....+.+.+..-+|+..
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~---s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSE---STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCC---ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 444555668888877654432222 222568899998 5666666554444444555444444444467777766633
Q ss_pred C----eeecCCCCCcEEEcCCCCcEEEEeecccccCcc-CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHH
Q 017147 156 R----VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 230 (376)
Q Consensus 156 ~----i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~l 230 (376)
+ .+|+++|+-|.++.. +..+|+.++|+.+.... .......+|++.|++|++.. .-.++.++|+|..|+-+|..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVt-ny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVT-NYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceec-CCcccccccccccccCchHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHHH
Confidence 3 478999999999986 78899999999983222 22234567788999999873 34577889999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC
Q 017147 231 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310 (376)
Q Consensus 231 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 310 (376)
..|.++|. ..++.+++. ...+-.....+.+ -|.++-.....+|-+.-..||.
T Consensus 1434 s~~n~~fi-----~flq~~Lkg-----------iidn~tf~sIe~l------------~pgdaNve~~~~Ll~K~~~rp~ 1485 (2724)
T KOG1826|consen 1434 SDGNAYFI-----FFLQPALKG-----------IIDNHTFFSIEKL------------KPGDANVEALHRLLWKYMERPG 1485 (2724)
T ss_pred hcccHHHH-----HHHHHHHcC-----------ccccccccccccc------------CCCcccHHHHHHHHHHhhhcch
Confidence 98988773 222222221 1111111111111 1334444455555556678999
Q ss_pred HHHHhcCCCccc
Q 017147 311 ALEACAHPFFDE 322 (376)
Q Consensus 311 ~~e~l~hp~~~~ 322 (376)
-...+.-|.|.-
T Consensus 1486 q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1486 QYISLSRDHFAV 1497 (2724)
T ss_pred hhhhcccccccc
Confidence 999888888754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00081 Score=59.78 Aligned_cols=132 Identities=17% Similarity=0.237 Sum_probs=72.8
Q ss_pred eecCCCeeEEEEEEcCCCcEEEEEEeecccc----chHHHHHHHHhCCCCcee-eeceeeeecCCCCceEEEEEeecccc
Q 017147 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVI-SLKHCFFSTTSKNELFLNLVMEYVPE 116 (376)
Q Consensus 42 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~~~ 116 (376)
+..|-.+.+|++. .+++.+++|....... ...+|..+++.+....++ +++.. . . -++|+||++|
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~---~----~~~v~e~i~G 72 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILV--N---E----HWLLVEWLEG 72 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEE--e---C----CEEEEEeccC
Confidence 4567888999887 3567888987644322 246788899888654332 22221 1 1 2489999987
Q ss_pred hHHH---------------HHHhh---hhcCCCcCH-HHHHHHHHHH---------HHHHHHhhc-------CCCeeecC
Q 017147 117 SMYR---------------VLKHY---SSANQRMPL-IYVKLYTYQI---------FRGLAYIHT-------VPRVCHRD 161 (376)
Q Consensus 117 ~l~~---------------~l~~~---~~~~~~l~~-~~~~~i~~qi---------~~al~~LH~-------~~~i~H~d 161 (376)
.... .+... .....+++. ..+..+..++ ...++.+-. ...++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 3211 11100 001111221 1222222222 111221211 02589999
Q ss_pred CCCCcEEEcCCCCcEEEEeeccccc
Q 017147 162 LKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 162 lkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
+.|.||+++. ++ +.|+||..|..
T Consensus 153 l~~~Nil~~~-~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVTP-QG-LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEeC-CC-CEEEeccccCc
Confidence 9999999986 44 78999998853
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0034 Score=59.03 Aligned_cols=71 Identities=23% Similarity=0.309 Sum_probs=46.2
Q ss_pred eeeeecCCCeeEEEEEEcCCCcEEEEEEeec-----------cccchHHHHHHHHhCC---CCceeeeceeeeecCCCCc
Q 017147 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-----------DRRYKNRELQLMRVMD---HPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~-----------~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~ 104 (376)
.+.||.|.++.||++.....++.++||.-.. .......|.+.|+.+. ..++.+++++- ...
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~--- 105 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EEL--- 105 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCC---
Confidence 4679999999999999754446899997431 1122346777777753 23456655432 211
Q ss_pred eEEEEEeecccc
Q 017147 105 LFLNLVMEYVPE 116 (376)
Q Consensus 105 ~~~~lv~e~~~~ 116 (376)
.++|||++++
T Consensus 106 --~~lVME~L~~ 115 (401)
T PRK09550 106 --AVTVMEDLSD 115 (401)
T ss_pred --CEEEEecCCC
Confidence 5599999874
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0013 Score=55.32 Aligned_cols=101 Identities=20% Similarity=0.178 Sum_probs=73.6
Q ss_pred HHHHHHHHhCCC-CceeeeceeeeecCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhh
Q 017147 75 NRELQLMRVMDH-PNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152 (376)
Q Consensus 75 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 152 (376)
..|.-+++.+.+ +++.++++.+ . -+++.||.+. +++.. ......-...++.....++.+++..+++|+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~-~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~ 76 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGI-YRPLSQFLQSPWEQRAKIALQLLELLEELD 76 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccc-ccccccccccCHHHHHHHHHHHHHHHHHHh
Confidence 357888888876 5899988876 2 3478899984 33211 000011134678889999999999999998
Q ss_pred cC--CCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 153 TV--PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 153 ~~--~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
.. ..+.-.|++|+|+-++. ++++|++|.+.+..
T Consensus 77 ~~~~~~~~lcDv~~~nfgv~~-~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 77 HGPLGFFYLCDVSPDNFGVND-DGRLKLIDLDDVFV 111 (188)
T ss_pred cCCCCcEEEeecchHHeEEeC-CCcEEEEechhcch
Confidence 61 24666899999999995 78899999998754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0074 Score=55.48 Aligned_cols=30 Identities=30% Similarity=0.261 Sum_probs=25.3
Q ss_pred CCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 155 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.+++|+|+.|.||+++. +...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEG-DRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEEC-CceEEEEeccccc
Confidence 48999999999999984 4445799999884
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0042 Score=56.84 Aligned_cols=145 Identities=17% Similarity=0.062 Sum_probs=76.0
Q ss_pred eeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCc--eeeeceeeeec-CCCCceEEEEEee
Q 017147 38 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPN--VISLKHCFFST-TSKNELFLNLVME 112 (376)
Q Consensus 38 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~-~~~~~~~~~lv~e 112 (376)
..+.++.|....+|++.. ++..+++|+.... ......|.+++..|.... +.+++...-.. ........+++++
T Consensus 26 ~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT--DVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred eccccCCccccceEEEEe--CCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 355677787789999874 3446888976543 233446777777774333 23332211000 0011234679999
Q ss_pred cccchH-----H-------HHHHhhh--hcCC--------CcC-HHH--HH----------HHHHHHHHHHHHhhc----
Q 017147 113 YVPESM-----Y-------RVLKHYS--SANQ--------RMP-LIY--VK----------LYTYQIFRGLAYIHT---- 153 (376)
Q Consensus 113 ~~~~~l-----~-------~~l~~~~--~~~~--------~l~-~~~--~~----------~i~~qi~~al~~LH~---- 153 (376)
|++|.. . +.+...- ..+- ..+ +.. .. .....+..+++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 987621 0 1111000 0000 000 000 00 001112233444431
Q ss_pred --CCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 154 --VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 154 --~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
..+++|+|+.+.||+++. ++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~-~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDG-DSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEEC-CceEEEeeccccc
Confidence 158999999999999986 5556899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0052 Score=55.79 Aligned_cols=144 Identities=14% Similarity=0.024 Sum_probs=76.1
Q ss_pred eeeeecCCCeeEEEEEEcCCCcEEEEEEeec-cccchHHHHHHHHhCCCCc--eeeeceeeeec-CCCCceEEEEEeecc
Q 017147 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQLMRVMDHPN--VISLKHCFFST-TSKNELFLNLVMEYV 114 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~-~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~-~~~~~~~~~lv~e~~ 114 (376)
.+.|..|....+|++.. ++..+++|+... .......|+.++..+.+.. +.+++...-.. ........+.|++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 55677788889999864 345799998764 2334456888888775433 33332210000 001112357899999
Q ss_pred cchHH------------HHH---Hhhhhc-CCC----cCHHHHHH------------HHHHHHHHHHHhhc------CCC
Q 017147 115 PESMY------------RVL---KHYSSA-NQR----MPLIYVKL------------YTYQIFRGLAYIHT------VPR 156 (376)
Q Consensus 115 ~~~l~------------~~l---~~~~~~-~~~----l~~~~~~~------------i~~qi~~al~~LH~------~~~ 156 (376)
+|... +.+ ...... ... ........ ....+..++.++.+ ..+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 76211 111 100000 000 00000000 01112223333332 147
Q ss_pred eeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 157 VCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 157 i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
++|+|+.|.||+++. +..+.|+||+.+.
T Consensus 177 l~HgD~~~~Nil~~~-~~~~~iIDfe~a~ 204 (296)
T cd05153 177 VIHADLFRDNVLFDG-DELSGVIDFYFAC 204 (296)
T ss_pred CCccCcCcccEEEeC-CceEEEeehhhhc
Confidence 999999999999996 5556899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.011 Score=53.83 Aligned_cols=75 Identities=7% Similarity=-0.032 Sum_probs=48.7
Q ss_pred eeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc--ccchHHHHHHHHhCCC---CceeeeceeeeecCCCCceEEEEEee
Q 017147 38 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDH---PNVISLKHCFFSTTSKNELFLNLVME 112 (376)
Q Consensus 38 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~~~~~~~~~~lv~e 112 (376)
-.+.||.|..+.||..... ++ .+.+|..... ......|...|+.+.. -.+.++++++..... ....++|||
T Consensus 18 ~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~--~g~~~LVmE 93 (297)
T PRK10593 18 RVECISEQPYAALWALYDS-QG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS--PGPDVLLLE 93 (297)
T ss_pred eeeecCCccceeEEEEEcC-CC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc--CCCeEEEEe
Confidence 3557999999999998642 23 5777765431 2466789999988854 245566554422211 223679999
Q ss_pred cccc
Q 017147 113 YVPE 116 (376)
Q Consensus 113 ~~~~ 116 (376)
+++|
T Consensus 94 ~i~G 97 (297)
T PRK10593 94 RLRG 97 (297)
T ss_pred ccCC
Confidence 9886
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.00078 Score=60.42 Aligned_cols=130 Identities=16% Similarity=0.176 Sum_probs=85.6
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeec----------c----------------ccchHHHHHHHHhCCCCc
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----------D----------------RRYKNRELQLMRVMDHPN 88 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~----------~----------------~~~~~~e~~~l~~l~h~~ 88 (376)
-|.++..||-|--+.||.+-+ ..|...++|.-.- . +....+|...|+.|....
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 477888999999999999985 4678888884311 0 111236888888775322
Q ss_pred --eeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCc
Q 017147 89 --VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 166 (376)
Q Consensus 89 --iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~N 166 (376)
+.+.+++ ...++|||++.|--+..+.+ ... +..+...+..-+.-|-. +|++|+|..-=|
T Consensus 172 fpVPkpiD~---------~RH~Vvmelv~g~Pl~~v~~------v~d---~~~ly~~lm~~Iv~la~-~GlIHgDFNEFN 232 (465)
T KOG2268|consen 172 FPVPKPIDH---------NRHCVVMELVDGYPLRQVRH------VED---PPTLYDDLMGLIVRLAN-HGLIHGDFNEFN 232 (465)
T ss_pred CCCCCcccc---------cceeeHHHhhcccceeeeee------cCC---hHHHHHHHHHHHHHHHH-cCceecccchhe
Confidence 2233221 12679999998731111111 111 22344455556667778 799999999999
Q ss_pred EEEcCCCCcEEEEeecccc
Q 017147 167 LLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 167 ill~~~~~~vkl~Dfg~a~ 185 (376)
|++.. ++.++++||--+-
T Consensus 233 imv~d-d~~i~vIDFPQmv 250 (465)
T KOG2268|consen 233 IMVKD-DDKIVVIDFPQMV 250 (465)
T ss_pred eEEec-CCCEEEeechHhh
Confidence 99995 6779999998654
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.018 Score=53.52 Aligned_cols=30 Identities=33% Similarity=0.617 Sum_probs=26.3
Q ss_pred CeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 156 ~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.++|+|+++.||+++..++.+.++||..|.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 689999999999998645679999999885
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.016 Score=53.47 Aligned_cols=69 Identities=23% Similarity=0.230 Sum_probs=42.5
Q ss_pred eeecCCCeeEEEEEEcCCCcEEEEEEeec-----------cccchHHHHHHHHhCC--CC-ceeeeceeeeecCCCCceE
Q 017147 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQ-----------DRRYKNRELQLMRVMD--HP-NVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 41 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~-----------~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~~ 106 (376)
.||.|....||++.+...++.++||.-.. +..+..-|...|+... -| .+.+++++ +...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~----- 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEM----- 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--cccc-----
Confidence 57999999999999754346899996421 1122245777777653 23 44454432 2222
Q ss_pred EEEEeecccc
Q 017147 107 LNLVMEYVPE 116 (376)
Q Consensus 107 ~~lv~e~~~~ 116 (376)
..+|||+++.
T Consensus 75 ~~~vMEdL~~ 84 (370)
T TIGR01767 75 AVTVMEDLSH 84 (370)
T ss_pred ceehHhhCcc
Confidence 4489999863
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.016 Score=53.53 Aligned_cols=29 Identities=24% Similarity=0.371 Sum_probs=25.6
Q ss_pred eeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 157 VCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 157 i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.+|+|+.+.||+++++++.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 79999999999997545679999999885
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.022 Score=52.03 Aligned_cols=29 Identities=28% Similarity=0.558 Sum_probs=25.1
Q ss_pred CCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 155 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD--NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC--CcEEEEECcccc
Confidence 48999999999999985 458999999774
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.039 Score=50.22 Aligned_cols=31 Identities=32% Similarity=0.494 Sum_probs=26.3
Q ss_pred CCeeecCCCCCcEEEcCC---CCcEEEEeecccc
Q 017147 155 PRVCHRDLKPQNLLVDPL---THQVKICDFGSAK 185 (376)
Q Consensus 155 ~~i~H~dlkp~Nill~~~---~~~vkl~Dfg~a~ 185 (376)
..++|+|+.|.||+++.+ .+.+.++||..|.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 368999999999999853 2679999999884
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.032 Score=52.27 Aligned_cols=71 Identities=17% Similarity=0.200 Sum_probs=45.1
Q ss_pred eeeeecCCCeeEEEEEEcCCCcEEEEEEeec----------cccchHHHHHHHHhCC--CC-ceeeeceeeeecCCCCce
Q 017147 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----------DRRYKNRELQLMRVMD--HP-NVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~----------~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~ 105 (376)
.+.||.|.-..||++.+...++.++||.-.. +..+..-|.+.|+... .| .+.+++.+ +...
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~---- 107 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVM---- 107 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHH----
Confidence 6678999999999999743457899996421 1222345777777653 23 45555432 2222
Q ss_pred EEEEEeecccc
Q 017147 106 FLNLVMEYVPE 116 (376)
Q Consensus 106 ~~~lv~e~~~~ 116 (376)
..+|||+++.
T Consensus 108 -~~~vMEdL~~ 117 (409)
T PRK12396 108 -NCCVMEDLSD 117 (409)
T ss_pred -hhHHHHhCcc
Confidence 4589999864
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.044 Score=50.12 Aligned_cols=30 Identities=23% Similarity=0.283 Sum_probs=26.4
Q ss_pred CCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 155 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.+++|+|+.+.|++++. ++.+-++||..+.
T Consensus 196 ~~lcHgD~~~~Nvl~~~-~~~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDE-TRGGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcC-CCCEEEEEhhhcc
Confidence 47999999999999986 5678999999885
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.07 Score=50.27 Aligned_cols=70 Identities=19% Similarity=0.247 Sum_probs=44.8
Q ss_pred eeeeeecCCCeeEEEEEEcCCCcEEEEEEeec-----------cccchHHHHHHHHhCC---CCceeeeceeeeecCCCC
Q 017147 38 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-----------DRRYKNRELQLMRVMD---HPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 38 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~-----------~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~ 103 (376)
..+.||.|....||++.+ .+..++||.-.. +......|...|+.+. ..++.+++.+. ++
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed 108 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RT 108 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CC
Confidence 366789999999999986 345688996541 2222345677776653 23566665543 21
Q ss_pred ceEEEEEeecccc
Q 017147 104 ELFLNLVMEYVPE 116 (376)
Q Consensus 104 ~~~~~lv~e~~~~ 116 (376)
. .+++||++++
T Consensus 109 ~--~vlvME~L~~ 119 (418)
T PLN02756 109 M--ALIGMRYLEP 119 (418)
T ss_pred C--CEEEEeecCC
Confidence 1 4588999975
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.078 Score=48.33 Aligned_cols=30 Identities=30% Similarity=0.530 Sum_probs=26.0
Q ss_pred CeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 156 ~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
.++|+|+.+.|+++++. .-+-+.||+.+..
T Consensus 199 ~lvHGD~~~gNlii~~~-~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPG-RPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCC-CeeEEEecccccc
Confidence 48999999999999974 4489999999864
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.24 Score=44.44 Aligned_cols=32 Identities=28% Similarity=0.458 Sum_probs=25.1
Q ss_pred CCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 155 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
..++|+|++|.||+++.++...-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999985333356999999853
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.067 Score=49.16 Aligned_cols=77 Identities=17% Similarity=0.183 Sum_probs=56.8
Q ss_pred CCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 102 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
.+..+.|++|++-.+++.. + ..-..+++..++.+.+..+.-+...-..-|||+...|||++ .|.|.|+||
T Consensus 296 de~~y~yl~~kdhgt~is~-i-------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId--~GnvtLIDf 365 (488)
T COG5072 296 DETLYLYLHFKDHGTPISI-I-------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID--EGNVTLIDF 365 (488)
T ss_pred CCceEEEEEEecCCceeee-e-------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee--cCceEEEEe
Confidence 4456788999988775422 1 12345667778888777777776523678999999999999 577999999
Q ss_pred cccccCc
Q 017147 182 GSAKQLI 188 (376)
Q Consensus 182 g~a~~~~ 188 (376)
-+++...
T Consensus 366 klsRl~~ 372 (488)
T COG5072 366 KLSRLSY 372 (488)
T ss_pred eeeeccc
Confidence 9998543
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.01 E-value=0.057 Score=50.30 Aligned_cols=60 Identities=30% Similarity=0.328 Sum_probs=38.9
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 171 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~ 171 (376)
..++-+|..| ++...++. ...++...+.+..-..+|+--+--..+.+|.|+.|.||++..
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 3366677777 66555542 334455555666656666644333368999999999999854
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.7 Score=43.59 Aligned_cols=28 Identities=32% Similarity=0.370 Sum_probs=23.8
Q ss_pred CeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 156 ~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
..+|.|+-+.||+.+. ..+.++||..|.
T Consensus 228 VfCHNDL~~gNIL~~~--~~l~lID~EYA~ 255 (383)
T PTZ00384 228 LFCHNDLFFTNILDFN--QGIYFIDFDFAG 255 (383)
T ss_pred eeeeccCCcccEEecC--CCEEEEEecccc
Confidence 6799999999999863 459999998874
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.54 Score=43.37 Aligned_cols=28 Identities=25% Similarity=0.315 Sum_probs=23.9
Q ss_pred CCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 155 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.+++|+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~--d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR--D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc--C-CcEEEeCCCCC
Confidence 4789999999999995 3 47899999885
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=94.46 E-value=0.064 Score=48.79 Aligned_cols=78 Identities=21% Similarity=0.230 Sum_probs=46.6
Q ss_pred EEeecccchHHHHHH-hhhhcCCCcCHHHHHHHHHHHHHHHH---HhhcCCCeeecCCCCCcEEEcCCCC----------
Q 017147 109 LVMEYVPESMYRVLK-HYSSANQRMPLIYVKLYTYQIFRGLA---YIHTVPRVCHRDLKPQNLLVDPLTH---------- 174 (376)
Q Consensus 109 lv~e~~~~~l~~~l~-~~~~~~~~l~~~~~~~i~~qi~~al~---~LH~~~~i~H~dlkp~Nill~~~~~---------- 174 (376)
||+++..++-.++-. .....+-..-.+.++.++.|++.-.- -|-...+.+|-||||+|||+-+...
T Consensus 248 IIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~ 327 (434)
T PF05445_consen 248 IIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRN 327 (434)
T ss_pred EEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeE
Confidence 888887654332211 11122223345667888888876541 2332357899999999999843222
Q ss_pred -------cEEEEeeccccc
Q 017147 175 -------QVKICDFGSAKQ 186 (376)
Q Consensus 175 -------~vkl~Dfg~a~~ 186 (376)
..+|.||.+|+.
T Consensus 328 ~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 328 YVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred EEecccceeeecccCHHHh
Confidence 356677777754
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.25 E-value=0.89 Score=41.04 Aligned_cols=72 Identities=13% Similarity=0.128 Sum_probs=42.1
Q ss_pred eeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-ccchHHHHHHHHhCC---CCceeeeceeeeecCCCCceEEEEEee
Q 017147 37 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMD---HPNVISLKHCFFSTTSKNELFLNLVME 112 (376)
Q Consensus 37 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~~lv~e 112 (376)
+-.+.++.|....+|++. .+++.+.+|.-... ......|..-|+.|. .-.+.+++.+..... . -|+|+|
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~---~--~fLlle 92 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD---D--AFLLLE 92 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS---C--CEEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC---C--ceEEEE
Confidence 345568889999999987 57889999977643 344567888888883 234555555442221 1 369999
Q ss_pred ccc
Q 017147 113 YVP 115 (376)
Q Consensus 113 ~~~ 115 (376)
|++
T Consensus 93 ~l~ 95 (288)
T PF03881_consen 93 FLE 95 (288)
T ss_dssp ---
T ss_pred eec
Confidence 986
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=92.47 E-value=0.11 Score=47.02 Aligned_cols=130 Identities=23% Similarity=0.274 Sum_probs=82.8
Q ss_pred eeeeeecCCCeeEEEEEEc------C----CCcEEEEEEeec-------------cc-c----------------chHHH
Q 017147 38 AERVVGTGSFGIVFQAKCL------E----TGETVAIKKVLQ-------------DR-R----------------YKNRE 77 (376)
Q Consensus 38 ~~~~lg~G~~g~Vy~~~~~------~----~~~~~aiK~~~~-------------~~-~----------------~~~~e 77 (376)
+..+|..|--+.|+.|.-- + ....||||++.. +. + ..++|
T Consensus 256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE 335 (531)
T KOG2269|consen 256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE 335 (531)
T ss_pred hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence 4456778888888877421 1 124589997631 00 0 01234
Q ss_pred HHHHHhC-----CCCceeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHh-
Q 017147 78 LQLMRVM-----DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI- 151 (376)
Q Consensus 78 ~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~L- 151 (376)
..-|.++ ..|-+|.+... .+||-|++.. .+..-.-....++..+.+..-.|+..++.-|
T Consensus 336 mhNL~RMq~~GlpcP~vV~lkkh------------vLVMsFiGd~---~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY 400 (531)
T KOG2269|consen 336 MHNLSRMQKHGLPCPQVVKLKKH------------VLVMSFIGDQ---GLAAPKLKNVELTDDERRNAYDQVQSIMCRLY 400 (531)
T ss_pred HHHHHHHHhcCCCCCceeeeecc------------eEEEEeecCC---CCCCccccccccChHHHHHHHHHHHHHHHHHH
Confidence 4444443 35677766443 3899999742 1111112345578888888788888887665
Q ss_pred hcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 152 H~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
|. .-+||.|++--|+|..+ +++-++|..-+-
T Consensus 401 ~E-c~LVHADlSEyN~Lw~~--gKvw~IDVsQsv 431 (531)
T KOG2269|consen 401 KE-CLLVHADLSEYNLLWTP--GKVWVIDVSQSV 431 (531)
T ss_pred Hh-hheeecchhhhhheecC--CceEEEechhcc
Confidence 45 58999999999999985 479999977653
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.38 E-value=0.38 Score=43.73 Aligned_cols=63 Identities=22% Similarity=0.237 Sum_probs=38.1
Q ss_pred EEeecccchHHHHHH-hhhhcCCCcCHHHHHHHHHHHHHHHHHh---hcCCCeeecCCCCCcEEEcC
Q 017147 109 LVMEYVPESMYRVLK-HYSSANQRMPLIYVKLYTYQIFRGLAYI---HTVPRVCHRDLKPQNLLVDP 171 (376)
Q Consensus 109 lv~e~~~~~l~~~l~-~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~~i~H~dlkp~Nill~~ 171 (376)
||+++..++-.++-. ...+.+-.--.+.++.++.|++.-.-.+ -...+.+|-||||+|||+-+
T Consensus 252 IIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd 318 (444)
T PHA03111 252 IIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFD 318 (444)
T ss_pred EEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEec
Confidence 778877643222211 1111222233566788899988765333 21257899999999999854
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=92.22 E-value=0.16 Score=43.62 Aligned_cols=30 Identities=40% Similarity=0.709 Sum_probs=20.2
Q ss_pred CeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 156 ~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
-++|+|+.|.||+++..++.++++||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 579999999999993347889999999885
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.21 E-value=0.13 Score=43.02 Aligned_cols=29 Identities=21% Similarity=0.338 Sum_probs=24.6
Q ss_pred CeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 156 ~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
-.+|+|+.|.|+++++ ++ ++|+||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~-~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSA-SG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEEC-CC-EEEEeCCcccC
Confidence 4599999999999985 55 99999999853
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 376 | ||||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-138 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-138 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-138 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-138 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-138 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-138 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-138 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-137 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-137 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-137 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-137 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-137 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-137 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-136 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-136 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-136 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-136 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-135 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-135 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-135 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-133 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-130 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-91 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-82 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-46 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-45 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-45 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-45 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-45 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-45 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-45 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-45 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-44 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-44 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-44 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-44 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-44 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-44 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-44 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-44 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-44 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-44 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-44 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-44 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-44 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-44 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-44 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-44 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-44 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-44 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-44 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-44 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-44 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-44 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-44 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-44 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-44 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-44 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-44 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-44 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-44 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-44 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-44 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-44 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-44 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-44 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-44 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-44 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-44 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-44 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-44 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-44 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-44 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-44 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-44 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-44 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-44 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-44 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-44 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-44 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-44 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-44 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-44 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-44 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-44 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-44 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-43 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-43 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-43 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-43 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-43 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-42 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-42 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-42 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-41 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-41 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-41 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-41 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-41 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-41 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-41 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-41 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-40 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-40 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-40 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-40 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-40 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-40 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-40 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-40 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-40 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-40 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-40 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-40 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-39 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-39 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-39 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-39 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-39 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-39 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-39 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-39 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-39 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-39 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-39 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-39 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-39 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-39 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-39 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-39 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-39 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-39 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-39 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-39 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-39 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-39 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-39 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-39 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-39 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-39 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-39 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-39 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-39 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-39 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-39 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-39 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-39 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-39 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-39 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-39 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-39 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-39 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-39 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-39 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-39 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-39 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-39 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-38 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-38 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-38 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-38 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-38 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-38 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-38 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-38 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-38 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-36 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-35 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-35 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-35 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-35 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-35 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-35 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-34 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-34 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-34 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-34 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-34 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-34 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-34 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-34 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-34 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-33 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-33 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-33 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-33 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-33 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-33 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-33 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-33 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-33 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-33 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-33 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-33 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-33 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-33 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-33 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-33 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-33 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-33 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-32 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-32 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-32 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-32 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-31 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-31 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-31 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-30 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-30 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-30 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-30 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-30 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-30 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 7e-30 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 7e-30 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-30 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-29 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-29 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-29 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-29 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-29 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-29 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-29 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-29 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-29 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-29 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-29 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-29 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-29 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 7e-29 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-28 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-28 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-28 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-28 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-28 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-28 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-28 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-28 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-28 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 7e-28 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 8e-28 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-27 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-27 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-27 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-27 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-27 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-27 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-27 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-27 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-26 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-26 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-26 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-26 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-25 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-25 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-25 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-25 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-23 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-21 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-21 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-21 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-21 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-20 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-20 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-20 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-20 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-20 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-19 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-19 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-19 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-19 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-19 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-19 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-19 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-19 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-19 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-19 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-19 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-19 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-19 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-19 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-19 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-19 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-19 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-19 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-19 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-19 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-19 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-19 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-19 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-19 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-19 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-19 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-19 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-19 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-19 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-18 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-18 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-18 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-18 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-18 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-18 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-18 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-18 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-18 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-18 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-18 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-18 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-18 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-17 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-17 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-17 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-17 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-17 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-17 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-17 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-17 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-17 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-17 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-17 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-17 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-16 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-16 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-16 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-16 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-16 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-16 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-16 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-16 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-16 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-16 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-16 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-16 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-16 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-16 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-16 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-15 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-15 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-15 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 5e-15 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 5e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-15 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 6e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-15 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-15 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 6e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-14 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-14 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-14 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-14 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-13 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-12 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-12 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-12 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 7e-12 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 7e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-11 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 5e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-11 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 6e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 6e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 6e-04 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 7e-04 |
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 621 bits (1604), Expect = 0.0
Identities = 217/369 (58%), Positives = 283/369 (76%), Gaps = 4/369 (1%)
Query: 2 EMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGET 61
++ ++ D I GK GE ++ I+Y +V+G GSFG+VFQAK +E+ E
Sbjct: 9 PLNGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESDE- 66
Query: 62 VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NELFLNLVMEYVPESMYR 120
VAIKKVLQD+R+KNRELQ+MR++ HPNV+ LK F+S K +E+FLNLV+EYVPE++YR
Sbjct: 67 VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYR 126
Query: 121 VLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 180
+HY+ Q MP++ +KLY YQ+ R LAYIH++ +CHRD+KPQNLL+DP + +K+ D
Sbjct: 127 ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLKLID 185
Query: 181 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 240
FGSAK LIAGE N+SYICSR+YRAPELIFGAT YTT+IDIWS GCV+AEL+ GQPLFPGE
Sbjct: 186 FGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245
Query: 241 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 300
+ +DQLVEIIKVLGTP+RE+I+ MNPNY + +FPQI+ HP+ KVF R PP+AIDL SRL
Sbjct: 246 SGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRL 305
Query: 301 LQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPD 360
L+Y+PS R TA+EA HPFFDELR AR+PNGR LPPLFN+ +E P+L+++L+P
Sbjct: 306 LEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLVPQ 365
Query: 361 HVKRQLGLN 369
H + +L
Sbjct: 366 HAEAELLSR 374
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 622 bits (1606), Expect = 0.0
Identities = 228/372 (61%), Positives = 290/372 (77%), Gaps = 4/372 (1%)
Query: 8 VDGSDHVTGHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK 65
+ S G ++T + G+ + Q +SY +V+G GSFG+V+QAK ++GE VAIK
Sbjct: 26 MKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK 85
Query: 66 KVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NELFLNLVMEYVPESMYRVLKH 124
KVLQD+R+KNRELQ+MR +DH N++ L++ F+S+ K +E++LNLV++YVPE++YRV +H
Sbjct: 86 KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 145
Query: 125 YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184
YS A Q +P+IYVKLY YQ+FR LAYIH+ +CHRD+KPQNLL+DP T +K+CDFGSA
Sbjct: 146 YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204
Query: 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 244
KQL+ GE N+SYICSR+YRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VD
Sbjct: 205 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264
Query: 245 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 304
QLVEIIKVLGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF R PPEAI L SRLL+Y+
Sbjct: 265 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 324
Query: 305 PSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 364
P+ R T LEACAH FFDELR+PN +LPNGR P LFNF + ++P L LIP H +
Sbjct: 325 PTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARI 384
Query: 365 QLGLNFLHPAGT 376
Q + A
Sbjct: 385 QAAASTPTNATA 396
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 589 bits (1521), Expect = 0.0
Identities = 154/357 (43%), Positives = 222/357 (62%), Gaps = 13/357 (3%)
Query: 16 GHIISTTIGGKNGEP--KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 73
G ++S E K+ + ER+ G G+FG V K TG +VAIKKV+QD R+
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62
Query: 74 KNRELQLMRVM---DHPNVISLKHCFFSTTSK--NELFLNLVMEYVPESMYRVLKHYSSA 128
+NRELQ+M+ + HPN++ L+ F++ + +++LN+VMEYVP++++R ++Y
Sbjct: 63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122
Query: 129 NQRMPLIYVKLYTYQIFRGLAYIHTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187
P I +K++ +Q+ R + +H VCHRD+KP N+LV+ +K+CDFGSAK+L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 188 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 247
E N++YICSR+YRAPELIFG YTT++DIWS GC+ AE++LG+P+F G+N+ QL
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242
Query: 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK---RMPPEAIDLASRLLQYS 304
EI++VLG P+RE +R +NP++TD K PW VF + EA DL S LLQY
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302
Query: 305 PSLRCTALEACAHPFFDELREPNARLPNGRPLPP-LFNF-KQELSGASPELVNKLIP 359
P R EA HP+FDEL +P +LPN + LP LF F E+ S KL+
Sbjct: 303 PEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVR 359
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 568 bits (1466), Expect = 0.0
Identities = 166/381 (43%), Positives = 241/381 (63%), Gaps = 44/381 (11%)
Query: 28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHP 87
G + Y + +GTGSFGIV + +E+G+ A+KKVLQD RYKNREL +M+V+DH
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60
Query: 88 NVISLKHCFFSTTSK---------------------------------NELFLNLVMEYV 114
N+I L F++T + +LN++MEYV
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 115 PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 174
P+++++VLK + + + +P+ + +Y YQ+FR + +IH++ +CHRD+KPQNLLV+ +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GICHRDIKPQNLLVNSKDN 179
Query: 175 QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 234
+K+CDFGSAK+LI E +++YICSRFYRAPEL+ GATEYT SID+WS GCV EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 235 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAI 294
PLF GE ++DQLV II+++GTPT+E++ MNP+YT+ RFP +KA W K+ + P AI
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299
Query: 295 DLASRLLQYSPSLRCTALEACAHPFFDELREP-------NARLPNG--RPLPPLFNF-KQ 344
DL ++L+Y P LR EA AHPFFD LR N+ P+G + +P LFNF
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPY 359
Query: 345 ELSGASPELVNKLIPDHVKRQ 365
ELS ++N+++P +
Sbjct: 360 ELSIIPGNVLNRILPKNFSPN 380
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 299 bits (769), Expect = e-101
Identities = 98/313 (31%), Positives = 157/313 (50%), Gaps = 22/313 (7%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 95
+G GS+G+VF+ + +TG+ VAIKK L+ RE+++++ + HPN+++L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
F K L L V EY ++ L Y + +P VK T+Q + + + H
Sbjct: 71 F---RRKRRLHL--VFEYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKH- 121
Query: 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 214
HRD+KP+N+L+ +K+CDFG A+ L + + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITK-HSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--EIRCMNPNYTDFR 272
+D+W+ GCV AELL G PL+PG++ VDQL I K LG ++ N ++ +
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240
Query: 273 FPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 331
P + P F + A+ L L P+ R T + HP+F+ +RE L
Sbjct: 241 IPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE-DLA 298
Query: 332 NGRPLPPLFNFKQ 344
P + Q
Sbjct: 299 KEHDKPAENLYFQ 311
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 3e-98
Identities = 96/295 (32%), Positives = 155/295 (52%), Gaps = 21/295 (7%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 95
VG GS+G+V + + +TG VAIKK L+ K RE++L++ + H N+++L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
K +L V E+V ++ L+ + + V+ Y +QI G+ + H+
Sbjct: 93 C---KKKKRWYL--VFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSH- 143
Query: 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 214
+ HRD+KP+N+LV + VK+CDFG A+ L GE + +R+YRAPEL+ G +Y
Sbjct: 144 NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--EIRCMNPNYTDFR 272
++D+W+ GC++ E+ +G+PLFPG++ +DQL I+ LG E+ NP + R
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262
Query: 273 FPQIKAH-PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
P+IK P + + ++ IDLA + L P R E H FF
Sbjct: 263 LPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 3e-97
Identities = 99/326 (30%), Positives = 169/326 (51%), Gaps = 33/326 (10%)
Query: 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMD 85
+Y+ +G G++ V++ K T VA+K++ R ++ RE+ L++ +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58
Query: 86 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 145
H N+++L + S L LV EY+ + + + L + + VKL+ +Q+
Sbjct: 59 HANIVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLL 110
Query: 146 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFY 202
RGLAY H +V HRDLKPQNLL++ ++K+ DFG A+ +Y + + +Y
Sbjct: 111 RGLAYCHR-QKVLHRDLKPQNLLINE-RGELKLADFGLARAK--SIPTKTYDNEVVTLWY 166
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--- 259
R P+++ G+T+Y+T ID+W GC+ E+ G+PLFPG +QL I ++LGTPT E
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226
Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
I + + +P+ +A R+ + DL ++LLQ+ R +A +A HPF
Sbjct: 227 GILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
Query: 320 FDELREPNARLPNGRPLPPLFNFKQE 345
F L E +LP+ + L + +
Sbjct: 285 FLSLGERIHKLPDTTSIFALKEIQLQ 310
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 8e-97
Identities = 88/313 (28%), Positives = 154/313 (49%), Gaps = 30/313 (9%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----RRYKNRELQLMRVMDHPNV 89
YM + +G G G+VF A + + VAIKK+ L D RE++++R +DH N+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70
Query: 90 ISLKHCFFSTTSKNELFLN---------LVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 140
+ + + S+ + +V EY+ + VL+ + + +L+
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLLEEHARLF 125
Query: 141 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----Y 196
YQ+ RGL YIH+ V HRDLKP NL ++ +KI DFG A+ + ++
Sbjct: 126 MYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 197 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
+ +++YR+P L+ YT +ID+W+AGC+ AE+L G+ LF G + ++Q+ I++ +
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 257 TREEIRCMNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314
E+ + + + P ++ + EA+D ++L +SP R TA EA
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAEEA 303
Query: 315 CAHPFFDELREPN 327
+HP+ P
Sbjct: 304 LSHPYMSIYSFPM 316
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 7e-96
Identities = 105/346 (30%), Positives = 181/346 (52%), Gaps = 34/346 (9%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 88
+ + ++G G++G+V A TGE VAIKK+ R RE+++++ H N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
+I++ + + +N + ++ E + ++RV+ Q + +++ + YQ R +
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAV 125
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-----------YI 197
+H V HRDLKP NLL++ +K+CDFG A+ + A+ S ++
Sbjct: 126 KVLHGS-NVIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 198 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257
+R+YRAPE++ + +Y+ ++D+WS GC+LAEL L +P+FPG + QL+ I ++GTP
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243
Query: 258 REEI--RCMNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
+ +P ++ P A P K+F + + P+ IDL R+L + P+ R TA E
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITAKE 302
Query: 314 ACAHPFFDELREPNARLPNGRPLPPL-FNFKQELSGASPELVNKLI 358
A HP+ +PN P G P+PP F F + + + KLI
Sbjct: 303 ALEHPYLQTYHDPN-DEPEGEPIPPSFFEFDHYKEALTTKDLKKLI 347
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 1e-94
Identities = 103/312 (33%), Positives = 157/312 (50%), Gaps = 33/312 (10%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDHPNVISL 92
+G G F V++A+ T + VAIKK+ R + RE++L++ + HPN+I L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 93 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
F ++ ++LV +++ + ++K + + ++K Y +GL Y+H
Sbjct: 78 LDAFGHKSN-----ISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIF 209
+ HRDLKP NLL+D +K+ DFG AK G N +Y + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLDE-NGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLF 185
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI---RCMNP 266
GA Y +D+W+ GC+LAELLL P PG++ +DQL I + LGTPT EE C P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
+Y F P H +F + +DL L ++P R TA +A +F P
Sbjct: 245 DYVT--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR--P 299
Query: 327 NARLPNGRPLPP 338
P P
Sbjct: 300 GPTPGCQLPRPN 311
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 2e-94
Identities = 87/303 (28%), Positives = 151/303 (49%), Gaps = 23/303 (7%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLMRVM-DHPNVISLK 93
Y R +G G + VF+A + E V +K + ++ K RE++++ + PN+I+L
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 97
Query: 94 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
S+ LV E+V + ++ L Q + ++ Y Y+I + L Y H+
Sbjct: 98 DIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS 148
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 213
+ + HRD+KP N+++D ++++ D+G A+ G+ + SR+++ PEL+
Sbjct: 149 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 207
Query: 214 YTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRC-----MNPN 267
Y S+D+WS GC+LA ++ +P F G + DQLV I KVLGT + ++P
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267
Query: 268 YTDFRFPQIKAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
+ D + W + H + PEA+D +LL+Y R TA EA HP+F +
Sbjct: 268 FND-ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326
Query: 324 REP 326
+
Sbjct: 327 VKD 329
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 4e-94
Identities = 97/332 (29%), Positives = 159/332 (47%), Gaps = 33/332 (9%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------------RELQL 80
Y +R + +GS+G V G VAIK+V RE++L
Sbjct: 24 YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 81 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL--IYVK 138
+ HPN++ L+ F L LV E + + +V+ QR+ + +++
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD-----QRIVISPQHIQ 137
Query: 139 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 198
+ Y I GL +H V HRDL P N+L+ + + ICDF A++ A Y+
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILLAD-NNDITICDFNLAREDTADANKTHYVT 195
Query: 199 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258
R+YRAPEL+ +T +D+WSAGCV+AE+ + LF G +QL +I++V+GTP
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 259 EEIRCM-NP---NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314
E++ +P +Y + A W V P A+DL +++L+++P R + +A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 315 CAHPFFDELREPNARLPNGRPLPPLFNFKQEL 346
HP+F+ L +P L G F+F + +
Sbjct: 315 LRHPYFESLFDPL-DLTEGLSER--FHFDESV 343
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 2e-93
Identities = 97/313 (30%), Positives = 154/313 (49%), Gaps = 41/313 (13%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 95
+G G++G V++A T ETVAIK++ + + RE+ L++ + H N+I LK
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
+ L L + EY LK Y N + + +K + YQ+ G+ + H+
Sbjct: 102 I---HHNHRLHL--IFEY----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS-R 151
Query: 156 RVCHRDLKPQNLLVDPLTH----QVKICDFGSAKQLIAGEANISY---ICSRFYRAPELI 208
R HRDLKPQNLL+ +KI DFG A+ G + I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRPPEIL 209
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMN 265
G+ Y+TS+DIWS C+ AE+L+ PLFPG++ +DQL +I +VLG P + +
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
P++ FP+ + +V + E +DL + +L+ P R +A A HP+F
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN-- 325
Query: 326 PNARLPNGRPLPP 338
P
Sbjct: 326 ---------DFDP 329
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 2e-92
Identities = 109/341 (31%), Positives = 177/341 (51%), Gaps = 36/341 (10%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 88
Y +G G++G+V A VAIKK+ R RE++++ H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
+I + + T + + +V + + +Y++LK Q + ++ + YQI RGL
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGL 141
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRA 204
YIH+ V HRDLKP NLL++ T +KICDFG A+ + Y+ +R+YRA
Sbjct: 142 KYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
PE++ + YT SIDIWS GC+LAE+L +P+FPG++ +DQL I+ +LG+P++E++ C+
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 265 -NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
N ++ P PW+++F +A+DL ++L ++P R +A AHP+ +
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318
Query: 322 ELR----EPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 358
+ EP A F F EL E + +LI
Sbjct: 319 QYYDPSDEPIA--------EAPFKFDMELDDLPKEKLKELI 351
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 3e-92
Identities = 102/294 (34%), Positives = 164/294 (55%), Gaps = 27/294 (9%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 95
VG G++G+V++AK G VA+K++ D + RE+ L++ + HPN++SL
Sbjct: 29 VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
S L LV E++ + + +VL + +K+Y YQ+ RG+A+ H
Sbjct: 88 IHSERC-----LTLVFEFMEKDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH- 138
Query: 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFGAT 212
R+ HRDLKPQNLL++ +K+ DFG A+ G SY + + +YRAP+++ G+
Sbjct: 139 RILHRDLKPQNLLINS-DGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 269
+Y+TS+DIWS GC+ AE++ G+PLFPG DQL +I +LGTP +++ + P +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
F + PW + E IDL S +L + P+ R +A +A HP+F +L
Sbjct: 255 QRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 8e-92
Identities = 97/294 (32%), Positives = 160/294 (54%), Gaps = 28/294 (9%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 95
+G G++G+V++A+ GET A+KK+ ++ + RE+ +++ + H N++ L
Sbjct: 10 IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
+ L LV E++ + + ++L + + K + Q+ G+AY H
Sbjct: 69 IHTKKR-----LVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFGAT 212
RV HRDLKPQNLL++ ++KI DFG A+ G Y I + +YRAP+++ G+
Sbjct: 120 RVLHRDLKPQNLLINR-EGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 269
+Y+T+IDIWS GC+ AE++ G PLFPG + DQL+ I ++LGTP + + + P Y
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKYD 235
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
F + PW K + IDL S++L+ P+ R TA +A H +F E
Sbjct: 236 PN-FTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 2e-91
Identities = 105/304 (34%), Positives = 162/304 (53%), Gaps = 25/304 (8%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHP 87
Y++ VG+G++G V A +GE VAIKK+ R Y REL L++ M H
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83
Query: 88 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
NVI L F +S + LVM ++ + +++ + ++ YQ+ +
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLK 137
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 206
GL YIH+ V HRDLKP NL V+ ++KI DFG A+ A Y+ +R+YRAPE
Sbjct: 138 GLKYIHSA-GVVHRDLKPGNLAVNE-DCELKILDFGLARH--ADAEMTGYVVTRWYRAPE 193
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 265
+I Y ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P E ++ + +
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253
Query: 266 PNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
+ PQ + ++F R P+A DL ++L+ R TA +A HPFF+
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312
Query: 324 REPN 327
R+P
Sbjct: 313 RDPE 316
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 2e-91
Identities = 104/335 (31%), Positives = 173/335 (51%), Gaps = 29/335 (8%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHP 87
Y + VG+G++G V A TG VAIKK+ R Y REL+L++ M H
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMRHE 84
Query: 88 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
NVI L F + ++ LVM ++ + +++K ++++ ++ YQ+ +
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLK 139
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 206
GL YIH + HRDLKP NL V+ ++KI DFG A+Q A Y+ +R+YRAPE
Sbjct: 140 GLRYIHAA-GIIHRDLKPGNLAVNE-DCELKILDFGLARQ--ADSEMTGYVVTRWYRAPE 195
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 265
+I YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV GTP E ++ + +
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255
Query: 266 PNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
++ P+++ + + P A++L ++L R TA EA AHP+F+ L
Sbjct: 256 DEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314
Query: 324 REPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 358
+ P ++ + + + ++
Sbjct: 315 HDTED-----EPQVQKYDDSFDDVDRTLDEWKRVT 344
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 6e-90
Identities = 102/298 (34%), Positives = 157/298 (52%), Gaps = 28/298 (9%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 95
+G G++G VF+AK ET E VA+K+V D + RE+ L++ + H N++ L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
S L LV E+ + + + S N + VK + +Q+ +GL + H+
Sbjct: 70 LHSDKK-----LTLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFGAT 212
V HRDLKPQNLL++ ++K+ +FG A+ G Y + + +YR P+++FGA
Sbjct: 121 NVLHRDLKPQNLLINR-NGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 213 EYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNY 268
Y+TSID+WSAGC+ AEL G+PLFPG + DQL I ++LGTPT E + + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
+ V ++ DL LL+ +P R +A EA HP+F + P
Sbjct: 237 KPYPMYPAT-TSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 7e-90
Identities = 96/320 (30%), Positives = 159/320 (49%), Gaps = 41/320 (12%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDHPNVISL 92
+G G++ V++ TG VA+K+V + + RE+ LM+ + H N++ L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 93 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSAN--QRMPLIYVKLYTYQIFRGLAY 150
+ L LV E++ + + + + N + + L VK + +Q+ +GLA+
Sbjct: 69 YDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPEL 207
H ++ HRDLKPQNLL++ Q+K+ DFG A+ G ++ + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLINK-RGQLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDV 179
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
+ G+ Y+TSIDIWS GC+LAE++ G+PLFPG N +QL I ++GTP E + P+
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN-ESLW---PS 235
Query: 268 YTDF-----RFPQIKAHPWHKVFHK----RMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
T Q +V + +D LLQ +P +R +A +A HP
Sbjct: 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295
Query: 319 FFDELREPNARLPNGRPLPP 338
+F E A + R
Sbjct: 296 WFAEYYHH-ASMGGSRSHHH 314
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 2e-89
Identities = 107/335 (31%), Positives = 170/335 (50%), Gaps = 29/335 (8%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHP 87
Y VG+G++G V A +TG VA+KK+ + R Y REL+L++ M H
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88
Query: 88 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
NVI L F S E + LV + + ++K Q++ +V+ YQI R
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILR 143
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 206
GL YIH+ + HRDLKP NL V+ ++KI DFG A+ + Y+ +R+YRAPE
Sbjct: 144 GLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TADEMTGYVATRWYRAPE 199
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 265
++ Y ++DIWS GC++AELL G+ LFPG + +DQL I++++GTP E ++ + +
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 266 PNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
+ ++ Q+ + VF P A+DL ++L R TA +A AH +F +
Sbjct: 260 ESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 324 REPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 358
+P+ P+ ++ E + L
Sbjct: 319 HDPDD-----EPVADPYDQSLESRDLLIDEWKSLT 348
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 3e-89
Identities = 99/337 (29%), Positives = 163/337 (48%), Gaps = 39/337 (11%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHP 87
Y + +G+G+ GIV A VAIKK+ R Y REL LM+ ++H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84
Query: 88 NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPL--IYVKLYTYQI 144
N+I L + F S E + +VME + ++ +V+ +M L + YQ+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI--------QMELDHERMSYLLYQM 136
Query: 145 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 204
G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +R+YRA
Sbjct: 137 LCGIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
PE+I G Y ++DIWS GC++ E++ G LFPG + +DQ ++I+ LGTP E ++ +
Sbjct: 195 PEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253
Query: 265 NPNYTDF--RFPQIKAHPWHKVFHKRMP-----------PEAIDLASRLLQYSPSLRCTA 311
P + P+ + + K+F + +A DL S++L S R +
Sbjct: 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313
Query: 312 LEACAHPFFDELREPNARLPNGRPLPPLFNF-KQELS 347
EA HP+ + +P+ P P ++E +
Sbjct: 314 DEALQHPYINVWYDPS-EAEAPPPKIPDKQLDEREHT 349
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 1e-88
Identities = 84/300 (28%), Positives = 139/300 (46%), Gaps = 31/300 (10%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RE---LQLMRVMDHPNV 89
+G G++G V++A+ +G VA+K V RE L+ + +HPNV
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
+ L ++ + E+ + LV E+V + + L + +P +K Q RGL
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLD--KAPPPGLPAETIKDLMRQFLRGLD 134
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPE 206
++H + HRDLKP+N+LV VK+ DFG A+ ++ + + +YRAPE
Sbjct: 135 FLHAN-CIVHRDLKPENILVTS-GGTVKLADFGLAR---IYSYQMALTPVVVTLWYRAPE 189
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
++ +T Y T +D+WS GC+ AE+ +PLF G + DQL +I ++G P ++ P
Sbjct: 190 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW----P 244
Query: 267 NYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
FP P V M L +L ++P R +A A H + +
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 1e-88
Identities = 101/382 (26%), Positives = 159/382 (41%), Gaps = 79/382 (20%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYKNRELQLMRVMDHP 87
Y ++GTGS+G V +A VAIKK+L+ R RE+ ++ ++H
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
+V+ + + L +V+E ++ + + +++K Y + G
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFR----TPVYLTELHIKTLLYNLLVG 168
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS------------ 195
+ Y+H+ + HRDLKP N LV+ VK+CDFG A+ + E S
Sbjct: 169 VKYVHSA-GILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 196 ----------------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL------- 232
++ +R+YRAPELI YT +ID+WS GC+ AELL
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 233 ----GQPLFPGENAV--------------------DQLVEIIKVLGTPTREEIRCM-NPN 267
PLFPG + DQL I +LGTP+ E+I + +
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED 346
Query: 268 YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
+ FP+ + + F +AI L R+L ++P+ R T E AHPFF E+R
Sbjct: 347 AKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405
Query: 326 PNARLPNGRPLPPLFNFKQELS 347
+ FN +
Sbjct: 406 AEVETNATEKVRLPFNDWMNMD 427
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 1e-88
Identities = 99/325 (30%), Positives = 157/325 (48%), Gaps = 34/325 (10%)
Query: 42 VGTGSFGIVFQAK-CLETGETVAIKKVLQDRRYKN-------RE---LQLMRVMDHPNVI 90
+G G++G VF+A+ G VA+K+V + RE L+ + +HPNV+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
L + + E L LV E+V + + L +P +K +Q+ RGL +
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDF 135
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPEL 207
+H+ RV HRDLKPQN+LV + Q+K+ DFG A+ ++ + + +YRAPE+
Sbjct: 136 LHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAPEV 190
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
+ ++ Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V+G P E+ P
Sbjct: 191 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR 245
Query: 268 YT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324
F A P K + DL + L ++P+ R +A A +HP+F +L
Sbjct: 246 DVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304
Query: 325 EPNARLPNGRPLPPLFNFKQELSGA 349
L P EL+ A
Sbjct: 305 RCKENLD---SHLPPSQNTSELNTA 326
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 272 bits (696), Expect = 7e-88
Identities = 96/332 (28%), Positives = 166/332 (50%), Gaps = 36/332 (10%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHP 87
Y + +G+G+ GIV A VAIKK+ + R Y REL LM+ ++H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121
Query: 88 NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
N+ISL + F + E + LVME + ++ +V++ + + YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLC 175
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 206
G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +R+YRAPE
Sbjct: 176 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 233
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+ LGTP E ++ + P
Sbjct: 234 VILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292
Query: 267 NYTDF--RFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTALE 313
++ P+ + K+F +K +A DL S++L P+ R + +
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352
Query: 314 ACAHPFFDELREPNARLPNGRPLPPLFNFKQE 345
A HP+ + +P P P +++ + +
Sbjct: 353 ALQHPYINVWYDPAEVEA---PPPQIYDKQLD 381
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 1e-86
Identities = 84/320 (26%), Positives = 141/320 (44%), Gaps = 36/320 (11%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMDHPNVIS 91
+G G+FG VF+A+ +TG+ VA+KKV +N RE+++++++ H NV++
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 80
Query: 92 LK---HCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRG 147
L S ++ + + LV ++ L S+ + L +K + G
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDF----CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ--LIAGEANISY---ICSRFY 202
L YIH ++ HRD+K N+L+ +K+ DFG A+ L Y + + +Y
Sbjct: 137 LYYIHRN-KILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--- 259
R PEL+ G +Y ID+W AGC++AE+ P+ G QL I ++ G+ T E
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254
Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
+ Y + + P A+DL +LL P+ R + +A H
Sbjct: 255 NVDNY-ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313
Query: 319 FFDELREPNARLPNGRPLPP 338
FF +P G
Sbjct: 314 FFWS--DPMPSDLKGMLSTH 331
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 2e-86
Identities = 91/361 (25%), Positives = 171/361 (47%), Gaps = 61/361 (16%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL---QD-----RRYKNRELQLMRVM-DH 86
Y + +G G++GIV+++ TGE VA+KK+ Q+ R + RE+ ++ + H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68
Query: 87 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
N+++L + + + +++L V +Y+ ++ V++ + ++ + YQ+ +
Sbjct: 69 ENIVNLLNVLRAD-NDRDVYL--VFDYMETDLHAVIR-----ANILEPVHKQYVVYQLIK 120
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----------- 195
+ Y+H+ + HRD+KP N+L++ VK+ DFG ++ + +
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 196 -----------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 244
Y+ +R+YRAPE++ G+T+YT ID+WS GC+L E+L G+P+FPG + ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238
Query: 245 QLVEIIKVLGTPTREEIRCM-NPNYTDF--RFPQIKAHPWHKVFHKRMP----------- 290
QL II V+ P+ E++ + +P +
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298
Query: 291 ----PEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQEL 346
EA+DL +LLQ++P+ R +A +A HPF PN + N +
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKH 358
Query: 347 S 347
S
Sbjct: 359 S 359
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 3e-85
Identities = 98/376 (26%), Positives = 164/376 (43%), Gaps = 75/376 (19%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQD--RRYKNRELQLMRVMDHP 87
Y+ + ++G GS+G V+ A T + VAIKKV L D R RE+ ++ +
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85
Query: 88 NVISLKHCFFSTTSK--NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 145
+I L +EL++ V+E + ++ K + ++K Y +
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFK----TPIFLTEEHIKTILYNLL 139
Query: 146 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS---------- 195
G +IH + HRDLKP N L++ VK+CDFG A+ + + +
Sbjct: 140 LGENFIHES-GIIHRDLKPANCLLNQ-DCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 196 -------------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-------- 234
++ +R+YRAPELI YT SIDIWS GC+ AELL
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
Query: 235 ---PLFPG-----------------ENAVDQLVEIIKVLGTPTREEIRCM-NPNYTDF-- 271
PLFPG ++ DQL I ++GTPT ++++ + P +
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 331
FP K + + + + I+L +L+++P+ R T +A HP+ ++R+
Sbjct: 318 LFPHRKPINLKQKYPS-ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENF 376
Query: 332 NGRPLPPLFNFKQELS 347
+ + + F+ LS
Sbjct: 377 STKKIILPFDDWMVLS 392
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 2e-81
Identities = 94/345 (27%), Positives = 157/345 (45%), Gaps = 40/345 (11%)
Query: 42 VGTGSFGIVFQAKCLE--TGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCFF 97
VG G++G V++AK + + A+K++ + RE+ L+R + HPNVISL+ F
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 98 STTSKNELFLNLVMEYVPESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIH 152
S + + L+ +Y ++ ++K + ++ ++P VK YQI G+ Y+H
Sbjct: 89 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 153 TVPRVCHRDLKPQNLLVDPLTH---QVKICDFGSAKQLIAGEANISYICSR----FYRAP 205
V HRDLKP N+LV +VKI D G A+ + ++ + +YRAP
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---------DQLVEIIKVLGTP 256
EL+ GA YT +IDIW+ GC+ AELL +P+F DQL I V+G P
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 264
Query: 257 TRE---------EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 307
+ E + ++ + + + + +A L +LL P
Sbjct: 265 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 324
Query: 308 RCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPE 352
R T+ +A P+F E +P + ++ L+ P+
Sbjct: 325 RITSEQAMQDPYFLE--DPLPTSDVFAGCQIPYPKREFLTEEEPD 367
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 6e-66
Identities = 97/339 (28%), Positives = 160/339 (47%), Gaps = 54/339 (15%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM------DH 86
Y +V+G GSFG V +A + + VA+K V ++R+ E++++ + +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 87 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
NVI + F T +N + + E + ++Y ++K + Q L V+ + + I +
Sbjct: 159 MNVIHMLENF---TFRNHICM--TFELLSMNLYELIK--KNKFQGFSLPLVRKFAHSILQ 211
Query: 147 GLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 205
L +H R+ H DLKP+N LL +K+ DFGS+ + +YI SRFYRAP
Sbjct: 212 CLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC--YEHQRVYTYIQSRFYRAP 268
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--- 262
E+I GA Y ID+WS GC+LAELL G PL PGE+ DQL +I++LG P+++ +
Sbjct: 269 EVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327
Query: 263 --------CMNPNYTDF---------------RFPQIKAHPWHKVFHKRMPPEA----ID 295
P Y R +++ P + + + +D
Sbjct: 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387
Query: 296 LASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGR 334
+ L++ P++R T +A HP+ R + P G
Sbjct: 388 FLKQCLEWDPAVRMTPGQALRHPWL---RRRLPKPPTGE 423
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 4e-65
Identities = 87/339 (25%), Positives = 146/339 (43%), Gaps = 42/339 (12%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM-----DHP 87
Y+ R +G G F V+ AK + VA+K V D+ Y E++L++ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 88 NVISLKHC-----FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 142
+ + H F+ N + + +V E + E++ ++K Y ++ +PLIYVK +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138
Query: 143 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFGSAKQLIAGEANISYI 197
Q+ GL Y+H + H D+KP+N+L++ + +KI D G+A E + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--YDEHYTNSI 196
Query: 198 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEIIK 251
+R YR+PE++ GA + DIWS C++ EL+ G LF + D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 252 VLGTPTREEIR-------CMNPNYTDFRFPQIKAHPWHKVFHKRMP------PEAIDLAS 298
+LG +R N ++K P V ++ E D S
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315
Query: 299 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLP 337
+LQ P R A HP+ + R L
Sbjct: 316 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 354
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 4e-65
Identities = 96/333 (28%), Positives = 150/333 (45%), Gaps = 56/333 (16%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM------DH 86
Y + ++G GSFG V +A E VAIK + + + N E++L+ +M
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 87 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
++ LK F +N L L V E + ++Y +L++ + + + L + + Q+
Sbjct: 116 YYIVHLKRHF---MFRNHLCL--VFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCT 168
Query: 147 GLAYIHTV-PRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 204
L ++ T + H DLKP+N LL +P +KI DFGS+ Q G+ YI SRFYR+
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--LGQRIYQYIQSRFYRS 226
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR-- 262
PE++ G Y +ID+WS GC+L E+ G+PLF G N VDQ+ +I++VLG P +
Sbjct: 227 PEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA 285
Query: 263 ---------CMNPNYTDFRFPQIKAH---PWHKVFH-----KRMPPEA------------ 293
+ + + K P + H + P
Sbjct: 286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVAD 345
Query: 294 ----IDLASRLLQYSPSLRCTALEACAHPFFDE 322
DL R+L Y P R A H FF +
Sbjct: 346 YLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 3e-63
Identities = 81/334 (24%), Positives = 137/334 (41%), Gaps = 54/334 (16%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN---RELQLMRVM------D 85
Y +G G+FG V + + G VA+K V RY E+Q++ +
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 86 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 145
+ + F + + V E + S Y +K L +++ YQI
Sbjct: 76 TFRCVQMLEWF---EHHGHICI--VFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQIC 128
Query: 146 RGLAYIHTVPRVCHRDLKPQN-LLVD-----------------PLTHQVKICDFGSAKQL 187
+ + ++H+ ++ H DLKP+N L V + +K+ DFGSA
Sbjct: 129 KSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--T 185
Query: 188 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 247
E + + + +R YRAPE+I ++ D+WS GC+L E LG +FP ++ + L
Sbjct: 186 YDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244
Query: 248 EIIKVLGTPTREEIR-CMNPNY-TDFRFPQIKAHPWHKVFHKRMPP-------------E 292
+ ++LG + I+ Y R + + + P
Sbjct: 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304
Query: 293 AIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
DL ++L+Y P+ R T EA HPFFD L++
Sbjct: 305 LFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 2e-62
Identities = 75/335 (22%), Positives = 135/335 (40%), Gaps = 60/335 (17%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM-----DHP 87
++ R +G G+FG V + ++ + A+K V ++Y E +++ + ++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
N++ F + + L + E + S+Y ++ + + +KLY +I +
Sbjct: 97 NIVKYHGKF---MYYDHMCL--IFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKA 149
Query: 148 LAYIHTVPRVCHRDLKPQN-LLVDPLTH-----------------------QVKICDFGS 183
L Y+ + + H DLKP+N LL DP +K+ DFG
Sbjct: 150 LNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 184 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 243
A + + S I +R YRAPE+I + S D+WS GCVLAEL G LF +
Sbjct: 209 A--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265
Query: 244 DQLVEIIKVLGTPTREEIR---------CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEA- 293
+ L + ++ + + +N + +P+ + K+ P
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325
Query: 294 -------IDLASRLLQYSPSLRCTALEACAHPFFD 321
D +LQ P+LR + E H F +
Sbjct: 326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 8e-62
Identities = 77/343 (22%), Positives = 130/343 (37%), Gaps = 54/343 (15%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN---RELQLMRVM------D 85
Y +G G+FG V + G VA+K + +Y+ E+ +++ + +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 86 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 145
+ + F + + E + ++ + LK + Q PL +V+ YQ+
Sbjct: 81 KFLCVLMSDWF---NFHGHMCI--AFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLC 133
Query: 146 RGLAYIHTVPRVCHRDLKPQN-LLVDPLTH-----------------QVKICDFGSAKQL 187
L ++H ++ H DLKP+N L V+ +++ DFGSA
Sbjct: 134 HALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--T 190
Query: 188 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 247
E + + + +R YR PE+I + D+WS GC+L E G LF + LV
Sbjct: 191 FDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249
Query: 248 EIIKVLGTPTREEIRCM---------NPNYTDFRFPQIKAHPWHKVFHKRMPPEA----- 293
+ K+LG I + + K M ++
Sbjct: 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309
Query: 294 -IDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRP 335
DL R+L++ P+ R T EA HPFF L R
Sbjct: 310 LFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 3e-58
Identities = 73/360 (20%), Positives = 124/360 (34%), Gaps = 62/360 (17%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPN- 88
Y + +G+G VFQ E + AIK V + E+ + + +
Sbjct: 58 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 89 -VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
+I L + ++ +VME + LK + + K Y +
Sbjct: 117 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 167
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRA 204
+ IH + H DLKP N L+ +K+ DFG A Q+ ++ S + + Y
Sbjct: 168 VHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224
Query: 205 PELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVL 253
PE I ++ + D+WS GC+L + G+ F N + +L II
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--- 281
Query: 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
+PN+ FP I + D+ L+ P R + E
Sbjct: 282 -----------DPNHE-IEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPE 317
Query: 314 ACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHP 373
AHP+ P ++ G + Q + SP + K + G +
Sbjct: 318 LLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 377
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 5e-58
Identities = 74/348 (21%), Positives = 124/348 (35%), Gaps = 67/348 (19%)
Query: 13 HVTGHIISTTIGGKNGEPKQTIS-----YMAERVVGTGSFGIVFQAKCLETGETVAIKKV 67
H H S G Q++S Y + +G+G VFQ E + AIK V
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV 60
Query: 68 ----LQDRRYKN--RELQLMRVMDHPN--VISLKHCFFSTTSKNELFLNLVMEYVPESMY 119
++ + E+ + + + +I L + ++ +VME +
Sbjct: 61 NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQYIYMVMECGNIDLN 115
Query: 120 RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 179
LK + + K Y + + IH + H DLKP N L+ +K+
Sbjct: 116 SWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLI 168
Query: 180 DFGSAKQLIAGEANI---SYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCV 226
DFG A Q+ ++ S + + Y PE I ++ + D+WS GC+
Sbjct: 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228
Query: 227 LAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVF 285
L + G+ F N + +L II +PN+ FP I
Sbjct: 229 LYYMTYGKTPFQQIINQISKLHAII--------------DPNHE-IEFPDI--------- 264
Query: 286 HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNG 333
+ D+ L+ P R + E AHP+ P ++ G
Sbjct: 265 ---PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 309
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 7e-58
Identities = 73/360 (20%), Positives = 124/360 (34%), Gaps = 62/360 (17%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPN- 88
Y + +G+G VFQ E + AIK V + E+ + + +
Sbjct: 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 89 -VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
+I L + ++ +VME + LK + + K Y +
Sbjct: 70 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 120
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRA 204
+ IH + H DLKP N L+ +K+ DFG A Q+ ++ S + + Y
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 205 PELIFG----------ATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVL 253
PE I ++ + D+WS GC+L + G+ F N + +L II
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--- 234
Query: 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
+PN+ FP I + D+ L+ P R + E
Sbjct: 235 -----------DPNHE-IEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPE 270
Query: 314 ACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHP 373
AHP+ P ++ G + Q + SP + K + G +
Sbjct: 271 LLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 330
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-56
Identities = 71/341 (20%), Positives = 115/341 (33%), Gaps = 55/341 (16%)
Query: 10 GSDHVTGHIISTTIGGKNGEPKQTIS-----YMAERVVGTGSFGIVFQAKCLETGETVAI 64
GS H H S + Y+ + +G G F V + L G A+
Sbjct: 2 GSSHHHHHHSSGREN--LYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYAL 59
Query: 65 KKVL----QDRRYKNRELQLMRVMDHPNVISLKHCFF-STTSKNELFLNLVMEYVPE-SM 118
K++L QDR RE + R+ +HPN++ L +K+E + L++ + ++
Sbjct: 60 KRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTL 117
Query: 119 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 178
+ ++ + + I RGL IH HRDLKP N+L+ Q +
Sbjct: 118 WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGD-EGQPVL 175
Query: 179 CDFGSAK----------QLIAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCV 226
D GS Q + + + C+ YRAPEL D+WS GCV
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235
Query: 227 LAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH 286
L ++ G+ + V + V PQ
Sbjct: 236 LYAMMFGEGPYDMVFQKGDSVALA-VQN---------------QLSIPQ----------S 269
Query: 287 KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327
R L + ++ P R + + P
Sbjct: 270 PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-56
Identities = 68/299 (22%), Positives = 109/299 (36%), Gaps = 52/299 (17%)
Query: 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQ-LMRVMDHP 87
S+ +G GS+G VF+ + E G A+K+ + +DR K E+ +V HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
+ L+ + L L E S+ + + + +P V Y
Sbjct: 118 CCVRLEQAWEEGGI-----LYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLA 169
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL 207
LA++H+ + H D+KP N+ + P + K+ DFG +L A Y APEL
Sbjct: 170 LAHLHS-QGLVHLDVKPANIFLGP-RGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
+ Y T+ D++S G + E+ L G QL +
Sbjct: 228 L--QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL---------------- 269
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
F + E + +L+ P LR TA A P R+P
Sbjct: 270 --------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL---RQP 311
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 7e-55
Identities = 69/299 (23%), Positives = 115/299 (38%), Gaps = 45/299 (15%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 89
Y +GTGS+G + + G+ + K++ +++ E+ L+R + HPN+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
+ T+ L +VMEY + V+ + Q + +V Q+ L
Sbjct: 68 VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 149 AYIH----TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYR 203
H V HRDLKP N+ +D VK+ DFG A+ L + + +Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
+PE + Y DIWS GC+L EL P F + +L I+
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------ 229
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
+ +F +I R E ++ +R+L R + E +P E
Sbjct: 230 ------EGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-54
Identities = 71/301 (23%), Positives = 125/301 (41%), Gaps = 51/301 (16%)
Query: 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMD-HPNVIS 91
IS+ + V+G G+ G + + + VA+K++L + + +RE+QL+R D HPNVI
Sbjct: 24 ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPESMY-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
K+ F + +E ++ V + + P+ ++ Q GLA+
Sbjct: 83 YFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAH 133
Query: 151 IHTVPRVCHRDLKPQNLLVDP----LTHQVKICDFGSAKQLIAGEANISY---IC-SRFY 202
+H++ + HRDLKP N+L+ + I DFG K+L G + S + + +
Sbjct: 134 LHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 203 RAPELIFGATE--YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 259
APE++ + T ++DI+SAGCV ++ G F +
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL----------------QR 236
Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
+ + P K A +L +++ P R +A HPF
Sbjct: 237 QANILLGAC-SLDCLH----PE-----KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286
Query: 320 F 320
F
Sbjct: 287 F 287
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 182 bits (462), Expect = 3e-54
Identities = 44/333 (13%), Positives = 90/333 (27%), Gaps = 57/333 (17%)
Query: 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHP 87
+ G +VF + +E E A+K + +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 88 NVISLKHCFFSTTSKNELFLN---------------------LVMEYVP---ESMYRVLK 123
+ + + + + L+M E ++ L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 124 HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183
++ + + T Q+ R A + + + H P NL + P ++ + D +
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMP-DGRLMLGDVSA 240
Query: 184 AKQLIAGEANISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 242
+ G + Y E + +T +++ W G + + F
Sbjct: 241 LWK--VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 243 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 302
+ L P + +P L R L
Sbjct: 299 GIKGSWKRPSLRVPGTD--------------------SLAFGSCTPLPDFVKTLIGRFLN 338
Query: 303 YSPSLRCTALEACAHPFFDELR-EPNARLPNGR 334
+ R LEA P F +L+ E ++ L G+
Sbjct: 339 FDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 5e-54
Identities = 57/301 (18%), Positives = 119/301 (39%), Gaps = 21/301 (6%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 90
++ ++G G+ VF+ + +TG+ AIK L+ + RE ++++ ++H N++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
L TT+++ L+ME+ P S+Y VL+ S+A +P + + G+
Sbjct: 71 KLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVGGMN 126
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLT---HQVKICDFGSAKQLIAGEANISYICSRFYRAPE 206
++ + HR++KP N++ K+ DFG+A++L E +S + Y P+
Sbjct: 127 HLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 207 LIFGAT-------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
+ A +Y ++D+WS G G F + E++ + T
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
+ P + + + + +L+ + A
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 320 F 320
Sbjct: 306 D 306
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 7e-54
Identities = 70/312 (22%), Positives = 112/312 (35%), Gaps = 59/312 (18%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISL 92
+ V+G G+FG V +A+ AIKK+ + E+ L+ ++H V+
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 93 KHCF--------FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQ 143
+ T K + L + MEY ++Y ++ + QR Q
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD---EYWRLFRQ 124
Query: 144 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR--- 200
I L+YIH+ + HRDLKP N+ +D + VKI DFG AK + +
Sbjct: 125 ILEALSYIHS-QGIIHRDLKPMNIFIDE-SRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 201 ------------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 248
Y A E++ G Y ID++S G + E++ P G V
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME----RVN 236
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 308
I+K L + FP P F + L+ + P+ R
Sbjct: 237 ILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLLIDHDPNKR 275
Query: 309 CTALEACAHPFF 320
A +
Sbjct: 276 PGARTLLNSGWL 287
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-52
Identities = 74/294 (25%), Positives = 120/294 (40%), Gaps = 44/294 (14%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 88
+ E+ +G G F V++A CL G VA+KKV + R +E+ L++ ++HPN
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
VI F LN+V+E + R++KH+ + +P V Y Q+
Sbjct: 94 VIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPE 206
L ++H+ RV HRD+KP N+ + T VK+ D G + + S + + +Y +PE
Sbjct: 149 LEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMN 265
I Y DIWS GC+L E+ Q F G+ + L + I +C
Sbjct: 207 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----------EQC-- 253
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
+P + + E L + + P R
Sbjct: 254 ------DYPPLPS--------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-52
Identities = 83/323 (25%), Positives = 137/323 (42%), Gaps = 60/323 (18%)
Query: 27 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMR-VM 84
N E ++E+++G GS G V + G VA+K++L D E++L+
Sbjct: 8 NFEQSLKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66
Query: 85 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMY-RVLKH--YSSANQRMPLIYVKLYT 141
DHPNVI +C +T + FL + +E ++ V +
Sbjct: 67 DHPNVIRY-YCSETT----DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 142 YQIFRGLAYIHTVPRVCHRDLKPQNLLVD------------PLTHQVKICDFGSAKQLIA 189
QI G+A++H++ ++ HRDLKPQN+LV ++ I DFG K+L +
Sbjct: 122 RQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 190 GEANISYICSRF-----YRAPELIFGATE------YTTSIDIWSAGCVLAELL-LGQPLF 237
G+++ + +RAPEL+ + T SIDI+S GCV +L G+ F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 238 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLA 297
+ + II+ F ++K + EA DL
Sbjct: 241 GDKY--SRESNIIR-----------------GIFSLDEMKCLHDRSL-----IAEATDLI 276
Query: 298 SRLLQYSPSLRCTALEACAHPFF 320
S+++ + P R TA++ HP F
Sbjct: 277 SQMIDHDPLKRPTAMKVLRHPLF 299
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-52
Identities = 61/297 (20%), Positives = 112/297 (37%), Gaps = 50/297 (16%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHC 95
+ ++G+G FG VF+AK G+T IK+V + RE++ + +DH N++ C
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 96 F-----------FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQ 143
+ +++ L + ME+ + ++ + ++ +++ + Q
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQ 130
Query: 144 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 203
I +G+ YIH+ ++ +RDLKP N+ + T QVKI DFG L + Y
Sbjct: 131 ITKGVDYIHS-KKLINRDLKPSNIFLVD-TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
+PE I +Y +D+++ G +LAELL ++
Sbjct: 189 SPEQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD------------ 233
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
+ + L +LL P R E
Sbjct: 234 -------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 7e-52
Identities = 77/325 (23%), Positives = 127/325 (39%), Gaps = 50/325 (15%)
Query: 29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQLM 81
+P+ Y+ R +G G F F+ +T E A K +L + E+ +
Sbjct: 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 69
Query: 82 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLY 140
R + H +V+ F + +F +V+E S+ + K + + + Y
Sbjct: 70 RSLAHQHVVGFHGFF---EDNDFVF--VVLELCRRRSLLELHK----RRKALTEPEARYY 120
Query: 141 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-S 199
QI G Y+H RV HRDLK NL ++ +VKI DFG A ++ +C +
Sbjct: 121 LRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCGT 178
Query: 200 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
Y APE++ ++ +D+WS GC++ LL+G+P F + + I K
Sbjct: 179 PNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------- 230
Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
++ P + P A L ++LQ P+ R T E F
Sbjct: 231 ----------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLNDEF 268
Query: 320 FDELREPNARLPNGRPLPPLFNFKQ 344
F P +PP F+
Sbjct: 269 FTSGYIPARLPITCLTIPPRFSIAP 293
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-51
Identities = 69/318 (21%), Positives = 120/318 (37%), Gaps = 47/318 (14%)
Query: 17 HIISTTIGGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQ 69
H S G Q++ Y+ + +G GSFG K E G IK++ +
Sbjct: 6 HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK 65
Query: 70 DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSA 128
+R RE+ ++ M HPN++ + F S L +VM+Y +++ +
Sbjct: 66 EREESRREVAVLANMKHPNIVQYRESFEENGS-----LYIVMDYCEGGDLFKRINAQK-- 118
Query: 129 NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188
+ + QI L ++H ++ HRD+K QN+ + V++ DFG A+ L
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTVQLGDFGIARVLN 176
Query: 189 AGEANISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 247
+ + +Y +PE+ Y DIW+ GCVL EL + F + + LV
Sbjct: 177 STVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLV 234
Query: 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 307
I ++ +Y + L S+L + +P
Sbjct: 235 LKII------SGSFPPVSLHY---------------------SYDLRSLVSQLFKRNPRD 267
Query: 308 RCTALEACAHPFFDELRE 325
R + F + E
Sbjct: 268 RPSVNSILEKGFIAKRIE 285
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-51
Identities = 67/313 (21%), Positives = 116/313 (37%), Gaps = 48/313 (15%)
Query: 16 GHIISTTIGGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRY 73
G +++ + + E ++ + + VG GSFG V + K +TG A+KKV L+ +
Sbjct: 39 GVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--F 96
Query: 74 KNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRM 132
+ EL + P ++ L +N+ ME + S+ +++K +
Sbjct: 97 RVEELVACAGLSSPRIVPLYGAVREGPW-----VNIFMELLEGGSLGQLIKQMG----CL 147
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 192
P Y Q GL Y+HT R+ H D+K N+L+ + +CDFG A L
Sbjct: 148 PEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206
Query: 193 NISYICSR------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 246
S + + APE++ G +DIWS+ C++ +L G +
Sbjct: 207 GKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC 265
Query: 247 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 306
++I P +I P L+ P
Sbjct: 266 LKIAS-EPPPI----------------REIPPS---------CAPLTAQAIQEGLRKEPV 299
Query: 307 LRCTALEACAHPF 319
R +A+E
Sbjct: 300 HRASAMELRRKVG 312
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-51
Identities = 78/304 (25%), Positives = 129/304 (42%), Gaps = 50/304 (16%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRVMDHPNVISLKHC 95
V+G G++GIV+ + L +AIK++ +D RY E+ L + + H N++
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83
Query: 96 FFSTTSKNELFLNLVMEYVPE-SMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
+ + S+N F+ + ME VP S+ +L+ + I YT QI GL Y+H
Sbjct: 84 YLGSFSENG-FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHD 140
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGAT 212
++ HRD+K N+L++ + +KI DFG++K+L ++ + Y APE+I
Sbjct: 141 -NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 213 E-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
Y + DIWS GC + E+ G+P F +L E + F
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM-----------------F 236
Query: 272 RFPQIKAHPWHKVFHKRMP----PEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327
+ K HP +P EA + + P R A + F +
Sbjct: 237 KVGMFKVHP-------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289
Query: 328 ARLP 331
P
Sbjct: 290 KTQP 293
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 5e-51
Identities = 77/326 (23%), Positives = 127/326 (38%), Gaps = 50/326 (15%)
Query: 29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQLM 81
+P+ Y+ R +G G F F+ +T E A K +L + E+ +
Sbjct: 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 95
Query: 82 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLY 140
R + H +V+ F + +F +V+E S+ + K + + + Y
Sbjct: 96 RSLAHQHVVGFHGFF---EDNDFVF--VVLELCRRRSLLELHK----RRKALTEPEARYY 146
Query: 141 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-S 199
QI G Y+H RV HRDLK NL ++ +VKI DFG A ++ +C +
Sbjct: 147 LRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCGT 204
Query: 200 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
Y APE++ ++ +D+WS GC++ LL+G+P F + + I K
Sbjct: 205 PNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------- 256
Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
++ P + P A L ++LQ P+ R T E F
Sbjct: 257 ----------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLNDEF 294
Query: 320 FDELREPNARLPNGRPLPPLFNFKQE 345
F P +PP F+
Sbjct: 295 FTSGYIPARLPITCLTIPPRFSIAPS 320
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-50
Identities = 64/318 (20%), Positives = 120/318 (37%), Gaps = 60/318 (18%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 90
+ + +G G FG+VF+AK AIK++ R RE++ + ++HP ++
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 91 SLKHCFF-------STTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTY 142
+ + S +++L + M+ E++ + + +R
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFL 125
Query: 143 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-- 200
QI + ++H+ + HRDLKP N+ VK+ DFG + E + +
Sbjct: 126 QIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 201 -----------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 249
Y +PE I G Y+ +DI+S G +L ELL P F + + +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239
Query: 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 309
++ + +FP + + P + +L SP R
Sbjct: 240 VR------------------NLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERP 272
Query: 310 TALEACAHPFFDELREPN 327
A+ + F++L P
Sbjct: 273 EAINIIENAVFEDLDFPG 290
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-50
Identities = 75/303 (24%), Positives = 129/303 (42%), Gaps = 50/303 (16%)
Query: 28 GEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQ 79
+ I + ++G GSF V++A+ + TG VAIK K + E++
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63
Query: 80 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK 138
+ + HP+++ L + F N ++ LV+E M R LK + + +
Sbjct: 64 IHCQLKHPSILELYNYF---EDSNYVY--LVLEMCHNGEMNRYLK---NRVKPFSENEAR 115
Query: 139 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 198
+ +QI G+ Y+H+ + HRDL NLL+ +KI DFG A QL +C
Sbjct: 116 HFMHQIITGMLYLHSH-GILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLC 173
Query: 199 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257
+ Y +PE+ + + D+WS GC+ LL+G+P F + + L +++
Sbjct: 174 GTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA----- 227
Query: 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
D+ P + + EA DL +LL+ +P+ R + H
Sbjct: 228 ------------DYEMP-----SF-------LSIEAKDLIHQLLRRNPADRLSLSSVLDH 263
Query: 318 PFF 320
PF
Sbjct: 264 PFM 266
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 7e-50
Identities = 76/302 (25%), Positives = 130/302 (43%), Gaps = 52/302 (17%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRVMDHPNVISL 92
R +G G FG V+ A+ ++ +A+K ++ + RE+++ + HPN++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 93 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
F ++ L++EY P ++YR L+ + Y ++ L+Y
Sbjct: 75 YGYFH---DATRVY--LILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYC 125
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 210
H+ RV HRD+KP+NLL+ ++KI DFG + + +C + Y PE+I G
Sbjct: 126 HS-KRVIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTD--LCGTLDYLPPEMIEG 181
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270
+ +D+WS G + E L+G+P F + I +V +
Sbjct: 182 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 223
Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 330
F FP + + A DL SRLL+++PS R E HP+ +
Sbjct: 224 FTFP-----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 271
Query: 331 PN 332
N
Sbjct: 272 QN 273
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 8e-50
Identities = 78/341 (22%), Positives = 135/341 (39%), Gaps = 55/341 (16%)
Query: 19 ISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QD 70
+ T G K +S Y + +G+G++G V + T AIK +
Sbjct: 20 LQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS 79
Query: 71 RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYS 126
E+ +++++DHPN++ L F +++ LVME E ++ ++
Sbjct: 80 NSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFN 134
Query: 127 SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSA 184
+ Q+ G+ Y+H + HRDLKP+NLL++ +KI DFG +
Sbjct: 135 EV-------DAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLS 186
Query: 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 244
+ + + +Y APE++ +Y D+WS G +L LL G P F G+ D
Sbjct: 187 AVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--D 242
Query: 245 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 304
Q EI+ ++ + W V A DL ++LQ+
Sbjct: 243 Q--EIL--------RKVEKGKYTFDS--------PEWKNV-----SEGAKDLIKQMLQFD 279
Query: 305 PSLRCTALEACAHPFFDELREPNARLPNGRPLPPLF-NFKQ 344
R +A +A HP+ E+ L N ++
Sbjct: 280 SQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRK 320
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 8e-50
Identities = 53/307 (17%), Positives = 117/307 (38%), Gaps = 28/307 (9%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 90
++ ++G G+ VF+ + +TG+ AIK L+ + RE ++++ ++H N++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
L TT+++ L+ME+ P + + ++ +P + + G+
Sbjct: 71 KLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLT---HQVKICDFGSAKQLIAGEANISYICSRFYRAP 205
++ + HR++KP N++ K+ DFG+A++L E +S + Y P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 206 ELIFGAT-------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258
++ A +Y ++D+WS G G F + E++ + T
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
+ P + + + + +L+ +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ----- 299
Query: 319 FFDELRE 325
FF E +
Sbjct: 300 FFAETSD 306
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 8e-50
Identities = 62/290 (21%), Positives = 116/290 (40%), Gaps = 42/290 (14%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH 94
+G GSF V++ ET VA ++ + K+ E ++++ + HPN++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 95 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
+ ST + + LV E + ++ LK + + M + ++ + QI +GL ++HT
Sbjct: 93 SWESTVKGKK-CIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT 147
Query: 154 -VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 212
P + HRDLK N+ + T VKI D G A A A + I + + APE+
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPEMY--EE 204
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
+Y S+D+++ G + E+ + + Q+ + T
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV------TSGVKPASFDKVAI-- 256
Query: 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
PE ++ ++ + R + + H FF E
Sbjct: 257 ------------------PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 9e-50
Identities = 87/322 (27%), Positives = 138/322 (42%), Gaps = 53/322 (16%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRVMDHPN 88
Y +RV+G GSFG V K TG+ A+K + D+ RE+QL++ +DHPN
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQI 144
++ L F +++ + LV E E ++ +S Q+
Sbjct: 88 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEV-------DAARIIRQV 135
Query: 145 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFY 202
G+ Y+H ++ HRDLKP+NLL++ + ++I DFG + A + I + +Y
Sbjct: 136 LSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 194
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
APE++ G Y D+WS G +L LL G P F G N D L ++ K
Sbjct: 195 IAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK----------- 241
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
+ F W KV A DL ++L Y PS+R +A +A H +
Sbjct: 242 ------GKYTFE---LPQWKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287
Query: 323 LREPNARLPNGRPLPPLFNFKQ 344
+ + + N +Q
Sbjct: 288 YTKEQISVDVPSLDNAILNIRQ 309
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 9e-50
Identities = 82/322 (25%), Positives = 132/322 (40%), Gaps = 53/322 (16%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQLMRVMDHPNV 89
Y ++G GSFG V + K T + A+K + +D RE++L++ +DHPN+
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIF 145
+ L ++ +V E E ++K +S Q+F
Sbjct: 84 MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131
Query: 146 RGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYR 203
G+ Y+H + HRDLKP+N+L++ +KI DFG + I + +Y
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
APE++ G Y D+WSAG +L LL G P F G+N D L +
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------ 236
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
+ F W + +A DL ++L + PSLR TA + HP+ +
Sbjct: 237 -----GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283
Query: 324 REPNARLPNGRPLPPLF-NFKQ 344
+ + L N +Q
Sbjct: 284 SSETPTISDLPSLESAMTNIRQ 305
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-49
Identities = 62/328 (18%), Positives = 127/328 (38%), Gaps = 52/328 (15%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN----------------REL 78
R + G F + + + + A+K + + R + EL
Sbjct: 37 RTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 79 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-----ESMYRVLKHYSSANQRMP 133
Q++ + + ++ + T+ +E+++ + EY+ + + +P
Sbjct: 95 QIITDIKNEYCLTCEGII---TNYDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 134 LIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 193
+ +K + +YIH +CHRD+KP N+L+D +VK+ DFG ++ ++ +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK-NGRVKLSDFGESEYMVDKKIK 208
Query: 194 ISYIC-SRFYRAPELIFGATEY-TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251
S + + PE + Y +DIWS G L + F + ++ +L I+
Sbjct: 209 GS--RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266
Query: 252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
+ I P + F + + + E ID L+ +P+ R T+
Sbjct: 267 ------TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317
Query: 312 LEACAHPFF-----DELREPNARLPNGR 334
+A H + ++LRE + L R
Sbjct: 318 EDALKHEWLADTNIEDLREFSKELYKKR 345
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 9e-49
Identities = 83/308 (26%), Positives = 130/308 (42%), Gaps = 54/308 (17%)
Query: 28 GEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLM 81
G K I+ Y E +G GS+G V A T A K ++D +E+++M
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 82 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYV 137
+ +DHPN+I L F ++ + LVME E RV+ + +
Sbjct: 61 KSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRES-------DA 108
Query: 138 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANIS 195
+ +AY H + V HRDLKP+N L + +K+ DFG A + G+ +
Sbjct: 109 ARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-MMR 166
Query: 196 YIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
+ +Y +P+++ G Y D WSAG ++ LL G P F + +++I +
Sbjct: 167 TKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG-- 222
Query: 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314
F FP W V P+A L RLL SP R T+L+A
Sbjct: 223 ---------------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQA 259
Query: 315 CAHPFFDE 322
H +F++
Sbjct: 260 LEHEWFEK 267
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-48
Identities = 76/323 (23%), Positives = 129/323 (39%), Gaps = 58/323 (17%)
Query: 17 HIISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQ 69
H + G +N + TI ++ +R +G+G+FG V + +G IK +
Sbjct: 3 HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62
Query: 70 DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--------ESMYRV 121
E+++++ +DHPN+I + F ++ + +VME S
Sbjct: 63 PMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR 117
Query: 122 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKIC 179
K S YV Q+ LAY H+ V H+DLKP+N+L + +KI
Sbjct: 118 GKALSEG-------YVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKII 169
Query: 180 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 239
DFG A+ + E + + + Y APE+ + T DIWSAG V+ LL G F G
Sbjct: 170 DFGLAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTG 227
Query: 240 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 299
+ + + + + + P+A+DL +
Sbjct: 228 TSLEEVQQKATYK-----------------EPNYAV---ECRP------LTPQAVDLLKQ 261
Query: 300 LLQYSPSLRCTALEACAHPFFDE 322
+L P R +A + H +F +
Sbjct: 262 MLTKDPERRPSAAQVLHHEWFKQ 284
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-48
Identities = 74/332 (22%), Positives = 129/332 (38%), Gaps = 63/332 (18%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----------------KVLQDRRYKNREL 78
Y R +G+G++G V K AIK + + E+
Sbjct: 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 79 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPL 134
L++ +DHPN+I L F +++ + LV E+ E +++ +
Sbjct: 98 SLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDEC------ 146
Query: 135 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEA 192
QI G+ Y+H + HRD+KP+N+L++ +KI DFG +
Sbjct: 147 -DAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 193 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
+ + +Y APE++ +Y D+WS G ++ LL G P F G+N DQ +II
Sbjct: 205 LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII-- 256
Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 312
+++ + + W + EA +L +L Y + RCTA
Sbjct: 257 ------KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAE 297
Query: 313 EACAHPFFDELREPNARLPNGRPLPPLFNFKQ 344
EA + + + L N ++
Sbjct: 298 EALNSRWIKKYANNINKSDQKTLCGALSNMRK 329
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 172 bits (436), Expect = 4e-48
Identities = 79/317 (24%), Positives = 131/317 (41%), Gaps = 19/317 (5%)
Query: 24 GGKNGEPKQTI--SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----R 76
GG++ + + +GTG FG V + +TGE VAIK+ Q+ KN
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61
Query: 77 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLN-LVMEYVPE-SMYRVLKHYSSANQRMPL 134
E+Q+M+ ++HPNV+S + L L MEY + + L + + +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC-GLKE 120
Query: 135 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEA 192
++ I L Y+H R+ HRDLKP+N+++ P + KI D G AK+L GE
Sbjct: 121 GPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
Query: 193 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
++ + Y APEL+ +YT ++D WS G + E + G F Q ++
Sbjct: 180 CTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR- 237
Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 312
+ E I + +F + P H + + +L + R T
Sbjct: 238 --EKSNEHIVVYDDLTGAVKFSSVLPTPNH--LSGILAGKLERWLQCMLMWHQRQRGTDP 293
Query: 313 EACAHPFFDELREPNAR 329
+ F L +
Sbjct: 294 QNPNVGCFQALDSILSL 310
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 6e-48
Identities = 78/348 (22%), Positives = 132/348 (37%), Gaps = 84/348 (24%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL---------QDRRYKNRELQLMRVMDH 86
Y + +G GS+G+V A +T AIK + +D E++LM+ + H
Sbjct: 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 87 PNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKL----- 139
PN+ L + ++E ++ LVME + ++ + + + VK
Sbjct: 88 PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 140 ------------------------------YTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 169
QIF L Y+H +CHRD+KP+N L
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLF 201
Query: 170 D-PLTHQVKICDFGSAKQLIAGEANISYIC-----SRFYRAPELIFGATE-YTTSIDIWS 222
+ ++K+ DFG +K+ Y + ++ APE++ E Y D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 223 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282
AG +L LL+G FPG N D + +++ F ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301
Query: 283 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 330
+ P A DL S LL + R A+ A HP+ + + ++
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 6e-48
Identities = 76/342 (22%), Positives = 120/342 (35%), Gaps = 64/342 (18%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVM-DHPNVI 90
RV+ G F V++A+ + +G A+K++L + R +E+ M+ + HPN++
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 91 SLKHCFF-----STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 145
S T + E L+ E + LK + + V YQ
Sbjct: 90 QFCSAASIGKEESDTGQAEFL--LLTELCKGQLVEFLKK-MESRGPLSCDTVLKIFYQTC 146
Query: 146 RGLAYIHT-VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-------------E 191
R + ++H P + HRDLK +NLL+ +K+CDFGSA + E
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSN-QGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 192 ANISYICSRFYRAPELI--FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 249
I+ + YR PE+I + DIW+ GC+L L Q F +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------ 259
Query: 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 309
R +N Y P H L +LQ +P R
Sbjct: 260 ------------RIVNGKY---SIPP----------HDTQYTVFHSLIRAMLQVNPEERL 294
Query: 310 TALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASP 351
+ E E+ P P+ L A+
Sbjct: 295 SIAEVVHQLQ--EIAAARNVNPK-SPITELLEQNGGYGSATL 333
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-47
Identities = 52/323 (16%), Positives = 93/323 (28%), Gaps = 80/323 (24%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVM-DHPN 88
+ +G+G FG VF+ G AIK+ D + RE+ V+ H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
V+ + + + EY S+ + +K Q+ RG
Sbjct: 73 VVRYFSAWAEDDH-----MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDP------------------LTHQVKICDFGSAKQLIA 189
L YIH+ + H D+KP N+ + KI D G ++
Sbjct: 128 LRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184
Query: 190 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 249
+ + A E++ + DI++ + +PL
Sbjct: 185 -SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN---------- 233
Query: 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP-------EAIDLASRLLQ 302
WH++ R+P E +L ++
Sbjct: 234 ----------------------------GDQWHEIRQGRLPRIPQVLSQEFTELLKVMIH 265
Query: 303 YSPSLRCTALEACAHPFFDELRE 325
P R +A+ H
Sbjct: 266 PDPERRPSAMALVKHSVLLSASR 288
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 1e-47
Identities = 69/296 (23%), Positives = 125/296 (42%), Gaps = 52/296 (17%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRVMDHPNVISL 92
R +G G FG V+ A+ + +A+K ++ ++ RE+++ + HPN++ +
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 93 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
+ +F + + L++E+ P +Y+ L+ + R + ++ L Y
Sbjct: 80 -YNYFHDRKR----IYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYC 130
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 210
H +V HRD+KP+NLL+ ++KI DFG + + C + Y PE+I G
Sbjct: 131 HE-RKVIHRDIKPENLLMG-YKGELKIADFGWSVHAPSLRRRTM--CGTLDYLPPEMIEG 186
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270
+ +D+W AG + E L+G P F + + I+ V D
Sbjct: 187 -KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------D 228
Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
+FP P+ + + DL S+LL+Y P R HP+
Sbjct: 229 LKFP-----PF-------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 5e-47
Identities = 77/339 (22%), Positives = 126/339 (37%), Gaps = 46/339 (13%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLMRVMDHPNVIS 91
Y +G+G+FG+V + TG K D+ E+ +M + HP +I+
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 92 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
L F K E+ L++E++ E R+ ++ V Y Q GL
Sbjct: 113 LHDAF---EDKYEMV--LILEFLSGGELFDRIAAEDYKMSEA----EVINYMRQACEGLK 163
Query: 150 YIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 208
++H + H D+KP+N++ VKI DFG A +L E + + APE I
Sbjct: 164 HMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-I 221
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
D+W+ G + LL G F GE+ ++ L + +
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC---------------- 265
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
D+ F + V PEA D LLQ P R T +A HP+ L+ ++
Sbjct: 266 -DWEFD---EDAFSSV-----SPEAKDFIKNLLQKEPRKRLTVHDALEHPW---LKGDHS 313
Query: 329 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLG 367
L + P +Q++ +
Sbjct: 314 NLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFS 352
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 5e-47
Identities = 76/306 (24%), Positives = 130/306 (42%), Gaps = 56/306 (18%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--------RELQLMRV 83
Y+ + +G+G+ G V A +T + VAI+ + + E+++++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 84 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYT 141
++HP +I +K+ F + +V+E + E +V+ + +R+ KLY
Sbjct: 197 LNHPCIIKIKNFFDAED------YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYF 245
Query: 142 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYIC- 198
YQ+ + Y+H + HRDLKP+N+L+ +KI DFG +K L + +C
Sbjct: 246 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 303
Query: 199 SRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
+ Y APE++ Y ++D WS G +L L G P F L + I G
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG-- 360
Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
+ F W +V +A+DL +LL P R T EA
Sbjct: 361 -------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALR 399
Query: 317 HPFFDE 322
HP+ +
Sbjct: 400 HPWLQD 405
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 6e-47
Identities = 65/355 (18%), Positives = 112/355 (31%), Gaps = 83/355 (23%)
Query: 20 STTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----------KVL 68
+ + GE +T + V+G +A ETGE+ + +
Sbjct: 61 PFRVESELGERPRT--LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 118
Query: 69 QDRRYKNR---------------------ELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107
Q + R L++ +I ++ + FL
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178
Query: 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL 167
M+ ++ VL +SS ++ + T Q+ R LA +H + H L+P ++
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDI 237
Query: 168 LVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI----------FGATEYTTS 217
++D V + F + A + SR + PEL T T S
Sbjct: 238 VLDQ-RGGVFLTGFEHLVRD---GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFS 293
Query: 218 IDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIK 277
D W+ G V+ + + A+ E I FR
Sbjct: 294 FDAWALGLVIYWIWCADLPITKDAALG------------GSEWI---------FRSC--- 329
Query: 278 AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP-NARLP 331
K +P L L+Y R L+A P +++LR +A LP
Sbjct: 330 ---------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALP 375
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-46
Identities = 79/333 (23%), Positives = 130/333 (39%), Gaps = 60/333 (18%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--------RELQLMRV 83
Y+ + +G+G+ G V A +T + VAIK + + E+++++
Sbjct: 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 84 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKL 139
++HP +I +K+ FF +V+E + E +V+ A + L
Sbjct: 72 LNHPCIIKIKN-FFDAED-----YYIVLELMEGGELFDKVVGNKRLKEATCK-------L 118
Query: 140 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYI 197
Y YQ+ + Y+H + HRDLKP+N+L+ +KI DFG +K L + +
Sbjct: 119 YFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL 176
Query: 198 C-SRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
C + Y APE++ Y ++D WS G +L L G P F L + I G
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG 235
Query: 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314
+ F W +V +A+DL +LL P R T EA
Sbjct: 236 ---------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEA 272
Query: 315 CAHPFFDELREPNARLPNGRPLPPLFNFKQELS 347
HP+ + Q L+
Sbjct: 273 LRHPWLQDEDMKRKFQDLLSEENESTALPQVLA 305
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-46
Identities = 82/320 (25%), Positives = 134/320 (41%), Gaps = 54/320 (16%)
Query: 17 HIISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQD 70
H + G +N + T + Y ++G GSFG V + K T + A+K ++
Sbjct: 3 HHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN 62
Query: 71 RRYKN--RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--H 124
+ RE++L++ +DHPN++ L ++ +V E E ++K
Sbjct: 63 KDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 125 YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFG 182
+S Q+F G+ Y+H + HRDLKP+N+L++ +KI DFG
Sbjct: 118 FSEH-------DAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 183 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 242
+ I + +Y APE++ G Y D+WSAG +L LL G P F G+N
Sbjct: 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 243 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 302
D L + + F W + +A DL ++L
Sbjct: 228 YDILKRVET-----------------GKYAFD---LPQWRTI-----SDDAKDLIRKMLT 262
Query: 303 YSPSLRCTALEACAHPFFDE 322
+ PSLR TA + HP+ +
Sbjct: 263 FHPSLRITATQCLEHPWIQK 282
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 8e-46
Identities = 78/323 (24%), Positives = 130/323 (40%), Gaps = 51/323 (15%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN---RELQLMRVMDHP 87
Y+ ++G GS+G V + ET A+K K+ + + +E+QL+R + H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
NVI L ++ K ++++ VMEY M +L +R P+ Y Q+ G
Sbjct: 67 NVIQLVDVLYNEE-KQKMYM--VMEYCVCGMQEMLDS--VPEKRFPVCQAHGYFCQLIDG 121
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYIC--SRFYRA 204
L Y+H+ + H+D+KP NLL+ +KI G + + S ++
Sbjct: 122 LEYLHSQ-GIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 205 PELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
PE+ G ++ +DIWSAG L + G F G+N + +L E I
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIG------------ 226
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
+ P P DL +L+Y P+ R + + H +F +
Sbjct: 227 ----KGSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270
Query: 324 REPNARLPNGRPLPPLFNFKQEL 346
P P+PP + K
Sbjct: 271 HPPAEAPV---PIPPSPDTKDRW 290
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-45
Identities = 73/306 (23%), Positives = 124/306 (40%), Gaps = 52/306 (16%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLMRVMDHPNVIS 91
++ V+G+G+F VF K TG+ A+K E+ +++ + H N+++
Sbjct: 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 92 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIFRG 147
L+ + S + LVM+ V E R+L+ Y+ + L Q+
Sbjct: 71 LEDIY---ESTTHYY--LVMQLVSGGELFDRILERGVYTEKDAS-------LVIQQVLSA 118
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYIC-SRFYRA 204
+ Y+H + HRDLKP+NLL ++ I DFG +K + +S C + Y A
Sbjct: 119 VKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVA 175
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
PE + Y+ ++D WS G + LL G P F E +I +
Sbjct: 176 PE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG------------ 222
Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324
+ F + W + A D LL+ P+ R T +A +HP+ D
Sbjct: 223 -----YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269
Query: 325 EPNARL 330
+ +
Sbjct: 270 ALHRDI 275
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-45
Identities = 75/317 (23%), Positives = 125/317 (39%), Gaps = 49/317 (15%)
Query: 14 VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 73
V H I + + + Y + +G GS+ + + T A+K + + +R
Sbjct: 4 VGVHSIVQQLHRNSIQFTDG--YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD 61
Query: 74 KNRELQLM-RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSA 128
E++++ R HPN+I+LK + + ++ +V E + E + ++L+ +S
Sbjct: 62 PTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSER 116
Query: 129 NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAK 185
+ I + + Y+H V HRDLKP N+L ++ICDFG AK
Sbjct: 117 EASA-------VLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 186 QLIAGEANISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 244
QL A + C + + APE + Y + DIWS G +L +L G F
Sbjct: 169 QLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT 227
Query: 245 QLVEIIKVL-GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 303
+ ++ G F W+ V A DL S++L
Sbjct: 228 PEEILARIGSG---------------KFSLS---GGYWNSV-----SDTAKDLVSKMLHV 264
Query: 304 SPSLRCTALEACAHPFF 320
P R TA HP+
Sbjct: 265 DPHQRLTAALVLRHPWI 281
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-45
Identities = 75/312 (24%), Positives = 122/312 (39%), Gaps = 58/312 (18%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRVMD 85
Y +G+G F IV + + TG+ A K + R RE+ ++R +
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 86 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYT 141
HPN+I+L F +K ++ L ++E V E + + + +
Sbjct: 67 HPNIITLHDIF---ENKTDVVL--ILELVSGGELFDFLAEKESLTEDE-------ATQFL 114
Query: 142 YQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYIC 198
QI G+ Y+H+ R+ H DLKP+N+++ + ++K+ DFG A ++ AG I
Sbjct: 115 KQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF 172
Query: 199 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257
+ + APE I D+WS G + LL G F GE + L I V
Sbjct: 173 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV----- 226
Query: 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
++ F + A D RLL P R T ++ H
Sbjct: 227 ------------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQSLEH 266
Query: 318 PFFDELREPNAR 329
+ +R N R
Sbjct: 267 SWIKAIRRRNVR 278
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-45
Identities = 73/301 (24%), Positives = 126/301 (41%), Gaps = 50/301 (16%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVA---IKKVLQDRRYKNRELQLMRVMDHPNVISL 92
YM +G G FGIV + + +T +K D+ +E+ ++ + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 93 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK---HYSSANQRMPLIYVKLYTYQIFRG 147
F S EL ++ E++ + R+ + + Y +Q+
Sbjct: 67 HESF---ESMEELV--MIFEFISGLDIFERINTSAFELNERE-------IVSYVHQVCEA 114
Query: 148 LAYIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAP 205
L ++H+ + H D++P+N++ + +KI +FG A+QL G+ N + + Y AP
Sbjct: 115 LQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAP 172
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
E + +T+ D+WS G ++ LL G F E +Q +II E I
Sbjct: 173 E-VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--------ENIMNAE 219
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
+ + F +I EA+D RLL R TA EA HP+ + E
Sbjct: 220 YTFDEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266
Query: 326 P 326
Sbjct: 267 R 267
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-45
Identities = 76/345 (22%), Positives = 132/345 (38%), Gaps = 47/345 (13%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVIS 91
Y +GTG+FG+V + TG A K V D+ +E+Q M V+ HP +++
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 92 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
L F + ++ E++ E +V ++ ++ + Y++ Q+ +GL
Sbjct: 219 LHDAFEDDNE-----MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 269
Query: 150 YIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 208
++H H DLKP+N++ ++++K+ DFG L ++ + + APE+
Sbjct: 270 HMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
G D+WS G + LL G F GEN + T ++ + N
Sbjct: 329 EG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------TLRNVKSCDWNM 375
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
D F I + D +LL P+ R T +A HP+ L NA
Sbjct: 376 DDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPW---LTPGNA 419
Query: 329 RLPNGR-PLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLH 372
+ + P + + L P H
Sbjct: 420 PGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKH 464
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-45
Identities = 70/319 (21%), Positives = 121/319 (37%), Gaps = 45/319 (14%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKHCFF 97
++V+G G G V + TG+ A+K +L D +E+ + P+++ + +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD-VY 91
Query: 98 STTSKNELFLNLVMEYVP------ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
+ L ++ME + R + ++ I + ++
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER-------EAAEIMRDIGTAIQFL 144
Query: 152 HTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 208
H+ + HRD+KP+NLL +K+ DFG AK+ + C + +Y APE +
Sbjct: 145 HSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-V 200
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
G +Y S D+WS G ++ LL G P F + + R Y
Sbjct: 201 LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR----------RIRLGQY 250
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-DELREPN 327
F P W +V +A L LL+ P+ R T + HP+ + P
Sbjct: 251 -GFPNP-----EWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ 299
Query: 328 ARLPNGRPLPPLFNFKQEL 346
L R L + E+
Sbjct: 300 TPLHTARVLQEDKDHWDEV 318
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 5e-45
Identities = 79/298 (26%), Positives = 122/298 (40%), Gaps = 53/298 (17%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--RELQLMRVMDHPNV 89
Y + +G G+F +V + TG A K K L R ++ RE ++ R + HPN+
Sbjct: 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIF 145
+ L + E F LV + V E ++ YS A+ QI
Sbjct: 68 VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 115
Query: 146 RGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 202
+AY H+ + HR+LKP+NLL+ VK+ DFG A ++ EA + Y
Sbjct: 116 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGY 173
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
+PE + Y+ +DIW+ G +L LL+G P F E+ +I
Sbjct: 174 LSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG---------- 222
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
+ +P + W V PEA L +L +P R TA +A P+
Sbjct: 223 -------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 5e-45
Identities = 78/311 (25%), Positives = 124/311 (39%), Gaps = 64/311 (20%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK-------------KVLQDRRYKNRELQ-LM 81
Y + ++G G +V + T + A+K +V + R +E+ L
Sbjct: 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 82 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYV 137
+V HPN+I LK + + F LV + + E + + S R
Sbjct: 79 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR------ 127
Query: 138 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 197
+ + +H + + HRDLKP+N+L+D +K+ DFG + QL GE + +
Sbjct: 128 -KIMRALLEVICALHKL-NIVHRDLKPENILLDD-DMNIKLTDFGFSCQLDPGEK-LREV 183
Query: 198 C-SRFYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251
C + Y APE+I + Y +D+WS G ++ LL G P F + L I+
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243
Query: 252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
+++F + W DL SR L P R TA
Sbjct: 244 G-----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYTA 278
Query: 312 LEACAHPFFDE 322
EA AHPFF +
Sbjct: 279 EEALAHPFFQQ 289
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-45
Identities = 73/327 (22%), Positives = 121/327 (37%), Gaps = 59/327 (18%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRVMD 85
Y +G+G F IV + + TG A K + R RE+ ++R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 86 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYT 141
H NVI+L + ++ ++ L ++E V E + + S +
Sbjct: 74 HHNVITLHDVY---ENRTDVVL--ILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 142 YQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYIC 198
QI G+ Y+HT ++ H DLKP+N+++ + +K+ DFG A ++ G I
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 199 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257
+ + APE I D+WS G + LL G F G+ + L I V
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV----- 233
Query: 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
+ F + A D +LL R T EA H
Sbjct: 234 ------------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273
Query: 318 PFFDELREPNARLPNGRPLPPLFNFKQ 344
P+ + + + L NF++
Sbjct: 274 PWITP-VDNQQAMVRRESVVNLENFRK 299
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-45
Identities = 86/347 (24%), Positives = 137/347 (39%), Gaps = 60/347 (17%)
Query: 17 HIISTTIGGKNGEPKQTIS---------YMAERVVGTGSFGIVFQAKCLETGETVAIK-- 65
H+ S T G + G + + Y + +G G+F +V + TG A K
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 66 --KVLQDRRYKN--RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMY 119
K L R ++ RE ++ R + HPN++ L + E F LV + V E
Sbjct: 63 NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFE 117
Query: 120 RVLK--HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQ 175
++ YS A+ QI +AY H+ + HR+LKP+NLL+
Sbjct: 118 DIVAREFYSEADAS-------HCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAA 169
Query: 176 VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 235
VK+ DFG A ++ EA + + Y +PE + Y+ +DIW+ G +L LL+G P
Sbjct: 170 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYP 228
Query: 236 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 295
F E+ +I + +P + W V PEA
Sbjct: 229 PFWDEDQHRLYAQIKAG-----------------AYDYP---SPEWDTV-----TPEAKS 263
Query: 296 LASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF 342
L +L +P R TA +A P+ + + + L F
Sbjct: 264 LIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKF 310
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 7e-45
Identities = 76/320 (23%), Positives = 124/320 (38%), Gaps = 52/320 (16%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 89
Y +G G+F +V + + G+ A + + RE ++ R++ HPN+
Sbjct: 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIF 145
+ L E L+ + V E ++ +YS A QI
Sbjct: 73 VRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEA-------DASHCIQQIL 120
Query: 146 RGLAYIHTVPRVCHRDLKPQNLL-VDPLTH-QVKICDFGSAKQLIAGEANISYIC-SRFY 202
+ + H + V HR+LKP+NLL L VK+ DFG A ++ + + Y
Sbjct: 121 EAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
+PE + Y +D+W+ G +L LL+G P F E+ +I
Sbjct: 180 LSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA----------- 227
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
+ FP + W V PEA DL +++L +PS R TA EA HP+
Sbjct: 228 ------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWISH 273
Query: 323 LREPNARLPNGRPLPPLFNF 342
+ + + L F
Sbjct: 274 RSTVASCMHRQETVDCLKKF 293
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 8e-45
Identities = 76/335 (22%), Positives = 125/335 (37%), Gaps = 60/335 (17%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK---------KVLQDRRYKNRELQLMRVMDH 86
Y V+G G F +V + ETG+ A+K RE + ++ H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 87 PNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIY----VKLY 140
P+++ L + ++ L +V E++ + + ++K + Y Y
Sbjct: 86 PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFV-----YSEAVASHY 135
Query: 141 TYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYI 197
QI L Y H + HRD+KP +L+ + + VK+ FG A QL
Sbjct: 136 MRQILEALRYCHDN-NIIHRDVKPHCVLLASKEN-SAPVKLGGFGVAIQLGESGLVAGGR 193
Query: 198 C-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
+ + APE + Y +D+W G +L LL G F G ++L E I
Sbjct: 194 VGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII----- 245
Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
++ W + A DL R+L P+ R T EA
Sbjct: 246 -----------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEALN 286
Query: 317 HPFFDELREPNARLPNGRPLPPL--FNFKQELSGA 349
HP+ E ++ + L FN +++L GA
Sbjct: 287 HPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGA 321
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 74/327 (22%), Positives = 123/327 (37%), Gaps = 59/327 (18%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRVMD 85
Y +G+G F IV + + TG A K + R RE+ ++R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 86 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYT 141
HPN+I+L + ++ ++ L ++E V E + + S +
Sbjct: 74 HPNIITLHDVY---ENRTDVVL--ILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 142 YQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYIC 198
QI G+ Y+HT ++ H DLKP+N+++ + +K+ DFG A ++ G I
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 199 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257
+ + APE I D+WS G + LL G F G+ + L I V
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV----- 233
Query: 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
+ F + + A D +LL R T EA H
Sbjct: 234 ------------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273
Query: 318 PFFDELREPNARLPNGRPLPPLFNFKQ 344
P+ + + + L NFK+
Sbjct: 274 PWITP-VDTQQAMVRRESVVNLENFKK 299
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-44
Identities = 73/327 (22%), Positives = 126/327 (38%), Gaps = 59/327 (18%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRVMD 85
Y +G+G F +V + + TG A K + R RE+ +++ +
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 86 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYT 141
HPNVI+L + +K ++ L ++E V E + + + +
Sbjct: 73 HPNVITLHEVY---ENKTDVIL--ILELVAGGELFDFLAEKESLTEEE-------ATEFL 120
Query: 142 YQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYIC 198
QI G+ Y+H++ ++ H DLKP+N+++ + ++KI DFG A ++ G I
Sbjct: 121 KQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF 178
Query: 199 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257
+ + APE I D+WS G + LL G F G+ + L + V
Sbjct: 179 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV----- 232
Query: 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
NY +F + A D RLL P R T ++ H
Sbjct: 233 ---------NY-EFEDE-----YFSNT-----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272
Query: 318 PFFDELREPNARLPNGRPLPPLFNFKQ 344
P+ ++ L + FK+
Sbjct: 273 PWIKP-KDTQQALSRKASAVNMEKFKK 298
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 2e-44
Identities = 77/330 (23%), Positives = 134/330 (40%), Gaps = 34/330 (10%)
Query: 22 TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYKNR 76
T K GE K + +G G+ G+VF+ +G +A K + R R
Sbjct: 22 TQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80
Query: 77 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLI 135
ELQ++ + P ++ F+S +++ ME++ S+ +VLK R+P
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQ 131
Query: 136 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 195
+ + + +GL Y+ ++ HRD+KP N+LV+ ++K+CDFG + QLI AN S
Sbjct: 132 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-S 189
Query: 196 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
++ +R Y +PE + G Y+ DIWS G L E+ +G+ P +A + + +
Sbjct: 190 FVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248
Query: 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVF---------------HKRMPPEAIDLASRL 300
E + + P +F E D ++
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 308
Query: 301 LQYSPSLRCTALEACAHPFFDELREPNARL 330
L +P+ R + H F
Sbjct: 309 LIKNPAERADLKQLMVHAFIKRSDAEEVDF 338
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 4e-44
Identities = 73/293 (24%), Positives = 117/293 (39%), Gaps = 43/293 (14%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKH 94
+ +V+G G G V Q T E A+K +LQD RE++L R P+++ +
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRI-V 121
Query: 95 CFFSTTSKNELFLNLVMEYVP------ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
+ L +VME + R + ++ I +
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER-------EASEIMKSIGEAI 174
Query: 149 AYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 205
Y+H++ + HRD+KP+NLL P +K+ DFG AK+ + + + + +Y AP
Sbjct: 175 QYLHSI-NIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
E + G +Y S D+WS G ++ LL G P F + + + R
Sbjct: 233 E-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----------RIRM 281
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
Y +F P W +V E L LL+ P+ R T E HP
Sbjct: 282 GQY-EFPNP-----EWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHP 323
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-43
Identities = 77/308 (25%), Positives = 129/308 (41%), Gaps = 63/308 (20%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK------------KVLQDRRYKNRELQLMR- 82
Y + V+G G +V + TG A+K ++ + R RE ++R
Sbjct: 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 83 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVK 138
V HP++I+L + S++ F+ LV + + E + + S R
Sbjct: 156 VAGHPHIITLIDSYESSS-----FMFLVFDLMRKGELFDYLTEKVALSEKETR------- 203
Query: 139 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 198
+ ++++H + HRDLKP+N+L+D Q+++ DFG + L GE + +C
Sbjct: 204 SIMRSLLEAVSFLHAN-NIVHRDLKPENILLDD-NMQIRLSDFGFSCHLEPGEK-LRELC 260
Query: 199 -SRFYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
+ Y APE++ + + Y +D+W+ G +L LL G P F + L I++
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG 320
Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 312
++F + W DL SRLLQ P R TA
Sbjct: 321 -----------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLTAE 355
Query: 313 EACAHPFF 320
+A HPFF
Sbjct: 356 QALQHPFF 363
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-43
Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 41/289 (14%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRVMDHPNVISLKH 94
+G G++G+V + + + +G+ +A+K++ Q+++ +L MR +D P ++
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 95 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 154
F + + ME + S+ + K Q +P + I + L ++H+
Sbjct: 74 ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG---A 211
V HRD+KP N+L++ QVK+CDFG + L+ A + Y APE I
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
Y+ DIWS G + EL + + + Q ++ + V
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS--------------- 231
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
PQ+ A + E +D S+ L+ + R T E HPFF
Sbjct: 232 --PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-43
Identities = 80/318 (25%), Positives = 136/318 (42%), Gaps = 45/318 (14%)
Query: 23 IGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNREL 78
+ K G + ++G G FG V + + TG +A K + ++D+ E+
Sbjct: 78 VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137
Query: 79 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIY 136
+M +DH N+I L F SKN++ LVMEYV E R++ + + +++
Sbjct: 138 SVMNQLDHANLIQLYDAF---ESKNDIV--LVMEYVDGGELFDRIIDESYNLTELDTILF 192
Query: 137 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANIS 195
+K QI G+ ++H + + H DLKP+N+L V+ Q+KI DFG A++ E +
Sbjct: 193 MK----QICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLK 246
Query: 196 YIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254
+ + APE + + D+WS G + LL G F G+N + L I+
Sbjct: 247 VNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC-- 303
Query: 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314
+ D + + EA + S+LL S R +A EA
Sbjct: 304 ------------RW-DLEDE-----EFQDI-----SEEAKEFISKLLIKEKSWRISASEA 340
Query: 315 CAHPFFDELREPNARLPN 332
HP+ + + +
Sbjct: 341 LKHPWLSDHKLHSRLSAQ 358
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-43
Identities = 76/312 (24%), Positives = 128/312 (41%), Gaps = 44/312 (14%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLM-RVMDHPNVISL 92
+ ++ +G GSF I + ++ + A+ K++ R N +E+ + HPN++ L
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAV-KIISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 93 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIFRGL 148
F ++L LVME + E R+ K H+S ++ +
Sbjct: 72 HEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASY-------IMRKLVSAV 119
Query: 149 AYIHTVPRVCHRDLKPQNLL-VDPLTH-QVKICDFGSAKQLIAGEANISYIC-SRFYRAP 205
+++H V V HRDLKP+NLL D + ++KI DFG A+ + C + Y AP
Sbjct: 120 SHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
E + Y S D+WS G +L +L GQ F + ++++ ++I+
Sbjct: 179 E-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG- 231
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
DF F W V EA DL LL P+ R + + + +
Sbjct: 232 ----DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279
Query: 326 -PNARLPNGRPL 336
+ L L
Sbjct: 280 LSSNPLMTPDIL 291
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-43
Identities = 75/311 (24%), Positives = 122/311 (39%), Gaps = 47/311 (15%)
Query: 20 STTIGGKNGEPKQTI-SYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRY 73
T G + Y + +G+G+FG+ + T E VA+K + +
Sbjct: 5 PVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ 64
Query: 74 KNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQR 131
RE+ R + HPN++ K + L ++MEY E L R
Sbjct: 65 --REIINHRSLRHPNIVRFKEVI---LTPTHLA--IIMEYASGGE-----LYERICNAGR 112
Query: 132 MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAKQLIAG 190
+ + Q+ G++Y H++ ++CHRDLK +N L+D ++KICDFG +K +
Sbjct: 113 FSEDEARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171
Query: 191 EANISYICSRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 249
S + + Y APE++ EY D+WS G L +L+G F
Sbjct: 172 SQPKSTVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-------- 222
Query: 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 309
T + I + + P R+ PE L SR+ P+ R
Sbjct: 223 EPRDYRKTIQRILSV-----KYSIPD----------DIRISPECCHLISRIFVADPATRI 267
Query: 310 TALEACAHPFF 320
+ E H +F
Sbjct: 268 SIPEIKTHSWF 278
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-43
Identities = 81/303 (26%), Positives = 127/303 (41%), Gaps = 50/303 (16%)
Query: 27 NGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR 82
+G + +S + E +G G+ IV++ K T + A+K + + K E+ ++
Sbjct: 44 DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 83 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVK 138
+ HPN+I LK F + E+ L V+E V E R+++ +YS +
Sbjct: 104 RLSHPNIIKLKEIF---ETPTEISL--VLELVTGGELFDRIVEKGYYSERDAA------- 151
Query: 139 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLL-VDPLTH-QVKICDFGSAKQLIAGEANISY 196
QI +AY+H + HRDLKP+NLL P +KI DFG +K + +
Sbjct: 152 DAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKT 209
Query: 197 IC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
+C + Y APE I Y +D+WS G + LL G F E + I
Sbjct: 210 VCGTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL---- 264
Query: 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315
C ++ F + W +V A DL +L+ P R T +A
Sbjct: 265 ------NC------EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQAL 304
Query: 316 AHP 318
HP
Sbjct: 305 QHP 307
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-42
Identities = 55/343 (16%), Positives = 101/343 (29%), Gaps = 84/343 (24%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----------------- 82
V+G +A ETGE+ + R + ++ M+
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 83 ---------------VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS 127
+I ++ + FL M+ ++ VL +SS
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 128 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187
++ + T Q+ R LA +H + H L+P ++++D V + F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQ-RGGVFLTGFEHLV-- 259
Query: 188 IAGEANISYICSRFYRAPELI---------FGATEYTTSIDIWSAGCVLAELLLGQPLFP 238
G + +S R + PE T T + D W+ G + +
Sbjct: 260 RDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318
Query: 239 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH--KRMPPEAIDL 296
+ A+ +F K +P L
Sbjct: 319 DDAALGGS-----------------------------------EWIFRSCKNIPQPVRAL 343
Query: 297 ASRLLQYSPSLRCTALEACAHPFFDELRE-PNARLPNGRPLPP 338
L+Y R L+A P +++LR +A LP +
Sbjct: 344 LEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGE 386
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-42
Identities = 66/297 (22%), Positives = 120/297 (40%), Gaps = 52/297 (17%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 90
+ + +G G++G V A T E VA+K + + +E+ + ++++H NV+
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
N +L +EY E L + MP + + +Q+ G+
Sbjct: 69 KFYGHR---REGNIQYL--FLEYCSGGE-----LFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYIC-SRFYRAP 205
Y+H + + HRD+KP+NLL+D +KI DFG A ++ +C + Y AP
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 206 ELIFGATEYT-TSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRC 263
EL+ E+ +D+WS G VL +L G+ P ++ + + +
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------ 223
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
PW K + + L ++L +PS R T + ++
Sbjct: 224 -----KKTYLN-----PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-42
Identities = 84/330 (25%), Positives = 138/330 (41%), Gaps = 53/330 (16%)
Query: 22 TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK-N 75
+I E +Y + +G G+F V A+ + TG VAIK ++ K
Sbjct: 3 SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF 62
Query: 76 RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMP 133
RE+++M++++HPN++ L ++ L+ L+MEY E + Y A+ RM
Sbjct: 63 REVRIMKILNHPNIVKLFEVI---ETEKTLY--LIMEYASGGE-----VFDYLVAHGRMK 112
Query: 134 LIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 193
+ QI + Y H R+ HRDLK +NLL+D +KI DFG + + G
Sbjct: 113 EKEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTVGGK- 169
Query: 194 ISYIC-SRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251
+ C + Y APEL G +Y +D+WS G +L L+ G F G+N + +L E +
Sbjct: 170 LDAFCGAPPYAAPELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL 227
Query: 252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
+R P + M + +L R L +P R T
Sbjct: 228 ----------------RGKYRIP-----FY-------MSTDCENLLKRFLVLNPIKRGTL 259
Query: 312 LEACAHPFFDELREPNARLPNGRPLPPLFN 341
+ + + E + P P + +
Sbjct: 260 EQIMKDRWINAGHEEDELKPFVEPELDISD 289
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-42
Identities = 84/308 (27%), Positives = 121/308 (39%), Gaps = 54/308 (17%)
Query: 24 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--R 76
G K+ + Y+ +G G+FG V + TG VA+K K+ R
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 77 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPL 134
E+Q +++ HP++I L ++ + F +VMEYV E L Y + R+
Sbjct: 61 EIQNLKLFRHPHIIKLYQVI---STPTDFF--MVMEYVSGGE-----LFDYICKHGRVEE 110
Query: 135 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEAN 193
+ + QI + Y H V HRDLKP+N+L+D KI DFG S
Sbjct: 111 MEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGEFLR 168
Query: 194 ISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
S C S Y APE+I G +DIWS G +L LL G F E+ V L + I+
Sbjct: 169 TS--CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFKKIR- 224
Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 312
F P + + L +LQ P R T
Sbjct: 225 ---------------GGVFYIP-----EY-------LNRSVATLLMHMLQVDPLKRATIK 257
Query: 313 EACAHPFF 320
+ H +F
Sbjct: 258 DIREHEWF 265
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-41
Identities = 70/311 (22%), Positives = 122/311 (39%), Gaps = 56/311 (18%)
Query: 37 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDH-PNV 89
+ + +G G F +V Q TG+ A K + + RR ++ E+ ++ + P V
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVP------ESMYRVLKHYSSANQRMPLIYVKLYTYQ 143
I+L + + +E+ L ++EY + + + S + V Q
Sbjct: 92 INLHEVY---ENTSEIIL--ILEYAAGGEIFSLCLPELAEMVSEND-------VIRLIKQ 139
Query: 144 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFGSAKQLIAGEANISYIC-SR 200
I G+ Y+H + H DLKPQN+L+ + +KI DFG ++++ + I +
Sbjct: 140 ILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTP 197
Query: 201 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260
Y APE I TT+ D+W+ G + LL F GE+ + + I +V
Sbjct: 198 EYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV-------- 248
Query: 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
+ + + V A D LL +P R TA +H +
Sbjct: 249 ---------NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291
Query: 321 DELREPNARLP 331
+ N P
Sbjct: 292 QQWDFENLFHP 302
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-41
Identities = 69/313 (22%), Positives = 127/313 (40%), Gaps = 50/313 (15%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 90
+ + +G G++G V A T E VA+K + + +E+ + ++++H NV+
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
N +L +EY E L + MP + + +Q+ G+
Sbjct: 69 KFYGHR---REGNIQYL--FLEYCSGGE-----LFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYIC-SRFYRAP 205
Y+H + + HRD+KP+NLL+D +KI DFG A ++ +C + Y AP
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 206 ELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
EL+ E+ +D+WS G VL +L G+ + DQ + + ++
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229
Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324
PW K + + L ++L +PS R T + ++++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269
Query: 325 EPNARLPNGRPLP 337
+ A+ P
Sbjct: 270 KKGAKRPRVTSGG 282
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-41
Identities = 73/311 (23%), Positives = 112/311 (36%), Gaps = 58/311 (18%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLM-RVMDHPNVISLK 93
E V+G G+ V L T + A+K + R RE++++ + H NV+ L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 94 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIFRGLA 149
F + E LV E + + + K H++ + + L
Sbjct: 78 EFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-------VVQDVASALD 125
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFGSAKQLIAGEANISYICSR---- 200
++H + HRDLKP+N+L H VKICDF +
Sbjct: 126 FLHN-KGIAHRDLKPENIL---CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 201 ----FYRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252
Y APE++ A+ Y D+WS G +L LL G P F G D + +
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241
Query: 253 LGTPTR---EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 309
E I+ + FP W + A DL S+LL R
Sbjct: 242 CPACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRDAKQRL 288
Query: 310 TALEACAHPFF 320
+A + HP+
Sbjct: 289 SAAQVLQHPWV 299
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 3e-41
Identities = 78/329 (23%), Positives = 129/329 (39%), Gaps = 53/329 (16%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-------MDHPNVISL 92
RV+G G FG VF + TG+ A KK+ + R K + Q V + ++SL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 93 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
+ F T + L LVM + + Y + + N YT QI GL +
Sbjct: 251 AYAF-ETKTD----LCLVMTIMNGGDIRYH-IYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 209
+H + +RDLKP+N+L+D + V+I D G A +L AG+ + + APEL+
Sbjct: 305 LHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
G EY S+D ++ G L E++ + F +E+
Sbjct: 363 G-EEYDFSVDYFALGVTLYEMIAARGPFRARGE------------KVENKEL-------- 401
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFFDELR 324
++ + + P + D LLQ P R + HP F ++
Sbjct: 402 ---KQRVLEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI- 455
Query: 325 EPN-ARLPNGRPLPPLFNFKQELSGASPE 352
+ +L G PP + + + +
Sbjct: 456 --SWRQLEAGMLTPPFVPDSRTVYAKNIQ 482
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-41
Identities = 70/332 (21%), Positives = 125/332 (37%), Gaps = 73/332 (21%)
Query: 24 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--- 75
G +G+ Q Y + +G GS+G+V A A+K K+++ +
Sbjct: 3 SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 76 ----------------------RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY 113
+E+ +++ +DHPNV+ L +++ L++ V E
Sbjct: 63 PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFEL 119
Query: 114 VP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 171
V M + + + Y + +G+ Y+H ++ HRD+KP NLLV
Sbjct: 120 VNQGPVMEVP------TLKPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGE 172
Query: 172 LTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGAT-EYT-TSIDIWSAGCVLA 228
+KI DFG + + +A +S + + APE + ++ ++D+W+ G L
Sbjct: 173 -DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231
Query: 229 ELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 288
+ GQ F E + L IK FP
Sbjct: 232 CFVFGQCPFMDER-IMCLHSKIK----------------SQALEFPD----------QPD 264
Query: 289 MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
+ + DL +R+L +P R E HP+
Sbjct: 265 IAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 8e-41
Identities = 71/299 (23%), Positives = 109/299 (36%), Gaps = 76/299 (25%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKH 94
+ +V+G G G V Q T E A+K +LQD RE++L R P+++ +
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVD 78
Query: 95 CFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYT--------YQI 144
+ L +VME + E R+ A +T I
Sbjct: 79 -VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-----------FTEREASEIMKSI 126
Query: 145 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFGSAKQLIAGEANISYICS 199
+ Y+H++ + HRD+KP+NLL T + +K+ DFG AK+ +
Sbjct: 127 GEAIQYLHSI-NIAHRDVKPENLL---YTSKRPNAILKLTDFGFAKETTGEK-------- 174
Query: 200 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
Y S D+WS G ++ LL G P F + + +
Sbjct: 175 --------------YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-------- 212
Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
R Y +F P W +V E L LL+ P+ R T E HP
Sbjct: 213 --RIRMGQY-EFPNP-----EWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHP 258
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-41
Identities = 72/300 (24%), Positives = 122/300 (40%), Gaps = 39/300 (13%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRVMDHPNVISLKH 94
+G G++G V + +G+ +A+K++ ++++ +L +MR D P ++
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 95 CFFSTTSKNELFLNLVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
F + ME + S + K+ YS + +P + T + L ++
Sbjct: 89 ALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 213
++ HRD+KP N+L+D + +K+CDFG + QL+ A R Y APE I +
Sbjct: 144 NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 214 ---YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270
Y D+WS G L EL G+ +P N+V + + V G P
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP-------------- 247
Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 330
PQ+ + F P I+ + L S R E HPF E +
Sbjct: 248 ---PQLSNSEERE-F----SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 77/294 (26%), Positives = 122/294 (41%), Gaps = 51/294 (17%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPN 88
Y+ +G GSFG V A +T + VA+K + + + RE+ ++++ HP+
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
+I L T+ ++ + V+EY ++ Y +RM + + QI +
Sbjct: 71 IIKLYDVI---TTPTDIVM--VIEYAGGELF----DYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYIC-SRFYRAPE 206
Y H ++ HRDLKP+NLL+D VKI DFG S S C S Y APE
Sbjct: 122 EYCHRH-KIVHRDLKPENLLLDD-NLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE 177
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
+I G +D+WS G VL +L+G+ F E + L + +
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN--------------- 221
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
+ P + + P A L R++ P R T E P+F
Sbjct: 222 -SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 88/341 (25%), Positives = 138/341 (40%), Gaps = 66/341 (19%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-------MDHPNVISL 92
RV+G G FG V + TG+ A KK+ + R K + + ++ V+SL
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 93 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
+ + T L LV+ + + + + Y P Y +I GL
Sbjct: 250 AYAY-ETKDA----LCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYAAEICCGLED 301
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 210
+H R+ +RDLKP+N+L+D H ++I D G A + G+ + + Y APE++
Sbjct: 302 LHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270
YT S D W+ GC+L E++ GQ F REE+
Sbjct: 360 -ERYTFSPDWWALGCLLYEMIAGQSPFQQRKK------------KIKREEV--------- 397
Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFFDELRE 325
+K P + + +R P+A L S+LL P+ R +A E HP F +L
Sbjct: 398 --ERLVKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL-- 451
Query: 326 PN-ARLPNGRPLPP------------LFNFKQELSGASPEL 353
N RL G PP + + +Q + EL
Sbjct: 452 -NFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTVKGVEL 491
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-40
Identities = 67/318 (21%), Positives = 112/318 (35%), Gaps = 61/318 (19%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-----RELQLMRVMD 85
Y ++G+G FG V+ + VAIK ++ N E+ L++ +
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 86 H--PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 143
VI L F + L ++E L + + + + + +Q
Sbjct: 105 SGFSGVIRLLDWF---ERPDSFVL--ILERPEPVQD--LFDFITERGALQEELARSFFWQ 157
Query: 144 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 202
+ + + H V HRD+K +N+L+D ++K+ DFGS L + +R Y
Sbjct: 158 VLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVY 214
Query: 203 RAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
PE I Y S +WS G +L +++ G F + EII+
Sbjct: 215 SPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR---------- 257
Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
F +R+ E L L PS R T E HP+
Sbjct: 258 -------GQVFFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298
Query: 322 ELREPNARLP-NGRPLPP 338
++ P + L P
Sbjct: 299 DVLLPQETAEIHLHSLSP 316
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-40
Identities = 77/304 (25%), Positives = 123/304 (40%), Gaps = 64/304 (21%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 92
+++G GSF V A+ L T AIK ++++ Y RE +M +DHP + L
Sbjct: 36 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 93 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
F +++ L + Y E L Y + YT +I L Y
Sbjct: 96 YFTF-----QDDEKLYFGLSYAKNGE-----LLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAP 205
+H + HRDLKP+N+L++ H ++I DFG+AK L + F Y +P
Sbjct: 146 LHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQAR--ANSFVGTAQYVSP 201
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
EL+ S D+W+ GC++ +L+ G P F N + + I
Sbjct: 202 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKII-------------- 245
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPF 319
++ FP ++ P+A DL +LL + R AHPF
Sbjct: 246 --KLEYDFP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
Query: 320 FDEL 323
F+ +
Sbjct: 292 FESV 295
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 73/302 (24%), Positives = 120/302 (39%), Gaps = 58/302 (19%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRVMDHPN 88
R++G G FG V+ + +TG+ A+K L +R K ++ L L+ D P
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
++ + + F + ++L +++ + + Y + +H ++ Y +I
Sbjct: 254 IVCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIIL 303
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 206
GL ++H V +RDLKP N+L+D H V+I D G A + + + + + Y APE
Sbjct: 304 GLEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPE 360
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
++ Y +S D +S GC+L +LL G F D + EI
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI----- 402
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CT---ALEACAHPFFD 321
PE L LLQ + R C A E PFF
Sbjct: 403 ------DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454
Query: 322 EL 323
L
Sbjct: 455 SL 456
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-39
Identities = 61/301 (20%), Positives = 110/301 (36%), Gaps = 46/301 (15%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRVMDHPNVISLKH 94
+G+G+ G V++ + +TG +A+K++ ++ + +L +++ D P ++
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 95 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 154
F + T + + ME + K +P + T I + L Y+
Sbjct: 92 TFITNTD-----VFIAMELMGTC---AEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI----FG 210
V HRD+KP N+L+D Q+K+CDFG + +L+ +A Y APE I
Sbjct: 144 HGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMNPNYT 269
+Y D+WS G L EL GQ + + L ++++ P
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP------------- 247
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 329
P + H + L R + H F
Sbjct: 248 ----PLLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296
Query: 330 L 330
+
Sbjct: 297 V 297
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 1e-38
Identities = 88/309 (28%), Positives = 126/309 (40%), Gaps = 57/309 (18%)
Query: 25 GKNGEPKQTI-SYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--R 76
+ + + I Y+ +G G+FG V K TG VA+K K+ R
Sbjct: 6 KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65
Query: 77 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPL 134
E+Q +++ HP++I L ++ +++F+ VMEYV E L Y N R+
Sbjct: 66 EIQNLKLFRHPHIIKLYQVI---STPSDIFM--VMEYVSGGE-----LFDYICKNGRLDE 115
Query: 135 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEAN 193
+ QI G+ Y H V HRDLKP+N+L+D KI DFG S
Sbjct: 116 KESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGEFLR 173
Query: 194 ISYIC-SRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251
S C S Y APE+I G Y +DIWS+G +L LL G F ++ V L + I
Sbjct: 174 TS--CGSPNYAAPEVISG-RLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKIC 229
Query: 252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311
F P + + P I L +LQ P R T
Sbjct: 230 ----------------DGIFYTP-----QY-------LNPSVISLLKHMLQVDPMKRATI 261
Query: 312 LEACAHPFF 320
+ H +F
Sbjct: 262 KDIREHEWF 270
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-38
Identities = 80/297 (26%), Positives = 129/297 (43%), Gaps = 58/297 (19%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 91
+++G G+FG V K TG A+K +L+ + E ++++ HP + +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMK-ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 92 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
LK+ F T + L VMEY E + + S + + Y +I L
Sbjct: 213 LKYSF-QTHDR----LCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALD 262
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 208
Y+H+ V +RDLK +NL++D H +KI DFG K+ I A + C + Y APE++
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
+Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 322 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL----------------M 363
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 320
+ RFP + + PEA L S LL+ P R A E H FF
Sbjct: 364 EEIRFP------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 2e-38
Identities = 34/316 (10%), Positives = 92/316 (29%), Gaps = 66/316 (20%)
Query: 35 SYMAERVVGTGSFGIVFQAKC-----LETGETVAIK----KVLQDRRYKNRELQLMRVMD 85
++G G+F V++A + + +K + + ++ ++
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125
Query: 86 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQ 143
+ +N L V E + + + ++ + MP V + +
Sbjct: 126 QHMFMKFYSAHLF---QNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 144 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ----------VKICDFGSAKQLIAGEAN 193
+ + +H + H D+KP N ++ + + + D G + +
Sbjct: 181 MLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 194 ---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEI 249
+ + ++ E++ + ID + + +L G + E + +
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298
Query: 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 309
+ R P + W++ FH +L
Sbjct: 299 FR--------------------RLPHL--DMWNEFFHV------------MLNIPDCHHL 324
Query: 310 TALEACAHPFFDELRE 325
+L+ ++
Sbjct: 325 PSLDLLRQKLKKVFQQ 340
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 4e-38
Identities = 81/364 (22%), Positives = 136/364 (37%), Gaps = 84/364 (23%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRVM-----DHP 87
Y R +G G F V+ + ++ + VA+K V Y E++L++ + + P
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98
Query: 88 N---VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 144
N V+ L F + N + +V E + + + + + Q +PL VK Q+
Sbjct: 99 NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155
Query: 145 FRGLAYIHTVPRVCHRDLKPQNLLV----------------------------------- 169
+GL Y+HT R+ H D+KP+N+L+
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 170 -------------DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTT 216
+ +VKI D G+A + I +R YR+ E++ G+ Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNAC--WVHKHFTEDIQTRQYRSLEVLIGS-GYNT 272
Query: 217 SIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEIIKVLGTPTREEIR-------C 263
DIWS C+ EL G LF + D + II++LG R+ I
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMP------PEAIDLASRLLQYSPSLRCTALEACAH 317
++K +V ++ D +L+ P R TA E H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392
Query: 318 PFFD 321
P+ +
Sbjct: 393 PWLN 396
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-38
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 18/215 (8%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCF 96
E VVG G+FG+V +AK + VAIK++ + K EL+ + ++HPN++
Sbjct: 13 EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVK----L 66
Query: 97 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--T 153
+ + LVMEY S+Y VL H + + + Q +G+AY+H
Sbjct: 67 YGACLNP---VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 213
+ HRDLKP NLL+ +KICDFG+A + + S + APE+ G +
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSAAWMAPEVFEG-SN 179
Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 248
Y+ D++S G +L E++ + F +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 76/297 (25%), Positives = 130/297 (43%), Gaps = 59/297 (19%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 91
+++G G+FG V + TG A+K +L+ + E ++++ HP + +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMK-ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 92 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
LK+ F T + L VMEY E + + + + + Y +I L
Sbjct: 70 LKYAF-QTHDR----LCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALE 119
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 208
Y+H+ V +RD+K +NL++D H +KI DFG K+ I+ A + C + Y APE++
Sbjct: 120 YLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
+Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 178 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL----------------M 219
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 320
+ RFP + + PEA L + LL+ P R A E H FF
Sbjct: 220 EEIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 73/320 (22%), Positives = 113/320 (35%), Gaps = 62/320 (19%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-----RELQLMRVMD 85
Y ++G G FG VF L VAIK +VL + E+ L+ +
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 86 ----HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT 141
HP VI L +F T LV+E + L Y + + + +
Sbjct: 93 AGGGHPGVIRL-LDWFETQEG----FMLVLERPLPAQD--LFDYITEKGPLGEGPSRCFF 145
Query: 142 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SR 200
Q+ + + H+ V HRD+K +N+L+D K+ DFGS L + +R
Sbjct: 146 GQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTR 202
Query: 201 FYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
Y PE I +Y +WS G +L +++ G F + EI++
Sbjct: 203 VYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA------- 248
Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
+ FP + P+ L R L PS R + E P+
Sbjct: 249 ----------ELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286
Query: 320 FDELREPNARLPNGRPLPPL 339
E P+ PL
Sbjct: 287 MQTPAEDVPLNPSKGGPAPL 306
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 68/299 (22%), Positives = 117/299 (39%), Gaps = 60/299 (20%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-------RELQLMRV 83
Y +G+G+FG V+ A E + V +K KVL+D ++ E+ ++
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 84 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 143
++H N+I + F +N+ F LVME + L + + R+ Q
Sbjct: 86 VEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLD--LFAFIDRHPRLDEPLASYIFRQ 138
Query: 144 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 202
+ + Y+ + HRD+K +N+++ +K+ DFGSA L G+ C + Y
Sbjct: 139 LVSAVGYLRLK-DIIHRDIKDENIVIAE-DFTIKLIDFGSAAYLERGK-LFYTFCGTIEY 195
Query: 203 RAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
APE++ G Y +++WS G L L+ + F +L E ++
Sbjct: 196 CAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE---------- 238
Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
P + E + L S LLQ P R T + P+
Sbjct: 239 -------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 69/298 (23%), Positives = 125/298 (41%), Gaps = 54/298 (18%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 92
R +G GSFG V + +T + A+K K ++ R +ELQ+M+ ++HP +++L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 93 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
+ F +F +V++ + + Y + + N VKL+ ++ L Y
Sbjct: 81 WYS-FQDEED--MF--MVVDLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDY 130
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF- 209
+ R+ HRD+KP N+L+D H V I DF A L + ++ Y APE+
Sbjct: 131 LQNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 210 -GATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTPTREEIRCMNP 266
Y+ ++D WS G ELL G+ + ++ ++V +
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--------------- 233
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-CAHPFFDEL 323
T +P E + L +LL+ +P R + L P+ +++
Sbjct: 234 -TTVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-37
Identities = 64/359 (17%), Positives = 125/359 (34%), Gaps = 105/359 (29%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 90
+ + +G G FG+VF+AK AIK++ R RE++ + ++HP ++
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 91 SLKH----------------------------------------------------CFFS 98
+
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 99 TTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 157
S +++L + M+ E++ + S R + + ++ QI + ++H+ +
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI-QIAEAVEFLHS-KGL 185
Query: 158 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-------------AGEANISYICSRFYRA 204
HRDLKP N+ VK+ DFG + A + + ++ Y +
Sbjct: 186 MHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
PE I G Y+ +DI+S G +L ELL E ++++ ++R
Sbjct: 245 PEQIHG-NNYSHKVDIFSLGLILFELL--YSFSTQM-------ERVRII-----TDVR-- 287
Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
+ +FP + + P+ + +L SP+ R A + + F+ L
Sbjct: 288 -----NLKFPLLFTQKY---------PQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-37
Identities = 49/219 (22%), Positives = 87/219 (39%), Gaps = 30/219 (13%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVMDHP 87
E+ +G G FG+V + + ++ VAIK ++ RE+ +M ++HP
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
N++ + +VME+VP +Y L + I
Sbjct: 84 NIVK----LYGLMHNP---PRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIAL 133
Query: 147 GLAYIHTV-PRVCHRDLKPQNLLVD----PLTHQVKICDFGSAKQLIAGEANISYICSRF 201
G+ Y+ P + HRDL+ N+ + K+ DFG ++ + + + +
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQ 191
Query: 202 YRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPG 239
+ APE I E YT D +S +L +L G+ F
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-37
Identities = 79/294 (26%), Positives = 125/294 (42%), Gaps = 56/294 (19%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHPNVI 90
+++G GSFG VF A+ +T + AIK L+ + L +HP +
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIK-ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
+ F T L VMEY+ + MY + + L Y +I GL
Sbjct: 82 HMFCTF-QTKEN----LFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGL 131
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 207
++H+ + +RDLK N+L+D H +KI DFG K+ + G+A + C + Y APE+
Sbjct: 132 QFLHSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 189
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
+ G +Y S+D WS G +L E+L+GQ F G++ ++L I+
Sbjct: 190 LLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR---------------- 231
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-CAHPFF 320
+ +P + + EA DL +L P R HP F
Sbjct: 232 MDNPFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 76/298 (25%), Positives = 124/298 (41%), Gaps = 59/298 (19%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 91
RV+G GSFG V A+ ETG+ A+K + +D ++ +++ L +HP +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 92 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
L CF + + LF VME+V + M+ + K +R + Y +I L
Sbjct: 89 LFCCF---QTPDRLFF--VMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALM 138
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 208
++H + +RDLK N+L+D H K+ DFG K+ I + C + Y APE++
Sbjct: 139 FLHDK-GIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
Y ++D W+ G +L E+L G F EN D L E I
Sbjct: 197 QE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL----------------N 238
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR------CTALEACAHPFF 320
+ +P + +A + + +P++R HPFF
Sbjct: 239 DEVVYP------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 75/297 (25%), Positives = 120/297 (40%), Gaps = 59/297 (19%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQ--------LMRVMDHPNVI 90
+V+G GSFG V A+ A+K VLQ K +E + L++ + HP ++
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
L F T K L V++Y+ E Y + + + + Y +I L
Sbjct: 103 GLHFSF-QTADK----LYFVLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASAL 152
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 207
Y+H++ + +RDLKP+N+L+D H + + DFG K+ I + S C + Y APE+
Sbjct: 153 GYLHSL-NIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
+ Y ++D W G VL E+L G P F N ++ + I
Sbjct: 211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL---------------- 252
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR----CTALEACAHPFF 320
+ + A L LLQ + R +E +H FF
Sbjct: 253 NKPLQLK------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 76/314 (24%), Positives = 120/314 (38%), Gaps = 67/314 (21%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM---DHPNVISL 92
+V+G G+F V K +TG+ A+K + + K E+ V+ D + L
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 93 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
F +N L+ LVMEY + + S +R+P + Y +I +
Sbjct: 127 HFAF---QDENYLY--LVMEYYVGGDLLT----LLSKFGERIPAEMARFYLAEIVMAIDS 177
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAP 205
+H + HRD+KP N+L+D H +++ DFGS +L A S + Y +P
Sbjct: 178 VHRL-GYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLV---AVGTPDYLSP 232
Query: 206 ELI------FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
E++ G Y D W+ G E+ GQ F ++ + I
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI--------- 282
Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR---CTALEACA 316
++ P + +P EA D RLL P R A +
Sbjct: 283 ----VHYK-EHLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327
Query: 317 HPFF-----DELRE 325
HPFF D LR+
Sbjct: 328 HPFFFGLDWDGLRD 341
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 78/297 (26%), Positives = 121/297 (40%), Gaps = 58/297 (19%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 91
V+G GSFG V ++ T E A+K + +D ++ +++ L P +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 92 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
L CF T + L VMEYV + MY + + R + Y +I GL
Sbjct: 86 LHSCF-QTMDR----LYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLF 135
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 208
++ + + +RDLK N+++D H +KI DFG K+ I C + Y APE+I
Sbjct: 136 FLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 193
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
Y S+D W+ G +L E+L GQ F GE+ D+L + I +
Sbjct: 194 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI------MEHNV------- 238
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 320
+P K M EA+ + L+ P R + H FF
Sbjct: 239 ---AYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-36
Identities = 72/312 (23%), Positives = 122/312 (39%), Gaps = 65/312 (20%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQ--DRRYKNRELQLMRVMDHPNVISL 92
+V+G G+FG V K + A+K ++L+ + E ++ D + +L
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 93 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
+ F +++ L LVM+Y + + S R+P + Y ++ +
Sbjct: 140 HYAF-----QDDNNLYLVMDYYVGGDLLT----LLSKFEDRLPEEMARFYLAEMVIAIDS 190
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAP 205
+H + HRD+KP N+L+D H +++ DFGS +L+ S + Y +P
Sbjct: 191 VHQL-HYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSV---AVGTPDYISP 245
Query: 206 ELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
E++ G Y D WS G + E+L G+ F E+ + + I
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI----------- 293
Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHP 318
MN F+FP + A DL RL+ S R + HP
Sbjct: 294 --MNHK-ERFQFPT---------QVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHP 340
Query: 319 FF-----DELRE 325
FF D +R
Sbjct: 341 FFSGIDWDNIRN 352
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 74/304 (24%), Positives = 130/304 (42%), Gaps = 69/304 (22%)
Query: 40 RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRRYKNR---ELQLMRVMDHPN 88
RV+G G +G VFQ + + TG+ A+K ++++ + E ++ + HP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
++ L + F T K L L++EY+ E ++ + Y +I
Sbjct: 83 IVDLIYAF-QTGGK----LYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISM 132
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF----- 201
L ++H + +RDLKP+N++++ H VK+ DFG K+ I F
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTV----THTFCGTIE 186
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
Y APE++ + + ++D WS G ++ ++L G P F GEN + ++ I + ++
Sbjct: 187 YMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKI------LKCKL 238
Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACA 316
P + EA DL +LL+ + + R A E A
Sbjct: 239 ----------NLP------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276
Query: 317 HPFF 320
HPFF
Sbjct: 277 HPFF 280
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 76/305 (24%), Positives = 122/305 (40%), Gaps = 50/305 (16%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHP 87
Y + V+G+G+ +V A C E VAIK++ + + +E+Q M HP
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELL---KEIQAMSQCHHP 73
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLI----YVKLYTY 142
N++S F K+EL+ LVM+ + S+ ++KH + + + +
Sbjct: 74 NIVSYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 143 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-- 200
++ GL Y+H HRD+K N+L+ V+I DFG + L A +I+ R
Sbjct: 129 EVLEGLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFL-ATGGDITRNKVRKT 185
Query: 201 -----FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
+ APE++ Y DIWS G EL G + + L+ ++
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ---- 241
Query: 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315
N P ++ K K+ + S LQ P R TA E
Sbjct: 242 ---------ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
Query: 316 AHPFF 320
H FF
Sbjct: 287 RHKFF 291
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-35
Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 32/219 (14%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHPNVI 90
E ++G G FG V++A + G+ VA+K D +E +L ++ HPN+I
Sbjct: 12 EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
+L+ N L LVME+ + RVL +R+P + + QI RG+
Sbjct: 70 ALRGV--CLKEPN---LCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMN 119
Query: 150 YIH--TVPRVCHRDLKPQNLLVD-------PLTHQVKICDFGSAKQLIAGEANISYICSR 200
Y+H + + HRDLK N+L+ +KI DFG A+ +S +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAY 178
Query: 201 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 239
+ APE+I + ++ D+WS G +L ELL G+ F G
Sbjct: 179 AWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-35
Identities = 68/298 (22%), Positives = 125/298 (41%), Gaps = 50/298 (16%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 91
RV+G GS+ V + +T A+K V ++ + ++ + +HP ++
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 92 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
L C F T S+ L V+EYV + M+ + + +++P + + Y+ +I L
Sbjct: 75 LHSC-FQTESR----LFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 124
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 208
Y+H + +RDLK N+L+D H +K+ D+G K+ + S C + Y APE++
Sbjct: 125 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 182
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
G +Y S+D W+ G ++ E++ G+ F + D + T + +
Sbjct: 183 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL------- 227
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR------CTALEACAHPFF 320
F I + + +A + L P R + HPFF
Sbjct: 228 ----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 5e-35
Identities = 74/298 (24%), Positives = 127/298 (42%), Gaps = 59/298 (19%)
Query: 40 RVVGTGSFGIVFQAK---CLETGETVAIK-----KVLQDRRYKNR-ELQLMRVMDHPNVI 90
+V+G GSFG VF K + + A+K + R + + E ++ ++HP ++
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
L + F T K L L+++++ + R+ K VK Y ++ L
Sbjct: 90 KLHYAF-QTEGK----LYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALAL 139
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 207
++H++ + +RDLKP+N+L+D H +K+ DFG +K+ I E C + Y APE+
Sbjct: 140 DHLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
+ +T S D WS G ++ E+L G F G++ + + +I
Sbjct: 198 VNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMIL---------------- 239
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 320
PQ + PEA L L + +P+ R E H FF
Sbjct: 240 KAKLGMPQ------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-35
Identities = 71/304 (23%), Positives = 122/304 (40%), Gaps = 62/304 (20%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 92
+V+G G+FG V + T + A+K ++++ + E +M + P V+ L
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 93 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
+ F +++ +L +VMEY+P + + ++ N +P + + YT ++ L
Sbjct: 135 FYAF-----QDDRYLYMVMEYMPGGD-LVNLMS-----NYDVPEKWARFYTAEVVLALDA 183
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAP 205
IH++ HRD+KP N+L+D H +K+ DFG+ ++ Y +P
Sbjct: 184 IHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDT---AVGTPDYISP 238
Query: 206 ELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
E++ G Y D WS G L E+L+G F ++ V T +I
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------------TYSKI- 285
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPF 319
MN FP + EA +L L +R E H F
Sbjct: 286 -MNHK-NSLTFP----------DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLF 332
Query: 320 FDEL 323
F
Sbjct: 333 FKND 336
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-35
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 92
+ +G GSFG V +A+ G VA+K +++ + RE+ +M+ + HPN++
Sbjct: 42 KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 93 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
+ T L + V EY+ S+YR+L H S A +++ Y + +G+ Y+
Sbjct: 100 MG---AVTQPPNLSI--VTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 152 HTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIF 209
H P + HR+LK NLLVD + VK+CDFG ++ + + S + + APE++
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDK-KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPG 239
D++S G +L EL Q +
Sbjct: 213 D-EPSNEKSDVYSFGVILWELATLQQPWGN 241
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 78/297 (26%), Positives = 121/297 (40%), Gaps = 58/297 (19%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 91
V+G GSFG V ++ T E A+K + +D ++ +++ L P +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 92 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
L CF T + L VMEYV + MY + + R + Y +I GL
Sbjct: 407 LHSCF-QTMDR----LYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLF 456
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 208
++ + + +RDLK N+++D H +KI DFG K+ I C + Y APE+I
Sbjct: 457 FLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 514
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
Y S+D W+ G +L E+L GQ F GE+ D+L + I +
Sbjct: 515 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI------MEHNV------- 559
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 320
+P K M EA+ + L+ P R + H FF
Sbjct: 560 ---AYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 68/298 (22%), Positives = 125/298 (41%), Gaps = 50/298 (16%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 91
RV+G GS+ V + +T A++ V ++ + ++ + +HP ++
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 92 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
L C F T S+ L V+EYV + M+ + + +++P + + Y+ +I L
Sbjct: 118 LHSC-FQTESR----LFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 167
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 208
Y+H + +RDLK N+L+D H +K+ D+G K+ + S C + Y APE++
Sbjct: 168 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 225
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
G +Y S+D W+ G ++ E++ G+ F + D + T + +
Sbjct: 226 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL------- 270
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFF 320
F I + + +A + L P R C HPFF
Sbjct: 271 ----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-34
Identities = 56/338 (16%), Positives = 111/338 (32%), Gaps = 47/338 (13%)
Query: 43 GTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN--RELQLMRVMDHPNVISLKHCF 96
G V A+ TGE V ++++ + EL + ++ +HPN++ + F
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 97 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
+ L +V ++ S ++ + M + + + + L YIH +
Sbjct: 96 IADNE-----LWVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM- 147
Query: 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA--------GEANISYICSRFYRAPEL 207
HR +K ++L+ + +V + S +I+ + + + +PE+
Sbjct: 148 GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 208 IF-GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK--------------- 251
+ Y DI+S G EL G F A L+E +
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 266
Query: 252 --VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 309
+ ++ + T +H+ P + LQ +P R
Sbjct: 267 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326
Query: 310 TALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELS 347
+A H FF + LP L ++
Sbjct: 327 SASTLLNHSFFK-----QIKRRASEALPELLRPVTPIT 359
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 74/299 (24%), Positives = 126/299 (42%), Gaps = 60/299 (20%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 92
+ +GTGSFG V K E+G A+K KV++ + + E ++++ ++ P ++ L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 93 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
+ F K+ L +VMEYV E + + R + + Y QI Y
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGE-----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 209
+H++ + +RDLKP+NLL+D + +++ DFG AK++ + +C + APE+I
Sbjct: 157 LHSL-DLIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWTLCGTPEALAPEIIL 211
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
Y ++D W+ G ++ E+ G P F + Q+ E I
Sbjct: 212 S-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIV----------------SG 253
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-----EACAHPFFDEL 323
RFP + DL LLQ + R L + H +F
Sbjct: 254 KVRFP------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-34
Identities = 79/306 (25%), Positives = 125/306 (40%), Gaps = 74/306 (24%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 92
R +GTGSFG V + G A+K V++ + + N E ++ ++ HP +I +
Sbjct: 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 93 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
F ++ + ++M+Y+ E + K +QR P K Y ++ L Y
Sbjct: 72 WGTF-----QDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEY 121
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG--------EANISYICSRFY 202
+H+ + +RDLKP+N+L+D H +KI DFG AK + + Y
Sbjct: 122 LHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD----------Y 169
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
APE++ Y SID WS G ++ E+L G F N + E I
Sbjct: 170 IAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL----------- 216
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-----EACAH 317
+ RFP + DL SRL+ S R L + H
Sbjct: 217 -----NAELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259
Query: 318 PFFDEL 323
P+F E+
Sbjct: 260 PWFKEV 265
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-34
Identities = 78/296 (26%), Positives = 130/296 (43%), Gaps = 53/296 (17%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPN 88
+ R +G GSFG V+ A+ + E VAIKK+ + N +E++ ++ + HPN
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
I + C+ ++ + LVMEY S +L+ + + + + + T+ +GL
Sbjct: 116 TIQYRGCYL---REHTAW--LVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGL 167
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYRAPE 206
AY+H+ + HRD+K N+L L+ VK+ DFGSA + AN S++ + ++ APE
Sbjct: 168 AYLHSH-NMIHRDVKAGNIL---LSEPGLVKLGDFGSASIM--APAN-SFVGTPYWMAPE 220
Query: 207 LIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
+I E Y +D+WS G EL +P NA+ L I +
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------N 268
Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
P +++ W + F + LQ P R T+ H F
Sbjct: 269 ES-------PALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFV 309
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-34
Identities = 74/306 (24%), Positives = 130/306 (42%), Gaps = 65/306 (21%)
Query: 40 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHP 87
+V+GTG++G VF + + +TG+ A+K + + + + L + P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIF 145
+++L + F T +K L+L+++Y+ E + + +R V++Y +I
Sbjct: 120 FLVTLHYAF-QTETK----LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIV 169
Query: 146 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---- 201
L ++H + + +RD+K +N+L+D H V + DFG +K+ +A E F
Sbjct: 170 LALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETER---AYDFCGTI 224
Query: 202 -YRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
Y AP+++ G + ++D WS G ++ ELL G F + + EI
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--------R 276
Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEA 314
I ++ +PQ M A DL RLL P R A E
Sbjct: 277 RIL-----KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 319
Query: 315 CAHPFF 320
H FF
Sbjct: 320 KEHLFF 325
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-33
Identities = 71/300 (23%), Positives = 129/300 (43%), Gaps = 47/300 (15%)
Query: 27 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMR 82
G+PK+ Y +G G+ G V+ A + TG+ VAI+++ + E+ +MR
Sbjct: 15 VGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 83 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYT 141
+PN+++ + +EL+ +VMEY+ S+ V+ M +
Sbjct: 73 ENKNPNIVNYLDSYL---VGDELW--VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVC 122
Query: 142 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSR 200
+ + L ++H+ +V HRD+K N+L+ + VK+ DFG Q+ ++ + + +
Sbjct: 123 RECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180
Query: 201 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260
++ APE++ Y +DIWS G + E++ G+P + EN + L I GTP +
Sbjct: 181 YWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQN 238
Query: 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
+F D +R L+ R +A E H F
Sbjct: 239 -----------------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKELLQHQFL 273
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-33
Identities = 75/303 (24%), Positives = 119/303 (39%), Gaps = 50/303 (16%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 90
+ +G GSFG VF+ T + VAIK + + +E+ ++ D P V
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
+ T L ++MEY+ S +L+ + + +I +GL
Sbjct: 84 KYYGSYLKDTK-----LWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLD 133
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA--GEANISYICSRFYRAPEL 207
Y+H+ + HRD+K N+L+ +VK+ DFG A QL + N +++ + F+ APE+
Sbjct: 134 YLHSE-KKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRN-TFVGTPFWMAPEV 190
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
I + Y + DIWS G EL G+P + + L I K PT E
Sbjct: 191 IKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEG------- 241
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327
+ K + L PS R TA E H F +
Sbjct: 242 ------------NYSKPLK--------EFVEACLNKEPSFRPTAKELLKHKFILRNAKKT 281
Query: 328 ARL 330
+ L
Sbjct: 282 SYL 284
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-33
Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 34/216 (15%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRVMDHPNVIS-LKH 94
+ +G G +G V+ K GE VA+K + RE + +M H N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 95 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYVKLYTYQIFRGLAYIH 152
T S +L+L + +Y S+Y LK + A + L Y GL ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKLAY------SSVSGLCHLH 151
Query: 153 TV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS-----R 200
T P + HRDLK +N+LV I D G A + I+ + + +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 201 FYRAPELIFGAT-----EYTTSIDIWSAGCVLAELL 231
Y PE++ + + D++S G +L E+
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 9e-33
Identities = 73/310 (23%), Positives = 128/310 (41%), Gaps = 48/310 (15%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMR-VMDHPNVIS 91
+ +VG G++G V++ + ++TG+ AIK + + +E+ +++ H N+ +
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 92 LKHCFFSTTSKNELF-LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
F L LVME+ S+ ++K ++ + ++ +I RGL+
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKGNTLKEEWIAYICREILRGLS 143
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISYICSRFYRAP 205
++H +V HRD+K QN+L LT +VK+ DFG + QL G N ++I + ++ AP
Sbjct: 144 HLHQ-HKVIHRDIKGQNVL---LTENAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAP 198
Query: 206 ELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
E+I Y D+WS G E+ G P + + L I +
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---------- 248
Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321
NP P++K+ W K F L + S R + HPF
Sbjct: 249 ---NP------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQLMKHPFIR 291
Query: 322 ELREPNARLP 331
+
Sbjct: 292 DQPNERQVRI 301
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 73/300 (24%), Positives = 127/300 (42%), Gaps = 47/300 (15%)
Query: 27 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMR 82
G+P+ + +G GS GIV A+ +G VA+K + Q R E+ +MR
Sbjct: 40 QGDPRLL--LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMR 97
Query: 83 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYT 141
H NV+ + + EL+ ++ME++ ++ ++ R+ +
Sbjct: 98 DYQHFNVVEMYKSYL---VGEELW--VLMEFLQGGALTDIVSQ-----VRLNEEQIATVC 147
Query: 142 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSR 200
+ + LAY+H V HRD+K ++L+ L +VK+ DFG Q+ S + +
Sbjct: 148 EAVLQALAYLHA-QGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTP 205
Query: 201 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260
++ APE+I + Y T +DIWS G ++ E++ G+P + ++ V + + P +
Sbjct: 206 YWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKN 263
Query: 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
+H V D R+L P R TA E HPF
Sbjct: 264 -----------------SHKVSPVLR--------DFLERMLVRDPQERATAQELLDHPFL 298
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 77/292 (26%), Positives = 123/292 (42%), Gaps = 47/292 (16%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLK 93
+ +G GS+G V++A ETG+ VAIK+V + + +E+ +M+ D P+V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 94 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
+F +L+ +VMEY S+ +++ N+ + + +GL Y+H
Sbjct: 91 GSYF---KNTDLW--IVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 153 TVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISYICSRFYRAPELI 208
+ R HRD+K N+L L K+ DFG A QL + N + I + F+ APE+I
Sbjct: 143 FM-RKIHRDIKAGNIL---LNTEGHAKLADFGVAGQLTDTMAKRN-TVIGTPFWMAPEVI 197
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
Y DIWS G E+ G+P + + + + I PT +
Sbjct: 198 QEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRK-------- 247
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
W F D + L SP R TA + HPF
Sbjct: 248 ---------PELWSDNFT--------DFVKQCLVKSPEQRATATQLLQHPFV 282
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 39/211 (18%), Positives = 78/211 (36%), Gaps = 22/211 (10%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISL 92
+ G +++ + G + +K + R N E +R+ HPNV+ +
Sbjct: 15 LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 93 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
S L+ ++P S+Y VL + N + + + RG+A++
Sbjct: 73 LGA---CQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 152 HTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 210
HT+ P + L +++++D +I + + + APE +
Sbjct: 128 HTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPGRMYAPA----WVAPEALQK 182
Query: 211 --ATEYTTSIDIWSAGCVLAELLLGQPLFPG 239
S D+WS +L EL+ + F
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 34/216 (15%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRVMDHPNVIS-LKH 94
VG G +G V++ GE VA+K +D + RE L ++ H N++ +
Sbjct: 13 LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 95 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYVKLYTYQIFRGLAYIH 152
S S +L+L + Y S+Y L+ + + ++ I GLA++H
Sbjct: 71 DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRIVL------SIASGLAHLH 122
Query: 153 TV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS-----R 200
P + HRDLK +N+LV Q I D G A + + +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKK-NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 201 FYRAPELI-----FGATEYTTSIDIWSAGCVLAELL 231
Y APE++ + +DIW+ G VL E+
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-32
Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 35/231 (15%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRVMDHPNVISLKH 94
V+G G FG + ETGE + +K++++ +R +E+++MR ++HPNV+
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK--- 71
Query: 95 CFF--STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
F K LN + EY+ ++ ++K S + + P + I G+AY+
Sbjct: 72 -FIGVLYKDKR---LNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-------- 203
H++ + HRDL N LV V + DFG A+ ++ + + S
Sbjct: 125 HSM-NIIHRDLNSHNCLVRE-NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 204 -------APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 247
APE+I G Y +D++S G VL E++ P
Sbjct: 183 VGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-32
Identities = 68/303 (22%), Positives = 119/303 (39%), Gaps = 39/303 (12%)
Query: 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRVMDHPNV 89
++ V G FG V++A+ E VA+K QD++ E + + M H N+
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80
Query: 90 IS-LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYVKLYTYQIFR 146
+ + T+ +L+L + + + S+ LK S N+ + + R
Sbjct: 81 LQFIGAEKRGTSVDVDLWL--ITAFHEKGSLSDFLKANVVSWNELCHIAET------MAR 132
Query: 147 GLAYIHT---------VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG--EANIS 195
GLAY+H P + HRD+K +N+L+ I DFG A + AG +
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN-NLTACIADFGLALKFEAGKSAGDTH 191
Query: 196 YIC-SRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
+R Y APE++ GA + ID+++ G VL EL G L
Sbjct: 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251
Query: 251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310
++ P+ E+++ + P ++ + W K M + + R +
Sbjct: 252 EIGQHPSLEDMQ--EVVVHKKKRPVLRDY-WQKHAGMAM---LCETIEECWDHDAEARLS 305
Query: 311 ALE 313
A
Sbjct: 306 AGC 308
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-32
Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 34/216 (15%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRVMDHPNVIS-LKH 94
+ +G G FG V++ K GE VA+K ++ R RE + ++ H N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 95 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYVKLYTYQIFRGLAYIH 152
+ +L+L V +Y S++ L Y+ + + L GLA++H
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGMIKLAL------STASGLAHLH 156
Query: 153 TV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS-----R 200
P + HRDLK +N+LV I D G A + + I + +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 201 FYRAPELIFGAT-----EYTTSIDIWSAGCVLAELL 231
Y APE++ + E DI++ G V E+
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-32
Identities = 55/224 (24%), Positives = 100/224 (44%), Gaps = 26/224 (11%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 92
+ +G+GSFG V++ K VA+K + E+ ++R H N++
Sbjct: 29 GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84
Query: 93 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
F ++ +L + V ++ S+Y L ++ + + + Q RG+ Y+
Sbjct: 85 ---FMGYSTAPQLAI--VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYL 136
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELI 208
H + HRDLK N+ + + VKI DFG A + + + + APE+I
Sbjct: 137 HA-KSIIHRDLKSNNIFLHE-DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 209 FGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250
Y+ D+++ G VL EL+ GQ + N DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 68/301 (22%), Positives = 128/301 (42%), Gaps = 58/301 (19%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 88
+ +G G+FG V++AK ETG A K + L+D E++++ DHP
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI---VEIEILATCDHPY 77
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
++ L ++ +L+ +++E+ P ++ ++ ++ + +++ Q+
Sbjct: 78 IVKLLGAYY---HDGKLW--IMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEA 129
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISYICSRFYR 203
L ++H+ R+ HRDLK N+L +T +++ DFG + + + + + S+I + ++
Sbjct: 130 LNFLHSK-RIIHRDLKAGNVL---MTLEGDIRLADFGVSAKNLKTLQKRD-SFIGTPYWM 184
Query: 204 APELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259
APE++ T Y DIWS G L E+ +P N + L++I K PT
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLL 243
Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
W F D L +P R +A + HPF
Sbjct: 244 T-----------------PSKWSVEFR--------DFLKIALDKNPETRPSAAQLLEHPF 278
Query: 320 F 320
Sbjct: 279 V 279
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 52/245 (21%), Positives = 96/245 (39%), Gaps = 41/245 (16%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 92
++G G FG V+ + VAI+ + +R ++ RE+ R H NV+
Sbjct: 38 GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 93 K-HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
C S L + + ++Y V++ A + + + +I +G+ Y
Sbjct: 95 MGAC----MSPPHLAI--ITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF------YRA 204
+H + H+DLK +N+ D +V I DFG +A R + A
Sbjct: 146 LHAKGIL-HKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 205 PELIFGATE--------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
PE+I + ++ D+++ G + EL + F + A II +GT
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----EAIIWQMGTG 258
Query: 257 TREEI 261
+ +
Sbjct: 259 MKPNL 263
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-29
Identities = 72/306 (23%), Positives = 120/306 (39%), Gaps = 48/306 (15%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRELQLMRV--MDHPNVISLKHC 95
++G G +G V++ VA+K +R+ E + RV M+H N+
Sbjct: 18 LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 96 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT- 153
T+ + LVMEY P S+ + L ++S + + + RGLAY+HT
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-----AHSVTRGLAYLHTE 130
Query: 154 -------VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---------ANISYI 197
P + HRDL +N+LV I DFG + +L A IS +
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKN-DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 198 CSRFYRAPELIFGA------TEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVD-QLVEI 249
+ Y APE++ GA +D+++ G + E+ + LFPGE+ + Q+
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249
Query: 250 IKVLGTPTREEIR---CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 306
+V PT E+++ R P+ W + + +
Sbjct: 250 TEVGNHPTFEDMQVLVSRE----KQR-PKFPEA-WKE--NSLAVRSLKETIEDCWDQDAE 301
Query: 307 LRCTAL 312
R TA
Sbjct: 302 ARLTAQ 307
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-28
Identities = 67/240 (27%), Positives = 110/240 (45%), Gaps = 37/240 (15%)
Query: 17 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------ 70
H+I I + Y +G G V+ A+ VAIK +
Sbjct: 3 HMIGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKE 52
Query: 71 ---RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS 127
+R++ RE+ + H N++S+ +++ + LVMEY+ L Y
Sbjct: 53 ETLKRFE-REVHNSSQLSHQNIVSM----IDVDEEDDCYY-LVMEYIEG---PTLSEYIE 103
Query: 128 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187
++ + + +T QI G+ + H + R+ HRD+KPQN+L+D +KI DFG AK
Sbjct: 104 SHGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDS-NKTLKIFDFGIAK-- 159
Query: 188 IAGEANISY----ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 243
E +++ + + Y +PE G + DI+S G VL E+L+G+P F GE AV
Sbjct: 160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECT-DIYSIGIVLYEMLVGEPPFNGETAV 218
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMDH 86
Y ++G G V A+ L VA+K VL+ R++ RE Q ++H
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFR-REAQNAAALNH 71
Query: 87 PNVISLKHCFFSTTSKNELFLN---LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 143
P ++++ + T +VMEYV L+ M
Sbjct: 72 PAIVAV----YDTGEAETPAGPLPYIVMEYVDG---VTLRDIVHTEGPMTPKRAIEVIAD 124
Query: 144 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY----ICS 199
+ L + H + HRD+KP N+++ T+ VK+ DFG A+ + +++ I +
Sbjct: 125 ACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 200 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 243
Y +PE G + S D++S GCVL E+L G+P F G++ V
Sbjct: 183 AQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 63/257 (24%), Positives = 110/257 (42%), Gaps = 42/257 (16%)
Query: 36 YMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQD-------RRYKNRELQLMRVMDHP 87
Y + + G G ++ A G V +K L E Q + + HP
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAMAM-AERQFLAEVVHP 139
Query: 88 NVISLKHCFFSTTSKNELFLN-LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIF 145
+++ + F T ++ + +VMEYV +S+ R Q++P+ Y +I
Sbjct: 140 SIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEIL 192
Query: 146 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-----IAGEANISYICSR 200
L+Y+H++ V + DLKP+N+++ Q+K+ D G+ ++ + G
Sbjct: 193 PALSYLHSIGLV-YNDLKPENIMLTE--EQLKLIDLGAVSRINSFGYLYGTPG------- 242
Query: 201 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-E 259
++APE++ T + DI++ G LA L L P G VD L E VL T
Sbjct: 243 -FQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGR-YVDGLPEDDPVLKTYDSYG 298
Query: 260 EI--RCMNPNYTDFRFP 274
+ R ++P+ RF
Sbjct: 299 RLLRRAIDPDPRQ-RFT 314
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 50/219 (22%), Positives = 83/219 (37%), Gaps = 26/219 (11%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYK---NRELQLMRVMDHP 87
Y R+VG G G V++A+ VA+K ++ D ++ RE + + P
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
+V+ + + L + M + L + QI
Sbjct: 95 HVVPI----HDFGEIDGQ-LYVDMRLING---VDLAAMLRRQGPLAPPRAVAIVRQIGSA 146
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYR 203
L H HRD+KP+N+LV + DFG A + + + + + +Y
Sbjct: 147 LDAAHAA-GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYM 202
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 242
APE + T DI++ CVL E L G P + G+
Sbjct: 203 APERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQL 240
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-22
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 30/210 (14%)
Query: 39 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 89
+ +G G+FG V + TGE VA+KK LQ ++ RE+++++ + H N+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 148
+ K ++ L+MEY+P Y L+ Y ++ R+ I + YT QI +G+
Sbjct: 74 VKYKGV--CYSAGRRNLK-LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------F 201
Y+ T R HRDL +N+LV+ ++VKI DFG K L + + + F
Sbjct: 128 EYLGTK-RYIHRDLATRNILVEN-ENRVKIGDFGLTKVL---PQDKEFFKVKEPGESPIF 182
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELL 231
+ APE + ++++ + D+WS G VL EL
Sbjct: 183 WYAPESLT-ESKFSVASDVWSFGVVLYELF 211
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-22
Identities = 68/228 (29%), Positives = 98/228 (42%), Gaps = 30/228 (13%)
Query: 39 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 89
R +G G FG V TGE VA+K + D ++ +E+ ++R + H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
I K C L LVMEYVP L+ Y + + L + L+ QI G+A
Sbjct: 96 IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLPRH-SIGLAQLLLFAQQICEGMA 148
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------FY 202
Y+H HRDL +N+L+D VKI DFG AK + Y R F+
Sbjct: 149 YLHAQ-HYIHRDLAARNVLLDN-DRLVKIGDFGLAKAV---PEGHEYYRVREDGDSPVFW 203
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 249
APE + + + D+WS G L ELL +L+ I
Sbjct: 204 YAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-22
Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 28/209 (13%)
Query: 39 ERVVGTGSFGIVFQAKCL----ETGETVAIKK----VLQDRRYKNRELQLMRVMDHPNVI 90
+ +G G+FG V + TGE VA+KK + R RE+++++ + H N++
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 149
K ++ L+MEY+P Y L+ Y ++ R+ I + YT QI +G+
Sbjct: 106 KYKGV--CYSAGRRNLK-LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------FY 202
Y+ T R HRDL +N+LV+ ++VKI DFG K L + Y + F+
Sbjct: 160 YLGTK-RYIHRDLATRNILVEN-ENRVKIGDFGLTKVL---PQDKEYYKVKEPGESPIFW 214
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELL 231
APE + ++++ + D+WS G VL EL
Sbjct: 215 YAPESLT-ESKFSVASDVWSFGVVLYELF 242
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-22
Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 29/210 (13%)
Query: 39 ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 89
R +G G FG V + TGE VA+K + + + +E++++R + H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSAN-QRMPLIYVKLYTYQIFRGL 148
+ K T L+ME++P LK Y N ++ L Y QI +G+
Sbjct: 86 VKYKGI--CTEDGGNGIK-LIMEFLP---SGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------F 201
Y+ + + HRDL +N+LV+ HQVKI DFG K + E + Y + F
Sbjct: 140 DYLGSR-QYVHRDLAARNVLVES-EHQVKIGDFGLTKAI---ETDKEYYTVKDDRDSPVF 194
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELL 231
+ APE + + + + D+WS G L ELL
Sbjct: 195 WYAPECLMQSK-FYIASDVWSFGVTLHELL 223
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-22
Identities = 50/228 (21%), Positives = 88/228 (38%), Gaps = 40/228 (17%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN------RELQLMRVMDHPNV 89
R++G G FG V +A+ + VA+K + D + RE M+ DHP+V
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 90 ISLKH-CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL--YTYQIF 145
L S +++ ++ ++ L L L + I
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 146 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-- 203
G+ Y+ + HRDL +N ++ V + DFG ++++ +G+ +YR
Sbjct: 148 CGMEYLSSR-NFIHRDLAARNCMLAE-DMTVCVADFGLSRKIYSGD---------YYRQG 196
Query: 204 ----------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
A E L YT D+W+ G + E++ GQ + G
Sbjct: 197 CASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAG 242
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-21
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 30/210 (14%)
Query: 39 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 89
+G G+FG V + TG VA+K LQ RE+Q+++ + +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 148
+ + + ++ L LVMEY+P L+ + ++ R+ + LY+ QI +G+
Sbjct: 87 VKYRGVSYGPGRQS---LRLVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------F 201
Y+ + R HRDL +N+LV+ VKI DFG AK L + Y R F
Sbjct: 141 EYLGSR-RCVHRDLAARNILVES-EAHVKIADFGLAKLL---PLDKDYYVVREPGQSPIF 195
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELL 231
+ APE + ++ D+WS G VL EL
Sbjct: 196 WYAPESLS-DNIFSRQSDVWSFGVVLYELF 224
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 47/227 (20%), Positives = 87/227 (38%), Gaps = 39/227 (17%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE---TVAIKKV------LQDRRYKNRELQLMRVMDHPNV 89
+++G G FG V + + VA+K + ++ E M+ HPNV
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL--YTYQIFR 146
I L +S+ +++ ++ ++ L + + L + I
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR--- 203
G+ Y+ HRDL +N ++ V + DFG +K++ +G+ +YR
Sbjct: 159 GMEYLSNR-NFLHRDLAARNCMLRD-DMTVCVADFGLSKKIYSGD---------YYRQGR 207
Query: 204 ---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
A E L YT+ D+W+ G + E+ G +PG
Sbjct: 208 IAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPG 252
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 30/227 (13%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE----TVAIK--KVLQDRRYKN---RELQLMRVMDHPNV 89
+V+G+G+FG V++ + GE VAIK + + E +M +D+P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 148
L + + L+ + +P + L Y ++ + Y+ + QI +G+
Sbjct: 80 CRL----LGICLTSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 205
Y+ R+ HRDL +N+LV VKI DFG AK L A E + + A
Sbjct: 131 NYLEDR-RLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 206 E-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 248
E ++ YT D+WS G + EL+ G + G A + ++E
Sbjct: 189 ESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 60/243 (24%), Positives = 102/243 (41%), Gaps = 38/243 (15%)
Query: 39 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RVMDHP 87
+ +G G+FG V +A + TVA+K + L +R EL+++ + +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPL 134
N+++L + L ++ EY + + + L
Sbjct: 88 NIVNLLGA----CTIGGPTL-VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 135 IYVKLYT--YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 192
L + YQ+ +G+A++ + HRDL +N+L+ KICDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTH-GRITKICDFGLARDIKNDSN 200
Query: 193 NISYICSRF-YR--APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 248
+ +R + APE IF YT D+WS G L EL LG +PG + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 249 IIK 251
+IK
Sbjct: 260 MIK 262
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-19
Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 27/210 (12%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCF 96
+ +G G FG V G VA+K + D + E +M + H N++ L
Sbjct: 26 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL---- 79
Query: 97 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHTV 154
+ + L +V EY+ L Y + R L L ++ + + Y+
Sbjct: 80 LGVIVEEKGGLYIVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LIFG 210
HRDL +N+LV + K+ DFG K+ + + + + APE L
Sbjct: 137 -NFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREK 189
Query: 211 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
+++T D+WS G +L E+ G+ +P
Sbjct: 190 --KFSTKSDVWSFGILLWEIYSFGRVPYPR 217
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 52/210 (24%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 95
+ +G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL--- 281
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 153
++ F ++ E++ Y L Y R + V L QI + Y+
Sbjct: 282 -LGVCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFG 210
HR+L +N LV H VK+ DFG + +L+ G+ ++ ++F + APE +
Sbjct: 337 K-NFIHRNLAARNCLVGE-NHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAY 393
Query: 211 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
++ D+W+ G +L E+ G +PG
Sbjct: 394 NK-FSIKSDVWAFGVLLWEIATYGMSPYPG 422
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 63/233 (27%), Positives = 108/233 (46%), Gaps = 41/233 (17%)
Query: 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIK--KVLQDRRYKN---RELQLM 81
P + + ++RV+G G FG+V+ + ++ + AIK + + + RE LM
Sbjct: 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 82 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP----LIYV 137
R ++HPNV++L E ++++ Y+ + L + + QR P LI
Sbjct: 77 RGLNHPNVLAL----IGIMLPPEGLPHVLLPYMC---HGDLLQFIRSPQRNPTVKDLIS- 128
Query: 138 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 197
+ Q+ RG+ Y+ + HRDL +N ++D + VK+ DFG A+ ++ E Y
Sbjct: 129 --FGLQVARGMEYLAEQ-KFVHRDLAARNCMLDE-SFTVKVADFGLARDILDRE----YY 180
Query: 198 CSRFYR---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
+ +R A E L +TT D+WS G +L ELL G P +
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRH 231
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-19
Identities = 53/226 (23%), Positives = 96/226 (42%), Gaps = 28/226 (12%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE----TVAIK--KVLQDRRYKN---RELQLMRVMDHPNV 89
+V+G+G FG V + + GE V IK + R+ + + +DH ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 148
+ L + L LV +Y+P L + ++ + + + QI +G+
Sbjct: 78 VRL----LGLCPGSSLQ--LVTQYLP---LGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 205
Y+ + HR+L +N+L+ QV++ DFG A L + + Y ++ + A
Sbjct: 129 YYLEEH-GMVHRNLAARNVLLKS-PSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 248
E I YT D+WS G + EL+ G + G + L+E
Sbjct: 187 ESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 7e-19
Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 28/226 (12%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 89
+V+G+G+FG V++ + GE VAIK++ + K E +M +D+P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 148
L TS + L+ + +P + L Y ++ + Y+ + QI +G+
Sbjct: 80 CRLLGI--CLTST----VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 205
Y+ R+ HRDL +N+LV VKI DFG AK L A E + + A
Sbjct: 131 NYLEDR-RLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 248
E I YT D+WS G + EL+ G + G A + ++E
Sbjct: 189 ESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 95
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 153
++ S+ ++ +V EY+ L + L +L QI G+AY+
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFG 210
+ HRDL+ N+LV K+ DFG A+ LI + ++F + APE
Sbjct: 299 M-NYVHRDLRAANILVGE-NLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALY 355
Query: 211 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
+T D+WS G +L EL G+ +PG
Sbjct: 356 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 384
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 27/210 (12%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCF 96
+ +G G FG V G VA+K + D + E +M + H N++ L
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL---- 251
Query: 97 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHTV 154
+ + L +V EY+ L Y + R L L ++ + + Y+
Sbjct: 252 LGVIVEEKGGLYIVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LIFG 210
HRDL +N+LV + K+ DFG K+ + + + + APE L
Sbjct: 309 -NFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREK 361
Query: 211 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
+++T D+WS G +L E+ G+ +P
Sbjct: 362 --KFSTKSDVWSFGILLWEIYSFGRVPYPR 389
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-19
Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 95
+ +G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL--- 74
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 153
++ F ++ E++ Y L Y R + V L QI + Y+
Sbjct: 75 -LGVCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE-LIF 209
HRDL +N LV H VK+ DFG ++ L+ G+ ++ ++F + APE L +
Sbjct: 130 K-NFIHRDLAARNCLVGE-NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 210 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
+++ D+W+ G +L E+ G +PG
Sbjct: 187 N--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 33/220 (15%)
Query: 37 MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKN------RELQLMRVMDHPN 88
+ ++ +G+G+FG V + VA+K + + E +M+ +D+P
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
++ + LVME L Y N+ + + +Q+ G+
Sbjct: 80 IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR----- 203
Y+ HRDL +N+L+ H KI DFG +K L A E +Y ++ +
Sbjct: 131 KYLEES-NFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADE---NYYKAQTHGKWPVK 185
Query: 204 --APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
APE + + ++++ D+WS G ++ E GQ + G
Sbjct: 186 WYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRG 223
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 95
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 153
++ S+ ++ +V EY+ L + L +L QI G+AY+
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFG 210
+ HRDL+ N+LV K+ DFG A+ LI + ++F + APE
Sbjct: 382 M-NYVHRDLRAANILVGE-NLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALY 438
Query: 211 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
+T D+WS G +L EL G+ +PG
Sbjct: 439 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 467
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 51/229 (22%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 90
V+G G FG V+ L+ A+K + + + E +M+ HPNV+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP----LIYVKLYTYQIFR 146
SL S+ +V+ Y+ + L+++ P LI + Q+ +
Sbjct: 90 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG---FGLQVAK 139
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR--- 203
G+ Y+ + + HRDL +N ++D VK+ DFG A+ + E +Y
Sbjct: 140 GMKYLASK-KFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE---------YYSVHN 188
Query: 204 -----------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
A E L ++TT D+WS G +L EL+ G P +P
Sbjct: 189 KTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 235
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLK 93
+G G+FG VF + VA+K + + E ++++ HPN++ L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177
Query: 94 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
++ + +VME V L+ + R+ + + G+ Y+
Sbjct: 178 ---IGVCTQKQPIY-IVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LI 208
+ + HRDL +N LV + +KI DFG +++ G S + + APE L
Sbjct: 231 SKCCI-HRDLAARNCLVTE-KNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 209 FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
+G Y++ D+WS G +L E LG +P
Sbjct: 289 YG--RYSSESDVWSFGILLWETFSLGASPYPN 318
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 83.4 bits (205), Expect = 4e-18
Identities = 51/336 (15%), Positives = 91/336 (27%), Gaps = 86/336 (25%)
Query: 42 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRE--------------------LQL 80
+G G FG VFQ VAIK + ++ N L
Sbjct: 28 IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 81 MRVMDHPNVISLKHCFF---------------------------STTSKNELFLNLVMEY 113
I L ++LF+ L E+
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 114 VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 173
+ ++ SS K +Q+ LA R HRDL N+L+ T
Sbjct: 146 GGIDLEQMRTKLSSLAT------AKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK-T 198
Query: 174 HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 233
K+ + K L +YT S V ++ +
Sbjct: 199 SLKKLHYTLNGKSSTIPSCG-------------LQVSIIDYTLSRLERDGIVVFCDVSMD 245
Query: 234 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-------NYTDFRFPQIKAHPW--HKV 284
+ LF G+ D +I +++ +P +Y + + +
Sbjct: 246 EDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTP 303
Query: 285 FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
K++ + + +L +S +A +
Sbjct: 304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 6e-18
Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 50/243 (20%)
Query: 40 RVVGTGSFGIVFQAKCLETGE-----TVAIKKV-----LQDRRYKNRELQLMRVMDHPNV 89
R +G GSFG+V++ + VAIK V +++R E +M+ + +V
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK----HYSSANQRMPLIYVKL--YTY 142
+ L S+ + L ++ME + + L+ ++ P K+
Sbjct: 91 VRLLGV----VSQGQPTL-VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 143 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 202
+I G+AY++ V HRDL +N +V VKI DFG + + + +Y
Sbjct: 146 EIADGMAYLNANKFV-HRDLAARNCMVAE-DFTVKIGDFGMTRDIYETD---------YY 194
Query: 203 R------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 248
R +PE L G +TT D+WS G VL E+ L + + G + +Q++
Sbjct: 195 RKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLR 251
Query: 249 IIK 251
+
Sbjct: 252 FVM 254
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 6e-18
Identities = 59/249 (23%), Positives = 103/249 (41%), Gaps = 53/249 (21%)
Query: 40 RVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMD-HPN 88
+ +G G+FG V +A T TVA+K + + R EL+++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLI 135
V++L T L +++E+ E + + + L
Sbjct: 93 VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 136 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 195
++ Y++Q+ +G+ ++ + + HRDL +N+L+ + VKICDFG A+ +
Sbjct: 149 HLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIY----KDP 202
Query: 196 YICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENA 242
Y APE IF YT D+WS G +L E+ LG +PG
Sbjct: 203 D-----YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 243 VDQLVEIIK 251
++ +K
Sbjct: 257 DEEFCRRLK 265
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 8e-18
Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 95
E+ +G G FG V+ A + VA+K + E +M+ + H ++ L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--- 248
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 153
+ +K ++ ++ E++ L + +++ KL ++ QI G+A+I
Sbjct: 249 -HAVVTKEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE-LIF 209
HRDL+ N+LV + KI DFG A ++I + ++F + APE + F
Sbjct: 303 R-NYIHRDLRAANILVSA-SLVCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAINF 359
Query: 210 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
G +T D+WS G +L E++ G+ +PG
Sbjct: 360 G--SFTIKSDVWSFGILLMEIVTYGRIPYPG 388
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 41/224 (18%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 90
V+G G FG V+ L+ A+K + + + E +M+ HPNV+
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP----LIYVKLYTYQIFR 146
SL S+ +V+ Y+ + L+++ P LI + Q+ +
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG---FGLQVAK 203
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR--- 203
G+ ++ + + HRDL +N ++D VK+ DFG A+ + E +
Sbjct: 204 GMKFLASK-KFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE----FDSVHNKTGAK 257
Query: 204 ------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
A E L ++TT D+WS G +L EL+ G P +P
Sbjct: 258 LPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 299
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 58/249 (23%), Positives = 101/249 (40%), Gaps = 54/249 (21%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE-----TVAIKKV-----LQDRRYKNRELQLM-RVMDHP 87
+ +G G+FG V +A G+ VA+K + ++ EL++M + H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYVP---------ESMYRVLKHYSSANQRMPLIYVK 138
N+++L + L ++ EY + + A
Sbjct: 111 NIVNLLGA----CTHGGPVL-VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 139 L--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 196
L ++ Q+ +G+A++ + HRD+ +N+L+ H KI DFG A+ ++ N S
Sbjct: 166 LLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTN-GHVAKIGDFGLARDIM----NDSN 219
Query: 197 ICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPGENA 242
Y APE IF YT D+WS G +L E+ LG P +PG
Sbjct: 220 -----YIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPGILV 272
Query: 243 VDQLVEIIK 251
+ +++K
Sbjct: 273 NSKFYKLVK 281
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 62/258 (24%), Positives = 100/258 (38%), Gaps = 63/258 (24%)
Query: 39 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RVMDHP 87
+V+G+G+FG V A VA+K + +R EL++M ++ H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYVP------------------ESMYRVLKHYSSAN 129
N+++L T ++ L+ EY E Y K
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 130 QRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187
L + L + YQ+ +G+ ++ HRDL +N+LV VKICDFG A+ +
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTH-GKVVKICDFGLARDI 222
Query: 188 IAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAEL--LLG 233
++ Y APE +F YT D+WS G +L E+ L
Sbjct: 223 MSDSN---------YVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGV 272
Query: 234 QPLFPGENAVDQLVEIIK 251
P +PG ++I+
Sbjct: 273 NP-YPGIPVDANFYKLIQ 289
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 95
+G G FG V+ VA+K + Q + E LM+ + H ++ L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 153
++ ++ ++ ++ EY+ L + + L KL QI G+A+I
Sbjct: 74 -YAVVTQEPIY--IITEYMENG---SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LIF 209
HRDL+ N+LV T KI DFG A +LI + ++F + APE + +
Sbjct: 128 R-NYIHRDLRAANILVSD-TLSCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 210 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
G +T D+WS G +L E++ G+ +PG
Sbjct: 185 G--TFTIKSDVWSFGILLTEIVTHGRIPYPG 213
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 43/346 (12%), Positives = 76/346 (21%), Gaps = 88/346 (25%)
Query: 3 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 62
S+A D V G G+ Y G +QA V
Sbjct: 12 ESSAPPDDVQLVPGA---RIANGR---------YRLLIFHGGVPPLQFWQALDTALDRQV 59
Query: 63 AIKKVL----QDRRYKNR---ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP 115
A+ V + +D P V + L +V E++
Sbjct: 60 ALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV----LDVVHTRAGGL-VVAEWIR 114
Query: 116 -ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 174
S+ V + + H V P + V
Sbjct: 115 GGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAHRAG-VALSIDHPSRVRVSI-DG 166
Query: 175 QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 234
V + DI G L LL+ +
Sbjct: 167 DVVLAYPA-------------------TMPDA--------NPQDDIRGIGASLYALLVNR 199
Query: 235 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAI 294
P L + E ++ + +P +
Sbjct: 200 WPLPEAGVRSGLAPAERDTAGQPI-EPADIDRD---------------------IPFQIS 237
Query: 295 DLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLF 340
+A+R +Q +R + + +++ A L P+
Sbjct: 238 AVAARSVQGDGGIRSASTLL------NLMQQATAVADRTEVLGPID 277
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 33/220 (15%)
Query: 37 MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 89
+A+ +G G+FG V Q + VAIK + Q + E Q+M +D+P +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
+ L L LVME +++ L + +P+ V +Q+ G+
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGM 449
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR----- 203
Y+ HR+L +N+L+ H KI DFG +K L A + SY +R
Sbjct: 450 KYLEEK-NFVHRNLAARNVLLVN-RHYAKISDFGLSKALGADD---SYYTARSAGKWPLK 504
Query: 204 --APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
APE + F ++++ D+WS G + E L GQ +
Sbjct: 505 WYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK 542
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-17
Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 90
E+++G+G G V + G+ VAIK + + R E +M DHPN+I
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
L ++ L + +V EY+ S+ L+ + M L+ + G+
Sbjct: 114 RL----EGVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVG---MLRGVGAGMR 165
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS--RF-YR--A 204
Y+ + HRDL +N+LVD K+ DFG ++ ++ + + +Y + + R A
Sbjct: 166 YLSDL-GYVHRDLAARNVLVDS-NLVCKVSDFGLSR-VLEDDPDAAYTTTGGKIPIRWTA 222
Query: 205 PE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
PE + F ++++ D+WS G V+ E+L G+ +
Sbjct: 223 PEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWN 257
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 8e-17
Identities = 60/258 (23%), Positives = 100/258 (38%), Gaps = 64/258 (24%)
Query: 39 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 88
+ +G G FG V +A TVA+K + + R E +++ ++HP+
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVP-------------------ESMYRVLKHYSSAN 129
VI L + L L++EY S
Sbjct: 88 VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 130 QRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187
L L + +QI +G+ Y+ + ++ HRDL +N+LV ++KI DFG ++ +
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEM-KLVHRDLAARNILVAE-GRKMKISDFGLSRDV 200
Query: 188 IAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LG- 233
Y A E +F YTT D+WS G +L E++ LG
Sbjct: 201 Y----EEDS-----YVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGG 250
Query: 234 QPLFPGENAVDQLVEIIK 251
P +PG ++L ++K
Sbjct: 251 NP-YPGIP-PERLFNLLK 266
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 9e-17
Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 43/225 (19%)
Query: 37 MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 89
+A+ +G G+FG V Q + VAIK + Q + E Q+M +D+P +
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 148
+ L L LVME L + + +P+ V +Q+ G+
Sbjct: 73 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR----- 203
Y+ HRDL +N+L+ H KI DFG +K L A ++ +Y
Sbjct: 124 KYLEEK-NFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDS--------YYTARSAG 173
Query: 204 -------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
APE + F ++++ D+WS G + E L GQ +
Sbjct: 174 KWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK 216
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 58/259 (22%), Positives = 103/259 (39%), Gaps = 59/259 (22%)
Query: 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKV----LQDRRYKNRELQL 80
++ I R +G G+FG VF A+C VA+K + L R+ RE +L
Sbjct: 13 KRRDIVLK--RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 81 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSAN 129
+ + H +++ + + +V EY+ +L
Sbjct: 71 LTNLQHEHIVKFYGV----CGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 130 QRMPLIYVKLY--TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187
+ L ++ QI G+ Y+ + HRDL +N LV VKI DFG ++ +
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGA-NLLVKIGDFGMSRDV 183
Query: 188 IAGEANISYICSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG 233
+ + +YR PE +++ ++TT D+WS G +L E+ G
Sbjct: 184 YSTD---------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYG 232
Query: 234 -QPLFPGENAVDQLVEIIK 251
QP + + +++E I
Sbjct: 233 KQP-WFQLS-NTEVIECIT 249
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 90
++VVG G FG V + + +VAIK + K R E +M DHPN+I
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
L +K++ + +V EY+ S+ L+ + + + L+ I G+
Sbjct: 110 RL----EGVVTKSKPVM-IVTEYMENGSLDSFLRKHDAQFTVIQLVG---MLRGIASGMK 161
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 203
Y+ + HRDL +N+L++ K+ DFG + L + + +R +
Sbjct: 162 YLSDM-GYVHRDLAARNILINS-NLVCKVSDFGLGRVL--EDDPEAAYTTRGGKIPIRWT 217
Query: 204 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
+PE + + ++T++ D+WS G VL E++ G+ +
Sbjct: 218 SPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWE 253
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 47/210 (22%), Positives = 88/210 (41%), Gaps = 23/210 (10%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 95
+ +G+G FG+V L + VAIK + + + E ++M + HP ++ L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL--- 68
Query: 96 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 154
+ + LV E++ + L+ L+ + G+AY+
Sbjct: 69 -YGVCLEQAPIC-LVTEFMEHGCLSDYLRTQRGLFAAETLLG---MCLDVCEGMAYLEEA 123
Query: 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE-LIFG 210
V HRDL +N LV +K+ DFG + + + S ++F + +PE F
Sbjct: 124 -CVIHRDLAARNCLVGE-NQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 211 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
Y++ D+WS G ++ E+ G+ +
Sbjct: 181 --RYSSKSDVWSFGVLMWEVFSEGKIPYEN 208
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 51/222 (22%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVMDHPNVISL- 92
+ ++G G FG V++ L G VA+K+ + E + L HP+++SL
Sbjct: 44 KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLI 101
Query: 93 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPL-------IYVKLYTYQI 144
C +NE+ L + +Y+ ++ R L Y S M + I +
Sbjct: 102 GFC----DERNEMIL--IYKYMENGNLKRHL--YGSDLPTMSMSWEQRLEICI-----GA 148
Query: 145 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF--- 201
RGL Y+HT + HRD+K N+L+D KI DFG +K E + +++ +
Sbjct: 149 ARGLHYLHT-RAIIHRDVKSINILLDE-NFVPKITDFGISK--KGTELDQTHLSTVVKGT 204
Query: 202 --YRAPELIFGATEY------TTSIDIWSAGCVLAELLLGQP 235
Y P EY T D++S G VL E+L +
Sbjct: 205 LGYIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 57/249 (22%), Positives = 99/249 (39%), Gaps = 56/249 (22%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE-----TVAIKKV----LQDRRYKNRELQLMRVMDHPNV 89
+ +G G+FG VF A+C VA+K + R+ RE +L+ ++ H ++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVP----------ESMYRVLKHYSSANQRMPLIYVKL 139
+ ++ L +V EY+ L PL +L
Sbjct: 106 VRFFGV----CTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 140 --YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 197
Q+ G+ Y+ + HRDL +N LV VKI DFG ++ + + +
Sbjct: 161 LAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQ-GLVVKIGDFGMSRDIYSTD------ 212
Query: 198 CSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPGENA 242
+YR PE +++ ++TT D+WS G VL E+ G QP + +
Sbjct: 213 ---YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQLS- 265
Query: 243 VDQLVEIIK 251
+ ++ I
Sbjct: 266 NTEAIDCIT 274
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 46/250 (18%), Positives = 83/250 (33%), Gaps = 49/250 (19%)
Query: 15 TGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK 74
G ++ G + ++ + +G+G FG+++ A E A V + +
Sbjct: 27 EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77
Query: 75 N---RELQLMRVMDHPNVISLK--------------HCFFSTTSKNELFLNLVMEYVPES 117
EL+ + + + I + T K + +VME +
Sbjct: 78 GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137
Query: 118 MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT-HQV 176
L+ S N V ++ L YIH V H D+K NLL+ QV
Sbjct: 138 ----LQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYV-HGDIKAANLLLGYKNPDQV 192
Query: 177 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSI------------DIWSAG 224
+ D+G + + + Y + G E+ TS+ D+ G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247
Query: 225 CVLAELLLGQ 234
+ L G+
Sbjct: 248 YCMLRWLCGK 257
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 34/218 (15%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 90
R +G G FG V Q + VAIK R E MR DHP+++
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 149
L ++N ++ ++ME L+ + + + L + LY YQ+ LA
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 203
Y+ + V HRD+ +N+LV VK+ DFG ++ + + +Y + +
Sbjct: 506 YLESKRFV-HRDIAARNVLVSS-NDCVKLGDFGLSRYM----EDSTYYKASKGKLPIKWM 559
Query: 204 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
APE + F +T++ D+W G + E+L G F G
Sbjct: 560 APESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQG 595
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 49/213 (23%), Positives = 95/213 (44%), Gaps = 29/213 (13%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 95
+ +G+G FG+V K VA+K + + ++ +E Q M + HP ++
Sbjct: 13 LKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKF--- 68
Query: 96 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 154
+ SK +V EY+ + L+ + + L+ Y + G+A++ +
Sbjct: 69 -YGVCSKEYPIY-IVTEYISNGCLLNYLRSHGKGLEPSQLLE---MCYDVCEGMAFLESH 123
Query: 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------APE-L 207
+ HRDL +N LVD VK+ DFG + ++ + Y+ S + APE
Sbjct: 124 -QFIHRDLAARNCLVDR-DLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSAPEVF 177
Query: 208 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
+ +Y++ D+W+ G ++ E+ LG+ +
Sbjct: 178 HYF--KYSSKSDVWAFGILMWEVFSLGKMPYDL 208
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-16
Identities = 35/227 (15%), Positives = 77/227 (33%), Gaps = 44/227 (19%)
Query: 39 ERVVGTGSFGIVFQAKCLETGET-------VAIKKVLQDRRYKN----RELQLMRVMDHP 87
+G G+F +F+ E G+ V +K + + R + +M + H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
+++ + + + LV E+V S+ LK + + + Q+
Sbjct: 73 HLVLN----YGVCVCGDENI-LVQEFVKFGSLDTYLKKNKNCINILWKLE---VAKQLAA 124
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-------VKICDFGSAKQLIAGEANISYICS 199
+ ++ + H ++ +N+L+ + +K+ D G + ++ +
Sbjct: 125 AMHFLEEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-------- 175
Query: 200 RFYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
+ PE I + D WS G L E+ G
Sbjct: 176 -ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-16
Identities = 48/231 (20%), Positives = 85/231 (36%), Gaps = 47/231 (20%)
Query: 39 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 88
R +G G+FG V++ + + VA+K + QD E ++ +H N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVL-KHYSSANQRMPLIYVKL--YTYQI 144
++ + ++ +++E + + L + +Q L + L I
Sbjct: 136 IVRCIGV----SLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 145 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFY 202
G Y+ HRD+ +N L+ KI DFG A+ + +Y
Sbjct: 191 ACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG---------YY 240
Query: 203 R------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
R PE + G +T+ D WS G +L E+ LG +P
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-16
Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 34/220 (15%)
Query: 39 ERVVGTGSFGIVFQAKC-LETGET--VAIKKVLQDRRYKN-------RELQLMRVMDHPN 88
+G GSFG+V + + +G+T VA+K + D + RE+ M +DH N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRG 147
+I L + + +V E P L +Q L + Y Q+ G
Sbjct: 83 LIRL----YGVVLTPPMK--MVTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR---- 203
+ Y+ + R HRDL +NLL+ VKI DFG + L + Y+ +
Sbjct: 134 MGYLESK-RFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDD--HYVMQEHRKVPFA 189
Query: 204 --APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
APE L ++ + D W G L E+ GQ + G
Sbjct: 190 WCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIG 227
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-16
Identities = 46/223 (20%), Positives = 82/223 (36%), Gaps = 43/223 (19%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDH-PNVISL 92
Y R +G GSFG++F+ L + VAIK + E + +++ + ++
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 93 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
+ + L LV++ + S+ +L ++ + V + Q+ + IH
Sbjct: 72 YYF-----GQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIH 123
Query: 153 TVPRVCHRDLKPQNLLV----DPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YR 203
V +RD+KP N L+ + + + DFG K Y YR
Sbjct: 124 EKSLV-YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF---------YRDPVTKQHIPYR 173
Query: 204 APELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 234
+ + G Y SI D+ + G V L G
Sbjct: 174 EKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-16
Identities = 49/231 (21%), Positives = 85/231 (36%), Gaps = 47/231 (20%)
Query: 39 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 88
R +G G+FG V++ + + VA+K + QD E ++ +H N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVL-KHYSSANQRMPLIYVKL--YTYQI 144
++ + ++ ++ME + + L + +Q L + L I
Sbjct: 95 IVRCIGV----SLQSLPRF-ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 145 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFY 202
G Y+ HRD+ +N L+ KI DFG A+ + +Y
Sbjct: 150 ACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS---------YY 199
Query: 203 R------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
R PE + G +T+ D WS G +L E+ LG +P
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 248
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 7e-16
Identities = 60/252 (23%), Positives = 105/252 (41%), Gaps = 57/252 (22%)
Query: 39 ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RVMD 85
+ +G G+FG V A+ + VA+K + +D E+++M +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 86 HPNVISLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSANQRMPL 134
H N+I+L +++ +++EY + S N L
Sbjct: 134 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 135 IYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 192
L YQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ + +
Sbjct: 189 SSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHHID- 245
Query: 193 NISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
+Y+ APE +F YT D+WS G +L E+ LG +PG
Sbjct: 246 --------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG 296
Query: 240 ENAVDQLVEIIK 251
V++L +++K
Sbjct: 297 VP-VEELFKLLK 307
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 9e-16
Identities = 55/218 (25%), Positives = 100/218 (45%), Gaps = 34/218 (15%)
Query: 39 ERVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 90
R++G G FG V++ VA+K +D N+ E +M+ +DHP+++
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 149
L + + ++ME P Y L HY N+ + ++ + LY+ QI + +A
Sbjct: 77 KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 203
Y+ ++ HRD+ +N+LV VK+ DFG ++ + + Y + R
Sbjct: 128 YLESI-NCVHRDIAVRNILVAS-PECVKLGDFGLSRYIEDED----YYKASVTRLPIKWM 181
Query: 204 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
+PE + F +TT+ D+W + E+L G+ F
Sbjct: 182 SPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFW 217
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 55/239 (23%), Positives = 88/239 (36%), Gaps = 57/239 (23%)
Query: 39 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 88
+G FG V++ E + VAIK + R E L + HPN
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSANQRMPLIYV 137
V+ L +K++ ++ Y V + L
Sbjct: 74 VVCLLGV----VTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 138 KL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 195
QI G+ Y+ + V H+DL +N+LV VKI D G +++ A +
Sbjct: 129 DFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLVYD-KLNVKISDLGLFREVYAAD---- 182
Query: 196 YICSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPG 239
+Y+ APE +++G +++ DIWS G VL E+ G QP + G
Sbjct: 183 -----YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YCG 233
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE----TVAIKKV-----LQDRRYKNRELQLMRVMDHPNV 89
++V+G G FG V++ + VAIK + + R E +M H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
I L SK + + ++ EY+ ++ + L+ + L+ I G+
Sbjct: 109 IRL----EGVISKYKPMM-IITEYMENGALDKFLREKDGEFSVLQLVG---MLRGIAAGM 160
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS--RF-YR-- 203
Y+ + HRDL +N+LV+ K+ DFG ++ ++ + +Y S + R
Sbjct: 161 KYLANM-NYVHRDLAARNILVNS-NLVCKVSDFGLSR-VLEDDPEATYTTSGGKIPIRWT 217
Query: 204 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
APE + + +T++ D+WS G V+ E++ G+ +
Sbjct: 218 APEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWE 253
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-15
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 44/223 (19%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 90
R +G G FG V Q + VAIK R E MR DHP+++
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 149
L ++N ++ ++ME L+ + + + L + LY YQ+ LA
Sbjct: 80 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 203
Y+ + R HRD+ +N+LV VK+ DFG ++ + +Y+
Sbjct: 131 YLESK-RFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDST---------YYKASKGKL 179
Query: 204 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
APE + F +T++ D+W G + E+L G F G
Sbjct: 180 PIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQG 220
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 63/268 (23%), Positives = 107/268 (39%), Gaps = 68/268 (25%)
Query: 30 PKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQ 79
P+ I Y+ R +G G+FG VFQA+ E VA+K + + RE
Sbjct: 45 PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 80 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYS 126
LM D+PN++ L + + L+ EY+ P ++ +
Sbjct: 103 LMAEFDNPNIVKLLGV----CAVGKPMC-LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 127 SANQRMPLIYVKLYT--------YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 178
S R+ + Q+ G+AY+ + HRDL +N LV VKI
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGE-NMVVKI 215
Query: 179 CDFGSAKQLIAGEANISYICSRFYR------------APE-LIFGATEYTTSIDIWSAGC 225
DFG ++ + + + +Y+ PE + + YTT D+W+ G
Sbjct: 216 ADFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGV 264
Query: 226 VLAELL-LG-QPLFPGENAVDQLVEIIK 251
VL E+ G QP + G ++++ ++
Sbjct: 265 VLWEIFSYGLQP-YYGMA-HEEVIYYVR 290
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 44/223 (19%), Positives = 83/223 (37%), Gaps = 43/223 (19%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYKNRELQLMRVMDH-PNVISL 92
+ + +G G+FG + K L T E VAIK + + E + + + + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 93 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
+ + +V+E + S+ + ++ L V + Q+ + Y+H
Sbjct: 71 YYF-----GPCGKYNAMVLELLGPSLEDLFD---LCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 153 TVPRVCHRDLKPQNLLV----DPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YR 203
+ + +RD+KP+N L+ + + I DF AK+ YI YR
Sbjct: 123 SK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE---------YIDPETKKHIPYR 172
Query: 204 APELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 234
+ + G Y SI D+ + G + L G
Sbjct: 173 EHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 61/252 (24%), Positives = 109/252 (43%), Gaps = 57/252 (22%)
Query: 39 ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RVMD 85
+ +G G FG V A+ + + TVA+K + +D E+++M +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 86 HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-----------SMYRVLKHYSSANQRMPL 134
H N+I+L +++ +++EY + + + +
Sbjct: 146 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 135 IYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 192
+ L TYQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ +
Sbjct: 201 TFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDIN---- 254
Query: 193 NISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
NI Y Y+ APE +F YT D+WS G ++ E+ LG +PG
Sbjct: 255 NIDY-----YKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 308
Query: 240 ENAVDQLVEIIK 251
V++L +++K
Sbjct: 309 IP-VEELFKLLK 319
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 58/240 (24%), Positives = 102/240 (42%), Gaps = 56/240 (23%)
Query: 39 ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RVMD 85
+ +G G+FG V A+ + + TVA+K + +D E+++M +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 86 HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-----------SMYRVLKHYSSANQRMPL 134
H N+I+L +++ +++EY + + + +
Sbjct: 100 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 135 IYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 192
+ L TYQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ +
Sbjct: 155 TFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDI----N 208
Query: 193 NISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
NI Y Y+ APE +F YT D+WS G ++ E+ LG +PG
Sbjct: 209 NIDY-----YKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 5e-15
Identities = 69/296 (23%), Positives = 118/296 (39%), Gaps = 70/296 (23%)
Query: 41 VVGTGSFGIVFQAKCLETGETVAIKK--------VLQ-DRRYKNRELQLMRVMDHPNVIS 91
+G G FG+V++ + TVA+KK + +++ E+++M H N++
Sbjct: 38 KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQ-EIKVMAKCQHENLVE 94
Query: 92 LKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPL-------IYVKLYTYQ 143
L S+ + LV Y+P S +L S + PL I
Sbjct: 95 LLGF--SSDGDDLC---LVYVYMPNGS---LLDRLSCLDGTPPLSWHMRCKIAQG----- 141
Query: 144 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-- 201
G+ ++H + HRD+K N+L+D KI DFG A+ + + + + SR
Sbjct: 142 AANGINFLHENHHI-HRDIKSANILLDE-AFTAKISDFGLAR--ASEKFAQTVMTSRIVG 197
Query: 202 ---YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ------LVEIIKV 252
Y APE + G E T DI+S G VL E++ G P AVD+ L++I +
Sbjct: 198 TTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP------AVDEHREPQLLLDIKEE 249
Query: 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 308
+ + ++ D ++ +AS+ L + R
Sbjct: 250 IEDEEKTIEDYIDKKMNDADSTSVE--------------AMYSVASQCLHEKKNKR 291
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-15
Identities = 48/210 (22%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 95
+ +GTG FG+V K VAIK + + ++ E ++M + H ++ L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL--- 84
Query: 96 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 154
+ +K ++ EY+ + L+ Q L+ + + Y+ +
Sbjct: 85 -YGVCTKQRPIF-IITEYMANGCLLNYLREMRHRFQTQQLLE---MCKDVCEAMEYLESK 139
Query: 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LIFG 210
+ HRDL +N LV+ VK+ DFG ++ + + S + S+F R PE L++
Sbjct: 140 -QFLHRDLAARNCLVND-QGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYS 196
Query: 211 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
++++ DIW+ G ++ E+ LG+ +
Sbjct: 197 --KFSSKSDIWAFGVLMWEIYSLGKMPYER 224
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 41/252 (16%), Positives = 82/252 (32%), Gaps = 50/252 (19%)
Query: 15 TGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG--------ETVAIKK 66
TG +++ G + + + + GI+++A T + ++K
Sbjct: 32 TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82
Query: 67 VLQDRRYKNRELQLMRVMDHPNVISLK-----------HCFFSTTSKNELFLNLVMEYVP 115
+D R N + R V K C +++ LV+ +
Sbjct: 83 DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLG 141
Query: 116 ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT-H 174
S+ L + V ++ L ++H V H ++ +N+ VDP
Sbjct: 142 RSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENEYV-HGNVTAENIFVDPEDQS 198
Query: 175 QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSI------------DIWS 222
QV + +G A + +++Y G E+ S+ D+ S
Sbjct: 199 QVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSDLQS 253
Query: 223 AGCVLAELLLGQ 234
G + + L G
Sbjct: 254 LGYCMLKWLYGF 265
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 2e-14
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 40/217 (18%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLK 93
+ ++G G FG V++ + L G VA+K++ ++R E++++ + H N++ L+
Sbjct: 35 KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 94 HCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPL-------IYVKLYTYQIF 145
T L LV Y+ S+ L + PL I +
Sbjct: 94 GF--CMTPTERL---LVYPYMANGSVASCL--RERPESQPPLDWPKRQRIALG-----SA 141
Query: 146 RGLAYIHTV--PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-- 201
RGLAY+H P++ HRD+K N+L+D + + DFG AK + + +++ +
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLM---DYKDTHVTTAVRG 197
Query: 202 ---YRAPE-LIFGATEYTTSIDIWSAGCVLAELLLGQ 234
+ APE L G + + D++ G +L EL+ GQ
Sbjct: 198 TIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQ 232
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 31/216 (14%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDH-PNVISL 92
Y R +G+GSFG ++ + GE VAIK ++ E ++ ++M + ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 93 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
+ C + +VME + S+ + +++ L V L Q+ + YIH
Sbjct: 71 RWC-----GAEGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 153 TVPRVCHRDLKPQNLLV--DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 210
+ HRD+KP N L+ + V I DFG AK+ + +I YR + + G
Sbjct: 123 SK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH-QHIP---YRENKNLTG 177
Query: 211 ATEYTTSI------------DIWSAGCVLAELLLGQ 234
Y SI D+ S G VL LG
Sbjct: 178 TARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 58/236 (24%), Positives = 97/236 (41%), Gaps = 56/236 (23%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE--TVAIKKV-----LQDRRYKNRELQLM-RVMDHPNVI 90
+ V+G G+FG V +A+ + G AIK++ D R EL+++ ++ HPN+I
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSANQRMPLIYVKL 139
+L + L+ L +EY P + + + L +L
Sbjct: 90 NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 140 --YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 197
+ + RG+ Y+ + HRDL +N+LV + KI DFG ++
Sbjct: 145 LHFAADVARGMDYLSQK-QFIHRDLAARNILVGE-NYVAKIADFGLSR-------GQEV- 194
Query: 198 CSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 239
Y A E L + YTT+ D+WS G +L E++ LG + G
Sbjct: 195 ----YVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 50/216 (23%), Positives = 92/216 (42%), Gaps = 31/216 (14%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVM-DHPNVISL 92
+ R +G+GSFG ++ ++T E VAIK ++ E ++ R++ + ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 93 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
+ + LVM+ + S+ + ++++ L V + Q+ + ++H
Sbjct: 69 RWF-----GVEGDYNVLVMDLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 153 TVPRVCHRDLKPQNLLV--DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 210
+ HRD+KP N L+ +QV I DFG AK+ + +I YR + + G
Sbjct: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH-QHIP---YRENKNLTG 175
Query: 211 ATEYTTSI------------DIWSAGCVLAELLLGQ 234
Y S+ D+ S G VL L G
Sbjct: 176 TARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 46/251 (18%), Positives = 79/251 (31%), Gaps = 50/251 (19%)
Query: 16 GHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQA-----KCLETGETVAIKKVLQD 70
G II+ + +G G FG ++ A + + + +K D
Sbjct: 26 GEIITDMAAAA---------WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD 76
Query: 71 RRYKNRELQLMRVMDHPNVISLK--------------HCFFSTTSKNELFLNLVMEYVPE 116
EL+ + P I + + ++M+
Sbjct: 77 NGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS 136
Query: 117 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT-HQ 175
+ K Y + +R V + +I L YIH V H D+K NLL++ Q
Sbjct: 137 DLQ---KIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYV-HGDIKASNLLLNYKNPDQ 192
Query: 176 VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSI------------DIWSA 223
V + D+G A + + +Y G E+ TSI D+
Sbjct: 193 VYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEIL 247
Query: 224 GCVLAELLLGQ 234
G + + L G
Sbjct: 248 GYCMIQWLTGH 258
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 49/187 (26%), Positives = 82/187 (43%), Gaps = 12/187 (6%)
Query: 73 YKNRELQLMRVMDHPNVI--SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ 130
YK + + + D+ I LK S TS + +E S +
Sbjct: 128 YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED-LY 186
Query: 131 RMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188
+ L L Y++Q+ +G+ ++ + + HRDL +N+L+ + VKICDFG A+ +
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE-KNVVKICDFGLARDIY 244
Query: 189 AGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 244
+ +R + APE IF YT D+WS G +L E+ LG +PG +
Sbjct: 245 KDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303
Query: 245 QLVEIIK 251
+ +K
Sbjct: 304 EFCRRLK 310
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 376 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.96 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.57 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.42 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.2 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.17 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.08 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.96 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.96 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.96 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.52 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.52 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.31 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.22 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.12 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.97 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.86 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.83 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.82 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.63 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.62 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.61 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.47 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.42 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.93 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-64 Score=474.90 Aligned_cols=319 Identities=33% Similarity=0.618 Sum_probs=256.2
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 106 (376)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|+.++|||||++++++..... .+...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999999999999999996432 233479999999999999999998754321 23345
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
+|||||||+|+|.+.+. ..+.+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~~-~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVNE-NCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCSEEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TCCEEECCCTTCBC
T ss_pred EEEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccCC-CCCEEEeecceeee
Confidence 89999999999888775 45789999999999999999999999 79999999999999996 78899999999986
Q ss_pred CccC-----CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 187 LIAG-----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 187 ~~~~-----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
.... ....+.+||++|+|||++.+...|+.++||||+||++|+|++|++||.+.+..+++..|.+..|.|+...+
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 5332 22346789999999999988777899999999999999999999999999999999999999999987655
Q ss_pred hhcCcCCCC---CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCC
Q 017147 262 RCMNPNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPP 338 (376)
Q Consensus 262 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~ 338 (376)
......... ..++.....+|...++ .+|++++|||.+||++||++|||++|+|+||||+...++.... ...+
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p----~~~~ 362 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYP-GADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEP----DCAP 362 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHST-TCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSC----CCSS
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCC-CCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCcccc----CCCC
Confidence 432211100 1234444455666554 4899999999999999999999999999999999987664432 2234
Q ss_pred CCCchhhhccCCHHHHhhhcHHHHH
Q 017147 339 LFNFKQELSGASPELVNKLIPDHVK 363 (376)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (376)
.+++..+....+.+.+++.+-+++.
T Consensus 363 ~~~~~~~~~~~~~~~~k~~i~~ei~ 387 (398)
T 4b99_A 363 PFDFAFDREALTRERIKEAIVAEIE 387 (398)
T ss_dssp CCCCHHHHSCCCHHHHHHHHHHHHH
T ss_pred CCCCccchhhcCHHHHHHHHHHHHH
Confidence 4555555566677777766655543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-65 Score=454.31 Aligned_cols=251 Identities=29% Similarity=0.433 Sum_probs=203.0
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
..++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+++.++|||||++++++.+ .
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~ 85 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-----K 85 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----C
Confidence 3568999999999999999999999999999999986432 234589999999999999999999843 3
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 105 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 105 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..+|+|||||+|+|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 86 ~~~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~~-~~~vkl~DFGla 159 (275)
T 3hyh_A 86 DEIIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLDE-HLNVKIADFGLS 159 (275)
T ss_dssp SEEEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECT-TCCEEECCSSCC
T ss_pred CEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEECC-CCCEEEeecCCC
Confidence 45899999999998888763 4679999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
+.........+.+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+.+.
T Consensus 160 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~------------ 227 (275)
T 3hyh_A 160 NIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG------------ 227 (275)
T ss_dssp ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------------
T ss_pred eecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC------------
Confidence 87666655667899999999999977665678999999999999999999999998877777666542
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
.+. ++..+|+++++||.+||++||++|||++|+++||||+.
T Consensus 228 -----~~~------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 228 -----VYT------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -----CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -----CCC------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 111 22347999999999999999999999999999999974
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-65 Score=458.35 Aligned_cols=256 Identities=30% Similarity=0.516 Sum_probs=221.3
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
..++|++++.||+|+||+||+|+++.+++.||||++.+. .....+|+++|+.++|||||+++++|. +.
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~ 104 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DD 104 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eC
Confidence 446899999999999999999999999999999999643 233468999999999999999999994 34
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
..+|||||||+| +|.+.+.. .+.+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 105 ~~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~~-~g~vKl~DFGl 178 (311)
T 4aw0_A 105 EKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGT 178 (311)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTT
T ss_pred CEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEcC-CCCEEEEEcCC
Confidence 459999999985 88887763 4679999999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccCC---CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 184 AKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 184 a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
|+...... ...+.+||+.|||||++.+. .|+.++||||+||++|+|++|++||.+.+..+.+.+|.+.
T Consensus 179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-------- 249 (311)
T 4aw0_A 179 AKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL-------- 249 (311)
T ss_dssp CEECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------
T ss_pred ceecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------
Confidence 98764332 24467899999999999765 4899999999999999999999999999988888877762
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHH------HhcCCCcccccCCCC
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE------ACAHPFFDELREPNA 328 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e------~l~hp~~~~~~~~~~ 328 (376)
++. ++..+|+++++||.+||++||++|||++| +++||||+++.|...
T Consensus 250 ---------~~~------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 250 ---------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp ---------CCC------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred ---------CCC------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 111 23457999999999999999999999987 589999999987654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-63 Score=454.24 Aligned_cols=252 Identities=28% Similarity=0.424 Sum_probs=215.9
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
..|++++.||+|+||+||+|+++.+|+.||||++... .....+|+.+|+.++|||||+++++|.+.. .+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEEE
Confidence 4699999999999999999999999999999998543 344568999999999999999999995543 4999
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
|||||+| +|.+++.. ..+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus 149 vmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~-~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVS 221 (346)
T ss_dssp EECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEECC-CCCEEEecCcCceecC
Confidence 9999995 77776642 569999999999999999999999 79999999999999996 7789999999998765
Q ss_pred cC-CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017147 189 AG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267 (376)
Q Consensus 189 ~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 267 (376)
.. ....+.+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..+.+......
T Consensus 222 ~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~---------- 290 (346)
T 4fih_A 222 KEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL---------- 290 (346)
T ss_dssp SSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC----------
T ss_pred CCCCcccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC----------
Confidence 44 334567899999999999654 589999999999999999999999999988888777655211000
Q ss_pred CCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
..+..+|+++++||.+||++||++|||++|+|+||||++..
T Consensus 291 ----------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 291 ----------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp ----------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ----------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 01234799999999999999999999999999999998753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-63 Score=454.41 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=210.6
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|+.++|||||++++++.+. ..
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-----~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN-----GS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC-----CE
Confidence 468999999999999999999999999999999996542 2345899999999999999999999543 34
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+|||||||+| +|.+.+.. .....+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus 98 ~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~-~g~vKl~DFGla~ 173 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTVQLGDFGIAR 173 (350)
T ss_dssp EEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEECT-TCCEEECSTTEES
T ss_pred EEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECC-CCCEEEcccccce
Confidence 8999999985 88888763 234568999999999999999999999 79999999999999996 7789999999998
Q ss_pred cCccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 186 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 186 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
...... ...+.+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+.++.+..-.
T Consensus 174 ~~~~~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~--------- 243 (350)
T 4b9d_A 174 VLNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP--------- 243 (350)
T ss_dssp CCCHHHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---------
T ss_pred eecCCcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---------
Confidence 764432 23456799999999999764 5899999999999999999999999999988888877662110
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
.++..+|+++++||.+||++||++|||++|+|+||||+.
T Consensus 244 -------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 244 -------------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred -------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 012347999999999999999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-62 Score=456.12 Aligned_cols=251 Identities=28% Similarity=0.426 Sum_probs=215.7
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
..|++++.||+|+||+||+|+++.+|+.||||++... .....+|+.+|+.++|||||+++++|.+.. .+||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC-----EEEE
Confidence 4699999999999999999999999999999998643 344568999999999999999999995543 4899
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
|||||+| +|.+++.. ..+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus 226 VmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~~-~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVS 298 (423)
T ss_dssp EEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEECT-TCCEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcC-CCCEEEecCccceECC
Confidence 9999995 77776643 569999999999999999999999 79999999999999996 7789999999998764
Q ss_pred cC-CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017147 189 AG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267 (376)
Q Consensus 189 ~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 267 (376)
.. ....+.+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..+.......
T Consensus 299 ~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~----------- 366 (423)
T 4fie_A 299 KEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR----------- 366 (423)
T ss_dssp SSCCCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----------
T ss_pred CCCccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-----------
Confidence 43 334567899999999999654 58999999999999999999999999998888877765521100
Q ss_pred CCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
......+|+++++||.+||++||++|||++|+|+||||++.
T Consensus 367 ---------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 367 ---------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp ---------------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ---------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 00123479999999999999999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-61 Score=456.71 Aligned_cols=353 Identities=61% Similarity=1.086 Sum_probs=309.2
Q ss_pred ecCCCCccCcEEEeccCCCCCCCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHhCCCC
Q 017147 8 VDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHP 87 (376)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~ 87 (376)
.+....+...+......+..+. ....+|++.+.||+|+||+||+|++..+++ +|+|++..+.....+|+.+++.++||
T Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~ 92 (394)
T 4e7w_A 15 LNPLDDPNKVIKVLASDGKTGE-QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHP 92 (394)
T ss_dssp -----CCCCCEEEEEEESSSCC-EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCT
T ss_pred ecCCCCCCceEEEEecCCCCCC-cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCC
Confidence 3444445555555555555444 456789999999999999999999887666 99999887777777999999999999
Q ss_pred ceeeeceeeeecCC-CCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCc
Q 017147 88 NVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 166 (376)
Q Consensus 88 ~iv~~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~N 166 (376)
||+++++++..... .+..++|+||||+++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|
T Consensus 93 niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~N 171 (394)
T 4e7w_A 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQN 171 (394)
T ss_dssp TBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGG
T ss_pred CcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHH
Confidence 99999999876544 5667789999999998888887766677889999999999999999999999 799999999999
Q ss_pred EEEcCCCCcEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHH
Q 017147 167 LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 246 (376)
Q Consensus 167 ill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 246 (376)
||++..++.+||+|||+++............+|+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+
T Consensus 172 ill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l 251 (394)
T 4e7w_A 172 LLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL 251 (394)
T ss_dssp EEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99995478999999999987766666667889999999999977767999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 247 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 247 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
..+.+.+|.|..+.+...++++....++.....+|...+...+++++++||.+||++||.+|||+.|+++||||+.+++.
T Consensus 252 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 252 VEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331 (394)
T ss_dssp HHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred HHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred CCCCCCCCCCCCCCCchhhhccCCHHHHhhhcHHHHH
Q 017147 327 NARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 363 (376)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (376)
....+....+|+++++..+.....++.+..++|++..
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (394)
T 4e7w_A 332 EARMPNGRELPPLFNWTKEELSVRPDLISRLVPQHAE 368 (394)
T ss_dssp CCCCTTSSCCCCSCCCCHHHHHTCGGGHHHHSCGGGC
T ss_pred cccCCCCCCCCCcCCCCHHHhhcCHHHHHhhccHhhh
Confidence 8877788889999999887777788888888887763
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-61 Score=434.69 Aligned_cols=252 Identities=24% Similarity=0.363 Sum_probs=208.6
Q ss_pred eeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
|++.+.||+|+||+||+|.++.+++.||+|++.... ....+|+.+|+.++|||||+++++|.... .....+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence 478889999999999999999999999999986532 23458999999999999999999885433 33556899
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCC--eeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|||||+| +|.+.+.. ...+++..++.++.||+.||+|||+ +| |+||||||+|||++..++.+||+|||+|+.
T Consensus 107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 9999995 77777753 4679999999999999999999999 78 999999999999985467899999999975
Q ss_pred CccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 187 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
.. .....+.+||+.|||||++.+ .|+.++|||||||++|+|+||++||.+.+....+...+.....|
T Consensus 182 ~~-~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~---------- 248 (290)
T 3fpq_A 182 KR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP---------- 248 (290)
T ss_dssp CC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----------
T ss_pred CC-CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC----------
Confidence 43 334556789999999999854 49999999999999999999999998776655544333210000
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
..++..+++++++||.+||++||++|||++|+|+||||++
T Consensus 249 ----------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 249 ----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 1123347889999999999999999999999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-62 Score=443.77 Aligned_cols=253 Identities=27% Similarity=0.433 Sum_probs=210.5
Q ss_pred cceeeeeeeeecCCCeeEEEEEEc---CCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
.++|++++.||+|+||+||+|++. .+++.||||++.+. .....+|+.+|+.++|||||++++++.+.
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~---- 98 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE---- 98 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET----
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC----
Confidence 368999999999999999999985 46789999998643 23346799999999999999999999543
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
..+|||||||+| +|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 99 -~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~-~g~vKl~DFG 171 (304)
T 3ubd_A 99 -GKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDE-EGHIKLTDFG 171 (304)
T ss_dssp -TEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECT-TSCEEEESSE
T ss_pred -CEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEcC-CCCEEecccc
Confidence 348999999995 77777753 4679999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccC-CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 183 SAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 183 ~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
+|+..... ....+.+||+.|||||++.+. .|+.++||||+||++|+|++|++||.+.+..+.+..+.+.
T Consensus 172 la~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--------- 241 (304)
T 3ubd_A 172 LSKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA--------- 241 (304)
T ss_dssp EEEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred cceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC---------
Confidence 99865433 334567899999999999765 5899999999999999999999999999988888877652
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCcccccCC
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 326 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 326 (376)
.+. ++..+|+++++||++||++||++||| ++|+++||||+++.|.
T Consensus 242 --------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~ 291 (304)
T 3ubd_A 242 --------KLG------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN 291 (304)
T ss_dssp --------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred --------CCC------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence 111 23357999999999999999999998 5899999999998654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-60 Score=451.68 Aligned_cols=330 Identities=67% Similarity=1.180 Sum_probs=291.2
Q ss_pred CCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecC-CCCceEE
Q 017147 29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTT-SKNELFL 107 (376)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 107 (376)
......+|++.+.||+|+||+||+|++..+++.||||++..+.....+|+++++.++|+||++++++++... ..+..++
T Consensus 49 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp CCCEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred CCcccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 445667899999999999999999999999999999999887777778999999999999999999886543 3456678
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
++||||+++++.+.+..+......+++..++.++.||+.||.|||+ +||+||||||+|||++.+++.+||+|||+++..
T Consensus 129 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 8999999999888888776777889999999999999999999999 799999999999999975678999999999876
Q ss_pred ccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017147 188 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267 (376)
Q Consensus 188 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 267 (376)
..........+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++.++++.+|.|..+.+...+++
T Consensus 208 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~ 287 (420)
T 1j1b_A 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287 (420)
T ss_dssp CTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSC
T ss_pred ccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 66555667789999999999977667999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCchhhhc
Q 017147 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELS 347 (376)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (376)
+.++.++.+...+|...+...+++++++||.+||++||.+|||+.|+++||||+.++++....+.....+..+++.....
T Consensus 288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (420)
T 1j1b_A 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL 367 (420)
T ss_dssp CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHH
T ss_pred hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCCHHHh
Confidence 99999999999999999999999999999999999999999999999999999999888776666667777777765443
Q ss_pred cCCHHHHhhhcH
Q 017147 348 GASPELVNKLIP 359 (376)
Q Consensus 348 ~~~~~~~~~~~~ 359 (376)
...+.....++|
T Consensus 368 ~~~~~~~~~~~~ 379 (420)
T 1j1b_A 368 SSNPPLATILIP 379 (420)
T ss_dssp TTCGGGHHHHSC
T ss_pred ccChhHHHhhCC
Confidence 444444444433
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-62 Score=443.59 Aligned_cols=257 Identities=26% Similarity=0.358 Sum_probs=213.8
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
....|++.+.||+|+||+||+|+++.+|+.||||++..+... .+|+.+++.++|||||++++++.+. ..+||||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-~~E~~il~~l~HpnIV~l~~~~~~~-----~~~~ivm 129 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-VEELVACAGLSSPRIVPLYGAVREG-----PWVNIFM 129 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-THHHHTTTTCCCTTBCCEEEEEEET-----TEEEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-HHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEE
Confidence 346799999999999999999999999999999999765443 4799999999999999999998543 3489999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
|||+| +|.+.++. .+.+++..++.|+.||+.||+|||+ +||+||||||+|||++.++..+||+|||+|+.....
T Consensus 130 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred eccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 99995 88887763 3679999999999999999999999 799999999999999974447999999999866443
Q ss_pred CC------ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 191 EA------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 191 ~~------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
.. ....+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..+... .++
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~------- 274 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP------- 274 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG-------
T ss_pred CcccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC-------
Confidence 22 1235799999999999765 5899999999999999999999999988776666666541 110
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHH-------------hcCCCcccccCC
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-------------CAHPFFDELREP 326 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~-------------l~hp~~~~~~~~ 326 (376)
...++..+|+++.+||.+||++||.+|||+.|+ |+|||+...+++
T Consensus 275 -----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 275 -----------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp -----------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred -----------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 011334589999999999999999999999997 689999887654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=449.91 Aligned_cols=331 Identities=50% Similarity=0.963 Sum_probs=284.6
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCC-----------
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS----------- 101 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----------- 101 (376)
.++|++.+.||+|+||+||+|.+..+++.||||++..+.....+|+.+++.++||||+++++++.....
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 85 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD 85 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence 458999999999999999999999999999999998887777799999999999999999999865433
Q ss_pred ----------------------CCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeee
Q 017147 102 ----------------------KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 159 (376)
Q Consensus 102 ----------------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H 159 (376)
....++++||||++++|.+.+..+......+++..++.++.||+.||.|||+ +||+|
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi~H 164 (383)
T 3eb0_A 86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICH 164 (383)
T ss_dssp ------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEEC
T ss_pred cccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CcCcc
Confidence 3455688999999999999988877778899999999999999999999999 79999
Q ss_pred cCCCCCcEEEcCCCCcEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCC
Q 017147 160 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 239 (376)
Q Consensus 160 ~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 239 (376)
|||||+|||++..++.+||+|||+++............+|+.|+|||++.+...++.++||||+||++|+|++|++||.+
T Consensus 165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 244 (383)
T 3eb0_A 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG 244 (383)
T ss_dssp SCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence 99999999998557889999999998776666666778899999999997766789999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 017147 240 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319 (376)
Q Consensus 240 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 319 (376)
.+..+.+..+++.+|.|..+.+...++.+.+..++......|...++..+++++.+||.+||++||.+|||+.|+|+|||
T Consensus 245 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (383)
T 3eb0_A 245 ETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324 (383)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccC-------CCCCCCCC--CCCCCCCCchh-hhccCCHHHHhhhcHHHHHh
Q 017147 320 FDELRE-------PNARLPNG--RPLPPLFNFKQ-ELSGASPELVNKLIPDHVKR 364 (376)
Q Consensus 320 ~~~~~~-------~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 364 (376)
|+.+++ .....+.. ..+|.++++.. +++...++...+++|++...
T Consensus 325 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 379 (383)
T 3eb0_A 325 FDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFSP 379 (383)
T ss_dssp GHHHHHC------------------CCCCSCCCHHHHHHSCHHHHHHHSCC----
T ss_pred HHHHHhhccccccccccCCCcccCCCCCCCCCCHHHHhcCCHHHHhhcCchhhcc
Confidence 998765 22223333 56777888774 45556888888888877544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-60 Score=443.16 Aligned_cols=282 Identities=28% Similarity=0.458 Sum_probs=218.3
Q ss_pred CcccceeeeeeeeecCCCeeEEEEEEc---CCCcEEEEEEeeccc--cchHHHHHHHHhC-CCCceeeeceeeeecCCCC
Q 017147 30 PKQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~--~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 103 (376)
|...++|++.+.||+|+||+||+|+++ .+++.||+|++.+.. ....+|+++|+.+ +||||++++++|.+.
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~---- 92 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN---- 92 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET----
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC----
Confidence 445678999999999999999999875 467899999886543 3345899999988 699999999998443
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
..+|+|||||+| +|.+.+ ..+++..++.++.||+.||+|||+ +||+||||||+|||++.+.+.+||+|||
T Consensus 93 -~~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 93 -DHVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp -TEEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred -CEEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 348999999985 776665 358999999999999999999999 7999999999999999755799999999
Q ss_pred ccccCccCC-----------------------------CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhC
Q 017147 183 SAKQLIAGE-----------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 233 (376)
Q Consensus 183 ~a~~~~~~~-----------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g 233 (376)
+|+...... ...+.+||++|+|||++.+...|+.++||||+||++|+|++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 997543221 123457999999999998777799999999999999999999
Q ss_pred CCCC-CCCChHHHHHHHHHHhCCCCHHHHhhcCcC-------C--------------CCCCCCCC----CCCChhhhccc
Q 017147 234 QPLF-PGENAVDQLVEIIKVLGTPTREEIRCMNPN-------Y--------------TDFRFPQI----KAHPWHKVFHK 287 (376)
Q Consensus 234 ~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-------~--------------~~~~~~~~----~~~~~~~~~~~ 287 (376)
+.|| .+.+..+++..|.+.+|.+........... . .+...|.. ...........
T Consensus 244 ~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 323 (361)
T 4f9c_A 244 RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN 323 (361)
T ss_dssp CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence 9998 567788899999998886554333211100 0 00001110 00111112234
Q ss_pred CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 288 RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 288 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
.+|++++|||++||++||++|+|++|+|+||||++++
T Consensus 324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 324 EVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp TCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 5899999999999999999999999999999999863
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=418.56 Aligned_cols=261 Identities=22% Similarity=0.381 Sum_probs=193.1
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC------
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS------ 101 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------ 101 (376)
..+|++++.||+|+||+||+|+++.+++.||||++.... ....+|+.+|+.++|||||+++++|.....
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 357999999999999999999999999999999986432 234579999999999999999999865443
Q ss_pred -CCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEE
Q 017147 102 -KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 179 (376)
Q Consensus 102 -~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~ 179 (376)
....++|+|||||+| +|.+.+.... ......+..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~-~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEECC-CCcEEEc
Confidence 234568999999985 7777775321 11234566788999999999999999 79999999999999996 7789999
Q ss_pred eecccccCccCCC-------------ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHH
Q 017147 180 DFGSAKQLIAGEA-------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 246 (376)
Q Consensus 180 Dfg~a~~~~~~~~-------------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 246 (376)
|||+|+....... ..+.+||+.|||||++.+. .|+.++|||||||++|+|++ ||.+.. +..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~~--~~~ 234 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQM--ERV 234 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSHH--HHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCcc--HHH
Confidence 9999986543321 2345799999999999764 59999999999999999996 775432 222
Q ss_pred HHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 247 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 247 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
..+........+.. ....++.+.+||.+||++||++|||+.|+|+||||+++.++
T Consensus 235 ~~~~~~~~~~~p~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 235 RTLTDVRNLKFPPL-------------------------FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP 289 (299)
T ss_dssp HHHHHHHTTCCCHH-------------------------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred HHHHHHhcCCCCCC-------------------------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence 22222211111000 01246788999999999999999999999999999988665
Q ss_pred C
Q 017147 327 N 327 (376)
Q Consensus 327 ~ 327 (376)
.
T Consensus 290 ~ 290 (299)
T 4g31_A 290 G 290 (299)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-58 Score=451.27 Aligned_cols=258 Identities=25% Similarity=0.370 Sum_probs=212.6
Q ss_pred CCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchH---HHHHHHHhCCCCceeeeceeeee
Q 017147 29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKN---RELQLMRVMDHPNVISLKHCFFS 98 (376)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~---~e~~~l~~l~h~~iv~~~~~~~~ 98 (376)
.+.-.++|++++.||+|+||+||+|+++.+|+.||||++.+.. .... .++.+++.++|||||+++++|.+
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 3445678999999999999999999999999999999996532 1122 34566777899999999999943
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEE
Q 017147 99 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 177 (376)
Q Consensus 99 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vk 177 (376)
...+|||||||+| +|...+.. .+.+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+|
T Consensus 264 -----~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld~-~G~vK 332 (689)
T 3v5w_A 264 -----PDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVR 332 (689)
T ss_dssp -----SSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECT-TSCEE
T ss_pred -----CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEeC-CCCEE
Confidence 4459999999995 77777753 4679999999999999999999999 79999999999999996 77899
Q ss_pred EEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhC
Q 017147 178 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVLG 254 (376)
Q Consensus 178 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~ 254 (376)
|+|||+|+..... ...+.+||+.|||||++.+...|+.++|||||||++|+|++|++||.+.+.. +....+...
T Consensus 333 L~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~-- 409 (689)
T 3v5w_A 333 ISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-- 409 (689)
T ss_dssp ECCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--
T ss_pred ecccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--
Confidence 9999999876443 3456789999999999965556999999999999999999999999764322 222222220
Q ss_pred CCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCcccccCCC
Q 017147 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPN 327 (376)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~~ 327 (376)
.. .++..+|+++++||.+||++||.+|++ ++|+++||||+++.|..
T Consensus 410 ---------------~~------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~ 460 (689)
T 3v5w_A 410 ---------------AV------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 460 (689)
T ss_dssp ---------------CC------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred ---------------CC------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence 01 123458999999999999999999998 79999999999987764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-57 Score=444.69 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=223.4
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
..++|++++.||+|+||+||+|.++.+|+.||+|++.... ....+|+.+|+.++|||||+++++|. +...+
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-----~~~~~ 229 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEM 229 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----CSSEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEE
Confidence 4578999999999999999999999999999999986542 33458999999999999999999994 34459
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC-CCcEEEEeecccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL-THQVKICDFGSAK 185 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~-~~~vkl~Dfg~a~ 185 (376)
|||||||+| +|.+.+.. ....+++..++.|+.||+.||+|||+ +||+||||||+|||++.+ .+.+||+|||+|+
T Consensus 230 ~iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~ 305 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305 (573)
T ss_dssp EEEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCE
T ss_pred EEEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeecccee
Confidence 999999985 77776642 44679999999999999999999999 799999999999999853 3689999999999
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.........+.+||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+.+..+.+......
T Consensus 306 ~~~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~-------- 376 (573)
T 3uto_A 306 HLDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD-------- 376 (573)
T ss_dssp ECCTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC--------
T ss_pred EccCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC--------
Confidence 88777666778999999999999765 589999999999999999999999999998888877765321111
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCC
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 327 (376)
......+|++++|||++||++||.+|||++|+|+||||+...++.
T Consensus 377 -----------------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 377 -----------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp -----------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred -----------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 112235799999999999999999999999999999999866543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-56 Score=402.08 Aligned_cols=254 Identities=24% Similarity=0.352 Sum_probs=207.4
Q ss_pred cceeeeeeeeecCCCeeEEEEEEc-----CCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
.++|.+.+.||+|+||+||+|++. .++..||||++.... ....+|+++|+.++|||||++++++.+..
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~--- 88 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD--- 88 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS---
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC---
Confidence 357999999999999999999875 357889999986532 33458999999999999999999985433
Q ss_pred ceEEEEEeeccc-chHHHHHHhhh---------hcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCC
Q 017147 104 ELFLNLVMEYVP-ESMYRVLKHYS---------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 173 (376)
Q Consensus 104 ~~~~~lv~e~~~-~~l~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~ 173 (376)
.+|||||||+ |+|.+.+.... .....+++..+..++.||+.||.|||+ ++|+||||||+|||++. +
T Consensus 89 --~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~~-~ 164 (299)
T 4asz_A 89 --PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGE-N 164 (299)
T ss_dssp --SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-G
T ss_pred --EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEECC-C
Confidence 3889999998 58888886432 234579999999999999999999999 79999999999999996 7
Q ss_pred CcEEEEeecccccCccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017147 174 HQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 249 (376)
Q Consensus 174 ~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i 249 (376)
+.+||+|||+|+........ ....||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+.+..+.+..+
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 88999999999865433322 235689999999999765 59999999999999999998 99999999888777766
Q ss_pred HHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
.+.... ..+..+|+++.+|+.+||+.||++|||++++ |+|++++.
T Consensus 244 ~~~~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~ 288 (299)
T 4asz_A 244 TQGRVL----------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA 288 (299)
T ss_dssp HHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred HcCCCC----------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence 552110 0234579999999999999999999999999 56887754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-55 Score=421.43 Aligned_cols=286 Identities=31% Similarity=0.560 Sum_probs=230.3
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 104 (376)
..++|++++.||+|+||+||+|.+..+++.||||++.+. .....+|+.+++.++||||+++++++..... +..
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999999999999999999653 2233579999999999999999999854432 233
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 105 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 105 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..+|+||||+++++.+.+. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 140 ~~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~~-~~~~kl~DFG~a 211 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 211 (464)
T ss_dssp CEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCCCC
T ss_pred CeEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEeC-CCCEEEEEEEee
Confidence 4588999999998777664 348999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
+...........+||++|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+++..+++.+|.|..+.+...
T Consensus 212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 212 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp -----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 876655555678899999999999765 5899999999999999999999999999999999999999999998877654
Q ss_pred CcCCCCC--CCCCCCCCChhhhcccC-----------CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 265 NPNYTDF--RFPQIKAHPWHKVFHKR-----------MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 265 ~~~~~~~--~~~~~~~~~~~~~~~~~-----------~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
.+....+ ..+......+...++.. .++++++||.+||++||++|||++|+|+||||+.+..+
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~ 365 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 365 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence 3221111 11222223333333322 15679999999999999999999999999999987554
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=418.27 Aligned_cols=322 Identities=31% Similarity=0.512 Sum_probs=239.4
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
..++|++++.||+|+||+||+|.++.+++.||||++.+.. ....+|+.+|+.++||||+++++++.....+...
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3478999999999999999999999999999999986432 2345799999999999999999998665544555
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.+|+||||++++|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 131 ~~~lv~e~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~-~~~~kl~DFGla~ 204 (458)
T 3rp9_A 131 ELYVVLEIADSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVNQ-DCSVKVCDFGLAR 204 (458)
T ss_dssp CEEEEECCCSEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TCCEEECCCTTCB
T ss_pred eEEEEEeccccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEECC-CCCEeecccccch
Confidence 689999999999888775 45679999999999999999999999 79999999999999996 7789999999998
Q ss_pred cCccCC----------------------------CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-----
Q 017147 186 QLIAGE----------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL----- 232 (376)
Q Consensus 186 ~~~~~~----------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~----- 232 (376)
...... .....+||++|+|||++.....++.++|||||||++|+|++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 653221 12346789999999988666679999999999999999998
Q ss_pred ------CCCCCCCCC--------------------hHHHHHHHHHHhCCCCHHHHhhcCcCCC---CCCCCCCCCCChhh
Q 017147 233 ------GQPLFPGEN--------------------AVDQLVEIIKVLGTPTREEIRCMNPNYT---DFRFPQIKAHPWHK 283 (376)
Q Consensus 233 ------g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 283 (376)
|.++|++.+ ..+++..+.+.+|.|..+.+........ ...++......+..
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 788887765 3678889999999999887765432100 00223333334444
Q ss_pred hcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCchhhhccCCHHHHhhhcHHHHH
Q 017147 284 VFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 363 (376)
Q Consensus 284 ~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (376)
.++ .+++++++||++||++||.+|||++|+|+||||+.+++..............++ +....+.+.++..+.+++.
T Consensus 365 ~~~-~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~e~~ 440 (458)
T 3rp9_A 365 RFP-ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFN---DWMNMDEPQLRYAFVKEIQ 440 (458)
T ss_dssp GST-TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSC---TTSCCCHHHHHHHHHHHHT
T ss_pred HCC-CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCcc---ccccCCHHHHHHHHHHHHH
Confidence 443 469999999999999999999999999999999999877554333222222221 2345666777776666654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-54 Score=410.97 Aligned_cols=322 Identities=30% Similarity=0.492 Sum_probs=248.3
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
..++|++.+.||+|+||+||+|.++.+++.||||++.... ....+|+.+|+.++|+||+++++++.........
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4568999999999999999999999999999999986431 2345899999999999999999998655433334
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.+|+||||++++|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~-~~~~kL~DFGla~ 177 (432)
T 3n9x_A 104 ELYIVLEIADSDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLLNQ-DCSVKVCDFGLAR 177 (432)
T ss_dssp CEEEEEECCSEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred eEEEEEecCCcCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEECC-CCCEEEccCCCcc
Confidence 589999999999888775 45679999999999999999999999 79999999999999996 7789999999998
Q ss_pred cCccCC-----------------------CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh----------
Q 017147 186 QLIAGE-----------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL---------- 232 (376)
Q Consensus 186 ~~~~~~-----------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~---------- 232 (376)
...... .....+||++|+|||++.....++.++||||+||++|+|++
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 257 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence 654332 12467889999999998666779999999999999999998
Q ss_pred -CCCCCCCCC-----------------hHHHHHHHHHHhCCCCHHHHhhcCcCCC-C--CCCCCCCCCChhhhcccCCCh
Q 017147 233 -GQPLFPGEN-----------------AVDQLVEIIKVLGTPTREEIRCMNPNYT-D--FRFPQIKAHPWHKVFHKRMPP 291 (376)
Q Consensus 233 -g~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~ 291 (376)
|.++|.+.+ ..+++..+.+.+|.|+.+.+........ . ..++.....++...++ .+++
T Consensus 258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~ 336 (432)
T 3n9x_A 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP-SISD 336 (432)
T ss_dssp GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST-TSCH
T ss_pred cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC-CCCH
Confidence 566666654 4678999999999999887765432100 0 0122223334444443 4799
Q ss_pred hHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCchhhhccCCHHHHhhhcHHHHH
Q 017147 292 EAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 363 (376)
Q Consensus 292 ~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (376)
++++||++||++||.+|||++|+|+||||+.+++..........+...++ +....+.+.++.++-+++.
T Consensus 337 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~e~~ 405 (432)
T 3n9x_A 337 DGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFD---DWMVLSETQLRYIFLKEVQ 405 (432)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSC---TTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChh---hcccCCHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999877544322222222222 2234666777776666654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=408.65 Aligned_cols=292 Identities=30% Similarity=0.608 Sum_probs=226.2
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------ccchHHHHHHHHhCC-CCceeeeceeeeecCCCCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 104 (376)
..++|++++.||+|+||+||+|.++.+++.||||++.+. .....+|+.+++.+. ||||+++++++.... .
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~ 83 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN---D 83 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT---S
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC---C
Confidence 456899999999999999999999999999999998543 223347999999997 999999999885432 2
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 105 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 105 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..+|+|||||+++|...+.. ..+++..++.++.||+.||+|||+ .||+||||||+|||++. ++.+||+|||+|
T Consensus 84 ~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~a 156 (388)
T 3oz6_A 84 RDVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLNA-ECHVKVADFGLS 156 (388)
T ss_dssp SCEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTC
T ss_pred CEEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEcC-CCCEEecCCccc
Confidence 34889999999998887763 478999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCcc----------------------CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCCh
Q 017147 185 KQLIA----------------------GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 242 (376)
Q Consensus 185 ~~~~~----------------------~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 242 (376)
+.... .......+||++|+|||++.+...++.++||||+||++|+|++|++||.+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 75432 11123467899999999997766799999999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCCCCCCC------CCCCCCChhhh------------cccCCChhHHHHHHhhcCcC
Q 017147 243 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRF------PQIKAHPWHKV------------FHKRMPPEAIDLASRLLQYS 304 (376)
Q Consensus 243 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~------------~~~~~~~~~~~li~~~L~~d 304 (376)
.+++..+...++.|..+.+......+..... .......+... ....+++++++||.+||++|
T Consensus 237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 9999999999999998877644322211000 00000011111 11257899999999999999
Q ss_pred CCCCCCHHHHhcCCCcccccCCCCCCCCC
Q 017147 305 PSLRCTALEACAHPFFDELREPNARLPNG 333 (376)
Q Consensus 305 p~~R~t~~e~l~hp~~~~~~~~~~~~~~~ 333 (376)
|++|||++|+|+||||+.+..+.......
T Consensus 317 P~~R~t~~e~l~Hp~~~~~~~~~~~~~~~ 345 (388)
T 3oz6_A 317 PNKRISANDALKHPFVSIFHNPNEEPNCD 345 (388)
T ss_dssp GGGSCCHHHHTTSTTTTTTCCGGGCCCCS
T ss_pred cccCCCHHHHhCCHHHHHhcCCccCCCCC
Confidence 99999999999999999987765544333
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=398.96 Aligned_cols=302 Identities=45% Similarity=0.870 Sum_probs=249.3
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccc---hHHHHHHHHhCCCCceeeeceeeeecCC--CCceE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---KNRELQLMRVMDHPNVISLKHCFFSTTS--KNELF 106 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~~~~ 106 (376)
..++|++.+.||+|+||+||+|.++.+++.||||++..+... ..+++..+..++||||+++++++..... ....+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence 457899999999999999999999999999999998665433 3456667788899999999999865433 44567
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhh--cCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
+++||||+++++...+..+......+++..++.++.|++.||.||| + +||+||||||+|||++..++.+||+|||++
T Consensus 101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 8899999999988888776667788999999999999999999999 9 799999999999999865788999999999
Q ss_pred ccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
.............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+..+.+...
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3e3p_A 180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259 (360)
T ss_dssp BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence 87766665566788999999999977666899999999999999999999999999999999999999999999998888
Q ss_pred CcCCCCCCCCCCCCCChhhhccc---CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCCC
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHK---RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGR 334 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~ 334 (376)
.+......+......+|...+.. ..++++.+||.+||++||.+|||+.|+|+||||+++..+....+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~ 332 (360)
T 3e3p_A 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNK 332 (360)
T ss_dssp CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSC
T ss_pred ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCC
Confidence 77766666665566666666554 25789999999999999999999999999999999887665544433
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=397.47 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=198.7
Q ss_pred cceeeeeeeeecCCCeeEEEEEEc-----CCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
..++.+.+.||+|+||+||+|+++ .+++.||||++.... ....+|+++|+.++|||||++++++.+..
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~--- 116 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR--- 116 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS---
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC---
Confidence 457999999999999999999865 368899999986432 33458999999999999999999985433
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhh-----------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC
Q 017147 104 ELFLNLVMEYVP-ESMYRVLKHYSS-----------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 171 (376)
Q Consensus 104 ~~~~~lv~e~~~-~~l~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~ 171 (376)
.+|||||||+ |+|.+.+..... ...++++..+..|+.||+.||.|||+ ++|+||||||+|||++.
T Consensus 117 --~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 117 --PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp --SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET
T ss_pred --EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEECC
Confidence 3899999999 588888764321 23569999999999999999999999 79999999999999996
Q ss_pred CCCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 017147 172 LTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 247 (376)
Q Consensus 172 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 247 (376)
++.+||+|||+|+....... .....||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+.+..+.+.
T Consensus 194 -~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 194 -GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp -TTEEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred -CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 78999999999986543322 2345789999999999654 59999999999999999999 999999988887777
Q ss_pred HHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 248 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.+.+.... ..+..+++++.+|+.+||+.||++|||++|++++
T Consensus 272 ~i~~g~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 272 CITQGREL----------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHTCCC----------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHcCCCC----------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 66552110 1234579999999999999999999999999763
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=391.43 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=195.1
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
.+++++.+.||+|+||+||+|+.. ..||||++.... ....+|+.+++.++|||||++++++.. + .
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----~--~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK----D--N 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S--S
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC----C--e
Confidence 357889999999999999999854 359999885321 234589999999999999999997621 1 1
Q ss_pred EEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+|||||||+ |+|.+.+.. ....+++..+..|+.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+|+
T Consensus 106 ~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~~-~~~~Ki~DFGla~ 180 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLHE-GLTVKIGDFGLAT 180 (307)
T ss_dssp CEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEET-TEEEEECCCSSCB
T ss_pred EEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEECC-CCcEEEeeccCce
Confidence 679999999 588777753 34679999999999999999999999 79999999999999996 7889999999998
Q ss_pred cCccCC---CceeeeeccccCchhhhhCC--CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 186 QLIAGE---ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 186 ~~~~~~---~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
...... .....+||+.|||||++.+. ..|+.++|||||||++|||+||+.||.+.+....+..++.....+
T Consensus 181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~---- 256 (307)
T 3omv_A 181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS---- 256 (307)
T ss_dssp C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC----
T ss_pred ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC----
Confidence 654322 23456899999999999643 358999999999999999999999999887766665554421110
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
|. ....+..+++++.+||.+||+.||++|||+.|+++
T Consensus 257 -------------p~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 257 -------------PD------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp -------------CC------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred -------------CC------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 10 01123457899999999999999999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=385.65 Aligned_cols=280 Identities=34% Similarity=0.576 Sum_probs=228.5
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
++|++.+.||+|+||+||+|.++.+++.||+|++.... ....+|+.+++.++||||+++++++... ..+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-----CEE
Confidence 57999999999999999999999999999999986432 2335799999999999999999998543 348
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
|+||||+++++.+.+.. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus 77 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~~-~~~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEEC
T ss_pred EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeecccceec
Confidence 89999999988777653 45679999999999999999999999 79999999999999996 778999999999865
Q ss_pred ccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 188 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 188 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.... ......+|+.|+|||++.+...++.++||||+||++|+|++|..| |.+.+..+.+..+.+..+.+....+....
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 4332 234457799999999997766689999999999999999987655 77888888999999999988876554432
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.......++..............+++++++||++||+.||++|||++|+++||||+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 2111112222222222222334588999999999999999999999999999999975
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=393.65 Aligned_cols=249 Identities=24% Similarity=0.291 Sum_probs=203.5
Q ss_pred cceeeeeeeeecCCCeeEEEEEEc-----CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
..++++.+.||+|+||+||+|... .+++.||||++.... ....+|+.+++.++|||||++++++....
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~-- 102 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ-- 102 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC--
Confidence 357889999999999999999854 467899999985432 33568999999999999999999984433
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhh------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEE
Q 017147 103 NELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 169 (376)
Q Consensus 103 ~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill 169 (376)
.+|||||||+ |+|.+.|..... ....+++..+..++.||+.||+|||+ ++|+||||||+|||+
T Consensus 103 ---~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 103 ---PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLV 178 (308)
T ss_dssp ---SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred ---EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceEE
Confidence 3789999998 588888864221 13468999999999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeecccccCccCC---CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHH
Q 017147 170 DPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 245 (376)
Q Consensus 170 ~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 245 (376)
+. ++.+||+|||+|+...... ......||+.|+|||++.+. .|+.++|||||||++|||+| |..||.+.+..+.
T Consensus 179 ~~-~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 179 YD-KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp CG-GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred CC-CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 96 7889999999998654332 22345789999999999765 59999999999999999998 8999999988777
Q ss_pred HHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 246 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 246 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
+..+.+....| .+..+++++.+|+.+||+.||++|||+.|++++
T Consensus 257 ~~~i~~~~~~~----------------------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 257 VEMIRNRQVLP----------------------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCC----------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 66654321111 234578999999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=388.86 Aligned_cols=283 Identities=36% Similarity=0.669 Sum_probs=230.5
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
...++|++++.||+|+||+||+|.+. +++.||+|++.... ....+|+.+++.++||||+++++++.. .
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~ 91 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-----E 91 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-----S
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-----C
Confidence 35679999999999999999999985 58999999986432 234589999999999999999999843 3
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 105 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 105 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..+|+||||+++++.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 92 ~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a 166 (311)
T 3niz_A 92 RCLTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINS-DGALKLADFGLA 166 (311)
T ss_dssp SCEEEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTC
T ss_pred CEEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEECC-CCCEEEccCcCc
Confidence 34889999999988887753 44569999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 185 KQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 185 ~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
....... ......+|+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+.+..+...++.+....+..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 167 RAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp EETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG
T ss_pred eecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh
Confidence 8654332 233457799999999997766789999999999999999999999999999999999999999887665443
Q ss_pred cCc--CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 264 MNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 264 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
... .+....+......+|.... ..+++++++||.+||++||++|||++|+|+||||+++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred hhccchhhhcccccccCCcHHHhC-cccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 221 1111222333334444433 457899999999999999999999999999999998743
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-53 Score=388.26 Aligned_cols=259 Identities=29% Similarity=0.448 Sum_probs=219.4
Q ss_pred CCCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 017147 28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 101 (376)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (376)
......++|++.+.||+|+||+||+|.+..+|+.||||++.+.. ....+|+.+++.++||||+++++++..
T Consensus 9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--- 85 (328)
T 3fe3_A 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET--- 85 (328)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE---
Confidence 34456778999999999999999999999999999999986542 223479999999999999999999843
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEe
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 180 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~D 180 (376)
...+|+||||+++ +|.+.+.. .+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus 86 --~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~~-~~~~kl~D 157 (328)
T 3fe3_A 86 --EKTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLDA-DMNIKIAD 157 (328)
T ss_dssp --SSEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECS
T ss_pred --CCEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEcC-CCCEEEee
Confidence 3448999999975 77777653 3679999999999999999999999 79999999999999996 77899999
Q ss_pred ecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 181 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 181 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
||++.............||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+....+...
T Consensus 158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------- 229 (328)
T 3fe3_A 158 FGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-------- 229 (328)
T ss_dssp TTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred ccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------
Confidence 999987665555566789999999999987665568999999999999999999999999887777666541
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
.+. ++..+++++.+||++||+.||.+|||++|+++||||+.....
T Consensus 230 ---------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (328)
T 3fe3_A 230 ---------KYR------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE 274 (328)
T ss_dssp ---------CCC------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred ---------CCC------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence 111 122378999999999999999999999999999999876543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=391.63 Aligned_cols=290 Identities=32% Similarity=0.628 Sum_probs=231.8
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
++|++++.||+|+||+||+|.+..+++.||+|++..... ...+|+.+++.++||||+++++++.... ..|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-----SLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS-----CEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC-----EEE
Confidence 579999999999999999999999999999998854322 2236999999999999999999985433 388
Q ss_pred EEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 109 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 109 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
+||||++++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++....
T Consensus 77 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 77 LVFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLINE-RGELKLADFGLARAKS 151 (324)
T ss_dssp EEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEECT-TCCEEECSSSEEECC-
T ss_pred EEecccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEECC-CCCEEEccCccccccc
Confidence 9999999998887764 34569999999999999999999999 79999999999999996 6789999999997554
Q ss_pred cCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc-
Q 017147 189 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP- 266 (376)
Q Consensus 189 ~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 266 (376)
... ......+|+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+.+..+.+.++.+....+.....
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 332 233457799999999997766789999999999999999999999999999999999999999888765543211
Q ss_pred -CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCCC
Q 017147 267 -NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGR 334 (376)
Q Consensus 267 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~ 334 (376)
.+..+.++......+... ...+++++.+||.+||++||.+|||++|+|+||||.++.......+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~ 299 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSH-APRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTT 299 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHH-CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTS
T ss_pred hhhcccccccccchhhhhh-cCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCC
Confidence 112223333333333222 3457999999999999999999999999999999999876655544433
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=393.06 Aligned_cols=320 Identities=33% Similarity=0.617 Sum_probs=253.5
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
..+|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++...........
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 358999999999999999999999999999999986432 233579999999999999999999865544444568
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
|+||||++++|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus 106 ~iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEEC
T ss_pred EEEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEECC-CCCEEEEeCcceEec
Confidence 89999999998888753 469999999999999999999999 79999999999999996 778999999999865
Q ss_pred ccCCC----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 188 IAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 188 ~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
..... .....+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+..+.+.+
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 43322 23457899999999987666689999999999999999999999999999999999999999999887654
Q ss_pred cCcCC---CCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCC
Q 017147 264 MNPNY---TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLF 340 (376)
Q Consensus 264 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~ 340 (376)
..... .....+.....+|...+ ..+++++.+||.+||++||++|||+.|+|+||||+....+.... .....+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~----~~~~~~ 333 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP----IAEAPF 333 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSC----CCSSCC
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhC-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCccccc----CCCCcC
Confidence 32110 00122222333444443 34799999999999999999999999999999999875543321 222344
Q ss_pred CchhhhccCCHHHHhhhcHHHHHh
Q 017147 341 NFKQELSGASPELVNKLIPDHVKR 364 (376)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~ 364 (376)
.+..+......+.+++++.+++++
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~e~~~ 357 (364)
T 3qyz_A 334 KFDMELDDLPKEKLKELIFEETAR 357 (364)
T ss_dssp CCC-----CCHHHHHHHHHHHTGG
T ss_pred CcccccccCCHHHHHHHHHHHHHH
Confidence 555566677778888777666443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=392.99 Aligned_cols=316 Identities=32% Similarity=0.561 Sum_probs=239.5
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 105 (376)
..+|++.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..... ....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999999999999999985432 233579999999999999999999854422 1223
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.+|+||||++++|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred eEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEcC-CCCEEEEeeeccc
Confidence 4689999998888887753 568999999999999999999999 79999999999999996 7789999999998
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.... ......+|++|+|||++.+...++.++||||+||++|+|++|++||.+.+..+++..+.+..|.++.+.+....
T Consensus 177 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 177 QADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp ECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred cccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 6533 23456789999999999875679999999999999999999999999999999999999999999987765433
Q ss_pred cCCC-C--CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCc
Q 017147 266 PNYT-D--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF 342 (376)
Q Consensus 266 ~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 342 (376)
.... . ..++......+...+ ..+++++.+||.+||+.||.+|||++|+|+||||+.+.+....... + .++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~----~-~~~~ 328 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQV----Q-KYDD 328 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CC----C-CCCC
T ss_pred hHHHHHHHHhCCCCCCCCHHHHC-CCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCC----C-CCCC
Confidence 2100 0 022333344454443 3579999999999999999999999999999999998765433211 1 2233
Q ss_pred hhhhccCCHHHHhhhcHHHHH
Q 017147 343 KQELSGASPELVNKLIPDHVK 363 (376)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~ 363 (376)
..+....+.+..++++.+++.
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~ 349 (367)
T 1cm8_A 329 SFDDVDRTLDEWKRVTYKEVL 349 (367)
T ss_dssp C-----CCHHHHHHHHHHHHH
T ss_pred ChhhhcCCHHHHHHHHHHHHH
Confidence 323334555666666555543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=393.56 Aligned_cols=250 Identities=25% Similarity=0.371 Sum_probs=202.8
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCC-----CcEEEEEEeeccc-----cchHHHHHHHHhCCC-CceeeeceeeeecCCC
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRVMDH-PNVISLKHCFFSTTSK 102 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~ 102 (376)
++|++.+.||+|+||+||+|.+..+ ++.||||.+.... ....+|+.+|..++| ||||++++++....
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~-- 141 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-- 141 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT--
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC--
Confidence 6899999999999999999997654 3679999986532 234579999999976 89999999874332
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhh------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEE
Q 017147 103 NELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 169 (376)
Q Consensus 103 ~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill 169 (376)
..+|||||||+ |+|.+.|+.... ....+++..+..++.||+.||+|||+ ++|+||||||+|||+
T Consensus 142 --~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~NILl 218 (353)
T 4ase_A 142 --GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILL 218 (353)
T ss_dssp --SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred --CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCccceee
Confidence 23789999999 588888865332 13458999999999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHH
Q 017147 170 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 245 (376)
Q Consensus 170 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 245 (376)
+. ++.+||+|||+|+....... .....||+.|||||++.+. .|+.++|||||||++|||+| |..||.+.+..+.
T Consensus 219 ~~-~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 219 SE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp CG-GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred CC-CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 96 78899999999986644332 2245789999999999765 59999999999999999998 9999998765555
Q ss_pred HHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 246 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 246 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
+..++..-..+ ..+..+++++.+||.+||+.||++|||+.|+++|
T Consensus 297 ~~~~i~~g~~~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 297 FCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCC---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 54444321111 1223478999999999999999999999999987
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=382.72 Aligned_cols=285 Identities=30% Similarity=0.524 Sum_probs=230.9
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---------cchHHHHHHHHhCC---CCceeeeceeeeec
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMD---HPNVISLKHCFFST 99 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~---h~~iv~~~~~~~~~ 99 (376)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3468999999999999999999999999999999986322 23457777777664 99999999998776
Q ss_pred CCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEE
Q 017147 100 TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 179 (376)
Q Consensus 100 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~ 179 (376)
.......+++||||++++|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~-~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTS-GGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEECT-TSCEEEC
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcC-CCCEEEe
Confidence 65666678999999999988887642 23349999999999999999999999 79999999999999996 7789999
Q ss_pred eecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 180 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 180 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
|||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.+...
T Consensus 163 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eCccccccCCCcccCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 99999876655555667889999999999765 48999999999999999999999999999999999999999888765
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.+..... .....++.....++.. ....+++++.+||.+||++||++|||+.|+|+||||++.
T Consensus 242 ~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 242 DWPRDVS-LPRGAFPPRGPRPVQS-VVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TSCSSCS-SCGGGSCCCCCCCHHH-HSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hccchhh-ccccccCCCCCCcHHH-hCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 5432211 1111222222223332 334589999999999999999999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=379.57 Aligned_cols=278 Identities=35% Similarity=0.646 Sum_probs=222.8
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
++|++.+.||+|+||+||+|.+ .+++.||+|++.... ....+|+.+++.++||||+++++++.... .+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC-----eE
Confidence 5799999999999999999998 678999999985432 23458999999999999999999985433 38
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
|+||||++++|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 76 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAF 150 (288)
T ss_dssp EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECCTTHHHHH
T ss_pred EEEEEecCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEEeECcccccc
Confidence 89999999988887763 34678999999999999999999999 79999999999999996 778999999999754
Q ss_pred ccC-CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
... .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.+....+.....
T Consensus 151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence 322 2233457799999999997666689999999999999999999999999999999999999888876654432211
Q ss_pred CC-CCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 267 NY-TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 267 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.. .+..++.....+|.. +...+++++.+||.+||+.||++|||++|+++||||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp STTCCTTCCCCCCCCGGG-TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccccccccccCccHHH-HhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 00 001122222223333 334589999999999999999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=382.92 Aligned_cols=289 Identities=32% Similarity=0.571 Sum_probs=218.1
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
..+|++++.||+|+||+||+|.++.+++.||+|++.... ....+|+.+++.++||||+++++++. ....+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH-----TENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC-----CTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE-----ECCeE
Confidence 357999999999999999999999999999999986432 23458999999999999999999983 33458
Q ss_pred EEEeecccchHHHHHHhhhh--cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 108 NLVMEYVPESMYRVLKHYSS--ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
|+||||++++|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 79 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 79 TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINK-RGQLKLGDFGLAR 156 (317)
T ss_dssp EEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCSSCE
T ss_pred EEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEcC-CCCEEECcCccce
Confidence 89999999998888865332 23458999999999999999999999 79999999999999996 7789999999998
Q ss_pred cCccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 186 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 186 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
...... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....+...
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence 654332 2335578999999999976666899999999999999999999999999999999999999888776544332
Q ss_pred Cc--CCCCCCCCCCCCCCh----hhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCC
Q 017147 265 NP--NYTDFRFPQIKAHPW----HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 329 (376)
Q Consensus 265 ~~--~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~ 329 (376)
.. .+.. .++......+ .......+++++.+||.+||+.||++|||++|+|+||||++.......
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~ 306 (317)
T 2pmi_A 237 TKLPKYNP-NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASM 306 (317)
T ss_dssp GGCTTCCT-TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC----
T ss_pred hhhhhccc-ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhc
Confidence 11 1100 1111111111 222334578999999999999999999999999999999998765443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-53 Score=393.05 Aligned_cols=318 Identities=33% Similarity=0.543 Sum_probs=237.3
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 104 (376)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..... ...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3468999999999999999999999999999999985432 233479999999999999999998854321 122
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 105 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 105 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..+|+|+|+++++|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 107 ~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~-~~~~kL~DFG~a 179 (367)
T 2fst_X 107 NDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLA 179 (367)
T ss_dssp CCCEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECC----
T ss_pred CeEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEECC-CCCEEEeecccc
Confidence 34789999998887776642 579999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
+.... ......+|++|+|||++.+...++.++||||+||++|+|++|++||.+.+..+++..+.+.+|.|..+.+...
T Consensus 180 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 180 RHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred ccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 76432 2345688999999999977567899999999999999999999999999999999999999999998776644
Q ss_pred CcCCC-C--CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCC
Q 017147 265 NPNYT-D--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFN 341 (376)
Q Consensus 265 ~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~ 341 (376)
..... . ..++.....++...++ .+++++.+||.+||++||++|||+.|+|+||||+.+..+.... ..+.++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~-----~~~~~~ 331 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFI-GANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP-----VADPYD 331 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTT-TCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCC-----CCCCCC
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCC-CCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCC-----CCCCCC
Confidence 32100 0 0223333445555443 4799999999999999999999999999999999987665331 122344
Q ss_pred chhhhccCCHHHHhhhcHHHHHh
Q 017147 342 FKQELSGASPELVNKLIPDHVKR 364 (376)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~ 364 (376)
...+......+..++++-+++..
T Consensus 332 ~~~~~~~~~~~~~~~~~~~e~~~ 354 (367)
T 2fst_X 332 QSLESRDLLIDEWKSLTYDEVIS 354 (367)
T ss_dssp GGGSSCCCCHHHHHHHHHHHHHH
T ss_pred cchhhccCCHHHHHHHHHHHHHH
Confidence 44444456677777777676654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-53 Score=392.01 Aligned_cols=255 Identities=27% Similarity=0.468 Sum_probs=210.8
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 102 (376)
...++|++++.||+|+||+||+|+++.+++.||+|++.+.. ....+|..+++.+ +||||+++++++..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~---- 95 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT---- 95 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe----
Confidence 34578999999999999999999999999999999987532 2334788899887 79999999999843
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
...+|+||||++| +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 96 -~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~-~g~ikL~DF 168 (353)
T 3txo_A 96 -PDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLDH-EGHCKLADF 168 (353)
T ss_dssp -SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCC
T ss_pred -CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEECC-CCCEEEccc
Confidence 3348999999985 77766653 3679999999999999999999999 79999999999999996 778999999
Q ss_pred cccccCcc-CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 182 GSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 182 g~a~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
|+|+.... .....+.+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.+.
T Consensus 169 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-------- 239 (353)
T 3txo_A 169 GMCKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-------- 239 (353)
T ss_dssp TTCBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred cceeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------
Confidence 99985432 2334466889999999999654 4899999999999999999999999999988888777652
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH------HHHhcCCCcccccCC
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELREP 326 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~------~e~l~hp~~~~~~~~ 326 (376)
... ++..+++++.+||++||++||.+||++ +++++||||+++.|.
T Consensus 240 ---------~~~------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~ 290 (353)
T 3txo_A 240 ---------EVV------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA 290 (353)
T ss_dssp ---------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred ---------CCC------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence 111 223478999999999999999999998 899999999998655
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=388.32 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=218.3
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTT 100 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (376)
...++|++.+.||+|+||+||+|.++.+|+.||+|++.+.. ....+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--- 85 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE--- 85 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE---
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE---
Confidence 45678999999999999999999999999999999986532 23468999999999999999999984
Q ss_pred CCCceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC---cE
Q 017147 101 SKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH---QV 176 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~---~v 176 (376)
....+|+||||++ ++|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+
T Consensus 86 --~~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~v 158 (361)
T 2yab_A 86 --NRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHI 158 (361)
T ss_dssp --CSSEEEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCE
T ss_pred --eCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCE
Confidence 3345899999997 57777664 35679999999999999999999999 79999999999999986332 79
Q ss_pred EEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017147 177 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256 (376)
Q Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 256 (376)
||+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+.......
T Consensus 159 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~ 237 (361)
T 2yab_A 159 KLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237 (361)
T ss_dssp EECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred EEEecCCceEcCCCCccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 99999999877665555667899999999999654 58999999999999999999999999998887777665522111
Q ss_pred CHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
...++..+++++++||.+||..||.+|||+.|+++||||+.+.
T Consensus 238 -------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 238 -------------------------DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp -------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred -------------------------CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 1122345799999999999999999999999999999998653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=385.83 Aligned_cols=284 Identities=33% Similarity=0.603 Sum_probs=231.2
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
...++|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 105 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN----- 105 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-----
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-----
Confidence 45679999999999999999999999999999999985432 2335899999999999999999998543
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC----CCCcEEEEe
Q 017147 105 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP----LTHQVKICD 180 (376)
Q Consensus 105 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~----~~~~vkl~D 180 (376)
..+|+||||++++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ....+||+|
T Consensus 106 ~~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 106 HRLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp TEEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred CEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEECc
Confidence 34889999999998887763 4569999999999999999999999 79999999999999953 245699999
Q ss_pred ecccccCccC-CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 181 FGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 181 fg~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
||++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.+...
T Consensus 181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 181 FGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp TTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred CCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence 9999765322 223445779999999999776668999999999999999999999999999999999999998888765
Q ss_pred HHhhcC--cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 260 EIRCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 260 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
.+.... +.+ ...++......+...+...+++++++||.+||++||.+|||++|+|+||||++..+
T Consensus 261 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 261 TWPGVTALPDW-KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp TSTTGGGSTTC-CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhh-hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 544321 111 11344455556666666778999999999999999999999999999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=383.88 Aligned_cols=253 Identities=27% Similarity=0.439 Sum_probs=214.9
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
.++|++++.||+|+||+||+|+++.+++.||+|++.+.. ....+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-----~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-----CC
Confidence 468999999999999999999999999999999986531 234579999999999999999998843 33
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
.+|+||||++| +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~vkL~DFG~a 152 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEECC-CCCEEEeeccch
Confidence 48999999986 77666652 3579999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCcc-CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 185 KQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 185 ~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
+.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------- 220 (337)
T 1o6l_A 153 KEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME----------- 220 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred hhcccCCCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence 86432 3344567899999999998654 5899999999999999999999999998877776666541
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCC
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 326 (376)
... ++..+++++.+||.+||+.||.+|| +++|+++||||+.+.+.
T Consensus 221 ------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 221 ------EIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp ------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ------CCC------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 111 2235799999999999999999999 89999999999987654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=390.56 Aligned_cols=320 Identities=30% Similarity=0.507 Sum_probs=234.5
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 104 (376)
..++|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++..... ...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 4568999999999999999999999999999999986532 223579999999999999999998854331 233
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 105 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 105 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..+|+||||+++++.+.+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 103 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~a 174 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 174 (371)
T ss_dssp CEEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECCCCC-
T ss_pred cceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcC-CCCEEEEEeecc
Confidence 4688999999998887774 358999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
.............+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+.++.+..+.+...
T Consensus 175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 175 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ---------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred cccccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 866544444567889999999999764 5899999999999999999999999999999999999999998887766543
Q ss_pred CcCCCCC--CCCCCCCCChhhhccc-----------CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCC
Q 017147 265 NPNYTDF--RFPQIKAHPWHKVFHK-----------RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 331 (376)
Q Consensus 265 ~~~~~~~--~~~~~~~~~~~~~~~~-----------~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~ 331 (376)
.+....+ ..+......+...++. ..++++++||.+||+.||++|||++|+|+||||+...++....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~- 332 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE- 332 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHT-
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccC-
Confidence 2211100 0111111122222211 1256899999999999999999999999999998765442221
Q ss_pred CCCCCCCCCCchhhhccCCHHHHhhhcHHHHH
Q 017147 332 NGRPLPPLFNFKQELSGASPELVNKLIPDHVK 363 (376)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (376)
.+.|.......+....+.+..++++.+++.
T Consensus 333 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (371)
T 2xrw_A 333 --APPPKIPDKQLDEREHTIEEWKELIYKEVM 362 (371)
T ss_dssp --CCCCCCCTTTTCCCCCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCChhhccccCcHHHHHHHHHHHHH
Confidence 111222222223344566777777766654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-52 Score=389.10 Aligned_cols=256 Identities=24% Similarity=0.446 Sum_probs=209.2
Q ss_pred CcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 017147 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 101 (376)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 101 (376)
.....+|++++.||+|+||+||+|+++.+++.||+|++.+.. .....|..++..+ +||||+++++++.+
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--- 124 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--- 124 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC---
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE---
Confidence 345678999999999999999999999999999999987542 2245788888776 89999999999843
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEe
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 180 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~D 180 (376)
...+|+||||++| +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus 125 --~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~-~g~ikL~D 196 (396)
T 4dc2_A 125 --ESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIKLTD 196 (396)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECC
T ss_pred --CCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEECC-CCCEEEee
Confidence 3448999999986 77666653 3679999999999999999999999 79999999999999996 77899999
Q ss_pred ecccccC-ccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChH--------H-HHHHHH
Q 017147 181 FGSAKQL-IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV--------D-QLVEII 250 (376)
Q Consensus 181 fg~a~~~-~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~-~~~~i~ 250 (376)
||+|+.. .......+.+||+.|+|||++.+. .++.++|||||||++|+|++|++||...... + ....+.
T Consensus 197 FGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~ 275 (396)
T 4dc2_A 197 YGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 275 (396)
T ss_dssp CTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH
T ss_pred cceeeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh
Confidence 9999863 333445567899999999999764 5899999999999999999999999653221 1 222222
Q ss_pred HHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH------HHHhcCCCccccc
Q 017147 251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELR 324 (376)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~------~e~l~hp~~~~~~ 324 (376)
.. .. .++..+++++++||++||++||.+||++ +|+++||||+++.
T Consensus 276 ~~-----------------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 276 EK-----------------QI------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp HC-----------------CC------------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred cc-----------------cc------------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 20 11 1234579999999999999999999985 7999999999987
Q ss_pred CC
Q 017147 325 EP 326 (376)
Q Consensus 325 ~~ 326 (376)
|.
T Consensus 327 w~ 328 (396)
T 4dc2_A 327 WD 328 (396)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=382.17 Aligned_cols=284 Identities=34% Similarity=0.596 Sum_probs=228.4
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 84 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--- 84 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT---
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC---
Confidence 4568999999999999999999999999999999985421 2345799999999999999999998433
Q ss_pred CceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 103 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 103 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
...++||||+++++...+.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 85 --~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg 157 (346)
T 1ua2_A 85 --SNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDE-NGVLKLADFG 157 (346)
T ss_dssp --TCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCCG
T ss_pred --CceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEcC-CCCEEEEecc
Confidence 33889999999988777753 34568899999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 183 SAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 183 ~a~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
++....... ......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+....+
T Consensus 158 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 158 LAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp GGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 998654332 2345678999999999976666899999999999999999999999999999999999999888877655
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
...........+......++... ...+++++++||.+||+.||++|||++|+|+||||++...+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHI-FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHH-CTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred hhhccCcccccccccCCCChHHh-hccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence 44332211222222233333333 24578999999999999999999999999999999876443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-51 Score=378.94 Aligned_cols=323 Identities=31% Similarity=0.585 Sum_probs=247.5
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
..++|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++..........
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4568999999999999999999999999999999985432 22347999999999999999998875443334456
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
.|+||||+.++|.+.+.. ..+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 89 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLINS-NCDLKVCDFGLARI 161 (353)
T ss_dssp EEEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCEE
T ss_pred EEEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcC-CCcEEEEecccccc
Confidence 889999999998887753 568999999999999999999999 79999999999999996 77899999999976
Q ss_pred CccCCC-----------ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017147 187 LIAGEA-----------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255 (376)
Q Consensus 187 ~~~~~~-----------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 255 (376)
...... .....||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 543211 123467999999999876667899999999999999999999999999999999888888887
Q ss_pred CCHHHHh-hcCcC-CCC--CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCC
Q 017147 256 PTREEIR-CMNPN-YTD--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 331 (376)
Q Consensus 256 ~~~~~~~-~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~ 331 (376)
+...... +.... ..+ -..+.....++... ...+++++.+||.+||+.||++|||+.|+++||||+....+.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~ 320 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKM-FPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPE 320 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHH-STTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCC
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhh-cccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccc
Confidence 7632111 00000 000 01111222223322 2357999999999999999999999999999999999877654432
Q ss_pred CCCCCCCCCCchhhhccCCHHHHhhhcHHHH
Q 017147 332 NGRPLPPLFNFKQELSGASPELVNKLIPDHV 362 (376)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (376)
.....+..+.+.......+.+.+++++..++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (353)
T 2b9h_A 321 GEPIPPSFFEFDHYKEALTTKDLKKLIWNEI 351 (353)
T ss_dssp CCCCCGGGGGGGCCSSCCCHHHHHHHHHHHH
T ss_pred cCCCCcceeeecchhhcCCHHHHHHHHHHHh
Confidence 2222223344454555677778887776665
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=371.22 Aligned_cols=285 Identities=32% Similarity=0.591 Sum_probs=222.5
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
.++|++++.||+|+||+||+|.+..+++.||+|++..... ...+|+.+++.++||||+++++++... ..
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-----RR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-----Ce
Confidence 4689999999999999999999999999999998865432 234799999999999999999998543 34
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
.++||||++++++..+. .....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 151 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILITK-HSVIKLCDFGFARL 151 (311)
T ss_dssp EEEEEECCSEEHHHHHH---HTSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEE
T ss_pred EEEEEEeCCCchHHHHH---hhhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEcC-CCCEEEeeCCCchh
Confidence 88999999986544443 245679999999999999999999999 79999999999999996 77899999999986
Q ss_pred CccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc-
Q 017147 187 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM- 264 (376)
Q Consensus 187 ~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~- 264 (376)
..... ......+|+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+....+.+.++..........
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 152 LTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp CC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred ccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccc
Confidence 54332 2345678999999999987667899999999999999999999999999999999998888887766543322
Q ss_pred -CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCC
Q 017147 265 -NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327 (376)
Q Consensus 265 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 327 (376)
...+.....+..............+++++.+||.+||+.||.+|||++|+++||||+++++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 112222222222221111122235899999999999999999999999999999999986553
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=378.75 Aligned_cols=319 Identities=30% Similarity=0.563 Sum_probs=240.7
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---------------cchHHHHHHHHhCCCCceeeeceeee
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------------RYKNRELQLMRVMDHPNVISLKHCFF 97 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------------~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (376)
.++|++.+.||+|+||.||+|.+.. ++.||||++.... ....+|+.+++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 4689999999999999999999754 8999999885421 23458999999999999999999987
Q ss_pred ecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEE
Q 017147 98 STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 177 (376)
Q Consensus 98 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vk 177 (376)
.........+|+||||+++++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~-~~~~k 174 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLAD-NNDIT 174 (362)
T ss_dssp ECCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEE
T ss_pred eccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEcC-CCCEE
Confidence 766566667899999999998887763 44579999999999999999999999 79999999999999996 77899
Q ss_pred EEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017147 178 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257 (376)
Q Consensus 178 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 257 (376)
|+|||++.............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+.
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99999998655555555678899999999997756689999999999999999999999999999999999999999988
Q ss_pred HHHHhhcCcC----CCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCC
Q 017147 258 REEIRCMNPN----YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNG 333 (376)
Q Consensus 258 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~ 333 (376)
...+...... +............|... ...+++.+.+||.+||+.||.+|||+.|+++||||+.+..+....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~--- 330 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAV-VPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLT--- 330 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHH-STTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGT---
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhh-CCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccc---
Confidence 7655432110 11111222223333333 345789999999999999999999999999999999986553322
Q ss_pred CCCCCCCCchhhhccCCHHHHhhhcHHHHH
Q 017147 334 RPLPPLFNFKQELSGASPELVNKLIPDHVK 363 (376)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (376)
..++..+.+.. ...+.....+.+..++.
T Consensus 331 ~~~~~~~~~~~--~~~~~~~~~~~~~~e~~ 358 (362)
T 3pg1_A 331 EGLSERFHFDE--SVTDVYDMHKIFTAEVE 358 (362)
T ss_dssp TTCCCCCCCCT--TCCCHHHHHHHHHHHHH
T ss_pred cccccccChhh--hhhhHHHHHHHHHHHHH
Confidence 12222222222 33455555555555543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=388.72 Aligned_cols=259 Identities=25% Similarity=0.422 Sum_probs=217.0
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
..++|++++.||+|+||+||+|+++.+++.||+|++.+. .....+|+.+++.++||||+++++++. +.
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~ 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-----DD 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----EC
Confidence 356899999999999999999999999999999998642 234568999999999999999999984 34
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
..+|+|||||+| +|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~-~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeECC-CCCEEEeccce
Confidence 458999999974 77777653 468999999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccCCC--ceeeeeccccCchhhhhCCCC---CCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 184 AKQLIAGEA--NISYICSRFYRAPELIFGATE---YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 184 a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
|+....... ..+.+||+.|+|||++.+... ++.++|||||||++|+|++|++||.+.+..+...++.+....
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--- 291 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS--- 291 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH---
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc---
Confidence 986544332 235678999999999975432 788999999999999999999999999988888877653110
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCcccccCCC
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPN 327 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~e~l~hp~~~~~~~~~ 327 (376)
..+|. ...+|+++++||++||+.+|.+ |++++|+++||||+++.|..
T Consensus 292 ------------~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~ 340 (410)
T 3v8s_A 292 ------------LTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW 340 (410)
T ss_dssp ------------CCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred ------------ccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence 01111 1247999999999999999988 99999999999999987653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=377.13 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=218.1
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
..++|++.+.||+|+||+||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++.+. ..+|
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~ 77 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESM-----EELV 77 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-----CEEE
Confidence 3568999999999999999999999999999999886432 2345899999999999999999998443 3489
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC-CCcEEEEeeccccc
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQ 186 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~-~~~vkl~Dfg~a~~ 186 (376)
+|||||+| +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++.. ++.+||+|||++..
T Consensus 78 lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 78 MIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 99999986 77776642 34579999999999999999999999 799999999999999853 57899999999987
Q ss_pred CccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 187 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
...........+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+.+..+.+.........
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------ 226 (321)
T 1tki_A 154 LKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA------ 226 (321)
T ss_dssp CCTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH------
T ss_pred CCCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh------
Confidence 7666555667889999999999654 479999999999999999999999999988887777766322222211
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
...+|+++++||.+||..||.+|||+.|+|+||||+..
T Consensus 227 -------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 227 -------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp -------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred -------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 23479999999999999999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-52 Score=383.09 Aligned_cols=255 Identities=28% Similarity=0.475 Sum_probs=213.9
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 102 (376)
...++|++.+.||+|+||+||+|+++.+++.||||++.+.. .....|..++..+ +||||+++++++.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~---- 89 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT---- 89 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe----
Confidence 34578999999999999999999999999999999996532 2334688888876 99999999998843
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
...+|+||||++| +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 90 -~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~vkL~DF 162 (345)
T 1xjd_A 90 -KENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDK-DGHIKIADF 162 (345)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCC
T ss_pred -CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEECC-CCCEEEeEC
Confidence 3348999999985 77777653 3579999999999999999999999 79999999999999996 678999999
Q ss_pred cccccCcc-CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 182 GSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 182 g~a~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
|+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 163 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-------- 233 (345)
T 1xjd_A 163 GMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-------- 233 (345)
T ss_dssp TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred hhhhhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--------
Confidence 99986433 2334567889999999999664 4899999999999999999999999998887777666541
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHH-HHhcCCCcccccCC
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREP 326 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~-e~l~hp~~~~~~~~ 326 (376)
... ++..+++++++||.+||+.||++||++. ++++||||+.+.|.
T Consensus 234 ---------~~~------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~ 279 (345)
T 1xjd_A 234 ---------NPF------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 279 (345)
T ss_dssp ---------CCC------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred ---------CCC------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence 001 2234789999999999999999999998 99999999988654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-51 Score=381.36 Aligned_cols=316 Identities=34% Similarity=0.583 Sum_probs=242.3
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCC-Cce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~~~ 105 (376)
..+|.+.+.||+|+||+||+|.++.+++.||||++.... ....+|+.+++.++||||+++++++...... ...
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 358999999999999999999999999999999986532 2334799999999999999999998544321 112
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.+|+||||+.++|.+.+. ..+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 121 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNE-DCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCCEEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECSTTCC-
T ss_pred eEEEEEccccccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEECC-CCCEEEEecCccc
Confidence 248999999998766652 459999999999999999999999 79999999999999996 7789999999997
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+..+.+....
T Consensus 193 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 193 HADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred cccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 5432 23346779999999999775678999999999999999999999999999999999999999999877665432
Q ss_pred cCCCC---CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCc
Q 017147 266 PNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF 342 (376)
Q Consensus 266 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 342 (376)
..... ...+......+... ...+++++.+||.+||+.||++|||+.|+|+||||+.++.+........++ ..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~----~~ 345 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQL-FPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPF----DD 345 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHH-STTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCC----CC
T ss_pred hhhhhhhhhccCCCcchhHHHh-ccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCc----Cc
Confidence 21100 01122222233332 235799999999999999999999999999999999887665443222222 22
Q ss_pred hhhhccCCHHHHhhhcHHHHH
Q 017147 343 KQELSGASPELVNKLIPDHVK 363 (376)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~ 363 (376)
..+....+.+..++.+.+++.
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~ 366 (371)
T 4exu_A 346 SLEHEKLTVDEWKQHIYKEIV 366 (371)
T ss_dssp TTSSCCCCHHHHHHHHHHHHH
T ss_pred chhhcccchHHHHHHHHHHHH
Confidence 223344555666666655543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=389.68 Aligned_cols=263 Identities=25% Similarity=0.397 Sum_probs=219.4
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
.++|++.+.||+|+||+||+|+++.+++.||+|++.+. .....+|+.++..++||||+++++++.+ ..
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-----~~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD-----DN 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC-----SS
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CC
Confidence 46899999999999999999999999999999998642 2335689999999999999999998843 34
Q ss_pred EEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
.+|+|||||+ |+|.+.+.. ....+++..++.++.||+.||+|||+ .||+||||||+|||++. ++.+||+|||+|
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~~-~g~vkL~DFGla 222 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDM-NGHIRLADFGSC 222 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEcC-CCCEEEcchhhh
Confidence 4899999997 477777753 24679999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCccCCCc--eeeeeccccCchhhhh----CCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 185 KQLIAGEAN--ISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 185 ~~~~~~~~~--~~~~~t~~y~aPE~l~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
+........ ...+||+.|+|||++. +...++.++|||||||++|+|++|++||.+.+..+.+.+++.....
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--- 299 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER--- 299 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH---
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc---
Confidence 765443332 2357899999999986 2445899999999999999999999999999988888877642110
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCcccccCCCCC
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPNAR 329 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~e~l~hp~~~~~~~~~~~ 329 (376)
+.+|. ....+++++++||++||+.+|++ |++++|+++||||+++.|....
T Consensus 300 ------------~~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~ 351 (437)
T 4aw2_A 300 ------------FQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIR 351 (437)
T ss_dssp ------------CCCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGG
T ss_pred ------------ccCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHh
Confidence 11111 01247999999999999999988 9999999999999999877543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=377.15 Aligned_cols=256 Identities=25% Similarity=0.458 Sum_probs=209.1
Q ss_pred CcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 017147 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 101 (376)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 101 (376)
+...++|++.+.||+|+||+||+|+++.+++.||+|++.+.. ....+|+.+++.+ +||||+++++++.+
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--- 81 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--- 81 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe---
Confidence 345678999999999999999999999999999999997542 2234788899887 89999999999843
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEe
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 180 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~D 180 (376)
...+|+||||++| +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus 82 --~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~~kL~D 153 (345)
T 3a8x_A 82 --ESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIKLTD 153 (345)
T ss_dssp --SSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECC
T ss_pred --CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECC-CCCEEEEe
Confidence 3458999999985 77766653 3579999999999999999999999 79999999999999996 77899999
Q ss_pred ecccccCc-cCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCC---------hHHHHHHHH
Q 017147 181 FGSAKQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---------AVDQLVEII 250 (376)
Q Consensus 181 fg~a~~~~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~~i~ 250 (376)
||+++... ........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.... .......+.
T Consensus 154 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~ 232 (345)
T 3a8x_A 154 YGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 232 (345)
T ss_dssp GGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH
T ss_pred ccccccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH
Confidence 99998643 23334566889999999999664 58999999999999999999999997532 112222222
Q ss_pred HHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH------HHHhcCCCccccc
Q 017147 251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELR 324 (376)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~------~e~l~hp~~~~~~ 324 (376)
.. ... ++..+++++++||.+||+.||.+||++ +++++||||+++.
T Consensus 233 ~~-----------------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 233 EK-----------------QIR------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp HC-----------------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred cC-----------------CCC------------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 20 011 233579999999999999999999995 8999999999886
Q ss_pred CC
Q 017147 325 EP 326 (376)
Q Consensus 325 ~~ 326 (376)
|.
T Consensus 284 w~ 285 (345)
T 3a8x_A 284 WD 285 (345)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-51 Score=373.14 Aligned_cols=251 Identities=29% Similarity=0.486 Sum_probs=215.1
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
.++|++.+.||+|+||+||+|+++.+++.||+|++.+.. ....+|+.+++.++||||+++++++.+ ..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-----CC
Confidence 468999999999999999999999999999999986532 234579999999999999999998843 34
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
.+|+||||++| +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~~kL~Dfg~a 153 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDK-NGHIKITDFGFA 153 (318)
T ss_dssp EEEEEECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECT-TSCEEECCCSSC
T ss_pred EEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEcC-CCCEEEeecCcc
Confidence 58999999985 7777775 34679999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
+.... ...+..||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....+.+.
T Consensus 154 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------ 218 (318)
T 1fot_A 154 KYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------------ 218 (318)
T ss_dssp EECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC------------
T ss_pred eecCC--ccccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence 86533 33456789999999999654 5899999999999999999999999998888777777652
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCC
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 326 (376)
... ++..+++++.+||.+||+.||++|+ +++++++||||+++.+.
T Consensus 219 -----~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 219 -----ELR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp -----CCC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred -----CCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 111 2234789999999999999999999 89999999999987654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=387.32 Aligned_cols=252 Identities=29% Similarity=0.455 Sum_probs=211.5
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
...++|++.+.||+|+||+||+|.+..+++.||+|++.+. .....+|+.+++.++||||+++++++...
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~---- 81 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP---- 81 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS----
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC----
Confidence 4567899999999999999999999999999999998643 22456899999999999999999998443
Q ss_pred ceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 104 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 104 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
..+|+||||++|++.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 82 -~~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~-~~~~kl~DFG~ 154 (336)
T 3h4j_B 82 -TDIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLDD-NLNVKIADFGL 154 (336)
T ss_dssp -SEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEECT-TCCEEECCSSC
T ss_pred -CEEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEcC-CCCEEEEEecc
Confidence 34889999999998887753 3579999999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 184 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 184 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
+.............||+.|+|||++.+....+.++|||||||++|+|++|..||.+.........
T Consensus 155 s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~--------------- 219 (336)
T 3h4j_B 155 SNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK--------------- 219 (336)
T ss_dssp TBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC---------------
T ss_pred ceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH---------------
Confidence 98776666566778999999999997655447899999999999999999999976542211100
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
.. .....++..+++++.+||++||+.||.+|||++|+++||||+.
T Consensus 220 ------------i~--~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 220 ------------VN--SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp ------------CC--SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred ------------HH--cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 00 0011133457999999999999999999999999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=373.76 Aligned_cols=256 Identities=25% Similarity=0.400 Sum_probs=216.1
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTT 100 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (376)
...++|++.+.||+|+||.||+|.++.+++.||+|++.... ....+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 85 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-- 85 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--
Confidence 45678999999999999999999999999999999986432 234689999999999999999998843
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC----c
Q 017147 101 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH----Q 175 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~----~ 175 (376)
...+|+||||+++ +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++ .
T Consensus 86 ---~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~-~~~~~~~ 156 (326)
T 2y0a_A 86 ---KTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD-RNVPKPR 156 (326)
T ss_dssp ---SSEEEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESC-SSSSSCC
T ss_pred ---CCEEEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEec-CCCCCCC
Confidence 3348899999975 7777664 34679999999999999999999999 79999999999999986 44 7
Q ss_pred EEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017147 176 VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255 (376)
Q Consensus 176 vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 255 (376)
+||+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 157 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 235 (326)
T 2y0a_A 157 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235 (326)
T ss_dssp EEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC
T ss_pred EEEEECCCCeECCCCCccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC
Confidence 999999999876555555567889999999998654 5899999999999999999999999998887777666553211
Q ss_pred CCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.. ......+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 236 ~~-------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 236 FE-------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp CC-------------------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred cC-------------------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 11 11223478999999999999999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=376.92 Aligned_cols=288 Identities=28% Similarity=0.488 Sum_probs=227.4
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC---
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS--- 101 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 101 (376)
...++|++.+.||+|+||+||+|.++.+++.||+|++.... ....+|+.+++.++||||+++++++.....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 35679999999999999999999999999999999885432 233589999999999999999998865432
Q ss_pred CCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 102 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
.....+|+||||+++++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 94 ~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Df 168 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITR-DGVLKLADF 168 (351)
T ss_dssp ---CEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCC
T ss_pred cCCceEEEEEeccCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcC-CCCEEEccc
Confidence 11345889999999988877753 34569999999999999999999999 79999999999999996 778999999
Q ss_pred cccccCccC-----CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017147 182 GSAKQLIAG-----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256 (376)
Q Consensus 182 g~a~~~~~~-----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 256 (376)
|++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999765422 222345779999999999776668999999999999999999999999999999999999988887
Q ss_pred CHHHHhhcCc--CCCCCCCCCCCCCChhhhcc-cCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 257 TREEIRCMNP--NYTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 257 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
....+..... .+................+. ...++++.+||.+||++||.+|||++|+|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 7654432211 11111111111111111111 1137789999999999999999999999999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=376.58 Aligned_cols=256 Identities=27% Similarity=0.428 Sum_probs=217.9
Q ss_pred CCCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 017147 28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTT 100 (376)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (376)
......++|++++.||+|+||+||+|+++.+++.||+|++.+.. ....+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 112 (350)
T 1rdq_E 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-- 112 (350)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred ccCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--
Confidence 34456789999999999999999999999999999999986432 234579999999999999999998843
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEE
Q 017147 101 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 179 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~ 179 (376)
...+|+||||++| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus 113 ---~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~~kL~ 183 (350)
T 1rdq_E 113 ---NSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQ-QGYIQVT 183 (350)
T ss_dssp ---SSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEEC
T ss_pred ---CCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEECC-CCCEEEc
Confidence 3458999999974 77777753 3569999999999999999999999 79999999999999996 7789999
Q ss_pred eecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 180 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 180 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
|||+++.... ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 184 DFg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------- 253 (350)
T 1rdq_E 184 DFGFAKRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------- 253 (350)
T ss_dssp CCTTCEECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------
T ss_pred ccccceeccC--CcccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-------
Confidence 9999986533 23456899999999999654 5899999999999999999999999998887777776652
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCcccccCC
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 326 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 326 (376)
... ++..+++++.+||.+||+.||.+||+ ++++++||||+.+.+.
T Consensus 254 ----------~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~ 303 (350)
T 1rdq_E 254 ----------KVR------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp ----------CCC------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred ----------CCC------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence 111 22347999999999999999999998 9999999999987654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=385.92 Aligned_cols=280 Identities=32% Similarity=0.570 Sum_probs=228.6
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc---chHHHHHHHHhC------CCCceeeeceeeeecCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVM------DHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~ 102 (376)
...+|++.+.||+|+||+||+|.+..+++.||||++..... ...+|+.+++.+ +|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~--- 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR--- 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET---
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC---
Confidence 45689999999999999999999999999999999976532 334688888777 577999999988543
Q ss_pred CceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCc--EEEEe
Q 017147 103 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICD 180 (376)
Q Consensus 103 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~--vkl~D 180 (376)
..+|+||||++++|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++. +||+|
T Consensus 172 --~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~~-~~~~~vkL~D 245 (429)
T 3kvw_A 172 --NHICMTFELLSMNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLKQ-QGRSGIKVID 245 (429)
T ss_dssp --TEEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEESS-TTSCCEEECC
T ss_pred --CeEEEEEeccCCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcc-CCCcceEEee
Confidence 348999999999998888642 23458999999999999999999999 79999999999999996 444 99999
Q ss_pred ecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 181 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 181 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
||++.... ....+..+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+++.++.|+...
T Consensus 246 FG~a~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~ 322 (429)
T 3kvw_A 246 FGSSCYEH--QRVYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322 (429)
T ss_dssp CTTCEETT--CCCCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccceecC--CcccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 99997543 233456889999999999765 489999999999999999999999999999999999999999999876
Q ss_pred HhhcCcC--------CCCC----------------------CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC
Q 017147 261 IRCMNPN--------YTDF----------------------RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310 (376)
Q Consensus 261 ~~~~~~~--------~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 310 (376)
+...... +..+ .........|...+....++++.+||++||++||++|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 5532110 0000 000112334556666667899999999999999999999
Q ss_pred HHHHhcCCCcccc
Q 017147 311 ALEACAHPFFDEL 323 (376)
Q Consensus 311 ~~e~l~hp~~~~~ 323 (376)
++|+|+||||+..
T Consensus 403 a~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 403 PGQALRHPWLRRR 415 (429)
T ss_dssp HHHHHTSTTTC--
T ss_pred HHHHhCChhhccC
Confidence 9999999999874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=381.89 Aligned_cols=257 Identities=25% Similarity=0.385 Sum_probs=213.4
Q ss_pred CcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
....++|++++.||+|+||+||+|.+..+++.||+|++.+.. ....+|+.+++.++||||+++++++.+
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~---- 86 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD---- 86 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence 345678999999999999999999999999999999986432 234579999999999999999998843
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
...+|+||||+.| +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 87 -~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~g~vkL~DF 159 (384)
T 4fr4_A 87 -EEDMFMVVDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLDE-HGHVHITDF 159 (384)
T ss_dssp -SSEEEEEECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCC
T ss_pred -CCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEECC-CCCEEEecc
Confidence 3348999999975 6666664 45679999999999999999999999 79999999999999996 778999999
Q ss_pred cccccCccCCCceeeeeccccCchhhhhC--CCCCCchhhhHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCC
Q 017147 182 GSAKQLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGTP 256 (376)
Q Consensus 182 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~ 256 (376)
|++.............||+.|+|||++.+ ...++.++|||||||++|+|++|..||..... .+....+...
T Consensus 160 G~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~---- 235 (384)
T 4fr4_A 160 NIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT---- 235 (384)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC----
T ss_pred ceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc----
Confidence 99987766666667889999999999854 23488999999999999999999999975432 2222222210
Q ss_pred CHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-HHHHhcCCCcccccCC
Q 017147 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEACAHPFFDELREP 326 (376)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-~~e~l~hp~~~~~~~~ 326 (376)
.. .++..+++++.+||.+||+.||.+||+ ++++++||||+++.|.
T Consensus 236 -------------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~ 281 (384)
T 4fr4_A 236 -------------VV------------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD 281 (384)
T ss_dssp -------------CC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred -------------cc------------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence 00 122347899999999999999999998 8999999999988764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=377.02 Aligned_cols=261 Identities=27% Similarity=0.374 Sum_probs=213.0
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc---------ccchHHHHHHHHhCCCCceeeeceeeeecCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS 101 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (376)
...++|++.+.||+|+||+||+|.++.+++.||||++... .....+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 98 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD-- 98 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--
Confidence 4457899999999999999999999999999999998532 23356899999999999999999988543
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCC--CcEEE
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVKI 178 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~--~~vkl 178 (376)
..+|+|||||+| +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+|||++.++ ..+||
T Consensus 99 ---~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl 174 (351)
T 3c0i_A 99 ---GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKL 174 (351)
T ss_dssp ---TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEE
T ss_pred ---CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEE
Confidence 348999999984 7777776555556679999999999999999999999 7999999999999998532 34999
Q ss_pred EeecccccCccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017147 179 CDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257 (376)
Q Consensus 179 ~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 257 (376)
+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. .+....+.+......
T Consensus 175 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~ 252 (351)
T 3c0i_A 175 GGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMN 252 (351)
T ss_dssp CCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCC
T ss_pred ecCcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCC
Confidence 99999986654332 3356789999999999654 58999999999999999999999998753 344444443211111
Q ss_pred HHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
.. ....+++++++||.+||+.||++|||+.++++||||+...
T Consensus 253 ~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 253 PR-------------------------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp HH-------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred cc-------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 11 1134789999999999999999999999999999998743
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=383.41 Aligned_cols=263 Identities=27% Similarity=0.425 Sum_probs=217.5
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
..++|++.+.||+|+||+||+|+++.+++.||+|++.+. .....+|..++..++|+||+++++++.+ .
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-----~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD-----E 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC-----S
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----C
Confidence 356899999999999999999999999999999998642 2345689999999999999999998843 3
Q ss_pred eEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
..+|+||||++ |+|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld~-~g~vkL~DFGl 208 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLDR-CGHIRLADFGS 208 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeecC-CCCEEEeechh
Confidence 45899999997 588777753 23579999999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccCCC--ceeeeeccccCchhhhhC------CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017147 184 AKQLIAGEA--NISYICSRFYRAPELIFG------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255 (376)
Q Consensus 184 a~~~~~~~~--~~~~~~t~~y~aPE~l~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 255 (376)
++....... ....+||+.|+|||++.+ ...++.++|||||||++|+|++|++||.+.+..+...++.+....
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 288 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 986644432 224578999999999862 345899999999999999999999999999888887777642100
Q ss_pred CCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCC---CCHHHHhcCCCcccccCCCCC
Q 017147 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR---CTALEACAHPFFDELREPNAR 329 (376)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---~t~~e~l~hp~~~~~~~~~~~ 329 (376)
..+|. +...+|+++++||++||+ +|.+| ++++|+++||||+.+.|....
T Consensus 289 ---------------~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~ 340 (412)
T 2vd5_A 289 ---------------LSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR 340 (412)
T ss_dssp ---------------CCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred ---------------cCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence 00110 123479999999999999 99998 489999999999999887553
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=366.63 Aligned_cols=253 Identities=25% Similarity=0.400 Sum_probs=212.5
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
...+|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.... .+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~ 92 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----EL 92 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC-----EE
Confidence 3568999999999999999999999999999999986432 33457999999999999999999885433 38
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|+||||+.+ +|.+.+.. ..+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 93 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQ 165 (297)
T ss_dssp EEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEECC-CCCEEEeeCCCcee
Confidence 899999975 77776653 368999999999999999999999 79999999999999996 77899999999876
Q ss_pred CccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 187 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 187 ~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+........
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------- 236 (297)
T 3fxz_A 166 ITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-------- 236 (297)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC--------
T ss_pred cCCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence 544332 3456789999999999764 589999999999999999999999999887776665554211100
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
..+..+++.+.+||.+||+.||.+|||++|+++||||+..
T Consensus 237 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 237 ------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp ------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ------------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 0123478999999999999999999999999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-51 Score=387.80 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=213.6
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
...++|++.+.||+|+||+||+|.++.+++.||+|++.... ....+|+.+++.++||||+++++++. ..
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~ 82 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS-----EE 82 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE-----CS
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE-----EC
Confidence 45678999999999999999999999999999999986543 23458999999999999999999884 34
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC--CCCcEEEEee
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDF 181 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~--~~~~vkl~Df 181 (376)
...|+|||||.| +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+||
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~----~~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~~vkL~DF 157 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIV----AREYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADF 157 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred CEEEEEEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCCcEEEccC
Confidence 458999999986 7777665 34679999999999999999999999 79999999999999984 2467999999
Q ss_pred cccccCccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 182 GSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 182 g~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
|++........ .....||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+.+..+.......
T Consensus 158 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~---- 232 (444)
T 3soa_A 158 GLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF---- 232 (444)
T ss_dssp SSCBCCCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC----
T ss_pred ceeEEecCCCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC----
Confidence 99976654332 3456789999999999654 58999999999999999999999999998888777766521111
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
+. .....+++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 233 -------------~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 233 -------------PS--------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp -------------CT--------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred -------------Cc--------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 10 0113479999999999999999999999999999999764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=378.61 Aligned_cols=257 Identities=28% Similarity=0.422 Sum_probs=215.1
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
...++|++.+.||+|+||.||+|.++.+++.||+|++.... ....+|+.+++.++||||+++++++. ..
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~ 100 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EE 100 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eC
Confidence 34568999999999999999999999999999999986542 23457999999999999999999884 33
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC--CCcEEEEee
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDF 181 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~--~~~vkl~Df 181 (376)
...|+||||+.| +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.+ +..+||+||
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Df 175 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADF 175 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred CEEEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeec
Confidence 458899999986 7766664 34679999999999999999999999 799999999999999853 246999999
Q ss_pred cccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 182 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
|++.............||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+......
T Consensus 176 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~------ 248 (362)
T 2bdw_A 176 GLAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD------ 248 (362)
T ss_dssp TTCBCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC------
T ss_pred CcceEecCCcccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC------
Confidence 999876655555567889999999999654 5899999999999999999999999998887777666552111
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
++. .....+++++++||.+||+.||.+|||+.++|+||||...
T Consensus 249 -----------~~~--------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 249 -----------YPS--------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp -----------CCT--------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred -----------CCc--------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 110 0112478999999999999999999999999999999764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-51 Score=380.29 Aligned_cols=257 Identities=25% Similarity=0.434 Sum_probs=211.3
Q ss_pred CcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccc-------hHHHHHH-HHhCCCCceeeeceeeeecCC
Q 017147 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQL-MRVMDHPNVISLKHCFFSTTS 101 (376)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-------~~~e~~~-l~~l~h~~iv~~~~~~~~~~~ 101 (376)
....++|++++.||+|+||+||+|+++.+++.||+|++.+.... ...|..+ ++.++||||+++++++..
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--- 110 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--- 110 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC---
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe---
Confidence 34567999999999999999999999999999999999754321 2234444 467899999999998843
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEe
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 180 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~D 180 (376)
...+|+||||++| +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus 111 --~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~g~ikL~D 182 (373)
T 2r5t_A 111 --ADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDS-QGHIVLTD 182 (373)
T ss_dssp --SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECC
T ss_pred --CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECC-CCCEEEee
Confidence 3358999999986 77766653 3578999999999999999999999 79999999999999996 77899999
Q ss_pred ecccccCcc-CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 181 FGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 181 fg~a~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
||+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 183 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------- 254 (373)
T 2r5t_A 183 FGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK------- 254 (373)
T ss_dssp CCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-------
T ss_pred CccccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------
Confidence 999986332 3334567889999999999654 5899999999999999999999999998888877777652
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCcccccCCC
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREPN 327 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~e~l~hp~~~~~~~~~ 327 (376)
... ++..+++++++||.+||+.||.+|+++ .++++||||+.+.|..
T Consensus 255 ----------~~~------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~ 304 (373)
T 2r5t_A 255 ----------PLQ------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD 304 (373)
T ss_dssp ----------CCC------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred ----------ccC------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence 011 223579999999999999999999986 6999999999887653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-51 Score=385.23 Aligned_cols=292 Identities=32% Similarity=0.530 Sum_probs=213.8
Q ss_pred ccceeee-eeeeecCCCeeEEEEEEc--CCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 32 QTISYMA-ERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 32 ~~~~y~~-~~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
..+.|++ .+.||+|+||+||+|.++ .+++.||||++.... ....+|+.+|+.++||||+++++++.... ...
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~~ 94 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHA---DRK 94 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETT---TTE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCC---CCe
Confidence 3456887 558999999999999976 578899999986543 34568999999999999999999986533 234
Q ss_pred EEEEeecccchHHHHHHhhhhc-----CCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEc---CCCCcEEE
Q 017147 107 LNLVMEYVPESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD---PLTHQVKI 178 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~---~~~~~vkl 178 (376)
+|+||||+.++|.+.+...... ...+++..++.++.||+.||.|||+ +||+||||||+|||+. ..++.+||
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 8899999999998888643322 2359999999999999999999999 7999999999999993 23678999
Q ss_pred EeecccccCccC----CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCCh---------HHH
Q 017147 179 CDFGSAKQLIAG----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQ 245 (376)
Q Consensus 179 ~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~ 245 (376)
+|||+++..... .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+... .++
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 999999865432 2233467899999999997766689999999999999999999999987654 478
Q ss_pred HHHHHHHhCCCCHHHHhhcCcC---------CCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 246 LVEIIKVLGTPTREEIRCMNPN---------YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 246 ~~~i~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
+..+.+.+|.|....|...... +....+.......+........++.+.+||.+||++||.+|||++|+|+
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 8899999998886554432110 0000000000001111122234789999999999999999999999999
Q ss_pred CCCcccccCCC
Q 017147 317 HPFFDELREPN 327 (376)
Q Consensus 317 hp~~~~~~~~~ 327 (376)
||||+....+.
T Consensus 334 hp~f~~~~~~~ 344 (405)
T 3rgf_A 334 DPYFLEDPLPT 344 (405)
T ss_dssp SGGGTSSSCCC
T ss_pred ChhhccCCCCc
Confidence 99998865443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-51 Score=376.06 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=211.5
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEE
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
...++|++.+.||+|+||+||+|.++.+++.||+|++.+......+|++++..+ +||||+++++++. +...+|+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~l 93 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYD-----DGKYVYV 93 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEE-----CSSEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEE-----cCCEEEE
Confidence 456789999999999999999999999999999999988777778899998887 7999999999984 3445899
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC---cEEEEeecccc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH---QVKICDFGSAK 185 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~---~vkl~Dfg~a~ 185 (376)
|||||.| +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||+...++ .+||+|||++.
T Consensus 94 v~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 94 VTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EECCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 9999985 7777665 34679999999999999999999999 79999999999999854333 59999999998
Q ss_pred cCccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHhCCCCHHHH
Q 017147 186 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 186 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~ 261 (376)
...... ...+..+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+. +..+.+..+...
T Consensus 169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~--------- 238 (342)
T 2qr7_A 169 QLRAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG--------- 238 (342)
T ss_dssp ECBCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC---------
T ss_pred cCcCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC---------
Confidence 654432 33456789999999999654 4889999999999999999999999863 333444443331
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
.+.+ ....+..+++++++||++||..||++|||+.++++||||.++.
T Consensus 239 --------~~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 239 --------KFSL--------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp --------CCCC--------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred --------Cccc--------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence 0111 0112235799999999999999999999999999999997653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-51 Score=377.79 Aligned_cols=255 Identities=28% Similarity=0.421 Sum_probs=214.3
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 102 (376)
...++|++.+.||+|+||+||+|+++.+++.||+|++.+.. .....|..++..+ +||+|+++++++..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~---- 92 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT---- 92 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC----
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc----
Confidence 34578999999999999999999999999999999986532 2234788888877 79999999998843
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
...+|+||||++| +|...+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 93 -~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~g~vkL~DF 165 (353)
T 2i0e_A 93 -MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDS-EGHIKIADF 165 (353)
T ss_dssp -SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCC
T ss_pred -CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEcC-CCcEEEEeC
Confidence 3458999999985 77777653 3579999999999999999999999 79999999999999996 778999999
Q ss_pred cccccCcc-CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 182 GSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 182 g~a~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
|+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.+.
T Consensus 166 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-------- 236 (353)
T 2i0e_A 166 GMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-------- 236 (353)
T ss_dssp TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred CcccccccCCcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--------
Confidence 99986432 3334567889999999999654 5899999999999999999999999999888877777652
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCcccccCC
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 326 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 326 (376)
... ++..+++++++||.+||+.||.+||+ ++++++||||+.+.|.
T Consensus 237 ---------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~ 286 (353)
T 2i0e_A 237 ---------NVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 286 (353)
T ss_dssp ---------CCC------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred ---------CCC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence 111 22357999999999999999999994 6999999999987654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=371.35 Aligned_cols=282 Identities=33% Similarity=0.593 Sum_probs=228.1
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+|+.+++.++||||+++++++... .
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 97 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-----K 97 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----T
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC-----C
Confidence 46789999999999999999999999999999999864432 234799999999999999999998433 3
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
..|+||||++++++..+. .....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 98 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~ 172 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLE---LFPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQ-SGVVKLCDFGFAR 172 (331)
T ss_dssp EEEEEEECCSEEHHHHHH---HSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCTTC-
T ss_pred EEEEEEecCCcchHHHHH---hhccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEcC-CCcEEEEeCCCce
Confidence 488999999986555543 245679999999999999999999999 79999999999999996 7789999999997
Q ss_pred cCccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh-
Q 017147 186 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC- 263 (376)
Q Consensus 186 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~- 263 (376)
...... ......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.........
T Consensus 173 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 173 TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred eecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence 654322 234467899999999997765689999999999999999999999999999999999999888877654332
Q ss_pred -cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 264 -MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 264 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
..+.+.....+..............+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 233344445555444333333444689999999999999999999999999999999863
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=374.79 Aligned_cols=253 Identities=21% Similarity=0.246 Sum_probs=186.3
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccc---hHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---KNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
.+|.+.+.||+|+||+||+|++ +|+.||||++..+... .+.|+..+..++|||||++++++.... .....+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEE
Confidence 4799999999999999999987 6899999998654322 234566667889999999999986543 223457899
Q ss_pred eeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCC--------CeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 111 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP--------RVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 111 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--------~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
||||+ |+|.+.+.. ..+++..+..++.|++.||.|||+ + +|+||||||+|||++. ++.+||+||
T Consensus 80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~~-~~~~Ki~DF 152 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADL 152 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEECT-TSCEEECCC
T ss_pred ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEECC-CCCEEEEeC
Confidence 99998 588887753 468999999999999999999997 6 9999999999999996 788999999
Q ss_pred cccccCccCCC-----ceeeeeccccCchhhhhCCC-----CCCchhhhHhHHHHHHHHHhCCCCCCCCCh---------
Q 017147 182 GSAKQLIAGEA-----NISYICSRFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENA--------- 242 (376)
Q Consensus 182 g~a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------- 242 (376)
|+|+....... ....+||+.|||||++.+.. .++.++|||||||++|||+||.+||.....
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 99976544332 22457899999999996532 256799999999999999999887643321
Q ss_pred -----HHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 243 -----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 243 -----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.+.+...... .. .+-.+|. .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~-------------~~-~rp~~p~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCE-------------QK-LRPNIPN-------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CSSCCHHHHHHHHTT-------------SC-CCCCCCG-------GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHhc-------------cc-CCCCCCc-------cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1111111100 00 0000000 00001123568899999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=377.13 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=216.3
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
...++|++.+.||+|+||+||+|.++.+++.||+|++... .....+|+.+++.++||||+++++++.. ...
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~ 122 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYE 122 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-----CCE
Confidence 3457899999999999999999999999999999998653 2345689999999999999999999843 344
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC-CCCcEEEEeeccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSA 184 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~-~~~~vkl~Dfg~a 184 (376)
+|+||||+.| +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ..+.+||+|||++
T Consensus 123 ~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a 198 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLA 198 (387)
T ss_dssp EEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEecccc
Confidence 8999999985 76666542 34579999999999999999999999 79999999999999974 2467999999999
Q ss_pred ccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
.............+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~---------- 267 (387)
T 1kob_A 199 TKLNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW---------- 267 (387)
T ss_dssp EECCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC----------
T ss_pred eecCCCcceeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------
Confidence 877655555567889999999999654 589999999999999999999999999888777766654211
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
.++ ......+++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 268 -------~~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 268 -------EFD--------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp -------CCC--------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred -------CCC--------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 110 111234799999999999999999999999999999998743
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-50 Score=372.60 Aligned_cols=316 Identities=34% Similarity=0.580 Sum_probs=239.9
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCC-Cce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~~~ 105 (376)
.++|.+.+.||+|+||+||+|.++.+|+.||||++.... ....+|+.+++.++||||+++++++...... ...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999999999999999986432 2335799999999999999999988543321 112
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.+|+||||+.++|.+.+. ..+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 103 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~~-~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNE-DCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCSEEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECT-TCCEEECSTTCTT
T ss_pred eEEEEeccccCCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeECC-CCcEEEeeccccc
Confidence 358999999987655442 459999999999999999999999 79999999999999996 7789999999997
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..|.+..+.+....
T Consensus 175 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 175 HADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp C----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred CCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 5432 23346789999999999765678999999999999999999999999999999999999999988877655433
Q ss_pred cCCCC---CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCc
Q 017147 266 PNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF 342 (376)
Q Consensus 266 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 342 (376)
..... ...+......+... ...+++++.+||.+||+.||++|||+.++++||||+.++.+........ .++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~----~~~~ 327 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQL-FPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ----PFDD 327 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTT-CTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS----CCCC
T ss_pred hHHHHHHHHhCcCCCCccHHHh-cCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCC----CCcc
Confidence 21000 01111122222222 2357899999999999999999999999999999998876544322221 2232
Q ss_pred hhhhccCCHHHHhhhcHHHHH
Q 017147 343 KQELSGASPELVNKLIPDHVK 363 (376)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~ 363 (376)
..+....+.+..++.+.+++.
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~ 348 (353)
T 3coi_A 328 SLEHEKLTVDEWKQHIYKEIV 348 (353)
T ss_dssp TTTTCCCCHHHHHHHHHHHHH
T ss_pred chhhccCCHHHHHHHHHHHHH
Confidence 333345566666665555543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=363.39 Aligned_cols=292 Identities=33% Similarity=0.563 Sum_probs=234.3
Q ss_pred CCcccceeeeeeeeecCCCeeEEEEEEc-CCCcEEEEEEeeccc------cchHHHHHHHHhC---CCCceeeeceeeee
Q 017147 29 EPKQTISYMAERVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDR------RYKNRELQLMRVM---DHPNVISLKHCFFS 98 (376)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~------~~~~~e~~~l~~l---~h~~iv~~~~~~~~ 98 (376)
.....++|++.+.||+|+||+||+|.+. .+++.||+|++.... ....+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp CCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred ccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 3445678999999999999999999995 678999999885422 2345788777766 89999999998864
Q ss_pred cCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEE
Q 017147 99 TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 178 (376)
Q Consensus 99 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl 178 (376)
........+++||||++++|.+.+... ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~~-~~~~kl 161 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKL 161 (326)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEE
T ss_pred cccCCCceEEEEEecCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEcC-CCCEEE
Confidence 444456678999999999988887642 23458999999999999999999999 79999999999999996 778999
Q ss_pred EeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 179 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 179 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
+|||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+..
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 162 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp CSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred ecCcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 999999866544444566789999999999654 4899999999999999999999999999999999999998888876
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCC
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 327 (376)
..+...... ....+......+. ..+...+++.+.+||.+||+.||.+|||+.++++||||++++...
T Consensus 241 ~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 241 EDWPRDVAL-PRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 307 (326)
T ss_dssp GGSCTTCSS-CGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred ccCcccccc-chhhhcccCcchh-hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence 654321111 0111111111122 223456899999999999999999999999999999999876543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=360.24 Aligned_cols=257 Identities=28% Similarity=0.442 Sum_probs=208.8
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
..++|++.+.||+|+||+||+|.++.+++.+|+|++.... ....+|+.+++.++||||+++++++.. ...
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 94 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-----YHN 94 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-----CCe
Confidence 4578999999999999999999999999999999986543 334689999999999999999998843 334
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC--CCcEEEEeecc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGS 183 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~--~~~vkl~Dfg~ 183 (376)
.|+||||+++ +|.+.+.........+++..++.++.|++.||+|||+ +||+||||||+||+++.. .+.+||+|||+
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 8899999985 8888887665566889999999999999999999999 799999999999999532 46799999999
Q ss_pred cccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 184 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 184 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
+.............+|+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 174 a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--------- 242 (285)
T 3is5_A 174 AELFKSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP--------- 242 (285)
T ss_dssp CCC----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred ceecCCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc---------
Confidence 98765555555677899999999984 3589999999999999999999999998876665544433110
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
.+ + .....+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus 243 ---~~-----~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 243 ---NY-----A---------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ---CC-----C---------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ---cc-----c---------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 00 0 001236889999999999999999999999999999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-50 Score=368.67 Aligned_cols=255 Identities=27% Similarity=0.458 Sum_probs=207.4
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEc---CCCcEEEEEEeeccc--------cchHHHHHHHHhCCCCceeeeceeeeec
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVMDHPNVISLKHCFFST 99 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (376)
...++|++.+.||+|+||+||+|++. .+++.||+|++.+.. ....+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 34578999999999999999999985 689999999986432 2335799999999999999999988543
Q ss_pred CCCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEE
Q 017147 100 TSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 178 (376)
Q Consensus 100 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl 178 (376)
. .+|+||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||
T Consensus 94 ~-----~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~-~~~~kl 162 (327)
T 3a62_A 94 G-----KLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLNH-QGHVKL 162 (327)
T ss_dssp S-----CEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECT-TSCEEE
T ss_pred C-----EEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEECC-CCcEEE
Confidence 3 38999999984 77776653 3568999999999999999999999 79999999999999996 778999
Q ss_pred EeecccccCccC-CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017147 179 CDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257 (376)
Q Consensus 179 ~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 257 (376)
+|||+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+..
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---- 237 (327)
T 3a62_A 163 TDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK---- 237 (327)
T ss_dssp CCCSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC----
T ss_pred EeCCcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC----
Confidence 999998754322 223345789999999999654 58999999999999999999999999988887777666521
Q ss_pred HHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCC
Q 017147 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326 (376)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 326 (376)
.. ++..+++++.+||.+||+.||.+|| ++.++++||||+.+.+.
T Consensus 238 -------------~~------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~ 286 (327)
T 3a62_A 238 -------------LN------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE 286 (327)
T ss_dssp -------------CC------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred -------------CC------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence 01 1234789999999999999999999 89999999999987654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=386.25 Aligned_cols=255 Identities=30% Similarity=0.450 Sum_probs=217.0
Q ss_pred CCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 017147 29 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 101 (376)
Q Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (376)
.....++|.+.+.||+|+||+||+|.+..+|+.||||++.+.. ....+|+.+++.++||||+++++++...
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-- 88 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-- 88 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS--
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--
Confidence 3456678999999999999999999999999999999986432 2346899999999999999999998433
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEe
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 180 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~D 180 (376)
..+|+||||++| +|.+.+. ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus 89 ---~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~~-~~~vkL~D 159 (476)
T 2y94_A 89 ---SDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDA-HMNAKIAD 159 (476)
T ss_dssp ---SEEEEEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEECT-TCCEEECC
T ss_pred ---CEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEec-CCCeEEEe
Confidence 348999999974 7766654 45679999999999999999999999 79999999999999996 77899999
Q ss_pred ecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 181 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 181 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
||++..........+.+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+....
T Consensus 160 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------- 232 (476)
T 2y94_A 160 FGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI------- 232 (476)
T ss_dssp CSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-------
T ss_pred ccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-------
Confidence 9999877665555667899999999999776545789999999999999999999999888777666655411
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
+. .+..+++++.+||++||+.||.+|||+.++++||||+..
T Consensus 233 ----------~~------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 233 ----------FY------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ----------CC------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ----------cC------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 01 123478999999999999999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=389.89 Aligned_cols=258 Identities=28% Similarity=0.451 Sum_probs=215.4
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----------------cchHHHHHHHHhCCCCceeeec
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------------RYKNRELQLMRVMDHPNVISLK 93 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----------------~~~~~e~~~l~~l~h~~iv~~~ 93 (376)
...++|++++.||+|+||+||+|.++.+++.||+|++.+.. ....+|+.+++.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35678999999999999999999999999999999986432 2245799999999999999999
Q ss_pred eeeeecCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC
Q 017147 94 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL 172 (376)
Q Consensus 94 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~ 172 (376)
+++. ....+|+|||||+| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.+
T Consensus 113 ~~~~-----~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~ 182 (504)
T 3q5i_A 113 DVFE-----DKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILLENK 182 (504)
T ss_dssp EEEE-----CSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESST
T ss_pred EEEE-----cCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEEecC
Confidence 9984 34458999999985 77776653 3569999999999999999999999 799999999999999863
Q ss_pred CC--cEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017147 173 TH--QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250 (376)
Q Consensus 173 ~~--~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 250 (376)
+. .+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..+.+..+.
T Consensus 183 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 260 (504)
T 3q5i_A 183 NSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260 (504)
T ss_dssp TCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 32 699999999987766655667789999999999853 48999999999999999999999999999888877776
Q ss_pred HHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
+........ ....+|+++++||++||++||.+|||++|+|+||||+....
T Consensus 261 ~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 261 KGKYYFDFN-------------------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp HCCCCCCHH-------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred cCCCCCCcc-------------------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 532111111 12347999999999999999999999999999999987543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=366.18 Aligned_cols=258 Identities=26% Similarity=0.450 Sum_probs=205.6
Q ss_pred CCCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------------------------------cchHHH
Q 017147 28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------------------------RYKNRE 77 (376)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------------------------~~~~~e 77 (376)
+.....++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 86 (298)
T 2zv2_A 7 GDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE 86 (298)
T ss_dssp ---CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred CCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence 34456679999999999999999999999999999999986432 234579
Q ss_pred HHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 017147 78 LQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 156 (376)
Q Consensus 78 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ 156 (376)
+.+++.++||||+++++++... ....+|+||||+++ +|.+. .....+++..++.++.||+.||.|||+ +|
T Consensus 87 ~~~l~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ 157 (298)
T 2zv2_A 87 IAILKKLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEV-----PTLKPLSEDQARFYFQDLIKGIEYLHY-QK 157 (298)
T ss_dssp HHHHHTCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCS-----SCSSCCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred HHHHHhCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHH-----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence 9999999999999999988542 23458899999986 43332 134579999999999999999999999 79
Q ss_pred eeecCCCCCcEEEcCCCCcEEEEeecccccCccCCC-ceeeeeccccCchhhhhCCCC--CCchhhhHhHHHHHHHHHhC
Q 017147 157 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLG 233 (376)
Q Consensus 157 i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~--~~~~~DiwslG~il~~ll~g 233 (376)
|+||||||+|||++. ++.+||+|||++........ .....+|+.|+|||++.+... ++.++|||||||++|+|++|
T Consensus 158 ivH~Dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g 236 (298)
T 2zv2_A 158 IIHRDIKPSNLLVGE-DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236 (298)
T ss_dssp EECCCCCGGGEEECT-TSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred eeccCCCHHHEEECC-CCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence 999999999999996 77899999999986544332 234578999999999865432 37889999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHH
Q 017147 234 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313 (376)
Q Consensus 234 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 313 (376)
..||.+.+.......+.... ..++. ...+++++.+||.+||+.||++|||+.|
T Consensus 237 ~~pf~~~~~~~~~~~~~~~~-----------------~~~~~----------~~~~~~~l~~li~~~l~~dp~~R~s~~e 289 (298)
T 2zv2_A 237 QCPFMDERIMCLHSKIKSQA-----------------LEFPD----------QPDIAEDLKDLITRMLDKNPESRIVVPE 289 (298)
T ss_dssp SCSSCCSSHHHHHHHHHHCC-----------------CCCCS----------SSCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred CCCCCCccHHHHHHHHhccc-----------------CCCCC----------ccccCHHHHHHHHHHhhcChhhCCCHHH
Confidence 99999887665554443310 01110 1247899999999999999999999999
Q ss_pred HhcCCCccc
Q 017147 314 ACAHPFFDE 322 (376)
Q Consensus 314 ~l~hp~~~~ 322 (376)
+++||||+.
T Consensus 290 ~l~hp~~~~ 298 (298)
T 2zv2_A 290 IKLHPWVTR 298 (298)
T ss_dssp HTTCHHHHC
T ss_pred HhcCccccC
Confidence 999999963
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=367.05 Aligned_cols=284 Identities=29% Similarity=0.515 Sum_probs=220.9
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-ccchHHHHHHHHhCC-CCceeeeceeeeecCCCCceEEE
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
...++|++.+.||+|+||+||+|.+..+++.||+|++... .....+|+.+++.++ ||||+++++++.... ....+
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~---~~~~~ 109 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTPA 109 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCCEE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCC---CCceE
Confidence 3457899999999999999999999999999999998643 344568999999997 999999999885422 33478
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||+.+ +|...+ ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||++...
T Consensus 110 lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EEEECCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999996 544443 248899999999999999999999 799999999999999975558999999999876
Q ss_pred ccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHh-hcC
Q 017147 188 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEIIKVLGTPTREEIR-CMN 265 (376)
Q Consensus 188 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~-~~~ 265 (376)
..........+|+.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+.+.++.+...... ...
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 65555556788999999999977567899999999999999999999998 4556667777777766654332211 111
Q ss_pred cCCCCC---CCCCCCCCChhhhc----ccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 266 PNYTDF---RFPQIKAHPWHKVF----HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 266 ~~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
...... .........|...+ ...+++++.+||.+||++||.+|||++|+|+||||+++.+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 000000 00011111222221 2237899999999999999999999999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=366.85 Aligned_cols=257 Identities=25% Similarity=0.333 Sum_probs=207.6
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
+..++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++. ...
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~ 78 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGN 78 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCC
Confidence 35678999999999999999999999999999999985432 34568999999999999999999884 334
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..|+||||+++ +|.+.+ .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~-~~~~kl~Dfg~a 152 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGLA 152 (323)
T ss_dssp EEEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTTC
T ss_pred eEEEEEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEeC-CCCEEEEEeecc
Confidence 58899999986 554444 345679999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCccCC---CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 185 KQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 185 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
....... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+...............
T Consensus 153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----- 227 (323)
T 3tki_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----- 227 (323)
T ss_dssp EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT-----
T ss_pred ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc-----
Confidence 7653322 22356789999999999776545789999999999999999999998765432222221110000
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
.. ....+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus 228 ----------------~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 228 ----------------LN-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp ----------------ST-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ----------------CC-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 00 0134789999999999999999999999999999998753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=377.15 Aligned_cols=259 Identities=27% Similarity=0.460 Sum_probs=196.6
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
..++|++.+.||+|+||+||+|.++.+++.||+|++.... ....+|+.+++.++||||+++++++... ..+|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~ 92 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTP-----THLA 92 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeC-----CEEE
Confidence 4568999999999999999999999999999999997543 3346899999999999999999998543 3488
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCC-CcEEEEeeccccc
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT-HQVKICDFGSAKQ 186 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~-~~vkl~Dfg~a~~ 186 (376)
+||||+.+ +|.+.+.. ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ ..+||+|||+++.
T Consensus 93 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 93 IIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 99999975 77776653 3579999999999999999999999 7999999999999998522 2499999999975
Q ss_pred CccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 187 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
...........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.+.....
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~---------- 237 (361)
T 3uc3_A 168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV---------- 237 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT----------
T ss_pred ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC----------
Confidence 5444445567899999999999776544455999999999999999999998765433333322211000
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.+.++. ...+++++.+||.+||+.||.+|||+.|+++||||...
T Consensus 238 ---~~~~~~----------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 238 ---KYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp ---CCCCCT----------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred ---CCCCCC----------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 011111 12478999999999999999999999999999999653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=357.13 Aligned_cols=262 Identities=26% Similarity=0.385 Sum_probs=216.4
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++. ...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EES 78 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCC
Confidence 3568999999999999999999999999999999986543 23357999999999999999999883 334
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC--CCcEEEEeec
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFG 182 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~--~~~vkl~Dfg 182 (376)
..|+||||+.+ +|.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++.+ +..+||+|||
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg 153 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFG 153 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence 48899999986 76666653 3568999999999999999999999 799999999999999752 2349999999
Q ss_pred ccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 183 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 183 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
++.............+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.......+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----- 227 (284)
T 3kk8_A 154 LAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP----- 227 (284)
T ss_dssp TCEECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-----
T ss_pred eeEEcccCccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCC-----
Confidence 99876655555567889999999999654 489999999999999999999999999887777766654211111
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCC
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 329 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~ 329 (376)
......+++++.+||.+||+.||++|||++|+++||||++.++....
T Consensus 228 --------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~ 274 (284)
T 3kk8_A 228 --------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA 274 (284)
T ss_dssp --------------------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGS
T ss_pred --------------------chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhH
Confidence 00112478999999999999999999999999999999886554433
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=385.10 Aligned_cols=257 Identities=28% Similarity=0.421 Sum_probs=208.9
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
...++|++.+.||+|+||.||+|.++.+++.||||++.+.. ....+|+.+++.++||||+++++++....
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--- 221 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--- 221 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT---
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC---
Confidence 34578999999999999999999999999999999986431 22346888999999999999999985433
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
.+|+||||+++ +|...+.. ...+++..++.++.||+.||+|||+.+||+||||||+|||++. ++.+||+|||
T Consensus 222 --~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~-~~~~kl~DFG 294 (446)
T 4ejn_A 222 --RLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK-DGHIKITDFG 294 (446)
T ss_dssp --EEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECS-SSCEEECCCC
T ss_pred --EEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECC-CCCEEEccCC
Confidence 48999999986 66666643 3579999999999999999999996149999999999999996 7789999999
Q ss_pred ccccCccC-CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 183 SAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 183 ~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--------- 364 (446)
T 4ejn_A 295 LCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--------- 364 (446)
T ss_dssp CCCTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred CceeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC---------
Confidence 99764332 233456789999999999664 5899999999999999999999999998887777666541
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCCC
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 327 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~~ 327 (376)
... ++..+++++.+||.+||++||.+|| |++|+++||||+++.+..
T Consensus 365 --------~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~ 415 (446)
T 4ejn_A 365 --------EIR------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH 415 (446)
T ss_dssp --------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred --------CCC------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHH
Confidence 111 2234789999999999999999999 999999999999986553
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=363.68 Aligned_cols=258 Identities=26% Similarity=0.380 Sum_probs=216.4
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTT 100 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (376)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 86 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN-- 86 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence 34578999999999999999999999999999999986532 234689999999999999999998843
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC---cE
Q 017147 101 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH---QV 176 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~---~v 176 (376)
...+|+||||+++ +|.+.+. ....+++..++.++.|++.||.|||+ +||+||||||+||+++.++. .+
T Consensus 87 ---~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~~~~~~~~~~ 158 (321)
T 2a2a_A 87 ---RTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHI 158 (321)
T ss_dssp ---SSEEEEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCE
T ss_pred ---CCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEecCCCCcCCE
Confidence 3348899999974 7777765 35679999999999999999999999 79999999999999986332 79
Q ss_pred EEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017147 177 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256 (376)
Q Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 256 (376)
||+|||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 159 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 237 (321)
T 2a2a_A 159 KLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237 (321)
T ss_dssp EECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred EEccCccceecCccccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc
Confidence 99999999876655555566789999999999654 58999999999999999999999999988777776655421111
Q ss_pred CHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
. ..+...+++.+.+||.+||+.||++|||++|+++||||+.+.
T Consensus 238 ~-------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 238 D-------------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp C-------------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred C-------------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 1 112235789999999999999999999999999999998764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=368.68 Aligned_cols=279 Identities=25% Similarity=0.436 Sum_probs=222.0
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCC-----CCceeeeceeeeecCCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD-----HPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~ 103 (376)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... .....|+.+++.+. ||||+++++++....
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~--- 109 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD--- 109 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT---
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC---
Confidence 4468999999999999999999999999999999986432 23456899999986 999999999885443
Q ss_pred ceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC------------
Q 017147 104 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP------------ 171 (376)
Q Consensus 104 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~------------ 171 (376)
..|+||||++++|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.
T Consensus 110 --~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 110 --HMCLIFEPLGPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp --EEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred --eeEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchhc
Confidence 48899999988988888642 23458999999999999999999999 79999999999999973
Q ss_pred ------------CCCcEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCC
Q 017147 172 ------------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 239 (376)
Q Consensus 172 ------------~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 239 (376)
.++.+||+|||++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 256799999999975433 23456789999999999765 589999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCcCCC-C--------CCCCCCCCCC--------hhhhcccCCChhHHHHHHhhcC
Q 017147 240 ENAVDQLVEIIKVLGTPTREEIRCMNPNYT-D--------FRFPQIKAHP--------WHKVFHKRMPPEAIDLASRLLQ 302 (376)
Q Consensus 240 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~--------~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~L~ 302 (376)
.+..+.+..+....+.++...+........ . ..++...... ....+....++.+.+||.+||+
T Consensus 262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 999999999998888877765543221100 0 0011100000 0000111235788899999999
Q ss_pred cCCCCCCCHHHHhcCCCcc
Q 017147 303 YSPSLRCTALEACAHPFFD 321 (376)
Q Consensus 303 ~dp~~R~t~~e~l~hp~~~ 321 (376)
+||++|||+.|+|+||||+
T Consensus 342 ~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 342 IDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SSGGGSCCHHHHTTSGGGC
T ss_pred CChhhCCCHHHHhcCcccC
Confidence 9999999999999999996
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=374.40 Aligned_cols=289 Identities=20% Similarity=0.304 Sum_probs=209.9
Q ss_pred CcccceeeeeeeeecC--CCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 017147 30 PKQTISYMAERVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 101 (376)
Q Consensus 30 ~~~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (376)
....++|++++.||+| +||+||+|.++.+++.||||++.... ....+|+.+++.++||||+++++++....
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~- 99 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN- 99 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC-
Confidence 3456799999999999 99999999999999999999996543 23357999999999999999999985433
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEe
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 180 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~D 180 (376)
.+|+|||||.+ +|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus 100 ----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~d 171 (389)
T 3gni_B 100 ----ELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISV-DGKVYLSG 171 (389)
T ss_dssp ----EEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECC
T ss_pred ----EEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEcc
Confidence 48999999985 777777542 23569999999999999999999999 79999999999999996 77899999
Q ss_pred ecccccCccCC--------CceeeeeccccCchhhhhCC-CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017147 181 FGSAKQLIAGE--------ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 251 (376)
Q Consensus 181 fg~a~~~~~~~--------~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 251 (376)
||.+....... ......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 251 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 99886443221 11224678899999999663 4589999999999999999999999988776655544432
Q ss_pred HhCCCCHH-------HHh-hc-----CcCCCCCCC---C-CCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 017147 252 VLGTPTRE-------EIR-CM-----NPNYTDFRF---P-QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314 (376)
Q Consensus 252 ~~~~~~~~-------~~~-~~-----~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 314 (376)
..-..... ... .. .....+... + ..........++..+++++.+||++||++||++|||++|+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 331 (389)
T 3gni_B 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL 331 (389)
T ss_dssp ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 11000000 000 00 000000000 0 0000011122345688999999999999999999999999
Q ss_pred hcCCCcccccCCC
Q 017147 315 CAHPFFDELREPN 327 (376)
Q Consensus 315 l~hp~~~~~~~~~ 327 (376)
|+||||+.+.+..
T Consensus 332 l~hp~f~~~~~~~ 344 (389)
T 3gni_B 332 LNHSFFKQIKRRA 344 (389)
T ss_dssp TTSGGGGGC---C
T ss_pred hcCHHHHHHhhcc
Confidence 9999999887543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=386.54 Aligned_cols=257 Identities=29% Similarity=0.460 Sum_probs=214.4
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
...++|++.+.||+|+||+||+|.++.+++.||+|++.+. .....+|+.+++.++||||+++++++.. .
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~ 93 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----S 93 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-----C
Confidence 4567999999999999999999999999999999998532 2344689999999999999999999843 3
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC--CCCcEEEEee
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDF 181 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~--~~~~vkl~Df 181 (376)
..+|+|||||.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+||
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 168 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDF 168 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred CEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEEC
Confidence 458999999985 77776653 3579999999999999999999999 79999999999999963 2457999999
Q ss_pred cccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 182 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
|++.............||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..+.+..+.........
T Consensus 169 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--- 243 (486)
T 3mwu_A 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL--- 243 (486)
T ss_dssp SCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS---
T ss_pred CcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---
Confidence 99987665555556789999999999965 4899999999999999999999999999888877776652111110
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
.....+|+++++||.+||+.||.+|||+.++|+||||+...
T Consensus 244 ----------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 244 ----------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp ----------------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred ----------------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 01134799999999999999999999999999999998764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=366.14 Aligned_cols=257 Identities=26% Similarity=0.389 Sum_probs=196.8
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
...++|++.+.||+|+||+||+|.+..+++.||+|++... .....+|+.+++.++||||+++++++.. ....+
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFET-----PTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEEC-----SSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEec-----CCeEE
Confidence 4557899999999999999999999999999999998654 3345579999999999999999999843 33488
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC--CCCcEEEEeecccc
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGSAK 185 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~--~~~~vkl~Dfg~a~ 185 (376)
+||||+.+ +|.+.+. ....+++..++.++.|++.||.|||+ +||+||||||+|||++. .++.+||+|||+++
T Consensus 125 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 125 LVLELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp EEECCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 99999985 7766664 34679999999999999999999999 79999999999999973 25789999999998
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhc
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 264 (376)
............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..... .+..+.+...
T Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~---------- 268 (349)
T 2w4o_A 200 IVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY---------- 268 (349)
T ss_dssp -------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC----------
T ss_pred ccCcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC----------
Confidence 66554444566789999999999654 58999999999999999999999998766554 3333332100
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.+ .......++.++.+||++||+.||++|||+.|+++||||+..
T Consensus 269 -------~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 269 -------YF--------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp -------CC--------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred -------cc--------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 00 011123478999999999999999999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=384.73 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=213.5
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
...++|++.+.||+|+||+||+|+++.+|+.||+|++.+.. ....+|+.+++.++||||+++++++..
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----- 256 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET----- 256 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-----
Confidence 34578999999999999999999999999999999996432 234579999999999999999998843
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
...+|+||||++| +|...+.........+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~~-~g~vkL~DFG 334 (543)
T 3c4z_A 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDD-DGNVRISDLG 334 (543)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCCT
T ss_pred CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEeC-CCCEEEeecc
Confidence 3448999999985 7777776543345679999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCC
Q 017147 183 SAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA----VDQLVEIIKVLGTPT 257 (376)
Q Consensus 183 ~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~ 257 (376)
+++....... ....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+. .+....+...
T Consensus 335 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~----- 408 (543)
T 3c4z_A 335 LAVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ----- 408 (543)
T ss_dssp TCEECCTTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-----
T ss_pred eeeeccCCCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-----
Confidence 9987654433 3345899999999999764 589999999999999999999999987642 3333333321
Q ss_pred HHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCcccccCC
Q 017147 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 326 (376)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 326 (376)
.. .++..+++++++||++||+.||++||+ ++++++||||+.+.|.
T Consensus 409 ------------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 409 ------------AV------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp ------------CC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred ------------cc------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 00 122357999999999999999999996 5899999999987654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=358.60 Aligned_cols=258 Identities=25% Similarity=0.382 Sum_probs=199.7
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccc------hHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
..++|++.+.||+|+||+||+|.+..+++.||+|++...... ..++...++.++||||+++++++....
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~----- 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG----- 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-----
Confidence 356899999999999999999999999999999998643211 223445578889999999999885433
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCC-CeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..|+||||+++++.+.+.........+++..++.++.|++.||.|||+ + |++||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~ 157 (290)
T 3fme_A 80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINA-LGQVKMCDFGIS 157 (290)
T ss_dssp SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEECT-TCCEEBCCC---
T ss_pred CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECC-CCCEEEeecCCc
Confidence 388999999999988887766677889999999999999999999999 7 9999999999999996 778999999999
Q ss_pred ccCccCCCceeeeeccccCchhhh---hCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHH
Q 017147 185 KQLIAGEANISYICSRFYRAPELI---FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l---~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~ 260 (376)
.............+|+.|+|||++ .....++.++||||+||++|+|++|..||.... ....+........ +
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~---- 232 (290)
T 3fme_A 158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-P---- 232 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC-C----
T ss_pred ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC-C----
Confidence 876555555556789999999997 344568999999999999999999999998743 3333433333100 0
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
......+++++.+||.+||+.||++|||+.|+++||||+..
T Consensus 233 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 233 ----------------------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp ----------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ----------------------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 00112468999999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=362.88 Aligned_cols=247 Identities=27% Similarity=0.353 Sum_probs=197.4
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccc------hHHHHHHH-HhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLM-RVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
++|++.+.||+|+||+||+|.++.+++.||||++...... ...|+..+ +..+|+||+++++++.. ...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-----~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-----GGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-----CCE
Confidence 6899999999999999999999999999999988543221 12344333 44489999999998843 334
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
+|+||||++++|.+.+.. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 132 ~~lv~e~~~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~-~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLGP-RGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEEEECCCCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECG-GGCEEECCCTTCEE
T ss_pred EEEEEeccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECC-CCCEEEccceeeee
Confidence 899999999998887764 34679999999999999999999999 79999999999999986 77899999999987
Q ss_pred CccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 187 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
...........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...... +.+ +.
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--~~----------- 268 (311)
T 3p1a_A 207 LGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--GY----------- 268 (311)
T ss_dssp CC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT--TC-----------
T ss_pred cccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc--cC-----------
Confidence 655555556678999999999865 589999999999999999999777655332211 111 00
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
....+...+++++.+||.+||+.||++|||++|+++||||++
T Consensus 269 --------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 269 --------------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp --------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred --------------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 011223457999999999999999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-50 Score=386.60 Aligned_cols=258 Identities=31% Similarity=0.519 Sum_probs=217.9
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
...++|++.+.||+|+||+||+|.++.+++.||||++.+. .....+|+.+++.++||||+++++++. .
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~ 97 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-----D 97 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence 4567899999999999999999999999999999998543 223458999999999999999999984 3
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC--CCCcEEEEe
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICD 180 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~--~~~~vkl~D 180 (376)
...+|+|||||.+ +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 172 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDANIRIID 172 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred CCEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCCcEEEEe
Confidence 4458999999985 7766664 35679999999999999999999999 79999999999999952 357899999
Q ss_pred ecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 181 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 181 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
||++.............||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..+.+..+.+......
T Consensus 173 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--- 247 (484)
T 3nyv_A 173 FGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE--- 247 (484)
T ss_dssp TTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---
T ss_pred eeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence 999987666555566788999999999965 489999999999999999999999999998888777765211111
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
......+|+++++||++||++||.+|||+.|+|+||||+....
T Consensus 248 ----------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 248 ----------------------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp ----------------------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred ----------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 0011347999999999999999999999999999999988654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=386.11 Aligned_cols=258 Identities=29% Similarity=0.454 Sum_probs=212.7
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
...++|++.+.||+|+||+||+|.++.+++.||+|++.+.. ....+|+.+|+.++||||+++++++.+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----- 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET----- 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-----
Confidence 44578999999999999999999999999999999986432 234579999999999999999998843
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
...+|+||||++| +|...+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld~-~g~vKL~DFG 331 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLDD-HGHIRISDLG 331 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCCT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEeC-CCCeEEEecc
Confidence 3358999999975 777666531 23459999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCHH
Q 017147 183 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 183 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~ 259 (376)
++............+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+. ...+...+...
T Consensus 332 la~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~------ 404 (576)
T 2acx_A 332 LAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------ 404 (576)
T ss_dssp TCEECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC------
T ss_pred cceecccCccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc------
Confidence 99877655555567899999999999664 489999999999999999999999987642 12222222110
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCC
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 326 (376)
...++..+++++++||++||+.||.+|| +++|+++||||+++.+.
T Consensus 405 ----------------------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~ 454 (576)
T 2acx_A 405 ----------------------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454 (576)
T ss_dssp ----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred ----------------------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence 0012345799999999999999999999 79999999999987654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=362.74 Aligned_cols=288 Identities=30% Similarity=0.504 Sum_probs=221.2
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecC-------
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTT------- 100 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------- 100 (376)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3468999999999999999999999999999999886432 23457999999999999999998874321
Q ss_pred --CCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEE
Q 017147 101 --SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 178 (376)
Q Consensus 101 --~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl 178 (376)
.......|+||||++++|.+.+. ...+++..++.++.|++.||+|||+ +||+||||||+||+++.+++.+||
T Consensus 89 ~~~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp --CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEE
Confidence 12335688999999998887774 3578999999999999999999999 799999999999999865778999
Q ss_pred EeecccccCccCC----CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017147 179 CDFGSAKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254 (376)
Q Consensus 179 ~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 254 (376)
+|||++....... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999998653221 123345688999999987756789999999999999999999999999999888888888777
Q ss_pred CCCHHHHhhcCcCCCCCCCC--CCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 255 TPTREEIRCMNPNYTDFRFP--QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
.+..+...........+... .....++. .+...+++++.+||.+||+.||.+|||++|+++||||+....+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLT-QLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHH-HHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChh-HhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 66655443321111000000 00011111 2234589999999999999999999999999999999986554
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=353.99 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=215.8
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
..++|++.+.||+|+||+||+|.+..++..+|+|++... .....+|+.+++.++||||+++++++.. ....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 81 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED-----NTDI 81 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCeE
Confidence 456899999999999999999999999999999998653 2344689999999999999999998843 3448
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEE---cCCCCcEEEEeecc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGS 183 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill---~~~~~~vkl~Dfg~ 183 (376)
|+||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+||++ +. ++.+||+|||+
T Consensus 82 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~-~~~~~l~Dfg~ 155 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSP-DSPLKLIDFGL 155 (277)
T ss_dssp EEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSST-TCCEEECCCTT
T ss_pred EEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCCC-CCcEEEEeccc
Confidence 899999985 77666653 3568999999999999999999999 799999999999999 53 67899999999
Q ss_pred cccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 184 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 184 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
+.............+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.+.....+...
T Consensus 156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 230 (277)
T 3f3z_A 156 AARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKD--- 230 (277)
T ss_dssp CEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH---
T ss_pred ceeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchh---
Confidence 987666655566788999999999854 389999999999999999999999999888877777665322222211
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
...+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus 231 ----------------------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 231 ----------------------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp ----------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred ----------------------hhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 123689999999999999999999999999999998743
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=371.51 Aligned_cols=254 Identities=28% Similarity=0.393 Sum_probs=206.8
Q ss_pred eeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
|...+.||+|+||+||+|.+..+++.||+|++... .....+|+.+++.++||||+++++++.. ...+|+||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv~ 165 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-----KNDIVLVM 165 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEEEE
Confidence 34467899999999999999999999999998653 2344689999999999999999998843 33488999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEc-CCCCcEEEEeecccccCcc
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD-PLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~-~~~~~vkl~Dfg~a~~~~~ 189 (376)
||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ ..++.+||+|||+++....
T Consensus 166 E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 166 EYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp ECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 99985 77666653 33568999999999999999999999 7999999999999984 2357899999999987765
Q ss_pred CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 017147 190 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269 (376)
Q Consensus 190 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 269 (376)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 242 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~------------ 308 (373)
T 2x4f_A 242 REKLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE------------ 308 (373)
T ss_dssp TCBCCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC------------
T ss_pred ccccccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC------------
Confidence 5555566789999999998654 589999999999999999999999999998888877766321111
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
......+++++++||.+||+.||.+|||+.|+|+||||++.+
T Consensus 309 -------------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 309 -------------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp -------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred -------------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 011134789999999999999999999999999999998753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=383.43 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=212.6
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
..++|++++.||+|+||+||+|.++.++..||+|++.+. .....+|+.+++.++||||+++++++.. ..
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~ 109 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-----KR 109 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CC
Confidence 456899999999999999999999999999999998643 2334589999999999999999999843 34
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC--CCcEEEEeec
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFG 182 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~--~~~vkl~Dfg 182 (376)
.+|+|||||.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.. .+.+||+|||
T Consensus 110 ~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG 184 (494)
T 3lij_A 110 NYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFG 184 (494)
T ss_dssp EEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence 48999999985 77666653 3568999999999999999999999 799999999999999752 3459999999
Q ss_pred ccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 183 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 183 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
++.............||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..+.+..+.........
T Consensus 185 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---- 258 (494)
T 3lij_A 185 LSAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS---- 258 (494)
T ss_dssp TCEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS----
T ss_pred CCeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----
Confidence 9987766655566789999999999853 5899999999999999999999999999888877777653211110
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
.....+|+++++||++||+.||.+|||+.++|+||||+...
T Consensus 259 ---------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 259 ---------------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp ---------------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred ---------------------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 11234799999999999999999999999999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=366.22 Aligned_cols=264 Identities=28% Similarity=0.451 Sum_probs=210.7
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++..
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---- 99 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED---- 99 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc----
Confidence 3478999999999999999999999999999999986432 334579999999999999999999843
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhc------------------------------------CCCcCHHHHHHHHHHHH
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSSA------------------------------------NQRMPLIYVKLYTYQIF 145 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qi~ 145 (376)
....|+|||||+| +|.+.+..+... ...+++..++.++.||+
T Consensus 100 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 100 -EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp -SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred -CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 3458999999975 777666321111 22356788999999999
Q ss_pred HHHHHhhcCCCeeecCCCCCcEEEcCCC-CcEEEEeecccccCccCC-----CceeeeeccccCchhhhhCC-CCCCchh
Q 017147 146 RGLAYIHTVPRVCHRDLKPQNLLVDPLT-HQVKICDFGSAKQLIAGE-----ANISYICSRFYRAPELIFGA-TEYTTSI 218 (376)
Q Consensus 146 ~al~~LH~~~~i~H~dlkp~Nill~~~~-~~vkl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~l~~~-~~~~~~~ 218 (376)
.||.|||+ +||+||||||+||+++.++ ..+||+|||++....... ......+|+.|+|||++.+. ..++.++
T Consensus 179 ~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 179 SALHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHHH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHHH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999999 7999999999999998532 279999999997543321 12356789999999998642 4689999
Q ss_pred hhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHH
Q 017147 219 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 298 (376)
Q Consensus 219 DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 298 (376)
|||||||++|+|++|..||.+.+..+....+........ ......+++++.+||.
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~ 312 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE-------------------------NPNYNVLSPLARDLLS 312 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT-------------------------SGGGGGSCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccC-------------------------CcccccCCHHHHHHHH
Confidence 999999999999999999999988887777665211111 0111236899999999
Q ss_pred hhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 299 RLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 299 ~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
+||+.||.+|||+.++++||||+++.+.
T Consensus 313 ~~l~~~p~~Rps~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 313 NLLNRNVDERFDAMRALQHPWISQFSDK 340 (345)
T ss_dssp HHSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred HHcCCChhHCCCHHHHhcChhhccChHh
Confidence 9999999999999999999999987654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=395.74 Aligned_cols=255 Identities=28% Similarity=0.433 Sum_probs=215.4
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 103 (376)
..++|++++.||+|+||+||+|+++.+++.||||++.+.. .....|..++..+ +|++|+.+++++ ..
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence 4568999999999999999999999999999999986532 2334688888877 799999999888 33
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
...+|+||||++| +|...+.. ...+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~~-~g~ikL~DFG 487 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDS-EGHIKIADFG 487 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEECS-SSCEEECCCT
T ss_pred CCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEcC-CCcEEEeecc
Confidence 4458999999985 77777653 3579999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCc-cCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 183 SAKQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 183 ~a~~~~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
+++... ......+..||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..|.+.
T Consensus 488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--------- 557 (674)
T 3pfq_A 488 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--------- 557 (674)
T ss_dssp TCEECCCTTCCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS---------
T ss_pred eeeccccCCcccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC---------
Confidence 998543 23344567899999999999654 5899999999999999999999999999988887777641
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCcccccCCC
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREPN 327 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e~l~hp~~~~~~~~~ 327 (376)
... ++..+++++++||++||++||++|+++ +|+++||||+.+.|..
T Consensus 558 --------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~ 608 (674)
T 3pfq_A 558 --------NVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 608 (674)
T ss_dssp --------CCC------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred --------CCC------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence 111 234579999999999999999999997 9999999999987653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=362.47 Aligned_cols=250 Identities=28% Similarity=0.430 Sum_probs=211.0
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
..|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++.... .
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----T 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----e
Confidence 56999999999999999999999999999999986432 23357999999999999999999885433 4
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
.|+||||+.|++.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 129 ~~lv~e~~~g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 129 AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASI 203 (348)
T ss_dssp EEEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEET-TTEEEECCCTTCBS
T ss_pred EEEEEecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEeeccCcee
Confidence 889999999988887753 34679999999999999999999999 79999999999999996 78899999999976
Q ss_pred CccCCCceeeeeccccCchhhhhC--CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 187 LIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
... .....||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+..+.+..+..... +.
T Consensus 204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-~~------- 272 (348)
T 1u5q_A 204 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PA------- 272 (348)
T ss_dssp SSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CC-------
T ss_pred cCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CC-------
Confidence 533 234678999999999853 34589999999999999999999999998887776665554210 00
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.....+++.+.+||.+||+.||++|||++++++||||...
T Consensus 273 -------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 273 -------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred -------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 0112468899999999999999999999999999999763
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=365.96 Aligned_cols=284 Identities=32% Similarity=0.529 Sum_probs=219.3
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc---chHHHHHHHHhCC-CC-----ceeeeceeeeecCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMD-HP-----NVISLKHCFFSTTS 101 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~ 101 (376)
...++|++.+.||+|+||+||+|.+..+++.||||++..... ....|+.+++.++ |+ +|+++.+++...
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~-- 128 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR-- 128 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET--
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC--
Confidence 345789999999999999999999999999999999975432 2346888888775 44 488888887543
Q ss_pred CCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhc-CCCeeecCCCCCcEEEcC-CCCcEEEE
Q 017147 102 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT-VPRVCHRDLKPQNLLVDP-LTHQVKIC 179 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~i~H~dlkp~Nill~~-~~~~vkl~ 179 (376)
..+|+||||++++|.+.+... ....+++..++.++.|++.||.|||+ ..||+||||||+|||++. .++.+||+
T Consensus 129 ---~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 129 ---NHLCLVFEMLSYNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp ---TEEEEEEECCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred ---CceEEEEecCCCCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 348899999999998888642 23468999999999999999999994 159999999999999953 35679999
Q ss_pred eecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 180 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 180 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
|||++..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.++..
T Consensus 204 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 280 (382)
T 2vx3_A 204 DFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH 280 (382)
T ss_dssp CCTTCEETTC--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eccCceeccc--ccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999976532 23456789999999999765 48999999999999999999999999999999999999999988876
Q ss_pred HHhhcCcC------CC--CC----------CCCCCCCCChhhhcccC-----------------CChhHHHHHHhhcCcC
Q 017147 260 EIRCMNPN------YT--DF----------RFPQIKAHPWHKVFHKR-----------------MPPEAIDLASRLLQYS 304 (376)
Q Consensus 260 ~~~~~~~~------~~--~~----------~~~~~~~~~~~~~~~~~-----------------~~~~~~~li~~~L~~d 304 (376)
.+...... .. .+ .+.......+...+... .++++++||.+||++|
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 360 (382)
T 2vx3_A 281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD 360 (382)
T ss_dssp HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence 65421100 00 00 00000001111111000 0147899999999999
Q ss_pred CCCCCCHHHHhcCCCccccc
Q 017147 305 PSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 305 p~~R~t~~e~l~hp~~~~~~ 324 (376)
|++|||++|+|+||||+...
T Consensus 361 P~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 361 PKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp TTTSCCHHHHTTSGGGCC--
T ss_pred hhhCCCHHHHhcCcccccCC
Confidence 99999999999999998753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=370.46 Aligned_cols=261 Identities=25% Similarity=0.372 Sum_probs=200.0
Q ss_pred ccceeeee-eeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHH-HhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 32 QTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 32 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
..++|.+. +.||+|+||+||+|.++.+++.||||++... ....+|+.++ +..+||||+++++++.... .+..++|+
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~l 136 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI 136 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEE
Confidence 45678777 7899999999999999999999999998643 3455788876 5568999999999874322 23556899
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC--CCcEEEEeeccccc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGSAKQ 186 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~--~~~vkl~Dfg~a~~ 186 (376)
|||||.| +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.. ++.+||+|||+++.
T Consensus 137 v~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 9999985 888777531 23469999999999999999999999 799999999999999853 56799999999987
Q ss_pred CccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCHHHHh
Q 017147 187 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD----QLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~ 262 (376)
..........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+... ....+...
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~---------- 282 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG---------- 282 (400)
T ss_dssp CC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT----------
T ss_pred cCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC----------
Confidence 655555556788999999999854 458999999999999999999999998765322 12222110
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.+.++. .....+++++++||++||+.||++|||+.|+++||||...
T Consensus 283 -------~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 283 -------QYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp -------CCCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -------cccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 111110 0113479999999999999999999999999999999863
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=352.89 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=211.0
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc----------ccchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
.++|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 79 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN---- 79 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC----
Confidence 46799999999999999999999999999999988643 2234689999999999999999998843
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCC---CcEEE
Q 017147 103 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT---HQVKI 178 (376)
Q Consensus 103 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~---~~vkl 178 (376)
....++||||++ ++|.+.+.. ...+++..++.++.|++.||.|||+ +|++||||||+||+++.++ ..+||
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~~kl 153 (283)
T 3bhy_A 80 -KTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKL 153 (283)
T ss_dssp -SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSSSSCCEEE
T ss_pred -CCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEecCCCCCCceEE
Confidence 334889999997 577777753 3578999999999999999999999 7999999999999998633 17999
Q ss_pred EeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 179 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 179 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
+|||++.............+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+.+..+........
T Consensus 154 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 231 (283)
T 3bhy_A 154 IDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD- 231 (283)
T ss_dssp CCCTTCEECC--------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC-
T ss_pred EecccceeccCCCcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc-
Confidence 999999876555444556789999999998654 589999999999999999999999999887776665543211111
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCC
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 327 (376)
......+++.+.+||.+||+.||++|||+.++++||||+.+++..
T Consensus 232 ------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 232 ------------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp ------------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred ------------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 112234789999999999999999999999999999999876553
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=361.41 Aligned_cols=256 Identities=26% Similarity=0.407 Sum_probs=188.1
Q ss_pred ccceeeee---eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-cchHHHHHHHHhCC-CCceeeeceeeeecCCCCceE
Q 017147 32 QTISYMAE---RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 32 ~~~~y~~~---~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 106 (376)
...+|.+. +.||+|+||+||+|.++.+++.||+|++.+.. ....+|+.+++.+. ||||+++++++. +...
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~ 80 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLH 80 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSE
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCE
Confidence 34578775 78999999999999999999999999997643 44568999999997 999999999984 3345
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCC--CcEEEEeecc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFGS 183 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~--~~vkl~Dfg~ 183 (376)
.|+||||+++ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ ..+||+|||+
T Consensus 81 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~ 155 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIK----KKKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGF 155 (325)
T ss_dssp EEEEECCCCSCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred EEEEEEccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEecccc
Confidence 8899999986 7777775 34679999999999999999999999 7999999999999998532 2799999999
Q ss_pred cccCccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChH-------HHHHHHHHHhCC
Q 017147 184 AKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-------DQLVEIIKVLGT 255 (376)
Q Consensus 184 a~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~ 255 (376)
+....... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.. +.+..+.+.
T Consensus 156 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~--- 231 (325)
T 3kn6_A 156 ARLKPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG--- 231 (325)
T ss_dssp CEECCC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT---
T ss_pred ceecCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC---
Confidence 97654332 23456779999999998654 5899999999999999999999999875432 222222110
Q ss_pred CCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.+. +.......+++++++||.+||+.||.+|||++++++||||++.
T Consensus 232 --------------~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 232 --------------DFS--------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp --------------CCC--------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred --------------CCC--------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 000 0111123479999999999999999999999999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=363.25 Aligned_cols=253 Identities=28% Similarity=0.459 Sum_probs=212.3
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------------cchHHHHHHHHhC-CCCceeeeceeeeecC
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVM-DHPNVISLKHCFFSTT 100 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 100 (376)
++|++.+.||+|+||.||+|.++.+|+.||||++.... ....+|+.+++.+ +||||+++++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 57999999999999999999999999999999986432 2235789999998 79999999998843
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEE
Q 017147 101 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 179 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~ 179 (376)
....|+||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ .|++||||||+||+++. ++.+||+
T Consensus 172 ---~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~~-~~~ikl~ 242 (365)
T 2y7j_A 172 ---SSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLDD-NMQIRLS 242 (365)
T ss_dssp ---SSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEEC
T ss_pred ---CCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEEE
Confidence 3458999999986 77776653 3579999999999999999999999 79999999999999996 7889999
Q ss_pred eecccccCccCCCceeeeeccccCchhhhhCC-----CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017147 180 DFGSAKQLIAGEANISYICSRFYRAPELIFGA-----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254 (376)
Q Consensus 180 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 254 (376)
|||++.............||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 322 (365)
T 2y7j_A 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322 (365)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999877665555667889999999998532 3478899999999999999999999998887777666655322
Q ss_pred CCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
...... ...+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 323 ~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 323 QFSSPE-------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp CCCHHH-------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCCcc-------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 111111 1246889999999999999999999999999999973
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=350.97 Aligned_cols=253 Identities=28% Similarity=0.455 Sum_probs=209.4
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
...++|++.+.||+|+||+||+|.+..+++.||+|++... .....+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 80 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD----- 80 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-----
Confidence 3467899999999999999999999999999999998543 2234579999999999999999998843
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
....++||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~~-~~~~~l~Dfg 154 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGS-AGELKIADFG 154 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEECT-TSCEEECSCC
T ss_pred CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEcC-CCCEEEEecc
Confidence 3348899999985 77777653 3568999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 183 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 183 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 224 (279)
T 3fdn_A 155 WSVHAPSS-RRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-------- 224 (279)
T ss_dssp EESCC---------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--------
T ss_pred ccccCCcc-cccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC--------
Confidence 98654332 23456789999999998654 578999999999999999999999999887777666554210
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
. ++..+++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 225 ---------~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 225 ---------T------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp ---------C------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred ---------C------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 1 12346899999999999999999999999999999988543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=362.00 Aligned_cols=246 Identities=24% Similarity=0.391 Sum_probs=207.0
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------------cchHHHHHHHHhCCCCceeeeceeeeec
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFST 99 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (376)
..++|++.+.||+|+||+||+|.++.+++.||+|++.... ....+|+.+++.++||||+++++++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-- 99 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE-- 99 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE--
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 4568999999999999999999999999999999986542 23347999999999999999999983
Q ss_pred CCCCceEEEEEeeccc-c-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEE
Q 017147 100 TSKNELFLNLVMEYVP-E-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 177 (376)
Q Consensus 100 ~~~~~~~~~lv~e~~~-~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vk 177 (376)
....+++||||+. | +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+|
T Consensus 100 ---~~~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~k 170 (335)
T 3dls_A 100 ---NQGFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAE-DFTIK 170 (335)
T ss_dssp ---CSSEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEE
T ss_pred ---eCCEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEcC-CCcEE
Confidence 3445889999986 4 6666664 45679999999999999999999999 79999999999999996 77899
Q ss_pred EEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017147 178 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257 (376)
Q Consensus 178 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 257 (376)
|+|||++.............||+.|+|||++.+...++.++|||||||++|+|++|..||...... ..
T Consensus 171 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~------ 238 (335)
T 3dls_A 171 LIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE------ 238 (335)
T ss_dssp ECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT------
T ss_pred EeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh------
Confidence 999999987766665667789999999999977654588999999999999999999999653210 00
Q ss_pred HHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.. ...+..+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 239 -----------~~------------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 239 -----------AA------------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp -----------TC------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred -----------hc------------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 00 00122378999999999999999999999999999999763
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=367.53 Aligned_cols=283 Identities=28% Similarity=0.409 Sum_probs=220.3
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCC--------CCceeeeceeeeecCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD--------HPNVISLKHCFFSTTS 101 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~--------h~~iv~~~~~~~~~~~ 101 (376)
.++|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++ |+||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~- 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG- 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-
Confidence 468999999999999999999999999999999997543 33457999998885 788999999885332
Q ss_pred CCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCC-CeeecCCCCCcEEEcCCC-------
Q 017147 102 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLT------- 173 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~i~H~dlkp~Nill~~~~------- 173 (376)
.....+|+||||+++++++.+... ....+++..++.++.||+.||.|||+ + ||+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhhh
Confidence 245568999999999888877542 33569999999999999999999999 8 999999999999998632
Q ss_pred -----------------------------------------CcEEEEeecccccCccCCCceeeeeccccCchhhhhCCC
Q 017147 174 -----------------------------------------HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 212 (376)
Q Consensus 174 -----------------------------------------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~ 212 (376)
..+||+|||++...... .....+|+.|+|||++.+..
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC
Confidence 27999999999765432 34457899999999997654
Q ss_pred CCCchhhhHhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHHHhhcCcCCCCC-------CCCCCCCC
Q 017147 213 EYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVDQLVEIIKVLGTPTREEIRCMNPNYTDF-------RFPQIKAH 279 (376)
Q Consensus 213 ~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~ 279 (376)
++.++|||||||++|+|++|+.||.+.+ ..+.+..+.+.+|.++...+........-+ ........
T Consensus 270 -~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 270 -YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp -CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred -CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 8999999999999999999999998755 567788888888988776553221110000 00000000
Q ss_pred Chhh------hcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 280 PWHK------VFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 280 ~~~~------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
.... .+....++++.+||.+||+.||++|||+.|+|+||||++
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0000 011224567899999999999999999999999999974
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=358.79 Aligned_cols=258 Identities=22% Similarity=0.365 Sum_probs=199.6
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC-----
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS----- 101 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 101 (376)
..++|++.+.||+|+||+||+|+++.+++.||||++.... ....+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3568999999999999999999999999999999986432 334589999999999999999998865432
Q ss_pred -----------------------------------------------CCceEEEEEeecccc-hHHHHHHhhhhcCCCcC
Q 017147 102 -----------------------------------------------KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMP 133 (376)
Q Consensus 102 -----------------------------------------------~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~ 133 (376)
....++++|||||++ +|.+.+.... .....+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~ 162 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDRE 162 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSC
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchh
Confidence 223458899999986 7777665322 223456
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCC-------------Cceeeeecc
Q 017147 134 LIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-------------ANISYICSR 200 (376)
Q Consensus 134 ~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~~~t~ 200 (376)
+..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++...... ......||+
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hHHHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEeC-CCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 66789999999999999999 79999999999999996 7789999999998665432 123356899
Q ss_pred ccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCC
Q 017147 201 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHP 280 (376)
Q Consensus 201 ~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (376)
.|+|||++.+. .++.++|||||||++|+|++|..|+.. ....+..........
T Consensus 241 ~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~~--------------------- 293 (332)
T 3qd2_B 241 LYMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFPL--------------------- 293 (332)
T ss_dssp GGSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCCH---------------------
T ss_pred CccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCCc---------------------
Confidence 99999999765 589999999999999999998876521 111111111110000
Q ss_pred hhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 281 WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 281 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.....++++.+||.+||+.||.+|||+.|+++||||+++
T Consensus 294 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 294 ----LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp ----HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred ----ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 011246788999999999999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=372.94 Aligned_cols=256 Identities=28% Similarity=0.452 Sum_probs=198.4
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTT 100 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (376)
.++|.+.+.||+|+||+||+|.++.+++.||+|++.+.. ....+|+.+++.++||||+++++++.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--- 210 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--- 210 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence 468999999999999999999999999999999986532 13468999999999999999999862
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC--CCcEE
Q 017147 101 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVK 177 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~--~~~vk 177 (376)
.. ..|+||||+++ +|.+.+ .....+++..++.++.|++.||+|||+ +||+||||||+|||++.. +..+|
T Consensus 211 --~~-~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 --AE-DYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp --SS-EEEEEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred --cC-ceEEEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEE
Confidence 11 16799999986 554433 355779999999999999999999999 799999999999999742 33599
Q ss_pred EEeecccccCccCCCceeeeeccccCchhhhhC--CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017147 178 ICDFGSAKQLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255 (376)
Q Consensus 178 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 255 (376)
|+|||+++............||+.|+|||++.+ ...++.++|||||||++|+|++|++||.+......+...+.....
T Consensus 283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~ 362 (419)
T 3i6u_A 283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362 (419)
T ss_dssp ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence 999999987665555556788999999999853 345788999999999999999999999876543333322221100
Q ss_pred CCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
. +.......+++.+.+||.+||+.||.+|||++|+|+||||++.
T Consensus 363 ~------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 363 N------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp C------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred C------------------------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 0 0111223478999999999999999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=353.58 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=209.7
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
.....|...+.||+|+||+||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++.... .
T Consensus 42 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~ 116 (321)
T 2c30_A 42 DPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE-----E 116 (321)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----E
T ss_pred CchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECC-----E
Confidence 33446888999999999999999999999999999986433 23458999999999999999999885443 3
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.|+||||+++ +|.+.+. ...+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 117 ~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~ 189 (321)
T 2c30_A 117 LWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLTL-DGRVKLSDFGFCA 189 (321)
T ss_dssp EEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCE
T ss_pred EEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCcEEEeeeeeee
Confidence 8899999986 6666553 3569999999999999999999999 79999999999999996 7789999999987
Q ss_pred cCccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 186 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 186 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+........
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 261 (321)
T 2c30_A 190 QISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL------- 261 (321)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-------
T ss_pred ecccCccccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-------
Confidence 654432 2345678999999999965 4589999999999999999999999998887766655543110000
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.....+++++.+||.+||+.||++|||+.++++||||...
T Consensus 262 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 262 -------------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp -------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred -------------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 0112368899999999999999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=352.20 Aligned_cols=256 Identities=29% Similarity=0.451 Sum_probs=212.1
Q ss_pred CcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
+....+|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 86 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED---- 86 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc----
Confidence 345568999999999999999999999999999999986542 233579999999999999999998843
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
....++||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+||
T Consensus 87 -~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~df 159 (294)
T 2rku_A 87 -NDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDF 159 (294)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCC
T ss_pred -CCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEcC-CCCEEEEec
Confidence 3458899999985 76666542 3578999999999999999999999 79999999999999996 778999999
Q ss_pred cccccCccC-CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 182 GSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 182 g~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
|++...... .......+|+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+....+....+...
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------- 230 (294)
T 2rku_A 160 GLATKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------- 230 (294)
T ss_dssp TTCEECCSTTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--------
T ss_pred cCceecccCccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc--------
Confidence 999765432 22344678999999999865 45899999999999999999999999988776655544321
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
... ++..+++.+.+||.+||+.||++|||++++++||||++...+
T Consensus 231 ---------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 231 ---------EYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp ---------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred ---------cCC------------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence 011 123478899999999999999999999999999999875443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=350.11 Aligned_cols=259 Identities=27% Similarity=0.391 Sum_probs=214.3
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------------cchHHHHHHHHhCC-CCceeeeceee
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRVMD-HPNVISLKHCF 96 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------------~~~~~e~~~l~~l~-h~~iv~~~~~~ 96 (376)
...++|++.+.||+|+||.||+|.++.+++.||+|++.... ....+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999999999999999986432 22347899999995 99999999988
Q ss_pred eecCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCc
Q 017147 97 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 175 (376)
Q Consensus 97 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~ 175 (376)
. .....++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.
T Consensus 94 ~-----~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~ 162 (298)
T 1phk_A 94 E-----TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDD-DMN 162 (298)
T ss_dssp E-----CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCC
T ss_pred c-----cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEcC-CCc
Confidence 3 33458899999985 77777753 3578999999999999999999999 79999999999999996 778
Q ss_pred EEEEeecccccCccCCCceeeeeccccCchhhhh-----CCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017147 176 VKICDFGSAKQLIAGEANISYICSRFYRAPELIF-----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250 (376)
Q Consensus 176 vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 250 (376)
+||+|||++.............+|+.|+|||++. ....++.++|||||||++|+|++|..||.+.+.......+.
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 242 (298)
T 1phk_A 163 IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242 (298)
T ss_dssp EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh
Confidence 9999999998766555555677899999999985 23457899999999999999999999999888777666655
Q ss_pred HHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
....... ......+++.+.+||.+||+.||.+|||+.++++||||++...
T Consensus 243 ~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 243 SGNYQFG-------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp HTCCCCC-------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred cCCcccC-------------------------cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 4211100 0011246899999999999999999999999999999998643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=351.70 Aligned_cols=259 Identities=28% Similarity=0.432 Sum_probs=212.0
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc--------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 79 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE--- 79 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC----
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---
Confidence 3468999999999999999999999999999999986432 33458999999999999999999875332
Q ss_pred ceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 104 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 104 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
....|+||||+.+++.+.+... ....+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.+||+|||+
T Consensus 80 ~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~~-~~~~kl~dfg~ 155 (305)
T 2wtk_C 80 KQKMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTT-GGTLKISALGV 155 (305)
T ss_dssp --CEEEEEECCSEEHHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTT
T ss_pred CCeEEEEehhccCCHHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcC-CCcEEeecccc
Confidence 2348899999999877777643 34679999999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccC---CCceeeeeccccCchhhhhCCC-CCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 184 AKQLIAG---EANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 184 a~~~~~~---~~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
+...... .......+|+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~------- 228 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG------- 228 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-------
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-------
Confidence 9765432 2223456799999999986533 2477999999999999999999999988877666555441
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
.+. ++..+++.+.+||.+||+.||.+|||+.++++||||+.....
T Consensus 229 ----------~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 229 ----------SYA------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp ----------CCC------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred ----------CCC------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 001 223478999999999999999999999999999999986544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=346.34 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=208.3
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
...|++.+.||+|+||+||+|.+..++..||+|++.... ....+|+.+++.++||||+++++++.... .+...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCce
Confidence 347999999999999999999999999999999986432 22357999999999999999999875443 34566
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCC--eeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
+|+||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ +| ++||||||+||+++..++.+||+|||+
T Consensus 104 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 8899999975 77777753 3668999999999999999999999 78 999999999999984477899999999
Q ss_pred cccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 184 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 184 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
+..... .......+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+................
T Consensus 179 ~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 247 (290)
T 1t4h_A 179 ATLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-------- 247 (290)
T ss_dssp GGGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--------
T ss_pred cccccc-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC--------
Confidence 975433 33445678999999998853 4899999999999999999999999886655544333221000
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
...+....++++.+||.+||+.||.+|||++++++||||++
T Consensus 248 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 248 ------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ------------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 11123346789999999999999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=356.19 Aligned_cols=263 Identities=25% Similarity=0.340 Sum_probs=210.4
Q ss_pred ccceeeee-eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCC-CCceeeeceeeeecCCCC
Q 017147 32 QTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 32 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 103 (376)
..++|.+. +.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.+. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~-----~ 100 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE-----N 100 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----C
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE-----e
Confidence 44678888 89999999999999999999999999986432 23457999999885 699999999983 3
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC--CCCcEEEEe
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICD 180 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~--~~~~vkl~D 180 (376)
...+|+||||+.+ +|.+.+.. .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ..+.+||+|
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred CCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCCcEEEee
Confidence 3448899999986 65554421 234679999999999999999999999 79999999999999985 246899999
Q ss_pred ecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 181 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 181 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.........
T Consensus 178 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-- 254 (327)
T 3lm5_A 178 FGMSRKIGHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE-- 254 (327)
T ss_dssp GGGCEEC---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--
T ss_pred CccccccCCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc--
Confidence 9999876555555567889999999999654 5899999999999999999999999998888777766653221111
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCC
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~ 328 (376)
.....+++.+.+||.+||+.||.+|||++++|+||||+.+.+...
T Consensus 255 -----------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 255 -----------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp -----------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred -----------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 112347899999999999999999999999999999998866543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=355.91 Aligned_cols=255 Identities=29% Similarity=0.442 Sum_probs=213.0
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
....+|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++.+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 112 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED----- 112 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence 34568999999999999999999999999999999986542 234579999999999999999998843
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
...+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~-~~~~kl~Dfg 186 (335)
T 2owb_A 113 NDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFG 186 (335)
T ss_dssp SSEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCT
T ss_pred CCeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEcC-CCCEEEeecc
Confidence 3458999999985 77666543 3578999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccC-CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 183 SAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 183 ~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
++...... .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+...
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------- 256 (335)
T 2owb_A 187 LATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--------- 256 (335)
T ss_dssp TCEECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT---------
T ss_pred CceecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC---------
Confidence 99865432 223446789999999999664 4899999999999999999999999988876666554431
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
.+. ++..+++++.+||.+||+.||++|||++|+++||||.....+
T Consensus 257 --------~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 257 --------EYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp --------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred --------CCC------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence 011 123478899999999999999999999999999999875443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=348.50 Aligned_cols=253 Identities=29% Similarity=0.427 Sum_probs=203.3
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 82 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST----- 82 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----
Confidence 45678999999999999999999999999999999986432 234579999999999999999998843
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
....|+||||+.+ +|.+.+.. ...+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~dfg 156 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDA-HMNAKIADFG 156 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEECT-TSCEEECCCC
T ss_pred CCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEECC-CCCEEEeecc
Confidence 3348899999975 88777753 3568999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 183 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 183 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
++.............+|+.|+|||++.+....+.++|+||||+++|+|++|..||.+.+.......+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 227 (276)
T 2h6d_A 157 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV--------- 227 (276)
T ss_dssp GGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred cccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---------
Confidence 99876555444556789999999999765544689999999999999999999999887766655544310
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.. ++..++..+.+||.+||+.||.+|||+.++++||||++.
T Consensus 228 --------~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 228 --------FY------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp --------CC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred --------cc------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 00 123468899999999999999999999999999999863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=354.16 Aligned_cols=258 Identities=26% Similarity=0.363 Sum_probs=197.6
Q ss_pred ccceeeee-eeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHh-CCCCceeeeceeeeecCCCCce
Q 017147 32 QTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRV-MDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 32 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
..++|++. +.||+|+||+||+|.+..+++.||||++.... ....+|+.+++. ++||||+++++++... .
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-----~ 84 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-----D 84 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----C
Confidence 45689985 78999999999999999999999999986542 334579999988 4799999999998543 3
Q ss_pred EEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC--cEEEEeec
Q 017147 106 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFG 182 (376)
Q Consensus 106 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~--~vkl~Dfg 182 (376)
.+|+||||+. ++|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+||+|||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred EEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 4899999998 587777753 3578999999999999999999999 79999999999999986332 39999999
Q ss_pred ccccCccCC--------CceeeeeccccCchhhhhCC----CCCCchhhhHhHHHHHHHHHhCCCCCCCCChH-------
Q 017147 183 SAKQLIAGE--------ANISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV------- 243 (376)
Q Consensus 183 ~a~~~~~~~--------~~~~~~~t~~y~aPE~l~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------- 243 (376)
++....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 239 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence 987543221 12234689999999998541 34788999999999999999999999875421
Q ss_pred --------HHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017147 244 --------DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315 (376)
Q Consensus 244 --------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 315 (376)
.....+.... +.++ ......+++++++||.+||+.||.+|||+.|++
T Consensus 240 ~~~~~~~~~~~~~i~~~~-----------------~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 294 (316)
T 2ac3_A 240 EACPACQNMLFESIQEGK-----------------YEFP--------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294 (316)
T ss_dssp -CCHHHHHHHHHHHHHCC-----------------CCCC--------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred ccchhHHHHHHHHHhccC-----------------cccC--------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence 1222222210 0111 011124789999999999999999999999999
Q ss_pred cCCCccccc
Q 017147 316 AHPFFDELR 324 (376)
Q Consensus 316 ~hp~~~~~~ 324 (376)
+||||+...
T Consensus 295 ~hp~~~~~~ 303 (316)
T 2ac3_A 295 QHPWVQGCA 303 (316)
T ss_dssp HSTTCC---
T ss_pred cChhhcCCC
Confidence 999999764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=346.65 Aligned_cols=252 Identities=26% Similarity=0.465 Sum_probs=211.5
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
...++|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.++||||+++++++..
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 85 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD----- 85 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-----
Confidence 3457899999999999999999999999999999998543 1334689999999999999999998843
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
....|+||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~Dfg 159 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMGY-KGELKIADFG 159 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECT-TCCEEECCCT
T ss_pred CCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEcC-CCCEEEeccc
Confidence 3348899999985 87777753 3568999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 183 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 183 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
++...... ......+|+.|+|||++.+. .++.++|+|||||++|+|++|..||...+..+....+...
T Consensus 160 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---------- 227 (284)
T 2vgo_A 160 WSVHAPSL-RRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV---------- 227 (284)
T ss_dssp TCEECSSS-CBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT----------
T ss_pred ccccCccc-ccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc----------
Confidence 98654332 23456789999999999654 4899999999999999999999999988876665554431
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
+.. ++..++.++.+||.+||+.||.+|||++++++||||+...
T Consensus 228 -------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 228 -------DLK------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp -------CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred -------ccC------------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 011 2234789999999999999999999999999999998753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=349.21 Aligned_cols=252 Identities=28% Similarity=0.478 Sum_probs=185.9
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.. .
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 83 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-----S 83 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-----S
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-----C
Confidence 4568999999999999999999999999999999986432 334689999999999999999998843 3
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
...|+||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~~-~~~~kl~dfg~ 158 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTR-NMNIKIADFGL 158 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEECT-TCCEEECCCTT
T ss_pred CeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEEEeecc
Confidence 458899999975 77766653 34678999999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccC-CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 184 AKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 184 a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
+...... .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+.+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------- 226 (278)
T 3cok_A 159 ATQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL----------- 226 (278)
T ss_dssp CEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS-----------
T ss_pred eeeccCCCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh-----------
Confidence 9765432 223346789999999998654 478999999999999999999999987654332221100
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.++ ..+..++.++.+||.+||+.||++|||++++++||||...
T Consensus 227 ------~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 227 ------ADY------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp ------SCC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred ------ccc------------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 011 1223478999999999999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=361.62 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=199.1
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCC--CCceeeeceeeeecCCCCce
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD--HPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~ 105 (376)
.+|++.+.||+|+||+||+|.+.. ++.||||++.... ....+|+.+++.++ |+||+++++++.. ..
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----CC
Confidence 469999999999999999999764 8999999986542 23457999999997 5999999998743 33
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.+|+|||+.+++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ++.+||+|||+++
T Consensus 130 ~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~--~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGIAN 202 (390)
T ss_dssp EEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEES--SSCEEECCCSSSC
T ss_pred EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEE--CCeEEEEecCccc
Confidence 4899999877888888763 4578999999999999999999999 7999999999999996 4679999999998
Q ss_pred cCccCCC---ceeeeeccccCchhhhhCC----------CCCCchhhhHhHHHHHHHHHhCCCCCCCCChH-HHHHHHHH
Q 017147 186 QLIAGEA---NISYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIK 251 (376)
Q Consensus 186 ~~~~~~~---~~~~~~t~~y~aPE~l~~~----------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~ 251 (376)
....... .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.... ..+..+..
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~ 282 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence 6543322 2346789999999998651 35889999999999999999999999875432 33333221
Q ss_pred HhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
. . .... ++...+.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 283 ~---~------------~~~~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 283 P---N------------HEIE------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp T---T------------SCCC------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred c---c------------ccCC------------CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 0 0 0011 1223578999999999999999999999999999998643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=366.64 Aligned_cols=266 Identities=14% Similarity=0.124 Sum_probs=189.0
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-------chHHHHHHHHhC--CCCceeeeceee-------
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVM--DHPNVISLKHCF------- 96 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l--~h~~iv~~~~~~------- 96 (376)
...|++.+.||+|+||+||+|.+..+++.||+|++..... ...+|+.+++.+ +||||++++..+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 4469999999999999999999999999999999976432 223564444444 699988855333
Q ss_pred eecCC------------CCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHH------HHHHHHHHHHHHHhhcCCCee
Q 017147 97 FSTTS------------KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV------KLYTYQIFRGLAYIHTVPRVC 158 (376)
Q Consensus 97 ~~~~~------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~------~~i~~qi~~al~~LH~~~~i~ 158 (376)
..... .....+|+||||++++|.+.+..... .+.+... ..++.||+.||+|||+ +||+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS-KGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCc
Confidence 21111 01145889999999999998875322 2333333 5666999999999999 7999
Q ss_pred ecCCCCCcEEEcCCCCcEEEEeecccccCccCCCceeeeeccccCchhhhhCC-CCCCchhhhHhHHHHHHHHHhCCCCC
Q 017147 159 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLF 237 (376)
Q Consensus 159 H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslG~il~~ll~g~~pf 237 (376)
||||||+|||++. ++.+||+|||+++.... ......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||
T Consensus 217 HrDikp~NIll~~-~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 217 HGHFTPDNLFIMP-DGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp ETTCSGGGEEECT-TSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred cCcCCHHHEEECC-CCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 9999999999996 77899999999986532 22245677999999999641 45899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 238 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 238 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.+..... ...+............+.......+++.+.+||.+||+.||++|||+.++++|
T Consensus 294 ~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 294 GLVTPGI--------------------KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TBCCTTC--------------------TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCcCccc--------------------ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 8764220 00111111111111111222224689999999999999999999999999999
Q ss_pred CCcccccC
Q 017147 318 PFFDELRE 325 (376)
Q Consensus 318 p~~~~~~~ 325 (376)
|||+++.+
T Consensus 354 p~f~~~~~ 361 (371)
T 3q60_A 354 PEFLQLQN 361 (371)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=358.63 Aligned_cols=277 Identities=20% Similarity=0.299 Sum_probs=207.7
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.++|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++.... ....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---CceE
Confidence 458999999999999999999999999999999986432 23358999999999999999999875433 2247
Q ss_pred EEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEE----cCCCCcEEEEeec
Q 017147 108 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV----DPLTHQVKICDFG 182 (376)
Q Consensus 108 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill----~~~~~~vkl~Dfg 182 (376)
|+||||++ ++|.+.+... .....+++..++.++.||+.||.|||+ +||+||||||+|||+ +. .+.+||+|||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~-~~~~kL~Dfg 161 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDG-QSVYKLTDFG 161 (319)
T ss_dssp EEEEECCTTCBHHHHHHSG-GGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTTS-CEEEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHh-ccccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCCC-CceEEEccCC
Confidence 89999998 5787777643 223449999999999999999999999 799999999999998 53 5679999999
Q ss_pred ccccCccCCCceeeeeccccCchhhhhC-------CCCCCchhhhHhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHH
Q 017147 183 SAKQLIAGEANISYICSRFYRAPELIFG-------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA----VDQLVEIIK 251 (376)
Q Consensus 183 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~ 251 (376)
++.............+|+.|+|||++.. ...++.++|||||||++|+|++|..||..... .+.+..+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 9987766655566778999999999852 34589999999999999999999999975432 334444433
Q ss_pred HhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 017147 252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319 (376)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 319 (376)
.........+........++. ...+....+...+++.+.+||++||++||++|||++|+|+||-
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWS----GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEE----SSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccC----ccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 211111000000000000000 0000111122335678999999999999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=350.54 Aligned_cols=254 Identities=26% Similarity=0.416 Sum_probs=210.8
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.. ...+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 81 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES-----TTHY 81 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc-----CCEE
Confidence 4568999999999999999999999999999999986542 234689999999999999999998843 3348
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEE---cCCCCcEEEEeecc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGS 183 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill---~~~~~~vkl~Dfg~ 183 (376)
|+||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ +|++||||||+||++ +. ++.+||+|||+
T Consensus 82 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~~-~~~~kl~Dfg~ 155 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPEE-NSKIMITDFGL 155 (304)
T ss_dssp EEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSST-TCCEEBCSCST
T ss_pred EEEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCCC-CCCEEEccCCc
Confidence 899999985 77777653 3568999999999999999999999 799999999999999 43 67899999999
Q ss_pred cccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 184 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 184 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
+...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.+....
T Consensus 156 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-------- 225 (304)
T 2jam_A 156 SKMEQNG-IMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE-------- 225 (304)
T ss_dssp TCCCCCB-TTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC--------
T ss_pred ceecCCC-ccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 9754332 23345689999999998654 5899999999999999999999999998877766666542110
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
+...+...+++++.+||.+||+.||++|||++++++||||+..
T Consensus 226 -----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 226 -----------------FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp -----------------CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred -----------------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 0111223578999999999999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=352.94 Aligned_cols=283 Identities=27% Similarity=0.487 Sum_probs=219.9
Q ss_pred ccceeeeeeeeecCCCeeEEEEEE-cCCCcEEEEEEeeccc---cchHHHHHHHHhCCCC------ceeeeceeeeecCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKC-LETGETVAIKKVLQDR---RYKNRELQLMRVMDHP------NVISLKHCFFSTTS 101 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~ 101 (376)
..++|++.+.||+|+||+||+|.+ ..+++.||+|++.... ....+|+.+++.++|+ +++++++++...
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~-- 89 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH-- 89 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET--
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC--
Confidence 446899999999999999999998 5678999999986543 3345788888888765 488988887433
Q ss_pred CCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC---------
Q 017147 102 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--------- 172 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~--------- 172 (376)
..+|+||||++++|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++..
T Consensus 90 ---~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 90 ---GHICIVFELLGLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp ---TEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred ---CcEEEEEcCCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCc
Confidence 358999999988988888642 23468999999999999999999999 799999999999999853
Q ss_pred ---------CCcEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChH
Q 017147 173 ---------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 243 (376)
Q Consensus 173 ---------~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 243 (376)
++.+||+|||++..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 34699999999975432 23456789999999999654 5899999999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcC-CC---CCCCCCCC---------CCChhh--hcccCCChhHHHHHHhhcCcCCCCC
Q 017147 244 DQLVEIIKVLGTPTREEIRCMNPN-YT---DFRFPQIK---------AHPWHK--VFHKRMPPEAIDLASRLLQYSPSLR 308 (376)
Q Consensus 244 ~~~~~i~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~---------~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~R 308 (376)
+.+..+.+..+..+...+...... +. ...++... ..++.. ......++++.+||.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 888888888888776655432211 00 00000000 000000 0011235678999999999999999
Q ss_pred CCHHHHhcCCCcccccC
Q 017147 309 CTALEACAHPFFDELRE 325 (376)
Q Consensus 309 ~t~~e~l~hp~~~~~~~ 325 (376)
||+.|+++||||+.++.
T Consensus 321 pt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 321 ITLREALKHPFFDLLKK 337 (339)
T ss_dssp CCHHHHTTSGGGGGGGC
T ss_pred cCHHHHhcCHHHHHHhc
Confidence 99999999999998764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=346.49 Aligned_cols=253 Identities=20% Similarity=0.248 Sum_probs=204.3
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhC-CCCceeeeceeeeecCCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 103 (376)
...++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+..+..+ +||||+++++++....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~--- 84 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD--- 84 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT---
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC---
Confidence 44678999999999999999999999999999999986532 2334688888888 9999999999885433
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC-----------
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP----------- 171 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~----------- 171 (376)
..++||||+++ +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+||+++.
T Consensus 85 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 85 --HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp --EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC------------
T ss_pred --eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCccccccc
Confidence 48899999975 8888887655555779999999999999999999999 79999999999999984
Q ss_pred -------CCCcEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHH
Q 017147 172 -------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 244 (376)
Q Consensus 172 -------~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 244 (376)
....+||+|||.+....... ...+|+.|+|||++.+...++.++|||||||++|+|++|.+|+......
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~- 237 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW- 237 (289)
T ss_dssp --------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH-
T ss_pred ccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH-
Confidence 23479999999997654332 3458999999999976656778999999999999999999887554322
Q ss_pred HHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 245 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 245 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
..+.+. .. ..++..+++++.+||.+||+.||++|||+.++++||||++.
T Consensus 238 --~~~~~~-------------------~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 238 --HEIRQG-------------------RL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp --HHHHTT-------------------CC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred --HHHHcC-------------------CC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 222110 00 01233578999999999999999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=358.70 Aligned_cols=292 Identities=30% Similarity=0.494 Sum_probs=222.7
Q ss_pred CCCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCC-----------CCceeeec
Q 017147 28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD-----------HPNVISLK 93 (376)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~-----------h~~iv~~~ 93 (376)
+.+...++|++.+.||+|+||+||+|.+..+++.||||++..+. ....+|+.+++.++ |+||++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 13 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 34445678999999999999999999999999999999987543 33457888888876 89999999
Q ss_pred eeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCC-CeeecCCCCCcEEEcC-
Q 017147 94 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDP- 171 (376)
Q Consensus 94 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~i~H~dlkp~Nill~~- 171 (376)
+++.... .+...+++||||++++|.+.+... ....+++..++.++.||+.||.|||+ + ||+||||||+|||++.
T Consensus 93 ~~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 93 DHFNHKG-PNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEEEEEE-TTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEE
T ss_pred HHhhccC-CCCceEEEEEecCCCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEecc
Confidence 9885443 334568899999988998888653 23558999999999999999999999 8 9999999999999952
Q ss_pred ----CCCcEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCC------
Q 017147 172 ----LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------ 241 (376)
Q Consensus 172 ----~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------ 241 (376)
....+||+|||++...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 2347999999999765432 3345789999999999765 48999999999999999999999998654
Q ss_pred hHHHHHHHHHHhCCCCHHHHhhcCcC---C---CC-CCCCCCCCCChhh------hcccCCChhHHHHHHhhcCcCCCCC
Q 017147 242 AVDQLVEIIKVLGTPTREEIRCMNPN---Y---TD-FRFPQIKAHPWHK------VFHKRMPPEAIDLASRLLQYSPSLR 308 (376)
Q Consensus 242 ~~~~~~~i~~~~~~~~~~~~~~~~~~---~---~~-~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~R 308 (376)
..+.+..+.+.+|.++...+...... + .. .........+... .++..+++++.+||.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 55677888888888876554321100 0 00 0000111111111 1223356789999999999999999
Q ss_pred CCHHHHhcCCCcccccCC
Q 017147 309 CTALEACAHPFFDELREP 326 (376)
Q Consensus 309 ~t~~e~l~hp~~~~~~~~ 326 (376)
||+.|+|+||||++....
T Consensus 326 pt~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 326 ADAGGLVNHPWLKDTLGM 343 (373)
T ss_dssp BCHHHHHTCGGGTTCTTC
T ss_pred CCHHHHhhChhhhcccCc
Confidence 999999999999986433
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=355.63 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=198.5
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCC--CceeeeceeeeecCCCCc
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDH--PNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~ 104 (376)
..+|++.+.||+|+||+||+|.+ .+++.||+|++.... ....+|+.+++.++| +||+++++++.. .
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-----~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----D 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-----C
Confidence 34799999999999999999997 468999999986432 233579999999987 999999998843 3
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 105 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 105 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..+|+|||+.+++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ++.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~--~~~~kl~DFG~a 154 (343)
T 3dbq_A 82 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGIA 154 (343)
T ss_dssp SEEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE--TTEEEECCCSSS
T ss_pred CEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEE--CCcEEEeecccc
Confidence 45899999888898888763 4679999999999999999999999 7999999999999997 467999999999
Q ss_pred ccCccCCC---ceeeeeccccCchhhhhC----------CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Q 017147 185 KQLIAGEA---NISYICSRFYRAPELIFG----------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEII 250 (376)
Q Consensus 185 ~~~~~~~~---~~~~~~t~~y~aPE~l~~----------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~ 250 (376)
........ .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.... ..+..+.
T Consensus 155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 234 (343)
T 3dbq_A 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234 (343)
T ss_dssp CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence 86543322 234678999999999854 245889999999999999999999999875432 2222222
Q ss_pred HHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
. .. . ...++...++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 235 ~---~~------------~------------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 235 D---PN------------H------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp C---TT------------S------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred c---CC------------c------------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 1 00 0 0112234578999999999999999999999999999998643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=352.86 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=204.6
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------------cchHHHHHHHHhCCCCceeeeceeeeec
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFST 99 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (376)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-
Confidence 4468999999999999999999999999999999885432 234689999999999999999988732
Q ss_pred CCCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCC--CcE
Q 017147 100 TSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQV 176 (376)
Q Consensus 100 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~--~~v 176 (376)
. . +|+||||+.+ +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+||+++.++ ..+
T Consensus 87 ~----~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~ 156 (322)
T 2ycf_A 87 E----D-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLI 156 (322)
T ss_dssp S----S-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCE
T ss_pred C----c-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeE
Confidence 1 1 7899999985 7766654 45679999999999999999999999 7999999999999998532 249
Q ss_pred EEEeecccccCccCCCceeeeeccccCchhhhh--CCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017147 177 KICDFGSAKQLIAGEANISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254 (376)
Q Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 254 (376)
||+|||++.............+|+.|+|||++. +...++.++|||||||++|+|++|..||........+...+....
T Consensus 157 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (322)
T 2ycf_A 157 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236 (322)
T ss_dssp EECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC
T ss_pred EEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc
Confidence 999999998664443334567899999999974 345588999999999999999999999987554322222222100
Q ss_pred CCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.. +.......+++++.+||.+||+.||++|||++++++||||+..
T Consensus 237 ~~------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 237 YN------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp CC------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred cc------------------------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 00 0111123478999999999999999999999999999999764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=343.70 Aligned_cols=256 Identities=24% Similarity=0.337 Sum_probs=205.7
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 79 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NI 79 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-----CE
Confidence 4578999999999999999999999999999999986432 3345799999999999999999988443 34
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.|+||||+++ +|.+.+ .....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++.
T Consensus 80 ~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~ 153 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGLAT 153 (276)
T ss_dssp EEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTTCE
T ss_pred EEEEEEecCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEcc-CCCEEEeeCCCcc
Confidence 8899999986 655444 345679999999999999999999999 79999999999999996 7789999999997
Q ss_pred cCccCC---CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 186 QLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 186 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
...... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+............... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~------ 226 (276)
T 2yex_A 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-T------ 226 (276)
T ss_dssp ECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC-T------
T ss_pred ccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc-c------
Confidence 653322 223456799999999997655457899999999999999999999987654322211111000 0
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
.. . ....+++.+.+||.+||+.||++|||++|+++||||++..
T Consensus 227 ---------~~-----~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 227 ---------YL-----N-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp ---------TS-----T-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ---------cc-----C-----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 00 0 0124789999999999999999999999999999998753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=371.87 Aligned_cols=255 Identities=19% Similarity=0.219 Sum_probs=194.6
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHH---HHHHhCCCCceeeeceee------
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNREL---QLMRVMDHPNVISLKHCF------ 96 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~---~~l~~l~h~~iv~~~~~~------ 96 (376)
.++|++.+.||+|+||+||+|.++.+++.||||++.... ....+|+ .+++.++||||+++++.+
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 468999999999999999999999999999999986321 2345788 455556899999998433
Q ss_pred -eecC---------CCCce---EEEEEeecccchHHHHHHhhhhc---CCCcCHHHHHHHHHHHHHHHHHhhcCCCeeec
Q 017147 97 -FSTT---------SKNEL---FLNLVMEYVPESMYRVLKHYSSA---NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 160 (376)
Q Consensus 97 -~~~~---------~~~~~---~~~lv~e~~~~~l~~~l~~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~ 160 (376)
.... ..... ..|+||||++|+|.+.+...... ...+++..++.++.||+.||+|||+ +||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 2211 11111 37899999999999888753221 1235568888999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEEeecccccCccCCCceeeeeccccCchhhhhCC----------CCCCchhhhHhHHHHHHHH
Q 017147 161 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCVLAEL 230 (376)
Q Consensus 161 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~----------~~~~~~~DiwslG~il~~l 230 (376)
||||+|||++. ++.+||+|||+++... .......| +.|+|||++.+. ..++.++|||||||++|+|
T Consensus 231 Dikp~NIll~~-~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 231 YLRPVDIVLDQ-RGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCCGGGEEECT-TCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcC-CCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 99999999996 6789999999998532 23344566 999999999764 2589999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC
Q 017147 231 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 310 (376)
Q Consensus 231 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 310 (376)
++|+.||.+.+.......+. .....+++++.+||.+||+.||++|||
T Consensus 307 ltg~~Pf~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWIF---------------------------------RSCKNIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp HHSSCCC------CCSGGGG---------------------------------SSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred HHCCCCCcccccccchhhhh---------------------------------hhccCCCHHHHHHHHHHcCCCchhCCC
Confidence 99999997654321111000 011347899999999999999999999
Q ss_pred HHHHhcCCCcccccC
Q 017147 311 ALEACAHPFFDELRE 325 (376)
Q Consensus 311 ~~e~l~hp~~~~~~~ 325 (376)
+.++++||||+.++.
T Consensus 354 ~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 354 PLQAMETPEYEQLRT 368 (377)
T ss_dssp HHHHHTSHHHHHHHH
T ss_pred HHHHhhChHHHHHHH
Confidence 999999999988653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=346.40 Aligned_cols=257 Identities=29% Similarity=0.465 Sum_probs=212.1
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.. ..
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 94 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SS 94 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-----CC
Confidence 3468999999999999999999999999999999986432 234589999999999999999998843 33
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC--CCcEEEEeec
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFG 182 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~--~~~vkl~Dfg 182 (376)
..|+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +|++||||||+||+++.. +..+||+|||
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred eEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccC
Confidence 48899999975 77666653 3568999999999999999999999 799999999999999753 2369999999
Q ss_pred ccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 183 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 183 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
++.............+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 242 (287)
T 2wei_A 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD----- 242 (287)
T ss_dssp GGGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----
T ss_pred cceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-----
Confidence 9986655544455678999999999854 389999999999999999999999999887776665554211000
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
. .....+++++.+||++||+.||++|||+.++++||||++..+
T Consensus 243 ----------~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 243 ----------L----------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (287)
T ss_dssp ----------S----------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred ----------c----------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence 0 011247899999999999999999999999999999988643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=351.55 Aligned_cols=260 Identities=23% Similarity=0.343 Sum_probs=207.9
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
..++|++.+.||+|+||+||+|.+..+++.||+|++..+.. ...+|+.+++.++||||+++++++.... ...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 88 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG 88 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCC
Confidence 45689999999999999999999999999999999865421 2357889999999999999999875443 223
Q ss_pred eEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
...|+||||++ ++|.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~ 162 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEET-TSCEEECCCSC
T ss_pred cccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEcC-CCCEEEeeccC
Confidence 45689999997 477777753 3579999999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccCCC----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 184 AKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 184 a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
+........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......+.
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-- 239 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP-- 239 (311)
T ss_dssp C------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH--
T ss_pred cccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc--
Confidence 976543321 2235689999999999765 589999999999999999999999999887776666554221111
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
......+++++.+||.+||+.||.+||++.+++.|+|++...
T Consensus 240 -----------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 240 -----------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp -----------------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred -----------------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 111234789999999999999999999999999999998654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=355.68 Aligned_cols=284 Identities=25% Similarity=0.425 Sum_probs=219.3
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCC-cEEEEEEeeccc---cchHHHHHHHHhCCCCc------eeeeceeeeecCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR---RYKNRELQLMRVMDHPN------VISLKHCFFSTTS 101 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~ 101 (376)
..++|++.+.||+|+||+||+|.+..++ +.||+|++.... ....+|+.+++.++|++ ++.+.+++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~--- 93 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF--- 93 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE---
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee---
Confidence 3468999999999999999999998777 689999986532 33457899999887665 7777777733
Q ss_pred CCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC----------
Q 017147 102 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP---------- 171 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~---------- 171 (376)
...+|+||||+++++.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 94 --~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 94 --HGHMCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp --TTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred --CCeEEEEEeccCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeccccccccccc
Confidence 3348899999998888877642 23569999999999999999999999 79999999999999932
Q ss_pred --------CCCcEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChH
Q 017147 172 --------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 243 (376)
Q Consensus 172 --------~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 243 (376)
.++.+||+|||++..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 267899999999975432 23456789999999999654 5899999999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcCCCC----CCCCCCC---------CCChhhh--cccCCChhHHHHHHhhcCcCCCCC
Q 017147 244 DQLVEIIKVLGTPTREEIRCMNPNYTD----FRFPQIK---------AHPWHKV--FHKRMPPEAIDLASRLLQYSPSLR 308 (376)
Q Consensus 244 ~~~~~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~~---------~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R 308 (376)
+.+..+.+..+.++...+......... ..++... ..++... .....+.++.+||.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 989888888888877655432111000 0000000 0000000 001124578999999999999999
Q ss_pred CCHHHHhcCCCcccccCC
Q 017147 309 CTALEACAHPFFDELREP 326 (376)
Q Consensus 309 ~t~~e~l~hp~~~~~~~~ 326 (376)
||+.|+++||||+.+...
T Consensus 326 pt~~e~l~hp~f~~~~~~ 343 (355)
T 2eu9_A 326 ITLAEALLHPFFAGLTPE 343 (355)
T ss_dssp CCHHHHTTSGGGGGCCHH
T ss_pred cCHHHHhcChhhcCCChh
Confidence 999999999999987543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=342.10 Aligned_cols=260 Identities=26% Similarity=0.371 Sum_probs=213.3
Q ss_pred CcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
|...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++....
T Consensus 2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 78 (279)
T 2w5a_A 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT--- 78 (279)
T ss_dssp -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG---
T ss_pred CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC---
Confidence 345679999999999999999999999999999999986432 23457999999999999999999875432
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCC-----eeecCCCCCcEEEcCCCCcEE
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-----VCHRDLKPQNLLVDPLTHQVK 177 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~-----i~H~dlkp~Nill~~~~~~vk 177 (376)
...+|+||||+++ +|.+.+.........+++..++.++.|++.||+|||+ +| ++||||||+||+++. ++.+|
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~~-~~~~k 156 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDG-KQNVK 156 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEECS-SSCEE
T ss_pred CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEcC-CCCEE
Confidence 3348899999985 8888887655556679999999999999999999999 78 999999999999996 77899
Q ss_pred EEeecccccCccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017147 178 ICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256 (376)
Q Consensus 178 l~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 256 (376)
|+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-- 233 (279)
T 2w5a_A 157 LGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-- 233 (279)
T ss_dssp ECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--
T ss_pred EecCchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc--
Confidence 999999976543322 2245679999999999764 489999999999999999999999998887666555544110
Q ss_pred CHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
+ .++..+++++.+||.+||+.||.+|||+.|+++|||+..-
T Consensus 234 -----------------~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 234 -----------------R---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp -----------------C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred -----------------c---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 0 1123478999999999999999999999999999999863
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=357.92 Aligned_cols=260 Identities=26% Similarity=0.436 Sum_probs=204.7
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEc---CCCcEEEEEEeecc--------ccchHHHHHHHHhC-CCCceeeeceeeee
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD--------RRYKNRELQLMRVM-DHPNVISLKHCFFS 98 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~--------~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 98 (376)
...++|++.+.||+|+||+||+|++. .+++.||||++.+. .....+|+.+++.+ +|+||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 34579999999999999999999985 58899999988542 12334799999999 69999999998844
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEE
Q 017147 99 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 177 (376)
Q Consensus 99 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vk 177 (376)
. ..+|+||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+|
T Consensus 131 ~-----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~k 199 (355)
T 1vzo_A 131 E-----TKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHVV 199 (355)
T ss_dssp T-----TEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEE
T ss_pred C-----ceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCcEE
Confidence 3 348899999985 77777753 3568999999999999999999999 79999999999999996 77899
Q ss_pred EEeecccccCccCC--CceeeeeccccCchhhhhCC-CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017147 178 ICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254 (376)
Q Consensus 178 l~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 254 (376)
|+|||+++...... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||...+.......+.+...
T Consensus 200 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 279 (355)
T 1vzo_A 200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279 (355)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred EeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh
Confidence 99999997653322 22345789999999999753 3478999999999999999999999975432221222211100
Q ss_pred CCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCC
Q 017147 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326 (376)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 326 (376)
.. ...++..+++.+.+||.+||+.||.+|| |++++++||||+.+.+.
T Consensus 280 --------~~-----------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~ 331 (355)
T 1vzo_A 280 --------KS-----------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 331 (355)
T ss_dssp --------HC-----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred --------cc-----------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChh
Confidence 00 0012234789999999999999999999 99999999999987654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=343.96 Aligned_cols=258 Identities=24% Similarity=0.413 Sum_probs=206.8
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.... .
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 90 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG-----K 90 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------C
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC-----e
Confidence 34568999999999999999999999999999999885432 23457999999999999999999885433 3
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.++||||+++ +|...+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++.
T Consensus 91 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMTL-EGDIRLADFGVSA 165 (302)
T ss_dssp EEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECT-TSCEEECCCHHHH
T ss_pred EEEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEECC-CCCEEEEECCCCc
Confidence 8899999986 66655543 34669999999999999999999999 79999999999999996 6789999999875
Q ss_pred cCccC-CCceeeeeccccCchhhhh----CCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 186 QLIAG-EANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 186 ~~~~~-~~~~~~~~t~~y~aPE~l~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
..... .......+|+.|+|||++. ....++.++|||||||++|+|++|..||...+.......+.......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---- 241 (302)
T 2j7t_A 166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT---- 241 (302)
T ss_dssp HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----
T ss_pred cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc----
Confidence 32211 1223457899999999984 34458899999999999999999999999988777665554421100
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
...+..++.++.+||.+||+.||.+|||+.++++||||+.+.
T Consensus 242 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 242 ----------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp ----------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ----------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 011234688999999999999999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=342.95 Aligned_cols=256 Identities=29% Similarity=0.437 Sum_probs=205.8
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
...++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++.... .+|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNT-----DLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-----EEE
Confidence 34568999999999999999999999999999999987543 34568999999999999999999885433 488
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ .|++||||||+||+++. ++.+||+|||++...
T Consensus 101 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLNT-EGHAKLADFGVAGQL 175 (314)
T ss_dssp EEEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEEC
T ss_pred EEeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEECC-CCCEEEeecccchhh
Confidence 99999986 77777652 35679999999999999999999999 79999999999999996 678999999999765
Q ss_pred ccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
.... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+..... +
T Consensus 176 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~---------- 243 (314)
T 3com_A 176 TDTMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-P---------- 243 (314)
T ss_dssp BTTBSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C----------
T ss_pred hhhccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-c----------
Confidence 4332 23345789999999998654 589999999999999999999999998876655544332100 0
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.+ ..+..++..+.+||.+||+.||.+|||+.++++||||+..
T Consensus 244 ---~~------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 244 ---TF------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp ---CC------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred ---cc------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 00 0122368899999999999999999999999999999875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=349.19 Aligned_cols=267 Identities=27% Similarity=0.398 Sum_probs=191.9
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.++|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.++||||+++++++..... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~ 88 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE-----L 88 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSC-----E
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC-----c
Confidence 45899999999999999999999999999999987543 2334578999999999999999998854433 8
Q ss_pred EEEeecccc-hHHHHHHhhhh----cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 108 NLVMEYVPE-SMYRVLKHYSS----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~----~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
++||||+++ +|.+.+..... ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~dfg 166 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLGE-DGSVQIADFG 166 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECT-TCCEEECCCH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEcC-CCCEEEEecc
Confidence 899999974 78777764322 24568999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCC------CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017147 183 SAKQLIAGE------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256 (376)
Q Consensus 183 ~a~~~~~~~------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 256 (376)
++....... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.............. +
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~ 244 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND--P 244 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS--C
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC--C
Confidence 987553321 12345689999999998654458999999999999999999999998877655443332210 0
Q ss_pred CHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
. ..............+++++.+||.+||+.||.+|||+.++++||||++.+.
T Consensus 245 ~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 245 P-----------------SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp C-----------------CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred C-----------------ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 0 000000011123457899999999999999999999999999999998654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=357.34 Aligned_cols=282 Identities=25% Similarity=0.400 Sum_probs=207.7
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++... ..
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 105 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GE 105 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-----TE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-----CE
Confidence 4568999999999999999999999999999999986542 2345799999999999999999988543 34
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCC-CeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
+|+||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ . ||+||||||+||+++. ++.+||+|||++
T Consensus 106 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNS-RGEIKLCDFGVS 179 (360)
T ss_dssp EEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECT-TCCEEECCCCCC
T ss_pred EEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEECC-CCCEEEEECCCC
Confidence 8899999986 88777753 3568999999999999999999998 5 9999999999999996 778999999998
Q ss_pred ccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCCHHHHhh
Q 017147 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG-TPTREEIRC 263 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~ 263 (376)
...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+..... .........
T Consensus 180 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 180 GQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HHHHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred cccccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 654322 23346789999999999654 589999999999999999999999998776554332211111 000000000
Q ss_pred c--CcCCCCCCCCCCCC------------CChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 264 M--NPNYTDFRFPQIKA------------HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 264 ~--~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
. ......+....... ..........++.++.+||.+||++||++|||++|+|+||||+.....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 334 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 334 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence 0 00000000000000 000011122468899999999999999999999999999999886543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=351.21 Aligned_cols=267 Identities=22% Similarity=0.343 Sum_probs=187.3
Q ss_pred Ccccceeeeee-eeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 30 PKQTISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 30 ~~~~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
....++|.+.+ .||+|+||+||+|.++.+++.||+|++........+....++.++|+||+++++++.... .+..+++
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~ 102 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLL 102 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEE
Confidence 34567899965 699999999999999999999999999776555555556678889999999999885433 3355688
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC--CCcEEEEeecccc
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGSAK 185 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~--~~~vkl~Dfg~a~ 185 (376)
+||||+.+ +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||+++.+ ++.+||+|||++.
T Consensus 103 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 99999986 888777632 23579999999999999999999999 799999999999999752 3459999999997
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+................
T Consensus 180 ~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------- 247 (336)
T 3fhr_A 180 ETTQN-ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL---------- 247 (336)
T ss_dssp EC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------
T ss_pred ecccc-ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc----------
Confidence 65432 2345677999999999854 44889999999999999999999999776544332211111000
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
..+.+ .......+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 248 ---~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 248 ---GQYGF--------PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ------CC--------CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ---ccccc--------CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 00000 011123479999999999999999999999999999999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=340.28 Aligned_cols=250 Identities=28% Similarity=0.416 Sum_probs=209.2
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.+.|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.... .+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-----KL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-----eE
Confidence 357999999999999999999999999999999986432 33468999999999999999999885433 48
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|+||||+++ +|.+.+. ...+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++..
T Consensus 96 ~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~Dfg~~~~ 168 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSE-HGEVKLADFGVAGQ 168 (303)
T ss_dssp EEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEECC-CCCEEEeeccccee
Confidence 899999986 7766653 3579999999999999999999999 79999999999999996 77899999999976
Q ss_pred CccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 187 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 187 ~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.+.. +
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~--------- 236 (303)
T 3a7i_A 169 LTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--P--------- 236 (303)
T ss_dssp CBTTBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--C---------
T ss_pred cCccccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC--C---------
Confidence 54433 23345789999999999654 58899999999999999999999999887766555443310 0
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
..+...++..+.+||.+||+.||.+|||+.++++||||...
T Consensus 237 -----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 237 -----------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp -----------------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred -----------------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 01223478999999999999999999999999999999764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=343.86 Aligned_cols=262 Identities=24% Similarity=0.396 Sum_probs=206.6
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc---ccchHHHHHHHHhC-CCCceeeeceeeeecCCC-Cce
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSK-NEL 105 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~-~~~ 105 (376)
...++|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.+ +||||+++++++...... ...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 3467899999999999999999999999999999998643 33456899999998 799999999998654321 134
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
.+|+||||+++ +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~-~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTE-NAEVKLVDFGVS 176 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECT-TCCEEECCCTTT
T ss_pred eEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEcC-CCCEEEeeCcCc
Confidence 58899999986 888877642 23568999999999999999999999 79999999999999996 778999999998
Q ss_pred ccCccCC-CceeeeeccccCchhhhhC----CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 185 KQLIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 185 ~~~~~~~-~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
....... ......+|+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+....+..+..... +
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~--- 252 (326)
T 2x7f_A 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA-P--- 252 (326)
T ss_dssp C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C---
T ss_pred eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-c---
Confidence 7654322 2334578999999999852 34578999999999999999999999998887666554433100 0
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
......+++.+.+||.+||..||.+|||+.++++||||++.
T Consensus 253 -----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 253 -----------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp -----------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred -----------------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 00123468999999999999999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=348.69 Aligned_cols=248 Identities=26% Similarity=0.399 Sum_probs=205.5
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----------cchHHHHHHHHhCC--CCceeeeceeeee
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMD--HPNVISLKHCFFS 98 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~--h~~iv~~~~~~~~ 98 (376)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++ |+||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 45678999999999999999999999999999999986532 23457999999996 5999999998843
Q ss_pred cCCCCceEEEEEeeccc--chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcE
Q 017147 99 TTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 176 (376)
Q Consensus 99 ~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~v 176 (376)
....++|||++. ++|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+
T Consensus 120 -----~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 120 -----PDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp -----SSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEE
T ss_pred -----CCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCCCE
Confidence 334889999997 678777753 3678999999999999999999999 7999999999999998547889
Q ss_pred EEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017147 177 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256 (376)
Q Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 256 (376)
||+|||++...... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||..... +.. +
T Consensus 190 kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~--~-- 258 (320)
T 3a99_A 190 KLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--G-- 258 (320)
T ss_dssp EECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--C--
T ss_pred EEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--c--
Confidence 99999999865433 233467899999999997665457899999999999999999999975321 111 0
Q ss_pred CHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
. ..+...+++++.+||.+||+.||++|||++++++||||++..
T Consensus 259 -------------~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 259 -------------Q------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp -------------C------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred -------------c------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 0 012235789999999999999999999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=339.03 Aligned_cols=257 Identities=26% Similarity=0.360 Sum_probs=203.9
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++. ..
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~ 83 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE-----ED 83 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE-----CS
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee-----eC
Confidence 4568999999999999999999999999999999885422 23357999999999999999999883 34
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
..+|+||||++| +|.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~ 157 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDS-NKTLKIFDFGI 157 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCSS
T ss_pred CeEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEEeCCC
Confidence 458899999986 77777753 3579999999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccCCC--ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 184 AKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 184 a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
+........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+......... .
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-~------ 229 (294)
T 4eqm_A 158 AKALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS-V------ 229 (294)
T ss_dssp STTC-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC-C------
T ss_pred ccccccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc-C------
Confidence 976543322 2345689999999999765 48999999999999999999999999988766554433210 0
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
..........+++.+.++|.+||+.||.+||+..+.+.+.|..-+.
T Consensus 230 -----------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 230 -----------------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp -----------------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred -----------------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 1112223345799999999999999999999777777777765543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=338.08 Aligned_cols=258 Identities=25% Similarity=0.371 Sum_probs=199.5
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCC--------
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTS-------- 101 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-------- 101 (376)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 468999999999999999999999999999999986543 234579999999999999999998765321
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEe
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 180 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~D 180 (376)
......|+||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~~-~~~~kl~d 159 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDE-SRNVKIGD 159 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECC
T ss_pred ccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEcC-CCCEEEee
Confidence 345678999999985 88887763 34567889999999999999999999 79999999999999996 77899999
Q ss_pred ecccccCccC---------------CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCCh-HH
Q 017147 181 FGSAKQLIAG---------------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VD 244 (376)
Q Consensus 181 fg~a~~~~~~---------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~ 244 (376)
||++...... .......+|+.|+|||++.+...++.++|||||||++|+|++ ||..... .+
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 9999765321 122345689999999999766568999999999999999998 5543222 22
Q ss_pred HHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 245 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 245 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
....+... ... +...+....++.+.+||++||+.||.+|||+.++++||||+..
T Consensus 237 ~~~~~~~~-----------------~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 237 ILKKLRSV-----------------SIE--------FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHST-----------------TCC--------CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHHhcccc-----------------ccc--------cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 22222110 000 1111234467889999999999999999999999999999753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=337.10 Aligned_cols=257 Identities=26% Similarity=0.444 Sum_probs=200.3
Q ss_pred eeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
|.....||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++... ...++||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~ 98 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-----GFIKIFM 98 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-----CcEEEEE
Confidence 334448999999999999999999999999986542 2345799999999999999999988443 3488999
Q ss_pred eccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||++ ++|.+.+... .....+++..++.++.|++.||.|||+ +|++||||||+||+++..++.+||+|||++......
T Consensus 99 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 99 EQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp ECCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred EeCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 9997 4777777542 223456789999999999999999999 799999999999999865678999999999765432
Q ss_pred C-CceeeeeccccCchhhhhCC-CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 017147 191 E-ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268 (376)
Q Consensus 191 ~-~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 268 (376)
. ......+|+.|+|||++.+. ..++.++|||||||++|+|++|..||..................
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------- 243 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV------------- 243 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC-------------
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc-------------
Confidence 2 23345789999999998643 23789999999999999999999999765433322111111110
Q ss_pred CCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
...++..+++++.+||.+||+.||++|||+.++++||||+....
T Consensus 244 -------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 244 -------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp -------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred -------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence 01123357899999999999999999999999999999987543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=345.07 Aligned_cols=262 Identities=26% Similarity=0.360 Sum_probs=186.4
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-----chHHHHH-HHHhCCCCceeeeceeeeecCCCCceE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQ-LMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
.++|++.+.||+|+||.||+|.++.+++.||||++..... ....|+. +++.++||||+++++++... ..
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-----~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-----GD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-----SE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-----Cc
Confidence 4689999999999999999999999999999999865421 1123444 67788999999999988543 34
Q ss_pred EEEEeecccchHHHHHHhhhh-cCCCcCHHHHHHHHHHHHHHHHHhhcCC-CeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~-~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
.++||||++++|.+.+..... ....+++..++.++.|++.||.|||+ + ||+||||||+||+++. ++.+||+|||++
T Consensus 96 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~~ 173 (327)
T 3aln_A 96 CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDR-SGNIKLCDFGIS 173 (327)
T ss_dssp EEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEET-TTEEEECCCSSS
T ss_pred eEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEcC-CCCEEEccCCCc
Confidence 889999999988887764322 35779999999999999999999999 8 9999999999999996 788999999999
Q ss_pred ccCccCCCceeeeeccccCchhhhh---CCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHH
Q 017147 185 KQLIAGEANISYICSRFYRAPELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLGTPTREE 260 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~ 260 (376)
.............+|+.|+|||++. ....++.++|||||||++|+|++|..||.+.+... .+..+.
T Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---------- 243 (327)
T 3aln_A 174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV---------- 243 (327)
T ss_dssp CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC----------
T ss_pred eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh----------
Confidence 8765544444557899999999983 23458899999999999999999999998754221 110000
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
... ...+.......+++++.+||.+||+.||.+|||+.++++||||.....
T Consensus 244 ---------~~~-----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 244 ---------KGD-----PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294 (327)
T ss_dssp ---------CSC-----CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred ---------cCC-----CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence 000 001111122357899999999999999999999999999999987543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=340.65 Aligned_cols=258 Identities=23% Similarity=0.347 Sum_probs=190.4
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
...++|++.+.||+|+||.||+|.++.+++.||||++..... ...++..+++.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~----- 96 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN----- 96 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----
Confidence 345789999999999999999999999999999999865422 122344567888999999999988443
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCC-CeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
..+|+||||+++.+..+... ....+++..++.++.|++.||.|||+ + |++||||||+||+++. ++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~ 171 (318)
T 2dyl_A 97 TDVFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDE-RGQIKLCDFGI 171 (318)
T ss_dssp SEEEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECT-TSCEEECCCTT
T ss_pred CcEEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECC-CCCEEEEECCC
Confidence 34889999997655544432 34679999999999999999999998 6 9999999999999996 77899999999
Q ss_pred cccCccCCCceeeeeccccCchhhhh----CCCCCCchhhhHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCH
Q 017147 184 AKQLIAGEANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 184 a~~~~~~~~~~~~~~t~~y~aPE~l~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~ 258 (376)
+.............+|+.|+|||++. ....++.++|||||||++|+|++|..||.... ..+.+..+.... +.
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~- 248 (318)
T 2dyl_A 172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE--PP- 248 (318)
T ss_dssp C--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC--CC-
T ss_pred chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC--CC-
Confidence 97665554445567899999999984 23457899999999999999999999998743 444444443310 00
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
.++ ....+++++.+||.+||+.||.+|||++++++||||+...
T Consensus 249 -------------~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 249 -------------LLP----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp -------------CCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred -------------CCC----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 000 0124689999999999999999999999999999998764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=346.21 Aligned_cols=275 Identities=20% Similarity=0.331 Sum_probs=207.4
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---------------------cchHHHHHHHHhCCCCce
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------------------RYKNRELQLMRVMDHPNV 89 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------------------~~~~~e~~~l~~l~h~~i 89 (376)
...++|++.+.||+|+||.||+|.+ +++.||+|++.... ....+|+.+++.++||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 4457899999999999999999998 89999999986431 445689999999999999
Q ss_pred eeeceeeeecCCCCceEEEEEeecccc-hHHHHHHhh--hhc--CCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCC
Q 017147 90 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY--SSA--NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 164 (376)
Q Consensus 90 v~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~--~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp 164 (376)
+++++++... ...|+||||+++ +|.+.+... ... ...+++..++.++.|++.||.|||+.+|++||||||
T Consensus 106 ~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p 180 (348)
T 2pml_X 106 LTCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKP 180 (348)
T ss_dssp CCCSEEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCG
T ss_pred ceEEEEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCCh
Confidence 9999998443 348899999986 655441100 112 577999999999999999999999713999999999
Q ss_pred CcEEEcCCCCcEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCc-hhhhHhHHHHHHHHHhCCCCCCCCCh-
Q 017147 165 QNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTT-SIDIWSAGCVLAELLLGQPLFPGENA- 242 (376)
Q Consensus 165 ~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~- 242 (376)
+||+++. ++.+||+|||++...... ......+|+.|+|||++.+...++. ++|||||||++|+|++|..||.+.+.
T Consensus 181 ~Nil~~~-~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 181 SNILMDK-NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp GGEEECT-TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred HhEEEcC-CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 9999996 778999999999765433 3345678999999999976544655 99999999999999999999988776
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 243 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 243 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
.+....+.......+. ....+..+ ... .........+++++.+||.+||+.||.+|||+.|+++||||++
T Consensus 259 ~~~~~~i~~~~~~~~~--------~~~~~~~~-~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 259 VELFNNIRTKNIEYPL--------DRNHFLYP-LTN-KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHHHHHHTSCCCCCCC--------SSSSSTTT-TCC---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHhccCcCCcc--------chhhhhcc-ccc-cccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 4444433221000000 00000000 000 0011122457899999999999999999999999999999987
Q ss_pred cc
Q 017147 323 LR 324 (376)
Q Consensus 323 ~~ 324 (376)
..
T Consensus 329 ~~ 330 (348)
T 2pml_X 329 TN 330 (348)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=336.66 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=194.7
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
..+|++.+.||+|+||+||+|.+ +++.||+|++.... ....+|+.+++.++||||+++++++.... .
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP-----N 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-----C
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----c
Confidence 46899999999999999999987 68899999986543 22347999999999999999999884333 3
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCC--eeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
+++||||+.+ +|.+.+.... ....+++..++.++.|++.||+|||+ +| |+||||||+||+++. ++.+||+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~~-~~~~kL~Dfg~ 185 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDK-KYTVKVCDFGL 185 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEECT-TCCEEECCCC-
T ss_pred eEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEeC-CCcEEECCCCC
Confidence 7899999985 7777775311 11248999999999999999999999 79 999999999999996 77899999999
Q ss_pred cccCccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 184 AKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 184 a~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~------- 257 (309)
T 3p86_A 186 SRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR------- 257 (309)
T ss_dssp ----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC-------
T ss_pred CccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------
Confidence 97543332 23356789999999999654 4899999999999999999999999988877665544321110
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc--CCCccc
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDE 322 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~--hp~~~~ 322 (376)
..++..+++++.+||.+||+.||.+|||+.++++ +++++.
T Consensus 258 --------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 258 --------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred --------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0123457899999999999999999999999986 445443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=358.79 Aligned_cols=255 Identities=26% Similarity=0.390 Sum_probs=192.6
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-ccchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEEEe
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
.+|.+.+.||+|+||+|+. ....+++.||||++... .....+|+.+++.+ +||||+++++++.+ ..+.|+||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-----~~~~~lv~ 97 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKD-----RQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec-----CCEEEEEE
Confidence 3799999999999999764 44568999999998654 34567899999999 79999999988743 34489999
Q ss_pred ecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC----CCcEEEEeecccccC
Q 017147 112 EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL----THQVKICDFGSAKQL 187 (376)
Q Consensus 112 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~----~~~vkl~Dfg~a~~~ 187 (376)
|||+|+|.+.+.. ....+.+..++.++.||+.||.|||+ +||+||||||+|||++.. ...+||+|||+++..
T Consensus 98 E~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 98 ELCAATLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp ECCSEEHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred ECCCCCHHHHHHh---cCCCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 9999998888864 23345555677899999999999999 799999999999999531 236889999999866
Q ss_pred ccCC----CceeeeeccccCchhhhhC--CCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 188 IAGE----ANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 188 ~~~~----~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
.... ......||+.|+|||++.+ ...++.++|||||||++|+|++ |..||......... .+. +...
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~---~~~~--- 246 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILL---GACS--- 246 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHT---TCCC---
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHh---ccCC---
Confidence 4332 2334678999999999864 3446789999999999999999 99999765433221 111 1100
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
.+... .....+..+.+||.+||+.||.+|||+.++++||||..+.
T Consensus 247 ------------~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 247 ------------LDCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp ------------CTTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred ------------ccccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 00000 0011356789999999999999999999999999998654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=338.19 Aligned_cols=249 Identities=19% Similarity=0.221 Sum_probs=199.9
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc--ccchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
..++|++.+.||+|+||+||+|.+..+++.||||++... .....+|+.+++.+ +|+||+++++++... ...|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG-----KYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEET-----TEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecC-----CccE
Confidence 446899999999999999999999999999999998643 34467899999999 999999999988443 3488
Q ss_pred EEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCc-----EEEEeecc
Q 017147 109 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFGS 183 (376)
Q Consensus 109 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~-----vkl~Dfg~ 183 (376)
+||||++++|.+.+.. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++. +||+|||+
T Consensus 82 lv~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~~-~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 82 MVLELLGPSLEDLFDL---CDRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIGR-PGNKTQQVIHIIDFAL 156 (330)
T ss_dssp EEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECC-GGGTCTTSEEECCCTT
T ss_pred EEEEeCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecc-CCCCCCceEEEEEccc
Confidence 9999997788888764 24679999999999999999999999 79999999999999986 554 99999999
Q ss_pred cccCccCCC--------ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHH
Q 017147 184 AKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKV 252 (376)
Q Consensus 184 a~~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~ 252 (376)
++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+. .+.+..+...
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~ 235 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT 235 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence 986543322 2356789999999999764 589999999999999999999999987443 3334433332
Q ss_pred hCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
....+.+. .....+ ++.+||.+||+.||.+||+++++++
T Consensus 236 ~~~~~~~~------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 236 KRATPIEV------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHSCHHH------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hccCCHHH------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11111110 111234 9999999999999999999988764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=335.24 Aligned_cols=254 Identities=24% Similarity=0.434 Sum_probs=202.1
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
.++|++.+.||+|+||+||+|.+..+++.||+|++... .....+|+.+++.++||||+++++++... ...+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----CeeE
Confidence 46899999999999999999999999999999988543 23345899999999999999999998543 3488
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||+.+ +|.+.+.. ....+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVRE-NKNVVVADFGLARLM 158 (310)
T ss_dssp EEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEECT-TSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEECC-CCCEEEeecccceec
Confidence 99999986 87777753 35679999999999999999999999 79999999999999996 778999999999765
Q ss_pred ccCCCc---------------eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 017147 188 IAGEAN---------------ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252 (376)
Q Consensus 188 ~~~~~~---------------~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 252 (376)
...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~------ 231 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD------ 231 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT------
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH------
Confidence 333221 14578999999999965 45899999999999999999999998754321000
Q ss_pred hCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
.............+..+++.+.+||.+||+.||++|||+.++++ |++.++.
T Consensus 232 --------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~~ 282 (310)
T 3s95_A 232 --------------------FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRM 282 (310)
T ss_dssp --------------------SSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred --------------------HhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHH
Confidence 00000000111223457899999999999999999999999986 7776643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=340.17 Aligned_cols=249 Identities=26% Similarity=0.390 Sum_probs=197.7
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----------cchHHHHHHHHhC----CCCceeeeceee
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVM----DHPNVISLKHCF 96 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l----~h~~iv~~~~~~ 96 (376)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.+ +|+||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34568999999999999999999999999999999985432 2234699999998 899999999988
Q ss_pred eecCCCCceEEEEEeec-cc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC
Q 017147 97 FSTTSKNELFLNLVMEY-VP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 174 (376)
Q Consensus 97 ~~~~~~~~~~~~lv~e~-~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~ 174 (376)
... ...++|||+ +. ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++..++
T Consensus 108 ~~~-----~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 108 ETQ-----EGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp ----------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTTT
T ss_pred ecC-----CeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCCC
Confidence 433 347899998 55 588777753 3569999999999999999999999 79999999999999984478
Q ss_pred cEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017147 175 QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 254 (376)
Q Consensus 175 ~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 254 (376)
.+||+|||++...... ......+|+.|+|||++.+....+.++|||||||++|+|++|+.||..... +...
T Consensus 178 ~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~-- 248 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEA-- 248 (312)
T ss_dssp EEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHT--
T ss_pred eEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhh--
Confidence 8999999999865433 334567899999999987655445689999999999999999999975321 1110
Q ss_pred CCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
.. .++..++.++.+||.+||+.||++|||++|+++||||+....
T Consensus 249 ---------------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 249 ---------------EL------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp ---------------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred ---------------cc------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 00 122347899999999999999999999999999999997644
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=329.32 Aligned_cols=250 Identities=18% Similarity=0.209 Sum_probs=202.3
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc--ccchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
..++|++.+.||+|+||+||+|.+..+++.||+|++... .....+|+.+++.+ +|+|++++++++.. ....+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~~ 82 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHNV 82 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCC-----CceeE
Confidence 445799999999999999999999999999999988643 34567899999999 79999999988733 33488
Q ss_pred EEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC-----cEEEEeecc
Q 017147 109 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-----QVKICDFGS 183 (376)
Q Consensus 109 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~-----~vkl~Dfg~ 183 (376)
+||||++++|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++ .+||+|||+
T Consensus 83 lv~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~-~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 83 LVIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGR-PNSKNANMIYVVDFGM 157 (298)
T ss_dssp EEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECC-SSSTTTTCEEECCCTT
T ss_pred EEEEecCCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecc-CCCCCCCeEEEEECcc
Confidence 9999998888888864 34569999999999999999999999 79999999999999985 33 399999999
Q ss_pred cccCccCCC--------ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHH
Q 017147 184 AKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKV 252 (376)
Q Consensus 184 a~~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~ 252 (376)
+........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+ ....+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 986544322 2345689999999998654 48999999999999999999999998743 33444444332
Q ss_pred hCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
...+... .....+++++.+||.+||+.||++|||++++++
T Consensus 237 ~~~~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 237 KQSTPLR------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHSCHH------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccCccHH------------------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 2111111 112347899999999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=334.47 Aligned_cols=252 Identities=24% Similarity=0.328 Sum_probs=197.0
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCC--CCceeeeceeeeecCCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD--HPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~ 103 (376)
...+|++.+.||+|+||.||+|.+. +++.||+|++.... ....+|+.+++.++ |+||+++++++..
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~----- 99 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----- 99 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC-----
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec-----
Confidence 3458999999999999999999975 58999999986432 23357999999997 5999999998843
Q ss_pred ceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 104 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 104 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
....|+|||+.+++|.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++ ++.+||+|||+
T Consensus 100 ~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~--~~~~kL~Dfg~ 172 (313)
T 3cek_A 100 DQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGI 172 (313)
T ss_dssp SSEEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE--TTEEEECCCSS
T ss_pred CCEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEE--CCeEEEeeccc
Confidence 334889999888898888763 4578999999999999999999999 7999999999999997 47899999999
Q ss_pred cccCccCCC---ceeeeeccccCchhhhhCC----------CCCCchhhhHhHHHHHHHHHhCCCCCCCCChH-HHHHHH
Q 017147 184 AKQLIAGEA---NISYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEI 249 (376)
Q Consensus 184 a~~~~~~~~---~~~~~~t~~y~aPE~l~~~----------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i 249 (376)
+........ .....+|+.|+|||++.+. ..++.++|||||||++|+|++|..||...... ..+..+
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence 976543322 2345689999999998541 35788999999999999999999999875433 222222
Q ss_pred HHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
... . .. ..++...++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 253 ~~~---~------------~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 253 IDP---N------------HE------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HCT---T------------SC------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred Hhc---c------------cc------------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 110 0 00 11223357899999999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=347.67 Aligned_cols=256 Identities=18% Similarity=0.213 Sum_probs=204.7
Q ss_pred ccceeeeeeeeecCCCeeEEEEE-----EcCCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTS 101 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (376)
...+|++.+.||+|+||+||+|. +..+++.||||++... .....+|+.+++.++||||+++++++....
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 147 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL- 147 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-
Confidence 34689999999999999999999 4557789999998543 123457999999999999999999884433
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhh---cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC--CCc
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQ 175 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~--~~~ 175 (376)
..|+||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.+ +..
T Consensus 148 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 148 ----PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp ----SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCC
T ss_pred ----CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCce
Confidence 37899999974 88888865432 23468999999999999999999999 799999999999999842 335
Q ss_pred EEEEeecccccCccC---CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017147 176 VKICDFGSAKQLIAG---EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 251 (376)
Q Consensus 176 vkl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 251 (376)
+||+|||+++..... .......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..+..
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~ 301 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999999744222 222345668899999999764 48999999999999999998 9999999887776665543
Q ss_pred HhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
.... ..+..+++.+.+||.+||+.||.+|||+.++++|.++-.
T Consensus 302 ~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 302 GGRM----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 2110 012347889999999999999999999999999988754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=336.57 Aligned_cols=247 Identities=23% Similarity=0.300 Sum_probs=200.1
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCc---EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
....+|++.+.||+|+||+||+|.+..+++ .||||++.... ....+|+.+++.++||||+++++++.
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 120 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT----- 120 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 345789999999999999999999986655 49999986532 23457999999999999999999883
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
.....|+||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Df 195 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVDS-NLVCKVSDF 195 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCC
T ss_pred eCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEECC-CCCEEECCC
Confidence 33448899999975 87777753 34679999999999999999999999 79999999999999996 788999999
Q ss_pred cccccCccCCCc----eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 017147 182 GSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 256 (376)
Q Consensus 182 g~a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 256 (376)
|++......... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......+
T Consensus 196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 274 (325)
T 3kul_A 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP 274 (325)
T ss_dssp SSCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred CcccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC
Confidence 999865443221 123346789999999654 48999999999999999999 999999988777666554421111
Q ss_pred CHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+..+++++.+||.+||..||.+|||+.++++
T Consensus 275 ----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 275 ----------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12347899999999999999999999999985
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=327.67 Aligned_cols=245 Identities=19% Similarity=0.307 Sum_probs=201.4
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
.++|++.+.||+|+||+||+|.+. +++.||+|++.... ....+|+.+++.++||||+++++++... ...|+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 82 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICL 82 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CceEE
Confidence 468999999999999999999986 57789999987543 3346899999999999999999988433 33889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++....
T Consensus 83 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVL 157 (269)
T ss_dssp EEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECG-GGCEEECCTTGGGGBC
T ss_pred EEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEcC-CCCEEecccccccccc
Confidence 9999985 77777653 34568999999999999999999999 79999999999999986 6789999999997553
Q ss_pred cCC--CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 189 AGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 189 ~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
... ......+|+.|+|||++.+. .++.++||||+||++|+|++ |..||.+.+..+....+......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---------- 226 (269)
T 4hcu_A 158 DDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---------- 226 (269)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC----------
T ss_pred ccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC----------
Confidence 322 12234557789999999654 48999999999999999999 99999998877766655432110
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
..+..+++++.+|+.+||+.||.+|||+.++++|
T Consensus 227 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 227 ------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1123468899999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=328.26 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=209.3
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecC-----------
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTT----------- 100 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----------- 100 (376)
...+|++.+.||+|+||.||+|.+..+++.||+|++........+|+.+++.++||||+++++++....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 88 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS 88 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence 446899999999999999999999999999999999887778889999999999999999998874311
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEE
Q 017147 101 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 179 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~ 179 (376)
......+|+||||+++ +|.+.+... ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~ 164 (284)
T 2a19_B 89 RSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLVD-TKQVKIG 164 (284)
T ss_dssp CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEEC
T ss_pred ccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEcC-CCCEEEC
Confidence 1234568899999996 888887642 23578999999999999999999999 79999999999999996 7889999
Q ss_pred eecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 180 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 180 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
|||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|..||.... .....+..
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~-------- 233 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD-------- 233 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT--------
T ss_pred cchhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc--------
Confidence 99999876655555566789999999999764 58999999999999999999998874321 11111110
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
..++..++.++.+||.+||+.||.+|||+.++++|++.-.
T Consensus 234 -----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 -----------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp -----------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred -----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 0012346889999999999999999999999999987643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=342.48 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=200.7
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEc-------CCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeee
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFS 98 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 98 (376)
..++|++.+.||+|+||+||+|.+. .++..||+|++.... ....+|+.+++.+ +||||+++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3478999999999999999999975 345679999986542 2345799999999 89999999998843
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHHhhhh------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCC
Q 017147 99 TTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 165 (376)
Q Consensus 99 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~ 165 (376)
. ..+|+||||+.+ +|.+.+..... ....+++..+..++.||+.||+|||+ +||+||||||+
T Consensus 159 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~ 232 (370)
T 2psq_A 159 D-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAAR 232 (370)
T ss_dssp S-----SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGG
T ss_pred C-----CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchh
Confidence 3 338899999985 88888765321 13458999999999999999999999 79999999999
Q ss_pred cEEEcCCCCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCC
Q 017147 166 NLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 241 (376)
Q Consensus 166 Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 241 (376)
|||++. ++.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+
T Consensus 233 NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 233 NVLVTE-NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp GEEECT-TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hEEECC-CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999996 77899999999986543322 2234457889999999764 48999999999999999999 999999887
Q ss_pred hHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 242 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
..+....+..... ...+..+++++.+||.+||+.||.+|||+.|++++
T Consensus 311 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 311 VEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGGHHHHHHTTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6655544332100 01123478899999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=336.80 Aligned_cols=261 Identities=21% Similarity=0.277 Sum_probs=189.0
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCc---EEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
..++|++.+.||+|+||+||+|.+..++. .||+|++.... ....+|+.+++.++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34589999999999999999999887765 89999886432 2345899999999999999999988654332
Q ss_pred C-ceEEEEEeecccc-hHHHHHHhhhh--cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEE
Q 017147 103 N-ELFLNLVMEYVPE-SMYRVLKHYSS--ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 178 (376)
Q Consensus 103 ~-~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl 178 (376)
+ ....++||||+.+ +|.+.+..... ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~~-~~~~kl 178 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLAE-DMTVCV 178 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCEEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEcC-CCCEEE
Confidence 1 1224899999986 78777754322 22368999999999999999999999 79999999999999996 778999
Q ss_pred EeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 017147 179 CDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 254 (376)
Q Consensus 179 ~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 254 (376)
+|||++........ .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~ 257 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred eeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence 99999976543322 2234457789999999664 48999999999999999999 9999998887766655543110
Q ss_pred CCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-------HHHHhcCCCcccc
Q 017147 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-------ALEACAHPFFDEL 323 (376)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-------~~e~l~hp~~~~~ 323 (376)
. ..+..+++++.+||.+||+.||.+||| ++++++|||+...
T Consensus 258 ~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 258 L----------------------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp C----------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred C----------------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 0 012347899999999999999999999 7788999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=350.82 Aligned_cols=259 Identities=30% Similarity=0.430 Sum_probs=190.8
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
.+.|.+.+.||+|+||+||.+. ..+|+.||||++..+. ....+|+.+++.+ +||||+++++++. ....+|+|
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~~~~~lv 87 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSET-----TDRFLYIA 87 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEE-----CSSEEEEE
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCeEEEE
Confidence 4568888999999999998754 5689999999986543 3346899999876 8999999998873 34458999
Q ss_pred eecccchHHHHHHhhhhcCCC---cCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC------------CCc
Q 017147 111 MEYVPESMYRVLKHYSSANQR---MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL------------THQ 175 (376)
Q Consensus 111 ~e~~~~~l~~~l~~~~~~~~~---l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~------------~~~ 175 (376)
||||+|+|.+.+......... .++..++.++.||+.||+|||+ +||+||||||+|||++.. +..
T Consensus 88 ~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceE
Confidence 999999998888643221111 1333467899999999999999 799999999999999742 347
Q ss_pred EEEEeecccccCccCCC-----ceeeeeccccCchhhhhC------CCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChH
Q 017147 176 VKICDFGSAKQLIAGEA-----NISYICSRFYRAPELIFG------ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAV 243 (376)
Q Consensus 176 vkl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~l~~------~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 243 (376)
+||+|||++........ .....||+.|+|||++.+ ...++.++|||||||++|+|++ |..||.+....
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 99999999987644322 224578999999999965 2458999999999999999999 99999776543
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 244 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 244 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
+ ..+.+.. +..+... ......+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 247 ~--~~i~~~~-----------------~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 247 E--SNIIRGI-----------------FSLDEMK-----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp H--HHHHHTC-----------------CCCCCCT-----TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred H--HHHhcCC-----------------CCccccc-----ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 3 2222210 0111100 0011124678999999999999999999999999999964
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=340.97 Aligned_cols=257 Identities=14% Similarity=0.129 Sum_probs=196.3
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCC-----CcEEEEEEeeccccchHH---------------HHHHHHhCCCCceeeec
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRRYKNR---------------ELQLMRVMDHPNVISLK 93 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~~~~~~---------------e~~~l~~l~h~~iv~~~ 93 (376)
.+|++.+.||+|+||+||+|.+..+ ++.||+|++..+.....+ |+..++.++|+||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 4899999999999999999998765 588999998765543333 34455566799999999
Q ss_pred eeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEc--C
Q 017147 94 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD--P 171 (376)
Q Consensus 94 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~--~ 171 (376)
+++.... .+..+.|+||||++++|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++ .
T Consensus 115 ~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 115 GSGLHDK-NGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEE-TTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEESSC
T ss_pred eeeeecc-CCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEecCC
Confidence 9886543 34566899999997788888764 34679999999999999999999999 7999999999999998 5
Q ss_pred CCCcEEEEeecccccCccCCC--------ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChH
Q 017147 172 LTHQVKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 243 (376)
Q Consensus 172 ~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 243 (376)
++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....
T Consensus 190 -~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 190 -PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp -TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred -CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 67899999999976543321 1234589999999999664 4899999999999999999999999864333
Q ss_pred HHHHHHHHH-hCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 244 DQLVEIIKV-LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 244 ~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
......... ............. ....+++++.+|+.+||+.||.+||++.++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCF-------------------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHS-------------------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHhhhhHHHHHHHhc-------------------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 322222221 1111111110000 01346899999999999999999999998875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=340.03 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=200.9
Q ss_pred cceeeeeeeeecCCCeeEEEEE-----EcCCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 101 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 101 (376)
.++|++.+.||+|+||.||+|. +..+++.||||++.... ....+|+.++..+ +||||+++++++....
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~- 99 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 99 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC-
Confidence 4689999999999999999998 55677899999986532 2345799999999 7899999999874322
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhc----------------------------------------------------
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSSA---------------------------------------------------- 128 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~---------------------------------------------------- 128 (376)
..+++|||||.+ +|.+.+......
T Consensus 100 ---~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 100 ---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp ---SCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred ---CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 237799999985 888887643211
Q ss_pred ----------CCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCC---cee
Q 017147 129 ----------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NIS 195 (376)
Q Consensus 129 ----------~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~ 195 (376)
...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++........ ...
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~ 254 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDPDYVRKGD 254 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcC-CCcEEEEeccceeeecccccchhccc
Confidence 1228999999999999999999999 79999999999999996 77899999999986543322 234
Q ss_pred eeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCC
Q 017147 196 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 274 (376)
Q Consensus 196 ~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (376)
..+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+.........+
T Consensus 255 ~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------------ 315 (359)
T 3vhe_A 255 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------------------ 315 (359)
T ss_dssp CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC------------------
T ss_pred cCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC------------------
Confidence 5678899999999754 58999999999999999998 999999877555554444321111
Q ss_pred CCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 275 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
..+..+++++.++|.+||+.||.+|||+.++++|
T Consensus 316 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 316 ---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 0123478999999999999999999999999876
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=324.42 Aligned_cols=246 Identities=19% Similarity=0.286 Sum_probs=200.7
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
..++|++.+.||+|+||.||+|.+. ++..||+|++.... ....+|+.+++.++||||+++++++. .....+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS-----KEYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCceE
Confidence 3568999999999999999999865 56789999986543 33458999999999999999999883 333488
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVDR-DLCVKVSDFGMTRYV 154 (268)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEECT-TCCEEECCTTCEEEC
T ss_pred EEEEccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEECC-CCCEEEccCccceec
Confidence 99999975 67777754 23468999999999999999999999 79999999999999996 778999999999765
Q ss_pred ccCCCc--eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 188 IAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 188 ~~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
...... ....+|+.|+|||++.+. .++.++||||+||++|+|++ |..||...+..+....+......
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 224 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL--------- 224 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC---------
T ss_pred chhhhhcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC---------
Confidence 443221 223446779999999654 48999999999999999999 99999988877666555431100
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
..+...++.+.+||.+||+.||++|||+.++++|
T Consensus 225 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 225 -------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp -------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0122368899999999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=351.89 Aligned_cols=273 Identities=22% Similarity=0.336 Sum_probs=202.1
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.++|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++.... ....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCee
Confidence 458999999999999999999999999999999986432 23358999999999999999999875433 2247
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEE----cCCCCcEEEEeec
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV----DPLTHQVKICDFG 182 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill----~~~~~~vkl~Dfg 182 (376)
|+|||||.+ +|.+.+... .....+++..++.++.||+.||+|||+ +||+||||||+|||+ +. .+.+||+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~-~~~~kL~DFG 161 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDG-QSVYKLTDFG 161 (396)
T ss_dssp EEEECCCTTEEHHHHTTSG-GGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTTS-CEEEEECCGG
T ss_pred EEEEecCCCCCHHHHHHhh-hcccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCCC-ceeEEEecCC
Confidence 899999975 777776532 223349999999999999999999999 799999999999998 53 5679999999
Q ss_pred ccccCccCCCceeeeeccccCchhhhhCC-------CCCCchhhhHhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHH
Q 017147 183 SAKQLIAGEANISYICSRFYRAPELIFGA-------TEYTTSIDIWSAGCVLAELLLGQPLFPGEN----AVDQLVEIIK 251 (376)
Q Consensus 183 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~ 251 (376)
+++............||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.... ..+.+..+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 99876655555567789999999998541 346789999999999999999999996532 3344444433
Q ss_pred HhCCCCHHHHhhcCc-CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 252 VLGTPTREEIRCMNP-NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 252 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
+.|. ..+..... ....+.+. ...+....+...+++.+.++|++||++||++|||++++++
T Consensus 242 --~~p~-~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 242 --GKPS-GAISGVQKAENGPIDWS--GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp --SCCT-TCCEEEECSTTCCEEEE--SSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred --CCCc-ccchhheeccCCCcccC--ccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 2222 11110000 00000000 0000111122335568899999999999999999998854
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=337.61 Aligned_cols=267 Identities=24% Similarity=0.264 Sum_probs=197.4
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
...+|++.+.||+|+||+||+|.+. ++.||||++..... ...+|+.+++.++||||+++++++..... ....+|
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEE
Confidence 3468999999999999999999874 78999999865432 23458888999999999999999865432 234578
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCC----------CeeecCCCCCcEEEcCCCCcEE
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP----------RVCHRDLKPQNLLVDPLTHQVK 177 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~----------~i~H~dlkp~Nill~~~~~~vk 177 (376)
+||||+++ +|.+.+.. ..+++..++.++.|++.||.|||+ . ||+||||||+|||++. ++.+|
T Consensus 99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~-~~~~k 171 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKN-NLTAC 171 (322)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECT-TCCEE
T ss_pred EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECC-CCeEE
Confidence 99999985 88887753 459999999999999999999999 8 9999999999999996 77899
Q ss_pred EEeecccccCccCCC---ceeeeeccccCchhhhhCC----CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017147 178 ICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 250 (376)
Q Consensus 178 l~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 250 (376)
|+|||+++....... .....+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+...........
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999976543322 2235789999999999653 235568899999999999999999998754322211111
Q ss_pred HHhCCCCHHHHhhcC-cCCCCCCCCCCCCCChhhhc-ccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 251 KVLGTPTREEIRCMN-PNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 251 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
...+.+....+.... .... .+ .+...+ ....++++.+||.+||+.||++|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~---~~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKK---RP-----VLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCC---CC-----CCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccCCchhhhhhhhhcccC---CC-----CccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 222222222222110 0000 00 000000 0113456999999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=336.37 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=185.6
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCC-CCceeeeceeeeecCC---CCce
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMD-HPNVISLKHCFFSTTS---KNEL 105 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~---~~~~ 105 (376)
.+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.+. ||||+++++++..... ....
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 48999999999999999999999999999999885442 23357899999996 9999999998853322 4556
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCC--eeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
.+++||||++|+|.+.+.... ....+++..++.++.||+.||.|||+ +| |+||||||+|||++. ++.+||+|||+
T Consensus 108 ~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~ 184 (337)
T 3ll6_A 108 EFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSN-QGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEECCSEEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECT-TSCEEBCCCTT
T ss_pred eEEEEEEecCCCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECC-CCCEEEecCcc
Confidence 688999999999988886532 34579999999999999999999999 79 999999999999996 77899999999
Q ss_pred cccCccCCC-------------ceeeeeccccCchhhhh--CCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 017147 184 AKQLIAGEA-------------NISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 248 (376)
Q Consensus 184 a~~~~~~~~-------------~~~~~~t~~y~aPE~l~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 248 (376)
+........ .....+|+.|+|||++. ....++.++|||||||++|+|++|..||.+.........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 976543321 11446899999999983 234578999999999999999999999976543322110
Q ss_pred HHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 017147 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319 (376)
Q Consensus 249 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 319 (376)
. +.. ......+..+.+||++||+.||.+|||+.|+++|-+
T Consensus 265 ~---------------------~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 265 K---------------------YSI----------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ----------------------CCC----------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred c---------------------ccC----------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 0 000 011235778999999999999999999999998744
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=324.63 Aligned_cols=244 Identities=23% Similarity=0.358 Sum_probs=195.9
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRVMDHPNVISLKHCFFSTT 100 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (376)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--- 93 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH--- 93 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET---
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec---
Confidence 3468999999999999999999999999999999985322 33457999999999999999999872
Q ss_pred CCCceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCC--eeecCCCCCcEEEcCCCCc--
Q 017147 101 SKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQ-- 175 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--i~H~dlkp~Nill~~~~~~-- 175 (376)
... ++||||++ ++|.+.+.. ....+++..++.++.|++.||.|||+ +| |+||||||+||+++. ++.
T Consensus 94 --~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~-~~~~~ 164 (287)
T 4f0f_A 94 --NPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQS-LDENA 164 (287)
T ss_dssp --TTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESC-CCTTC
T ss_pred --CCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEec-cCCCC
Confidence 222 49999998 577676653 44679999999999999999999999 79 999999999999985 443
Q ss_pred ---EEEEeecccccCccCCCceeeeeccccCchhhhhC-CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHH--HHHH
Q 017147 176 ---VKICDFGSAKQLIAGEANISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ--LVEI 249 (376)
Q Consensus 176 ---vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i 249 (376)
+||+|||++..... ......+|+.|+|||++.+ ...++.++|||||||++|+|++|..||...+.... ...+
T Consensus 165 ~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 242 (287)
T 4f0f_A 165 PVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242 (287)
T ss_dssp SCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred ceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence 99999999974332 3445678999999999843 33468899999999999999999999987654332 2222
Q ss_pred HHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.. .+. ...++..+++++.+||.+||+.||.+|||++++++
T Consensus 243 ~~-~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 243 RE-EGL--------------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HH-SCC--------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hc-cCC--------------------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 21 110 11123457899999999999999999999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=341.51 Aligned_cols=246 Identities=22% Similarity=0.296 Sum_probs=200.3
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
..++|++.+.||+|+||.||+|.++.+++.||+|.+.... ....+|+.+++.++||||+++++++... ..
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 186 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QP 186 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-----SS
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-----CC
Confidence 3468999999999999999999999999999999886432 2345799999999999999999988433 23
Q ss_pred EEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+|+||||++ |+|.+.+.. ....+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 187 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~~-~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVTE-KNVLKISDFGMSR 261 (377)
T ss_dssp CEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCGGGCE
T ss_pred cEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEcC-CCcEEECcCCCce
Confidence 789999998 588877763 33468999999999999999999999 79999999999999996 7789999999997
Q ss_pred cCccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 186 QLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 186 ~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
........ ....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~------ 334 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL------ 334 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC------
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 54332111 122357789999999654 48999999999999999998 99999988876655443321000
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..+..+++++.+||.+||+.||++|||+.++++
T Consensus 335 ----------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 335 ----------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 012347889999999999999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=338.05 Aligned_cols=250 Identities=23% Similarity=0.337 Sum_probs=202.6
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCC-------CcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeee
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFS 98 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 98 (376)
..++|++.+.||+|+||+||+|.+..+ +..||+|++.... ....+|+.+++.+ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 347899999999999999999997643 3579999986542 2345799999999 99999999998843
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHHhhhh------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCC
Q 017147 99 TTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 165 (376)
Q Consensus 99 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~ 165 (376)
. ...|+||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+
T Consensus 147 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~ 220 (382)
T 3tt0_A 147 D-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAAR 220 (382)
T ss_dssp S-----SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGG
T ss_pred C-----CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCcc
Confidence 3 337899999985 88888865321 12469999999999999999999999 79999999999
Q ss_pred cEEEcCCCCcEEEEeecccccCccCC---CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCC
Q 017147 166 NLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 241 (376)
Q Consensus 166 Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 241 (376)
|||++. ++.+||+|||++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+
T Consensus 221 NIll~~-~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 221 NVLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GEEECT-TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eEEEcC-CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999996 7789999999998654332 22234568889999999764 58999999999999999999 999999888
Q ss_pred hHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 242 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
..+....+..... ...+..+++++.+||.+||+.||++|||+.+++++
T Consensus 299 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 299 VEELFKLLKEGHR----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHHTTCC----------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCC----------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7666554443110 01123478999999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=325.40 Aligned_cols=253 Identities=23% Similarity=0.253 Sum_probs=200.3
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
...++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++|++++..+..+... ....+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~ 81 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNV 81 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCC----CCceE
Confidence 34568999999999999999999999999999999886443 3456899999999998877766555332 23478
Q ss_pred EEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEc--CCCCcEEEEeeccccc
Q 017147 109 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQVKICDFGSAKQ 186 (376)
Q Consensus 109 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~--~~~~~vkl~Dfg~a~~ 186 (376)
+||||++++|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++ ..++.+||+|||++..
T Consensus 82 lv~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 82 MVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEecCCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 9999998888888763 34579999999999999999999999 7999999999999994 2367899999999986
Q ss_pred CccCCC--------ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCC
Q 017147 187 LIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGT 255 (376)
Q Consensus 187 ~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~ 255 (376)
...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+. .+.+..+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence 544322 2345789999999999664 489999999999999999999999987432 2233333321111
Q ss_pred CCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+. ..+...+++++.+||.+||+.||++|||++++++
T Consensus 237 ~~~------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 237 TPI------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SCH------------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred Cch------------------------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 111 1112347899999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=328.45 Aligned_cols=255 Identities=20% Similarity=0.263 Sum_probs=193.9
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcC---CCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
...+|++.+.||+|+||+||+|.+.. +++.||+|.+.... ....+|+.+++.++||||+++++++......
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 44689999999999999999998765 45689999986432 2245799999999999999999998665544
Q ss_pred CceEEEEEeecccc-hHHHHHHhhh--hcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEE
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYS--SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 179 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~ 179 (376)
.....++||||+.+ +|.+.+.... .....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~-~~~~kl~ 189 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLRD-DMTVCVA 189 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEECT-TSCEEEC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCcEEEe
Confidence 33457899999985 7777774322 234679999999999999999999999 79999999999999996 7789999
Q ss_pred eecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 017147 180 DFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT 255 (376)
Q Consensus 180 Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 255 (376)
|||++........ .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~- 267 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR- 267 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC-
Confidence 9999976543321 2234557889999999654 58999999999999999999 9999998877665554433110
Q ss_pred CCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
...+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 268 ---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 ---------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ---------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123478999999999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=334.33 Aligned_cols=250 Identities=24% Similarity=0.318 Sum_probs=201.2
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEE--EEEEeecc-----ccchHHHHHHHHhC-CCCceeeeceeeeecCCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETV--AIKKVLQD-----RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~--aiK~~~~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 103 (376)
..++|++.+.||+|+||.||+|.+..++..+ |+|.+... .....+|+.+++.+ +||||+++++++...
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~---- 98 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR---- 98 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET----
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC----
Confidence 3478999999999999999999999888865 99988642 23346799999999 899999999998443
Q ss_pred ceEEEEEeecccc-hHHHHHHhhh------------hcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEc
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 170 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~ 170 (376)
..+|+||||+++ +|.+.+.... .....+++..++.++.||+.||.|||+ +||+||||||+||+++
T Consensus 99 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 99 -GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG 176 (327)
T ss_dssp -TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC
T ss_pred -CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEEc
Confidence 348899999975 8888876432 223579999999999999999999999 7999999999999998
Q ss_pred CCCCcEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017147 171 PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 249 (376)
Q Consensus 171 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i 249 (376)
. ++.+||+|||++.............+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 177 ~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 254 (327)
T 1fvr_A 177 E-NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254 (327)
T ss_dssp G-GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred C-CCeEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence 6 678999999999754433333445568889999999654 47999999999999999998 99999988876655443
Q ss_pred HHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.... ....+..+++++.+||.+||+.||.+|||++++++|
T Consensus 255 ~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 255 PQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GGTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCC----------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2210 001123468999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=331.26 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=200.7
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEc-----CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 101 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (376)
...+|++.+.||+|+||.||+|.+. .+++.||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 98 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD-- 98 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC--
Confidence 3568999999999999999999984 455889999986532 2345799999999999999999988433
Q ss_pred CCceEEEEEeeccc-chHHHHHHhhhh--------------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeec
Q 017147 102 KNELFLNLVMEYVP-ESMYRVLKHYSS--------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 160 (376)
Q Consensus 102 ~~~~~~~lv~e~~~-~~l~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~ 160 (376)
...|+||||+. ++|.+.+..... ....+++..++.++.||+.||.|||+ +||+||
T Consensus 99 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~ 174 (314)
T 2ivs_A 99 ---GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLVHR 174 (314)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred ---CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCccc
Confidence 33889999998 588888765332 12358999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCC
Q 017147 161 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 236 (376)
Q Consensus 161 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~p 236 (376)
||||+||+++. ++.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..|
T Consensus 175 dikp~NIli~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 175 DLAARNILVAE-GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCSGGGEEEET-TTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccchheEEEcC-CCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999996 78899999999976543322 1233457889999999764 48999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 237 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 237 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
|.+.+.......+..... ...+..+++++.+||.+||+.||++|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~ 304 (314)
T 2ivs_A 253 YPGIPPERLFNLLKTGHR----------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304 (314)
T ss_dssp STTCCGGGHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHhhcCCc----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 998876655443332100 0112347899999999999999999999999986
Q ss_pred C
Q 017147 317 H 317 (376)
Q Consensus 317 h 317 (376)
+
T Consensus 305 ~ 305 (314)
T 2ivs_A 305 D 305 (314)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=328.86 Aligned_cols=251 Identities=24% Similarity=0.259 Sum_probs=197.0
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
..++|++.+.||+|+||+||+|.+..+++.||+|++... .....+|+.+++.++|++++..+..+... ....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCC----CCceEE
Confidence 446899999999999999999999999999999986543 34567899999999998888777665432 234789
Q ss_pred EeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEE---cCCCCcEEEEeeccccc
Q 017147 110 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 110 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill---~~~~~~vkl~Dfg~a~~ 186 (376)
||||++++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||+ +. ++.+||+|||++..
T Consensus 83 v~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~-~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 83 VMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKK-GNLVYIIDFGLAKK 157 (296)
T ss_dssp EEECCCCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGGG-TTCEEECCCTTCEE
T ss_pred EEEccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccCC-CCeEEEecCcccee
Confidence 999998888888763 34569999999999999999999999 799999999999999 54 67899999999986
Q ss_pred CccCCC--------ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCC
Q 017147 187 LIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVLGT 255 (376)
Q Consensus 187 ~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~ 255 (376)
...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.. ..+..+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence 544322 2345789999999999664 4899999999999999999999999875432 222222221111
Q ss_pred CCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+. ......+++++.+||.+||+.||++|||++++++
T Consensus 237 ~~~------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 237 TPI------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SCH------------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred chh------------------------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 110 1112346899999999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=332.49 Aligned_cols=255 Identities=14% Similarity=0.137 Sum_probs=191.8
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcC---CCcEEEEEEeeccccc---------------hHHHHHHHHhCCCCceeeecee
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRY---------------KNRELQLMRVMDHPNVISLKHC 95 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~---------------~~~e~~~l~~l~h~~iv~~~~~ 95 (376)
++|++.+.||+|+||+||+|.+.. ++..+|+|++...... ..+|+..++.++|+||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 589999999999999999999987 7889999998754322 2256777888899999999998
Q ss_pred eeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC-
Q 017147 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH- 174 (376)
Q Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~- 174 (376)
+.... .+....|+||||++++|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++
T Consensus 117 ~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~ 189 (345)
T 2v62_A 117 GLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGY-KNP 189 (345)
T ss_dssp EEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEES-SST
T ss_pred ccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEcc-CCC
Confidence 86533 33556899999997788777653 3379999999999999999999999 79999999999999986 44
Q ss_pred -cEEEEeecccccCccCCC--------ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCC--ChH
Q 017147 175 -QVKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE--NAV 243 (376)
Q Consensus 175 -~vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~ 243 (376)
.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+. +..
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 899999999976533211 1345789999999999765 5899999999999999999999999652 222
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 244 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 244 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.............+...... . -...+++++.+||.+||+.||++|||++++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~-~-------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLKW-A-------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHHH-S-------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhhcccccHHHHhh-c-------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 22222222211111111110 0 01147899999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=335.90 Aligned_cols=249 Identities=26% Similarity=0.323 Sum_probs=201.1
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEc-----CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 101 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (376)
..++|++.+.||+|+||.||+|.+. .+++.||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 122 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG-- 122 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC--
Confidence 3468999999999999999999987 345899999986542 2345799999999999999999988433
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhc--------------------CCCcCHHHHHHHHHHHHHHHHHhhcCCCeeec
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSSA--------------------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 160 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~ 160 (376)
...|+||||+++ +|.+.+...... ...+++..++.++.||+.||.|||+ +||+||
T Consensus 123 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~ 198 (343)
T 1luf_A 123 ---KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHR 198 (343)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred ---CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 338899999985 888887653211 2679999999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEEeecccccCccCC---CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCC
Q 017147 161 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 236 (376)
Q Consensus 161 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~p 236 (376)
||||+||+++. ++.+||+|||++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..|
T Consensus 199 Dlkp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 199 DLATRNCLVGE-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CCSGGGEEECG-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCCcceEEECC-CCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCc
Confidence 99999999996 7789999999987543222 22345668899999998764 48999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 237 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 237 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
|.+.+..+....+.+... ..++..+++++.+||.+||+.||++|||+.++++
T Consensus 277 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 277 YYGMAHEEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp TTTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCChHHHHHHHhCCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 998887766655443100 0112347899999999999999999999999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=326.73 Aligned_cols=246 Identities=18% Similarity=0.260 Sum_probs=198.7
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
..++|++.+.||+|+||.||++.+. ++..||+|++.... ....+|+.+++.++|+||+++++++.. ....|
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 95 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIF 95 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEec-----CCCeE
Confidence 4568999999999999999999875 67789999987543 334689999999999999999998843 33488
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||+.+ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 96 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~~-~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 96 IITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVND-QGVVKVSDFGLSRYV 170 (283)
T ss_dssp EEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECT-TSCEEECSTTGGGGB
T ss_pred EEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEcC-CCCEEEccccccccc
Confidence 99999974 77777753 23569999999999999999999999 79999999999999996 778999999999755
Q ss_pred ccCCC--ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 188 IAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 188 ~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
..... .....+|+.|+|||++.+. .++.++||||+||++|+|++ |..||...+..+....+.+.....
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-------- 241 (283)
T 3gen_A 171 LDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-------- 241 (283)
T ss_dssp CCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC--------
T ss_pred cccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC--------
Confidence 33211 1233457789999999755 48999999999999999998 999999988777666555421110
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.+...++.+.+||.+||+.||.+|||+.++++|
T Consensus 242 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 242 --------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp --------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 123368899999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=322.43 Aligned_cols=243 Identities=28% Similarity=0.435 Sum_probs=189.0
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc--------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
.++|++.+.||+|+||.||+|.+ +++.||+|++.... ....+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-----E 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-----C
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-----C
Confidence 45899999999999999999997 48899999885431 234579999999999999999998843 3
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCC---eeecCCCCCcEEEcCC-------C
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR---VCHRDLKPQNLLVDPL-------T 173 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~---i~H~dlkp~Nill~~~-------~ 173 (376)
...|+||||+++ +|.+.+. ...+++..++.++.|++.||.|||+ +| |+||||||+||+++.. +
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred CceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEecccccccccC
Confidence 348899999985 6655553 4579999999999999999999999 78 8999999999999852 5
Q ss_pred CcEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 017147 174 HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 253 (376)
Q Consensus 174 ~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 253 (376)
+.+||+|||++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 153 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 230 (271)
T 3dtc_A 153 KILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230 (271)
T ss_dssp CCEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred cceEEccCCccccccccc-ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence 679999999997654332 3356789999999999764 48999999999999999999999999887666554433210
Q ss_pred CCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
....++..+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 231 ---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 231 ---------------------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ---------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 0011234578999999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=328.22 Aligned_cols=253 Identities=23% Similarity=0.283 Sum_probs=189.9
Q ss_pred CCCCCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeee
Q 017147 26 KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFS 98 (376)
Q Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (376)
........++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++..
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 2h34_A 26 ESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI 105 (309)
T ss_dssp --------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred ccCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee
Confidence 3344456789999999999999999999999999999999986432 234579999999999999999998854
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEE
Q 017147 99 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 177 (376)
Q Consensus 99 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vk 177 (376)
. ...|+||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+|
T Consensus 106 ~-----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~~-~~~~k 174 (309)
T 2h34_A 106 D-----GQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVSA-DDFAY 174 (309)
T ss_dssp T-----TEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEE
T ss_pred C-----CeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEcC-CCCEE
Confidence 3 348899999985 88777753 3568999999999999999999999 79999999999999996 67899
Q ss_pred EEeecccccCccCC--CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017147 178 ICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255 (376)
Q Consensus 178 l~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 255 (376)
|+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+... +....... .
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~-~ 251 (309)
T 2h34_A 175 LVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSV-MGAHINQA-I 251 (309)
T ss_dssp ECSCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-HHHHHHSC-C
T ss_pred EecCccCccccccccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-HHHHhccC-C
Confidence 99999987654332 1234568999999999865 458999999999999999999999998866542 22222210 0
Q ss_pred CCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-CHHHHhc
Q 017147 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-TALEACA 316 (376)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-t~~e~l~ 316 (376)
+ ........+++++.+||.+||+.||++|| |++++++
T Consensus 252 ~------------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 252 P------------------------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp C------------------------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred C------------------------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 0 01112345789999999999999999999 7777764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=326.53 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=201.4
Q ss_pred cceeeeeeeeecCCCeeEEEEEE-----cCCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 101 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 101 (376)
.++|++.+.||+|+||+||+|.+ ..+++.||+|++.... ....+|+.+++.+ +||||+++++++....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~- 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG- 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC-
Confidence 46899999999999999999985 4567899999986542 3345799999999 9999999999884433
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhh--------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCc
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSS--------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 166 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~N 166 (376)
..++||||+++ +|.+.+..... ....+++..++.++.|++.||.|||+ +||+||||||+|
T Consensus 101 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~N 175 (313)
T 1t46_A 101 ----PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN 175 (313)
T ss_dssp ----SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred ----CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccce
Confidence 37899999985 88888764321 12358999999999999999999999 799999999999
Q ss_pred EEEcCCCCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCh
Q 017147 167 LLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 242 (376)
Q Consensus 167 ill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 242 (376)
|+++. ++.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+...
T Consensus 176 il~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 176 ILLTH-GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp EEEET-TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred EEEcC-CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 99996 78899999999986644432 1234567889999998664 48999999999999999999 9999988776
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 243 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 243 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.............+ ..+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 254 DSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHhccCCCC---------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 55555444321100 1123468999999999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=331.86 Aligned_cols=246 Identities=22% Similarity=0.295 Sum_probs=195.6
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcE----EEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGET----VAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----~aiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
...+|++.+.||+|+||+||+|.+..+++. ||+|.+... .....+|+.+++.++||||+++++++..
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 86 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG---- 86 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB----
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----
Confidence 346899999999999999999999888876 677766432 2334589999999999999999997721
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
...++||||+. |+|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 87 --~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~-~~~~kl~Df 159 (325)
T 3kex_A 87 --SSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLKS-PSQVQVADF 159 (325)
T ss_dssp --SSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEESS-SSCEEECSC
T ss_pred --CccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEECC-CCeEEECCC
Confidence 12779999998 477777653 23578899999999999999999999 79999999999999986 778999999
Q ss_pred cccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 017147 182 GSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 257 (376)
Q Consensus 182 g~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 257 (376)
|+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--- 235 (325)
T 3kex_A 160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER--- 235 (325)
T ss_dssp SGGGGSCCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB---
T ss_pred CcccccCcccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---
Confidence 99987644332 2334567789999999754 48999999999999999999 9999998776555444332100
Q ss_pred HHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
...+..++.++.+||.+||+.||.+|||+.++++|
T Consensus 236 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 236 -------------------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp -------------------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred -------------------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00122357889999999999999999999999876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=323.99 Aligned_cols=247 Identities=22% Similarity=0.339 Sum_probs=203.8
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
...+|++.+.||+|+||+||+|.+..+++.||+|++..+. ....+|+.+++.++||||+++++++.. ....|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 85 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFY 85 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCEE
Confidence 4568999999999999999999999999999999987553 334589999999999999999998843 33388
Q ss_pred EEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||+. ++|.+.+... ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 86 ~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEECG-GGCEEECCCCGGGTS
T ss_pred EEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEcC-CCCEEEccCccceec
Confidence 9999998 5888877542 34568999999999999999999999 79999999999999986 678999999999866
Q ss_pred ccCCCc--eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 188 IAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 188 ~~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
...... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.......+.....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~---------- 230 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---------- 230 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----------
T ss_pred cCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC----------
Confidence 443322 234567889999999655 48999999999999999999 9999998776655444332110
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
...+..+++++.+||.+||+.||.+|||+.++++
T Consensus 231 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 231 ------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 0112347899999999999999999999999974
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=326.38 Aligned_cols=243 Identities=16% Similarity=0.220 Sum_probs=194.4
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCC-------cEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETG-------ETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTT 100 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (376)
..++|++.+.||+|+||+||+|.+..++ ..||+|++.... ....+|+.+++.++||||+++++++....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 4568999999999999999999998877 469999986443 23457999999999999999999885433
Q ss_pred CCCceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCc----
Q 017147 101 SKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ---- 175 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~---- 175 (376)
..++||||+. ++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.
T Consensus 86 -----~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~~~~ 155 (289)
T 4fvq_A 86 -----ENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLIR-EEDRKTG 155 (289)
T ss_dssp -----CCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEEE-CCBGGGT
T ss_pred -----CCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEec-CCccccc
Confidence 3789999998 588887764 23448999999999999999999999 79999999999999986 444
Q ss_pred ----EEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhC-CCCCCCCChHHHHHHHH
Q 017147 176 ----VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEII 250 (376)
Q Consensus 176 ----vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~ 250 (376)
+||+|||++..... .....+|+.|+|||++.+...++.++|||||||++|+|++| .+||...+...... ..
T Consensus 156 ~~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~ 231 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FY 231 (289)
T ss_dssp BCCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HH
T ss_pred ccceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-Hh
Confidence 99999999865432 22345788999999997645689999999999999999995 56665555443332 22
Q ss_pred HHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
... ..++...++++.+||.+||+.||.+|||+.++++|
T Consensus 232 ~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 232 EDR-----------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HTT-----------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hcc-----------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 210 00122357889999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=328.12 Aligned_cols=258 Identities=28% Similarity=0.406 Sum_probs=193.5
Q ss_pred ccceeeeeeeeecCCCeeEEEEE----EcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
...+|++.+.||+|+||+||+|+ +..+++.||+|++.... ....+|+.+++.++||||+++++++....
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 84 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--- 84 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 34689999999999999999998 56789999999986543 23458999999999999999999874322
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
...+++||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~-~~~~kl~Dfg 159 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVEN-ENRVKIGDFG 159 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCCC
T ss_pred CCceEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEcC-CCeEEEccCc
Confidence 1237899999975 88887764 23458999999999999999999999 79999999999999996 7889999999
Q ss_pred ccccCccCCC----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 183 SAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 183 ~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
++........ .....+++.|+|||++.+. .++.++|||||||++|+|++|..||...... . .+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~---~~~~~~~~~ 233 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAE--F---MRMIGNDKQ 233 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--H---HHHHCTTCC
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHH--H---HhhhcCccc
Confidence 9986543322 1223457779999999765 4899999999999999999999998654221 1 111111110
Q ss_pred H------HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 259 E------EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 259 ~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
. ........ . ....+..+++++.+||.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~-~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 234 GQMIVFHLIELLKNN-G------------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp THHHHHHHHHHHHTT-C------------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cchhHHHHHHHHhcc-C------------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 00000000 0 01123457899999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=331.31 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=200.1
Q ss_pred cceeeeeeeeecCCCeeEEEEEEc-----CCCcEEEEEEeecc-----ccchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQD-----RRYKNRELQLMRVM-DHPNVISLKHCFFSTTS 101 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 101 (376)
.++|++.+.||+|+||+||+|.+. .++..||+|++... .....+|+.+++.+ +||||+++++++...
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-- 121 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-- 121 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC--
Confidence 468999999999999999999973 45678999998643 23345899999999 899999999988443
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhc-------------------CCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecC
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSSA-------------------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 161 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~d 161 (376)
...|+||||+++ +|.+.+...... ...+++..++.++.||+.||.|||+ +||+|||
T Consensus 122 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~D 197 (344)
T 1rjb_A 122 ---GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD 197 (344)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred ---CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence 338899999975 888887643211 1348999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCC
Q 017147 162 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLF 237 (376)
Q Consensus 162 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf 237 (376)
|||+||+++. ++.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||
T Consensus 198 ikp~NIll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 198 LAARNVLVTH-GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp CSGGGEEEET-TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CChhhEEEcC-CCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 9999999996 78899999999976544332 1234568889999998664 48999999999999999998 99999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 238 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 238 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.+......+..+...... ...+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 276 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 276 PGIPVDANFYKLIQNGFK---------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp TTCCCSHHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCcHHHHHHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 887765555444431100 01123468999999999999999999999999976
Q ss_pred C
Q 017147 318 P 318 (376)
Q Consensus 318 p 318 (376)
.
T Consensus 329 l 329 (344)
T 1rjb_A 329 L 329 (344)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=333.21 Aligned_cols=268 Identities=22% Similarity=0.302 Sum_probs=202.0
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
..++|++.+.||+|+||+||+|.+ .+++.||+|++.... ....+|+.+++.++||||+++++++.... .
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~ 101 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----E 101 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS-----C
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCC-----c
Confidence 346899999999999999999984 468999999986432 23568999999999999999999884433 3
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCC---CeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP---RVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
.++||||+.+ +|.+.+.........+++..++.++.|++.||.|||+ + ||+||||||+|||++. ++.+||+|||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg 179 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDE-EFEAVVGDFG 179 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEECT-TCCEEECCCS
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEECC-CCCEEeccCc
Confidence 7899999985 8888887655555669999999999999999999999 8 9999999999999996 7789999999
Q ss_pred ccccCccCCC--ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCC
Q 017147 183 SAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN----AVDQLVEIIKVLGTP 256 (376)
Q Consensus 183 ~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~ 256 (376)
++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.... ..........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----- 253 (326)
T 3uim_A 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK----- 253 (326)
T ss_dssp SCEECCSSSSCEECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT-----
T ss_pred cccccCcccccccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH-----
Confidence 9986543332 2234589999999999654 48999999999999999999999995211 0000111100
Q ss_pred CHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
...................+....++.+.+|+.+||+.||.+|||+.++++|-.-..
T Consensus 254 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 254 ---------GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp ---------TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred ---------HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 000011111111111112222234578999999999999999999999998765443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=332.62 Aligned_cols=247 Identities=25% Similarity=0.345 Sum_probs=192.8
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEE----EEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETV----AIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTS 101 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~----aiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (376)
....+|++.+.||+|+||+||+|.+..+++.+ |+|.+... .....+|+.+++.++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 34568999999999999999999998887654 77766432 233457999999999999999999885321
Q ss_pred CCceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEe
Q 017147 102 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 180 (376)
Q Consensus 102 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~D 180 (376)
.++|+||+. |+|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|
T Consensus 91 -----~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~~-~~~~kl~D 160 (327)
T 3poz_A 91 -----VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVKITD 160 (327)
T ss_dssp -----EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEEECC
T ss_pred -----eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEECC-CCCEEEcc
Confidence 568888888 577777753 35679999999999999999999999 79999999999999996 78899999
Q ss_pred ecccccCccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 017147 181 FGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 256 (376)
Q Consensus 181 fg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 256 (376)
||+++........ ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 161 fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~- 238 (327)
T 3poz_A 161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL- 238 (327)
T ss_dssp TTHHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-
T ss_pred CcceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC-
Confidence 9999765433322 233457789999999764 48999999999999999999 99999887765544333321100
Q ss_pred CHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
..+..++.++.+|+.+||+.||.+|||+.+++++
T Consensus 239 ---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 239 ---------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ---------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ---------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0123368899999999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=323.91 Aligned_cols=247 Identities=27% Similarity=0.353 Sum_probs=189.8
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCC---CcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
...++|++.+.||+|+||+||+|.+..+ +..||+|.+.... ....+|+.+++.++||||+++++++.. .
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~-- 88 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N-- 88 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S--
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-C--
Confidence 3457899999999999999999998754 4569999875432 234579999999999999999998721 1
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
..|+||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+|||++. ++.+||+||
T Consensus 89 ---~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Df 160 (281)
T 1mp8_A 89 ---PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDF 160 (281)
T ss_dssp ---SCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECC-
T ss_pred ---ccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEECC-CCCEEECcc
Confidence 26799999985 77777753 34568999999999999999999999 79999999999999996 788999999
Q ss_pred cccccCccCCC--ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 182 GSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 182 g~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
|++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~--- 236 (281)
T 1mp8_A 161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--- 236 (281)
T ss_dssp ------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---
T ss_pred ccccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC---
Confidence 99976543322 1233457789999999654 48999999999999999997 99999988776665554431100
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.++..+++++.+||.+||+.||++|||+.+++++
T Consensus 237 -------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 237 -------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0223578999999999999999999999999753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=328.80 Aligned_cols=259 Identities=24% Similarity=0.295 Sum_probs=207.8
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEc-----CCCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTS 101 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (376)
..++|++.+.||+|+||.||+|.++ .+++.||+|.+..... ...+|+.+++.++|+||+++++++...
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 100 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-- 100 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS--
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC--
Confidence 4568999999999999999999876 4578899999865322 234799999999999999999988433
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhc------CCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSSA------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 174 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~ 174 (376)
...++||||+++ +|.+.+...... ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++
T Consensus 101 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~-~~ 175 (322)
T 1p4o_A 101 ---QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE-DF 175 (322)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECT-TC
T ss_pred ---CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEcC-CC
Confidence 337899999985 888887643221 2457899999999999999999999 79999999999999996 77
Q ss_pred cEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 017147 175 QVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 250 (376)
Q Consensus 175 ~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 250 (376)
.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 899999999975533321 2234568899999998654 48999999999999999999 899999888766655544
Q ss_pred HHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC------CCccccc
Q 017147 251 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH------PFFDELR 324 (376)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h------p~~~~~~ 324 (376)
+... ...+..+++.+.+||.+||+.||.+|||+.++++| |+|+.+.
T Consensus 255 ~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~ 306 (322)
T 1p4o_A 255 EGGL----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 306 (322)
T ss_dssp TTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred cCCc----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccc
Confidence 3100 00123478999999999999999999999999876 7777665
Q ss_pred CC
Q 017147 325 EP 326 (376)
Q Consensus 325 ~~ 326 (376)
..
T Consensus 307 ~~ 308 (322)
T 1p4o_A 307 FY 308 (322)
T ss_dssp ST
T ss_pred cc
Confidence 44
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=325.58 Aligned_cols=255 Identities=25% Similarity=0.341 Sum_probs=193.3
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-chHHHHHHHHh--CCCCceeeeceeeeecCCCCceEE
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRV--MDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
...++|++.+.||+|+||+||+|.+ +++.||+|++..... ...+|.+++.. ++||||+++++++.... .....+
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~ 81 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQL 81 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCcee
Confidence 3457899999999999999999987 789999999865432 23456666666 79999999998875433 345568
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhh--------cCCCeeecCCCCCcEEEcCCCCcEEE
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--------TVPRVCHRDLKPQNLLVDPLTHQVKI 178 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~i~H~dlkp~Nill~~~~~~vkl 178 (376)
|+||||+++ +|.+.+. ...+++..++.++.|++.||.||| + +||+||||||+|||++. ++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~-~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKK-NGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECT-TSCEEE
T ss_pred EEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcC-CCCEEE
Confidence 899999985 8777774 357999999999999999999999 8 79999999999999996 778999
Q ss_pred EeecccccCccCCCc-----eeeeeccccCchhhhhCCC-----CCCchhhhHhHHHHHHHHHhC----------CCCCC
Q 017147 179 CDFGSAKQLIAGEAN-----ISYICSRFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLG----------QPLFP 238 (376)
Q Consensus 179 ~Dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~l~~~~-----~~~~~~DiwslG~il~~ll~g----------~~pf~ 238 (376)
+|||++......... ....||+.|+|||++.+.. .++.++|||||||++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999999754433322 2347899999999996543 234789999999999999999 88886
Q ss_pred CCCh----HHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 017147 239 GENA----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 314 (376)
Q Consensus 239 ~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 314 (376)
.... ...........+. .+... ...+....++++.+||.+||+.||++|||+.++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i 293 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQ-----------------RPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCC-----------------CCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ccCCCCcchhhhhHHHhccCC-----------------CCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHH
Confidence 5322 2222222111000 00000 011122346789999999999999999999999
Q ss_pred hc
Q 017147 315 CA 316 (376)
Q Consensus 315 l~ 316 (376)
++
T Consensus 294 ~~ 295 (301)
T 3q4u_A 294 KK 295 (301)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=323.42 Aligned_cols=257 Identities=28% Similarity=0.465 Sum_probs=193.0
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
....+|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.++|+||+++++++....
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 105 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--- 105 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT---
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC---
Confidence 4557899999999999999999999999999999998642 123357999999999999999999885433
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
..++||||+.+ +|.+.+.........+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||
T Consensus 106 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~~-~~~~kl~Dfg 181 (310)
T 2wqm_A 106 --ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLG 181 (310)
T ss_dssp --EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCC-
T ss_pred --cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEcC-CCCEEEEecc
Confidence 48899999986 8888887666667789999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHH
Q 017147 183 SAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 183 ~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~ 260 (376)
++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ...+........
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------ 254 (310)
T 2wqm_A 182 LGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD------ 254 (310)
T ss_dssp -----------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC------
T ss_pred ceeeecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc------
Confidence 9876543322 2345689999999998654 589999999999999999999999976432 112211111100
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
++. .....+++++.+||.+||+.||.+|||+.++++ .++.+
T Consensus 255 ------------~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~--~l~~l 295 (310)
T 2wqm_A 255 ------------YPP--------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD--VAKRM 295 (310)
T ss_dssp ------------SCC--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred ------------CCC--------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH--HHHHH
Confidence 000 011346899999999999999999999999985 34444
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=334.65 Aligned_cols=267 Identities=22% Similarity=0.233 Sum_probs=199.0
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
...++|++.+.||+|+||+||+|.+ .+++.||+|++.... ....+|+.+++.++||||+++++++... ..
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 109 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER-----NE 109 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT-----TC
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----Ce
Confidence 4567999999999999999999995 478999999886443 2345899999999999999999988433 33
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.++||||+++ +|.+.+.........+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLDE-NFVPKITDFGISK 187 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEECT-TCCEEECCCTTCE
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEECC-CCCEEEeeccccc
Confidence 7899999985 6666554322233468999999999999999999999 79999999999999996 7889999999997
Q ss_pred cCccCC---CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 186 QLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 186 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+........ ...
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~~-- 259 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VES-- 259 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HHH--
T ss_pred ccccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hhc--
Confidence 543222 22345689999999998665 4899999999999999999999999765432211100000 000
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 318 (376)
.... .+...........+....+..+.+++.+||+.||++|||+.|+++|.
T Consensus 260 ~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 260 HNNG-----QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HTTT-----CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cccc-----cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0000 01111111111222233467899999999999999999999999764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=346.29 Aligned_cols=254 Identities=20% Similarity=0.203 Sum_probs=192.7
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-------ccchHHHHHHHHhCCC-Cceeeec---------ee
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDH-PNVISLK---------HC 95 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h-~~iv~~~---------~~ 95 (376)
...|...+.||+|+||+||+|.+..+|+.||||++... .....+|+.+++.++| ++...+. +.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 35699999999999999999999999999999988632 2234588989998877 2221111 11
Q ss_pred e------------eecCCCCceEEEEEeecccchHHHHHHhh---hhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeec
Q 017147 96 F------------FSTTSKNELFLNLVMEYVPESMYRVLKHY---SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 160 (376)
Q Consensus 96 ~------------~~~~~~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~ 160 (376)
. ..........++++|+++.++|.+++... ......+++..+..++.||+.||+|||+ +||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence 1 11000112236789999999888887533 2234568888999999999999999999 799999
Q ss_pred CCCCCcEEEcCCCCcEEEEeecccccCccCCCceeeeeccccCchhhhh---------CCCCCCchhhhHhHHHHHHHHH
Q 017147 161 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF---------GATEYTTSIDIWSAGCVLAELL 231 (376)
Q Consensus 161 dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~---------~~~~~~~~~DiwslG~il~~ll 231 (376)
||||+|||++. ++.+||+|||+++..... .....| +.|+|||++. ....++.++|||||||++|+|+
T Consensus 236 DiKp~NILl~~-~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 236 YLRPVDIVLDQ-RGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCCGGGEEECT-TCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred CcccceEEEec-CCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 99999999997 677999999998754333 334566 9999999983 3344788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH
Q 017147 232 LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 311 (376)
Q Consensus 232 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~ 311 (376)
+|+.||.+.+..+....+ +. -...+++++.+||.+||+.||++|||+
T Consensus 312 tg~~Pf~~~~~~~~~~~~-----------------------~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~ 358 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEWI-----------------------FR----------SCKNIPQPVRALLEGFLRYPKEDRLLP 358 (413)
T ss_dssp HSSCCCCTTGGGSCSGGG-----------------------GS----------SCCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCcchhhhHHHH-----------------------Hh----------hcccCCHHHHHHHHHHccCChhhCcCH
Confidence 999999876532111100 00 012478999999999999999999999
Q ss_pred HHHhcCCCccccc
Q 017147 312 LEACAHPFFDELR 324 (376)
Q Consensus 312 ~e~l~hp~~~~~~ 324 (376)
.++++||||+.+.
T Consensus 359 ~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 359 LQAMETPEYEQLR 371 (413)
T ss_dssp HHHTTSHHHHHHH
T ss_pred HHHHhCHHHHHHH
Confidence 9999999998764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=330.30 Aligned_cols=254 Identities=23% Similarity=0.364 Sum_probs=198.0
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
++|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.++||||+++++++.... ......|+
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~l 107 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAWL 107 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEE
Confidence 5899999999999999999999999999999988543 233458999999999999999999885432 23456889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
||||+.+ +|.+.+.........+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++....
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~~~-~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGD-EGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCCSSCEESC
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcC-CCCEEEEecCcchhcc
Confidence 9999996 8888887665567789999999999999999999999 79999999999999986 7789999999987543
Q ss_pred cCCC----------ceeeeeccccCchhhhhCCC--CCCchhhhHhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Q 017147 189 AGEA----------NISYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGT 255 (376)
Q Consensus 189 ~~~~----------~~~~~~t~~y~aPE~l~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~ 255 (376)
.... .....||+.|+|||++.+.. .++.++|||||||++|+|++|..||...... +........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--- 262 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN--- 262 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC---
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc---
Confidence 2111 11235689999999985432 2688999999999999999999999531100 001111110
Q ss_pred CCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
....+ ....+++++.+||.+||+.||.+|||+.++++|
T Consensus 263 --------------~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 263 --------------QLSIP----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp --------------C--CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------cCCCC----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 00000 112468899999999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=329.71 Aligned_cols=245 Identities=26% Similarity=0.364 Sum_probs=190.9
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEE----EEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETV----AIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~----aiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
...+|++.+.||+|+||+||+|.+..+++.+ |+|.+... .....+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 90 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-- 90 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS--
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC--
Confidence 3468999999999999999999998888765 66655322 233457999999999999999999885321
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
.++|++|+. ++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 91 ----~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kL~Df 161 (327)
T 3lzb_A 91 ----VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVKITDF 161 (327)
T ss_dssp ----EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEEECCT
T ss_pred ----ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEcC-CCCEEEccC
Confidence 668888887 477777753 34679999999999999999999999 79999999999999986 788999999
Q ss_pred cccccCccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 017147 182 GSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 257 (376)
Q Consensus 182 g~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 257 (376)
|++......... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......+
T Consensus 162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~- 239 (327)
T 3lzb_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP- 239 (327)
T ss_dssp TC----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-
T ss_pred cceeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 999865433322 233457789999999764 48999999999999999999 999999887665544433211000
Q ss_pred HHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+..++.++.+||.+||+.||.+|||+.|+++
T Consensus 240 ---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 240 ---------------------------QPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ---------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 12346889999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=320.81 Aligned_cols=246 Identities=24% Similarity=0.349 Sum_probs=189.7
Q ss_pred cccceeeee-eeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHH-HhCCCCceeeeceeeeecCCCCceEEE
Q 017147 31 KQTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 31 ~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
...++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++||||+++++++.... .+...+|
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~ 91 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLL 91 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEE
Confidence 456678887 7899999999999999999999999998654 3455788877 6779999999999885422 2355689
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC--CCcEEEEeecccc
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGSAK 185 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~--~~~vkl~Dfg~a~ 185 (376)
+||||+++ +|.+.+... ....+++..++.++.|++.||.|||+ +||+||||||+||+++.. ++.+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 99999985 888877642 23469999999999999999999999 799999999999999853 4679999999986
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
... ...++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 169 ~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-------------- 212 (299)
T 3m2w_A 169 ETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-------------- 212 (299)
T ss_dssp ECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC--------------
T ss_pred ccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH--------------
Confidence 431 12478899999999999999999999977654322110000
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
.... ....+.......+++++.+||.+||+.||.+|||+.|+++||||++..
T Consensus 213 ----~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 213 ----RIRM---GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp ----SSCT---TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred ----HHhh---ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 0000 001111112245799999999999999999999999999999998753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=327.60 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=200.5
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCc-----EEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 101 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 101 (376)
.++|++.+.||+|+||+||+|.+..+++ .||+|.+.... ....+|+.+++.+ +||||+++++++...
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 122 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG-- 122 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC--
Confidence 4689999999999999999999987664 79999886542 2345899999999 899999999988433
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhh----------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEc
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSS----------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 170 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~ 170 (376)
..+|+||||+++ +|.+.+..... ....+++..++.++.|++.||.|||+ +||+||||||+|||++
T Consensus 123 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 123 ---GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLLT 198 (333)
T ss_dssp ---SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGCEEE
T ss_pred ---CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceEEEC
Confidence 338899999985 88888764322 14568999999999999999999999 7999999999999999
Q ss_pred CCCCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHH
Q 017147 171 PLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 246 (376)
Q Consensus 171 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 246 (376)
. ++.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+......+
T Consensus 199 ~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 199 N-GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp G-GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred C-CCeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 6 77899999999976543322 1234567889999998764 48999999999999999998 99999887765555
Q ss_pred HHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 247 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 247 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..+......+ ..+...++++.+||.+||+.||.+|||+.++++
T Consensus 277 ~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 277 YKLVKDGYQM---------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 5544421110 012236889999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=316.59 Aligned_cols=245 Identities=19% Similarity=0.303 Sum_probs=200.3
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+|+.+++.++||||+++++++... ...|+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CCeEE
Confidence 458999999999999999999986 67889999997543 3446899999999999999999988443 33889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVL 155 (267)
T ss_dssp EECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECG-GGCEEECCTTGGGGBC
T ss_pred EEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEECC-CCCEEEcccccccccc
Confidence 9999985 77777753 34568999999999999999999999 79999999999999986 7789999999997553
Q ss_pred cCC--CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 189 AGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 189 ~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
... ......+|+.|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+....+.....
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~----------- 223 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----------- 223 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----------
T ss_pred cccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc-----------
Confidence 221 11234557789999999654 48999999999999999999 8999998887766655543110
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
...+...++.+.+|+.+||+.||.+|||+.+++++
T Consensus 224 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 224 -----------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00122468899999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=323.54 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=199.5
Q ss_pred cceeeeeeeeecCCCeeEEEEEE-----cCCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 101 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 101 (376)
.++|++.+.||+|+||+||+|.+ ..+++.||+|++.... ....+|+.+++.+ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-- 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC--
Confidence 46899999999999999999985 3567899999986542 2345799999999 689999999987432
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhc------------CCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEE
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYSSA------------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 168 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nil 168 (376)
...+++||||+++ +|.+.+...... ...+++..++.++.|++.||.|||+ +||+||||||+||+
T Consensus 104 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil 180 (316)
T 2xir_A 104 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL 180 (316)
T ss_dssp --TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred --CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEE
Confidence 2237899999985 888877642211 1238999999999999999999999 79999999999999
Q ss_pred EcCCCCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHH
Q 017147 169 VDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD 244 (376)
Q Consensus 169 l~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 244 (376)
++. ++.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+
T Consensus 181 ~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 181 LSE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp ECG-GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred ECC-CCCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 986 77899999999986544332 1235668899999999764 48999999999999999998 999998876544
Q ss_pred HHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 245 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 245 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.+.........+ ..+..+++++.++|.+||+.||.+|||+.++++|
T Consensus 259 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 259 EFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 444333321100 0123468899999999999999999999999876
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=325.55 Aligned_cols=250 Identities=24% Similarity=0.354 Sum_probs=199.5
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEc-------CCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeee
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFS 98 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 98 (376)
..++|++.+.||+|+||+||+|.+. .+++.||+|++.... ....+|+.+++.+ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4478999999999999999999976 456789999986542 2345799999999 89999999998843
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHHhhhh------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCC
Q 017147 99 TTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 165 (376)
Q Consensus 99 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~ 165 (376)
. ..+|+||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+
T Consensus 113 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~ 186 (334)
T 2pvf_A 113 D-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAAR 186 (334)
T ss_dssp S-----SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGG
T ss_pred C-----CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCccc
Confidence 3 348899999985 88888764321 12348999999999999999999999 79999999999
Q ss_pred cEEEcCCCCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCC
Q 017147 166 NLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 241 (376)
Q Consensus 166 Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 241 (376)
||+++. ++.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+
T Consensus 187 NIll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 187 NVLVTE-NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GEEECT-TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eEEEcC-CCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 999996 77899999999976544322 2233457889999998664 48999999999999999999 999999888
Q ss_pred hHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 242 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 242 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
..+....+...... ..+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 265 VEELFKLLKEGHRM----------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCC----------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77666554442100 0123478999999999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=319.78 Aligned_cols=247 Identities=24% Similarity=0.336 Sum_probs=196.3
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcC---CCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
...++|++.+.||+|+||+||+|.+.. ++..||+|.+... .....+|+.+++.++||||+++++++...
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 85 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE--- 85 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS---
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---
Confidence 345789999999999999999998654 3456999998654 23345799999999999999999987321
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
..|+||||+.+ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+||
T Consensus 86 ---~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Df 157 (281)
T 3cc6_A 86 ---PTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVAS-PECVKLGDF 157 (281)
T ss_dssp ---SCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEEE-TTEEEECCC
T ss_pred ---CCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEECC-CCcEEeCcc
Confidence 15799999985 77777753 34568999999999999999999999 79999999999999996 778999999
Q ss_pred cccccCccCCC--ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 182 GSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 182 g~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
|++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||......+....+......+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~-- 234 (281)
T 3cc6_A 158 GLSRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP-- 234 (281)
T ss_dssp CGGGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC--
T ss_pred CCCcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC--
Confidence 99986543322 2234457889999999654 48999999999999999998 999998777666555444321100
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.+..+++.+.+||.+||+.||++|||+.+++++
T Consensus 235 --------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 235 --------------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp --------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 123468999999999999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=320.76 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=194.6
Q ss_pred cceeeeeeeeecCCCeeEEEEE----EcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
..+|++.+.||+|+||.||+|. +..+++.||+|++.... ....+|+.+++.++||||+++++++....
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG--- 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---
Confidence 3569999999999999999999 56789999999986432 33468999999999999999999885432
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
...+++||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg 171 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVES-EHQVKIGDFG 171 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCCT
T ss_pred CceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEcC-CCCEEECccc
Confidence 2337899999985 88777753 34569999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCCC----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 183 SAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 183 ~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|..|+..... ......+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~ 245 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPMA-----LFLKMIGPTHG 245 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHH-----HHHHHHCSCCG
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchhh-----HHhhccCCccc
Confidence 9986654432 2234567789999999664 478999999999999999999988643211 11111111110
Q ss_pred HH----H-hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 259 EE----I-RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 259 ~~----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.. + ...... . ....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~-~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 246 QMTVTRLVNTLKEG-K------------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp GGHHHHHHHHHHTT-C------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ccCHHHHHHHHhcc-C------------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 00 0 000000 0 01123457899999999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=319.43 Aligned_cols=247 Identities=26% Similarity=0.304 Sum_probs=198.7
Q ss_pred cceeeeee-eeecCCCeeEEEEEEc--CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 33 TISYMAER-VVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 33 ~~~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
.++|.+.+ .||+|+||.||+|.+. .++..||+|++.... ....+|+.+++.++||||+++++++ ....
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~--- 83 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA--- 83 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS---
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC---
Confidence 35677776 9999999999999864 467889999986532 2345799999999999999999987 2221
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
.++||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||+
T Consensus 84 --~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~Dfg~ 156 (287)
T 1u59_A 84 --LMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVN-RHYAKISDFGL 156 (287)
T ss_dssp --EEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEE-TTEEEECCCTT
T ss_pred --cEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEcC-CCCEEECcccc
Confidence 7899999986 77776642 34669999999999999999999999 79999999999999996 78899999999
Q ss_pred cccCccCCCc----eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 184 AKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 184 a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
+......... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~---- 231 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---- 231 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC----
T ss_pred eeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc----
Confidence 9865433221 223457889999999654 48999999999999999998 9999998887665554433100
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 319 (376)
..++..+++++.+||.+||+.||.+|||+.++++|.+
T Consensus 232 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 232 ------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ------------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 0122357899999999999999999999999998744
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=318.56 Aligned_cols=249 Identities=24% Similarity=0.328 Sum_probs=187.0
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
...++|++.+.||+|+||+||+|.+. ..+|+|++.... ....+|+.+++.++|+||++++++. ...
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~---- 92 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP---- 92 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS----
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC----
Confidence 34468999999999999999999864 359999885432 2345799999999999999998854 111
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
..++||||+.+ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus 93 -~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~ 166 (289)
T 3og7_A 93 -QLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLHE-DNTVKIGDFGL 166 (289)
T ss_dssp -SCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET-TTEEEECCCC-
T ss_pred -ccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEECC-CCCEEEcccee
Confidence 26799999985 77666642 34679999999999999999999999 79999999999999996 78899999999
Q ss_pred cccCccC---CCceeeeeccccCchhhhhC--CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 184 AKQLIAG---EANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 184 a~~~~~~---~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
+...... .......+|+.|+|||++.. ...++.++|||||||++|+|++|..||.+....+.+.........+..
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc
Confidence 9754322 12234568999999999852 345788999999999999999999999987776666555543211110
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
...+...+++++.+||.+||+.||.+|||+.++++
T Consensus 247 -----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 247 -----------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -----------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 01122347899999999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=331.79 Aligned_cols=257 Identities=13% Similarity=0.149 Sum_probs=195.6
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCC--------CcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeee-------
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLET--------GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFS------- 98 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~--------~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------- 98 (376)
++|++.+.||+|+||.||+|.+..+ ++.||+|.+... ....+|+.+++.++||||+++++.+..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 5899999999999999999999874 889999998755 456689999999999999984332110
Q ss_pred ----cCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC
Q 017147 99 ----TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 174 (376)
Q Consensus 99 ----~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~ 174 (376)
.........|+||||+.++|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl~~~-~~ 196 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSLGRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFVDP-ED 196 (352)
T ss_dssp CCCEEEEETTTEEEEEEECCCEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEEEET-TE
T ss_pred chhhccccCCcEEEEEecCCCcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEEcC-CC
Confidence 000123458899999977998888642 23679999999999999999999999 79999999999999996 55
Q ss_pred --cEEEEeecccccCccCCC--------ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCC-hH
Q 017147 175 --QVKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AV 243 (376)
Q Consensus 175 --~vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~ 243 (376)
.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.. ..
T Consensus 197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 275 (352)
T 2jii_A 197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT 275 (352)
T ss_dssp EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccCCcCH
Confidence 899999999976543221 1234789999999999654 58999999999999999999999998764 33
Q ss_pred HHHHHHHH-HhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 244 DQLVEIIK-VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 244 ~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
+.+..... ....+. .+.. .......+++++.+||.+||+.||++|||++++++
T Consensus 276 ~~~~~~~~~~~~~~~---------~~~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 276 EDIMKQKQKFVDKPG---------PFVG-----------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHHHHHHHHHSCC---------CEEC-----------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhccCChh---------hhhh-----------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 33332222 111110 0000 00011246899999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=318.10 Aligned_cols=243 Identities=24% Similarity=0.284 Sum_probs=195.1
Q ss_pred cceeeeee-eeecCCCeeEEEEE--EcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 33 TISYMAER-VVGTGSFGIVFQAK--CLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 33 ~~~y~~~~-~lg~G~~g~Vy~~~--~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
..+|++.+ .||+|+||+||+|. +..+++.||+|++.... ....+|+.+++.++||||+++++++ ...
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~--- 90 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE--- 90 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS---
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC---
Confidence 45899998 99999999999995 45677899999986532 2345799999999999999999987 222
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
..++||||+. ++|.+.+.. ...+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||
T Consensus 91 --~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg 162 (291)
T 1xbb_A 91 --SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDFG 162 (291)
T ss_dssp --SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCCT
T ss_pred --CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEeC-CCcEEEccCC
Confidence 2789999998 477777753 4569999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCCCc----eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 017147 183 SAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 257 (376)
Q Consensus 183 ~a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 257 (376)
++......... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--- 238 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER--- 238 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---
Confidence 99765443322 123346789999999654 47899999999999999999 9999998887665544432100
Q ss_pred HHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..++..+++++.++|.+||+.||.+|||+.++++
T Consensus 239 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 239 -------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112347899999999999999999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=332.81 Aligned_cols=246 Identities=24% Similarity=0.308 Sum_probs=188.8
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEc---CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
...+|++.+.||+|+||+||+|+++ .++..||||++.... ....+|+.+++.++||||+++++++...
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---- 118 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS---- 118 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS----
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC----
Confidence 4468999999999999999999876 467789999986432 2345799999999999999999988433
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
...|+||||++ ++|.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 119 -~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg 192 (373)
T 2qol_A 119 -KPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILINS-NLVCKVSDFG 192 (373)
T ss_dssp -SSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC-
T ss_pred -CceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEcC-CCCEEECcCc
Confidence 33789999997 588777753 34579999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCCCc----eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 017147 183 SAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 257 (376)
Q Consensus 183 ~a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 257 (376)
+++........ ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......+
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~- 270 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP- 270 (373)
T ss_dssp ---------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC-
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 99865433211 122346789999999654 48999999999999999998 999999888776655543321111
Q ss_pred HHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+..++..+.+||.+||+.||.+|||+.++++
T Consensus 271 ---------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 271 ---------------------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ---------------------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 11246889999999999999999999998875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=327.29 Aligned_cols=256 Identities=18% Similarity=0.211 Sum_probs=199.8
Q ss_pred ccceeeeeeeeecCCCeeEEEEE-----EcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 101 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (376)
...+|++.+.||+|+||.||+|. +..+++.||+|.+.... ....+|+.+++.++||||+++++++....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 106 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL- 106 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC-
Confidence 45689999999999999999999 55678899999985432 23457999999999999999999884433
Q ss_pred CCceEEEEEeeccc-chHHHHHHhhhh---cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC--CCc
Q 017147 102 KNELFLNLVMEYVP-ESMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQ 175 (376)
Q Consensus 102 ~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~--~~~ 175 (376)
..|+||||++ ++|.+.+..... ....+++..++.++.|++.||.|||+ +||+||||||+|||++.+ +..
T Consensus 107 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 107 ----PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ----SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCC
T ss_pred ----CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcce
Confidence 3789999996 588888865322 12458999999999999999999999 799999999999999842 346
Q ss_pred EEEEeecccccCccCC---CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017147 176 VKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 251 (376)
Q Consensus 176 vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 251 (376)
+||+|||++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence 9999999987443222 12234568899999998654 48999999999999999998 9999998877665554433
Q ss_pred HhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
.... ..+..+++.+.+||.+||+.||.+|||+.++++|.|+-.
T Consensus 261 ~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 261 GGRM----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp TCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 1100 012347899999999999999999999999999998754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=314.63 Aligned_cols=245 Identities=18% Similarity=0.253 Sum_probs=198.0
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
..++|++.+.||+|+||+||+|.+ +++.||+|++.... ....+|+.+++.++||||+++++++.... ..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~ 82 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---AP 82 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CC
Confidence 457899999999999999999998 48899999986432 23457899999999999999999885432 23
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCC--eeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
..++||||+++ +|.+.+.. .....+++..++.++.|++.||.|||+ +| ++||||||+||+++. ++.++|+|||
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~-~~~~~l~~~~ 158 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDE-DMTARISMAD 158 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECT-TSCEEEEGGG
T ss_pred CeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcC-CcceeEEecc
Confidence 47899999985 88887763 122358999999999999999999999 79 999999999999996 7789999998
Q ss_pred ccccCccCCCceeeeeccccCchhhhhCCCC--CCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 183 SAKQLIAGEANISYICSRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 183 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
++..... ....+|+.|+|||++.+... ++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 159 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---- 230 (271)
T 3kmu_A 159 VKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP---- 230 (271)
T ss_dssp SCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC----
T ss_pred ceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC----
Confidence 8754322 23567999999999976432 2338999999999999999999999888777665554421111
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.++..+++++.+||.+||+.||++|||++++++
T Consensus 231 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 231 -----------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 123457899999999999999999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=325.95 Aligned_cols=264 Identities=25% Similarity=0.324 Sum_probs=199.0
Q ss_pred cccceeeeeeeeecCCCeeEEEEE----EcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
...++|++.+.||+|+||.||+|. +..+++.||+|++.... ....+|+.+++.++|+||+++++++...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP--- 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS---
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC---
Confidence 345689999999999999999999 56789999999986543 2346899999999999999999987542
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
+...+|+||||++ ++|.+.+... ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~-~~~~kl~Df 171 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVES-EAHVKIADF 171 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCG
T ss_pred CCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEECC-CCCEEEccc
Confidence 3345889999996 5787777642 3468999999999999999999999 79999999999999996 788999999
Q ss_pred cccccCccCCC----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017147 182 GSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257 (376)
Q Consensus 182 g~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 257 (376)
|++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.............. ...+.
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~ 249 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE-RDVPA 249 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCH
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc-ccccc
Confidence 99986543332 1234567889999999664 479999999999999999999999975433211100000 00000
Q ss_pred HHHH-hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 258 REEI-RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 258 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
...+ ...... .....+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 250 LSRLLELLEEG-------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhcc-------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 000000 0011233578999999999999999999999999643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=360.12 Aligned_cols=286 Identities=26% Similarity=0.340 Sum_probs=206.3
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCC-CCceE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELF 106 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 106 (376)
.++|++.+.||+|+||+||+|.+..+++.||||++... .....+|+.+++.++||||+++++++..... .....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 46899999999999999999999999999999988653 2234579999999999999999887643111 12344
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC--cEEEEeecc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGS 183 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~--~vkl~Dfg~ 183 (376)
.|+||||++| +|.+.+... .....+++..++.++.|++.||.|||+ +||+||||||+||+++.++. .+||+|||+
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~-~~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSS-SCTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEEeCCCCCHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 7899999975 887777642 223368999999999999999999999 79999999999999986322 489999999
Q ss_pred cccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 184 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 184 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
+.............+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.......... ...........
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~~~~~ 246 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNEHIVV 246 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT---CC------CCS
T ss_pred ccccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh---hhcccchhhhh
Confidence 987766555566788999999999865 45899999999999999999999999876543221110 00000000000
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
.........+.. ..+....+...+++.+.+||.+||++||.+|||+.++++||||+.+...
T Consensus 247 ~~~l~g~~~~~~--~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~i 307 (676)
T 3qa8_A 247 YDDLTGAVKFSS--VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI 307 (676)
T ss_dssp CCCCSSSCCCCS--SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHH
T ss_pred hhhhcccccccc--ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHH
Confidence 000011111111 1111222334467899999999999999999999999999999876543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=335.93 Aligned_cols=254 Identities=22% Similarity=0.267 Sum_probs=199.5
Q ss_pred CcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
+...++|++.+.||+|+||.||+|.+..+++.||||++... .....+|+++++.++|++.+..+..+.. ...+.
T Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~ 78 (483)
T 3sv0_A 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYN 78 (483)
T ss_dssp CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEE
T ss_pred CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEE
Confidence 45567899999999999999999999999999999987543 3456789999999998665554444432 22347
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEc--CCCCcEEEEeecccc
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQVKICDFGSAK 185 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~--~~~~~vkl~Dfg~a~ 185 (376)
++||||+.++|.+++.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++ ..++.+||+|||+++
T Consensus 79 ~lvme~~g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 79 VLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp EEEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEEECCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 89999998898888863 34679999999999999999999999 7999999999999993 236789999999998
Q ss_pred cCccCCC--------ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhC
Q 017147 186 QLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLG 254 (376)
Q Consensus 186 ~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~ 254 (376)
....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+... .+.+..+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence 6544332 1256789999999999664 489999999999999999999999987543 333333333211
Q ss_pred CCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
....+ .+...+++++.+||.+||+.||.+||++.++++
T Consensus 234 ~~~~~------------------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 234 ATSIE------------------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HSCHH------------------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccHH------------------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11111 112347899999999999999999999987653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=335.47 Aligned_cols=244 Identities=22% Similarity=0.310 Sum_probs=197.8
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
...+|++.+.||+|+||.||++.+. ++.||||++..+. ....+|+.+++.++||||+++++++.... ..+|+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~i 264 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYI 264 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----CceEE
Confidence 4568999999999999999999874 7799999987543 33468999999999999999999875432 23889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
||||+++ +|.+.+... ....+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 265 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TSCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEECC-CCCEEEeeCCCccccc
Confidence 9999985 888887642 23347899999999999999999999 79999999999999996 7789999999997543
Q ss_pred cCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017147 189 AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267 (376)
Q Consensus 189 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 267 (376)
.. .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.+...
T Consensus 341 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------- 404 (450)
T 1k9a_A 341 ST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------------- 404 (450)
T ss_dssp --------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC-------------
T ss_pred cc--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence 22 2233567889999999764 58999999999999999998 9999998776665554433110
Q ss_pred CCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
...+..+++++.+||.+||+.||.+|||+.++++
T Consensus 405 ---------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 405 ---------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0122357899999999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=343.63 Aligned_cols=247 Identities=21% Similarity=0.335 Sum_probs=202.1
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
...+|++.+.||+|+||.||+|.++.++..||||.+..+. ....+|+.+++.++||||+++++++.... .+|
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~ 292 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFY 292 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCC-----cEE
Confidence 3467999999999999999999999999999999987543 33458999999999999999999884332 378
Q ss_pred EEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||+. |+|.+.+... ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++..
T Consensus 293 lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 293 IITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVGE-NHLVKVADFGLSRLM 368 (495)
T ss_dssp EEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECG-GGCEEECCTTCEECC
T ss_pred EEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEECC-CCcEEEeecccceec
Confidence 9999998 5888887642 33568999999999999999999999 79999999999999986 778999999999865
Q ss_pred ccCCC--ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 188 IAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 188 ~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
..... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---------- 437 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---------- 437 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----------
T ss_pred cCCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 43221 1123446789999999654 48999999999999999999 9999998876655444332100
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
...+..+++++.+||.+||+.||.+|||+.++++
T Consensus 438 ------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 438 ------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 0122357899999999999999999999999974
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=322.72 Aligned_cols=247 Identities=21% Similarity=0.290 Sum_probs=193.2
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCC----cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
...+|++.+.||+|+||+||+|.+..++ ..||+|.+.... ....+|+.+++.++||||+++++++..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 117 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK---- 117 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec----
Confidence 4468999999999999999999987553 459999986432 223579999999999999999998833
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
....++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus 118 -~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Df 191 (333)
T 1mqb_A 118 -YKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSDF 191 (333)
T ss_dssp -SSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC
T ss_pred -CCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEECC-CCcEEECCC
Confidence 3348899999986 77777753 34679999999999999999999999 79999999999999996 778999999
Q ss_pred cccccCccCCCc----eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 017147 182 GSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 256 (376)
Q Consensus 182 g~a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 256 (376)
|++......... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.+....+
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 270 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 270 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred CcchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC
Confidence 999765433211 123347789999999654 48999999999999999999 999999888766655544311100
Q ss_pred CHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 271 ----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 271 ----------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ----------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ----------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 122468899999999999999999999998864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=318.03 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=195.2
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCC---cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
....+|++.+.||+|+||+||+|.+..++ ..+|+|.+.... ....+|+.+++.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 98 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS--- 98 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS---
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC---
Confidence 34568999999999999999999976443 458999886432 2345799999999999999999986432
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
....++||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus 99 -~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Df 172 (298)
T 3f66_A 99 -EGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDE-KFTVKVADF 172 (298)
T ss_dssp -SSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEECSC
T ss_pred -CCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEECC-CCCEEECcc
Confidence 2237799999986 88777753 34668999999999999999999999 79999999999999996 778999999
Q ss_pred cccccCccCC-----CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 017147 182 GSAKQLIAGE-----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT 255 (376)
Q Consensus 182 g~a~~~~~~~-----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 255 (376)
|++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 3f66_A 173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 251 (298)
T ss_dssp GGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC
T ss_pred cccccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC
Confidence 9997654322 12334567889999999664 48999999999999999999 67888877765555444331110
Q ss_pred CCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..+..+++.+.++|.+||+.||.+|||+.++++
T Consensus 252 ----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 252 ----------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112346889999999999999999999999885
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=316.02 Aligned_cols=245 Identities=21% Similarity=0.313 Sum_probs=192.0
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
...++|++.+.||+|+||+||+|.+ +++.||+|++..+. ....+|+.+++.++||||+++++++... ....|
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~~ 91 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY 91 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCceE
Confidence 3457899999999999999999987 58899999986543 3345799999999999999999986432 22378
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||+++ +|.+.+.... ...+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEA 167 (278)
T ss_dssp EEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCEEECCCCC----
T ss_pred EEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEeC-CCcEEEeeccccccc
Confidence 99999986 8888776421 2347889999999999999999999 79999999999999996 778999999998754
Q ss_pred ccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+.+..
T Consensus 168 ~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~------------- 231 (278)
T 1byg_A 168 SST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY------------- 231 (278)
T ss_dssp ----------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-------------
T ss_pred ccc--ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-------------
Confidence 332 2234568899999999654 48999999999999999998 999998877655444332210
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
....+..+++.+.++|.+||+.||.+|||+.++++
T Consensus 232 ---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 232 ---------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 01122357899999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=336.55 Aligned_cols=245 Identities=25% Similarity=0.361 Sum_probs=199.3
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
..++|++.+.||+|+||+||+|.+. ++..||||++.... ....+|+.+++.++||||+++++++. .. .+|
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~-----~~~ 258 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE-----PIY 258 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS-----SCE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC-----ccE
Confidence 3468999999999999999999975 46789999987543 33458999999999999999998873 11 277
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||+.+ +|.+.+... ....+++..+..++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++..
T Consensus 259 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSA-SLVCKIADFGLARVI 334 (454)
T ss_dssp EEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECT-TCCEEECSTTGGGGB
T ss_pred EEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEECC-CCcEEEeeCCCceEc
Confidence 99999984 888887632 22357888999999999999999999 79999999999999996 778999999999865
Q ss_pred ccCCC--ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 188 IAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 188 ~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
..... .....+|+.|+|||++... .++.++|||||||++|+|++ |..||.+.+..+....+.+....+
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~-------- 405 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP-------- 405 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC--------
T ss_pred CCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 33211 1223457789999999654 48999999999999999999 999999988877776655421111
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+..+++++.+||.+||+.||++|||++++++
T Consensus 406 --------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 406 --------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp --------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 12347899999999999999999999998874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=314.70 Aligned_cols=249 Identities=23% Similarity=0.395 Sum_probs=195.8
Q ss_pred CcccceeeeeeeeecCCCeeEEEEEEcCCCc---EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 017147 30 PKQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 101 (376)
Q Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (376)
+.....|.+.+.||+|+||+||+|.+..+++ .||+|.+.... ....+|+.+++.++||||+++++++.....
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (298)
T 3pls_A 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG 96 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred cccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC
Confidence 3445578899999999999999999765554 79999886432 233579999999999999999998854332
Q ss_pred CCceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEe
Q 017147 102 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 180 (376)
Q Consensus 102 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~D 180 (376)
..++||||+. ++|.+.+.. ....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+|
T Consensus 97 ----~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~~-~~~~kl~D 167 (298)
T 3pls_A 97 ----LPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLDE-SFTVKVAD 167 (298)
T ss_dssp ----CCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEECC
T ss_pred ----CcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCcEEeCc
Confidence 2479999997 577777753 35678999999999999999999999 79999999999999996 77899999
Q ss_pred ecccccCccCC-----CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 017147 181 FGSAKQLIAGE-----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 254 (376)
Q Consensus 181 fg~a~~~~~~~-----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 254 (376)
||++....... ......+|+.|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+.....
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
T 3pls_A 168 FGLARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR 246 (298)
T ss_dssp TTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC
T ss_pred CCCcccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC
Confidence 99997543321 22334568899999999654 58999999999999999999 5566666665554443332110
Q ss_pred CCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 255 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
. ..+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 247 ~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 247 L----------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp C----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C----------------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0 012346889999999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=313.96 Aligned_cols=244 Identities=25% Similarity=0.310 Sum_probs=197.2
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
.++|++.+.||+|+||.||+|.+. ++..||+|.+.... ....+|+.+++.++||||+++++++.. . ..++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~-----~~~~ 84 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E-----PIYI 84 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-----SCEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-C-----CcEE
Confidence 468999999999999999999965 56789999986543 334589999999999999999988631 1 1679
Q ss_pred Eeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
||||+. ++|.+.+... ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++....
T Consensus 85 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSD-TLSCKIADFGLARLIE 160 (279)
T ss_dssp EEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTCEECS
T ss_pred EEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEcC-CCCEEECCCccccccc
Confidence 999997 4777776431 12368999999999999999999999 79999999999999996 7789999999998654
Q ss_pred cCCC--ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 189 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 189 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.+...
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------- 228 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR----------- 228 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred CcccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC-----------
Confidence 3321 1223457789999999654 48999999999999999999 9999998887766555433110
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
...+..+++++.+||.+||+.||++|||++++++
T Consensus 229 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 229 -----------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0112347899999999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=322.46 Aligned_cols=277 Identities=24% Similarity=0.331 Sum_probs=192.6
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccc-hHHHHH--HHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-KNRELQ--LMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~e~~--~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
...++|++.+.||+|+||+||+|.+ +++.||+|++...... ...|.+ .+..++|+||+++++.+......+...+
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 3457899999999999999999976 7899999998654322 223333 4455899999999987655555666678
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCC---------CeeecCCCCCcEEEcCCCCcEE
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP---------RVCHRDLKPQNLLVDPLTHQVK 177 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------~i~H~dlkp~Nill~~~~~~vk 177 (376)
|+||||+++ +|.+.+.. ...++..++.++.||+.||.|||+ . ||+||||||+|||++. ++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~-~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKN-DGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECT-TSCEE
T ss_pred EEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcC-CCcEE
Confidence 999999975 88877753 345888999999999999999999 8 9999999999999996 77899
Q ss_pred EEeecccccCccCC---------CceeeeeccccCchhhhhCC------CCCCchhhhHhHHHHHHHHHhCCCCC-CCCC
Q 017147 178 ICDFGSAKQLIAGE---------ANISYICSRFYRAPELIFGA------TEYTTSIDIWSAGCVLAELLLGQPLF-PGEN 241 (376)
Q Consensus 178 l~Dfg~a~~~~~~~---------~~~~~~~t~~y~aPE~l~~~------~~~~~~~DiwslG~il~~ll~g~~pf-~~~~ 241 (376)
|+|||++....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..|| .+..
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999997654321 12234689999999999652 23567899999999999999996655 3322
Q ss_pred hHHHHHHHHH-HhCCCCHHHHhhc-CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh----
Q 017147 242 AVDQLVEIIK-VLGTPTREEIRCM-NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC---- 315 (376)
Q Consensus 242 ~~~~~~~i~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l---- 315 (376)
..+....+.. ....+....+... ........++.. |. ....+++++.+||.+||+.||++|||+.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA----WK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT----CC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc----cc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 1111000111 1111222111110 000000011100 00 0011345799999999999999999999994
Q ss_pred --cCCCccc
Q 017147 316 --AHPFFDE 322 (376)
Q Consensus 316 --~hp~~~~ 322 (376)
.++|-++
T Consensus 315 ~ll~~~~~~ 323 (336)
T 3g2f_A 315 ELMMIWERN 323 (336)
T ss_dssp HHHHCCCC-
T ss_pred HHHHHHHhc
Confidence 4666655
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=315.61 Aligned_cols=243 Identities=30% Similarity=0.429 Sum_probs=185.6
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
.++|++.+.||+|+||+||+|.+ .++.||+|++.... ....+|+.+++.++||||+++++++. +. .|+|
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~lv 77 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCLV 77 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEEE
Confidence 46899999999999999999987 47889999986543 33458999999999999999998773 22 5799
Q ss_pred eecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcC--CCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 111 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 111 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
|||+++ +|.+.+... .....+++..+..++.|++.||.|||+. +||+||||||+||+++.++..+||+|||++...
T Consensus 78 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EECCTTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEcCCCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 999985 887777532 1122478899999999999999999983 389999999999999874445899999999754
Q ss_pred ccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHhhcC
Q 017147 188 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD--QLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 188 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~ 265 (376)
... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ....+.. +..
T Consensus 157 ~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~--------- 222 (307)
T 2eva_A 157 QTH--MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GTR--------- 222 (307)
T ss_dssp ----------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TCC---------
T ss_pred ccc--cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CCC---------
Confidence 322 2345689999999999654 58999999999999999999999997644322 1111111 100
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
......+++.+.+||.+||+.||++|||++++++
T Consensus 223 -----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 223 -----------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp -----------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112347899999999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=322.22 Aligned_cols=253 Identities=24% Similarity=0.323 Sum_probs=187.3
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-chHHHHHHHHh--CCCCceeeeceeeeecCCCCceEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRV--MDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
.++|++.+.||+|+||.||+|++. ++.||+|++..... ...+|.+++.. ++||||+++++++.... .....+|+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l 112 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQLYL 112 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCEEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCceEE
Confidence 468999999999999999999874 89999999865433 22345555554 48999999999886543 22245889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCC--------CeeecCCCCCcEEEcCCCCcEEEEe
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP--------RVCHRDLKPQNLLVDPLTHQVKICD 180 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--------~i~H~dlkp~Nill~~~~~~vkl~D 180 (376)
||||+.+ +|.+.+.. ..+++..++.++.|++.||.|||+ + ||+||||||+|||++. ++.+||+|
T Consensus 113 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~-~~~~kl~D 185 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKK-NGTCCIAD 185 (337)
T ss_dssp EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECT-TSCEEECC
T ss_pred EEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECC-CCCEEEEe
Confidence 9999986 88887753 469999999999999999999999 8 9999999999999996 77899999
Q ss_pred ecccccCccCCCc-----eeeeeccccCchhhhhCCCCCCc------hhhhHhHHHHHHHHHhC----------CCCCCC
Q 017147 181 FGSAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTT------SIDIWSAGCVLAELLLG----------QPLFPG 239 (376)
Q Consensus 181 fg~a~~~~~~~~~-----~~~~~t~~y~aPE~l~~~~~~~~------~~DiwslG~il~~ll~g----------~~pf~~ 239 (376)
||++......... ....||+.|+|||++.+.. +.. ++|||||||++|+|++| ..||..
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 9999765433222 2457899999999996544 333 49999999999999999 667754
Q ss_pred CCh----HHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017147 240 ENA----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315 (376)
Q Consensus 240 ~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 315 (376)
... ...........+. ...++ .......+++++.+||.+||+.||.+|||+.+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~--------------~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKL--------------RPSFP-------NRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCC--------------CCCCC-------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hcCCCCchhhhHHHHhhhcc--------------Ccccc-------ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence 321 1222211110000 00000 0001123567899999999999999999999998
Q ss_pred cC
Q 017147 316 AH 317 (376)
Q Consensus 316 ~h 317 (376)
+|
T Consensus 324 ~~ 325 (337)
T 3mdy_A 324 KT 325 (337)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=328.00 Aligned_cols=248 Identities=22% Similarity=0.342 Sum_probs=187.8
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCC---cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
....|++.+.||+|+||+||+|.+..++ ..||+|.+.... ....+|+.+++.++||||+++++++....
T Consensus 87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--- 163 (373)
T 3c1x_A 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE--- 163 (373)
T ss_dssp TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS---
T ss_pred hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC---
Confidence 3457999999999999999999976443 468999885432 23457999999999999999999864322
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
...|+||||+++ +|.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 164 -~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~~~~kL~DFG 237 (373)
T 3c1x_A 164 -GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDE-KFTVKVADFG 237 (373)
T ss_dssp -SCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC-
T ss_pred -CCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEECC-CCCEEEeecc
Confidence 236799999985 88777753 34568899999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCCC-----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 017147 183 SAKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 256 (376)
Q Consensus 183 ~a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 256 (376)
+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+.+...
T Consensus 238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~-- 314 (373)
T 3c1x_A 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-- 314 (373)
T ss_dssp --------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC--
T ss_pred ccccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC--
Confidence 9976533221 1234557889999999654 58999999999999999999 7889987765554444332100
Q ss_pred CHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
...+..+++.+.++|.+||+.||++|||+.+++++
T Consensus 315 --------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 315 --------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00123478899999999999999999999999863
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=333.37 Aligned_cols=244 Identities=26% Similarity=0.315 Sum_probs=195.0
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
.++|++.+.||+|+||+||+|.+.. +..||||++.... ....+|+.+++.++||||+++++++.. ...|+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~i 255 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI 255 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceEE
Confidence 4689999999999999999999864 4679999987543 334689999999999999999988732 12679
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
||||+.+ +|.+.+... ....+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 256 v~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLIE 331 (452)
T ss_dssp EECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCTTC---
T ss_pred EehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEECC-CCCEEECCCccceecC
Confidence 9999985 888887532 23468999999999999999999999 79999999999999986 7789999999998654
Q ss_pred cCCC--ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 189 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 189 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+..+.+....
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---------- 400 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------- 400 (452)
T ss_dssp -----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------
T ss_pred CCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 3221 1233457789999998654 48999999999999999999 99999998877766555432110
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..+..+++.+.+||.+||+.||++|||++++++
T Consensus 401 ------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 401 ------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp ------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 012347899999999999999999999999885
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=318.59 Aligned_cols=257 Identities=23% Similarity=0.310 Sum_probs=193.5
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc--------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
.|...+.||+|+||+||+|.+ +++.||+|++... .....+|+.+++.++||||+++++++.... .
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~ 104 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD-----D 104 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----S
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCC-----c
Confidence 455668999999999999986 6889999988542 123457999999999999999999884433 3
Q ss_pred EEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.++||||++ ++|.+.+... .....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++.
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~Dfg~~~ 181 (307)
T 2nru_A 105 LCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLDE-AFTAKISDFGLAR 181 (307)
T ss_dssp CEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred eEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEcC-CCcEEEeeccccc
Confidence 789999997 5777777542 234679999999999999999999999 79999999999999996 7789999999987
Q ss_pred cCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 186 QLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 186 ~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
....... .....+|+.|+|||++.+ .++.++|||||||++|+|++|.+||.+......+..+.+...........
T Consensus 182 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (307)
T 2nru_A 182 ASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED 259 (307)
T ss_dssp ECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHH
T ss_pred ccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhh
Confidence 6543222 223467999999999854 47899999999999999999999998765443333332221111000000
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
..... ++ ......++.+.+++.+||+.||.+|||+.+++++
T Consensus 260 ~~~~~-----~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 260 YIDKK-----MN---------DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HSCSS-----CS---------CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hcccc-----cc---------ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00000 00 0111235688999999999999999999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=324.70 Aligned_cols=247 Identities=13% Similarity=0.192 Sum_probs=190.8
Q ss_pred cceeeeeeeeecCCCeeEEEE-----EEcCCCcEEEEEEeeccc-cchHHHHHHHHhCC---CCceeeeceeeeecCCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQA-----KCLETGETVAIKKVLQDR-RYKNRELQLMRVMD---HPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~-----~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~ 103 (376)
.++|++.+.||+|+||+||+| .+..+++.||+|++.... .....|+.+++.++ |+||+.+++++.....
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~-- 141 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG-- 141 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC--
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC--
Confidence 368999999999999999999 467789999999986543 33457888888887 8999999998854443
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhh-cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC---------
Q 017147 104 ELFLNLVMEYVP-ESMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--------- 172 (376)
Q Consensus 104 ~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~--------- 172 (376)
.|+|||||+ |+|.+.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++..
T Consensus 142 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 142 ---SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp ---EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGTCC-----
T ss_pred ---cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEecccccCcccccc
Confidence 789999998 588888865433 35679999999999999999999999 799999999999999741
Q ss_pred -CCcEEEEeecccccCc---cCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 017147 173 -THQVKICDFGSAKQLI---AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 248 (376)
Q Consensus 173 -~~~vkl~Dfg~a~~~~---~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 248 (376)
++.+||+|||+|+... .........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 5789999999996543 222334567899999999997654 8999999999999999999999996533210
Q ss_pred HHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 017147 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319 (376)
Q Consensus 249 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 319 (376)
...... ++. + ..++.+.+++.+||+.+|.+|++..+.+.+.+
T Consensus 293 -------------~~~~~~-----~~~---------~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 293 -------------CKPEGL-----FRR---------L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp -------------EEECSC-----CTT---------C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred -------------eeechh-----ccc---------c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 000000 000 0 13668899999999999999977655555444
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=314.14 Aligned_cols=250 Identities=26% Similarity=0.349 Sum_probs=191.6
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcC-CCc--EEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLE-TGE--TVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~--~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
.++|++.+.||+|+||+||+|.+.. +++ .||+|++.... ....+|+.+++.++||||+++++++....
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC--
Confidence 4589999999999999999998643 333 68999885431 23357999999999999999999884321
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
.++||||+. ++|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+||
T Consensus 95 ----~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~~-~~~~kl~Df 165 (291)
T 1u46_A 95 ----MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLAT-RDLVKIGDF 165 (291)
T ss_dssp ----CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TTEEEECCC
T ss_pred ----ceeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEcC-CCCEEEccc
Confidence 679999998 588777764 23568999999999999999999999 79999999999999996 778999999
Q ss_pred cccccCccCCCc----eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 017147 182 GSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 256 (376)
Q Consensus 182 g~a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 256 (376)
|++......... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..+......+
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (291)
T 1u46_A 166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244 (291)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred cccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC
Confidence 999866443322 233457789999999654 47899999999999999999 999999988776665544311000
Q ss_pred CHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
..+..+++++.++|.+||+.||.+|||+.++++ +++++
T Consensus 245 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~~ 282 (291)
T 1u46_A 245 ---------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEA 282 (291)
T ss_dssp ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred ---------------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH--HHHHh
Confidence 012347899999999999999999999999986 45443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=316.47 Aligned_cols=260 Identities=28% Similarity=0.369 Sum_probs=193.6
Q ss_pred cee-eeeeeeecCCCeeEEEEE----EcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 34 ISY-MAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 34 ~~y-~~~~~lg~G~~g~Vy~~~----~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
.+| ++++.||+|+||+||++. +..+++.||+|++..+. ....+|+.+++.++||||+++++++....
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 106 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG--- 106 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC---
Confidence 455 999999999999998875 34578999999987542 23458999999999999999999886532
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
...+++||||+++ +|.+.+.. ..+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~~-~~~~kl~Dfg 179 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDN-DRLVKIGDFG 179 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCGG
T ss_pred CceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEcC-CCCEEECCcc
Confidence 2348899999985 77776642 358999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCCC----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 183 SAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 183 ~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||........ ...+....
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~~~ 253 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-----ELIGIAQG 253 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHHCSCCH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-----hhhccccc
Confidence 9987654432 2234567889999999764 478999999999999999999999975432110 00000000
Q ss_pred H----HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 259 E----EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 259 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
. .+........ ....+..+++++.+||.+||+.||.+|||+.++++ +++.+
T Consensus 254 ~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~--~L~~l 308 (318)
T 3lxp_A 254 QMTVLRLTELLERGE------------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP--ILKTV 308 (318)
T ss_dssp HHHHHHHHHHHHTTC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred chhHHHHHHHHhccc------------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH--HHHHH
Confidence 0 0000000000 01122457899999999999999999999999984 44443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=315.19 Aligned_cols=258 Identities=28% Similarity=0.407 Sum_probs=195.4
Q ss_pred ccceeeeeeeeecCCCeeEEEEE----EcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
...+|++.+.||+|+||.||+|. +..+++.||+|++.... ....+|+.+++.++||||+++++++....
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 115 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--- 115 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC---
Confidence 45689999999999999999998 46789999999986542 23458999999999999999999875432
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
...+++||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~-~~~~kL~Dfg 190 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVEN-ENRVKIGDFG 190 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TTEEEECCCT
T ss_pred CCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEcC-CCcEEEecCc
Confidence 2237899999985 88887764 34568999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCCCc----eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 183 SAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 183 ~a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
++......... ....++..|+|||++.+. .++.++|||||||++|+|++|..||...... ..+..+....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~~~-----~~~~~~~~~~ 264 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQ 264 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH-----HHHHHCTTCC
T ss_pred chhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCHHH-----HHHhhccccc
Confidence 99866443321 223457779999999664 4789999999999999999999998643211 1111111110
Q ss_pred HH------HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 259 EE------IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 259 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.. ....... .. ...+..+++++.+||.+||+.||++|||+.++++
T Consensus 265 ~~~~~~~~~~~~~~~-~~------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 265 GQMIVFHLIELLKNN-GR------------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp THHHHHHHHHHHHTT-CC------------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhhHHHHHHHhhcC-CC------------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 0000000 00 0112357899999999999999999999999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=332.56 Aligned_cols=247 Identities=20% Similarity=0.198 Sum_probs=183.0
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------------cchHHHHHHHHhCC---------CCceee
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMD---------HPNVIS 91 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~---------h~~iv~ 91 (376)
.++|++.+.||+|+||+||+|++ +++.||||++.... ....+|+.+++.++ |+||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46899999999999999999998 78999999997542 33468999998886 666666
Q ss_pred eceee-----------------eecC--------CCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHH
Q 017147 92 LKHCF-----------------FSTT--------SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIF 145 (376)
Q Consensus 92 ~~~~~-----------------~~~~--------~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~ 145 (376)
+.+++ .... ......+|+|||||.+ ++++.+. ...+++..++.++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHH
Confidence 55543 2200 0113458999999975 4444442 25689999999999999
Q ss_pred HHHHHhh-cCCCeeecCCCCCcEEEcCCCC--------------------cEEEEeecccccCccCCCceeeeeccccCc
Q 017147 146 RGLAYIH-TVPRVCHRDLKPQNLLVDPLTH--------------------QVKICDFGSAKQLIAGEANISYICSRFYRA 204 (376)
Q Consensus 146 ~al~~LH-~~~~i~H~dlkp~Nill~~~~~--------------------~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~a 204 (376)
.||.||| + +||+||||||+|||++. ++ .+||+|||+|+..... ..+||+.|+|
T Consensus 172 ~aL~~lH~~-~~ivHrDlKp~NILl~~-~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~a 245 (336)
T 2vuw_A 172 ASLAVAEAS-LRFEHRDLHWGNVLLKK-TSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHHH-HCCBCSCCCGGGEEEEE-CSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTC
T ss_pred HHHHHHHHh-CCEeECCCCHHHEEEec-cCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccC
Confidence 9999999 9 79999999999999996 43 8999999999865432 4588999999
Q ss_pred hhhhhCCCCCCchhhhHhHHHH-HHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChh
Q 017147 205 PELIFGATEYTTSIDIWSAGCV-LAELLLGQPLFPGENAVD-QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 282 (376)
Q Consensus 205 PE~l~~~~~~~~~~DiwslG~i-l~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (376)
||++.+.. +.++||||+|++ .++++.|..||.+..... ....+..... ++... .
T Consensus 246 PE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~------------------~~~~~----~ 301 (336)
T 2vuw_A 246 EDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT------------------FKTKC----N 301 (336)
T ss_dssp SGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCC------------------CSSCC----C
T ss_pred hhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhc------------------cCccc----c
Confidence 99996543 889999998776 777888999995422111 1122221100 00000 0
Q ss_pred hhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh-cCCCcc
Q 017147 283 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-AHPFFD 321 (376)
Q Consensus 283 ~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l-~hp~~~ 321 (376)
......+++++++||++||++| |++|+| +||||+
T Consensus 302 ~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 302 TPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp SHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 1112236889999999999987 999999 999995
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=338.54 Aligned_cols=247 Identities=26% Similarity=0.314 Sum_probs=194.1
Q ss_pred eeeeee-eeecCCCeeEEEEEEc--CCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 35 SYMAER-VVGTGSFGIVFQAKCL--ETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 35 ~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
++.+.+ .||+|+||+||+|.++ .++..||||++... .....+|+.+++.++||||+++++++.. . .
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~-----~ 409 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E-----A 409 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S-----S
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C-----C
Confidence 455555 8999999999999876 35667999998653 2334589999999999999999998743 1 1
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+|+|||||.+ +|.+.+.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 410 ~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~-~~~vkL~DFGla~ 484 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLVN-RHYAKISDFGLSK 484 (613)
T ss_dssp EEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCCSTTT
T ss_pred eEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEcC-CCcEEEeeccCcc
Confidence 7899999985 77766642 34669999999999999999999999 79999999999999996 7889999999998
Q ss_pred cCccCCCc----eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 186 QLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 186 ~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
........ ....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+.+...
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~------ 557 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR------ 557 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC------
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC------
Confidence 65433221 122346789999999654 58999999999999999998 9999999887776655543110
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh---cCCCcc
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC---AHPFFD 321 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l---~hp~~~ 321 (376)
..++..+++++.+||.+||+.||++|||+.+++ ++.|+.
T Consensus 558 ----------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 558 ----------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ----------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 012235789999999999999999999999874 454443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=339.53 Aligned_cols=236 Identities=25% Similarity=0.301 Sum_probs=189.7
Q ss_pred eeeecCCCeeEEEEEE--cCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTGSFGIVFQAKC--LETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~--~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.||+|+||+||+|.+ +.+++.||||++.... ....+|+.+++.++||||+++++++. ... .++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~-----~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AES-----WMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSS-----EEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCC-----EEEEE
Confidence 4799999999999954 4567899999986532 23458999999999999999999873 111 67999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||+.+ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.....
T Consensus 449 E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~~-~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 449 EMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRAD 522 (635)
T ss_dssp ECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCTTHHHHTTC-
T ss_pred EccCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEeC-CCCEEEEEcCCccccccC
Confidence 99985 7777775 35679999999999999999999999 79999999999999996 778999999999865433
Q ss_pred CC----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 191 EA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 191 ~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.. .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+.+....
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---------- 591 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---------- 591 (635)
T ss_dssp ------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------
T ss_pred ccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 22 1223457889999999654 48999999999999999998 99999998887766555442110
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..+..+++++.+||.+||+.||++|||++++++
T Consensus 592 ------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 592 ------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 112347899999999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=336.53 Aligned_cols=244 Identities=26% Similarity=0.322 Sum_probs=198.7
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
.++|++.+.||+|+||.||+|.+.. +..||||++.... ....+|+.+|+.++|+||+++++++.. ..+|+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~l 338 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI 338 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccceE
Confidence 4689999999999999999999864 4679999987543 345689999999999999999988732 12779
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
||||+.+ +|.+.+... ....+++..+..++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 339 v~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLIE 414 (535)
T ss_dssp EECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCTTSTTTCC
T ss_pred eeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEcC-CCcEEEcccccceecC
Confidence 9999985 888887532 23458999999999999999999999 79999999999999986 7789999999997653
Q ss_pred cCC--CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 189 AGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 189 ~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
... ......++..|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+..+.+....
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---------- 483 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------- 483 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC----------
T ss_pred CCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 321 11223456789999998654 48999999999999999999 99999998877766655431110
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
..+..+++++.+||.+||+.||++|||++++++
T Consensus 484 ------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 484 ------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 012347899999999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=312.96 Aligned_cols=252 Identities=20% Similarity=0.252 Sum_probs=195.3
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
...++|++.+.||+|+||.||+|.+.. .+|+|++... .....+|+.+++.++|+||+++++++....
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 102 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP---- 102 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS----
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC----
Confidence 345789999999999999999999754 4999988532 233457999999999999999999885443
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
.+++||||+.+ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++ ++.+||+|||+
T Consensus 103 -~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~--~~~~~l~Dfg~ 175 (319)
T 2y4i_B 103 -HLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYD--NGKVVITDFGL 175 (319)
T ss_dssp -CEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC----CCEECCCSC
T ss_pred -ceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEe--CCCEEEeecCC
Confidence 38899999984 77766642 34468999999999999999999999 7999999999999998 46799999999
Q ss_pred cccCccC------CCceeeeeccccCchhhhhC--------CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 017147 184 AKQLIAG------EANISYICSRFYRAPELIFG--------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 249 (376)
Q Consensus 184 a~~~~~~------~~~~~~~~t~~y~aPE~l~~--------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 249 (376)
+...... .......+|+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.........+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 255 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 8654211 12233457899999999864 234789999999999999999999999988876665544
Q ss_pred HHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
....... .....++.++.+||.+||+.||.+|||+.++++ .++.+..
T Consensus 256 ~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~ 302 (319)
T 2y4i_B 256 GTGMKPN---------------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPK 302 (319)
T ss_dssp HTTCCCC---------------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC--
T ss_pred ccCCCCC---------------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHH
Confidence 3311000 011236889999999999999999999999985 4555433
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=315.76 Aligned_cols=253 Identities=22% Similarity=0.264 Sum_probs=191.9
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-cchHHHHHHHHh--CCCCceeeeceeeeecCCCCceEEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRV--MDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
++|++.+.||+|+||+||+|.+ +++.||+|++.... ....+|+++++. ++||||+++++++.... ......|+|
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~lv 118 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV 118 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEEE
Confidence 6899999999999999999997 58999999986543 334578888887 78999999999885443 112248899
Q ss_pred eecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhh--------cCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 111 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--------TVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 111 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
|||+++ +|.+.+.. ..+++..++.++.|++.||.||| + +||+||||||+|||++. ++.+||+||
T Consensus 119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~-~~~~kL~Df 191 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKK-NGTCCIADL 191 (342)
T ss_dssp ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECT-TSCEEECCC
T ss_pred EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECC-CCCEEEEEC
Confidence 999986 88887753 46899999999999999999999 8 79999999999999996 778999999
Q ss_pred cccccCccCCC-----ceeeeeccccCchhhhhCCCC-----CCchhhhHhHHHHHHHHHhC----------CCCCCCCC
Q 017147 182 GSAKQLIAGEA-----NISYICSRFYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLG----------QPLFPGEN 241 (376)
Q Consensus 182 g~a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~-----~~~~~DiwslG~il~~ll~g----------~~pf~~~~ 241 (376)
|++........ .....+|+.|+|||++.+... ++.++|||||||++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 99976544332 234568999999999965432 23689999999999999999 78886643
Q ss_pred h----HHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 242 A----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 242 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
. .+.+........ ....++. ......++..+.+||.+||+.||++|||+.++++|
T Consensus 272 ~~~~~~~~~~~~~~~~~--------------~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQK--------------LRPNIPN-------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSC--------------CCCCCCG-------GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHHH--------------hCCCCcc-------cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 2 122221111000 0000000 00111235678999999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=337.85 Aligned_cols=245 Identities=28% Similarity=0.376 Sum_probs=197.3
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCC---CcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
..++|++.+.||+|+||+||+|.+..+ +..||+|.+.... ....+|+.+++.++||||+++++++.. +
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----N 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----S
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----C
Confidence 446899999999999999999998654 4579999876432 334579999999999999999998721 1
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
..|+||||++ |+|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 464 --~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~~-~~~vkL~DFG 536 (656)
T 2j0j_A 464 --PVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFG 536 (656)
T ss_dssp --SCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCCC
T ss_pred --ceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEeC-CCCEEEEecC
Confidence 2679999998 587777753 34568999999999999999999999 79999999999999996 7889999999
Q ss_pred ccccCccCCCc--eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 183 SAKQLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 183 ~a~~~~~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
+++........ ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..+......+
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~--- 612 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP--- 612 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---
Confidence 99865433221 223457889999999654 58999999999999999997 999999988877776665421110
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
++..+++.+.+||.+||+.||.+|||+.++++
T Consensus 613 -------------------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 613 -------------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp -------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 12347899999999999999999999999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=338.16 Aligned_cols=243 Identities=24% Similarity=0.360 Sum_probs=195.8
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcC-CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
..++|++.+.||+|+||+||+|.+.. +++.||||++.... ....+|+.+++.++||||+++++++......+..
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 34789999999999999999999976 78999999886432 2335799999999999999999998766554555
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
..|+||||++| +|.+.+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++. +.+||+|||++
T Consensus 158 ~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~~--~~~kl~DFG~a 228 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTE--EQLKLIDLGAV 228 (681)
T ss_dssp EEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECS--SCEEECCCTTC
T ss_pred eeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEeC--CcEEEEecccc
Confidence 67899999986 5544332 379999999999999999999999 79999999999999985 37999999999
Q ss_pred ccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
+..... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.... +
T Consensus 229 ~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~---------- 283 (681)
T 2pzi_A 229 SRINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------G---------- 283 (681)
T ss_dssp EETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------S----------
T ss_pred hhcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----------c----------
Confidence 865433 345789999999998653 589999999999999999999998653210 0
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.+. ..+ ....++.+.+||.+||+.||.+||+..+.+.|+|+.-+
T Consensus 284 --------~~~--~~~-----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 --------LPE--DDP-----VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp --------CCT--TCH-----HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --------ccc--ccc-----ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000 000 01136789999999999999999999999999998654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=294.04 Aligned_cols=227 Identities=15% Similarity=0.045 Sum_probs=176.6
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
...++|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.++..++||||+++++++...
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~---- 103 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR---- 103 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET----
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC----
Confidence 34478999999999999999999999999999999986542 2345799999999999999999998543
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
...|+||||++| +|.+.+.. + .....+..++.|++.||+|||+ +||+||||||+|||++. ++.+||++++
T Consensus 104 -~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~~-~g~~kl~~~~ 174 (286)
T 3uqc_A 104 -AGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSI-DGDVVLAYPA 174 (286)
T ss_dssp -TEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEET-TSCEEECSCC
T ss_pred -CcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEcC-CCCEEEEecc
Confidence 348899999985 77776632 2 3556788899999999999999 79999999999999996 6778887432
Q ss_pred ccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 183 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 183 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
|++ .++.++|||||||++|+|++|+.||.+.+..+.+..
T Consensus 175 -------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-------------- 213 (286)
T 3uqc_A 175 -------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-------------- 213 (286)
T ss_dssp -------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--------------
T ss_pred -------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--------------
Confidence 333 278999999999999999999999987653211100
Q ss_pred hcCcCCCCCCCCCC-CCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 263 CMNPNYTDFRFPQI-KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 263 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
..... ........+...+++++.+||.+||+.||.+| |+.++++ .++.+
T Consensus 214 ---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~--~L~~~ 263 (286)
T 3uqc_A 214 ---------AERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN--LMQQA 263 (286)
T ss_dssp ---------CCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH--HHHHH
T ss_pred ---------HHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH--HHHHH
Confidence 00000 00111122334689999999999999999999 9999986 34443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-33 Score=274.07 Aligned_cols=180 Identities=19% Similarity=0.082 Sum_probs=123.7
Q ss_pred eeecCCCeeEEEEEEcCCCcEEEEEEeeccc--------------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCce
Q 017147 41 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 41 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 105 (376)
..+.|++|.+..++..-.|+.||+|.+.++. ....+|+++|+++ .|+||+++++++ +++.
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 4667778888777777789999999986541 2245799999999 699999999998 4555
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
.+|||||||+| +|.+.+. ..+++++. .|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 316 ~~yLVMEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~~-dg~vKL~DFGlA 386 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVDA-RQHARLIDFGSI 386 (569)
T ss_dssp EEEEEEECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEECT-TSCEEECCCTTE
T ss_pred EEEEEEecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEECC-CCCEEEeecccC
Confidence 59999999997 7777775 45667654 478999999999999 79999999999999996 778999999999
Q ss_pred ccCccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCC
Q 017147 185 KQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 236 (376)
Q Consensus 185 ~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~p 236 (376)
+...... ...+.+||+.|+|||++.+ .+..++|+||+|++++.|.++..+
T Consensus 387 r~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 387 VTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred eeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence 8664432 3445789999999999865 367889999999998887655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=232.71 Aligned_cols=179 Identities=17% Similarity=0.211 Sum_probs=132.9
Q ss_pred eeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 37 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 37 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
...+.||+|+||+||++. ..++.+++|+..... ....+|+++++.++||||+++..+......
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~--- 413 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN--- 413 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT---
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc---
Confidence 456789999999999994 467889999764321 123589999999999999955444433222
Q ss_pred eEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
.|+||||++ ++|.+.+.. +..++.|++.||+|||+ +||+||||||+|||++. .+||+|||+
T Consensus 414 --~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~---~~kL~DFGl 475 (540)
T 3en9_A 414 --KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK---DLYIIDFGL 475 (540)
T ss_dssp --TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS---SEEECCCTT
T ss_pred --cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC---eEEEEECcc
Confidence 579999998 577776642 56889999999999999 79999999999999994 899999999
Q ss_pred cccCccCCC--------ceeeeeccccCchhhhhC-CCCCCchhhhHhHHHHHHHHHhCCCCCC
Q 017147 184 AKQLIAGEA--------NISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFP 238 (376)
Q Consensus 184 a~~~~~~~~--------~~~~~~t~~y~aPE~l~~-~~~~~~~~DiwslG~il~~ll~g~~pf~ 238 (376)
++....... ..+..||+.|+|||++.+ ...|+..+|+||..+-..+.+.++.+|.
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 987644322 135678999999999854 1237888999999988888887776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.6e-24 Score=190.02 Aligned_cols=138 Identities=17% Similarity=0.203 Sum_probs=108.2
Q ss_pred eeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----------------------cchHHHHHHHHhCCCCceeeec
Q 017147 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------------------RYKNRELQLMRVMDHPNVISLK 93 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------------------~~~~~e~~~l~~l~h~~iv~~~ 93 (376)
|.+.+.||+|+||.||+|.+ .+|+.||+|.+.... ....+|+.+++.++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 33449999999999999999 889999999985321 22458999999999 5 6666
Q ss_pred eeeeecCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC
Q 017147 94 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL 172 (376)
Q Consensus 94 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~ 172 (376)
+++. . ...|+||||++| +|.+ +. ......++.|++.||.|||+ .||+||||||+|||++
T Consensus 168 ~~~~-~-----~~~~lvmE~~~g~~L~~-l~----------~~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~-- 227 (282)
T 1zar_A 168 KVYA-W-----EGNAVLMELIDAKELYR-VR----------VENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS-- 227 (282)
T ss_dssp CEEE-E-----ETTEEEEECCCCEEGGG-CC----------CSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE--
T ss_pred eEEe-c-----cceEEEEEecCCCcHHH-cc----------hhhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE--
Confidence 6542 2 225799999986 5544 21 12345799999999999999 7999999999999999
Q ss_pred CCcEEEEeecccccCccCCCceeeeeccccCchhhhh
Q 017147 173 THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 209 (376)
Q Consensus 173 ~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~ 209 (376)
++.+||+|||+|.. +..+.|||.+.
T Consensus 228 ~~~vkl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 EEGIWIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp TTEEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred CCcEEEEECCCCeE------------CCCCCHHHHHH
Confidence 67899999999852 34578999873
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=5e-21 Score=169.55 Aligned_cols=135 Identities=19% Similarity=0.227 Sum_probs=102.7
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcE--EEEEEeeccc----------------------------cchHHHHHHHHhC
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDR----------------------------RYKNRELQLMRVM 84 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~aiK~~~~~~----------------------------~~~~~e~~~l~~l 84 (376)
-|.+.+.||+|+||.||+|.+..+|+. ||||++.... ....+|+.+++.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 488999999999999999998788999 9999864321 1345799999999
Q ss_pred CCCceeeeceeeeecCCCCceEEEEEeecccc------hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhh-cCCCe
Q 017147 85 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE------SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH-TVPRV 157 (376)
Q Consensus 85 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~i 157 (376)
.|+++.... .+. .. ..++||||+++ .|.+... ..++..+..++.|++.||.||| + .||
T Consensus 128 ~~~~i~~p~-~~~-~~-----~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~-~gi 192 (258)
T 1zth_A 128 KEAGVSVPQ-PYT-YM-----KNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQE-AEL 192 (258)
T ss_dssp HHTTCCCCC-EEE-EE-----TTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHT-SCE
T ss_pred HhCCCCCCe-EEE-cC-----CCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHH-CCE
Confidence 887642221 111 11 15699999953 4443321 1234567889999999999999 9 799
Q ss_pred eecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 158 CHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 158 ~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+||||||+|||++. .++|+|||+|...
T Consensus 193 vHrDlkp~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC---cEEEEECcccccC
Confidence 99999999999984 7999999999643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.5e-17 Score=153.27 Aligned_cols=134 Identities=15% Similarity=0.156 Sum_probs=90.1
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc----------c----------------hHHHHHHHHhCCCCc
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----------Y----------------KNRELQLMRVMDHPN 88 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----------~----------------~~~e~~~l~~l~h~~ 88 (376)
-|++...||+|++|.||+|.+ .+|+.||||++..... . ..+|...|.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 399999999999999999997 4799999998743210 0 013444555553333
Q ss_pred eeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEE
Q 017147 89 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 168 (376)
Q Consensus 89 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nil 168 (376)
+... ..+ .... .+|||||++|..+ .... ....+..++.|++.+|.+||+ .||+||||||.|||
T Consensus 175 v~vp-~p~-~~~~-----~~LVME~i~G~~L---~~l~------~~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NIL 237 (397)
T 4gyi_A 175 FPVP-EPI-AQSR-----HTIVMSLVDALPM---RQVS------SVPDPASLYADLIALILRLAK-HGLIHGDFNEFNIL 237 (397)
T ss_dssp CSCC-CEE-EEET-----TEEEEECCSCEEG---GGCC------CCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEE
T ss_pred CCCC-eee-eccC-----ceEEEEecCCccH---hhhc------ccHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEE
Confidence 2111 111 1111 3599999997421 1111 112346788999999999999 79999999999999
Q ss_pred EcCCCC---------cEEEEeeccccc
Q 017147 169 VDPLTH---------QVKICDFGSAKQ 186 (376)
Q Consensus 169 l~~~~~---------~vkl~Dfg~a~~ 186 (376)
++.++. .+.|+||+-+-.
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EeCCCCcccccccccceEEEEeCCccc
Confidence 985321 388999997743
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=2.3e-11 Score=107.39 Aligned_cols=136 Identities=15% Similarity=0.087 Sum_probs=99.5
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeec----cccchHHHHHHHHhCC-CCceeeeceeeeecCCCCceEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~----~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
...|++...++.|+.+.||++.. .+..+++|.... ......+|+.+++.+. +..+.+++++... ....
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~ 85 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DGWS 85 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEE
T ss_pred hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----CCce
Confidence 35699999999999999999974 368999998863 3345678999999885 5566677766532 2347
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcC--------------------------------
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-------------------------------- 154 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-------------------------------- 154 (376)
|+|||+++| ++.+.+. +......++.++..++..||+.
T Consensus 86 ~lv~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred EEEEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 899999998 4333210 1112345677888888999971
Q ss_pred --------------------------CCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 155 --------------------------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 155 --------------------------~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
..++|+|++|.||+++. +..+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET-TEEEEECCCTTCE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC-CcEEEEEEchhcc
Confidence 24899999999999985 5556799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=4.4e-10 Score=98.76 Aligned_cols=133 Identities=14% Similarity=0.061 Sum_probs=88.8
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-ccchHHHHHHHHhCCCCc--eeeeceeeeecCCCCceEEEEEe
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMDHPN--VISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
.|.+....+.|..+.||++. ..+|..+++|..... .....+|+.+++.+.+.+ +.+++...... ...++||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-----~~~~~v~ 94 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRDWLLL 94 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCEEEEE
T ss_pred CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-----CCCEEEE
Confidence 46665544566679999996 456778999987543 234568999999886544 34455544222 2378999
Q ss_pred ecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCC------------------------------------
Q 017147 112 EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP------------------------------------ 155 (376)
Q Consensus 112 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------------ 155 (376)
||++|..+. .. ... ...++.++..++..||+..
T Consensus 95 e~i~G~~l~-~~-------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 95 GEVPGQDLL-SS-------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp ECCSSEETT-TS-------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EecCCcccC-cC-------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999984222 10 111 1245566777777777621
Q ss_pred ---------------------CeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 156 ---------------------RVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 156 ---------------------~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+++|+|++|.||+++. +..+.|+||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~liD~~~a~ 213 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVEN-GRFSGFIDCGRLG 213 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEET-TEEEEECCCTTCE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEEC-CcEEEEEcchhcc
Confidence 2999999999999985 5556699999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=2.4e-09 Score=98.88 Aligned_cols=140 Identities=16% Similarity=0.158 Sum_probs=97.4
Q ss_pred eeeeeecCCCeeEEEEEEcCCCcEEEEEEee--cc-----ccchHHHHHHHHhCCC--CceeeeceeeeecCCCCceEEE
Q 017147 38 AERVVGTGSFGIVFQAKCLETGETVAIKKVL--QD-----RRYKNRELQLMRVMDH--PNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 38 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~--~~-----~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
..+.|+.|.++.||++... +..+++|+.. .. .....+|+.+++.+.. ..+.+++..+.+. ......|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSCE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCeE
Confidence 4667899999999998753 4688899775 22 3456689999999874 3456665554222 1113366
Q ss_pred EEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 017147 109 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV---------------------------------- 154 (376)
Q Consensus 109 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---------------------------------- 154 (376)
+||||++|... .. .....++......++.+++.+|..||+.
T Consensus 118 ~vme~v~G~~l---~~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 118 YIMEFVSGRVL---WD--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEECCCCBCC---CC--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEecCCeec---CC--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 99999998421 10 1123467777888899999999999962
Q ss_pred -----------------------CCeeecCCCCCcEEEcCCCC-cEEEEeeccccc
Q 017147 155 -----------------------PRVCHRDLKPQNLLVDPLTH-QVKICDFGSAKQ 186 (376)
Q Consensus 155 -----------------------~~i~H~dlkp~Nill~~~~~-~vkl~Dfg~a~~ 186 (376)
..++|+|++|.||+++.++. .+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999986443 368999999863
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.96 E-value=3.9e-10 Score=101.77 Aligned_cols=184 Identities=15% Similarity=0.193 Sum_probs=107.8
Q ss_pred eeeeecCCCeeEEEEEEcCCCcEEEEEEeecc--ccchHHHHHHHHhCC-CCceeeeceeeee-cCCCCceEEEEEeecc
Q 017147 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMD-HPNVISLKHCFFS-TTSKNELFLNLVMEYV 114 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~~~~~~lv~e~~ 114 (376)
.+.++.|....||++. ..+++|..... .....+|..+++.+. +..+. .-.++.. .........|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~-vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLP-IPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSC-CCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCC-CCceEeecCCCCCCCcceEEEccc
Confidence 3458999999999863 46899976543 234568999998874 33321 1112211 1112222356899999
Q ss_pred cc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 017147 115 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--------------------------------------- 154 (376)
Q Consensus 115 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--------------------------------------- 154 (376)
+| .+..... ..++..+...++.|+...+..||+.
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 97 3322111 2345555555666666666666641
Q ss_pred ------------------CCeeecCCCCCcEEEcCC-CCcEEEEeecccccCccCCCceeeeecccc---Cchhhhh---
Q 017147 155 ------------------PRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQLIAGEANISYICSRFY---RAPELIF--- 209 (376)
Q Consensus 155 ------------------~~i~H~dlkp~Nill~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y---~aPE~l~--- 209 (376)
..++|+|++|.||+++.+ +..+.|+||+.+........ ......+ .+|+...
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D---l~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND---FISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH---HHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH---HHHHHhhccccCHHHHHHHH
Confidence 247999999999999864 34578999999864221100 0000011 2222210
Q ss_pred C-CC---------CCCchhhhHhHHHHHHHHHhCCCCC
Q 017147 210 G-AT---------EYTTSIDIWSAGCVLAELLLGQPLF 237 (376)
Q Consensus 210 ~-~~---------~~~~~~DiwslG~il~~ll~g~~pf 237 (376)
. -. ....-.+.|++|.++|.+.+|..+|
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 00 0122368999999999999999876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=2e-06 Score=77.43 Aligned_cols=69 Identities=10% Similarity=-0.056 Sum_probs=44.8
Q ss_pred eeeeecCCCeeEEEEEEcCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCc---eeeeceeeeecCCCCceEEEEEeec
Q 017147 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPN---VISLKHCFFSTTSKNELFLNLVMEY 113 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~~---iv~~~~~~~~~~~~~~~~~~lv~e~ 113 (376)
.+.++.|....||++ +..+++|+-... .....+|..+|+.+.+.. +.+.+.+.. . .....++|||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~--~--~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK--R--SDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE--C--TTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc--c--CCCceEEEEec
Confidence 345788998999988 567889975322 234568999999987532 333333221 1 12235699999
Q ss_pred ccc
Q 017147 114 VPE 116 (376)
Q Consensus 114 ~~~ 116 (376)
++|
T Consensus 95 i~G 97 (306)
T 3tdw_A 95 VQG 97 (306)
T ss_dssp CCS
T ss_pred cCC
Confidence 997
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=2.5e-05 Score=68.66 Aligned_cols=130 Identities=16% Similarity=0.173 Sum_probs=79.7
Q ss_pred eecCCCe-eEEEEEEcCCCcEEEEEEeeccc-cchHHHHHHHHhCCC-CceeeeceeeeecCCCCceEEEEEeecccc-h
Q 017147 42 VGTGSFG-IVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMDH-PNVISLKHCFFSTTSKNELFLNLVMEYVPE-S 117 (376)
Q Consensus 42 lg~G~~g-~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~ 117 (376)
+..|..| .||+......+..+.+|.-.... ....+|...|+.+.. -.+.+++.+..+. ...|+|||+++| .
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-----~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-----DDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-----CeEEEEEEeeCCcc
Confidence 4445444 69998877778889999775432 234678999888853 1234444444222 236799999987 3
Q ss_pred HHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 017147 118 MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV------------------------------------------- 154 (376)
Q Consensus 118 l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------------------------------------------- 154 (376)
+.+..... ......+..++...|.-||+.
T Consensus 107 ~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 107 AFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 33322110 011122333444444444431
Q ss_pred --------------CCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 155 --------------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 155 --------------~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
..++|+|+.|.||+++. ++.+-|+||+.+.
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~-~~~~~viDwe~a~ 222 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDE-GKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEET-TEEEEECCCTTCE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEEC-CeEEEEEECcccc
Confidence 12789999999999985 5556699999885
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.08 E-value=1.1e-05 Score=73.35 Aligned_cols=30 Identities=27% Similarity=0.589 Sum_probs=26.3
Q ss_pred CCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 155 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
..++|+|+++.||+++. ++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~-~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGE-NEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECG-GGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeC-CCcEEEEehhhcc
Confidence 58999999999999975 5679999999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=2.2e-05 Score=73.15 Aligned_cols=71 Identities=20% Similarity=0.164 Sum_probs=44.0
Q ss_pred eeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----------cchHHHHHHHHhCCC--C-ceeeeceeeeecCCCCc
Q 017147 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRVMDH--P-NVISLKHCFFSTTSKNE 104 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----------~~~~~e~~~l~~l~h--~-~iv~~~~~~~~~~~~~~ 104 (376)
.+.||.|..+.||++....+++.+++|...... .....|.++++.+.. + .+.+++.+ +.. .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~---~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE---M 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT---T
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCC---c
Confidence 567899999999999765567889999754221 123568888887742 2 23344322 222 1
Q ss_pred eEEEEEeecccc
Q 017147 105 LFLNLVMEYVPE 116 (376)
Q Consensus 105 ~~~~lv~e~~~~ 116 (376)
.++|||+++|
T Consensus 110 --~~lvmE~l~g 119 (397)
T 2olc_A 110 --AVTVMEDLSH 119 (397)
T ss_dssp --TEEEECCCTT
T ss_pred --cEEEEEeCCC
Confidence 3599999976
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=3.6e-05 Score=70.58 Aligned_cols=78 Identities=12% Similarity=0.081 Sum_probs=48.7
Q ss_pred eeeeee-ecCCCeeEEEEEEc--C----CCcEEEEEEeeccc-------cchHHHHHHHHhCCC---Cceeeeceeeeec
Q 017147 37 MAERVV-GTGSFGIVFQAKCL--E----TGETVAIKKVLQDR-------RYKNRELQLMRVMDH---PNVISLKHCFFST 99 (376)
Q Consensus 37 ~~~~~l-g~G~~g~Vy~~~~~--~----~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h---~~iv~~~~~~~~~ 99 (376)
...+.| +.|..+.+|++... . ++..+++|...... ....+|+.+++.+.. -.+.+++....+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345677 88888999988753 0 25679999765432 345689988887743 2344554443211
Q ss_pred CCCCceEEEEEeecccc
Q 017147 100 TSKNELFLNLVMEYVPE 116 (376)
Q Consensus 100 ~~~~~~~~~lv~e~~~~ 116 (376)
......|+|||+++|
T Consensus 103 --~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 103 --DVLGTPFFLMDYVEG 117 (357)
T ss_dssp --TTTSSCEEEEECCCC
T ss_pred --CccCCceEEEEecCC
Confidence 111234689999986
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.52 E-value=0.0011 Score=55.37 Aligned_cols=97 Identities=18% Similarity=0.072 Sum_probs=62.2
Q ss_pred hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHh-hcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCCcee
Q 017147 117 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI-HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 195 (376)
Q Consensus 117 ~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~ 195 (376)
+|.++|.. .+.+++++++|.+++|.+.+|.-+ +. +.-..+=+.|..|++.. +|.|.+.+ +.+.
T Consensus 34 SL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~~~~i~~~~~i~l~~-dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARR-RQPRHRVRSAAQIRVWR-DGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSGGGEEEET-TSCEEECC-C-------------
T ss_pred cHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhc-ccCCceecCCcceEEec-CCceeccc-cccc----------
Confidence 67888875 468899999999999999998776 22 12123334578888886 66665543 1110
Q ss_pred eeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh
Q 017147 196 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 232 (376)
Q Consensus 196 ~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~ 232 (376)
.....+.|||... ...+.+.=|+|||+++|.-+-
T Consensus 98 -~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred -ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 1122467888752 235688899999999999985
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.0004 Score=61.95 Aligned_cols=65 Identities=15% Similarity=0.106 Sum_probs=40.4
Q ss_pred eeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCcee-eeceeeeecCCCCceEEEEEeecc
Q 017147 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVI-SLKHCFFSTTSKNELFLNLVMEYV 114 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~ 114 (376)
.+.|+.|....+|++ ..+++|+..... ....+|+.+++.+....+. +++... . +. -++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~---~~--~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--P---AT--GVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--T---TT--CCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--C---CC--CEEEEeec
Confidence 677889999999998 568899775432 2235788887776433332 333221 1 11 23789999
Q ss_pred -cc
Q 017147 115 -PE 116 (376)
Q Consensus 115 -~~ 116 (376)
+|
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 54
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0014 Score=61.51 Aligned_cols=79 Identities=13% Similarity=-0.041 Sum_probs=45.6
Q ss_pred hcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccCCCceeeee--ccccCchhhhhCCCC--CCchhhhHhHHHHH
Q 017147 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIFGATE--YTTSIDIWSAGCVL 227 (376)
Q Consensus 152 H~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~--t~~y~aPE~l~~~~~--~~~~~DiwslG~il 227 (376)
+. ..++|+|++|.|||++. ++ +.++||+.+......-....... ...|.+|+....... .....++.++...+
T Consensus 230 ~~-~~liHGDl~~~Nil~~~-~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 230 RA-QALIHGDLHTGSVMVTQ-DS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp BC-CEEECSCCSGGGEEECS-SC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CC-CeEEecCCCCCcEEEeC-CC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 45 68999999999999985 44 99999999864321111111111 133566654421110 11234445677777
Q ss_pred HHHHhC
Q 017147 228 AELLLG 233 (376)
Q Consensus 228 ~~ll~g 233 (376)
+..+.+
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 776654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.002 Score=57.80 Aligned_cols=142 Identities=12% Similarity=0.070 Sum_probs=73.2
Q ss_pred eeeeeecCCCeeEEEEEEcCCCcEEEEEEeec--cccchHHHHHHHHhCCCCce--eeeceeeeecCCC----CceEEEE
Q 017147 38 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--DRRYKNRELQLMRVMDHPNV--ISLKHCFFSTTSK----NELFLNL 109 (376)
Q Consensus 38 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~--~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~----~~~~~~l 109 (376)
-.+.|+.|....+|++... +..+++|.... .......|..+++.+....+ .+++.. .... .....++
T Consensus 26 ~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~---~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR---KDGELLGELSGRPAA 100 (322)
T ss_dssp EEEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB---TTCCSCEEETTEEEE
T ss_pred EeeccCCCcccceEEEEeC--CccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCC---CCCCEEEEECCEEEE
Confidence 3456788888999998753 33688998865 33445678888877743222 233211 0100 0123578
Q ss_pred EeecccchH------------HHH---HHhhhhc-CCC----cCHH-HHHH--------------HHHHHHHHHHHhhc-
Q 017147 110 VMEYVPESM------------YRV---LKHYSSA-NQR----MPLI-YVKL--------------YTYQIFRGLAYIHT- 153 (376)
Q Consensus 110 v~e~~~~~l------------~~~---l~~~~~~-~~~----l~~~-~~~~--------------i~~qi~~al~~LH~- 153 (376)
++++++|.. .+. +...... ... .... .... +-..+...++.+..
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 999998621 011 1111000 000 0100 0000 00012233444431
Q ss_pred -----CCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 154 -----VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 154 -----~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
..+++|+|+.+.||+++. +..+.|+||+.+.
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~-~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLG-DELSGLIDFYFAC 216 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred CcccCCcccCCCCCCccCEEEeC-CceEEEecchhcc
Confidence 147999999999999985 4445799999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0042 Score=54.82 Aligned_cols=70 Identities=17% Similarity=0.163 Sum_probs=48.0
Q ss_pred eeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCC---ceeeeceeeeecCCCCceEEE
Q 017147 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHP---NVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~~~~~~ 108 (376)
..-++.+|.|..+.||++. ..+|+.|.+|+-.... .....|...|+.|... .+.+++.. . . -+
T Consensus 17 v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~--~----~~ 86 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW---D--D----RT 86 (288)
T ss_dssp EEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---E--T----TE
T ss_pred eEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---c--C----ce
Confidence 4556789999999999998 4678999999765432 2356899999988532 22333221 1 1 24
Q ss_pred EEeeccc
Q 017147 109 LVMEYVP 115 (376)
Q Consensus 109 lv~e~~~ 115 (376)
+|||++.
T Consensus 87 lv~e~l~ 93 (288)
T 3f7w_A 87 LAMEWVD 93 (288)
T ss_dssp EEEECCC
T ss_pred EEEEeec
Confidence 8899986
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.016 Score=54.83 Aligned_cols=69 Identities=14% Similarity=0.239 Sum_probs=44.2
Q ss_pred eeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc---chHHHHHHHHhCCCCcee-eeceeeeecCCCCceEEEEEeecc
Q 017147 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVI-SLKHCFFSTTSKNELFLNLVMEYV 114 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~ 114 (376)
.+.|+.|-...+|++.....+..+++|+...... ...+|..+++.|...++. +++..+ .+ ..||||+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEee
Confidence 4568888889999998754457899997744321 225899999988765553 444433 11 1489998
Q ss_pred cc
Q 017147 115 PE 116 (376)
Q Consensus 115 ~~ 116 (376)
+|
T Consensus 184 ~G 185 (458)
T 2qg7_A 184 DG 185 (458)
T ss_dssp CS
T ss_pred CC
Confidence 75
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0054 Score=54.91 Aligned_cols=71 Identities=14% Similarity=0.038 Sum_probs=49.3
Q ss_pred eeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-cchHHHHHHHHhCC---CCceeeeceeeeecCCCCceEEEEEeecc
Q 017147 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMD---HPNVISLKHCFFSTTSKNELFLNLVMEYV 114 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 114 (376)
.+.|+.|....+|++.. ++..+++|...... .....|...|+.|. ...+.+++..... ....++|||++
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEEEec
Confidence 46689999999999874 46789999776442 33567888888774 2445555554321 23478999999
Q ss_pred cc
Q 017147 115 PE 116 (376)
Q Consensus 115 ~~ 116 (376)
+|
T Consensus 114 ~G 115 (312)
T 3jr1_A 114 NK 115 (312)
T ss_dssp CC
T ss_pred cC
Confidence 85
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0091 Score=56.03 Aligned_cols=70 Identities=14% Similarity=0.238 Sum_probs=45.3
Q ss_pred eeeeeecCCCeeEEEEEEcC-------CCcEEEEEEeec-cc-cchHHHHHHHHhCCCCce-eeeceeeeecCCCCceEE
Q 017147 38 AERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQ-DR-RYKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 38 ~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~-~~-~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~ 107 (376)
-.+.|+.|....||++.... ++..+.+|+... .. ....+|..+++.+...++ .++++.+ .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----
Confidence 35568888889999998642 257899998744 22 334478888887754343 3444433 11
Q ss_pred EEEeecccc
Q 017147 108 NLVMEYVPE 116 (376)
Q Consensus 108 ~lv~e~~~~ 116 (376)
.+|+||++|
T Consensus 148 g~v~e~l~G 156 (429)
T 1nw1_A 148 GRLEEYIPS 156 (429)
T ss_dssp EEEECCCCE
T ss_pred CEEEEEeCC
Confidence 178899875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0069 Score=54.42 Aligned_cols=73 Identities=14% Similarity=0.031 Sum_probs=43.4
Q ss_pred eeeecCCCeeEEEEEEcCCCcEEEEEEeecc---ccchHHHHHHHHhCCCCc--eeeeceeeeecCC--CCceEEEEEee
Q 017147 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRVMDHPN--VISLKHCFFSTTS--KNELFLNLVME 112 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~--~~~~~~~lv~e 112 (376)
..++ |....||++.. .+|+.+++|..... ......|..+++.+.... +.+++.. +... ......+++|+
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEE
Confidence 3466 88889998763 35668999988632 334456888877774322 3333321 1000 01234578999
Q ss_pred cccc
Q 017147 113 YVPE 116 (376)
Q Consensus 113 ~~~~ 116 (376)
+++|
T Consensus 108 ~i~G 111 (328)
T 1zyl_A 108 SVGG 111 (328)
T ss_dssp CCCC
T ss_pred ecCC
Confidence 9986
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.014 Score=52.61 Aligned_cols=32 Identities=41% Similarity=0.476 Sum_probs=26.8
Q ss_pred CCeeecCCCCCcEEEcCC---CCcEEEEeeccccc
Q 017147 155 PRVCHRDLKPQNLLVDPL---THQVKICDFGSAKQ 186 (376)
Q Consensus 155 ~~i~H~dlkp~Nill~~~---~~~vkl~Dfg~a~~ 186 (376)
..++|||+.+.||+++.+ ...+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 589999999999999852 15789999998863
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0052 Score=56.37 Aligned_cols=69 Identities=13% Similarity=0.136 Sum_probs=40.4
Q ss_pred eeeeecCCCeeEEEEEEcC--------CCcEEEEEEeecccc---chHHHHHHHHhCCCCce-eeeceeeeecCCCCceE
Q 017147 39 ERVVGTGSFGIVFQAKCLE--------TGETVAIKKVLQDRR---YKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELF 106 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~--------~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~ 106 (376)
.+.|+.|....+|++.... .+..+++|+...... ....|..+++.+...++ .+++..+ .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~---- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----N---- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----C----
Confidence 4567788889999998643 136889997754322 23578888887754343 3444332 1
Q ss_pred EEEEeecccc
Q 017147 107 LNLVMEYVPE 116 (376)
Q Consensus 107 ~~lv~e~~~~ 116 (376)
-++||||++|
T Consensus 109 ~~~v~e~i~G 118 (369)
T 3c5i_A 109 GGRIEEWLYG 118 (369)
T ss_dssp TEEEEECCCS
T ss_pred CcEEEEEecC
Confidence 1378999875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.61 E-value=0.013 Score=54.00 Aligned_cols=138 Identities=14% Similarity=0.210 Sum_probs=74.2
Q ss_pred eeeeecCCCeeEEEEEEcC-------CCcEEEEEEeecc---ccchHHHHHHHHhCCCCce-eeeceeeeecCCCCceEE
Q 017147 39 ERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQD---RRYKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~---~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~ 107 (376)
.+.|..|....+|++.... +++.|.+|+.... .....+|..+++.+...++ .+++..+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~---- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE---- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----
Confidence 3457778888999988632 3578999976332 2233478888887753333 3343333 22
Q ss_pred EEEeecccch-H--------------HHHHHhhhhc----CCCc--CHHHHHHHHHHHHH-------------------H
Q 017147 108 NLVMEYVPES-M--------------YRVLKHYSSA----NQRM--PLIYVKLYTYQIFR-------------------G 147 (376)
Q Consensus 108 ~lv~e~~~~~-l--------------~~~l~~~~~~----~~~l--~~~~~~~i~~qi~~-------------------a 147 (376)
.+||||++|. + .+.+...-.. .... ...++..++.++-. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 1789999751 1 1111111011 1111 23455555544321 1
Q ss_pred HHH----hhc---CCCeeecCCCCCcEEEcCC---CCcEEEEeecccc
Q 017147 148 LAY----IHT---VPRVCHRDLKPQNLLVDPL---THQVKICDFGSAK 185 (376)
Q Consensus 148 l~~----LH~---~~~i~H~dlkp~Nill~~~---~~~vkl~Dfg~a~ 185 (376)
+.. |.. ...++|+|+.+.||+++.+ .+.+.++||..+.
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 222 221 1368999999999999863 2579999999875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.47 E-value=0.011 Score=53.54 Aligned_cols=30 Identities=27% Similarity=0.506 Sum_probs=25.9
Q ss_pred CCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 155 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
..++|+|+.+.||+++. ++.+.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~-~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGN-EESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECG-GGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeC-CCeEEEEECCCCe
Confidence 47999999999999985 5669999998875
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.93 E-value=0.27 Score=45.74 Aligned_cols=69 Identities=12% Similarity=0.156 Sum_probs=43.4
Q ss_pred eeeeecCCCeeEEEEEEcCC-------CcEEEEEEeecccc---chHHHHHHHHhCCCCce-eeeceeeeecCCCCceEE
Q 017147 39 ERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDRR---YKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~~-------~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~ 107 (376)
++.+..|....+|++..... ++.|++|+...... ...+|..+++.+...++ .++++.+ . -
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~----~ 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----P----E 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----T
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----C
Confidence 44567788899999986421 57899998654321 23578888888753333 3333322 1 1
Q ss_pred EEEeecccc
Q 017147 108 NLVMEYVPE 116 (376)
Q Consensus 108 ~lv~e~~~~ 116 (376)
+.|+||++|
T Consensus 146 ~~I~efI~G 154 (424)
T 3mes_A 146 GRIEEFIDG 154 (424)
T ss_dssp EEEEECCCS
T ss_pred CEEEEEeCC
Confidence 478999986
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 376 | ||||
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-123 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-74 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-70 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-70 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-67 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-66 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-66 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-65 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-65 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-64 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-64 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-63 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-62 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-62 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-60 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-60 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-59 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-58 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-57 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-57 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-56 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-53 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-51 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-51 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-50 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-48 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-48 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-41 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-40 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-39 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-39 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-39 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-38 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-37 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-36 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-35 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-35 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-35 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-19 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 357 bits (917), Expect = e-123
Identities = 225/346 (65%), Positives = 281/346 (81%), Gaps = 3/346 (0%)
Query: 19 ISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL 78
+ T G P Q +SY +V+G GSFG+V+QAK ++GE VAIKKVLQD+R+KNREL
Sbjct: 6 VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 79 QLMRVMDHPNVISLKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV 137
Q+MR +DH N++ L++ F+S+ K+E++LNLV++YVPE++YRV +HYS A Q +P+IYV
Sbjct: 65 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 138 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 197
KLY YQ+FR LAYIH+ +CHRD+KPQNLL+DP T +K+CDFGSAKQL+ GE N+SYI
Sbjct: 125 KLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 198 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257
CSR+YRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
RE+IR MNPNYT+F+FPQIKAHPW KVF R PPEAI L SRLL+Y+P+ R T LEACAH
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 318 PFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 363
FFDELR+PN +LPNGR P LFNF + ++P L LIP H +
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 2e-74
Identities = 108/341 (31%), Positives = 177/341 (51%), Gaps = 24/341 (7%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKN---RELQLMRVMDHPNVI 90
Y +G G++G+V A VAIKK+ + + Y RE++++ H N+I
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
+ + T + + LV + +Y++LK Q + ++ + YQI RGL Y
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKY 124
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYRAPE 206
IH+ V HRDLKP NLL++ T +KICDFG A+ + Y+ +R+YRAPE
Sbjct: 125 IHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-- 264
++ + YT SIDIWS GC+LAE+L +P+FPG++ +DQL I+ +LG+P++E++ C+
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 265 -NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
P PW+++F +A+DL ++L ++P R +A AHP+ ++
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301
Query: 324 REPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 364
+P+ F F EL E + +LI + R
Sbjct: 302 YDPSDE----PIAEAPFKFDMELDDLPKEKLKELIFEETAR 338
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 1e-70
Identities = 74/305 (24%), Positives = 130/305 (42%), Gaps = 31/305 (10%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 90
+ +G G+ G+VF+ +G +A K + + + RELQ++ + P ++
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
F+S +++ ME++ L R+P + + + +GL Y
Sbjct: 68 GFYGAFYSDGE-----ISICMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 210
+ ++ HRD+KP N+LV+ ++K+CDFG + QLI AN S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMNPNYT 269
T Y+ DIWS G L E+ +G+ P +A +L+ +V G R P
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 270 DFRF--------------PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315
+ I P K+ E D ++ L +P+ R +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 316 AHPFF 320
H F
Sbjct: 297 VHAFI 301
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 6e-70
Identities = 96/304 (31%), Positives = 150/304 (49%), Gaps = 23/304 (7%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDHPNVI 90
+G G F V++A+ T + VAIKK+ R + RE++L++ + HPN+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
L F ++ ++LV +++ + + + ++K Y +GL Y
Sbjct: 64 GLLDAFGHKSN-----ISLVFDFMETDL---EVIIKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 209
+H + HRDLKP NLL+D +K+ DFG AK + ++ +R+YRAPEL+F
Sbjct: 116 LHQ-HWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
GA Y +D+W+ GC+LAELLL P PG++ +DQL I + LGTPT E+ M
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR--EPN 327
F P H +F + +DL L ++P R TA +A +F P
Sbjct: 234 YVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292
Query: 328 ARLP 331
+LP
Sbjct: 293 CQLP 296
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 2e-67
Identities = 104/337 (30%), Positives = 164/337 (48%), Gaps = 23/337 (6%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 89
Y VG+G++G V A +TG VA+KK+ + + REL+L++ M H NV
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
I L F S E ++ ++ + + Q++ +V+ YQI RGL
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLK 135
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 209
YIH+ + HRDLKP NL V+ KI DFG A+ + Y+ +R+YRAPE++
Sbjct: 136 YIHS-ADIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191
Query: 210 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
Y ++DIWS GC++AELL G+ LFPG + +DQL I++++GTP E ++ ++
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 270 DF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
Q+ + VF P A+DL ++L R TA +A AH +F + +P
Sbjct: 252 RNYIQSLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310
Query: 327 NARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 363
+ P+ ++ E + L D V
Sbjct: 311 DD-----EPVADPYDQSFESRDLLIDEWKSLTYDEVI 342
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 3e-66
Identities = 103/316 (32%), Positives = 167/316 (52%), Gaps = 21/316 (6%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 89
Y + VG+G++G V A TG VAIKK+ + + + REL+L++ M H NV
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 90 ISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
I L F + ++ LVM ++ + +++KH +++ ++ YQ+ +GL
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGL 134
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 208
YIH + HRDLKP NL V+ ++KI DFG A+Q Y+ +R+YRAPE+I
Sbjct: 135 RYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV GTP E ++ + +
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 269 TDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
P+++ + + P A++L ++L R TA EA AHP+F+ L +
Sbjct: 251 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309
Query: 326 PNARLPNGRPLPPLFN 341
P + F+
Sbjct: 310 TE-DEPQVQKYDDSFD 324
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 9e-66
Identities = 101/307 (32%), Positives = 167/307 (54%), Gaps = 21/307 (6%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 89
+ +G G++G+V++A+ TGE VA+KK+ D + RE+ L++ ++HPN+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
+ L E L LV E++ + + + + SA +PL +K Y +Q+ +GLA
Sbjct: 64 VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLA 116
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELI 208
+ H+ RV HRDLKPQNLL++ +K+ DFG A+ + + +YRAPE++
Sbjct: 117 FCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPN 267
G Y+T++DIWS GC+ AE++ + LFPG++ +DQL I + LGTP +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327
FP+ + KV + + L S++L Y P+ R +A A AHPFF ++ +P
Sbjct: 235 DYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP- 292
Query: 328 ARLPNGR 334
+P+ R
Sbjct: 293 --VPHLR 297
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 209 bits (533), Expect = 1e-65
Identities = 89/300 (29%), Positives = 148/300 (49%), Gaps = 21/300 (7%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLM-RVMDHPNVISLK 93
Y R +G G + VF+A + E V +K + ++ K RE++++ + PN+I+L
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96
Query: 94 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
S+ LV E+V + ++ L Q + ++ Y Y+I + L Y H+
Sbjct: 97 DIVKDPVSRT---PALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS 147
Query: 154 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 213
+ + HRD+KP N+++D ++++ D+G A+ G+ + SR+++ PEL+
Sbjct: 148 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206
Query: 214 YTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
Y S+D+WS GC+LA ++ + P F G + DQLV I KVLGT + D R
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 273 FPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324
F I W + H + PEA+D +LL+Y R TA EA HP+F +
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 1e-65
Identities = 81/309 (26%), Positives = 146/309 (47%), Gaps = 22/309 (7%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 89
Y +G G+FG VF+A+ +TG+ VA+KKVL + + RE+++++++ H NV
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 90 ISLKHCFFSTTS---KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
++L + S + + + LV ++ + S+ + L +K +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDL---AGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-----SYICSRF 201
GL YIH ++ HRD+K N+L+ +K+ DFG A+ + + + + + +
Sbjct: 129 GLYYIHR-NKILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
YR PEL+ G +Y ID+W AGC++AE+ P+ G QL I ++ G+ T E
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 262 RCMNPNYTDFRFPQIKAHP---WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318
++ + +K ++ P A+DL +LL P+ R + +A H
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 319 FFDELREPN 327
FF P+
Sbjct: 307 FFWSDPMPS 315
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 207 bits (528), Expect = 1e-64
Identities = 71/325 (21%), Positives = 127/325 (39%), Gaps = 41/325 (12%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVIS 91
Y +GTG+FG+V + TG A K V+ D+ +E+Q M V+ HP +++
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
L F NE+ + + E++ + + + + +M Y Q+ +GL ++
Sbjct: 88 LHDAF---EDDNEMVM--IYEFMSGGE--LFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 152 HTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 210
H H DLKP+N++ ++++K+ DFG L ++ + + APE+ G
Sbjct: 141 HE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270
D+WS G + LL G F GEN + L +
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA---------- 248
Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP--NA 328
+ + D +LL P+ R T +A HP+ P ++
Sbjct: 249 ---------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
Query: 329 RLPNGRPLPPLFNFKQELSGASPEL 353
++P+ R + K + L
Sbjct: 294 QIPSSRYTKIRDSIKTKYDAWPEPL 318
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 4e-64
Identities = 97/299 (32%), Positives = 155/299 (51%), Gaps = 17/299 (5%)
Query: 36 YMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDRRYKN------RELQLMRVM---D 85
Y +G G++G VF+A+ L+ G VA+K+V + RE+ ++R + +
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 86 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 145
HPNV+ L + + E L LV E+V + + L +P +K +Q+
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLL 126
Query: 146 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 205
RGL ++H+ RV HRDLKPQN+LV + Q+K+ DFG A+ A S + + +YRAP
Sbjct: 127 RGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
E++ + Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V+G P E+ +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW-PRD 242
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324
F A P K + DL + L ++P+ R +A A +HP+F +L
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (513), Expect = 3e-63
Identities = 101/299 (33%), Positives = 156/299 (52%), Gaps = 18/299 (6%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 89
Y +G G++G VF+AK ET E VA+K+V D + RE+ L++ + H N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
+ L ++ L LV E+ + K++ S N + VK + +Q+ +GL
Sbjct: 64 VRLHDVL-----HSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELI 208
+ H+ V HRDLKPQNLL++ ++K+ +FG A+ S + + +YR P+++
Sbjct: 116 FCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 209 FGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
FGA Y+TSID+WSAGC+ AEL +PLFPG + DQL I ++LGTPT E+ M
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
+P A ++ DL LL+ +P R +A EA HP+F + P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 4e-62
Identities = 72/328 (21%), Positives = 133/328 (40%), Gaps = 32/328 (9%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKHCFF 97
+V+G G G V Q T E A+ K+LQD RE++L R P+++ + +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75
Query: 98 STTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 156
+ + + L +VME + ++ ++ +Q I + Y+H++
Sbjct: 76 NLYAGRK-CLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-N 131
Query: 157 VCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 214
+ HRD+KP+NLL +K+ DFG AK+ + + + + +Y APE++ +Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKY 190
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 274
S D+WS G ++ LL G P F + + + + IR + + +
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------KTRIRMGQYEFPNPEWS 242
Query: 275 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-DELREPNARLPNG 333
++ E L LL+ P+ R T E HP+ + P L
Sbjct: 243 EV-------------SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289
Query: 334 RPLPPLFNFKQELSGASPELVNKLIPDH 361
R L +++ + + D+
Sbjct: 290 RVLKEDKERWEDVKEEMTSALATMRVDY 317
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 198 bits (505), Expect = 5e-62
Identities = 96/295 (32%), Positives = 157/295 (53%), Gaps = 20/295 (6%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 89
Y +G G++G+V++A+ GET A+KK+ ++ + RE+ +++ + H N+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
+ L + L LV E++ + + ++L + + K + Q+ G+A
Sbjct: 63 VKLYDVIH-----TKKRLVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIA 114
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELI 208
Y H RV HRDLKPQNLL++ ++KI DFG A+ I I + +YRAP+++
Sbjct: 115 YCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPN 267
G+ +Y+T+IDIWS GC+ AE++ G PLFPG + DQL+ I ++LGTP +
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
D F + PW K + IDL S++L+ P+ R TA +A H +F E
Sbjct: 233 KYDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-60
Identities = 66/301 (21%), Positives = 114/301 (37%), Gaps = 44/301 (14%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 90
+ + +G G++G V A T E VA+K V R +E+ + ++++H NV+
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
L +EY + MP + + +Q+ G+ Y
Sbjct: 67 KFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAPEL 207
+H + HRD+KP+NLL+D +KI DFG A + Y APEL
Sbjct: 119 LHG-IGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 208 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267
+ + +D+WS G VL +L G+ + + Q K T
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL---------- 226
Query: 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327
+PW K+ + L ++L +PS R T + ++++ +
Sbjct: 227 -----------NPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG 270
Query: 328 A 328
A
Sbjct: 271 A 271
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 196 bits (498), Expect = 3e-60
Identities = 71/322 (22%), Positives = 126/322 (39%), Gaps = 42/322 (13%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVIS 91
Y +G+G+FG+V + TG K + D+ E+ +M + HP +I+
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
L F K E+ L ++E++ + ++ + +M V Y Q GL ++
Sbjct: 91 LHDAF---EDKYEMVL--ILEFLSGG--ELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143
Query: 152 HTVPRVCHRDLKPQNLLVD-PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 210
H + H D+KP+N++ + VKI DFG A +L E + + APE++
Sbjct: 144 HE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 202
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270
D+W+ G + LL G F GE+ ++ L + + +
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF--------- 252
Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 330
+ PEA D LLQ P R T +A HP+ + ++ L
Sbjct: 253 ----------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL---KGDHSNL 293
Query: 331 PNGRPLPPLFNFKQELSGASPE 352
+ P +Q++ +
Sbjct: 294 TSRIPSSRYNKIRQKIKEKYAD 315
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 4e-60
Identities = 64/289 (22%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 92
+ +G GSF V++ ET VA ++ + K+ E ++++ + HPN++
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 93 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
+ + +T K + + LV E + LK Y + M + ++ + QI +GL ++H
Sbjct: 74 -YDSWESTVKGKKCIVLVTELMTSGT---LKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 153 T-VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 211
T P + HRDLK N+ + T VKI D G A A A + I + + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPEMYEE- 187
Query: 212 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 271
+Y S+D+++ G + E+ + + Q+ + P
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS------------- 233
Query: 272 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
F K PE ++ ++ + R + + H FF
Sbjct: 234 -------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 5e-60
Identities = 66/296 (22%), Positives = 115/296 (38%), Gaps = 45/296 (15%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQLMRVMDHPNV 89
Y +GTGS+G + + G+ + K++ +++ E+ L+R + HPN+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
+ T+ L +VMEY + V+ + Q + +V Q+ L
Sbjct: 66 VRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 149 AYIH----TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYR 203
H V HRDLKP N+ +D VK+ DFG A+ L + +++ + +Y
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
+PE + Y DIWS GC+L EL P F + + +I +
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----------- 229
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
+F +I E ++ +R+L R + E +P
Sbjct: 230 --------KFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 5e-60
Identities = 99/355 (27%), Positives = 176/355 (49%), Gaps = 34/355 (9%)
Query: 26 KNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RE 77
+ G+ T+ Y + +G+G+ GIV A VAIKK+ + + + RE
Sbjct: 7 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 66
Query: 78 LQLMRVMDHPNVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIY 136
L LM+ ++H N+ISL + F + E + LVME + ++ +V++ +
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------ 120
Query: 137 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 196
+ YQ+ G+ ++H+ + HRDLKP N++V +KI DFG A+ Y
Sbjct: 121 MSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPY 178
Query: 197 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
+ +R+YRAPE+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+ LGTP
Sbjct: 179 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 257 TREEIRCMNPNYTDF--RFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQY 303
E ++ + P ++ P+ + K+F +K +A DL S++L
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 304 SPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 358
P+ R + +A HP+ + +P P P +++ + + + E +LI
Sbjct: 298 DPAKRISVDDALQHPYINVWYDPAEVEA---PPPQIYDKQLDEREHTIEEWKELI 349
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 1e-59
Identities = 61/294 (20%), Positives = 111/294 (37%), Gaps = 44/294 (14%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVIS 91
+ +G G+FG V++A+ ET A K + ++ E+ ++ DHPN++
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
L F+ + L +++E+ + + +++ Q L Y+
Sbjct: 74 LLDAFYYENN-----LWILIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFG 210
H ++ HRDLK N+L +K+ DFG + + S+I + ++ APE++
Sbjct: 127 HD-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184
Query: 211 AT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
T Y D+WS G L E+ +P N + L++I
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI----------------- 227
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
K+ P R D + L+ + R T + HPF
Sbjct: 228 ---------AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 194 bits (493), Expect = 2e-59
Identities = 98/357 (27%), Positives = 160/357 (44%), Gaps = 49/357 (13%)
Query: 28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM 84
GEP + Y+ R +G G F V+ AK + VA+K V D+ Y E++L++ +
Sbjct: 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 66
Query: 85 DHPNVISLKH----------CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL 134
+ + F+ N + + +V E + E++ ++K Y ++ +PL
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPL 124
Query: 135 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-----QVKICDFGSAKQLIA 189
IYVK + Q+ GL Y+H + H D+KP+N+L++ + Q+KI D G+A
Sbjct: 125 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD- 183
Query: 190 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------V 243
E + I +R YR+PE++ GA + DIWS C++ EL+ G LF +
Sbjct: 184 -EHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 244 DQLVEIIKVLGTPTREEIRCMNPNYTDF-------RFPQIKAHPWHKV------FHKRMP 290
D + +II++LG +R T F ++K P V F K
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301
Query: 291 PEAIDLASRLLQYSPSLRCTALEACAHPFF------DELREPNARL-PNGRPLPPLF 340
E D S +LQ P R A HP+ +E+R P+ L +G +P F
Sbjct: 302 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 358
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 3e-59
Identities = 74/305 (24%), Positives = 119/305 (39%), Gaps = 49/305 (16%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPN 88
+ R +G GSFG V+ A+ + E VAIKK+ + N +E++ ++ + HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
I + C+ E LVMEY S + + + + T+ +GL
Sbjct: 77 TIQYRGCYL-----REHTAWLVMEYCLGSA---SDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 208
AY+H+ + HRD+K N+L+ VK+ DFGSA + S++ + ++ APE+I
Sbjct: 129 AYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASIM---APANSFVGTPYWMAPEVI 183
Query: 209 FGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
E Y +D+WS G EL +P NA+ L I +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
+ + + LQ P R T+ H F R P
Sbjct: 229 ------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276
Query: 327 NARLP 331
+
Sbjct: 277 TVIMD 281
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-58
Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 48/292 (16%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRVMDHPN 88
+ R +G G FG V+ A+ ++ +A+K + RE+++ + HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
++ L F T + L++EY P + + Y ++ L
Sbjct: 68 ILRLYGYFHDATR-----VYLILEYAPLGT---VYRELQKLSKFDEQRTATYITELANAL 119
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 208
+Y H+ RV HRD+KP+NLL+ ++KI DFG + + + + Y PE+I
Sbjct: 120 SYCHS-KRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRT-TLCGTLDYLPPEMI 176
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
G + +D+WS G + E L+G+P F + I +V
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------- 219
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320
+F FP + A DL SRLL+++PS R E HP+
Sbjct: 220 -EFTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 4e-58
Identities = 68/296 (22%), Positives = 119/296 (40%), Gaps = 40/296 (13%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRVMDHPNVISL 92
YM +G G FGIV + + +T K V D+ +E+ ++ + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 93 KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
F S L ++ E++ ++ + ++ + + Y +Q+ L ++
Sbjct: 67 HESFESMEE-----LVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFL 118
Query: 152 HTVPRVCHRDLKPQNLLVDPLTH-QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 210
H+ + H D++P+N++ +KI +FG A+QL G+ + Y APE+
Sbjct: 119 HS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177
Query: 211 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270
+T+ D+WS G ++ LL G F E + I+ T E
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--------- 227
Query: 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
K + EA+D RLL R TA EA HP+ + E
Sbjct: 228 ----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-57
Identities = 74/325 (22%), Positives = 133/325 (40%), Gaps = 52/325 (16%)
Query: 28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRV 83
G+PK+ Y +G G+ G V+ A + TG+ VAI+++ + E+ +MR
Sbjct: 16 GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 84 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 143
+PN+++ + +EL++ VMEY + M + +
Sbjct: 74 NKNPNIVNYLDSY---LVGDELWV--VMEY----LAGGSLTDVVTETCMDEGQIAAVCRE 124
Query: 144 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 202
+ L ++H+ +V HRD+K N+L+ VK+ DFG Q+ ++ S + + ++
Sbjct: 125 CLQALEFLHSN-QVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 203 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262
APE++ Y +DIWS G + E++ G+P + EN + L I GTP
Sbjct: 183 MAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP------ 234
Query: 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322
+ + P +++ D +R L R +A E H F
Sbjct: 235 -------ELQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275
Query: 323 LREPNARLPNGRPLPPLFNFKQELS 347
+ L PL +E +
Sbjct: 276 AKPL-------SSLTPLIAAAKEAT 293
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 184 bits (469), Expect = 7e-57
Identities = 78/306 (25%), Positives = 122/306 (39%), Gaps = 54/306 (17%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------------LQDRRYKNRELQLMR 82
Y + ++G G +V + T + A+K + + R +E+ ++R
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 83 -VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT 141
V HPN+I LK + + F LV + + + L Y + + +
Sbjct: 65 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGE---LFDYLTEKVTLSEKETRKIM 116
Query: 142 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 201
+ + +H + HRDLKP+N+L+D + +K+ DFG + QL GE +
Sbjct: 117 RALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 174
Query: 202 YRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256
Y APE+I + Y +D+WS G ++ LL G P F + L I
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227
Query: 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316
M+ NY F P+ DL SR L P R TA EA A
Sbjct: 228 -------MSGNY-QFGSPE----------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
Query: 317 HPFFDE 322
HPFF +
Sbjct: 270 HPFFQQ 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (471), Expect = 1e-56
Identities = 70/303 (23%), Positives = 114/303 (37%), Gaps = 42/303 (13%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 90
Y V+GTG+F V A+ T + VAIK + + E+ ++ + HPN++
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
+L + S L+L +M+ V L +Q+ + Y
Sbjct: 71 ALDDIY---ESGGHLYL--IMQLVS---GGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYRAPELI 208
+H + HRDLKP+NLL L ++ I DFG +K G + + Y APE++
Sbjct: 123 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
Y+ ++D WS G + LL G P F EN +I+K
Sbjct: 182 AQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--------- 231
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 328
+ + A D L++ P R T +A HP+ +
Sbjct: 232 ----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275
Query: 329 RLP 331
+
Sbjct: 276 NIH 278
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 5e-56
Identities = 82/320 (25%), Positives = 127/320 (39%), Gaps = 59/320 (18%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRVMDHPN 88
+ +++G GSF V A+ L T AIK + Y RE +M +DHP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
+ L F +L+ + Y L Y + YT +I L
Sbjct: 70 FVKLYFTF---QDDEKLYF--GLSYAKNGE---LLKYIRKIGSFDETCTRFYTAEIVSAL 121
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAP 205
Y+H + HRDLKP+N+L++ ++I DFG+AK L S++ + Y +P
Sbjct: 122 EYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
EL+ S D+W+ GC++ +L+ G P F N +IIK+
Sbjct: 180 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------------- 225
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC------AHPF 319
++ FP+ + P+A DL +LL + R E AHPF
Sbjct: 226 ----EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
Query: 320 FDELREPNARLPNGRPLPPL 339
F+ + L P P L
Sbjct: 270 FESVT--WENLHQQTP-PKL 286
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-53
Identities = 69/324 (21%), Positives = 125/324 (38%), Gaps = 51/324 (15%)
Query: 31 KQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------REL 78
++ + Y +G+G F +V + + TG A K + + R + RE+
Sbjct: 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 79 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVK 138
+++ + HPNVI+L + +N+ + L++E V L + + + +
Sbjct: 65 SILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGE---LFDFLAEKESLTEEEAT 116
Query: 139 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD---PLTHQVKICDFGSAKQLIAGEANIS 195
+ QI G+ Y+H+ ++ H DLKP+N+++ ++KI DFG A ++ G +
Sbjct: 117 EFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 196 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 255
+ + APE++ D+WS G + LL G F G+ + L + V
Sbjct: 176 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315
E + A D RLL P R T ++
Sbjct: 235 FEDE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269
Query: 316 AHPFFDELREPNARLPNGRPLPPL 339
HP+ A L + P
Sbjct: 270 QHPWIKPKDTQQA-LSSAWSHPQF 292
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 8e-53
Identities = 88/338 (26%), Positives = 140/338 (41%), Gaps = 62/338 (18%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHP 87
++ +++G GSFG VF A+ +T + AIK + +D + +++ L +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
+ + F + + L VMEY+ L ++ + + L Y +I G
Sbjct: 64 FLTHMFCTF-----QTKENLFFVMEYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 206
L ++H+ + +RDLK N+L+D H KI DFG K+ + G+A + C + Y APE
Sbjct: 116 LQFLHS-KGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173
Query: 207 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
++ G +Y S+D WS G +L E+L+GQ F G++ + IR NP
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNP 220
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-AHPFFDELRE 325
Y + + EA DL +L P R HP F E+
Sbjct: 221 FYPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263
Query: 326 PNARLPNGRPLPP----------LFNFKQELSGASPEL 353
L PP NF +E P L
Sbjct: 264 --EELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRL 299
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 3e-51
Identities = 64/303 (21%), Positives = 109/303 (35%), Gaps = 56/303 (18%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMD 85
Y ++G+G FG V+ + VAIK V +DR E+ L++ +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 86 --HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 143
VI L F S L++E L + + + + + +Q
Sbjct: 66 SGFSGVIRLLDWFERPDS-----FVLILERPEPVQD--LFDFITERGALQEELARSFFWQ 118
Query: 144 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 203
+ + + H V HRD+K +N+L+D ++K+ DFGS L+ + +R Y
Sbjct: 119 VLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
PE I + S +WS G +L +++ G F + + +
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR------------------ 218
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323
F +R+ E L L PS R T E HP+ ++
Sbjct: 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261
Query: 324 REP 326
P
Sbjct: 262 LLP 264
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 171 bits (435), Expect = 8e-51
Identities = 72/320 (22%), Positives = 121/320 (37%), Gaps = 55/320 (17%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMD 85
+ R++G G FG V+ + +TG+ A+K + + R + L L+ D
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 86 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 145
P ++ + + F + L+ +++ + L ++ S + ++ Y +I
Sbjct: 66 CPFIVCMSYAFHTPDK-----LSFILDLMNGGD---LHYHLSQHGVFSEADMRFYAAEII 117
Query: 146 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 205
GL ++H V +RDLKP N+L+D H V+I D G A + + S + Y AP
Sbjct: 118 LGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAP 174
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
E++ Y +S D +S GC+L +LL G F D+ L
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------- 227
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFF 320
PE L LLQ + R A E PFF
Sbjct: 228 -------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
Query: 321 DELREPNARLPNGRPLPPLF 340
L + ++ + PP
Sbjct: 269 RSL---DWQMVFLQKYPPPL 285
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 169 bits (430), Expect = 1e-50
Identities = 76/300 (25%), Positives = 125/300 (41%), Gaps = 54/300 (18%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 88
+ R +GTGSFG V + G A+K + L+ + N E ++ ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
+I + F ++ + ++M+Y+ L +QR P K Y ++ L
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLAL 117
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 208
Y+H+ + +RDLKP+N+L+D H +KI DFG AK + + + + Y APE++
Sbjct: 118 EYLHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173
Query: 209 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268
Y SID WS G ++ E+L G F N + +I+
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 215
Query: 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDEL 323
+ RFP + DL SRL+ S R + HP+F E+
Sbjct: 216 AELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 4e-48
Identities = 62/299 (20%), Positives = 108/299 (36%), Gaps = 51/299 (17%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISL 92
+ +G+GSFG V++ K VA+K + Q + E+ ++R H N++
Sbjct: 13 GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 93 KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
L +V ++ S+Y L + +I + Q +G+ Y+
Sbjct: 70 MGYS------TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYL 120
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELI 208
H + HRDLK N+ + VKI DFG A + + S + APE+I
Sbjct: 121 HA-KSIIHRDLKSNNIFLHE-DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 209 FG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
Y+ D+++ G VL EL+ GQ + N DQ++ ++
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--------------- 223
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
+ P + P L + L+ R + A + L
Sbjct: 224 --RGYLSPDLSKVR------SNCPKAMKRLMAECLKKKRDERPLFPQILAS--IELLAR 272
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 161 bits (409), Expect = 5e-48
Identities = 62/295 (21%), Positives = 107/295 (36%), Gaps = 43/295 (14%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPN 88
Y ++G G V A+ L VA+K + D RE Q ++HP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 148
++++ + T L +VMEYV L+ M + L
Sbjct: 69 IVAVYDTGEAETPAGPLPY-IVMEYVDGVT---LRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 149 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYRA 204
+ H + HRD+KP N+++ T+ VK+ DFG A+ + ++ + I + Y +
Sbjct: 125 NFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 205 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
PE G D++S GCVL E+L G+P F G++ V + ++ P
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236
Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
H+ + + + + L +P R
Sbjct: 237 --------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 8e-48
Identities = 71/311 (22%), Positives = 122/311 (39%), Gaps = 53/311 (17%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 92
+++G G+FG V + TG A+K + ++ E ++++ HP + +L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 93 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
K+ F + L VMEY L + S + + Y +I L Y+H
Sbjct: 71 KYAFQT-----HDRLCFVMEYANGGE---LFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 212
+ V +RD+K +NL++D +KI DFG K+ I+ A + C +
Sbjct: 123 S-RDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
+Y ++D W G V+ E++ G+ F ++ I+ + R
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----------------EEIR 223
Query: 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFFDELREPN 327
FP + + PEA L + LL+ P R A E H FF +
Sbjct: 224 FP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN--W 269
Query: 328 ARLPNGRPLPP 338
+ + LPP
Sbjct: 270 QDVVQKKLLPP 280
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 5e-45
Identities = 53/282 (18%), Positives = 100/282 (35%), Gaps = 45/282 (15%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCFF 97
+ +G G FG V G VA+K + D + E +M + H N++ L
Sbjct: 13 QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 98 STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 156
L +V EY+ + S+ L+ S + + ++ + + Y+
Sbjct: 71 EEKGG----LYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEG-NN 123
Query: 157 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTT 216
HRDL +N+LV + K+ DFG K+ + + APE + +++T
Sbjct: 124 FVHRDLAARNVLVSE-DNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFST 179
Query: 217 SIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 275
D+WS G +L E+ G+ +P D + + K ++
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------------GYKMD- 220
Query: 276 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
PP ++ ++R + L+
Sbjct: 221 ---------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 3e-44
Identities = 58/302 (19%), Positives = 103/302 (34%), Gaps = 45/302 (14%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLK 93
Y R +G+GSFG ++ + GE VAIK ++ E ++ ++M I
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 94 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
+ + +VME + S+ ++ +++ L V L Q+ + YIH+
Sbjct: 69 RWCGAEGD----YNVMVMELLGPSL---EDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 154 VPRVCHRDLKPQNLLV--DPLTHQVKICDFGSAKQLIAGEANI--------SYICSRFYR 203
HRD+KP N L+ + V I DFG AK+ + + + Y
Sbjct: 122 -KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 204 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263
+ G E + D+ S G VL LG + G A + + ++ I
Sbjct: 181 SINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFF 320
+ Y P E + + + + F
Sbjct: 240 LCKGY---------------------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278
Query: 321 DE 322
+
Sbjct: 279 RQ 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 151 bits (381), Expect = 1e-43
Identities = 48/267 (17%), Positives = 94/267 (35%), Gaps = 24/267 (8%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLK 93
Y R +G GSFG++F+ L + VAIK + E + +++ I
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 94 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 153
+ F L LV++ + S+ +L ++ + V + Q+ + IH
Sbjct: 67 YYFGQE----GLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 154 VPRVCHRDLKPQNLLVD----PLTHQVKICDFGSAKQLIAGEANI--------SYICSRF 201
+ +RD+KP N L+ + + + DFG K + +
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
Y + G E + D+ + G V L G + G A + ++ +
Sbjct: 179 YMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKR 288
R + + + F + + + F
Sbjct: 238 RELCAGFPE-EFYKYMHYARNLAFDAT 263
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (370), Expect = 2e-41
Identities = 61/313 (19%), Positives = 115/313 (36%), Gaps = 57/313 (18%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISL 92
+ +GTGSFG V K E+G A+K + L+ + E ++++ ++ P ++ L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 93 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
+ F + + + + + R + + Y QI Y+H
Sbjct: 107 EFSFKDN--------SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 212
++ + +RDLKP+NLL+D +++ DFG AK++ + + APE+I
Sbjct: 159 SL-DLIYRDLKPENLLIDQ-QGYIQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILS-K 213
Query: 213 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
Y ++D W+ G ++ E+ G P F + + +I
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----------------------- 250
Query: 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP-----SLRCTALEACAHPFFDELREPN 327
F + DL LLQ +L+ + H +F +
Sbjct: 251 ------VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF---ATTD 301
Query: 328 ARLPNGRPLPPLF 340
R + F
Sbjct: 302 WIAIYQRKVEAPF 314
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-41
Identities = 73/332 (21%), Positives = 131/332 (39%), Gaps = 58/332 (17%)
Query: 36 YMAERVVGTGSFGIVFQAKCL---ETGETVAIKKV--------LQDRRYKNRELQLMRVM 84
+ +V+GTG++G VF + + +TG+ A+K + + + E Q++ +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 85 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 144
+ H F T +K L+L+++Y+ L + S +R V++Y +I
Sbjct: 86 RQSPFLVTLHYAFQTETK----LHLILDYI---NGGELFTHLSQRERFTEHEVQIYVGEI 138
Query: 145 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC---SRF 201
L ++H + +RD+K +N+L+D V + DFG +K+ +A E +Y +
Sbjct: 139 VLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
+ G + + ++D WS G ++ ELL G F + + EI +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---------- 246
Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACA 316
P + + M A DL RLL P R A E
Sbjct: 247 -----RILKSEPP----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291
Query: 317 HPFFDELREPNARLPNGRPLPPLFNFKQELSG 348
H FF ++ L + P FK +
Sbjct: 292 HLFFQKINW--DDLAAKKVPAP---FKPVIRD 318
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 4e-41
Identities = 61/300 (20%), Positives = 112/300 (37%), Gaps = 37/300 (12%)
Query: 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRVMDHPNVIS 91
+ + + +G G FG V++ K GE VA+K + ++ E+ ++ H N++
Sbjct: 4 TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 92 LKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
+ + L LV +Y S++ L Y + + + GLA+
Sbjct: 62 F-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAH 115
Query: 151 IHTV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-- 201
+H P + HRDLK +N+LV I D G A + + I +
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 202 ---YRAPELIFGA-----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 253
Y APE++ + E DI++ G V E+ + G + QL V
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233
Query: 254 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
P+ EE+R + +++ + ++ + + + R TAL
Sbjct: 234 SDPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 6e-40
Identities = 65/296 (21%), Positives = 103/296 (34%), Gaps = 47/296 (15%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 95
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
S+ +++ V EY+ + + + L + QI G+AY+
Sbjct: 81 V----SEEPIYI--VTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVER-M 132
Query: 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATE 213
HRDL+ N+LV K+ DFG A+ + E A + APE
Sbjct: 133 NYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190
Query: 214 YTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 272
+T D+WS G +L EL G+ +PG + L ++ + P E
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----------- 239
Query: 273 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDELREP 326
P DL + + P R T A +F
Sbjct: 240 -----------------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-39
Identities = 59/293 (20%), Positives = 100/293 (34%), Gaps = 47/293 (16%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISL 92
+G G FG V+ VA+K + Q + E LM+ + H ++ L
Sbjct: 15 LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 93 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 152
++ +++ + EY+ S ++ + + QI G+A+I
Sbjct: 74 YAVV----TQEPIYI--ITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE 126
Query: 153 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIFG 210
HRDL+ N+LV KI DFG A+ + E + APE I
Sbjct: 127 E-RNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 211 ATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 269
+T D+WS G +L E++ G+ +PG + + + +
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------ 225
Query: 270 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFF 320
+ V P E L + P R T + FF
Sbjct: 226 ----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 1e-39
Identities = 48/291 (16%), Positives = 98/291 (33%), Gaps = 45/291 (15%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCF 96
+ +G+G FG+V + VAIK + + + E ++M + HP ++ L
Sbjct: 11 QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 97 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 156
+ LV E++ + + + + + G+AY+
Sbjct: 70 LEQA-----PICLVFEFMEHGC--LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-AC 121
Query: 157 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIFGATEY 214
V HRDL +N LV +K+ DFG + ++ + S + +PE+ + Y
Sbjct: 122 VIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179
Query: 215 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 274
++ D+WS G ++ E+ + + ++VE I
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------------------- 216
Query: 275 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325
+ + + + + P R E+ E
Sbjct: 217 ----TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ--LAEIAE 261
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 1e-39
Identities = 62/303 (20%), Positives = 109/303 (35%), Gaps = 56/303 (18%)
Query: 39 ERVVGTGSFGIVFQAKC--LETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVI 90
++ +G+G+FG V + + +TVA+K + + E +M+ +D+P ++
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
+ + + LVME L Y N+ + + +Q+ G+ Y
Sbjct: 72 RMIGICEAES------WMLVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYICSRFYRAPE 206
+ HRDL +N+L+ H KI DFG +K L A E A + APE
Sbjct: 123 LEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 207 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
I ++++ D+WS G ++ E GQ + G + + K
Sbjct: 181 CINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------------- 225
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA---HPFFDE 322
R P E DL + Y R + ++D
Sbjct: 226 ----GERMG----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
Query: 323 LRE 325
+ E
Sbjct: 272 VNE 274
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-39
Identities = 61/288 (21%), Positives = 102/288 (35%), Gaps = 51/288 (17%)
Query: 40 RVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRRYKN-------RELQLMRVMDHPNV 89
+G GSFG+V + + +VA+K + D + RE+ M +DH N+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 149
I L + + +V E P + +L L + Y Q+ G+
Sbjct: 74 IRLYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 150 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAPE 206
Y+ + R HRDL +NLL+ VKI DFG + L + + + F
Sbjct: 126 YLES-KRFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 207 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265
++ + D W G L E+ GQ + G N L +I K
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-------------- 229
Query: 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
R P+ + P + ++ + + P R T +
Sbjct: 230 ---EGERLPRP----------EDCPQDIYNVMVQCWAHKPEDRPTFVA 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (351), Expect = 2e-39
Identities = 55/294 (18%), Positives = 111/294 (37%), Gaps = 43/294 (14%)
Query: 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 95
+ +G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 96 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 155
++ E++ + Q + + + QI + Y+
Sbjct: 82 CTREPP-----FYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK-K 134
Query: 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATE 213
HRDL +N LV H VK+ DFG ++ + A+ + APE + +
Sbjct: 135 NFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192
Query: 214 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273
++ D+W+ G +L E+ + Q+ E+++ D+R
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------------KDYRM 235
Query: 274 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327
+ P + +L Q++PS R + E H F+ + + +
Sbjct: 236 E----------RPEGCPEKVYELMRACWQWNPSDRPSFAE--IHQAFETMFQES 277
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (350), Expect = 4e-39
Identities = 66/309 (21%), Positives = 114/309 (36%), Gaps = 54/309 (17%)
Query: 35 SYMAERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRVMDH 86
E+V+G G FG V G+ VAIK + + RR E +M DH
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86
Query: 87 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 146
PNVI L+ +T + ++ E++ + + + +I + I
Sbjct: 87 PNVIHLEGVVTKST-----PVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAA 139
Query: 147 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR------ 200
G+ Y+ HRDL +N+LV+ K+ DFG ++ L ++ +Y +
Sbjct: 140 GMKYLAD-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 201 FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTRE 259
+ APE I ++T++ D+WS G V+ E++ G+ + D + I +
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-------- 248
Query: 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 319
D+R P P L Q + R +
Sbjct: 249 ----------DYRLP----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT-L 287
Query: 320 FDELREPNA 328
+R PN+
Sbjct: 288 DKMIRNPNS 296
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 4e-39
Identities = 71/304 (23%), Positives = 116/304 (38%), Gaps = 53/304 (17%)
Query: 40 RVVGTGSFGIVFQAKCLETGET----VAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 90
+V+G+G+FG V++ + GE VAIK++ + K E +M +D+P+V
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
L ++T + L+ + +P +L + + Y+ + QI +G+ Y
Sbjct: 75 RLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR---FYRAPEL 207
+ R+ HRDL +N+LV H VKI DFG AK L A E + + A E
Sbjct: 127 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 208 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
I YT D+WS G + EL+ G + G A ++ I++
Sbjct: 185 ILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILE--------------- 227
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326
R P + + + R E F R+P
Sbjct: 228 --KGERLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDP 274
Query: 327 NARL 330
L
Sbjct: 275 QRYL 278
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-38
Identities = 61/314 (19%), Positives = 111/314 (35%), Gaps = 70/314 (22%)
Query: 39 ERVVGTGSFGIVFQAKCLETGET-----VAIKKVLQDRRYKN-----RELQLM-RVMDHP 87
+V+G+G+FG V A +T VA+K + + EL++M ++ H
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK-------------------HYSS 127
N+++L T ++ L+ EY + L+
Sbjct: 102 NIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 128 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187
+ + + YQ+ +G+ ++ HRDL +N+LV VKICDFG A+ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDLAARNVLVTH-GKVVKICDFGLARDI 214
Query: 188 IAGEANISYICSR---FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAV 243
++ + +R + APE +F YT D+WS G +L E+ LG +PG
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 244 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 303
++I+ F+ E + +
Sbjct: 274 ANFYKLIQ-----------------NGFKMD----------QPFYATEEIYIIMQSCWAF 306
Query: 304 SPSLRCTALEACAH 317
R + +
Sbjct: 307 DSRKRPSFPNLTSF 320
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 4e-38
Identities = 50/284 (17%), Positives = 103/284 (36%), Gaps = 45/284 (15%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCF 96
+ +GTG FG+V K VAIK + + ++ E ++M + H ++ L
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 97 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 156
T + +F ++ EY+ +L + R + + + Y+ + +
Sbjct: 69 ---TKQRPIF--IITEYMANGC--LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQ 120
Query: 157 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS--YICSRFYRAPELIFGATEY 214
HRDL +N LV+ VK+ DFG ++ ++ E S + PE++ +++
Sbjct: 121 FLHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178
Query: 215 TTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 273
++ DIW+ G ++ E+ LG+ + + I + L
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----------------R 222
Query: 274 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
P + + + R T ++
Sbjct: 223 PHL------------ASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 2e-37
Identities = 59/293 (20%), Positives = 111/293 (37%), Gaps = 51/293 (17%)
Query: 39 ERVVGTGSFGIVFQAKCLE---TGETVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 90
V+G G FG V+ L+ A+K + + + E +M+ HPNV+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 150
SL ++E +V+ Y+ R + + + Q+ +G+ +
Sbjct: 92 SLLGICL----RSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKF 145
Query: 151 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-----FYRAP 205
+ + + HRDL +N ++D VK+ DFG A+ + E + + + + A
Sbjct: 146 LAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
E + ++TT D+WS G +L EL+ G P +P N D V +++ R +
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GRRLL 254
Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
P Y P ++ + +R + E +
Sbjct: 255 QPEY--------------------CPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 3e-37
Identities = 66/303 (21%), Positives = 108/303 (35%), Gaps = 54/303 (17%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDRRYKN-----RELQLMRVMDHPNVIS 91
+ +G G+FG V Q + VAIK + Q + RE Q+M +D+P ++
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 92 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 151
L + L LVME + K + +P+ V +Q+ G+ Y+
Sbjct: 74 LIGVCQAEA------LMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 152 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR----FYRAPEL 207
HRDL +N+L+ H KI DFG +K L A ++ + + + APE
Sbjct: 126 EE-KNFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 208 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266
I ++++ D+WS G + E L GQ + + + I + E
Sbjct: 184 INF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC----- 237
Query: 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA---HPFFDEL 323
PPE L S Y R L ++
Sbjct: 238 -----------------------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274
Query: 324 REP 326
+
Sbjct: 275 SKV 277
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-36
Identities = 61/300 (20%), Positives = 110/300 (36%), Gaps = 56/300 (18%)
Query: 39 ERVVGTGSFGIVFQAKCLETGE--TVAIKKV-----LQDRRYKNRELQLM-RVMDHPNVI 90
+ V+G G+FG V +A+ + G AIK++ D R EL+++ ++ HPN+I
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 91 SLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLK------------HYSSANQRMPLIYV 137
+L + +L L +EY P ++ L+ +S + +
Sbjct: 75 NLLGACE-----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 138 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 197
+ + RG+ Y+ + HRDL +N+LV + KI DFG ++
Sbjct: 130 LHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGR 187
Query: 198 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 257
+ A E + + YTT+ D+WS G +L E++ +L E +
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------ 240
Query: 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
+R E DL + + P R + +
Sbjct: 241 -----------QGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-35
Identities = 66/305 (21%), Positives = 114/305 (37%), Gaps = 65/305 (21%)
Query: 39 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RVMDHP 87
+ +G G+FG V +A + TVA+K + L +R EL+++ + +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHY--------------SSANQRM 132
N+++L T + + EY + L+ +
Sbjct: 88 NIVNLLGAC---TIGGPTLV--ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 133 PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 192
L + ++YQ+ +G+A++ + HRDL +N+L+ KICDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTH-GRITKICDFGLARDIKNDSN 200
Query: 193 NISYICSR---FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 248
+ +R + APE IF YT D+WS G L EL LG +PG + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 249 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 308
+IK + + + P E D+ P R
Sbjct: 260 MIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
Query: 309 CTALE 313
T +
Sbjct: 293 PTFKQ 297
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-35
Identities = 68/293 (23%), Positives = 101/293 (34%), Gaps = 50/293 (17%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRVMDHP 87
R +G G FG V Q + VAIK R +E MR DHP
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 88 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 147
+++ L E + ++ME R + L + LY YQ+
Sbjct: 69 HIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTA 120
Query: 148 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAP 205
LAY+ + R HRD+ +N+LV VK+ DFG ++ + + + AP
Sbjct: 121 LAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 206 ELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264
E I +T++ D+W G + E+L+ G F G D + I P
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC--- 234
Query: 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317
PP L ++ Y PS R E A
Sbjct: 235 -------------------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-35
Identities = 55/292 (18%), Positives = 95/292 (32%), Gaps = 50/292 (17%)
Query: 35 SYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRVMD 85
++V+G G FG V++ + VAIK + K E +M
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 86 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 145
H N+I L+ + ++ EY+ K + ++ + I
Sbjct: 68 HHNIIRLEGVISKYKP-----MMIITEYMENGAL--DKFLREKDGEFSVLQLVGMLRGIA 120
Query: 146 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC----SRF 201
G+ Y+ HRDL +N+LV+ K+ DFG ++ L
Sbjct: 121 AGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 202 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261
+ APE I + S D+WS G V+ E++ E + ++++ I
Sbjct: 179 WTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------- 227
Query: 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 313
FR P P L + Q + R +
Sbjct: 228 -------DGFRLP----------TPMDCPSAIYQLMMQCWQQERARRPKFAD 262
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-35
Identities = 68/321 (21%), Positives = 115/321 (35%), Gaps = 64/321 (19%)
Query: 36 YMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQD------RRYKNRELQLMRVM 84
+ +G G+FG V +A T TVA+K + + R + L+ +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 85 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY------------SSANQR 131
H NV++L L +++E+ ++ L+
Sbjct: 75 HHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 132 MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 191
+ L ++ Y++Q+ +G+ ++ + + HRDL +N+L+ + VKICDFG A+ +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDP 188
Query: 192 ANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLV 247
+ + APE IF YT D+WS G +L E+ +PG ++
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 248 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 307
+K T R P PE PS
Sbjct: 248 RRLK---------------EGTRMRAPDY------------TTPEMYQTMLDCWHGEPSQ 280
Query: 308 RCTALEACAHPFFDELREPNA 328
R T E H L + NA
Sbjct: 281 RPTFSELVEH--LGNLLQANA 299
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (312), Expect = 1e-33
Identities = 67/321 (20%), Positives = 108/321 (33%), Gaps = 73/321 (22%)
Query: 40 RVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 89
R +G G+FG VFQA+ E VA+K + ++ RE LM D+PN+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 90 ISLKHCFFSTTSKNELFLNLVMEYVP---------------------ESMYRVLKHYSSA 128
+ + L + EY+ + + S
Sbjct: 79 V---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 129 NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188
+ Q+ G+AY+ + HRDL +N LV VKI DFG ++ +
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVGE-NMVVKIADFGLSRNIY 191
Query: 189 AGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 244
+ + A+ + + PE IF YTT D+W+ G VL E+ G + G +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 245 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 304
+ + I A P + P E +L
Sbjct: 251 VIYYVRD----------------------GNILACP------ENCPLELYNLMRLCWSKL 282
Query: 305 PSLRCTALEACAHPFFDELRE 325
P+ R + H + E
Sbjct: 283 PADRPSFCS--IHRILQRMCE 301
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-32
Identities = 61/309 (19%), Positives = 114/309 (36%), Gaps = 66/309 (21%)
Query: 36 YMAERVVGTGSFGIVFQAKCLETGE-------TVAIKKVLQD------RRYKNRELQLMR 82
+ + +G G+FG V A+ + + VA+K + D + +
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 83 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY------------SSAN 129
+ H N+I+L + L +++EY + ++ L+ +
Sbjct: 75 IGKHKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 130 QRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189
+++ + YQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHH 187
Query: 190 GEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQ 245
+ + + APE +F YT D+WS G +L E+ LG +PG V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245
Query: 246 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 305
L +++K R E + P
Sbjct: 246 LFKLLK-----------------EGHRMD----------KPSNCTNELYMMMRDCWHAVP 278
Query: 306 SLRCTALEA 314
S R T +
Sbjct: 279 SQRPTFKQL 287
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 9e-31
Identities = 62/312 (19%), Positives = 111/312 (35%), Gaps = 63/312 (20%)
Query: 39 ERVVGTGSFGIVFQAKC-----LETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 88
R +G GSFG+V++ E VAIK V +++R E +M+ + +
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84
Query: 89 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLI------YVKLYT 141
V+ L ++ME + + L+ A P++ +
Sbjct: 85 VVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 142 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--- 198
+I G+AY++ + HRDL +N +V VKI DFG + + +
Sbjct: 140 GEIADGMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 199 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPT 257
+ +PE + +TT D+WS G VL E+ L + + G + L +++
Sbjct: 198 PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------ 250
Query: 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------ 311
P +L QY+P +R +
Sbjct: 251 ----------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
Query: 312 LEACAHPFFDEL 323
++ P F E+
Sbjct: 289 IKEEMEPGFREV 300
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.5 bits (203), Expect = 3e-19
Identities = 31/200 (15%), Positives = 62/200 (31%), Gaps = 24/200 (12%)
Query: 40 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFST 99
+++G G VF E +K + ++++ R + L
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVK-FHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 100 TSKNELFL---NLVMEYVPESMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAYIHTVP 155
+ L + Y E +++ + + + I +A +
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH-R 122
Query: 156 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA------NISYICSRFYRAPELIF 209
+ H DL N+LV + I DF + ++ ++ I + F R
Sbjct: 123 GIVHGDLSQYNVLVSE--EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSR------ 174
Query: 210 GATEYTTSIDIWSAGCVLAE 229
Y T DI SA + +
Sbjct: 175 ---TYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 376 | |||
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.11 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.68 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.65 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.65 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.49 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.29 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-65 Score=473.13 Aligned_cols=327 Identities=68% Similarity=1.190 Sum_probs=288.0
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecC-CCCceEEEEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTT-SKNELFLNLV 110 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~~lv 110 (376)
...+|+.+++||+|+||+||+|+++.+|+.||||++.++.....+|+.+|+.++|+||++++++|.... ..+..++|+|
T Consensus 18 ~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred ccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 345799999999999999999999999999999999888777789999999999999999999986543 3456678999
Q ss_pred eecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 111 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 111 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||||++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+++.....
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 9999998888887766777889999999999999999999999 799999999999999975668999999999877666
Q ss_pred CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 017147 191 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 270 (376)
Q Consensus 191 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 270 (376)
....+..||+.|+|||.+.+...++.++||||+||++|+|++|++||.+.+..+.+..+.+.+|.+..+.+....+.+.+
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 256 (350)
T d1q5ka_ 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256 (350)
T ss_dssp SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence 66677889999999999987777999999999999999999999999999999999999999999999999999999888
Q ss_pred CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCchhhhccCC
Q 017147 271 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGAS 350 (376)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (376)
..++.....++.......++++++|||.+||++||++|||+.|+|+||||++++.+....+.....+...++..+..+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 336 (350)
T d1q5ka_ 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSN 336 (350)
T ss_dssp CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTTC
T ss_pred ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCCHhhccCC
Confidence 89999888888888888899999999999999999999999999999999999888777777777777777765544455
Q ss_pred HHHHhhhcH
Q 017147 351 PELVNKLIP 359 (376)
Q Consensus 351 ~~~~~~~~~ 359 (376)
++....++|
T Consensus 337 ~~~~~~~~p 345 (350)
T d1q5ka_ 337 PPLATILIP 345 (350)
T ss_dssp GGGHHHHSC
T ss_pred ccccccCCC
Confidence 555444444
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-61 Score=430.03 Aligned_cols=254 Identities=25% Similarity=0.338 Sum_probs=209.2
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
..++|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+.+++.++||||+++++++.+. ..
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-----~~ 77 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NI 77 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET-----TE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-----ce
Confidence 4678999999999999999999999999999999986432 3456899999999999999999998543 34
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+|+|||||+| +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus 78 ~~ivmEy~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~-~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGLAT 151 (271)
T ss_dssp EEEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred eEEEEeccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECC-CCCEEEccchhhe
Confidence 8999999985 6655543 45789999999999999999999999 79999999999999996 6789999999998
Q ss_pred cCccCC---CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 186 QLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 186 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
...... ...+.+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+...............
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~------ 225 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------ 225 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT------
T ss_pred eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------
Confidence 764332 23456899999999999776655788999999999999999999998765443333222210000
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
......+|+++++||.+||+.||++|||++|+|+||||++
T Consensus 226 --------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 --------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp --------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred --------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0011347999999999999999999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-61 Score=433.65 Aligned_cols=275 Identities=35% Similarity=0.615 Sum_probs=228.9
Q ss_pred eeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 38 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 38 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
.++.||+|+||+||+|+++.+|+.||||++.... ....+|+.+++.++|||||++++++.... .+|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~-----~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-----NIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-----CCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC-----cee
Confidence 4688999999999999999999999999985432 23458999999999999999999984433 388
Q ss_pred EEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 109 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 109 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
+|||||.+++...+. .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus 77 ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~-~~~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFG 151 (299)
T ss_dssp EEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCCGGGSTTT
T ss_pred ehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecC-CCccccccCccccccC
Confidence 999999987655553 356779999999999999999999999 79999999999999996 7889999999998654
Q ss_pred cCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017147 189 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267 (376)
Q Consensus 189 ~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 267 (376)
... .....+||+.|+|||++.+...|+.++||||+||++|+|++|.+||.+.+..+++..+.+.+|.+..+.+......
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence 433 3345678999999999977667899999999999999999999999999999999999999999887765543333
Q ss_pred CCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.....+......++...+. .++++++|||.+||++||++|||++|+|+||||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFS-AAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCT-TCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred chhhhhccCCCCChHHhcc-cCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 2333333444444544443 579999999999999999999999999999999874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-61 Score=426.29 Aligned_cols=248 Identities=29% Similarity=0.498 Sum_probs=213.0
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
.++|++++.||+|+||+||+|+++.+++.||+|++.+. .....+|+.+++.++||||+++++++.+ ..
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----AT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-----CC
Confidence 46899999999999999999999999999999998642 2234579999999999999999999843 34
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
.+|+|||||++ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~-~~~~kl~DFG~a 153 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGS-AGELKIADFGWS 153 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCCSC
T ss_pred EEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecC-CCCEeeccccee
Confidence 48999999995 77777653 4579999999999999999999999 79999999999999996 678999999999
Q ss_pred ccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.
T Consensus 154 ~~~~~~-~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------------ 219 (263)
T d2j4za1 154 VHAPSS-RRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 219 (263)
T ss_dssp SCCCCC-CCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------------
T ss_pred eecCCC-cccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC------------
Confidence 865433 34567899999999999764 5899999999999999999999999998887777665541
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
.+. ++..+|+++++||.+||+.||++|||++|+|+||||++
T Consensus 220 -----~~~------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 220 -----EFT------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -----CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -----CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 111 23357999999999999999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-61 Score=429.83 Aligned_cols=255 Identities=30% Similarity=0.517 Sum_probs=214.5
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
.++|++++.||+|+||+||+|+++.+++.||||++.+.. ....+|+++++.++||||+++++++.+ ..
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~ 81 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DE 81 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-----SS
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-----CC
Confidence 468999999999999999999999999999999986431 234689999999999999999999843 34
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
.+|+|||||+| +|.+.+. ..+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~~ivmEy~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~-~~~vkl~DFG~a 155 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGTA 155 (288)
T ss_dssp EEEEEECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTC
T ss_pred EEEEEEEccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCC-CceEEecccccc
Confidence 48999999985 7777665 34679999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCccCC---CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 185 KQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 185 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
+...... ...+.+||+.|+|||++.+. .|+.++||||+||++|+|++|+.||.+.+..+.+.++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--------- 225 (288)
T d1uu3a_ 156 KVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------- 225 (288)
T ss_dssp EECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT---------
T ss_pred eecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC---------
Confidence 8764332 23356799999999999765 4899999999999999999999999999888877766541
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHH------HhcCCCcccccCCCC
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE------ACAHPFFDELREPNA 328 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e------~l~hp~~~~~~~~~~ 328 (376)
.+. ++..+|+++++||++||+.||++|||++| +++||||+++.+...
T Consensus 226 --------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l 278 (288)
T d1uu3a_ 226 --------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278 (288)
T ss_dssp --------CCC------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred --------CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence 111 23457999999999999999999999987 589999999876643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-60 Score=427.51 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=212.7
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
++|++.+.||+|+||+||+|.++.+|+.||||++.... ....+|+.+++.++|||||++++++.+.. .+|+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC-----EEEE
Confidence 47999999999999999999999999999999986432 23468999999999999999999985443 4899
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
|||||+| +|.+.+. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus 95 vmEy~~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~-~~~vkl~DFG~a~~~~ 167 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQIT 167 (293)
T ss_dssp EEECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECC-CCcEeeccchhheeec
Confidence 9999996 6665543 2469999999999999999999999 79999999999999996 6789999999998764
Q ss_pred cCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017147 189 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 267 (376)
Q Consensus 189 ~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 267 (376)
... .....+||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+.+..+..... +.
T Consensus 168 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~---------- 235 (293)
T d1yhwa1 168 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PE---------- 235 (293)
T ss_dssp STTCCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CC----------
T ss_pred cccccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CC----------
Confidence 433 34566799999999999664 589999999999999999999999999888877776655311 10
Q ss_pred CCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 268 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
...+..+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 236 ---------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 236 ---------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ---------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ---------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 0112347999999999999999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-60 Score=422.32 Aligned_cols=254 Identities=26% Similarity=0.365 Sum_probs=205.1
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
.++|++++.||+|+||+||+|+++.+|+.||+|++.... ....+|+++++.++|||||++++++.+.. ...
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC---CCE
Confidence 468999999999999999999999999999999986542 22457999999999999999999886432 223
Q ss_pred EEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCC-----eeecCCCCCcEEEcCCCCcEEEEe
Q 017147 107 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-----VCHRDLKPQNLLVDPLTHQVKICD 180 (376)
Q Consensus 107 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~-----i~H~dlkp~Nill~~~~~~vkl~D 180 (376)
+|+|||||+ |+|.+.+.........+++..++.++.||+.||+|||+ +| |+||||||+|||++. ++.+||+|
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~~-~~~vkl~D 157 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDG-KQNVKLGD 157 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEECT-TSCEEECC
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcCC-CCcEEEee
Confidence 789999998 48888887666677889999999999999999999998 56 999999999999996 78899999
Q ss_pred ecccccCccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 181 FGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 181 fg~a~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
||+|+...... ...+..||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....+.+..-
T Consensus 158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~----- 231 (269)
T d2java1 158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF----- 231 (269)
T ss_dssp HHHHHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-----
T ss_pred ccceeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 99998765433 2345788999999999965 4589999999999999999999999999888777766654200
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 320 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 320 (376)
+ .++..+|+++.+||++||+.||++|||++|+++|||+
T Consensus 232 --------------~---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 232 --------------R---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp --------------C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --------------C---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 0 1223579999999999999999999999999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-60 Score=428.63 Aligned_cols=255 Identities=26% Similarity=0.392 Sum_probs=201.9
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
..+.|++.+.||+|+||+||+|+++.+++.||||++.+.. ....+|+.+|+.++|||||++++++. +...
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~ 81 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE-----SGGH 81 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCE
Confidence 3467999999999999999999999999999999986532 23347999999999999999999984 3445
Q ss_pred EEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC--CCCcEEEEeecc
Q 017147 107 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGS 183 (376)
Q Consensus 107 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~--~~~~vkl~Dfg~ 183 (376)
+|+|||||+ |+|.+.+. ..+.+++..++.++.||+.||+|||+ +||+||||||+|||+.. +++.+||+|||+
T Consensus 82 ~~lvmE~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~ 156 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGL 156 (307)
T ss_dssp EEEEECCCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred EEEEEeccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCceEEEeccce
Confidence 899999998 58877775 45679999999999999999999999 79999999999999953 357899999999
Q ss_pred cccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 184 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 184 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
|+.........+.+||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+....+.+....+
T Consensus 157 a~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~------- 228 (307)
T d1a06a_ 157 SKMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF------- 228 (307)
T ss_dssp ----------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC-------
T ss_pred eEEccCCCeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC-------
Confidence 9877666666677899999999999664 58999999999999999999999999988887777666521111
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
.......+|+++++||.+||++||++|||++|+++||||++
T Consensus 229 ------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 229 ------------------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp ------------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred ------------------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 11123458999999999999999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.5e-60 Score=434.66 Aligned_cols=260 Identities=25% Similarity=0.384 Sum_probs=222.3
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
..++|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+.+|+.++|||||++++++.+. ..+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~ 98 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEM 98 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-----TEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEE
Confidence 4578999999999999999999999999999999986543 2345799999999999999999998543 348
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC-CCcEEEEeecccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL-THQVKICDFGSAK 185 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~-~~~vkl~Dfg~a~ 185 (376)
|+|||||+| +|.+.+.. ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+ ++.+||+|||+|+
T Consensus 99 ~ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~ 174 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 174 (350)
T ss_dssp EEEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchhe
Confidence 999999985 77776642 34679999999999999999999999 799999999999999642 4689999999998
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.........+..||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+........
T Consensus 175 ~~~~~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-------- 245 (350)
T d1koaa2 175 HLDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD-------- 245 (350)
T ss_dssp ECCTTSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC--------
T ss_pred ecccccccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence 87766667778899999999999765 489999999999999999999999999998888887776322111
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
......+|+++++||.+||++||++|||++|+|+||||+....+
T Consensus 246 -----------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 246 -----------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp -----------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred -----------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 11123479999999999999999999999999999999986544
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-59 Score=423.24 Aligned_cols=288 Identities=34% Similarity=0.579 Sum_probs=235.9
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCC-CcEEEEEEeecc------ccchHHHHHHHHhC---CCCceeeeceeeeecC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQD------RRYKNRELQLMRVM---DHPNVISLKHCFFSTT 100 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~aiK~~~~~------~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~ 100 (376)
...++|++++.||+|+||+||+|++..+ ++.||||++..+ .....+|+.+++.+ +||||++++++|....
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 3457899999999999999999999766 667999998542 22345788877766 7999999999987666
Q ss_pred CCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEe
Q 017147 101 SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 180 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~D 180 (376)
......+|++|||+++++...... .....+++..++.++.|++.||+|||+ +||+||||||+|||++. .+.+||+|
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~-~~~~kl~d 159 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLAD 159 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECS
T ss_pred cccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEcC-CCCeeecc
Confidence 566778999999999876655432 345679999999999999999999999 79999999999999996 77899999
Q ss_pred ecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 181 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 181 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
||+++............||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+.+..+.+..+.+....
T Consensus 160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 9999877666666778899999999999764 589999999999999999999999999999999999999999988766
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
+....... ...+......+. ..+...++++++|||++||++||++|||++|+|+||||+++++
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 239 WPRDVALP-RQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp SCTTCSSC-GGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccccch-hhhhccccccch-hhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 54322111 111111112222 2344568999999999999999999999999999999998753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-59 Score=424.06 Aligned_cols=283 Identities=35% Similarity=0.660 Sum_probs=232.9
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
++|++++.||+|+||+||+|+++.+|+.||||++..+ .....+|+.+|+.++|||||++++++.+.. .+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~-----~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-----KL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc-----ce
Confidence 6899999999999999999999999999999998543 233458999999999999999999995543 48
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
|+||||+.+++...+.. .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+..
T Consensus 77 ~iv~e~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~-~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAF 152 (298)
T ss_dssp EEEEECCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECSTTHHHHH
T ss_pred eEEEeecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecc-cCcceeccCCcceec
Confidence 99999999887766643 245679999999999999999999999 79999999999999996 678999999999765
Q ss_pred ccC-CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
... .......||+.|+|||++.....++.++|+||+||++|+|++|+.||.+.+..+.+..+.+..+.+....+.....
T Consensus 153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 433 3344568899999999987777678999999999999999999999999999999999999888877654443211
Q ss_pred CC-CCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCC
Q 017147 267 NY-TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 326 (376)
Q Consensus 267 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 326 (376)
.. ....++......+.... ..+|++++|||++||++||++|||++|+|+||||+++..+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHS-TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccccccchhhhc-cCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 10 11122333333343333 3578999999999999999999999999999999988554
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-59 Score=430.27 Aligned_cols=253 Identities=27% Similarity=0.435 Sum_probs=216.7
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
.++|++++.||+|+||+||+|+++.+|+.||||++.++. ....+|+.+|+.++||||+++++++. +..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec-----ccc
Confidence 468999999999999999999999999999999986431 23457999999999999999999994 444
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
.+|+|||||+| +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 79 ~~~iv~ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~-~g~vkl~DFG~a 152 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTTC
T ss_pred ccccceeccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecC-CCCEEEeecccc
Confidence 59999999996 6666554 34679999999999999999999999 79999999999999997 678999999999
Q ss_pred ccCcc-CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 185 KQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 185 ~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
+.... .......+||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+....+...
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~----------- 220 (337)
T d1o6la_ 153 KEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME----------- 220 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred cccccCCcccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC-----------
Confidence 86544 3344567899999999999665 5899999999999999999999999999988777666551
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCcccccCC
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 326 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 326 (376)
.+. ++..+|+++++||++||++||.+|++ ++|+++||||+++.+.
T Consensus 221 ------~~~------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~ 270 (337)
T d1o6la_ 221 ------EIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp ------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ------CCC------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHH
Confidence 111 23458999999999999999999994 9999999999987543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-59 Score=422.49 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=218.5
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTT 100 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (376)
+..++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|+.++|||||++++++.+
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-- 84 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-- 84 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--
Confidence 34578999999999999999999999999999999986431 234589999999999999999999843
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCC---cE
Q 017147 101 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH---QV 176 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~---~v 176 (376)
...+|+|||||+| +|.+.+.. .+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++. .+
T Consensus 85 ---~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~v 156 (293)
T d1jksa_ 85 ---KTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRI 156 (293)
T ss_dssp ---SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCE
T ss_pred ---CCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccce
Confidence 4458999999985 77777753 3579999999999999999999999 79999999999999986332 59
Q ss_pred EEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017147 177 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256 (376)
Q Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 256 (376)
||+|||+|..........+..+|+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+.+..+.+.....
T Consensus 157 kl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1jksa_ 157 KIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235 (293)
T ss_dssp EECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC
T ss_pred EecchhhhhhcCCCccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 99999999877666666677889999999999654 58999999999999999999999999999888877765532111
Q ss_pred CHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
...+...+|+++++||++||+.||++|||++|+|+||||+...+
T Consensus 236 -------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 236 -------------------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp -------------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred -------------------------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 12223457999999999999999999999999999999987544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-59 Score=421.69 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=212.6
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
.+.|++++.||+|+||+||+|+++.+++.||+|++... .....+|+++|+.++|||||++++++.+.. .+|
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~~ 85 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-----NLW 85 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT-----EEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-----eEE
Confidence 35799999999999999999999999999999998643 234568999999999999999999985443 488
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+|||||++ +|...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+|+..
T Consensus 86 lvmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~-~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKN 160 (288)
T ss_dssp EEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECC-CCCEEEEechhhhcc
Confidence 99999985 66665543 34679999999999999999999999 79999999999999996 778999999999755
Q ss_pred ccCC-CceeeeeccccCchhhhhC----CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017147 188 IAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 262 (376)
Q Consensus 188 ~~~~-~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (376)
.... ...+..||+.|+|||++.. ...|+.++||||+||++|+|++|++||.+.+..+.+..+.+.....
T Consensus 161 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~------ 234 (288)
T d2jfla1 161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT------ 234 (288)
T ss_dssp HHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC------
T ss_pred CCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence 3322 2335678999999999842 3457899999999999999999999999988888777766521000
Q ss_pred hcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 263 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
...+..+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 235 --------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 235 --------------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp --------------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred --------------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0012347999999999999999999999999999999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-59 Score=414.86 Aligned_cols=252 Identities=24% Similarity=0.361 Sum_probs=207.4
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
.|++.+.||+|+||+||+|.++.+++.||+|++.... ....+|+++|+.++|||||++++++.... .+...+|
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~ 88 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIV 88 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEE
Confidence 3578889999999999999999999999999986532 23457999999999999999999886543 3345688
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCC--eeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+|||||++ +|.+.+.. ...+++..++.++.||+.||+|||+ ++ |+||||||+|||++.+++.+||+|||+|+
T Consensus 89 ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 99999985 77776653 4679999999999999999999999 78 99999999999997556789999999997
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
... .....+.+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+......+.+.+.. +..
T Consensus 164 ~~~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~--------- 230 (270)
T d1t4ha_ 164 LKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVK--------- 230 (270)
T ss_dssp GCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCC---------
T ss_pred ecc-CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCC---------
Confidence 543 333456789999999999854 4899999999999999999999999876655544333221 100
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 321 (376)
...++...++++++||.+||++||++|||++|+|+||||+
T Consensus 231 ----------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 231 ----------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ----------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ----------------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 0112344789999999999999999999999999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.8e-59 Score=430.73 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=219.6
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
..++|++++.||+|+||+||+|.++.+|+.||||++.... ....+|+.+|+.++|||||+++++|. +...+
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~ 101 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEM 101 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence 4578999999999999999999999999999999986543 23457999999999999999999984 33458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC-CCCcEEEEeecccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAK 185 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~-~~~~vkl~Dfg~a~ 185 (376)
|+|||||+| +|.+.+. .....+++.+++.++.||+.||+|||+ +||+||||||+|||++. .++.+||+|||+|+
T Consensus 102 ~ivmE~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~ 177 (352)
T d1koba_ 102 VLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLAT 177 (352)
T ss_dssp EEEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEEEEcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCCeEEEeecccce
Confidence 999999995 6655443 245579999999999999999999999 79999999999999973 35789999999999
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.........+..+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.+....++
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~-------- 248 (352)
T d1koba_ 178 KLNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD-------- 248 (352)
T ss_dssp ECCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC--------
T ss_pred ecCCCCceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence 87776667778899999999999654 589999999999999999999999999998888877766321111
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
......+|+++++||.+||++||.+|||++|+|+||||+..
T Consensus 249 -----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 249 -----------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp -----------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -----------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 11223579999999999999999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-59 Score=420.96 Aligned_cols=249 Identities=28% Similarity=0.427 Sum_probs=211.0
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
..|+.++.||+|+||+||+|+++.+++.||||++..... ...+|+.+|+.++|||||++++++.+.. .
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----T 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----E
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC-----E
Confidence 469999999999999999999999999999999865432 2357999999999999999999985443 4
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 107 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 107 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
+|+|||||.++++..+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+|..
T Consensus 90 ~~iv~E~~~~g~l~~~~---~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~-~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASI 164 (309)
T ss_dssp EEEEEECCSEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEET-TTEEEECCCTTCBS
T ss_pred EEEEEEecCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEECC-CCCEEEeecccccc
Confidence 89999999976555443 245679999999999999999999999 79999999999999996 78899999999986
Q ss_pred CccCCCceeeeeccccCchhhhhCC--CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 187 LIAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
... .....||+.|+|||++.+. ..|+.++|||||||++|+|++|..||.+.+..+.+..+......+
T Consensus 165 ~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~-------- 233 (309)
T d1u5ra_ 165 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA-------- 233 (309)
T ss_dssp SSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------
T ss_pred cCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC--------
Confidence 533 3456899999999998642 358999999999999999999999999988887777666521100
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
..+..+|+++++||.+||+.||.+|||++|+|+||||..
T Consensus 234 -------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 234 -------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp -------------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred -------------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 012347899999999999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-58 Score=420.62 Aligned_cols=251 Identities=29% Similarity=0.487 Sum_probs=214.8
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
.++|++++.||+|+||+||+|+++.+|+.||||++.++ .....+|+.+++.++||||+++++++.+ ..
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~ 77 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQ 77 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SS
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-----CC
Confidence 35799999999999999999999999999999998643 2234589999999999999999999843 34
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
.+|+|||||.| ++...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 78 ~~~ivmE~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~-~g~vkL~DFG~a 151 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDK-NGHIKITDFGFA 151 (316)
T ss_dssp EEEEEECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECT-TSCEEECCCSSC
T ss_pred eeeeEeeecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcC-CCCEEEecCccc
Confidence 58999999996 4444443 46778999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 185 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 185 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
+.... ...+.+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+....+.+.
T Consensus 152 ~~~~~--~~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------------ 216 (316)
T d1fota_ 152 KYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------------ 216 (316)
T ss_dssp EECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC------------
T ss_pred eEecc--ccccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC------------
Confidence 86543 33467899999999999654 5899999999999999999999999999988888777652
Q ss_pred CcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCC
Q 017147 265 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326 (376)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 326 (376)
... ++..+|++++++|.+||++||.+|+ |++++++||||+++.+.
T Consensus 217 -----~~~------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 217 -----ELR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp -----CCC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred -----CCC------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 111 2234799999999999999999996 89999999999998654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-59 Score=429.75 Aligned_cols=280 Identities=26% Similarity=0.437 Sum_probs=206.5
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
.++|++++.||+|+||+||+|+++.+|+.||+|++..+. ....+|+.+|+.++|||||+++++|.+. ..+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-----SEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEE
Confidence 568999999999999999999999999999999986432 2345799999999999999999999543 348
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccccc
Q 017147 108 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 186 (376)
Q Consensus 108 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~ 186 (376)
|+|||||.| +|.+.+.. .+.+++..++.++.|++.||.|||+.+||+||||||+|||++. ++.+||+|||+|+.
T Consensus 80 ~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~-~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQ 154 (322)
T ss_dssp EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT-TCCEEECCCCCCHH
T ss_pred EEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECC-CCCEEEeeCCCccc
Confidence 999999995 77777753 3579999999999999999999996139999999999999996 77899999999986
Q ss_pred CccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcC
Q 017147 187 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~ 265 (376)
.... ...+.+||++|+|||++.+. .|+.++||||+||++|+|++|+.||.+.+..+. ...+....+.+.........
T Consensus 155 ~~~~-~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 155 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HHHH-TC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred cCCC-ccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 5332 23467899999999999875 599999999999999999999999987664332 22222222222111100000
Q ss_pred cC--CCCC---CCCCCC---------CCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 266 PN--YTDF---RFPQIK---------AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 266 ~~--~~~~---~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
.. .... ..+... ...........+|.+++|||.+||++||++|||++|+|+||||++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 00 0000 000000 00000111123688999999999999999999999999999998754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4e-58 Score=409.66 Aligned_cols=254 Identities=28% Similarity=0.405 Sum_probs=216.8
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------------cchHHHHHHHHhCC-CCceeeeceeeee
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRVMD-HPNVISLKHCFFS 98 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------------~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 98 (376)
.++|++.+.||+|+||+||+|+++.+++.||||++.+.. ....+|+.+++.++ ||||+++++++.
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~- 80 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE- 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc-
Confidence 368999999999999999999999999999999986532 12347999999997 999999999984
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEE
Q 017147 99 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 177 (376)
Q Consensus 99 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vk 177 (376)
+...+|||||||+| +|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+|
T Consensus 81 ----~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~-~~~~k 150 (277)
T d1phka_ 81 ----TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDD-DMNIK 150 (277)
T ss_dssp ----CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEE
T ss_pred ----cCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcC-CCCeE
Confidence 34458999999985 88888763 4579999999999999999999999 79999999999999996 77899
Q ss_pred EEeecccccCccCCCceeeeeccccCchhhhhC-----CCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 017147 178 ICDFGSAKQLIAGEANISYICSRFYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252 (376)
Q Consensus 178 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 252 (376)
|+|||+++............||+.|+|||.+.+ ...++.++||||+||++|+|++|+.||.+.+..+....+.+.
T Consensus 151 l~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~ 230 (277)
T d1phka_ 151 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230 (277)
T ss_dssp ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred EccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC
Confidence 999999988766666667789999999999853 344788999999999999999999999999988877777652
Q ss_pred hCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
.-.+ ......++|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 231 ~~~~-------------------------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 231 NYQF-------------------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp CCCC-------------------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCCC-------------------------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 1110 01112348999999999999999999999999999999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-58 Score=420.89 Aligned_cols=256 Identities=26% Similarity=0.398 Sum_probs=219.7
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
..++|++++.||+|+||+||+|.++.+++.||||++.... ....+|+++|+.++|||||+++++|.+. ..+|
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~ 77 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESM-----EELV 77 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEE
Confidence 3578999999999999999999999999999999996543 2345899999999999999999999543 3489
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC-CCcEEEEeeccccc
Q 017147 109 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQ 186 (376)
Q Consensus 109 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~-~~~vkl~Dfg~a~~ 186 (376)
+|||||+| +|.+.+.. ....+++.+++.++.||+.||+|||+ +||+||||||+|||++.+ ...+||+|||+++.
T Consensus 78 lvmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 78 MIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhc
Confidence 99999995 77776642 34579999999999999999999999 799999999999999752 35799999999987
Q ss_pred CccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 187 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 187 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
...........+|+.|+|||.+.+. .|+.++||||+||++|+|++|..||.+.+..+.+..+.+.....+..
T Consensus 154 ~~~~~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~------- 225 (321)
T d1tkia_ 154 LKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE------- 225 (321)
T ss_dssp CCTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH-------
T ss_pred cccCCcccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh-------
Confidence 7666666677889999999998654 58999999999999999999999999999988888887743222221
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
....+|+++++||.+||.+||++|||++|+++||||+.
T Consensus 226 ------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 226 ------------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ------------------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 22347999999999999999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-57 Score=420.58 Aligned_cols=285 Identities=35% Similarity=0.626 Sum_probs=229.3
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 105 (376)
.++|++++.||+|+||+||+|.++.+|+.||||++.+.. ....+|+.+|+.++|||||+++++|..... ....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999999999999999986432 234579999999999999999999865432 2334
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.+|+|||||+.++....+. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+|++|||+|+
T Consensus 97 ~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~-~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred eEEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhccc-cccccccccccee
Confidence 5789999998777766542 579999999999999999999999 79999999999999996 7889999999998
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.... ......+|+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.++.+.+....
T Consensus 170 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 170 QADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp ECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 6533 33457889999999999877778999999999999999999999999999999999999999999887665432
Q ss_pred cCCC---CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCC
Q 017147 266 PNYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 327 (376)
Q Consensus 266 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 327 (376)
.... ...++......+...+ ..++++++|||++||.+||++|||++|+|+||||+.+++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~ 311 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred chhhhhhhccCCcccccchHHhc-cCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcc
Confidence 2110 0122333334444333 45799999999999999999999999999999999986543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-57 Score=410.36 Aligned_cols=277 Identities=35% Similarity=0.649 Sum_probs=225.2
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
++|++++.||+|+||+||+|+++ +++.||||++.... ....+|+.+|+.++||||+++++++..... .
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-----~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-----L 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC-----E
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc-----e
Confidence 58999999999999999999985 78999999985432 234589999999999999999999955443 8
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
|++|||+.++++..+.. ..+.+++..++.++.||+.||+|||+ .||+||||||+|||++. ++.+||+|||.|...
T Consensus 76 ~i~~e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~-~~~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAF 150 (286)
T ss_dssp EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECCTTHHHHH
T ss_pred eEEEEeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEcC-CCCEEecccccceec
Confidence 89999999887666643 45789999999999999999999999 79999999999999997 788999999999765
Q ss_pred ccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 188 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 188 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
.... ......+++.|+|||.+.+...++.++||||+||++|+|++|++||.+.+..+++.++.+.++.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence 4332 234557899999999998777789999999999999999999999999999999999999999887665543221
Q ss_pred CCC-CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 267 NYT-DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 267 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
... ...+......++. .+...++++++|||++||++||++|||++|+|+||||++
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWE-SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp STTCCTTCCCCCCCCGG-GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhhcccccccccCcchh-hhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 111 1112222222333 334568999999999999999999999999999999974
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6e-58 Score=421.78 Aligned_cols=256 Identities=27% Similarity=0.418 Sum_probs=217.7
Q ss_pred CCCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 017147 28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTT 100 (376)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (376)
..+...++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|+.++||||+++++++..
T Consensus 35 ~~~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-- 112 (350)
T d1rdqe_ 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-- 112 (350)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred cCCCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc--
Confidence 34455689999999999999999999999999999999986432 234589999999999999999999843
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEE
Q 017147 101 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 179 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~ 179 (376)
...+|+||||+.| ++...+. ..+.+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+
T Consensus 113 ---~~~~~~v~e~~~~g~l~~~l~----~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~-~g~ikL~ 183 (350)
T d1rdqe_ 113 ---NSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQ-QGYIQVT 183 (350)
T ss_dssp ---SSEEEEEEECCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEEC
T ss_pred ---ccccccccccccccchhhhHh----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccCC-CCCEEee
Confidence 3448899999996 6666654 33579999999999999999999999 79999999999999996 6789999
Q ss_pred eecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 180 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 180 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
|||+|+.... ...+..||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+....+..+.....
T Consensus 184 DFG~a~~~~~--~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~----- 255 (350)
T d1rdqe_ 184 DFGFAKRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV----- 255 (350)
T ss_dssp CCTTCEECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----
T ss_pred eceeeeeccc--ccccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-----
Confidence 9999987643 33467899999999999764 589999999999999999999999999988887777765210
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCC
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 326 (376)
. ++..+|+++.+||++||++||.+|+ |++++++||||+++.+.
T Consensus 256 ------------~------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 256 ------------R------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp ------------C------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred ------------C------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence 1 1235799999999999999999995 89999999999987654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.6e-58 Score=425.45 Aligned_cols=256 Identities=26% Similarity=0.382 Sum_probs=208.5
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cch---HHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYK---NRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~---~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ... .+++.+++.++|||||++++++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~---- 78 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---- 78 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE----
Confidence 357999999999999999999999999999999986432 111 234677778899999999999843
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 103 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 103 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
...+|+|||||+| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 79 -~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~-~g~iKl~DF 151 (364)
T d1omwa3 79 -PDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDL 151 (364)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECS-SSCEEECCC
T ss_pred -CCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcC-CCcEEEeee
Confidence 3348999999994 77777753 4678999999999999999999999 79999999999999996 778999999
Q ss_pred cccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017147 182 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 261 (376)
Q Consensus 182 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (376)
|+|+..... ......||+.|+|||++.+...|+.++|||||||++|+|++|+.||.+.+..+...........
T Consensus 152 Gla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------ 224 (364)
T d1omwa3 152 GLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------ 224 (364)
T ss_dssp TTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC------
T ss_pred ceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC------
Confidence 999866443 3445689999999999976566899999999999999999999999876543332211111110
Q ss_pred hhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCcccccCC
Q 017147 262 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 326 (376)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 326 (376)
...++..+|+++++||.+||++||.+||| ++|+++||||+++.+.
T Consensus 225 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~ 274 (364)
T d1omwa3 225 --------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 274 (364)
T ss_dssp --------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred --------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence 01123458999999999999999999999 7999999999987654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-57 Score=416.72 Aligned_cols=317 Identities=33% Similarity=0.618 Sum_probs=243.9
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
.+|++++.||+|+||+||+|.++.+|+.||||++.+... ...+|+.+|+.++||||+++++++..........+|
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 479999999999999999999999999999999864322 334799999999999999999998665544555678
Q ss_pred EEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 109 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 109 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
+++++++|+|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|....
T Consensus 88 l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~-~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEECC
T ss_pred EEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEECC-CCCEEEcccCceeecc
Confidence 8888888899888853 469999999999999999999999 79999999999999996 7789999999997654
Q ss_pred cCCC----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017147 189 AGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 264 (376)
Q Consensus 189 ~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (376)
.... ....++|+.|+|||++.....++.++||||+||++|+|++|++||.+.+..+........++.+........
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 3322 345678999999999866666899999999999999999999999999999999998888888876654322
Q ss_pred CcC---CCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCC
Q 017147 265 NPN---YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFN 341 (376)
Q Consensus 265 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~ 341 (376)
... ......+.....+|...++ .+++++++||.+||++||.+|||++|+|+||||+......... ..+...+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~----~~~~~~~ 315 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFP-NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP----IAEAPFK 315 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCT-TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSC----CCSSCC-
T ss_pred hhhhhhcccccCCccCCCCHHHhCC-CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCc----cccCccC
Confidence 100 0011233333445555444 5799999999999999999999999999999999775543321 1223445
Q ss_pred chhhhccCCHHHHhhhcHHHH
Q 017147 342 FKQELSGASPELVNKLIPDHV 362 (376)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~ 362 (376)
+..+..+...+.+++++.++.
T Consensus 316 ~~~~~~~~~~~~l~~l~~~e~ 336 (345)
T d1pmea_ 316 FDMELDDLPKEKLKELIFEET 336 (345)
T ss_dssp -------CCHHHHHHHHHHHS
T ss_pred CChhhhhCCHHHHHHHHHHHH
Confidence 556666777777777765554
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-58 Score=417.93 Aligned_cols=251 Identities=29% Similarity=0.506 Sum_probs=211.3
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHH-HhCCCCceeeeceeeeecCCCCce
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLM-RVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
++|++++.||+|+||+||+|+++.+++.||||++.++. .....|..++ +.++||||+++++++.+ ..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-----~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-----KE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----SS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-----CC
Confidence 57999999999999999999999999999999996432 1223455555 47899999999999844 34
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
.+|+|||||++ +|...+. ....+++.+++.++.||+.||+|||+ +||+||||||+|||++. .+.+||+|||++
T Consensus 77 ~~yivmEy~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~-~~~~kl~DFG~a 150 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDK-DGHIKIADFGMC 150 (320)
T ss_dssp EEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTTC
T ss_pred ceeEEEeecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeecC-CCceeccccchh
Confidence 48999999985 7777665 34678999999999999999999999 79999999999999996 788999999999
Q ss_pred ccCccCC-CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017147 185 KQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 263 (376)
Q Consensus 185 ~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (376)
+...... ......||+.|+|||++.+. .|+.++||||+||++|+|++|+.||.+.+..+....+... .+
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~------- 220 (320)
T d1xjda_ 151 KENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP------- 220 (320)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-------
T ss_pred hhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC-------
Confidence 8654433 33456889999999999764 5899999999999999999999999999888777766541 11
Q ss_pred cCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHH-HHhcCCCcccccC
Q 017147 264 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELRE 325 (376)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~-e~l~hp~~~~~~~ 325 (376)
. ++..+|+++++||++||++||++|||+. ++++||||+++++
T Consensus 221 --------~------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 221 --------F------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp --------C------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred --------C------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence 1 2335799999999999999999999995 8999999998754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-58 Score=408.75 Aligned_cols=245 Identities=26% Similarity=0.402 Sum_probs=205.0
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----------cchHHHHHHHHhCC--CCceeeeceeeeecC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMD--HPNVISLKHCFFSTT 100 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~ 100 (376)
.++|++.+.||+|+||+||+|.++.+|+.||||++.++. ....+|+.+++.++ ||||+++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--
Confidence 457999999999999999999999999999999986432 22358999999987 8999999999843
Q ss_pred CCCceEEEEEeecccc--hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEE
Q 017147 101 SKNELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 178 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl 178 (376)
...+|+||||+.+ ++.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||
T Consensus 81 ---~~~~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl 152 (273)
T d1xwsa_ 81 ---PDSFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKL 152 (273)
T ss_dssp ---SSEEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEE
T ss_pred ---CCeEEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEE
Confidence 3348899999974 5555554 34679999999999999999999999 799999999999999975678999
Q ss_pred EeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 179 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 179 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
+|||+|+.... ....+..||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+ .+.+.
T Consensus 153 ~DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~------ 219 (273)
T d1xwsa_ 153 IDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG------ 219 (273)
T ss_dssp CCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC------
T ss_pred Cccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc------
Confidence 99999976433 334567899999999999776656788999999999999999999997632 12220
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
.. .++..+|+++++||++||++||++|||++|+|+||||+++
T Consensus 220 -----------~~------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 220 -----------QV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp -----------CC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -----------cc------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 00 1234589999999999999999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.5e-57 Score=413.60 Aligned_cols=282 Identities=28% Similarity=0.512 Sum_probs=224.8
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-cchHHHHHHHHhCC-CCceeeeceeeeecCCCCceEEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
.++|++++.||+|+||+||+|+++.+++.||||++.... ....+|+.+|+.++ ||||++++++|.... ...+++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~---~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecC---CCceeEE
Confidence 468999999999999999999999999999999986543 44568999999995 999999999885432 2348899
Q ss_pred eecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 111 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 111 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
||||.++.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||+|||+|+.....
T Consensus 111 ~e~~~~~~L~~------~~~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 111 FEHVNNTDFKQ------LYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EECCCSCBGGG------TTTSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EeecCCCcHHH------HhcCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999743211 23579999999999999999999999 799999999999999975677999999999877666
Q ss_pred CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCC-CChHHHHHHHHHHhCCCCHHHHhhcCc---
Q 017147 191 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIRCMNP--- 266 (376)
Q Consensus 191 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~--- 266 (376)
.......+|+.|+|||.+.+...++.++||||+||++|+|++|..||.. .+..++...+.+.+|.+....+.....
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 6666778899999999998777789999999999999999999999965 445667777777777655443322111
Q ss_pred --CCCCCCCCCCCCCChhhh----cccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccC
Q 017147 267 --NYTDFRFPQIKAHPWHKV----FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 325 (376)
Q Consensus 267 --~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 325 (376)
.+.+ ..+......+... ....++++++|||++||++||.+|||++|+|+||||+.+.+
T Consensus 264 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 264 DPRFND-ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CGGGGG-TCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred Ccccch-hcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 1111 1111111222222 22347899999999999999999999999999999998764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-57 Score=416.01 Aligned_cols=318 Identities=31% Similarity=0.527 Sum_probs=233.0
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 105 (376)
.++|++++.||+|+||+||+|.++.+|+.||||++.+.. ....+|+.+++.++||||++++++|..... +...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999999999999999996532 234589999999999999999999854432 3456
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.+|+|||||.++++..+. ..+++..++.++.||+.||+|||+ .||+||||||+|||++. ++.+|++|||+++
T Consensus 96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~~-~~~~kl~df~~~~ 167 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCCCC--
T ss_pred eeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCcccccccc-ccceeeechhhhh
Confidence 789999999998776653 568999999999999999999999 79999999999999997 6779999999998
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
............+|+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+......++...++.+..+.+....
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred ccccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 77666666677889999999999764 58999999999999999999999999999999999999999998888776443
Q ss_pred cCCCCC--CCCCCCCCChhhhc-----------ccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCC
Q 017147 266 PNYTDF--RFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN 332 (376)
Q Consensus 266 ~~~~~~--~~~~~~~~~~~~~~-----------~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~ 332 (376)
..+.++ ..+......+...+ ....+++++|||++||.+||++||||+|+|+||||+...++....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~-- 324 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE-- 324 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHT--
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCccccc--
Confidence 221111 00111111111111 122467899999999999999999999999999999865432221
Q ss_pred CCCCCCCCCchhhhccCCHHHHhhhcHHHH
Q 017147 333 GRPLPPLFNFKQELSGASPELVNKLIPDHV 362 (376)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (376)
...|...+...+....+.+..++++-.++
T Consensus 325 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (355)
T d2b1pa1 325 -APPPQIYDKQLDEREHTIEEWKELIYKEV 353 (355)
T ss_dssp -CCCC-------CCCCCCHHHHHHHHHHHH
T ss_pred -CCCCCCCCcchhhhhcCHHHHHHHHHHHh
Confidence 11223333333334556666666654444
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-57 Score=416.14 Aligned_cols=265 Identities=24% Similarity=0.358 Sum_probs=210.8
Q ss_pred cccceeeeee-eeecCCCeeEEEEEEcCCCcEEEEEEeeccccchHHHHHHHH-hCCCCceeeeceeeeecCCCCceEEE
Q 017147 31 KQTISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-VMDHPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 31 ~~~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
...++|.+.. .||+|+||+||+|+++.+++.||||++.+. ....+|+.++. ..+|||||+++++|.+.. ....++|
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~ 85 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLL 85 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEE
Confidence 4567899875 699999999999999999999999998654 44568998865 558999999999885432 3356689
Q ss_pred EEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCC--CCcEEEEeecccc
Q 017147 109 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGSAK 185 (376)
Q Consensus 109 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~--~~~vkl~Dfg~a~ 185 (376)
+|||||+ |+|.+.+.. .....+++.+++.++.||+.||+|||+ +||+||||||+|||++.. .+.+||+|||+|+
T Consensus 86 ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceee
Confidence 9999998 588888763 224579999999999999999999999 799999999999999852 3569999999998
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
............||+.|+|||++.+. .|+.++|||||||++|+|+||++||.+.+.......+...+.
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~----------- 230 (335)
T d2ozaa1 163 ETTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----------- 230 (335)
T ss_dssp ECCCCCCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC-----------
T ss_pred eccCCCccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHh-----------
Confidence 77666666778899999999998654 589999999999999999999999988765544433322110
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
...+.+| ......+|+++++||++||++||++|||+.|+++||||.+
T Consensus 231 --~~~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 231 --MGQYEFP--------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp --SCSSSCC--------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred --cCCCCCC--------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 0111111 1112247999999999999999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-56 Score=410.88 Aligned_cols=315 Identities=34% Similarity=0.555 Sum_probs=245.1
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 105 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 105 (376)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|+.++||||+++++++..... ++..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999999999999999986542 233579999999999999999998854432 2333
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 106 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 106 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.+++++++++|+|.+++. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~-~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccccc-cccccccccchhc
Confidence 455666666678877764 3579999999999999999999999 79999999999999996 7889999999997
Q ss_pred cCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 186 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 186 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
... ....+..||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+.......+.+..+.+..+......
T Consensus 170 ~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 170 HTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred ccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 543 334456789999999998777778999999999999999999999999999999999999999888876554322
Q ss_pred cCCC---CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCc
Q 017147 266 PNYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF 342 (376)
Q Consensus 266 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 342 (376)
.... ....+......+...+ ..++++++|||++||++||++|||++|+|+||||+.+..+... +....+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~-----~~~~~~~~ 321 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-----PVADPYDQ 321 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSC-----CCCCCCCC
T ss_pred chhhhhhhhhcccCCCcchhhhc-CCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccC-----CCCCCCCC
Confidence 1100 0122233334444443 3579999999999999999999999999999999987654332 23344455
Q ss_pred hhhhccCCHHHHhhhcHHHH
Q 017147 343 KQELSGASPELVNKLIPDHV 362 (376)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~ 362 (376)
..+..+...+..++++-+++
T Consensus 322 ~~~~~~~~~~~~k~~~~~e~ 341 (348)
T d2gfsa1 322 SFESRDLLIDEWKSLTYDEV 341 (348)
T ss_dssp GGGGCCCCHHHHHHHHHHHH
T ss_pred cccchhcCHHHHHHHHHHHh
Confidence 55556677777777665554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=398.46 Aligned_cols=281 Identities=35% Similarity=0.573 Sum_probs=227.2
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 107 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 107 (376)
++|++++.||+|+||+||+|+++.+++.||||++..+. ....+|+.+|+.++||||+++++++.+. ...
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-----cce
Confidence 58999999999999999999999999999999986432 2335899999999999999999998443 348
Q ss_pred EEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccC
Q 017147 108 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 187 (376)
Q Consensus 108 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~ 187 (376)
+++++++.++.+..+. ...+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||.|+..
T Consensus 77 ~iv~~~~~~~~l~~~~---~~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~-~~~~kl~DFG~a~~~ 151 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEEC
T ss_pred eEEeeecccccccccc---ccccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCccccccc-CCceeeeecchhhcc
Confidence 8999999986554443 356788999999999999999999999 79999999999999996 678999999999876
Q ss_pred ccCCC-ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 188 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 188 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
..... .....+++.|+|||++.+...++.++||||+||++|+|++|+.| |.+.+..+.+..+....+.+....+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence 54432 33455688999999997776689999999999999999999877 56777788888888888887765544332
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 324 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 324 (376)
........+..............++++++|||++||++||.+|||++|+|+||||+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 22222222222222223334456899999999999999999999999999999998764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-56 Score=404.74 Aligned_cols=287 Identities=28% Similarity=0.496 Sum_probs=224.4
Q ss_pred cccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC---
Q 017147 31 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS--- 101 (376)
Q Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 101 (376)
...++|++++.||+|+||+||+|+++.+|+.||||++..+. ....+|+.+|+.++|+||+++++++.....
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 44689999999999999999999999999999999885432 224589999999999999999998854321
Q ss_pred CCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEee
Q 017147 102 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 181 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Df 181 (376)
.....+|+|||||.+++..... .....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~-~~~~kl~df 161 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITR-DGVLKLADF 161 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCC
T ss_pred ccCceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeecC-CCcEEeeec
Confidence 2234588999999987665543 356779999999999999999999999 79999999999999997 778999999
Q ss_pred cccccCccC-----CCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017147 182 GSAKQLIAG-----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256 (376)
Q Consensus 182 g~a~~~~~~-----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 256 (376)
|+++..... ....+.+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+.+..+.+
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999755422 223345789999999999877778999999999999999999999999999999999999999888
Q ss_pred CHHHHhhcCcC--CCCCCCCCCCCCChhhhcc-cCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 017147 257 TREEIRCMNPN--YTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 322 (376)
Q Consensus 257 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 322 (376)
..+........ +..+.............+. ...+++++|||.+||++||++|||++|+|+||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 76554432211 1111111111111111111 124788999999999999999999999999999985
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-54 Score=386.51 Aligned_cols=257 Identities=23% Similarity=0.349 Sum_probs=203.4
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
..++|++.+.||+|+||+||+|+++.+++.||||++.++. ....+|+.+++.++||||+++++++.... ...
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~ 83 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG 83 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSS
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCC
Confidence 4567999999999999999999999999999999986432 12457999999999999999999886544 344
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
..+|+|||||+| +|...+. ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.++|+|||.
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~-~~~~~l~d~~~ 157 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGI 157 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEET-TSCEEECCCTT
T ss_pred ceEEEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCc-cccceeehhhh
Confidence 568899999996 6655554 34679999999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccCC----CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 184 AKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 184 a~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
+....... .....+||+.|+|||++.+. .++.++||||+||++|+|+||++||.+.+..+.+.++.+....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~--- 233 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP--- 233 (277)
T ss_dssp CEECC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC---
T ss_pred hhhhccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC---
Confidence 86543322 23456789999999999654 58999999999999999999999999998888777766521111
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 321 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 321 (376)
.......+|+++.+||.+||++||.+||+..+.+.|+|.+
T Consensus 234 ----------------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 ----------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ----------------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----------------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 1112345899999999999999999999544445567764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-53 Score=381.40 Aligned_cols=251 Identities=21% Similarity=0.335 Sum_probs=202.6
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
.++|++.+.||+|+||+||+|.++.+++.||||++..+.. ...+|+.+|+.++|||||++++++.+.. .+|+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCC-----eeEE
Confidence 3589999999999999999999999999999999865533 3458999999999999999999984433 3789
Q ss_pred Eeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
|||||+ |++...+.. .....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus 91 v~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCCTTTCC
T ss_pred EeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEECC-CCcEEEccccceeecC
Confidence 999999 577777653 244678999999999999999999999 79999999999999996 7889999999998765
Q ss_pred cCCCc--eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 189 AGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 189 ~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
..... ....+|+.|+|||++.+. .|+.++||||+||++|+|++|..| |.+.+... +.+++..-.
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~~i~~~~----------- 233 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDY----------- 233 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHHTTC-----------
T ss_pred CCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHHHHhcCC-----------
Confidence 44332 234578899999999765 489999999999999999996655 44554443 333333100
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 323 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 323 (376)
...++..+|+++.+||.+||+.||++|||++|+++ +|+.+
T Consensus 234 ----------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~ 273 (287)
T d1opja_ 234 ----------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM 273 (287)
T ss_dssp ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred ----------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence 01123457999999999999999999999999965 55544
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-53 Score=375.07 Aligned_cols=244 Identities=19% Similarity=0.306 Sum_probs=192.8
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
.+|++.+.||+|+||+||+|.++ +++.||||++..+. ....+|+++++.++|||||++++++.... .+|+|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-----~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCC-----ceEEE
Confidence 47999999999999999999975 56789999987543 33458999999999999999999985433 37899
Q ss_pred eecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 111 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 111 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
||||++ +|.+.+.. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+++....
T Consensus 79 ~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~-~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp EECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECG-GGCEEECSCC-------
T ss_pred EEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeecC-CCCeEecccchheeccC
Confidence 999985 77776653 44678999999999999999999999 79999999999999996 77899999999986644
Q ss_pred CCC--ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 190 GEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 190 ~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
... .....||+.|+|||++.+. .++.++|||||||++|||+| |.+||...+..+.+..+......
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~----------- 221 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL----------- 221 (263)
T ss_dssp -----------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-----------
T ss_pred CCceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-----------
Confidence 332 2245679999999999654 58999999999999999999 57778777776666665542111
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
..+..+++++.+||.+||+.||++|||++|+++|
T Consensus 222 -----------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 222 -----------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1123468999999999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-53 Score=386.38 Aligned_cols=249 Identities=23% Similarity=0.344 Sum_probs=201.7
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCc-----EEEEEEeecc-----ccchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKVLQD-----RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~aiK~~~~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 102 (376)
++|++.+.||+|+||+||+|.++.+++ .||+|.+... .....+|+.++..+ +|||||++++++.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~-- 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG-- 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC--
Confidence 689999999999999999999876554 6999988543 22345799999888 8999999999985433
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhh-------------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCC
Q 017147 103 NELFLNLVMEYVP-ESMYRVLKHYSS-------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 162 (376)
Q Consensus 103 ~~~~~~lv~e~~~-~~l~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dl 162 (376)
.+|+|||||+ |+|.+.+..... ....+++..++.++.||+.||+|||+ +||+||||
T Consensus 115 ---~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRDl 190 (325)
T d1rjba_ 115 ---PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDL 190 (325)
T ss_dssp ---SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETTC
T ss_pred ---eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccC
Confidence 3889999998 488888764321 12458999999999999999999999 79999999
Q ss_pred CCCcEEEcCCCCcEEEEeecccccCccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCC
Q 017147 163 KPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP 238 (376)
Q Consensus 163 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~ 238 (376)
||+|||++. ++.+||+|||+|+........ .+..+|+.|+|||++.+. .++.++|||||||++|||++ |.+||.
T Consensus 191 Kp~Nill~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 191 AARNVLVTH-GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp SGGGEEEET-TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred chhcccccc-CCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCC
Confidence 999999996 788999999999865544332 245679999999999764 58999999999999999998 899999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 239 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 239 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
+.+..+.+.++++.-..+ ..+..+|+++++||.+||+.||++|||++|+++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCC---------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 877766666665521110 1233579999999999999999999999999876
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-53 Score=377.97 Aligned_cols=248 Identities=24% Similarity=0.292 Sum_probs=196.4
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
.++|++.+.||+|+||+||+|+.. ..||||++.... ....+|+.+++.++|||||+++++... + .
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~----~--~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA----P--Q 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S--S
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec----c--E
Confidence 357999999999999999999753 469999985331 234579999999999999999886521 1 2
Q ss_pred EEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+++|||||+ |+|.+.+.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~-~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHE-DLTVKIGDFGLAT 152 (276)
T ss_dssp CEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET-TSSEEECCCCCSC
T ss_pred EEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcC-CCCEEEcccccee
Confidence 679999998 587777753 34679999999999999999999999 79999999999999996 7889999999997
Q ss_pred cCccCC---CceeeeeccccCchhhhhCC--CCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 186 QLIAGE---ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 186 ~~~~~~---~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
...... ...+..||+.|+|||++.+. ..|+.++|||||||++|||+||+.||.+.+....+..+......++
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p--- 229 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP--- 229 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC---
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC---
Confidence 654322 22345789999999998643 3479999999999999999999999998877766655554311111
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.....+..+++++.+||.+||+.||++|||++|+++|
T Consensus 230 --------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 230 --------------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp --------------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0111234578999999999999999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.6e-53 Score=379.92 Aligned_cols=246 Identities=25% Similarity=0.323 Sum_probs=190.7
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCc---EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
..+|++.+.||+|+||+||+|.++.+++ .||||.+.... ....+|+.+|+.++|||||++++++....
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~---- 100 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST---- 100 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC----
Confidence 4689999999999999999999987765 58899875432 23458999999999999999999984433
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
.+|+|||||++ +|.+.+.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 101 -~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFGl 174 (299)
T d1jpaa_ 101 -PVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNS-NLVCKVSDFGL 174 (299)
T ss_dssp -SCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC--
T ss_pred -EEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECC-CCcEEECCccc
Confidence 38899999995 66665542 34579999999999999999999999 79999999999999996 78899999999
Q ss_pred cccCccCCCc------eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 017147 184 AKQLIAGEAN------ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 256 (376)
Q Consensus 184 a~~~~~~~~~------~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 256 (376)
|+........ ....+|+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+.+..+.+....+
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 253 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP 253 (299)
T ss_dssp ---------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9865433221 124568899999999764 58999999999999999998 899999988877766654421111
Q ss_pred CHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.+..+++++.+||.+||+.||++|||+.|++++
T Consensus 254 ----------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 254 ----------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ----------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ----------------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 123478999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=378.29 Aligned_cols=250 Identities=25% Similarity=0.324 Sum_probs=202.2
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
.++|++.+.||+|+||+||+|.++ +++.||||++..+. ....+|+.+++.++|||||++++++.. . .+|+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~-----~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E-----PIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-----SCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-C-----CeEE
Confidence 368999999999999999999975 67889999996543 234689999999999999999997632 1 1679
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
|||||++ +|.+.+... ....+++..+..++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus 85 v~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~-~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSD-TLSCKIADFGLARLIE 160 (272)
T ss_dssp EEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeec-ccceeeccccceEEcc
Confidence 9999985 666655322 23458999999999999999999999 79999999999999996 7889999999998765
Q ss_pred cCCC--ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 189 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 189 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.... .....+|+.|+|||++.+. .++.++|||||||++|||+| |.+||...+..+.+..+.+...
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~----------- 228 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR----------- 228 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred CCccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------
Confidence 4332 2345678999999999754 48999999999999999999 5666777766666555443110
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc--CCCccc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDE 322 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~--hp~~~~ 322 (376)
...+..+++++.+||.+||+.||++|||++++++ |+||..
T Consensus 229 -----------------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 229 -----------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 0122357899999999999999999999999998 888864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=370.25 Aligned_cols=244 Identities=18% Similarity=0.262 Sum_probs=203.2
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
++|++++.||+|+||+||+|+++ +++.||||++.++. ....+|+.+++.++||||+++++++.... .+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~-----~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-----PIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSS-----SEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----ceEEE
Confidence 47999999999999999999974 78899999987643 33458999999999999999999884433 38899
Q ss_pred eeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 111 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 111 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
|||++ |++...+.. ....+++..+.+++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++....
T Consensus 78 ~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~-~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 78 TEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVND-QGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECT-TCCEEECCCSSCCBCSS
T ss_pred EEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEcC-CCcEEECcchhheeccC
Confidence 99998 566665542 34568899999999999999999999 79999999999999996 78899999999986544
Q ss_pred CCC--ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017147 190 GEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 266 (376)
Q Consensus 190 ~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 266 (376)
... .....+|+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+....
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~----------- 220 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL----------- 220 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-----------
T ss_pred CCceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence 332 2235678999999999764 48999999999999999998 89999999887776666542111
Q ss_pred CCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 267 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
..+...++++.+||++||+.||++|||++++++|
T Consensus 221 -----------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 221 -----------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -----------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1123478899999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=386.67 Aligned_cols=258 Identities=26% Similarity=0.445 Sum_probs=208.0
Q ss_pred cceeeeeeeeecCCCeeEEEEEEc---CCCcEEEEEEeecc--------ccchHHHHHHHHhCCC-CceeeeceeeeecC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD--------RRYKNRELQLMRVMDH-PNVISLKHCFFSTT 100 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~--------~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~ 100 (376)
.++|++++.||+|+||+||+|++. .+|+.||||++.+. .....+|++++++++| |||+++++++.+.
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~- 101 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 101 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-
Confidence 478999999999999999999974 46899999988532 1234589999999977 7999999988443
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEE
Q 017147 101 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 179 (376)
Q Consensus 101 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~ 179 (376)
..++++|||+.+ +|.+.+. ....+++..++.++.||+.||+|||+ .||+||||||+|||++. ++.+||+
T Consensus 102 ----~~~~~v~e~~~~~~L~~~i~----~~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~-~~~vkL~ 171 (322)
T d1vzoa_ 102 ----TKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLT 171 (322)
T ss_dssp ----TEEEEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEES
T ss_pred ----CceeeeeecccccHHHHHHH----hcccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeecC-CCCEEEe
Confidence 348999999995 7766665 34567899999999999999999999 79999999999999997 6789999
Q ss_pred eecccccCccCC--CceeeeeccccCchhhhhCCC-CCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017147 180 DFGSAKQLIAGE--ANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 256 (376)
Q Consensus 180 Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 256 (376)
|||+++...... ...+..|++.|+|||.+.+.. .++.++|||||||++|+|++|..||.+.+..+....+.+.....
T Consensus 172 DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~ 251 (322)
T d1vzoa_ 172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251 (322)
T ss_dssp CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred eccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence 999998654332 234567899999999996543 46889999999999999999999998876555554444421100
Q ss_pred CHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCcccccCC
Q 017147 257 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 326 (376)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 326 (376)
...++..+|+++++||.+||++||++|| |++|+++||||+.+++.
T Consensus 252 -------------------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~ 301 (322)
T d1vzoa_ 252 -------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 301 (322)
T ss_dssp -------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred -------------------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHH
Confidence 0012335799999999999999999999 58999999999987643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=374.64 Aligned_cols=249 Identities=26% Similarity=0.318 Sum_probs=201.8
Q ss_pred ceeeeeee-eecCCCeeEEEEEEcC--CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 017147 34 ISYMAERV-VGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 105 (376)
Q Consensus 34 ~~y~~~~~-lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 105 (376)
++|.+.+. ||+|+||+||+|.++. ++..||||++.... ....+|+++|+.++|||||++++++.. ..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~---- 82 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA---- 82 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS----
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce----
Confidence 57888885 9999999999998764 34579999986432 234579999999999999999998732 21
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeeccc
Q 017147 106 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 184 (376)
Q Consensus 106 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a 184 (376)
+|+|||||++ +|.+.+. .....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 83 -~~lvmE~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~-~~~~Kl~DFGla 156 (285)
T d1u59a_ 83 -LMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVN-RHYAKISDFGLS 156 (285)
T ss_dssp -EEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEE-TTEEEECCCTTC
T ss_pred -EEEEEEeCCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeecc-CCceeeccchhh
Confidence 7899999995 7766654 244679999999999999999999999 79999999999999996 788999999999
Q ss_pred ccCccCCCc----eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 185 KQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 185 ~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
+........ ....+|+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~----- 230 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----- 230 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-----
T ss_pred hcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 876543322 234578899999999655 48999999999999999998 9999999887776655543110
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHH---hcCCCccc
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA---CAHPFFDE 322 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~---l~hp~~~~ 322 (376)
..++..+|+++.+||.+||+.||++|||+.++ |+|+|+.-
T Consensus 231 -----------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 231 -----------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 01234579999999999999999999998877 68898854
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=374.02 Aligned_cols=243 Identities=24% Similarity=0.311 Sum_probs=194.7
Q ss_pred eeeecCCCeeEEEEEEc--CCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 017147 40 RVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 111 (376)
Q Consensus 40 ~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 111 (376)
+.||+|+||+||+|.++ .+++.||||++..+. ....+|+.+|+.++|||||++++++.. .. .|+||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~-----~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES-----WMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SS-----EEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CC-----EEEEE
Confidence 46999999999999864 456789999985432 234589999999999999999998732 21 67999
Q ss_pred ecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCccC
Q 017147 112 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 190 (376)
Q Consensus 112 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~ 190 (376)
|||++ +|.+.+. ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.....
T Consensus 87 E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~-~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 87 EMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRAD 160 (277)
T ss_dssp ECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcccc-cCcccccchhhhhhcccc
Confidence 99985 7776665 45679999999999999999999999 79999999999999996 788999999999865443
Q ss_pred CCc----eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 191 EAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 191 ~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
... ....||+.|+|||++.+. .++.++|||||||++|||++ |++||.+.+..+....+.+...
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~----------- 228 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER----------- 228 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred ccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 322 234678999999999764 48999999999999999998 8999999887766555443100
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHH---hcCCCcccc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA---CAHPFFDEL 323 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~---l~hp~~~~~ 323 (376)
..++..+|+++.+||.+||+.||++|||++++ |+|+|++-+
T Consensus 229 -----------------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 229 -----------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272 (277)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred -----------------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcC
Confidence 01224579999999999999999999999987 567776543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=367.97 Aligned_cols=251 Identities=25% Similarity=0.327 Sum_probs=198.1
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
.++|++.+.||+|+||+||+|.++.+ +.||||++..+. ....+|+.+++.++|||||++++++.. . . +++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~---~--~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E---P--IYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S---S--CEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-C---C--eEE
Confidence 46899999999999999999998655 579999986543 335689999999999999999998732 1 1 679
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCc
Q 017147 110 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 188 (376)
Q Consensus 110 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~ 188 (376)
|||||++ ++...+.. .....+++.++..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 89 v~Ey~~~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~-~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLIE 164 (285)
T ss_dssp EECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCTTC---
T ss_pred EEEecCCCchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEECC-CCcEEEcccchhhhcc
Confidence 9999995 56655543 233569999999999999999999999 79999999999999996 7889999999998654
Q ss_pred cCCC--ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017147 189 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 265 (376)
Q Consensus 189 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 265 (376)
.... .....+|+.|+|||++... .++.++|||||||++|||++| .+||.+....+.+..+.+....
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~---------- 233 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------- 233 (285)
T ss_dssp -----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------
T ss_pred CCCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC----------
Confidence 3332 2335679999999999754 489999999999999999995 5666666666666555432111
Q ss_pred cCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc--CCCcccc
Q 017147 266 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDEL 323 (376)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~--hp~~~~~ 323 (376)
..+..+++++++||.+||+.||++|||++++++ |+||+..
T Consensus 234 ------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 234 ------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 122357999999999999999999999999987 8899764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=366.53 Aligned_cols=245 Identities=27% Similarity=0.350 Sum_probs=190.3
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCC---cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
.++|++++.||+|+||+||+|.+..++ ..||||.+.... ....+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 358999999999999999999987554 468999875321 234579999999999999999998732
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
..+|+|||||++ ++...+. .....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~-~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGL 154 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHH---HTTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECC---
T ss_pred CeEEEEEEeccCCcHHhhhh---ccCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecC-CCcEEEccchh
Confidence 127899999995 6655544 245679999999999999999999999 79999999999999996 78899999999
Q ss_pred cccCccCCC--ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017147 184 AKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 260 (376)
Q Consensus 184 a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (376)
|+....... .....+|+.|+|||++.+. .++.++|||||||++|||++ |.+||.+.+..+.+..+.+....
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~----- 228 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----- 228 (273)
T ss_dssp ----------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-----
T ss_pred heeccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence 986543322 2345668999999999654 58999999999999999998 89999998887777665442110
Q ss_pred HhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 261 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.++..+|+++.+||.+||+.||++|||++|+++|
T Consensus 229 -----------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 229 -----------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1234579999999999999999999999999876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-51 Score=371.83 Aligned_cols=245 Identities=26% Similarity=0.356 Sum_probs=195.3
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCc----EEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
.+|++++.||+|+||+||+|.++.+|+ .||+|++... .....+|+.+++.++|||||++++++....
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~---- 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST---- 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC----
Confidence 469999999999999999999988876 5888877532 233468999999999999999999885321
Q ss_pred eEEEEEeeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
.++++||+. ++|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 85 --~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~-~~~~kl~DFGl 157 (317)
T d1xkka_ 85 --VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVKITDFGL 157 (317)
T ss_dssp --EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEEECCCSH
T ss_pred --eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeCC-CCCeEeecccc
Confidence 456677776 577766543 46779999999999999999999999 79999999999999996 78899999999
Q ss_pred cccCccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 184 AKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 184 a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
|+........ ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+....+.+....+
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~--- 233 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP--- 233 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC---
T ss_pred ceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---
Confidence 9876443332 234579999999999765 58999999999999999998 899999887766555444321110
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 318 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 318 (376)
.+..+++++.+||.+||+.||++|||+.|+++|.
T Consensus 234 -------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 234 -------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp -------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -------------------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 1234789999999999999999999999999883
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=359.21 Aligned_cols=244 Identities=20% Similarity=0.272 Sum_probs=187.8
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCC----cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 104 (376)
..|++.++||+|+||+||+|.++.++ ..||||++.... ....+|+.+++.++|||||++++++....
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~---- 82 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK---- 82 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC----
Confidence 46999999999999999999987654 469999985432 23457999999999999999999885433
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecc
Q 017147 105 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 183 (376)
Q Consensus 105 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~ 183 (376)
..++|||||.+ ++...+. .....+++..+..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 83 -~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFGl 156 (283)
T d1mqba_ 83 -PMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSDFGL 156 (283)
T ss_dssp -SEEEEEECCTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCCCC
T ss_pred -ceEEEEEecccCcchhhhh---cccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECC-CCeEEEcccch
Confidence 38899999996 4544443 245679999999999999999999999 79999999999999996 78899999999
Q ss_pred cccCccCCC----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCH
Q 017147 184 AKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTR 258 (376)
Q Consensus 184 a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (376)
++....... .....||+.|+|||++.+. .++.++|||||||++|||++| .+||.+.+..+.+..+.+...
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~---- 231 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---- 231 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC----
Confidence 986544322 1234578999999999664 589999999999999999995 555666665555444332111
Q ss_pred HHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 259 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
...+..+++++.+||.+||+.||++|||+.|+++
T Consensus 232 ------------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 232 ------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 0122347889999999999999999999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=363.51 Aligned_cols=250 Identities=25% Similarity=0.361 Sum_probs=188.9
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcC-----CCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 102 (376)
++|++.+.||+|+||+||+|.+.. +++.||||++.... ....+|..++.++ +|+||+.+++++....
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~-- 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-- 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT--
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC--
Confidence 589999999999999999999754 34689999986432 2223556666555 6889999988764322
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhh------------cCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEE
Q 017147 103 NELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 169 (376)
Q Consensus 103 ~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill 169 (376)
..+++|||||+ |+|.+.+..... ....+++..+..++.||+.||.|||+ +||+||||||+|||+
T Consensus 91 --~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 --GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILL 167 (299)
T ss_dssp --SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred --CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCccceeE
Confidence 23789999998 588888764322 13458999999999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhC-CCCCCCCChHHH
Q 017147 170 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQ 245 (376)
Q Consensus 170 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~ 245 (376)
+. ++.+||+|||+|+....... .....||+.|+|||++.+. .++.++||||+||++|||++| .+||.+.+..+.
T Consensus 168 ~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 168 SE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp CG-GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred CC-CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 96 77899999999986543322 2345789999999999764 589999999999999999986 578988766555
Q ss_pred HHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 246 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 246 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
+..++.....+ ..+..+++++++||.+||+.||++|||++|+++|
T Consensus 246 ~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 246 FCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 55544421111 1223478999999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=365.88 Aligned_cols=250 Identities=23% Similarity=0.306 Sum_probs=203.4
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcE--EEEEEeecc-----ccchHHHHHHHHhC-CCCceeeeceeeeecCCCC
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQD-----RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~aiK~~~~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 103 (376)
..++|++.+.||+|+||+||+|.++.++.. ||||++... .....+|+++|+.+ +|||||++++++....
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~--- 84 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--- 84 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT---
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC---
Confidence 446899999999999999999999988864 677876432 23456899999998 7999999999986543
Q ss_pred ceEEEEEeeccc-chHHHHHHhh------------hhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEc
Q 017147 104 ELFLNLVMEYVP-ESMYRVLKHY------------SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 170 (376)
Q Consensus 104 ~~~~~lv~e~~~-~~l~~~l~~~------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~ 170 (376)
.+|+||||++ |+|.+.+... ......+++..+..++.||+.||.|||+ ++|+||||||+|||++
T Consensus 85 --~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 85 --YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG 161 (309)
T ss_dssp --EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC
T ss_pred --eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEEc
Confidence 3899999999 5888877532 1235679999999999999999999999 7999999999999999
Q ss_pred CCCCcEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhC-CCCCCCCChHHHHHHH
Q 017147 171 PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEI 249 (376)
Q Consensus 171 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i 249 (376)
. ++.+||+|||+++............+|+.|+|||.+.+. .++.++|||||||++|+|++| .+||.+.+..+....+
T Consensus 162 ~-~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i 239 (309)
T d1fvra_ 162 E-NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239 (309)
T ss_dssp G-GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred C-CCceEEccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 6 778999999999876555555566789999999999765 489999999999999999996 5688888877666554
Q ss_pred HHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 250 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
.+.. ...++..+++++.+||.+||+.||++|||++|+++|
T Consensus 240 ~~~~----------------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 240 PQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GGTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcC----------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3310 001223578999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=358.80 Aligned_cols=243 Identities=26% Similarity=0.335 Sum_probs=190.3
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCC-C--cEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLET-G--ETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 103 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~-~--~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (376)
++|++.+.||+|+||+||+|+...+ + ..||||++.++ .....+|+.+|+.++||||+++++++.+.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---- 83 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---- 83 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec----
Confidence 5799999999999999999986533 3 36899988542 12345899999999999999999988432
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 104 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 104 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
.+++|||||++ ++.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 84 --~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~-~~~vkl~DfG 156 (273)
T d1u46a_ 84 --PMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLAT-RDLVKIGDFG 156 (273)
T ss_dssp --SCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TTEEEECCCT
T ss_pred --chheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhcccc-ccceeeccch
Confidence 26799999984 66665543 34569999999999999999999999 79999999999999997 7789999999
Q ss_pred ccccCccCCCc----eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 017147 183 SAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 257 (376)
Q Consensus 183 ~a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 257 (376)
+++........ ....++..|+|||++.+. .++.++|||||||++|||+| |..||.+.+..+.+..+.+....+
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~- 234 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL- 234 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC-
Confidence 99876444332 223457789999999764 48999999999999999998 899999999888877665421110
Q ss_pred HHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017147 258 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 315 (376)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 315 (376)
..+..+|+++.+||.+||+.||++|||+++++
T Consensus 235 --------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 235 --------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred --------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 12345789999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-50 Score=362.91 Aligned_cols=261 Identities=23% Similarity=0.267 Sum_probs=199.9
Q ss_pred ccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 017147 32 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 109 (376)
Q Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 109 (376)
..++|++.+.||+|+||+||+|.++.+|+.||||++..+ ......|+++++.++|++++..+..+... ....++
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~~i 80 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVM 80 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec----CCEEEE
Confidence 345799999999999999999999999999999987643 34567899999999988766655544322 234789
Q ss_pred EeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC--CCCcEEEEeecccccC
Q 017147 110 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGSAKQL 187 (376)
Q Consensus 110 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~--~~~~vkl~Dfg~a~~~ 187 (376)
||||+++++...+.. ....+++..+..++.|++.||+|||+ +||+||||||+|||++. .+..+||+|||+|+..
T Consensus 81 vme~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 81 VMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 999999987766643 45679999999999999999999999 79999999999999864 2346999999999876
Q ss_pred ccCCC--------ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017147 188 IAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 188 ~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (376)
..... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+.+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~- 234 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS- 234 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-
Confidence 43321 2345789999999999664 4899999999999999999999999887655444333221100000
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHH---HHhcCCCccc
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL---EACAHPFFDE 322 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~---e~l~hp~~~~ 322 (376)
.+ .......+|+++.+||.+||+.||++||+++ ++|+|+|.+.
T Consensus 235 -------------------~~-~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 235 -------------------TP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp -------------------SC-HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -------------------CC-hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 00 1112235799999999999999999999986 5578887644
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=355.49 Aligned_cols=244 Identities=21% Similarity=0.314 Sum_probs=194.2
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
.++|++.+.||+|+||.||+|.+ +|..||||++.++. ....+|+++++.++||||+++++++.+.. ..+|+|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcEEEE
Confidence 45799999999999999999998 47789999996653 34568999999999999999999875322 227899
Q ss_pred eeccc-chHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccccCcc
Q 017147 111 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 189 (376)
Q Consensus 111 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~~~~~ 189 (376)
|||++ |+|.+.+... ....+++..+..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++....
T Consensus 80 ~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~-~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASS 155 (262)
T ss_dssp ECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCEEECCCCC------
T ss_pred EeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheecC-CCCEeecccccceecCC
Confidence 99998 4788877542 22358999999999999999999999 79999999999999996 78899999999986433
Q ss_pred CCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 017147 190 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 268 (376)
Q Consensus 190 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 268 (376)
. .....+|+.|+|||++.+. .++.++|||||||++|||+| |++||...+..+....+.+..
T Consensus 156 ~--~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~--------------- 217 (262)
T d1byga_ 156 T--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------------- 217 (262)
T ss_dssp --------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---------------
T ss_pred C--CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---------------
Confidence 2 3345678899999999765 58999999999999999998 799998887766655543210
Q ss_pred CCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 269 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
...++..+++++.+||++||..||++|||+.+++++
T Consensus 218 -------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 218 -------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp -------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 111234578999999999999999999999999873
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-49 Score=359.47 Aligned_cols=248 Identities=25% Similarity=0.318 Sum_probs=199.6
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcC-----CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
.++|++.+.||+|+||+||+|+.+. +++.||||++..+. ....+|+.+++.++||||+++++++.....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~- 90 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP- 90 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS-
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc-
Confidence 4579999999999999999999753 56789999986432 334689999999999999999998854333
Q ss_pred CceEEEEEeeccc-chHHHHHHhhh--------------------hcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecC
Q 017147 103 NELFLNLVMEYVP-ESMYRVLKHYS--------------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 161 (376)
Q Consensus 103 ~~~~~~lv~e~~~-~~l~~~l~~~~--------------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~d 161 (376)
.+++|||+. |+|.+.+.... .....+++..+..++.|++.||+|||+ ++|+|||
T Consensus 91 ----~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrD 165 (301)
T d1lufa_ 91 ----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD 165 (301)
T ss_dssp ----CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred ----eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEeeE
Confidence 789999998 58887775321 123358899999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEEeecccccCccCC---CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCC-CCC
Q 017147 162 LKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLF 237 (376)
Q Consensus 162 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~-~pf 237 (376)
|||+|||++. ++.+||+|||+|+...... ...+..+|+.|+|||.+.+. .|+.++|||||||++|||++|. +||
T Consensus 166 lKp~NILld~-~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 166 LATRNCLVGE-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp CSGGGEEECG-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EcccceEECC-CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999996 7889999999997543332 22345678999999999764 5899999999999999999985 789
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 238 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 238 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+.+..+.+..+.+... ...+..+++++.+||.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~e~~~~v~~~~~----------------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHcCCC----------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 98888877766543110 0123457899999999999999999999999954
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=357.58 Aligned_cols=248 Identities=23% Similarity=0.340 Sum_probs=194.0
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcCCC-------cEEEEEEeecccc-----chHHHHHHHHhC-CCCceeeeceeeeec
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLETG-------ETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFST 99 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 99 (376)
.++|++++.||+|+||.||+|++..++ ..||||++.++.. ...+|...+..+ +|||||++++++.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 468999999999999999999976654 3699999865432 223577777777 899999999998443
Q ss_pred CCCCceEEEEEeeccc-chHHHHHHhhh------------hcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCc
Q 017147 100 TSKNELFLNLVMEYVP-ESMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 166 (376)
Q Consensus 100 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~N 166 (376)
...++|||||. |++.+.+.... .....+++..+..++.||+.||+|||+ ++|+||||||+|
T Consensus 92 -----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~N 165 (299)
T d1fgka_ 92 -----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN 165 (299)
T ss_dssp -----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred -----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeecccc
Confidence 34889999998 47877775432 123568999999999999999999999 799999999999
Q ss_pred EEEcCCCCcEEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCh
Q 017147 167 LLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 242 (376)
Q Consensus 167 ill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 242 (376)
||++. ++.+||+|||+++....... .....+|+.|+|||.+.+. .|+.++|||||||++|+|++ |.+||.+.+.
T Consensus 166 iLl~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 166 VLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp EEECT-TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eeecC-CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 99996 77899999999986644332 2345678999999999764 59999999999999999998 7999988887
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 243 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 243 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+....+.+. ..+ .++..+++++.+||.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~i~~~-~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 244 EELFKLLKEG-HRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHTT-CCC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcC-CCC---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 6655444321 000 123457899999999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-48 Score=362.08 Aligned_cols=291 Identities=30% Similarity=0.482 Sum_probs=211.6
Q ss_pred CCCcccceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc---cchHHHHHHHHhCC-----------CCceeeec
Q 017147 28 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD-----------HPNVISLK 93 (376)
Q Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~-----------h~~iv~~~ 93 (376)
|++-..++|++++.||+|+||+||+|+++.+|+.||||++.++. ....+|+.+++.++ |+||++++
T Consensus 7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 33333457999999999999999999999999999999997653 23357888888775 57889888
Q ss_pred eeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCC
Q 017147 94 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 173 (376)
Q Consensus 94 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~ 173 (376)
+++.... ......++.++++.++...... ......+++..++.++.||+.||.|||+..||+||||||+|||++.++
T Consensus 87 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~ 163 (362)
T d1q8ya_ 87 DHFNHKG-PNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 163 (362)
T ss_dssp EEEEEEE-TTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred EEeeecc-ccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccC
Confidence 8774432 2222333344444444333332 235577899999999999999999999635999999999999997532
Q ss_pred C-----cEEEEeecccccCccCCCceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCC------h
Q 017147 174 H-----QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------A 242 (376)
Q Consensus 174 ~-----~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~ 242 (376)
. .++++|||.+..... ......+|+.|+|||++.+. .++.++|+||+||++++|++|+.||...+ .
T Consensus 164 ~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~ 240 (362)
T d1q8ya_ 164 SPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240 (362)
T ss_dssp TTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cccccceeeEeeccccccccc--ccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence 2 499999999975433 33456789999999999765 48999999999999999999999997543 3
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcC-------CCCCCCCCCCCCChhhhc------ccCCChhHHHHHHhhcCcCCCCCC
Q 017147 243 VDQLVEIIKVLGTPTREEIRCMNPN-------YTDFRFPQIKAHPWHKVF------HKRMPPEAIDLASRLLQYSPSLRC 309 (376)
Q Consensus 243 ~~~~~~i~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~L~~dp~~R~ 309 (376)
.+.+...+..+|.++...+...... ............++.... ....+++++|||.+||++||.+||
T Consensus 241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence 4567778888898877665432110 000111222222222221 223467899999999999999999
Q ss_pred CHHHHhcCCCccccc
Q 017147 310 TALEACAHPFFDELR 324 (376)
Q Consensus 310 t~~e~l~hp~~~~~~ 324 (376)
|++|+|+||||++..
T Consensus 321 ta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 321 DAGGLVNHPWLKDTL 335 (362)
T ss_dssp CHHHHHTCGGGTTCT
T ss_pred CHHHHhcCcccCCCC
Confidence 999999999999654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=356.41 Aligned_cols=255 Identities=24% Similarity=0.297 Sum_probs=206.0
Q ss_pred cceeeeeeeeecCCCeeEEEEEEcC-----CCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSK 102 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (376)
.++|++.+.||+|+||+||+|.++. ++..||||++.+... ...+|+.+++.++||||+++++++....
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-- 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-- 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS--
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC--
Confidence 3689999999999999999998753 357899999865322 2358999999999999999999884433
Q ss_pred CceEEEEEeeccc-chHHHHHHhhh------hcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCc
Q 017147 103 NELFLNLVMEYVP-ESMYRVLKHYS------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 175 (376)
Q Consensus 103 ~~~~~~lv~e~~~-~~l~~~l~~~~------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~ 175 (376)
..++|||||. |+|.+.+.... .....+++..+..++.|++.||.|||+ ++|+||||||+|||++. ++.
T Consensus 97 ---~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld~-~~~ 171 (308)
T d1p4oa_ 97 ---PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE-DFT 171 (308)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECT-TCC
T ss_pred ---ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeecC-Cce
Confidence 2789999998 57777665322 112346889999999999999999999 79999999999999996 788
Q ss_pred EEEEeecccccCccCCC---ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhC-CCCCCCCChHHHHHHHHH
Q 017147 176 VKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIK 251 (376)
Q Consensus 176 vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~ 251 (376)
+||+|||+|+....... .....+|+.|+|||.+.+. .++.++|||||||++|||+|| .+||.+.+..+.+..+.+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~ 250 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 99999999986544332 2334679999999999765 489999999999999999997 588998888877776654
Q ss_pred HhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc------CCCcccc
Q 017147 252 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA------HPFFDEL 323 (376)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~------hp~~~~~ 323 (376)
.... ..+..+++.+.+||.+||+.||++|||++++++ +|+|+++
T Consensus 251 ~~~~----------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 251 GGLL----------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300 (308)
T ss_dssp TCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred CCCC----------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence 2110 012347899999999999999999999999987 7777654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-48 Score=351.88 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=201.0
Q ss_pred cceeeeeeeeecCCCeeEEEEEEc-----CCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 017147 33 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 101 (376)
Q Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 101 (376)
.++|++.+.||+|+||.||+|+.+ .+++.||||++.... ....+|+.+++.+ +|||||++++++....
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~- 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG- 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC-
Confidence 468999999999999999999863 456789999986543 2234789999998 6999999999984433
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhh--------------hcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCc
Q 017147 102 KNELFLNLVMEYVPE-SMYRVLKHYS--------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 166 (376)
Q Consensus 102 ~~~~~~~lv~e~~~~-~l~~~l~~~~--------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~N 166 (376)
.+|+|||||++ ++...+.... .....+++..+..++.||+.||+|||+ +|++||||||+|
T Consensus 101 ----~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp~N 175 (311)
T d1t46a_ 101 ----PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN 175 (311)
T ss_dssp ----SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred ----EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccccccc
Confidence 38899999984 7777775432 123468999999999999999999999 799999999999
Q ss_pred EEEcCCCCcEEEEeecccccCccCCCc---eeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHh-CCCCCCCCCh
Q 017147 167 LLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 242 (376)
Q Consensus 167 ill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 242 (376)
|+++. ++.+|++|||.++........ ....+|+.|+|||++.+. .++.++|||||||++|+|+| |.+||.+.+.
T Consensus 176 Il~~~-~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 176 ILLTH-GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp EEEET-TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccc-cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 99996 788999999999876543322 235779999999999754 58999999999999999998 7788888777
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 243 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 243 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
.+.+.++++.-..+ ..+..+++++.+||.+||+.||.+|||++++++
T Consensus 254 ~~~~~~~i~~~~~~---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 254 DSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCCCC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 66666665531111 112347899999999999999999999999985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.1e-48 Score=346.74 Aligned_cols=249 Identities=18% Similarity=0.212 Sum_probs=198.8
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc--ccchHHHHHHHHhCCC-CceeeeceeeeecCCCCceEEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDH-PNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
++|++++.||+|+||+||+|+++.+|+.||||++... .....+|++.++.++| +|++.+++++.. ....|+|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeec-----CCccEEE
Confidence 5799999999999999999999999999999988543 3446789999999976 899998887733 3348899
Q ss_pred eecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcC----CCCcEEEEeeccccc
Q 017147 111 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP----LTHQVKICDFGSAKQ 186 (376)
Q Consensus 111 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~----~~~~vkl~Dfg~a~~ 186 (376)
|||++++|...+.. ....+++..+..++.|++.||+|||+ +||+||||||+|||++. ..+.+||+|||+|+.
T Consensus 80 me~~~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 80 IDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEecCCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99999998887753 44679999999999999999999999 79999999999999963 246799999999986
Q ss_pred CccCC--------CceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCC
Q 017147 187 LIAGE--------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGT 255 (376)
Q Consensus 187 ~~~~~--------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~ 255 (376)
..... ...+..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ......+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 54321 12345789999999999764 589999999999999999999999986543 2333333322111
Q ss_pred CCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 256 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
++.. .+..++|+++.+++..|+..+|++||+.+.+.+
T Consensus 235 ~~~~------------------------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 235 TPLR------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp SCHH------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CChH------------------------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1111 112347899999999999999999999876643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-48 Score=348.15 Aligned_cols=245 Identities=20% Similarity=0.288 Sum_probs=188.8
Q ss_pred eeeeeeeeecCCCeeEEEEEEcCCC---cEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 017147 35 SYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 106 (376)
Q Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 106 (376)
.+...++||+|+||+||+|.+..++ ..||||++.+. .....+|+++|++++||||+++++++.... ..
T Consensus 28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~ 103 (311)
T d1r0pa_ 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GS 103 (311)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TE
T ss_pred eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----Cc
Confidence 3444688999999999999987654 35899998542 133468999999999999999999875432 24
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 107 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 107 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
+++|||||++ ++.+++. .....+++..+..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 104 ~~lv~E~~~~g~l~~~~~---~~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~-~~~~kL~DFG~~~ 178 (311)
T d1r0pa_ 104 PLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLAR 178 (311)
T ss_dssp EEEEEECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEECSSGGGC
T ss_pred eEEEEEEeecCchhhhhc---cccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECC-CCCEEEecccchh
Confidence 7899999996 6555554 245567888899999999999999999 79999999999999996 7889999999998
Q ss_pred cCccCCC-----ceeeeeccccCchhhhhCCCCCCchhhhHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHH
Q 017147 186 QLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTRE 259 (376)
Q Consensus 186 ~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~ 259 (376)
....... .....||+.|+|||.+.+. .++.++|||||||++|||++|..||.... ..+....+.+. ..
T Consensus 179 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g--~~--- 252 (311)
T d1r0pa_ 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--RR--- 252 (311)
T ss_dssp CTTTTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT--CC---
T ss_pred hccccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--CC---
Confidence 6543322 2235678999999998654 58999999999999999999777665543 32333322221 00
Q ss_pred HHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017147 260 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 317 (376)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 317 (376)
...+..+++++.+||.+||+.||++|||+.|+++|
T Consensus 253 -----------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 253 -----------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01223478999999999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=342.46 Aligned_cols=267 Identities=22% Similarity=0.224 Sum_probs=187.1
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccccc-h--HHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-K--NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 110 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~--~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 110 (376)
.+|.+.+.||+|+||+||+|+. +|+.||||++..+... . +.|+..+..++||||+++++++.... .....+|+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEE
Confidence 5799999999999999999986 6899999998654322 2 23455556789999999999987654 334458899
Q ss_pred eecccc-hHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcC-------CCeeecCCCCCcEEEcCCCCcEEEEeec
Q 017147 111 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-------PRVCHRDLKPQNLLVDPLTHQVKICDFG 182 (376)
Q Consensus 111 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-------~~i~H~dlkp~Nill~~~~~~vkl~Dfg 182 (376)
||||++ +|...++. ..+++.....++.|++.||.|||+. +||+||||||+|||++. ++.+||+|||
T Consensus 80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~-~~~~Kl~DFG 153 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLG 153 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT-TSCEEECCCT
T ss_pred EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcC-CCCeEEEecC
Confidence 999985 88888753 4689999999999999999999962 49999999999999996 7889999999
Q ss_pred ccccCccCCC-----ceeeeeccccCchhhhhCCC-----CCCchhhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 017147 183 SAKQLIAGEA-----NISYICSRFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 252 (376)
Q Consensus 183 ~a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 252 (376)
+++....... .....||+.|+|||++.+.. .++.++|||||||++|||+||.+||........... ...
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~-~~~ 232 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-DLV 232 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-TTS
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh-hcc
Confidence 9986644332 23467899999999985432 256789999999999999999988743221100000 000
Q ss_pred hCCCCHHHHhhcCcCCCCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017147 253 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 316 (376)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 316 (376)
...+..+.+..... ....-|... ...........+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~--~~~~~p~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 233 PSDPSVEEMRKVVC--EQKLRPNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CSSCCHHHHHHHHT--TSCCCCCCC----GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cccchHHHHHHHHh--ccccCCCCC----cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 00001010000000 000000000 00001112346889999999999999999999976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=2.7e-25 Score=185.99 Aligned_cols=158 Identities=18% Similarity=0.116 Sum_probs=114.9
Q ss_pred eeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeeccc----------------------cchHHHHHHHHhCCCCceeeec
Q 017147 36 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------------------RYKNRELQLMRVMDHPNVISLK 93 (376)
Q Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------------------~~~~~e~~~l~~l~h~~iv~~~ 93 (376)
|.+++.||+|+||+||+|.+. +|+.||||++.... ....+|...+..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568899999999999999974 78999999864211 1112577888899999988876
Q ss_pred eeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCcCHHHHHHHHHHHHHHHHHhhcCCCeeecCCCCCcEEEcCCC
Q 017147 94 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 173 (376)
Q Consensus 94 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i~H~dlkp~Nill~~~~ 173 (376)
+.. . .+++|||+++... ..++...+..++.|++.|+.|||+ +||+||||||+|||+++
T Consensus 81 ~~~-----~----~~lvme~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~-- 138 (191)
T d1zara2 81 AWE-----G----NAVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSE-- 138 (191)
T ss_dssp EEE-----T----TEEEEECCCCEEG----------GGCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEET--
T ss_pred Eec-----C----CEEEEEeeccccc----------cchhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeeeC--
Confidence 542 1 2599999997411 124445567899999999999999 79999999999999985
Q ss_pred CcEEEEeecccccCccCCCceeeeeccccCc------hhhhhCCCCCCchhhhHhHHH
Q 017147 174 HQVKICDFGSAKQLIAGEANISYICSRFYRA------PELIFGATEYTTSIDIWSAGC 225 (376)
Q Consensus 174 ~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~a------PE~l~~~~~~~~~~DiwslG~ 225 (376)
..++|+|||.|......... .|.. .+.+ ...|+.++|+||+.-
T Consensus 139 ~~~~liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f--~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 139 EGIWIIDFPQSVEVGEEGWR-------EILERDVRNIITYF--SRTYRTEKDINSAID 187 (191)
T ss_dssp TEEEECCCTTCEETTSTTHH-------HHHHHHHHHHHHHH--HHHHCCCCCHHHHHH
T ss_pred CCEEEEECCCcccCCCCCcH-------HHHHHHHHHHHHHH--cCCCCCcccHHHHHH
Confidence 44999999998754322211 1111 1222 134789999999754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.11 E-value=7.1e-06 Score=69.66 Aligned_cols=76 Identities=17% Similarity=0.118 Sum_probs=49.1
Q ss_pred ceeeeeeeeecCCCeeEEEEEEcCCCcEEEEEEeecc----ccchHHHHHHHHhCC-CCceeeeceeeeecCCCCceEEE
Q 017147 34 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~ 108 (376)
..|++.+..+.++.+.||++. .+++.+.+|..... .....+|...++.+. +-.+.+++... ......+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~ 86 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSN 86 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceE
Confidence 467777766656668999886 36677888977543 224567888888774 22234444433 1223477
Q ss_pred EEeecccc
Q 017147 109 LVMEYVPE 116 (376)
Q Consensus 109 lv~e~~~~ 116 (376)
+||++++|
T Consensus 87 lv~~~l~G 94 (263)
T d1j7la_ 87 LLMSEADG 94 (263)
T ss_dssp EEEECCSS
T ss_pred EEEEeccc
Confidence 99999987
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.68 E-value=0.00019 Score=64.45 Aligned_cols=71 Identities=20% Similarity=0.130 Sum_probs=42.8
Q ss_pred eeeeecCCCeeEEEEEEcCCCcEEEEEEeecc-----------ccchHHHHHHHHhCC-C--CceeeeceeeeecCCCCc
Q 017147 39 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----------RRYKNRELQLMRVMD-H--PNVISLKHCFFSTTSKNE 104 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----------~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~~~~~~ 104 (376)
.+.||.|....||++.+..+++.+++|.-... ......|.+.|+.+. + ..+.+++. ++...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~--- 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEM--- 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTT---
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCC---
Confidence 45689999999999998777889999964321 112346888887663 2 23444433 22222
Q ss_pred eEEEEEeecccc
Q 017147 105 LFLNLVMEYVPE 116 (376)
Q Consensus 105 ~~~~lv~e~~~~ 116 (376)
.++|||++++
T Consensus 106 --~~lvmE~L~~ 115 (392)
T d2pula1 106 --AVTVMEDLSH 115 (392)
T ss_dssp --TEEEECCCTT
T ss_pred --CEEEEeccCC
Confidence 3489999974
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.65 E-value=0.00019 Score=60.18 Aligned_cols=69 Identities=13% Similarity=0.065 Sum_probs=42.9
Q ss_pred eecCC-CeeEEEEEEcCCCcEEEEEEeeccc-cchHHHHHHHHhCCCCc--eeeeceeeeecCCCCceEEEEEeecccc
Q 017147 42 VGTGS-FGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMDHPN--VISLKHCFFSTTSKNELFLNLVMEYVPE 116 (376)
Q Consensus 42 lg~G~-~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e~~~~ 116 (376)
+..|. .+.||++.. .++..+.+|...... .....|...++.+.... +.+++.+..+ ....++||++++|
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-----~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeeccc-----ccceEEEEEeeec
Confidence 34444 468898874 456778889765443 34567888888775433 3444443322 2236799999975
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.65 E-value=0.0046 Score=55.12 Aligned_cols=69 Identities=14% Similarity=0.222 Sum_probs=44.2
Q ss_pred eeeeecCCCeeEEEEEEcC-------CCcEEEEEEeecccc--chHHHHHHHHhCCCCcee-eeceeeeecCCCCceEEE
Q 017147 39 ERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDRR--YKNRELQLMRVMDHPNVI-SLKHCFFSTTSKNELFLN 108 (376)
Q Consensus 39 ~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~--~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~ 108 (376)
++.|+.|-.-.+|++.... ..+.|.+++...... ...+|..+++.+.-.++. +++..+ ++ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----c
Confidence 4568889999999998643 345678887653222 234788888877543443 454443 21 3
Q ss_pred EEeecccc
Q 017147 109 LVMEYVPE 116 (376)
Q Consensus 109 lv~e~~~~ 116 (376)
+|+||++|
T Consensus 118 ~I~efi~g 125 (395)
T d1nw1a_ 118 RLEEYIPS 125 (395)
T ss_dssp EEECCCCE
T ss_pred eEEEEecc
Confidence 78888875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.49 E-value=0.0085 Score=51.77 Aligned_cols=71 Identities=15% Similarity=-0.026 Sum_probs=40.5
Q ss_pred CCCeeEEEEEEcCCCcEEEEEEeecc---ccchHHHHHHHHhCCCCcee--eeceeeeecCCCCceEEEEEeecccc
Q 017147 45 GSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRVMDHPNVI--SLKHCFFSTTSKNELFLNLVMEYVPE 116 (376)
Q Consensus 45 G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~e~~~l~~l~h~~iv--~~~~~~~~~~~~~~~~~~lv~e~~~~ 116 (376)
+.-..||++.. .+|+.|++|+.... ...+..|...+..|....+. .....--........+.+.++++++|
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cccceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 33468999984 67889999987653 23455788888777533221 11111000000123446788888864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.29 E-value=0.012 Score=50.41 Aligned_cols=30 Identities=27% Similarity=0.203 Sum_probs=25.6
Q ss_pred CCeeecCCCCCcEEEcCCCCcEEEEeecccc
Q 017147 155 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 185 (376)
Q Consensus 155 ~~i~H~dlkp~Nill~~~~~~vkl~Dfg~a~ 185 (376)
.|++|+|+.++|++++. +...-|+||+.|.
T Consensus 183 ~giIHgDl~~dNvl~~~-~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLG-DELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred cccccCCcchhhhhccc-ccceeEecccccc
Confidence 58999999999999995 5556799999884
|